sampleid	sample_name	run_prefix	experimental_strategy	cgc_base_name	filename	analyte_amount	analyte_A260A280Ratio	aliquot_concentration	cgc_id	cgc_filename	vital_status	gender	race	ethnicity	disease_type	data_subtype	tcga_sample_id	cgc_case_uuid	sample_type	cgc_platform	gdc_file_uuid	primary_site	age_at_diagnosis	cgc_sample_uuid	cgc_aliquot_uuid	tcga_aliquot_id	reference_genome	tcga_case_id	investigation	days_to_death	knightlabID	data_submitting_center_label	tissue_source_site_label	country_of_sample_procurement	portion_is_ffpe	pathologic_t_label	pathologic_n_label	histological_diagnosis_label	pathologic_stage_label	PlateCenter	PlateCenterFlag
13722.58cfa82de4b0c9d6adf6a4c2	58cfa82de4b0c9d6adf6a4c2	12dd02ea14d0a87df23ce3bef406fe27.filtered.	WGS	12dd02ea14d0a87df23ce3bef406fe27	12dd02ea14d0a87df23ce3bef406fe27.bam	32.75	NA	0.08	58cfa82de4b0c9d6adf6a4c2	12dd02ea14d0a87df23ce3bef406fe27.bam	Dead	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-B6-A0I1-01A	5DD423E8-FEAA-4568-A750-500948C41D6C	Primary Tumor	Illumina HiSeq	30cac8b3-f09f-4eeb-8dff-e77e8b9c13fd	Breast	73	2A5F4696-6E02-4FE9-B66D-8C2AE93B7C2F	2290B078-6A5B-4C83-9DFB-B525BBF14E4E	TCGA-B6-A0I1-01A-11D-A21Q-09	GRCh37-lite	TCGA-B6-A0I1	TCGA-BRCA	2361	s5473	Washington University School of Medicine	Duke	United States	NO	T2	N0	Infiltrating Ductal Carcinoma	Stage IIA	A21Q-09	TRUE
13722.58cfa82de4b0c9d6adf6a502	58cfa82de4b0c9d6adf6a502	3d9f475186150ea055fddf25af7bb7e3.filtered.	WGS	3d9f475186150ea055fddf25af7bb7e3	3d9f475186150ea055fddf25af7bb7e3.bam	64.35	1.7	0.08	58cfa82de4b0c9d6adf6a502	3d9f475186150ea055fddf25af7bb7e3.bam	Alive	FEMALE	WHITE	HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-EY-A1GW-01A	F8AC5FD2-11F2-4B3A-A3A6-FF1A6D8E1CAE	Primary Tumor	Illumina HiSeq	b2829fb0-5912-46cd-a87b-e2dcbb14192d	Uterus	73	22CB3D87-7FAB-419A-B071-1ADC6B810719	EC31E921-0782-4F77-AC23-4190AF1E61EE	TCGA-EY-A1GW-01A-22D-A13L-09	GRCh37-lite	TCGA-EY-A1GW	TCGA-UCEC	NA	s4407	Washington University School of Medicine	University of North Carolina	United States	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A13L-09	FALSE
13722.58cfa82de4b0c9d6adf6a4ce	58cfa82de4b0c9d6adf6a4ce	2258e57e8e0af9db6969a1da86177ca7.filtered.	WGS	2258e57e8e0af9db6969a1da86177ca7	2258e57e8e0af9db6969a1da86177ca7.bam	62.02	2.08	0.08	58cfa82de4b0c9d6adf6a4ce	2258e57e8e0af9db6969a1da86177ca7.bam	Alive	FEMALE	ASIAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-AO-A03L-01A	1174F6E4-FFBE-4E59-A000-8D861C968369	Primary Tumor	Illumina HiSeq	e374014a-934d-4eee-b1e3-53ec285ea08e	Breast	34	00F81E98-E5C3-43B2-9757-F769EC17F3F8	8F558713-F32B-403B-AEDF-C79EFEB41C67	TCGA-AO-A03L-01A-41D-A19H-09	GRCh37-lite	TCGA-AO-A03L	TCGA-BRCA	NA	s6617	Washington University School of Medicine	MSKCC	None	NO	T3	N2	Infiltrating Ductal Carcinoma	Stage IIIA	A19H-09	TRUE
13722.58cfa82de4b0c9d6adf6a48a	58cfa82de4b0c9d6adf6a48a	142ba22e796cab1075278cd533a287c8.filtered.	WGS	142ba22e796cab1075278cd533a287c8	142ba22e796cab1075278cd533a287c8.bam	93.54	2.18	0.07	58cfa82de4b0c9d6adf6a48a	142ba22e796cab1075278cd533a287c8.bam	Alive	FEMALE	WHITE	Not available	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-AP-A0L9-01A	7B9947D5-E86B-4006-8890-EA5209584A88	Primary Tumor	Illumina HiSeq	56ea48ea-3024-42a8-9753-85711f00712f	Uterus	71	53D0521F-10D6-4F70-9277-D99025A6B963	2B78DE4E-4C8B-4ADF-A058-3DAE797E7881	TCGA-AP-A0L9-01A-11D-A066-09	GRCh37-lite	TCGA-AP-A0L9	TCGA-UCEC	NA	s4234	Washington University School of Medicine	MSKCC	None	NO	Not available	Not available	Serous endometrial adenocarcinoma	Not available	A066-09	TRUE
13722.58cfa82de4b0c9d6adf6a4d4	58cfa82de4b0c9d6adf6a4d4	406aecbc23505359850e57fbf05d5b67.filtered.	WGS	406aecbc23505359850e57fbf05d5b67	406aecbc23505359850e57fbf05d5b67.bam	85.32	1.85	0.08	58cfa82de4b0c9d6adf6a4d4	406aecbc23505359850e57fbf05d5b67.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	Not available	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-AP-A0LI-01A	E1E8DC66-467C-48A5-BE56-3DB4F665B9F1	Primary Tumor	Illumina HiSeq	626ae092-ba0a-4c13-b860-b407436bc53b	Uterus	67	981D9E3B-63C5-41E9-827F-7F1D268D62F4	DEC775C5-7D9A-4DC5-B399-DC4B7BA49D73	TCGA-AP-A0LI-01A-11D-A066-09	GRCh37-lite	TCGA-AP-A0LI	TCGA-UCEC	NA	s5189	Washington University School of Medicine	MSKCC	None	NO	Not available	Not available	Serous endometrial adenocarcinoma	Not available	A066-09	TRUE
13722.58cfa82de4b0c9d6adf6a529	58cfa82de4b0c9d6adf6a529	4aa512860ab86fb3f56ebdc8fcd69ce1.filtered.	WGS	4aa512860ab86fb3f56ebdc8fcd69ce1	4aa512860ab86fb3f56ebdc8fcd69ce1.bam	116.74	2	0.08	58cfa82de4b0c9d6adf6a529	4aa512860ab86fb3f56ebdc8fcd69ce1.bam	Alive	FEMALE	WHITE	Not available	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-AP-A0LE-01A	DCFF8659-ECCA-4798-80A3-DD6E7642BA2B	Primary Tumor	Illumina HiSeq	b5fe9da4-e8c6-4c5a-ae7f-b1227dcafe8f	Uterus	57	9C4A32CF-DE40-4996-91A9-56F1C18D69A4	638E80C7-9A6E-4A32-A621-FC4168E72343	TCGA-AP-A0LE-01A-11D-A127-09	GRCh37-lite	TCGA-AP-A0LE	TCGA-UCEC	NA	s4982	Washington University School of Medicine	MSKCC	None	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A127-09	FALSE
13722.58cfa82de4b0c9d6adf6a46d	58cfa82de4b0c9d6adf6a46d	0434f7930c67bd9c412cb31f2ada0466.filtered.	WGS	0434f7930c67bd9c412cb31f2ada0466	0434f7930c67bd9c412cb31f2ada0466.bam	27.89	1.93	0.08	58cfa82de4b0c9d6adf6a46d	0434f7930c67bd9c412cb31f2ada0466.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-BH-A18R-01A	F6E1EC78-5AD9-4879-9B7E-262D17B166AD	Primary Tumor	Illumina HiSeq	14062e7f-b11d-44a9-ae98-3383c517bf91	Breast	50	518BE2C7-FBA5-47B1-8C8B-FEF812FA74A4	9C70688D-6E43-4520-9262-EAAE4E4D597D	TCGA-BH-A18R-01A-11D-A19H-09	GRCh37-lite	TCGA-BH-A18R	TCGA-BRCA	1142	s6259	Washington University School of Medicine	University of Pittsburgh	None	NO	T2b	N1	Infiltrating Ductal Carcinoma	Stage IIA	A19H-09	TRUE
13722.58cfa82de4b0c9d6adf6a52c	58cfa82de4b0c9d6adf6a52c	08f5ca11eae517c5ad7ce14a801eaf99.filtered.	WGS	08f5ca11eae517c5ad7ce14a801eaf99	08f5ca11eae517c5ad7ce14a801eaf99.bam	46.2	1.89	0.07	58cfa82de4b0c9d6adf6a52c	08f5ca11eae517c5ad7ce14a801eaf99.bam	Alive	FEMALE	Not available	Not available	Breast Invasive Carcinoma	Aligned reads	TCGA-A8-A07I-01A	566792AE-F853-4A47-856D-F02CDCFCB18A	Primary Tumor	Illumina HiSeq	6453f2d2-c0d0-46ee-a131-4a59788bb4c3	Breast	69	0D2E50FA-DAEF-45A3-97B2-5D71AB03CFBF	A6C14EBC-81A2-44F7-AF87-2B7EC85E5696	TCGA-A8-A07I-01A-11D-A19H-09	GRCh37-lite	TCGA-A8-A07I	TCGA-BRCA	NA	s5784	Washington University School of Medicine	Indivumed	Germany	NO	T2	N2a	Infiltrating Ductal Carcinoma	Stage IIIA	A19H-09	TRUE
13722.58cfa82de4b0c9d6adf6a542	58cfa82de4b0c9d6adf6a542	161c6ea1a81d271566d819bb40703564.filtered.	WGS	161c6ea1a81d271566d819bb40703564	161c6ea1a81d271566d819bb40703564.bam	71.74	1.98	0.09	58cfa82de4b0c9d6adf6a542	161c6ea1a81d271566d819bb40703564.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-BG-A18C-01A	66E305CA-8A16-44F0-B837-85E529B7AD55	Primary Tumor	Illumina HiSeq	358cf81d-1664-4a81-9bdc-eddc1d95f8f4	Uterus	72	37F209B1-C738-441C-B205-EAEC4E2ADE4E	6E599FCC-D79A-4E0F-B451-C20768C989F9	TCGA-BG-A18C-01A-11D-A325-09	GRCh37-lite	TCGA-BG-A18C	TCGA-UCEC	NA	s5187	Washington University School of Medicine	University of Pittsburgh	None	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A325-09	TRUE
13722.58cfa82de4b0c9d6adf6a59b	58cfa82de4b0c9d6adf6a59b	63caf3c72c859d6a05579c2a05cead25.filtered.	WGS	63caf3c72c859d6a05579c2a05cead25	63caf3c72c859d6a05579c2a05cead25.bam	32.95	NA	0.08	58cfa82de4b0c9d6adf6a59b	63caf3c72c859d6a05579c2a05cead25.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-GM-A3XL-01A	65CAC997-4D39-4501-85EC-4FCB328A8EB5	Primary Tumor	Illumina HiSeq	77d3443d-1bf9-4867-89a2-65cc8e10141b	Breast	49	FED3A891-21BE-4196-B9EF-0BF7C8F976AA	B27D75BA-5989-4200-BFE9-F1B7D7CF8008	TCGA-GM-A3XL-01A-11D-A22X-09	GRCh37-lite	TCGA-GM-A3XL	TCGA-BRCA	NA	s6264	Washington University School of Medicine	MD Anderson	United States	NO	T2	N0 (i-)	Infiltrating Ductal Carcinoma	Stage IIA	A22X-09	FALSE
13722.58cfa82de4b0c9d6adf6a580	58cfa82de4b0c9d6adf6a580	2db39072c0d1914dea2d317877070812.filtered.	WGS	2db39072c0d1914dea2d317877070812	2db39072c0d1914dea2d317877070812.bam	81.48	1.85	0.08	58cfa82de4b0c9d6adf6a580	2db39072c0d1914dea2d317877070812.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-B6-A0I2-01A	328DFCB0-B5AE-43F2-BC87-DAD0AB3DF9E7	Primary Tumor	Illumina HiSeq	1f31bdc1-69ef-49bf-8200-d73661b23c67	Breast	45	47436CE0-438F-475B-AC0D-1972D0C5285E	A2D9325E-DA9D-42F1-A360-328D17ED492B	TCGA-B6-A0I2-01A-11D-A12L-09	GRCh37-lite	TCGA-B6-A0I2	TCGA-BRCA	NA	s5788	Washington University School of Medicine	Duke	United States	NO	T1c	N0 (i-)	Infiltrating Ductal Carcinoma	Stage IA	A12L-09	FALSE
13722.58cfa82de4b0c9d6adf6a556	58cfa82de4b0c9d6adf6a556	063d6bdd81ba674cf8ce55970b76bc7d.filtered.	WGS	063d6bdd81ba674cf8ce55970b76bc7d	063d6bdd81ba674cf8ce55970b76bc7d.bam	NA	NA	0.08	58cfa82de4b0c9d6adf6a556	063d6bdd81ba674cf8ce55970b76bc7d.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-AX-A05S-01A	3A4A6AFF-4720-41FC-A114-85F38610EBB1	Primary Tumor	Illumina HiSeq	982e6db1-dd32-43ea-821b-612393624334	Uterus	81	3D8F263F-6866-4B92-AAEE-743EC5514865	C082DC34-457E-40EC-8258-E11E8ED362C2	TCGA-AX-A05S-01A-11D-A013-09	GRCh37-lite	TCGA-AX-A05S	TCGA-UCEC	413	s5186	Washington University School of Medicine	Gynecologic Oncology Group	United States	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A013-09	TRUE
13722.58cfa82de4b0c9d6adf6a548	58cfa82de4b0c9d6adf6a548	0d9ef8b814476b334be08fe7ee6ea88c.filtered.	WGS	0d9ef8b814476b334be08fe7ee6ea88c	0d9ef8b814476b334be08fe7ee6ea88c.bam	66.73	2.23	0.07	58cfa82de4b0c9d6adf6a548	0d9ef8b814476b334be08fe7ee6ea88c.bam	Alive	FEMALE	Not available	Not available	Breast Invasive Carcinoma	Aligned reads	TCGA-A8-A075-01A	7861A5F2-8910-4BCB-9C34-F79C5ACD6E21	Primary Tumor	Illumina HiSeq	4d604b9e-e0ae-4c4e-b844-4c1d7924d75b	Breast	42	D3263082-946D-4420-8A63-8D67EEEE09C5	6C8E9197-FD16-4FED-BFDA-E349CAB26314	TCGA-A8-A075-01A-11D-A19H-09	GRCh37-lite	TCGA-A8-A075	TCGA-BRCA	NA	s6451	Washington University School of Medicine	Indivumed	Germany	NO	T2	N1a	Infiltrating Ductal Carcinoma	Stage IIB	A19H-09	TRUE
13722.58cfa82de4b0c9d6adf6a5a6	58cfa82de4b0c9d6adf6a5a6	5e03098f26dc684c1f21cc0094f04543.filtered.	WGS	5e03098f26dc684c1f21cc0094f04543	5e03098f26dc684c1f21cc0094f04543.bam	27.49	NA	0.08	58cfa82de4b0c9d6adf6a5a6	5e03098f26dc684c1f21cc0094f04543.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Sarcoma	Aligned reads	TCGA-DX-A3U6-01A	6201394F-B70E-4F14-9519-FF9D5F06EB09	Primary Tumor	Illumina HiSeq	d62aa69c-0aa5-4eab-b882-d3aca07cdd27	Mesenchymal	63	ACEA4025-F740-4A60-AD51-EAF61964256B	DB650EFF-4E2C-4CE3-9124-7697B6E03359	TCGA-DX-A3U6-01A-11D-A29N-09	GRCh37-lite	TCGA-DX-A3U6	TCGA-SARC	NA	s2341	Washington University School of Medicine	Memorial Sloan Kettering	United States	NO	Not available	Not available	Not available	Not available	A29N-09	FALSE
13722.58cfa82de4b0c9d6adf6a59d	58cfa82de4b0c9d6adf6a59d	6507fcb7033a99eba7d09d1768996237.filtered.	WGS	6507fcb7033a99eba7d09d1768996237	6507fcb7033a99eba7d09d1768996237.bam	128.45	2.03	0.08	58cfa82de4b0c9d6adf6a59d	6507fcb7033a99eba7d09d1768996237.bam	Dead	FEMALE	BLACK OR AFRICAN AMERICAN	Not available	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-AP-A0L8-01A	9AA8C2B4-DB32-4899-BF0C-D578CB175E90	Primary Tumor	Illumina HiSeq	13a692ca-4d87-484b-aec0-1562b201470f	Uterus	70	D1A7A58F-7A35-4A94-A337-051AE56DED00	15D597DE-D26C-4CE1-B0CB-077E39B55F30	TCGA-AP-A0L8-01A-11D-A066-09	GRCh37-lite	TCGA-AP-A0L8	TCGA-UCEC	1484	s5378	Washington University School of Medicine	MSKCC	None	NO	Not available	Not available	Serous endometrial adenocarcinoma	Not available	A066-09	TRUE
13722.58cfa82de4b0c9d6adf6a546	58cfa82de4b0c9d6adf6a546	0efe658adac35f9288ebc6e59891a34b.filtered.	WGS	0efe658adac35f9288ebc6e59891a34b	0efe658adac35f9288ebc6e59891a34b.bam	66.38	2	0.08	58cfa82de4b0c9d6adf6a546	0efe658adac35f9288ebc6e59891a34b.bam	Alive	FEMALE	WHITE	Not available	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-AP-A05A-01A	C350B53B-3C27-4B9E-8B57-D7B6A1205A1F	Primary Tumor	Illumina HiSeq	1e8db39a-fb8e-4aa5-8cce-962a219e02e7	Uterus	81	482153FB-E69D-4748-9CF4-E281EC141518	99696731-C88F-427B-975B-1D90013E63FF	TCGA-AP-A05A-01A-11D-A013-09	GRCh37-lite	TCGA-AP-A05A	TCGA-UCEC	NA	s4980	Washington University School of Medicine	MSKCC	None	NO	Not available	Not available	Serous endometrial adenocarcinoma	Not available	A013-09	TRUE
13722.58cfa82de4b0c9d6adf6a572	58cfa82de4b0c9d6adf6a572	29d8acadae6e2c6643400b1090ef29f2.filtered.	WGS	29d8acadae6e2c6643400b1090ef29f2	29d8acadae6e2c6643400b1090ef29f2.bam	61.59	1.88	0.08	58cfa82de4b0c9d6adf6a572	29d8acadae6e2c6643400b1090ef29f2.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-A1-A0SM-01A	784DE7AC-8424-42EB-83D4-A1BEBAA42B97	Primary Tumor	Illumina HiSeq	d1b482b0-0e66-4620-bc89-bfc93541735d	Breast	77	289F5433-4834-401F-9361-EFC8E883E630	546B982F-60D9-43DF-9761-09369AFBEE2D	TCGA-A1-A0SM-01A-11D-A19H-09	GRCh37-lite	TCGA-A1-A0SM	TCGA-BRCA	NA	s6111	Washington University School of Medicine	UCSF	United States	NO	T2	N0 (i-)	Infiltrating Ductal Carcinoma	Stage IIA	A19H-09	TRUE
13722.58cfa82de4b0c9d6adf6a5f2	58cfa82de4b0c9d6adf6a5f2	58c9640b867e208cc0db2f7a975b1c51.filtered.	WGS	58c9640b867e208cc0db2f7a975b1c51	58c9640b867e208cc0db2f7a975b1c51.bam	48.69	2.02	0.08	58cfa82de4b0c9d6adf6a5f2	58c9640b867e208cc0db2f7a975b1c51.bam	Alive	FEMALE	WHITE	Not available	Breast Invasive Carcinoma	Aligned reads	TCGA-BH-A0DT-01A	74F31744-0AED-4633-BEEC-4E203315F0B7	Primary Tumor	Illumina HiSeq	4ac2ec89-0e27-40ab-949e-6cb716b4d9e1	Breast	41	EB11D414-2F0E-44A1-843C-ECACC7212E91	30DBE353-86D5-40ED-84C2-DBDDF7BEB17B	TCGA-BH-A0DT-01A-21D-A12B-09	GRCh37-lite	TCGA-BH-A0DT	TCGA-BRCA	NA	s5480	Washington University School of Medicine	University of Pittsburgh	None	NO	T1c	N1a	Infiltrating Ductal Carcinoma	Stage IIA	A12B-09	FALSE
13722.58cfa82de4b0c9d6adf6a656	58cfa82de4b0c9d6adf6a656	801434f25120f36fe582c7906500e08e.filtered.	WGS	801434f25120f36fe582c7906500e08e	801434f25120f36fe582c7906500e08e.bam	21.21	NA	0.08	58cfa82de4b0c9d6adf6a656	801434f25120f36fe582c7906500e08e.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-A2-A3KC-01A	2D29A4AC-98E7-4663-9DD6-5681BC32AC2E	Primary Tumor	Illumina HiSeq	449d2c68-674e-4e86-89ff-574170845aa1	Breast	55	8318A9A4-E78E-4DB8-97C7-2CC733D0C512	F9F04E42-63A2-4EE1-ADE4-9E5BB5C20CDD	TCGA-A2-A3KC-01A-11D-A20S-09	GRCh37-lite	TCGA-A2-A3KC	TCGA-BRCA	NA	s5952	Washington University School of Medicine	Walter Reed	United States	NO	T2	N1a	Infiltrating Lobular Carcinoma	Stage IIB	A20S-09	FALSE
13722.58cfa82de4b0c9d6adf6a5d4	58cfa82de4b0c9d6adf6a5d4	5b90de51bbfaf67cf060a869713e0324.filtered.	WGS	5b90de51bbfaf67cf060a869713e0324	5b90de51bbfaf67cf060a869713e0324.bam	56.64	1.95	0.08	58cfa82de4b0c9d6adf6a5d4	5b90de51bbfaf67cf060a869713e0324.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-E2-A152-01A	A8015490-9740-45C9-8BD2-EB6D1BEEFC2E	Primary Tumor	Illumina HiSeq	fe904377-4375-437b-8774-c80f11c6e0ff	Breast	56	0EF32921-BB7A-4055-A6ED-E8CED5F824E4	8691C87F-2468-44BB-A670-3DCCD6DA33C6	TCGA-E2-A152-01A-11D-A19H-09	GRCh37-lite	TCGA-E2-A152	TCGA-BRCA	NA	s6915	Washington University School of Medicine	Roswell Park	None	NO	T1c	N0	Infiltrating Ductal Carcinoma	Stage I	A19H-09	TRUE
13722.58cfa82de4b0c9d6adf6a610	58cfa82de4b0c9d6adf6a610	6e5cc39dc99c646350c2188f42625edd.filtered.	WGS	6e5cc39dc99c646350c2188f42625edd	6e5cc39dc99c646350c2188f42625edd.bam	59.06	1.95	0.08	58cfa82de4b0c9d6adf6a610	6e5cc39dc99c646350c2188f42625edd.bam	Dead	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-C5-A0TN-01A	14C65927-B9DD-4EF6-9917-DB7BC431FF2F	Primary Tumor	Illumina HiSeq	f860da6f-1cec-4913-aa35-b32670a1734f	Cervix	21	59B0B757-7D08-4B3E-9974-FD02747D3665	945E6808-2887-4F32-AC32-8F9E00353BF6	TCGA-C5-A0TN-01A-21D-A200-09	GRCh37-lite	TCGA-C5-A0TN	TCGA-CESC	348	s1165	Washington University School of Medicine	Medical College of Wisconsin	United States	NO	T1b	N1	Cervical Squamous Cell Carcinoma	Not available	A200-09	TRUE
13722.58cfa82de4b0c9d6adf6a66b	58cfa82de4b0c9d6adf6a66b	6f9e6813a75e86e0dd1890966a4457d9.filtered.	WGS	6f9e6813a75e86e0dd1890966a4457d9	6f9e6813a75e86e0dd1890966a4457d9.bam	66.32	1.9	0.07	58cfa82de4b0c9d6adf6a66b	6f9e6813a75e86e0dd1890966a4457d9.bam	Alive	FEMALE	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-BS-A0U9-01B	5FFA2EC6-2D94-4B09-8FB9-3591CF38FA4F	Primary Tumor	Illumina HiSeq	47ea3545-65e4-4c78-8780-1377ec259db5	Uterus	59	99D6D536-AF2C-4C9B-9995-5B4032D54479	82BE6087-A491-42D4-9B48-6A10D1BACE18	TCGA-BS-A0U9-01B-21D-A10M-09	GRCh37-lite	TCGA-BS-A0U9	TCGA-UCEC	NA	s4413	Washington University School of Medicine	University of Hawaii	None	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A10M-09	FALSE
13722.58cfa82de4b0c9d6adf6a624	58cfa82de4b0c9d6adf6a624	52a567ba68a991f7946cfbf0a1803a67.filtered.	WGS	52a567ba68a991f7946cfbf0a1803a67	52a567ba68a991f7946cfbf0a1803a67.bam	71.56	1.94	0.09	58cfa82de4b0c9d6adf6a624	52a567ba68a991f7946cfbf0a1803a67.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-EY-A1GS-01A	C10B2885-70EA-4D32-BC48-8B85530DF702	Primary Tumor	Illumina HiSeq	e36825eb-c127-473a-a3d0-8c56a941a1a6	Uterus	71	99540910-61A1-434B-9937-216DFAC5F719	0C39C03A-EC84-42C6-BE69-8E98BC7A9F5A	TCGA-EY-A1GS-01A-11D-A13L-09	GRCh37-lite	TCGA-EY-A1GS	TCGA-UCEC	NA	s4236	Washington University School of Medicine	University of North Carolina	United States	NO	Not available	Not available	Serous endometrial adenocarcinoma	Not available	A13L-09	FALSE
13722.58cfa82de4b0c9d6adf6a60e	58cfa82de4b0c9d6adf6a60e	52cd8d256fb4230a57b9973428e5d8a4.filtered.	WGS	52cd8d256fb4230a57b9973428e5d8a4	52cd8d256fb4230a57b9973428e5d8a4.bam	35.28	1.85	0.07	58cfa82de4b0c9d6adf6a60e	52cd8d256fb4230a57b9973428e5d8a4.bam	Alive	FEMALE	Not available	Not available	Breast Invasive Carcinoma	Aligned reads	TCGA-A8-A092-01A	38A8B734-9ACC-42F9-B5B7-E51B0DFC6504	Primary Tumor	Illumina HiSeq	3a2d527a-e52b-426a-aad8-0a7691cf835b	Breast	48	8B5C7E4D-A220-4499-9E38-7DEACC1776A2	CC4F9175-A8C8-424A-99D7-8BD11CAE0E52	TCGA-A8-A092-01A-11D-A19H-09	GRCh37-lite	TCGA-A8-A092	TCGA-BRCA	NA	s6262	Washington University School of Medicine	Indivumed	Germany	NO	T2	N2a	Infiltrating Ductal Carcinoma	Stage IIIA	A19H-09	TRUE
13722.58cfa82de4b0c9d6adf6a676	58cfa82de4b0c9d6adf6a676	6e7789618e7259fb52cad2908f02f68b.filtered.	WGS	6e7789618e7259fb52cad2908f02f68b	6e7789618e7259fb52cad2908f02f68b.bam	43.84	1.95	0.08	58cfa82de4b0c9d6adf6a676	6e7789618e7259fb52cad2908f02f68b.bam	Dead	FEMALE	BLACK OR AFRICAN AMERICAN	Not available	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-AP-A052-01A	BD4284A7-260D-48B3-9B48-A1C578C30D27	Primary Tumor	Illumina HiSeq	94e31842-d1e3-47ad-bee2-70890b17580f	Uterus	59	33C21DCA-F3B3-48CD-9FC5-AD316598F23E	C75CC75A-7496-420F-B526-EA63C77E9839	TCGA-AP-A052-01A-11D-A013-09	GRCh37-lite	TCGA-AP-A052	TCGA-UCEC	669	s4769	Washington University School of Medicine	MSKCC	None	NO	Not available	Not available	Serous endometrial adenocarcinoma	Not available	A013-09	TRUE
13722.58cfa82de4b0c9d6adf6a6c0	58cfa82de4b0c9d6adf6a6c0	869d810ce565d6181a7a0471f851fd20.filtered.	WGS	869d810ce565d6181a7a0471f851fd20	869d810ce565d6181a7a0471f851fd20.bam	107.78	2.13	0.09	58cfa82de4b0c9d6adf6a6c0	869d810ce565d6181a7a0471f851fd20.bam	Alive	FEMALE	WHITE	Not available	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-B5-A0K8-01A	24118B8F-59FE-482A-AED3-7B1BDE1571B7	Primary Tumor	Illumina HiSeq	48423c41-27b2-43d8-8358-735f4bcd008a	Uterus	71	66184035-AF3E-4C2B-901A-0709C49DC54E	554B9439-7E11-43EC-8BC3-448C59100B9E	TCGA-B5-A0K8-01A-11D-A14K-09	GRCh37-lite	TCGA-B5-A0K8	TCGA-UCEC	NA	s4415	Washington University School of Medicine	Duke	United States	NO	Not available	Not available	Serous endometrial adenocarcinoma	Not available	A14K-09	FALSE
13722.58cfa82de4b0c9d6adf6a6d6	58cfa82de4b0c9d6adf6a6d6	91d578e349e51da30596c416f3e08405.filtered.	WGS	91d578e349e51da30596c416f3e08405	91d578e349e51da30596c416f3e08405.bam	56.8	1.82	0.08	58cfa82de4b0c9d6adf6a6d6	91d578e349e51da30596c416f3e08405.bam	Dead	FEMALE	WHITE	Not available	Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-C5-A1ML-01A	374F614A-BCD1-4283-AC6F-FC27DDC79987	Primary Tumor	Illumina HiSeq	897d140f-721c-4162-9f3e-e8b883560558	Cervix	49	F5495789-2C61-42F2-B6B6-A14E00D2F985	F658C350-FB89-4268-8A59-A07E365F4221	TCGA-C5-A1ML-01A-11D-A200-09	GRCh37-lite	TCGA-C5-A1ML	TCGA-CESC	636	s1355	Washington University School of Medicine	Medical College of Wisconsin	United States	NO	Not available	Not available	Cervical Squamous Cell Carcinoma	Not available	A200-09	TRUE
13722.58cfa82de4b0c9d6adf6a6ec	58cfa82de4b0c9d6adf6a6ec	9730009cb05430035cc9988462351cef.filtered.	WGS	9730009cb05430035cc9988462351cef	9730009cb05430035cc9988462351cef.bam	38.58	2.02	0.08	58cfa82de4b0c9d6adf6a6ec	9730009cb05430035cc9988462351cef.bam	Alive	FEMALE	Not available	Not available	Breast Invasive Carcinoma	Aligned reads	TCGA-AR-A0TX-01A	C364E81C-EB1E-4870-AB37-9C661F5F2E3D	Primary Tumor	Illumina HiSeq	e9fddd42-1948-4df8-ac61-4db49de8123f	Breast	64	D5ADAF35-04B1-4198-B308-F4720B3D6417	DDC7377D-82C3-480A-BE3C-3D1DA52C77D4	TCGA-AR-A0TX-01A-11D-A19H-09	GRCh37-lite	TCGA-AR-A0TX	TCGA-BRCA	NA	s5632	Washington University School of Medicine	Mayo	None	NO	T1	N1	Infiltrating Ductal Carcinoma	Stage IIA	A19H-09	TRUE
13722.58cfa82de4b0c9d6adf6a70c	58cfa82de4b0c9d6adf6a70c	9fd4a7bb1756a87afb37ac7a45bbe196.filtered.	WGS	9fd4a7bb1756a87afb37ac7a45bbe196	9fd4a7bb1756a87afb37ac7a45bbe196.bam	56.47	1.91	0.09	58cfa82de4b0c9d6adf6a70c	9fd4a7bb1756a87afb37ac7a45bbe196.bam	Dead	FEMALE	WHITE	Not available	Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-C5-A1BF-01B	262311A0-7A10-4934-8FBA-11EE581AD738	Primary Tumor	Illumina HiSeq	913cddd8-a6ed-4824-8b2c-02f3160028d6	Cervix	46	37670DB3-74D9-4176-BC34-65D2E062D1CB	7DC3E035-C7AE-4164-A62B-9C2460812B05	TCGA-C5-A1BF-01B-11D-A200-09	GRCh37-lite	TCGA-C5-A1BF	TCGA-CESC	570	s1169	Washington University School of Medicine	Medical College of Wisconsin	United States	NO	TX	N0	Cervical Squamous Cell Carcinoma	Not available	A200-09	TRUE
13722.58cfa82de4b0c9d6adf6a710	58cfa82de4b0c9d6adf6a710	G12519.TCGA-34-2600-01A-01D-0963-08.5.filtered.	WGS	G12519.TCGA-34-2600-01A-01D-0963-08.5	G12519.TCGA-34-2600-01A-01D-0963-08.5.bam	626	1.9	0.16	58cfa82de4b0c9d6adf6a710	G12519.TCGA-34-2600-01A-01D-0963-08.5.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-34-2600-01A	DA61857A-B00E-4A19-AB02-8FBB2EE56BEA	Primary Tumor	Illumina HiSeq	c9a14cf5-32b5-43f5-991f-26b83b6a7727	Lung	76	B0C827C6-B7EF-420B-9A6F-7E8B79C320CC	E9CB8877-8E83-46C0-93F0-EA20530C9400	TCGA-34-2600-01A-01D-0963-08	HG19_Broad_variant	TCGA-34-2600	TCGA-LUSC	1874	s10072	Broad Institute of MIT and Harvard	University of Pittsburgh	United States	NO	T1	N0	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage IA	0963-08	FALSE
13722.58cfa82de4b0c9d6adf6a6e0	58cfa82de4b0c9d6adf6a6e0	8acca8432df87fc66fbf834556f68a20.filtered.	WGS	8acca8432df87fc66fbf834556f68a20	8acca8432df87fc66fbf834556f68a20.bam	92.82	1.95	0.08	58cfa82de4b0c9d6adf6a6e0	8acca8432df87fc66fbf834556f68a20.bam	Alive	FEMALE	WHITE	Not available	Breast Invasive Carcinoma	Aligned reads	TCGA-A2-A04X-01A	733A2A0F-B37A-4B81-B49E-3C0F30D1EB37	Primary Tumor	Illumina HiSeq	055e605f-56b9-4ca6-8856-1f32ab8e34a6	Breast	34	ABFF5667-7EF4-46C1-AD34-CEABC27E7992	41F140B8-72B9-4AE3-8B25-6144D9F94D0F	TCGA-A2-A04X-01A-21D-A19H-09	GRCh37-lite	TCGA-A2-A04X	TCGA-BRCA	NA	s6767	Washington University School of Medicine	Walter Reed	None	NO	T2	N0 (i-)	Infiltrating Ductal Carcinoma	Stage IIA	A19H-09	TRUE
13722.58cfa82de4b0c9d6adf6a71a	58cfa82de4b0c9d6adf6a71a	G14855.TCGA-05-4389-01A-01D-1931-08.4.filtered.	WGS	G14855.TCGA-05-4389-01A-01D-1931-08.4	G14855.TCGA-05-4389-01A-01D-1931-08.4.bam	372.53	1.9	0.14	58cfa82de4b0c9d6adf6a71a	G14855.TCGA-05-4389-01A-01D-1931-08.4.bam	Alive	MALE	Not available	Not available	Lung Adenocarcinoma	Aligned reads	TCGA-05-4389-01A	A3DE401D-91FE-49A2-BB07-81C1A06506E6	Primary Tumor	Illumina HiSeq	0979871e-d324-4f7e-98da-f65ff17a74d7	Lung	70	ED61AC6A-F21F-4B88-928A-029340D4AEBD	14BF9BFB-14D6-4CAC-A556-828F680E8A15	TCGA-05-4389-01A-01D-1931-08	HG19_Broad_variant	TCGA-05-4389	TCGA-LUAD	NA	s11426	Broad Institute of MIT and Harvard	Indivumed	Germany	NO	T1	N0	Lung Adenocarcinoma Mixed Subtype	Stage IA	1931-08	TRUE
13722.58cfa82de4b0c9d6adf6a728	58cfa82de4b0c9d6adf6a728	G14857.TCGA-73-4666-01A-01D-1931-08.4.filtered.	WGS	G14857.TCGA-73-4666-01A-01D-1931-08.4	G14857.TCGA-73-4666-01A-01D-1931-08.4.bam	375.23	1.9	0.16	58cfa82de4b0c9d6adf6a728	G14857.TCGA-73-4666-01A-01D-1931-08.4.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-73-4666-01A	4C31127E-D095-4978-9DAC-35153C27F6ED	Primary Tumor	Illumina HiSeq	16906318-0783-402c-9f2c-b8e22348748c	Lung	52	5BAE2E45-6DBC-458C-A66F-702EB1AF7357	9FFCB7FA-424C-4F93-87A7-CE5E9053C613	TCGA-73-4666-01A-01D-1931-08	HG19_Broad_variant	TCGA-73-4666	TCGA-LUAD	NA	s10758	Broad Institute of MIT and Harvard	Roswell Park	United States	NO	T1	N0	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage IV	1931-08	TRUE
13722.58cfa82de4b0c9d6adf6a72c	58cfa82de4b0c9d6adf6a72c	G14858.TCGA-73-4659-01A-01D-1931-08.3.filtered.	WGS	G14858.TCGA-73-4659-01A-01D-1931-08.3	G14858.TCGA-73-4659-01A-01D-1931-08.3.bam	665.52	1.9	0.15	58cfa82de4b0c9d6adf6a72c	G14858.TCGA-73-4659-01A-01D-1931-08.3.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-73-4659-01A	CD0DC947-B708-464E-BEB7-954C9D4583E7	Primary Tumor	Illumina HiSeq	967b7c80-0ec2-4e5f-81fd-07bffeeeaa7f	Lung	66	C35A5ED1-1821-4077-BA1E-B972DFA3233B	53D32D8B-5649-42B0-8C52-2C39AF2A961B	TCGA-73-4659-01A-01D-1931-08	HG19_Broad_variant	TCGA-73-4659	TCGA-LUAD	711	s10973	Broad Institute of MIT and Harvard	Roswell Park	United States	NO	T2	N2	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage IIIA	1931-08	TRUE
13722.58cfa82de4b0c9d6adf6a73a	58cfa82de4b0c9d6adf6a73a	G14847.TCGA-05-4397-01A-01D-1931-08.6.filtered.	WGS	G14847.TCGA-05-4397-01A-01D-1931-08.6	G14847.TCGA-05-4397-01A-01D-1931-08.6.bam	573.23	1.9	0.14	58cfa82de4b0c9d6adf6a73a	G14847.TCGA-05-4397-01A-01D-1931-08.6.bam	Dead	MALE	Not available	Not available	Lung Adenocarcinoma	Aligned reads	TCGA-05-4397-01A	6DFD47D2-831A-4386-9051-F78199A16BB5	Primary Tumor	Illumina HiSeq	48ff480a-fd08-4db2-8ba6-ce90769d4811	Lung	65	C4C061CD-E926-400B-B18C-B47C234337CA	0B19BEE7-5281-4915-9D98-C20EB3E84ECF	TCGA-05-4397-01A-01D-1931-08	HG19_Broad_variant	TCGA-05-4397	TCGA-LUAD	731	s11424	Broad Institute of MIT and Harvard	Indivumed	Germany	NO	T2	N1	Lung Adenocarcinoma Mixed Subtype	Stage IIB	1931-08	TRUE
13722.58cfa82de4b0c9d6adf6a780	58cfa82de4b0c9d6adf6a780	G16920.TCGA-CZ-4856-01A-02D-2048-08.1.filtered.	WGS	G16920.TCGA-CZ-4856-01A-02D-2048-08.1	G16920.TCGA-CZ-4856-01A-02D-2048-08.1.bam	34.73	1.9	0.15	58cfa82de4b0c9d6adf6a780	G16920.TCGA-CZ-4856-01A-02D-2048-08.1.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-CZ-4856-01A	FCECAFA8-8B8B-4AE6-81BC-73ACF05B211A	Primary Tumor	Illumina HiSeq	11912043-5f81-4764-94e5-b6a0218a906c	Kidney	62	6F6C9F00-D6E5-452F-BA04-F77B146B780B	A7293FEF-B5D3-4572-A38B-5DC4F8A67C12	TCGA-CZ-4856-01A-02D-2048-08	HG19_Broad_variant	TCGA-CZ-4856	TCGA-KIRC	NA	s9935	Broad Institute of MIT and Harvard	Harvard	None	NO	T1b	N0	Kidney Clear Cell Renal Carcinoma	Stage I	2048-08	FALSE
13722.58cfa82de4b0c9d6adf6a740	58cfa82de4b0c9d6adf6a740	G14850.TCGA-49-4486-01A-01D-1931-08.3.filtered.	WGS	G14850.TCGA-49-4486-01A-01D-1931-08.3	G14850.TCGA-49-4486-01A-01D-1931-08.3.bam	142.53	1.9	0.14	58cfa82de4b0c9d6adf6a740	G14850.TCGA-49-4486-01A-01D-1931-08.3.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-49-4486-01A	61C655EC-52B5-453F-A6CC-B2ABA445B027	Primary Tumor	Illumina HiSeq	53a1d9af-aa10-4382-bfad-f13af3c6cab9	Lung	72	5AE9B10F-347C-48C3-90CD-9290055CFE4B	23D86395-9E20-4CF9-BF7E-F76544A1F772	TCGA-49-4486-01A-01D-1931-08	HG19_Broad_variant	TCGA-49-4486	TCGA-LUAD	2318	s10628	Broad Institute of MIT and Harvard	Johns Hopkins	United States	NO	T1	N0	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage IA	1931-08	TRUE
13722.58cfa82de4b0c9d6adf6a784	58cfa82de4b0c9d6adf6a784	G16922.TCGA-BP-5010-01A-02D-2048-08.1.filtered.	WGS	G16922.TCGA-BP-5010-01A-02D-2048-08.1	G16922.TCGA-BP-5010-01A-02D-2048-08.1.bam	227.73	1.9	0.14	58cfa82de4b0c9d6adf6a784	G16922.TCGA-BP-5010-01A-02D-2048-08.1.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-BP-5010-01A	9F5C0A43-D222-484A-9249-D288387DD7A1	Primary Tumor	Illumina HiSeq	5909062c-40ed-4237-b615-c18d204060eb	Kidney	63	4057D69A-52EF-451B-BD74-6436919970C9	A4F8305F-4409-4776-B34D-4878D18C8693	TCGA-BP-5010-01A-02D-2048-08	HG19_Broad_variant	TCGA-BP-5010	TCGA-KIRC	878	s8999	Broad Institute of MIT and Harvard	MSKCC	None	NO	T3a	N0	Kidney Clear Cell Renal Carcinoma	Stage III	2048-08	FALSE
13722.58cfa82ee4b0c9d6adf6a7e1	58cfa82ee4b0c9d6adf6a7e1	G25784.TCGA-91-6840-01A-11D-1945-08.3.filtered.	WGS	G25784.TCGA-91-6840-01A-11D-1945-08.3	G25784.TCGA-91-6840-01A-11D-1945-08.3.bam	315.7	1.9	0.05	58cfa82ee4b0c9d6adf6a7e1	G25784.TCGA-91-6840-01A-11D-1945-08.3.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-91-6840-01A	D5326429-9805-47F9-97B0-FBDA658E3F01	Primary Tumor	Illumina HiSeq	27c919e7-a635-4c6d-a12d-31d1ee814e12	Lung	59	AF744755-51EB-4DAF-9029-5CF88730B1DC	09BC8542-4EA1-4599-91B3-D606425B37E2	TCGA-91-6840-01A-11D-1945-08	HG19_Broad_variant	TCGA-91-6840	TCGA-LUAD	NA	s11430	Broad Institute of MIT and Harvard	ABS - IUPUI	United States	NO	T1b	N0	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage IA	1945-08	TRUE
13722.58cfa82ee4b0c9d6adf6a7ee	58cfa82ee4b0c9d6adf6a7ee	G26378.TCGA-02-2483-01A-01D-1494-08.1.filtered.	WGS	G26378.TCGA-02-2483-01A-01D-1494-08.1	G26378.TCGA-02-2483-01A-01D-1494-08.1.bam	264.7	1.9	0.05	58cfa82ee4b0c9d6adf6a7ee	G26378.TCGA-02-2483-01A-01D-1494-08.1.bam	Alive	MALE	ASIAN	NOT HISPANIC OR LATINO	Glioblastoma Multiforme	Aligned reads	TCGA-02-2483-01A	A2AC9937-F351-4D78-9261-264BF6C21E0C	Primary Tumor	Illumina HiSeq	8f0bfbe1-af94-4579-bcd2-696056315c1e	Brain	43	724D75C1-7F82-4208-8510-3E89F3679BDE	4D7F2C74-862B-4AAD-98E1-FA831F14A905	TCGA-02-2483-01A-01D-1494-08	HG19_Broad_variant	TCGA-02-2483	TCGA-GBM	NA	s14171	Broad Institute of MIT and Harvard	MD Anderson Cancer Center	None	NO	Not available	Not available	Untreated primary (de novo) GBM	Not available	1494-08	TRUE
13722.58cfa82ee4b0c9d6adf6a7e6	58cfa82ee4b0c9d6adf6a7e6	G25774.TCGA-05-5429-01A-01D-1625-08.2.filtered.	WGS	G25774.TCGA-05-5429-01A-01D-1625-08.2	G25774.TCGA-05-5429-01A-01D-1625-08.2.bam	670.7	1.9	0.05	58cfa82ee4b0c9d6adf6a7e6	G25774.TCGA-05-5429-01A-01D-1625-08.2.bam	Alive	MALE	Not available	Not available	Lung Adenocarcinoma	Aligned reads	TCGA-05-5429-01A	63BD2175-4B7C-44C9-AEF3-9EFC8F79837B	Primary Tumor	Illumina HiSeq	5860c273-a773-4f6a-b5a1-a2999bc37419	Lung	60	FBC90B42-7D26-456B-A166-41993A1D3F0D	37D0CF1B-1743-4852-8073-372B16B5C17D	TCGA-05-5429-01A-01D-1625-08	HG19_Broad_variant	TCGA-05-5429	TCGA-LUAD	NA	s10632	Broad Institute of MIT and Harvard	Indivumed	Germany	NO	T3	N2	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage IIIA	1625-08	FALSE
13722.58cfa82ee4b0c9d6adf6a894	58cfa82ee4b0c9d6adf6a894	G26383.TCGA-02-2485-01A-01D-1494-08.1.filtered.	WGS	G26383.TCGA-02-2485-01A-01D-1494-08.1	G26383.TCGA-02-2485-01A-01D-1494-08.1.bam	521.7	1.9	0.05	58cfa82ee4b0c9d6adf6a894	G26383.TCGA-02-2485-01A-01D-1494-08.1.bam	Alive	MALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Glioblastoma Multiforme	Aligned reads	TCGA-02-2485-01A	521EA765-1BD1-423D-A75D-091243DF37A9	Primary Tumor	Illumina HiSeq	fd79ff6d-c0aa-4d12-8e39-1e3f1aab26a2	Brain	53	5B5F7C1D-8F3D-4F35-8295-58BC3EEFEAB0	0332B017-17D5-4083-8FC4-9D6F8FDBBBDE	TCGA-02-2485-01A-01D-1494-08	HG19_Broad_variant	TCGA-02-2485	TCGA-GBM	NA	s14220	Broad Institute of MIT and Harvard	MD Anderson Cancer Center	None	NO	Not available	Not available	Untreated primary (de novo) GBM	Not available	1494-08	TRUE
13722.58cfa82ee4b0c9d6adf6a7ea	58cfa82ee4b0c9d6adf6a7ea	G23065.TCGA_BA_5153_01A_01D_2268_08.1.filtered.	WGS	G23065.TCGA_BA_5153_01A_01D_2268_08.1	G23065.TCGA_BA_5153_01A_01D_2268_08.1.bam	422.7	1.9	0.15	58cfa82ee4b0c9d6adf6a7ea	G23065.TCGA_BA_5153_01A_01D_2268_08.1.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-BA-5153-01A	B3631718-9E0A-454C-BEE1-8F36EBC509D8	Primary Tumor	Illumina HiSeq	29740348-2de4-44e6-bdb0-05a2fb2fd9eb	Head and Neck	51	2DC7070A-9C70-4BB1-9634-8C934BB9C8D1	24D2B176-B1AB-4789-B394-616B722E63DF	TCGA-BA-5153-01A-01D-2268-08	HG19_Broad_variant	TCGA-BA-5153	TCGA-HNSC	1762	s15484	Broad Institute of MIT and Harvard	UNC	None	NO	T2	NX	Head and Neck Squamous Cell Carcinoma	Not available	2268-08	TRUE
13722.58cfa82ee4b0c9d6adf6a8c2	58cfa82ee4b0c9d6adf6a8c2	G35154.TCGA-CS-6668-01A-11D-1893-08.2.filtered.	WGS	G35154.TCGA-CS-6668-01A-11D-1893-08.2	G35154.TCGA-CS-6668-01A-11D-1893-08.2.bam	220	1.9	0.05	58cfa82ee4b0c9d6adf6a8c2	G35154.TCGA-CS-6668-01A-11D-1893-08.2.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-CS-6668-01A	A5D3F3FB-6541-419D-B47E-720D438F1BFF	Primary Tumor	Illumina HiSeq	698a92bc-1d75-4e94-a533-d41f6a195e9b	Brain	57	C6784C8A-FA04-429D-9290-40BD95F2D94D	D414E076-DCB6-4EDF-ADEF-0ABDC57354EA	TCGA-CS-6668-01A-11D-1893-08	HG19_Broad_variant	TCGA-CS-6668	TCGA-LGG	NA	s8320	Broad Institute of MIT and Harvard	Thomas Jefferson University	United States	NO	Not available	Not available	Oligodendroglioma	Not available	1893-08	FALSE
13722.58cfa82ee4b0c9d6adf6a950	58cfa82ee4b0c9d6adf6a950	G32522.TCGA-BJ-A191-01A-11D-A13W-08.1.filtered.	WGS	G32522.TCGA-BJ-A191-01A-11D-A13W-08.1	G32522.TCGA-BJ-A191-01A-11D-A13W-08.1.bam	110.16	1.93	0.09	58cfa82ee4b0c9d6adf6a950	G32522.TCGA-BJ-A191-01A-11D-A13W-08.1.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-BJ-A191-01A	2501EE46-8D38-448B-8765-E9C9706CBBE8	Primary Tumor	Illumina HiSeq	fe7c5f35-ecea-4165-8fa8-7a178959b096	Thyroid	49	C92FC4E3-7A96-4000-A969-AA894CA58A33	64C2E6A0-2341-49C4-A6DD-656E7BB505DD	TCGA-BJ-A191-01A-11D-A13W-08	HG19_Broad_variant	TCGA-BJ-A191	TCGA-THCA	NA	s11973	Broad Institute of MIT and Harvard	University of Pittsburgh	United States	NO	T1b	N0	Other  specify	Stage I	A13W-08	TRUE
13722.58cfa82ee4b0c9d6adf6a8c4	58cfa82ee4b0c9d6adf6a8c4	G35154.TCGA-E1-5318-01A-01D-1468-08.1.filtered.	WGS	G35154.TCGA-E1-5318-01A-01D-1468-08.1	G35154.TCGA-E1-5318-01A-01D-1468-08.1.bam	161	1.9	0.05	58cfa82ee4b0c9d6adf6a8c4	G35154.TCGA-E1-5318-01A-01D-1468-08.1.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-E1-5318-01A	400B2FA3-BAF7-4BAA-99B4-88B9F25B5049	Primary Tumor	Illumina HiSeq	0fc8cc9a-c3ea-48d6-8f7d-18ab9b69ffb1	Brain	42	EDC32A96-F912-4348-80D4-72D08129DB53	8C46A1DF-1C10-4188-992A-A55B782494C9	TCGA-E1-5318-01A-01D-1468-08	HG19_Broad_variant	TCGA-E1-5318	TCGA-LGG	2379	s8326	Broad Institute of MIT and Harvard	Duke	United States	NO	Not available	Not available	Oligodendroglioma	Not available	1468-08	FALSE
13722.58cfa82ee4b0c9d6adf6a9d8	58cfa82ee4b0c9d6adf6a9d8	G25252.TCGA-CV-7416-01A-11D-2334-08.1.filtered.	WGS	G25252.TCGA-CV-7416-01A-11D-2334-08.1	G25252.TCGA-CV-7416-01A-11D-2334-08.1.bam	242.7	NA	0.05	58cfa82ee4b0c9d6adf6a9d8	G25252.TCGA-CV-7416-01A-11D-2334-08.1.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-7416-01A	96415324-6859-41EB-8D07-BE4E6F7D9781	Primary Tumor	Illumina HiSeq	1374c517-8c54-4a22-80e6-0f48eb1d4de6	Head and Neck	29	2E08CFFB-DA11-40A5-81AB-3B1BFFA5E2CE	2738B06F-155B-4CB8-983B-AD61D451E5AE	TCGA-CV-7416-01A-11D-2334-08	HG19_Broad_variant	TCGA-CV-7416	TCGA-HNSC	763	s15604	Broad Institute of MIT and Harvard	MD Anderson Cancer Center	United States	NO	T4a	Not available	Head and Neck Squamous Cell Carcinoma	Stage IVA	2334-08	FALSE
13722.58cfa82ee4b0c9d6adf6a9ee	58cfa82ee4b0c9d6adf6a9ee	G26398.TCGA-06-5411-01A-01D-1696-08.2.filtered.	WGS	G26398.TCGA-06-5411-01A-01D-1696-08.2	G26398.TCGA-06-5411-01A-01D-1696-08.2.bam	407.03	1.9	0.05	58cfa82ee4b0c9d6adf6a9ee	G26398.TCGA-06-5411-01A-01D-1696-08.2.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Glioblastoma Multiforme	Aligned reads	TCGA-06-5411-01A	3F960D3B-A58C-43D0-A8A4-F3555B399C9D	Primary Tumor	Illumina HiSeq	a5235cf1-9584-4e39-be51-b383765f3fec	Brain	51	7790FA3D-C06F-4C74-B180-CA6D4F53DC7D	2FDAB641-D73B-4F9A-AA4C-C1944F131A69	TCGA-06-5411-01A-01D-1696-08	HG19_Broad_variant	TCGA-06-5411	TCGA-GBM	254	s14170	Broad Institute of MIT and Harvard	Henry Ford Hospital	None	NO	Not available	Not available	Untreated primary (de novo) GBM	Not available	1696-08	FALSE
13722.58cfa82ee4b0c9d6adf6a997	58cfa82ee4b0c9d6adf6a997	G25787.TCGA-78-7156-01A-11D-2036-08.1.filtered.	WGS	G25787.TCGA-78-7156-01A-11D-2036-08.1	G25787.TCGA-78-7156-01A-11D-2036-08.1.bam	405.7	NA	0.05	58cfa82ee4b0c9d6adf6a997	G25787.TCGA-78-7156-01A-11D-2036-08.1.bam	Dead	MALE	WHITE	Not available	Lung Adenocarcinoma	Aligned reads	TCGA-78-7156-01A	7B0622AB-63EA-483F-AE40-D3EA587BDBBA	Primary Tumor	Illumina HiSeq	f02c1668-47cc-4ebd-a656-5c2a70f1ae9f	Lung	62	FAB452A2-A57A-4D63-80BC-2AD2B5A20F03	D17EDA6C-B986-4BA3-B0E9-BAC7A751C26A	TCGA-78-7156-01A-11D-2036-08	HG19_Broad_variant	TCGA-78-7156	TCGA-LUAD	976	s10761	Broad Institute of MIT and Harvard	Prince Charles Hospital	Australia	NO	T4	N1	Lung Adenocarcinoma Mixed Subtype	Stage IV	2036-08	TRUE
13722.58cfa82ee4b0c9d6adf6a95a	58cfa82ee4b0c9d6adf6a95a	G23063.TCGA_CR_7385_01A_11D_2268_08.1.filtered.	WGS	G23063.TCGA_CR_7385_01A_11D_2268_08.1	G23063.TCGA_CR_7385_01A_11D_2268_08.1.bam	289.7	NA	0.15	58cfa82ee4b0c9d6adf6a95a	G23063.TCGA_CR_7385_01A_11D_2268_08.1.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CR-7385-01A	9F89510C-ED07-471F-B35E-7C87C237B9FE	Primary Tumor	Illumina HiSeq	0d321573-5651-4eb3-9f8c-a11f802e5e92	Head and Neck	42	4C4A6867-BABE-4032-A639-A9B31CDDDC6C	6BBD66DD-EFEE-4D6E-B02F-F88E98526B82	TCGA-CR-7385-01A-11D-2268-08	HG19_Broad_variant	TCGA-CR-7385	TCGA-HNSC	NA	s15605	Broad Institute of MIT and Harvard	Vanderbilt University	United States	NO	T1	NX	Head and Neck Squamous Cell Carcinoma	Not available	2268-08	TRUE
13722.58cfa82ee4b0c9d6adf6a9f6	58cfa82ee4b0c9d6adf6a9f6	G32526.TCGA-EL-A3TB-01A-11D-A22D-08.2.filtered.	WGS	G32526.TCGA-EL-A3TB-01A-11D-A22D-08.2	G32526.TCGA-EL-A3TB-01A-11D-A22D-08.2.bam	42.57	NA	0.07	58cfa82ee4b0c9d6adf6a9f6	G32526.TCGA-EL-A3TB-01A-11D-A22D-08.2.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-EL-A3TB-01A	A09D0BE0-FD41-4B30-B488-9A9F2ABEF8E7	Primary Tumor	Illumina HiSeq	3b8dc42d-2715-4480-a0f4-7595b3520131	Thyroid	47	11671156-4BBF-4A3C-B074-7D6C27EE4FEE	0567D3E6-6278-4D0A-81AE-C084D73C6DD3	TCGA-EL-A3TB-01A-11D-A22D-08	HG19_Broad_variant	TCGA-EL-A3TB	TCGA-THCA	NA	s12084	Broad Institute of MIT and Harvard	MD Anderson	United States	NO	T3	N1a	Thyroid Papillary Carcinoma - Classical/usual	Stage III	A22D-08	TRUE
13722.58cfa82ee4b0c9d6adf6aa58	58cfa82ee4b0c9d6adf6aa58	G32530.TCGA-EM-A3AQ-01A-11D-A20C-08.1.filtered.	WGS	G32530.TCGA-EM-A3AQ-01A-11D-A20C-08.1	G32530.TCGA-EM-A3AQ-01A-11D-A20C-08.1.bam	59.1	NA	0.08	58cfa82ee4b0c9d6adf6aa58	G32530.TCGA-EM-A3AQ-01A-11D-A20C-08.1.bam	Alive	FEMALE	Not available	Not available	Thyroid Carcinoma	Aligned reads	TCGA-EM-A3AQ-01A	E8F56D0F-EEE4-4DEF-A43A-DEC91F4382A1	Primary Tumor	Illumina HiSeq	c13857f7-bb38-4650-9294-ad8287c6c137	Thyroid	85	E13C3F11-913D-4371-9A7D-5E4DF15FB42A	DBACC1AD-C88A-4BCF-A45F-E9C83C762164	TCGA-EM-A3AQ-01A-11D-A20C-08	HG19_Broad_variant	TCGA-EM-A3AQ	TCGA-THCA	NA	s12215	Broad Institute of MIT and Harvard	University Health Network	Canada	NO	T1b	N0	Thyroid Papillary Carcinoma - Classical/usual	Stage I	A20C-08	FALSE
13722.58cfa82ee4b0c9d6adf6aa12	58cfa82ee4b0c9d6adf6aa12	G26396.TCGA-41-5651-01A-01D-1696-08.1.filtered.	WGS	G26396.TCGA-41-5651-01A-01D-1696-08.1	G26396.TCGA-41-5651-01A-01D-1696-08.1.bam	350.03	1.9	0.05	58cfa82ee4b0c9d6adf6aa12	G26396.TCGA-41-5651-01A-01D-1696-08.1.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Glioblastoma Multiforme	Aligned reads	TCGA-41-5651-01A	C184C3CA-7AD3-4202-B108-CB9FD5F5D947	Primary Tumor	Illumina HiSeq	cdec514c-a32f-496a-81c5-cde0ec0a3b5c	Brain	59	90F74516-FB74-4D3F-9D73-5D2BEE2ED381	5FD77BA9-5015-4D8B-86A0-582E5C76BDD6	TCGA-41-5651-01A-01D-1696-08	HG19_Broad_variant	TCGA-41-5651	TCGA-GBM	NA	s14304	Broad Institute of MIT and Harvard	Christiana Healthcare	None	NO	Not available	Not available	Untreated primary (de novo) GBM	Not available	1696-08	FALSE
13722.58cfa82ee4b0c9d6adf6aa18	58cfa82ee4b0c9d6adf6aa18	G26362.TCGA-06-0157-01A-01D-1491-08.1.filtered.	WGS	G26362.TCGA-06-0157-01A-01D-1491-08.1	G26362.TCGA-06-0157-01A-01D-1491-08.1.bam	331.7	1.89	0.05	58cfa82ee4b0c9d6adf6aa18	G26362.TCGA-06-0157-01A-01D-1491-08.1.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Glioblastoma Multiforme	Aligned reads	TCGA-06-0157-01A	EA3B5DA2-6A12-400C-BF0F-E442F5EC1132	Primary Tumor	Illumina HiSeq	a1c991b7-fe00-4252-815c-ac64d737bcff	Brain	63	BD8A1623-5006-4E03-9EB7-0C5A6F9E73D0	B1E62D8E-24D2-4118-8CD0-3142ACEBDD5B	TCGA-06-0157-01A-01D-1491-08	HG19_Broad_variant	TCGA-06-0157	TCGA-GBM	97	s14345	Broad Institute of MIT and Harvard	Henry Ford Hospital	None	NO	Not available	Not available	Untreated primary (de novo) GBM	Not available	1491-08	FALSE
13722.58cfa82ee4b0c9d6adf6aab6	58cfa82ee4b0c9d6adf6aab6	G32450.TCGA-FD-A3N5-01A-11D-A21A-08.3.filtered.	WGS	G32450.TCGA-FD-A3N5-01A-11D-A21A-08.3	G32450.TCGA-FD-A3N5-01A-11D-A21A-08.3.bam	30.45	NA	0.08	58cfa82ee4b0c9d6adf6aab6	G32450.TCGA-FD-A3N5-01A-11D-A21A-08.3.bam	Alive	MALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-FD-A3N5-01A	A658BECF-3934-49F2-9E74-291DCA61D4BB	Primary Tumor	Illumina HiSeq	3519f8d9-0eab-45e8-b398-5ddc469243cd	Bladder	69	66559B5F-AB2F-406B-9EDB-0F5085EEC7C5	418A3DEC-96FF-4719-BECB-E1A8260CCE2F	TCGA-FD-A3N5-01A-11D-A21A-08	HG19_Broad_variant	TCGA-FD-A3N5	TCGA-BLCA	NA	s2677	Broad Institute of MIT and Harvard	BLN - University Of Chicago	United States	NO	T2b	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage II	A21A-08	TRUE
13722.58cfa82ee4b0c9d6adf6aade	58cfa82ee4b0c9d6adf6aade	G32461.TCGA-BT-A3PJ-01A-21D-A21Z-08.1.filtered.	WGS	G32461.TCGA-BT-A3PJ-01A-21D-A21Z-08.1	G32461.TCGA-BT-A3PJ-01A-21D-A21Z-08.1.bam	55.89	NA	0.07	58cfa82ee4b0c9d6adf6aade	G32461.TCGA-BT-A3PJ-01A-21D-A21Z-08.1.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-BT-A3PJ-01A	CB664EEF-BE6F-44EF-AA90-6F6DA0E6440A	Primary Tumor	Illumina HiSeq	d7aa3a92-c61a-478e-af73-14d0204cba5d	Bladder	76	29D79B83-FA80-490E-A8A1-C51C9AD061FE	B73523D7-F5A5-4140-8537-4DF4D1ECF465	TCGA-BT-A3PJ-01A-21D-A21Z-08	HG19_Broad_variant	TCGA-BT-A3PJ	TCGA-BLCA	NA	s3071	Broad Institute of MIT and Harvard	University of Pittsburgh	United States	NO	T3a	N3	Muscle invasive urothelial carcinoma (pT2 or above)	Stage III	A21Z-08	TRUE
13722.58cfa82ee4b0c9d6adf6aa8c	58cfa82ee4b0c9d6adf6aa8c	G32527.TCGA-FE-A3PD-01A-11D-A21Z-08.1.filtered.	WGS	G32527.TCGA-FE-A3PD-01A-11D-A21Z-08.1	G32527.TCGA-FE-A3PD-01A-11D-A21Z-08.1.bam	59.24	NA	0.08	58cfa82ee4b0c9d6adf6aa8c	G32527.TCGA-FE-A3PD-01A-11D-A21Z-08.1.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-FE-A3PD-01A	39D90499-8549-4DA5-B391-C421F18FACF1	Primary Tumor	Illumina HiSeq	afcdae7e-5422-4f04-a64d-6bbdf39605aa	Thyroid	17	A6C23CA9-E6F4-4A2C-BB86-25EF76076381	5BDCA282-C671-48FF-B32B-2380996016C0	TCGA-FE-A3PD-01A-11D-A21Z-08	HG19_Broad_variant	TCGA-FE-A3PD	TCGA-THCA	NA	s12339	Broad Institute of MIT and Harvard	Ohio State University	United States	NO	T2	N0	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	Stage I	A21Z-08	TRUE
13722.58cfa82ee4b0c9d6adf6aae4	58cfa82ee4b0c9d6adf6aae4	G32464.TCGA-BT-A20P-01A-11D-A14W-08.1.filtered.	WGS	G32464.TCGA-BT-A20P-01A-11D-A14W-08.1	G32464.TCGA-BT-A20P-01A-11D-A14W-08.1.bam	75.72	2.03	0.08	58cfa82ee4b0c9d6adf6aae4	G32464.TCGA-BT-A20P-01A-11D-A14W-08.1.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-BT-A20P-01A	F48937ED-E294-41F0-8872-7010391167A9	Primary Tumor	Illumina HiSeq	d714be1b-c30c-4f13-8a00-4bf93507bb1c	Bladder	81	6B43EEEC-4FEB-4062-827A-E63ED8CE3820	E6C78A98-F45B-482B-A551-4F11B8C1FF8B	TCGA-BT-A20P-01A-11D-A14W-08	HG19_Broad_variant	TCGA-BT-A20P	TCGA-BLCA	544	s3394	Broad Institute of MIT and Harvard	University of Pittsburgh	United States	NO	T3a	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage III	A14W-08	TRUE
13722.58cfa82ee4b0c9d6adf6ab28	58cfa82ee4b0c9d6adf6ab28	G26381.TCGA-14-1823-01A-01D-1494-08.1.filtered.	WGS	G26381.TCGA-14-1823-01A-01D-1494-08.1	G26381.TCGA-14-1823-01A-01D-1494-08.1.bam	365.37	1.91	0.05	58cfa82ee4b0c9d6adf6ab28	G26381.TCGA-14-1823-01A-01D-1494-08.1.bam	Dead	FEMALE	WHITE	Not available	Glioblastoma Multiforme	Aligned reads	TCGA-14-1823-01A	A515CF2D-E918-4958-9BF6-E611B425A97E	Primary Tumor	Illumina HiSeq	38fe2fc2-ccf1-494b-89f0-54ed8a5a213c	Brain	58	7EAD0574-478A-4FE1-AABE-34965101B05D	4A1AD661-F6AE-44E8-B50B-72FF658FF22B	TCGA-14-1823-01A-01D-1494-08	HG19_Broad_variant	TCGA-14-1823	TCGA-GBM	543	s13928	Broad Institute of MIT and Harvard	Emory University	None	NO	Not available	Not available	Untreated primary (de novo) GBM	Not available	1494-08	TRUE
13722.58cfa82ee4b0c9d6adf6ab42	58cfa82ee4b0c9d6adf6ab42	G32525.TCGA-DJ-A13W-01A-11D-A10S-08.3.filtered.	WGS	G32525.TCGA-DJ-A13W-01A-11D-A10S-08.3	G32525.TCGA-DJ-A13W-01A-11D-A10S-08.3.bam	50.62	1.95	0.08	58cfa82ee4b0c9d6adf6ab42	G32525.TCGA-DJ-A13W-01A-11D-A10S-08.3.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-DJ-A13W-01A	3B48CC5E-3396-4DD5-893D-54B75B98B016	Primary Tumor	Illumina HiSeq	2a8caa63-ca28-490f-8b5c-13db08afd1c8	Thyroid	45	4DCA97A5-B0E5-4383-8CC5-B6FF07741647	0C18A8B7-BAD1-4AA4-A6DF-472F89D9761C	TCGA-DJ-A13W-01A-11D-A10S-08	HG19_Broad_variant	TCGA-DJ-A13W	TCGA-THCA	NA	s12736	Broad Institute of MIT and Harvard	Memorial Sloan Kettering	United States	NO	T1b	N0	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	Stage I	A10S-08	TRUE
13722.58cfa82ee4b0c9d6adf6ab62	58cfa82ee4b0c9d6adf6ab62	G26402.TCGA-06-2570-01A-01D-1495-08.1.filtered.	WGS	G26402.TCGA-06-2570-01A-01D-1495-08.1	G26402.TCGA-06-2570-01A-01D-1495-08.1.bam	502.7	1.9	0.05	58cfa82ee4b0c9d6adf6ab62	G26402.TCGA-06-2570-01A-01D-1495-08.1.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Glioblastoma Multiforme	Aligned reads	TCGA-06-2570-01A	B37D944C-C65C-46D6-BB8B-3EB37CB85B68	Primary Tumor	Illumina HiSeq	c73a5a07-9d52-4d32-a3bc-1c70f3116562	Brain	21	42200DBC-8248-461D-BF90-5386360213A9	04339769-517C-448D-A7CA-951F83608C60	TCGA-06-2570-01A-01D-1495-08	HG19_Broad_variant	TCGA-06-2570	TCGA-GBM	NA	s13893	Broad Institute of MIT and Harvard	Henry Ford Hospital	None	NO	Not available	Not available	Untreated primary (de novo) GBM	Not available	1495-08	FALSE
13722.58cfa82ee4b0c9d6adf6ab00	58cfa82ee4b0c9d6adf6ab00	G26405.TCGA-14-2554-01A-01D-1494-08.1.filtered.	WGS	G26405.TCGA-14-2554-01A-01D-1494-08.1	G26405.TCGA-14-2554-01A-01D-1494-08.1.bam	335.7	1.9	0.05	58cfa82ee4b0c9d6adf6ab00	G26405.TCGA-14-2554-01A-01D-1494-08.1.bam	Dead	FEMALE	WHITE	Not available	Glioblastoma Multiforme	Aligned reads	TCGA-14-2554-01A	B1C4579C-72FA-4974-830C-B6A81ACE45F4	Primary Tumor	Illumina HiSeq	88f8661f-2c61-4518-94b2-eae9bec254e6	Brain	52	E8013962-7049-4596-AA49-E6403F608D98	53DEC97D-0464-4FFD-8E2E-95B2B9A03AF0	TCGA-14-2554-01A-01D-1494-08	HG19_Broad_variant	TCGA-14-2554	TCGA-GBM	532	s14371	Broad Institute of MIT and Harvard	Emory University	None	NO	Not available	Not available	Untreated primary (de novo) GBM	Not available	1494-08	TRUE
13722.58cfa82ee4b0c9d6adf6aba2	58cfa82ee4b0c9d6adf6aba2	G26376.TCGA-27-2523-01A-01D-1494-08.1.filtered.	WGS	G26376.TCGA-27-2523-01A-01D-1494-08.1	G26376.TCGA-27-2523-01A-01D-1494-08.1.bam	742.7	1.9	0.05	58cfa82ee4b0c9d6adf6aba2	G26376.TCGA-27-2523-01A-01D-1494-08.1.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Glioblastoma Multiforme	Aligned reads	TCGA-27-2523-01A	737B35E1-D668-4FCE-9B6E-76946C7952B6	Primary Tumor	Illumina HiSeq	6359c1e1-c29c-4c79-a8ae-237f7a11a242	Brain	63	96881D37-7A3E-4910-B897-19453118FE7C	D60F54F5-B154-42C4-99FB-CEA4E7A33DC7	TCGA-27-2523-01A-01D-1494-08	HG19_Broad_variant	TCGA-27-2523	TCGA-GBM	489	s13892	Broad Institute of MIT and Harvard	Milan - Italy, Fondazione IRCCS Instituto Neuroligico C. Besta	None	NO	Not available	Not available	Untreated primary (de novo) GBM	Not available	1494-08	TRUE
13722.58cfa82ee4b0c9d6adf6ac76	58cfa82ee4b0c9d6adf6ac76	G41960.TCGA-50-5932-01A-11D-1753-08.2.filtered.	WGS	G41960.TCGA-50-5932-01A-11D-1753-08.2	G41960.TCGA-50-5932-01A-11D-1753-08.2.bam	289.4	1.9	0.05	58cfa82ee4b0c9d6adf6ac76	G41960.TCGA-50-5932-01A-11D-1753-08.2.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-50-5932-01A	EBCBA7F2-CE13-4BAE-97CD-91A6B1DCD465	Primary Tumor	Illumina HiSeq	3c2b6b67-de08-43ef-a735-28548120fa66	Lung	75	7ECB9621-7A1F-4876-9DFB-9B77CC4CB7B4	6726C157-F688-491D-8B56-35628645DF89	TCGA-50-5932-01A-11D-1753-08	HG19_Broad_variant	TCGA-50-5932	TCGA-LUAD	1235	s11324	Broad Institute of MIT and Harvard	University of Pittsburgh	United States	NO	T2	N1	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage IIB	1753-08	TRUE
13722.58cfa82ee4b0c9d6adf6ac34	58cfa82ee4b0c9d6adf6ac34	G39020.TCGA-BR-4280-01A-01D-A290-08.1.filtered.	WGS	G39020.TCGA-BR-4280-01A-01D-A290-08.1	G39020.TCGA-BR-4280-01A-01D-A290-08.1.bam	252.9	1.9	0.07	58cfa82ee4b0c9d6adf6ac34	G39020.TCGA-BR-4280-01A-01D-A290-08.1.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-BR-4280-01A	E0916597-E489-45EF-A8F7-653A3C6591EF	Primary Tumor	Illumina HiSeq	82a3e711-b833-4607-8007-dd29e00eea85	Stomach	78	797D2D3A-F01C-4985-B27C-4E4C2838D34D	388A8875-C3F5-494E-8456-28BE8D3626E1	TCGA-BR-4280-01A-01D-A290-08	HG19_Broad_variant	TCGA-BR-4280	TCGA-STAD	NA	s14679	Broad Institute of MIT and Harvard	Asterand	Russia	NO	T2b	N1	Stomach  Adenocarcinoma  Not Otherwise Specified (NOS)	Stage III	A290-08	TRUE
13722.58cfa82ee4b0c9d6adf6ace9	58cfa82ee4b0c9d6adf6ace9	G39020.TCGA-CG-4443-01A-01D-A290-08.2.filtered.	WGS	G39020.TCGA-CG-4443-01A-01D-A290-08.2	G39020.TCGA-CG-4443-01A-01D-A290-08.2.bam	261.2	1.9	0.08	58cfa82ee4b0c9d6adf6ace9	G39020.TCGA-CG-4443-01A-01D-A290-08.2.bam	Alive	MALE	Not available	Not available	Stomach Adenocarcinoma	Aligned reads	TCGA-CG-4443-01A	8CB0144B-BE6B-40A1-86A2-708F96D9B615	Primary Tumor	Illumina HiSeq	67df24ad-ea00-45a4-b4b5-b494b97f34df	Stomach	68	F4FB736A-42C9-4367-A327-D0D1C4CBA359	D8D5585D-32CD-4AC4-B410-A4122A17A558	TCGA-CG-4443-01A-01D-A290-08	HG19_Broad_variant	TCGA-CG-4443	TCGA-STAD	NA	s14391	Broad Institute of MIT and Harvard	Indivumed	Germany	NO	T1	N0	Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS)	Stage IA	A290-08	TRUE
13722.58cfa82ee4b0c9d6adf6af48	58cfa82ee4b0c9d6adf6af48	G41960.TCGA-78-7158-01A-11D-2036-08.2.filtered.	WGS	G41960.TCGA-78-7158-01A-11D-2036-08.2	G41960.TCGA-78-7158-01A-11D-2036-08.2.bam	575.7	NA	0.05	58cfa82ee4b0c9d6adf6af48	G41960.TCGA-78-7158-01A-11D-2036-08.2.bam	Dead	FEMALE	WHITE	Not available	Lung Adenocarcinoma	Aligned reads	TCGA-78-7158-01A	501C987E-D1EB-48A9-89EB-72A5062C90B4	Primary Tumor	Illumina HiSeq	a905fe2c-571c-4769-9c35-b107679cad76	Lung	59	EE0D4640-5609-430E-8B80-3058A3F313A8	199BBB0F-996C-40C1-B06D-2066F04BE778	TCGA-78-7158-01A-11D-2036-08	HG19_Broad_variant	TCGA-78-7158	TCGA-LUAD	179	s11325	Broad Institute of MIT and Harvard	Prince Charles Hospital	Australia	NO	T4	N2	Lung Adenocarcinoma Mixed Subtype	Stage IIIB	2036-08	TRUE
13722.58cfa82ee4b0c9d6adf6b056	58cfa82ee4b0c9d6adf6b056	G41960.TCGA-97-8171-01A-11D-2284-08.2.filtered.	WGS	G41960.TCGA-97-8171-01A-11D-2284-08.2	G41960.TCGA-97-8171-01A-11D-2284-08.2.bam	239.3	NA	0.05	58cfa82ee4b0c9d6adf6b056	G41960.TCGA-97-8171-01A-11D-2284-08.2.bam	Alive	MALE	ASIAN	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-97-8171-01A	397D3F69-1453-4057-B177-8723EEC923D1	Primary Tumor	Illumina HiSeq	e34a02d6-fc08-42eb-af7c-d4b40644bcf3	Lung	81	84CB5264-6158-40EC-8B65-F96A4A7D6CE4	FA2C3620-7E82-4B12-B135-87986F0F2890	TCGA-97-8171-01A-11D-2284-08	HG19_Broad_variant	TCGA-97-8171	TCGA-LUAD	NA	s10766	Broad Institute of MIT and Harvard	Washington University - NYU	United States	NO	T2a	N2	Lung Papillary Adenocarcinoma	Stage IV	2284-08	FALSE
13722.58cfa82fe4b0c9d6adf6b976	58cfa82fe4b0c9d6adf6b976	TCGA-AA-3666-01A-02D-1981-10_wgs_Illumina.filtered.	WGS	TCGA-AA-3666-01A-02D-1981-10_wgs_Illumina	TCGA-AA-3666-01A-02D-1981-10_wgs_Illumina.bam	554.96	1.9	0.17	58cfa82fe4b0c9d6adf6b976	TCGA-AA-3666-01A-02D-1981-10_wgs_Illumina.bam	Dead	MALE	Not available	Not available	Colon Adenocarcinoma	Aligned reads	TCGA-AA-3666-01A	A512701F-88BB-4B05-8C94-FD285B9DD13E	Primary Tumor	Illumina HiSeq	6788c172-0c9d-4042-a664-c53d8e8a5cf9	Colorectal	68	F1064663-1462-4901-8BF7-9F50DA5EE7B1	6051F40A-99E5-4461-9255-0E70D757B4D5	TCGA-AA-3666-01A-02D-1981-10	GRCh37-lite	TCGA-AA-3666	TCGA-COAD	61	s13025	Baylor College of Medicine	Indivumed	Germany	NO	T3	N1	Colon Adenocarcinoma	Stage III	1981-10	FALSE
13722.58cfa830e4b0c9d6adf6baba	58cfa830e4b0c9d6adf6baba	TCGA-AA-A01S-01A-21D-A17O-10_wgs_Illumina.filtered.	WGS	TCGA-AA-A01S-01A-21D-A17O-10_wgs_Illumina	TCGA-AA-A01S-01A-21D-A17O-10_wgs_Illumina.bam	89.57	1.8	0.07	58cfa830e4b0c9d6adf6baba	TCGA-AA-A01S-01A-21D-A17O-10_wgs_Illumina.bam	Alive	FEMALE	Not available	Not available	Colon Adenocarcinoma	Aligned reads	TCGA-AA-A01S-01A	84E34CF2-B3BB-4A1A-8FB7-6C2C604C4008	Primary Tumor	Illumina HiSeq	02f49f2b-40ad-427b-bb81-6ef0c6efc46d	Colorectal	47	5743700C-CBD3-4F87-8109-6349A96EB605	A64000DF-16E5-4B88-865F-5C680ADF60EB	TCGA-AA-A01S-01A-21D-A17O-10	GRCh37-lite	TCGA-AA-A01S	TCGA-COAD	NA	s12877	Baylor College of Medicine	Indivumed	Germany	NO	T3	N1	Colon Adenocarcinoma	Stage III	A17O-10	TRUE
13722.58cfa830e4b0c9d6adf6bbb2	58cfa830e4b0c9d6adf6bbb2	TCGA-AA-A02O-01A-21D-A17O-10_wgs_Illumina.filtered.	WGS	TCGA-AA-A02O-01A-21D-A17O-10_wgs_Illumina	TCGA-AA-A02O-01A-21D-A17O-10_wgs_Illumina.bam	107.64	2.11	0.08	58cfa830e4b0c9d6adf6bbb2	TCGA-AA-A02O-01A-21D-A17O-10_wgs_Illumina.bam	Alive	MALE	Not available	Not available	Colon Adenocarcinoma	Aligned reads	TCGA-AA-A02O-01A	6FA41234-9077-4D05-A295-6820F3BEDF5B	Primary Tumor	Illumina HiSeq	22eeeeaf-8aa8-45e6-ace6-b84917c3b402	Colorectal	82	2151DC9E-F76A-4CFF-8A20-B7C107D59C27	4019C219-C51E-479F-8A9D-CFA6816ED696	TCGA-AA-A02O-01A-21D-A17O-10	GRCh37-lite	TCGA-AA-A02O	TCGA-COAD	NA	s12872	Baylor College of Medicine	Indivumed	Germany	NO	T3	N0	Colon Adenocarcinoma	Stage II	A17O-10	TRUE
13722.58cfa830e4b0c9d6adf6bf00	58cfa830e4b0c9d6adf6bf00	TCGA-BP-5168-01A-01D-2099-10_Illumina.filtered.	WGS	TCGA-BP-5168-01A-01D-2099-10_Illumina	TCGA-BP-5168-01A-01D-2099-10_Illumina.bam	129.4	1.9	0.15	58cfa830e4b0c9d6adf6bf00	TCGA-BP-5168-01A-01D-2099-10_Illumina.bam	Dead	MALE	WHITE	Not available	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-BP-5168-01A	781ACAFA-A58B-4180-BBCA-C5B675D51B17	Primary Tumor	Illumina HiSeq	a353f21b-796e-4d66-a273-83755c9b0525	Kidney	75	233C6672-A850-48E0-99FD-024CF1A76B4C	D991F23A-DC1B-427A-B798-BD4187D3AA02	TCGA-BP-5168-01A-01D-2099-10	GRCh37-lite	TCGA-BP-5168	TCGA-KIRC	1463	s8837	Baylor College of Medicine	MSKCC	None	NO	T1a	NX	Kidney Clear Cell Renal Carcinoma	Stage I	2099-10	FALSE
13722.58cfa830e4b0c9d6adf6c294	58cfa830e4b0c9d6adf6c294	TCGA-BP-4781-01A-01D-2098-10_Illumina.filtered.	WGS	TCGA-BP-4781-01A-01D-2098-10_Illumina	TCGA-BP-4781-01A-01D-2098-10_Illumina.bam	69.07	1.9	0.16	58cfa830e4b0c9d6adf6c294	TCGA-BP-4781-01A-01D-2098-10_Illumina.bam	Alive	MALE	WHITE	Not available	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-BP-4781-01A	80C4FC5B-DC7D-4308-8C81-6E83625963B5	Primary Tumor	Illumina HiSeq	d6c662c6-17e1-4d7c-ab4b-9a002c00648b	Kidney	78	15423D9C-91C3-4FE5-9880-A28840ACB75A	FBF937F1-5F30-470C-8A77-46CD1C41E073	TCGA-BP-4781-01A-01D-2098-10	GRCh37-lite	TCGA-BP-4781	TCGA-KIRC	NA	s8836	Baylor College of Medicine	MSKCC	None	NO	T1a	NX	Kidney Clear Cell Renal Carcinoma	Stage I	2098-10	TRUE
13722.58cfa831e4b0c9d6adf6c480	58cfa831e4b0c9d6adf6c480	TCGA-CJ-5682-01A-11D-2103-10_Illumina.filtered.	WGS	TCGA-CJ-5682-01A-11D-2103-10_Illumina	TCGA-CJ-5682-01A-11D-2103-10_Illumina.bam	155.4	1.9	0.15	58cfa831e4b0c9d6adf6c480	TCGA-CJ-5682-01A-11D-2103-10_Illumina.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-CJ-5682-01A	4C325EE1-9B8E-45D4-A0A7-E47EC1EAC402	Primary Tumor	Illumina HiSeq	5586870f-0a22-4bd6-b331-defce06a0f46	Kidney	60	3D38F604-E571-422D-B645-BF73A0348243	DACD4CC2-FC2B-4FBD-ADF6-C8A46AE69C91	TCGA-CJ-5682-01A-11D-2103-10	GRCh37-lite	TCGA-CJ-5682	TCGA-KIRC	NA	s9450	Baylor College of Medicine	MD Anderson Cancer Center	None	NO	T3a	NX	Kidney Clear Cell Renal Carcinoma	Stage IV	2103-10	FALSE
13722.58cfa83ce4b0c9d6adf72ec2	58cfa83ce4b0c9d6adf72ec2	cf3a026c76b42c90171b25f03c7b18ad.filtered.	WGS	cf3a026c76b42c90171b25f03c7b18ad	cf3a026c76b42c90171b25f03c7b18ad.bam	68.2	1.89	0.07	58cfa83ce4b0c9d6adf72ec2	cf3a026c76b42c90171b25f03c7b18ad.bam	Dead	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-A2-A0CM-01A	EB2DBB4F-66B6-4525-8323-431970F7A64E	Primary Tumor	Illumina HiSeq	a6c27294-bf51-4eac-a2b6-885f5757b32b	Breast	40	EA7FB858-C17B-40D4-9A22-CBD9DA614B65	4B9CBBE5-CBD6-4CDE-853A-FA96A176E86D	TCGA-A2-A0CM-01A-31D-A128-09	GRCh37-lite	TCGA-A2-A0CM	TCGA-BRCA	754	s6255	Washington University School of Medicine	Walter Reed	None	NO	T2	N0 (i-)	Infiltrating Ductal Carcinoma	Stage IIA	A128-09	TRUE
13722.58cfa83ce4b0c9d6adf72e98	58cfa83ce4b0c9d6adf72e98	c7785537c59d3349dd69e0f8e87266b7.filtered.	WGS	c7785537c59d3349dd69e0f8e87266b7	c7785537c59d3349dd69e0f8e87266b7.bam	27.86	1.93	0.08	58cfa83ce4b0c9d6adf72e98	c7785537c59d3349dd69e0f8e87266b7.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-E2-A1LL-01A	2A84997D-CCEE-4F46-BEA2-752534F26416	Primary Tumor	Illumina HiSeq	85360168-d41d-4201-8416-2cb4b45fca0f	Breast	73	E57574E4-7E01-4E61-BD29-EE4EC63DDDD6	47312F61-5EF4-4F25-9320-8FBB4758790E	TCGA-E2-A1LL-01A-11D-A142-09	GRCh37-lite	TCGA-E2-A1LL	TCGA-BRCA	NA	s5780	Washington University School of Medicine	Roswell Park	United States	NO	T3	N2a	Infiltrating Ductal Carcinoma	Stage IIIA	A142-09	FALSE
13722.58cfa83ce4b0c9d6adf72ee4	58cfa83ce4b0c9d6adf72ee4	d8812a052472972b8c4ec509bc9bec1f.filtered.	WGS	d8812a052472972b8c4ec509bc9bec1f	d8812a052472972b8c4ec509bc9bec1f.bam	70.78	1.98	0.08	58cfa83ce4b0c9d6adf72ee4	d8812a052472972b8c4ec509bc9bec1f.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-AX-A06B-01A	95E6D327-9AB7-45DE-9527-F5634B3995C3	Primary Tumor	Illumina HiSeq	4f89c64d-ad85-45a6-a62b-e78fcbe761b3	Uterus	72	A43F90B7-4A6C-423C-82DE-AD2C330AE0FB	55ADA396-0878-4724-8EBE-00DA367EED3D	TCGA-AX-A06B-01A-11D-A325-09	GRCh37-lite	TCGA-AX-A06B	TCGA-UCEC	NA	s4974	Washington University School of Medicine	Gynecologic Oncology Group	United States	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A325-09	TRUE
13722.58cfa83ce4b0c9d6adf72fd0	58cfa83ce4b0c9d6adf72fd0	b2efe67d968c5b6634b971bdef73c05a.filtered.	WGS	b2efe67d968c5b6634b971bdef73c05a	b2efe67d968c5b6634b971bdef73c05a.bam	60.09	1.81	0.07	58cfa83ce4b0c9d6adf72fd0	b2efe67d968c5b6634b971bdef73c05a.bam	Alive	FEMALE	WHITE	Not available	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-B5-A11H-01A	DEE43082-4AA7-4650-981C-A779E9FE7B55	Primary Tumor	Illumina HiSeq	f7538b9e-e9b1-41fd-b09d-9ef50a3553d5	Uterus	67	D78D2F6B-3EB3-4082-A7EA-F7B6202CDC58	ACCFC45B-EAE0-4991-A488-E217CDB46655	TCGA-B5-A11H-01A-11D-A122-09	GRCh37-lite	TCGA-B5-A11H	TCGA-UCEC	NA	s4571	Washington University School of Medicine	Duke	United States	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A122-09	TRUE
13722.58cfa83ce4b0c9d6adf72e96	58cfa83ce4b0c9d6adf72e96	c7084960dc3d5bdf5efebd6a16721e46.filtered.	WGS	c7084960dc3d5bdf5efebd6a16721e46	c7084960dc3d5bdf5efebd6a16721e46.bam	52.3	2.08	0.08	58cfa83ce4b0c9d6adf72e96	c7084960dc3d5bdf5efebd6a16721e46.bam	Alive	FEMALE	Not available	Not available	Breast Invasive Carcinoma	Aligned reads	TCGA-A8-A08S-01A	2779FA01-AC93-4E80-A997-3385F72172C3	Primary Tumor	Illumina HiSeq	b026f426-bb3a-4c0e-b90d-6ec93bde0f53	Breast	71	960D194F-FE39-42A0-831D-5C031CF93544	2C6F1862-BB82-4E7E-9CB3-338BDF022FF4	TCGA-A8-A08S-01A-11D-A19H-09	GRCh37-lite	TCGA-A8-A08S	TCGA-BRCA	NA	s6252	Washington University School of Medicine	Indivumed	Germany	NO	T1c	N1	Infiltrating Ductal Carcinoma	Stage IIA	A19H-09	TRUE
13722.58cfa83ce4b0c9d6adf72fd8	58cfa83ce4b0c9d6adf72fd8	bcbfebca137feee918342e841c0bb404.filtered.	WGS	bcbfebca137feee918342e841c0bb404	bcbfebca137feee918342e841c0bb404.bam	93.85	1.93	0.08	58cfa83ce4b0c9d6adf72fd8	bcbfebca137feee918342e841c0bb404.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-AX-A1CI-01A	FBA80122-D8B2-4D8D-A032-9767E8160F9F	Primary Tumor	Illumina HiSeq	47f4dbcb-cbdc-4e4e-a4b2-5080f3e683cf	Uterus	61	DDD2F9E0-0AA3-425B-9D74-74FCC638CB08	92126163-00C3-41F2-9CE6-7AAD5F621407	TCGA-AX-A1CI-01A-11D-A135-09	GRCh37-lite	TCGA-AX-A1CI	TCGA-UCEC	NA	s4572	Washington University School of Medicine	Gynecologic Oncology Group	None	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A135-09	FALSE
13722.58cfa83ce4b0c9d6adf72ee6	58cfa83ce4b0c9d6adf72ee6	daf008933258f806fa354a9618f801be.filtered.	WGS	daf008933258f806fa354a9618f801be	daf008933258f806fa354a9618f801be.bam	62.71	NA	0.08	58cfa83ce4b0c9d6adf72ee6	daf008933258f806fa354a9618f801be.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-EK-A2PK-01A	0809BA8B-4AB6-4F43-934C-C1CCBC014A7E	Primary Tumor	Illumina HiSeq	7109053e-8be0-4965-a5eb-a9bbab5ee53f	Cervix	43	5F613800-55DF-497F-A544-5B12CB9446CE	B3B3A27C-EE9A-42AF-A6D1-9AF5970A98B9	TCGA-EK-A2PK-01A-11D-A18J-09	GRCh37-lite	TCGA-EK-A2PK	TCGA-CESC	NA	s1506	Washington University School of Medicine	Gynecologic Oncology Group	United States	NO	Not available	Not available	Cervical Squamous Cell Carcinoma	Not available	A18J-09	TRUE
13722.58cfa83ce4b0c9d6adf730f0	58cfa83ce4b0c9d6adf730f0	ed7c0d707af5e0862abe28d9bbea0aec.filtered.	WGS	ed7c0d707af5e0862abe28d9bbea0aec	ed7c0d707af5e0862abe28d9bbea0aec.bam	82.92	2	0.08	58cfa83ce4b0c9d6adf730f0	ed7c0d707af5e0862abe28d9bbea0aec.bam	Alive	FEMALE	ASIAN	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-A5-A0GE-01A	A587E62E-430E-4F1B-82B7-6FBE856FDAF1	Primary Tumor	Illumina HiSeq	acd74d29-be09-40a4-b713-578d8469edd7	Uterus	38	20C3F64D-ACF6-45B3-9ACE-2F93B3A951C8	23CC70C4-B744-4FA0-A0DE-B25C0FDF212F	TCGA-A5-A0GE-01A-11D-A066-09	GRCh37-lite	TCGA-A5-A0GE	TCGA-UCEC	NA	s4765	Washington University School of Medicine	Cedars Sinai	None	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A066-09	TRUE
13722.58cfa83ce4b0c9d6adf72f94	58cfa83ce4b0c9d6adf72f94	f45f02f7da5f0692a3a5e6f53061ff05.filtered.	WGS	f45f02f7da5f0692a3a5e6f53061ff05	f45f02f7da5f0692a3a5e6f53061ff05.bam	103.95	1.98	0.08	58cfa83ce4b0c9d6adf72f94	f45f02f7da5f0692a3a5e6f53061ff05.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-AP-A053-01A	AF37D8F0-FEA0-47F6-BE0A-2FB55A5DA5C4	Primary Tumor	Illumina HiSeq	f5bf0f66-e1e7-424f-90df-9ec48601cece	Uterus	90	E1121A9E-BC27-44EB-A1AD-EB0AB10B7C3A	B77084AB-8148-49E0-B3F9-90F7D9EA1862	TCGA-AP-A053-01A-21D-A013-09	GRCh37-lite	TCGA-AP-A053	TCGA-UCEC	NA	s4574	Washington University School of Medicine	MSKCC	None	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A013-09	TRUE
13722.58cfa83ce4b0c9d6adf73120	58cfa83ce4b0c9d6adf73120	c4db7ecd250c14ade136a8948ac7149e.filtered.	WGS	c4db7ecd250c14ade136a8948ac7149e	c4db7ecd250c14ade136a8948ac7149e.bam	46.45	1.84	0.08	58cfa83ce4b0c9d6adf73120	c4db7ecd250c14ade136a8948ac7149e.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-EW-A1J5-01A	5D8ED961-A012-4B6B-BFFB-9468D3953646	Primary Tumor	Illumina HiSeq	17593e20-8cc4-4961-8ff5-871806aeed93	Breast	59	BF42E8CE-CD3E-46C8-92F9-EA5CDA443A6F	98BB3025-0637-4106-8621-12DF7B5D662F	TCGA-EW-A1J5-01A-11D-A13L-09	GRCh37-lite	TCGA-EW-A1J5	TCGA-BRCA	NA	s6251	Washington University School of Medicine	University of Miami	United States	NO	T3	N0 (i-)	Infiltrating Lobular Carcinoma	Stage IIB	A13L-09	FALSE
13722.58cfa83ce4b0c9d6adf730e8	58cfa83ce4b0c9d6adf730e8	e05892d1ff93e157f1df1fbaf7b2de29.filtered.	WGS	e05892d1ff93e157f1df1fbaf7b2de29	e05892d1ff93e157f1df1fbaf7b2de29.bam	65.45	2.08	0.08	58cfa83ce4b0c9d6adf730e8	e05892d1ff93e157f1df1fbaf7b2de29.bam	Alive	FEMALE	Not available	Not available	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-EO-A1Y8-01A	DE4E13C8-5AD0-46D2-AE54-B9CA22B939D8	Primary Tumor	Illumina HiSeq	9346f0a9-a615-49bc-997e-3ef137b190b7	Uterus	87	5B0A8519-3FEA-46D6-8F6D-EC85C403B416	EA6EFCD1-11DE-45F0-8BDE-F1C06AD27E79	TCGA-EO-A1Y8-01A-11D-A159-09	GRCh37-lite	TCGA-EO-A1Y8	TCGA-UCEC	NA	s4401	Washington University School of Medicine	University Health Network	Canada	NO	Not available	Not available	Serous endometrial adenocarcinoma	Not available	A159-09	FALSE
13722.58cfa83ce4b0c9d6adf72ea6	58cfa83ce4b0c9d6adf72ea6	d1ee2de36aac63e924ff27efa16ae3dc.filtered.	WGS	d1ee2de36aac63e924ff27efa16ae3dc	d1ee2de36aac63e924ff27efa16ae3dc.bam	94.43	2	0.08	58cfa83ce4b0c9d6adf72ea6	d1ee2de36aac63e924ff27efa16ae3dc.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-AP-A0LH-01A	7DCE4215-01F6-43E9-9378-9E22C26C23A2	Primary Tumor	Illumina HiSeq	35b27702-57f1-4e49-8d49-3efa49e48c34	Uterus	60	4C657AD4-2C53-4EA9-82B5-52996E74E3FF	19C1C97F-A3EC-44A8-8A20-6F97CAED1A4F	TCGA-AP-A0LH-01A-11D-A066-09	GRCh37-lite	TCGA-AP-A0LH	TCGA-UCEC	1106	s4969	Washington University School of Medicine	MSKCC	None	NO	Not available	Not available	Mixed serous and endometrioid	Not available	A066-09	TRUE
13722.58cfa83ce4b0c9d6adf731a2	58cfa83ce4b0c9d6adf731a2	a8fa89810891a177c65d943664f1e99b.filtered.	WGS	a8fa89810891a177c65d943664f1e99b	a8fa89810891a177c65d943664f1e99b.bam	106.68	1.91	0.08	58cfa83ce4b0c9d6adf731a2	a8fa89810891a177c65d943664f1e99b.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-DI-A1NN-01A	944A102F-3475-45AA-9E30-4B92D1449F00	Primary Tumor	Illumina HiSeq	b518c962-e072-40bd-962b-f0eebac9aa3b	Uterus	63	5FABCE9C-0DFB-4B0D-8478-599FD181A84F	95E8D38A-122E-494C-A304-BEF4275FED7E	TCGA-DI-A1NN-01A-11D-A34H-09	GRCh37-lite	TCGA-DI-A1NN	TCGA-UCEC	NA	s4760	Washington University School of Medicine	MD Anderson	United States	NO	Not available	Not available	Serous endometrial adenocarcinoma	Not available	A34H-09	TRUE
13722.58cfa83ce4b0c9d6adf73168	58cfa83ce4b0c9d6adf73168	f31cfe2ad0117626a14c5b0dea28c02d.filtered.	WGS	f31cfe2ad0117626a14c5b0dea28c02d	f31cfe2ad0117626a14c5b0dea28c02d.bam	91.48	2.08	0.08	58cfa83ce4b0c9d6adf73168	f31cfe2ad0117626a14c5b0dea28c02d.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-AP-A0LF-01A	748E38B1-2EAD-4A0A-8881-D640617B856B	Primary Tumor	Illumina HiSeq	edd786b0-5020-470f-a33f-28c99bef68c0	Uterus	82	902E2DD8-81E5-4949-A57B-92B3EFD86C63	460F7427-EBCF-404B-9E9E-E0278D0BCA95	TCGA-AP-A0LF-01A-11D-A122-09	GRCh37-lite	TCGA-AP-A0LF	TCGA-UCEC	NA	s5374	Washington University School of Medicine	MSKCC	None	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A122-09	TRUE
13722.58cfa83ce4b0c9d6adf73074	58cfa83ce4b0c9d6adf73074	f69f0ef802b7feefa79f55fe3e188902.filtered.	WGS	f69f0ef802b7feefa79f55fe3e188902	f69f0ef802b7feefa79f55fe3e188902.bam	35.42	1.97	0.08	58cfa83ce4b0c9d6adf73074	f69f0ef802b7feefa79f55fe3e188902.bam	Alive	FEMALE	ASIAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-C8-A12Q-01A	A824B3BD-34D5-4CC1-A92F-F9D6AC0F1814	Primary Tumor	Illumina HiSeq	bb80680a-245c-421b-a3ef-198dc78bad1e	Breast	78	8867F07E-0993-4C9A-96DF-18E24801BA80	D8C6D4B8-F279-4EDC-AAA3-A1CC266AEC4D	TCGA-C8-A12Q-01A-11D-A19H-09	GRCh37-lite	TCGA-C8-A12Q	TCGA-BRCA	NA	s6108	Washington University School of Medicine	ILSbio	None	NO	T1	N2	Infiltrating Ductal Carcinoma	Stage IIIA	A19H-09	TRUE
13722.58cfa83ce4b0c9d6adf7310e	58cfa83ce4b0c9d6adf7310e	c31801ffe0265e1332d28d053c9a4955.filtered.	WGS	c31801ffe0265e1332d28d053c9a4955	c31801ffe0265e1332d28d053c9a4955.bam	64.37	1.97	0.08	58cfa83ce4b0c9d6adf7310e	c31801ffe0265e1332d28d053c9a4955.bam	Alive	FEMALE	ASIAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-C8-A12L-01A	441919EB-8C9F-478C-BDA3-8DE4F8295E8A	Primary Tumor	Illumina HiSeq	c12fbad8-2c66-4967-9bfe-6837f6d1e5d4	Breast	67	E3CF8F8C-8FE6-45E2-B786-7DB5590C08CB	D5372745-95CF-4572-A6E7-E7F5B796911A	TCGA-C8-A12L-01A-11D-A19H-09	GRCh37-lite	TCGA-C8-A12L	TCGA-BRCA	NA	s5945	Washington University School of Medicine	ILSbio	Vietnam	NO	T2	N0 (i-)	Infiltrating Ductal Carcinoma	Stage IIA	A19H-09	TRUE
13722.58cfa83ce4b0c9d6adf72f75	58cfa83ce4b0c9d6adf72f75	f059a2333e0663ef4831e98db4f4c9e5.filtered.	WGS	f059a2333e0663ef4831e98db4f4c9e5	f059a2333e0663ef4831e98db4f4c9e5.bam	69.64	1.86	0.08	58cfa83ce4b0c9d6adf72f75	f059a2333e0663ef4831e98db4f4c9e5.bam	Alive	FEMALE	Not available	Not available	Breast Invasive Carcinoma	Aligned reads	TCGA-A8-A08B-01A	D8D7A6C2-6427-4F47-968C-6C3AFFBA4617	Primary Tumor	Illumina HiSeq	f0967810-7b67-40b6-9995-a392153f2fba	Breast	52	1964ADDF-C524-4C72-B596-009235BAD133	F6114C69-71A1-47D5-9B28-B0227B1872F7	TCGA-A8-A08B-01A-11D-A19H-09	GRCh37-lite	TCGA-A8-A08B	TCGA-BRCA	NA	s6447	Washington University School of Medicine	Indivumed	Germany	NO	T2	N0	Infiltrating Ductal Carcinoma	Stage IIA	A19H-09	TRUE
13722.58cfa82fe4b0c9d6adf6b62c	58cfa82fe4b0c9d6adf6b62c	TCGA-50-5941-01A-11D-1751_111007_SN590_0110_C003AACXX_s_3_rg.sorted.filtered.	WGS	TCGA-50-5941-01A-11D-1751_111007_SN590_0110_C003AACXX_s_3_rg.sorted	TCGA-50-5941-01A-11D-1751_111007_SN590_0110_C003AACXX_s_3_rg.sorted.bam	237.4	1.9	0.16	58cfa82fe4b0c9d6adf6b62c	TCGA-50-5941-01A-11D-1751_111007_SN590_0110_C003AACXX_s_3_rg.sorted.bam	Alive	FEMALE	WHITE	Not available	Lung Adenocarcinoma	Aligned reads	TCGA-50-5941-01A	F3F024C2-52F1-400E-946C-398F5B72E6DC	Primary Tumor	Illumina HiSeq	f7c353bf-7be8-42d0-88d0-e89032718c2f	Lung	55	91719392-76CE-479F-BA05-E43BF0201CC4	666720AF-64D9-4A63-BE57-2B8E49E79413	TCGA-50-5941-01A-11D-1751-02	HG19_Broad_variant	TCGA-50-5941	TCGA-LUAD	NA	s11128	Harvard Medical School	University of Pittsburgh	United States	NO	T2a	N2	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage IIIA	1751-02	TRUE
13722.58cfa82ee4b0c9d6adf6af20	58cfa82ee4b0c9d6adf6af20	TCGA-05-4415-01A-22D-1853_111204_SN208_0256_C0562ACXX_s_5_rg.sorted.filtered.	WGS	TCGA-05-4415-01A-22D-1853_111204_SN208_0256_C0562ACXX_s_5_rg.sorted	TCGA-05-4415-01A-22D-1853_111204_SN208_0256_C0562ACXX_s_5_rg.sorted.bam	143.7	1.9	0.14	58cfa82ee4b0c9d6adf6af20	TCGA-05-4415-01A-22D-1853_111204_SN208_0256_C0562ACXX_s_5_rg.sorted.bam	Dead	MALE	Not available	Not available	Lung Adenocarcinoma	Aligned reads	TCGA-05-4415-01A	D15B7B29-C5C5-41D8-B83B-7CC12FE92820	Primary Tumor	Illumina HiSeq	ae778c61-5e62-4f34-9b62-f28d9acf21b1	Lung	57	57E160F5-45FC-44EF-95C6-54E112E3B7F5	4CD99514-20D0-439F-9B9F-BDDCEE5D950F	TCGA-05-4415-01A-22D-1853-02	HG19_Broad_variant	TCGA-05-4415	TCGA-LUAD	91	s11220	Harvard Medical School	Indivumed	Germany	NO	T4	N2	Lung Adenocarcinoma Mixed Subtype	Stage IIIB	1853-02	TRUE
13722.58cfa82fe4b0c9d6adf6b6d8	58cfa82fe4b0c9d6adf6b6d8	TCGA-50-5942-01A-21D-1751_111007_SN590_0110_C003AACXX_s_5_rg.sorted.filtered.	WGS	TCGA-50-5942-01A-21D-1751_111007_SN590_0110_C003AACXX_s_5_rg.sorted	TCGA-50-5942-01A-21D-1751_111007_SN590_0110_C003AACXX_s_5_rg.sorted.bam	168.4	1.9	0.14	58cfa82fe4b0c9d6adf6b6d8	TCGA-50-5942-01A-21D-1751_111007_SN590_0110_C003AACXX_s_5_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-50-5942-01A	75DD635E-8E0C-4C0B-B21C-20F77770218D	Primary Tumor	Illumina HiSeq	915fe8ed-278a-43fb-90cd-986d5c65e9ad	Lung	67	AED669E8-23B6-4786-9398-6BB048815DFA	8DC8F884-F58B-4EFA-AE96-C87AB7F6D991	TCGA-50-5942-01A-21D-1751-02	HG19_Broad_variant	TCGA-50-5942	TCGA-LUAD	NA	s10794	Harvard Medical School	University of Pittsburgh	United States	NO	T1	N0	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage IA	1751-02	TRUE
13722.58cfa82fe4b0c9d6adf6b648	58cfa82fe4b0c9d6adf6b648	TCGA-86-6562-01A-11D-1751_120403_SN1222_0094_BD0UKBACXX_s_3_rg.sorted.filtered.	WGS	TCGA-86-6562-01A-11D-1751_120403_SN1222_0094_BD0UKBACXX_s_3_rg.sorted	TCGA-86-6562-01A-11D-1751_120403_SN1222_0094_BD0UKBACXX_s_3_rg.sorted.bam	237.4	1.9	0.13	58cfa82fe4b0c9d6adf6b648	TCGA-86-6562-01A-11D-1751_120403_SN1222_0094_BD0UKBACXX_s_3_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-86-6562-01A	DCD066BA-5894-453E-B1DA-82092858C3DB	Primary Tumor	Illumina HiSeq	71d960e2-40e8-4084-bcc1-5ebbefc183af	Lung	52	DE4BB1D0-8BD9-4614-85CA-C39D8C636BCC	3AB9FD95-4329-4DD3-823D-F2E050CBA3C1	TCGA-86-6562-01A-11D-1751-02	HG19_Broad_variant	TCGA-86-6562	TCGA-LUAD	NA	s11014	Harvard Medical School	Asterand	Russia	NO	T2a	N1	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage IIA	1751-02	TRUE
13722.58cfa82fe4b0c9d6adf6b60d	58cfa82fe4b0c9d6adf6b60d	TCGA-38-4631-01A-01D-1751_120305_SN1120_0118_AD0L4HACXX_s_5_rg.sorted.filtered.	WGS	TCGA-38-4631-01A-01D-1751_120305_SN1120_0118_AD0L4HACXX_s_5_rg.sorted	TCGA-38-4631-01A-01D-1751_120305_SN1120_0118_AD0L4HACXX_s_5_rg.sorted.bam	387.4	1.9	0.15	58cfa82fe4b0c9d6adf6b60d	TCGA-38-4631-01A-01D-1751_120305_SN1120_0118_AD0L4HACXX_s_5_rg.sorted.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-38-4631-01A	2483621A-4DB3-41AB-AA33-B9427EA8A0AF	Primary Tumor	Illumina HiSeq	b1dd06d4-cd7d-4e62-8deb-12fed31731b5	Lung	72	13B0D336-205A-42AC-8A50-DB0EB065013D	B1FA802A-C88E-4B8D-88FF-4545DCF326DE	TCGA-38-4631-01A-01D-1751-02	HG19_Broad_variant	TCGA-38-4631	TCGA-LUAD	354	s11229	Harvard Medical School	UNC	United States	NO	T2	N0	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage IB	1751-02	TRUE
13722.58cfa82fe4b0c9d6adf6b748	58cfa82fe4b0c9d6adf6b748	TCGA-44-6776-01A-11D-1853_111207_SN590_0112_D09CDACXX_s_7_rg.sorted.filtered.	WGS	TCGA-44-6776-01A-11D-1853_111207_SN590_0112_D09CDACXX_s_7_rg.sorted	TCGA-44-6776-01A-11D-1853_111207_SN590_0112_D09CDACXX_s_7_rg.sorted.bam	142.7	1.9	0.15	58cfa82fe4b0c9d6adf6b748	TCGA-44-6776-01A-11D-1853_111207_SN590_0112_D09CDACXX_s_7_rg.sorted.bam	Alive	FEMALE	WHITE	Not available	Lung Adenocarcinoma	Aligned reads	TCGA-44-6776-01A	C2A1DE2E-6451-4C95-8CE6-263F2B7E6EFF	Primary Tumor	Illumina HiSeq	bb5d193c-cc97-466b-9b28-bdbf5cf255e8	Lung	60	64FB8EBA-A055-4128-92CA-695A3A6F8EBD	5BC01EC3-A1C2-41BB-A9C5-95946A066FA6	TCGA-44-6776-01A-11D-1853-02	HG19_Broad_variant	TCGA-44-6776	TCGA-LUAD	NA	s10660	Harvard Medical School	Christiana Healthcare	United States	NO	T1	N0	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage IA	1853-02	TRUE
13722.58cfa82fe4b0c9d6adf6b680	58cfa82fe4b0c9d6adf6b680	TCGA-49-4488-01A-01D-1751_120309_SN208_0274_AD0R6DACXX_s_1_rg.sorted.filtered.	WGS	TCGA-49-4488-01A-01D-1751_120309_SN208_0274_AD0R6DACXX_s_1_rg.sorted	TCGA-49-4488-01A-01D-1751_120309_SN208_0274_AD0R6DACXX_s_1_rg.sorted.bam	195.4	1.9	0.14	58cfa82fe4b0c9d6adf6b680	TCGA-49-4488-01A-01D-1751_120309_SN208_0274_AD0R6DACXX_s_1_rg.sorted.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-49-4488-01A	D721BFE0-90E3-415E-B9F3-1A270EFA5FBB	Primary Tumor	Illumina HiSeq	26421230-2518-42aa-85ee-f9c83d47a6ba	Lung	74	1AEA8530-43FD-47EA-A2F1-377267DC9D33	DA0D3199-053B-4789-A217-CA2BFB83D57E	TCGA-49-4488-01A-01D-1751-02	HG19_Broad_variant	TCGA-49-4488	TCGA-LUAD	869	s11236	Harvard Medical School	Johns Hopkins	United States	NO	T1	N0	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage IA	1751-02	TRUE
13722.58cfa82fe4b0c9d6adf6b8c0	58cfa82fe4b0c9d6adf6b8c0	TCGA-49-6743-01A-11D-1853_111218_SN208_0258_C054RACXX_s_3_rg.sorted.filtered.	WGS	TCGA-49-6743-01A-11D-1853_111218_SN208_0258_C054RACXX_s_3_rg.sorted	TCGA-49-6743-01A-11D-1853_111218_SN208_0258_C054RACXX_s_3_rg.sorted.bam	219.7	1.9	0.14	58cfa82fe4b0c9d6adf6b8c0	TCGA-49-6743-01A-11D-1853_111218_SN208_0258_C054RACXX_s_3_rg.sorted.bam	Alive	FEMALE	WHITE	Not available	Lung Adenocarcinoma	Aligned reads	TCGA-49-6743-01A	A391D49F-A822-460B-981C-6FBE1868EE38	Primary Tumor	Illumina HiSeq	8b2cdd00-4024-407a-94a7-dbfe5eaa6cd1	Lung	81	5D7DAE28-FC9F-4160-83AA-122F999668B0	3B48B0C9-B9B9-4926-97CA-7232A360A0EE	TCGA-49-6743-01A-11D-1853-02	HG19_Broad_variant	TCGA-49-6743	TCGA-LUAD	NA	s10998	Harvard Medical School	Johns Hopkins	United States	NO	T1	N2	Lung Clear Cell Adenocarcinoma	Stage IIIA	1853-02	TRUE
13722.58cfa82fe4b0c9d6adf6b6fc	58cfa82fe4b0c9d6adf6b6fc	TCGA-55-6712-01A-11D-1853_120312_SN1120_0121_BD0RHPACXX_s_5_rg.sorted.filtered.	WGS	TCGA-55-6712-01A-11D-1853_120312_SN1120_0121_BD0RHPACXX_s_5_rg.sorted	TCGA-55-6712-01A-11D-1853_120312_SN1120_0121_BD0RHPACXX_s_5_rg.sorted.bam	218.7	1.9	0.15	58cfa82fe4b0c9d6adf6b6fc	TCGA-55-6712-01A-11D-1853_120312_SN1120_0121_BD0RHPACXX_s_5_rg.sorted.bam	Alive	MALE	WHITE	Not available	Lung Adenocarcinoma	Aligned reads	TCGA-55-6712-01A	F17D3463-AF6C-42C2-A8E9-FAE45F69286F	Primary Tumor	Illumina HiSeq	fb1682cf-0fca-4bf1-963d-67a3a177fe98	Lung	71	EA75499C-7BF0-47BE-9B09-3C12AAA22F12	61ADB041-60CE-4263-BEB3-33A4DBBA217B	TCGA-55-6712-01A-11D-1853-02	HG19_Broad_variant	TCGA-55-6712	TCGA-LUAD	NA	s11345	Harvard Medical School	International Genomics Consortium	United States	NO	T2a	N1	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage IIA	1853-02	TRUE
13722.58cfa82fe4b0c9d6adf6b8d9	58cfa82fe4b0c9d6adf6b8d9	TCGA-50-5055-01A-01D-1623_120205_SN590_0136_BD0LRYACXX_s_5_rg.sorted.filtered.	WGS	TCGA-50-5055-01A-01D-1623_120205_SN590_0136_BD0LRYACXX_s_5_rg.sorted	TCGA-50-5055-01A-01D-1623_120205_SN590_0136_BD0LRYACXX_s_5_rg.sorted.bam	853.7	1.9	0.17	58cfa82fe4b0c9d6adf6b8d9	TCGA-50-5055-01A-01D-1623_120205_SN590_0136_BD0LRYACXX_s_5_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-50-5055-01A	CC3D9750-7CE0-489F-86D4-8017B7EBED29	Primary Tumor	Illumina HiSeq	97723d64-755b-4f00-b641-95ad083c397e	Lung	79	68D19E88-7FBD-48CC-A09F-55C47BFAF6E7	323E338B-1BA7-49E2-811B-C1FEE673A926	TCGA-50-5055-01A-01D-1623-02	HG19_Broad_variant	TCGA-50-5055	TCGA-LUAD	NA	s11008	Harvard Medical School	University of Pittsburgh	United States	NO	T1	N1	Lung Adenocarcinoma Mixed Subtype	Stage IIA	1623-02	TRUE
13722.58cfa82fe4b0c9d6adf6b8f4	58cfa82fe4b0c9d6adf6b8f4	TCGA-A7-A0DC-01B-04D-A22S_120816_SN1222_0144_AD16PUACXX_s_2_rg.sorted.filtered.	WGS	TCGA-A7-A0DC-01B-04D-A22S_120816_SN1222_0144_AD16PUACXX_s_2_rg.sorted	TCGA-A7-A0DC-01B-04D-A22S_120816_SN1222_0144_AD16PUACXX_s_2_rg.sorted.bam	6.58	NA	0.15	58cfa82fe4b0c9d6adf6b8f4	TCGA-A7-A0DC-01B-04D-A22S_120816_SN1222_0144_AD16PUACXX_s_2_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-A7-A0DC-01B	CB9F5E50-F49D-4899-8895-9367AFCC1015	Primary Tumor	Illumina HiSeq	b8f1a569-bcd5-4da4-a1ea-ae76c98a5d91	Breast	63	00B54C99-C26D-423A-9871-2552C1603A9C	A253B105-73B8-4E33-8870-B31CCFB02847	TCGA-A7-A0DC-01B-04D-A22S-26	HG19_Broad_variant	TCGA-A7-A0DC	TCGA-BRCA	NA	s6121	MD Anderson - Institute for Applied Cancer Science	Christiana Healthcare	None	YES	T1c	N0 (i-)	Infiltrating Ductal Carcinoma	Stage IA	A22S-26	FALSE
13722.58cfa830e4b0c9d6adf6bb6a	58cfa830e4b0c9d6adf6bb6a	TCGA-75-6205-01A-11D-1751_111116_SN208_0255_D09F1ACXX_s_4_rg.sorted.filtered.	WGS	TCGA-75-6205-01A-11D-1751_111116_SN208_0255_D09F1ACXX_s_4_rg.sorted	TCGA-75-6205-01A-11D-1751_111116_SN208_0255_D09F1ACXX_s_4_rg.sorted.bam	267.4	1.9	0.15	58cfa830e4b0c9d6adf6bb6a	TCGA-75-6205-01A-11D-1751_111116_SN208_0255_D09F1ACXX_s_4_rg.sorted.bam	Dead	FEMALE	Not available	Not available	Lung Adenocarcinoma	Aligned reads	TCGA-75-6205-01A	9A63F744-4ED4-4B4D-AAC6-F9BDA66AA563	Primary Tumor	Illumina HiSeq	ccc090ad-afab-4e7d-b71b-dcd39a87e359	Lung	NA	D845174B-1A04-4D22-B34F-C48D7AE35233	A5D194B2-0A92-49A1-9AC3-FC4C1B6ADE92	TCGA-75-6205-01A-11D-1751-02	HG19_Broad_variant	TCGA-75-6205	TCGA-LUAD	NA	s10666	Harvard Medical School	Ontario Institute for Cancer Research (OICR)	Canada	NO	T2a	N0	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage IB	1751-02	TRUE
13722.58cfa830e4b0c9d6adf6bdd4	58cfa830e4b0c9d6adf6bdd4	TCGA-BH-A0BM-01A-11D-A060_130725_SN590_0234_BC29HAACXX_s_3_rg.sorted.filtered.	WGS	TCGA-BH-A0BM-01A-11D-A060_130725_SN590_0234_BC29HAACXX_s_3_rg.sorted	TCGA-BH-A0BM-01A-11D-A060_130725_SN590_0234_BC29HAACXX_s_3_rg.sorted.bam	18.62	1.9	0.15	58cfa830e4b0c9d6adf6bdd4	TCGA-BH-A0BM-01A-11D-A060_130725_SN590_0234_BC29HAACXX_s_3_rg.sorted.bam	Alive	FEMALE	WHITE	Not available	Breast Invasive Carcinoma	Aligned reads	TCGA-BH-A0BM-01A	C2AEEE6C-BA10-4CF9-B560-C739580F7BF3	Primary Tumor	Illumina HiSeq	46f039c4-a705-4933-bf85-0e96e80e5024	Breast	54	5423B7F8-D2BB-47C8-9AF8-3D3E1276888C	FA99DD38-37F1-4B24-960E-617F92CDADD0	TCGA-BH-A0BM-01A-11D-A060-02	HG19_Broad_variant	TCGA-BH-A0BM	TCGA-BRCA	NA	s6772	Harvard Medical School	University of Pittsburgh	None	NO	T2	N1a	Infiltrating Ductal Carcinoma	Stage IIB	A060-02	TRUE
13722.58cfa82fe4b0c9d6adf6b6f8	58cfa82fe4b0c9d6adf6b6f8	TCGA-50-6593-01A-11D-1751_120105_SN1120_0107_AC054PACXX_s_3_rg.sorted.filtered.	WGS	TCGA-50-6593-01A-11D-1751_120105_SN1120_0107_AC054PACXX_s_3_rg.sorted	TCGA-50-6593-01A-11D-1751_120105_SN1120_0107_AC054PACXX_s_3_rg.sorted.bam	245.4	1.8	0.13	58cfa82fe4b0c9d6adf6b6f8	TCGA-50-6593-01A-11D-1751_120105_SN1120_0107_AC054PACXX_s_3_rg.sorted.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-50-6593-01A	E10568FE-0436-43F2-9F0F-48F9903868C4	Primary Tumor	Illumina HiSeq	f552d49e-eaf1-4d8f-bd11-0f2017c95ba3	Lung	49	3B2ED302-D8F1-4078-95F0-3B5C5B322DEB	BC00F0B2-D91E-444A-91A4-08AC5F09CA1F	TCGA-50-6593-01A-11D-1751-02	HG19_Broad_variant	TCGA-50-6593	TCGA-LUAD	336	s11456	Harvard Medical School	University of Pittsburgh	United States	NO	T1	N2	Lung Adenocarcinoma Mixed Subtype	Stage IIIA	1751-02	TRUE
13722.58cfa830e4b0c9d6adf6be66	58cfa830e4b0c9d6adf6be66	TCGA-BJ-A3PT-01A-12D-A221_120530_SN1222_0111_BD12L1ACXX_s_1_rg.sorted.filtered.	WGS	TCGA-BJ-A3PT-01A-12D-A221_120530_SN1222_0111_BD12L1ACXX_s_1_rg.sorted	TCGA-BJ-A3PT-01A-12D-A221_120530_SN1222_0111_BD12L1ACXX_s_1_rg.sorted.bam	17.47	NA	0.15	58cfa830e4b0c9d6adf6be66	TCGA-BJ-A3PT-01A-12D-A221_120530_SN1222_0111_BD12L1ACXX_s_1_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-BJ-A3PT-01A	29C4319C-3EAD-42B1-810D-418DA8D515C4	Primary Tumor	Illumina HiSeq	0d7263bd-8ffa-4ba1-93c4-0444afd9b56e	Thyroid	51	8C112A5F-AE83-4B13-8E00-802382729344	EC6A8D75-A25A-4179-BAF4-53607841AC09	TCGA-BJ-A3PT-01A-12D-A221-26	HG19_Broad_variant	TCGA-BJ-A3PT	TCGA-THCA	NA	s12747	MD Anderson - Institute for Applied Cancer Science	University of Pittsburgh	United States	NO	T3	N0	Thyroid Papillary Carcinoma - Classical/usual	Stage III	A221-26	TRUE
13722.58cfa830e4b0c9d6adf6be88	58cfa830e4b0c9d6adf6be88	TCGA-BJ-A291-01A-11D-A16N_120718_SN590_0169_AC0WL7ACXX_s_8_rg.sorted.filtered.	WGS	TCGA-BJ-A291-01A-11D-A16N_120718_SN590_0169_AC0WL7ACXX_s_8_rg.sorted	TCGA-BJ-A291-01A-11D-A16N_120718_SN590_0169_AC0WL7ACXX_s_8_rg.sorted.bam	30.94	1.89	0.15	58cfa830e4b0c9d6adf6be88	TCGA-BJ-A291-01A-11D-A16N_120718_SN590_0169_AC0WL7ACXX_s_8_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-BJ-A291-01A	D4C68C1C-A3F3-4E0C-B555-D457378A1D24	Primary Tumor	Illumina HiSeq	bb0bf0e4-e29d-422a-879e-b8dc7f5c720b	Thyroid	56	D1612961-A709-487B-A4D1-CE42F0B9AA54	E28A1E8B-41A3-44C0-ADBC-6A203C92DDF5	TCGA-BJ-A291-01A-11D-A16N-02	HG19_Broad_variant	TCGA-BJ-A291	TCGA-THCA	NA	s11990	Harvard Medical School	University of Pittsburgh	United States	NO	T1	N0	Thyroid Papillary Carcinoma - Classical/usual	Stage I	A16N-02	TRUE
13722.58cfa830e4b0c9d6adf6beea	58cfa830e4b0c9d6adf6beea	TCGA-AP-A0LL-01A-12D-A101_120330_SN208_0279_BC0L73ACXX_s_3_rg.sorted.filtered.	WGS	TCGA-AP-A0LL-01A-12D-A101_120330_SN208_0279_BC0L73ACXX_s_3_rg.sorted	TCGA-AP-A0LL-01A-12D-A101_120330_SN208_0279_BC0L73ACXX_s_3_rg.sorted.bam	106.84	1.77	0.15	58cfa830e4b0c9d6adf6beea	TCGA-AP-A0LL-01A-12D-A101_120330_SN208_0279_BC0L73ACXX_s_3_rg.sorted.bam	Alive	FEMALE	WHITE	Not available	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-AP-A0LL-01A	D17668C4-5D66-4E16-8B70-B54616581AAE	Primary Tumor	Illumina HiSeq	0ea2fbb0-cc11-44d9-9706-2523b9d268be	Uterus	56	488A7462-8348-422C-91D3-7D9F0C39D25E	0D29C555-7C7C-4BBB-A4C6-E554CC758CA7	TCGA-AP-A0LL-01A-12D-A101-02	HG19_Broad_variant	TCGA-AP-A0LL	TCGA-UCEC	NA	s4595	Harvard Medical School	MSKCC	None	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A101-02	TRUE
13722.58cfa830e4b0c9d6adf6bcc6	58cfa830e4b0c9d6adf6bcc6	TCGA-AP-A0L9-01A-11D-A043_120318_SN590_0147_BD0U3RACXX_s_3_rg.sorted.filtered.	WGS	TCGA-AP-A0L9-01A-11D-A043_120318_SN590_0147_BD0U3RACXX_s_3_rg.sorted	TCGA-AP-A0L9-01A-11D-A043_120318_SN590_0147_BD0U3RACXX_s_3_rg.sorted.bam	93.54	2.18	0.15	58cfa830e4b0c9d6adf6bcc6	TCGA-AP-A0L9-01A-11D-A043_120318_SN590_0147_BD0U3RACXX_s_3_rg.sorted.bam	Alive	FEMALE	WHITE	Not available	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-AP-A0L9-01A	7B9947D5-E86B-4006-8890-EA5209584A88	Primary Tumor	Illumina HiSeq	df10c3ed-7978-4d58-b4f6-52a76db0994a	Uterus	71	53D0521F-10D6-4F70-9277-D99025A6B963	DAA573AF-564D-456D-8181-DF4C07B77672	TCGA-AP-A0L9-01A-11D-A043-02	HG19_Broad_variant	TCGA-AP-A0L9	TCGA-UCEC	NA	s4423	Harvard Medical School	MSKCC	None	NO	Not available	Not available	Serous endometrial adenocarcinoma	Not available	A043-02	TRUE
13722.58cfa830e4b0c9d6adf6bf44	58cfa830e4b0c9d6adf6bf44	TCGA-AX-A2HD-01A-21D-A17E_120511_SN1120_0141_BC0VK9ACXX_s_1_rg.sorted.filtered.	WGS	TCGA-AX-A2HD-01A-21D-A17E_120511_SN1120_0141_BC0VK9ACXX_s_1_rg.sorted	TCGA-AX-A2HD-01A-21D-A17E_120511_SN1120_0141_BC0VK9ACXX_s_1_rg.sorted.bam	115.02	1.84	0.16	58cfa830e4b0c9d6adf6bf44	TCGA-AX-A2HD-01A-21D-A17E_120511_SN1120_0141_BC0VK9ACXX_s_1_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-AX-A2HD-01A	A8DEF1A0-A136-47F4-9AD9-60EBCF9B726B	Primary Tumor	Illumina HiSeq	b9d10df5-eb11-4976-b3dd-10e970fc715d	Uterus	69	5A2EDE97-0CF7-44D7-A789-92EE9BDA3D6C	C24E7F27-2155-4727-B6D8-8E5BC16D9197	TCGA-AX-A2HD-01A-21D-A17E-02	HG19_Broad_variant	TCGA-AX-A2HD	TCGA-UCEC	NA	s4428	Harvard Medical School	Gynecologic Oncology Group	United States	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A17E-02	TRUE
13722.58cfa830e4b0c9d6adf6c062	58cfa830e4b0c9d6adf6c062	TCGA-B6-A0RI-01A-11D-A060_130807_SN590_0236_BC291KACXX_s_3_rg.sorted.filtered.	WGS	TCGA-B6-A0RI-01A-11D-A060_130807_SN590_0236_BC291KACXX_s_3_rg.sorted	TCGA-B6-A0RI-01A-11D-A060_130807_SN590_0236_BC291KACXX_s_3_rg.sorted.bam	78.5	1.92	0.14	58cfa830e4b0c9d6adf6c062	TCGA-B6-A0RI-01A-11D-A060_130807_SN590_0236_BC291KACXX_s_3_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-B6-A0RI-01A	BFD55808-DDDD-44C3-97D7-41600497B992	Primary Tumor	Illumina HiSeq	9283f68e-d261-4afd-b0eb-0a29fdda83ca	Breast	44	973EE776-E287-4568-A43D-7B16CC0094A9	71542129-1393-4608-B81C-1767A5051763	TCGA-B6-A0RI-01A-11D-A060-02	HG19_Broad_variant	TCGA-B6-A0RI	TCGA-BRCA	NA	s6273	Harvard Medical School	Duke	United States	NO	T4b	N1b	Infiltrating Ductal Carcinoma	Stage IIIB	A060-02	TRUE
13722.58cfa830e4b0c9d6adf6c134	58cfa830e4b0c9d6adf6c134	TCGA-B6-A0RG-01A-11D-A060_130807_SN590_0235_AC29RAACXX_s_3_rg.sorted.filtered.	WGS	TCGA-B6-A0RG-01A-11D-A060_130807_SN590_0235_AC29RAACXX_s_3_rg.sorted	TCGA-B6-A0RG-01A-11D-A060_130807_SN590_0235_AC29RAACXX_s_3_rg.sorted.bam	40.26	2.11	0.15	58cfa830e4b0c9d6adf6c134	TCGA-B6-A0RG-01A-11D-A060_130807_SN590_0235_AC29RAACXX_s_3_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-B6-A0RG-01A	9B13927C-7357-44FD-8385-92AE6A656B7D	Primary Tumor	Illumina HiSeq	b38ff19d-a769-4388-81e2-03263bba7985	Breast	26	B98AA84F-5144-4062-BADC-32E89368D684	E71ED8ED-7371-4423-83C8-6075A6FC7C39	TCGA-B6-A0RG-01A-11D-A060-02	HG19_Broad_variant	TCGA-B6-A0RG	TCGA-BRCA	NA	s5640	Harvard Medical School	Duke	United States	NO	T3	N0 (i-)	Infiltrating Ductal Carcinoma	Stage IIB	A060-02	TRUE
13722.58cfa830e4b0c9d6adf6c128	58cfa830e4b0c9d6adf6c128	TCGA-B6-A0RE-01A-11D-A060_130725_SN590_0234_BC29HAACXX_s_7_rg.sorted.filtered.	WGS	TCGA-B6-A0RE-01A-11D-A060_130725_SN590_0234_BC29HAACXX_s_7_rg.sorted	TCGA-B6-A0RE-01A-11D-A060_130725_SN590_0234_BC29HAACXX_s_7_rg.sorted.bam	49.61	2.14	0.16	58cfa830e4b0c9d6adf6c128	TCGA-B6-A0RE-01A-11D-A060_130725_SN590_0234_BC29HAACXX_s_7_rg.sorted.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-B6-A0RE-01A	08DA7C4C-3067-4BCF-9D7A-78566DF72E69	Primary Tumor	Illumina HiSeq	f7dd44eb-562f-4d27-8c45-5ec7fbf49448	Breast	61	270BE245-2239-4E96-A917-79CCA40868BA	D5CE279A-3A7F-43E7-894C-265E9504C3FD	TCGA-B6-A0RE-01A-11D-A060-02	HG19_Broad_variant	TCGA-B6-A0RE	TCGA-BRCA	NA	s6769	Harvard Medical School	Duke	United States	NO	TX	N0 (i-)	Infiltrating Ductal Carcinoma	Stage X	A060-02	TRUE
13722.58cfa830e4b0c9d6adf6c1a0	58cfa830e4b0c9d6adf6c1a0	TCGA-B7-5818-01A-11D-1598_121130_SN1222_0160_AC1F13ACXX_s_8_rg.sorted.filtered.	WGS	TCGA-B7-5818-01A-11D-1598_121130_SN1222_0160_AC1F13ACXX_s_8_rg.sorted	TCGA-B7-5818-01A-11D-1598_121130_SN1222_0160_AC1F13ACXX_s_8_rg.sorted.bam	411	1.9	0.14	58cfa830e4b0c9d6adf6c1a0	TCGA-B7-5818-01A-11D-1598_121130_SN1222_0160_AC1F13ACXX_s_8_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-B7-5818-01A	6E03B415-84A1-4B91-8717-1A41EDD4A255	Primary Tumor	Illumina HiSeq	9924779b-8261-4ea6-9925-28dd5a0aed8a	Stomach	62	FD97CDF5-0F7F-48A2-B5DA-5C5F56A89166	0EBF1A63-C6E4-49FE-B21B-AE46FF14261D	TCGA-B7-5818-01A-11D-1598-02	HG19_Broad_variant	TCGA-B7-5818	TCGA-STAD	NA	s14963	Harvard Medical School	Cureline	Russia	NO	T2	N0	Stomach  Adenocarcinoma  Diffuse Type	Stage IB	1598-02	TRUE
13722.58cfa830e4b0c9d6adf6c136	58cfa830e4b0c9d6adf6c136	TCGA-BS-A0UJ-01A-12D-A101_120407_SN590_0151_BC0KKJACXX_s_3_rg.sorted.filtered.	WGS	TCGA-BS-A0UJ-01A-12D-A101_120407_SN590_0151_BC0KKJACXX_s_3_rg.sorted	TCGA-BS-A0UJ-01A-12D-A101_120407_SN590_0151_BC0KKJACXX_s_3_rg.sorted.bam	125.71	2	0.17	58cfa830e4b0c9d6adf6c136	TCGA-BS-A0UJ-01A-12D-A101_120407_SN590_0151_BC0KKJACXX_s_3_rg.sorted.bam	Alive	FEMALE	ASIAN	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-BS-A0UJ-01A	FF82548A-F1BB-4DAA-A8F7-B3831B5843AD	Primary Tumor	Illumina HiSeq	094adbd4-f2af-42bb-9509-0dcfa2c6672f	Uterus	68	2EA1339F-A5EB-4552-AC13-858FA70E606E	15FDA615-0A79-4211-B5DE-F61741E8937A	TCGA-BS-A0UJ-01A-12D-A101-02	HG19_Broad_variant	TCGA-BS-A0UJ	TCGA-UCEC	NA	s5221	Harvard Medical School	University of Hawaii	None	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A101-02	TRUE
13722.58cfa830e4b0c9d6adf6c1a6	58cfa830e4b0c9d6adf6c1a6	TCGA-BH-A0HB-01A-11D-A060_130725_SN590_0234_BC29HAACXX_s_5_rg.sorted.filtered.	WGS	TCGA-BH-A0HB-01A-11D-A060_130725_SN590_0234_BC29HAACXX_s_5_rg.sorted	TCGA-BH-A0HB-01A-11D-A060_130725_SN590_0234_BC29HAACXX_s_5_rg.sorted.bam	58.9	2	0.14	58cfa830e4b0c9d6adf6c1a6	TCGA-BH-A0HB-01A-11D-A060_130725_SN590_0234_BC29HAACXX_s_5_rg.sorted.bam	Alive	FEMALE	WHITE	Not available	Breast Invasive Carcinoma	Aligned reads	TCGA-BH-A0HB-01A	0C1023C0-D2CE-4940-8047-7642F1DC3965	Primary Tumor	Illumina HiSeq	c9a434dc-8ce3-485f-88aa-a2373f6cdfac	Breast	55	19193B8F-1E1B-448C-B934-93F25E60D45B	49556237-D73F-4DE9-B5D9-7169DB7A53C5	TCGA-BH-A0HB-01A-11D-A060-02	HG19_Broad_variant	TCGA-BH-A0HB	TCGA-BRCA	NA	s6275	Harvard Medical School	University of Pittsburgh	None	NO	T1c	N0 (i-)	Infiltrating Ductal Carcinoma	Stage IA	A060-02	TRUE
13722.58cfa830e4b0c9d6adf6c138	58cfa830e4b0c9d6adf6c138	TCGA-BS-A0UF-01A-11D-A101_120407_SN590_0151_BC0KKJACXX_s_1_rg.sorted.filtered.	WGS	TCGA-BS-A0UF-01A-11D-A101_120407_SN590_0151_BC0KKJACXX_s_1_rg.sorted	TCGA-BS-A0UF-01A-11D-A101_120407_SN590_0151_BC0KKJACXX_s_1_rg.sorted.bam	110.21	1.89	0.17	58cfa830e4b0c9d6adf6c138	TCGA-BS-A0UF-01A-11D-A101_120407_SN590_0151_BC0KKJACXX_s_1_rg.sorted.bam	Alive	FEMALE	ASIAN	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-BS-A0UF-01A	F77D7256-2CCF-42A7-9B30-332AC24CA812	Primary Tumor	Illumina HiSeq	33e84ef1-730b-4f0b-9967-bca62c9f631c	Uterus	65	C805F55A-322F-4A11-AE0C-4BBC365D1BD6	D1F78FB2-7BB7-4BF7-8EC7-E2E08F579A38	TCGA-BS-A0UF-01A-11D-A101-02	HG19_Broad_variant	TCGA-BS-A0UF	TCGA-UCEC	NA	s5220	Harvard Medical School	University of Hawaii	None	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A101-02	TRUE
13722.58cfa830e4b0c9d6adf6c1e1	58cfa830e4b0c9d6adf6c1e1	TCGA-BG-A0MT-01A-11D-A101_120330_SN1120_0129_BD0UCLACXX_s_8_rg.sorted.filtered.	WGS	TCGA-BG-A0MT-01A-11D-A101_120330_SN1120_0129_BD0UCLACXX_s_8_rg.sorted	TCGA-BG-A0MT-01A-11D-A101_120330_SN1120_0129_BD0UCLACXX_s_8_rg.sorted.bam	93.28	1.98	0.17	58cfa830e4b0c9d6adf6c1e1	TCGA-BG-A0MT-01A-11D-A101_120330_SN1120_0129_BD0UCLACXX_s_8_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-BG-A0MT-01A	082E32C5-7F82-466A-B52D-A3293A8F8E57	Primary Tumor	Illumina HiSeq	3499ad67-e5ed-4030-9fba-fac9fa52f9c5	Uterus	64	91F629F5-6938-4F5C-BA2E-1F519CE6B255	23FB2C48-BE95-4169-BB10-00EA361C5687	TCGA-BG-A0MT-01A-11D-A101-02	HG19_Broad_variant	TCGA-BG-A0MT	TCGA-UCEC	NA	s5217	Harvard Medical School	University of Pittsburgh	None	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A101-02	TRUE
13722.58cfa830e4b0c9d6adf6bf40	58cfa830e4b0c9d6adf6bf40	TCGA-AX-A1CJ-01A-11D-A133_120511_SN1120_0141_BC0VK9ACXX_s_5_rg.sorted.filtered.	WGS	TCGA-AX-A1CJ-01A-11D-A133_120511_SN1120_0141_BC0VK9ACXX_s_5_rg.sorted	TCGA-AX-A1CJ-01A-11D-A133_120511_SN1120_0141_BC0VK9ACXX_s_5_rg.sorted.bam	100.97	1.91	0.17	58cfa830e4b0c9d6adf6bf40	TCGA-AX-A1CJ-01A-11D-A133_120511_SN1120_0141_BC0VK9ACXX_s_5_rg.sorted.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-AX-A1CJ-01A	ABAF757B-F79F-40BD-96E3-E2C0F63061F0	Primary Tumor	Illumina HiSeq	f42806a5-e473-4ae8-bb1a-aa11fe2dde53	Uterus	59	72D06DDF-9FB2-4577-BFDB-B0E463105B4A	A4EE1BB7-59FF-4034-ABA1-9AF4F62B42B0	TCGA-AX-A1CJ-01A-11D-A133-02	HG19_Broad_variant	TCGA-AX-A1CJ	TCGA-UCEC	NA	s5388	Harvard Medical School	Gynecologic Oncology Group	None	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A133-02	FALSE
13722.58cfa830e4b0c9d6adf6c208	58cfa830e4b0c9d6adf6c208	TCGA-BA-5558-01A-01D-1509_120420_SN1120_0135_BD0T5FACXX_s_5_rg.sorted.filtered.	WGS	TCGA-BA-5558-01A-01D-1509_120420_SN1120_0135_BD0T5FACXX_s_5_rg.sorted	TCGA-BA-5558-01A-01D-1509_120420_SN1120_0135_BD0T5FACXX_s_5_rg.sorted.bam	252.7	1.9	0.15	58cfa830e4b0c9d6adf6c208	TCGA-BA-5558-01A-01D-1509_120420_SN1120_0135_BD0T5FACXX_s_5_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-BA-5558-01A	6A1AA50C-097C-4E04-8DDD-12D50F8A5AC2	Primary Tumor	Illumina HiSeq	4116c10d-23f4-49f2-bd5a-9b9466f08bfb	Head and Neck	65	EB749281-B3DC-43E4-812E-F5F5004A21ED	41737268-345A-4F87-B2DB-E184247E1396	TCGA-BA-5558-01A-01D-1509-02	HG19_Broad_variant	TCGA-BA-5558	TCGA-HNSC	NA	s15610	Harvard Medical School	UNC	None	NO	TX	NX	Head and Neck Squamous Cell Carcinoma	Not available	1509-02	TRUE
13722.58cfa830e4b0c9d6adf6c236	58cfa830e4b0c9d6adf6c236	TCGA-BJ-A0Z3-01A-11D-A13U_120706_SN1120_0170_BD1422ACXX_s_7_rg.sorted.filtered.	WGS	TCGA-BJ-A0Z3-01A-11D-A13U_120706_SN1120_0170_BD1422ACXX_s_7_rg.sorted	TCGA-BJ-A0Z3-01A-11D-A13U_120706_SN1120_0170_BD1422ACXX_s_7_rg.sorted.bam	64.48	1.98	0.16	58cfa830e4b0c9d6adf6c236	TCGA-BJ-A0Z3-01A-11D-A13U_120706_SN1120_0170_BD1422ACXX_s_7_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-BJ-A0Z3-01A	331CAE6E-2868-4C58-9302-709A9FF7D025	Primary Tumor	Illumina HiSeq	ddae4f5a-aed4-4466-9434-23f6ed312d19	Thyroid	33	6BF032C1-B7D5-4B1C-BF41-C9BFEAFA5E7A	3D0982B1-944E-4C03-AAA4-F8FD4602D4C9	TCGA-BJ-A0Z3-01A-11D-A13U-02	HG19_Broad_variant	TCGA-BJ-A0Z3	TCGA-THCA	NA	s12628	Harvard Medical School	University of Pittsburgh	United States	NO	T1	N0	Thyroid Papillary Carcinoma - Classical/usual	Stage I	A13U-02	TRUE
13722.58cfa830e4b0c9d6adf6c23a	58cfa830e4b0c9d6adf6c23a	TCGA-BT-A20R-01A-12D-A16N_120920_SN1222_0151_BD1D5CACXX_s_3_rg.sorted.filtered.	WGS	TCGA-BT-A20R-01A-12D-A16N_120920_SN1222_0151_BD1D5CACXX_s_3_rg.sorted	TCGA-BT-A20R-01A-12D-A16N_120920_SN1222_0151_BD1D5CACXX_s_3_rg.sorted.bam	26.04	1.91	0.17	58cfa830e4b0c9d6adf6c23a	TCGA-BT-A20R-01A-12D-A16N_120920_SN1222_0151_BD1D5CACXX_s_3_rg.sorted.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-BT-A20R-01A	F8780A4B-7F55-41D1-BF92-8513955D150E	Primary Tumor	Illumina HiSeq	e997f623-927f-4dae-8fe9-590eef9a9f59	Bladder	79	20231B7F-CB6A-4CD0-9C46-10D4E959D483	78460059-E3A1-40F1-89B5-2F69C6E2E0F1	TCGA-BT-A20R-01A-12D-A16N-02	HG19_Broad_variant	TCGA-BT-A20R	TCGA-BLCA	154	s2696	Harvard Medical School	University of Pittsburgh	United States	NO	T3b	N1	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV	A16N-02	TRUE
13722.58cfa830e4b0c9d6adf6c29c	58cfa830e4b0c9d6adf6c29c	TCGA-BS-A0T9-01A-11D-A12F_120523_SN1222_0109_BD12MPACXX_s_3_rg.sorted.filtered.	WGS	TCGA-BS-A0T9-01A-11D-A12F_120523_SN1222_0109_BD12MPACXX_s_3_rg.sorted	TCGA-BS-A0T9-01A-11D-A12F_120523_SN1222_0109_BD12MPACXX_s_3_rg.sorted.bam	66.31	1.98	0.16	58cfa830e4b0c9d6adf6c29c	TCGA-BS-A0T9-01A-11D-A12F_120523_SN1222_0109_BD12MPACXX_s_3_rg.sorted.bam	Dead	FEMALE	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-BS-A0T9-01A	4EB95566-0E73-4260-853E-F7DF650667A0	Primary Tumor	Illumina HiSeq	2c61f255-688e-4a53-83fd-bea3b66d5a15	Uterus	39	3C9FF865-013F-427A-8D4D-C8E60EA346A1	CB5B905D-7287-41B3-9B49-B2F7FF7D2173	TCGA-BS-A0T9-01A-11D-A12F-02	HG19_Broad_variant	TCGA-BS-A0T9	TCGA-UCEC	1428	s4260	Harvard Medical School	University of Hawaii	None	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A12F-02	TRUE
13722.58cfa830e4b0c9d6adf6c2aa	58cfa830e4b0c9d6adf6c2aa	TCGA-BR-4201-01A-01D-1128_120816_SN590_0175_AD16M6ACXX_s_5_rg.sorted.filtered.	WGS	TCGA-BR-4201-01A-01D-1128_120816_SN590_0175_AD16M6ACXX_s_5_rg.sorted	TCGA-BR-4201-01A-01D-1128_120816_SN590_0175_AD16M6ACXX_s_5_rg.sorted.bam	204.9	1.9	0.15	58cfa830e4b0c9d6adf6c2aa	TCGA-BR-4201-01A-01D-1128_120816_SN590_0175_AD16M6ACXX_s_5_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-BR-4201-01A	8520654B-2192-46CF-9D72-1DDB885A7C55	Primary Tumor	Illumina HiSeq	359db0d8-a78f-4d9d-9a3e-9f1a04472df0	Stomach	66	B42CC87B-4BB0-433D-8AFB-CB314B8CBA30	FE12C75F-5A26-40A8-BEF0-742FAD4CD0E5	TCGA-BR-4201-01A-01D-1128-02	HG19_Broad_variant	TCGA-BR-4201	TCGA-STAD	NA	s14529	Harvard Medical School	Asterand	Russia	NO	T2a	NX	Stomach  Adenocarcinoma  Not Otherwise Specified (NOS)	Not available	1128-02	TRUE
13722.58cfa831e4b0c9d6adf6c34a	58cfa831e4b0c9d6adf6c34a	TCGA-CG-5718-01A-11D-1598_121029_SN208_0438_AC18NJACXX_s_6_rg.sorted.filtered.	WGS	TCGA-CG-5718-01A-11D-1598_121029_SN208_0438_AC18NJACXX_s_6_rg.sorted	TCGA-CG-5718-01A-11D-1598_121029_SN208_0438_AC18NJACXX_s_6_rg.sorted.bam	563	1.9	0.15	58cfa831e4b0c9d6adf6c34a	TCGA-CG-5718-01A-11D-1598_121029_SN208_0438_AC18NJACXX_s_6_rg.sorted.bam	Alive	FEMALE	Not available	Not available	Stomach Adenocarcinoma	Aligned reads	TCGA-CG-5718-01A	D5C58161-05ED-4472-81ED-176216F49929	Primary Tumor	Illumina HiSeq	98032563-24e7-466c-9f90-1ba67975f2f9	Stomach	78	5865A287-63C4-44F7-92D5-C4F3C323AF89	1A108108-EEAC-4EE8-AFD7-871AFA69054B	TCGA-CG-5718-01A-11D-1598-02	HG19_Broad_variant	TCGA-CG-5718	TCGA-STAD	NA	s14903	Harvard Medical School	Indivumed	Germany	NO	T2b	N1	Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS)	Stage II	1598-02	TRUE
13722.58cfa830e4b0c9d6adf6c2db	58cfa830e4b0c9d6adf6c2db	TCGA-C4-A0F0-01A-12D-A10R_120926_SN590_0181_AC19HCACXX_s_5_rg.sorted.filtered.	WGS	TCGA-C4-A0F0-01A-12D-A10R_120926_SN590_0181_AC19HCACXX_s_5_rg.sorted	TCGA-C4-A0F0-01A-12D-A10R_120926_SN590_0181_AC19HCACXX_s_5_rg.sorted.bam	13.51	1.77	0.15	58cfa830e4b0c9d6adf6c2db	TCGA-C4-A0F0-01A-12D-A10R_120926_SN590_0181_AC19HCACXX_s_5_rg.sorted.bam	Alive	MALE	Not available	Not available	Bladder Urothelial Carcinoma	Aligned reads	TCGA-C4-A0F0-01A	40398C03-A9CC-476B-9EE9-AECF161BE43F	Primary Tumor	Illumina HiSeq	38f56daa-7d69-4fe0-8895-10e22397ee2a	Bladder	60	54234A11-8674-4B01-B2EF-A4C6D772AA43	5584A4A7-2EA1-46D8-8960-8905689D5720	TCGA-C4-A0F0-01A-12D-A10R-02	HG19_Broad_variant	TCGA-C4-A0F0	TCGA-BLCA	NA	s2862	Harvard Medical School	Indivumed	Germany	NO	T2b	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage II	A10R-02	TRUE
13722.58cfa830e4b0c9d6adf6c31e	58cfa830e4b0c9d6adf6c31e	TCGA-CF-A27C-01A-11D-A16N_120920_SN1222_0151_BD1D5CACXX_s_7_rg.sorted.filtered.	WGS	TCGA-CF-A27C-01A-11D-A16N_120920_SN1222_0151_BD1D5CACXX_s_7_rg.sorted	TCGA-CF-A27C-01A-11D-A16N_120920_SN1222_0151_BD1D5CACXX_s_7_rg.sorted.bam	67.64	2.28	0.18	58cfa830e4b0c9d6adf6c31e	TCGA-CF-A27C-01A-11D-A16N_120920_SN1222_0151_BD1D5CACXX_s_7_rg.sorted.bam	Alive	MALE	ASIAN	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-CF-A27C-01A	7FEE9D6F-C0EA-43C2-89C2-66D965A077A8	Primary Tumor	Illumina HiSeq	ecc65751-9b59-49c3-a142-7a4c61174649	Bladder	52	EAD6792B-4E52-4C28-891C-6D8696873A13	1E553EB3-8C42-48A1-87A7-BFA8541CE568	TCGA-CF-A27C-01A-11D-A16N-02	HG19_Broad_variant	TCGA-CF-A27C	TCGA-BLCA	NA	s2873	Harvard Medical School	ILSbio	Vietnam	NO	T3	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage III	A16N-02	TRUE
13722.58cfa831e4b0c9d6adf6c366	58cfa831e4b0c9d6adf6c366	TCGA-CG-5720-01A-11D-1598_121029_SN208_0439_BD1KHKACXX_s_2_rg.sorted.filtered.	WGS	TCGA-CG-5720-01A-11D-1598_121029_SN208_0439_BD1KHKACXX_s_2_rg.sorted	TCGA-CG-5720-01A-11D-1598_121029_SN208_0439_BD1KHKACXX_s_2_rg.sorted.bam	135	1.9	0.14	58cfa831e4b0c9d6adf6c366	TCGA-CG-5720-01A-11D-1598_121029_SN208_0439_BD1KHKACXX_s_2_rg.sorted.bam	Dead	MALE	Not available	Not available	Stomach Adenocarcinoma	Aligned reads	TCGA-CG-5720-01A	7C9EA4FA-4CBC-4941-945A-E531E1D48304	Primary Tumor	Illumina HiSeq	6cf7bbf9-63f5-40e8-b595-c9012a1825ba	Stomach	71	1B2E1B50-8D4E-4E62-9B1B-B484936BD6EB	98CE6D0E-465C-40FA-9408-33AA7A25FBB2	TCGA-CG-5720-01A-11D-1598-02	HG19_Broad_variant	TCGA-CG-5720	TCGA-STAD	30	s14984	Harvard Medical School	Indivumed	Germany	NO	T2	N0	Stomach  Adenocarcinoma  Not Otherwise Specified (NOS)	Stage IB	1598-02	TRUE
13722.58cfa831e4b0c9d6adf6c3b0	58cfa831e4b0c9d6adf6c3b0	TCGA-BH-A0H7-01A-13D-A060_130725_SN590_0233_AD2B3HACXX_s_7_rg.sorted.filtered.	WGS	TCGA-BH-A0H7-01A-13D-A060_130725_SN590_0233_AD2B3HACXX_s_7_rg.sorted	TCGA-BH-A0H7-01A-13D-A060_130725_SN590_0233_AD2B3HACXX_s_7_rg.sorted.bam	20.53	2	0.15	58cfa831e4b0c9d6adf6c3b0	TCGA-BH-A0H7-01A-13D-A060_130725_SN590_0233_AD2B3HACXX_s_7_rg.sorted.bam	Alive	FEMALE	WHITE	Not available	Breast Invasive Carcinoma	Aligned reads	TCGA-BH-A0H7-01A	2021ED1F-DC75-4701-B8B8-1386466E4802	Primary Tumor	Illumina HiSeq	d5ab471a-88d1-4966-865a-f7fa29214fe4	Breast	65	69BFA6CE-ED46-4321-A107-347C49D68951	E0E60B71-1EFA-4896-B89F-D05974CDCF48	TCGA-BH-A0H7-01A-13D-A060-02	HG19_Broad_variant	TCGA-BH-A0H7	TCGA-BRCA	NA	s5801	Harvard Medical School	University of Pittsburgh	None	NO	T1c	N2a	Infiltrating Ductal Carcinoma	Stage IIIA	A060-02	TRUE
13722.58cfa831e4b0c9d6adf6c37e	58cfa831e4b0c9d6adf6c37e	TCGA-CG-5719-01A-11D-1598_121029_SN208_0439_BD1KHKACXX_s_1_rg.sorted.filtered.	WGS	TCGA-CG-5719-01A-11D-1598_121029_SN208_0439_BD1KHKACXX_s_1_rg.sorted	TCGA-CG-5719-01A-11D-1598_121029_SN208_0439_BD1KHKACXX_s_1_rg.sorted.bam	46	1.9	0.16	58cfa831e4b0c9d6adf6c37e	TCGA-CG-5719-01A-11D-1598_121029_SN208_0439_BD1KHKACXX_s_1_rg.sorted.bam	Alive	FEMALE	Not available	Not available	Stomach Adenocarcinoma	Aligned reads	TCGA-CG-5719-01A	263F67E0-0A28-42E6-B3F3-1DDD0D397220	Primary Tumor	Illumina HiSeq	e6237df3-92e8-4e8b-92a4-b09d3515f16f	Stomach	54	606573EE-ED11-4DB5-ABAF-E842EC575EEE	9008E364-B8F3-4923-B0CC-6ED34AA7BAC3	TCGA-CG-5719-01A-11D-1598-02	HG19_Broad_variant	TCGA-CG-5719	TCGA-STAD	NA	s15247	Harvard Medical School	Indivumed	Germany	NO	T4	N0	Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS)	Stage IV	1598-02	TRUE
13722.58cfa831e4b0c9d6adf6c3b8	58cfa831e4b0c9d6adf6c3b8	TCGA-CG-5724-01A-11D-1598_121011_SN208_0434_AC18MYACXX_s_7_rg.sorted.filtered.	WGS	TCGA-CG-5724-01A-11D-1598_121011_SN208_0434_AC18MYACXX_s_7_rg.sorted	TCGA-CG-5724-01A-11D-1598_121011_SN208_0434_AC18MYACXX_s_7_rg.sorted.bam	362	1.9	0.15	58cfa831e4b0c9d6adf6c3b8	TCGA-CG-5724-01A-11D-1598_121011_SN208_0434_AC18MYACXX_s_7_rg.sorted.bam	Dead	MALE	Not available	Not available	Stomach Adenocarcinoma	Aligned reads	TCGA-CG-5724-01A	0B4E8D73-459D-4930-9D1A-ABB8D53E1844	Primary Tumor	Illumina HiSeq	b1cebb86-fe73-4b53-899d-9e6a4caa800b	Stomach	59	4D624B21-5AEE-42B8-B192-8AFECB51434D	8611C0AC-38E4-4BFD-A1C4-56CABFCF6374	TCGA-CG-5724-01A-11D-1598-02	HG19_Broad_variant	TCGA-CG-5724	TCGA-STAD	366	s15248	Harvard Medical School	Indivumed	Germany	NO	T3	N3	Stomach  Adenocarcinoma  Diffuse Type	Stage IV	1598-02	TRUE
13722.58cfa831e4b0c9d6adf6c3d6	58cfa831e4b0c9d6adf6c3d6	TCGA-CG-5734-01A-11D-1598_121023_SN208_0436_AC1CMBACXX_s_7_rg.sorted.filtered.	WGS	TCGA-CG-5734-01A-11D-1598_121023_SN208_0436_AC1CMBACXX_s_7_rg.sorted	TCGA-CG-5734-01A-11D-1598_121023_SN208_0436_AC1CMBACXX_s_7_rg.sorted.bam	206	1.9	0.15	58cfa831e4b0c9d6adf6c3d6	TCGA-CG-5734-01A-11D-1598_121023_SN208_0436_AC1CMBACXX_s_7_rg.sorted.bam	Dead	MALE	Not available	Not available	Stomach Adenocarcinoma	Aligned reads	TCGA-CG-5734-01A	2A227292-C73D-45FC-AB68-CDFAF7AEF9E7	Primary Tumor	Illumina HiSeq	4cac9679-5c5e-4b51-b7a0-0d82ab2c2237	Stomach	68	A0237637-3859-47D9-A60E-0AF8C6884B4A	12BCC59A-0A89-4087-B976-A22F66D8190C	TCGA-CG-5734-01A-11D-1598-02	HG19_Broad_variant	TCGA-CG-5734	TCGA-STAD	243	s14990	Harvard Medical School	Indivumed	Germany	NO	T3	N1	Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS)	Stage IIIA	1598-02	TRUE
13722.58cfa831e4b0c9d6adf6c3dc	58cfa831e4b0c9d6adf6c3dc	TCGA-CG-5726-01A-11D-1598_121011_SN208_0435_BD1E43ACXX_s_2_rg.sorted.filtered.	WGS	TCGA-CG-5726-01A-11D-1598_121011_SN208_0435_BD1E43ACXX_s_2_rg.sorted	TCGA-CG-5726-01A-11D-1598_121011_SN208_0435_BD1E43ACXX_s_2_rg.sorted.bam	217	1.9	0.16	58cfa831e4b0c9d6adf6c3dc	TCGA-CG-5726-01A-11D-1598_121011_SN208_0435_BD1E43ACXX_s_2_rg.sorted.bam	Dead	MALE	Not available	Not available	Stomach Adenocarcinoma	Aligned reads	TCGA-CG-5726-01A	863AD936-E2A0-471C-8D95-3A548BB94AFA	Primary Tumor	Illumina HiSeq	87491384-bbcf-4127-8cf0-59e692b8e37b	Stomach	73	C881739A-982C-436F-9BE2-4638DB792C53	D472F361-BC94-44A5-9158-5BD999C96C27	TCGA-CG-5726-01A-11D-1598-02	HG19_Broad_variant	TCGA-CG-5726	TCGA-STAD	881	s15130	Harvard Medical School	Indivumed	Germany	NO	T1	N0	Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS)	Stage IA	1598-02	TRUE
13722.58cfa831e4b0c9d6adf6c3f0	58cfa831e4b0c9d6adf6c3f0	TCGA-C5-A2LX-01A-11D-A18I_140206_SN1222_0239_BC2RAKACXX_s_5_rg.sorted.filtered.	WGS	TCGA-C5-A2LX-01A-11D-A18I_140206_SN1222_0239_BC2RAKACXX_s_5_rg.sorted	TCGA-C5-A2LX-01A-11D-A18I_140206_SN1222_0239_BC2RAKACXX_s_5_rg.sorted.bam	82.12	NA	0.18	58cfa831e4b0c9d6adf6c3f0	TCGA-C5-A2LX-01A-11D-A18I_140206_SN1222_0239_BC2RAKACXX_s_5_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-C5-A2LX-01A	B82F4C6D-530F-4B0E-8F33-995633CB254A	Primary Tumor	Illumina HiSeq	ef574f7b-2b69-4be8-83f3-cc02df579a0a	Cervix	54	41BEBEA3-11C2-4748-8E60-082CFB8E0251	F4772B1E-699C-4C3D-9E0B-1BD4634A7F36	TCGA-C5-A2LX-01A-11D-A18I-02	HG19_Broad_variant	TCGA-C5-A2LX	TCGA-CESC	NA	s1175	Harvard Medical School	Medical College of Wisconsin	United States	NO	T2	N1	Cervical Squamous Cell Carcinoma	Not available	A18I-02	TRUE
13722.58cfa831e4b0c9d6adf6c3fc	58cfa831e4b0c9d6adf6c3fc	TCGA-CH-5788-01A-11D-1572_130125_SN208_0450_AC1K3NACXX_s_3_rg.sorted.filtered.	WGS	TCGA-CH-5788-01A-11D-1572_130125_SN208_0450_AC1K3NACXX_s_3_rg.sorted	TCGA-CH-5788-01A-11D-1572_130125_SN208_0450_AC1K3NACXX_s_3_rg.sorted.bam	257.7	1.9	0.16	58cfa831e4b0c9d6adf6c3fc	TCGA-CH-5788-01A-11D-1572_130125_SN208_0450_AC1K3NACXX_s_3_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-CH-5788-01A	C039014F-821C-43D6-9D3C-914F9C8D98FA	Primary Tumor	Illumina HiSeq	8bd51d54-e1be-4a0a-bad5-3b8013692b90	Prostate	69	144E0265-C04E-4538-A721-94DEF2570486	ADB6611D-7A44-4FFE-A48B-FF8E24696B38	TCGA-CH-5788-01A-11D-1572-02	HG19_Broad_variant	TCGA-CH-5788	TCGA-PRAD	NA	s3595	Harvard Medical School	Indivumed	Germany	NO	T3b	N1	Prostate Adenocarcinoma Acinar Type	Not available	1572-02	TRUE
13722.58cfa831e4b0c9d6adf6c39a	58cfa831e4b0c9d6adf6c39a	TCGA-CG-5721-01A-11D-1598_121011_SN208_0434_AC18MYACXX_s_1_rg.sorted.filtered.	WGS	TCGA-CG-5721-01A-11D-1598_121011_SN208_0434_AC18MYACXX_s_1_rg.sorted	TCGA-CG-5721-01A-11D-1598_121011_SN208_0434_AC18MYACXX_s_1_rg.sorted.bam	211	1.9	0.16	58cfa831e4b0c9d6adf6c39a	TCGA-CG-5721-01A-11D-1598_121011_SN208_0434_AC18MYACXX_s_1_rg.sorted.bam	Alive	MALE	Not available	Not available	Stomach Adenocarcinoma	Aligned reads	TCGA-CG-5721-01A	588ABAEA-AB16-42F4-9457-5901EE791B5F	Primary Tumor	Illumina HiSeq	450e30b5-bcb4-4169-a48f-bbf3db7feda2	Stomach	58	B79123B9-5094-426D-8267-FD4A1C9F2778	8DE4E4AE-4C98-4D4E-BC77-2C205D817E01	TCGA-CG-5721-01A-11D-1598-02	HG19_Broad_variant	TCGA-CG-5721	TCGA-STAD	NA	s14555	Harvard Medical School	Indivumed	Germany	NO	T4	N1	Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS)	Stage IV	1598-02	TRUE
13722.58cfa831e4b0c9d6adf6c5c8	58cfa831e4b0c9d6adf6c5c8	TCGA-CG-4469-01A-01D-1154_130815_VM001_0005_VMR0005CXX_s_7_rg.sorted.filtered.	WGS	TCGA-CG-4469-01A-01D-1154_130815_VM001_0005_VMR0005CXX_s_7_rg.sorted	TCGA-CG-4469-01A-01D-1154_130815_VM001_0005_VMR0005CXX_s_7_rg.sorted.bam	298.2	1.9	0.14	58cfa831e4b0c9d6adf6c5c8	TCGA-CG-4469-01A-01D-1154_130815_VM001_0005_VMR0005CXX_s_7_rg.sorted.bam	Dead	MALE	Not available	Not available	Stomach Adenocarcinoma	Aligned reads	TCGA-CG-4469-01A	2AC986F6-CD6F-4CA5-90CC-7A105CFE85EA	Primary Tumor	Illumina HiSeq	ed99ca3f-0ae6-43ab-a171-dc2774cf52e2	Stomach	70	2A3D7538-D377-4D94-BB61-BF77BA56BE1B	9BAFEA4B-CCC4-4F5D-8BFE-BD13D56741F6	TCGA-CG-4469-01A-01D-1154-02	HG19_Broad_variant	TCGA-CG-4469	TCGA-STAD	215	s14988	Harvard Medical School	Indivumed	Germany	NO	T3	N3	Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS)	Stage IV	1154-02	TRUE
13722.58cfa830e4b0c9d6adf6c214	58cfa830e4b0c9d6adf6c214	TCGA-BA-4077-01B-01D-1431_120310_SN590_0145_BD0RGYACXX_s_7_rg.sorted.filtered.	WGS	TCGA-BA-4077-01B-01D-1431_120310_SN590_0145_BD0RGYACXX_s_7_rg.sorted	TCGA-BA-4077-01B-01D-1431_120310_SN590_0145_BD0RGYACXX_s_7_rg.sorted.bam	246.33	1.9	0.15	58cfa830e4b0c9d6adf6c214	TCGA-BA-4077-01B-01D-1431_120310_SN590_0145_BD0RGYACXX_s_7_rg.sorted.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-BA-4077-01B	4BFBCE2B-9D0B-4E8A-950F-FD8E0BA3E05A	Primary Tumor	Illumina HiSeq	4f243210-88ea-4d9f-88fd-faf45b45d38e	Head and Neck	45	327BBCA7-FA25-4A92-BE27-21A4C184C760	8428602A-5EEC-4D09-B187-02B1CFF24EB5	TCGA-BA-4077-01B-01D-1431-02	HG19_Broad_variant	TCGA-BA-4077	TCGA-HNSC	1134	s16314	Harvard Medical School	UNC	None	NO	T4a	N0	Head and Neck Squamous Cell Carcinoma	Stage IVA	1431-02	TRUE
13722.58cfa831e4b0c9d6adf6c61a	58cfa831e4b0c9d6adf6c61a	TCGA-CG-4305-01A-01D-1154_130815_VM001_0001_VMR0001CXX_s_1_rg.sorted.filtered.	WGS	TCGA-CG-4305-01A-01D-1154_130815_VM001_0001_VMR0001CXX_s_1_rg.sorted	TCGA-CG-4305-01A-01D-1154_130815_VM001_0001_VMR0001CXX_s_1_rg.sorted.bam	264.2	1.9	0.13	58cfa831e4b0c9d6adf6c61a	TCGA-CG-4305-01A-01D-1154_130815_VM001_0001_VMR0001CXX_s_1_rg.sorted.bam	Alive	MALE	Not available	Not available	Stomach Adenocarcinoma	Aligned reads	TCGA-CG-4305-01A	E0E35051-FBB4-4389-AEDB-87BDE84D21AD	Primary Tumor	Illumina HiSeq	dad3a237-d784-4731-bbef-c4d3dce49fa2	Stomach	69	6B64B4A0-EDC8-4DC3-B527-D320DED81351	A01B1633-2A30-4379-80AC-72799C14B5C7	TCGA-CG-4305-01A-01D-1154-02	HG19_Broad_variant	TCGA-CG-4305	TCGA-STAD	NA	s14981	Harvard Medical School	Indivumed	Germany	NO	T2a	N1	Stomach  Adenocarcinoma  Not Otherwise Specified (NOS)	Stage II	1154-02	TRUE
13722.58cfa831e4b0c9d6adf6c670	58cfa831e4b0c9d6adf6c670	TCGA-CS-4944-01A-01D-1465_130808_SN208_0487_AC28U7ACXX_s_3_rg.sorted.filtered.	WGS	TCGA-CS-4944-01A-01D-1465_130808_SN208_0487_AC28U7ACXX_s_3_rg.sorted	TCGA-CS-4944-01A-01D-1465_130808_SN208_0487_AC28U7ACXX_s_3_rg.sorted.bam	18	1.9	0.14	58cfa831e4b0c9d6adf6c670	TCGA-CS-4944-01A-01D-1465_130808_SN208_0487_AC28U7ACXX_s_3_rg.sorted.bam	Alive	MALE	WHITE	Not available	Brain Lower Grade Glioma	Aligned reads	TCGA-CS-4944-01A	64CD17EB-C778-45E9-B994-02B68182E51B	Primary Tumor	Illumina HiSeq	c266d33e-c72f-4059-b287-2f1bbd6fd48b	Brain	50	F1AA24E4-BC7F-427F-9CEB-8CAAFABFE535	63B56E68-639B-483B-B777-EAD4BDDC112C	TCGA-CS-4944-01A-01D-1465-02	HG19_Broad_variant	TCGA-CS-4944	TCGA-LGG	NA	s8127	Harvard Medical School	Thomas Jefferson University	United States	NO	Not available	Not available	Astrocytoma	Not available	1465-02	TRUE
13722.58cfa831e4b0c9d6adf6c5ed	58cfa831e4b0c9d6adf6c5ed	TCGA-CG-4306-01A-01D-1154_130815_VM001_0001_VMR0001CXX_s_3_rg.sorted.filtered.	WGS	TCGA-CG-4306-01A-01D-1154_130815_VM001_0001_VMR0001CXX_s_3_rg.sorted	TCGA-CG-4306-01A-01D-1154_130815_VM001_0001_VMR0001CXX_s_3_rg.sorted.bam	213.2	1.9	0.14	58cfa831e4b0c9d6adf6c5ed	TCGA-CG-4306-01A-01D-1154_130815_VM001_0001_VMR0001CXX_s_3_rg.sorted.bam	Dead	MALE	Not available	Not available	Stomach Adenocarcinoma	Aligned reads	TCGA-CG-4306-01A	73D177F7-8C0A-42F6-A73D-8073C0E6142B	Primary Tumor	Illumina HiSeq	97a524b1-432a-4c20-adcf-5e45ee168834	Stomach	90	78785DB9-C3D5-4C26-BBEF-E741C4AAE429	42E4D7EE-860D-498E-AA00-D2AB42EB4ECA	TCGA-CG-4306-01A-01D-1154-02	HG19_Broad_variant	TCGA-CG-4306	TCGA-STAD	31	s14827	Harvard Medical School	Indivumed	Germany	NO	T3	N2	Stomach  Adenocarcinoma  Not Otherwise Specified (NOS)	Stage IV	1154-02	TRUE
13722.58cfa831e4b0c9d6adf6c73a	58cfa831e4b0c9d6adf6c73a	TCGA-D7-6524-01A-11D-1798_130214_SN1120_0237_BD1TGLACXX_s_5_rg.sorted.filtered.	WGS	TCGA-D7-6524-01A-11D-1798_130214_SN1120_0237_BD1TGLACXX_s_5_rg.sorted	TCGA-D7-6524-01A-11D-1798_130214_SN1120_0237_BD1TGLACXX_s_5_rg.sorted.bam	274.4	1.9	0.16	58cfa831e4b0c9d6adf6c73a	TCGA-D7-6524-01A-11D-1798_130214_SN1120_0237_BD1TGLACXX_s_5_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-D7-6524-01A	7EF3F065-1928-4A58-B5A6-76DDDB8488CF	Primary Tumor	Illumina HiSeq	67f702e7-84ad-4d23-90e7-03040d417e4d	Stomach	53	6F14723A-AF83-402D-AB98-B4ED29A93AAF	48540EAA-46FD-4C0A-9893-1FF69D205F79	TCGA-D7-6524-01A-11D-1798-02	HG19_Broad_variant	TCGA-D7-6524	TCGA-STAD	NA	s14557	Harvard Medical School	Greater Poland Cancer Center	Poland	NO	T2	N1	Stomach  Adenocarcinoma  Diffuse Type	Stage II	1798-02	TRUE
13722.58cfa831e4b0c9d6adf6c6be	58cfa831e4b0c9d6adf6c6be	TCGA-CN-4742-01A-02D-1509_120420_SN208_0285_AD0T5JACXX_s_1_rg.sorted.filtered.	WGS	TCGA-CN-4742-01A-02D-1509_120420_SN208_0285_AD0T5JACXX_s_1_rg.sorted	TCGA-CN-4742-01A-02D-1509_120420_SN208_0285_AD0T5JACXX_s_1_rg.sorted.bam	52.7	1.9	0.16	58cfa831e4b0c9d6adf6c6be	TCGA-CN-4742-01A-02D-1509_120420_SN208_0285_AD0T5JACXX_s_1_rg.sorted.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CN-4742-01A	444E5BFC-D4E5-4B0D-B96D-88ECEA8873E9	Primary Tumor	Illumina HiSeq	e655fe0a-a859-4967-b69c-4c8d36a8a7e0	Head and Neck	48	507B9A1D-BFBF-43F8-86D2-665A488441AF	A9768535-FE1C-4B4F-B709-DED0809BA592	TCGA-CN-4742-01A-02D-1509-02	HG19_Broad_variant	TCGA-CN-4742	TCGA-HNSC	397	s15892	Harvard Medical School	University of Pittsburgh	None	NO	T4a	N2b	Head and Neck Squamous Cell Carcinoma	Stage IVA	1509-02	TRUE
13722.58cfa831e4b0c9d6adf6c702	58cfa831e4b0c9d6adf6c702	TCGA-CV-5966-01A-11D-1681_120427_SN1120_0136_AC0JEMACXX_s_2_rg.sorted.filtered.	WGS	TCGA-CV-5966-01A-11D-1681_120427_SN1120_0136_AC0JEMACXX_s_2_rg.sorted	TCGA-CV-5966-01A-11D-1681_120427_SN1120_0136_AC0JEMACXX_s_2_rg.sorted.bam	99	1.9	0.14	58cfa831e4b0c9d6adf6c702	TCGA-CV-5966-01A-11D-1681_120427_SN1120_0136_AC0JEMACXX_s_2_rg.sorted.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-5966-01A	0D0731E2-8D82-4B6D-9258-2896A770A868	Primary Tumor	Illumina HiSeq	a774b0c6-39f6-4601-9c2a-5a81369b9f87	Head and Neck	63	E71C33E9-1F74-4CF6-B6BF-985D0C96F71E	84D0CA61-132A-4B85-A343-0C55DE088B0C	TCGA-CV-5966-01A-11D-1681-02	HG19_Broad_variant	TCGA-CV-5966	TCGA-HNSC	545	s16335	Harvard Medical School	MD Anderson Cancer Center	None	NO	T4a	N1	Head and Neck Squamous Cell Carcinoma	Stage IVA	1681-02	TRUE
13722.58cfa831e4b0c9d6adf6c7aa	58cfa831e4b0c9d6adf6c7aa	TCGA-D1-A17R-01A-11D-A12F_120523_SN1222_0109_BD12MPACXX_s_1_rg.sorted.filtered.	WGS	TCGA-D1-A17R-01A-11D-A12F_120523_SN1222_0109_BD12MPACXX_s_1_rg.sorted	TCGA-D1-A17R-01A-11D-A12F_120523_SN1222_0109_BD12MPACXX_s_1_rg.sorted.bam	76.31	1.88	0.16	58cfa831e4b0c9d6adf6c7aa	TCGA-D1-A17R-01A-11D-A12F_120523_SN1222_0109_BD12MPACXX_s_1_rg.sorted.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-D1-A17R-01A	73A0DD38-115D-48FB-B683-04AA5D612F2A	Primary Tumor	Illumina HiSeq	5425360b-22c2-480d-aa90-d7b4b67dad49	Uterus	58	205DE3E7-B078-4904-82C3-3D0F757D94A8	DF3E4C9B-67D4-46FF-BFE0-4F55A72CA179	TCGA-D1-A17R-01A-11D-A12F-02	HG19_Broad_variant	TCGA-D1-A17R	TCGA-UCEC	339	s5227	Harvard Medical School	Mayo Clinic	None	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A12F-02	TRUE
13722.58cfa831e4b0c9d6adf6c7b1	58cfa831e4b0c9d6adf6c7b1	TCGA-CN-6996-01A-11D-1911_120504_SN1222_0101_AC0UMDACXX_s_5_rg.sorted.filtered.	WGS	TCGA-CN-6996-01A-11D-1911_120504_SN1222_0101_AC0UMDACXX_s_5_rg.sorted	TCGA-CN-6996-01A-11D-1911_120504_SN1222_0101_AC0UMDACXX_s_5_rg.sorted.bam	155.7	NA	0.15	58cfa831e4b0c9d6adf6c7b1	TCGA-CN-6996-01A-11D-1911_120504_SN1222_0101_AC0UMDACXX_s_5_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CN-6996-01A	49B94421-FE82-4F24-8EF2-820674142418	Primary Tumor	Illumina HiSeq	533cea76-ea79-4b37-8e72-5626bc894990	Head and Neck	58	2C3790CE-A54D-431B-B76C-FA25441AA41C	5367CF72-E404-4203-AD7D-CF7663072EA7	TCGA-CN-6996-01A-11D-1911-02	HG19_Broad_variant	TCGA-CN-6996	TCGA-HNSC	NA	s16180	Harvard Medical School	University of Pittsburgh	United States	NO	T3	N2b	Head and Neck Squamous Cell Carcinoma	Stage IVA	1911-02	TRUE
13722.58cfa831e4b0c9d6adf6c7c8	58cfa831e4b0c9d6adf6c7c8	TCGA-D1-A17K-01A-11D-A12F_120523_SN1222_0108_AC0VL4ACXX_s_2_rg.sorted.filtered.	WGS	TCGA-D1-A17K-01A-11D-A12F_120523_SN1222_0108_AC0VL4ACXX_s_2_rg.sorted	TCGA-D1-A17K-01A-11D-A12F_120523_SN1222_0108_AC0VL4ACXX_s_2_rg.sorted.bam	56.36	1.95	0.15	58cfa831e4b0c9d6adf6c7c8	TCGA-D1-A17K-01A-11D-A12F_120523_SN1222_0108_AC0VL4ACXX_s_2_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-D1-A17K-01A	5C22C8D6-5805-455C-8E1C-E6B8006738E4	Primary Tumor	Illumina HiSeq	312dd86a-5fc1-4446-bfd6-fe867e3617f2	Uterus	74	CA213835-EFC5-4216-A762-A6B320B516BF	3E67F5BD-C5A6-4CDD-8D71-78038D316447	TCGA-D1-A17K-01A-11D-A12F-02	HG19_Broad_variant	TCGA-D1-A17K	TCGA-UCEC	NA	s4617	Harvard Medical School	Mayo Clinic	None	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A12F-02	TRUE
13722.58cfa831e4b0c9d6adf6c7cb	58cfa831e4b0c9d6adf6c7cb	TCGA-CX-7085-01A-21D-2317_120710_SN590_0166_AC0VNFACXX_s_3_rg.sorted.filtered.	WGS	TCGA-CX-7085-01A-21D-2317_120710_SN590_0166_AC0VNFACXX_s_3_rg.sorted	TCGA-CX-7085-01A-21D-2317_120710_SN590_0166_AC0VNFACXX_s_3_rg.sorted.bam	262.73	NA	0.15	58cfa831e4b0c9d6adf6c7cb	TCGA-CX-7085-01A-21D-2317_120710_SN590_0166_AC0VNFACXX_s_3_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CX-7085-01A	2A7B4613-F908-4E78-98ED-857DCD7ED774	Primary Tumor	Illumina HiSeq	2a118e3e-c8f9-43b4-b1d7-4659e37a96ce	Head and Neck	77	A07E086C-1D2D-4D92-A663-ECD7EA4DBD73	57FA3BBB-D571-475C-95A2-AAEDFF4835FC	TCGA-CX-7085-01A-21D-2317-26	HG19_Broad_variant	TCGA-CX-7085	TCGA-HNSC	NA	s16056	MD Anderson - Institute for Applied Cancer Science	Medical College of Georgia	United States	NO	T1	N0	Head and Neck Squamous Cell Carcinoma	Stage I	2317-26	TRUE
13722.58cfa831e4b0c9d6adf6c78a	58cfa831e4b0c9d6adf6c78a	TCGA-CV-5439-01A-01D-1681_120427_SN1120_0136_AC0JEMACXX_s_1_rg.sorted.filtered.	WGS	TCGA-CV-5439-01A-01D-1681_120427_SN1120_0136_AC0JEMACXX_s_1_rg.sorted	TCGA-CV-5439-01A-01D-1681_120427_SN1120_0136_AC0JEMACXX_s_1_rg.sorted.bam	262	1.9	0.17	58cfa831e4b0c9d6adf6c78a	TCGA-CV-5439-01A-01D-1681_120427_SN1120_0136_AC0JEMACXX_s_1_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-5439-01A	3EE863DA-7991-414F-82D8-2B6502D4C061	Primary Tumor	Illumina HiSeq	e10c02de-cabd-4311-baab-3bb90e13717f	Head and Neck	62	C94D8E61-8A15-4702-90EF-37616F1C015B	A1170138-A1B1-4D13-B66B-0507D3DE897B	TCGA-CV-5439-01A-01D-1681-02	HG19_Broad_variant	TCGA-CV-5439	TCGA-HNSC	546	s16194	Harvard Medical School	MD Anderson Cancer Center	None	NO	T3	N2b	Head and Neck Squamous Cell Carcinoma	Stage IVA	1681-02	TRUE
13722.58cfa831e4b0c9d6adf6c7f7	58cfa831e4b0c9d6adf6c7f7	TCGA-D1-A17C-01A-11D-A12F_120418_SN1222_0097_AC0M28ACXX_s_1_rg.sorted.filtered.	WGS	TCGA-D1-A17C-01A-11D-A12F_120418_SN1222_0097_AC0M28ACXX_s_1_rg.sorted	TCGA-D1-A17C-01A-11D-A12F_120418_SN1222_0097_AC0M28ACXX_s_1_rg.sorted.bam	46.77	1.95	0.15	58cfa831e4b0c9d6adf6c7f7	TCGA-D1-A17C-01A-11D-A12F_120418_SN1222_0097_AC0M28ACXX_s_1_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-D1-A17C-01A	6F4F0CDD-8387-45D0-A9E8-EFCE6260159D	Primary Tumor	Illumina HiSeq	554e5953-4680-4681-a963-fcc940b3f448	Uterus	78	2D5AC7FC-BED4-4C7F-927D-9B44846324C4	99444E9D-219B-4653-9410-B258D28DEEB7	TCGA-D1-A17C-01A-11D-A12F-02	HG19_Broad_variant	TCGA-D1-A17C	TCGA-UCEC	NA	s4801	Harvard Medical School	Mayo Clinic	None	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A12F-02	TRUE
13722.58cfa831e4b0c9d6adf6c803	58cfa831e4b0c9d6adf6c803	TCGA-D1-A16N-01A-11D-A12F_120522_SN208_0301_BC0VNWACXX_s_2_rg.sorted.filtered.	WGS	TCGA-D1-A16N-01A-11D-A12F_120522_SN208_0301_BC0VNWACXX_s_2_rg.sorted	TCGA-D1-A16N-01A-11D-A12F_120522_SN208_0301_BC0VNWACXX_s_2_rg.sorted.bam	99.18	1.97	0.15	58cfa831e4b0c9d6adf6c803	TCGA-D1-A16N-01A-11D-A12F_120522_SN208_0301_BC0VNWACXX_s_2_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-D1-A16N-01A	DBBBDDAE-D711-40F5-BD10-863735885B1F	Primary Tumor	Illumina HiSeq	0cea9a43-7170-4273-879f-084cb6e14196	Uterus	51	6D916A47-DCFF-4C98-9E88-348AAA353F98	133CBA56-19C9-47AE-AB5E-37FF35A7E71E	TCGA-D1-A16N-01A-11D-A12F-02	HG19_Broad_variant	TCGA-D1-A16N	TCGA-UCEC	NA	s4263	Harvard Medical School	Mayo Clinic	None	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A12F-02	TRUE
13722.58cfa831e4b0c9d6adf6c836	58cfa831e4b0c9d6adf6c836	TCGA-D7-6521-01A-11D-1798_130214_SN1120_0237_BD1TGLACXX_s_1_rg.sorted.filtered.	WGS	TCGA-D7-6521-01A-11D-1798_130214_SN1120_0237_BD1TGLACXX_s_1_rg.sorted	TCGA-D7-6521-01A-11D-1798_130214_SN1120_0237_BD1TGLACXX_s_1_rg.sorted.bam	131.4	1.9	0.14	58cfa831e4b0c9d6adf6c836	TCGA-D7-6521-01A-11D-1798_130214_SN1120_0237_BD1TGLACXX_s_1_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-D7-6521-01A	6DE6B8E2-03EB-4F32-B5A3-BEA73FC632B4	Primary Tumor	Illumina HiSeq	72a895e9-b1b0-4b79-a5e6-6bae340e8798	Stomach	65	C3D9FC3B-EF2A-4D02-B7A4-5D1463AD5EF3	0F49F6E2-C6C8-4F3E-8755-BAA962453E71	TCGA-D7-6521-01A-11D-1798-02	HG19_Broad_variant	TCGA-D7-6521	TCGA-STAD	NA	s14838	Harvard Medical School	Greater Poland Cancer Center	Poland	NO	T2b	N2	Stomach  Adenocarcinoma  Diffuse Type	Stage IIIA	1798-02	TRUE
13722.58cfa831e4b0c9d6adf6c82b	58cfa831e4b0c9d6adf6c82b	TCGA-D1-A17Q-01A-11D-A12F_120418_SN1222_0097_AC0M28ACXX_s_2_rg.sorted.filtered.	WGS	TCGA-D1-A17Q-01A-11D-A12F_120418_SN1222_0097_AC0M28ACXX_s_2_rg.sorted	TCGA-D1-A17Q-01A-11D-A12F_120418_SN1222_0097_AC0M28ACXX_s_2_rg.sorted.bam	77.69	1.86	0.16	58cfa831e4b0c9d6adf6c82b	TCGA-D1-A17Q-01A-11D-A12F_120418_SN1222_0097_AC0M28ACXX_s_2_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-D1-A17Q-01A	CA8DBBFD-8928-4E25-94C6-B875DE631BBD	Primary Tumor	Illumina HiSeq	77e56615-42dd-4c50-a518-cc93c3b80107	Uterus	54	B6ABEB01-B6EA-4AB4-AA00-AE16CFC88B7C	59FB249D-4C77-40B1-A557-98281869AC91	TCGA-D1-A17Q-01A-11D-A12F-02	HG19_Broad_variant	TCGA-D1-A17Q	TCGA-UCEC	NA	s4442	Harvard Medical School	Mayo Clinic	None	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A12F-02	TRUE
13722.58cfa831e4b0c9d6adf6c8c4	58cfa831e4b0c9d6adf6c8c4	TCGA-CN-5373-01A-01D-1431_120420_SN1120_0134_AC0J8YACXX_s_4_rg.sorted.filtered.	WGS	TCGA-CN-5373-01A-01D-1431_120420_SN1120_0134_AC0J8YACXX_s_4_rg.sorted	TCGA-CN-5373-01A-01D-1431_120420_SN1120_0134_AC0J8YACXX_s_4_rg.sorted.bam	165.7	1.9	0.14	58cfa831e4b0c9d6adf6c8c4	TCGA-CN-5373-01A-01D-1431_120420_SN1120_0134_AC0J8YACXX_s_4_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CN-5373-01A	546F01D5-AED5-4FB8-91C0-0FD5E0FDE935	Primary Tumor	Illumina HiSeq	22213a76-97e9-4565-8074-c3046269b70a	Head and Neck	55	9D73D061-F1E1-47BA-929D-FEEB6C191279	3FE7F18F-8AA4-4AFE-8AF0-256876F7E86E	TCGA-CN-5373-01A-01D-1431-02	HG19_Broad_variant	TCGA-CN-5373	TCGA-HNSC	NA	s16035	Harvard Medical School	University of Pittsburgh	None	NO	T1	N0	Head and Neck Squamous Cell Carcinoma	Stage I	1431-02	TRUE
13722.58cfa831e4b0c9d6adf6c8e8	58cfa831e4b0c9d6adf6c8e8	TCGA-CV-6441-01A-11D-1681_120427_SN208_0287_AC0J25ACXX_s_2_rg.sorted.filtered.	WGS	TCGA-CV-6441-01A-11D-1681_120427_SN208_0287_AC0J25ACXX_s_2_rg.sorted	TCGA-CV-6441-01A-11D-1681_120427_SN208_0287_AC0J25ACXX_s_2_rg.sorted.bam	46	1.9	0.14	58cfa831e4b0c9d6adf6c8e8	TCGA-CV-6441-01A-11D-1681_120427_SN208_0287_AC0J25ACXX_s_2_rg.sorted.bam	Dead	MALE	WHITE	HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-6441-01A	59398D50-45CF-4812-A24E-0C00C0199971	Primary Tumor	Illumina HiSeq	4df6f8df-9255-4e46-8936-baeab0ed20c2	Head and Neck	60	192C9F36-08EC-4F7F-8137-1A9BD0282D98	FE879D88-4817-4ED8-9FB2-EE92AF1A582F	TCGA-CV-6441-01A-11D-1681-02	HG19_Broad_variant	TCGA-CV-6441	TCGA-HNSC	292	s15779	Harvard Medical School	MD Anderson Cancer Center	United States	NO	T3	N0	Head and Neck Squamous Cell Carcinoma	Stage III	1681-02	TRUE
13722.58cfa831e4b0c9d6adf6c8ea	58cfa831e4b0c9d6adf6c8ea	TCGA-CV-7411-01A-11D-2317_120730_SN1222_0140_AC11GKACXX_s_5_rg.sorted.filtered.	WGS	TCGA-CV-7411-01A-11D-2317_120730_SN1222_0140_AC11GKACXX_s_5_rg.sorted	TCGA-CV-7411-01A-11D-2317_120730_SN1222_0140_AC11GKACXX_s_5_rg.sorted.bam	80.73	NA	0.16	58cfa831e4b0c9d6adf6c8ea	TCGA-CV-7411-01A-11D-2317_120730_SN1222_0140_AC11GKACXX_s_5_rg.sorted.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-7411-01A	600FC87B-A177-4BF9-9084-457F7E7E102C	Primary Tumor	Illumina HiSeq	7db9b308-952d-4c12-98c4-9de1f4b9fbd2	Head and Neck	64	24876E1A-E07E-4F74-86BF-3395A88CE4A1	221E7B51-6E05-45A9-99AC-EB705D3B2AD8	TCGA-CV-7411-01A-11D-2317-26	HG19_Broad_variant	TCGA-CV-7411	TCGA-HNSC	2717	s15526	MD Anderson - Institute for Applied Cancer Science	MD Anderson Cancer Center	United States	NO	T4a	N0	Head and Neck Squamous Cell Carcinoma	Stage IVA	2317-26	TRUE
13722.58cfa831e4b0c9d6adf6c91f	58cfa831e4b0c9d6adf6c91f	TCGA-DK-A1AB-01A-11D-A13U_121002_SN1222_0154_AC1A3DACXX_s_3_rg.sorted.filtered.	WGS	TCGA-DK-A1AB-01A-11D-A13U_121002_SN1222_0154_AC1A3DACXX_s_3_rg.sorted	TCGA-DK-A1AB-01A-11D-A13U_121002_SN1222_0154_AC1A3DACXX_s_3_rg.sorted.bam	43.47	2	0.18	58cfa831e4b0c9d6adf6c91f	TCGA-DK-A1AB-01A-11D-A13U_121002_SN1222_0154_AC1A3DACXX_s_3_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-DK-A1AB-01A	F027D254-EC01-4882-A8A7-964AE90B7D49	Primary Tumor	Illumina HiSeq	a5005e15-2ada-4bf4-9a61-0febc81a99ca	Bladder	74	253F84AB-FCE2-4E2D-955B-0B8D13A9E4F0	D1F85B58-EBF8-4A73-A5E0-8DFE62CF1164	TCGA-DK-A1AB-01A-11D-A13U-02	HG19_Broad_variant	TCGA-DK-A1AB	TCGA-BLCA	NA	s2707	Harvard Medical School	Memorial Sloan Kettering	United States	NO	T4a	N2	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV	A13U-02	TRUE
13722.58cfa831e4b0c9d6adf6c8f2	58cfa831e4b0c9d6adf6c8f2	TCGA-CV-5976-01A-11D-1681_120427_SN1120_0137_BD0T3FACXX_s_2_rg.sorted.filtered.	WGS	TCGA-CV-5976-01A-11D-1681_120427_SN1120_0137_BD0T3FACXX_s_2_rg.sorted	TCGA-CV-5976-01A-11D-1681_120427_SN1120_0137_BD0T3FACXX_s_2_rg.sorted.bam	135	1.9	0.15	58cfa831e4b0c9d6adf6c8f2	TCGA-CV-5976-01A-11D-1681_120427_SN1120_0137_BD0T3FACXX_s_2_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-5976-01A	23062172-7361-4E61-8EE6-B0A613D72A24	Primary Tumor	Illumina HiSeq	ef7745ae-17be-41bc-a3a5-c24eeda89075	Head and Neck	50	EEF68956-D624-4CD0-9C48-28FAF052C5F9	2581BC16-0DEF-40BC-8A97-54A1AE577E26	TCGA-CV-5976-01A-11D-1681-02	HG19_Broad_variant	TCGA-CV-5976	TCGA-HNSC	NA	s16041	Harvard Medical School	MD Anderson Cancer Center	None	NO	T4a	N2b	Head and Neck Squamous Cell Carcinoma	Stage IVA	1681-02	TRUE
13722.58cfa831e4b0c9d6adf6c93f	58cfa831e4b0c9d6adf6c93f	TCGA-DK-A1AC-01A-11D-A13U_121002_SN1222_0154_AC1A3DACXX_s_5_rg.sorted.filtered.	WGS	TCGA-DK-A1AC-01A-11D-A13U_121002_SN1222_0154_AC1A3DACXX_s_5_rg.sorted	TCGA-DK-A1AC-01A-11D-A13U_121002_SN1222_0154_AC1A3DACXX_s_5_rg.sorted.bam	61.12	1.95	0.15	58cfa831e4b0c9d6adf6c93f	TCGA-DK-A1AC-01A-11D-A13U_121002_SN1222_0154_AC1A3DACXX_s_5_rg.sorted.bam	Alive	MALE	WHITE	Not available	Bladder Urothelial Carcinoma	Aligned reads	TCGA-DK-A1AC-01A	36C14E9D-1863-4C55-BBBB-F8C9DD418932	Primary Tumor	Illumina HiSeq	befc5d25-55df-4a22-b4e4-25508f3935c9	Bladder	72	CD2FB6B8-5DB9-42B4-A407-A5B6F7B8665F	221E5DDE-BAB0-456C-87BE-DB54998FE197	TCGA-DK-A1AC-01A-11D-A13U-02	HG19_Broad_variant	TCGA-DK-A1AC	TCGA-BLCA	NA	s2884	Harvard Medical School	Memorial Sloan Kettering	United States	NO	T3b	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage III	A13U-02	TRUE
13722.58cfa831e4b0c9d6adf6ca71	58cfa831e4b0c9d6adf6ca71	TCGA-DO-A1JZ-01A-11D-A13U_120706_SN1222_0123_BD1488ACXX_s_6_rg.sorted.filtered.	WGS	TCGA-DO-A1JZ-01A-11D-A13U_120706_SN1222_0123_BD1488ACXX_s_6_rg.sorted	TCGA-DO-A1JZ-01A-11D-A13U_120706_SN1222_0123_BD1488ACXX_s_6_rg.sorted.bam	91.81	1.77	0.15	58cfa831e4b0c9d6adf6ca71	TCGA-DO-A1JZ-01A-11D-A13U_120706_SN1222_0123_BD1488ACXX_s_6_rg.sorted.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-DO-A1JZ-01A	169F045F-1739-4B0B-9BDC-028AACA420F8	Primary Tumor	Illumina HiSeq	a349224e-f179-4a21-ae6f-5807917a484d	Thyroid	23	2EEB72CD-8A11-4ED1-87B0-3CF0C1BF1FB5	C69C86EC-D4E4-422B-88F8-AF3CE8B14148	TCGA-DO-A1JZ-01A-11D-A13U-02	HG19_Broad_variant	TCGA-DO-A1JZ	TCGA-THCA	NA	s12377	Harvard Medical School	Medical College of Georgia	United States	NO	T2	NX	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	Stage I	A13U-02	TRUE
13722.58cfa831e4b0c9d6adf6cb00	58cfa831e4b0c9d6adf6cb00	TCGA-EA-A3QE-01A-21D-A245_140124_SN1440_0178_AC2PL6ACXX_s_5_rg.sorted.filtered.	WGS	TCGA-EA-A3QE-01A-21D-A245_140124_SN1440_0178_AC2PL6ACXX_s_5_rg.sorted	TCGA-EA-A3QE-01A-21D-A245_140124_SN1440_0178_AC2PL6ACXX_s_5_rg.sorted.bam	67	NA	0.14	58cfa831e4b0c9d6adf6cb00	TCGA-EA-A3QE-01A-21D-A245_140124_SN1440_0178_AC2PL6ACXX_s_5_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-EA-A3QE-01A	A4E444B5-BBCA-4EF0-B92F-908D608CBB91	Primary Tumor	Illumina HiSeq	14055776-9bfb-42c1-a760-39fb0c8dba92	Cervix	45	36FFA53D-1404-49C0-B9C1-A3EB1ECBC6B9	80A263E0-9F91-48FD-B53C-7E2A25710BF3	TCGA-EA-A3QE-01A-21D-A245-26	HG19_Broad_variant	TCGA-EA-A3QE	TCGA-CESC	NA	s1524	MD Anderson - Institute for Applied Cancer Science	Asterand	Russia	NO	T1b	N0	Cervical Squamous Cell Carcinoma	Not available	A245-26	TRUE
13722.58cfa831e4b0c9d6adf6cb04	58cfa831e4b0c9d6adf6cb04	TCGA-EA-A3HT-01A-61D-A245_140124_SN1440_0178_AC2PL6ACXX_s_2_rg.sorted.filtered.	WGS	TCGA-EA-A3HT-01A-61D-A245_140124_SN1440_0178_AC2PL6ACXX_s_2_rg.sorted	TCGA-EA-A3HT-01A-61D-A245_140124_SN1440_0178_AC2PL6ACXX_s_2_rg.sorted.bam	54.34	NA	0.15	58cfa831e4b0c9d6adf6cb04	TCGA-EA-A3HT-01A-61D-A245_140124_SN1440_0178_AC2PL6ACXX_s_2_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-EA-A3HT-01A	3C5B2452-014B-495F-B86A-F522ED84BC3B	Primary Tumor	Illumina HiSeq	e0e70b08-26f3-48d5-80c3-4836e9faa569	Cervix	68	8460C1E5-0029-4D66-AF11-373324347800	CE1A5984-E350-46A3-BF53-B32DEC8F8AF0	TCGA-EA-A3HT-01A-61D-A245-26	HG19_Broad_variant	TCGA-EA-A3HT	TCGA-CESC	NA	s1182	MD Anderson - Institute for Applied Cancer Science	Asterand	Russia	NO	T1b	N0	Cervical Squamous Cell Carcinoma	Not available	A245-26	TRUE
13722.58cfa831e4b0c9d6adf6ca93	58cfa831e4b0c9d6adf6ca93	TCGA-D1-A16R-01A-11D-A12F_120523_SN1222_0109_BD12MPACXX_s_5_rg.sorted.filtered.	WGS	TCGA-D1-A16R-01A-11D-A12F_120523_SN1222_0109_BD12MPACXX_s_5_rg.sorted	TCGA-D1-A16R-01A-11D-A12F_120523_SN1222_0109_BD12MPACXX_s_5_rg.sorted.bam	93.33	1.39	0.17	58cfa831e4b0c9d6adf6ca93	TCGA-D1-A16R-01A-11D-A12F_120523_SN1222_0109_BD12MPACXX_s_5_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-D1-A16R-01A	40F43483-B504-4EA7-AD24-40682B10CAAC	Primary Tumor	Illumina HiSeq	3574ade8-f6bc-44dc-94ce-8ea657978707	Uterus	39	F57EB4ED-4393-4DC3-9362-A4757EF8B21D	93FEF054-0782-4A27-A27B-22176874E805	TCGA-D1-A16R-01A-11D-A12F-02	HG19_Broad_variant	TCGA-D1-A16R	TCGA-UCEC	NA	s4618	Harvard Medical School	Mayo Clinic	None	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A12F-02	TRUE
13722.58cfa831e4b0c9d6adf6cb25	58cfa831e4b0c9d6adf6cb25	TCGA-E8-A242-01A-21D-A16N_121204_SN208_0442_BC1F7YACXX_s_3_rg.sorted.filtered.	WGS	TCGA-E8-A242-01A-21D-A16N_121204_SN208_0442_BC1F7YACXX_s_3_rg.sorted	TCGA-E8-A242-01A-21D-A16N_121204_SN208_0442_BC1F7YACXX_s_3_rg.sorted.bam	17.09	1.94	0.18	58cfa831e4b0c9d6adf6cb25	TCGA-E8-A242-01A-21D-A16N_121204_SN208_0442_BC1F7YACXX_s_3_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-E8-A242-01A	4D9DE9A1-7DF1-412E-9F16-15DD51B4C5F5	Primary Tumor	Illumina HiSeq	0e5bb14f-1671-4b8a-9a38-e1d389ecd440	Thyroid	56	225B76AD-DB11-457A-9A77-E1F333895E5C	EA178797-16FB-41AB-B71F-3B397153CE63	TCGA-E8-A242-01A-21D-A16N-02	HG19_Broad_variant	TCGA-E8-A242	TCGA-THCA	NA	s12378	Harvard Medical School	Asterand	United States	NO	T3	N0	Thyroid Papillary Carcinoma - Classical/usual	Stage III	A16N-02	TRUE
13722.58cfa831e4b0c9d6adf6ca01	58cfa831e4b0c9d6adf6ca01	TCGA-DQ-5625-01A-01D-1868_120427_SN208_0288_BD0RWBACXX_s_1_rg.sorted.filtered.	WGS	TCGA-DQ-5625-01A-01D-1868_120427_SN208_0288_BD0RWBACXX_s_1_rg.sorted	TCGA-DQ-5625-01A-01D-1868_120427_SN208_0288_BD0RWBACXX_s_1_rg.sorted.bam	154.7	1.9	0.15	58cfa831e4b0c9d6adf6ca01	TCGA-DQ-5625-01A-01D-1868_120427_SN208_0288_BD0RWBACXX_s_1_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-DQ-5625-01A	53D9A130-4A3A-4491-85CD-9A44415A1632	Primary Tumor	Illumina HiSeq	33b84364-a81e-48fd-89d6-552802c7ff18	Head and Neck	52	74856E66-109F-4A68-A496-8FA66729FE1F	9641D13E-BE95-46BB-8330-6128EE15D47C	TCGA-DQ-5625-01A-01D-1868-02	HG19_Broad_variant	TCGA-DQ-5625	TCGA-HNSC	NA	s16058	Harvard Medical School	University of Michigan	United States	NO	TX	NX	Head and Neck Squamous Cell Carcinoma	Not available	1868-02	TRUE
13722.58cfa831e4b0c9d6adf6cbf7	58cfa831e4b0c9d6adf6cbf7	TCGA-EK-A2PL-01A-11D-A18I_140204_SN208_0508_BC2R1UACXX_s_1_rg.sorted.filtered.	WGS	TCGA-EK-A2PL-01A-11D-A18I_140204_SN208_0508_BC2R1UACXX_s_1_rg.sorted	TCGA-EK-A2PL-01A-11D-A18I_140204_SN208_0508_BC2R1UACXX_s_1_rg.sorted.bam	72.21	NA	0.16	58cfa831e4b0c9d6adf6cbf7	TCGA-EK-A2PL-01A-11D-A18I_140204_SN208_0508_BC2R1UACXX_s_1_rg.sorted.bam	Alive	FEMALE	WHITE	Not available	Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-EK-A2PL-01A	45CADCF3-EA98-4063-9255-5C18D6A5CBAB	Primary Tumor	Illumina HiSeq	ca898dd4-73fc-4fa3-8d2b-3d4f27be4736	Cervix	36	6EE33187-69A7-4328-9521-173CFCDE7A1B	2AC0C1AB-11A3-4806-82FE-08529AD8BBDD	TCGA-EK-A2PL-01A-11D-A18I-02	HG19_Broad_variant	TCGA-EK-A2PL	TCGA-CESC	NA	s1187	Harvard Medical School	Gynecologic Oncology Group	United States	NO	Not available	Not available	Cervical Squamous Cell Carcinoma	Not available	A18I-02	TRUE
13722.58cfa831e4b0c9d6adf6cbd9	58cfa831e4b0c9d6adf6cbd9	TCGA-EJ-5515-01A-01D-1572_130131_SN1120_0235_BD1TAFACXX_s_1_rg.sorted.filtered.	WGS	TCGA-EJ-5515-01A-01D-1572_130131_SN1120_0235_BD1TAFACXX_s_1_rg.sorted	TCGA-EJ-5515-01A-01D-1572_130131_SN1120_0235_BD1TAFACXX_s_1_rg.sorted.bam	150.7	1.9	0.14	58cfa831e4b0c9d6adf6cbd9	TCGA-EJ-5515-01A-01D-1572_130131_SN1120_0235_BD1TAFACXX_s_1_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-EJ-5515-01A	19CF56B2-A85B-43E7-971F-5680B9B1A67A	Primary Tumor	Illumina HiSeq	25dbfef2-277f-4974-a326-2747d9494a2d	Prostate	60	5FBA6E4A-3D7D-478E-AFA6-E66C816E7852	C124D41D-EBD2-4DAE-A344-8518DB3354A4	TCGA-EJ-5515-01A-01D-1572-02	HG19_Broad_variant	TCGA-EJ-5515	TCGA-PRAD	NA	s4132	Harvard Medical School	University of Pittsburgh	United States	NO	T3a	N0	Prostate Adenocarcinoma Acinar Type	Not available	1572-02	TRUE
13722.58cfa831e4b0c9d6adf6cba8	58cfa831e4b0c9d6adf6cba8	TCGA-EJ-5525-01A-01D-1572_130221_SN1120_0238_AC1TDEACXX_s_1_rg.sorted.filtered.	WGS	TCGA-EJ-5525-01A-01D-1572_130221_SN1120_0238_AC1TDEACXX_s_1_rg.sorted	TCGA-EJ-5525-01A-01D-1572_130221_SN1120_0238_AC1TDEACXX_s_1_rg.sorted.bam	333.7	1.9	0.15	58cfa831e4b0c9d6adf6cba8	TCGA-EJ-5525-01A-01D-1572_130221_SN1120_0238_AC1TDEACXX_s_1_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-EJ-5525-01A	554A7381-46FD-4301-B91B-5AF7F173C350	Primary Tumor	Illumina HiSeq	10ab041f-88f9-463c-873d-508073d1672b	Prostate	67	351AF15C-B213-4621-8BCB-3F4DDCF72553	333DDE15-F4B2-4301-A6AC-59C7F4CD6639	TCGA-EJ-5525-01A-01D-1572-02	HG19_Broad_variant	TCGA-EJ-5525	TCGA-PRAD	NA	s3602	Harvard Medical School	University of Pittsburgh	United States	NO	T2c	N0	Prostate Adenocarcinoma Acinar Type	Not available	1572-02	TRUE
13722.58cfa831e4b0c9d6adf6cbfc	58cfa831e4b0c9d6adf6cbfc	TCGA-EJ-5506-01A-01D-1572_130315_SN590_0220_BD1WFMACXX_s_5_rg.sorted.filtered.	WGS	TCGA-EJ-5506-01A-01D-1572_130315_SN590_0220_BD1WFMACXX_s_5_rg.sorted	TCGA-EJ-5506-01A-01D-1572_130315_SN590_0220_BD1WFMACXX_s_5_rg.sorted.bam	238.7	1.9	0.15	58cfa831e4b0c9d6adf6cbfc	TCGA-EJ-5506-01A-01D-1572_130315_SN590_0220_BD1WFMACXX_s_5_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-EJ-5506-01A	E5E4D3B6-8E58-4DCF-8F67-A00E656A8E27	Primary Tumor	Illumina HiSeq	bd66d4a0-aa1a-4bf3-a764-cb7292bc89b1	Prostate	67	9EBDA113-B0FC-4233-87AC-DAD0E7D033DE	CED987BC-B780-487A-A82E-2EB589AD3796	TCGA-EJ-5506-01A-01D-1572-02	HG19_Broad_variant	TCGA-EJ-5506	TCGA-PRAD	NA	s3780	Harvard Medical School	University of Pittsburgh	United States	NO	T3b	N1	Prostate Adenocarcinoma Acinar Type	Not available	1572-02	TRUE
13722.58cfa831e4b0c9d6adf6cc23	58cfa831e4b0c9d6adf6cc23	TCGA-EJ-5503-01A-01D-1572_130223_SN590_0214_BC1UJ3ACXX_s_7_rg.sorted.filtered.	WGS	TCGA-EJ-5503-01A-01D-1572_130223_SN590_0214_BC1UJ3ACXX_s_7_rg.sorted	TCGA-EJ-5503-01A-01D-1572_130223_SN590_0214_BC1UJ3ACXX_s_7_rg.sorted.bam	172.7	1.9	0.16	58cfa831e4b0c9d6adf6cc23	TCGA-EJ-5503-01A-01D-1572_130223_SN590_0214_BC1UJ3ACXX_s_7_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-EJ-5503-01A	AA252F78-EBF3-42F9-86AF-BB6E57345706	Primary Tumor	Illumina HiSeq	4eba210f-0895-487c-9b48-db8a8c629cc4	Prostate	50	627B9FF8-2557-4470-824A-B76A8BCD1E9F	68211C41-2971-4B41-8EEE-75FFB78175BC	TCGA-EJ-5503-01A-01D-1572-02	HG19_Broad_variant	TCGA-EJ-5503	TCGA-PRAD	NA	s3782	Harvard Medical School	University of Pittsburgh	United States	NO	T3a	N0	Prostate Adenocarcinoma Acinar Type	Not available	1572-02	TRUE
13722.58cfa831e4b0c9d6adf6cc4c	58cfa831e4b0c9d6adf6cc4c	TCGA-EA-A1QS-01A-61D-A232_140124_SN208_0506_BC2PD5ACXX_s_2_rg.sorted.filtered.	WGS	TCGA-EA-A1QS-01A-61D-A232_140124_SN208_0506_BC2PD5ACXX_s_2_rg.sorted	TCGA-EA-A1QS-01A-61D-A232_140124_SN208_0506_BC2PD5ACXX_s_2_rg.sorted.bam	36.95	NA	0.15	58cfa831e4b0c9d6adf6cc4c	TCGA-EA-A1QS-01A-61D-A232_140124_SN208_0506_BC2PD5ACXX_s_2_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-EA-A1QS-01A	6F9D21C0-3B88-450D-A249-3E9BAFBA2DFA	Primary Tumor	Illumina HiSeq	c7f62ea9-e05f-40ea-9e4c-1771bd722b74	Cervix	46	8389C79E-164E-4462-ADCD-364DB3AFB463	109962B4-F4A5-4C72-B902-92516110FE7E	TCGA-EA-A1QS-01A-61D-A232-26	HG19_Broad_variant	TCGA-EA-A1QS	TCGA-CESC	NA	s1361	MD Anderson - Institute for Applied Cancer Science	Asterand	Russia	NO	T1b1	N0	Cervical Squamous Cell Carcinoma	Not available	A232-26	TRUE
13722.58cfa831e4b0c9d6adf6cc76	58cfa831e4b0c9d6adf6cc76	TCGA-ER-A194-01A-11D-A18Y_120723_SN1120_0178_BD1887ACXX_s_4_rg.sorted.filtered.	WGS	TCGA-ER-A194-01A-11D-A18Y_120723_SN1120_0178_BD1887ACXX_s_4_rg.sorted	TCGA-ER-A194-01A-11D-A18Y_120723_SN1120_0178_BD1887ACXX_s_4_rg.sorted.bam	30.36	NA	0.17	58cfa831e4b0c9d6adf6cc76	TCGA-ER-A194-01A-11D-A18Y_120723_SN1120_0178_BD1887ACXX_s_4_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Skin Cutaneous Melanoma	Aligned reads	TCGA-ER-A194-01A	2BBF00F4-7798-4DAD-9894-96202C9132BE	Primary Tumor	Illumina HiSeq	40a52169-d476-4650-a043-d5fda21a4213	Skin	77	EA15A5B0-8BA7-4114-853F-E3396E81CCEB	411370DC-4C66-484F-AC7E-42A19E486DFC	TCGA-ER-A194-01A-11D-A18Y-02	HG19_Broad_variant	TCGA-ER-A194	TCGA-SKCM	1354	s7693	Harvard Medical School	University of Pittsburgh	United States	NO	Not available	N0	Not available	Not available	A18Y-02	TRUE
13722.58cfa831e4b0c9d6adf6cd09	58cfa831e4b0c9d6adf6cd09	TCGA-EX-A3L1-01A-11D-A245_140124_SN1440_0178_AC2PL6ACXX_s_6_rg.sorted.filtered.	WGS	TCGA-EX-A3L1-01A-11D-A245_140124_SN1440_0178_AC2PL6ACXX_s_6_rg.sorted	TCGA-EX-A3L1-01A-11D-A245_140124_SN1440_0178_AC2PL6ACXX_s_6_rg.sorted.bam	44.57	NA	0.14	58cfa831e4b0c9d6adf6cd09	TCGA-EX-A3L1-01A-11D-A245_140124_SN1440_0178_AC2PL6ACXX_s_6_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-EX-A3L1-01A	F5D90810-8C4B-4CED-9360-383E42CB54B3	Primary Tumor	Illumina HiSeq	73141d26-4c6a-46e1-ab5f-b431f2f35c23	Cervix	32	89AD6395-973B-4011-BFBD-6759209406BE	6F24A0BE-76D7-4388-B73A-32BE2E902470	TCGA-EX-A3L1-01A-11D-A245-26	HG19_Broad_variant	TCGA-EX-A3L1	TCGA-CESC	NA	s1530	MD Anderson - Institute for Applied Cancer Science	University of North Carolina	United States	NO	T2a1	N0	Cervical Squamous Cell Carcinoma	Not available	A245-26	TRUE
13722.58cfa831e4b0c9d6adf6ccdf	58cfa831e4b0c9d6adf6ccdf	TCGA-EM-A3O7-01A-11D-A221_120524_SN1120_0145_BD12MWACXX_s_1_rg.sorted.filtered.	WGS	TCGA-EM-A3O7-01A-11D-A221_120524_SN1120_0145_BD12MWACXX_s_1_rg.sorted	TCGA-EM-A3O7-01A-11D-A221_120524_SN1120_0145_BD12MWACXX_s_1_rg.sorted.bam	34.81	NA	0.15	58cfa831e4b0c9d6adf6ccdf	TCGA-EM-A3O7-01A-11D-A221_120524_SN1120_0145_BD12MWACXX_s_1_rg.sorted.bam	Alive	FEMALE	Not available	Not available	Thyroid Carcinoma	Aligned reads	TCGA-EM-A3O7-01A	3A211D5A-085F-4902-86B6-50E4EB36B897	Primary Tumor	Illumina HiSeq	c3515173-4e8f-4198-a9de-0bf2232c3fbd	Thyroid	46	362F0CC2-B884-404B-8DF1-2BFC2A75E9C3	AF35D79C-4F32-4B6E-8FDE-BDA9D715A542	TCGA-EM-A3O7-01A-11D-A221-26	HG19_Broad_variant	TCGA-EM-A3O7	TCGA-THCA	NA	s12383	MD Anderson - Institute for Applied Cancer Science	University Health Network	Canada	NO	T3	NX	Thyroid Papillary Carcinoma - Classical/usual	Stage III	A221-26	TRUE
13722.58cfa831e4b0c9d6adf6cdb6	58cfa831e4b0c9d6adf6cdb6	TCGA-FG-5963-01A-11D-1703_130813_SN1440_0161_BC29ENACXX_s_1_rg.sorted.filtered.	WGS	TCGA-FG-5963-01A-11D-1703_130813_SN1440_0161_BC29ENACXX_s_1_rg.sorted	TCGA-FG-5963-01A-11D-1703_130813_SN1440_0161_BC29ENACXX_s_1_rg.sorted.bam	7.3	2	0.13	58cfa831e4b0c9d6adf6cdb6	TCGA-FG-5963-01A-11D-1703_130813_SN1440_0161_BC29ENACXX_s_1_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-FG-5963-01A	68F550CA-3A33-45E4-B1C9-14F99E543263	Primary Tumor	Illumina HiSeq	11f814ba-95e7-4824-ab33-1e14947dcbd5	Brain	23	41C647E8-6A53-464B-9EFC-78547C514519	166F687B-F395-4AC7-A06A-78826A0722E7	TCGA-FG-5963-01A-11D-1703-02	HG19_Broad_variant	TCGA-FG-5963	TCGA-LGG	NA	s8148	Harvard Medical School	Case Western	United States	NO	Not available	Not available	Astrocytoma	Not available	1703-02	TRUE
13722.58cfa831e4b0c9d6adf6cd9c	58cfa831e4b0c9d6adf6cd9c	TCGA-FD-A3SR-01A-11D-A233_120830_SN208_0424_BD1DKLACXX_s_7_rg.sorted.filtered.	WGS	TCGA-FD-A3SR-01A-11D-A233_120830_SN208_0424_BD1DKLACXX_s_7_rg.sorted	TCGA-FD-A3SR-01A-11D-A233_120830_SN208_0424_BD1DKLACXX_s_7_rg.sorted.bam	39.24	NA	0.14	58cfa831e4b0c9d6adf6cd9c	TCGA-FD-A3SR-01A-11D-A233_120830_SN208_0424_BD1DKLACXX_s_7_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-FD-A3SR-01A	72D6E9AA-4A99-4FC9-A67B-4631E95FB043	Primary Tumor	Illumina HiSeq	e8c95d25-27f4-4cba-b644-eb39019c6cc0	Bladder	68	8E9683F4-52B4-4646-921E-7BF89F56774A	93A2B3C4-915C-46BE-9D36-C244036B7A0C	TCGA-FD-A3SR-01A-11D-A233-26	HG19_Broad_variant	TCGA-FD-A3SR	TCGA-BLCA	602	s3116	MD Anderson - Institute for Applied Cancer Science	BLN - University Of Chicago	United States	NO	T4a	N2	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV	A233-26	TRUE
13722.58cfa832e4b0c9d6adf6ce58	58cfa832e4b0c9d6adf6ce58	TCGA-FU-A3HY-01A-11D-A245_140124_SN1440_0178_AC2PL6ACXX_s_7_rg.sorted.filtered.	WGS	TCGA-FU-A3HY-01A-11D-A245_140124_SN1440_0178_AC2PL6ACXX_s_7_rg.sorted	TCGA-FU-A3HY-01A-11D-A245_140124_SN1440_0178_AC2PL6ACXX_s_7_rg.sorted.bam	37.56	NA	0.16	58cfa832e4b0c9d6adf6ce58	TCGA-FU-A3HY-01A-11D-A245_140124_SN1440_0178_AC2PL6ACXX_s_7_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-FU-A3HY-01A	674E010C-7AD4-4DC2-86B0-284CD4560633	Primary Tumor	Illumina HiSeq	30d23ada-985e-43b1-9cc5-9e3931905b07	Cervix	47	A5879A60-AA8B-4DA0-904A-9FFE2968418C	0FD6C08E-8B41-422F-A6BA-1234E6596ADA	TCGA-FU-A3HY-01A-11D-A245-26	HG19_Broad_variant	TCGA-FU-A3HY	TCGA-CESC	NA	s1531	MD Anderson - Institute for Applied Cancer Science	International Genomics Consortium	United States	NO	T1b2	N1	Cervical Squamous Cell Carcinoma	Not available	A245-26	TRUE
13722.58cfa831e4b0c9d6adf6cdba	58cfa831e4b0c9d6adf6cdba	TCGA-ER-A19K-01A-21D-A18Y_120723_SN1120_0177_AC11GTACXX_s_1_rg.sorted.filtered.	WGS	TCGA-ER-A19K-01A-21D-A18Y_120723_SN1120_0177_AC11GTACXX_s_1_rg.sorted	TCGA-ER-A19K-01A-21D-A18Y_120723_SN1120_0177_AC11GTACXX_s_1_rg.sorted.bam	38.56	NA	0.15	58cfa831e4b0c9d6adf6cdba	TCGA-ER-A19K-01A-21D-A18Y_120723_SN1120_0177_AC11GTACXX_s_1_rg.sorted.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Skin Cutaneous Melanoma	Aligned reads	TCGA-ER-A19K-01A	F9E36BC2-484F-48E8-82BA-99026957277A	Primary Tumor	Illumina HiSeq	7f909731-9b4e-45a5-b8e0-ae6d67969159	Skin	79	E358B11D-2A35-45AE-8910-AE2DC06D39F4	EB5E15F5-55E7-433C-8DD2-AA3DF568F0CF	TCGA-ER-A19K-01A-21D-A18Y-02	HG19_Broad_variant	TCGA-ER-A19K	TCGA-SKCM	469	s7862	Harvard Medical School	University of Pittsburgh	United States	NO	T4b	N0	Not available	Stage IIC	A18Y-02	TRUE
13722.58cfa832e4b0c9d6adf6ce8a	58cfa832e4b0c9d6adf6ce8a	TCGA-G2-A2EL-01A-12D-A18D_120912_SN1222_0148_AC188PACXX_s_5_rg.sorted.filtered.	WGS	TCGA-G2-A2EL-01A-12D-A18D_120912_SN1222_0148_AC188PACXX_s_5_rg.sorted	TCGA-G2-A2EL-01A-12D-A18D_120912_SN1222_0148_AC188PACXX_s_5_rg.sorted.bam	27.96	NA	0.16	58cfa832e4b0c9d6adf6ce8a	TCGA-G2-A2EL-01A-12D-A18D_120912_SN1222_0148_AC188PACXX_s_5_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-G2-A2EL-01A	30C7445E-D0C4-4A0F-96A4-27E4259EE10B	Primary Tumor	Illumina HiSeq	15128dae-4500-4372-9676-d23d4c116527	Bladder	77	90F1D206-3E97-4C88-922C-FE4773C37CAA	D850DDCD-6E04-4EB4-887C-E1AE410C301C	TCGA-G2-A2EL-01A-12D-A18D-02	HG19_Broad_variant	TCGA-G2-A2EL	TCGA-BLCA	819	s3122	Harvard Medical School	MD Anderson	United States	NO	Not available	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage II	A18D-02	TRUE
13722.58cfa832e4b0c9d6adf6ce96	58cfa832e4b0c9d6adf6ce96	TCGA-G2-A2EC-01A-11D-A17R_120927_SN208_0433_BD1D5JACXX_s_5_rg.sorted.filtered.	WGS	TCGA-G2-A2EC-01A-11D-A17R_120927_SN208_0433_BD1D5JACXX_s_5_rg.sorted	TCGA-G2-A2EC-01A-11D-A17R_120927_SN208_0433_BD1D5JACXX_s_5_rg.sorted.bam	18.46	NA	0.18	58cfa832e4b0c9d6adf6ce96	TCGA-G2-A2EC-01A-11D-A17R_120927_SN208_0433_BD1D5JACXX_s_5_rg.sorted.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-G2-A2EC-01A	28E25FFB-8B0C-4839-A735-ED7B78E3213A	Primary Tumor	Illumina HiSeq	0d4b7559-34dc-4690-a8e9-144698537cdd	Bladder	58	2DA969E6-9A63-4C03-8347-01A51496C224	09ED2111-236D-47C1-A82D-7919C8EEA5B2	TCGA-G2-A2EC-01A-11D-A17R-02	HG19_Broad_variant	TCGA-G2-A2EC	TCGA-BLCA	NA	s3303	Harvard Medical School	MD Anderson	United States	NO	Not available	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage II	A17R-02	TRUE
13722.58cfa831e4b0c9d6adf6cd7a	58cfa831e4b0c9d6adf6cd7a	TCGA-EY-A1GC-01A-11D-A13I_120516_SN1222_0107_BD12HYACXX_s_5_rg.sorted.filtered.	WGS	TCGA-EY-A1GC-01A-11D-A13I_120516_SN1222_0107_BD12HYACXX_s_5_rg.sorted	TCGA-EY-A1GC-01A-11D-A13I_120516_SN1222_0107_BD12HYACXX_s_5_rg.sorted.bam	63.8	1.81	0.16	58cfa831e4b0c9d6adf6cd7a	TCGA-EY-A1GC-01A-11D-A13I_120516_SN1222_0107_BD12HYACXX_s_5_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-EY-A1GC-01A	EBC25A41-BECB-4395-AE33-483A304B07D8	Primary Tumor	Illumina HiSeq	e6c7f95a-f103-4fbc-a123-91eefcfbf4c2	Uterus	62	06BE0E15-E48E-4243-AD8D-86CCA9DA68F9	C8E60958-98D8-4EE6-BAA1-DEEEECFF141F	TCGA-EY-A1GC-01A-11D-A13I-02	HG19_Broad_variant	TCGA-EY-A1GC	TCGA-UCEC	NA	s4620	Harvard Medical School	University of North Carolina	United States	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A13I-02	FALSE
13722.58cfa832e4b0c9d6adf6ceac	58cfa832e4b0c9d6adf6ceac	TCGA-FD-A3NA-01A-11D-A21C_120830_SN590_0177_BD141PACXX_s_1_rg.sorted.filtered.	WGS	TCGA-FD-A3NA-01A-11D-A21C_120830_SN590_0177_BD141PACXX_s_1_rg.sorted	TCGA-FD-A3NA-01A-11D-A21C_120830_SN590_0177_BD141PACXX_s_1_rg.sorted.bam	63.16	NA	0.16	58cfa832e4b0c9d6adf6ceac	TCGA-FD-A3NA-01A-11D-A21C_120830_SN590_0177_BD141PACXX_s_1_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-FD-A3NA-01A	14917461-DAE4-44CB-909D-42AC45AEF450	Primary Tumor	Illumina HiSeq	8c4c1672-fea7-4c17-a6d0-d4a0f3c04558	Bladder	60	7BD000AB-6F48-4A9E-98A4-EAF47D6E3C05	37789FCA-0C64-49B7-A704-572A19BD2645	TCGA-FD-A3NA-01A-11D-A21C-26	HG19_Broad_variant	TCGA-FD-A3NA	TCGA-BLCA	NA	s3114	MD Anderson - Institute for Applied Cancer Science	BLN - University Of Chicago	United States	NO	T2b	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage II	A21C-26	TRUE
13722.58cfa832e4b0c9d6adf6cf46	58cfa832e4b0c9d6adf6cf46	TCGA-G9-6371-01A-11D-1784_130215_SN590_0212_BC1NP2ACXX_s_7_rg.sorted.filtered.	WGS	TCGA-G9-6371-01A-11D-1784_130215_SN590_0212_BC1NP2ACXX_s_7_rg.sorted	TCGA-G9-6371-01A-11D-1784_130215_SN590_0212_BC1NP2ACXX_s_7_rg.sorted.bam	59.4	2	0.17	58cfa832e4b0c9d6adf6cf46	TCGA-G9-6371-01A-11D-1784_130215_SN590_0212_BC1NP2ACXX_s_7_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-G9-6371-01A	D5C43A14-21AB-4178-AE33-2D8B7BAA256F	Primary Tumor	Illumina HiSeq	46c365e2-d78e-45ed-8356-c9ad57629c34	Prostate	58	2F91086C-ADCD-4A79-96AA-58819AB28A57	570A6B67-7527-4F71-B37F-5D9102648470	TCGA-G9-6371-01A-11D-1784-02	HG19_Broad_variant	TCGA-G9-6371	TCGA-PRAD	NA	s3798	Harvard Medical School	Roswell Park	United States	NO	T2c	Not available	Prostate Adenocarcinoma Acinar Type	Not available	1784-02	TRUE
13722.58cfa832e4b0c9d6adf6cf7a	58cfa832e4b0c9d6adf6cf7a	TCGA-G9-6499-01A-12D-1957_130412_SN590_0224_BC1YMJACXX_s_2_rg.sorted.filtered.	WGS	TCGA-G9-6499-01A-12D-1957_130412_SN590_0224_BC1YMJACXX_s_2_rg.sorted	TCGA-G9-6499-01A-12D-1957_130412_SN590_0224_BC1YMJACXX_s_2_rg.sorted.bam	62.7	2	0.14	58cfa832e4b0c9d6adf6cf7a	TCGA-G9-6499-01A-12D-1957_130412_SN590_0224_BC1YMJACXX_s_2_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-G9-6499-01A	ACD5CEEF-C5CF-4E95-9394-C50FDBC70C8D	Primary Tumor	Illumina HiSeq	db7d4277-9d52-4996-ab7f-5e6ddc01c234	Prostate	66	424FB9D8-F70E-4A36-B895-A766176EEE7C	24062AD0-10DD-4BFB-B805-CA18C57D1FA0	TCGA-G9-6499-01A-12D-1957-02	HG19_Broad_variant	TCGA-G9-6499	TCGA-PRAD	NA	s3459	Harvard Medical School	Roswell Park	United States	NO	T3a	N0	Prostate Adenocarcinoma Acinar Type	Not available	1957-02	TRUE
13722.58cfa832e4b0c9d6adf6cf82	58cfa832e4b0c9d6adf6cf82	TCGA-G9-6348-01A-11D-1784_130115_SN590_0208_BD1TAGACXX_s_7_rg.sorted.filtered.	WGS	TCGA-G9-6348-01A-11D-1784_130115_SN590_0208_BD1TAGACXX_s_7_rg.sorted	TCGA-G9-6348-01A-11D-1784_130115_SN590_0208_BD1TAGACXX_s_7_rg.sorted.bam	59.4	1.9	0.14	58cfa832e4b0c9d6adf6cf82	TCGA-G9-6348-01A-11D-1784_130115_SN590_0208_BD1TAGACXX_s_7_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-G9-6348-01A	8AD78C4F-C84C-4F9E-88C9-42A05EB65498	Primary Tumor	Illumina HiSeq	32ce4cfa-ee58-4c85-8e6b-9e7fd9bb6b8e	Prostate	68	A692E125-CCFC-4376-9CEA-2410511882BF	68D451D5-F3A1-46C9-BD28-05D71D2C94FC	TCGA-G9-6348-01A-11D-1784-02	HG19_Broad_variant	TCGA-G9-6348	TCGA-PRAD	NA	s3447	Harvard Medical School	Roswell Park	United States	NO	T2c	N0	Prostate Adenocarcinoma Acinar Type	Not available	1784-02	TRUE
13722.58cfa832e4b0c9d6adf6cf7f	58cfa832e4b0c9d6adf6cf7f	TCGA-GD-A3OP-01A-21D-A221_120902_SN1222_0147_AC195DACXX_s_1_rg.sorted.filtered.	WGS	TCGA-GD-A3OP-01A-21D-A221_120902_SN1222_0147_AC195DACXX_s_1_rg.sorted	TCGA-GD-A3OP-01A-21D-A221_120902_SN1222_0147_AC195DACXX_s_1_rg.sorted.bam	15.89	NA	0.17	58cfa832e4b0c9d6adf6cf7f	TCGA-GD-A3OP-01A-21D-A221_120902_SN1222_0147_AC195DACXX_s_1_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-GD-A3OP-01A	31DA07BB-6752-49A3-A7EA-5427C04A9458	Primary Tumor	Illumina HiSeq	e01f55a8-4fbe-4f9a-8617-ce0e6900f177	Bladder	84	C0773229-5A20-4451-9DB5-F757E34921AE	AB6D114E-DF58-4912-85F4-3C385CAA3749	TCGA-GD-A3OP-01A-21D-A221-26	HG19_Broad_variant	TCGA-GD-A3OP	TCGA-BLCA	NA	s3125	MD Anderson - Institute for Applied Cancer Science	ABS - IUPUI	United States	NO	T4a	N2	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV	A221-26	TRUE
13722.58cfa832e4b0c9d6adf6cfdc	58cfa832e4b0c9d6adf6cfdc	TCGA-HC-7232-01A-11D-2111_130517_SN590_0231_BC24V6ACXX_s_4_rg.sorted.filtered.	WGS	TCGA-HC-7232-01A-11D-2111_130517_SN590_0231_BC24V6ACXX_s_4_rg.sorted	TCGA-HC-7232-01A-11D-2111_130517_SN590_0231_BC24V6ACXX_s_4_rg.sorted.bam	168.3	NA	0.16	58cfa832e4b0c9d6adf6cfdc	TCGA-HC-7232-01A-11D-2111_130517_SN590_0231_BC24V6ACXX_s_4_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-HC-7232-01A	CE3585D3-7388-4D05-84C8-64E0883003B3	Primary Tumor	Illumina HiSeq	26e5268d-e95b-44da-ae7c-dfb6fe50a127	Prostate	66	0F4B7D00-1C4C-4634-A45E-10F8949ABB43	E847C3F1-CE33-494C-8D95-F82314C95F01	TCGA-HC-7232-01A-11D-2111-02	HG19_Broad_variant	TCGA-HC-7232	TCGA-PRAD	NA	s4156	Harvard Medical School	International Genomics Consortium	United States	NO	T3b	Not available	Prostate Adenocarcinoma Acinar Type	Not available	2111-02	TRUE
13722.58cfa832e4b0c9d6adf6cfb8	58cfa832e4b0c9d6adf6cfb8	TCGA-GC-A3I6-01A-11D-A210_120912_SN1222_0149_BD1CW3ACXX_s_5_rg.sorted.filtered.	WGS	TCGA-GC-A3I6-01A-11D-A210_120912_SN1222_0149_BD1CW3ACXX_s_5_rg.sorted	TCGA-GC-A3I6-01A-11D-A210_120912_SN1222_0149_BD1CW3ACXX_s_5_rg.sorted.bam	65	NA	0.16	58cfa832e4b0c9d6adf6cfb8	TCGA-GC-A3I6-01A-11D-A210_120912_SN1222_0149_BD1CW3ACXX_s_5_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-GC-A3I6-01A	74CBB078-9AAE-422A-A7AF-DD29EBCA949E	Primary Tumor	Illumina HiSeq	ec0a1f1d-c6e7-4b4a-a296-02087e0b6586	Bladder	45	DB9442F6-38F2-4092-9E85-F5EC0C924025	8B23B777-2BF2-422A-8AB3-1DF94EE61690	TCGA-GC-A3I6-01A-11D-A210-26	HG19_Broad_variant	TCGA-GC-A3I6	TCGA-BLCA	NA	s2733	MD Anderson - Institute for Applied Cancer Science	International Genomics Consortium	United States	NO	T3a	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage III	A210-26	TRUE
13722.58cfa832e4b0c9d6adf6d018	58cfa832e4b0c9d6adf6d018	TCGA-FT-A3EE-01A-11D-A204_121002_SN1222_0155_BD1ERHACXX_s_1_rg.sorted.filtered.	WGS	TCGA-FT-A3EE-01A-11D-A204_121002_SN1222_0155_BD1ERHACXX_s_1_rg.sorted	TCGA-FT-A3EE-01A-11D-A204_121002_SN1222_0155_BD1ERHACXX_s_1_rg.sorted.bam	35.79	NA	0.15	58cfa832e4b0c9d6adf6d018	TCGA-FT-A3EE-01A-11D-A204_121002_SN1222_0155_BD1ERHACXX_s_1_rg.sorted.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-FT-A3EE-01A	CCE62116-3DCD-400D-ADA0-9839CA02466E	Primary Tumor	Illumina HiSeq	7bd31003-35c9-4165-b964-e3d1e803dbe9	Bladder	80	2356F78C-0653-468F-83DB-6CF6107BD259	0C871E11-F5FB-4B9E-B286-163187A68992	TCGA-FT-A3EE-01A-11D-A204-02	HG19_Broad_variant	TCGA-FT-A3EE	TCGA-BLCA	99	s2913	Harvard Medical School	BLN - University of Miami	United States	NO	T4a	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage III	A204-02	TRUE
13722.58cfa832e4b0c9d6adf6d04e	58cfa832e4b0c9d6adf6d04e	TCGA-G9-6329-01A-13D-1957_130222_SN1222_0174_BC1RNEACXX_s_1_rg.sorted.filtered.	WGS	TCGA-G9-6329-01A-13D-1957_130222_SN1222_0174_BC1RNEACXX_s_1_rg.sorted	TCGA-G9-6329-01A-13D-1957_130222_SN1222_0174_BC1RNEACXX_s_1_rg.sorted.bam	41.7	1.9	0.15	58cfa832e4b0c9d6adf6d04e	TCGA-G9-6329-01A-13D-1957_130222_SN1222_0174_BC1RNEACXX_s_1_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-G9-6329-01A	A08FD0A6-A89A-4ADB-B641-D4C1238ABB71	Primary Tumor	Illumina HiSeq	1971b9d7-8a67-4447-835d-23525622c037	Prostate	67	E004F38D-C874-4E03-830B-4E554EF3E274	46BEFA09-3AF0-415C-994E-330B07586058	TCGA-G9-6329-01A-13D-1957-02	HG19_Broad_variant	TCGA-G9-6329	TCGA-PRAD	NA	s3796	Harvard Medical School	Roswell Park	United States	NO	T2c	Not available	Prostate Adenocarcinoma Acinar Type	Not available	1957-02	TRUE
13722.58cfa832e4b0c9d6adf6d044	58cfa832e4b0c9d6adf6d044	TCGA-GD-A2C5-01A-12D-A17R_120927_SN208_0432_AC188LACXX_s_6_rg.sorted.filtered.	WGS	TCGA-GD-A2C5-01A-12D-A17R_120927_SN208_0432_AC188LACXX_s_6_rg.sorted	TCGA-GD-A2C5-01A-12D-A17R_120927_SN208_0432_AC188LACXX_s_6_rg.sorted.bam	40.79	NA	0.16	58cfa832e4b0c9d6adf6d044	TCGA-GD-A2C5-01A-12D-A17R_120927_SN208_0432_AC188LACXX_s_6_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-GD-A2C5-01A	5D54C742-5A8E-4C40-8D62-95E75E210AB8	Primary Tumor	Illumina HiSeq	27e88ee3-dcb4-43c4-9653-c55aa1851cb1	Bladder	53	2CD62676-762C-461D-B111-1F81E7CD5877	EEB315EA-D1B6-4F92-91B0-9AAAC7083D68	TCGA-GD-A2C5-01A-12D-A17R-02	HG19_Broad_variant	TCGA-GD-A2C5	TCGA-BLCA	NA	s2920	Harvard Medical School	ABS - IUPUI	United States	NO	T3a	N2	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV	A17R-02	TRUE
13722.58cfa832e4b0c9d6adf6d188	58cfa832e4b0c9d6adf6d188	TCGA-HC-7233-01A-11D-2111_130517_SN590_0231_BC24V6ACXX_s_6_rg.sorted.filtered.	WGS	TCGA-HC-7233-01A-11D-2111_130517_SN590_0231_BC24V6ACXX_s_6_rg.sorted	TCGA-HC-7233-01A-11D-2111_130517_SN590_0231_BC24V6ACXX_s_6_rg.sorted.bam	207.3	NA	0.14	58cfa832e4b0c9d6adf6d188	TCGA-HC-7233-01A-11D-2111_130517_SN590_0231_BC24V6ACXX_s_6_rg.sorted.bam	Alive	MALE	WHITE	Not available	Prostate Adenocarcinoma	Aligned reads	TCGA-HC-7233-01A	E2B33861-2247-413F-B2E5-9BE3B604666C	Primary Tumor	Illumina HiSeq	b16d1760-889f-44f7-a1c1-1dfa3f31efc3	Prostate	73	848C2C7B-918E-4A09-BAD9-3B3D59BBC101	8262CCFE-6E66-412E-A8C8-E4FA91979764	TCGA-HC-7233-01A-11D-2111-02	HG19_Broad_variant	TCGA-HC-7233	TCGA-PRAD	NA	s3813	Harvard Medical School	International Genomics Consortium	Yemen	NO	T2a	N0	Prostate Adenocarcinoma Acinar Type	Not available	2111-02	TRUE
13722.58cfa832e4b0c9d6adf6d10e	58cfa832e4b0c9d6adf6d10e	TCGA-HW-7489-01A-11D-2022_130913_SN1440_0168_BD2B0UACXX_s_2_rg.sorted.filtered.	WGS	TCGA-HW-7489-01A-11D-2022_130913_SN1440_0168_BD2B0UACXX_s_2_rg.sorted	TCGA-HW-7489-01A-11D-2022_130913_SN1440_0168_BD2B0UACXX_s_2_rg.sorted.bam	56	NA	0.14	58cfa832e4b0c9d6adf6d10e	TCGA-HW-7489-01A-11D-2022_130913_SN1440_0168_BD2B0UACXX_s_2_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-HW-7489-01A	6957D45E-7CCB-457D-800D-C2A2037F4F01	Primary Tumor	Illumina HiSeq	e81e0ec5-b546-421b-a1ee-5adf17fd07c0	Brain	38	B4E032D1-B12E-4DC0-8978-899760F0A245	BBCC5F2C-08F5-424D-8A66-099084F3C47E	TCGA-HW-7489-01A-11D-2022-02	HG19_Broad_variant	TCGA-HW-7489	TCGA-LGG	NA	s8578	Harvard Medical School	MSKCC	United States	NO	Not available	Not available	Oligoastrocytoma	Not available	2022-02	TRUE
13722.58cfa832e4b0c9d6adf6d0d4	58cfa832e4b0c9d6adf6d0d4	TCGA-FY-A3I5-01B-11D-A221_120610_SN1120_0151_AC0WN0ACXX_s_1_rg.sorted.filtered.	WGS	TCGA-FY-A3I5-01B-11D-A221_120610_SN1120_0151_AC0WN0ACXX_s_1_rg.sorted	TCGA-FY-A3I5-01B-11D-A221_120610_SN1120_0151_AC0WN0ACXX_s_1_rg.sorted.bam	41.37	NA	0.14	58cfa832e4b0c9d6adf6d0d4	TCGA-FY-A3I5-01B-11D-A221_120610_SN1120_0151_AC0WN0ACXX_s_1_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-FY-A3I5-01B	52203FF5-57B2-4D56-8935-2FF1EB61D7B8	Primary Tumor	Illumina HiSeq	ed0cff3d-a985-40a9-b0df-ec57b3bcdd50	Thyroid	64	7AEC7C70-6A5A-48D5-A863-A8DB40D93097	C32A9B9D-B381-4492-9BBC-8F25B09D18C1	TCGA-FY-A3I5-01B-11D-A221-26	HG19_Broad_variant	TCGA-FY-A3I5	TCGA-THCA	NA	s12119	MD Anderson - Institute for Applied Cancer Science	International Genomics Consortium	United States	NO	T3	N0	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	Stage III	A221-26	TRUE
13722.58cfa832e4b0c9d6adf6d128	58cfa832e4b0c9d6adf6d128	TCGA-G2-A3IE-01A-11D-A210_120912_SN1222_0149_BD1CW3ACXX_s_3_rg.sorted.filtered.	WGS	TCGA-G2-A3IE-01A-11D-A210_120912_SN1222_0149_BD1CW3ACXX_s_3_rg.sorted	TCGA-G2-A3IE-01A-11D-A210_120912_SN1222_0149_BD1CW3ACXX_s_3_rg.sorted.bam	48.07	NA	0.15	58cfa832e4b0c9d6adf6d128	TCGA-G2-A3IE-01A-11D-A210_120912_SN1222_0149_BD1CW3ACXX_s_3_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-G2-A3IE-01A	C65BA2B8-E867-42E8-BBD0-C2CDF5130CFB	Primary Tumor	Illumina HiSeq	171a2a97-43d5-41cc-a9ae-2f685c3ed80f	Bladder	51	FC529667-D055-4FC3-806D-C0431D9A6CFF	5C93720D-56AA-4324-8543-9B37351BC9B6	TCGA-G2-A3IE-01A-11D-A210-26	HG19_Broad_variant	TCGA-G2-A3IE	TCGA-BLCA	612	s2917	MD Anderson - Institute for Applied Cancer Science	MD Anderson	United States	NO	Not available	NX	Muscle invasive urothelial carcinoma (pT2 or above)	Stage II	A210-26	TRUE
13722.58cfa832e4b0c9d6adf6d194	58cfa832e4b0c9d6adf6d194	TCGA-G9-6377-01A-11D-1957_130405_SN590_0222_BD21LGACXX_s_8_rg.sorted.filtered.	WGS	TCGA-G9-6377-01A-11D-1957_130405_SN590_0222_BD21LGACXX_s_8_rg.sorted	TCGA-G9-6377-01A-11D-1957_130405_SN590_0222_BD21LGACXX_s_8_rg.sorted.bam	95.7	1.9	0.15	58cfa832e4b0c9d6adf6d194	TCGA-G9-6377-01A-11D-1957_130405_SN590_0222_BD21LGACXX_s_8_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-G9-6377-01A	007F9081-5093-4323-B4F8-CD510BF20705	Primary Tumor	Illumina HiSeq	126d92ca-d172-491d-9366-11555d88901b	Prostate	61	8F105D0D-0630-46FC-8168-DCBA11A5197F	811D74B4-6F98-4B1F-9ADD-CB949E4B5B20	TCGA-G9-6377-01A-11D-1957-02	HG19_Broad_variant	TCGA-G9-6377	TCGA-PRAD	NA	s3977	Harvard Medical School	Roswell Park	United States	NO	T2c	N0	Prostate Adenocarcinoma Acinar Type	Not available	1957-02	TRUE
13722.58cfa832e4b0c9d6adf6d1a4	58cfa832e4b0c9d6adf6d1a4	TCGA-IG-A50L-01A-11D-A267_131120_SN1222_0230_BC29YPACXX_s_1_rg.sorted.filtered.	WGS	TCGA-IG-A50L-01A-11D-A267_131120_SN1222_0230_BC29YPACXX_s_1_rg.sorted	TCGA-IG-A50L-01A-11D-A267_131120_SN1222_0230_BC29YPACXX_s_1_rg.sorted.bam	22.45	NA	0.17	58cfa832e4b0c9d6adf6d1a4	TCGA-IG-A50L-01A-11D-A267_131120_SN1222_0230_BC29YPACXX_s_1_rg.sorted.bam	Alive	MALE	ASIAN	NOT HISPANIC OR LATINO	Esophageal Carcinoma	Aligned reads	TCGA-IG-A50L-01A	9E54A27F-D0FA-4A5B-91BC-13E27FED2A3D	Primary Tumor	Illumina HiSeq	3e7102a5-f6cf-4918-83d4-8bc4a36d6eda	Esophagus	58	5B30B4D1-4FC6-4712-92B4-E3BE5131551E	62296F7F-6BE0-41E3-A2AA-27B3D1ACE0C7	TCGA-IG-A50L-01A-11D-A267-26	HG19_Broad_variant	TCGA-IG-A50L	TCGA-ESCA	NA	s1815	MD Anderson - Institute for Applied Cancer Science	Asterand	Vietnam	NO	T3	N1	Not available	Stage IIIA	A267-26	TRUE
13722.58cfa832e4b0c9d6adf6d1dc	58cfa832e4b0c9d6adf6d1dc	TCGA-HT-7473-01A-11D-2022_130913_SN1440_0167_AC2A6PACXX_s_4_rg.sorted.filtered.	WGS	TCGA-HT-7473-01A-11D-2022_130913_SN1440_0167_AC2A6PACXX_s_4_rg.sorted	TCGA-HT-7473-01A-11D-2022_130913_SN1440_0167_AC2A6PACXX_s_4_rg.sorted.bam	122.7	NA	0.15	58cfa832e4b0c9d6adf6d1dc	TCGA-HT-7473-01A-11D-2022_130913_SN1440_0167_AC2A6PACXX_s_4_rg.sorted.bam	Alive	MALE	WHITE	HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-HT-7473-01A	DBFACCB0-E8C0-48E8-9AEF-570267574822	Primary Tumor	Illumina HiSeq	0c3613f1-9a5e-42d1-a1a9-884cf56894f4	Brain	28	D302390B-4B66-48E6-92DE-612504B34FA3	A664FDA7-9BF1-4016-A16A-BCA75C6D139C	TCGA-HT-7473-01A-11D-2022-02	HG19_Broad_variant	TCGA-HT-7473	TCGA-LGG	NA	s8154	Harvard Medical School	Case Western - St Joes	United States	NO	Not available	Not available	Oligoastrocytoma	Not available	2022-02	TRUE
13722.58cfa832e4b0c9d6adf6d1b5	58cfa832e4b0c9d6adf6d1b5	TCGA-HI-7170-01A-11D-2111_130607_SN590_0232_BD26R5ACXX_s_5_rg.sorted.filtered.	WGS	TCGA-HI-7170-01A-11D-2111_130607_SN590_0232_BD26R5ACXX_s_5_rg.sorted	TCGA-HI-7170-01A-11D-2111_130607_SN590_0232_BD26R5ACXX_s_5_rg.sorted.bam	96.3	NA	0.15	58cfa832e4b0c9d6adf6d1b5	TCGA-HI-7170-01A-11D-2111_130607_SN590_0232_BD26R5ACXX_s_5_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-HI-7170-01A	6394E00A-1F6F-4EA2-B885-373BBB59DEF9	Primary Tumor	Illumina HiSeq	4eefa9f0-575b-4039-912a-7c0e58f4e508	Prostate	58	70BF0C3E-0C06-4168-996C-46783752FA37	1C5E0781-5295-427A-B94A-062B2708B62C	TCGA-HI-7170-01A-11D-2111-02	HG19_Broad_variant	TCGA-HI-7170	TCGA-PRAD	NA	s3629	Harvard Medical School	Fox Chase	United States	NO	T2c	N0	Prostate Adenocarcinoma Acinar Type	Not available	2111-02	TRUE
13722.58cfa832e4b0c9d6adf6d288	58cfa832e4b0c9d6adf6d288	TCGA-HT-7476-01A-11D-2022_130913_SN1440_0167_AC2A6PACXX_s_6_rg.sorted.filtered.	WGS	TCGA-HT-7476-01A-11D-2022_130913_SN1440_0167_AC2A6PACXX_s_6_rg.sorted	TCGA-HT-7476-01A-11D-2022_130913_SN1440_0167_AC2A6PACXX_s_6_rg.sorted.bam	31.7	NA	0.15	58cfa832e4b0c9d6adf6d288	TCGA-HT-7476-01A-11D-2022_130913_SN1440_0167_AC2A6PACXX_s_6_rg.sorted.bam	Alive	MALE	WHITE	HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-HT-7476-01A	27D0D3CB-16C0-4BA8-9662-95917F665004	Primary Tumor	Illumina HiSeq	8eda6747-01ab-4378-b3c9-6f638de37412	Brain	26	50823838-03B8-4CD8-A40D-8439011C9B38	06ABBC57-F759-43B4-AD0A-3CEE74E012B5	TCGA-HT-7476-01A-11D-2022-02	HG19_Broad_variant	TCGA-HT-7476	TCGA-LGG	NA	s8370	Harvard Medical School	Case Western - St Joes	United States	NO	Not available	Not available	Astrocytoma	Not available	2022-02	TRUE
13722.58cfa832e4b0c9d6adf6d3d0	58cfa832e4b0c9d6adf6d3d0	TCGA-L5-A43J-01A-12D-A248_121211_SN208_0443_BC1H55ACXX_s_5_rg.sorted.filtered.	WGS	TCGA-L5-A43J-01A-12D-A248_121211_SN208_0443_BC1H55ACXX_s_5_rg.sorted	TCGA-L5-A43J-01A-12D-A248_121211_SN208_0443_BC1H55ACXX_s_5_rg.sorted.bam	17.75	NA	0.17	58cfa832e4b0c9d6adf6d3d0	TCGA-L5-A43J-01A-12D-A248_121211_SN208_0443_BC1H55ACXX_s_5_rg.sorted.bam	Dead	MALE	WHITE	Not available	Esophageal Carcinoma	Aligned reads	TCGA-L5-A43J-01A	209E2E16-CB88-4A8F-9CDB-10E152CAA26C	Primary Tumor	Illumina HiSeq	ed639604-bac1-4406-ad55-5a821261a54a	Esophagus	90	EEA7BE16-BAF9-4101-A712-CFAF5349476E	9BDD056B-DEC2-4856-9093-94FD133CF06B	TCGA-L5-A43J-01A-12D-A248-26	HG19_Broad_variant	TCGA-L5-A43J	TCGA-ESCA	131	s1739	MD Anderson - Institute for Applied Cancer Science	University of Michigan	United States	NO	T3	N0	Not available	Stage IIB	A248-26	TRUE
13722.58cfa832e4b0c9d6adf6d578	58cfa832e4b0c9d6adf6d578	TCGA-V4-A9EM-01A-11D-A40D_140808_SN590_0253_AC499NACXX_s_2_rg.sorted.filtered.	WGS	TCGA-V4-A9EM-01A-11D-A40D_140808_SN590_0253_AC499NACXX_s_2_rg.sorted	TCGA-V4-A9EM-01A-11D-A40D_140808_SN590_0253_AC499NACXX_s_2_rg.sorted.bam	31.67	NA	0.15	58cfa832e4b0c9d6adf6d578	TCGA-V4-A9EM-01A-11D-A40D_140808_SN590_0253_AC499NACXX_s_2_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Uveal Melanoma	Aligned reads	TCGA-V4-A9EM-01A	711EB720-4CB7-48DE-9350-5C729BF9F0DA	Primary Tumor	Illumina HiSeq	f3dd06ee-2d71-4310-b226-e94b83da83f7	Eye	53	79658DC3-F2B6-4C5E-9BF7-2C0E440BA3BF	2A1955C2-F55D-48EF-A013-AA69288C3A0C	TCGA-V4-A9EM-01A-11D-A40D-26	HG19_Broad_variant	TCGA-V4-A9EM	TCGA-UVM	NA	s233	MD Anderson - Institute for Applied Cancer Science	Institut Curie	France	NO	T4a	N0	Not available	Stage IIIA	A40D-26	TRUE
13722.58cfa832e4b0c9d6adf6d57a	58cfa832e4b0c9d6adf6d57a	TCGA-LN-A4MQ-01A-11D-A28P_131120_SN1222_0230_BC29YPACXX_s_4_rg.sorted.filtered.	WGS	TCGA-LN-A4MQ-01A-11D-A28P_131120_SN1222_0230_BC29YPACXX_s_4_rg.sorted	TCGA-LN-A4MQ-01A-11D-A28P_131120_SN1222_0230_BC29YPACXX_s_4_rg.sorted.bam	35.61	NA	0.16	58cfa832e4b0c9d6adf6d57a	TCGA-LN-A4MQ-01A-11D-A28P_131120_SN1222_0230_BC29YPACXX_s_4_rg.sorted.bam	Alive	MALE	ASIAN	NOT HISPANIC OR LATINO	Esophageal Carcinoma	Aligned reads	TCGA-LN-A4MQ-01A	33C0199A-BE0C-46D1-BB1E-889BFAEDF20B	Primary Tumor	Illumina HiSeq	beb51eaa-d60f-4bae-a401-293cb0ff9121	Esophagus	46	23CF07BE-97E6-4F55-A8F2-FF03CDBBA74E	4B6D7228-2E11-44F6-A1F4-DABF2085BB05	TCGA-LN-A4MQ-01A-11D-A28P-26	HG19_Broad_variant	TCGA-LN-A4MQ	TCGA-ESCA	NA	s1868	MD Anderson - Institute for Applied Cancer Science	ILSbio	Vietnam	NO	T3	N1	Not available	Stage III	A28P-26	TRUE
13722.58cfa832e4b0c9d6adf6d5b4	58cfa832e4b0c9d6adf6d5b4	TCGA-LN-A49P-01A-11D-A248_121212_SN1120_0205_AC1F18ACXX_s_3_rg.sorted.filtered.	WGS	TCGA-LN-A49P-01A-11D-A248_121212_SN1120_0205_AC1F18ACXX_s_3_rg.sorted	TCGA-LN-A49P-01A-11D-A248_121212_SN1120_0205_AC1F18ACXX_s_3_rg.sorted.bam	26.81	NA	0.16	58cfa832e4b0c9d6adf6d5b4	TCGA-LN-A49P-01A-11D-A248_121212_SN1120_0205_AC1F18ACXX_s_3_rg.sorted.bam	Alive	MALE	ASIAN	NOT HISPANIC OR LATINO	Esophageal Carcinoma	Aligned reads	TCGA-LN-A49P-01A	B64A5F5A-5913-432E-9D08-0FF67A8C6B64	Primary Tumor	Illumina HiSeq	bc96d005-85da-45f9-924a-a168644b49c0	Esophagus	71	4B768A42-B383-40A9-9A6F-511974E9E4C8	044EA190-FCC0-41BE-99F7-274A1DDA540B	TCGA-LN-A49P-01A-11D-A248-26	HG19_Broad_variant	TCGA-LN-A49P	TCGA-ESCA	NA	s1760	MD Anderson - Institute for Applied Cancer Science	ILSbio	Vietnam	NO	T3	N0	Not available	Stage IIA	A248-26	TRUE
13722.58cfa82ee4b0c9d6adf6b092	58cfa82ee4b0c9d6adf6b092	TCGA-05-4417-01A-22D-1853_111204_SN208_0256_C0562ACXX_s_6_rg.sorted.filtered.	WGS	TCGA-05-4417-01A-22D-1853_111204_SN208_0256_C0562ACXX_s_6_rg.sorted	TCGA-05-4417-01A-22D-1853_111204_SN208_0256_C0562ACXX_s_6_rg.sorted.bam	184.7	1.9	0.16	58cfa82ee4b0c9d6adf6b092	TCGA-05-4417-01A-22D-1853_111204_SN208_0256_C0562ACXX_s_6_rg.sorted.bam	Alive	FEMALE	Not available	Not available	Lung Adenocarcinoma	Aligned reads	TCGA-05-4417-01A	A244A99A-D7CC-4FB1-BC76-B66886481621	Primary Tumor	Illumina HiSeq	f4f3791e-3b72-4f33-986c-dca1cf3ada94	Lung	51	9AB40E48-6979-43CB-9ACF-1D4F474CAD4D	B7C6B0BD-AB9E-4211-8B3A-786B45C43F3D	TCGA-05-4417-01A-22D-1853-02	HG19_Broad_variant	TCGA-05-4417	TCGA-LUAD	NA	s11437	Harvard Medical School	Indivumed	Germany	NO	T2	N0	Lung Adenocarcinoma Mixed Subtype	Stage IB	1853-02	TRUE
13722.58cfa82fe4b0c9d6adf6b62e	58cfa82fe4b0c9d6adf6b62e	TCGA-75-6206-01A-11D-1751_111116_SN208_0255_D09F1ACXX_s_5_rg.sorted.filtered.	WGS	TCGA-75-6206-01A-11D-1751_111116_SN208_0255_D09F1ACXX_s_5_rg.sorted	TCGA-75-6206-01A-11D-1751_111116_SN208_0255_D09F1ACXX_s_5_rg.sorted.bam	304.4	1.9	0.16	58cfa82fe4b0c9d6adf6b62e	TCGA-75-6206-01A-11D-1751_111116_SN208_0255_D09F1ACXX_s_5_rg.sorted.bam	Alive	MALE	Not available	Not available	Lung Adenocarcinoma	Aligned reads	TCGA-75-6206-01A	C4C1469D-752F-42B6-8686-714AD4A8AC97	Primary Tumor	Illumina HiSeq	2b0c2142-3073-4443-9998-a7e909add85d	Lung	NA	4AFC6152-819B-4E55-817D-DF8A42EB0D36	B6836DCC-F7D7-45BF-AE7C-DE6F2140779E	TCGA-75-6206-01A-11D-1751-02	HG19_Broad_variant	TCGA-75-6206	TCGA-LUAD	NA	s11131	Harvard Medical School	Ontario Institute for Cancer Research (OICR)	Canada	NO	T2	N0	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage IB	1751-02	TRUE
13722.58cfa82fe4b0c9d6adf6b701	58cfa82fe4b0c9d6adf6b701	TCGA-44-6775-01A-11D-1853_111207_SN590_0112_D09CDACXX_s_4_rg.sorted.filtered.	WGS	TCGA-44-6775-01A-11D-1853_111207_SN590_0112_D09CDACXX_s_4_rg.sorted	TCGA-44-6775-01A-11D-1853_111207_SN590_0112_D09CDACXX_s_4_rg.sorted.bam	237.3	1.9	0.16	58cfa82fe4b0c9d6adf6b701	TCGA-44-6775-01A-11D-1853_111207_SN590_0112_D09CDACXX_s_4_rg.sorted.bam	Alive	FEMALE	WHITE	HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-44-6775-01A	3C4FF061-D214-4D1C-8D2E-3034F207C252	Primary Tumor	Illumina HiSeq	c17b3c9b-e41f-48e2-9cde-facc8537afbc	Lung	72	7C606F64-69A1-465C-9F4E-2EB1EBEDA5D7	8B286297-0077-44ED-9093-6F13E2CA4EBA	TCGA-44-6775-01A-11D-1853-02	HG19_Broad_variant	TCGA-44-6775	TCGA-LUAD	NA	s11454	Harvard Medical School	Christiana Healthcare	United States	NO	T2a	N0	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage IB	1853-02	TRUE
13722.58cfa82fe4b0c9d6adf6b8de	58cfa82fe4b0c9d6adf6b8de	TCGA-A7-A0D9-01A-31D-A060_130807_SN590_0235_AC29RAACXX_s_5_rg.sorted.filtered.	WGS	TCGA-A7-A0D9-01A-31D-A060_130807_SN590_0235_AC29RAACXX_s_5_rg.sorted	TCGA-A7-A0D9-01A-31D-A060_130807_SN590_0235_AC29RAACXX_s_5_rg.sorted.bam	59.5	2.02	0.17	58cfa82fe4b0c9d6adf6b8de	TCGA-A7-A0D9-01A-31D-A060_130807_SN590_0235_AC29RAACXX_s_5_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-A7-A0D9-01A	17BAEF7C-D97D-4B98-AB53-503EF856523D	Primary Tumor	Illumina HiSeq	43dc32db-2202-486d-82f4-388e37224379	Breast	37	C144AE50-ED29-4E27-BBEE-FA81E79AC7DB	7CD9AC40-F6B5-4C68-9D9A-D57845B812DB	TCGA-A7-A0D9-01A-31D-A060-02	HG19_Broad_variant	TCGA-A7-A0D9	TCGA-BRCA	NA	s5638	Harvard Medical School	Christiana Healthcare	None	NO	T2	N0 (i-)	Infiltrating Ductal Carcinoma	Stage IIA	A060-02	TRUE
13722.58cfa82fe4b0c9d6adf6b8d4	58cfa82fe4b0c9d6adf6b8d4	TCGA-50-5049-01A-01D-1623_120205_SN590_0136_BD0LRYACXX_s_3_rg.sorted.filtered.	WGS	TCGA-50-5049-01A-01D-1623_120205_SN590_0136_BD0LRYACXX_s_3_rg.sorted	TCGA-50-5049-01A-01D-1623_120205_SN590_0136_BD0LRYACXX_s_3_rg.sorted.bam	743.7	1.9	0.16	58cfa82fe4b0c9d6adf6b8d4	TCGA-50-5049-01A-01D-1623_120205_SN590_0136_BD0LRYACXX_s_3_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-50-5049-01A	9944F46F-9FA8-4E2C-A806-776BEC7F8803	Primary Tumor	Illumina HiSeq	16ea05eb-f830-4b36-83bb-989c8de99568	Lung	70	21B2F32E-CCEA-4B20-86D3-6647E99825CF	26ED24EC-1AD1-492D-B2CB-46314B47919E	TCGA-50-5049-01A-01D-1623-02	HG19_Broad_variant	TCGA-50-5049	TCGA-LUAD	NA	s11457	Harvard Medical School	University of Pittsburgh	United States	NO	T2	N0	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage IA	1623-02	TRUE
13722.58cfa82fe4b0c9d6adf6b896	58cfa82fe4b0c9d6adf6b896	TCGA-49-6742-01A-11D-1853_111218_SN208_0258_C054RACXX_s_1_rg.sorted.filtered.	WGS	TCGA-49-6742-01A-11D-1853_111218_SN208_0258_C054RACXX_s_1_rg.sorted	TCGA-49-6742-01A-11D-1853_111218_SN208_0258_C054RACXX_s_1_rg.sorted.bam	39.7	2	0.13	58cfa82fe4b0c9d6adf6b896	TCGA-49-6742-01A-11D-1853_111218_SN208_0258_C054RACXX_s_1_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-49-6742-01A	21FB46F9-4BBB-441C-AF19-A687E9138344	Primary Tumor	Illumina HiSeq	eeeb9a6f-97a9-4db9-aeb9-c5afaf9d0153	Lung	70	F0A4AE58-D5BC-4AB0-B1CF-0D951EA91FC7	04467FAB-BB2F-4F26-AF9E-39C09D920A63	TCGA-49-6742-01A-11D-1853-02	HG19_Broad_variant	TCGA-49-6742	TCGA-LUAD	NA	s10655	Harvard Medical School	Johns Hopkins	United States	NO	T2a	N1	Mucinous (Colloid) Carcinoma	Stage IIA	1853-02	TRUE
13722.58cfa82fe4b0c9d6adf6b8f2	58cfa82fe4b0c9d6adf6b8f2	TCGA-50-5932-01A-11D-1751_111007_SN590_0110_C003AACXX_s_6_rg.sorted.filtered.	WGS	TCGA-50-5932-01A-11D-1751_111007_SN590_0110_C003AACXX_s_6_rg.sorted	TCGA-50-5932-01A-11D-1751_111007_SN590_0110_C003AACXX_s_6_rg.sorted.bam	289.4	1.9	0.15	58cfa82fe4b0c9d6adf6b8f2	TCGA-50-5932-01A-11D-1751_111007_SN590_0110_C003AACXX_s_6_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-50-5932-01A	EBCBA7F2-CE13-4BAE-97CD-91A6B1DCD465	Primary Tumor	Illumina HiSeq	a1be116a-f392-49b3-97c6-b674ac8dee93	Lung	75	7ECB9621-7A1F-4876-9DFB-9B77CC4CB7B4	B9ACEF1D-8029-47AB-9830-06B2FF147CDB	TCGA-50-5932-01A-11D-1751-02	HG19_Broad_variant	TCGA-50-5932	TCGA-LUAD	1235	s10661	Harvard Medical School	University of Pittsburgh	United States	NO	T2	N1	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage IIB	1751-02	TRUE
13722.58cfa82fe4b0c9d6adf6b697	58cfa82fe4b0c9d6adf6b697	TCGA-44-5643-01A-01D-1623_120228_SN1120_0116_AD0KRVACXX_s_7_rg.sorted.filtered.	WGS	TCGA-44-5643-01A-01D-1623_120228_SN1120_0116_AD0KRVACXX_s_7_rg.sorted	TCGA-44-5643-01A-01D-1623_120228_SN1120_0116_AD0KRVACXX_s_7_rg.sorted.bam	672.7	1.9	0.15	58cfa82fe4b0c9d6adf6b697	TCGA-44-5643-01A-01D-1623_120228_SN1120_0116_AD0KRVACXX_s_7_rg.sorted.bam	Alive	MALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-44-5643-01A	27FCEEC1-3298-4CDD-A4E6-8F5CF34604F0	Primary Tumor	Illumina HiSeq	d7fc0a17-7a0f-4345-904e-dd40d39ebbc3	Lung	53	ED5B47C1-569F-492B-8D6C-155E3BA79ACB	98EAE374-5F58-4544-BB02-BF605A09AD15	TCGA-44-5643-01A-01D-1623-02	HG19_Broad_variant	TCGA-44-5643	TCGA-LUAD	NA	s10778	Harvard Medical School	Christiana Healthcare	United States	NO	T2b	N2	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage IIIA	1623-02	TRUE
13722.58cfa82fe4b0c9d6adf6b942	58cfa82fe4b0c9d6adf6b942	TCGA-A5-A0GN-01A-11D-A043_120324_SN1120_0127_BC0L80ACXX_s_3_rg.sorted.filtered.	WGS	TCGA-A5-A0GN-01A-11D-A043_120324_SN1120_0127_BC0L80ACXX_s_3_rg.sorted	TCGA-A5-A0GN-01A-11D-A043_120324_SN1120_0127_BC0L80ACXX_s_3_rg.sorted.bam	65.96	1.81	0.16	58cfa82fe4b0c9d6adf6b942	TCGA-A5-A0GN-01A-11D-A043_120324_SN1120_0127_BC0L80ACXX_s_3_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-A5-A0GN-01A	A2A2DBDA-D10C-49C4-86A8-61BAF6160CDA	Primary Tumor	Illumina HiSeq	7270b44f-635f-48bf-b3c4-8042b4557613	Uterus	65	F6F9C40B-1E58-47A3-B518-9694FB5FF2CF	41896FDE-677E-419C-B8B9-0171D6669A4A	TCGA-A5-A0GN-01A-11D-A043-02	HG19_Broad_variant	TCGA-A5-A0GN	TCGA-UCEC	NA	s4589	Harvard Medical School	Cedars Sinai	None	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A043-02	TRUE
13722.58cfa82fe4b0c9d6adf6b904	58cfa82fe4b0c9d6adf6b904	TCGA-49-4512-01A-21D-1853_120123_SN590_0134_AC0DJKACXX_s_6_rg.sorted.filtered.	WGS	TCGA-49-4512-01A-21D-1853_120123_SN590_0134_AC0DJKACXX_s_6_rg.sorted	TCGA-49-4512-01A-21D-1853_120123_SN590_0134_AC0DJKACXX_s_6_rg.sorted.bam	180.7	1.9	0.15	58cfa82fe4b0c9d6adf6b904	TCGA-49-4512-01A-21D-1853_120123_SN590_0134_AC0DJKACXX_s_6_rg.sorted.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-49-4512-01A	A1E65587-24C1-4B41-92A7-4E1F15FFFD78	Primary Tumor	Illumina HiSeq	bfba789d-2b84-4c34-89f9-7a38586facf6	Lung	69	D809A778-D1AC-4406-AB09-67CC70F1F0C2	6D2569C8-4E18-423B-852D-315DDC3AE2F7	TCGA-49-4512-01A-21D-1853-02	HG19_Broad_variant	TCGA-49-4512	TCGA-LUAD	905	s10780	Harvard Medical School	Johns Hopkins	United States	NO	T2	N2	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage IIIA	1853-02	TRUE
13722.58cfa82fe4b0c9d6adf6ba08	58cfa82fe4b0c9d6adf6ba08	TCGA-A5-A0G2-01A-11D-A043_120301_SN590_0142_AD0LPVACXX_s_1_rg.sorted.filtered.	WGS	TCGA-A5-A0G2-01A-11D-A043_120301_SN590_0142_AD0LPVACXX_s_1_rg.sorted	TCGA-A5-A0G2-01A-11D-A043_120301_SN590_0142_AD0LPVACXX_s_1_rg.sorted.bam	104.46	2.03	0.15	58cfa82fe4b0c9d6adf6ba08	TCGA-A5-A0G2-01A-11D-A043_120301_SN590_0142_AD0LPVACXX_s_1_rg.sorted.bam	Alive	FEMALE	ASIAN	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-A5-A0G2-01A	4ABBD258-0F0C-4428-901D-625D47AD363A	Primary Tumor	Illumina HiSeq	f5289cfe-4208-4623-896c-ec78fb5f7dc5	Uterus	57	771811E3-740E-42FE-BE9C-FD485997EAAE	579C21E4-83BD-4DAE-B030-53E0930DEACA	TCGA-A5-A0G2-01A-11D-A043-02	HG19_Broad_variant	TCGA-A5-A0G2	TCGA-UCEC	NA	s4773	Harvard Medical School	Cedars Sinai	None	NO	Not available	Not available	Serous endometrial adenocarcinoma	Not available	A043-02	TRUE
13722.58cfa82fe4b0c9d6adf6ba48	58cfa82fe4b0c9d6adf6ba48	TCGA-A5-A0G5-01A-11D-A043_120327_SN590_0148_BC0LM8ACXX_s_3_rg.sorted.filtered.	WGS	TCGA-A5-A0G5-01A-11D-A043_120327_SN590_0148_BC0LM8ACXX_s_3_rg.sorted	TCGA-A5-A0G5-01A-11D-A043_120327_SN590_0148_BC0LM8ACXX_s_3_rg.sorted.bam	83.98	2	0.17	58cfa82fe4b0c9d6adf6ba48	TCGA-A5-A0G5-01A-11D-A043_120327_SN590_0148_BC0LM8ACXX_s_3_rg.sorted.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	Not available	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-A5-A0G5-01A	4806D9A6-E65D-4A82-B422-1B287980A0C6	Primary Tumor	Illumina HiSeq	db20abab-2eed-4958-a741-e31199adb617	Uterus	73	FA7392E8-335E-4465-9272-4A19DC99412E	EDFD99A3-38A2-4E43-A3D1-B1D19EA818E5	TCGA-A5-A0G5-01A-11D-A043-02	HG19_Broad_variant	TCGA-A5-A0G5	TCGA-UCEC	NA	s5382	Harvard Medical School	Cedars Sinai	None	NO	Not available	Not available	Serous endometrial adenocarcinoma	Not available	A043-02	TRUE
13722.58cfa82fe4b0c9d6adf6b9c6	58cfa82fe4b0c9d6adf6b9c6	TCGA-73-4658-01A-01D-1751_120309_SN208_0274_AD0R6DACXX_s_5_rg.sorted.filtered.	WGS	TCGA-73-4658-01A-01D-1751_120309_SN208_0274_AD0R6DACXX_s_5_rg.sorted	TCGA-73-4658-01A-01D-1751_120309_SN208_0274_AD0R6DACXX_s_5_rg.sorted.bam	150.4	1.9	0.15	58cfa82fe4b0c9d6adf6b9c6	TCGA-73-4658-01A-01D-1751_120309_SN208_0274_AD0R6DACXX_s_5_rg.sorted.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-73-4658-01A	AFB91740-2668-46D7-BA01-BB26153AD1C7	Primary Tumor	Illumina HiSeq	9ee6d96c-98e7-4829-94dc-f41e5f078854	Lung	80	BFDE37F2-AB6F-4426-A33D-EF9D21772F02	6A3AFDA7-56BB-4120-AB92-6EDA217BC214	TCGA-73-4658-01A-01D-1751-02	HG19_Broad_variant	TCGA-73-4658	TCGA-LUAD	1600	s11130	Harvard Medical School	Roswell Park	United States	NO	T2	N0	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage IB	1751-02	TRUE
13722.58cfa830e4b0c9d6adf6bbbc	58cfa830e4b0c9d6adf6bbbc	TCGA-A2-A0EU-01A-22D-A060_130807_SN590_0235_AC29RAACXX_s_1_rg.sorted.filtered.	WGS	TCGA-A2-A0EU-01A-22D-A060_130807_SN590_0235_AC29RAACXX_s_1_rg.sorted	TCGA-A2-A0EU-01A-22D-A060_130807_SN590_0235_AC29RAACXX_s_1_rg.sorted.bam	40.68	1.8	0.14	58cfa830e4b0c9d6adf6bbbc	TCGA-A2-A0EU-01A-22D-A060_130807_SN590_0235_AC29RAACXX_s_1_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-A2-A0EU-01A	C0427237-B476-4AF4-B664-7BD479922EA5	Primary Tumor	Illumina HiSeq	f8f8a691-8930-46b3-9cd7-1b8ac6895baf	Breast	79	69DBB2AE-3F19-4C29-9C24-810AE60312F3	7F0FA628-7A18-4E52-81CC-3E213C431D3E	TCGA-A2-A0EU-01A-22D-A060-02	HG19_Broad_variant	TCGA-A2-A0EU	TCGA-BRCA	NA	s5489	Harvard Medical School	Walter Reed	None	NO	T1c	N0 (i-)	Infiltrating Ductal Carcinoma	Stage IA	A060-02	TRUE
13722.58cfa830e4b0c9d6adf6bc7a	58cfa830e4b0c9d6adf6bc7a	TCGA-AO-A0JL-01A-11D-A060_130725_SN590_0234_BC29HAACXX_s_1_rg.sorted.filtered.	WGS	TCGA-AO-A0JL-01A-11D-A060_130725_SN590_0234_BC29HAACXX_s_1_rg.sorted	TCGA-AO-A0JL-01A-11D-A060_130725_SN590_0234_BC29HAACXX_s_1_rg.sorted.bam	48.13	1.89	0.13	58cfa830e4b0c9d6adf6bc7a	TCGA-AO-A0JL-01A-11D-A060_130725_SN590_0234_BC29HAACXX_s_1_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-AO-A0JL-01A	D5D8E76E-2F2A-49BC-BA0A-D51283611B16	Primary Tumor	Illumina HiSeq	b39a31b9-dd85-403d-ac11-d7b6dd2703a6	Breast	59	834D2E25-DA72-413B-BB0E-3BEB24D46472	A34C3F47-AD37-4777-A733-07AE8F4B4BFF	TCGA-AO-A0JL-01A-11D-A060-02	HG19_Broad_variant	TCGA-AO-A0JL	TCGA-BRCA	NA	s5639	Harvard Medical School	MSKCC	None	NO	T2	N2a	Infiltrating Ductal Carcinoma	Stage IIIA	A060-02	TRUE
13722.58cfa830e4b0c9d6adf6bd78	58cfa830e4b0c9d6adf6bd78	TCGA-AO-A0JJ-01A-11D-A060_130725_SN590_0233_AD2B3HACXX_s_3_rg.sorted.filtered.	WGS	TCGA-AO-A0JJ-01A-11D-A060_130725_SN590_0233_AD2B3HACXX_s_3_rg.sorted	TCGA-AO-A0JJ-01A-11D-A060_130725_SN590_0233_AD2B3HACXX_s_3_rg.sorted.bam	29.04	1.87	0.14	58cfa830e4b0c9d6adf6bd78	TCGA-AO-A0JJ-01A-11D-A060_130725_SN590_0233_AD2B3HACXX_s_3_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-AO-A0JJ-01A	BEF7B135-A727-45E8-850A-CC4CD56C49AA	Primary Tumor	Illumina HiSeq	6d955c96-b34d-4aea-961b-378e856ae8cb	Breast	54	008DAFDD-A3D1-4801-8C0A-8714E2B58E48	ED24B69D-599E-42ED-BBE3-5C4F59FABED4	TCGA-AO-A0JJ-01A-11D-A060-02	HG19_Broad_variant	TCGA-AO-A0JJ	TCGA-BRCA	NA	s6271	Harvard Medical School	MSKCC	None	NO	T2	N1a	Infiltrating Lobular Carcinoma	Stage IIB	A060-02	TRUE
13722.58cfa830e4b0c9d6adf6bdcc	58cfa830e4b0c9d6adf6bdcc	TCGA-BH-A0H6-01A-21D-A060_130725_SN590_0233_AD2B3HACXX_s_1_rg.sorted.filtered.	WGS	TCGA-BH-A0H6-01A-21D-A060_130725_SN590_0233_AD2B3HACXX_s_1_rg.sorted	TCGA-BH-A0H6-01A-21D-A060_130725_SN590_0233_AD2B3HACXX_s_1_rg.sorted.bam	71.16	2.03	0.15	58cfa830e4b0c9d6adf6bdcc	TCGA-BH-A0H6-01A-21D-A060_130725_SN590_0233_AD2B3HACXX_s_1_rg.sorted.bam	Alive	FEMALE	WHITE	Not available	Breast Invasive Carcinoma	Aligned reads	TCGA-BH-A0H6-01A	AEB6A3A6-B57A-4C53-90E6-E833777DD2A1	Primary Tumor	Illumina HiSeq	9c69c17b-33de-4bb8-be9f-7e0dcde9db0a	Breast	82	B2921C9D-C655-46F3-86E5-2FC2BED1ED33	57D73BC9-950E-42A3-B9FB-6045117112B7	TCGA-BH-A0H6-01A-21D-A060-02	HG19_Broad_variant	TCGA-BH-A0H6	TCGA-BRCA	NA	s5963	Harvard Medical School	University of Pittsburgh	None	NO	T1b	NX	Infiltrating Ductal Carcinoma	Stage I	A060-02	TRUE
13722.58cfa830e4b0c9d6adf6ba9b	58cfa830e4b0c9d6adf6ba9b	TCGA-A5-A0GJ-01A-11D-A043_120318_SN590_0146_AC0KH7ACXX_s_7_rg.sorted.filtered.	WGS	TCGA-A5-A0GJ-01A-11D-A043_120318_SN590_0146_AC0KH7ACXX_s_7_rg.sorted	TCGA-A5-A0GJ-01A-11D-A043_120318_SN590_0146_AC0KH7ACXX_s_7_rg.sorted.bam	92.8	2.11	0.16	58cfa830e4b0c9d6adf6ba9b	TCGA-A5-A0GJ-01A-11D-A043_120318_SN590_0146_AC0KH7ACXX_s_7_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-A5-A0GJ-01A	94817E78-78F5-4556-9394-610DF65605E2	Primary Tumor	Illumina HiSeq	d5b73d0f-c14a-4a54-a8e1-14bc027cfef5	Uterus	44	48FA5B7D-E488-4743-A7CE-ACEB9945F00B	A5D63CC4-892C-4357-B8A1-2BF50CF425DC	TCGA-A5-A0GJ-01A-11D-A043-02	HG19_Broad_variant	TCGA-A5-A0GJ	TCGA-UCEC	NA	s5384	Harvard Medical School	Cedars Sinai	None	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A043-02	TRUE
13722.58cfa830e4b0c9d6adf6be6c	58cfa830e4b0c9d6adf6be6c	TCGA-BL-A13J-01A-11D-A10R_120920_SN1222_0150_AC1927ACXX_s_8_rg.sorted.filtered.	WGS	TCGA-BL-A13J-01A-11D-A10R_120920_SN1222_0150_AC1927ACXX_s_8_rg.sorted	TCGA-BL-A13J-01A-11D-A10R_120920_SN1222_0150_AC1927ACXX_s_8_rg.sorted.bam	57.46	1.9	0.15	58cfa830e4b0c9d6adf6be6c	TCGA-BL-A13J-01A-11D-A10R_120920_SN1222_0150_AC1927ACXX_s_8_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-BL-A13J-01A	556FCBC8-172A-4AF1-8822-AE036E8D68E8	Primary Tumor	Illumina HiSeq	58daf5d5-0c54-4a8c-b756-35565cdc9671	Bladder	65	CF23846D-A7D2-40A9-8B51-49A27967D101	782CEFE1-C28F-40BA-93A2-66279184EEF6	TCGA-BL-A13J-01A-11D-A10R-02	HG19_Broad_variant	TCGA-BL-A13J	TCGA-BLCA	81	s3080	Harvard Medical School	Christiana Healthcare	United States	NO	T4	N2	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV	A10R-02	TRUE
13722.58cfa830e4b0c9d6adf6be82	58cfa830e4b0c9d6adf6be82	TCGA-BL-A0C8-01A-11D-A10R_120926_SN590_0181_AC19HCACXX_s_1_rg.sorted.filtered.	WGS	TCGA-BL-A0C8-01A-11D-A10R_120926_SN590_0181_AC19HCACXX_s_1_rg.sorted	TCGA-BL-A0C8-01A-11D-A10R_120926_SN590_0181_AC19HCACXX_s_1_rg.sorted.bam	69.7	2	0.17	58cfa830e4b0c9d6adf6be82	TCGA-BL-A0C8-01A-11D-A10R_120926_SN590_0181_AC19HCACXX_s_1_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-BL-A0C8-01A	A6003B1C-56A9-430A-A5E2-B70AF3F81BDB	Primary Tumor	Illumina HiSeq	19df03d2-75d2-408e-86e2-482ddeed9736	Bladder	73	5FEED572-07C0-4DA0-8649-CA8F8682657A	AB020F79-BA66-457C-9D77-DDD87C799538	TCGA-BL-A0C8-01A-11D-A10R-02	HG19_Broad_variant	TCGA-BL-A0C8	TCGA-BLCA	NA	s2690	Harvard Medical School	Christiana Healthcare	United States	NO	T1	NX	Not available	Stage I	A10R-02	TRUE
13722.58cfa830e4b0c9d6adf6c02c	58cfa830e4b0c9d6adf6c02c	TCGA-BJ-A0ZC-01A-12D-A13U_120706_SN1222_0123_BD1488ACXX_s_1_rg.sorted.filtered.	WGS	TCGA-BJ-A0ZC-01A-12D-A13U_120706_SN1222_0123_BD1488ACXX_s_1_rg.sorted	TCGA-BJ-A0ZC-01A-12D-A13U_120706_SN1222_0123_BD1488ACXX_s_1_rg.sorted.bam	26.88	1.91	0.16	58cfa830e4b0c9d6adf6c02c	TCGA-BJ-A0ZC-01A-12D-A13U_120706_SN1222_0123_BD1488ACXX_s_1_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-BJ-A0ZC-01A	6675C581-297D-44CD-B80F-AE7E53D48228	Primary Tumor	Illumina HiSeq	a470b305-96a5-43a8-b1f4-db15c7b0b4d5	Thyroid	55	1F945AFF-7BC2-40F5-87DB-92313E541243	0E4A0528-883D-47A5-B399-57B1B15EC412	TCGA-BJ-A0ZC-01A-12D-A13U-02	HG19_Broad_variant	TCGA-BJ-A0ZC	TCGA-THCA	NA	s12232	Harvard Medical School	University of Pittsburgh	United States	NO	T1	N0	Thyroid Papillary Carcinoma - Classical/usual	Stage I	A13U-02	TRUE
13722.58cfa830e4b0c9d6adf6c120	58cfa830e4b0c9d6adf6c120	TCGA-BJ-A0ZG-01A-11D-A10R_120711_SN1120_0174_BD13R2ACXX_s_5_rg.sorted.filtered.	WGS	TCGA-BJ-A0ZG-01A-11D-A10R_120711_SN1120_0174_BD13R2ACXX_s_5_rg.sorted	TCGA-BJ-A0ZG-01A-11D-A10R_120711_SN1120_0174_BD13R2ACXX_s_5_rg.sorted.bam	37.3	1.98	0.16	58cfa830e4b0c9d6adf6c120	TCGA-BJ-A0ZG-01A-11D-A10R_120711_SN1120_0174_BD13R2ACXX_s_5_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-BJ-A0ZG-01A	A3810F36-D2B4-4A45-AD08-A4DBFB9D27AA	Primary Tumor	Illumina HiSeq	44c5a52a-3434-4e05-a510-33799f327c93	Thyroid	80	3AC025C9-FEC6-4997-8630-085750DC84E0	D030DC18-6E50-4679-8BF9-26A1DAEC8F79	TCGA-BJ-A0ZG-01A-11D-A10R-02	HG19_Broad_variant	TCGA-BJ-A0ZG	TCGA-THCA	NA	s12101	Harvard Medical School	University of Pittsburgh	United States	NO	T1	N0	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	Stage I	A10R-02	TRUE
13722.58cfa830e4b0c9d6adf6c228	58cfa830e4b0c9d6adf6c228	TCGA-BT-A20X-01A-11D-A16N_120920_SN1222_0151_BD1D5CACXX_s_5_rg.sorted.filtered.	WGS	TCGA-BT-A20X-01A-11D-A16N_120920_SN1222_0151_BD1D5CACXX_s_5_rg.sorted	TCGA-BT-A20X-01A-11D-A16N_120920_SN1222_0151_BD1D5CACXX_s_5_rg.sorted.bam	38.54	1.64	0.16	58cfa830e4b0c9d6adf6c228	TCGA-BT-A20X-01A-11D-A16N_120920_SN1222_0151_BD1D5CACXX_s_5_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-BT-A20X-01A	BE8B3F36-AAA1-4302-B28E-DE1996FACEAF	Primary Tumor	Illumina HiSeq	256c8b67-1fea-4666-b42c-21e8860946e3	Bladder	56	4D7D3354-6588-4E02-9354-AB5044BA1AB3	B9EE2E33-FF09-41FE-901C-453588041DCE	TCGA-BT-A20X-01A-11D-A16N-02	HG19_Broad_variant	TCGA-BT-A20X	TCGA-BLCA	251	s2692	Harvard Medical School	University of Pittsburgh	United States	NO	T4a	N2	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV	A16N-02	TRUE
13722.58cfa830e4b0c9d6adf6c298	58cfa830e4b0c9d6adf6c298	TCGA-BH-A0GY-01A-11D-A060_130807_SN590_0235_AC29RAACXX_s_7_rg.sorted.filtered.	WGS	TCGA-BH-A0GY-01A-11D-A060_130807_SN590_0235_AC29RAACXX_s_7_rg.sorted	TCGA-BH-A0GY-01A-11D-A060_130807_SN590_0235_AC29RAACXX_s_7_rg.sorted.bam	48.65	2.08	0.16	58cfa830e4b0c9d6adf6c298	TCGA-BH-A0GY-01A-11D-A060_130807_SN590_0235_AC29RAACXX_s_7_rg.sorted.bam	Alive	FEMALE	WHITE	Not available	Breast Invasive Carcinoma	Aligned reads	TCGA-BH-A0GY-01A	7D9D3522-EC3B-4EFE-8C8E-C0E675276EF5	Primary Tumor	Illumina HiSeq	bcac7e1b-ddeb-43d6-ba44-db40336bf564	Breast	67	A7E71EAC-1768-4FC2-8EBA-1576D22E0F43	F5C72179-9BDA-4BC6-B006-93EB616804BC	TCGA-BH-A0GY-01A-11D-A060-02	HG19_Broad_variant	TCGA-BH-A0GY	TCGA-BRCA	NA	s6771	Harvard Medical School	University of Pittsburgh	None	NO	T2	N1	Infiltrating Ductal Carcinoma	Stage IIA	A060-02	TRUE
13722.58cfa830e4b0c9d6adf6c12e	58cfa830e4b0c9d6adf6c12e	TCGA-BS-A0UM-01A-11D-A101_120622_SN1120_0155_AC0WVLACXX_s_1_rg.sorted.filtered.	WGS	TCGA-BS-A0UM-01A-11D-A101_120622_SN1120_0155_AC0WVLACXX_s_1_rg.sorted	TCGA-BS-A0UM-01A-11D-A101_120622_SN1120_0155_AC0WVLACXX_s_1_rg.sorted.bam	107.99	2	0.17	58cfa830e4b0c9d6adf6c12e	TCGA-BS-A0UM-01A-11D-A101_120622_SN1120_0155_AC0WVLACXX_s_1_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-BS-A0UM-01A	A7C565FC-C711-4B63-9549-4CD74D1F57C2	Primary Tumor	Illumina HiSeq	942f9e1e-4e57-4325-a7d0-0a464cda140a	Uterus	64	6F70F18E-5C53-4F1F-A63D-62BD27039B8D	6CD1B997-3123-4934-A06C-14A5CF1BEBFC	TCGA-BS-A0UM-01A-11D-A101-02	HG19_Broad_variant	TCGA-BS-A0UM	TCGA-UCEC	NA	s5009	Harvard Medical School	University of Hawaii	None	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A101-02	TRUE
13722.58cfa831e4b0c9d6adf6c33c	58cfa831e4b0c9d6adf6c33c	TCGA-CG-4475-01A-01D-1154_121026_SN1120_0198_BC188JACXX_s_7_rg.sorted.filtered.	WGS	TCGA-CG-4475-01A-01D-1154_121026_SN1120_0198_BC188JACXX_s_7_rg.sorted	TCGA-CG-4475-01A-01D-1154_121026_SN1120_0198_BC188JACXX_s_7_rg.sorted.bam	128.2	1.9	0.14	58cfa831e4b0c9d6adf6c33c	TCGA-CG-4475-01A-01D-1154_121026_SN1120_0198_BC188JACXX_s_7_rg.sorted.bam	Alive	MALE	Not available	Not available	Stomach Adenocarcinoma	Aligned reads	TCGA-CG-4475-01A	CAD2ADC1-0F41-4651-9C80-AE9961E2DC8D	Primary Tumor	Illumina HiSeq	8d322c4d-bfdb-40cc-a222-87ff33a87718	Stomach	76	3E5D09C6-8F98-4701-BD24-FCA581343DE8	86D8A371-57BB-4DC7-9872-0EB4542208DC	TCGA-CG-4475-01A-01D-1154-02	HG19_Broad_variant	TCGA-CG-4475	TCGA-STAD	NA	s14706	Harvard Medical School	Indivumed	Germany	NO	T3	N1	Not available	Stage IIB	1154-02	TRUE
13722.58cfa831e4b0c9d6adf6c342	58cfa831e4b0c9d6adf6c342	TCGA-CG-4475-01A-01D-1154_130815_VM001_0006_VMR0006CXX_s_5_rg.sorted.filtered.	WGS	TCGA-CG-4475-01A-01D-1154_130815_VM001_0006_VMR0006CXX_s_5_rg.sorted	TCGA-CG-4475-01A-01D-1154_130815_VM001_0006_VMR0006CXX_s_5_rg.sorted.bam	128.2	1.9	0.14	58cfa831e4b0c9d6adf6c342	TCGA-CG-4475-01A-01D-1154_130815_VM001_0006_VMR0006CXX_s_5_rg.sorted.bam	Alive	MALE	Not available	Not available	Stomach Adenocarcinoma	Aligned reads	TCGA-CG-4475-01A	CAD2ADC1-0F41-4651-9C80-AE9961E2DC8D	Primary Tumor	Illumina HiSeq	77dce8cf-5642-43d4-8111-4f72d2ef30ef	Stomach	76	3E5D09C6-8F98-4701-BD24-FCA581343DE8	86D8A371-57BB-4DC7-9872-0EB4542208DC	TCGA-CG-4475-01A-01D-1154-02	HG19_Broad_variant	TCGA-CG-4475	TCGA-STAD	NA	s14639	Harvard Medical School	Indivumed	Germany	NO	T3	N1	Not available	Stage IIB	1154-02	TRUE
13722.58cfa831e4b0c9d6adf6c39e	58cfa831e4b0c9d6adf6c39e	TCGA-C5-A2M1-01A-11D-A18I_140206_SN1222_0239_BC2RAKACXX_s_6_rg.sorted.filtered.	WGS	TCGA-C5-A2M1-01A-11D-A18I_140206_SN1222_0239_BC2RAKACXX_s_6_rg.sorted	TCGA-C5-A2M1-01A-11D-A18I_140206_SN1222_0239_BC2RAKACXX_s_6_rg.sorted.bam	54.44	NA	0.16	58cfa831e4b0c9d6adf6c39e	TCGA-C5-A2M1-01A-11D-A18I_140206_SN1222_0239_BC2RAKACXX_s_6_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-C5-A2M1-01A	8911C80C-C903-48E4-AF5B-FFEDEF9ABC47	Primary Tumor	Illumina HiSeq	374c6310-126e-48e8-8b83-145f75714a4b	Cervix	37	065BB06F-5BB7-4F79-B374-97A3011F22AE	E2DAD681-2B26-43A0-804B-0F2DD17B1EFE	TCGA-C5-A2M1-01A-11D-A18I-02	HG19_Broad_variant	TCGA-C5-A2M1	TCGA-CESC	NA	s1518	Harvard Medical School	Medical College of Wisconsin	United States	NO	T1b1	N0	Endocervical Type of Adenocarcinoma	Not available	A18I-02	TRUE
13722.58cfa831e4b0c9d6adf6c388	58cfa831e4b0c9d6adf6c388	TCGA-CG-5723-01A-11D-1598_121011_SN208_0434_AC18MYACXX_s_3_rg.sorted.filtered.	WGS	TCGA-CG-5723-01A-11D-1598_121011_SN208_0434_AC18MYACXX_s_3_rg.sorted	TCGA-CG-5723-01A-11D-1598_121011_SN208_0434_AC18MYACXX_s_3_rg.sorted.bam	224	1.9	0.14	58cfa831e4b0c9d6adf6c388	TCGA-CG-5723-01A-11D-1598_121011_SN208_0434_AC18MYACXX_s_3_rg.sorted.bam	Alive	MALE	Not available	Not available	Stomach Adenocarcinoma	Aligned reads	TCGA-CG-5723-01A	0F00AD32-E4BE-49D4-A02A-D233BFC913C5	Primary Tumor	Illumina HiSeq	9e55e0ac-b9dd-42dd-afe7-d6f93c1dcc88	Stomach	83	4CCD9CCB-BF50-44EB-AA55-133D8824C433	9A2DC75A-E7BE-4226-9D8C-940946F75958	TCGA-CG-5723-01A-11D-1598-02	HG19_Broad_variant	TCGA-CG-5723	TCGA-STAD	NA	s14417	Harvard Medical School	Indivumed	Germany	NO	T2	N1	Stomach  Adenocarcinoma  Not Otherwise Specified (NOS)	Stage II	1598-02	TRUE
13722.58cfa831e4b0c9d6adf6c3ac	58cfa831e4b0c9d6adf6c3ac	TCGA-CG-5722-01A-21D-1598_121011_SN208_0434_AC18MYACXX_s_2_rg.sorted.filtered.	WGS	TCGA-CG-5722-01A-21D-1598_121011_SN208_0434_AC18MYACXX_s_2_rg.sorted	TCGA-CG-5722-01A-21D-1598_121011_SN208_0434_AC18MYACXX_s_2_rg.sorted.bam	195	1.9	0.15	58cfa831e4b0c9d6adf6c3ac	TCGA-CG-5722-01A-21D-1598_121011_SN208_0434_AC18MYACXX_s_2_rg.sorted.bam	Alive	FEMALE	Not available	Not available	Stomach Adenocarcinoma	Aligned reads	TCGA-CG-5722-01A	F35E8FEF-F61D-4614-B73F-F7E1D0F21F52	Primary Tumor	Illumina HiSeq	05762233-5294-478d-b462-14b931579f63	Stomach	67	30D63C9D-E36A-4654-86B5-5D7A622089C2	F262DDED-846F-4DEB-8FC3-EF0DF814ECA4	TCGA-CG-5722-01A-21D-1598-02	HG19_Broad_variant	TCGA-CG-5722	TCGA-STAD	NA	s14642	Harvard Medical School	Indivumed	Germany	NO	T3	N2	Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS)	Stage IV	1598-02	TRUE
13722.58cfa831e4b0c9d6adf6c3ec	58cfa831e4b0c9d6adf6c3ec	TCGA-CH-5748-01A-11D-1572_130103_SN1222_0165_AC1FBHACXX_s_3_rg.sorted.filtered.	WGS	TCGA-CH-5748-01A-11D-1572_130103_SN1222_0165_AC1FBHACXX_s_3_rg.sorted	TCGA-CH-5748-01A-11D-1572_130103_SN1222_0165_AC1FBHACXX_s_3_rg.sorted.bam	196.7	1.9	0.14	58cfa831e4b0c9d6adf6c3ec	TCGA-CH-5748-01A-11D-1572_130103_SN1222_0165_AC1FBHACXX_s_3_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-CH-5748-01A	0AF98331-9305-41E9-AF55-30390016D65E	Primary Tumor	Illumina HiSeq	02aa8440-93b8-43d7-a58b-6c4421e05321	Prostate	64	A499BF51-B137-4DA9-87A3-D1B1A0F04695	24A0496A-CA69-4AE3-BF8A-92289C738E9F	TCGA-CH-5748-01A-11D-1572-02	HG19_Broad_variant	TCGA-CH-5748	TCGA-PRAD	NA	s3413	Harvard Medical School	Indivumed	Germany	NO	T3a	N0	Prostate Adenocarcinoma Acinar Type	Not available	1572-02	TRUE
13722.58cfa831e4b0c9d6adf6c3dd	58cfa831e4b0c9d6adf6c3dd	TCGA-CH-5744-01A-11D-1572_130104_SN1120_0209_BD1KP6ACXX_s_5_rg.sorted.filtered.	WGS	TCGA-CH-5744-01A-11D-1572_130104_SN1120_0209_BD1KP6ACXX_s_5_rg.sorted	TCGA-CH-5744-01A-11D-1572_130104_SN1120_0209_BD1KP6ACXX_s_5_rg.sorted.bam	249.7	1.9	0.15	58cfa831e4b0c9d6adf6c3dd	TCGA-CH-5744-01A-11D-1572_130104_SN1120_0209_BD1KP6ACXX_s_5_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-CH-5744-01A	4E76DE8E-CB0D-4B83-8AB4-53BC67A7A9D3	Primary Tumor	Illumina HiSeq	b48809ce-93ac-45d2-b127-bf6ee8bd6870	Prostate	64	DCCEAF54-0BCE-4650-9980-9843ABCE0C41	B3198EFA-5613-4B16-BA05-4F0AACCCC00F	TCGA-CH-5744-01A-11D-1572-02	HG19_Broad_variant	TCGA-CH-5744	TCGA-PRAD	NA	s3771	Harvard Medical School	Indivumed	Germany	NO	T2c	N0	Prostate Adenocarcinoma Acinar Type	Not available	1572-02	TRUE
13722.58cfa831e4b0c9d6adf6c3fe	58cfa831e4b0c9d6adf6c3fe	TCGA-CH-5792-01A-11D-1572_130125_SN208_0451_BD1RB1ACXX_s_3_rg.sorted.filtered.	WGS	TCGA-CH-5792-01A-11D-1572_130125_SN208_0451_BD1RB1ACXX_s_3_rg.sorted	TCGA-CH-5792-01A-11D-1572_130125_SN208_0451_BD1RB1ACXX_s_3_rg.sorted.bam	61.7	1.9	0.17	58cfa831e4b0c9d6adf6c3fe	TCGA-CH-5792-01A-11D-1572_130125_SN208_0451_BD1RB1ACXX_s_3_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-CH-5792-01A	8A5F2D7F-835C-4726-B238-F82D6A7F25BD	Primary Tumor	Illumina HiSeq	1c4a46f6-fc5f-44b1-b30a-5baaa806e78b	Prostate	57	DA5F8107-7B69-45B5-8BEB-21D17B066CB4	5975F57F-2918-46C2-B59F-38FAA67A49BA	TCGA-CH-5792-01A-11D-1572-02	HG19_Broad_variant	TCGA-CH-5792	TCGA-PRAD	NA	s3933	Harvard Medical School	Indivumed	Germany	NO	T3a	N0	Prostate Adenocarcinoma Acinar Type	Not available	1572-02	TRUE
13722.58cfa831e4b0c9d6adf6c440	58cfa831e4b0c9d6adf6c440	TCGA-CH-5789-01A-11D-1572_130125_SN208_0450_AC1K3NACXX_s_5_rg.sorted.filtered.	WGS	TCGA-CH-5789-01A-11D-1572_130125_SN208_0450_AC1K3NACXX_s_5_rg.sorted	TCGA-CH-5789-01A-11D-1572_130125_SN208_0450_AC1K3NACXX_s_5_rg.sorted.bam	148.7	1.9	0.15	58cfa831e4b0c9d6adf6c440	TCGA-CH-5789-01A-11D-1572_130125_SN208_0450_AC1K3NACXX_s_5_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-CH-5789-01A	BE5411DC-3CAA-4B25-9B94-CE463E8E52B4	Primary Tumor	Illumina HiSeq	fc8da645-2fde-4ef8-9ee7-8b8101580793	Prostate	61	3C42EB4B-DB63-4F81-8D28-A439E932C716	1D569000-EA8E-4D54-A581-AEE36E66688E	TCGA-CH-5789-01A-11D-1572-02	HG19_Broad_variant	TCGA-CH-5789	TCGA-PRAD	NA	s3779	Harvard Medical School	Indivumed	Germany	NO	T3a	N0	Prostate Adenocarcinoma Acinar Type	Not available	1572-02	TRUE
13722.58cfa831e4b0c9d6adf6c467	58cfa831e4b0c9d6adf6c467	TCGA-CH-5751-01A-11D-1572_130103_SN1222_0165_AC1FBHACXX_s_7_rg.sorted.filtered.	WGS	TCGA-CH-5751-01A-11D-1572_130103_SN1222_0165_AC1FBHACXX_s_7_rg.sorted	TCGA-CH-5751-01A-11D-1572_130103_SN1222_0165_AC1FBHACXX_s_7_rg.sorted.bam	226.7	1.9	0.15	58cfa831e4b0c9d6adf6c467	TCGA-CH-5751-01A-11D-1572_130103_SN1222_0165_AC1FBHACXX_s_7_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-CH-5751-01A	721E76D0-4B1D-4E78-ADB8-1344B8030062	Primary Tumor	Illumina HiSeq	c152f07f-eb7f-464d-ba51-ce1b55777952	Prostate	68	6D8CE214-3A06-4F7C-858B-709A40EBBE25	FC06702A-2C27-42FD-A925-D0DB20C358E7	TCGA-CH-5751-01A-11D-1572-02	HG19_Broad_variant	TCGA-CH-5751	TCGA-PRAD	NA	s3425	Harvard Medical School	Indivumed	Germany	NO	T4	N1	Prostate Adenocarcinoma Acinar Type	Not available	1572-02	TRUE
13722.58cfa831e4b0c9d6adf6c446	58cfa831e4b0c9d6adf6c446	TCGA-CH-5750-01A-11D-1572_130103_SN1222_0165_AC1FBHACXX_s_5_rg.sorted.filtered.	WGS	TCGA-CH-5750-01A-11D-1572_130103_SN1222_0165_AC1FBHACXX_s_5_rg.sorted	TCGA-CH-5750-01A-11D-1572_130103_SN1222_0165_AC1FBHACXX_s_5_rg.sorted.bam	300.7	1.9	0.16	58cfa831e4b0c9d6adf6c446	TCGA-CH-5750-01A-11D-1572_130103_SN1222_0165_AC1FBHACXX_s_5_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-CH-5750-01A	DC40CF49-B208-4F59-B5F0-CFBDD02970B2	Primary Tumor	Illumina HiSeq	d0338227-feec-4f2e-bcfa-89c723bb89b5	Prostate	72	0386D0E9-7BD8-467F-BA97-A379C1D67A83	E1FEA0C9-E1D6-49C2-9DFF-9DC87F7776E9	TCGA-CH-5750-01A-11D-1572-02	HG19_Broad_variant	TCGA-CH-5750	TCGA-PRAD	NA	s3591	Harvard Medical School	Indivumed	Germany	NO	T2c	N0	Prostate Adenocarcinoma Acinar Type	Not available	1572-02	TRUE
13722.58cfa831e4b0c9d6adf6c420	58cfa831e4b0c9d6adf6c420	TCGA-BT-A20T-01A-11D-A14U_120926_SN1222_0152_AC187DACXX_s_7_rg.sorted.filtered.	WGS	TCGA-BT-A20T-01A-11D-A14U_120926_SN1222_0152_AC187DACXX_s_7_rg.sorted	TCGA-BT-A20T-01A-11D-A14U_120926_SN1222_0152_AC187DACXX_s_7_rg.sorted.bam	59.68	2.07	0.17	58cfa831e4b0c9d6adf6c420	TCGA-BT-A20T-01A-11D-A14U_120926_SN1222_0152_AC187DACXX_s_7_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-BT-A20T-01A	096B4F32-10C1-4737-A0DD-CAE04C54EE33	Primary Tumor	Illumina HiSeq	e605a62d-c633-415e-bba0-2174fd3ad94e	Bladder	63	52F538EF-B05D-4C76-9976-CE6D49158016	3929BC99-B4FC-4EB9-BDEA-1986EA49AF2A	TCGA-BT-A20T-01A-11D-A14U-02	HG19_Broad_variant	TCGA-BT-A20T	TCGA-BLCA	453	s2871	Harvard Medical School	University of Pittsburgh	United States	NO	T3b	N1	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV	A14U-02	TRUE
13722.58cfa831e4b0c9d6adf6c558	58cfa831e4b0c9d6adf6c558	TCGA-CN-4733-01A-02D-1868_120427_SN208_0287_AC0J25ACXX_s_5_rg.sorted.filtered.	WGS	TCGA-CN-4733-01A-02D-1868_120427_SN208_0287_AC0J25ACXX_s_5_rg.sorted	TCGA-CN-4733-01A-02D-1868_120427_SN208_0287_AC0J25ACXX_s_5_rg.sorted.bam	7.7	1.9	0.14	58cfa831e4b0c9d6adf6c558	TCGA-CN-4733-01A-02D-1868_120427_SN208_0287_AC0J25ACXX_s_5_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CN-4733-01A	DEDD71B4-8537-4947-839E-90ACEDDD0893	Primary Tumor	Illumina HiSeq	c1887d1c-970a-4e8d-80df-a16844daef9f	Head and Neck	61	A1FD1C9D-C763-488A-8649-FF069F56D2BE	1CB41C9B-FB04-438D-A9FB-89D6186E0D37	TCGA-CN-4733-01A-02D-1868-02	HG19_Broad_variant	TCGA-CN-4733	TCGA-HNSC	NA	s15880	Harvard Medical School	University of Pittsburgh	None	NO	T1	N1	Head and Neck Squamous Cell Carcinoma	Stage III	1868-02	TRUE
13722.58cfa830e4b0c9d6adf6c0fe	58cfa830e4b0c9d6adf6c0fe	TCGA-B5-A0K4-01A-11D-A043_120504_SN590_0156_BC0H68ACXX_s_3_rg.sorted.filtered.	WGS	TCGA-B5-A0K4-01A-11D-A043_120504_SN590_0156_BC0H68ACXX_s_3_rg.sorted	TCGA-B5-A0K4-01A-11D-A043_120504_SN590_0156_BC0H68ACXX_s_3_rg.sorted.bam	31.24	2.03	0.14	58cfa830e4b0c9d6adf6c0fe	TCGA-B5-A0K4-01A-11D-A043_120504_SN590_0156_BC0H68ACXX_s_3_rg.sorted.bam	Alive	FEMALE	Not available	Not available	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-B5-A0K4-01A	A8F38E37-978B-4435-B676-E8D4C34DA909	Primary Tumor	Illumina HiSeq	a95ec772-f010-453f-b4a3-20abf1f681e3	Uterus	51	A4AC1F6E-3411-47AE-9592-513B3D32223F	4612DB59-3A8E-4F32-968A-76BCE0D4F042	TCGA-B5-A0K4-01A-11D-A043-02	HG19_Broad_variant	TCGA-B5-A0K4	TCGA-UCEC	NA	s5389	Harvard Medical School	Duke	United States	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A043-02	TRUE
13722.58cfa831e4b0c9d6adf6c6ea	58cfa831e4b0c9d6adf6c6ea	TCGA-CG-4442-01A-01D-1154_130815_VM001_0004_VMR0004CXX_s_1_rg.sorted.filtered.	WGS	TCGA-CG-4442-01A-01D-1154_130815_VM001_0004_VMR0004CXX_s_1_rg.sorted	TCGA-CG-4442-01A-01D-1154_130815_VM001_0004_VMR0004CXX_s_1_rg.sorted.bam	165.2	1.9	0.14	58cfa831e4b0c9d6adf6c6ea	TCGA-CG-4442-01A-01D-1154_130815_VM001_0004_VMR0004CXX_s_1_rg.sorted.bam	Alive	MALE	Not available	Not available	Stomach Adenocarcinoma	Aligned reads	TCGA-CG-4442-01A	8FCCFF71-3710-4CB9-B8AF-61707AEBE5D8	Primary Tumor	Illumina HiSeq	3a08f497-17a4-4b39-87b6-680e2fa13379	Stomach	85	51927F82-2585-465B-92ED-36EF46D44FAB	7597FC80-5A3C-4999-97B2-4DCB55609CC2	TCGA-CG-4442-01A-01D-1154-02	HG19_Broad_variant	TCGA-CG-4442	TCGA-STAD	NA	s14635	Harvard Medical School	Indivumed	Germany	NO	T2	N0	Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS)	Stage IB	1154-02	TRUE
13722.58cfa831e4b0c9d6adf6c720	58cfa831e4b0c9d6adf6c720	TCGA-D7-6527-01A-11D-1798_130218_SN208_0453_AC1T26ACXX_s_3_rg.sorted.filtered.	WGS	TCGA-D7-6527-01A-11D-1798_130218_SN208_0453_AC1T26ACXX_s_3_rg.sorted	TCGA-D7-6527-01A-11D-1798_130218_SN208_0453_AC1T26ACXX_s_3_rg.sorted.bam	84.4	1.9	0.13	58cfa831e4b0c9d6adf6c720	TCGA-D7-6527-01A-11D-1798_130218_SN208_0453_AC1T26ACXX_s_3_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-D7-6527-01A	CB622CD6-776D-4681-8A67-4ADDD61C66B8	Primary Tumor	Illumina HiSeq	d1534b7a-a5b2-4083-9736-d1ad62a97ad2	Stomach	62	8461CE68-3A6F-4343-8977-78448123F373	F91DFFCE-5185-4555-92EA-919E94EB9569	TCGA-D7-6527-01A-11D-1798-02	HG19_Broad_variant	TCGA-D7-6527	TCGA-STAD	NA	s14496	Harvard Medical School	Greater Poland Cancer Center	Poland	NO	T2	N1	Stomach Intestinal Adenocarcinoma Papillary Type	Stage II	1798-02	TRUE
13722.58cfa831e4b0c9d6adf6c6a2	58cfa831e4b0c9d6adf6c6a2	TCGA-CQ-6223-01A-11D-1911_120504_SN1222_0102_BC0VHDACXX_s_3_rg.sorted.filtered.	WGS	TCGA-CQ-6223-01A-11D-1911_120504_SN1222_0102_BC0VHDACXX_s_3_rg.sorted	TCGA-CQ-6223-01A-11D-1911_120504_SN1222_0102_BC0VHDACXX_s_3_rg.sorted.bam	325.7	1.9	0.15	58cfa831e4b0c9d6adf6c6a2	TCGA-CQ-6223-01A-11D-1911_120504_SN1222_0102_BC0VHDACXX_s_3_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CQ-6223-01A	D9E8C707-E61A-4813-8DC0-2472E9CCF12B	Primary Tumor	Illumina HiSeq	d12d744d-5a58-4e30-bcb7-b8c033a8255d	Head and Neck	69	775DB365-3533-41D9-B635-582292B22700	6CE8A7EC-2730-49E4-81F0-47B03A54EA1A	TCGA-CQ-6223-01A-11D-1911-02	HG19_Broad_variant	TCGA-CQ-6223	TCGA-HNSC	NA	s16038	Harvard Medical School	University Health Network, Toronto	Canada	NO	T2	N0	Head and Neck Squamous Cell Carcinoma	Stage II	1911-02	TRUE
13722.58cfa831e4b0c9d6adf6c710	58cfa831e4b0c9d6adf6c710	TCGA-CV-7428-01A-11D-2317_120623_SN1222_0119_BC0WLLACXX_s_2_rg.sorted.filtered.	WGS	TCGA-CV-7428-01A-11D-2317_120623_SN1222_0119_BC0WLLACXX_s_2_rg.sorted	TCGA-CV-7428-01A-11D-2317_120623_SN1222_0119_BC0WLLACXX_s_2_rg.sorted.bam	325.73	NA	0.16	58cfa831e4b0c9d6adf6c710	TCGA-CV-7428-01A-11D-2317_120623_SN1222_0119_BC0WLLACXX_s_2_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-7428-01A	90D3C240-5CB6-4601-A852-B5CDFBCD6483	Primary Tumor	Illumina HiSeq	234197c5-8479-49c1-9f04-5e9171364a3d	Head and Neck	47	F3CFC60B-ADA9-4549-8CDB-6CEBABB1E6B3	BA021325-B1CC-4C81-99B7-7B7349CFFFB6	TCGA-CV-7428-01A-11D-2317-26	HG19_Broad_variant	TCGA-CV-7428	TCGA-HNSC	1671	s15784	MD Anderson - Institute for Applied Cancer Science	MD Anderson Cancer Center	United States	NO	T4a	N2b	Head and Neck Squamous Cell Carcinoma	Stage IVA	2317-26	TRUE
13722.58cfa831e4b0c9d6adf6c6ad	58cfa831e4b0c9d6adf6c6ad	TCGA-CV-5970-01A-11D-1681_120427_SN1120_0136_AC0JEMACXX_s_3_rg.sorted.filtered.	WGS	TCGA-CV-5970-01A-11D-1681_120427_SN1120_0136_AC0JEMACXX_s_3_rg.sorted	TCGA-CV-5970-01A-11D-1681_120427_SN1120_0136_AC0JEMACXX_s_3_rg.sorted.bam	115	1.9	0.15	58cfa831e4b0c9d6adf6c6ad	TCGA-CV-5970-01A-11D-1681_120427_SN1120_0136_AC0JEMACXX_s_3_rg.sorted.bam	Dead	MALE	WHITE	HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-5970-01A	1F6167D9-C99D-4873-8D6E-E62A1C964135	Primary Tumor	Illumina HiSeq	e7fcc1c5-e66d-4024-adb8-45def5252f1a	Head and Neck	59	4DF92618-5E63-46D7-8526-846932BCE3C2	7EBDEF16-0A0E-4DB2-AB6A-7B6115A7B739	TCGA-CV-5970-01A-11D-1681-02	HG19_Broad_variant	TCGA-CV-5970	TCGA-HNSC	406	s15509	Harvard Medical School	MD Anderson Cancer Center	None	NO	T4a	N2b	Head and Neck Squamous Cell Carcinoma	Stage IVA	1681-02	TRUE
13722.58cfa831e4b0c9d6adf6c737	58cfa831e4b0c9d6adf6c737	TCGA-CV-7263-01A-11D-2317_120623_SN1222_0118_AD13T1ACXX_s_8_rg.sorted.filtered.	WGS	TCGA-CV-7263-01A-11D-2317_120623_SN1222_0118_AD13T1ACXX_s_8_rg.sorted	TCGA-CV-7263-01A-11D-2317_120623_SN1222_0118_AD13T1ACXX_s_8_rg.sorted.bam	170.73	NA	0.14	58cfa831e4b0c9d6adf6c737	TCGA-CV-7263-01A-11D-2317_120623_SN1222_0118_AD13T1ACXX_s_8_rg.sorted.bam	Dead	MALE	BLACK OR AFRICAN AMERICAN	Not available	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-7263-01A	93B742EB-5FC3-4CE2-B7F6-C89F97E0DCC9	Primary Tumor	Illumina HiSeq	d8d79518-dd53-49b5-850c-3af45043e30c	Head and Neck	64	54DCB9AC-FD35-49C2-A790-B1F016160183	32435F1B-5D36-4335-B25E-43B89202F1B2	TCGA-CV-7263-01A-11D-2317-26	HG19_Broad_variant	TCGA-CV-7263	TCGA-HNSC	560	s15776	MD Anderson - Institute for Applied Cancer Science	MD Anderson Cancer Center	United States	NO	T2	NX	Head and Neck Squamous Cell Carcinoma	Stage II	2317-26	TRUE
13722.58cfa831e4b0c9d6adf6c6fc	58cfa831e4b0c9d6adf6c6fc	TCGA-CV-5431-01A-01D-1509_120420_SN208_0285_AD0T5JACXX_s_3_rg.sorted.filtered.	WGS	TCGA-CV-5431-01A-01D-1509_120420_SN208_0285_AD0T5JACXX_s_3_rg.sorted	TCGA-CV-5431-01A-01D-1509_120420_SN208_0285_AD0T5JACXX_s_3_rg.sorted.bam	464.7	1.8	0.15	58cfa831e4b0c9d6adf6c6fc	TCGA-CV-5431-01A-01D-1509_120420_SN208_0285_AD0T5JACXX_s_3_rg.sorted.bam	Dead	MALE	WHITE	HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-5431-01A	64BB5550-2735-4401-A0DB-58EC1020A32D	Primary Tumor	Illumina HiSeq	0cba1ad9-9899-40b0-9fa7-dc39030c04e7	Head and Neck	73	BE567C0A-3833-45D7-B846-D229A8E16E16	D751368D-5948-42EF-8C61-D24595CAC1E9	TCGA-CV-5431-01A-01D-1509-02	HG19_Broad_variant	TCGA-CV-5431	TCGA-HNSC	522	s16334	Harvard Medical School	MD Anderson Cancer Center	None	NO	T3	N2c	Head and Neck Squamous Cell Carcinoma	Stage IVA	1509-02	TRUE
13722.58cfa831e4b0c9d6adf6c748	58cfa831e4b0c9d6adf6c748	TCGA-CV-6959-01A-11D-1911_120505_SN1120_0138_AD11NHACXX_s_4_rg.sorted.filtered.	WGS	TCGA-CV-6959-01A-11D-1911_120505_SN1120_0138_AD11NHACXX_s_4_rg.sorted	TCGA-CV-6959-01A-11D-1911_120505_SN1120_0138_AD11NHACXX_s_4_rg.sorted.bam	264.7	1.9	0.13	58cfa831e4b0c9d6adf6c748	TCGA-CV-6959-01A-11D-1911_120505_SN1120_0138_AD11NHACXX_s_4_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-6959-01A	EF3CE0E5-D2E8-4616-8B1A-A78C591CF235	Primary Tumor	Illumina HiSeq	ff9553cc-07a7-497f-be70-1ad5b8e09130	Head and Neck	48	07FB167A-3F61-4517-A79E-BA2042F10A3A	E1D21CB1-4329-447E-AC5B-EC31BF045495	TCGA-CV-6959-01A-11D-1911-02	HG19_Broad_variant	TCGA-CV-6959	TCGA-HNSC	256	s15903	Harvard Medical School	MD Anderson Cancer Center	United States	NO	T3	N0	Head and Neck Squamous Cell Carcinoma	Stage III	1911-02	TRUE
13722.58cfa831e4b0c9d6adf6c76c	58cfa831e4b0c9d6adf6c76c	TCGA-CV-7178-01A-21D-2317_120623_SN1222_0118_AD13T1ACXX_s_7_rg.sorted.filtered.	WGS	TCGA-CV-7178-01A-21D-2317_120623_SN1222_0118_AD13T1ACXX_s_7_rg.sorted	TCGA-CV-7178-01A-21D-2317_120623_SN1222_0118_AD13T1ACXX_s_7_rg.sorted.bam	199.73	NA	0.16	58cfa831e4b0c9d6adf6c76c	TCGA-CV-7178-01A-21D-2317_120623_SN1222_0118_AD13T1ACXX_s_7_rg.sorted.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-7178-01A	8F044599-3FBE-4B69-B67D-49AEE9168545	Primary Tumor	Illumina HiSeq	f76f830b-a361-4cf5-a60f-69d4d574723f	Head and Neck	64	CAAB8E84-3225-4543-949E-7B7EB11244A2	A139820A-0B76-4A95-A3EE-DDDDF514A9C3	TCGA-CV-7178-01A-21D-2317-26	HG19_Broad_variant	TCGA-CV-7178	TCGA-HNSC	2166	s15900	MD Anderson - Institute for Applied Cancer Science	MD Anderson Cancer Center	United States	NO	T4a	N2	Head and Neck Squamous Cell Carcinoma	Stage IVA	2317-26	TRUE
13722.58cfa831e4b0c9d6adf6c757	58cfa831e4b0c9d6adf6c757	TCGA-CV-7183-01A-11D-2317_120710_SN590_0166_AC0VNFACXX_s_7_rg.sorted.filtered.	WGS	TCGA-CV-7183-01A-11D-2317_120710_SN590_0166_AC0VNFACXX_s_7_rg.sorted	TCGA-CV-7183-01A-11D-2317_120710_SN590_0166_AC0VNFACXX_s_7_rg.sorted.bam	7.43	NA	0.14	58cfa831e4b0c9d6adf6c757	TCGA-CV-7183-01A-11D-2317_120710_SN590_0166_AC0VNFACXX_s_7_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-7183-01A	DE206681-3E27-4D4F-8669-AEFB12B5B1E3	Primary Tumor	Illumina HiSeq	f449ea84-f7cf-4a26-bc43-707ac56f0038	Head and Neck	53	0BFD11FD-B227-41EF-BD54-7BE877BCE5A2	C2030338-EFEF-48CD-B893-BBDB8D85456E	TCGA-CV-7183-01A-11D-2317-26	HG19_Broad_variant	TCGA-CV-7183	TCGA-HNSC	NA	s15652	MD Anderson - Institute for Applied Cancer Science	MD Anderson Cancer Center	United States	NO	T2	N0	Head and Neck Squamous Cell Carcinoma	Stage II	2317-26	TRUE
13722.58cfa831e4b0c9d6adf6c7fb	58cfa831e4b0c9d6adf6c7fb	TCGA-D7-6526-01A-11D-1798_130218_SN208_0453_AC1T26ACXX_s_1_rg.sorted.filtered.	WGS	TCGA-D7-6526-01A-11D-1798_130218_SN208_0453_AC1T26ACXX_s_1_rg.sorted	TCGA-D7-6526-01A-11D-1798_130218_SN208_0453_AC1T26ACXX_s_1_rg.sorted.bam	423.4	1.9	0.15	58cfa831e4b0c9d6adf6c7fb	TCGA-D7-6526-01A-11D-1798_130218_SN208_0453_AC1T26ACXX_s_1_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-D7-6526-01A	A28E57E2-9071-4558-856A-162F7A837380	Primary Tumor	Illumina HiSeq	0a9e4a52-46b9-4c50-9dd3-9418ed5569e2	Stomach	67	DDCEA84E-3135-445C-BA0D-62F686463797	737041EA-9798-4D2E-9C0B-371F533E058F	TCGA-D7-6526-01A-11D-1798-02	HG19_Broad_variant	TCGA-D7-6526	TCGA-STAD	NA	s15251	Harvard Medical School	Greater Poland Cancer Center	Poland	NO	T3	N2	Stomach  Intestinal Adenocarcinoma  Tubular Type	Stage IIIA	1798-02	TRUE
13722.58cfa831e4b0c9d6adf6c889	58cfa831e4b0c9d6adf6c889	TCGA-D7-6525-01A-11D-1798_130214_SN1120_0237_BD1TGLACXX_s_7_rg.sorted.filtered.	WGS	TCGA-D7-6525-01A-11D-1798_130214_SN1120_0237_BD1TGLACXX_s_7_rg.sorted	TCGA-D7-6525-01A-11D-1798_130214_SN1120_0237_BD1TGLACXX_s_7_rg.sorted.bam	198.4	1.9	0.15	58cfa831e4b0c9d6adf6c889	TCGA-D7-6525-01A-11D-1798_130214_SN1120_0237_BD1TGLACXX_s_7_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-D7-6525-01A	82F9A197-040D-4C5E-89D9-D87A7AA0168D	Primary Tumor	Illumina HiSeq	03097d75-d0ad-4e1e-8a9b-5157a768cc05	Stomach	58	C1AC6717-828B-4289-9755-7C56A6FC1392	26A09728-CA75-4E29-A222-0826899E0800	TCGA-D7-6525-01A-11D-1798-02	HG19_Broad_variant	TCGA-D7-6525	TCGA-STAD	NA	s14493	Harvard Medical School	Greater Poland Cancer Center	Poland	NO	T2	N2	Stomach  Adenocarcinoma  Diffuse Type	Stage IIIA	1798-02	TRUE
13722.58cfa831e4b0c9d6adf6c7dd	58cfa831e4b0c9d6adf6c7dd	TCGA-CV-6933-01A-11D-1911_120504_SN208_0296_AC0V09ACXX_s_3_rg.sorted.filtered.	WGS	TCGA-CV-6933-01A-11D-1911_120504_SN208_0296_AC0V09ACXX_s_3_rg.sorted	TCGA-CV-6933-01A-11D-1911_120504_SN208_0296_AC0V09ACXX_s_3_rg.sorted.bam	361.7	1.9	0.15	58cfa831e4b0c9d6adf6c7dd	TCGA-CV-6933-01A-11D-1911_120504_SN208_0296_AC0V09ACXX_s_3_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-6933-01A	2A749317-0156-4213-8482-B2C2D6E52E9B	Primary Tumor	Illumina HiSeq	76d94513-c228-445e-91f7-474a75422b69	Head and Neck	53	8C57C9E6-75BD-442C-984D-3709D2AC4CEC	662EA9EC-86E3-46EE-91C9-6972DA5B5CA1	TCGA-CV-6933-01A-11D-1911-02	HG19_Broad_variant	TCGA-CV-6933	TCGA-HNSC	2741	s15516	Harvard Medical School	MD Anderson Cancer Center	United States	NO	T3	N1	Head and Neck Squamous Cell Carcinoma	Stage III	1911-02	TRUE
13722.58cfa831e4b0c9d6adf6c8a6	58cfa831e4b0c9d6adf6c8a6	TCGA-D7-6519-01A-11D-1798_130214_SN1120_0236_AC1RPCACXX_s_5_rg.sorted.filtered.	WGS	TCGA-D7-6519-01A-11D-1798_130214_SN1120_0236_AC1RPCACXX_s_5_rg.sorted	TCGA-D7-6519-01A-11D-1798_130214_SN1120_0236_AC1RPCACXX_s_5_rg.sorted.bam	266.4	1.9	0.14	58cfa831e4b0c9d6adf6c8a6	TCGA-D7-6519-01A-11D-1798_130214_SN1120_0236_AC1RPCACXX_s_5_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-D7-6519-01A	E37CAE9E-0656-4B89-B326-739A5CC859E0	Primary Tumor	Illumina HiSeq	66b2b99b-ac75-4068-9d05-34e6dbe9721d	Stomach	64	FA7426E1-FCFB-4B08-AD50-1D9E903A81FB	D7D0FD1C-F540-4BE1-A10B-160F59970FFF	TCGA-D7-6519-01A-11D-1798-02	HG19_Broad_variant	TCGA-D7-6519	TCGA-STAD	NA	s15249	Harvard Medical School	Greater Poland Cancer Center	Poland	NO	T2	N1	Stomach  Adenocarcinoma  Diffuse Type	Stage IIIB	1798-02	TRUE
13722.58cfa831e4b0c9d6adf6c902	58cfa831e4b0c9d6adf6c902	TCGA-DB-5273-01A-01D-1465_130808_SN208_0488_BC294YACXX_s_1_rg.sorted.filtered.	WGS	TCGA-DB-5273-01A-01D-1465_130808_SN208_0488_BC294YACXX_s_1_rg.sorted	TCGA-DB-5273-01A-01D-1465_130808_SN208_0488_BC294YACXX_s_1_rg.sorted.bam	64	1.9	0.15	58cfa831e4b0c9d6adf6c902	TCGA-DB-5273-01A-01D-1465_130808_SN208_0488_BC294YACXX_s_1_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-DB-5273-01A	AE2DB022-EB4F-4B65-89B6-9FD4439DDEEF	Primary Tumor	Illumina HiSeq	844bcbca-fe48-4dee-be69-4cef2ac59e27	Brain	33	4BA48810-3915-4567-9D35-615DF00006E4	6F0ACC8E-2A73-4B08-AAA3-A29EBE61E6B7	TCGA-DB-5273-01A-01D-1465-02	HG19_Broad_variant	TCGA-DB-5273	TCGA-LGG	NA	s8751	Harvard Medical School	Mayo Clinic - Rochester	United States	NO	Not available	Not available	Astrocytoma	Not available	1465-02	TRUE
13722.58cfa831e4b0c9d6adf6c8a2	58cfa831e4b0c9d6adf6c8a2	TCGA-DQ-5631-01A-01D-1868_120504_SN1222_0101_AC0UMDACXX_s_2_rg.sorted.filtered.	WGS	TCGA-DQ-5631-01A-01D-1868_120504_SN1222_0101_AC0UMDACXX_s_2_rg.sorted	TCGA-DQ-5631-01A-01D-1868_120504_SN1222_0101_AC0UMDACXX_s_2_rg.sorted.bam	207.7	1.9	0.14	58cfa831e4b0c9d6adf6c8a2	TCGA-DQ-5631-01A-01D-1868_120504_SN1222_0101_AC0UMDACXX_s_2_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-DQ-5631-01A	10B3F56A-E61E-486B-8D3C-176668D5DC34	Primary Tumor	Illumina HiSeq	9aae2925-69ec-44f9-bc1d-bfefd16ce242	Head and Neck	52	2E4AA773-6094-46BD-A97F-9694E80C71CF	5B9E894B-444B-4DCF-9E6C-C1F398A52A81	TCGA-DQ-5631-01A-01D-1868-02	HG19_Broad_variant	TCGA-DQ-5631	TCGA-HNSC	548	s15916	Harvard Medical School	University of Michigan	United States	NO	TX	NX	Head and Neck Squamous Cell Carcinoma	Not available	1868-02	TRUE
13722.58cfa831e4b0c9d6adf6c8c8	58cfa831e4b0c9d6adf6c8c8	TCGA-CV-6952-01A-11D-1911_120505_SN1120_0138_AD11NHACXX_s_1_rg.sorted.filtered.	WGS	TCGA-CV-6952-01A-11D-1911_120505_SN1120_0138_AD11NHACXX_s_1_rg.sorted	TCGA-CV-6952-01A-11D-1911_120505_SN1120_0138_AD11NHACXX_s_1_rg.sorted.bam	111.7	1.9	0.15	58cfa831e4b0c9d6adf6c8c8	TCGA-CV-6952-01A-11D-1911_120505_SN1120_0138_AD11NHACXX_s_1_rg.sorted.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-6952-01A	7ED006E8-461F-4664-BFFF-55FA6812743C	Primary Tumor	Illumina HiSeq	7145e1a2-e609-45d9-a111-efe59656286d	Head and Neck	65	18E70193-5D78-41DD-9FCA-AF5E54594AD3	EAA6BAF6-1D90-471D-BBFF-2230B87339E4	TCGA-CV-6952-01A-11D-1911-02	HG19_Broad_variant	TCGA-CV-6952	TCGA-HNSC	185	s15647	Harvard Medical School	MD Anderson Cancer Center	United States	NO	T3	N2b	Head and Neck Squamous Cell Carcinoma	Stage IVA	1911-02	TRUE
13722.58cfa831e4b0c9d6adf6c90c	58cfa831e4b0c9d6adf6c90c	TCGA-DK-A2HX-01A-12D-A18D_120913_SN208_0429_AC187FACXX_s_1_rg.sorted.filtered.	WGS	TCGA-DK-A2HX-01A-12D-A18D_120913_SN208_0429_AC187FACXX_s_1_rg.sorted	TCGA-DK-A2HX-01A-12D-A18D_120913_SN208_0429_AC187FACXX_s_1_rg.sorted.bam	16.46	NA	0.14	58cfa831e4b0c9d6adf6c90c	TCGA-DK-A2HX-01A-12D-A18D_120913_SN208_0429_AC187FACXX_s_1_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-DK-A2HX-01A	C728FAC9-5452-4759-A4ED-A366E0F757CB	Primary Tumor	Illumina HiSeq	17e4edb9-ac80-43de-a7c1-66edf1201ac0	Bladder	80	537F3FE6-4E8E-4570-827A-0F5CAB193BE0	4BAFEFB4-28D5-4126-B6B7-AE5B0D03F05D	TCGA-DK-A2HX-01A-12D-A18D-02	HG19_Broad_variant	TCGA-DK-A2HX	TCGA-BLCA	NA	s2712	Harvard Medical School	Memorial Sloan Kettering	United States	NO	T3	N2	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV	A18D-02	TRUE
13722.58cfa831e4b0c9d6adf6c912	58cfa831e4b0c9d6adf6c912	TCGA-DK-A2I2-01A-11D-A17R_120927_SN208_0433_BD1D5JACXX_s_3_rg.sorted.filtered.	WGS	TCGA-DK-A2I2-01A-11D-A17R_120927_SN208_0433_BD1D5JACXX_s_3_rg.sorted	TCGA-DK-A2I2-01A-11D-A17R_120927_SN208_0433_BD1D5JACXX_s_3_rg.sorted.bam	49.35	NA	0.16	58cfa831e4b0c9d6adf6c912	TCGA-DK-A2I2-01A-11D-A17R_120927_SN208_0433_BD1D5JACXX_s_3_rg.sorted.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-DK-A2I2-01A	234086DD-5A74-4FF1-94AB-BAD43EE69D5C	Primary Tumor	Illumina HiSeq	99517da2-f39e-4005-8efc-4487b92c0dcc	Bladder	63	45F8E4B6-5D36-47D7-A77D-E5E4C15848B3	767D7AA5-093D-48AB-BCDA-92729F4B95B7	TCGA-DK-A2I2-01A-11D-A17R-02	HG19_Broad_variant	TCGA-DK-A2I2	TCGA-BLCA	237	s2708	Harvard Medical School	Memorial Sloan Kettering	United States	NO	T3	N3	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV	A17R-02	TRUE
13722.58cfa831e4b0c9d6adf6c91b	58cfa831e4b0c9d6adf6c91b	TCGA-DK-A2I1-01A-11D-A17R_120927_SN208_0433_BD1D5JACXX_s_1_rg.sorted.filtered.	WGS	TCGA-DK-A2I1-01A-11D-A17R_120927_SN208_0433_BD1D5JACXX_s_1_rg.sorted	TCGA-DK-A2I1-01A-11D-A17R_120927_SN208_0433_BD1D5JACXX_s_1_rg.sorted.bam	37.09	NA	0.15	58cfa831e4b0c9d6adf6c91b	TCGA-DK-A2I1-01A-11D-A17R_120927_SN208_0433_BD1D5JACXX_s_1_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-DK-A2I1-01A	036B9681-AB58-4734-A8FD-E0D5D078BF5A	Primary Tumor	Illumina HiSeq	724308ea-3fa9-4762-9800-445a044e94f2	Bladder	73	F9BD70B2-6CDE-48E5-9F0D-55D86CCFEBA8	010259EE-2667-4B8E-BB20-0F75F53A64BA	TCGA-DK-A2I1-01A-11D-A17R-02	HG19_Broad_variant	TCGA-DK-A2I1	TCGA-BLCA	NA	s2704	Harvard Medical School	Memorial Sloan Kettering	United States	NO	T2b	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage II	A17R-02	TRUE
13722.58cfa831e4b0c9d6adf6c936	58cfa831e4b0c9d6adf6c936	TCGA-D1-A16E-01A-22D-A12F_120523_SN1222_0109_BD12MPACXX_s_4_rg.sorted.filtered.	WGS	TCGA-D1-A16E-01A-22D-A12F_120523_SN1222_0109_BD12MPACXX_s_4_rg.sorted	TCGA-D1-A16E-01A-22D-A12F_120523_SN1222_0109_BD12MPACXX_s_4_rg.sorted.bam	37.7	1.95	0.15	58cfa831e4b0c9d6adf6c936	TCGA-D1-A16E-01A-22D-A12F_120523_SN1222_0109_BD12MPACXX_s_4_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-D1-A16E-01A	E70465F6-1922-4EB7-B646-8B01AD3CE77B	Primary Tumor	Illumina HiSeq	d5fd8d77-e4f4-4b13-b244-0dbbc2f74021	Uterus	73	58FC1E66-39C4-44D1-BDD3-338E0D833792	0651FC75-DFFC-4271-8832-2DB47C642804	TCGA-D1-A16E-01A-22D-A12F-02	HG19_Broad_variant	TCGA-D1-A16E	TCGA-UCEC	NA	s4439	Harvard Medical School	Mayo Clinic	None	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A12F-02	TRUE
13722.58cfa831e4b0c9d6adf6ca1b	58cfa831e4b0c9d6adf6ca1b	TCGA-DK-A2I6-01A-12D-A18D_120913_SN208_0429_AC187FACXX_s_6_rg.sorted.filtered.	WGS	TCGA-DK-A2I6-01A-12D-A18D_120913_SN208_0429_AC187FACXX_s_6_rg.sorted	TCGA-DK-A2I6-01A-12D-A18D_120913_SN208_0429_AC187FACXX_s_6_rg.sorted.bam	57.02	NA	0.16	58cfa831e4b0c9d6adf6ca1b	TCGA-DK-A2I6-01A-12D-A18D_120913_SN208_0429_AC187FACXX_s_6_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-DK-A2I6-01A	DE810AF0-4C18-4E8F-9836-F8ABC425E3EB	Primary Tumor	Illumina HiSeq	6567cd2d-a1e5-4226-9239-77c48c09c55e	Bladder	81	A536F8F9-3A68-4792-880D-387D78FD0C66	B791021D-173E-4B08-8769-A9F289818D11	TCGA-DK-A2I6-01A-12D-A18D-02	HG19_Broad_variant	TCGA-DK-A2I6	TCGA-BLCA	NA	s2703	Harvard Medical School	Memorial Sloan Kettering	United States	NO	T2b	N1	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV	A18D-02	TRUE
13722.58cfa831e4b0c9d6adf6cae8	58cfa831e4b0c9d6adf6cae8	TCGA-D7-6522-01A-11D-1798_130214_SN1120_0237_BD1TGLACXX_s_3_rg.sorted.filtered.	WGS	TCGA-D7-6522-01A-11D-1798_130214_SN1120_0237_BD1TGLACXX_s_3_rg.sorted	TCGA-D7-6522-01A-11D-1798_130214_SN1120_0237_BD1TGLACXX_s_3_rg.sorted.bam	52.7	1.9	0.14	58cfa831e4b0c9d6adf6cae8	TCGA-D7-6522-01A-11D-1798_130214_SN1120_0237_BD1TGLACXX_s_3_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-D7-6522-01A	8BB3FACB-1933-4350-9F78-74537559E000	Primary Tumor	Illumina HiSeq	ac3cc7c3-e03a-4218-b297-d6c525338753	Stomach	58	825AE87A-69C0-44AC-A1AF-D1FAD7746C05	030D9DF5-48AB-46F4-AC23-F299A069191C	TCGA-D7-6522-01A-11D-1798-02	HG19_Broad_variant	TCGA-D7-6522	TCGA-STAD	NA	s15197	Harvard Medical School	Greater Poland Cancer Center	Poland	NO	T2	N0	Stomach  Adenocarcinoma  Diffuse Type	Stage IB	1798-02	TRUE
13722.58cfa831e4b0c9d6adf6cb0e	58cfa831e4b0c9d6adf6cb0e	TCGA-EA-A3Y4-01A-51D-A245_140124_SN1440_0178_AC2PL6ACXX_s_1_rg.sorted.filtered.	WGS	TCGA-EA-A3Y4-01A-51D-A245_140124_SN1440_0178_AC2PL6ACXX_s_1_rg.sorted	TCGA-EA-A3Y4-01A-51D-A245_140124_SN1440_0178_AC2PL6ACXX_s_1_rg.sorted.bam	30.33	NA	0.15	58cfa831e4b0c9d6adf6cb0e	TCGA-EA-A3Y4-01A-51D-A245_140124_SN1440_0178_AC2PL6ACXX_s_1_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-EA-A3Y4-01A	3AC62513-B5F4-4063-AABD-DAD08A1F56FB	Primary Tumor	Illumina HiSeq	32cd0b72-100c-4e6c-81f1-6be30738cafb	Cervix	40	FF97C148-76BA-480E-9456-5DD7D7238373	A7529CB6-2386-410F-B09A-62E10BAFF8CB	TCGA-EA-A3Y4-01A-51D-A245-26	HG19_Broad_variant	TCGA-EA-A3Y4	TCGA-CESC	NA	s1362	MD Anderson - Institute for Applied Cancer Science	Asterand	Ukraine	NO	T1b	N0	Cervical Squamous Cell Carcinoma	Not available	A245-26	TRUE
13722.58cfa831e4b0c9d6adf6cba0	58cfa831e4b0c9d6adf6cba0	TCGA-EJ-5519-01A-01D-1572_130218_SN208_0454_BD1TBTACXX_s_1_rg.sorted.filtered.	WGS	TCGA-EJ-5519-01A-01D-1572_130218_SN208_0454_BD1TBTACXX_s_1_rg.sorted	TCGA-EJ-5519-01A-01D-1572_130218_SN208_0454_BD1TBTACXX_s_1_rg.sorted.bam	233.7	1.9	0.15	58cfa831e4b0c9d6adf6cba0	TCGA-EJ-5519-01A-01D-1572_130218_SN208_0454_BD1TBTACXX_s_1_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-EJ-5519-01A	5313A055-C2D7-4CBD-A8C1-57AC85912D89	Primary Tumor	Illumina HiSeq	75f448c7-b10b-4c15-ae49-4eb217c65391	Prostate	64	EEE1828E-D25F-462B-9735-89CA2ECCC7E1	4C2E88A3-B668-40A8-B625-B6D7A48DEAF5	TCGA-EJ-5519-01A-01D-1572-02	HG19_Broad_variant	TCGA-EJ-5519	TCGA-PRAD	NA	s3949	Harvard Medical School	University of Pittsburgh	United States	NO	T3b	N1	Prostate Adenocarcinoma Acinar Type	Not available	1572-02	TRUE
13722.58cfa831e4b0c9d6adf6cc40	58cfa831e4b0c9d6adf6cc40	TCGA-EK-A2R7-01A-11D-A18I_140204_SN208_0508_BC2R1UACXX_s_3_rg.sorted.filtered.	WGS	TCGA-EK-A2R7-01A-11D-A18I_140204_SN208_0508_BC2R1UACXX_s_3_rg.sorted	TCGA-EK-A2R7-01A-11D-A18I_140204_SN208_0508_BC2R1UACXX_s_3_rg.sorted.bam	66.58	NA	0.17	58cfa831e4b0c9d6adf6cc40	TCGA-EK-A2R7-01A-11D-A18I_140204_SN208_0508_BC2R1UACXX_s_3_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-EK-A2R7-01A	D7A75BF5-5189-4978-99D9-FCEF91C9FBD2	Primary Tumor	Illumina HiSeq	b998e76d-dff1-4454-abce-bbe7b5a6c398	Cervix	45	EE9A22DF-8612-4B71-AF3A-6B16C73197EA	9C763A04-CC5B-41E1-A5AC-2CB06B9E80C3	TCGA-EK-A2R7-01A-11D-A18I-02	HG19_Broad_variant	TCGA-EK-A2R7	TCGA-CESC	NA	s1526	Harvard Medical School	Gynecologic Oncology Group	United States	NO	T1b1	N1	Cervical Squamous Cell Carcinoma	Not available	A18I-02	TRUE
13722.58cfa831e4b0c9d6adf6cc5c	58cfa831e4b0c9d6adf6cc5c	TCGA-EJ-5502-01A-01D-1572_130329_SN590_0221_BD1WHDACXX_s_5_rg.sorted.filtered.	WGS	TCGA-EJ-5502-01A-01D-1572_130329_SN590_0221_BD1WHDACXX_s_5_rg.sorted	TCGA-EJ-5502-01A-01D-1572_130329_SN590_0221_BD1WHDACXX_s_5_rg.sorted.bam	238.7	1.9	0.17	58cfa831e4b0c9d6adf6cc5c	TCGA-EJ-5502-01A-01D-1572_130329_SN590_0221_BD1WHDACXX_s_5_rg.sorted.bam	Alive	MALE	Not available	Not available	Prostate Adenocarcinoma	Aligned reads	TCGA-EJ-5502-01A	48E83A4C-C602-494A-80CD-E2F4B4DD701E	Primary Tumor	Illumina HiSeq	40f605db-50a6-4ed1-b652-61045959ba2e	Prostate	50	D36A0B54-6E09-4EE2-923B-C1516D78BB03	0432A271-DB73-434C-971A-B3B2C3FD2285	TCGA-EJ-5502-01A-01D-1572-02	HG19_Broad_variant	TCGA-EJ-5502	TCGA-PRAD	NA	s3785	Harvard Medical School	University of Pittsburgh	United States	NO	T2c	N0	Prostate Adenocarcinoma Acinar Type	Not available	1572-02	TRUE
13722.58cfa831e4b0c9d6adf6cba4	58cfa831e4b0c9d6adf6cba4	TCGA-EJ-5521-01A-01D-1572_130218_SN208_0454_BD1TBTACXX_s_3_rg.sorted.filtered.	WGS	TCGA-EJ-5521-01A-01D-1572_130218_SN208_0454_BD1TBTACXX_s_3_rg.sorted	TCGA-EJ-5521-01A-01D-1572_130218_SN208_0454_BD1TBTACXX_s_3_rg.sorted.bam	72.7	1.9	0.14	58cfa831e4b0c9d6adf6cba4	TCGA-EJ-5521-01A-01D-1572_130218_SN208_0454_BD1TBTACXX_s_3_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-EJ-5521-01A	D44D4BCB-BEB1-4464-ACD2-9972751F5018	Primary Tumor	Illumina HiSeq	c9a43591-8317-4ff5-a2e9-33c98c6a6012	Prostate	63	9EEBD2EC-AF9D-493C-A006-A436C28D4CD3	83248990-416D-48F0-B6F4-59C4C7CEEBD8	TCGA-EJ-5521-01A-01D-1572-02	HG19_Broad_variant	TCGA-EJ-5521	TCGA-PRAD	NA	s4134	Harvard Medical School	University of Pittsburgh	United States	NO	T3a	N0	Prostate Adenocarcinoma Acinar Type	Not available	1572-02	TRUE
13722.58cfa831e4b0c9d6adf6cc68	58cfa831e4b0c9d6adf6cc68	TCGA-EK-A2R8-01A-21D-A18I_140204_SN208_0508_BC2R1UACXX_s_4_rg.sorted.filtered.	WGS	TCGA-EK-A2R8-01A-21D-A18I_140204_SN208_0508_BC2R1UACXX_s_4_rg.sorted	TCGA-EK-A2R8-01A-21D-A18I_140204_SN208_0508_BC2R1UACXX_s_4_rg.sorted.bam	58.64	NA	0.17	58cfa831e4b0c9d6adf6cc68	TCGA-EK-A2R8-01A-21D-A18I_140204_SN208_0508_BC2R1UACXX_s_4_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-EK-A2R8-01A	D4510801-8CE4-4F10-8B31-25C0A39B5135	Primary Tumor	Illumina HiSeq	d050a7c3-8fe5-472e-bc71-4dff85991e92	Cervix	48	6B8E0AF3-1632-4FED-9A37-879EA013AE24	80B2C20E-8EFB-4105-8A96-A695FCFB73CB	TCGA-EK-A2R8-01A-21D-A18I-02	HG19_Broad_variant	TCGA-EK-A2R8	TCGA-CESC	NA	s1190	Harvard Medical School	Gynecologic Oncology Group	United States	NO	T1b2	N1	Cervical Squamous Cell Carcinoma	Not available	A18I-02	TRUE
13722.58cfa831e4b0c9d6adf6cca9	58cfa831e4b0c9d6adf6cca9	TCGA-ER-A196-01A-11D-A18Y_120723_SN1120_0178_BD1887ACXX_s_3_rg.sorted.filtered.	WGS	TCGA-ER-A196-01A-11D-A18Y_120723_SN1120_0178_BD1887ACXX_s_3_rg.sorted	TCGA-ER-A196-01A-11D-A18Y_120723_SN1120_0178_BD1887ACXX_s_3_rg.sorted.bam	32.16	NA	0.17	58cfa831e4b0c9d6adf6cca9	TCGA-ER-A196-01A-11D-A18Y_120723_SN1120_0178_BD1887ACXX_s_3_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Skin Cutaneous Melanoma	Aligned reads	TCGA-ER-A196-01A	A9EB1022-FFD3-42DE-A39D-2126FC7EC0CE	Primary Tumor	Illumina HiSeq	ef8b8b6f-6812-446b-b27c-03db8997900d	Skin	64	239F69F7-E78A-4B09-BF00-E521F63A3BB4	77937F29-C94F-4251-A0AB-9D07DED92796	TCGA-ER-A196-01A-11D-A18Y-02	HG19_Broad_variant	TCGA-ER-A196	TCGA-SKCM	NA	s8021	Harvard Medical School	University of Pittsburgh	United States	NO	T4b	N0	Not available	Stage IIC	A18Y-02	TRUE
13722.58cfa831e4b0c9d6adf6ccf8	58cfa831e4b0c9d6adf6ccf8	TCGA-FD-A3SP-01A-31D-A233_120830_SN208_0424_BD1DKLACXX_s_3_rg.sorted.filtered.	WGS	TCGA-FD-A3SP-01A-31D-A233_120830_SN208_0424_BD1DKLACXX_s_3_rg.sorted	TCGA-FD-A3SP-01A-31D-A233_120830_SN208_0424_BD1DKLACXX_s_3_rg.sorted.bam	26.79	NA	0.15	58cfa831e4b0c9d6adf6ccf8	TCGA-FD-A3SP-01A-31D-A233_120830_SN208_0424_BD1DKLACXX_s_3_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-FD-A3SP-01A	5F99DCFF-D809-4C87-8024-C9B30BD565E9	Primary Tumor	Illumina HiSeq	2da38f98-8b94-404e-99e7-7a8d58aa25c1	Bladder	60	3592A9C5-124E-428F-B1F9-40429C591429	9BE9B27C-A33C-450E-806D-7C791472DAE6	TCGA-FD-A3SP-01A-31D-A233-26	HG19_Broad_variant	TCGA-FD-A3SP	TCGA-BLCA	NA	s3112	MD Anderson - Institute for Applied Cancer Science	BLN - University Of Chicago	United States	NO	T3b	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage III	A233-26	TRUE
13722.58cfa831e4b0c9d6adf6cd84	58cfa831e4b0c9d6adf6cd84	TCGA-FE-A235-01A-11D-A16N_121204_SN208_0442_BC1F7YACXX_s_1_rg.sorted.filtered.	WGS	TCGA-FE-A235-01A-11D-A16N_121204_SN208_0442_BC1F7YACXX_s_1_rg.sorted	TCGA-FE-A235-01A-11D-A16N_121204_SN208_0442_BC1F7YACXX_s_1_rg.sorted.bam	74.82	2	0.17	58cfa831e4b0c9d6adf6cd84	TCGA-FE-A235-01A-11D-A16N_121204_SN208_0442_BC1F7YACXX_s_1_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-FE-A235-01A	C781B49E-D08F-49E6-B774-7CFE4100E92D	Primary Tumor	Illumina HiSeq	7eafbe04-60be-48a5-8e8a-937b1dde35e8	Thyroid	26	377A0CBF-6A82-43FA-BC95-DADECED8916D	F3F4F8FB-6FAD-46B7-85D0-C591EB926DD7	TCGA-FE-A235-01A-11D-A16N-02	HG19_Broad_variant	TCGA-FE-A235	TCGA-THCA	NA	s12528	Harvard Medical School	Ohio State University	United States	NO	T2	N1	Thyroid Papillary Carcinoma - Classical/usual	Stage I	A16N-02	TRUE
13722.58cfa832e4b0c9d6adf6ce02	58cfa832e4b0c9d6adf6ce02	TCGA-EJ-5524-01A-01D-1572_130218_SN208_0454_BD1TBTACXX_s_7_rg.sorted.filtered.	WGS	TCGA-EJ-5524-01A-01D-1572_130218_SN208_0454_BD1TBTACXX_s_7_rg.sorted	TCGA-EJ-5524-01A-01D-1572_130218_SN208_0454_BD1TBTACXX_s_7_rg.sorted.bam	248.7	1.9	0.14	58cfa832e4b0c9d6adf6ce02	TCGA-EJ-5524-01A-01D-1572_130218_SN208_0454_BD1TBTACXX_s_7_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-EJ-5524-01A	4048C139-1329-4E6A-8D2F-C0AA104A68EE	Primary Tumor	Illumina HiSeq	bc7b862d-c88b-41f2-9061-6c4895d6b5be	Prostate	57	C197A81D-2AA5-4285-88E3-761798E2C190	4B173FC3-DBE0-47AA-8ACC-D36466B5522D	TCGA-EJ-5524-01A-01D-1572-02	HG19_Broad_variant	TCGA-EJ-5524	TCGA-PRAD	NA	s3435	Harvard Medical School	University of Pittsburgh	United States	NO	T3a	N0	Prostate Adenocarcinoma Acinar Type	Not available	1572-02	TRUE
13722.58cfa831e4b0c9d6adf6cd7c	58cfa831e4b0c9d6adf6cd7c	TCGA-FD-A3B3-01A-12D-A204_121002_SN1222_0155_BD1ERHACXX_s_7_rg.sorted.filtered.	WGS	TCGA-FD-A3B3-01A-12D-A204_121002_SN1222_0155_BD1ERHACXX_s_7_rg.sorted	TCGA-FD-A3B3-01A-12D-A204_121002_SN1222_0155_BD1ERHACXX_s_7_rg.sorted.bam	42.39	NA	0.15	58cfa831e4b0c9d6adf6cd7c	TCGA-FD-A3B3-01A-12D-A204_121002_SN1222_0155_BD1ERHACXX_s_7_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-FD-A3B3-01A	4B5D873B-BFDA-482E-92A0-BF84C0F9032A	Primary Tumor	Illumina HiSeq	6b702a7f-ff83-4ff2-96a8-9da2f015ebcc	Bladder	74	769EE027-5ED7-4EC2-86B5-FE40F9D6FB5A	57731F40-BBEF-4C7B-BFDC-CE75DA6EB1EB	TCGA-FD-A3B3-01A-12D-A204-02	HG19_Broad_variant	TCGA-FD-A3B3	TCGA-BLCA	NA	s2903	Harvard Medical School	BLN - University Of Chicago	United States	NO	T3	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage III	A204-02	TRUE
13722.58cfa832e4b0c9d6adf6ceb7	58cfa832e4b0c9d6adf6ceb7	TCGA-EJ-5522-01A-01D-1572_130218_SN208_0454_BD1TBTACXX_s_5_rg.sorted.filtered.	WGS	TCGA-EJ-5522-01A-01D-1572_130218_SN208_0454_BD1TBTACXX_s_5_rg.sorted	TCGA-EJ-5522-01A-01D-1572_130218_SN208_0454_BD1TBTACXX_s_5_rg.sorted.bam	414.7	1.9	0.17	58cfa832e4b0c9d6adf6ceb7	TCGA-EJ-5522-01A-01D-1572_130218_SN208_0454_BD1TBTACXX_s_5_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-EJ-5522-01A	214884EF-A932-4FC3-B6FF-16CE5164DA3E	Primary Tumor	Illumina HiSeq	ee0fc9f9-f7ac-4f93-a066-2751ffaa3959	Prostate	51	8AC1E1E7-8266-48E0-8D4C-D78873111341	2312B3FC-1F68-43D5-8B19-D449089F153C	TCGA-EJ-5522-01A-01D-1572-02	HG19_Broad_variant	TCGA-EJ-5522	TCGA-PRAD	NA	s4133	Harvard Medical School	University of Pittsburgh	United States	NO	T2c	N0	Prostate Adenocarcinoma Acinar Type	Not available	1572-02	TRUE
13722.58cfa832e4b0c9d6adf6ce60	58cfa832e4b0c9d6adf6ce60	TCGA-GV-A3QF-01A-31D-A233_120904_SN1120_0186_BC1911ACXX_s_4_rg.sorted.filtered.	WGS	TCGA-GV-A3QF-01A-31D-A233_120904_SN1120_0186_BC1911ACXX_s_4_rg.sorted	TCGA-GV-A3QF-01A-31D-A233_120904_SN1120_0186_BC1911ACXX_s_4_rg.sorted.bam	21.58	NA	0.16	58cfa832e4b0c9d6adf6ce60	TCGA-GV-A3QF-01A-31D-A233_120904_SN1120_0186_BC1911ACXX_s_4_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-GV-A3QF-01A	47990D5E-A0E1-4752-86F5-4F5B84E219DF	Primary Tumor	Illumina HiSeq	bcac19c7-1e8c-40ba-a577-39fce12db063	Bladder	79	6647C98E-7AA1-49E4-A067-D53AEBACFF9C	F7B433D0-F5DA-4E9C-9C32-A614FB4F614C	TCGA-GV-A3QF-01A-31D-A233-26	HG19_Broad_variant	TCGA-GV-A3QF	TCGA-BLCA	NA	s2931	MD Anderson - Institute for Applied Cancer Science	BLN - Cleveland Clinic	United States	NO	T3b	N2	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV	A233-26	TRUE
13722.58cfa832e4b0c9d6adf6ced1	58cfa832e4b0c9d6adf6ced1	TCGA-EJ-5542-01A-01D-1572_130221_SN1120_0239_BD1V59ACXX_s_5_rg.sorted.filtered.	WGS	TCGA-EJ-5542-01A-01D-1572_130221_SN1120_0239_BD1V59ACXX_s_5_rg.sorted	TCGA-EJ-5542-01A-01D-1572_130221_SN1120_0239_BD1V59ACXX_s_5_rg.sorted.bam	214.7	1.9	0.15	58cfa832e4b0c9d6adf6ced1	TCGA-EJ-5542-01A-01D-1572_130221_SN1120_0239_BD1V59ACXX_s_5_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-EJ-5542-01A	5A92EC4C-36EE-4588-ACA2-E3303F29C7AD	Primary Tumor	Illumina HiSeq	45ba9a12-204e-4ab8-b544-61f2519b176f	Prostate	60	DFFC7994-E957-4451-A9DB-56D4560D6547	185234ED-0A19-490C-86D8-19762FB13C1A	TCGA-EJ-5542-01A-01D-1572-02	HG19_Broad_variant	TCGA-EJ-5542	TCGA-PRAD	NA	s3964	Harvard Medical School	University of Pittsburgh	United States	NO	T3a	N0	Prostate Adenocarcinoma Acinar Type	Not available	1572-02	TRUE
13722.58cfa832e4b0c9d6adf6cec2	58cfa832e4b0c9d6adf6cec2	TCGA-HC-7080-01A-11D-1957_130422_SN590_0225_BD23TLACXX_s_2_rg.sorted.filtered.	WGS	TCGA-HC-7080-01A-11D-1957_130422_SN590_0225_BD23TLACXX_s_2_rg.sorted	TCGA-HC-7080-01A-11D-1957_130422_SN590_0225_BD23TLACXX_s_2_rg.sorted.bam	398.7	NA	0.13	58cfa832e4b0c9d6adf6cec2	TCGA-HC-7080-01A-11D-1957_130422_SN590_0225_BD23TLACXX_s_2_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-HC-7080-01A	FD50FF41-EC9D-4DB1-A673-36BA0CA1EAC8	Primary Tumor	Illumina HiSeq	4012de79-f9d8-4ee6-ab04-538482e6a66c	Prostate	66	E30730B8-81F1-49A8-8446-547B5C3CC730	CEF3C431-0329-4619-834B-DC57B33399A5	TCGA-HC-7080-01A-11D-1957-02	HG19_Broad_variant	TCGA-HC-7080	TCGA-PRAD	NA	s3807	Harvard Medical School	International Genomics Consortium	United States	NO	T2a	N0	Prostate Adenocarcinoma Acinar Type	Not available	1957-02	TRUE
13722.58cfa832e4b0c9d6adf6ced3	58cfa832e4b0c9d6adf6ced3	TCGA-EJ-5527-01A-01D-1572_130221_SN1120_0238_AC1TDEACXX_s_5_rg.sorted.filtered.	WGS	TCGA-EJ-5527-01A-01D-1572_130221_SN1120_0238_AC1TDEACXX_s_5_rg.sorted	TCGA-EJ-5527-01A-01D-1572_130221_SN1120_0238_AC1TDEACXX_s_5_rg.sorted.bam	188.7	1.9	0.15	58cfa832e4b0c9d6adf6ced3	TCGA-EJ-5527-01A-01D-1572_130221_SN1120_0238_AC1TDEACXX_s_5_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-EJ-5527-01A	BA0C9096-5F35-4F0A-AE98-EE1A695B55F0	Primary Tumor	Illumina HiSeq	62c0aaa3-44c3-4b25-b1cb-8e6196d66189	Prostate	69	15A638FE-4DFD-4280-AD40-5E0D5FDE3812	AE85C536-0580-4A34-B686-161D337E7951	TCGA-EJ-5527-01A-01D-1572-02	HG19_Broad_variant	TCGA-EJ-5527	TCGA-PRAD	NA	s3443	Harvard Medical School	University of Pittsburgh	United States	NO	T3a	N0	Prostate Adenocarcinoma Acinar Type	Not available	1572-02	TRUE
13722.58cfa832e4b0c9d6adf6cf07	58cfa832e4b0c9d6adf6cf07	TCGA-HC-7079-01A-11D-1957_130412_SN590_0224_BC1YMJACXX_s_8_rg.sorted.filtered.	WGS	TCGA-HC-7079-01A-11D-1957_130412_SN590_0224_BC1YMJACXX_s_8_rg.sorted	TCGA-HC-7079-01A-11D-1957_130412_SN590_0224_BC1YMJACXX_s_8_rg.sorted.bam	133	NA	0.15	58cfa832e4b0c9d6adf6cf07	TCGA-HC-7079-01A-11D-1957_130412_SN590_0224_BC1YMJACXX_s_8_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-HC-7079-01A	10FBE481-F111-4F88-AE45-4D67CB265567	Primary Tumor	Illumina HiSeq	5debd428-e42f-459c-8945-f3e0a3053b9e	Prostate	51	190EF71A-5B5D-4009-B707-68F10147CB65	3935531A-0F99-4617-A5B6-6774E74CEE5E	TCGA-HC-7079-01A-11D-1957-02	HG19_Broad_variant	TCGA-HC-7079	TCGA-PRAD	NA	s3624	Harvard Medical School	International Genomics Consortium	United States	NO	T3a	N0	Prostate Adenocarcinoma Acinar Type	Not available	1957-02	TRUE
13722.58cfa832e4b0c9d6adf6cf34	58cfa832e4b0c9d6adf6cf34	TCGA-G9-6363-01A-21D-1784_130215_SN590_0211_AC1UJWACXX_s_5_rg.sorted.filtered.	WGS	TCGA-G9-6363-01A-21D-1784_130215_SN590_0211_AC1UJWACXX_s_5_rg.sorted	TCGA-G9-6363-01A-21D-1784_130215_SN590_0211_AC1UJWACXX_s_5_rg.sorted.bam	313.4	1.8	0.13	58cfa832e4b0c9d6adf6cf34	TCGA-G9-6363-01A-21D-1784_130215_SN590_0211_AC1UJWACXX_s_5_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-G9-6363-01A	B5B3871C-078C-46A7-AC50-EF916D4A6781	Primary Tumor	Illumina HiSeq	a64da28b-c092-4dfb-9503-06c15e566ac3	Prostate	64	65D588FF-58E3-4932-A7F4-25EF23C433D5	DBF42C34-D2E5-4136-83F5-093453913D5B	TCGA-G9-6363-01A-21D-1784-02	HG19_Broad_variant	TCGA-G9-6363	TCGA-PRAD	NA	s3452	Harvard Medical School	Roswell Park	United States	NO	T4	N0	Prostate Adenocarcinoma Acinar Type	Not available	1784-02	TRUE
13722.58cfa832e4b0c9d6adf6ceed	58cfa832e4b0c9d6adf6ceed	TCGA-FY-A3R7-01A-11D-A221_120611_SN1222_0114_AC0WL3ACXX_s_3_rg.sorted.filtered.	WGS	TCGA-FY-A3R7-01A-11D-A221_120611_SN1222_0114_AC0WL3ACXX_s_3_rg.sorted	TCGA-FY-A3R7-01A-11D-A221_120611_SN1222_0114_AC0WL3ACXX_s_3_rg.sorted.bam	10.86	NA	0.15	58cfa832e4b0c9d6adf6ceed	TCGA-FY-A3R7-01A-11D-A221_120611_SN1222_0114_AC0WL3ACXX_s_3_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-FY-A3R7-01A	B983A678-B0AE-42C2-8F37-D6ECAF07413B	Primary Tumor	Illumina HiSeq	8f5f6e5a-6274-4d57-8dbd-2dc9d5bc3544	Thyroid	50	E85B6BC8-C182-4483-8F53-F312D5A545CB	5F86B67F-ECBC-477C-B72A-F41F104E03A2	TCGA-FY-A3R7-01A-11D-A221-26	HG19_Broad_variant	TCGA-FY-A3R7	TCGA-THCA	NA	s12009	MD Anderson - Institute for Applied Cancer Science	International Genomics Consortium	United States	NO	T3	N1a	Thyroid Papillary Carcinoma - Classical/usual	Stage III	A221-26	TRUE
13722.58cfa832e4b0c9d6adf6cfe4	58cfa832e4b0c9d6adf6cfe4	TCGA-G9-6333-01A-12D-1957_130222_SN1222_0174_BC1RNEACXX_s_3_rg.sorted.filtered.	WGS	TCGA-G9-6333-01A-12D-1957_130222_SN1222_0174_BC1RNEACXX_s_3_rg.sorted	TCGA-G9-6333-01A-12D-1957_130222_SN1222_0174_BC1RNEACXX_s_3_rg.sorted.bam	157.7	1.9	0.14	58cfa832e4b0c9d6adf6cfe4	TCGA-G9-6333-01A-12D-1957_130222_SN1222_0174_BC1RNEACXX_s_3_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-G9-6333-01A	64BF32C9-9466-404A-A147-E7A0B9E91E34	Primary Tumor	Illumina HiSeq	0e4674b7-f8ed-422c-909a-b2bfdf58ecf1	Prostate	66	98013499-4FAC-4378-9D7E-B3686003A4FC	F6373E03-914F-44B2-954D-E63DE95F89E8	TCGA-G9-6333-01A-12D-1957-02	HG19_Broad_variant	TCGA-G9-6333	TCGA-PRAD	NA	s3611	Harvard Medical School	Roswell Park	United States	NO	T2c	N0	Prostate Adenocarcinoma Acinar Type	Not available	1957-02	TRUE
13722.58cfa832e4b0c9d6adf6cfd8	58cfa832e4b0c9d6adf6cfd8	TCGA-FU-A3TQ-01A-11D-A232_140124_SN1120_0291_AC2PHAACXX_s_3_rg.sorted.filtered.	WGS	TCGA-FU-A3TQ-01A-11D-A232_140124_SN1120_0291_AC2PHAACXX_s_3_rg.sorted	TCGA-FU-A3TQ-01A-11D-A232_140124_SN1120_0291_AC2PHAACXX_s_3_rg.sorted.bam	59.29	NA	0.15	58cfa832e4b0c9d6adf6cfd8	TCGA-FU-A3TQ-01A-11D-A232_140124_SN1120_0291_AC2PHAACXX_s_3_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-FU-A3TQ-01A	7218AA6F-3345-484F-A329-A3B6169A67C7	Primary Tumor	Illumina HiSeq	87ede4e6-17e6-4287-8ee3-cde27de3aa7d	Cervix	55	2F3BFFB4-2C85-4B72-9AF5-4DB9DC358AE6	7018744F-49FF-4F47-AEE5-07F0DEA5D7D3	TCGA-FU-A3TQ-01A-11D-A232-26	HG19_Broad_variant	TCGA-FU-A3TQ	TCGA-CESC	NA	s1199	MD Anderson - Institute for Applied Cancer Science	International Genomics Consortium	United States	NO	T2b	N1	Cervical Squamous Cell Carcinoma	Not available	A232-26	TRUE
13722.58cfa832e4b0c9d6adf6d00c	58cfa832e4b0c9d6adf6d00c	TCGA-HC-7230-01A-11D-2111_130517_SN590_0230_AD24B4ACXX_s_8_rg.sorted.filtered.	WGS	TCGA-HC-7230-01A-11D-2111_130517_SN590_0230_AD24B4ACXX_s_8_rg.sorted	TCGA-HC-7230-01A-11D-2111_130517_SN590_0230_AD24B4ACXX_s_8_rg.sorted.bam	142.3	NA	0.14	58cfa832e4b0c9d6adf6d00c	TCGA-HC-7230-01A-11D-2111_130517_SN590_0230_AD24B4ACXX_s_8_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-HC-7230-01A	03C66CF8-BC68-4EE1-A322-689A29B72262	Primary Tumor	Illumina HiSeq	40ad0094-93d2-45aa-a8b1-070359637c85	Prostate	50	B8BAC212-127D-4EEE-8647-3BDDC13C9415	CE9AA8B5-5CDB-42F1-A810-7F48FC241D20	TCGA-HC-7230-01A-11D-2111-02	HG19_Broad_variant	TCGA-HC-7230	TCGA-PRAD	NA	s3804	Harvard Medical School	International Genomics Consortium	United States	NO	T2c	N0	Prostate Adenocarcinoma Acinar Type	Not available	2111-02	TRUE
13722.58cfa832e4b0c9d6adf6d014	58cfa832e4b0c9d6adf6d014	TCGA-G9-6336-01A-11D-1784_130115_SN590_0208_BD1TAGACXX_s_5_rg.sorted.filtered.	WGS	TCGA-G9-6336-01A-11D-1784_130115_SN590_0208_BD1TAGACXX_s_5_rg.sorted	TCGA-G9-6336-01A-11D-1784_130115_SN590_0208_BD1TAGACXX_s_5_rg.sorted.bam	81.4	1.9	0.14	58cfa832e4b0c9d6adf6d014	TCGA-G9-6336-01A-11D-1784_130115_SN590_0208_BD1TAGACXX_s_5_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-G9-6336-01A	59207BCD-F127-481F-B576-8716DA7D7D97	Primary Tumor	Illumina HiSeq	35e1082b-0264-4bb6-93d6-1d0e1b133135	Prostate	57	34C8B195-ECAB-492B-AED2-43ACFEDEF708	DB1475AB-0C9E-4D4C-B7F4-88DD8BB2F9B9	TCGA-G9-6336-01A-11D-1784-02	HG19_Broad_variant	TCGA-G9-6336	TCGA-PRAD	NA	s3799	Harvard Medical School	Roswell Park	United States	NO	Not available	N0	Prostate Adenocarcinoma Acinar Type	Not available	1784-02	TRUE
13722.58cfa832e4b0c9d6adf6cff0	58cfa832e4b0c9d6adf6cff0	TCGA-GD-A3OS-01A-12D-A221_120906_SN208_0426_BC194HACXX_s_7_rg.sorted.filtered.	WGS	TCGA-GD-A3OS-01A-12D-A221_120906_SN208_0426_BC194HACXX_s_7_rg.sorted	TCGA-GD-A3OS-01A-12D-A221_120906_SN208_0426_BC194HACXX_s_7_rg.sorted.bam	37.3	NA	0.14	58cfa832e4b0c9d6adf6cff0	TCGA-GD-A3OS-01A-12D-A221_120906_SN208_0426_BC194HACXX_s_7_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-GD-A3OS-01A	2A41B7D4-132F-4FB6-87B5-487C445379C7	Primary Tumor	Illumina HiSeq	2a801113-8404-4c17-9d60-508761ec1659	Bladder	54	C629CD55-54D7-4E31-AB90-955EBFF0B20A	80DBF776-1B0B-454C-9DA6-9688816A294D	TCGA-GD-A3OS-01A-12D-A221-26	HG19_Broad_variant	TCGA-GD-A3OS	TCGA-BLCA	NA	s2922	MD Anderson - Institute for Applied Cancer Science	ABS - IUPUI	United States	NO	Not available	NX	Muscle invasive urothelial carcinoma (pT2 or above)	Stage II	A221-26	TRUE
13722.58cfa832e4b0c9d6adf6d015	58cfa832e4b0c9d6adf6d015	TCGA-G9-6332-01A-11D-1784_130115_SN590_0208_BD1TAGACXX_s_3_rg.sorted.filtered.	WGS	TCGA-G9-6332-01A-11D-1784_130115_SN590_0208_BD1TAGACXX_s_3_rg.sorted	TCGA-G9-6332-01A-11D-1784_130115_SN590_0208_BD1TAGACXX_s_3_rg.sorted.bam	156.4	1.9	0.15	58cfa832e4b0c9d6adf6d015	TCGA-G9-6332-01A-11D-1784_130115_SN590_0208_BD1TAGACXX_s_3_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-G9-6332-01A	C46022F8-B122-4367-836B-EC1AE641A87D	Primary Tumor	Illumina HiSeq	91b58182-30c5-4b45-bf21-ee32128e4ad0	Prostate	55	30558AEB-76B7-4D27-99C0-E3EE21A00BD1	B9FAA261-1FA4-4870-B98F-60153ED7AD8C	TCGA-G9-6332-01A-11D-1784-02	HG19_Broad_variant	TCGA-G9-6332	TCGA-PRAD	NA	s3974	Harvard Medical School	Roswell Park	United States	NO	T3a	N0	Prostate Adenocarcinoma Acinar Type	Not available	1784-02	TRUE
13722.58cfa832e4b0c9d6adf6d06c	58cfa832e4b0c9d6adf6d06c	TCGA-HC-7211-01A-11D-2111_130517_SN590_0230_AD24B4ACXX_s_2_rg.sorted.filtered.	WGS	TCGA-HC-7211-01A-11D-2111_130517_SN590_0230_AD24B4ACXX_s_2_rg.sorted	TCGA-HC-7211-01A-11D-2111_130517_SN590_0230_AD24B4ACXX_s_2_rg.sorted.bam	286.3	NA	0.14	58cfa832e4b0c9d6adf6d06c	TCGA-HC-7211-01A-11D-2111_130517_SN590_0230_AD24B4ACXX_s_2_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-HC-7211-01A	EC3870C9-4930-4AF7-B2EB-1E16C9EC9F14	Primary Tumor	Illumina HiSeq	c6d8e1f6-600a-4387-a51a-8812fee4f285	Prostate	62	79BF8C2C-470E-4BE8-8144-9C0B366ECADD	226F7F0E-AC30-4F20-87A2-EB8128402BE4	TCGA-HC-7211-01A-11D-2111-02	HG19_Broad_variant	TCGA-HC-7211	TCGA-PRAD	NA	s3622	Harvard Medical School	International Genomics Consortium	United States	NO	T2c	N0	Prostate Adenocarcinoma Acinar Type	Not available	2111-02	TRUE
13722.58cfa832e4b0c9d6adf6d116	58cfa832e4b0c9d6adf6d116	TCGA-JX-A3Q0-01A-11D-A245_140124_SN1440_0179_BD2DRDACXX_s_3_rg.sorted.filtered.	WGS	TCGA-JX-A3Q0-01A-11D-A245_140124_SN1440_0179_BD2DRDACXX_s_3_rg.sorted	TCGA-JX-A3Q0-01A-11D-A245_140124_SN1440_0179_BD2DRDACXX_s_3_rg.sorted.bam	42.52	NA	0.14	58cfa832e4b0c9d6adf6d116	TCGA-JX-A3Q0-01A-11D-A245_140124_SN1440_0179_BD2DRDACXX_s_3_rg.sorted.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-JX-A3Q0-01A	20280122-A66A-4C83-8F25-0B9D97558DC2	Primary Tumor	Illumina HiSeq	20d5be50-f8a2-406a-9415-bc65cdff0cad	Cervix	63	04FFDFC0-A73F-47AE-9014-73870B69AD91	A7EE4E31-77DF-470B-A748-87BB4DF76FD5	TCGA-JX-A3Q0-01A-11D-A245-26	HG19_Broad_variant	TCGA-JX-A3Q0	TCGA-CESC	NA	s1218	MD Anderson - Institute for Applied Cancer Science	Washington University	United States	NO	T3	N0	Cervical Squamous Cell Carcinoma	Not available	A245-26	TRUE
13722.58cfa832e4b0c9d6adf6d153	58cfa832e4b0c9d6adf6d153	TCGA-FU-A3YQ-01A-11D-A232_140124_SN1120_0291_AC2PHAACXX_s_6_rg.sorted.filtered.	WGS	TCGA-FU-A3YQ-01A-11D-A232_140124_SN1120_0291_AC2PHAACXX_s_6_rg.sorted	TCGA-FU-A3YQ-01A-11D-A232_140124_SN1120_0291_AC2PHAACXX_s_6_rg.sorted.bam	36.15	NA	0.15	58cfa832e4b0c9d6adf6d153	TCGA-FU-A3YQ-01A-11D-A232_140124_SN1120_0291_AC2PHAACXX_s_6_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-FU-A3YQ-01A	6E01248B-C551-4F52-8066-CB2D26EB6394	Primary Tumor	Illumina HiSeq	104b02af-20c0-4d30-ba14-f5028b3a3ee4	Cervix	35	84A97589-63AE-4151-89F3-40F5AA9DE72E	5C95B361-B203-400F-B18A-8375849F5B84	TCGA-FU-A3YQ-01A-11D-A232-26	HG19_Broad_variant	TCGA-FU-A3YQ	TCGA-CESC	NA	s1205	MD Anderson - Institute for Applied Cancer Science	International Genomics Consortium	United States	NO	T1b1	N0	Cervical Squamous Cell Carcinoma	Not available	A232-26	TRUE
13722.58cfa832e4b0c9d6adf6d16e	58cfa832e4b0c9d6adf6d16e	TCGA-IG-A5S3-01A-11D-A28P_131120_SN1222_0230_BC29YPACXX_s_7_rg.sorted.filtered.	WGS	TCGA-IG-A5S3-01A-11D-A28P_131120_SN1222_0230_BC29YPACXX_s_7_rg.sorted	TCGA-IG-A5S3-01A-11D-A28P_131120_SN1222_0230_BC29YPACXX_s_7_rg.sorted.bam	45.06	NA	0.15	58cfa832e4b0c9d6adf6d16e	TCGA-IG-A5S3-01A-11D-A28P_131120_SN1222_0230_BC29YPACXX_s_7_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Esophageal Carcinoma	Aligned reads	TCGA-IG-A5S3-01A	DF0125B2-5278-4DED-B3B7-9FC829FE9F63	Primary Tumor	Illumina HiSeq	736bee98-6905-4aea-a839-1157081fd524	Esophagus	69	9595654D-B5F8-4571-A80A-BDD179881D91	AC4D24CB-89FC-4744-9227-4F65D8893F90	TCGA-IG-A5S3-01A-11D-A28P-26	HG19_Broad_variant	TCGA-IG-A5S3	TCGA-ESCA	NA	s1827	MD Anderson - Institute for Applied Cancer Science	Asterand	Russia	NO	T3	N0	Not available	Stage IIB	A28P-26	TRUE
13722.58cfa832e4b0c9d6adf6d1a2	58cfa832e4b0c9d6adf6d1a2	TCGA-HI-7168-01A-11D-2111_130517_SN590_0231_BC24V6ACXX_s_8_rg.sorted.filtered.	WGS	TCGA-HI-7168-01A-11D-2111_130517_SN590_0231_BC24V6ACXX_s_8_rg.sorted	TCGA-HI-7168-01A-11D-2111_130517_SN590_0231_BC24V6ACXX_s_8_rg.sorted.bam	116.3	NA	0.14	58cfa832e4b0c9d6adf6d1a2	TCGA-HI-7168-01A-11D-2111_130517_SN590_0231_BC24V6ACXX_s_8_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-HI-7168-01A	25D70934-01A5-45A2-9960-68D3058B6965	Primary Tumor	Illumina HiSeq	97c2b4ae-c671-4cf5-8b44-5c36e7e8fb57	Prostate	62	DD410832-95AA-4FA6-A2B9-3FECA6F70E1D	9FD5990D-22E1-4D64-996D-543BCD447500	TCGA-HI-7168-01A-11D-2111-02	HG19_Broad_variant	TCGA-HI-7168	TCGA-PRAD	NA	s3633	Harvard Medical School	Fox Chase	United States	NO	T3b	N0	Prostate Adenocarcinoma Acinar Type	Not available	2111-02	TRUE
13722.58cfa832e4b0c9d6adf6d1c9	58cfa832e4b0c9d6adf6d1c9	TCGA-HM-A3JK-01A-11D-A245_140124_SN1440_0179_BD2DRDACXX_s_1_rg.sorted.filtered.	WGS	TCGA-HM-A3JK-01A-11D-A245_140124_SN1440_0179_BD2DRDACXX_s_1_rg.sorted	TCGA-HM-A3JK-01A-11D-A245_140124_SN1440_0179_BD2DRDACXX_s_1_rg.sorted.bam	58.55	NA	0.15	58cfa832e4b0c9d6adf6d1c9	TCGA-HM-A3JK-01A-11D-A245_140124_SN1440_0179_BD2DRDACXX_s_1_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-HM-A3JK-01A	7C4CD55F-750E-4941-A9F3-0632A75D6531	Primary Tumor	Illumina HiSeq	cc4a29a9-d389-4d17-b8c7-53fcc5731b22	Cervix	64	88C6E5CB-D33E-4042-BE7B-12A081ACDAFB	EDAC7C77-CA42-461B-9006-F65E3EB6B7AB	TCGA-HM-A3JK-01A-11D-A245-26	HG19_Broad_variant	TCGA-HM-A3JK	TCGA-CESC	NA	s1208	MD Anderson - Institute for Applied Cancer Science	Christiana Healthcare	United States	NO	T2b	N1	Cervical Squamous Cell Carcinoma	Not available	A245-26	TRUE
13722.58cfa832e4b0c9d6adf6d12c	58cfa832e4b0c9d6adf6d12c	TCGA-G2-A2EK-01A-22D-A18D_120913_SN208_0429_AC187FACXX_s_3_rg.sorted.filtered.	WGS	TCGA-G2-A2EK-01A-22D-A18D_120913_SN208_0429_AC187FACXX_s_3_rg.sorted	TCGA-G2-A2EK-01A-22D-A18D_120913_SN208_0429_AC187FACXX_s_3_rg.sorted.bam	16.85	NA	0.18	58cfa832e4b0c9d6adf6d12c	TCGA-G2-A2EK-01A-22D-A18D_120913_SN208_0429_AC187FACXX_s_3_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-G2-A2EK-01A	5DA1CB68-C438-4DDC-999F-90AED0C4BD7A	Primary Tumor	Illumina HiSeq	f98c8702-90e5-4e7a-ad12-d11a9af57bf5	Bladder	57	FF1691F2-DF11-4068-8D8D-A778F384EC60	8A75CF19-7645-489D-AAEC-5D9AD293C4B1	TCGA-G2-A2EK-01A-22D-A18D-02	HG19_Broad_variant	TCGA-G2-A2EK	TCGA-BLCA	NA	s2725	Harvard Medical School	MD Anderson	United States	NO	Not available	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage II	A18D-02	TRUE
13722.58cfa832e4b0c9d6adf6d25c	58cfa832e4b0c9d6adf6d25c	TCGA-JX-A3PZ-01A-11D-A245_140124_SN1440_0179_BD2DRDACXX_s_2_rg.sorted.filtered.	WGS	TCGA-JX-A3PZ-01A-11D-A245_140124_SN1440_0179_BD2DRDACXX_s_2_rg.sorted	TCGA-JX-A3PZ-01A-11D-A245_140124_SN1440_0179_BD2DRDACXX_s_2_rg.sorted.bam	19.49	NA	0.14	58cfa832e4b0c9d6adf6d25c	TCGA-JX-A3PZ-01A-11D-A245_140124_SN1440_0179_BD2DRDACXX_s_2_rg.sorted.bam	Dead	FEMALE	WHITE	Not available	Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-JX-A3PZ-01A	3DF6ABE2-2123-4BFA-A4E4-88DF5F940C04	Primary Tumor	Illumina HiSeq	ecad03c2-29cd-48c4-8c37-7eade85970f7	Cervix	25	BD39C4C4-A4DD-4B2D-9F3C-608CA8708958	1B04D621-E036-4D1E-9D57-6CCCD0C020D8	TCGA-JX-A3PZ-01A-11D-A245-26	HG19_Broad_variant	TCGA-JX-A3PZ	TCGA-CESC	642	s1540	MD Anderson - Institute for Applied Cancer Science	Washington University	United States	NO	T1b	N0	Cervical Squamous Cell Carcinoma	Not available	A245-26	TRUE
13722.58cfa832e4b0c9d6adf6d284	58cfa832e4b0c9d6adf6d284	TCGA-HT-7481-01A-11D-2022_130913_SN1440_0168_BD2B0UACXX_s_1_rg.sorted.filtered.	WGS	TCGA-HT-7481-01A-11D-2022_130913_SN1440_0168_BD2B0UACXX_s_1_rg.sorted	TCGA-HT-7481-01A-11D-2022_130913_SN1440_0168_BD2B0UACXX_s_1_rg.sorted.bam	22	NA	0.13	58cfa832e4b0c9d6adf6d284	TCGA-HT-7481-01A-11D-2022_130913_SN1440_0168_BD2B0UACXX_s_1_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-HT-7481-01A	BFF37DE3-DC68-4E69-BDFC-8B524DD7774F	Primary Tumor	Illumina HiSeq	fbc2ca18-8dd6-41c3-9ec3-0189f96877ce	Brain	39	712405B3-14C4-4C26-9839-1749763D816B	AF69E75D-03C6-4EB0-A0B8-129BE37E30A2	TCGA-HT-7481-01A-11D-2022-02	HG19_Broad_variant	TCGA-HT-7481	TCGA-LGG	NA	s8762	Harvard Medical School	Case Western - St Joes	United States	NO	Not available	Not available	Oligodendroglioma	Not available	2022-02	TRUE
13722.58cfa832e4b0c9d6adf6d279	58cfa832e4b0c9d6adf6d279	TCGA-HT-7475-01A-11D-2022_130913_SN1440_0167_AC2A6PACXX_s_5_rg.sorted.filtered.	WGS	TCGA-HT-7475-01A-11D-2022_130913_SN1440_0167_AC2A6PACXX_s_5_rg.sorted	TCGA-HT-7475-01A-11D-2022_130913_SN1440_0167_AC2A6PACXX_s_5_rg.sorted.bam	79.7	NA	0.15	58cfa832e4b0c9d6adf6d279	TCGA-HT-7475-01A-11D-2022_130913_SN1440_0167_AC2A6PACXX_s_5_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-HT-7475-01A	41456932-436E-4CDB-BFE8-97D089656786	Primary Tumor	Illumina HiSeq	13942ed5-f37e-4807-b133-369aab923f17	Brain	67	5E11FC94-CCDB-4E53-9A9D-5D7707157674	B59DECE1-1DE9-46D3-B5CD-0EFD8F453F8D	TCGA-HT-7475-01A-11D-2022-02	HG19_Broad_variant	TCGA-HT-7475	TCGA-LGG	NA	s8372	Harvard Medical School	Case Western - St Joes	United States	NO	Not available	Not available	Oligoastrocytoma	Not available	2022-02	TRUE
13722.58cfa832e4b0c9d6adf6d3b6	58cfa832e4b0c9d6adf6d3b6	TCGA-L5-A4ON-01A-11D-A267_131120_SN1222_0229_AD2FDGACXX_s_7_rg.sorted.filtered.	WGS	TCGA-L5-A4ON-01A-11D-A267_131120_SN1222_0229_AD2FDGACXX_s_7_rg.sorted	TCGA-L5-A4ON-01A-11D-A267_131120_SN1222_0229_AD2FDGACXX_s_7_rg.sorted.bam	47.01	NA	0.17	58cfa832e4b0c9d6adf6d3b6	TCGA-L5-A4ON-01A-11D-A267_131120_SN1222_0229_AD2FDGACXX_s_7_rg.sorted.bam	Dead	MALE	WHITE	Not available	Esophageal Carcinoma	Aligned reads	TCGA-L5-A4ON-01A	CABA34F2-3877-48CA-9FBC-665C3960F574	Primary Tumor	Illumina HiSeq	9bb22695-702d-410d-98a3-d4adcf022a94	Esophagus	65	B801A0D7-09E8-48D8-9C8E-C6D52767F7C1	469616E0-7C5B-491E-8D25-E71CCDB27D18	TCGA-L5-A4ON-01A-11D-A267-26	HG19_Broad_variant	TCGA-L5-A4ON	TCGA-ESCA	558	s1843	MD Anderson - Institute for Applied Cancer Science	University of Michigan	United States	NO	T1	N1	Not available	Stage IIB	A267-26	TRUE
13722.58cfa832e4b0c9d6adf6d407	58cfa832e4b0c9d6adf6d407	TCGA-VD-A8KJ-01A-11D-A40D_140731_SN208_0522_AC59K7ACXX_s_6_rg.sorted.filtered.	WGS	TCGA-VD-A8KJ-01A-11D-A40D_140731_SN208_0522_AC59K7ACXX_s_6_rg.sorted	TCGA-VD-A8KJ-01A-11D-A40D_140731_SN208_0522_AC59K7ACXX_s_6_rg.sorted.bam	45.14	NA	0.16	58cfa832e4b0c9d6adf6d407	TCGA-VD-A8KJ-01A-11D-A40D_140731_SN208_0522_AC59K7ACXX_s_6_rg.sorted.bam	Alive	MALE	Not available	Not available	Uveal Melanoma	Aligned reads	TCGA-VD-A8KJ-01A	7289BC25-2551-4C6D-B2FA-C7E13859B9B3	Primary Tumor	Illumina HiSeq	fc31e7c7-1135-4bd9-b27a-14853ce2751f	Eye	53	81194B66-EBA6-4AD8-A745-6CABD69218F0	EB63AF0F-8072-47F0-8CC6-02A5B28126C7	TCGA-VD-A8KJ-01A-11D-A40D-26	HG19_Broad_variant	TCGA-VD-A8KJ	TCGA-UVM	NA	s274	MD Anderson - Institute for Applied Cancer Science	University of Liverpool	United Kingdom	NO	T3a	NX	Not available	Stage IIB	A40D-26	TRUE
13722.58cfa832e4b0c9d6adf6d558	58cfa832e4b0c9d6adf6d558	TCGA-L5-A4OM-01A-11D-A267_131120_SN1222_0229_AD2FDGACXX_s_1_rg.sorted.filtered.	WGS	TCGA-L5-A4OM-01A-11D-A267_131120_SN1222_0229_AD2FDGACXX_s_1_rg.sorted	TCGA-L5-A4OM-01A-11D-A267_131120_SN1222_0229_AD2FDGACXX_s_1_rg.sorted.bam	36.8	NA	0.17	58cfa832e4b0c9d6adf6d558	TCGA-L5-A4OM-01A-11D-A267_131120_SN1222_0229_AD2FDGACXX_s_1_rg.sorted.bam	Alive	FEMALE	WHITE	Not available	Esophageal Carcinoma	Aligned reads	TCGA-L5-A4OM-01A	1A578AE7-5C0B-48EF-8BAF-7189DF703A93	Primary Tumor	Illumina HiSeq	2069622c-925f-4886-8005-9b8680ecc584	Esophagus	54	01EF1408-F028-4F6C-B09E-9BBB8D738704	081DEE66-D2A2-4FF2-94A1-6E3219D878D7	TCGA-L5-A4OM-01A-11D-A267-26	HG19_Broad_variant	TCGA-L5-A4OM	TCGA-ESCA	NA	s1842	MD Anderson - Institute for Applied Cancer Science	University of Michigan	United States	NO	T1	N0	Not available	Stage IA	A267-26	TRUE
13722.58cfa832e4b0c9d6adf6d630	58cfa832e4b0c9d6adf6d630	TCGA-LN-A49Y-01A-11D-A267_131120_SN1222_0229_AD2FDGACXX_s_5_rg.sorted.filtered.	WGS	TCGA-LN-A49Y-01A-11D-A267_131120_SN1222_0229_AD2FDGACXX_s_5_rg.sorted	TCGA-LN-A49Y-01A-11D-A267_131120_SN1222_0229_AD2FDGACXX_s_5_rg.sorted.bam	41.86	NA	0.16	58cfa832e4b0c9d6adf6d630	TCGA-LN-A49Y-01A-11D-A267_131120_SN1222_0229_AD2FDGACXX_s_5_rg.sorted.bam	Alive	MALE	ASIAN	NOT HISPANIC OR LATINO	Esophageal Carcinoma	Aligned reads	TCGA-LN-A49Y-01A	87FABA0E-28E7-4A7E-A7E1-12582EC68FAC	Primary Tumor	Illumina HiSeq	61d40e9e-a5c9-4e35-8e7f-5e08661da9b6	Esophagus	77	E443EA94-586E-4A0B-8330-55336AAE9A15	9AAF77BB-57CB-4073-BA2E-380B80303B0B	TCGA-LN-A49Y-01A-11D-A267-26	HG19_Broad_variant	TCGA-LN-A49Y	TCGA-ESCA	NA	s1870	MD Anderson - Institute for Applied Cancer Science	ILSbio	Vietnam	NO	T3	N0	Not available	Stage IIA	A267-26	TRUE
13722.58cfa832e4b0c9d6adf6d545	58cfa832e4b0c9d6adf6d545	TCGA-L5-A43E-01A-11D-A248_130115_SN590_0207_AC1H8PACXX_s_1_rg.sorted.filtered.	WGS	TCGA-L5-A43E-01A-11D-A248_130115_SN590_0207_AC1H8PACXX_s_1_rg.sorted	TCGA-L5-A43E-01A-11D-A248_130115_SN590_0207_AC1H8PACXX_s_1_rg.sorted.bam	40.6	NA	0.15	58cfa832e4b0c9d6adf6d545	TCGA-L5-A43E-01A-11D-A248_130115_SN590_0207_AC1H8PACXX_s_1_rg.sorted.bam	Alive	MALE	WHITE	Not available	Esophageal Carcinoma	Aligned reads	TCGA-L5-A43E-01A	6969FE5A-5993-48E5-95C5-C5C7D3D08205	Primary Tumor	Illumina HiSeq	70d7fe7a-b9ff-4651-94bd-cc39c64b3657	Esophagus	74	5C8F603A-B8D3-407C-8E74-559C5F8C4D0E	2BDCF492-4741-430F-B1C3-ED029AD05FD6	TCGA-L5-A43E-01A-11D-A248-26	HG19_Broad_variant	TCGA-L5-A43E	TCGA-ESCA	NA	s1916	MD Anderson - Institute for Applied Cancer Science	University of Michigan	United States	NO	T1	N0	Not available	Stage I	A248-26	TRUE
13722.58cfa82de4b0c9d6adf6a464	58cfa82de4b0c9d6adf6a464	459f50a1a35d272785306ecb71cc5754.filtered.	WGS	459f50a1a35d272785306ecb71cc5754	459f50a1a35d272785306ecb71cc5754.bam	39.58	NA	0.08	58cfa82de4b0c9d6adf6a464	459f50a1a35d272785306ecb71cc5754.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Sarcoma	Aligned reads	TCGA-FX-A2QS-01A	2905CBD1-719B-46D9-B8AF-8FE4927BC473	Primary Tumor	Illumina HiSeq	8906cefc-240d-4590-8d00-1004fa85fd22	Mesenchymal	61	5402D273-3B02-4BF7-A0A4-625A59FED4CC	7D332CB1-BA25-47E4-8BF8-D25E14F40D59	TCGA-FX-A2QS-01A-11D-A21Q-09	GRCh37-lite	TCGA-FX-A2QS	TCGA-SARC	NA	s2486	Washington University School of Medicine	International Genomics Consortium	None	NO	Not available	Not available	Not available	Not available	A21Q-09	TRUE
13722.58cfa82de4b0c9d6adf6a444	58cfa82de4b0c9d6adf6a444	05b05a3f284cf713011e4bd81b09ab5e.filtered.	WGS	05b05a3f284cf713011e4bd81b09ab5e	05b05a3f284cf713011e4bd81b09ab5e.bam	26.91	1.86	0.07	58cfa82de4b0c9d6adf6a444	05b05a3f284cf713011e4bd81b09ab5e.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	Not available	Breast Invasive Carcinoma	Aligned reads	TCGA-BH-A0AV-01A	790FF5DB-B7F3-4946-AAED-305F66B1DD6A	Primary Tumor	Illumina HiSeq	b2a1b1a3-a780-4be9-9a65-8937ba5df3b0	Breast	52	DCE6CAC3-6C76-4574-B7A8-C7083B12F22E	9032B7FE-E38A-4641-A45E-67041668ADC4	TCGA-BH-A0AV-01A-31D-A10Y-09	GRCh37-lite	TCGA-BH-A0AV	TCGA-BRCA	NA	s6450	Washington University School of Medicine	University of Pittsburgh	None	NO	T1c	N0	Infiltrating Ductal Carcinoma	Stage I	A10Y-09	FALSE
13722.58cfa82de4b0c9d6adf6a4a6	58cfa82de4b0c9d6adf6a4a6	3a96e8c557be05593e3dbb1fccbb73d1.filtered.	WGS	3a96e8c557be05593e3dbb1fccbb73d1	3a96e8c557be05593e3dbb1fccbb73d1.bam	74.02	2.18	0.09	58cfa82de4b0c9d6adf6a4a6	3a96e8c557be05593e3dbb1fccbb73d1.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-EW-A1PB-01A	88DB1340-E4BF-451A-87C0-6E9168296F5E	Primary Tumor	Illumina HiSeq	2ba1984b-043e-4cc5-8bc4-10b6c2915f61	Breast	70	DA9DC40B-0350-4B8C-8A7A-15100D5AEB90	9DDF2119-A222-4FA5-A9F3-0BEC7EEEA36B	TCGA-EW-A1PB-01A-11D-A142-09	GRCh37-lite	TCGA-EW-A1PB	TCGA-BRCA	NA	s6454	Washington University School of Medicine	University of Miami	United States	NO	T3	N1a	Infiltrating Ductal Carcinoma	Stage IIIA	A142-09	FALSE
13722.58cfa82de4b0c9d6adf6a4a8	58cfa82de4b0c9d6adf6a4a8	1460837133c752e48d8ded9f16cc5949.filtered.	WGS	1460837133c752e48d8ded9f16cc5949	1460837133c752e48d8ded9f16cc5949.bam	43.68	1.56	0.08	58cfa82de4b0c9d6adf6a4a8	1460837133c752e48d8ded9f16cc5949.bam	Dead	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-E2-A1LK-01A	1D27253F-B036-44E7-A04D-8DA5BBF57419	Primary Tumor	Illumina HiSeq	cdbdb1d9-4c6d-4a22-8867-42722b596ae9	Breast	84	CC937913-802F-48CD-A490-E6B90F007C5D	4E84EED6-82A8-4E91-B0FD-61EC6EF69CE9	TCGA-E2-A1LK-01A-21D-A14G-09	GRCh37-lite	TCGA-E2-A1LK	TCGA-BRCA	266	s6757	Washington University School of Medicine	Roswell Park	United States	NO	T4b	N3a	Infiltrating Ductal Carcinoma	Stage IIIC	A14G-09	FALSE
13722.58cfa82de4b0c9d6adf6a4b2	58cfa82de4b0c9d6adf6a4b2	1d839fbbdcb1971d9a0ef13b9f7a8b2e.filtered.	WGS	1d839fbbdcb1971d9a0ef13b9f7a8b2e	1d839fbbdcb1971d9a0ef13b9f7a8b2e.bam	69.79	1.98	0.08	58cfa82de4b0c9d6adf6a4b2	1d839fbbdcb1971d9a0ef13b9f7a8b2e.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-AN-A0AT-01A	05506F4C-E701-4A9D-AE06-97F066AADE43	Primary Tumor	Illumina HiSeq	5285cd99-09bc-48e5-abcb-11230d5f40f0	Breast	62	B2905A3F-810B-4E74-AF5C-42D513D91746	F848B66F-BD9E-4FBA-AFD4-EB58848D1EF4	TCGA-AN-A0AT-01A-11D-A045-09	GRCh37-lite	TCGA-AN-A0AT	TCGA-BRCA	NA	s6760	Washington University School of Medicine	Cureline	None	NO	T2	N0	Infiltrating Ductal Carcinoma	Stage IIA	A045-09	FALSE
13722.58cfa82de4b0c9d6adf6a50c	58cfa82de4b0c9d6adf6a50c	437fd4c58a0c6f406413c5f2b3073d0a.filtered.	WGS	437fd4c58a0c6f406413c5f2b3073d0a	437fd4c58a0c6f406413c5f2b3073d0a.bam	63.5	1.98	0.08	58cfa82de4b0c9d6adf6a50c	437fd4c58a0c6f406413c5f2b3073d0a.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-E2-A156-01A	F05D314C-5EC5-4E2A-B785-9A702716F111	Primary Tumor	Illumina HiSeq	3d9a2788-2bc3-4df9-bae7-fef37f6096b8	Breast	61	9D39F2CF-84B5-45BA-8C40-0A42D8F303B7	2DA2B745-068D-408C-9163-3B3A78D4AAED	TCGA-E2-A156-01A-11D-A314-09	GRCh37-lite	TCGA-E2-A156	TCGA-BRCA	NA	s6622	Washington University School of Medicine	Roswell Park	None	NO	T1c	N0	Infiltrating Ductal Carcinoma	Stage I	A314-09	TRUE
13722.58cfa82de4b0c9d6adf6a50e	58cfa82de4b0c9d6adf6a50e	29084d88d2f33ba899ea13cb6d938384.filtered.	WGS	29084d88d2f33ba899ea13cb6d938384	29084d88d2f33ba899ea13cb6d938384.bam	41.07	1.97	0.07	58cfa82de4b0c9d6adf6a50e	29084d88d2f33ba899ea13cb6d938384.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-AN-A0XR-01A	F51AF6DB-2655-47FB-9FFC-83A503A728EA	Primary Tumor	Illumina HiSeq	19e1e7d4-80dd-4107-98b2-6796fe22947f	Breast	55	6EDCDB8A-80E8-42A8-86FF-3950C1F3CB89	E7DC7492-3A84-49C7-8DEA-8F508B53DC40	TCGA-AN-A0XR-01A-11D-A10G-09	GRCh37-lite	TCGA-AN-A0XR	TCGA-BRCA	NA	s5477	Washington University School of Medicine	Cureline	None	NO	T2	N2	Infiltrating Ductal Carcinoma	Stage IIIA	A10G-09	FALSE
13722.58cfa82de4b0c9d6adf6a52e	58cfa82de4b0c9d6adf6a52e	103f34ff20cea99f215bfb7393f043b8.filtered.	WGS	103f34ff20cea99f215bfb7393f043b8	103f34ff20cea99f215bfb7393f043b8.bam	45.75	2	0.09	58cfa82de4b0c9d6adf6a52e	103f34ff20cea99f215bfb7393f043b8.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-A2-A259-01A	3FC3755D-A3F8-4E2C-813F-FF124F2A75C1	Primary Tumor	Illumina HiSeq	767c5435-e3e1-4cdb-92e0-2b0961610118	Breast	70	EB2DE640-6C2A-4C8A-87C3-80F9FBDC3D9B	13D05F7A-E16A-40EF-9A15-21257DA2CF89	TCGA-A2-A259-01A-11D-A314-09	GRCh37-lite	TCGA-A2-A259	TCGA-BRCA	NA	s5785	Washington University School of Medicine	Walter Reed	United States	NO	T1c	N0 (i-)	Infiltrating Ductal Carcinoma	Stage I	A314-09	TRUE
13722.58cfa82de4b0c9d6adf6a526	58cfa82de4b0c9d6adf6a526	54edfd331e278de330c2f6fc9d8b6e06.filtered.	WGS	54edfd331e278de330c2f6fc9d8b6e06	54edfd331e278de330c2f6fc9d8b6e06.bam	45.22	2.08	0.08	58cfa82de4b0c9d6adf6a526	54edfd331e278de330c2f6fc9d8b6e06.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-E2-A15H-01A	5580B21A-2CDB-4777-AD79-6E06654144F5	Primary Tumor	Illumina HiSeq	f359078d-7930-4e46-a5d4-3978f5434622	Breast	38	7CB99442-005B-4611-94F9-03AF195EC7E3	6D7F44DF-E9F0-4542-A6D8-D14EE7804002	TCGA-E2-A15H-01A-11D-A19H-09	GRCh37-lite	TCGA-E2-A15H	TCGA-BRCA	NA	s5479	Washington University School of Medicine	Roswell Park	None	NO	T1c	N1mi	Infiltrating Ductal Carcinoma	Stage IIA	A19H-09	TRUE
13722.58cfa82de4b0c9d6adf6a53c	58cfa82de4b0c9d6adf6a53c	450a0ae734ab89c01b82ea2af8dacc92.filtered.	WGS	450a0ae734ab89c01b82ea2af8dacc92	450a0ae734ab89c01b82ea2af8dacc92.bam	75.68	1.83	0.09	58cfa82de4b0c9d6adf6a53c	450a0ae734ab89c01b82ea2af8dacc92.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-A2-A25B-01A	EADF8482-E60E-4307-ADB7-D5C3B9FA6CAE	Primary Tumor	Illumina HiSeq	372d2951-a381-41f0-88d7-72cc9da6b6db	Breast	39	2C619641-7849-4837-AB92-0DA80342B3E9	6E839EAF-1DBB-43F5-8846-C980E05540C7	TCGA-A2-A25B-01A-11D-A167-09	GRCh37-lite	TCGA-A2-A25B	TCGA-BRCA	NA	s6761	Washington University School of Medicine	Walter Reed	United States	NO	T2	N1	Infiltrating Ductal Carcinoma	Stage IIB	A167-09	FALSE
13722.58cfa82de4b0c9d6adf6a47e	58cfa82de4b0c9d6adf6a47e	2c5b37c2fff4a62ce10d93452de3771f.filtered.	WGS	2c5b37c2fff4a62ce10d93452de3771f	2c5b37c2fff4a62ce10d93452de3771f.bam	52.88	1.88	0.08	58cfa82de4b0c9d6adf6a47e	2c5b37c2fff4a62ce10d93452de3771f.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-A2-A0D1-01A	084C6AEC-94F7-4090-8F3F-59FA9E89721A	Primary Tumor	Illumina HiSeq	6d37aa75-54cd-423e-987a-342e9a2def7a	Breast	76	12ECE355-F1D0-446C-84E9-0AED3E6D29F8	E5593865-5F8E-4A4C-B36F-73FBE64D66DA	TCGA-A2-A0D1-01A-11D-A19H-09	GRCh37-lite	TCGA-A2-A0D1	TCGA-BRCA	NA	s5476	Washington University School of Medicine	Walter Reed	None	NO	T2	N0 (i-)	Infiltrating Ductal Carcinoma	Stage IIA	A19H-09	TRUE
13722.58cfa82de4b0c9d6adf6a574	58cfa82de4b0c9d6adf6a574	2cf824ff67beaee254d0025b0c57ecfb.filtered.	WGS	2cf824ff67beaee254d0025b0c57ecfb	2cf824ff67beaee254d0025b0c57ecfb.bam	23.2	1.82	0.08	58cfa82de4b0c9d6adf6a574	2cf824ff67beaee254d0025b0c57ecfb.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-D8-A27H-01A	0DCA98B0-F43E-45B6-9A02-00092C78678C	Primary Tumor	Illumina HiSeq	bdde252c-e43c-448b-8e22-1ff90c7c957b	Breast	72	B7542984-1410-45E6-B936-8333FF902EB4	6764E0A2-7A78-45C1-9189-6001C6518CE4	TCGA-D8-A27H-01A-11D-A314-09	GRCh37-lite	TCGA-D8-A27H	TCGA-BRCA	NA	s5786	Washington University School of Medicine	Greater Poland Cancer Center	Poland	NO	T2	N0	Infiltrating Ductal Carcinoma	Stage IIA	A314-09	TRUE
13722.58cfa82de4b0c9d6adf6a471	58cfa82de4b0c9d6adf6a471	1076369c844452a633e3edce84850064.filtered.	WGS	1076369c844452a633e3edce84850064	1076369c844452a633e3edce84850064.bam	59.16	1.89	0.09	58cfa82de4b0c9d6adf6a471	1076369c844452a633e3edce84850064.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-AX-A1C8-01A	BAD34C92-1E64-4187-A0B4-061105FD13BA	Primary Tumor	Illumina HiSeq	37d56097-9e5d-4008-bbc9-5bd69910436b	Uterus	77	83E4DFB0-F240-476B-BC25-F9F52C960AF5	00DB4DC2-3EC7-4FF9-9233-D69C8C8A607F	TCGA-AX-A1C8-01A-11D-A135-09	GRCh37-lite	TCGA-AX-A1C8	TCGA-UCEC	NA	s4403	Washington University School of Medicine	Gynecologic Oncology Group	None	NO	Not available	Not available	Serous endometrial adenocarcinoma	Not available	A135-09	FALSE
13722.58cfa82de4b0c9d6adf6a56a	58cfa82de4b0c9d6adf6a56a	2be207283820c51539ebdfde69ab84ca.filtered.	WGS	2be207283820c51539ebdfde69ab84ca	2be207283820c51539ebdfde69ab84ca.bam	58.3	1.95	0.08	58cfa82de4b0c9d6adf6a56a	2be207283820c51539ebdfde69ab84ca.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-EW-A1P8-01A	359F12F9-5C41-48A4-85BC-FD7E307BF7D8	Primary Tumor	Illumina HiSeq	3a2f0cf6-0405-4ef6-be7e-75054acf1343	Breast	58	BF055644-7BCA-43B6-8F5A-E21C42F7CF88	E55F338F-97E2-4394-AE23-C92606069485	TCGA-EW-A1P8-01A-11D-A142-09	GRCh37-lite	TCGA-EW-A1P8	TCGA-BRCA	239	s5627	Washington University School of Medicine	University of Miami	United States	NO	T2	N3b	Infiltrating Ductal Carcinoma	Stage IIIC	A142-09	FALSE
13722.58cfa82de4b0c9d6adf6a58a	58cfa82de4b0c9d6adf6a58a	186d1b12be64c51f2303cdddde357025.filtered.	WGS	186d1b12be64c51f2303cdddde357025	186d1b12be64c51f2303cdddde357025.bam	89.92	1.91	0.08	58cfa82de4b0c9d6adf6a58a	186d1b12be64c51f2303cdddde357025.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-C5-A1M9-01A	A3BE445A-A592-4073-815B-47AE41F9C4A0	Primary Tumor	Illumina HiSeq	e9ec290e-cad8-4af0-8b69-cf804598a951	Cervix	46	577057AF-7775-497B-BEE9-E04562648509	B9D1A64E-D445-4174-A5B4-76DD6EA69419	TCGA-C5-A1M9-01A-11D-A200-09	GRCh37-lite	TCGA-C5-A1M9	TCGA-CESC	1065	s1346	Washington University School of Medicine	Medical College of Wisconsin	United States	NO	T3b	N1	Endocervical Type of Adenocarcinoma	Not available	A200-09	TRUE
13722.58cfa82de4b0c9d6adf6a591	58cfa82de4b0c9d6adf6a591	682471ccf3c736af5187920ac83b2068.filtered.	WGS	682471ccf3c736af5187920ac83b2068	682471ccf3c736af5187920ac83b2068.bam	15.25	2.03	0.08	58cfa82de4b0c9d6adf6a591	682471ccf3c736af5187920ac83b2068.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-BH-A0EA-01A	1F601832-EEE3-48FB-ACF5-80C4A454F26E	Primary Tumor	Illumina HiSeq	b1ff5cfd-0f6e-4211-a58a-81b120d0eb6d	Breast	72	7F791228-DD77-4AB0-8227-D784A4C7FEA1	EEF9DCE1-6BA6-432B-BBE2-53C7DBE64FE7	TCGA-BH-A0EA-01A-11D-A314-09	GRCh37-lite	TCGA-BH-A0EA	TCGA-BRCA	991	s5949	Washington University School of Medicine	University of Pittsburgh	None	NO	T1c	N1a	Infiltrating Ductal Carcinoma	Stage IIA	A314-09	TRUE
13722.58cfa82de4b0c9d6adf6a5b8	58cfa82de4b0c9d6adf6a5b8	61a02d82b4437f653c127eb3d3e0a78d.filtered.	WGS	61a02d82b4437f653c127eb3d3e0a78d	61a02d82b4437f653c127eb3d3e0a78d.bam	50.85	1.97	0.08	58cfa82de4b0c9d6adf6a5b8	61a02d82b4437f653c127eb3d3e0a78d.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-E2-A14X-01A	60DF7543-6DA5-4C75-943B-5800C1E08234	Primary Tumor	Illumina HiSeq	775348e1-91bf-4bf9-93e9-ff9f955b5a79	Breast	55	A7CC9298-D6F1-48EF-A93A-9C75FC0CB800	74039ACD-5ACA-4C65-818C-3B577D295BE0	TCGA-E2-A14X-01A-11D-A10Y-09	GRCh37-lite	TCGA-E2-A14X	TCGA-BRCA	NA	s6116	Washington University School of Medicine	Roswell Park	None	NO	T2	N2	Infiltrating Ductal Carcinoma	Stage IIIA	A10Y-09	FALSE
13722.58cfa82de4b0c9d6adf6a596	58cfa82de4b0c9d6adf6a596	5f3d3040681cc587e66a46c6fe973f92.filtered.	WGS	5f3d3040681cc587e66a46c6fe973f92	5f3d3040681cc587e66a46c6fe973f92.bam	97.64	1.84	0.08	58cfa82de4b0c9d6adf6a596	5f3d3040681cc587e66a46c6fe973f92.bam	Alive	FEMALE	WHITE	Not available	Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-DS-A0VL-01A	DFD30F94-19E3-4838-95DF-14A3763419AF	Primary Tumor	Illumina HiSeq	2c9bc14c-a6d3-4389-8360-024e9c04a5d4	Cervix	25	CDF4AB19-F243-4EFC-A5DC-8253CBE48845	E07991A4-0901-4ED1-8704-AA376565D862	TCGA-DS-A0VL-01A-21D-A200-09	GRCh37-lite	TCGA-DS-A0VL	TCGA-CESC	NA	s1350	Washington University School of Medicine	Cedars Sinai	United States	NO	T1b1	N0	Cervical Squamous Cell Carcinoma	Not available	A200-09	TRUE
13722.58cfa82de4b0c9d6adf6a5de	58cfa82de4b0c9d6adf6a5de	6541447d40abf6e8944eb0fde79c5bb3.filtered.	WGS	6541447d40abf6e8944eb0fde79c5bb3	6541447d40abf6e8944eb0fde79c5bb3.bam	42.49	NA	0.08	58cfa82de4b0c9d6adf6a5de	6541447d40abf6e8944eb0fde79c5bb3.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Sarcoma	Aligned reads	TCGA-DX-A3LU-01A	E786DE34-4C21-460F-89AB-008DE4347049	Primary Tumor	Illumina HiSeq	5f6336e7-c966-4e89-81bd-15a9523a893c	Mesenchymal	60	39BBAA83-8143-4E62-836E-1584B41B073B	7D734D06-F2B1-4924-A201-620AC8084C49	TCGA-DX-A3LU-01A-11D-A21Q-09	GRCh37-lite	TCGA-DX-A3LU	TCGA-SARC	NA	s2489	Washington University School of Medicine	Memorial Sloan Kettering	United States	NO	Not available	Not available	Not available	Not available	A21Q-09	TRUE
13722.58cfa82de4b0c9d6adf6a5fc	58cfa82de4b0c9d6adf6a5fc	5e859f6467c712851a78fd973b655dc1.filtered.	WGS	5e859f6467c712851a78fd973b655dc1	5e859f6467c712851a78fd973b655dc1.bam	106.84	1.77	0.08	58cfa82de4b0c9d6adf6a5fc	5e859f6467c712851a78fd973b655dc1.bam	Alive	FEMALE	WHITE	Not available	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-AP-A0LL-01A	D17668C4-5D66-4E16-8B70-B54616581AAE	Primary Tumor	Illumina HiSeq	56b1f38e-7065-46ee-8f41-f17603791f9f	Uterus	56	488A7462-8348-422C-91D3-7D9F0C39D25E	0385961E-EA99-40B2-AD79-6872BC30D8A1	TCGA-AP-A0LL-01A-12D-A127-09	GRCh37-lite	TCGA-AP-A0LL	TCGA-UCEC	NA	s4412	Washington University School of Medicine	MSKCC	None	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A127-09	FALSE
13722.58cfa82de4b0c9d6adf6a5c6	58cfa82de4b0c9d6adf6a5c6	7abe99091880688658f0fbf83d4b2209.filtered.	WGS	7abe99091880688658f0fbf83d4b2209	7abe99091880688658f0fbf83d4b2209.bam	100.8	1.86	0.09	58cfa82de4b0c9d6adf6a5c6	7abe99091880688658f0fbf83d4b2209.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-C5-A1M8-01A	110CD100-5730-4873-9FAB-2AE6C8732062	Primary Tumor	Illumina HiSeq	bcb9d9ed-cd43-4eb0-a3e5-f667a80c20b7	Cervix	43	72FF7605-0905-4829-8B54-B76B45FBB0DF	07D20658-3DB4-47E7-877B-66536266EDFC	TCGA-C5-A1M8-01A-21D-A200-09	GRCh37-lite	TCGA-C5-A1M8	TCGA-CESC	NA	s1167	Washington University School of Medicine	Medical College of Wisconsin	United States	NO	T1b	N0	Cervical Squamous Cell Carcinoma	Not available	A200-09	TRUE
13722.58cfa82de4b0c9d6adf6a614	58cfa82de4b0c9d6adf6a614	511a3675203dfa8034f97dbe11cc6195.filtered.	WGS	511a3675203dfa8034f97dbe11cc6195	511a3675203dfa8034f97dbe11cc6195.bam	35.64	NA	0.08	58cfa82de4b0c9d6adf6a614	511a3675203dfa8034f97dbe11cc6195.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-GM-A2DF-01A	D6F7AFC0-1558-43AD-ACB1-2B5311ED2264	Primary Tumor	Illumina HiSeq	f577059e-baa8-4030-9baa-5857d30fbfec	Breast	53	66760E17-251D-4981-BB02-82C29B315080	7456ABD5-303E-4E6F-BF4E-47EFEFC7310F	TCGA-GM-A2DF-01A-11D-A17W-09	GRCh37-lite	TCGA-GM-A2DF	TCGA-BRCA	NA	s6763	Washington University School of Medicine	MD Anderson	United States	NO	T1c	N1a	Infiltrating Ductal Carcinoma	Stage IIA	A17W-09	FALSE
13722.58cfa82de4b0c9d6adf6a63e	58cfa82de4b0c9d6adf6a63e	4904c28d460c5452fabb15e54e66ee71.filtered.	WGS	4904c28d460c5452fabb15e54e66ee71	4904c28d460c5452fabb15e54e66ee71.bam	73.92	NA	0.09	58cfa82de4b0c9d6adf6a63e	4904c28d460c5452fabb15e54e66ee71.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-EW-A1PC-01B	F45210D3-9E66-4F5E-BEF1-5EE5547CC893	Primary Tumor	Illumina HiSeq	4ded0771-e685-45fb-99f1-4dc1212cc9fc	Breast	66	FB635F1D-5EE1-4E58-86EA-B1AADA2DE4BA	1C0E384F-7254-4AFE-93C0-B3FC6C6A7894	TCGA-EW-A1PC-01B-11D-A21Q-09	GRCh37-lite	TCGA-EW-A1PC	TCGA-BRCA	NA	s5789	Washington University School of Medicine	University of Miami	United States	NO	T3	N0 (i-)	Infiltrating Ductal Carcinoma	Stage IIB	A21Q-09	TRUE
13722.58cfa82de4b0c9d6adf6a65c	58cfa82de4b0c9d6adf6a65c	4fa7ea559428c6a86aecf3aa8cb8acc0.filtered.	WGS	4fa7ea559428c6a86aecf3aa8cb8acc0	4fa7ea559428c6a86aecf3aa8cb8acc0.bam	44.55	NA	0.08	58cfa82de4b0c9d6adf6a65c	4fa7ea559428c6a86aecf3aa8cb8acc0.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Sarcoma	Aligned reads	TCGA-DX-A2IZ-01A	6B189EFF-B919-49D6-8775-DBF32C9CCBBA	Primary Tumor	Illumina HiSeq	a3746833-4b30-4c7f-b95c-b534566de66c	Mesenchymal	60	B68F7194-1F05-4009-8ED2-58C5EBBCABA8	67BB70B2-B6F8-4AA9-80CE-48829F9FEC56	TCGA-DX-A2IZ-01A-11D-A21Q-09	GRCh37-lite	TCGA-DX-A2IZ	TCGA-SARC	NA	s2488	Washington University School of Medicine	Memorial Sloan Kettering	United States	NO	Not available	Not available	Not available	Not available	A21Q-09	TRUE
13722.58cfa82de4b0c9d6adf6a668	58cfa82de4b0c9d6adf6a668	7bb361e97c34cfa7d98b7297a5f65604.filtered.	WGS	7bb361e97c34cfa7d98b7297a5f65604	7bb361e97c34cfa7d98b7297a5f65604.bam	92.8	2.11	0.08	58cfa82de4b0c9d6adf6a668	7bb361e97c34cfa7d98b7297a5f65604.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-A5-A0GJ-01A	94817E78-78F5-4556-9394-610DF65605E2	Primary Tumor	Illumina HiSeq	b55c1811-4356-4978-a0f1-59bda1ab8a8c	Uterus	44	48FA5B7D-E488-4743-A7CE-ACEB9945F00B	B38D0777-4901-48B8-9CDC-33B7F13A424F	TCGA-A5-A0GJ-01A-11D-A325-09	GRCh37-lite	TCGA-A5-A0GJ	TCGA-UCEC	NA	s4240	Washington University School of Medicine	Cedars Sinai	None	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A325-09	TRUE
13722.58cfa82de4b0c9d6adf6a678	58cfa82de4b0c9d6adf6a678	5ccefc1bca215bf54bcca30953e25fc3.filtered.	WGS	5ccefc1bca215bf54bcca30953e25fc3	5ccefc1bca215bf54bcca30953e25fc3.bam	87.84	2.05	0.09	58cfa82de4b0c9d6adf6a678	5ccefc1bca215bf54bcca30953e25fc3.bam	Alive	FEMALE	WHITE	Not available	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-AJ-A23M-01A	D39DF936-4BC6-404D-9E1D-F6416CC5A34C	Primary Tumor	Illumina HiSeq	c45046fe-9086-4f96-bc47-68de65413b58	Uterus	61	ACBBC556-4E4E-4EBC-B408-55D69720A87D	96F337D2-CEC4-4484-87CD-AB2109D2BF50	TCGA-AJ-A23M-01A-11D-A34H-09	GRCh37-lite	TCGA-AJ-A23M	TCGA-UCEC	NA	s4238	Washington University School of Medicine	International Genomics Conosrtium	United States	NO	Not available	Not available	Serous endometrial adenocarcinoma	Not available	A34H-09	TRUE
13722.58cfa82de4b0c9d6adf6a69f	58cfa82de4b0c9d6adf6a69f	824558b943d0281e9fdc0f4e97a69b78.filtered.	WGS	824558b943d0281e9fdc0f4e97a69b78	824558b943d0281e9fdc0f4e97a69b78.bam	71.16	2.03	0.08	58cfa82de4b0c9d6adf6a69f	824558b943d0281e9fdc0f4e97a69b78.bam	Alive	FEMALE	WHITE	Not available	Breast Invasive Carcinoma	Aligned reads	TCGA-BH-A0H6-01A	AEB6A3A6-B57A-4C53-90E6-E833777DD2A1	Primary Tumor	Illumina HiSeq	8df89d9c-2eb9-459a-adf7-48c9867c9462	Breast	82	B2921C9D-C655-46F3-86E5-2FC2BED1ED33	AA58C09A-7799-4675-8310-D270224B163E	TCGA-BH-A0H6-01A-21D-A314-09	GRCh37-lite	TCGA-BH-A0H6	TCGA-BRCA	NA	s5792	Washington University School of Medicine	University of Pittsburgh	None	NO	T1b	NX	Infiltrating Ductal Carcinoma	Stage I	A314-09	TRUE
13722.58cfa82de4b0c9d6adf6a642	58cfa82de4b0c9d6adf6a642	56c4e1fd143ea68f16ed05f49f2cd315.filtered.	WGS	56c4e1fd143ea68f16ed05f49f2cd315	56c4e1fd143ea68f16ed05f49f2cd315.bam	29.64	1.95	0.07	58cfa82de4b0c9d6adf6a642	56c4e1fd143ea68f16ed05f49f2cd315.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-E2-A14P-01A	E4FC0909-F284-4471-866D-D8967B6ADCBC	Primary Tumor	Illumina HiSeq	6291117d-64a7-4c35-94bb-8e06275c498e	Breast	79	58BFE278-A80F-4722-B286-4D966214D244	74B57D2C-A83F-4798-B86B-A533975E4CC0	TCGA-E2-A14P-01A-31D-A19H-09	GRCh37-lite	TCGA-E2-A14P	TCGA-BRCA	NA	s5629	Washington University School of Medicine	Roswell Park	None	NO	T2	N3	Infiltrating Ductal Carcinoma	Stage IIIC	A19H-09	TRUE
13722.58cfa82de4b0c9d6adf6a69e	58cfa82de4b0c9d6adf6a69e	898a39476e967ce15adbf5f7f4230feb.filtered.	WGS	898a39476e967ce15adbf5f7f4230feb	898a39476e967ce15adbf5f7f4230feb.bam	60.86	NA	0.09	58cfa82de4b0c9d6adf6a69e	898a39476e967ce15adbf5f7f4230feb.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-C5-A2LT-01A	FB66B7F5-22CA-4D4D-97C2-30E6EDFFF781	Primary Tumor	Illumina HiSeq	f6c6e1bd-966a-4f96-b8ab-e8219607f960	Cervix	38	EEDE6958-96A5-433D-8823-503B58559ED4	0F6B355E-3898-4BE6-BE97-DA0C3840A4ED	TCGA-C5-A2LT-01A-11D-A18J-09	GRCh37-lite	TCGA-C5-A2LT	TCGA-CESC	NA	s1512	Washington University School of Medicine	Medical College of Wisconsin	United States	NO	T1b	N0	Cervical Squamous Cell Carcinoma	Not available	A18J-09	TRUE
13722.58cfa82de4b0c9d6adf6a658	58cfa82de4b0c9d6adf6a658	56ee38b83bbac3302bd71fef66bd52a5.filtered.	WGS	56ee38b83bbac3302bd71fef66bd52a5	56ee38b83bbac3302bd71fef66bd52a5.bam	73.22	2.09	0.07	58cfa82de4b0c9d6adf6a658	56ee38b83bbac3302bd71fef66bd52a5.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	Not available	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-B5-A0JN-01A	B60F22AC-A659-4F33-B01D-820E86A9A5C9	Primary Tumor	Illumina HiSeq	4a8180de-0459-43a0-9e22-6a115e56912c	Uterus	84	684C6894-FD49-4934-8962-9628ECE734FB	8DD14F0E-8601-4AA1-864C-3C49E768CDD1	TCGA-B5-A0JN-01A-11D-A10B-09	GRCh37-lite	TCGA-B5-A0JN	TCGA-UCEC	NA	s4410	Washington University School of Medicine	Duke	United States	NO	Not available	Not available	Serous endometrial adenocarcinoma	Not available	A10B-09	TRUE
13722.58cfa82de4b0c9d6adf6a6c4	58cfa82de4b0c9d6adf6a6c4	890d7ec2b62541e2e80696ea62529008.filtered.	WGS	890d7ec2b62541e2e80696ea62529008	890d7ec2b62541e2e80696ea62529008.bam	63.32	NA	0.07	58cfa82de4b0c9d6adf6a6c4	890d7ec2b62541e2e80696ea62529008.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-EK-A2RM-01A	C13215D9-26A8-4C8B-B4FE-5DA6AA3222AF	Primary Tumor	Illumina HiSeq	4bb49662-4b46-4288-a828-c518e6d697b2	Cervix	40	F0CA60FB-BD45-4F15-A791-0C5B1218D8EF	801E67C8-C506-410A-BDF0-856A66E974F4	TCGA-EK-A2RM-01A-21D-A18J-09	GRCh37-lite	TCGA-EK-A2RM	TCGA-CESC	NA	s1168	Washington University School of Medicine	Gynecologic Oncology Group	United States	NO	Not available	Not available	Cervical Squamous Cell Carcinoma	Not available	A18J-09	TRUE
13722.58cfa82de4b0c9d6adf6a6bc	58cfa82de4b0c9d6adf6a6bc	96931b4ebc549e6fc4857a1d420bb860.filtered.	WGS	96931b4ebc549e6fc4857a1d420bb860	96931b4ebc549e6fc4857a1d420bb860.bam	63.14	2.06	0.07	58cfa82de4b0c9d6adf6a6bc	96931b4ebc549e6fc4857a1d420bb860.bam	Dead	FEMALE	Not available	Not available	Breast Invasive Carcinoma	Aligned reads	TCGA-A8-A08L-01A	8BD68696-5EEB-46D7-9DC6-C39C849029A4	Primary Tumor	Illumina HiSeq	941e2188-e858-40d6-9f12-5faa6425a67f	Breast	89	C385C7FC-0E3E-4FC8-87C1-6DB442E5606F	FE04D042-A4CC-4A14-8197-415EA40951AA	TCGA-A8-A08L-01A-11D-A19H-09	GRCh37-lite	TCGA-A8-A08L	TCGA-BRCA	304	s5634	Washington University School of Medicine	Indivumed	Germany	NO	T3	N2a	Infiltrating Ductal Carcinoma	Stage IIIA	A19H-09	TRUE
13722.58cfa82de4b0c9d6adf6a6cf	58cfa82de4b0c9d6adf6a6cf	943f4d785b943d37fff5ff0c234c4566.filtered.	WGS	943f4d785b943d37fff5ff0c234c4566	943f4d785b943d37fff5ff0c234c4566.bam	87.75	1.92	0.08	58cfa82de4b0c9d6adf6a6cf	943f4d785b943d37fff5ff0c234c4566.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-D1-A16G-01A	16E69011-C295-479F-B521-86E66FBA498D	Primary Tumor	Illumina HiSeq	e4699f4c-2332-49b2-83cb-aff2eeb83c5b	Uterus	74	4C34ECB0-9351-4A55-9FF5-2062B7CB391A	65F9A820-F026-4A10-8BB7-1FBC3B38321E	TCGA-D1-A16G-01A-31D-A12J-09	GRCh37-lite	TCGA-D1-A16G	TCGA-UCEC	834	s4770	Washington University School of Medicine	Mayo Clinic	None	NO	Not available	Not available	Serous endometrial adenocarcinoma	Not available	A12J-09	FALSE
13722.58cfa82de4b0c9d6adf6a530	58cfa82de4b0c9d6adf6a530	11e9896c1184c4a8c38f78209b067bcf.filtered.	WGS	11e9896c1184c4a8c38f78209b067bcf	11e9896c1184c4a8c38f78209b067bcf.bam	31.82	1.93	0.08	58cfa82de4b0c9d6adf6a530	11e9896c1184c4a8c38f78209b067bcf.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-BS-A0TG-01A	13F31BCB-BEFD-4ED2-ADC0-DC9E9CE52B75	Primary Tumor	Illumina HiSeq	8a9ac951-0c3a-4112-8159-d585756fae14	Uterus	60	36E44603-A1EE-4A5B-9506-49A9358BF8D0	19DEF402-FB8D-4B27-90DD-CE9135A3C0A2	TCGA-BS-A0TG-01A-32D-A10B-09	GRCh37-lite	TCGA-BS-A0TG	TCGA-UCEC	NA	s4233	Washington University School of Medicine	University of Hawaii	None	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A10B-09	TRUE
13722.58cfa82de4b0c9d6adf6a708	58cfa82de4b0c9d6adf6a708	9e0aa323dd137c62bd3ba6626357862a.filtered.	WGS	9e0aa323dd137c62bd3ba6626357862a	9e0aa323dd137c62bd3ba6626357862a.bam	47.34	2	0.09	58cfa82de4b0c9d6adf6a708	9e0aa323dd137c62bd3ba6626357862a.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-E6-A1LZ-01A	9205C164-7975-421A-90C3-EDFE8DEF595C	Primary Tumor	Illumina HiSeq	d8f785e3-7de9-4e09-b830-5033e5eaa2f4	Uterus	76	62BFF77E-4FE6-4A9F-A867-345584608E7D	F7DCC2E4-1FC4-4B39-BC6A-720E66116D68	TCGA-E6-A1LZ-01A-11D-A142-09	GRCh37-lite	TCGA-E6-A1LZ	TCGA-UCEC	NA	s5193	Washington University School of Medicine	Roswell Park	United States	NO	Not available	Not available	Serous endometrial adenocarcinoma	Not available	A142-09	FALSE
13722.58cfa82ee4b0c9d6adf6a8ac	58cfa82ee4b0c9d6adf6a8ac	G35154.TCGA-EZ-7264-01A-11D-2024-08.2.filtered.	WGS	G35154.TCGA-EZ-7264-01A-11D-2024-08.2	G35154.TCGA-EZ-7264-01A-11D-2024-08.2.bam	329	NA	0.05	58cfa82ee4b0c9d6adf6a8ac	G35154.TCGA-EZ-7264-01A-11D-2024-08.2.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-EZ-7264-01A	FC3B7596-F515-446F-81DB-FED0154CA2C5	Primary Tumor	Illumina HiSeq	e0ea4522-35f1-40c7-92d2-5d1e7ec0cb63	Brain	47	EECBA415-5517-4265-8944-07AACBC679FB	00493087-9D9D-40CA-86D5-936F1B951C93	TCGA-EZ-7264-01A-11D-2024-08	HG19_Broad_variant	TCGA-EZ-7264	TCGA-LGG	NA	s8329	Broad Institute of MIT and Harvard	UNC	United States	NO	Not available	Not available	Oligodendroglioma	Not available	2024-08	FALSE
13722.58cfa82de4b0c9d6adf6a76e	58cfa82de4b0c9d6adf6a76e	G14581.TCGA-64-1680-01A-02D-1040-01.2.filtered.	WGS	G14581.TCGA-64-1680-01A-02D-1040-01.2	G14581.TCGA-64-1680-01A-02D-1040-01.2.bam	380.53	1.9	0.15	58cfa82de4b0c9d6adf6a76e	G14581.TCGA-64-1680-01A-02D-1040-01.2.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-64-1680-01A	1AB7AD70-0F80-41D8-8EFA-3BAEBC8223CC	Primary Tumor	Illumina HiSeq	6b9dbd25-b2c7-4ba6-8030-e98c1c8e9991	Lung	63	0BDBE623-CF95-465A-917D-87DFB6A8618E	DD09C7AA-744A-413D-839F-E75E1825F9F9	TCGA-64-1680-01A-02D-1040-01	HG19_Broad_variant	TCGA-64-1680	TCGA-LUAD	NA	s11313	Broad Institute of MIT and Harvard	Fox Chase	None	NO	T2a	N2	Lung Adenocarcinoma Mixed Subtype	Stage IV	1040-01	FALSE
13722.58cfa82ee4b0c9d6adf6a8d7	58cfa82ee4b0c9d6adf6a8d7	G32459.TCGA-BL-A13J-01A-11D-A10S-08.3.filtered.	WGS	G32459.TCGA-BL-A13J-01A-11D-A10S-08.3	G32459.TCGA-BL-A13J-01A-11D-A10S-08.3.bam	57.46	1.9	0.08	58cfa82ee4b0c9d6adf6a8d7	G32459.TCGA-BL-A13J-01A-11D-A10S-08.3.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-BL-A13J-01A	556FCBC8-172A-4AF1-8822-AE036E8D68E8	Primary Tumor	Illumina HiSeq	37852645-c37a-4adb-8701-9300e0dcdb65	Bladder	65	CF23846D-A7D2-40A9-8B51-49A27967D101	0C7ACA3F-E006-4DE3-AFC2-20B4F727D4FD	TCGA-BL-A13J-01A-11D-A10S-08	HG19_Broad_variant	TCGA-BL-A13J	TCGA-BLCA	81	s3075	Broad Institute of MIT and Harvard	Christiana Healthcare	United States	NO	T4	N2	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV	A10S-08	TRUE
13722.58cfa82ee4b0c9d6adf6a8b0	58cfa82ee4b0c9d6adf6a8b0	G35154.TCGA-FG-5964-01A-11D-1705-08.4.filtered.	WGS	G35154.TCGA-FG-5964-01A-11D-1705-08.4	G35154.TCGA-FG-5964-01A-11D-1705-08.4.bam	102.3	1.9	0.05	58cfa82ee4b0c9d6adf6a8b0	G35154.TCGA-FG-5964-01A-11D-1705-08.4.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-FG-5964-01A	648252DA-DD86-48D1-AE75-4257E3142B0B	Primary Tumor	Illumina HiSeq	7c465b99-b3c1-44c6-899f-74975fb3d594	Brain	62	7BBFBDD1-4CB9-479C-8152-924D79E112F2	C6888BE2-4517-41E4-A801-9C915F24E737	TCGA-FG-5964-01A-11D-1705-08	HG19_Broad_variant	TCGA-FG-5964	TCGA-LGG	NA	s8109	Broad Institute of MIT and Harvard	Case Western	United States	NO	Not available	Not available	Oligodendroglioma	Not available	1705-08	FALSE
13722.58cfa82ee4b0c9d6adf6a8d2	58cfa82ee4b0c9d6adf6a8d2	G32469.TCGA-DK-A1AG-01A-11D-A13W-08.3.filtered.	WGS	G32469.TCGA-DK-A1AG-01A-11D-A13W-08.3	G32469.TCGA-DK-A1AG-01A-11D-A13W-08.3.bam	70.38	1.89	0.08	58cfa82ee4b0c9d6adf6a8d2	G32469.TCGA-DK-A1AG-01A-11D-A13W-08.3.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-DK-A1AG-01A	F8C0A69C-DF53-4A0A-A30E-4424C0CE3DD5	Primary Tumor	Illumina HiSeq	af228568-1064-4709-8bc8-435278c73ca0	Bladder	65	64668AA0-DDE5-4534-8CD0-378881E4A4E4	7D2A22EB-7344-4CBA-AD7D-94C3F9EF3D7C	TCGA-DK-A1AG-01A-11D-A13W-08	HG19_Broad_variant	TCGA-DK-A1AG	TCGA-BLCA	NA	s2687	Broad Institute of MIT and Harvard	Memorial Sloan Kettering	United States	NO	T3	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage III	A13W-08	TRUE
13722.58cfa82ee4b0c9d6adf6a8ec	58cfa82ee4b0c9d6adf6a8ec	G35154.TCGA-HT-7695-01A-11D-2253-08.1.filtered.	WGS	G35154.TCGA-HT-7695-01A-11D-2253-08.1	G35154.TCGA-HT-7695-01A-11D-2253-08.1.bam	86	NA	0.05	58cfa82ee4b0c9d6adf6a8ec	G35154.TCGA-HT-7695-01A-11D-2253-08.1.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-HT-7695-01A	5017C115-39B8-4C5C-8BE6-2CB298D7C641	Primary Tumor	Illumina HiSeq	0e08feb2-0a06-458b-a3ea-797020f9a68f	Brain	29	8B58DBF3-022C-4337-9FAD-5AE43B1B84F2	86386B36-2950-4479-B79F-4B347053C8BC	TCGA-HT-7695-01A-11D-2253-08	HG19_Broad_variant	TCGA-HT-7695	TCGA-LGG	NA	s8538	Broad Institute of MIT and Harvard	Case Western - St Joes	United States	NO	Not available	Not available	Oligodendroglioma	Not available	2253-08	FALSE
13722.58cfa82ee4b0c9d6adf6a8e0	58cfa82ee4b0c9d6adf6a8e0	G35154.TCGA-DB-5278-01A-01D-1468-08.1.filtered.	WGS	G35154.TCGA-DB-5278-01A-01D-1468-08.1	G35154.TCGA-DB-5278-01A-01D-1468-08.1.bam	215.3	1.9	0.05	58cfa82ee4b0c9d6adf6a8e0	G35154.TCGA-DB-5278-01A-01D-1468-08.1.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-DB-5278-01A	010AAC75-3BFE-4BF2-B866-AF0F2D92F125	Primary Tumor	Illumina HiSeq	6780f08b-966e-4836-9cd8-46b87be05578	Brain	17	11437143-41F5-4005-9124-4D6A4A2F0E2D	6847E993-1414-4E6F-A2AF-39EBE218DD7C	TCGA-DB-5278-01A-01D-1468-08	HG19_Broad_variant	TCGA-DB-5278	TCGA-LGG	NA	s8101	Broad Institute of MIT and Harvard	Mayo Clinic - Rochester	United States	NO	Not available	Not available	Oligodendroglioma	Not available	1468-08	FALSE
13722.58cfa82ee4b0c9d6adf6a94d	58cfa82ee4b0c9d6adf6a94d	G35154.TCGA-DU-5874-01A-11D-1705-08.2.filtered.	WGS	G35154.TCGA-DU-5874-01A-11D-1705-08.2	G35154.TCGA-DU-5874-01A-11D-1705-08.2.bam	301.3	1.9	0.05	58cfa82ee4b0c9d6adf6a94d	G35154.TCGA-DU-5874-01A-11D-1705-08.2.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-DU-5874-01A	1CC53ADE-73C0-492B-A7DC-328269FD0E66	Primary Tumor	Illumina HiSeq	b0268c63-93dc-4e0b-b29b-217fd6028c92	Brain	62	3C7CE3D5-F9E4-4FAE-B033-2058446ED7F3	85D915B8-0184-4EC7-93AD-E9FFA2F5743B	TCGA-DU-5874-01A-11D-1705-08	HG19_Broad_variant	TCGA-DU-5874	TCGA-LGG	NA	s8546	Broad Institute of MIT and Harvard	Henry Ford Hospital	United States	NO	Not available	Not available	Oligodendroglioma	Not available	1705-08	FALSE
13722.58cfa82ee4b0c9d6adf6a952	58cfa82ee4b0c9d6adf6a952	G26382.TCGA-06-2557-01A-01D-1494-08.1.filtered.	WGS	G26382.TCGA-06-2557-01A-01D-1494-08.1	G26382.TCGA-06-2557-01A-01D-1494-08.1.bam	633.7	1.9	0.05	58cfa82ee4b0c9d6adf6a952	G26382.TCGA-06-2557-01A-01D-1494-08.1.bam	Dead	MALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Glioblastoma Multiforme	Aligned reads	TCGA-06-2557-01A	6C28F086-6A25-40B6-93EB-BBA0014ACDA6	Primary Tumor	Illumina HiSeq	582d62de-97f1-4c69-8559-dd865f368abd	Brain	76	19521291-90A2-4865-9D3F-25973130D22E	C27290E4-6835-448A-ABDC-DF8DDD5F4630	TCGA-06-2557-01A-01D-1494-08	HG19_Broad_variant	TCGA-06-2557	TCGA-GBM	33	s14370	Broad Institute of MIT and Harvard	Henry Ford Hospital	None	NO	Not available	Not available	Untreated primary (de novo) GBM	Not available	1494-08	TRUE
13722.58cfa82ee4b0c9d6adf6a967	58cfa82ee4b0c9d6adf6a967	G32458.TCGA-BT-A20V-01A-11D-A14W-08.2.filtered.	WGS	G32458.TCGA-BT-A20V-01A-11D-A14W-08.2	G32458.TCGA-BT-A20V-01A-11D-A14W-08.2.bam	101.87	2.11	0.08	58cfa82ee4b0c9d6adf6a967	G32458.TCGA-BT-A20V-01A-11D-A14W-08.2.bam	Dead	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-BT-A20V-01A	24F21425-B001-4986-AEDF-5B4DD851C6AD	Primary Tumor	Illumina HiSeq	a193bc83-ec94-46bb-b7ee-60b8b75c8ad8	Bladder	59	967443E3-35C3-4F41-9BB5-DC899D290806	973D0577-8CA4-44A1-817F-1D3C1BADA151	TCGA-BT-A20V-01A-11D-A14W-08	HG19_Broad_variant	TCGA-BT-A20V	TCGA-BLCA	154	s3252	Broad Institute of MIT and Harvard	University of Pittsburgh	United States	NO	T4a	N2	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV	A14W-08	TRUE
13722.58cfa82ee4b0c9d6adf6a980	58cfa82ee4b0c9d6adf6a980	G35154.TCGA-DU-7009-01A-11D-2024-08.2.filtered.	WGS	G35154.TCGA-DU-7009-01A-11D-2024-08.2	G35154.TCGA-DU-7009-01A-11D-2024-08.2.bam	130.3	NA	0.05	58cfa82ee4b0c9d6adf6a980	G35154.TCGA-DU-7009-01A-11D-2024-08.2.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-DU-7009-01A	01C4CA12-AC08-41DD-9E4F-BFB0971688A2	Primary Tumor	Illumina HiSeq	446ab57b-076e-4f55-b617-050e5f14bfa5	Brain	32	C7CA8FEE-BD73-435B-B351-216E5DC38726	4853FD17-7214-4F0C-984B-1BE0346CA4AB	TCGA-DU-7009-01A-11D-2024-08	HG19_Broad_variant	TCGA-DU-7009	TCGA-LGG	NA	s8105	Broad Institute of MIT and Harvard	Henry Ford Hospital	United States	NO	Not available	Not available	Oligodendroglioma	Not available	2024-08	FALSE
13722.58cfa82ee4b0c9d6adf6a9a8	58cfa82ee4b0c9d6adf6a9a8	G32468.TCGA-GD-A2C5-01A-12D-A17V-08.1.filtered.	WGS	G32468.TCGA-GD-A2C5-01A-12D-A17V-08.1	G32468.TCGA-GD-A2C5-01A-12D-A17V-08.1.bam	40.79	NA	0.08	58cfa82ee4b0c9d6adf6a9a8	G32468.TCGA-GD-A2C5-01A-12D-A17V-08.1.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-GD-A2C5-01A	5D54C742-5A8E-4C40-8D62-95E75E210AB8	Primary Tumor	Illumina HiSeq	5f1b4c77-5775-4a38-b100-dc28cb8fb2b3	Bladder	53	2CD62676-762C-461D-B111-1F81E7CD5877	2B142863-B963-4CC9-8F8F-C72503C93390	TCGA-GD-A2C5-01A-12D-A17V-08	HG19_Broad_variant	TCGA-GD-A2C5	TCGA-BLCA	NA	s3260	Broad Institute of MIT and Harvard	ABS - IUPUI	United States	NO	T3a	N2	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV	A17V-08	TRUE
13722.58cfa82ee4b0c9d6adf6a9aa	58cfa82ee4b0c9d6adf6a9aa	G32537.TCGA-EL-A3CX-01A-11D-A19J-08.2.filtered.	WGS	G32537.TCGA-EL-A3CX-01A-11D-A19J-08.2	G32537.TCGA-EL-A3CX-01A-11D-A19J-08.2.bam	46.65	NA	0.08	58cfa82ee4b0c9d6adf6a9aa	G32537.TCGA-EL-A3CX-01A-11D-A19J-08.2.bam	Alive	FEMALE	WHITE	HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-EL-A3CX-01A	934A58AF-0FFC-487E-9E95-FA7643B7D5CB	Primary Tumor	Illumina HiSeq	7466949f-795d-4b2c-99e4-92d507c8772e	Thyroid	22	C65B5941-3E1D-41C6-9458-CDE70425E7C7	D0A33FD2-085C-488B-B843-2CA97C85A5CB	TCGA-EL-A3CX-01A-11D-A19J-08	HG19_Broad_variant	TCGA-EL-A3CX	TCGA-THCA	NA	s12337	Broad Institute of MIT and Harvard	MD Anderson	United States	NO	T2	N0	Thyroid Papillary Carcinoma - Classical/usual	Stage I	A19J-08	FALSE
13722.58cfa82ee4b0c9d6adf6aa1c	58cfa82ee4b0c9d6adf6aa1c	G32465.TCGA-BT-A20Q-01A-11D-A14W-08.1.filtered.	WGS	G32465.TCGA-BT-A20Q-01A-11D-A14W-08.1	G32465.TCGA-BT-A20Q-01A-11D-A14W-08.1.bam	56.34	2.11	0.08	58cfa82ee4b0c9d6adf6aa1c	G32465.TCGA-BT-A20Q-01A-11D-A14W-08.1.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-BT-A20Q-01A	419DEAAC-EA45-4BDD-9FA0-B5CD8429B44F	Primary Tumor	Illumina HiSeq	1e07bbf1-7f3c-4472-b21e-f9eaa7b11659	Bladder	73	F3906CD4-31C7-48A8-935B-5B7FAFEC1AE7	8C619CBC-9E91-4716-9711-5236E55D8F46	TCGA-BT-A20Q-01A-11D-A14W-08	HG19_Broad_variant	TCGA-BT-A20Q	TCGA-BLCA	593	s3255	Broad Institute of MIT and Harvard	University of Pittsburgh	United States	NO	T3b	N2	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV	A14W-08	TRUE
13722.58cfa82ee4b0c9d6adf6a9e5	58cfa82ee4b0c9d6adf6a9e5	G26360.TCGA-32-1970-01A-01D-1494-08.1.filtered.	WGS	G26360.TCGA-32-1970-01A-01D-1494-08.1	G26360.TCGA-32-1970-01A-01D-1494-08.1.bam	398.7	1.9	0.05	58cfa82ee4b0c9d6adf6a9e5	G26360.TCGA-32-1970-01A-01D-1494-08.1.bam	Dead	MALE	WHITE	Not available	Glioblastoma Multiforme	Aligned reads	TCGA-32-1970-01A	6C5154D2-AF36-492F-B520-D925528824E4	Primary Tumor	Illumina HiSeq	ce02c656-69b1-46a5-a120-f424ab059f55	Brain	59	115D06A0-7FFB-4E2F-BC09-59EA55D12894	65723119-BDFE-46F0-B629-C171023ABD71	TCGA-32-1970-01A-01D-1494-08	HG19_Broad_variant	TCGA-32-1970	TCGA-GBM	468	s13979	Broad Institute of MIT and Harvard	St. Joseph's Hospital (AZ)	None	NO	Not available	Not available	Untreated primary (de novo) GBM	Not available	1494-08	TRUE
13722.58cfa82ee4b0c9d6adf6aa35	58cfa82ee4b0c9d6adf6aa35	G26363.TCGA-19-2624-01A-01D-1495-08.2.filtered.	WGS	G26363.TCGA-19-2624-01A-01D-1495-08.2	G26363.TCGA-19-2624-01A-01D-1495-08.2.bam	164.1	1.9	0.05	58cfa82ee4b0c9d6adf6aa35	G26363.TCGA-19-2624-01A-01D-1495-08.2.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Glioblastoma Multiforme	Aligned reads	TCGA-19-2624-01A	2F4A127F-101A-4192-B3E8-F9BE2C8648BC	Primary Tumor	Illumina HiSeq	d4065322-376e-4196-afdd-8e8b7d51e85b	Brain	51	C9E1BE85-0699-48B4-8977-0DB46AF4EC94	A8F86B64-914C-4D89-897B-33BCDD1759F7	TCGA-19-2624-01A-01D-1495-08	HG19_Broad_variant	TCGA-19-2624	TCGA-GBM	5	s14343	Broad Institute of MIT and Harvard	Case Western	None	NO	Not available	Not available	Untreated primary (de novo) GBM	Not available	1495-08	FALSE
13722.58cfa82ee4b0c9d6adf6aa38	58cfa82ee4b0c9d6adf6aa38	G23883.TCGA-A3-3324-01A-01D-2229-08.1.filtered.	WGS	G23883.TCGA-A3-3324-01A-01D-2229-08.1	G23883.TCGA-A3-3324-01A-01D-2229-08.1.bam	602.9	1.9	0.05	58cfa82ee4b0c9d6adf6aa38	G23883.TCGA-A3-3324-01A-01D-2229-08.1.bam	Alive	MALE	WHITE	Not available	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-A3-3324-01A	4FCA10BD-988A-47F9-8ED5-037C0D59D70C	Primary Tumor	Illumina HiSeq	4fa1626a-b369-4e9c-b908-528e1d550be7	Kidney	51	08CE626E-0734-4D54-BA3F-EA5702B886F3	BADA0A2B-88CC-4F38-9BE5-F4B698AE4DB1	TCGA-A3-3324-01A-01D-2229-08	HG19_Broad_variant	TCGA-A3-3324	TCGA-KIRC	NA	s9154	Broad Institute of MIT and Harvard	International Genomics Consortium	United States	NO	T1b	NX	Kidney Clear Cell Renal Carcinoma	Stage I	2229-08	FALSE
13722.58cfa82ee4b0c9d6adf6aa9e	58cfa82ee4b0c9d6adf6aa9e	G32455.TCGA-BT-A2LA-01A-11D-A18F-08.2.filtered.	WGS	G32455.TCGA-BT-A2LA-01A-11D-A18F-08.2	G32455.TCGA-BT-A2LA-01A-11D-A18F-08.2.bam	80.43	NA	0.07	58cfa82ee4b0c9d6adf6aa9e	G32455.TCGA-BT-A2LA-01A-11D-A18F-08.2.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-BT-A2LA-01A	797A71EE-372D-41E5-AEEE-5AB3C4661110	Primary Tumor	Illumina HiSeq	baad6267-e92d-4dc7-a751-271da7ad3f53	Bladder	54	6ED52558-8039-4658-A245-78A29968CE2F	45A7949D-E63F-4956-866C-DF51257032DE	TCGA-BT-A2LA-01A-11D-A18F-08	HG19_Broad_variant	TCGA-BT-A2LA	TCGA-BLCA	NA	s2851	Broad Institute of MIT and Harvard	University of Pittsburgh	United States	NO	T3a	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage III	A18F-08	FALSE
13722.58cfa82ee4b0c9d6adf6aae6	58cfa82ee4b0c9d6adf6aae6	G32531.TCGA-FK-A3S3-01A-11D-A22D-08.1.filtered.	WGS	G32531.TCGA-FK-A3S3-01A-11D-A22D-08.1	G32531.TCGA-FK-A3S3-01A-11D-A22D-08.1.bam	22.44	NA	0.09	58cfa82ee4b0c9d6adf6aae6	G32531.TCGA-FK-A3S3-01A-11D-A22D-08.1.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-FK-A3S3-01A	785803BB-42A8-4AFB-B7B4-58C114894408	Primary Tumor	Illumina HiSeq	5c7965a4-3e29-4c83-87e5-2e23f356287c	Thyroid	43	F5EBEFBE-50FA-465A-A355-2C099941039D	15ABB2A3-10A2-4E04-8EB9-6EADBD976AF0	TCGA-FK-A3S3-01A-11D-A22D-08	HG19_Broad_variant	TCGA-FK-A3S3	TCGA-THCA	NA	s12344	Broad Institute of MIT and Harvard	Johns Hopkins	United States	NO	T3	N1b	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	Stage I	A22D-08	TRUE
13722.58cfa82ee4b0c9d6adf6aaac	58cfa82ee4b0c9d6adf6aaac	G26375.TCGA-27-2528-01A-01D-1494-08.1.filtered.	WGS	G26375.TCGA-27-2528-01A-01D-1494-08.1	G26375.TCGA-27-2528-01A-01D-1494-08.1.bam	202.7	1.9	0.05	58cfa82ee4b0c9d6adf6aaac	G26375.TCGA-27-2528-01A-01D-1494-08.1.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Glioblastoma Multiforme	Aligned reads	TCGA-27-2528-01A	BE3A7EF3-34ED-40E1-9D9C-187940596B26	Primary Tumor	Illumina HiSeq	29b9c185-f979-47f1-91dc-9b8ca4759c35	Brain	62	3190BD1A-A83A-45F6-959A-863BBAE58FFE	374CBD87-428E-4509-85C1-B7D3302C30A0	TCGA-27-2528-01A-01D-1494-08	HG19_Broad_variant	TCGA-27-2528	TCGA-GBM	480	s14221	Broad Institute of MIT and Harvard	Milan - Italy, Fondazione IRCCS Instituto Neuroligico C. Besta	None	NO	Not available	Not available	Untreated primary (de novo) GBM	Not available	1494-08	TRUE
13722.58cfa82ee4b0c9d6adf6aaee	58cfa82ee4b0c9d6adf6aaee	G32466.TCGA-H4-A2HQ-01A-11D-A17V-08.2.filtered.	WGS	G32466.TCGA-H4-A2HQ-01A-11D-A17V-08.2	G32466.TCGA-H4-A2HQ-01A-11D-A17V-08.2.bam	54.46	NA	0.07	58cfa82ee4b0c9d6adf6aaee	G32466.TCGA-H4-A2HQ-01A-11D-A17V-08.2.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-H4-A2HQ-01A	CEDE5274-279D-4021-8ACA-5ECC4BF94D66	Primary Tumor	Illumina HiSeq	211fa39b-cffd-430e-b28a-b6624e81fb93	Bladder	64	CBEDC0DB-39FD-4661-9531-CC24D422FAC4	94108975-B7A0-40BA-AD39-E44CC62E8CC0	TCGA-H4-A2HQ-01A-11D-A17V-08	HG19_Broad_variant	TCGA-H4-A2HQ	TCGA-BLCA	NA	s3250	Broad Institute of MIT and Harvard	Medical College of Georgia	United States	NO	Not available	NX	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV	A17V-08	TRUE
13722.58cfa82ee4b0c9d6adf6aaa4	58cfa82ee4b0c9d6adf6aaa4	G26386.TCGA-06-0745-01A-01D-1492-08.1.filtered.	WGS	G26386.TCGA-06-0745-01A-01D-1492-08.1	G26386.TCGA-06-0745-01A-01D-1492-08.1.bam	339.57	1.91	0.05	58cfa82ee4b0c9d6adf6aaa4	G26386.TCGA-06-0745-01A-01D-1492-08.1.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Glioblastoma Multiforme	Aligned reads	TCGA-06-0745-01A	386B629E-FAB1-4033-B088-45D6EEB4A13E	Primary Tumor	Illumina HiSeq	02ccb42a-947e-4baf-90b2-dbd453844f63	Brain	59	6EB5B7FF-1797-4C31-AB5B-6DB2B2641C5B	41D50A3C-49FC-4D8A-9C25-BBBCD3A5DA6F	TCGA-06-0745-01A-01D-1492-08	HG19_Broad_variant	TCGA-06-0745	TCGA-GBM	239	s14305	Broad Institute of MIT and Harvard	Henry Ford Hospital	None	NO	Not available	Not available	Untreated primary (de novo) GBM	Not available	1492-08	FALSE
13722.58cfa82ee4b0c9d6adf6aae8	58cfa82ee4b0c9d6adf6aae8	G32454.TCGA-CF-A27C-01A-11D-A16O-08.4.filtered.	WGS	G32454.TCGA-CF-A27C-01A-11D-A16O-08.4	G32454.TCGA-CF-A27C-01A-11D-A16O-08.4.bam	67.64	2.28	0.09	58cfa82ee4b0c9d6adf6aae8	G32454.TCGA-CF-A27C-01A-11D-A16O-08.4.bam	Alive	MALE	ASIAN	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-CF-A27C-01A	7FEE9D6F-C0EA-43C2-89C2-66D965A077A8	Primary Tumor	Illumina HiSeq	456bc333-4951-4b6e-845e-2af77b0a86d7	Bladder	52	EAD6792B-4E52-4C28-891C-6D8696873A13	ACC629CB-AD03-4CEC-9B21-922E4932EF3E	TCGA-CF-A27C-01A-11D-A16O-08	HG19_Broad_variant	TCGA-CF-A27C	TCGA-BLCA	NA	s2678	Broad Institute of MIT and Harvard	ILSbio	Vietnam	NO	T3	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage III	A16O-08	FALSE
13722.58cfa82ee4b0c9d6adf6ab34	58cfa82ee4b0c9d6adf6ab34	G32460.TCGA-BT-A3PH-01A-11D-A21Z-08.2.filtered.	WGS	G32460.TCGA-BT-A3PH-01A-11D-A21Z-08.2	G32460.TCGA-BT-A3PH-01A-11D-A21Z-08.2.bam	56.18	NA	0.08	58cfa82ee4b0c9d6adf6ab34	G32460.TCGA-BT-A3PH-01A-11D-A21Z-08.2.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-BT-A3PH-01A	932BCDD4-5145-49E8-9A95-8A546396F572	Primary Tumor	Illumina HiSeq	6a3d1aec-7ab7-4703-b3f0-5ba3f396d70d	Bladder	76	33A83E54-3BE5-4A68-8AB0-D31D0BCD3B67	CDA1A403-16B6-487C-A82A-C377D1D0F89D	TCGA-BT-A3PH-01A-11D-A21Z-08	HG19_Broad_variant	TCGA-BT-A3PH	TCGA-BLCA	142	s3254	Broad Institute of MIT and Harvard	University of Pittsburgh	United States	NO	T3b	N2	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV	A21Z-08	TRUE
13722.58cfa82ee4b0c9d6adf6ab40	58cfa82ee4b0c9d6adf6ab40	G32559.TCGA-ER-A2NF-01A-11D-A19A-08.2.filtered.	WGS	G32559.TCGA-ER-A2NF-01A-11D-A19A-08.2	G32559.TCGA-ER-A2NF-01A-11D-A19A-08.2.bam	52.36	NA	0.08	58cfa82ee4b0c9d6adf6ab40	G32559.TCGA-ER-A2NF-01A-11D-A19A-08.2.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Skin Cutaneous Melanoma	Aligned reads	TCGA-ER-A2NF-01A	D32A4219-4CCA-470F-B6B3-11447D9F5E0B	Primary Tumor	Illumina HiSeq	a17559f3-505c-4dc1-855c-178b1740e1ac	Skin	53	52EDD1DB-F1C3-4B87-B959-B5B095E52463	0884FDF3-7A20-43BC-BF57-E71F36E11AB9	TCGA-ER-A2NF-01A-11D-A19A-08	HG19_Broad_variant	TCGA-ER-A2NF	TCGA-SKCM	NA	s7989	Broad Institute of MIT and Harvard	University of Pittsburgh	None	NO	T4b	N3	Not available	Stage IIIC	A19A-08	TRUE
13722.58cfa82ee4b0c9d6adf6abeb	58cfa82ee4b0c9d6adf6abeb	G35154.TCGA-HT-7689-01A-11D-2253-08.2.filtered.	WGS	G35154.TCGA-HT-7689-01A-11D-2253-08.2	G35154.TCGA-HT-7689-01A-11D-2253-08.2.bam	66	NA	0.05	58cfa82ee4b0c9d6adf6abeb	G35154.TCGA-HT-7689-01A-11D-2253-08.2.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-HT-7689-01A	D58B535A-6C95-43BB-AD88-0600E6447537	Primary Tumor	Illumina HiSeq	55583ba3-88d1-4c7c-8bf7-bfe2699d74da	Brain	58	80122820-0D29-4F56-BF14-AC5EEB6F2760	B95CD446-0FED-4DA2-892F-24B39D073AB4	TCGA-HT-7689-01A-11D-2253-08	HG19_Broad_variant	TCGA-HT-7689	TCGA-LGG	NA	s8336	Broad Institute of MIT and Harvard	Case Western - St Joes	United States	NO	Not available	Not available	Oligodendroglioma	Not available	2253-08	FALSE
13722.58cfa82de4b0c9d6adf6a484	58cfa82de4b0c9d6adf6a484	2d65798c16f002af919022459ec3009d.filtered.	WGS	2d65798c16f002af919022459ec3009d	2d65798c16f002af919022459ec3009d.bam	20	NA	0.09	58cfa82de4b0c9d6adf6a484	2d65798c16f002af919022459ec3009d.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Sarcoma	Aligned reads	TCGA-DX-A1KU-01A	EA0E5AE7-1F15-4504-AEA3-EFD1F6733304	Primary Tumor	Illumina HiSeq	f73eec26-a9f4-4fb0-bbaa-ca6aa00f1a51	Mesenchymal	82	B09E1197-D6CD-4A76-8E2F-3B8AF97D2390	C556F81B-8A6C-4BBB-876F-2E2CE570C185	TCGA-DX-A1KU-01A-32D-A24N-09	GRCh37-lite	TCGA-DX-A1KU	TCGA-SARC	427	s2481	Washington University School of Medicine	Memorial Sloan Kettering	United States	NO	Not available	Not available	Not available	Not available	A24N-09	TRUE
13722.58cfa82ee4b0c9d6adf6ac86	58cfa82ee4b0c9d6adf6ac86	G41960.TCGA-75-7030-01A-11D-1945-08.2.filtered.	WGS	G41960.TCGA-75-7030-01A-11D-1945-08.2	G41960.TCGA-75-7030-01A-11D-1945-08.2.bam	124.7	NA	0.05	58cfa82ee4b0c9d6adf6ac86	G41960.TCGA-75-7030-01A-11D-1945-08.2.bam	Alive	MALE	Not available	Not available	Lung Adenocarcinoma	Aligned reads	TCGA-75-7030-01A	DF576520-A6B6-4C9B-8D06-3F59CC5342FD	Primary Tumor	Illumina HiSeq	804a0fba-a82e-4501-9b0b-87c34318562d	Lung	NA	56C937B3-B48F-4662-B992-3265DBB6BC7D	0CE6F3ED-BDBC-4B70-9DB4-2E48F4BF644D	TCGA-75-7030-01A-11D-1945-08	HG19_Broad_variant	TCGA-75-7030	TCGA-LUAD	NA	s10636	Broad Institute of MIT and Harvard	Ontario Institute for Cancer Research (OICR)	Canada	NO	T3	N0	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage IIB	1945-08	TRUE
13722.58cfa82ee4b0c9d6adf6acc0	58cfa82ee4b0c9d6adf6acc0	G41960.TCGA-55-6984-01A-11D-1945-08.2.filtered.	WGS	G41960.TCGA-55-6984-01A-11D-1945-08.2	G41960.TCGA-55-6984-01A-11D-1945-08.2.bam	138.7	NA	0.05	58cfa82ee4b0c9d6adf6acc0	G41960.TCGA-55-6984-01A-11D-1945-08.2.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-55-6984-01A	F063DDBB-1668-40DF-9EC2-B0A23CA2C389	Primary Tumor	Illumina HiSeq	244af712-e56d-4419-bc80-cdbfc0262b92	Lung	71	76C0ADAE-EEF5-459E-A4C9-397D94EBFDCC	309F5324-5608-4F62-B744-5AB268B70927	TCGA-55-6984-01A-11D-1945-08	HG19_Broad_variant	TCGA-55-6984	TCGA-LUAD	760	s11321	Broad Institute of MIT and Harvard	International Genomics Consortium	United States	NO	T2	N1	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage IIB	1945-08	TRUE
13722.58cfa82ee4b0c9d6adf6ad83	58cfa82ee4b0c9d6adf6ad83	G39020.TCGA-BR-7722-01A-31D-2201-08.2.filtered.	WGS	G39020.TCGA-BR-7722-01A-31D-2201-08.2	G39020.TCGA-BR-7722-01A-31D-2201-08.2.bam	454.7	NA	0.05	58cfa82ee4b0c9d6adf6ad83	G39020.TCGA-BR-7722-01A-31D-2201-08.2.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-BR-7722-01A	8D3E3D09-BC61-4D5E-B8D6-5AEE6CB488AE	Primary Tumor	Illumina HiSeq	2ca0a03f-9d9d-49da-98e7-b0ade46e5b18	Stomach	62	58038C32-1359-49EB-AAFE-2F44EC697F52	0FA9CFBA-0F49-47D0-AB54-9DD2144E0A73	TCGA-BR-7722-01A-31D-2201-08	HG19_Broad_variant	TCGA-BR-7722	TCGA-STAD	NA	s14806	Broad Institute of MIT and Harvard	Asterand	Ukraine	NO	T3	N1	Stomach  Adenocarcinoma  Not Otherwise Specified (NOS)	Stage IIB	2201-08	FALSE
13722.58cfa82ee4b0c9d6adf6af24	58cfa82ee4b0c9d6adf6af24	G39020.TCGA-F1-6177-01A-11D-1800-08.2.filtered.	WGS	G39020.TCGA-F1-6177-01A-11D-1800-08.2	G39020.TCGA-F1-6177-01A-11D-1800-08.2.bam	466.4	1.8	0.05	58cfa82ee4b0c9d6adf6af24	G39020.TCGA-F1-6177-01A-11D-1800-08.2.bam	Alive	MALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-F1-6177-01A	C3CBA26E-38C2-4569-AFD6-6B045E604808	Primary Tumor	Illumina HiSeq	347b5bd7-20b6-4635-ae86-d43256011296	Stomach	90	0538EFDE-935D-4571-A200-B181AB622447	1D0617E8-2725-4411-B50F-E46EA1D43242	TCGA-F1-6177-01A-11D-1800-08	HG19_Broad_variant	TCGA-F1-6177	TCGA-STAD	NA	s14962	Broad Institute of MIT and Harvard	UNC	United States	NO	T1b	N1	Stomach  Adenocarcinoma  Not Otherwise Specified (NOS)	Stage I	1800-08	TRUE
13722.58cfa82ee4b0c9d6adf6adf6	58cfa82ee4b0c9d6adf6adf6	G39020.TCGA-CG-4442-01A-01D-A290-08.2.filtered.	WGS	G39020.TCGA-CG-4442-01A-01D-A290-08.2	G39020.TCGA-CG-4442-01A-01D-A290-08.2.bam	165.2	1.9	0.07	58cfa82ee4b0c9d6adf6adf6	G39020.TCGA-CG-4442-01A-01D-A290-08.2.bam	Alive	MALE	Not available	Not available	Stomach Adenocarcinoma	Aligned reads	TCGA-CG-4442-01A	8FCCFF71-3710-4CB9-B8AF-61707AEBE5D8	Primary Tumor	Illumina HiSeq	05a46a94-fa5c-4e76-b887-07ec0fa0af0f	Stomach	85	51927F82-2585-465B-92ED-36EF46D44FAB	7E305F31-FBB0-4BCE-894B-1DD85E303421	TCGA-CG-4442-01A-01D-A290-08	HG19_Broad_variant	TCGA-CG-4442	TCGA-STAD	NA	s15042	Broad Institute of MIT and Harvard	Indivumed	Germany	NO	T2	N0	Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS)	Stage IB	A290-08	TRUE
13722.58cfa82fe4b0c9d6adf6b909	58cfa82fe4b0c9d6adf6b909	TCGA-A3-3387-01A-01D-2102-10_Illumina.filtered.	WGS	TCGA-A3-3387-01A-01D-2102-10_Illumina	TCGA-A3-3387-01A-01D-2102-10_Illumina.bam	180.4	1.9	0.14	58cfa82fe4b0c9d6adf6b909	TCGA-A3-3387-01A-01D-2102-10_Illumina.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-A3-3387-01A	9DC7812B-C7A2-4DE4-BF6D-4C7261384A62	Primary Tumor	Illumina HiSeq	1abe0bf3-83d3-40d9-8e12-5729d760aeed	Kidney	49	413ED4FA-013A-4751-8F74-D54F6CF992C9	00BF0350-8C7C-4B9E-8143-13EA2DC1122F	TCGA-A3-3387-01A-01D-2102-10	GRCh37-lite	TCGA-A3-3387	TCGA-KIRC	NA	s9302	Baylor College of Medicine	International Genomics Consortium	United States	NO	T1a	N0	Kidney Clear Cell Renal Carcinoma	Stage I	2102-10	FALSE
13722.58cfa82fe4b0c9d6adf6ba1c	58cfa82fe4b0c9d6adf6ba1c	TCGA-AA-3664-01A-01D-1981-10_wgs_Illumina.filtered.	WGS	TCGA-AA-3664-01A-01D-1981-10_wgs_Illumina	TCGA-AA-3664-01A-01D-1981-10_wgs_Illumina.bam	338.96	1.9	0.16	58cfa82fe4b0c9d6adf6ba1c	TCGA-AA-3664-01A-01D-1981-10_wgs_Illumina.bam	Alive	FEMALE	Not available	Not available	Colon Adenocarcinoma	Aligned reads	TCGA-AA-3664-01A	A06C09A8-0951-49F4-A765-5147BBCAE109	Primary Tumor	Illumina HiSeq	c35bd7d9-ece5-492b-9d5f-dcc047684dc0	Colorectal	74	D448668C-90F3-40FA-9961-88407090DA31	B6B6E1D3-C592-4836-BDAD-D53AF2DBCC9A	TCGA-AA-3664-01A-01D-1981-10	GRCh37-lite	TCGA-AA-3664	TCGA-COAD	NA	s13365	Baylor College of Medicine	Indivumed	Germany	NO	T3	N0	Colon Adenocarcinoma	Stage II	1981-10	FALSE
13722.58cfa830e4b0c9d6adf6ba78	58cfa830e4b0c9d6adf6ba78	TCGA-AA-A03F-01A-11D-A17O-10_wgs_Illumina.filtered.	WGS	TCGA-AA-A03F-01A-11D-A17O-10_wgs_Illumina	TCGA-AA-A03F-01A-11D-A17O-10_wgs_Illumina.bam	124.44	1.85	0.09	58cfa830e4b0c9d6adf6ba78	TCGA-AA-A03F-01A-11D-A17O-10_wgs_Illumina.bam	Dead	FEMALE	Not available	Not available	Colon Adenocarcinoma	Aligned reads	TCGA-AA-A03F-01A	2A971E32-B0E7-4A3F-8C40-62D69C0307D8	Primary Tumor	Illumina HiSeq	d227eb87-8290-4223-b1d2-c241162935c9	Colorectal	90	8ABA8350-B5EE-4CA2-BC99-5C7922A886C4	18DD42D7-2D84-400E-9ADB-A38FAA916A9E	TCGA-AA-A03F-01A-11D-A17O-10	GRCh37-lite	TCGA-AA-A03F	TCGA-COAD	549	s12884	Baylor College of Medicine	Indivumed	Germany	NO	T3	N2	Colon Mucinous Adenocarcinoma	Stage III	A17O-10	TRUE
13722.58cfa830e4b0c9d6adf6bb68	58cfa830e4b0c9d6adf6bb68	TCGA-AA-A02Y-01A-43D-A17O-10_wgs_Illumina.filtered.	WGS	TCGA-AA-A02Y-01A-43D-A17O-10_wgs_Illumina	TCGA-AA-A02Y-01A-43D-A17O-10_wgs_Illumina.bam	84.8	1.91	0.08	58cfa830e4b0c9d6adf6bb68	TCGA-AA-A02Y-01A-43D-A17O-10_wgs_Illumina.bam	Alive	MALE	Not available	Not available	Colon Adenocarcinoma	Aligned reads	TCGA-AA-A02Y-01A	A435FDF4-A89A-499E-9006-CBB5693EAB26	Primary Tumor	Illumina HiSeq	258e501e-d510-4eda-b9fb-9d4bf0226c16	Colorectal	73	8537633B-6426-4B66-A2A3-FA942EEDF01B	B2AFBCBA-D67D-43F1-BE3B-05F3A5836EC0	TCGA-AA-A02Y-01A-43D-A17O-10	GRCh37-lite	TCGA-AA-A02Y	TCGA-COAD	NA	s13685	Baylor College of Medicine	Indivumed	Germany	NO	T2	N0	Colon Adenocarcinoma	Stage I	A17O-10	TRUE
13722.58cfa830e4b0c9d6adf6bc31	58cfa830e4b0c9d6adf6bc31	TCGA-AA-3994-01A-01D-1981-10_wgs_Illumina.filtered.	WGS	TCGA-AA-3994-01A-01D-1981-10_wgs_Illumina	TCGA-AA-3994-01A-01D-1981-10_wgs_Illumina.bam	631.89	1.9	0.16	58cfa830e4b0c9d6adf6bc31	TCGA-AA-3994-01A-01D-1981-10_wgs_Illumina.bam	Alive	MALE	Not available	Not available	Colon Adenocarcinoma	Aligned reads	TCGA-AA-3994-01A	750770DB-53CF-4021-A8C2-5E0DDB97FEF5	Primary Tumor	Illumina HiSeq	6cc193d6-40f0-46ba-aa41-4240fe42a46c	Colorectal	69	41933A62-1325-4089-80B5-06E3EBB238DA	D9690A27-BB02-498E-B15C-EE76E31D16EE	TCGA-AA-3994-01A-01D-1981-10	GRCh37-lite	TCGA-AA-3994	TCGA-COAD	NA	s12867	Baylor College of Medicine	Indivumed	Germany	NO	T3	N1	Colon Mucinous Adenocarcinoma	Stage IIIB	1981-10	FALSE
13722.58cfa830e4b0c9d6adf6bcc0	58cfa830e4b0c9d6adf6bcc0	TCGA-B0-5094-01A-01D-2099-10_wgs_Illumina.filtered.	WGS	TCGA-B0-5094-01A-01D-2099-10_wgs_Illumina	TCGA-B0-5094-01A-01D-2099-10_wgs_Illumina.bam	167.4	1.9	0.15	58cfa830e4b0c9d6adf6bcc0	TCGA-B0-5094-01A-01D-2099-10_wgs_Illumina.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-B0-5094-01A	8AAA4E25-5C12-4ACE-96DC-91AAA0C4457C	Primary Tumor	Illumina HiSeq	22151e7f-a939-414f-9658-14262a84253f	Kidney	62	B05A7F4B-BC56-4DA6-B810-79E7C3A5395E	D429C27A-5963-42FE-B3A0-7252C20669D8	TCGA-B0-5094-01A-01D-2099-10	GRCh37-lite	TCGA-B0-5094	TCGA-KIRC	333	s9445	Baylor College of Medicine	University of Pittsburgh	None	NO	T3b	N0	Kidney Clear Cell Renal Carcinoma	Stage IV	2099-10	FALSE
13722.58cfa830e4b0c9d6adf6bc3e	58cfa830e4b0c9d6adf6bc3e	TCGA-AG-3582-01A-01D-1989-10_wgs_Illumina.filtered.	WGS	TCGA-AG-3582-01A-01D-1989-10_wgs_Illumina	TCGA-AG-3582-01A-01D-1989-10_wgs_Illumina.bam	747.21	1.9	0.15	58cfa830e4b0c9d6adf6bc3e	TCGA-AG-3582-01A-01D-1989-10_wgs_Illumina.bam	Alive	MALE	Not available	Not available	Rectum Adenocarcinoma	Aligned reads	TCGA-AG-3582-01A	DB1E3104-8BFD-4353-854A-C478BA1F7D07	Primary Tumor	Illumina HiSeq	f968a6d9-8eb8-436a-92a3-b7080bdf5a3e	Colorectal	75	1B1EF856-EA45-4857-8B4B-C4330FA930D8	D452293A-6148-4FCF-9FBC-446815016751	TCGA-AG-3582-01A-01D-1989-10	GRCh37-lite	TCGA-AG-3582	TCGA-READ	NA	s2135	Baylor College of Medicine	Indivumed	Germany	NO	T3	N1	Rectal Adenocarcinoma	Stage IV	1989-10	TRUE
13722.58cfa830e4b0c9d6adf6bdad	58cfa830e4b0c9d6adf6bdad	TCGA-AG-3574-01A-01D-1989-10_wgs_Illumina.filtered.	WGS	TCGA-AG-3574-01A-01D-1989-10_wgs_Illumina	TCGA-AG-3574-01A-01D-1989-10_wgs_Illumina.bam	750.21	1.9	0.14	58cfa830e4b0c9d6adf6bdad	TCGA-AG-3574-01A-01D-1989-10_wgs_Illumina.bam	Alive	FEMALE	Not available	Not available	Rectum Adenocarcinoma	Aligned reads	TCGA-AG-3574-01A	0EDA7373-8335-455F-B90A-8C3540F28088	Primary Tumor	Illumina HiSeq	b41b6882-7cf8-49c6-aa56-8418d77c24cb	Colorectal	89	DA897A5D-B2CC-419F-ACD7-473B4928C5D5	ECF4E05A-0912-4B93-AD66-323002F0C845	TCGA-AG-3574-01A-01D-1989-10	GRCh37-lite	TCGA-AG-3574	TCGA-READ	NA	s2309	Baylor College of Medicine	Indivumed	Germany	NO	T3	N0	Rectal Adenocarcinoma	Stage II	1989-10	TRUE
13722.58cfa830e4b0c9d6adf6bfea	58cfa830e4b0c9d6adf6bfea	TCGA-AG-3885-01A-01D-0967-10_wgs_Illumina.filtered.	WGS	TCGA-AG-3885-01A-01D-0967-10_wgs_Illumina	TCGA-AG-3885-01A-01D-0967-10_wgs_Illumina.bam	688.31	1.9	0.15	58cfa830e4b0c9d6adf6bfea	TCGA-AG-3885-01A-01D-0967-10_wgs_Illumina.bam	Alive	FEMALE	Not available	Not available	Rectum Adenocarcinoma	Aligned reads	TCGA-AG-3885-01A	E5E4AA9F-6015-4D62-A088-69920D7F2500	Primary Tumor	Illumina HiSeq	f75ec564-baa7-4aeb-8c4e-21e77d60669d	Colorectal	71	7764DB67-5D9E-4421-86C6-7151ACA688D1	BB6150F7-23E4-40F2-B466-6B6EDD19C502	TCGA-AG-3885-01A-01D-0967-10	GRCh37-lite	TCGA-AG-3885	TCGA-READ	NA	s1964	Baylor College of Medicine	Indivumed	Germany	NO	T3	N1	Rectal Adenocarcinoma	Stage IIIB	0967-10	FALSE
13722.58cfa830e4b0c9d6adf6bf02	58cfa830e4b0c9d6adf6bf02	TCGA-BP-4968-01A-01D-2100-10_wgs_Illumina.filtered.	WGS	TCGA-BP-4968-01A-01D-2100-10_wgs_Illumina	TCGA-BP-4968-01A-01D-2100-10_wgs_Illumina.bam	68.77	1.9	0.14	58cfa830e4b0c9d6adf6bf02	TCGA-BP-4968-01A-01D-2100-10_wgs_Illumina.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-BP-4968-01A	1E417B93-837D-4110-9090-239EB82C3E20	Primary Tumor	Illumina HiSeq	e2ce6973-54d1-4e7b-88f1-cb684419ff11	Kidney	40	8CD2BBCD-3CE9-4B57-99DA-895B82300AF8	AAD8C8D6-D828-4AAC-9CFB-CEE893E36850	TCGA-BP-4968-01A-01D-2100-10	GRCh37-lite	TCGA-BP-4968	TCGA-KIRC	NA	s9162	Baylor College of Medicine	MSKCC	None	NO	T1b	N0	Kidney Clear Cell Renal Carcinoma	Stage I	2100-10	FALSE
13722.58cfa830e4b0c9d6adf6bef0	58cfa830e4b0c9d6adf6bef0	TCGA-BP-4327-01A-01D-1995-10_Illumina.filtered.	WGS	TCGA-BP-4327-01A-01D-1995-10_Illumina	TCGA-BP-4327-01A-01D-1995-10_Illumina.bam	119	1.9	0.14	58cfa830e4b0c9d6adf6bef0	TCGA-BP-4327-01A-01D-1995-10_Illumina.bam	Dead	FEMALE	WHITE	Not available	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-BP-4327-01A	9B84D013-713B-4571-888C-12863FDD4A52	Primary Tumor	Illumina HiSeq	02674510-9972-4120-8940-18449f4623e8	Kidney	75	45CC1D31-9B81-4268-B83A-5D4C740BD2B6	85448D11-9F84-44B7-8AE3-A115F24BDB76	TCGA-BP-4327-01A-01D-1995-10	GRCh37-lite	TCGA-BP-4327	TCGA-KIRC	109	s9565	Baylor College of Medicine	MSKCC	None	NO	T2	N0	Kidney Clear Cell Renal Carcinoma	Stage II	1995-10	FALSE
13722.58cfa831e4b0c9d6adf6c414	58cfa831e4b0c9d6adf6c414	TCGA-CJ-4639-01A-01D-2095-10_Illumina.filtered.	WGS	TCGA-CJ-4639-01A-01D-2095-10_Illumina	TCGA-CJ-4639-01A-01D-2095-10_Illumina.bam	90.64	1.9	0.15	58cfa831e4b0c9d6adf6c414	TCGA-CJ-4639-01A-01D-2095-10_Illumina.bam	Alive	FEMALE	WHITE	HISPANIC OR LATINO	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-CJ-4639-01A	3E976301-4042-4AC0-8F01-EF2F1A8161A6	Primary Tumor	Illumina HiSeq	d3739e9e-1149-4ec1-bb8d-f3b495ed1b4d	Kidney	49	11B1DCA7-6FCE-41C0-9580-A28CCF83E55C	063CFACF-9933-4A2D-8921-0AEB76E12779	TCGA-CJ-4639-01A-01D-2095-10	GRCh37-lite	TCGA-CJ-4639	TCGA-KIRC	NA	s9168	Baylor College of Medicine	MD Anderson Cancer Center	None	NO	T2	N0	Kidney Clear Cell Renal Carcinoma	Stage II	2095-10	FALSE
13722.58cfa831e4b0c9d6adf6c442	58cfa831e4b0c9d6adf6c442	TCGA-CJ-4885-01A-01D-2098-10_Illumina.filtered.	WGS	TCGA-CJ-4885-01A-01D-2098-10_Illumina	TCGA-CJ-4885-01A-01D-2098-10_Illumina.bam	75.7	1.9	0.15	58cfa831e4b0c9d6adf6c442	TCGA-CJ-4885-01A-01D-2098-10_Illumina.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-CJ-4885-01A	5338D435-68FB-4F0D-A3E6-C843F703F75F	Primary Tumor	Illumina HiSeq	e9c31511-6628-44c2-a7cf-b25609056ad9	Kidney	64	A30B3254-3963-48D1-9710-7C3CAC0B1993	72C0603B-AD49-4E53-8164-2B69614BB743	TCGA-CJ-4885-01A-01D-2098-10	GRCh37-lite	TCGA-CJ-4885	TCGA-KIRC	NA	s9171	Baylor College of Medicine	MD Anderson Cancer Center	None	NO	T3a	NX	Kidney Clear Cell Renal Carcinoma	Stage IV	2098-10	TRUE
13722.58cfa830e4b0c9d6adf6c2d1	58cfa830e4b0c9d6adf6c2d1	TCGA-B2-4099-01A-02D-2095-10_wgs_Illumina.filtered.	WGS	TCGA-B2-4099-01A-02D-2095-10_wgs_Illumina	TCGA-B2-4099-01A-02D-2095-10_wgs_Illumina.bam	660.34	1.9	0.16	58cfa830e4b0c9d6adf6c2d1	TCGA-B2-4099-01A-02D-2095-10_wgs_Illumina.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-B2-4099-01A	1ADB05D4-E1CA-4EDE-81C7-FF24A243ABAE	Primary Tumor	Illumina HiSeq	5a0ccacd-ed1b-47b2-818a-592a0cf426ad	Kidney	83	E242ADB8-DB67-475E-A0E4-52A622666B12	252A1C43-F954-44D7-8E31-6BCD0157A05C	TCGA-B2-4099-01A-02D-2095-10	GRCh37-lite	TCGA-B2-4099	TCGA-KIRC	NA	s9732	Baylor College of Medicine	Christiana Healthcare	None	NO	T1a	NX	Kidney Clear Cell Renal Carcinoma	Stage I	2095-10	FALSE
13722.58cfa83ce4b0c9d6adf72e9c	58cfa83ce4b0c9d6adf72e9c	c7d4da3dbfd3dbc673a6cbab28c5999b.filtered.	WGS	c7d4da3dbfd3dbc673a6cbab28c5999b	c7d4da3dbfd3dbc673a6cbab28c5999b.bam	83.75	1.81	0.08	58cfa83ce4b0c9d6adf72e9c	c7d4da3dbfd3dbc673a6cbab28c5999b.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	Not available	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-B5-A11I-01A	F6D136C7-C250-4361-9FED-50F513959A40	Primary Tumor	Illumina HiSeq	290cd155-e6e8-450c-89ce-7688b88465e9	Uterus	65	56652DDE-33DA-451E-A1C2-6E9884F9915A	31BC44B9-35FF-43FD-8A01-A834F3B1CE46	TCGA-B5-A11I-01A-11D-A10M-09	GRCh37-lite	TCGA-B5-A11I	TCGA-UCEC	NA	s4972	Washington University School of Medicine	Duke	United States	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A10M-09	FALSE
13722.58cfa831e4b0c9d6adf6c862	58cfa831e4b0c9d6adf6c862	TCGA-CW-6093-01A-11D-2279-10_wgs_Illumina.filtered.	WGS	TCGA-CW-6093-01A-11D-2279-10_wgs_Illumina	TCGA-CW-6093-01A-11D-2279-10_wgs_Illumina.bam	112.4	1.9	0.05	58cfa831e4b0c9d6adf6c862	TCGA-CW-6093-01A-11D-2279-10_wgs_Illumina.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-CW-6093-01A	3F93D1CF-A307-4E29-9E6F-239E9FFAA179	Primary Tumor	Illumina HiSeq	1e7df335-e096-49e1-8490-8be7151ec2db	Kidney	73	13BA18EB-C94B-4F6C-AB50-2A98A8044CED	51206157-94CC-4702-8247-C98283B487AA	TCGA-CW-6093-01A-11D-2279-10	GRCh37-lite	TCGA-CW-6093	TCGA-KIRC	NA	s9571	Baylor College of Medicine	Mayo Clinic - Rochester	United States	NO	T1a	NX	Kidney Clear Cell Renal Carcinoma	Stage I	2279-10	FALSE
13722.58cfa83ce4b0c9d6adf72ea2	58cfa83ce4b0c9d6adf72ea2	c365daeccf937ff8ec5b164169f4beb6.filtered.	WGS	c365daeccf937ff8ec5b164169f4beb6	c365daeccf937ff8ec5b164169f4beb6.bam	32.61	NA	0.08	58cfa83ce4b0c9d6adf72ea2	c365daeccf937ff8ec5b164169f4beb6.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-A2-A3XX-01A	53886143-C1C6-40E9-88E6-E4E5E0271FC8	Primary Tumor	Illumina HiSeq	c11a6c92-3f76-42d3-aa9d-e1e4c34f7cf5	Breast	49	0A1F4A81-38C6-407A-A33B-716A0F9A6B4D	C67409B2-AC25-42A0-8543-4636EF132FE4	TCGA-A2-A3XX-01A-21D-A23C-09	GRCh37-lite	TCGA-A2-A3XX	TCGA-BRCA	NA	s5622	Washington University School of Medicine	Walter Reed	United States	NO	T2	N0	Infiltrating Ductal Carcinoma	Stage IIA	A23C-09	FALSE
13722.58cfa83ce4b0c9d6adf72edf	58cfa83ce4b0c9d6adf72edf	e4a6e1d5b4230f26d94ced982fad1af3.filtered.	WGS	e4a6e1d5b4230f26d94ced982fad1af3	e4a6e1d5b4230f26d94ced982fad1af3.bam	94.6	1.95	0.08	58cfa83ce4b0c9d6adf72edf	e4a6e1d5b4230f26d94ced982fad1af3.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-E2-A109-01A	F0787165-6F58-4D67-B510-928EEA2C4882	Primary Tumor	Illumina HiSeq	33884ffd-f43a-4cb9-beb0-9c0a7d6f3f31	Breast	64	710EAE35-A21D-4939-8414-D2AF4EA02FDD	3585E133-B3C1-4D90-B5F2-2B867E0AE0EC	TCGA-E2-A109-01A-11D-A10M-09	GRCh37-lite	TCGA-E2-A109	TCGA-BRCA	NA	s5623	Washington University School of Medicine	Roswell Park	None	NO	T2	N0 (i-)	Infiltrating Ductal Carcinoma	Stage IIA	A10M-09	FALSE
13722.58cfa83ce4b0c9d6adf72eac	58cfa83ce4b0c9d6adf72eac	cfb494ec82ff531a0bc7eacc26f33717.filtered.	WGS	cfb494ec82ff531a0bc7eacc26f33717	cfb494ec82ff531a0bc7eacc26f33717.bam	83.96	1.98	0.08	58cfa83ce4b0c9d6adf72eac	cfb494ec82ff531a0bc7eacc26f33717.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-A5-A0GA-01A	71FED998-8FAC-4E6B-B38A-22C83E05E958	Primary Tumor	Illumina HiSeq	b68fc7e3-5a98-423d-8f72-b4b5f50435a5	Uterus	67	5A40330F-9307-4584-9557-5D19F2357FCC	577D5C9E-FBDA-41D5-B0B3-CDB733453EA5	TCGA-A5-A0GA-01A-11D-A066-09	GRCh37-lite	TCGA-A5-A0GA	TCGA-UCEC	543	s4763	Washington University School of Medicine	Cedars Sinai	None	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A066-09	TRUE
13722.58cfa83ce4b0c9d6adf72f03	58cfa83ce4b0c9d6adf72f03	b66e82ee0591fe581241dcc082de2e52.filtered.	WGS	b66e82ee0591fe581241dcc082de2e52	b66e82ee0591fe581241dcc082de2e52.bam	56.36	1.95	0.07	58cfa83ce4b0c9d6adf72f03	b66e82ee0591fe581241dcc082de2e52.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-D1-A17K-01A	5C22C8D6-5805-455C-8E1C-E6B8006738E4	Primary Tumor	Illumina HiSeq	03c25260-4914-4b4e-817e-05d0ba7e3ded	Uterus	74	CA213835-EFC5-4216-A762-A6B320B516BF	105A51C4-CC7E-4D0F-9CF8-E4D64A31D14D	TCGA-D1-A17K-01A-11D-A325-09	GRCh37-lite	TCGA-D1-A17K	TCGA-UCEC	NA	s5370	Washington University School of Medicine	Mayo Clinic	None	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A325-09	TRUE
13722.58cfa83ce4b0c9d6adf72ef8	58cfa83ce4b0c9d6adf72ef8	d9a4fed4943a3f61117cf771e1db8985.filtered.	WGS	d9a4fed4943a3f61117cf771e1db8985	d9a4fed4943a3f61117cf771e1db8985.bam	57.99	NA	0.08	58cfa83ce4b0c9d6adf72ef8	d9a4fed4943a3f61117cf771e1db8985.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	Not available	Breast Invasive Carcinoma	Aligned reads	TCGA-AC-A2BK-01A	6FA2A667-9C36-4526-8A58-1975E863A806	Primary Tumor	Illumina HiSeq	53c5c882-8386-48e7-b7dd-8815bcf6b316	Breast	78	B85BE663-EDBA-4E1E-A10C-D0297744A0E9	8E03E773-5557-4E78-889B-4710C515378F	TCGA-AC-A2BK-01A-11D-A314-09	GRCh37-lite	TCGA-AC-A2BK	TCGA-BRCA	NA	s6750	Washington University School of Medicine	International Genomics Consortium	United States	NO	T2	N2a	Infiltrating Ductal Carcinoma	Stage IIIA	A314-09	TRUE
13722.58cfa83ce4b0c9d6adf72f7d	58cfa83ce4b0c9d6adf72f7d	e82f5efc1a18908b7a00b45b9bfd5e18.filtered.	WGS	e82f5efc1a18908b7a00b45b9bfd5e18	e82f5efc1a18908b7a00b45b9bfd5e18.bam	48.87	1.91	0.08	58cfa83ce4b0c9d6adf72f7d	e82f5efc1a18908b7a00b45b9bfd5e18.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-AR-A1AY-01A	5FD9552A-C742-4388-940D-295D1107AE00	Primary Tumor	Illumina HiSeq	45a65b22-252b-4f92-bd7b-16a76d26c165	Breast	65	81FC993E-8F5A-4B3B-BEA3-4C4C2F5E4EF2	15F90EF0-831B-40A3-98BD-EC226A9E8B26	TCGA-AR-A1AY-01A-21D-A12Q-09	GRCh37-lite	TCGA-AR-A1AY	TCGA-BRCA	NA	s6905	Washington University School of Medicine	Mayo	None	NO	T1	N0	Infiltrating Ductal Carcinoma	Stage I	A12Q-09	FALSE
13722.58cfa83ce4b0c9d6adf72f43	58cfa83ce4b0c9d6adf72f43	cee8053647191b1b4b10e3f58a90b606.filtered.	WGS	cee8053647191b1b4b10e3f58a90b606	cee8053647191b1b4b10e3f58a90b606.bam	83.38	1.91	0.08	58cfa83ce4b0c9d6adf72f43	cee8053647191b1b4b10e3f58a90b606.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-E2-A1LG-01A	EF4CBD38-BC79-4D60-A715-647EDD2EBE9E	Primary Tumor	Illumina HiSeq	c24e6791-401c-4b37-bfe6-669f050ea42e	Breast	50	B462982A-4DD0-425E-BCE3-0EB8F5527264	7CDBE0E8-F614-4F54-B864-FD6B39E8EF1C	TCGA-E2-A1LG-01A-21D-A14K-09	GRCh37-lite	TCGA-E2-A1LG	TCGA-BRCA	NA	s5781	Washington University School of Medicine	Roswell Park	United States	NO	T2	N0	Infiltrating Lobular Carcinoma	Stage IIA	A14K-09	FALSE
13722.58cfa83ce4b0c9d6adf72f19	58cfa83ce4b0c9d6adf72f19	ccd535b1664251ecbc0fb70ec7dee554.filtered.	WGS	ccd535b1664251ecbc0fb70ec7dee554	ccd535b1664251ecbc0fb70ec7dee554.bam	17.51	1.95	0.07	58cfa83ce4b0c9d6adf72f19	ccd535b1664251ecbc0fb70ec7dee554.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-AO-A03N-01B	9435447E-D65F-408B-863B-6576B1D652DD	Primary Tumor	Illumina HiSeq	a198d001-d09b-4a43-9704-060db667151f	Breast	59	06B3E3CA-24B9-4E19-9E59-B51CC6D6735B	F8F749B7-547D-49FA-9DA2-44EED962B6FD	TCGA-AO-A03N-01B-11D-A19H-09	GRCh37-lite	TCGA-AO-A03N	TCGA-BRCA	NA	s6749	Washington University School of Medicine	MSKCC	None	NO	T2	N1a	Infiltrating Ductal Carcinoma	Stage IIB	A19H-09	TRUE
13722.58cfa83ce4b0c9d6adf72fae	58cfa83ce4b0c9d6adf72fae	a67ab1214f8c6bab30f876560e45768a.filtered.	WGS	a67ab1214f8c6bab30f876560e45768a	a67ab1214f8c6bab30f876560e45768a.bam	61.5	NA	0.08	58cfa83ce4b0c9d6adf72fae	a67ab1214f8c6bab30f876560e45768a.bam	Alive	FEMALE	WHITE	Not available	Sarcoma	Aligned reads	TCGA-IS-A3K7-01A	5A64F7E9-3833-4A3C-962B-13EB3E305C69	Primary Tumor	Illumina HiSeq	244fb4fa-4623-4468-acf2-601bb7f70990	Mesenchymal	63	7254C2AC-D8AC-4D6E-B444-4CB5F8A6EB36	AFEE5B10-3DFF-4E50-9575-BC9FE20C5DEA	TCGA-IS-A3K7-01A-11D-A21Q-09	GRCh37-lite	TCGA-IS-A3K7	TCGA-SARC	NA	s2458	Washington University School of Medicine	Memorial Sloan Kettering	United States	NO	Not available	Not available	Not available	Not available	A21Q-09	TRUE
13722.58cfa83ce4b0c9d6adf72fc8	58cfa83ce4b0c9d6adf72fc8	b939c2720803667f3b27acd9d4596892.filtered.	WGS	b939c2720803667f3b27acd9d4596892	b939c2720803667f3b27acd9d4596892.bam	36.4	NA	0.07	58cfa83ce4b0c9d6adf72fc8	b939c2720803667f3b27acd9d4596892.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Sarcoma	Aligned reads	TCGA-FX-A48G-01A	12BFD446-2EE5-4664-A492-C023D134F60F	Primary Tumor	Illumina HiSeq	1e67ee27-4af7-4e44-81ba-76ff196f16fb	Mesenchymal	56	CEEBA881-5A1D-4FDC-8C9D-D60B3FACECF2	CB5E1546-CDA6-4991-911C-F3DD9F1A475A	TCGA-FX-A48G-01A-11D-A24N-09	GRCh37-lite	TCGA-FX-A48G	TCGA-SARC	NA	s2464	Washington University School of Medicine	International Genomics Consortium	United States	NO	Not available	Not available	Not available	Not available	A24N-09	TRUE
13722.58cfa83ce4b0c9d6adf72fec	58cfa83ce4b0c9d6adf72fec	f45b766a6494688451a4e74a68b954b5.filtered.	WGS	f45b766a6494688451a4e74a68b954b5	f45b766a6494688451a4e74a68b954b5.bam	31.78	NA	0.08	58cfa83ce4b0c9d6adf72fec	f45b766a6494688451a4e74a68b954b5.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Sarcoma	Aligned reads	TCGA-HB-A43Z-01A	9C9B53E5-CDBE-4510-A839-4A3B5039681B	Primary Tumor	Illumina HiSeq	209a73b4-3820-4d16-9437-d67356ab9735	Mesenchymal	58	A6BBEE06-44BF-446A-8D21-550AA6E71960	16D33E09-2E21-4DA2-8E57-E78CE28C4408	TCGA-HB-A43Z-01A-11D-A24N-09	GRCh37-lite	TCGA-HB-A43Z	TCGA-SARC	NA	s2637	Washington University School of Medicine	University of North Carolina	United States	NO	Not available	Not available	Not available	Not available	A24N-09	TRUE
13722.58cfa83ce4b0c9d6adf72f9e	58cfa83ce4b0c9d6adf72f9e	a10df74fe68e2f8902de76b1691f26cd.filtered.	WGS	a10df74fe68e2f8902de76b1691f26cd	a10df74fe68e2f8902de76b1691f26cd.bam	69.7	2	0.07	58cfa83ce4b0c9d6adf72f9e	a10df74fe68e2f8902de76b1691f26cd.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-BK-A0CC-01A	2B865F8C-539F-4CB2-8F08-41709E9511E5	Primary Tumor	Illumina HiSeq	83ddf098-024c-49f8-80ef-b79b0b8182d5	Uterus	69	ED22CB10-EBDE-4019-9B6D-E19AB573CA94	E7D74D34-3255-4C20-90FD-B105E6E229C8	TCGA-BK-A0CC-01A-21D-A013-09	GRCh37-lite	TCGA-BK-A0CC	TCGA-UCEC	NA	s5180	Washington University School of Medicine	Christiana Healthcare	None	NO	Not available	Not available	Serous endometrial adenocarcinoma	Not available	A013-09	TRUE
13722.58cfa83ce4b0c9d6adf72f72	58cfa83ce4b0c9d6adf72f72	ea57989a2a3017624491e77218b0f326.filtered.	WGS	ea57989a2a3017624491e77218b0f326	ea57989a2a3017624491e77218b0f326.bam	44.27	1.98	0.08	58cfa83ce4b0c9d6adf72f72	ea57989a2a3017624491e77218b0f326.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-E2-A15E-01A	0A2A3529-F645-4967-9A58-89EE20B8BB62	Primary Tumor	Illumina HiSeq	3b80e735-e034-4867-be5e-52500f523ab5	Breast	40	9992EEB9-901B-4A32-BADC-E9BE7C9BA4BA	92B515EB-4036-4DAD-9CCA-DFB59C2EF26E	TCGA-E2-A15E-01A-11D-A19H-09	GRCh37-lite	TCGA-E2-A15E	TCGA-BRCA	NA	s6753	Washington University School of Medicine	Roswell Park	None	NO	T1c	N1a	Infiltrating Ductal Carcinoma	Stage IIA	A19H-09	TRUE
13722.58cfa83ce4b0c9d6adf7307f	58cfa83ce4b0c9d6adf7307f	b58386e952752d807a06a013a922b7ae.filtered.	WGS	b58386e952752d807a06a013a922b7ae	b58386e952752d807a06a013a922b7ae.bam	17.96	1.86	0.07	58cfa83ce4b0c9d6adf7307f	b58386e952752d807a06a013a922b7ae.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-A7-A13D-01A	8785012F-F73E-4D68-87CF-1D804AF32782	Primary Tumor	Illumina HiSeq	3c8a206a-59d4-412a-97c1-9dd31cb9b7c0	Breast	46	79FC9ED3-4E96-4C0E-869E-1756CBDABB39	418E916B-7A4E-4FAB-8616-15DCEC4D79F8	TCGA-A7-A13D-01A-13D-A12Q-09	GRCh37-lite	TCGA-A7-A13D	TCGA-BRCA	NA	s6443	Washington University School of Medicine	Christiana Healthcare	None	NO	T2	N0 (i-)	Infiltrating Ductal Carcinoma	Stage IIA	A12Q-09	FALSE
13722.58cfa83ce4b0c9d6adf730ca	58cfa83ce4b0c9d6adf730ca	fe1ba68c47fad6337f26bbdac35cbb2b.filtered.	WGS	fe1ba68c47fad6337f26bbdac35cbb2b	fe1ba68c47fad6337f26bbdac35cbb2b.bam	43.03	NA	0.08	58cfa83ce4b0c9d6adf730ca	fe1ba68c47fad6337f26bbdac35cbb2b.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-EK-A2RL-01A	61EB08D0-EA01-45E7-884B-AC3D6070172A	Primary Tumor	Illumina HiSeq	5848efed-18c8-413b-8a2c-9a63deec56ee	Cervix	32	DD3E80D9-0321-40AD-B963-25E2C94C6092	842DF341-D34F-4ED6-928C-EAF15BF7F667	TCGA-EK-A2RL-01A-11D-A34H-09	GRCh37-lite	TCGA-EK-A2RL	TCGA-CESC	NA	s1507	Washington University School of Medicine	Gynecologic Oncology Group	United States	NO	T1b1	N1	Endocervical Type of Adenocarcinoma	Not available	A34H-09	TRUE
13722.58cfa83ce4b0c9d6adf730cb	58cfa83ce4b0c9d6adf730cb	fa894126e254827396a4f68e2b369bc2.filtered.	WGS	fa894126e254827396a4f68e2b369bc2	fa894126e254827396a4f68e2b369bc2.bam	34.01	1.86	0.08	58cfa83ce4b0c9d6adf730cb	fa894126e254827396a4f68e2b369bc2.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-BH-A0DG-01A	0BC5744C-5FA3-45BB-87D0-70A02068B392	Primary Tumor	Illumina HiSeq	d1c980ac-6070-4a3b-8ff8-208b0f7897cf	Breast	30	3F104CF7-8DE8-4E77-8BAA-BAD1BBB493AC	EC4D4CBC-D5D1-418D-A292-CAD9576624FD	TCGA-BH-A0DG-01A-21D-A12Q-09	GRCh37-lite	TCGA-BH-A0DG	TCGA-BRCA	NA	s6908	Washington University School of Medicine	University of Pittsburgh	None	NO	T2	N0	Infiltrating Ductal Carcinoma	Stage IIA	A12Q-09	FALSE
13722.58cfa83ce4b0c9d6adf7309a	58cfa83ce4b0c9d6adf7309a	be7bcf9d37d9e65a46acadb6e8e3450e.filtered.	WGS	be7bcf9d37d9e65a46acadb6e8e3450e	be7bcf9d37d9e65a46acadb6e8e3450e.bam	58.65	1.91	0.08	58cfa83ce4b0c9d6adf7309a	be7bcf9d37d9e65a46acadb6e8e3450e.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-BH-A0BW-01A	5D1D00C6-FCAE-479E-AE1E-DE76EFD41D98	Primary Tumor	Illumina HiSeq	d87bcaa2-19f0-4c3b-8f85-8f47ed056ffc	Breast	71	DBEEDDC1-D149-46F7-91FF-D057F8C6BFFB	07B5141F-AC79-439B-883B-B0183BBE7FF5	TCGA-BH-A0BW-01A-11D-A10Y-09	GRCh37-lite	TCGA-BH-A0BW	TCGA-BRCA	NA	s6253	Washington University School of Medicine	University of Pittsburgh	None	NO	T1c	N0	Infiltrating Ductal Carcinoma	Stage I	A10Y-09	FALSE
13722.58cfa83ce4b0c9d6adf73128	58cfa83ce4b0c9d6adf73128	c71bbdff2d8e43b1dd7f270bf112e2c4.filtered.	WGS	c71bbdff2d8e43b1dd7f270bf112e2c4	c71bbdff2d8e43b1dd7f270bf112e2c4.bam	87.89	1.88	0.08	58cfa83ce4b0c9d6adf73128	c71bbdff2d8e43b1dd7f270bf112e2c4.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-AX-A0J1-01A	EC7A9D74-8B3F-4747-8926-1739A016AB2B	Primary Tumor	Illumina HiSeq	4d43e1fb-f822-45ec-b3db-8b91f598ced3	Uterus	80	AC14E378-2DE1-458A-B8CD-7C60131AA927	950486AD-14F8-480A-B079-9CC3CD842090	TCGA-AX-A0J1-01A-11D-A066-09	GRCh37-lite	TCGA-AX-A0J1	TCGA-UCEC	NA	s5470	Washington University School of Medicine	Gynecologic Oncology Group	None	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A066-09	TRUE
13722.58cfa83ce4b0c9d6adf73184	58cfa83ce4b0c9d6adf73184	aa55b92d7a3d9eabf7f8c19d30f85566.filtered.	WGS	aa55b92d7a3d9eabf7f8c19d30f85566	aa55b92d7a3d9eabf7f8c19d30f85566.bam	60.12	1.87	0.07	58cfa83ce4b0c9d6adf73184	aa55b92d7a3d9eabf7f8c19d30f85566.bam	Alive	FEMALE	ASIAN	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-BS-A0TC-01A	7B7D2D2B-ABE6-4F32-ADD0-3715096995D1	Primary Tumor	Illumina HiSeq	cfe5ac46-c8e7-4f91-a88f-bbbb286e9551	Uterus	69	C4C99327-B778-4E29-A111-75569AD38696	B0A83DF8-DD2C-4C1B-B238-9081D2C22258	TCGA-BS-A0TC-01A-11D-A10B-09	GRCh37-lite	TCGA-BS-A0TC	TCGA-UCEC	NA	s4395	Washington University School of Medicine	University of Hawaii	None	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A10B-09	TRUE
13722.58cfa83ce4b0c9d6adf73156	58cfa83ce4b0c9d6adf73156	a950fe8710031ec1f4934aa97d1d2437.filtered.	WGS	a950fe8710031ec1f4934aa97d1d2437	a950fe8710031ec1f4934aa97d1d2437.bam	96.72	1.83	0.07	58cfa83ce4b0c9d6adf73156	a950fe8710031ec1f4934aa97d1d2437.bam	Alive	FEMALE	ASIAN	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-BS-A0TD-01A	FFAA98A0-2B69-46DC-AEE5-C5C3F2ABBC38	Primary Tumor	Illumina HiSeq	d09c860a-701a-48f3-bace-b479e65e7493	Uterus	65	8BB3A057-8958-4F62-AF81-976DA2E92DF7	712BA532-FB1A-43FA-A356-B446B509CEB7	TCGA-BS-A0TD-01A-11D-A10B-09	GRCh37-lite	TCGA-BS-A0TD	TCGA-UCEC	NA	s5179	Washington University School of Medicine	University of Hawaii	None	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A10B-09	TRUE
13722.58cfa83ce4b0c9d6adf730d4	58cfa83ce4b0c9d6adf730d4	fe7b56f09624164caf93abc1f8d3bdc7.filtered.	WGS	fe7b56f09624164caf93abc1f8d3bdc7	fe7b56f09624164caf93abc1f8d3bdc7.bam	34.51	1.9	0.08	58cfa83ce4b0c9d6adf730d4	fe7b56f09624164caf93abc1f8d3bdc7.bam	Dead	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-B6-A0WX-01A	A482FC4C-FF1D-46A0-A968-7DF06422CC4B	Primary Tumor	Illumina HiSeq	1d0beca4-681e-4dbe-a6cf-f6c492c370b2	Breast	40	7DAA9124-2878-4708-AE74-28B17EF4898C	47B5D831-5287-4F62-B17A-6E5EFF2E4184	TCGA-B6-A0WX-01A-11D-A10G-09	GRCh37-lite	TCGA-B6-A0WX	TCGA-BRCA	653	s6109	Washington University School of Medicine	Duke	United States	NO	T3	N1b	Other  specify	Stage IIIA	A10G-09	FALSE
13722.58cfa83ce4b0c9d6adf73060	58cfa83ce4b0c9d6adf73060	a3d780740258da56025b3a939d1ea7d5.filtered.	WGS	a3d780740258da56025b3a939d1ea7d5	a3d780740258da56025b3a939d1ea7d5.bam	57.22	2.05	0.08	58cfa83ce4b0c9d6adf73060	a3d780740258da56025b3a939d1ea7d5.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-A2-A0YG-01A	C0892598-1F7B-4F23-9CD8-731F797753D5	Primary Tumor	Illumina HiSeq	64d3bdd6-809b-4c4e-bb57-71f60383b777	Breast	63	5006C942-BC9A-41CB-8674-2341B4E66230	4D409156-3A36-4C63-9AD6-B6AF34F27B06	TCGA-A2-A0YG-01A-21D-A19H-09	GRCh37-lite	TCGA-A2-A0YG	TCGA-BRCA	NA	s6747	Washington University School of Medicine	Walter Reed	None	NO	T2	N3a	Infiltrating Ductal Carcinoma	Stage IIIC	A19H-09	TRUE
13722.58cfa83ce4b0c9d6adf731cc	58cfa83ce4b0c9d6adf731cc	c60fa4aad576f1b3b720d3433a80345f.filtered.	WGS	c60fa4aad576f1b3b720d3433a80345f	c60fa4aad576f1b3b720d3433a80345f.bam	13.75	NA	0.07	58cfa83ce4b0c9d6adf731cc	c60fa4aad576f1b3b720d3433a80345f.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Sarcoma	Aligned reads	TCGA-DX-A3LY-01B	3505F91D-BC66-4732-84B6-18C5B32CA6B8	Primary Tumor	Illumina HiSeq	0f2523c6-fd2e-49ae-b8d1-eb4f0fd50867	Mesenchymal	66	A5697D2C-8E1A-42BE-8EBF-E57D6919BA65	DF4366C4-170F-4233-B577-A8EA277B069C	TCGA-DX-A3LY-01B-11D-A27P-09	GRCh37-lite	TCGA-DX-A3LY	TCGA-SARC	NA	s2629	Washington University School of Medicine	Memorial Sloan Kettering	United States	NO	Not available	Not available	Not available	Not available	A27P-09	FALSE
13722.58cfa83ce4b0c9d6adf72fea	58cfa83ce4b0c9d6adf72fea	f32bb0a94af8c21ac01c1ee17a7056ce.filtered.	WGS	f32bb0a94af8c21ac01c1ee17a7056ce	f32bb0a94af8c21ac01c1ee17a7056ce.bam	79.8	2.05	0.08	58cfa83ce4b0c9d6adf72fea	f32bb0a94af8c21ac01c1ee17a7056ce.bam	Alive	FEMALE	Not available	Not available	Breast Invasive Carcinoma	Aligned reads	TCGA-A8-A09I-01A	1557183C-AEDD-4DF6-B98A-3654667F7B69	Primary Tumor	Illumina HiSeq	767c9f80-f27b-4abe-91c6-394a72835d7a	Breast	84	A09A99F9-33E3-45D5-BFC2-F57CE149A527	987D41EE-6BAB-490C-B0F2-BF28C0089DE9	TCGA-A8-A09I-01A-22D-A19H-09	GRCh37-lite	TCGA-A8-A09I	TCGA-BRCA	NA	s6615	Washington University School of Medicine	Indivumed	Germany	NO	T2	N0	Infiltrating Ductal Carcinoma	Stage IIA	A19H-09	TRUE
13722.58cfa83ce4b0c9d6adf72f14	58cfa83ce4b0c9d6adf72f14	e52ff8a7016a0eac7ed93be3b1a7cfa2.filtered.	WGS	e52ff8a7016a0eac7ed93be3b1a7cfa2	e52ff8a7016a0eac7ed93be3b1a7cfa2.bam	90.97	2.13	0.08	58cfa83ce4b0c9d6adf72f14	e52ff8a7016a0eac7ed93be3b1a7cfa2.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-AP-A0LO-01A	A081DA6F-51F3-4555-A6B8-736F8C6CDA39	Primary Tumor	Illumina HiSeq	41a58f7b-d910-420e-ae2c-d37cc1f4a220	Uterus	45	9846D8F3-5B22-48E9-B972-A0FE9F509FB4	A0E317B1-3F3B-4D25-B2D9-FCC2211DFDA3	TCGA-AP-A0LO-01A-11D-A066-09	GRCh37-lite	TCGA-AP-A0LO	TCGA-UCEC	1016	s5372	Washington University School of Medicine	MSKCC	None	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A066-09	TRUE
13722.58cfa82de4b0c9d6adf6a461	58cfa82de4b0c9d6adf6a461	077f179af5b7fe13cbfcc88a10123c85.filtered.	WGS	077f179af5b7fe13cbfcc88a10123c85	077f179af5b7fe13cbfcc88a10123c85.bam	83.7	1.97	0.08	58cfa82de4b0c9d6adf6a461	077f179af5b7fe13cbfcc88a10123c85.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-C5-A1MI-01A	941F75A1-FEA4-4539-BA69-60BB11608F6D	Primary Tumor	Illumina HiSeq	e32cf6ef-190c-4456-b8a7-b40b9c9c8036	Cervix	50	A753BCF7-82D6-4FB1-AF0D-641898BBFF9C	14B8BBF2-310B-459B-B52D-A7EF510CE1CF	TCGA-C5-A1MI-01A-11D-A200-09	GRCh37-lite	TCGA-C5-A1MI	TCGA-CESC	1083	s1508	Washington University School of Medicine	Medical College of Wisconsin	United States	NO	T1b1	N1	Cervical Squamous Cell Carcinoma	Not available	A200-09	TRUE
13722.58cfa82de4b0c9d6adf6a48c	58cfa82de4b0c9d6adf6a48c	01e2ea9ed2554ea6df56ed963414b511.filtered.	WGS	01e2ea9ed2554ea6df56ed963414b511	01e2ea9ed2554ea6df56ed963414b511.bam	33.83	1.84	0.08	58cfa82de4b0c9d6adf6a48c	01e2ea9ed2554ea6df56ed963414b511.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-A7-A26G-01A	5ED024E8-D05E-4C65-9441-EDA9930CCC82	Primary Tumor	Illumina HiSeq	f7140aea-8ed7-4d5d-adfb-bd360e319805	Breast	50	F0CF4ACD-6B09-4538-B58C-E86C623B6C71	36D1A85E-A09B-4537-86E0-EAF1EB03AED8	TCGA-A7-A26G-01A-21D-A167-09	GRCh37-lite	TCGA-A7-A26G	TCGA-BRCA	NA	s6110	Washington University School of Medicine	Christiana Healthcare	United States	NO	T2	N0 (i+)	Other  specify	Stage IIA	A167-09	FALSE
13722.58cfa82de4b0c9d6adf6a4b4	58cfa82de4b0c9d6adf6a4b4	30e285b326196b3c05f1a202424a5b2f.filtered.	WGS	30e285b326196b3c05f1a202424a5b2f	30e285b326196b3c05f1a202424a5b2f.bam	53.44	1.91	0.08	58cfa82de4b0c9d6adf6a4b4	30e285b326196b3c05f1a202424a5b2f.bam	Dead	FEMALE	ASIAN	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-BS-A0TE-01A	09066FBF-6A1D-46C9-A4C5-C53340C3D1BA	Primary Tumor	Illumina HiSeq	18f27937-fb61-45fa-92f4-eacb3b722603	Uterus	35	2D1226A1-1C88-422B-9A8D-316BEBEB65FD	AF96DB5A-684F-41D1-A910-5A5193393D9C	TCGA-BS-A0TE-01A-11D-A10B-09	GRCh37-lite	TCGA-BS-A0TE	TCGA-UCEC	146	s4581	Washington University School of Medicine	University of Hawaii	None	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A10B-09	TRUE
13722.58cfa82de4b0c9d6adf6a4ea	58cfa82de4b0c9d6adf6a4ea	282e52fc396cb531fa21b3436906608f.filtered.	WGS	282e52fc396cb531fa21b3436906608f	282e52fc396cb531fa21b3436906608f.bam	35.31	NA	0.08	58cfa82de4b0c9d6adf6a4ea	282e52fc396cb531fa21b3436906608f.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-A2-A3Y0-01A	174850B4-5EC2-462B-A890-89BD1716B3C2	Primary Tumor	Illumina HiSeq	f1452ca5-f44b-4f35-a5eb-a8b1f9c44ef7	Breast	57	CAA2D510-9024-4D7D-B0EF-80FA4BE1E2EE	D8FBB398-D1DA-4444-984A-22C8523625DA	TCGA-A2-A3Y0-01A-11D-A23C-09	GRCh37-lite	TCGA-A2-A3Y0	TCGA-BRCA	NA	s6910	Washington University School of Medicine	Walter Reed	United States	NO	T2	N1a	Infiltrating Ductal Carcinoma	Stage IIB	A23C-09	FALSE
13722.58cfa82de4b0c9d6adf6a510	58cfa82de4b0c9d6adf6a510	3ef8e47cf81ea29f26bf77c4c33b453f.filtered.	WGS	3ef8e47cf81ea29f26bf77c4c33b453f	3ef8e47cf81ea29f26bf77c4c33b453f.bam	80.41	NA	0.08	58cfa82de4b0c9d6adf6a510	3ef8e47cf81ea29f26bf77c4c33b453f.bam	Alive	FEMALE	Not available	Not available	Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-DG-A2KJ-01A	7C93642D-7E05-40F8-B1EF-A014EDCFBA42	Primary Tumor	Illumina HiSeq	4399a247-c12c-480e-bc92-cf902a8a0a69	Cervix	50	4C1108C0-ED8A-4CAF-9417-DDFB6352C61E	8BE2B0F5-7BAD-4720-B13C-E95B32BDB933	TCGA-DG-A2KJ-01A-11D-A18J-09	GRCh37-lite	TCGA-DG-A2KJ	TCGA-CESC	NA	s1348	Washington University School of Medicine	Ontario Institute for Cancer Research	Canada	NO	T1b	N1	Cervical Squamous Cell Carcinoma	Not available	A18J-09	TRUE
13722.58cfa82de4b0c9d6adf6a64a	58cfa82de4b0c9d6adf6a64a	7e4be797a621ce82629293065b38f858.filtered.	WGS	7e4be797a621ce82629293065b38f858	7e4be797a621ce82629293065b38f858.bam	13.63	NA	0.09	58cfa82de4b0c9d6adf6a64a	7e4be797a621ce82629293065b38f858.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-C5-A2LV-01A	00BCA18C-B3D4-45A3-8F19-034CC40449A4	Primary Tumor	Illumina HiSeq	559f9675-671e-41a5-b073-7782ab8b5542	Cervix	36	CBAD0C55-915A-4F65-B040-57111EAD3BDE	3269608C-5DD7-452A-976A-31AC971AAC2F	TCGA-C5-A2LV-01A-11D-A18J-09	GRCh37-lite	TCGA-C5-A2LV	TCGA-CESC	NA	s1354	Washington University School of Medicine	Medical College of Wisconsin	United States	NO	T1b	N1	Cervical Squamous Cell Carcinoma	Not available	A18J-09	TRUE
13722.58cfa82de4b0c9d6adf6a44c	58cfa82de4b0c9d6adf6a44c	023c722ed278d2ab1cbbeef1bfee4130.filtered.	WGS	023c722ed278d2ab1cbbeef1bfee4130	023c722ed278d2ab1cbbeef1bfee4130.bam	45.87	1.86	0.08	58cfa82de4b0c9d6adf6a44c	023c722ed278d2ab1cbbeef1bfee4130.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-E9-A1NH-01A	B2AAC45B-2073-4C7A-ADB9-769A4FDCC111	Primary Tumor	Illumina HiSeq	f57cf947-b314-4a64-a112-d09cc8045594	Breast	71	FB0B2D84-D982-4D3A-9803-36420F2E7E46	13C312EC-0ADD-4758-AB8D-C193E2E08C6D	TCGA-E9-A1NH-01A-11D-A14G-09	GRCh37-lite	TCGA-E9-A1NH	TCGA-BRCA	NA	s6449	Washington University School of Medicine	Asterand	Russia	NO	T2	N1	Infiltrating Ductal Carcinoma	Stage IIB	A14G-09	FALSE
13722.58cfa82de4b0c9d6adf6a45b	58cfa82de4b0c9d6adf6a45b	46558eada33c446ae8c1b02d32740dab.filtered.	WGS	46558eada33c446ae8c1b02d32740dab	46558eada33c446ae8c1b02d32740dab.bam	31.03	NA	0.08	58cfa82de4b0c9d6adf6a45b	46558eada33c446ae8c1b02d32740dab.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Sarcoma	Aligned reads	TCGA-IS-A3KA-01A	257DC623-41E1-4FA3-859C-C787DB10BD60	Primary Tumor	Illumina HiSeq	5c922de0-6304-416e-a0aa-1a0cb42f0938	Mesenchymal	73	F8495459-CAF7-47CA-9B6A-7FE11FF1BA11	D8F0BECD-FDA8-41F4-A424-E082F9EAE22C	TCGA-IS-A3KA-01A-11D-A21Q-09	GRCh37-lite	TCGA-IS-A3KA	TCGA-SARC	413	s2485	Washington University School of Medicine	Memorial Sloan Kettering	United States	NO	Not available	Not available	Not available	Not available	A21Q-09	TRUE
13722.58cfa82de4b0c9d6adf6a47a	58cfa82de4b0c9d6adf6a47a	36b47238be0497f388623d943762497c.filtered.	WGS	36b47238be0497f388623d943762497c	36b47238be0497f388623d943762497c.bam	64.57	NA	0.08	58cfa82de4b0c9d6adf6a47a	36b47238be0497f388623d943762497c.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-EK-A2R9-01A	00AD0FFE-2105-4829-A495-1C2ACEB5BB31	Primary Tumor	Illumina HiSeq	d25f9f12-7f03-4bbe-befe-f9250955975c	Cervix	58	7EFD873D-8165-40F8-A07D-69CFD68A491E	9FF21093-58D7-4B69-AADE-C242A383EA56	TCGA-EK-A2R9-01A-11D-A34H-09	GRCh37-lite	TCGA-EK-A2R9	TCGA-CESC	NA	s1347	Washington University School of Medicine	Gynecologic Oncology Group	United States	NO	T1b1	N0	Cervical Squamous Cell Carcinoma	Not available	A34H-09	TRUE
13722.58cfa82de4b0c9d6adf6a4be	58cfa82de4b0c9d6adf6a4be	16c5b03f7a162662f87a6ef4eb8efdb7.filtered.	WGS	16c5b03f7a162662f87a6ef4eb8efdb7	16c5b03f7a162662f87a6ef4eb8efdb7.bam	78.05	1.93	0.08	58cfa82de4b0c9d6adf6a4be	16c5b03f7a162662f87a6ef4eb8efdb7.bam	Alive	FEMALE	WHITE	Not available	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-AP-A05D-01A	F7E06A10-74CA-4F52-A944-B3F22C016998	Primary Tumor	Illumina HiSeq	4cb18a3e-36df-43cb-ab17-5ba82f2a7949	Uterus	67	5B19AF28-1179-42CB-A474-856EF2048D5B	82D2EA5F-EBDC-4907-A287-FE837FD6B59C	TCGA-AP-A05D-01A-11D-A013-09	GRCh37-lite	TCGA-AP-A05D	TCGA-UCEC	NA	s4981	Washington University School of Medicine	MSKCC	None	NO	Not available	Not available	Serous endometrial adenocarcinoma	Not available	A013-09	TRUE
13722.58cfa82de4b0c9d6adf6a49a	58cfa82de4b0c9d6adf6a49a	1d2f2091a246a644d3f997d0edfd860a.filtered.	WGS	1d2f2091a246a644d3f997d0edfd860a	1d2f2091a246a644d3f997d0edfd860a.bam	17.4	1.97	0.08	58cfa82de4b0c9d6adf6a49a	1d2f2091a246a644d3f997d0edfd860a.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-A2-A0EY-01A	D67CD793-2931-429A-9084-2F3C4C8BE7AD	Primary Tumor	Illumina HiSeq	79cc669f-41ce-4384-ac00-fe94ad0c8cd5	Breast	62	2A3E4DBB-AAFF-4B14-BBED-F2D7CF0F8FA3	01658141-8398-4585-9F0F-8355DD9B0604	TCGA-A2-A0EY-01A-11D-A19H-09	GRCh37-lite	TCGA-A2-A0EY	TCGA-BRCA	NA	s5947	Washington University School of Medicine	Walter Reed	None	NO	T2	N1a	Infiltrating Ductal Carcinoma	Stage IIB	A19H-09	TRUE
13722.58cfa82de4b0c9d6adf6a4e6	58cfa82de4b0c9d6adf6a4e6	114daee2d5db94a8d315a300daafb728.filtered.	WGS	114daee2d5db94a8d315a300daafb728	114daee2d5db94a8d315a300daafb728.bam	20.16	NA	0.08	58cfa82de4b0c9d6adf6a4e6	114daee2d5db94a8d315a300daafb728.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Sarcoma	Aligned reads	TCGA-DX-A3U5-01A	8F3F6F7C-4B50-467E-A6E8-D836735913F6	Primary Tumor	Illumina HiSeq	bee06413-ec4c-4545-b54d-d858d6a6e6e3	Mesenchymal	52	FB5C61D6-717E-4798-8306-86EB196D5609	3C963890-6E79-4B16-A4AA-BAC04938B4D7	TCGA-DX-A3U5-01A-11D-A228-09	GRCh37-lite	TCGA-DX-A3U5	TCGA-SARC	NA	s2473	Washington University School of Medicine	Memorial Sloan Kettering	United States	NO	Not available	Not available	Not available	Not available	A228-09	FALSE
13722.58cfa82de4b0c9d6adf6a522	58cfa82de4b0c9d6adf6a522	2e173cba9eef7aec792a9b66d36c62fd.filtered.	WGS	2e173cba9eef7aec792a9b66d36c62fd	2e173cba9eef7aec792a9b66d36c62fd.bam	107.95	1.77	0.09	58cfa82de4b0c9d6adf6a522	2e173cba9eef7aec792a9b66d36c62fd.bam	Dead	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-BH-A1FC-01A	B97BF89A-7A85-4EEF-AE7E-F787AEAD1F0A	Primary Tumor	Illumina HiSeq	96f6b8e2-d4c6-44db-a8d4-3c7549e04038	Breast	78	3AD0093A-E57A-450A-B0EF-942C9B67A586	84C77098-03D0-4B22-AFB1-797703E85C6C	TCGA-BH-A1FC-01A-11D-A13L-09	GRCh37-lite	TCGA-BH-A1FC	TCGA-BRCA	3472	s6455	Washington University School of Medicine	University of Pittsburgh	None	NO	T1c	N1b	Medullary Carcinoma	Stage IIA	A13L-09	FALSE
13722.58cfa82de4b0c9d6adf6a514	58cfa82de4b0c9d6adf6a514	39d36a4631a0662e48415735c9e225a7.filtered.	WGS	39d36a4631a0662e48415735c9e225a7	39d36a4631a0662e48415735c9e225a7.bam	41.18	2.26	0.09	58cfa82de4b0c9d6adf6a514	39d36a4631a0662e48415735c9e225a7.bam	Dead	FEMALE	BLACK OR AFRICAN AMERICAN	Not available	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-B5-A1MY-01A	5D2F1A0F-A01B-48C2-B749-1CA710AA2BB4	Primary Tumor	Illumina HiSeq	d76a05f0-61cd-42ac-9cbe-0c1fe2a9a85e	Uterus	62	26189CF5-AE49-44CF-842B-35A3063AB93C	493E7008-551C-4C0E-B567-A0F31868629E	TCGA-B5-A1MY-01A-11D-A142-09	GRCh37-lite	TCGA-B5-A1MY	TCGA-UCEC	361	s4766	Washington University School of Medicine	Duke	United States	NO	Not available	Not available	Serous endometrial adenocarcinoma	Not available	A142-09	FALSE
13722.58cfa82de4b0c9d6adf6a518	58cfa82de4b0c9d6adf6a518	143a9f78e15769fd3d037c291de40599.filtered.	WGS	143a9f78e15769fd3d037c291de40599	143a9f78e15769fd3d037c291de40599.bam	85.82	2.12	0.07	58cfa82de4b0c9d6adf6a518	143a9f78e15769fd3d037c291de40599.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	Not available	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-B5-A0K3-01A	79ECC142-8F6E-4260-A7CE-C8E2A6212C35	Primary Tumor	Illumina HiSeq	b48383ea-36f6-4edd-ae2e-04b235d472a3	Uterus	62	ED31DDC2-FEDA-496E-A642-0C4B5DCE014D	D12CFD8B-682D-41DF-ACF8-EE7F68A6241C	TCGA-B5-A0K3-01A-11D-A325-09	GRCh37-lite	TCGA-B5-A0K3	TCGA-UCEC	NA	s5375	Washington University School of Medicine	Duke	United States	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A325-09	TRUE
13722.58cfa82de4b0c9d6adf6a53a	58cfa82de4b0c9d6adf6a53a	55d6e765b492c11513427738173a07b8.filtered.	WGS	55d6e765b492c11513427738173a07b8	55d6e765b492c11513427738173a07b8.bam	8.07	NA	0.08	58cfa82de4b0c9d6adf6a53a	55d6e765b492c11513427738173a07b8.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Sarcoma	Aligned reads	TCGA-FX-A3RE-01A	7F9031DA-124A-4A38-83E6-878A50E58C24	Primary Tumor	Illumina HiSeq	41901beb-8e75-49c2-8bc3-a73dcaff36b1	Mesenchymal	65	8FAEDD92-D7FA-452A-8210-741118E516F7	CDBBD701-9C05-4F9E-923D-06039DD8A04D	TCGA-FX-A3RE-01A-11D-A228-09	GRCh37-lite	TCGA-FX-A3RE	TCGA-SARC	NA	s2336	Washington University School of Medicine	International Genomics Consortium	United States	NO	Not available	Not available	Not available	Not available	A228-09	FALSE
13722.58cfa82de4b0c9d6adf6a535	58cfa82de4b0c9d6adf6a535	4d34550076e0e5e5f628e1f2d531963f.filtered.	WGS	4d34550076e0e5e5f628e1f2d531963f	4d34550076e0e5e5f628e1f2d531963f.bam	58.16	2	0.07	58cfa82de4b0c9d6adf6a535	4d34550076e0e5e5f628e1f2d531963f.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-A2-A0D4-01A	75113445-D2D6-44A0-866C-C9175E6D214B	Primary Tumor	Illumina HiSeq	ac8422e5-dfeb-40c6-ab1f-dddd9f7fb015	Breast	37	ACE39EF3-1B5E-4AD2-A20D-62957E524281	2B000AF3-2C9D-4EAA-AF3F-8101B7425C37	TCGA-A2-A0D4-01A-11D-A314-09	GRCh37-lite	TCGA-A2-A0D4	TCGA-BRCA	NA	s6624	Washington University School of Medicine	Walter Reed	None	NO	T2	N1a	Infiltrating Ductal Carcinoma	Stage IIB	A314-09	TRUE
13722.58cfa82de4b0c9d6adf6a51c	58cfa82de4b0c9d6adf6a51c	3016434d8255a1fb2b32ae1ae47ef1ec.filtered.	WGS	3016434d8255a1fb2b32ae1ae47ef1ec	3016434d8255a1fb2b32ae1ae47ef1ec.bam	57.13	1.93	0.08	58cfa82de4b0c9d6adf6a51c	3016434d8255a1fb2b32ae1ae47ef1ec.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-BH-A18U-01A	233B02F3-C4F0-4A67-9DB5-E68D5CDACCB6	Primary Tumor	Illumina HiSeq	8797ff7d-3b2a-4ac8-b8a3-375982e8413e	Breast	72	79763193-268D-49E7-B94C-5CB95F7271B6	FB9135D9-2ACF-41DD-8552-359E6B8C9470	TCGA-BH-A18U-01A-21D-A19H-09	GRCh37-lite	TCGA-BH-A18U	TCGA-BRCA	1563	s6912	Washington University School of Medicine	University of Pittsburgh	None	NO	T2	N2a	Infiltrating Ductal Carcinoma	Stage IIIA	A19H-09	TRUE
13722.58cfa82de4b0c9d6adf6a570	58cfa82de4b0c9d6adf6a570	2d3ccd84c9564a9f00feb1379762746c.filtered.	WGS	2d3ccd84c9564a9f00feb1379762746c	2d3ccd84c9564a9f00feb1379762746c.bam	78.11	1.95	0.08	58cfa82de4b0c9d6adf6a570	2d3ccd84c9564a9f00feb1379762746c.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-AX-A2H5-01A	C88E3901-F3EE-436A-BA80-143C8EAB7D69	Primary Tumor	Illumina HiSeq	6b01cf12-3537-4e5e-857f-de5dd14c85ce	Uterus	67	44EB96B4-5E4F-460B-BC51-ADD38CBC76A1	CC19A480-9C66-4EE8-A0C0-921ACAC02689	TCGA-AX-A2H5-01A-11D-A34H-09	GRCh37-lite	TCGA-AX-A2H5	TCGA-UCEC	NA	s5376	Washington University School of Medicine	Gynecologic Oncology Group	United States	NO	Not available	Not available	Serous endometrial adenocarcinoma	Not available	A34H-09	TRUE
13722.58cfa82de4b0c9d6adf6a599	58cfa82de4b0c9d6adf6a599	6520482bf50a726c446002cb9b06ac69.filtered.	WGS	6520482bf50a726c446002cb9b06ac69	6520482bf50a726c446002cb9b06ac69.bam	27.61	NA	0.08	58cfa82de4b0c9d6adf6a599	6520482bf50a726c446002cb9b06ac69.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Sarcoma	Aligned reads	TCGA-IE-A4EI-01A	C5E23947-253B-40D2-916A-277B2A580BE2	Primary Tumor	Illumina HiSeq	6070f836-ad03-4454-9395-d7c38f0949c9	Mesenchymal	67	1FE30A2F-22A6-4F88-9A3A-7A11359CC151	522DC834-8367-4F49-B93B-FCBA91A2DE7E	TCGA-IE-A4EI-01A-11D-A24N-09	GRCh37-lite	TCGA-IE-A4EI	TCGA-SARC	NA	s2339	Washington University School of Medicine	ABS - IUPUI	United States	NO	Not available	Not available	Not available	Not available	A24N-09	TRUE
13722.58cfa82de4b0c9d6adf6a4e2	58cfa82de4b0c9d6adf6a4e2	3868e1400ab74a5d31b7f3ace5862177.filtered.	WGS	3868e1400ab74a5d31b7f3ace5862177	3868e1400ab74a5d31b7f3ace5862177.bam	31.37	NA	0.08	58cfa82de4b0c9d6adf6a4e2	3868e1400ab74a5d31b7f3ace5862177.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-EK-A2RE-01A	9AA36AC2-8418-4109-A3C1-63CA8742BAAB	Primary Tumor	Illumina HiSeq	87fe03fa-225c-4d35-81a3-8b401d985fae	Cervix	26	7BCF54B6-3FFA-4014-92C6-51A7099E6F02	0D31A44F-1FC5-43A2-9633-36C4E650D3D2	TCGA-EK-A2RE-01A-11D-A34H-09	GRCh37-lite	TCGA-EK-A2RE	TCGA-CESC	NA	s1162	Washington University School of Medicine	Gynecologic Oncology Group	United States	NO	T2a2	N0	Cervical Squamous Cell Carcinoma	Not available	A34H-09	TRUE
13722.58cfa82de4b0c9d6adf6a5b2	58cfa82de4b0c9d6adf6a5b2	6822184f0a41bd067261cf1591f0dbf6.filtered.	WGS	6822184f0a41bd067261cf1591f0dbf6	6822184f0a41bd067261cf1591f0dbf6.bam	34.66	1.95	0.08	58cfa82de4b0c9d6adf6a5b2	6822184f0a41bd067261cf1591f0dbf6.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-AO-A12H-01A	B5B99291-507E-4B68-A039-9A0F571F55DF	Primary Tumor	Illumina HiSeq	55b85b3a-3eed-4a89-ab63-56b85e180571	Breast	69	D8AFCB32-81D0-43B3-AD5C-E8C735710624	5A535C49-D42E-43C6-9D32-DC76F28D4F0F	TCGA-AO-A12H-01A-11D-A10Y-09	GRCh37-lite	TCGA-AO-A12H	TCGA-BRCA	NA	s5481	Washington University School of Medicine	MSKCC	None	NO	T2	N0 (i-)	Other  specify	Stage IIA	A10Y-09	FALSE
13722.58cfa82de4b0c9d6adf6a5b3	58cfa82de4b0c9d6adf6a5b3	551a836dfba4ddbf7b7859a2395b7794.filtered.	WGS	551a836dfba4ddbf7b7859a2395b7794	551a836dfba4ddbf7b7859a2395b7794.bam	30.4	NA	0.09	58cfa82de4b0c9d6adf6a5b3	551a836dfba4ddbf7b7859a2395b7794.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Sarcoma	Aligned reads	TCGA-DX-A3M1-01A	B85E2156-D5AC-486C-93E1-86525EA41A64	Primary Tumor	Illumina HiSeq	bb1d2bd3-0664-4d25-a029-9fe225b91c2e	Mesenchymal	79	1AFCDB32-AE26-4747-A131-54E83DD84A46	72F0A49A-AEC8-47E5-846A-956C4DA1507C	TCGA-DX-A3M1-01A-11D-A228-09	GRCh37-lite	TCGA-DX-A3M1	TCGA-SARC	NA	s2338	Washington University School of Medicine	Memorial Sloan Kettering	United States	NO	Not available	Not available	Not available	Not available	A228-09	FALSE
13722.58cfa82de4b0c9d6adf6a58f	58cfa82de4b0c9d6adf6a58f	5ef6a0389326d4bf5accd20037a358d3.filtered.	WGS	5ef6a0389326d4bf5accd20037a358d3	5ef6a0389326d4bf5accd20037a358d3.bam	42.25	2	0.08	58cfa82de4b0c9d6adf6a58f	5ef6a0389326d4bf5accd20037a358d3.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-AQ-A04J-01A	9938CE5C-E74E-446E-A932-F096F85CC3B1	Primary Tumor	Illumina HiSeq	c57fe789-7ef3-4dcb-bc21-b7ccb5ff208e	Breast	45	09D6F42C-5E9F-4ADC-BD8C-E5DCA597FC01	467EF778-F481-44F3-9768-B9900252D2BA	TCGA-AQ-A04J-01A-02D-A128-09	GRCh37-lite	TCGA-AQ-A04J	TCGA-BRCA	NA	s6115	Washington University School of Medicine	Not available	United States	NO	T2	N0 (i+)	Infiltrating Ductal Carcinoma	Stage IIA	A128-09	TRUE
13722.58cfa82de4b0c9d6adf6a5ce	58cfa82de4b0c9d6adf6a5ce	730dac4f2b9e3f7bc83f758dbd514583.filtered.	WGS	730dac4f2b9e3f7bc83f758dbd514583	730dac4f2b9e3f7bc83f758dbd514583.bam	59.62	2.13	0.08	58cfa82de4b0c9d6adf6a5ce	730dac4f2b9e3f7bc83f758dbd514583.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-A5-A0GG-01A	A8614C49-C7F1-4DE9-BD2F-4764B094D604	Primary Tumor	Illumina HiSeq	c4002956-bdc1-4b16-810a-ccf4b006d29b	Uterus	76	B5B941E3-F828-4091-B9B1-6B38D1493847	F7187888-F261-4A39-99B4-966FD7207117	TCGA-A5-A0GG-01A-11D-A122-09	GRCh37-lite	TCGA-A5-A0GG	TCGA-UCEC	NA	s5379	Washington University School of Medicine	Cedars Sinai	None	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A122-09	TRUE
13722.58cfa82de4b0c9d6adf6a60c	58cfa82de4b0c9d6adf6a60c	749ef764c5fcf5ac98cf3e0086566a41.filtered.	WGS	749ef764c5fcf5ac98cf3e0086566a41	749ef764c5fcf5ac98cf3e0086566a41.bam	7.51	NA	0.08	58cfa82de4b0c9d6adf6a60c	749ef764c5fcf5ac98cf3e0086566a41.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Sarcoma	Aligned reads	TCGA-DX-A1L3-01A	9517413B-B5B8-4130-8BA1-D86D44ABE2EC	Primary Tumor	Illumina HiSeq	f5fa948e-2119-4b86-8bc3-7ef737ffdffe	Mesenchymal	60	19A45767-ABF7-4D53-B096-B59847FC47A8	18EC066E-8510-4921-9E35-45D85FB01E38	TCGA-DX-A1L3-01A-11D-A24N-09	GRCh37-lite	TCGA-DX-A1L3	TCGA-SARC	NA	s2347	Washington University School of Medicine	Memorial Sloan Kettering	United States	NO	Not available	Not available	Not available	Not available	A24N-09	TRUE
13722.58cfa82de4b0c9d6adf6a618	58cfa82de4b0c9d6adf6a618	5c56d50bef568c9257651f615ec606b3.filtered.	WGS	5c56d50bef568c9257651f615ec606b3	5c56d50bef568c9257651f615ec606b3.bam	70.96	1.93	0.08	58cfa82de4b0c9d6adf6a618	5c56d50bef568c9257651f615ec606b3.bam	Alive	FEMALE	WHITE	HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-EW-A1PH-01A	4DA999A0-EF41-4A0B-B1D1-446B39CC855A	Primary Tumor	Illumina HiSeq	877bbc2d-444f-44cf-8e0f-3fd2744c3f91	Breast	52	DD38BA60-656A-46F7-B22B-BCEE3B6D2F19	DF291849-4C35-44E1-B013-8F6B7EE36113	TCGA-EW-A1PH-01A-11D-A17G-09	GRCh37-lite	TCGA-EW-A1PH	TCGA-BRCA	NA	s5951	Washington University School of Medicine	University of Miami	United States	NO	T1c	N1a	Infiltrating Ductal Carcinoma	Stage IIA	A17G-09	FALSE
13722.58cfa82de4b0c9d6adf6a61e	58cfa82de4b0c9d6adf6a61e	67919d6ae2817354d43a764971e0608f.filtered.	WGS	67919d6ae2817354d43a764971e0608f	67919d6ae2817354d43a764971e0608f.bam	59.44	1.73	0.08	58cfa82de4b0c9d6adf6a61e	67919d6ae2817354d43a764971e0608f.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-C5-A1BN-01B	8A4DA4F0-30F2-497E-8A7C-988FD6B813CB	Primary Tumor	Illumina HiSeq	df3a48da-646a-4834-969a-131455b7baa9	Cervix	26	DD05713E-6D6D-4876-89DF-69A905D24500	06DAD93A-4B67-49B3-8FA5-F2546E22BAE7	TCGA-C5-A1BN-01B-11D-A200-09	GRCh37-lite	TCGA-C5-A1BN	TCGA-CESC	166	s1510	Washington University School of Medicine	Medical College of Wisconsin	United States	NO	Not available	Not available	Cervical Squamous Cell Carcinoma	Not available	A200-09	TRUE
13722.58cfa82de4b0c9d6adf6a640	58cfa82de4b0c9d6adf6a640	7a02be700709d5daf6393100f819a952.filtered.	WGS	7a02be700709d5daf6393100f819a952	7a02be700709d5daf6393100f819a952.bam	51.59	NA	0.08	58cfa82de4b0c9d6adf6a640	7a02be700709d5daf6393100f819a952.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Sarcoma	Aligned reads	TCGA-DX-A2J0-01A	2FF6AEDE-7BCD-440B-99AB-7A023FAF658E	Primary Tumor	Illumina HiSeq	99a5bf7b-7b43-4753-ac23-1a777776a1dc	Mesenchymal	61	A8673BA9-EF34-42CA-A73E-1EFB4F186E88	CB783F8B-D092-4104-B809-3F90B19DF7DF	TCGA-DX-A2J0-01A-11D-A21Q-09	GRCh37-lite	TCGA-DX-A2J0	TCGA-SARC	295	s2346	Washington University School of Medicine	Memorial Sloan Kettering	United States	NO	Not available	Not available	Not available	Not available	A21Q-09	TRUE
13722.58cfa82de4b0c9d6adf6a65e	58cfa82de4b0c9d6adf6a65e	6dfdd72436bacf6a5f435146137eee03.filtered.	WGS	6dfdd72436bacf6a5f435146137eee03	6dfdd72436bacf6a5f435146137eee03.bam	8.01	NA	0.08	58cfa82de4b0c9d6adf6a65e	6dfdd72436bacf6a5f435146137eee03.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Sarcoma	Aligned reads	TCGA-DX-A2J4-01A	F75D2589-FD7B-49A1-A1C8-0B4726B81F3C	Primary Tumor	Illumina HiSeq	ffc58c6a-5a11-4c5f-a5dd-b5082be0dc38	Mesenchymal	60	46E59502-D5DF-428B-BEEF-6AD1439B86C6	968929B0-6BFB-4A2C-BD4D-570BFCDB8A6A	TCGA-DX-A2J4-01A-32D-A21Q-09	GRCh37-lite	TCGA-DX-A2J4	TCGA-SARC	NA	s2340	Washington University School of Medicine	Memorial Sloan Kettering	United States	NO	Not available	Not available	Not available	Not available	A21Q-09	TRUE
13722.58cfa82de4b0c9d6adf6a674	58cfa82de4b0c9d6adf6a674	4e9520d4069328bdb2c43937716bc859.filtered.	WGS	4e9520d4069328bdb2c43937716bc859	4e9520d4069328bdb2c43937716bc859.bam	27.88	NA	0.08	58cfa82de4b0c9d6adf6a674	4e9520d4069328bdb2c43937716bc859.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Sarcoma	Aligned reads	TCGA-DX-A3U7-01A	EA3A524B-6EE3-4904-8924-29FCAA20985C	Primary Tumor	Illumina HiSeq	0c2d7c45-b582-429b-bf9f-ed279421c8a6	Mesenchymal	67	910CD9B0-5BBE-47E5-8F4C-A6E8AA580281	9E7B51FB-2249-451A-BF23-BB2A3D935928	TCGA-DX-A3U7-01A-11D-A29N-09	GRCh37-lite	TCGA-DX-A3U7	TCGA-SARC	NA	s2487	Washington University School of Medicine	Memorial Sloan Kettering	United States	NO	Not available	Not available	Not available	Not available	A29N-09	FALSE
13722.58cfa82de4b0c9d6adf6a68a	58cfa82de4b0c9d6adf6a68a	92b17b06dd8c1279647435d6dc17b382.filtered.	WGS	92b17b06dd8c1279647435d6dc17b382	92b17b06dd8c1279647435d6dc17b382.bam	23.61	1.87	0.07	58cfa82de4b0c9d6adf6a68a	92b17b06dd8c1279647435d6dc17b382.bam	Dead	FEMALE	Not available	Not available	Breast Invasive Carcinoma	Aligned reads	TCGA-A8-A09X-01A	27B05B15-A44B-45ED-A6E3-E7D1CA488EA9	Primary Tumor	Illumina HiSeq	8327f8db-6932-4661-a116-5909cd8e4c81	Breast	62	5A9087B1-D001-4FCC-B061-F59E7026E711	6DBC5C31-043B-40E9-BF1A-E7B4EC351B4D	TCGA-A8-A09X-01A-11D-A19H-09	GRCh37-lite	TCGA-A8-A09X	TCGA-BRCA	426	s5633	Washington University School of Medicine	Indivumed	Germany	NO	T2	N3a	Infiltrating Lobular Carcinoma	Stage IIIC	A19H-09	TRUE
13722.58cfa82de4b0c9d6adf6a65f	58cfa82de4b0c9d6adf6a65f	5b233e3c073c9b60910bddaec0e5ed79.filtered.	WGS	5b233e3c073c9b60910bddaec0e5ed79	5b233e3c073c9b60910bddaec0e5ed79.bam	71.04	2	0.07	58cfa82de4b0c9d6adf6a65f	5b233e3c073c9b60910bddaec0e5ed79.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	Not available	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-B5-A11G-01A	D2AA7D70-A25F-4A9E-9D52-37E372461824	Primary Tumor	Illumina HiSeq	bef94a7d-d7f5-4172-9a0c-5b3dc033ca00	Uterus	71	FE5D8E64-98B1-4EA7-ADDA-F28D12349A7E	42DE1441-6F3C-4B4D-B8B8-AD91E4B1DBE2	TCGA-B5-A11G-01A-13D-A122-09	GRCh37-lite	TCGA-B5-A11G	TCGA-UCEC	NA	s4411	Washington University School of Medicine	Duke	United States	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A122-09	TRUE
13722.58cfa82de4b0c9d6adf6a6da	58cfa82de4b0c9d6adf6a6da	917393fd54d541ee5bf939911e9e1142.filtered.	WGS	917393fd54d541ee5bf939911e9e1142	917393fd54d541ee5bf939911e9e1142.bam	17.01	NA	0.08	58cfa82de4b0c9d6adf6a6da	917393fd54d541ee5bf939911e9e1142.bam	Alive	FEMALE	ASIAN	NOT HISPANIC OR LATINO	Sarcoma	Aligned reads	TCGA-MO-A47R-01A	8654C2B5-27D7-43C5-9A39-7FDEFD7A0324	Primary Tumor	Illumina HiSeq	1e530776-868a-4b43-ac6b-7e692691b675	Mesenchymal	75	3D38F7C9-00DD-47C1-8649-C50574953AAB	7A5D3B6B-BE5A-4E55-9255-32A069B8AF3D	TCGA-MO-A47R-01A-11D-A24N-09	GRCh37-lite	TCGA-MO-A47R	TCGA-SARC	NA	s2492	Washington University School of Medicine	ILSbio	Vietnam	NO	Not available	Not available	Not available	Not available	A24N-09	TRUE
13722.58cfa82de4b0c9d6adf6a6d4	58cfa82de4b0c9d6adf6a6d4	84cabc6d988c220d0be27b3d2d76db69.filtered.	WGS	84cabc6d988c220d0be27b3d2d76db69	84cabc6d988c220d0be27b3d2d76db69.bam	17.19	NA	0.08	58cfa82de4b0c9d6adf6a6d4	84cabc6d988c220d0be27b3d2d76db69.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Sarcoma	Aligned reads	TCGA-IE-A4EK-01A	590FDB76-20EF-4F95-9783-7D80E7A25E5A	Primary Tumor	Illumina HiSeq	01fcfdba-18c9-4abf-84be-b5fbac48d25a	Mesenchymal	54	9963DA13-6EA7-48A3-A3DE-1C6A38F977B9	56681386-D407-4F53-AE4F-6C04437652F7	TCGA-IE-A4EK-01A-11D-A24N-09	GRCh37-lite	TCGA-IE-A4EK	TCGA-SARC	NA	s2494	Washington University School of Medicine	ABS - IUPUI	United States	NO	Not available	Not available	Not available	Not available	A24N-09	TRUE
13722.58cfa82ee4b0c9d6adf6a8aa	58cfa82ee4b0c9d6adf6a8aa	G35154.TCGA-E1-5319-01A-01D-1893-08.4.filtered.	WGS	G35154.TCGA-E1-5319-01A-01D-1893-08.4	G35154.TCGA-E1-5319-01A-01D-1893-08.4.bam	56	1.9	0.05	58cfa82ee4b0c9d6adf6a8aa	G35154.TCGA-E1-5319-01A-01D-1893-08.4.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-E1-5319-01A	84569C1A-6BAA-4380-AE3C-707DF1BE4618	Primary Tumor	Illumina HiSeq	6b14040f-a3ce-4fe5-a5f9-f311cd1ec11a	Brain	48	1EE9478B-84A5-4FFD-8499-F2E02A3A21D7	D252A54E-0377-4B3E-8228-26108EA704FA	TCGA-E1-5319-01A-01D-1893-08	HG19_Broad_variant	TCGA-E1-5319	TCGA-LGG	2907	s8323	Broad Institute of MIT and Harvard	Duke	United States	NO	Not available	Not available	Oligodendroglioma	Not available	1893-08	FALSE
13722.58cfa82ee4b0c9d6adf6a8f4	58cfa82ee4b0c9d6adf6a8f4	G32456.TCGA-CF-A3MF-01A-12D-A21A-08.2.filtered.	WGS	G32456.TCGA-CF-A3MF-01A-12D-A21A-08.2	G32456.TCGA-CF-A3MF-01A-12D-A21A-08.2.bam	55.07	NA	0.08	58cfa82ee4b0c9d6adf6a8f4	G32456.TCGA-CF-A3MF-01A-12D-A21A-08.2.bam	Alive	MALE	ASIAN	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-CF-A3MF-01A	1E308B12-0590-4DAE-94D0-A539FCF25DF7	Primary Tumor	Illumina HiSeq	62e960fb-aaf6-4d7e-b15d-1b5136f6fa37	Bladder	34	E9889071-4C6E-4761-9D65-06C6B5989FB7	C66C92D5-DF65-46E6-861D-D8A98808E6A3	TCGA-CF-A3MF-01A-12D-A21A-08	HG19_Broad_variant	TCGA-CF-A3MF	TCGA-BLCA	NA	s2683	Broad Institute of MIT and Harvard	ILSbio	Vietnam	NO	T3	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage III	A21A-08	TRUE
13722.58cfa82ee4b0c9d6adf6a91a	58cfa82ee4b0c9d6adf6a91a	G32524.TCGA-DJ-A1QL-01A-11D-A14W-08.2.filtered.	WGS	G32524.TCGA-DJ-A1QL-01A-11D-A14W-08.2	G32524.TCGA-DJ-A1QL-01A-11D-A14W-08.2.bam	77.76	1.96	0.09	58cfa82ee4b0c9d6adf6a91a	G32524.TCGA-DJ-A1QL-01A-11D-A14W-08.2.bam	Alive	MALE	Not available	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-DJ-A1QL-01A	E4B08E66-0772-4956-8670-E5C6553EECBE	Primary Tumor	Illumina HiSeq	c90da8dc-3705-4381-a713-d4a404dd09ce	Thyroid	70	62B6D426-E1E4-48E8-BC8F-6B07C67CC0D0	79169C46-7049-4576-9885-63973DB76AB9	TCGA-DJ-A1QL-01A-11D-A14W-08	HG19_Broad_variant	TCGA-DJ-A1QL	TCGA-THCA	NA	s12217	Broad Institute of MIT and Harvard	Memorial Sloan Kettering	United States	NO	T2	N0	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	Stage II	A14W-08	TRUE
13722.58cfa82ee4b0c9d6adf6a94c	58cfa82ee4b0c9d6adf6a94c	G35154.TCGA-CS-5395-01A-01D-1468-08.1.filtered.	WGS	G35154.TCGA-CS-5395-01A-01D-1468-08.1	G35154.TCGA-CS-5395-01A-01D-1468-08.1.bam	44	1.9	0.05	58cfa82ee4b0c9d6adf6a94c	G35154.TCGA-CS-5395-01A-01D-1468-08.1.bam	Dead	MALE	BLACK OR AFRICAN AMERICAN	Not available	Brain Lower Grade Glioma	Aligned reads	TCGA-CS-5395-01A	F86FA219-34E9-4812-8EDF-2B66D7219779	Primary Tumor	Illumina HiSeq	409fc6a2-e9df-4391-988e-bcb0d9e990b8	Brain	43	CB40F8BB-879E-496D-AE52-5535B277A952	3D477AC1-3BDF-4410-9594-1A3A1412C6AE	TCGA-CS-5395-01A-01D-1468-08	HG19_Broad_variant	TCGA-CS-5395	TCGA-LGG	639	s8319	Broad Institute of MIT and Harvard	Thomas Jefferson University	United States	NO	Not available	Not available	Oligodendroglioma	Not available	1468-08	FALSE
13722.58cfa82ee4b0c9d6adf6a95c	58cfa82ee4b0c9d6adf6a95c	G35154.TCGA-DU-7301-01A-11D-2086-08.3.filtered.	WGS	G35154.TCGA-DU-7301-01A-11D-2086-08.3	G35154.TCGA-DU-7301-01A-11D-2086-08.3.bam	33	NA	0.05	58cfa82ee4b0c9d6adf6a95c	G35154.TCGA-DU-7301-01A-11D-2086-08.3.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-DU-7301-01A	84AE73E4-3B39-4444-9BFB-3FC6057EAB32	Primary Tumor	Illumina HiSeq	a788486c-7bba-436f-a31c-a5d294155cc6	Brain	53	D6BFF803-8B4A-44A1-AF59-0F2BABA7895F	BA94C29B-B76E-4D67-BF5A-CE6BC45D85F8	TCGA-DU-7301-01A-11D-2086-08	HG19_Broad_variant	TCGA-DU-7301	TCGA-LGG	788	s8325	Broad Institute of MIT and Harvard	Henry Ford Hospital	United States	NO	Not available	Not available	Oligodendroglioma	Not available	2086-08	FALSE
13722.58cfa82ee4b0c9d6adf6a966	58cfa82ee4b0c9d6adf6a966	G35154.TCGA-HW-7487-01A-11D-2024-08.3.filtered.	WGS	G35154.TCGA-HW-7487-01A-11D-2024-08.3	G35154.TCGA-HW-7487-01A-11D-2024-08.3.bam	85	NA	0.05	58cfa82ee4b0c9d6adf6a966	G35154.TCGA-HW-7487-01A-11D-2024-08.3.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-HW-7487-01A	42251E02-B687-4BF1-A1B6-E3DD978542E4	Primary Tumor	Illumina HiSeq	efb882b9-fe40-4205-a704-5757740ee898	Brain	39	3040F10C-04E1-4CF8-8EAD-D74C856425C8	C1ABB741-4FCD-4161-B057-C7EFD619CC99	TCGA-HW-7487-01A-11D-2024-08	HG19_Broad_variant	TCGA-HW-7487	TCGA-LGG	NA	s8550	Broad Institute of MIT and Harvard	MSKCC	United States	NO	Not available	Not available	Oligodendroglioma	Not available	2024-08	FALSE
13722.58cfa82ee4b0c9d6adf6a974	58cfa82ee4b0c9d6adf6a974	G32462.TCGA-DK-A1A7-01A-11D-A13W-08.1.filtered.	WGS	G32462.TCGA-DK-A1A7-01A-11D-A13W-08.1	G32462.TCGA-DK-A1A7-01A-11D-A13W-08.1.bam	35.04	2	0.07	58cfa82ee4b0c9d6adf6a974	G32462.TCGA-DK-A1A7-01A-11D-A13W-08.1.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-DK-A1A7-01A	3ED614E7-F356-4D87-985B-D3BBBAE3BB40	Primary Tumor	Illumina HiSeq	7a0d461d-525e-4b3a-86d1-d6d3306fb405	Bladder	67	D68D16F7-6117-4D3D-8347-CF5CD3F23AE4	91F458E6-64B7-454D-A542-B0AA23638FD8	TCGA-DK-A1A7-01A-11D-A13W-08	HG19_Broad_variant	TCGA-DK-A1A7	TCGA-BLCA	NA	s3070	Broad Institute of MIT and Harvard	Memorial Sloan Kettering	United States	NO	T3	N2	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV	A13W-08	TRUE
13722.58cfa82ee4b0c9d6adf6a986	58cfa82ee4b0c9d6adf6a986	G35154.TCGA-DU-6407-01A-13D-1705-08.1.filtered.	WGS	G35154.TCGA-DU-6407-01A-13D-1705-08.1	G35154.TCGA-DU-6407-01A-13D-1705-08.1.bam	19.3	1.9	0.05	58cfa82ee4b0c9d6adf6a986	G35154.TCGA-DU-6407-01A-13D-1705-08.1.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-DU-6407-01A	70939245-41E0-4845-A473-5FEF719B9828	Primary Tumor	Illumina HiSeq	52ae2dd2-f573-41c6-ad1a-18b19c9eea35	Brain	35	29D91F2B-C040-46BC-9B9E-3A41790DC664	F92A34FA-014E-4B41-A6D0-3B46B8C8A3EE	TCGA-DU-6407-01A-13D-1705-08	HG19_Broad_variant	TCGA-DU-6407	TCGA-LGG	2875	s8532	Broad Institute of MIT and Harvard	Henry Ford Hospital	United States	NO	Not available	Not available	Oligodendroglioma	Not available	1705-08	FALSE
13722.58cfa82ee4b0c9d6adf6aa80	58cfa82ee4b0c9d6adf6aa80	G32533.TCGA-EM-A3FQ-01A-11D-A21A-08.3.filtered.	WGS	G32533.TCGA-EM-A3FQ-01A-11D-A21A-08.3	G32533.TCGA-EM-A3FQ-01A-11D-A21A-08.3.bam	10.98	NA	0.08	58cfa82ee4b0c9d6adf6aa80	G32533.TCGA-EM-A3FQ-01A-11D-A21A-08.3.bam	Alive	FEMALE	Not available	Not available	Thyroid Carcinoma	Aligned reads	TCGA-EM-A3FQ-01A	FEF9C64F-5959-4DA0-AAA2-66B56FC7B4C3	Primary Tumor	Illumina HiSeq	dbbab09c-382c-48f0-aeca-e5ec1cc0c948	Thyroid	19	4F88157A-572E-4236-B956-206A9E227DEB	79133E29-BA0B-4E2F-A6D9-BF294C5144F0	TCGA-EM-A3FQ-01A-11D-A21A-08	HG19_Broad_variant	TCGA-EM-A3FQ	TCGA-THCA	NA	s12731	Broad Institute of MIT and Harvard	University Health Network	Canada	NO	T3	N1b	Other  specify	Stage I	A21A-08	TRUE
13722.58cfa82ee4b0c9d6adf6aa88	58cfa82ee4b0c9d6adf6aa88	G32469.TCGA-DK-A1AG-01A-11D-A13W-08.2.filtered.	WGS	G32469.TCGA-DK-A1AG-01A-11D-A13W-08.2	G32469.TCGA-DK-A1AG-01A-11D-A13W-08.2.bam	70.38	1.89	0.08	58cfa82ee4b0c9d6adf6aa88	G32469.TCGA-DK-A1AG-01A-11D-A13W-08.2.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-DK-A1AG-01A	F8C0A69C-DF53-4A0A-A30E-4424C0CE3DD5	Primary Tumor	Illumina HiSeq	9ef4c333-8532-4ab7-bd4b-ba1161f87a6d	Bladder	65	64668AA0-DDE5-4534-8CD0-378881E4A4E4	7D2A22EB-7344-4CBA-AD7D-94C3F9EF3D7C	TCGA-DK-A1AG-01A-11D-A13W-08	HG19_Broad_variant	TCGA-DK-A1AG	TCGA-BLCA	NA	s2848	Broad Institute of MIT and Harvard	Memorial Sloan Kettering	United States	NO	T3	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage III	A13W-08	TRUE
13722.58cfa82ee4b0c9d6adf6aaba	58cfa82ee4b0c9d6adf6aaba	G32470.TCGA-FT-A3EE-01A-11D-A202-08.2.filtered.	WGS	G32470.TCGA-FT-A3EE-01A-11D-A202-08.2	G32470.TCGA-FT-A3EE-01A-11D-A202-08.2.bam	35.79	NA	0.07	58cfa82ee4b0c9d6adf6aaba	G32470.TCGA-FT-A3EE-01A-11D-A202-08.2.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-FT-A3EE-01A	CCE62116-3DCD-400D-ADA0-9839CA02466E	Primary Tumor	Illumina HiSeq	cff49411-c565-469a-83c7-9a253f6b129d	Bladder	80	2356F78C-0653-468F-83DB-6CF6107BD259	FFDD4FEB-ACA3-4104-B1E8-954D705A6450	TCGA-FT-A3EE-01A-11D-A202-08	HG19_Broad_variant	TCGA-FT-A3EE	TCGA-BLCA	99	s3067	Broad Institute of MIT and Harvard	BLN - University of Miami	United States	NO	T4a	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage III	A202-08	TRUE
13722.58cfa82ee4b0c9d6adf6aac4	58cfa82ee4b0c9d6adf6aac4	G32450.TCGA-FD-A3N5-01A-11D-A21A-08.1.filtered.	WGS	G32450.TCGA-FD-A3N5-01A-11D-A21A-08.1	G32450.TCGA-FD-A3N5-01A-11D-A21A-08.1.bam	30.45	NA	0.08	58cfa82ee4b0c9d6adf6aac4	G32450.TCGA-FD-A3N5-01A-11D-A21A-08.1.bam	Alive	MALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-FD-A3N5-01A	A658BECF-3934-49F2-9E74-291DCA61D4BB	Primary Tumor	Illumina HiSeq	2650b346-1fc6-4664-bfd1-3765e04cf29a	Bladder	69	66559B5F-AB2F-406B-9EDB-0F5085EEC7C5	418A3DEC-96FF-4719-BECB-E1A8260CCE2F	TCGA-FD-A3N5-01A-11D-A21A-08	HG19_Broad_variant	TCGA-FD-A3N5	TCGA-BLCA	NA	s3248	Broad Institute of MIT and Harvard	BLN - University Of Chicago	United States	NO	T2b	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage II	A21A-08	TRUE
13722.58cfa82ee4b0c9d6adf6aad4	58cfa82ee4b0c9d6adf6aad4	G32539.TCGA-EM-A3AL-01A-11D-A202-08.1.filtered.	WGS	G32539.TCGA-EM-A3AL-01A-11D-A202-08.1	G32539.TCGA-EM-A3AL-01A-11D-A202-08.1.bam	56.44	NA	0.08	58cfa82ee4b0c9d6adf6aad4	G32539.TCGA-EM-A3AL-01A-11D-A202-08.1.bam	Alive	FEMALE	Not available	Not available	Thyroid Carcinoma	Aligned reads	TCGA-EM-A3AL-01A	0C50A2C2-1D4C-45CA-9127-F96D4DB18DAF	Primary Tumor	Illumina HiSeq	6ad47953-e067-450e-9c68-69b531caba51	Thyroid	45	593736E0-1BED-4EAF-BAC9-E90620554F1D	248FD0ED-F14C-40B8-9F14-E9C7ADF16E22	TCGA-EM-A3AL-01A-11D-A202-08	HG19_Broad_variant	TCGA-EM-A3AL	TCGA-THCA	NA	s12613	Broad Institute of MIT and Harvard	University Health Network	Canada	NO	T1b	N0	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	Stage I	A202-08	TRUE
13722.58cfa82ee4b0c9d6adf6ab2e	58cfa82ee4b0c9d6adf6ab2e	G32467.TCGA-DK-A1A6-01A-11D-A13W-08.2.filtered.	WGS	G32467.TCGA-DK-A1A6-01A-11D-A13W-08.2	G32467.TCGA-DK-A1A6-01A-11D-A13W-08.2.bam	85.12	1.95	0.08	58cfa82ee4b0c9d6adf6ab2e	G32467.TCGA-DK-A1A6-01A-11D-A13W-08.2.bam	Alive	MALE	WHITE	Not available	Bladder Urothelial Carcinoma	Aligned reads	TCGA-DK-A1A6-01A	9C274536-3CA1-4F0E-93A8-1688074D862F	Primary Tumor	Illumina HiSeq	99a71c72-13a7-4c05-ae15-ccfd0da321dd	Bladder	53	7AD1CD01-0EA2-4FA4-9B05-C280BD256546	DF8A913C-5160-4FC5-950D-7C890E24E820	TCGA-DK-A1A6-01A-11D-A13W-08	HG19_Broad_variant	TCGA-DK-A1A6	TCGA-BLCA	NA	s3073	Broad Institute of MIT and Harvard	Memorial Sloan Kettering	United States	NO	T2a	N1	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV	A13W-08	TRUE
13722.58cfa82ee4b0c9d6adf6ab22	58cfa82ee4b0c9d6adf6ab22	G32467.TCGA-DK-A1A6-01A-11D-A13W-08.3.filtered.	WGS	G32467.TCGA-DK-A1A6-01A-11D-A13W-08.3	G32467.TCGA-DK-A1A6-01A-11D-A13W-08.3.bam	85.12	1.95	0.08	58cfa82ee4b0c9d6adf6ab22	G32467.TCGA-DK-A1A6-01A-11D-A13W-08.3.bam	Alive	MALE	WHITE	Not available	Bladder Urothelial Carcinoma	Aligned reads	TCGA-DK-A1A6-01A	9C274536-3CA1-4F0E-93A8-1688074D862F	Primary Tumor	Illumina HiSeq	694693d8-dc04-4516-bc18-e8a9ccb24d28	Bladder	53	7AD1CD01-0EA2-4FA4-9B05-C280BD256546	DF8A913C-5160-4FC5-950D-7C890E24E820	TCGA-DK-A1A6-01A-11D-A13W-08	HG19_Broad_variant	TCGA-DK-A1A6	TCGA-BLCA	NA	s2847	Broad Institute of MIT and Harvard	Memorial Sloan Kettering	United States	NO	T2a	N1	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV	A13W-08	TRUE
13722.58cfa82ee4b0c9d6adf6ab86	58cfa82ee4b0c9d6adf6ab86	G35153.TCGA-BA-A4IH-01A-11D-A25T-08.5.filtered.	WGS	G35153.TCGA-BA-A4IH-01A-11D-A25T-08.5	G35153.TCGA-BA-A4IH-01A-11D-A25T-08.5.bam	39.39	NA	0.07	58cfa82ee4b0c9d6adf6ab86	G35153.TCGA-BA-A4IH-01A-11D-A25T-08.5.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-BA-A4IH-01A	BD75D8EE-916B-4ABC-BF33-BCE6A4217076	Primary Tumor	Illumina HiSeq	dc2ac994-c455-4e1f-9319-2865614853ba	Head and Neck	57	F87EFB5E-24F5-4D2B-B6B3-987BBDA30E03	B537BC07-9998-49F4-BBBE-5B617152BFD9	TCGA-BA-A4IH-01A-11D-A25T-08	HG19_Broad_variant	TCGA-BA-A4IH	TCGA-HNSC	NA	s15747	Broad Institute of MIT and Harvard	UNC	United States	NO	T2	N1	Head and Neck Squamous Cell Carcinoma Basaloid Type	Stage IVA	A25T-08	FALSE
13722.58cfa82ee4b0c9d6adf6ab6c	58cfa82ee4b0c9d6adf6ab6c	G32462.TCGA-DK-A1A7-01A-11D-A13W-08.2.filtered.	WGS	G32462.TCGA-DK-A1A7-01A-11D-A13W-08.2	G32462.TCGA-DK-A1A7-01A-11D-A13W-08.2.bam	35.04	2	0.07	58cfa82ee4b0c9d6adf6ab6c	G32462.TCGA-DK-A1A7-01A-11D-A13W-08.2.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-DK-A1A7-01A	3ED614E7-F356-4D87-985B-D3BBBAE3BB40	Primary Tumor	Illumina HiSeq	4eade8e4-0984-473e-99f5-523fdc631190	Bladder	67	D68D16F7-6117-4D3D-8347-CF5CD3F23AE4	91F458E6-64B7-454D-A542-B0AA23638FD8	TCGA-DK-A1A7-01A-11D-A13W-08	HG19_Broad_variant	TCGA-DK-A1A7	TCGA-BLCA	NA	s3074	Broad Institute of MIT and Harvard	Memorial Sloan Kettering	United States	NO	T3	N2	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV	A13W-08	TRUE
13722.58cfa82ee4b0c9d6adf6aba3	58cfa82ee4b0c9d6adf6aba3	G32532.TCGA-EL-A3H1-01A-11D-A21A-08.3.filtered.	WGS	G32532.TCGA-EL-A3H1-01A-11D-A21A-08.3	G32532.TCGA-EL-A3H1-01A-11D-A21A-08.3.bam	31.88	NA	0.08	58cfa82ee4b0c9d6adf6aba3	G32532.TCGA-EL-A3H1-01A-11D-A21A-08.3.bam	Dead	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-EL-A3H1-01A	8D54A2ED-03F1-4A23-BDD2-F3395F5D3716	Primary Tumor	Illumina HiSeq	9cc1b2f2-01f5-4ed3-873b-152726b61e55	Thyroid	66	9ED0332E-C846-4091-BF6E-0C5BF55B9F1A	62FCEB56-8C6E-4D20-9D2F-5B7042854D23	TCGA-EL-A3H1-01A-11D-A21A-08	HG19_Broad_variant	TCGA-EL-A3H1	TCGA-THCA	1500	s12733	Broad Institute of MIT and Harvard	MD Anderson	United States	NO	T1	N0	Thyroid Papillary Carcinoma - Classical/usual	Stage I	A21A-08	TRUE
13722.58cfa82ee4b0c9d6adf6abaa	58cfa82ee4b0c9d6adf6abaa	G32463.TCGA-DK-A1A5-01A-11D-A13W-08.4.filtered.	WGS	G32463.TCGA-DK-A1A5-01A-11D-A13W-08.4	G32463.TCGA-DK-A1A5-01A-11D-A13W-08.4.bam	59.04	1.91	0.08	58cfa82ee4b0c9d6adf6abaa	G32463.TCGA-DK-A1A5-01A-11D-A13W-08.4.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-DK-A1A5-01A	904A8757-E0C5-41EF-B583-C8F170CAAAC1	Primary Tumor	Illumina HiSeq	f0ccddad-f1d5-4cd3-bad7-f9710dba4127	Bladder	79	A9EF3EC5-B1C1-481F-89CF-1729FAB50173	448FE471-3F4E-4DC8-A4E0-6F147DC93ABE	TCGA-DK-A1A5-01A-11D-A13W-08	HG19_Broad_variant	TCGA-DK-A1A5	TCGA-BLCA	65	s3066	Broad Institute of MIT and Harvard	Memorial Sloan Kettering	United States	NO	T2b	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage II	A13W-08	TRUE
13722.58cfa82ee4b0c9d6adf6abb8	58cfa82ee4b0c9d6adf6abb8	G32453.TCGA-DK-A3IL-01A-11D-A20D-08.3.filtered.	WGS	G32453.TCGA-DK-A3IL-01A-11D-A20D-08.3	G32453.TCGA-DK-A3IL-01A-11D-A20D-08.3.bam	32.38	NA	0.08	58cfa82ee4b0c9d6adf6abb8	G32453.TCGA-DK-A3IL-01A-11D-A20D-08.3.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-DK-A3IL-01A	178B28CD-99C3-48DC-8D09-1EF71B4CEE80	Primary Tumor	Illumina HiSeq	092f2192-b2d3-48e8-be2f-f56c1febe40b	Bladder	79	59D6683F-5EB7-493D-8E8E-78B88BE2CD70	4838B5A9-968C-4178-BFFB-3FAFE1F6DC09	TCGA-DK-A3IL-01A-11D-A20D-08	HG19_Broad_variant	TCGA-DK-A3IL	TCGA-BLCA	NA	s2844	Broad Institute of MIT and Harvard	Memorial Sloan Kettering	United States	NO	T3	N2	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV	A20D-08	TRUE
13722.58cfa82ee4b0c9d6adf6abd6	58cfa82ee4b0c9d6adf6abd6	G32535.TCGA-FK-A3SE-01A-11D-A22D-08.1.filtered.	WGS	G32535.TCGA-FK-A3SE-01A-11D-A22D-08.1	G32535.TCGA-FK-A3SE-01A-11D-A22D-08.1.bam	31.42	NA	0.08	58cfa82ee4b0c9d6adf6abd6	G32535.TCGA-FK-A3SE-01A-11D-A22D-08.1.bam	Alive	FEMALE	ASIAN	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-FK-A3SE-01A	AFB00CD4-E5DA-4251-86FB-532C3F65324C	Primary Tumor	Illumina HiSeq	e2561be5-1c52-4774-a3d5-2a7800d87c6a	Thyroid	31	D3CC158D-413D-49E6-8D23-3ED89FDEA94A	90883300-D4B6-45D7-AF9A-4E4CE4104500	TCGA-FK-A3SE-01A-11D-A22D-08	HG19_Broad_variant	TCGA-FK-A3SE	TCGA-THCA	NA	s12216	Broad Institute of MIT and Harvard	Johns Hopkins	United States	NO	T2	N1a	Thyroid Papillary Carcinoma - Classical/usual	Stage I	A22D-08	TRUE
13722.58cfa82ee4b0c9d6adf6ac56	58cfa82ee4b0c9d6adf6ac56	G39020.TCGA-BR-6452-01A-12D-1800-08.1.filtered.	WGS	G39020.TCGA-BR-6452-01A-12D-1800-08.1	G39020.TCGA-BR-6452-01A-12D-1800-08.1.bam	409.4	1.9	0.05	58cfa82ee4b0c9d6adf6ac56	G39020.TCGA-BR-6452-01A-12D-1800-08.1.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-BR-6452-01A	27988B3E-CDE1-4F4B-82A1-6D8AD08DB8E9	Primary Tumor	Illumina HiSeq	e69add2b-1a4d-44e6-8186-3fb2163afa5f	Stomach	78	76144F2F-2498-430D-B33C-F000394C427E	C8E961B4-E324-40A2-89F6-736EC3845BC9	TCGA-BR-6452-01A-12D-1800-08	HG19_Broad_variant	TCGA-BR-6452	TCGA-STAD	NA	s14524	Broad Institute of MIT and Harvard	Asterand	Russia	NO	T3	N0	Stomach  Adenocarcinoma  Not Otherwise Specified (NOS)	Stage IIA	1800-08	TRUE
13722.58cfa82ee4b0c9d6adf6ad73	58cfa82ee4b0c9d6adf6ad73	G32529.TCGA-ET-A3DV-01A-12D-A202-08.3.filtered.	WGS	G32529.TCGA-ET-A3DV-01A-12D-A202-08.3	G32529.TCGA-ET-A3DV-01A-12D-A202-08.3.bam	16.24	NA	0.08	58cfa82ee4b0c9d6adf6ad73	G32529.TCGA-ET-A3DV-01A-12D-A202-08.3.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-ET-A3DV-01A	B46D88E9-8477-4900-8DA9-5E7DBDED0653	Primary Tumor	Illumina HiSeq	6319fae0-343d-45e8-a507-cc9f7acf1b38	Thyroid	68	CE24FE0A-5C4D-4FBE-A02C-76345EAA2892	5DEEAA45-4C1B-4AB2-A487-93C548838F68	TCGA-ET-A3DV-01A-12D-A202-08	HG19_Broad_variant	TCGA-ET-A3DV	TCGA-THCA	NA	s12343	Broad Institute of MIT and Harvard	Johns Hopkins	United States	NO	T3	N0	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	Stage II	A202-08	TRUE
13722.58cfa82fe4b0c9d6adf6b858	58cfa82fe4b0c9d6adf6b858	TCGA-29-1710-01A-02D-0926-12_Illumina.filtered.	WGS	TCGA-29-1710-01A-02D-0926-12_Illumina	TCGA-29-1710-01A-02D-0926-12_Illumina.bam	265	1.9	0.15	58cfa82fe4b0c9d6adf6b858	TCGA-29-1710-01A-02D-0926-12_Illumina.bam	Dead	FEMALE	WHITE	Not available	Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-29-1710-01A	4261267C-7042-4C6E-83ED-12FB401003FC	Primary Tumor	Illumina HiSeq	3d865220-b0b8-4ca4-b4a1-56e05dc83e6f	Ovary	54	61513DA0-4EB3-4CAE-BFFF-7B05F3362488	6BA4DE87-C332-42B8-AF95-EB14A4C7F229	TCGA-29-1710-01A-02D-0926-12	NCBI36_BCM_variant	TCGA-29-1710	TCGA-OV	951	s17882	Baylor College of Medicine	Duke	None	NO	Not available	Not available	Serous Cystadenocarcinoma	Not available	0926-12	TRUE
13722.58cfa830e4b0c9d6adf6bb98	58cfa830e4b0c9d6adf6bb98	TCGA-A2-A0D0-01A-11D-A128-09_IlluminaGA-DNASeq_whole.filtered.	WGS	TCGA-A2-A0D0-01A-11D-A128-09_IlluminaGA-DNASeq_whole	TCGA-A2-A0D0-01A-11D-A128-09_IlluminaGA-DNASeq_whole.bam	66.88	1.91	0.08	58cfa830e4b0c9d6adf6bb98	TCGA-A2-A0D0-01A-11D-A128-09_IlluminaGA-DNASeq_whole.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-A2-A0D0-01A	324BCBA2-F6A4-45A6-807C-215BDFFCCA21	Primary Tumor	Illumina HiSeq	25ddf041-bc97-4ced-aa1a-cf0339d8c23b	Breast	60	7FD5702E-2D7B-4B79-B2D8-5CA4CA33CF65	71FDA5A9-7049-406F-9348-2C24F7DDF5F4	TCGA-A2-A0D0-01A-11D-A128-09	GRCh37-lite	TCGA-A2-A0D0	TCGA-BRCA	NA	s6270	Washington University School of Medicine	Walter Reed	None	NO	T2	N0 (i-)	Infiltrating Ductal Carcinoma	Stage IIA	A128-09	TRUE
13722.58cfa830e4b0c9d6adf6bcbd	58cfa830e4b0c9d6adf6bcbd	TCGA-B0-5693-01A-11D-2103-10_Illumina.filtered.	WGS	TCGA-B0-5693-01A-11D-2103-10_Illumina	TCGA-B0-5693-01A-11D-2103-10_Illumina.bam	344.4	1.9	0.14	58cfa830e4b0c9d6adf6bcbd	TCGA-B0-5693-01A-11D-2103-10_Illumina.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-B0-5693-01A	DB058EB4-9C5E-4226-92D1-DE24AEA83630	Primary Tumor	Illumina HiSeq	4a0c2db0-f10b-41b1-8aca-fcd712b7f672	Kidney	47	20A21A6F-F615-47F7-9935-B330B116D51B	FB194CA3-10AA-4DC5-8D08-619DDBD6D1B6	TCGA-B0-5693-01A-11D-2103-10	GRCh37-lite	TCGA-B0-5693	TCGA-KIRC	NA	s9937	Baylor College of Medicine	University of Pittsburgh	None	NO	T1b	NX	Kidney Clear Cell Renal Carcinoma	Stage I	2103-10	FALSE
13722.58cfa830e4b0c9d6adf6bdf1	58cfa830e4b0c9d6adf6bdf1	TCGA-AK-3428-01A-02D-2096-10_Illumina.filtered.	WGS	TCGA-AK-3428-01A-02D-2096-10_Illumina	TCGA-AK-3428-01A-02D-2096-10_Illumina.bam	23.4	1.9	0.14	58cfa830e4b0c9d6adf6bdf1	TCGA-AK-3428-01A-02D-2096-10_Illumina.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-AK-3428-01A	9DA334ED-314C-4445-BA29-FFD9BB42403C	Primary Tumor	Illumina HiSeq	46d21c8f-8493-4886-82f4-91fd488b4364	Kidney	62	0B96A41E-6A0C-4FC6-8F21-8E5F992CE5D1	D01710F9-EFC8-4B5F-9E53-300B30F9219F	TCGA-AK-3428-01A-02D-2096-10	GRCh37-lite	TCGA-AK-3428	TCGA-KIRC	NA	s9303	Baylor College of Medicine	Fox Chase	None	NO	T3b	N0	Kidney Clear Cell Renal Carcinoma	Stage III	2096-10	FALSE
13722.58cfa830e4b0c9d6adf6bdf8	58cfa830e4b0c9d6adf6bdf8	TCGA-AK-3454-01A-02D-2096-10_wgs_Illumina.filtered.	WGS	TCGA-AK-3454-01A-02D-2096-10_wgs_Illumina	TCGA-AK-3454-01A-02D-2096-10_wgs_Illumina.bam	28.07	1.9	0.15	58cfa830e4b0c9d6adf6bdf8	TCGA-AK-3454-01A-02D-2096-10_wgs_Illumina.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-AK-3454-01A	28E9B6F9-AB6A-400B-A6A9-79095A443591	Primary Tumor	Illumina HiSeq	54d1e202-1017-4494-af06-5b5747b7201c	Kidney	84	74741322-3B24-43E6-9CE1-F267B0555F62	FD74DE4D-6973-4597-A541-E8A13D80AD55	TCGA-AK-3454-01A-02D-2096-10	GRCh37-lite	TCGA-AK-3454	TCGA-KIRC	NA	s9731	Baylor College of Medicine	Fox Chase	United States	NO	T1b	NX	Kidney Clear Cell Renal Carcinoma	Stage I	2096-10	FALSE
13722.58cfa830e4b0c9d6adf6bdea	58cfa830e4b0c9d6adf6bdea	TCGA-BH-A0B9-01A-11D-A128-09_IlluminaGA-DNASeq_whole.filtered.	WGS	TCGA-BH-A0B9-01A-11D-A128-09_IlluminaGA-DNASeq_whole	TCGA-BH-A0B9-01A-11D-A128-09_IlluminaGA-DNASeq_whole.bam	73.41	1.97	0.07	58cfa830e4b0c9d6adf6bdea	TCGA-BH-A0B9-01A-11D-A128-09_IlluminaGA-DNASeq_whole.bam	Alive	FEMALE	WHITE	Not available	Breast Invasive Carcinoma	Aligned reads	TCGA-BH-A0B9-01A	5A57DC25-D252-4B22-B192-4DE630D7002F	Primary Tumor	Illumina HiSeq	1a49cb56-547c-4a77-84e6-116bc406ba19	Breast	44	8137FFEE-BB4F-4E5F-B831-ACFC9C5585A8	CF599959-6AAF-48EA-8A15-8EF09163BAD7	TCGA-BH-A0B9-01A-11D-A128-09	GRCh37-lite	TCGA-BH-A0B9	TCGA-BRCA	NA	s6770	Washington University School of Medicine	University of Pittsburgh	None	NO	T1c	N0 (i-)	Infiltrating Ductal Carcinoma	Stage IA	A128-09	TRUE
13722.58cfa830e4b0c9d6adf6c196	58cfa830e4b0c9d6adf6c196	TCGA-AK-3455-01A-01D-2233-10_wgs_Illumina.filtered.	WGS	TCGA-AK-3455-01A-01D-2233-10_wgs_Illumina	TCGA-AK-3455-01A-01D-2233-10_wgs_Illumina.bam	612.57	1.9	0.05	58cfa830e4b0c9d6adf6c196	TCGA-AK-3455-01A-01D-2233-10_wgs_Illumina.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-AK-3455-01A	2ED3296A-5B10-40D8-8AF4-90DC031657CD	Primary Tumor	Illumina HiSeq	77412ddb-2013-4e9c-aa60-2ce76f5269a8	Kidney	71	2D970196-BEEE-4783-90A1-E313A789DD92	A56CD282-F6C5-4373-B3D8-676562894598	TCGA-AK-3455-01A-01D-2233-10	GRCh37-lite	TCGA-AK-3455	TCGA-KIRC	683	s9730	Baylor College of Medicine	Fox Chase	United States	NO	T3b	NX	Kidney Clear Cell Renal Carcinoma	Stage III	2233-10	FALSE
13722.58cfa831e4b0c9d6adf6c7f4	58cfa831e4b0c9d6adf6c7f4	TCGA-CZ-5987-01A-11D-2104-10_Illumina.filtered.	WGS	TCGA-CZ-5987-01A-11D-2104-10_Illumina	TCGA-CZ-5987-01A-11D-2104-10_Illumina.bam	57.4	1.9	0.17	58cfa831e4b0c9d6adf6c7f4	TCGA-CZ-5987-01A-11D-2104-10_Illumina.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-CZ-5987-01A	F5759059-C0E3-4F1A-AF96-5C7197D3C33C	Primary Tumor	Illumina HiSeq	86bbaa26-53e2-4aa9-a257-0f86b5d2ca13	Kidney	60	6E67F804-5C82-4750-894A-0E85357F7E3D	FA5E2900-95E7-4700-9707-A329CD0C77FD	TCGA-CZ-5987-01A-11D-2104-10	GRCh37-lite	TCGA-CZ-5987	TCGA-KIRC	445	s9739	Baylor College of Medicine	Harvard	None	NO	T3b	NX	Kidney Clear Cell Renal Carcinoma	Stage IV	2104-10	FALSE
13722.58cfa831e4b0c9d6adf6cc42	58cfa831e4b0c9d6adf6cc42	TCGA-DV-5566-01A-01D-2104-10_wgs_Illumina.filtered.	WGS	TCGA-DV-5566-01A-01D-2104-10_wgs_Illumina	TCGA-DV-5566-01A-01D-2104-10_wgs_Illumina.bam	124.4	1.9	0.16	58cfa831e4b0c9d6adf6cc42	TCGA-DV-5566-01A-01D-2104-10_wgs_Illumina.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-DV-5566-01A	4B2EC8AA-8460-440E-B75B-6B92AE7A3FFC	Primary Tumor	Illumina HiSeq	67e2d2b4-5d60-46c8-85b0-236331ed66a8	Kidney	67	58578D50-1E0C-4F5E-929A-C969C5346B05	BCF54C96-2B62-4E24-926F-D77576250DD1	TCGA-DV-5566-01A-01D-2104-10	GRCh37-lite	TCGA-DV-5566	TCGA-KIRC	NA	s8844	Baylor College of Medicine	NCI Urologic Oncology Branch	None	NO	T1a	NX	Kidney Clear Cell Renal Carcinoma	Stage I	2104-10	FALSE
13722.58cfa831e4b0c9d6adf6c80b	58cfa831e4b0c9d6adf6c80b	TCGA-CZ-5454-01A-01D-2102-10_wgs_Illumina.filtered.	WGS	TCGA-CZ-5454-01A-01D-2102-10_wgs_Illumina	TCGA-CZ-5454-01A-01D-2102-10_wgs_Illumina.bam	99.4	1.9	0.15	58cfa831e4b0c9d6adf6c80b	TCGA-CZ-5454-01A-01D-2102-10_wgs_Illumina.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-CZ-5454-01A	F2801B21-5444-4CC3-A642-C60C6D82CD3D	Primary Tumor	Illumina HiSeq	c238e952-da1c-4af6-a799-62e9ff477374	Kidney	63	B8CCB09D-ACEB-4069-A911-89663575AB4B	B51FA117-2C0A-4E1D-8EC4-9F039073A486	TCGA-CZ-5454-01A-01D-2102-10	GRCh37-lite	TCGA-CZ-5454	TCGA-KIRC	722	s8843	Baylor College of Medicine	Harvard	None	NO	T2	N0	Kidney Clear Cell Renal Carcinoma	Stage IV	2102-10	FALSE
13722.58cfa83ce4b0c9d6adf72ea0	58cfa83ce4b0c9d6adf72ea0	cab14fc1d7b56274f68e25c36ca1fe72.filtered.	WGS	cab14fc1d7b56274f68e25c36ca1fe72	cab14fc1d7b56274f68e25c36ca1fe72.bam	117.13	2.03	0.08	58cfa83ce4b0c9d6adf72ea0	cab14fc1d7b56274f68e25c36ca1fe72.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-AP-A054-01A	D77E4DBC-B239-4742-8CB7-EFD427010D13	Primary Tumor	Illumina HiSeq	ac0e9eff-9bcd-4c94-a329-d07bcc7d5620	Uterus	64	DDFFB9C7-185F-402F-99B8-8058B40086D9	7364A112-61B9-41C6-B85F-18C97C54CEFD	TCGA-AP-A054-01A-11D-A066-09	GRCh37-lite	TCGA-AP-A054	TCGA-UCEC	709	s5371	Washington University School of Medicine	MSKCC	None	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A066-09	TRUE
13722.58cfa83ce4b0c9d6adf72eb0	58cfa83ce4b0c9d6adf72eb0	cea4bc4275e349522246f3666f7965b5.filtered.	WGS	cea4bc4275e349522246f3666f7965b5	cea4bc4275e349522246f3666f7965b5.bam	46.1	1.75	0.09	58cfa83ce4b0c9d6adf72eb0	cea4bc4275e349522246f3666f7965b5.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-D8-A27F-01A	1549DC64-3DAB-43FC-96E9-B07D520957E1	Primary Tumor	Illumina HiSeq	f4f2c07e-84b7-47d0-88fe-7032564a1ecc	Breast	40	7E9145F7-CCFF-4132-B2B7-9B992EEBEBF4	FC6D77A9-121B-48AB-A899-713C3D1319A2	TCGA-D8-A27F-01A-11D-A16D-09	GRCh37-lite	TCGA-D8-A27F	TCGA-BRCA	NA	s6967	Washington University School of Medicine	Greater Poland Cancer Center	Poland	NO	T2	N0	Infiltrating Ductal Carcinoma	Stage IIA	A16D-09	FALSE
13722.58cfa83ce4b0c9d6adf72ed8	58cfa83ce4b0c9d6adf72ed8	e56f2db4726f327debd64334f96bcd04.filtered.	WGS	e56f2db4726f327debd64334f96bcd04	e56f2db4726f327debd64334f96bcd04.bam	45.06	NA	0.08	58cfa83ce4b0c9d6adf72ed8	e56f2db4726f327debd64334f96bcd04.bam	Dead	FEMALE	WHITE	Not available	Sarcoma	Aligned reads	TCGA-IW-A3M5-01A	C20682A1-F340-430D-99F9-077FE093ED19	Primary Tumor	Illumina HiSeq	83802f59-1279-444a-b96b-4bbdf0aa3baa	Mesenchymal	76	34B60937-76B3-401C-A8DD-3F78E2B20A38	03CED0CE-186A-4349-8D98-572C2BC90382	TCGA-IW-A3M5-01A-22D-A21Q-09	GRCh37-lite	TCGA-IW-A3M5	TCGA-SARC	180	s2671	Washington University School of Medicine	Cedars Sinai	United States	NO	Not available	Not available	Not available	Not available	A21Q-09	TRUE
13722.58cfa83ce4b0c9d6adf72edb	58cfa83ce4b0c9d6adf72edb	df4a0a1fa966f237f85dc788514a4f3f.filtered.	WGS	df4a0a1fa966f237f85dc788514a4f3f	df4a0a1fa966f237f85dc788514a4f3f.bam	18.8	NA	0.08	58cfa83ce4b0c9d6adf72edb	df4a0a1fa966f237f85dc788514a4f3f.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-EW-A3U0-01A	D9DC3B59-613D-469E-8B4F-6C5A557EB26A	Primary Tumor	Illumina HiSeq	107557e5-5611-4f30-9544-e8c315cb063d	Breast	61	549F03A5-3F91-4975-9EEB-AA062264A602	0448206F-3ADE-4087-B1A9-4FB2D14E1367	TCGA-EW-A3U0-01A-11D-A228-09	GRCh37-lite	TCGA-EW-A3U0	TCGA-BRCA	NA	s6610	Washington University School of Medicine	University of Miami	United States	NO	T3	N1a	Infiltrating Ductal Carcinoma	Stage IIIA	A228-09	FALSE
13722.58cfa83ce4b0c9d6adf72ef4	58cfa83ce4b0c9d6adf72ef4	adc8fcb8e8a780076e27704767013d83.filtered.	WGS	adc8fcb8e8a780076e27704767013d83	adc8fcb8e8a780076e27704767013d83.bam	15.93	NA	0.08	58cfa83ce4b0c9d6adf72ef4	adc8fcb8e8a780076e27704767013d83.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Sarcoma	Aligned reads	TCGA-DX-A240-01A	3608BFBB-2A92-4EC2-A330-BF4790A8B65C	Primary Tumor	Illumina HiSeq	d31b896e-0c05-4b82-9143-a039f927b80f	Mesenchymal	51	8ACAF190-5A0D-440C-9C9A-B9EABDF661BE	3DB6E6CC-1A06-49B9-834E-B6611CDE4C4B	TCGA-DX-A240-01A-32D-A27P-09	GRCh37-lite	TCGA-DX-A240	TCGA-SARC	NA	s2670	Washington University School of Medicine	Memorial Sloan Kettering	United States	NO	Not available	Not available	Not available	Not available	A27P-09	FALSE
13722.58cfa83ce4b0c9d6adf72f45	58cfa83ce4b0c9d6adf72f45	e731bc4a6b242f2c3e68d238e90047f3.filtered.	WGS	e731bc4a6b242f2c3e68d238e90047f3	e731bc4a6b242f2c3e68d238e90047f3.bam	50.54	1.82	0.08	58cfa83ce4b0c9d6adf72f45	e731bc4a6b242f2c3e68d238e90047f3.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Sarcoma	Aligned reads	TCGA-DX-A23R-01A	B5F27002-4277-418D-90B0-CC5A2742692E	Primary Tumor	Illumina HiSeq	8611bde3-531a-4ac4-a742-255c5bd80352	Mesenchymal	55	05FC5924-07B1-422E-9D7C-7C0051F72368	35C797FD-CA81-4CEF-B6C4-7E3776F661B3	TCGA-DX-A23R-01A-11D-A26G-09	GRCh37-lite	TCGA-DX-A23R	TCGA-SARC	NA	s2632	Washington University School of Medicine	Memorial Sloan Kettering	United States	NO	Not available	Not available	Not available	Not available	A26G-09	FALSE
13722.58cfa83ce4b0c9d6adf72f0d	58cfa83ce4b0c9d6adf72f0d	b1b5f931c81fbd7859691665e3448ee8.filtered.	WGS	b1b5f931c81fbd7859691665e3448ee8	b1b5f931c81fbd7859691665e3448ee8.bam	7.27	NA	0.08	58cfa83ce4b0c9d6adf72f0d	b1b5f931c81fbd7859691665e3448ee8.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Sarcoma	Aligned reads	TCGA-DX-A1L0-01A	854E42BC-95B2-4B77-A4B2-FFBD6C28B281	Primary Tumor	Illumina HiSeq	f7205545-f757-4561-b291-cfe76e7014de	Mesenchymal	58	87E0C11A-CF75-4877-B4C8-23AA36631B4F	1C188BF5-2C99-4EB4-A774-59C75D53E643	TCGA-DX-A1L0-01A-11D-A24N-09	GRCh37-lite	TCGA-DX-A1L0	TCGA-SARC	564	s2461	Washington University School of Medicine	Memorial Sloan Kettering	United States	NO	Not available	Not available	Not available	Not available	A24N-09	TRUE
13722.58cfa83ce4b0c9d6adf72f2c	58cfa83ce4b0c9d6adf72f2c	e886a9905c6ddb08a07cd12351b2978e.filtered.	WGS	e886a9905c6ddb08a07cd12351b2978e	e886a9905c6ddb08a07cd12351b2978e.bam	6.36	NA	0.07	58cfa83ce4b0c9d6adf72f2c	e886a9905c6ddb08a07cd12351b2978e.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Sarcoma	Aligned reads	TCGA-DX-A1L2-01A	73D2E8EF-4E10-416A-845B-F48374E48ECB	Primary Tumor	Illumina HiSeq	f6170f04-5598-4fb8-9027-6176921b624d	Mesenchymal	78	901DFD62-799D-4E40-926E-22A5FD859B5A	4C59FB2D-21B6-4B09-8174-6102DE736E4D	TCGA-DX-A1L2-01A-22D-A24N-09	GRCh37-lite	TCGA-DX-A1L2	TCGA-SARC	NA	s2633	Washington University School of Medicine	Memorial Sloan Kettering	United States	NO	Not available	Not available	Not available	Not available	A24N-09	TRUE
13722.58cfa83ce4b0c9d6adf72f6c	58cfa83ce4b0c9d6adf72f6c	e869d292dcb3ead5c9128b76af2ac4bb.filtered.	WGS	e869d292dcb3ead5c9128b76af2ac4bb	e869d292dcb3ead5c9128b76af2ac4bb.bam	83.48	1.95	0.08	58cfa83ce4b0c9d6adf72f6c	e869d292dcb3ead5c9128b76af2ac4bb.bam	Dead	FEMALE	WHITE	Not available	Breast Invasive Carcinoma	Aligned reads	TCGA-AR-A256-01A	D3D545B3-457F-4389-821F-704CB24AFF7F	Primary Tumor	Illumina HiSeq	83a38860-cf50-4344-8dbf-97d4cda96864	Breast	45	87676C70-E2AD-4103-8BC0-3D3C1E40A790	EA43434B-197E-48AC-AE2E-46BC7F3776DE	TCGA-AR-A256-01A-11D-A167-09	GRCh37-lite	TCGA-AR-A256	TCGA-BRCA	2854	s6448	Washington University School of Medicine	Mayo	United States	NO	T2	N0	Infiltrating Ductal Carcinoma	Stage IIA	A167-09	FALSE
13722.58cfa83ce4b0c9d6adf72f7f	58cfa83ce4b0c9d6adf72f7f	a94a5ada9a0bb0f8ace6de28512984f7.filtered.	WGS	a94a5ada9a0bb0f8ace6de28512984f7	a94a5ada9a0bb0f8ace6de28512984f7.bam	110.87	2.41	0.08	58cfa83ce4b0c9d6adf72f7f	a94a5ada9a0bb0f8ace6de28512984f7.bam	Alive	FEMALE	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-BS-A0V8-01A	2B76CC9C-C379-43E4-9C3F-56197A3353BE	Primary Tumor	Illumina HiSeq	9fd5dab8-8c05-4a1c-829e-8e86285bc04f	Uterus	68	CF369A2C-D3C3-4FA3-B004-E4269530CEFF	8D4CB709-C95C-4BDC-844B-C0BFA2A3028E	TCGA-BS-A0V8-01A-11D-A122-09	GRCh37-lite	TCGA-BS-A0V8	TCGA-UCEC	NA	s5178	Washington University School of Medicine	University of Hawaii	None	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A122-09	TRUE
13722.58cfa83ce4b0c9d6adf72f7b	58cfa83ce4b0c9d6adf72f7b	ea3e2e897deb676e1aa5ff1ce3ef39eb.filtered.	WGS	ea3e2e897deb676e1aa5ff1ce3ef39eb	ea3e2e897deb676e1aa5ff1ce3ef39eb.bam	18.52	NA	0.08	58cfa83ce4b0c9d6adf72f7b	ea3e2e897deb676e1aa5ff1ce3ef39eb.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Sarcoma	Aligned reads	TCGA-IF-A4AJ-01A	4E8C570C-3CBE-4878-8B2C-B966868DD60D	Primary Tumor	Illumina HiSeq	5773814e-9b28-40f3-9285-0eed8b3ba493	Mesenchymal	80	86AE3E79-5C03-480F-8A5A-35BAC00CB89D	D53C2680-89AC-4F87-A7BA-F4C669546B76	TCGA-IF-A4AJ-01A-11D-A24N-09	GRCh37-lite	TCGA-IF-A4AJ	TCGA-SARC	767	s2634	Washington University School of Medicine	University of Texas MD Anderson Cancer Center	United States	NO	Not available	Not available	Not available	Not available	A24N-09	TRUE
13722.58cfa83ce4b0c9d6adf72fb2	58cfa83ce4b0c9d6adf72fb2	a71534313dd3551e1b02d0eed8d54add.filtered.	WGS	a71534313dd3551e1b02d0eed8d54add	a71534313dd3551e1b02d0eed8d54add.bam	55.26	NA	0.08	58cfa83ce4b0c9d6adf72fb2	a71534313dd3551e1b02d0eed8d54add.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-AR-A2LK-01A	1B703058-E596-45BC-80FE-8B98D545C2E2	Primary Tumor	Illumina HiSeq	452eb1a3-2221-409b-a97e-f3266c5737cd	Breast	62	D6F5C34A-0F5C-4AED-977A-74A1E5D50915	7B0B60C7-5FA0-440E-937F-8D82119330D6	TCGA-AR-A2LK-01A-11D-A17W-09	GRCh37-lite	TCGA-AR-A2LK	TCGA-BRCA	NA	s6746	Washington University School of Medicine	Mayo	United States	NO	T3	N2	Infiltrating Lobular Carcinoma	Stage III	A17W-09	FALSE
13722.58cfa83ce4b0c9d6adf72f9a	58cfa83ce4b0c9d6adf72f9a	a246b48a0a312eda5cafb748151a117b.filtered.	WGS	a246b48a0a312eda5cafb748151a117b	a246b48a0a312eda5cafb748151a117b.bam	74.65	1.93	0.09	58cfa83ce4b0c9d6adf72f9a	a246b48a0a312eda5cafb748151a117b.bam	Alive	FEMALE	WHITE	Not available	Breast Invasive Carcinoma	Aligned reads	TCGA-AR-A24Z-01A	9FEFBE7C-F66A-4940-843E-285CB7B392C1	Primary Tumor	Illumina HiSeq	1251c29c-8d85-4187-80dd-c459542e3080	Breast	57	5CDD3886-898B-4861-A748-D4164CE14A07	6C65CB6D-8C50-4C7C-BC84-EEEBE09FBE01	TCGA-AR-A24Z-01A-11D-A314-09	GRCh37-lite	TCGA-AR-A24Z	TCGA-BRCA	NA	s5942	Washington University School of Medicine	Mayo	United States	NO	T2	N0	Infiltrating Ductal Carcinoma	Stage IIA	A314-09	TRUE
13722.58cfa83ce4b0c9d6adf72fbd	58cfa83ce4b0c9d6adf72fbd	a765afe852088b93b14f4f8d87893494.filtered.	WGS	a765afe852088b93b14f4f8d87893494	a765afe852088b93b14f4f8d87893494.bam	49.61	2.14	0.08	58cfa83ce4b0c9d6adf72fbd	a765afe852088b93b14f4f8d87893494.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-B6-A0RE-01A	08DA7C4C-3067-4BCF-9D7A-78566DF72E69	Primary Tumor	Illumina HiSeq	6ed22fe1-529a-4ad1-8eb3-f50a383e4df4	Breast	61	270BE245-2239-4E96-A917-79CCA40868BA	1EB62ABC-7928-405B-84CC-F091CA5347B2	TCGA-B6-A0RE-01A-11D-A128-09	GRCh37-lite	TCGA-B6-A0RE	TCGA-BRCA	NA	s6250	Washington University School of Medicine	Duke	United States	NO	TX	N0 (i-)	Infiltrating Ductal Carcinoma	Stage X	A128-09	TRUE
13722.58cfa83ce4b0c9d6adf72f73	58cfa83ce4b0c9d6adf72f73	f0f3dfb66995edcb514e1ccebc2c7e4d.filtered.	WGS	f0f3dfb66995edcb514e1ccebc2c7e4d	f0f3dfb66995edcb514e1ccebc2c7e4d.bam	61.2	1.96	0.09	58cfa83ce4b0c9d6adf72f73	f0f3dfb66995edcb514e1ccebc2c7e4d.bam	Alive	FEMALE	ASIAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-C8-A130-01A	8CF54607-01CE-42B0-9BD9-8627EDD9F3B7	Primary Tumor	Illumina HiSeq	e70e14f9-ea63-4038-8a0e-5526391ea4fe	Breast	52	3BEA8456-DA16-4691-A260-5C94A83E2860	27F87D1E-2C32-4BEB-9677-62F7A286673D	TCGA-C8-A130-01A-31D-A19H-09	GRCh37-lite	TCGA-C8-A130	TCGA-BRCA	NA	s6751	Washington University School of Medicine	ILSbio	Vietnam	NO	T3	N2	Infiltrating Ductal Carcinoma	Stage IIIA	A19H-09	TRUE
13722.58cfa83ce4b0c9d6adf73082	58cfa83ce4b0c9d6adf73082	f56bc74c20a188c53b338d30ab71d4e2.filtered.	WGS	f56bc74c20a188c53b338d30ab71d4e2	f56bc74c20a188c53b338d30ab71d4e2.bam	89.42	1.98	0.08	58cfa83ce4b0c9d6adf73082	f56bc74c20a188c53b338d30ab71d4e2.bam	Alive	FEMALE	WHITE	Not available	Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-C5-A1BJ-01A	7941D1C7-5319-4E8D-A15F-60B61CB68A9B	Primary Tumor	Illumina HiSeq	0990b367-e2b6-4b2a-8ca1-dd9efab1866a	Cervix	34	C7B95D35-7FE9-4C25-94C6-AE6D7416A5C7	43BE43CB-A367-4A74-94E4-973ACAFCF576	TCGA-C5-A1BJ-01A-11D-A200-09	GRCh37-lite	TCGA-C5-A1BJ	TCGA-CESC	NA	s1344	Washington University School of Medicine	Medical College of Wisconsin	United States	NO	Not available	Not available	Cervical Squamous Cell Carcinoma	Not available	A200-09	TRUE
13722.58cfa83ce4b0c9d6adf7308c	58cfa83ce4b0c9d6adf7308c	faba826f62de3e18afab489ceee4b813.filtered.	WGS	faba826f62de3e18afab489ceee4b813	faba826f62de3e18afab489ceee4b813.bam	6.41	NA	0.07	58cfa83ce4b0c9d6adf7308c	faba826f62de3e18afab489ceee4b813.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Sarcoma	Aligned reads	TCGA-DX-A1KW-01A	CD73A55F-03C1-4DA0-9FA7-1AE4A263664E	Primary Tumor	Illumina HiSeq	1ac5c6a6-b264-4f58-b9fb-983c540128a7	Mesenchymal	67	4C93C0A4-73C4-48EF-91E0-40B2143833BC	63DB50D6-5EF2-44D0-9906-26EAE74ECF44	TCGA-DX-A1KW-01A-22D-A24N-09	GRCh37-lite	TCGA-DX-A1KW	TCGA-SARC	NA	s2636	Washington University School of Medicine	Memorial Sloan Kettering	United States	NO	Not available	Not available	Not available	Not available	A24N-09	TRUE
13722.58cfa83ce4b0c9d6adf730ac	58cfa83ce4b0c9d6adf730ac	ac2e74d430052ab39f0e2d8a23113736.filtered.	WGS	ac2e74d430052ab39f0e2d8a23113736	ac2e74d430052ab39f0e2d8a23113736.bam	33.01	NA	0.1	58cfa83ce4b0c9d6adf730ac	ac2e74d430052ab39f0e2d8a23113736.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-GI-A2C9-01A	9F6BE944-83DE-42AB-8738-F0022F475E61	Primary Tumor	Illumina HiSeq	5f4a8fdf-00c0-4ab7-8323-d04f23a9e4a8	Breast	58	143FC27D-E119-48FF-A5EA-BD6AAFC0404E	5DBF3203-CE73-41E4-BF9A-32FC856F73F5	TCGA-GI-A2C9-01A-11D-A21Q-09	GRCh37-lite	TCGA-GI-A2C9	TCGA-BRCA	NA	s5943	Washington University School of Medicine	ABS - IUPUI	United States	NO	T3	N0	Infiltrating Ductal Carcinoma	Stage IIB	A21Q-09	TRUE
13722.58cfa83ce4b0c9d6adf730ed	58cfa83ce4b0c9d6adf730ed	b2e10818826b4072c8f92e5b678b4332.filtered.	WGS	b2e10818826b4072c8f92e5b678b4332	b2e10818826b4072c8f92e5b678b4332.bam	76.73	1.92	0.08	58cfa83ce4b0c9d6adf730ed	b2e10818826b4072c8f92e5b678b4332.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-B6-A0IQ-01A	01EEF340-598C-4205-A990-CEC190AC2CA5	Primary Tumor	Illumina HiSeq	7f45dc68-74e8-4953-8221-00c2ba51dee4	Breast	40	183A47B2-1B00-4A72-ADEB-F35B55692EE1	8956D73D-7E36-4129-8A3E-D4F3B43BAF0B	TCGA-B6-A0IQ-01A-11D-A128-09	GRCh37-lite	TCGA-B6-A0IQ	TCGA-BRCA	NA	s6102	Washington University School of Medicine	Duke	United States	NO	T3	N1b	Infiltrating Ductal Carcinoma	Stage IIIA	A128-09	TRUE
13722.58cfa83ce4b0c9d6adf730c0	58cfa83ce4b0c9d6adf730c0	fd78ff5c667f21aef8657e218f7021a2.filtered.	WGS	fd78ff5c667f21aef8657e218f7021a2	fd78ff5c667f21aef8657e218f7021a2.bam	24.76	NA	0.08	58cfa83ce4b0c9d6adf730c0	fd78ff5c667f21aef8657e218f7021a2.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Sarcoma	Aligned reads	TCGA-FX-A3NJ-01A	7BAB6742-4E3D-4FCF-9B90-D3E0218B4D79	Primary Tumor	Illumina HiSeq	4031a13e-df1e-4608-8d52-01b9b1c04b9d	Mesenchymal	54	29FDA349-D725-4F69-BB11-95D5454400F4	408ED640-75F6-4346-BDD0-3B93C51ADAE5	TCGA-FX-A3NJ-01A-11D-A21Q-09	GRCh37-lite	TCGA-FX-A3NJ	TCGA-SARC	NA	s2672	Washington University School of Medicine	International Genomics Consortium	United States	NO	Not available	Not available	Not available	Not available	A21Q-09	TRUE
13722.58cfa83ce4b0c9d6adf730e0	58cfa83ce4b0c9d6adf730e0	ee32938babfe9b6967e9a4c5f49435dd.filtered.	WGS	ee32938babfe9b6967e9a4c5f49435dd	ee32938babfe9b6967e9a4c5f49435dd.bam	84.77	1.86	0.08	58cfa83ce4b0c9d6adf730e0	ee32938babfe9b6967e9a4c5f49435dd.bam	Alive	FEMALE	WHITE	Not available	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-AP-A0LD-01A	1200C8B7-A058-4C01-BBE2-04EC09A65245	Primary Tumor	Illumina HiSeq	d3a5aa02-ef8e-4ad1-adca-1c4b867fe524	Uterus	63	649DADDA-5823-4B0D-B5A2-49F501ADC029	9D2671B9-BD30-4E3C-AA74-01E31DD2531E	TCGA-AP-A0LD-01A-11D-A066-09	GRCh37-lite	TCGA-AP-A0LD	TCGA-UCEC	NA	s5185	Washington University School of Medicine	MSKCC	None	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A066-09	TRUE
13722.58cfa83ce4b0c9d6adf730fa	58cfa83ce4b0c9d6adf730fa	c03fa22a7c8629afd7ba660ae443cddc.filtered.	WGS	c03fa22a7c8629afd7ba660ae443cddc	c03fa22a7c8629afd7ba660ae443cddc.bam	74.86	1.88	0.08	58cfa83ce4b0c9d6adf730fa	c03fa22a7c8629afd7ba660ae443cddc.bam	Alive	FEMALE	WHITE	Not available	Breast Invasive Carcinoma	Aligned reads	TCGA-A2-A04Q-01A	B5FBA77B-1F50-4E71-95B2-566AFBA4BDD7	Primary Tumor	Illumina HiSeq	77a8d1fa-9421-4333-b128-8a4b8fddfc6f	Breast	48	E17E273D-6F53-4419-9F0C-1E4E667C5257	03B8122D-02D9-4AD0-96ED-001C0D100DE0	TCGA-A2-A04Q-01A-21D-A128-09	GRCh37-lite	TCGA-A2-A04Q	TCGA-BRCA	NA	s6903	Washington University School of Medicine	Walter Reed	None	NO	T1	N0 (i-)	Infiltrating Ductal Carcinoma	Stage IA	A128-09	TRUE
13722.58cfa83ce4b0c9d6adf7313a	58cfa83ce4b0c9d6adf7313a	ff180684131876b77d5fa19e93aaeb1e.filtered.	WGS	ff180684131876b77d5fa19e93aaeb1e	ff180684131876b77d5fa19e93aaeb1e.bam	52.23	NA	0.08	58cfa83ce4b0c9d6adf7313a	ff180684131876b77d5fa19e93aaeb1e.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Sarcoma	Aligned reads	TCGA-IW-A3M4-01A	0DA5EE6C-D012-4A57-9992-9D74937AAA5F	Primary Tumor	Illumina HiSeq	62a7d6f2-3b71-4449-83fe-da6beea65873	Mesenchymal	48	F854DB6B-57CB-4DA7-9252-B2ADE22C2675	6AA00162-6294-4CE7-B6B7-0C3452E24CD6	TCGA-IW-A3M4-01A-11D-A21Q-09	GRCh37-lite	TCGA-IW-A3M4	TCGA-SARC	NA	s2673	Washington University School of Medicine	Cedars Sinai	United States	NO	Not available	Not available	Not available	Not available	A21Q-09	TRUE
13722.58cfa83ce4b0c9d6adf73142	58cfa83ce4b0c9d6adf73142	e9efaac16efc09098f681fd6fdda9266.filtered.	WGS	e9efaac16efc09098f681fd6fdda9266	e9efaac16efc09098f681fd6fdda9266.bam	31.62	NA	0.08	58cfa83ce4b0c9d6adf73142	e9efaac16efc09098f681fd6fdda9266.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Sarcoma	Aligned reads	TCGA-DX-A3LS-01A	39F68467-3D37-4B19-AA43-ED7B120C619D	Primary Tumor	Illumina HiSeq	c94a5ebc-7224-41b0-96e9-6b057d782253	Mesenchymal	78	386455AA-441E-4BD2-A0A7-AD2ED278E5E6	075FC96D-6742-4EF3-9369-482592AD3A2F	TCGA-DX-A3LS-01A-11D-A21Q-09	GRCh37-lite	TCGA-DX-A3LS	TCGA-SARC	275	s2471	Washington University School of Medicine	Memorial Sloan Kettering	United States	NO	Not available	Not available	Not available	Not available	A21Q-09	TRUE
13722.58cfa83ce4b0c9d6adf731d0	58cfa83ce4b0c9d6adf731d0	ff361cc3e22a9619323ddbddf3aac564.filtered.	WGS	ff361cc3e22a9619323ddbddf3aac564	ff361cc3e22a9619323ddbddf3aac564.bam	49.41	NA	0.07	58cfa83ce4b0c9d6adf731d0	ff361cc3e22a9619323ddbddf3aac564.bam	Dead	MALE	Not available	Not available	Sarcoma	Aligned reads	TCGA-DX-A3U8-01A	D40C99D0-79F6-499D-B7F1-5FC4237CFC57	Primary Tumor	Illumina HiSeq	d104749e-66ed-4722-98a5-5d59447e5779	Mesenchymal	43	D40B2922-FA6A-4AFA-BDBF-7B517384AF74	729229FE-92B9-439B-ACD2-B49159116A41	TCGA-DX-A3U8-01A-11D-A29N-09	GRCh37-lite	TCGA-DX-A3U8	TCGA-SARC	138	s2638	Washington University School of Medicine	Memorial Sloan Kettering	United States	NO	Not available	Not available	Not available	Not available	A29N-09	FALSE
13722.58cfa83ce4b0c9d6adf731b8	58cfa83ce4b0c9d6adf731b8	b063d293e0df48fc160fc08c84c39531.filtered.	WGS	b063d293e0df48fc160fc08c84c39531	b063d293e0df48fc160fc08c84c39531.bam	9.71	NA	0.08	58cfa83ce4b0c9d6adf731b8	b063d293e0df48fc160fc08c84c39531.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Sarcoma	Aligned reads	TCGA-DX-A3LW-01A	2CACD9D0-8414-4F17-8259-C9D838597F39	Primary Tumor	Illumina HiSeq	0524db0d-7118-4575-ae31-3f7ebbf000c4	Mesenchymal	43	E25B5088-A3D4-4F3C-8335-308C571F6A30	9D691FA3-5C32-4B98-85C4-F6E0FD4C37E0	TCGA-DX-A3LW-01A-21D-A21Q-09	GRCh37-lite	TCGA-DX-A3LW	TCGA-SARC	NA	s2460	Washington University School of Medicine	Memorial Sloan Kettering	United States	NO	Not available	Not available	Not available	Not available	A21Q-09	TRUE
13722.58cfa82ee4b0c9d6adf6aee7	58cfa82ee4b0c9d6adf6aee7	TCGA-05-4410-01A-21D-1853_111204_SN208_0256_C0562ACXX_s_4_rg.sorted.filtered.	WGS	TCGA-05-4410-01A-21D-1853_111204_SN208_0256_C0562ACXX_s_4_rg.sorted	TCGA-05-4410-01A-21D-1853_111204_SN208_0256_C0562ACXX_s_4_rg.sorted.bam	182.7	1.9	0.16	58cfa82ee4b0c9d6adf6aee7	TCGA-05-4410-01A-21D-1853_111204_SN208_0256_C0562ACXX_s_4_rg.sorted.bam	Alive	MALE	Not available	Not available	Lung Adenocarcinoma	Aligned reads	TCGA-05-4410-01A	D28E465C-E553-4C53-8BB7-3D8199B9A8A5	Primary Tumor	Illumina HiSeq	bdcc8e9a-8d27-4167-ae6f-3c41b38c6c51	Lung	62	F8961F5C-E28B-44A2-8E4E-B5759FE2D849	51E2038A-2D9D-481D-A3B6-D5D5D6B33E4F	TCGA-05-4410-01A-21D-1853-02	HG19_Broad_variant	TCGA-05-4410	TCGA-LUAD	NA	s10773	Harvard Medical School	Indivumed	Germany	NO	T2	N0	Lung Adenocarcinoma Mixed Subtype	Stage IB	1853-02	TRUE
13722.58cfa82ee4b0c9d6adf6ae6c	58cfa82ee4b0c9d6adf6ae6c	TCGA-05-4405-01A-21D-1853_111204_SN208_0256_C0562ACXX_s_2.rg.sorted.filtered.	WGS	TCGA-05-4405-01A-21D-1853_111204_SN208_0256_C0562ACXX_s_2.rg.sorted	TCGA-05-4405-01A-21D-1853_111204_SN208_0256_C0562ACXX_s_2.rg.sorted.bam	175.7	1.9	0.17	58cfa82ee4b0c9d6adf6ae6c	TCGA-05-4405-01A-21D-1853_111204_SN208_0256_C0562ACXX_s_2.rg.sorted.bam	Alive	FEMALE	Not available	Not available	Lung Adenocarcinoma	Aligned reads	TCGA-05-4405-01A	F587C9AB-2949-4410-80D6-A050865D48AA	Primary Tumor	Illumina HiSeq	47fe3db4-7a54-4703-b3a4-7ad7def2469c	Lung	74	9CE83CC4-7B9B-4CE7-98F5-5CE8A8D70902	8A9ADFB9-6266-490D-B1B6-F66F43F3F657	TCGA-05-4405-01A-21D-1853-02	HG19_Broad_variant	TCGA-05-4405	TCGA-LUAD	NA	s10768	Harvard Medical School	Indivumed	Germany	NO	T2	N0	Lung Adenocarcinoma Mixed Subtype	Stage IB	1853-02	TRUE
13722.58cfa82fe4b0c9d6adf6b5dc	58cfa82fe4b0c9d6adf6b5dc	TCGA-50-5939-01A-11D-1623_120302_SN208_0271_BC0D91ACXX_s_3_rg.sorted.filtered.	WGS	TCGA-50-5939-01A-11D-1623_120302_SN208_0271_BC0D91ACXX_s_3_rg.sorted	TCGA-50-5939-01A-11D-1623_120302_SN208_0271_BC0D91ACXX_s_3_rg.sorted.bam	111.7	1.9	0.15	58cfa82fe4b0c9d6adf6b5dc	TCGA-50-5939-01A-11D-1623_120302_SN208_0271_BC0D91ACXX_s_3_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-50-5939-01A	12B79B4F-C28C-418E-A1E7-E622F33FDCC2	Primary Tumor	Illumina HiSeq	7a3d6187-a909-4946-83bf-0d6fc6a753ee	Lung	85	6A27F5F8-F4EE-45C7-B953-DDD7D0291DBB	08D803D0-A294-4F70-9560-563357172BBB	TCGA-50-5939-01A-11D-1623-02	HG19_Broad_variant	TCGA-50-5939	TCGA-LUAD	460	s11007	Harvard Medical School	University of Pittsburgh	United States	NO	T2	N0	Lung Adenocarcinoma Mixed Subtype	Stage IB	1623-02	TRUE
13722.58cfa82ee4b0c9d6adf6afae	58cfa82ee4b0c9d6adf6afae	TCGA-05-4425-01A-01D-1751_120305_SN1120_0118_AD0L4HACXX_s_3_rg.sorted.filtered.	WGS	TCGA-05-4425-01A-01D-1751_120305_SN1120_0118_AD0L4HACXX_s_3_rg.sorted	TCGA-05-4425-01A-01D-1751_120305_SN1120_0118_AD0L4HACXX_s_3_rg.sorted.bam	357.4	1.9	0.15	58cfa82ee4b0c9d6adf6afae	TCGA-05-4425-01A-01D-1751_120305_SN1120_0118_AD0L4HACXX_s_3_rg.sorted.bam	Alive	FEMALE	Not available	Not available	Lung Adenocarcinoma	Aligned reads	TCGA-05-4425-01A	69B23036-ADD9-42C9-941F-02FB74D9B08C	Primary Tumor	Illumina HiSeq	bf137f71-691f-42f6-a29c-e37a457bad18	Lung	70	98BEE17E-0B07-40D8-A70F-3163DBFD9C79	C0DC5772-8A3E-43BE-9059-FC524A5183C9	TCGA-05-4425-01A-01D-1751-02	HG19_Broad_variant	TCGA-05-4425	TCGA-LUAD	NA	s10775	Harvard Medical School	Indivumed	Germany	NO	T2	N0	Lung Adenocarcinoma Mixed Subtype	Stage IV	1751-02	TRUE
13722.58cfa82fe4b0c9d6adf6b720	58cfa82fe4b0c9d6adf6b720	TCGA-67-6217-01A-11D-1751_120309_SN208_0274_AD0R6DACXX_s_3_rg.sorted.filtered.	WGS	TCGA-67-6217-01A-11D-1751_120309_SN208_0274_AD0R6DACXX_s_3_rg.sorted	TCGA-67-6217-01A-11D-1751_120309_SN208_0274_AD0R6DACXX_s_3_rg.sorted.bam	282.4	1.9	0.13	58cfa82fe4b0c9d6adf6b720	TCGA-67-6217-01A-11D-1751_120309_SN208_0274_AD0R6DACXX_s_3_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-67-6217-01A	108A71CF-B9DB-47CD-AA74-C03EC989B41B	Primary Tumor	Illumina HiSeq	cb2962fe-7f6e-4a68-871a-11d696bb5279	Lung	73	BC0FE45C-3249-46D7-8991-C6888F0B9579	565E717D-310B-4FB1-B79A-5F40FF12BBB8	TCGA-67-6217-01A-11D-1751-02	HG19_Broad_variant	TCGA-67-6217	TCGA-LUAD	NA	s11244	Harvard Medical School	St Joseph's Medical Center (MD)	United States	NO	T2a	N1	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage IIA	1751-02	TRUE
13722.58cfa82fe4b0c9d6adf6b81e	58cfa82fe4b0c9d6adf6b81e	TCGA-A5-A0GE-01A-11D-A043_120214_SN590_0139_BC0DYEACXX_s_1_rg.sorted.filtered.	WGS	TCGA-A5-A0GE-01A-11D-A043_120214_SN590_0139_BC0DYEACXX_s_1_rg.sorted	TCGA-A5-A0GE-01A-11D-A043_120214_SN590_0139_BC0DYEACXX_s_1_rg.sorted.bam	82.92	2	0.17	58cfa82fe4b0c9d6adf6b81e	TCGA-A5-A0GE-01A-11D-A043_120214_SN590_0139_BC0DYEACXX_s_1_rg.sorted.bam	Alive	FEMALE	ASIAN	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-A5-A0GE-01A	A587E62E-430E-4F1B-82B7-6FBE856FDAF1	Primary Tumor	Illumina HiSeq	d3918efd-f063-4ea7-b839-9c0c143fd07c	Uterus	38	20C3F64D-ACF6-45B3-9ACE-2F93B3A951C8	3E23FB82-C875-460A-B19D-5EF9DCC58B9A	TCGA-A5-A0GE-01A-11D-A043-02	HG19_Broad_variant	TCGA-A5-A0GE	TCGA-UCEC	NA	s4995	Harvard Medical School	Cedars Sinai	None	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A043-02	TRUE
13722.58cfa82ee4b0c9d6adf6ae60	58cfa82ee4b0c9d6adf6ae60	TCGA-05-4390-01A-02D-1751_120305_SN1120_0118_AD0L4HACXX_s_1_rg.sorted.filtered.	WGS	TCGA-05-4390-01A-02D-1751_120305_SN1120_0118_AD0L4HACXX_s_1_rg.sorted	TCGA-05-4390-01A-02D-1751_120305_SN1120_0118_AD0L4HACXX_s_1_rg.sorted.bam	827.4	1.9	0.14	58cfa82ee4b0c9d6adf6ae60	TCGA-05-4390-01A-02D-1751_120305_SN1120_0118_AD0L4HACXX_s_1_rg.sorted.bam	Alive	FEMALE	Not available	Not available	Lung Adenocarcinoma	Aligned reads	TCGA-05-4390-01A	B8475929-2D9D-4909-BD62-59684A140BD7	Primary Tumor	Illumina HiSeq	625e3715-ed9e-4946-8c92-f5a93e92e6d4	Lung	58	C7F76210-D0F2-4FB8-80F1-35098DBE03DE	4BC393B5-F924-4D66-BC93-58A3CB2EBBC5	TCGA-05-4390-01A-02D-1751-02	HG19_Broad_variant	TCGA-05-4390	TCGA-LUAD	NA	s11328	Harvard Medical School	Indivumed	Germany	NO	T2	N0	Lung Adenocarcinoma Mixed Subtype	Stage IB	1751-02	TRUE
13722.58cfa82fe4b0c9d6adf6b674	58cfa82fe4b0c9d6adf6b674	TCGA-71-6725-01A-11D-1853_120312_SN1120_0121_BD0RHPACXX_s_7_rg.sorted.filtered.	WGS	TCGA-71-6725-01A-11D-1853_120312_SN1120_0121_BD0RHPACXX_s_7_rg.sorted	TCGA-71-6725-01A-11D-1853_120312_SN1120_0121_BD0RHPACXX_s_7_rg.sorted.bam	406.7	1.9	0.14	58cfa82fe4b0c9d6adf6b674	TCGA-71-6725-01A-11D-1853_120312_SN1120_0121_BD0RHPACXX_s_7_rg.sorted.bam	Alive	FEMALE	ASIAN	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-71-6725-01A	4B7CD595-E7F9-45A8-B736-A8C7C42D9539	Primary Tumor	Illumina HiSeq	9c1abbc4-5f6b-486c-a6a3-17a01c8783cb	Lung	48	83973755-FA6A-460A-A042-385B34698C39	1AD7566E-B9DD-43A3-94DC-96F525007EAA	TCGA-71-6725-01A-11D-1853-02	HG19_Broad_variant	TCGA-71-6725	TCGA-LUAD	NA	s11554	Harvard Medical School	ILSbio	Vietnam	NO	T2	N0	Lung Papillary Adenocarcinoma	Stage IB	1853-02	TRUE
13722.58cfa82fe4b0c9d6adf6b92a	58cfa82fe4b0c9d6adf6b92a	TCGA-91-6828-01A-11D-1853_120310_SN590_0144_AD0PNFACXX_s_3_rg.sorted.filtered.	WGS	TCGA-91-6828-01A-11D-1853_120310_SN590_0144_AD0PNFACXX_s_3_rg.sorted	TCGA-91-6828-01A-11D-1853_120310_SN590_0144_AD0PNFACXX_s_3_rg.sorted.bam	349.7	1.9	0.14	58cfa82fe4b0c9d6adf6b92a	TCGA-91-6828-01A-11D-1853_120310_SN590_0144_AD0PNFACXX_s_3_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-91-6828-01A	9536E32D-2707-48D2-A36D-08C521665BB9	Primary Tumor	Illumina HiSeq	94e2b6af-1f25-4698-9414-f3d916d26aee	Lung	70	CFE0F0E4-D8BF-40CE-99F1-2BF99CECA18B	2C0D4A9F-857D-4C6F-B616-304AB5922A2F	TCGA-91-6828-01A-11D-1853-02	HG19_Broad_variant	TCGA-91-6828	TCGA-LUAD	NA	s10802	Harvard Medical School	ABS - IUPUI	United States	NO	T1a	N0	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage IA	1853-02	TRUE
13722.58cfa82fe4b0c9d6adf6b9ab	58cfa82fe4b0c9d6adf6b9ab	TCGA-44-6777-01A-11D-1853_120123_SN590_0134_AC0DJKACXX_s_2_rg.sorted.filtered.	WGS	TCGA-44-6777-01A-11D-1853_120123_SN590_0134_AC0DJKACXX_s_2_rg.sorted	TCGA-44-6777-01A-11D-1853_120123_SN590_0134_AC0DJKACXX_s_2_rg.sorted.bam	36.7	1.9	0.15	58cfa82fe4b0c9d6adf6b9ab	TCGA-44-6777-01A-11D-1853_120123_SN590_0134_AC0DJKACXX_s_2_rg.sorted.bam	Dead	FEMALE	WHITE	Not available	Lung Adenocarcinoma	Aligned reads	TCGA-44-6777-01A	349E6F38-2C67-4A69-A777-B9173A2A27CF	Primary Tumor	Illumina HiSeq	8f0fdfb5-6a7c-4e9a-9a4f-d32f9aca542d	Lung	85	174E4405-4848-4E5E-93CC-0CDF2795C91A	AAAAE42F-88A5-4E99-8057-A92D6759BE19	TCGA-44-6777-01A-11D-1853-02	HG19_Broad_variant	TCGA-44-6777	TCGA-LUAD	987	s11550	Harvard Medical School	Christiana Healthcare	United States	NO	T2	NX	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage IB	1853-02	TRUE
13722.58cfa82fe4b0c9d6adf6b932	58cfa82fe4b0c9d6adf6b932	TCGA-91-6836-01A-21D-1853_120310_SN590_0144_AD0PNFACXX_s_7_rg.sorted.filtered.	WGS	TCGA-91-6836-01A-21D-1853_120310_SN590_0144_AD0PNFACXX_s_7_rg.sorted	TCGA-91-6836-01A-21D-1853_120310_SN590_0144_AD0PNFACXX_s_7_rg.sorted.bam	278.7	1.9	0.14	58cfa82fe4b0c9d6adf6b932	TCGA-91-6836-01A-21D-1853_120310_SN590_0144_AD0PNFACXX_s_7_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-91-6836-01A	0B31DBDF-0623-48E4-A0EC-017650DCEDA7	Primary Tumor	Illumina HiSeq	68fe0529-8b54-4c01-83f0-a5dc5097e2cb	Lung	52	49A0AB8A-F379-4394-ACCF-0B4B08D2DCC6	0D6B80DD-76A1-4174-9275-731B4A347213	TCGA-91-6836-01A-21D-1853-02	HG19_Broad_variant	TCGA-91-6836	TCGA-LUAD	NA	s10669	Harvard Medical School	ABS - IUPUI	United States	NO	T2	N0	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage IB	1853-02	TRUE
13722.58cfa830e4b0c9d6adf6ba81	58cfa830e4b0c9d6adf6ba81	TCGA-91-6831-01A-11D-1853_120305_SN1120_0119_BD0REAACXX_s_4_rg.sorted.filtered.	WGS	TCGA-91-6831-01A-11D-1853_120305_SN1120_0119_BD0REAACXX_s_4_rg.sorted	TCGA-91-6831-01A-11D-1853_120305_SN1120_0119_BD0REAACXX_s_4_rg.sorted.bam	196.7	1.9	0.14	58cfa830e4b0c9d6adf6ba81	TCGA-91-6831-01A-11D-1853_120305_SN1120_0119_BD0REAACXX_s_4_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-91-6831-01A	DB0B9E63-4272-4F29-BF0E-1EC0FE79A9D7	Primary Tumor	Illumina HiSeq	319d6c8c-207c-477a-8254-30695b75f9e2	Lung	66	7B1D8B50-F3DF-4AAB-A654-C3810D8D576D	0D0D96AE-A83B-4C09-8ED9-4A568E816EFC	TCGA-91-6831-01A-11D-1853-02	HG19_Broad_variant	TCGA-91-6831	TCGA-LUAD	NA	s10670	Harvard Medical School	ABS - IUPUI	United States	NO	T2	N0	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage IB	1853-02	TRUE
13722.58cfa830e4b0c9d6adf6be70	58cfa830e4b0c9d6adf6be70	TCGA-BJ-A28R-01A-11D-A16N_121204_SN208_0442_BC1F7YACXX_s_7_rg.sorted.filtered.	WGS	TCGA-BJ-A28R-01A-11D-A16N_121204_SN208_0442_BC1F7YACXX_s_7_rg.sorted	TCGA-BJ-A28R-01A-11D-A16N_121204_SN208_0442_BC1F7YACXX_s_7_rg.sorted.bam	82.3	2.03	0.16	58cfa830e4b0c9d6adf6be70	TCGA-BJ-A28R-01A-11D-A16N_121204_SN208_0442_BC1F7YACXX_s_7_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-BJ-A28R-01A	524A39EE-8FA3-418E-98A2-A6A90E9C8064	Primary Tumor	Illumina HiSeq	122e0c7e-da24-4121-907e-8b913b4e4147	Thyroid	38	F4906B86-3971-4ED3-AC3C-69635311FB45	A5170F7D-F298-4330-8272-8DACFF7775A1	TCGA-BJ-A28R-01A-11D-A16N-02	HG19_Broad_variant	TCGA-BJ-A28R	TCGA-THCA	NA	s11987	Harvard Medical School	University of Pittsburgh	United States	NO	T1	N0	Thyroid Papillary Carcinoma - Classical/usual	Stage I	A16N-02	TRUE
13722.58cfa82fe4b0c9d6adf6b8c6	58cfa82fe4b0c9d6adf6b8c6	TCGA-A5-A0GX-01A-11D-A043_120504_SN590_0156_BC0H68ACXX_s_2_rg.sorted.filtered.	WGS	TCGA-A5-A0GX-01A-11D-A043_120504_SN590_0156_BC0H68ACXX_s_2_rg.sorted	TCGA-A5-A0GX-01A-11D-A043_120504_SN590_0156_BC0H68ACXX_s_2_rg.sorted.bam	89.76	2.06	0.14	58cfa82fe4b0c9d6adf6b8c6	TCGA-A5-A0GX-01A-11D-A043_120504_SN590_0156_BC0H68ACXX_s_2_rg.sorted.bam	Alive	FEMALE	WHITE	Not available	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-A5-A0GX-01A	553F0CCD-4E6F-4AE2-9B39-97529EB3D826	Primary Tumor	Illumina HiSeq	cae767f1-aaee-4821-aa36-3ceb0b1756e8	Uterus	53	983A35A9-C825-4961-86C0-4C6133B5C9C1	FE0654FE-39AA-4993-8F36-768C7D829092	TCGA-A5-A0GX-01A-11D-A043-02	HG19_Broad_variant	TCGA-A5-A0GX	TCGA-UCEC	NA	s4989	Harvard Medical School	Cedars Sinai	None	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A043-02	TRUE
13722.58cfa830e4b0c9d6adf6bd92	58cfa830e4b0c9d6adf6bd92	TCGA-BG-A0LW-01A-11D-A043_120214_SN590_0138_AC0E8HACXX_s_5_rg.sorted.filtered.	WGS	TCGA-BG-A0LW-01A-11D-A043_120214_SN590_0138_AC0E8HACXX_s_5_rg.sorted	TCGA-BG-A0LW-01A-11D-A043_120214_SN590_0138_AC0E8HACXX_s_5_rg.sorted.bam	100.95	1.92	0.15	58cfa830e4b0c9d6adf6bd92	TCGA-BG-A0LW-01A-11D-A043_120214_SN590_0138_AC0E8HACXX_s_5_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-BG-A0LW-01A	68181BC9-AA8B-44EC-8601-564B30EA0561	Primary Tumor	Illumina HiSeq	89430da6-f21d-4534-8b48-c645836813b5	Uterus	47	6527EC31-1D41-49C2-93FF-11615A6CBA8B	5D88ADF5-468B-4377-B3E3-DF986C613D24	TCGA-BG-A0LW-01A-11D-A043-02	HG19_Broad_variant	TCGA-BG-A0LW	TCGA-UCEC	NA	s5003	Harvard Medical School	University of Pittsburgh	None	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A043-02	TRUE
13722.58cfa830e4b0c9d6adf6bda2	58cfa830e4b0c9d6adf6bda2	TCGA-BF-A1PX-01A-12D-A18Z_120518_SN1120_0142_AC0VG4ACXX_s_2_rg.sorted.filtered.	WGS	TCGA-BF-A1PX-01A-12D-A18Z_120518_SN1120_0142_AC0VG4ACXX_s_2_rg.sorted	TCGA-BF-A1PX-01A-12D-A18Z_120518_SN1120_0142_AC0VG4ACXX_s_2_rg.sorted.bam	42.01	NA	0.16	58cfa830e4b0c9d6adf6bda2	TCGA-BF-A1PX-01A-12D-A18Z_120518_SN1120_0142_AC0VG4ACXX_s_2_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Skin Cutaneous Melanoma	Aligned reads	TCGA-BF-A1PX-01A	197AC33E-D5DF-40DE-92F2-6EF7FE2AD6DD	Primary Tumor	Illumina HiSeq	4a62234d-e7fe-4cd1-a319-baafc27c9db8	Skin	56	EE2F9863-0DAE-4830-A780-E7745414BC3D	98B49A52-61EC-4A87-B2DD-EEFD6E0E028F	TCGA-BF-A1PX-01A-12D-A18Z-02	HG19_Broad_variant	TCGA-BF-A1PX	TCGA-SKCM	282	s7825	Harvard Medical School	Cureline	Russia	NO	T4b	N2a	Not available	Stage IIIB	A18Z-02	TRUE
13722.58cfa830e4b0c9d6adf6bee2	58cfa830e4b0c9d6adf6bee2	TCGA-AP-A0LO-01A-11D-A043_120318_SN590_0147_BD0U3RACXX_s_7_rg.sorted.filtered.	WGS	TCGA-AP-A0LO-01A-11D-A043_120318_SN590_0147_BD0U3RACXX_s_7_rg.sorted	TCGA-AP-A0LO-01A-11D-A043_120318_SN590_0147_BD0U3RACXX_s_7_rg.sorted.bam	90.97	2.13	0.17	58cfa830e4b0c9d6adf6bee2	TCGA-AP-A0LO-01A-11D-A043_120318_SN590_0147_BD0U3RACXX_s_7_rg.sorted.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-AP-A0LO-01A	A081DA6F-51F3-4555-A6B8-736F8C6CDA39	Primary Tumor	Illumina HiSeq	4726575a-1ad0-471a-8a8e-26eb668681f2	Uterus	45	9846D8F3-5B22-48E9-B972-A0FE9F509FB4	A91FCC79-7AE0-4BD1-BCAE-543E49E2D62E	TCGA-AP-A0LO-01A-11D-A043-02	HG19_Broad_variant	TCGA-AP-A0LO	TCGA-UCEC	1016	s4243	Harvard Medical School	MSKCC	None	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A043-02	TRUE
13722.58cfa830e4b0c9d6adf6bf52	58cfa830e4b0c9d6adf6bf52	TCGA-BR-4280-01A-01D-1128_121127_SN208_0440_AC1F4LACXX_s_1_rg.sorted.filtered.	WGS	TCGA-BR-4280-01A-01D-1128_121127_SN208_0440_AC1F4LACXX_s_1_rg.sorted	TCGA-BR-4280-01A-01D-1128_121127_SN208_0440_AC1F4LACXX_s_1_rg.sorted.bam	252.9	1.9	0.14	58cfa830e4b0c9d6adf6bf52	TCGA-BR-4280-01A-01D-1128_121127_SN208_0440_AC1F4LACXX_s_1_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-BR-4280-01A	E0916597-E489-45EF-A8F7-653A3C6591EF	Primary Tumor	Illumina HiSeq	418e722c-d444-43fe-87b1-6d8ce0ce5359	Stomach	78	797D2D3A-F01C-4985-B27C-4E4C2838D34D	7F073E1B-E936-44FF-B3C0-8F4C26ECC3A9	TCGA-BR-4280-01A-01D-1128-02	HG19_Broad_variant	TCGA-BR-4280	TCGA-STAD	NA	s14880	Harvard Medical School	Asterand	Russia	NO	T2b	N1	Stomach  Adenocarcinoma  Not Otherwise Specified (NOS)	Stage III	1128-02	TRUE
13722.58cfa830e4b0c9d6adf6bbf4	58cfa830e4b0c9d6adf6bbf4	TCGA-A5-A0GW-01A-11D-A043_120301_SN590_0142_AD0LPVACXX_s_5_rg.sorted.filtered.	WGS	TCGA-A5-A0GW-01A-11D-A043_120301_SN590_0142_AD0LPVACXX_s_5_rg.sorted	TCGA-A5-A0GW-01A-11D-A043_120301_SN590_0142_AD0LPVACXX_s_5_rg.sorted.bam	88.42	2.12	0.14	58cfa830e4b0c9d6adf6bbf4	TCGA-A5-A0GW-01A-11D-A043_120301_SN590_0142_AD0LPVACXX_s_5_rg.sorted.bam	Alive	FEMALE	ASIAN	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-A5-A0GW-01A	5B6B9D0F-787C-4AE9-AFD4-DE7CE6C57A42	Primary Tumor	Illumina HiSeq	84e2e6bd-f438-45e9-9d44-2af82246e341	Uterus	46	E84D0533-E892-4C1E-9415-99F92AA9A360	3DCC9DC1-990D-4053-967E-B8E4EE752C4E	TCGA-A5-A0GW-01A-11D-A043-02	HG19_Broad_variant	TCGA-A5-A0GW	TCGA-UCEC	NA	s4421	Harvard Medical School	Cedars Sinai	None	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A043-02	TRUE
13722.58cfa830e4b0c9d6adf6bfdf	58cfa830e4b0c9d6adf6bfdf	TCGA-BR-6801-01A-11D-1880_121220_SN1222_0164_BC1HJ3ACXX_s_5_rg.sorted.filtered.	WGS	TCGA-BR-6801-01A-11D-1880_121220_SN1222_0164_BC1HJ3ACXX_s_5_rg.sorted	TCGA-BR-6801-01A-11D-1880_121220_SN1222_0164_BC1HJ3ACXX_s_5_rg.sorted.bam	172.7	1.9	0.15	58cfa830e4b0c9d6adf6bfdf	TCGA-BR-6801-01A-11D-1880_121220_SN1222_0164_BC1HJ3ACXX_s_5_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-BR-6801-01A	24FED326-BDCF-4C20-A06E-7C1C3D6C9CC5	Primary Tumor	Illumina HiSeq	48843aff-35a1-472b-a298-6489ad1b7de7	Stomach	70	713F11EE-D285-4A3B-B421-1D416E5F8E52	FDD2EE8C-C74B-49B8-A530-8CC171C34804	TCGA-BR-6801-01A-11D-1880-02	HG19_Broad_variant	TCGA-BR-6801	TCGA-STAD	NA	s15450	Harvard Medical School	Asterand	Russia	NO	T3	N0	Stomach  Adenocarcinoma  Not Otherwise Specified (NOS)	Stage IIA	1880-02	TRUE
13722.58cfa830e4b0c9d6adf6c07c	58cfa830e4b0c9d6adf6c07c	TCGA-BJ-A0ZH-01A-11D-A10R_120711_SN208_0414_BD13L5ACXX_s_2_rg.sorted.filtered.	WGS	TCGA-BJ-A0ZH-01A-11D-A10R_120711_SN208_0414_BD13L5ACXX_s_2_rg.sorted	TCGA-BJ-A0ZH-01A-11D-A10R_120711_SN208_0414_BD13L5ACXX_s_2_rg.sorted.bam	57.81	1.95	0.16	58cfa830e4b0c9d6adf6c07c	TCGA-BJ-A0ZH-01A-11D-A10R_120711_SN208_0414_BD13L5ACXX_s_2_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-BJ-A0ZH-01A	866CA8AD-ADC9-45D4-AD92-9F8F1A161DDF	Primary Tumor	Illumina HiSeq	488591c3-7ba4-421a-9fc0-36d0604c8175	Thyroid	52	01EE736B-F907-465B-9142-C50BE0A3461B	8B8B2852-9D53-4654-A37C-2749C0F264ED	TCGA-BJ-A0ZH-01A-11D-A10R-02	HG19_Broad_variant	TCGA-BJ-A0ZH	TCGA-THCA	NA	s12096	Harvard Medical School	University of Pittsburgh	United States	NO	T2	N1b	Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features)	Stage IVA	A10R-02	TRUE
13722.58cfa830e4b0c9d6adf6c1de	58cfa830e4b0c9d6adf6c1de	TCGA-BT-A0YX-01A-11D-A10R_120920_SN1222_0150_AC1927ACXX_s_6_rg.sorted.filtered.	WGS	TCGA-BT-A0YX-01A-11D-A10R_120920_SN1222_0150_AC1927ACXX_s_6_rg.sorted	TCGA-BT-A0YX-01A-11D-A10R_120920_SN1222_0150_AC1927ACXX_s_6_rg.sorted.bam	62.34	1.97	0.15	58cfa830e4b0c9d6adf6c1de	TCGA-BT-A0YX-01A-11D-A10R_120920_SN1222_0150_AC1927ACXX_s_6_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-BT-A0YX-01A	22473AD4-DF39-4716-B558-3C1409D5FA0E	Primary Tumor	Illumina HiSeq	71886c7b-a73b-4c00-9555-5fd61b5e1347	Bladder	70	DA614214-F84C-43AB-983C-D9D76CF2D6AE	DC052DFC-26A8-4393-8849-FA954913C622	TCGA-BT-A0YX-01A-11D-A10R-02	HG19_Broad_variant	TCGA-BT-A0YX	TCGA-BLCA	NA	s2867	Harvard Medical School	University of Pittsburgh	None	NO	T3b	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage III	A10R-02	TRUE
13722.58cfa830e4b0c9d6adf6c0e2	58cfa830e4b0c9d6adf6c0e2	TCGA-BJ-A0ZF-01A-11D-A10R_120711_SN1120_0174_BD13R2ACXX_s_1_rg.sorted.filtered.	WGS	TCGA-BJ-A0ZF-01A-11D-A10R_120711_SN1120_0174_BD13R2ACXX_s_1_rg.sorted	TCGA-BJ-A0ZF-01A-11D-A10R_120711_SN1120_0174_BD13R2ACXX_s_1_rg.sorted.bam	67.32	2.02	0.17	58cfa830e4b0c9d6adf6c0e2	TCGA-BJ-A0ZF-01A-11D-A10R_120711_SN1120_0174_BD13R2ACXX_s_1_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-BJ-A0ZF-01A	8BEEE000-ECAB-4A49-9C9D-BB8E677AE199	Primary Tumor	Illumina HiSeq	9bd9796f-01f5-45d5-837b-b0bece0995f4	Thyroid	54	83A66A9D-916A-44E8-A7E6-A1385DB504DB	14EE09BE-144A-4461-8F5A-A738CC5D955E	TCGA-BJ-A0ZF-01A-11D-A10R-02	HG19_Broad_variant	TCGA-BJ-A0ZF	TCGA-THCA	NA	s12505	Harvard Medical School	University of Pittsburgh	United States	NO	T2	N0	Other  specify	Stage II	A10R-02	TRUE
13722.58cfa830e4b0c9d6adf6c206	58cfa830e4b0c9d6adf6c206	TCGA-BT-A20W-01A-21D-A14U_120921_SN208_0431_BD1D5FACXX_s_5_rg.sorted.filtered.	WGS	TCGA-BT-A20W-01A-21D-A14U_120921_SN208_0431_BD1D5FACXX_s_5_rg.sorted	TCGA-BT-A20W-01A-21D-A14U_120921_SN208_0431_BD1D5FACXX_s_5_rg.sorted.bam	77.69	1.98	0.17	58cfa830e4b0c9d6adf6c206	TCGA-BT-A20W-01A-21D-A14U_120921_SN208_0431_BD1D5FACXX_s_5_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-BT-A20W-01A	4DC5CFFE-ED8C-47AB-B5FC-F9615B5414F7	Primary Tumor	Illumina HiSeq	a817f2b5-a06a-422e-869a-694baf6bb127	Bladder	71	CA14F475-1BE4-450C-80C3-7094D23D0B3D	A32E59E0-242F-465D-8277-E0FE26124091	TCGA-BT-A20W-01A-21D-A14U-02	HG19_Broad_variant	TCGA-BT-A20W	TCGA-BLCA	254	s3085	Harvard Medical School	University of Pittsburgh	United States	NO	T2b	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage II	A14U-02	TRUE
13722.58cfa830e4b0c9d6adf6c319	58cfa830e4b0c9d6adf6c319	TCGA-BR-6705-01A-12D-1880_121220_SN1222_0163_AC1HA2ACXX_s_3_rg.sorted.filtered.	WGS	TCGA-BR-6705-01A-12D-1880_121220_SN1222_0163_AC1HA2ACXX_s_3_rg.sorted	TCGA-BR-6705-01A-12D-1880_121220_SN1222_0163_AC1HA2ACXX_s_3_rg.sorted.bam	27.7	1.9	0.15	58cfa830e4b0c9d6adf6c319	TCGA-BR-6705-01A-12D-1880_121220_SN1222_0163_AC1HA2ACXX_s_3_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-BR-6705-01A	B14F2FCB-E869-475E-BC7C-ADAF6E7E636F	Primary Tumor	Illumina HiSeq	cf5ffdf8-e424-4a51-862f-816cba0c92e0	Stomach	68	DB8D0AC1-23B7-49AB-8BB3-44782156F038	F55A158B-F7DB-4786-9553-65DEBCAE80BA	TCGA-BR-6705-01A-12D-1880-02	HG19_Broad_variant	TCGA-BR-6705	TCGA-STAD	NA	s15239	Harvard Medical School	Asterand	Ukraine	NO	T3	N3a	Stomach  Adenocarcinoma  Not Otherwise Specified (NOS)	Stage IIIB	1880-02	TRUE
13722.58cfa830e4b0c9d6adf6c310	58cfa830e4b0c9d6adf6c310	TCGA-BR-6710-01A-11D-1880_121220_SN1222_0164_BC1HJ3ACXX_s_3_rg.sorted.filtered.	WGS	TCGA-BR-6710-01A-11D-1880_121220_SN1222_0164_BC1HJ3ACXX_s_3_rg.sorted	TCGA-BR-6710-01A-11D-1880_121220_SN1222_0164_BC1HJ3ACXX_s_3_rg.sorted.bam	391.7	1.9	0.14	58cfa830e4b0c9d6adf6c310	TCGA-BR-6710-01A-11D-1880_121220_SN1222_0164_BC1HJ3ACXX_s_3_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-BR-6710-01A	012E99FE-E3E8-4BB0-BB74-5B0C9992187C	Primary Tumor	Illumina HiSeq	e0e0146e-bf19-42c8-801b-c5a6ed564c5b	Stomach	41	25E9E880-4EA1-40CF-BBB6-0F961C735C97	999D0F8C-6A89-4753-AD18-F44304EA78F9	TCGA-BR-6710-01A-11D-1880-02	HG19_Broad_variant	TCGA-BR-6710	TCGA-STAD	NA	s15383	Harvard Medical School	Asterand	Ukraine	NO	T2	N0	Stomach  Adenocarcinoma  Not Otherwise Specified (NOS)	Stage IB	1880-02	TRUE
13722.58cfa830e4b0c9d6adf6c2d8	58cfa830e4b0c9d6adf6c2d8	TCGA-BT-A3PH-01A-11D-A221_120902_SN1222_0147_AC195DACXX_s_7_rg.sorted.filtered.	WGS	TCGA-BT-A3PH-01A-11D-A221_120902_SN1222_0147_AC195DACXX_s_7_rg.sorted	TCGA-BT-A3PH-01A-11D-A221_120902_SN1222_0147_AC195DACXX_s_7_rg.sorted.bam	56.18	NA	0.16	58cfa830e4b0c9d6adf6c2d8	TCGA-BT-A3PH-01A-11D-A221_120902_SN1222_0147_AC195DACXX_s_7_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-BT-A3PH-01A	932BCDD4-5145-49E8-9A95-8A546396F572	Primary Tumor	Illumina HiSeq	9096dde9-2391-4c22-b816-2057b8adb483	Bladder	76	33A83E54-3BE5-4A68-8AB0-D31D0BCD3B67	4C010558-360B-44AF-A980-A1CCDF3AB9C7	TCGA-BT-A3PH-01A-11D-A221-26	HG19_Broad_variant	TCGA-BT-A3PH	TCGA-BLCA	142	s2699	MD Anderson - Institute for Applied Cancer Science	University of Pittsburgh	United States	NO	T3b	N2	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV	A221-26	TRUE
13722.58cfa831e4b0c9d6adf6c338	58cfa831e4b0c9d6adf6c338	TCGA-CG-4476-01A-01D-1154_130815_VM001_0006_VMR0006CXX_s_7_rg.sorted.filtered.	WGS	TCGA-CG-4476-01A-01D-1154_130815_VM001_0006_VMR0006CXX_s_7_rg.sorted	TCGA-CG-4476-01A-01D-1154_130815_VM001_0006_VMR0006CXX_s_7_rg.sorted.bam	127.2	1.9	0.14	58cfa831e4b0c9d6adf6c338	TCGA-CG-4476-01A-01D-1154_130815_VM001_0006_VMR0006CXX_s_7_rg.sorted.bam	Alive	MALE	Not available	Not available	Stomach Adenocarcinoma	Aligned reads	TCGA-CG-4476-01A	442D7415-D095-4962-8296-A14390BAD40A	Primary Tumor	Illumina HiSeq	87a698be-8fb0-4ced-842b-fdc852b98aa8	Stomach	69	37F5444F-A58D-4899-A11B-9C09ECD357FC	0C5818D8-5C20-4E4B-99CF-6F378CA6EBE7	TCGA-CG-4476-01A-01D-1154-02	HG19_Broad_variant	TCGA-CG-4476	TCGA-STAD	NA	s14983	Harvard Medical School	Indivumed	Germany	NO	T4b	N3a	Stomach  Adenocarcinoma  Diffuse Type	Stage IIIC	1154-02	TRUE
13722.58cfa831e4b0c9d6adf6c3e2	58cfa831e4b0c9d6adf6c3e2	TCGA-CH-5743-01A-21D-1572_130104_SN1120_0209_BD1KP6ACXX_s_3_rg.sorted.filtered.	WGS	TCGA-CH-5743-01A-21D-1572_130104_SN1120_0209_BD1KP6ACXX_s_3_rg.sorted	TCGA-CH-5743-01A-21D-1572_130104_SN1120_0209_BD1KP6ACXX_s_3_rg.sorted.bam	245.7	1.9	0.15	58cfa831e4b0c9d6adf6c3e2	TCGA-CH-5743-01A-21D-1572_130104_SN1120_0209_BD1KP6ACXX_s_3_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-CH-5743-01A	2DEE4BD8-B00E-4F8A-BFEA-5D8D1A068202	Primary Tumor	Illumina HiSeq	1c58f516-3239-499a-bbcd-f5a8d619d796	Prostate	66	6BD8573D-535F-4F6D-8EAF-60918B5DA578	EE5F51E6-F989-4380-A86F-29CBF50BA03A	TCGA-CH-5743-01A-21D-1572-02	HG19_Broad_variant	TCGA-CH-5743	TCGA-PRAD	NA	s3588	Harvard Medical School	Indivumed	Germany	NO	T2c	N0	Prostate Adenocarcinoma Acinar Type	Not available	1572-02	TRUE
13722.58cfa831e4b0c9d6adf6c3b2	58cfa831e4b0c9d6adf6c3b2	TCGA-CG-4476-01A-01D-1154_121029_SN208_0438_AC18NJACXX_s_1_rg.sorted.filtered.	WGS	TCGA-CG-4476-01A-01D-1154_121029_SN208_0438_AC18NJACXX_s_1_rg.sorted	TCGA-CG-4476-01A-01D-1154_121029_SN208_0438_AC18NJACXX_s_1_rg.sorted.bam	127.2	1.9	0.14	58cfa831e4b0c9d6adf6c3b2	TCGA-CG-4476-01A-01D-1154_121029_SN208_0438_AC18NJACXX_s_1_rg.sorted.bam	Alive	MALE	Not available	Not available	Stomach Adenocarcinoma	Aligned reads	TCGA-CG-4476-01A	442D7415-D095-4962-8296-A14390BAD40A	Primary Tumor	Illumina HiSeq	fa01457a-1a83-47ed-b744-7494b9756706	Stomach	69	37F5444F-A58D-4899-A11B-9C09ECD357FC	0C5818D8-5C20-4E4B-99CF-6F378CA6EBE7	TCGA-CG-4476-01A-01D-1154-02	HG19_Broad_variant	TCGA-CG-4476	TCGA-STAD	NA	s14554	Harvard Medical School	Indivumed	Germany	NO	T4b	N3a	Stomach  Adenocarcinoma  Diffuse Type	Stage IIIC	1154-02	TRUE
13722.58cfa831e4b0c9d6adf6c3e6	58cfa831e4b0c9d6adf6c3e6	TCGA-CH-5745-01A-11D-1572_130104_SN1120_0209_BD1KP6ACXX_s_7_rg.sorted.filtered.	WGS	TCGA-CH-5745-01A-11D-1572_130104_SN1120_0209_BD1KP6ACXX_s_7_rg.sorted	TCGA-CH-5745-01A-11D-1572_130104_SN1120_0209_BD1KP6ACXX_s_7_rg.sorted.bam	146.7	1.9	0.15	58cfa831e4b0c9d6adf6c3e6	TCGA-CH-5745-01A-11D-1572_130104_SN1120_0209_BD1KP6ACXX_s_7_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-CH-5745-01A	AC67D0DF-7DC0-4A1A-8B47-BEEC9B94DE86	Primary Tumor	Illumina HiSeq	c1d27dca-0355-41e5-a53b-0af94a125c6a	Prostate	68	BDA91E83-643B-4FAE-BFE9-B4660F3BDF02	780758FF-58EE-4B4B-AC71-DE15C89C4625	TCGA-CH-5745-01A-11D-1572-02	HG19_Broad_variant	TCGA-CH-5745	TCGA-PRAD	NA	s3770	Harvard Medical School	Indivumed	Germany	NO	T3a	N0	Prostate Adenocarcinoma Acinar Type	Not available	1572-02	TRUE
13722.58cfa831e4b0c9d6adf6c404	58cfa831e4b0c9d6adf6c404	TCGA-CH-5790-01A-11D-1572_130125_SN208_0450_AC1K3NACXX_s_7_rg.sorted.filtered.	WGS	TCGA-CH-5790-01A-11D-1572_130125_SN208_0450_AC1K3NACXX_s_7_rg.sorted	TCGA-CH-5790-01A-11D-1572_130125_SN208_0450_AC1K3NACXX_s_7_rg.sorted.bam	285.7	1.9	0.15	58cfa831e4b0c9d6adf6c404	TCGA-CH-5790-01A-11D-1572_130125_SN208_0450_AC1K3NACXX_s_7_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-CH-5790-01A	2B5EF82D-E137-43F6-BFEF-B202F20EE187	Primary Tumor	Illumina HiSeq	22e486a4-e20b-4211-b3fd-35f37d14e718	Prostate	64	5C8782C0-0B0D-4AFF-B996-423D214FF5FF	9BA30DBB-2730-48A1-94E5-10CCA134728F	TCGA-CH-5790-01A-11D-1572-02	HG19_Broad_variant	TCGA-CH-5790	TCGA-PRAD	NA	s3936	Harvard Medical School	Indivumed	Germany	NO	T2c	N0	Prostate Adenocarcinoma Acinar Type	Not available	1572-02	TRUE
13722.58cfa831e4b0c9d6adf6c406	58cfa831e4b0c9d6adf6c406	TCGA-C5-A3HE-01A-21D-A232_140124_SN1120_0292_BD2F1HACXX_s_8_rg.sorted.filtered.	WGS	TCGA-C5-A3HE-01A-21D-A232_140124_SN1120_0292_BD2F1HACXX_s_8_rg.sorted	TCGA-C5-A3HE-01A-21D-A232_140124_SN1120_0292_BD2F1HACXX_s_8_rg.sorted.bam	43.33	NA	0.15	58cfa831e4b0c9d6adf6c406	TCGA-C5-A3HE-01A-21D-A232_140124_SN1120_0292_BD2F1HACXX_s_8_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-C5-A3HE-01A	BC63DD2A-B8F6-4B30-A8D7-CE193BCD17F1	Primary Tumor	Illumina HiSeq	1d64c1f3-438b-4576-b2bc-74c1a26a2aca	Cervix	44	506D8B22-EE8D-4FB3-BB57-5CA79D6F5637	D0321E82-FF46-450C-AAF2-9FDCA2FF2590	TCGA-C5-A3HE-01A-21D-A232-26	HG19_Broad_variant	TCGA-C5-A3HE	TCGA-CESC	NA	s1514	MD Anderson - Institute for Applied Cancer Science	Medical College of Wisconsin	United States	NO	T1b2	N0	Cervical Squamous Cell Carcinoma	Not available	A232-26	TRUE
13722.58cfa831e4b0c9d6adf6c412	58cfa831e4b0c9d6adf6c412	TCGA-CH-5794-01A-11D-1572_130125_SN208_0451_BD1RB1ACXX_s_5_rg.sorted.filtered.	WGS	TCGA-CH-5794-01A-11D-1572_130125_SN208_0451_BD1RB1ACXX_s_5_rg.sorted	TCGA-CH-5794-01A-11D-1572_130125_SN208_0451_BD1RB1ACXX_s_5_rg.sorted.bam	52.7	2	0.15	58cfa831e4b0c9d6adf6c412	TCGA-CH-5794-01A-11D-1572_130125_SN208_0451_BD1RB1ACXX_s_5_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-CH-5794-01A	A80D3EE7-60DD-49BB-B049-9335AFC035F5	Primary Tumor	Illumina HiSeq	2cf518ee-af91-4cf0-a277-263170f71791	Prostate	65	D1A1CCFE-1215-4B34-94A9-C9765264F617	9D7EACBC-B476-4813-9215-AC0073382A25	TCGA-CH-5794-01A-11D-1572-02	HG19_Broad_variant	TCGA-CH-5794	TCGA-PRAD	NA	s3775	Harvard Medical School	Indivumed	Germany	NO	T2b	N0	Prostate Adenocarcinoma Acinar Type	Not available	1572-02	TRUE
13722.58cfa831e4b0c9d6adf6c438	58cfa831e4b0c9d6adf6c438	TCGA-CH-5772-01A-11D-1572_130125_SN208_0450_AC1K3NACXX_s_1_rg.sorted.filtered.	WGS	TCGA-CH-5772-01A-11D-1572_130125_SN208_0450_AC1K3NACXX_s_1_rg.sorted	TCGA-CH-5772-01A-11D-1572_130125_SN208_0450_AC1K3NACXX_s_1_rg.sorted.bam	85.7	1.9	0.16	58cfa831e4b0c9d6adf6c438	TCGA-CH-5772-01A-11D-1572_130125_SN208_0450_AC1K3NACXX_s_1_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-CH-5772-01A	ECF9F8BE-7830-4626-8617-694C68EF4074	Primary Tumor	Illumina HiSeq	97cf547a-bc4b-4b08-9f8e-c1986b18aa30	Prostate	63	068AC08D-1A9E-4C71-B436-4ED861A9DCF8	5C9AAB80-29D2-4D85-A9FE-99FA22222CA4	TCGA-CH-5772-01A-11D-1572-02	HG19_Broad_variant	TCGA-CH-5772	TCGA-PRAD	NA	s4128	Harvard Medical School	Indivumed	Germany	NO	T3a	N0	Prostate Adenocarcinoma Acinar Type	Not available	1572-02	TRUE
13722.58cfa831e4b0c9d6adf6c44a	58cfa831e4b0c9d6adf6c44a	TCGA-CH-5741-01A-11D-1572_130104_SN1120_0209_BD1KP6ACXX_s_1_rg.sorted.filtered.	WGS	TCGA-CH-5741-01A-11D-1572_130104_SN1120_0209_BD1KP6ACXX_s_1_rg.sorted	TCGA-CH-5741-01A-11D-1572_130104_SN1120_0209_BD1KP6ACXX_s_1_rg.sorted.bam	214.7	1.9	0.15	58cfa831e4b0c9d6adf6c44a	TCGA-CH-5741-01A-11D-1572_130104_SN1120_0209_BD1KP6ACXX_s_1_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-CH-5741-01A	B3BF57D4-E31A-4740-B438-FA826FB79550	Primary Tumor	Illumina HiSeq	ae88c859-e075-4e3a-ba86-e6018e71fa98	Prostate	56	B22CBB75-E6E5-443D-AB4E-1CFD0079C69A	6AC2CA6C-FC79-4E5D-B08F-029A4AC2577B	TCGA-CH-5741-01A-11D-1572-02	HG19_Broad_variant	TCGA-CH-5741	TCGA-PRAD	NA	s3589	Harvard Medical School	Indivumed	Germany	NO	T3b	N1	Prostate Adenocarcinoma Acinar Type	Not available	1572-02	TRUE
13722.58cfa831e4b0c9d6adf6c50c	58cfa831e4b0c9d6adf6c50c	TCGA-CF-A3MI-01A-11D-A210_120913_SN208_0428_BC188KACXX_s_1_rg.sorted.filtered.	WGS	TCGA-CF-A3MI-01A-11D-A210_120913_SN208_0428_BC188KACXX_s_1_rg.sorted	TCGA-CF-A3MI-01A-11D-A210_120913_SN208_0428_BC188KACXX_s_1_rg.sorted.bam	46.48	NA	0.14	58cfa831e4b0c9d6adf6c50c	TCGA-CF-A3MI-01A-11D-A210_120913_SN208_0428_BC188KACXX_s_1_rg.sorted.bam	Alive	MALE	ASIAN	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-CF-A3MI-01A	F1EBF96B-8DF9-4E59-ACEF-7AD433E40214	Primary Tumor	Illumina HiSeq	6559c325-d368-4f95-a2c0-df5efa895e3d	Bladder	62	A373568A-BBD3-4D67-92D6-96E8378065CF	86D4A4FB-47BB-4CD4-B481-CE9F815D38E6	TCGA-CF-A3MI-01A-11D-A210-26	HG19_Broad_variant	TCGA-CF-A3MI	TCGA-BLCA	NA	s3273	MD Anderson - Institute for Applied Cancer Science	ILSbio	Vietnam	NO	T2	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage II	A210-26	TRUE
13722.58cfa831e4b0c9d6adf6c530	58cfa831e4b0c9d6adf6c530	TCGA-CH-5753-01A-11D-1572_130103_SN1222_0166_BD1K7EACXX_s_3_rg.sorted.filtered.	WGS	TCGA-CH-5753-01A-11D-1572_130103_SN1222_0166_BD1K7EACXX_s_3_rg.sorted	TCGA-CH-5753-01A-11D-1572_130103_SN1222_0166_BD1K7EACXX_s_3_rg.sorted.bam	339.7	1.9	0.16	58cfa831e4b0c9d6adf6c530	TCGA-CH-5753-01A-11D-1572_130103_SN1222_0166_BD1K7EACXX_s_3_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-CH-5753-01A	928C48A0-68EE-4E28-AE83-9832E52850CA	Primary Tumor	Illumina HiSeq	971890ca-4817-4b12-b817-51caf2239fa3	Prostate	70	2BEEEBA8-47FE-4857-8704-E4C63E38C926	302AE7E6-2ADD-4556-8173-21EA12412058	TCGA-CH-5753-01A-11D-1572-02	HG19_Broad_variant	TCGA-CH-5753	TCGA-PRAD	NA	s3592	Harvard Medical School	Indivumed	Germany	NO	T3b	N1	Prostate Adenocarcinoma Acinar Type	Not available	1572-02	TRUE
13722.58cfa831e4b0c9d6adf6c531	58cfa831e4b0c9d6adf6c531	TCGA-CH-5768-01A-11D-1572_130104_SN208_0446_BD1KR5ACXX_s_3_rg.sorted.filtered.	WGS	TCGA-CH-5768-01A-11D-1572_130104_SN208_0446_BD1KR5ACXX_s_3_rg.sorted	TCGA-CH-5768-01A-11D-1572_130104_SN208_0446_BD1KR5ACXX_s_3_rg.sorted.bam	131.7	1.9	0.15	58cfa831e4b0c9d6adf6c531	TCGA-CH-5768-01A-11D-1572_130104_SN208_0446_BD1KR5ACXX_s_3_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-CH-5768-01A	F6C61A22-A711-416D-9E65-6A1B957E5B2E	Primary Tumor	Illumina HiSeq	98aa2eb7-52a4-424c-aa01-a574d0215ee6	Prostate	72	C4FF48C4-E953-4267-AB9C-3A09A97A88C4	9813DF8A-57D6-4D59-8534-3942B7FE672E	TCGA-CH-5768-01A-11D-1572-02	HG19_Broad_variant	TCGA-CH-5768	TCGA-PRAD	NA	s3420	Harvard Medical School	Indivumed	Germany	NO	T3a	N0	Prostate Adenocarcinoma Acinar Type	Not available	1572-02	TRUE
13722.58cfa830e4b0c9d6adf6c278	58cfa830e4b0c9d6adf6c278	TCGA-B5-A0K1-01A-11D-A043_120214_SN590_0138_AC0E8HACXX_s_3_rg.sorted.filtered.	WGS	TCGA-B5-A0K1-01A-11D-A043_120214_SN590_0138_AC0E8HACXX_s_3_rg.sorted	TCGA-B5-A0K1-01A-11D-A043_120214_SN590_0138_AC0E8HACXX_s_3_rg.sorted.bam	82.72	2.05	0.16	58cfa830e4b0c9d6adf6c278	TCGA-B5-A0K1-01A-11D-A043_120214_SN590_0138_AC0E8HACXX_s_3_rg.sorted.bam	Alive	FEMALE	WHITE	Not available	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-B5-A0K1-01A	40A3ED98-3892-449C-B07E-7B7612BD997E	Primary Tumor	Illumina HiSeq	fb29a0da-eb80-43a5-be71-85cf2d58268c	Uterus	69	B514F636-DEE3-45F3-BB31-197CA6A171F1	D4814366-AEF2-453B-8DC7-A731B5E53FE8	TCGA-B5-A0K1-01A-11D-A043-02	HG19_Broad_variant	TCGA-B5-A0K1	TCGA-UCEC	NA	s5211	Harvard Medical School	Duke	United States	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A043-02	TRUE
13722.58cfa831e4b0c9d6adf6c59e	58cfa831e4b0c9d6adf6c59e	TCGA-CG-4465-01A-01D-1154_130815_VM001_0005_VMR0005CXX_s_1_rg.sorted.filtered.	WGS	TCGA-CG-4465-01A-01D-1154_130815_VM001_0005_VMR0005CXX_s_1_rg.sorted	TCGA-CG-4465-01A-01D-1154_130815_VM001_0005_VMR0005CXX_s_1_rg.sorted.bam	122.2	1.9	0.13	58cfa831e4b0c9d6adf6c59e	TCGA-CG-4465-01A-01D-1154_130815_VM001_0005_VMR0005CXX_s_1_rg.sorted.bam	Dead	FEMALE	Not available	Not available	Stomach Adenocarcinoma	Aligned reads	TCGA-CG-4465-01A	C9AB5BF4-092A-420F-9B90-87DEEA58104C	Primary Tumor	Illumina HiSeq	543d167f-2418-4dea-b387-5baa5dc4309f	Stomach	69	89DAB798-0B26-470C-82AF-1B23C83FE4F5	2CCE681F-F5C6-496E-96C3-21046ECEAA56	TCGA-CG-4465-01A-01D-1154-02	HG19_Broad_variant	TCGA-CG-4465	TCGA-STAD	274	s14411	Harvard Medical School	Indivumed	Germany	NO	T4	N3	Stomach  Adenocarcinoma  Diffuse Type	Stage IV	1154-02	TRUE
13722.58cfa831e4b0c9d6adf6c5a0	58cfa831e4b0c9d6adf6c5a0	TCGA-CG-4465-01A-01D-1154_121026_SN1120_0197_AC1878ACXX_s_1_rg.sorted.filtered.	WGS	TCGA-CG-4465-01A-01D-1154_121026_SN1120_0197_AC1878ACXX_s_1_rg.sorted	TCGA-CG-4465-01A-01D-1154_121026_SN1120_0197_AC1878ACXX_s_1_rg.sorted.bam	122.2	1.9	0.13	58cfa831e4b0c9d6adf6c5a0	TCGA-CG-4465-01A-01D-1154_121026_SN1120_0197_AC1878ACXX_s_1_rg.sorted.bam	Dead	FEMALE	Not available	Not available	Stomach Adenocarcinoma	Aligned reads	TCGA-CG-4465-01A	C9AB5BF4-092A-420F-9B90-87DEEA58104C	Primary Tumor	Illumina HiSeq	cb9d270d-5328-46d7-b7ff-cb564fad9175	Stomach	69	89DAB798-0B26-470C-82AF-1B23C83FE4F5	2CCE681F-F5C6-496E-96C3-21046ECEAA56	TCGA-CG-4465-01A-01D-1154-02	HG19_Broad_variant	TCGA-CG-4465	TCGA-STAD	274	s14826	Harvard Medical School	Indivumed	Germany	NO	T4	N3	Stomach  Adenocarcinoma  Diffuse Type	Stage IV	1154-02	TRUE
13722.58cfa831e4b0c9d6adf6c56b	58cfa831e4b0c9d6adf6c56b	TCGA-CH-5746-01A-11D-1572_130103_SN1222_0165_AC1FBHACXX_s_1_rg.sorted.filtered.	WGS	TCGA-CH-5746-01A-11D-1572_130103_SN1222_0165_AC1FBHACXX_s_1_rg.sorted	TCGA-CH-5746-01A-11D-1572_130103_SN1222_0165_AC1FBHACXX_s_1_rg.sorted.bam	299.7	1.9	0.15	58cfa831e4b0c9d6adf6c56b	TCGA-CH-5746-01A-11D-1572_130103_SN1222_0165_AC1FBHACXX_s_1_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-CH-5746-01A	618272C0-C2ED-4BFB-BB4B-404F0987F822	Primary Tumor	Illumina HiSeq	c4373feb-ceca-4bb3-9db2-6f9e94d29605	Prostate	57	54AD063E-68D9-4104-856A-2BD3905FA971	ABAFDCA6-6109-4686-A058-BDBEB9ADD1E7	TCGA-CH-5746-01A-11D-1572-02	HG19_Broad_variant	TCGA-CH-5746	TCGA-PRAD	NA	s3930	Harvard Medical School	Indivumed	Germany	NO	T2c	N0	Prostate Adenocarcinoma Acinar Type	Not available	1572-02	TRUE
13722.58cfa831e4b0c9d6adf6c5ce	58cfa831e4b0c9d6adf6c5ce	TCGA-CG-5725-01A-11D-1598_121011_SN208_0435_BD1E43ACXX_s_1_rg.sorted.filtered.	WGS	TCGA-CG-5725-01A-11D-1598_121011_SN208_0435_BD1E43ACXX_s_1_rg.sorted	TCGA-CG-5725-01A-11D-1598_121011_SN208_0435_BD1E43ACXX_s_1_rg.sorted.bam	333.7	1.9	0.14	58cfa831e4b0c9d6adf6c5ce	TCGA-CG-5725-01A-11D-1598_121011_SN208_0435_BD1E43ACXX_s_1_rg.sorted.bam	Dead	MALE	Not available	Not available	Stomach Adenocarcinoma	Aligned reads	TCGA-CG-5725-01A	129D95CA-71EF-44AA-A93D-F87803C37C9A	Primary Tumor	Illumina HiSeq	61968fb0-fb5d-48fa-88eb-4cd76a6b4456	Stomach	72	E1DED05A-1BC0-42A7-A560-DD67EB804EB4	5254031E-CF64-4B0C-80D8-3EBB4A2DC70F	TCGA-CG-5725-01A-11D-1598-02	HG19_Broad_variant	TCGA-CG-5725	TCGA-STAD	457	s15129	Harvard Medical School	Indivumed	Germany	NO	T2	N0	Stomach  Adenocarcinoma  Not Otherwise Specified (NOS)	Stage IB	1598-02	TRUE
13722.58cfa831e4b0c9d6adf6c60a	58cfa831e4b0c9d6adf6c60a	TCGA-CQ-6220-01A-11D-1911_120504_SN1222_0102_BC0VHDACXX_s_1_rg.sorted.filtered.	WGS	TCGA-CQ-6220-01A-11D-1911_120504_SN1222_0102_BC0VHDACXX_s_1_rg.sorted	TCGA-CQ-6220-01A-11D-1911_120504_SN1222_0102_BC0VHDACXX_s_1_rg.sorted.bam	342.7	1.9	0.15	58cfa831e4b0c9d6adf6c60a	TCGA-CQ-6220-01A-11D-1911_120504_SN1222_0102_BC0VHDACXX_s_1_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CQ-6220-01A	96D0CEFE-7949-4736-A7DC-1E4FA94765EC	Primary Tumor	Illumina HiSeq	d86390d3-24c6-4e56-9b8a-d6b3ec75c989	Head and Neck	69	E0E75203-3982-40B2-A057-FAA8433DFB7A	C7EABDCF-81F2-4C87-946A-B5BA42056B04	TCGA-CQ-6220-01A-11D-1911-02	HG19_Broad_variant	TCGA-CQ-6220	TCGA-HNSC	985	s16037	Harvard Medical School	University Health Network, Toronto	Canada	NO	T3	N0	Head and Neck Squamous Cell Carcinoma	Stage III	1911-02	TRUE
13722.58cfa831e4b0c9d6adf6c610	58cfa831e4b0c9d6adf6c610	TCGA-CQ-6221-01A-11D-2317_120623_SN1222_0119_BC0WLLACXX_s_6_rg.sorted.filtered.	WGS	TCGA-CQ-6221-01A-11D-2317_120623_SN1222_0119_BC0WLLACXX_s_6_rg.sorted	TCGA-CQ-6221-01A-11D-2317_120623_SN1222_0119_BC0WLLACXX_s_6_rg.sorted.bam	12.33	NA	0.15	58cfa831e4b0c9d6adf6c610	TCGA-CQ-6221-01A-11D-2317_120623_SN1222_0119_BC0WLLACXX_s_6_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CQ-6221-01A	839B660C-98FE-4468-A2B3-408594350250	Primary Tumor	Illumina HiSeq	16de682b-970e-4857-821f-5a32d6b74f71	Head and Neck	79	65BAAE80-7FD5-40B1-B5FB-BDD013B70931	C90134BD-6F38-45B9-B82D-E84ACEB2E90F	TCGA-CQ-6221-01A-11D-2317-26	HG19_Broad_variant	TCGA-CQ-6221	TCGA-HNSC	NA	s15637	MD Anderson - Institute for Applied Cancer Science	University Health Network, Toronto	Canada	NO	T2	NX	Head and Neck Squamous Cell Carcinoma	Not available	2317-26	TRUE
13722.58cfa831e4b0c9d6adf6c602	58cfa831e4b0c9d6adf6c602	TCGA-CQ-6225-01A-11D-1911_120504_SN208_0296_AC0V09ACXX_s_1_rg.sorted.filtered.	WGS	TCGA-CQ-6225-01A-11D-1911_120504_SN208_0296_AC0V09ACXX_s_1_rg.sorted	TCGA-CQ-6225-01A-11D-1911_120504_SN208_0296_AC0V09ACXX_s_1_rg.sorted.bam	191.7	1.9	0.15	58cfa831e4b0c9d6adf6c602	TCGA-CQ-6225-01A-11D-1911_120504_SN208_0296_AC0V09ACXX_s_1_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CQ-6225-01A	90F44998-3C05-44B2-9501-BBD0F43C5147	Primary Tumor	Illumina HiSeq	a96392ab-a0d3-4c22-a2e2-08b58bb3e61b	Head and Neck	65	E907D8D4-C4C6-441F-9F19-FF3746E5D13E	40BFD664-E699-4F0D-9670-30D0F5CC8728	TCGA-CQ-6225-01A-11D-1911-02	HG19_Broad_variant	TCGA-CQ-6225	TCGA-HNSC	403	s16186	Harvard Medical School	University Health Network, Toronto	Canada	NO	T3	N0	Head and Neck Squamous Cell Carcinoma	Stage III	1911-02	TRUE
13722.58cfa831e4b0c9d6adf6c667	58cfa831e4b0c9d6adf6c667	TCGA-CG-4466-01A-01D-1154_121026_SN1120_0197_AC1878ACXX_s_2_rg.sorted.filtered.	WGS	TCGA-CG-4466-01A-01D-1154_121026_SN1120_0197_AC1878ACXX_s_2_rg.sorted	TCGA-CG-4466-01A-01D-1154_121026_SN1120_0197_AC1878ACXX_s_2_rg.sorted.bam	143.3	1.9	0.14	58cfa831e4b0c9d6adf6c667	TCGA-CG-4466-01A-01D-1154_121026_SN1120_0197_AC1878ACXX_s_2_rg.sorted.bam	Alive	FEMALE	Not available	Not available	Stomach Adenocarcinoma	Aligned reads	TCGA-CG-4466-01A	2F1B96B2-7031-4F7D-9490-14728D320F3E	Primary Tumor	Illumina HiSeq	cea9fe91-10d4-464c-80a6-24b7ed98ba9c	Stomach	81	0BC4ABB4-047B-4C8D-9F79-5B9EB32969E9	623D5E6A-A5D3-4580-BEF7-04673D42A1D0	TCGA-CG-4466-01A-01D-1154-02	HG19_Broad_variant	TCGA-CG-4466	TCGA-STAD	NA	s14757	Harvard Medical School	Indivumed	Germany	NO	T2a	N0	Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS)	Stage IB	1154-02	TRUE
13722.58cfa831e4b0c9d6adf6c69c	58cfa831e4b0c9d6adf6c69c	TCGA-CQ-6229-01A-11D-1911_120504_SN208_0296_AC0V09ACXX_s_2_rg.sorted.filtered.	WGS	TCGA-CQ-6229-01A-11D-1911_120504_SN208_0296_AC0V09ACXX_s_2_rg.sorted	TCGA-CQ-6229-01A-11D-1911_120504_SN208_0296_AC0V09ACXX_s_2_rg.sorted.bam	60.7	1.9	0.17	58cfa831e4b0c9d6adf6c69c	TCGA-CQ-6229-01A-11D-1911_120504_SN208_0296_AC0V09ACXX_s_2_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CQ-6229-01A	A091822C-447A-49A5-8C20-E329DF79599C	Primary Tumor	Illumina HiSeq	c3f7b43b-25d2-4df3-a85c-231a6708bf8c	Head and Neck	61	F01165B0-911A-45B0-BA7D-7CD0E723A2E4	4AF0777A-6FE3-49AE-B3B9-4AB077DDB007	TCGA-CQ-6229-01A-11D-1911-02	HG19_Broad_variant	TCGA-CQ-6229	TCGA-HNSC	NA	s15631	Harvard Medical School	University Health Network, Toronto	Canada	NO	T2	N0	Head and Neck Squamous Cell Carcinoma	Stage II	1911-02	TRUE
13722.58cfa831e4b0c9d6adf6c70c	58cfa831e4b0c9d6adf6c70c	TCGA-CV-5973-01A-11D-1681_120427_SN1120_0137_BD0T3FACXX_s_1_rg.sorted.filtered.	WGS	TCGA-CV-5973-01A-11D-1681_120427_SN1120_0137_BD0T3FACXX_s_1_rg.sorted	TCGA-CV-5973-01A-11D-1681_120427_SN1120_0137_BD0T3FACXX_s_1_rg.sorted.bam	115	1.9	0.15	58cfa831e4b0c9d6adf6c70c	TCGA-CV-5973-01A-11D-1681_120427_SN1120_0137_BD0T3FACXX_s_1_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-5973-01A	8FC1F1BE-D2D5-4B3A-9973-F4D964018BEB	Primary Tumor	Illumina HiSeq	4965236e-7173-4701-bd61-0550f3451b03	Head and Neck	62	5078222F-B257-4286-A29A-BC1E395149BC	55E8AEAC-4C0E-49DF-8F57-605E7C820B89	TCGA-CV-5973-01A-11D-1681-02	HG19_Broad_variant	TCGA-CV-5973	TCGA-HNSC	NA	s16193	Harvard Medical School	MD Anderson Cancer Center	None	NO	T3	N1	Head and Neck Squamous Cell Carcinoma	Stage III	1681-02	TRUE
13722.58cfa831e4b0c9d6adf6c6a0	58cfa831e4b0c9d6adf6c6a0	TCGA-CQ-6224-01A-11D-1911_120504_SN1222_0102_BC0VHDACXX_s_4_rg.sorted.filtered.	WGS	TCGA-CQ-6224-01A-11D-1911_120504_SN1222_0102_BC0VHDACXX_s_4_rg.sorted	TCGA-CQ-6224-01A-11D-1911_120504_SN1222_0102_BC0VHDACXX_s_4_rg.sorted.bam	40.7	2	0.16	58cfa831e4b0c9d6adf6c6a0	TCGA-CQ-6224-01A-11D-1911_120504_SN1222_0102_BC0VHDACXX_s_4_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CQ-6224-01A	D86FD392-FA5C-4142-A647-440E6C32D478	Primary Tumor	Illumina HiSeq	e8b32a2c-944e-4b3e-a302-ffe9e9f8a3ea	Head and Neck	52	AD242EAC-A5AE-42B7-85CE-3E4D0DD308D6	3FAD44AE-89FC-4BB4-BA86-15A0EF7E2C3A	TCGA-CQ-6224-01A-11D-1911-02	HG19_Broad_variant	TCGA-CQ-6224	TCGA-HNSC	NA	s15633	Harvard Medical School	University Health Network, Toronto	Canada	NO	T2	N2b	Head and Neck Squamous Cell Carcinoma	Stage IVA	1911-02	TRUE
13722.58cfa831e4b0c9d6adf6c77f	58cfa831e4b0c9d6adf6c77f	TCGA-D7-6815-01A-11D-1880_130111_SN208_0447_AC1JP0ACXX_s_1_rg.sorted.filtered.	WGS	TCGA-D7-6815-01A-11D-1880_130111_SN208_0447_AC1JP0ACXX_s_1_rg.sorted	TCGA-D7-6815-01A-11D-1880_130111_SN208_0447_AC1JP0ACXX_s_1_rg.sorted.bam	457	1.9	0.15	58cfa831e4b0c9d6adf6c77f	TCGA-D7-6815-01A-11D-1880_130111_SN208_0447_AC1JP0ACXX_s_1_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-D7-6815-01A	53086E20-A727-40D6-B42D-8030109B5130	Primary Tumor	Illumina HiSeq	aaa1a66d-814e-403e-bd88-38f4e3ea8c47	Stomach	70	B5F3D9A1-46B5-4A63-8F7D-9C993FE9340D	810C88A8-62F3-42C6-BBFD-A9D65E2A07A4	TCGA-D7-6815-01A-11D-1880-02	HG19_Broad_variant	TCGA-D7-6815	TCGA-STAD	NA	s14497	Harvard Medical School	Greater Poland Cancer Center	Poland	NO	T2	N2	Stomach  Intestinal Adenocarcinoma  Tubular Type	Stage IIB	1880-02	TRUE
13722.58cfa831e4b0c9d6adf6c768	58cfa831e4b0c9d6adf6c768	TCGA-D1-A1O0-01A-11D-A17E_120511_SN1120_0141_BC0VK9ACXX_s_3_rg.sorted.filtered.	WGS	TCGA-D1-A1O0-01A-11D-A17E_120511_SN1120_0141_BC0VK9ACXX_s_3_rg.sorted	TCGA-D1-A1O0-01A-11D-A17E_120511_SN1120_0141_BC0VK9ACXX_s_3_rg.sorted.bam	86.58	1.84	0.16	58cfa831e4b0c9d6adf6c768	TCGA-D1-A1O0-01A-11D-A17E_120511_SN1120_0141_BC0VK9ACXX_s_3_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-D1-A1O0-01A	A98BBE29-8817-4380-A738-3C1BF9F8E0CC	Primary Tumor	Illumina HiSeq	30d286e0-9e60-48a1-81f4-b35d81af6da1	Uterus	77	E113E0F0-3AE5-48A3-A226-AD920F41259E	8DF3928E-65CE-4578-96A4-BA3AE51E764C	TCGA-D1-A1O0-01A-11D-A17E-02	HG19_Broad_variant	TCGA-D1-A1O0	TCGA-UCEC	NA	s4619	Harvard Medical School	Mayo Clinic	United States	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A17E-02	TRUE
13722.58cfa831e4b0c9d6adf6c74d	58cfa831e4b0c9d6adf6c74d	TCGA-D1-A177-01A-21D-A12F_120523_SN1222_0108_AC0VL4ACXX_s_1_rg.sorted.filtered.	WGS	TCGA-D1-A177-01A-21D-A12F_120523_SN1222_0108_AC0VL4ACXX_s_1_rg.sorted	TCGA-D1-A177-01A-21D-A12F_120523_SN1222_0108_AC0VL4ACXX_s_1_rg.sorted.bam	86.4	1.36	0.15	58cfa831e4b0c9d6adf6c74d	TCGA-D1-A177-01A-21D-A12F_120523_SN1222_0108_AC0VL4ACXX_s_1_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-D1-A177-01A	E8C58D8B-51D7-4599-AF79-469EE6F269DB	Primary Tumor	Illumina HiSeq	cf08e174-408a-4212-8caf-72692bcb55af	Uterus	70	97587FD4-0F6F-4AF5-AC0A-7328ABB40E9C	2F6D7D10-84AA-48A6-9B8E-9CBB257C653D	TCGA-D1-A177-01A-21D-A12F-02	HG19_Broad_variant	TCGA-D1-A177	TCGA-UCEC	NA	s4800	Harvard Medical School	Mayo Clinic	None	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A12F-02	TRUE
13722.58cfa831e4b0c9d6adf6c7a3	58cfa831e4b0c9d6adf6c7a3	TCGA-CV-6954-01A-11D-1911_120505_SN1120_0138_AD11NHACXX_s_3_rg.sorted.filtered.	WGS	TCGA-CV-6954-01A-11D-1911_120505_SN1120_0138_AD11NHACXX_s_3_rg.sorted	TCGA-CV-6954-01A-11D-1911_120505_SN1120_0138_AD11NHACXX_s_3_rg.sorted.bam	62.7	1.9	0.15	58cfa831e4b0c9d6adf6c7a3	TCGA-CV-6954-01A-11D-1911_120505_SN1120_0138_AD11NHACXX_s_3_rg.sorted.bam	Dead	MALE	BLACK OR AFRICAN AMERICAN	Not available	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-6954-01A	402FD96C-76D3-4AC2-9F64-77BD34BE0ADB	Primary Tumor	Illumina HiSeq	115469a6-3c3e-4a3b-adf9-ed831266829c	Head and Neck	59	F72D39EA-7DB5-47C6-9428-3E26454C9A9A	7FA6660F-0B18-4F4D-AEA1-17C22A9DBAA6	TCGA-CV-6954-01A-11D-1911-02	HG19_Broad_variant	TCGA-CV-6954	TCGA-HNSC	2002	s16341	Harvard Medical School	MD Anderson Cancer Center	United States	NO	T4a	NX	Head and Neck Squamous Cell Carcinoma	Stage IVA	1911-02	TRUE
13722.58cfa831e4b0c9d6adf6c7f3	58cfa831e4b0c9d6adf6c7f3	TCGA-D7-5577-01A-01D-1598_121023_SN208_0437_BD1H3FACXX_s_1_rg.sorted.filtered.	WGS	TCGA-D7-5577-01A-01D-1598_121023_SN208_0437_BD1H3FACXX_s_1_rg.sorted	TCGA-D7-5577-01A-01D-1598_121023_SN208_0437_BD1H3FACXX_s_1_rg.sorted.bam	414	1.87	0.14	58cfa831e4b0c9d6adf6c7f3	TCGA-D7-5577-01A-01D-1598_121023_SN208_0437_BD1H3FACXX_s_1_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-D7-5577-01A	2DC154AA-C478-404B-A92E-86ABCC8DBDB7	Primary Tumor	Illumina HiSeq	e417c8be-9c96-4e81-a2c9-ac3f23791347	Stomach	53	93BBD9FD-2385-46C3-AF21-E46C72A8A75D	8FCA6D2A-04D8-4A60-AEA3-298853E74752	TCGA-D7-5577-01A-01D-1598-02	HG19_Broad_variant	TCGA-D7-5577	TCGA-STAD	NA	s14908	Harvard Medical School	Greater Poland Cancer Center	Poland	NO	T2	N3	Stomach  Intestinal Adenocarcinoma  Tubular Type	Stage IIIA	1598-02	TRUE
13722.58cfa831e4b0c9d6adf6c80f	58cfa831e4b0c9d6adf6c80f	TCGA-CV-6938-01A-11D-1911_120504_SN208_0296_AC0V09ACXX_s_4_rg.sorted.filtered.	WGS	TCGA-CV-6938-01A-11D-1911_120504_SN208_0296_AC0V09ACXX_s_4_rg.sorted	TCGA-CV-6938-01A-11D-1911_120504_SN208_0296_AC0V09ACXX_s_4_rg.sorted.bam	62.7	2	0.16	58cfa831e4b0c9d6adf6c80f	TCGA-CV-6938-01A-11D-1911_120504_SN208_0296_AC0V09ACXX_s_4_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-6938-01A	FF9DB03D-F81C-4079-8B05-F5A8C05B8CFE	Primary Tumor	Illumina HiSeq	a328ffc7-c5cd-4726-a75a-e625d33859a8	Head and Neck	87	9EB292E6-AE4D-4613-98EE-0197FD97B633	87E1BCCB-5B03-40AF-A262-0B2B5E6A08D2	TCGA-CV-6938-01A-11D-1911-02	HG19_Broad_variant	TCGA-CV-6938	TCGA-HNSC	144	s16050	Harvard Medical School	MD Anderson Cancer Center	United States	NO	T2	NX	Head and Neck Squamous Cell Carcinoma	Stage II	1911-02	TRUE
13722.58cfa831e4b0c9d6adf6c819	58cfa831e4b0c9d6adf6c819	TCGA-CN-6998-01A-23D-2317_120623_SN1222_0118_AD13T1ACXX_s_5_rg.sorted.filtered.	WGS	TCGA-CN-6998-01A-23D-2317_120623_SN1222_0118_AD13T1ACXX_s_5_rg.sorted	TCGA-CN-6998-01A-23D-2317_120623_SN1222_0118_AD13T1ACXX_s_5_rg.sorted.bam	9.03	NA	0.13	58cfa831e4b0c9d6adf6c819	TCGA-CN-6998-01A-23D-2317_120623_SN1222_0118_AD13T1ACXX_s_5_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CN-6998-01A	039788EC-1364-40C7-9E9D-13DC305674E9	Primary Tumor	Illumina HiSeq	d281a462-58dd-4303-9419-617fec3fcf35	Head and Neck	53	64C8DB8B-5D5C-4FBE-8996-4A7CB161D4A0	88B8B48D-51B8-4D46-9C36-E565A2582D94	TCGA-CN-6998-01A-23D-2317-26	HG19_Broad_variant	TCGA-CN-6998	TCGA-HNSC	NA	s16333	MD Anderson - Institute for Applied Cancer Science	University of Pittsburgh	United States	NO	T3	N2b	Head and Neck Squamous Cell Carcinoma	Stage IVA	2317-26	TRUE
13722.58cfa831e4b0c9d6adf6c858	58cfa831e4b0c9d6adf6c858	TCGA-D6-6517-01A-11D-1868_120427_SN208_0288_BD0RWBACXX_s_3_rg.sorted.filtered.	WGS	TCGA-D6-6517-01A-11D-1868_120427_SN208_0288_BD0RWBACXX_s_3_rg.sorted	TCGA-D6-6517-01A-11D-1868_120427_SN208_0288_BD0RWBACXX_s_3_rg.sorted.bam	209.7	1.9	0.15	58cfa831e4b0c9d6adf6c858	TCGA-D6-6517-01A-11D-1868_120427_SN208_0288_BD0RWBACXX_s_3_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-D6-6517-01A	EBE99910-E9F2-43DC-AD57-AC2F610B60C8	Primary Tumor	Illumina HiSeq	e84f34a5-8df7-4824-92d7-4f53b4bace58	Head and Neck	59	8C099F45-3FD6-4966-8CDB-CA4B9288B1A2	97962F6C-B2FB-4618-A5A4-7B376714EC62	TCGA-D6-6517-01A-11D-1868-02	HG19_Broad_variant	TCGA-D6-6517	TCGA-HNSC	NA	s15655	Harvard Medical School	Greater Poland Cancer Center	Poland	NO	T3	N0	Head and Neck Squamous Cell Carcinoma	Stage III	1868-02	TRUE
13722.58cfa831e4b0c9d6adf6c826	58cfa831e4b0c9d6adf6c826	TCGA-D1-A17U-01A-21D-A12F_120523_SN1222_0108_AC0VL4ACXX_s_3_rg.sorted.filtered.	WGS	TCGA-D1-A17U-01A-21D-A12F_120523_SN1222_0108_AC0VL4ACXX_s_3_rg.sorted	TCGA-D1-A17U-01A-21D-A12F_120523_SN1222_0108_AC0VL4ACXX_s_3_rg.sorted.bam	73.35	1.96	0.17	58cfa831e4b0c9d6adf6c826	TCGA-D1-A17U-01A-21D-A12F_120523_SN1222_0108_AC0VL4ACXX_s_3_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-D1-A17U-01A	6397C4A1-0A29-4C2C-B8CB-CE73AF93DD0B	Primary Tumor	Illumina HiSeq	8d00983f-b836-41a9-a4b9-51c75b4452a8	Uterus	53	1F1945EE-4CF3-43A3-9998-1C4528C7A511	1B9EB26F-48E0-4EBF-9094-5013E3DF2FBD	TCGA-D1-A17U-01A-21D-A12F-02	HG19_Broad_variant	TCGA-D1-A17U	TCGA-UCEC	NA	s4616	Harvard Medical School	Mayo Clinic	None	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A12F-02	TRUE
13722.58cfa831e4b0c9d6adf6c8bc	58cfa831e4b0c9d6adf6c8bc	TCGA-DK-A3IT-01A-31D-A210_120911_SN1120_0189_BD1D04ACXX_s_5_rg.sorted.filtered.	WGS	TCGA-DK-A3IT-01A-31D-A210_120911_SN1120_0189_BD1D04ACXX_s_5_rg.sorted	TCGA-DK-A3IT-01A-31D-A210_120911_SN1120_0189_BD1D04ACXX_s_5_rg.sorted.bam	24.31	NA	0.16	58cfa831e4b0c9d6adf6c8bc	TCGA-DK-A3IT-01A-31D-A210_120911_SN1120_0189_BD1D04ACXX_s_5_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-DK-A3IT-01A	58520C66-7688-435A-B09F-653B18768C41	Primary Tumor	Illumina HiSeq	276fd52d-8d51-4e03-85a5-a7f02ee03b71	Bladder	62	6B48DAE5-B757-450A-8248-65C2434A7AFC	CDBAE634-52F3-4165-A214-BB60BEC5D6C4	TCGA-DK-A3IT-01A-31D-A210-26	HG19_Broad_variant	TCGA-DK-A3IT	TCGA-BLCA	NA	s2715	MD Anderson - Institute for Applied Cancer Science	Memorial Sloan Kettering	United States	NO	T3	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage III	A210-26	TRUE
13722.58cfa831e4b0c9d6adf6c8c2	58cfa831e4b0c9d6adf6c8c2	TCGA-DK-A3IL-01A-11D-A210_120913_SN208_0428_BC188KACXX_s_3_rg.sorted.filtered.	WGS	TCGA-DK-A3IL-01A-11D-A210_120913_SN208_0428_BC188KACXX_s_3_rg.sorted	TCGA-DK-A3IL-01A-11D-A210_120913_SN208_0428_BC188KACXX_s_3_rg.sorted.bam	32.38	NA	0.16	58cfa831e4b0c9d6adf6c8c2	TCGA-DK-A3IL-01A-11D-A210_120913_SN208_0428_BC188KACXX_s_3_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-DK-A3IL-01A	178B28CD-99C3-48DC-8D09-1EF71B4CEE80	Primary Tumor	Illumina HiSeq	56a85daa-804e-4c68-b2be-c58cf3d5153e	Bladder	79	59D6683F-5EB7-493D-8E8E-78B88BE2CD70	F666A681-CA0D-4281-8E8A-156A24BBB63A	TCGA-DK-A3IL-01A-11D-A210-26	HG19_Broad_variant	TCGA-DK-A3IL	TCGA-BLCA	NA	s3282	MD Anderson - Institute for Applied Cancer Science	Memorial Sloan Kettering	United States	NO	T3	N2	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV	A210-26	TRUE
13722.58cfa831e4b0c9d6adf6c98e	58cfa831e4b0c9d6adf6c98e	TCGA-D7-6520-01A-11D-1798_130214_SN1120_0236_AC1RPCACXX_s_7_rg.sorted.filtered.	WGS	TCGA-D7-6520-01A-11D-1798_130214_SN1120_0236_AC1RPCACXX_s_7_rg.sorted	TCGA-D7-6520-01A-11D-1798_130214_SN1120_0236_AC1RPCACXX_s_7_rg.sorted.bam	94.4	1.9	0.14	58cfa831e4b0c9d6adf6c98e	TCGA-D7-6520-01A-11D-1798_130214_SN1120_0236_AC1RPCACXX_s_7_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-D7-6520-01A	3C573AF6-6298-49DE-8DE0-6A7F9CE9B000	Primary Tumor	Illumina HiSeq	46b79d94-56c0-4b23-955d-2395a50ecaf9	Stomach	53	7C162352-903E-4723-AF91-6FDD8E8EAD3B	F1CB7996-BD0E-4123-84E9-D359E5DB7700	TCGA-D7-6520-01A-11D-1798-02	HG19_Broad_variant	TCGA-D7-6520	TCGA-STAD	NA	s14494	Harvard Medical School	Greater Poland Cancer Center	Poland	NO	T2b	N2	Stomach  Intestinal Adenocarcinoma  Tubular Type	Stage IIIA	1798-02	TRUE
13722.58cfa830e4b0c9d6adf6c246	58cfa830e4b0c9d6adf6c246	TCGA-BA-4078-01A-01D-1431_120612_SN590_0161_AC0VUTACXX_s_5_rg.sorted.filtered.	WGS	TCGA-BA-4078-01A-01D-1431_120612_SN590_0161_AC0VUTACXX_s_5_rg.sorted	TCGA-BA-4078-01A-01D-1431_120612_SN590_0161_AC0VUTACXX_s_5_rg.sorted.bam	747.33	1.9	0.16	58cfa830e4b0c9d6adf6c246	TCGA-BA-4078-01A-01D-1431_120612_SN590_0161_AC0VUTACXX_s_5_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-BA-4078-01A	C7353D6A-82A2-4A0D-8CD4-8C8957943EDB	Primary Tumor	Illumina HiSeq	cf3b040a-b4be-41ce-a172-1a295ebd79b2	Head and Neck	83	2027EDE3-13F5-40F6-BEF6-16704981D676	66A9CFF2-397E-415E-BF54-9A75CCC80BDE	TCGA-BA-4078-01A-01D-1431-02	HG19_Broad_variant	TCGA-BA-4078	TCGA-HNSC	276	s15877	Harvard Medical School	UNC	None	NO	Not available	Not available	Head and Neck Squamous Cell Carcinoma	Not available	1431-02	TRUE
13722.58cfa831e4b0c9d6adf6c9b5	58cfa831e4b0c9d6adf6c9b5	TCGA-DK-A3IU-01A-11D-A210_120911_SN1120_0189_BD1D04ACXX_s_7_rg.sorted.filtered.	WGS	TCGA-DK-A3IU-01A-11D-A210_120911_SN1120_0189_BD1D04ACXX_s_7_rg.sorted	TCGA-DK-A3IU-01A-11D-A210_120911_SN1120_0189_BD1D04ACXX_s_7_rg.sorted.bam	34.01	NA	0.15	58cfa831e4b0c9d6adf6c9b5	TCGA-DK-A3IU-01A-11D-A210_120911_SN1120_0189_BD1D04ACXX_s_7_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-DK-A3IU-01A	F093F043-EFD4-4CBA-A87F-8CBB5C1ACD9E	Primary Tumor	Illumina HiSeq	346b87a3-0c3a-455c-b3c1-0fb96acd0f2f	Bladder	58	B9C39E8B-D689-499A-BC06-CE3BFFC9996C	8E8E8966-582A-45FF-96C2-EC0C1718C4F2	TCGA-DK-A3IU-01A-11D-A210-26	HG19_Broad_variant	TCGA-DK-A3IU	TCGA-BLCA	NA	s3285	MD Anderson - Institute for Applied Cancer Science	Memorial Sloan Kettering	United States	NO	T2b	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage II	A210-26	TRUE
13722.58cfa831e4b0c9d6adf6c9d3	58cfa831e4b0c9d6adf6c9d3	TCGA-DK-A1A3-01A-11D-A13U_120921_SN208_0431_BD1D5FACXX_s_7_rg.sorted.filtered.	WGS	TCGA-DK-A1A3-01A-11D-A13U_120921_SN208_0431_BD1D5FACXX_s_7_rg.sorted	TCGA-DK-A1A3-01A-11D-A13U_120921_SN208_0431_BD1D5FACXX_s_7_rg.sorted.bam	16.46	1.91	0.17	58cfa831e4b0c9d6adf6c9d3	TCGA-DK-A1A3-01A-11D-A13U_120921_SN208_0431_BD1D5FACXX_s_7_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-DK-A1A3-01A	C5B20CCC-523D-491C-8536-008E05C57212	Primary Tumor	Illumina HiSeq	0e78dec3-7b8b-425e-9cc5-489bf825e0ea	Bladder	60	954E46BA-514F-4708-AD3C-ECBF8CEF005A	DC0A234A-9177-4E2A-B218-212F1278B4A1	TCGA-DK-A1A3-01A-11D-A13U-02	HG19_Broad_variant	TCGA-DK-A1A3	TCGA-BLCA	NA	s3102	Harvard Medical School	Memorial Sloan Kettering	United States	NO	T3	N2	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV	A13U-02	TRUE
13722.58cfa831e4b0c9d6adf6c9d5	58cfa831e4b0c9d6adf6c9d5	TCGA-DK-A3IQ-01A-31D-A210_120911_SN1120_0189_BD1D04ACXX_s_3_rg.sorted.filtered.	WGS	TCGA-DK-A3IQ-01A-31D-A210_120911_SN1120_0189_BD1D04ACXX_s_3_rg.sorted	TCGA-DK-A3IQ-01A-31D-A210_120911_SN1120_0189_BD1D04ACXX_s_3_rg.sorted.bam	22.29	NA	0.16	58cfa831e4b0c9d6adf6c9d5	TCGA-DK-A3IQ-01A-31D-A210_120911_SN1120_0189_BD1D04ACXX_s_3_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-DK-A3IQ-01A	E44F60EC-66C4-45A2-A003-0A1FAF1D6E03	Primary Tumor	Illumina HiSeq	edc43d06-7118-46e7-894e-d40138b6d69c	Bladder	74	1E375786-DB8F-4A8C-BA1C-C6DD7DE1A9BE	DB940CE0-2357-4E83-AA19-AEA672A121D9	TCGA-DK-A3IQ-01A-31D-A210-26	HG19_Broad_variant	TCGA-DK-A3IQ	TCGA-BLCA	NA	s2894	MD Anderson - Institute for Applied Cancer Science	Memorial Sloan Kettering	United States	NO	T3	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage III	A210-26	TRUE
13722.58cfa831e4b0c9d6adf6c9c7	58cfa831e4b0c9d6adf6c9c7	TCGA-DQ-5630-01A-01D-1868_120504_SN1222_0101_AC0UMDACXX_s_1_rg.sorted.filtered.	WGS	TCGA-DQ-5630-01A-01D-1868_120504_SN1222_0101_AC0UMDACXX_s_1_rg.sorted	TCGA-DQ-5630-01A-01D-1868_120504_SN1222_0101_AC0UMDACXX_s_1_rg.sorted.bam	374.7	1.9	0.15	58cfa831e4b0c9d6adf6c9c7	TCGA-DQ-5630-01A-01D-1868_120504_SN1222_0101_AC0UMDACXX_s_1_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-DQ-5630-01A	91A712B5-A724-48D0-BA06-4F6857683463	Primary Tumor	Illumina HiSeq	865b23ff-32b6-41bf-8316-cde4e80d7873	Head and Neck	73	A0CDB208-E66F-4AD7-86FA-5077145A4A68	4C2960DA-103B-4620-ABCD-0EE586F39E0D	TCGA-DQ-5630-01A-01D-1868-02	HG19_Broad_variant	TCGA-DQ-5630	TCGA-HNSC	NA	s16346	Harvard Medical School	University of Michigan	United States	NO	TX	NX	Head and Neck Squamous Cell Carcinoma	Not available	1868-02	TRUE
13722.58cfa831e4b0c9d6adf6cac2	58cfa831e4b0c9d6adf6cac2	TCGA-DJ-A13R-01A-11D-A10R_120711_SN1120_0174_BD13R2ACXX_s_2_rg.sorted.filtered.	WGS	TCGA-DJ-A13R-01A-11D-A10R_120711_SN1120_0174_BD13R2ACXX_s_2_rg.sorted	TCGA-DJ-A13R-01A-11D-A10R_120711_SN1120_0174_BD13R2ACXX_s_2_rg.sorted.bam	78.88	1.95	0.16	58cfa831e4b0c9d6adf6cac2	TCGA-DJ-A13R-01A-11D-A10R_120711_SN1120_0174_BD13R2ACXX_s_2_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-DJ-A13R-01A	3E787A0E-B5D2-401E-B1E5-077376090B3A	Primary Tumor	Illumina HiSeq	84cf379b-0f45-44d0-b5e3-00a439bab300	Thyroid	50	27B0FF79-4213-4B57-B6E0-A393B8983D20	7B0104C8-1264-4580-94D1-C7C39D79C6E6	TCGA-DJ-A13R-01A-11D-A10R-02	HG19_Broad_variant	TCGA-DJ-A13R	TCGA-THCA	NA	s12368	Harvard Medical School	Memorial Sloan Kettering	United States	NO	T3	N0	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	Stage III	A10R-02	TRUE
13722.58cfa831e4b0c9d6adf6ca92	58cfa831e4b0c9d6adf6ca92	TCGA-DQ-5624-01A-01D-1868_120427_SN208_0288_BD0RWBACXX_s_5_rg.sorted.filtered.	WGS	TCGA-DQ-5624-01A-01D-1868_120427_SN208_0288_BD0RWBACXX_s_5_rg.sorted	TCGA-DQ-5624-01A-01D-1868_120427_SN208_0288_BD0RWBACXX_s_5_rg.sorted.bam	98.7	1.9	0.15	58cfa831e4b0c9d6adf6ca92	TCGA-DQ-5624-01A-01D-1868_120427_SN208_0288_BD0RWBACXX_s_5_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-DQ-5624-01A	B4A41682-4ACA-4F1D-BACD-66F5E6EC7466	Primary Tumor	Illumina HiSeq	72ea153a-e312-4f8e-8fa6-bd705df2b106	Head and Neck	43	39A74037-6C20-4713-A6AA-E972218EFF90	45F819EB-F6B5-4B82-9E47-060B2E111851	TCGA-DQ-5624-01A-01D-1868-02	HG19_Broad_variant	TCGA-DQ-5624	TCGA-HNSC	NA	s15532	Harvard Medical School	University of Michigan	United States	NO	TX	NX	Head and Neck Squamous Cell Carcinoma	Not available	1868-02	TRUE
13722.58cfa82fe4b0c9d6adf6b7fa	58cfa82fe4b0c9d6adf6b7fa	TCGA-38-4629-01A-02D-1203_120305_SN1120_0119_BD0REAACXX_s_8_rg.sorted.filtered.	WGS	TCGA-38-4629-01A-02D-1203_120305_SN1120_0119_BD0REAACXX_s_8_rg.sorted	TCGA-38-4629-01A-02D-1203_120305_SN1120_0119_BD0REAACXX_s_8_rg.sorted.bam	155.9	1.9	0.14	58cfa82fe4b0c9d6adf6b7fa	TCGA-38-4629-01A-02D-1203_120305_SN1120_0119_BD0REAACXX_s_8_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-38-4629-01A	127BF818-F7E5-46B5-A9DE-39F6D96B8B83	Primary Tumor	Illumina HiSeq	ecb1f536-930a-4c20-a11a-c69c6740295f	Lung	68	EB822F95-8B15-4C86-B5E5-B0AFE9C32E0C	51FF3351-1A43-458F-9BD9-99BD39FDDAF3	TCGA-38-4629-01A-02D-1203-02	HG19_Broad_variant	TCGA-38-4629	TCGA-LUAD	864	s11450	Harvard Medical School	UNC	None	NO	T3	N0	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage IIB	1203-02	TRUE
13722.58cfa831e4b0c9d6adf6cb17	58cfa831e4b0c9d6adf6cb17	TCGA-EA-A3QD-01A-32D-A232_140124_SN1120_0291_AC2PHAACXX_s_2_rg.sorted.filtered.	WGS	TCGA-EA-A3QD-01A-32D-A232_140124_SN1120_0291_AC2PHAACXX_s_2_rg.sorted	TCGA-EA-A3QD-01A-32D-A232_140124_SN1120_0291_AC2PHAACXX_s_2_rg.sorted.bam	58.49	NA	0.15	58cfa831e4b0c9d6adf6cb17	TCGA-EA-A3QD-01A-32D-A232_140124_SN1120_0291_AC2PHAACXX_s_2_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-EA-A3QD-01A	9E2E29E8-D94A-499F-A98A-5B53B2C38F3B	Primary Tumor	Illumina HiSeq	d97f385a-fc08-43a1-9481-35f9ffdfcc05	Cervix	59	987E1913-A506-4A06-B247-9FF778CE552B	677FE002-1736-4263-B2CE-D93983F0BF95	TCGA-EA-A3QD-01A-32D-A232-26	HG19_Broad_variant	TCGA-EA-A3QD	TCGA-CESC	NA	s1185	MD Anderson - Institute for Applied Cancer Science	Asterand	United States	NO	T1b1	N1	Cervical Squamous Cell Carcinoma	Not available	A232-26	TRUE
13722.58cfa831e4b0c9d6adf6cbaa	58cfa831e4b0c9d6adf6cbaa	TCGA-EJ-5526-01A-01D-1572_130221_SN1120_0238_AC1TDEACXX_s_3_rg.sorted.filtered.	WGS	TCGA-EJ-5526-01A-01D-1572_130221_SN1120_0238_AC1TDEACXX_s_3_rg.sorted	TCGA-EJ-5526-01A-01D-1572_130221_SN1120_0238_AC1TDEACXX_s_3_rg.sorted.bam	378.7	1.9	0.15	58cfa831e4b0c9d6adf6cbaa	TCGA-EJ-5526-01A-01D-1572_130221_SN1120_0238_AC1TDEACXX_s_3_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-EJ-5526-01A	EEC48399-5660-4B25-8D34-191B54315C72	Primary Tumor	Illumina HiSeq	e57f50b5-06be-4be0-8b02-706bfb439f25	Prostate	56	4DBE4FA2-308F-4D5B-BF33-4C051F7DC537	4AC5F198-9558-42C9-8285-91D3F826E0E9	TCGA-EJ-5526-01A-01D-1572-02	HG19_Broad_variant	TCGA-EJ-5526	TCGA-PRAD	NA	s4143	Harvard Medical School	University of Pittsburgh	United States	NO	T3a	N1	Prostate Adenocarcinoma Acinar Type	Not available	1572-02	TRUE
13722.58cfa831e4b0c9d6adf6cb9a	58cfa831e4b0c9d6adf6cb9a	TCGA-EJ-7317-01A-31D-2111_130422_SN590_0225_BD23TLACXX_s_6_rg.sorted.filtered.	WGS	TCGA-EJ-7317-01A-31D-2111_130422_SN590_0225_BD23TLACXX_s_6_rg.sorted	TCGA-EJ-7317-01A-31D-2111_130422_SN590_0225_BD23TLACXX_s_6_rg.sorted.bam	61.4	NA	0.16	58cfa831e4b0c9d6adf6cb9a	TCGA-EJ-7317-01A-31D-2111_130422_SN590_0225_BD23TLACXX_s_6_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-EJ-7317-01A	68FC3693-0910-4EE8-8997-99C6333B65F4	Primary Tumor	Illumina HiSeq	7c1cef2b-4606-4c6c-ad6d-b49ca86b9f74	Prostate	71	AEEA2F28-0766-42D7-9E6A-C14BEB03E692	B25F2F78-DB49-49DF-9150-DF43F23589A4	TCGA-EJ-7317-01A-31D-2111-02	HG19_Broad_variant	TCGA-EJ-7317	TCGA-PRAD	NA	s3959	Harvard Medical School	University of Pittsburgh	United States	NO	T2c	N0	Prostate Adenocarcinoma Acinar Type	Not available	2111-02	TRUE
13722.58cfa831e4b0c9d6adf6cbca	58cfa831e4b0c9d6adf6cbca	TCGA-EJ-5517-01A-01D-1572_130131_SN1120_0235_BD1TAFACXX_s_5_rg.sorted.filtered.	WGS	TCGA-EJ-5517-01A-01D-1572_130131_SN1120_0235_BD1TAFACXX_s_5_rg.sorted	TCGA-EJ-5517-01A-01D-1572_130131_SN1120_0235_BD1TAFACXX_s_5_rg.sorted.bam	52.7	1.9	0.15	58cfa831e4b0c9d6adf6cbca	TCGA-EJ-5517-01A-01D-1572_130131_SN1120_0235_BD1TAFACXX_s_5_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-EJ-5517-01A	4B9AA301-D2E3-47F3-B724-A34F420B2B6B	Primary Tumor	Illumina HiSeq	add98c6f-07de-48db-b930-82504d0dd976	Prostate	55	B5FE6254-D1C6-4BA2-BD75-5CAF4FB2E2B7	62E5A068-01A5-40EC-8FF9-097D627127A0	TCGA-EJ-5517-01A-01D-1572-02	HG19_Broad_variant	TCGA-EJ-5517	TCGA-PRAD	NA	s3437	Harvard Medical School	University of Pittsburgh	United States	NO	T2c	N0	Prostate Adenocarcinoma Acinar Type	Not available	1572-02	TRUE
13722.58cfa831e4b0c9d6adf6cbc7	58cfa831e4b0c9d6adf6cbc7	TCGA-EJ-7327-01A-11D-2111_130422_SN590_0225_BD23TLACXX_s_8_rg.sorted.filtered.	WGS	TCGA-EJ-7327-01A-11D-2111_130422_SN590_0225_BD23TLACXX_s_8_rg.sorted	TCGA-EJ-7327-01A-11D-2111_130422_SN590_0225_BD23TLACXX_s_8_rg.sorted.bam	261.3	NA	0.14	58cfa831e4b0c9d6adf6cbc7	TCGA-EJ-7327-01A-11D-2111_130422_SN590_0225_BD23TLACXX_s_8_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-EJ-7327-01A	E90AB72A-4BBB-4C37-B48A-8A1A85D79D04	Primary Tumor	Illumina HiSeq	fe462cbb-5d52-4a0e-8cb8-a7e6c0f39c7c	Prostate	61	992415EF-53DE-4C52-A538-07931E68182B	0FC53595-F61A-4171-B982-335AEE13CC85	TCGA-EJ-7327-01A-11D-2111-02	HG19_Broad_variant	TCGA-EJ-7327	TCGA-PRAD	NA	s4145	Harvard Medical School	University of Pittsburgh	United States	NO	T3b	N0	Prostate Adenocarcinoma Acinar Type	Not available	2111-02	TRUE
13722.58cfa831e4b0c9d6adf6cbee	58cfa831e4b0c9d6adf6cbee	TCGA-EK-A2PM-01A-11D-A18I_140204_SN208_0508_BC2R1UACXX_s_2_rg.sorted.filtered.	WGS	TCGA-EK-A2PM-01A-11D-A18I_140204_SN208_0508_BC2R1UACXX_s_2_rg.sorted	TCGA-EK-A2PM-01A-11D-A18I_140204_SN208_0508_BC2R1UACXX_s_2_rg.sorted.bam	43.27	NA	0.16	58cfa831e4b0c9d6adf6cbee	TCGA-EK-A2PM-01A-11D-A18I_140204_SN208_0508_BC2R1UACXX_s_2_rg.sorted.bam	Alive	FEMALE	WHITE	Not available	Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-EK-A2PM-01A	085FB6D8-6265-484E-9307-8292386714B7	Primary Tumor	Illumina HiSeq	332b29bf-f948-4e2c-bf51-f768f819e9e9	Cervix	81	2E7F29FB-97DE-4EE0-BCA7-6A51C4C3E5CF	C32BE42D-CF78-4F46-B461-748796CEDA4A	TCGA-EK-A2PM-01A-11D-A18I-02	HG19_Broad_variant	TCGA-EK-A2PM	TCGA-CESC	NA	s1195	Harvard Medical School	Gynecologic Oncology Group	United States	NO	Not available	Not available	Cervical Squamous Cell Carcinoma	Not available	A18I-02	TRUE
13722.58cfa831e4b0c9d6adf6cbdd	58cfa831e4b0c9d6adf6cbdd	TCGA-EJ-5532-01A-01D-1572_130221_SN1120_0239_BD1V59ACXX_s_3_rg.sorted.filtered.	WGS	TCGA-EJ-5532-01A-01D-1572_130221_SN1120_0239_BD1V59ACXX_s_3_rg.sorted	TCGA-EJ-5532-01A-01D-1572_130221_SN1120_0239_BD1V59ACXX_s_3_rg.sorted.bam	188.7	1.9	0.15	58cfa831e4b0c9d6adf6cbdd	TCGA-EJ-5532-01A-01D-1572_130221_SN1120_0239_BD1V59ACXX_s_3_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-EJ-5532-01A	AE3A0C92-148D-4F1C-8563-06AC1050F53E	Primary Tumor	Illumina HiSeq	e7c833a1-c77a-4c65-b268-1db73a7028e3	Prostate	57	F32F7738-BAD4-40C9-B49F-084BB098A05A	E5F35020-2A9F-47B3-8271-FEF8E1883567	TCGA-EJ-5532-01A-01D-1572-02	HG19_Broad_variant	TCGA-EJ-5532	TCGA-PRAD	NA	s3956	Harvard Medical School	University of Pittsburgh	United States	NO	T3a	N0	Prostate Adenocarcinoma Acinar Type	Not available	1572-02	TRUE
13722.58cfa831e4b0c9d6adf6cca3	58cfa831e4b0c9d6adf6cca3	TCGA-EJ-5499-01A-01D-1572_130223_SN590_0214_BC1UJ3ACXX_s_1_rg.sorted.filtered.	WGS	TCGA-EJ-5499-01A-01D-1572_130223_SN590_0214_BC1UJ3ACXX_s_1_rg.sorted	TCGA-EJ-5499-01A-01D-1572_130223_SN590_0214_BC1UJ3ACXX_s_1_rg.sorted.bam	91.7	1.9	0.15	58cfa831e4b0c9d6adf6cca3	TCGA-EJ-5499-01A-01D-1572_130223_SN590_0214_BC1UJ3ACXX_s_1_rg.sorted.bam	Alive	MALE	ASIAN	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-EJ-5499-01A	FD1AA612-DF86-4D48-892D-2ACEBD76EA96	Primary Tumor	Illumina HiSeq	21f9da4c-83ce-44b4-b002-e18cd232ac6b	Prostate	61	22C4F5C2-1B1E-4212-8110-09DBD5CE10A9	0F4314C9-967C-4EF1-9CF2-A7B206E6129E	TCGA-EJ-5499-01A-01D-1572-02	HG19_Broad_variant	TCGA-EJ-5499	TCGA-PRAD	NA	s3789	Harvard Medical School	University of Pittsburgh	United States	NO	T3a	N0	Prostate Adenocarcinoma Acinar Type	Not available	1572-02	TRUE
13722.58cfa831e4b0c9d6adf6cca6	58cfa831e4b0c9d6adf6cca6	TCGA-EJ-5497-01A-02D-1572_130125_SN1120_0233_AD1K3HACXX_s_5_rg.sorted.filtered.	WGS	TCGA-EJ-5497-01A-02D-1572_130125_SN1120_0233_AD1K3HACXX_s_5_rg.sorted	TCGA-EJ-5497-01A-02D-1572_130125_SN1120_0233_AD1K3HACXX_s_5_rg.sorted.bam	209.7	1.9	0.16	58cfa831e4b0c9d6adf6cca6	TCGA-EJ-5497-01A-02D-1572_130125_SN1120_0233_AD1K3HACXX_s_5_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-EJ-5497-01A	DEE02265-D8DD-4379-AE08-72D72B03A570	Primary Tumor	Illumina HiSeq	453a9559-644e-46b9-8be3-7e4511448e7e	Prostate	47	317BE3B2-B7C1-4772-9E33-D55EB4B9FAA9	0B2246C7-CE2E-427D-BA10-4A2C942D0986	TCGA-EJ-5497-01A-02D-1572-02	HG19_Broad_variant	TCGA-EJ-5497	TCGA-PRAD	NA	s3944	Harvard Medical School	University of Pittsburgh	United States	NO	T2c	N0	Prostate Adenocarcinoma Acinar Type	Not available	1572-02	TRUE
13722.58cfa831e4b0c9d6adf6cccc	58cfa831e4b0c9d6adf6cccc	TCGA-EJ-5530-01A-01D-1572_130221_SN1120_0238_AC1TDEACXX_s_7_rg.sorted.filtered.	WGS	TCGA-EJ-5530-01A-01D-1572_130221_SN1120_0238_AC1TDEACXX_s_7_rg.sorted	TCGA-EJ-5530-01A-01D-1572_130221_SN1120_0238_AC1TDEACXX_s_7_rg.sorted.bam	388.7	1.9	0.14	58cfa831e4b0c9d6adf6cccc	TCGA-EJ-5530-01A-01D-1572_130221_SN1120_0238_AC1TDEACXX_s_7_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-EJ-5530-01A	E4A755E3-4938-4321-B5A9-27A445036791	Primary Tumor	Illumina HiSeq	83b4e2b0-670b-441b-9b17-fa5c1da740c5	Prostate	61	27D61473-39D6-478A-A576-427D1AEDA01F	CBA52846-FAD3-4D21-8949-0105BD2AE713	TCGA-EJ-5530-01A-01D-1572-02	HG19_Broad_variant	TCGA-EJ-5530	TCGA-PRAD	NA	s3961	Harvard Medical School	University of Pittsburgh	United States	NO	T2c	N0	Prostate Adenocarcinoma Acinar Type	Not available	1572-02	TRUE
13722.58cfa831e4b0c9d6adf6cd62	58cfa831e4b0c9d6adf6cd62	TCGA-EJ-5498-01A-01D-1572_130125_SN1120_0233_AD1K3HACXX_s_7_rg.sorted.filtered.	WGS	TCGA-EJ-5498-01A-01D-1572_130125_SN1120_0233_AD1K3HACXX_s_7_rg.sorted	TCGA-EJ-5498-01A-01D-1572_130125_SN1120_0233_AD1K3HACXX_s_7_rg.sorted.bam	52.7	1.9	0.17	58cfa831e4b0c9d6adf6cd62	TCGA-EJ-5498-01A-01D-1572_130125_SN1120_0233_AD1K3HACXX_s_7_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-EJ-5498-01A	79EC7468-9AAF-4BB0-94C7-72BE4F497868	Primary Tumor	Illumina HiSeq	1ea5110e-6493-415f-ae21-019a8d1e2a17	Prostate	56	AAF0AF43-DAE0-4AA7-9D4C-6CAF1F039857	24F583BD-C378-4981-A661-97B8E39CE600	TCGA-EJ-5498-01A-01D-1572-02	HG19_Broad_variant	TCGA-EJ-5498	TCGA-PRAD	NA	s3948	Harvard Medical School	University of Pittsburgh	United States	NO	T2c	N0	Prostate Adenocarcinoma Acinar Type	Not available	1572-02	TRUE
13722.58cfa831e4b0c9d6adf6cd50	58cfa831e4b0c9d6adf6cd50	TCGA-FD-A3SQ-01A-21D-A233_120830_SN208_0424_BD1DKLACXX_s_5_rg.sorted.filtered.	WGS	TCGA-FD-A3SQ-01A-21D-A233_120830_SN208_0424_BD1DKLACXX_s_5_rg.sorted	TCGA-FD-A3SQ-01A-21D-A233_120830_SN208_0424_BD1DKLACXX_s_5_rg.sorted.bam	35.93	NA	0.14	58cfa831e4b0c9d6adf6cd50	TCGA-FD-A3SQ-01A-21D-A233_120830_SN208_0424_BD1DKLACXX_s_5_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-FD-A3SQ-01A	3071CB51-DCF5-41F7-B047-AFC2DCBF0AAF	Primary Tumor	Illumina HiSeq	104a1ca4-a3b6-42e6-b6ba-1b0916160573	Bladder	62	A78A8C62-06ED-4562-B529-D30A5D1508E7	749C6741-66D9-4BEE-B5D6-7F6C4F9F0F88	TCGA-FD-A3SQ-01A-21D-A233-26	HG19_Broad_variant	TCGA-FD-A3SQ	TCGA-BLCA	1423	s3295	MD Anderson - Institute for Applied Cancer Science	BLN - University Of Chicago	United States	NO	T3a	N2	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV	A233-26	TRUE
13722.58cfa831e4b0c9d6adf6cdc5	58cfa831e4b0c9d6adf6cdc5	TCGA-FD-A3SO-01A-11D-A233_120830_SN208_0424_BD1DKLACXX_s_1_rg.sorted.filtered.	WGS	TCGA-FD-A3SO-01A-11D-A233_120830_SN208_0424_BD1DKLACXX_s_1_rg.sorted	TCGA-FD-A3SO-01A-11D-A233_120830_SN208_0424_BD1DKLACXX_s_1_rg.sorted.bam	39.92	NA	0.14	58cfa831e4b0c9d6adf6cdc5	TCGA-FD-A3SO-01A-11D-A233_120830_SN208_0424_BD1DKLACXX_s_1_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-FD-A3SO-01A	94809FBF-4895-42C0-A7C6-F39EE1A41F1A	Primary Tumor	Illumina HiSeq	6b296020-484a-4cc2-a114-6c8a34ed5712	Bladder	68	869E3D55-CAD8-436E-B6A8-7ED90AD0A535	3D37A593-EFD7-4250-961D-D914E0AB8C13	TCGA-FD-A3SO-01A-11D-A233-26	HG19_Broad_variant	TCGA-FD-A3SO	TCGA-BLCA	168	s2911	MD Anderson - Institute for Applied Cancer Science	BLN - University Of Chicago	United States	NO	T3a	N1	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV	A233-26	TRUE
13722.58cfa832e4b0c9d6adf6ce0f	58cfa832e4b0c9d6adf6ce0f	TCGA-FD-A3B8-01A-31D-A210_120912_SN1120_0192_AC18ALACXX_s_7_rg.sorted.filtered.	WGS	TCGA-FD-A3B8-01A-31D-A210_120912_SN1120_0192_AC18ALACXX_s_7_rg.sorted	TCGA-FD-A3B8-01A-31D-A210_120912_SN1120_0192_AC18ALACXX_s_7_rg.sorted.bam	26.04	NA	0.16	58cfa832e4b0c9d6adf6ce0f	TCGA-FD-A3B8-01A-31D-A210_120912_SN1120_0192_AC18ALACXX_s_7_rg.sorted.bam	Alive	MALE	WHITE	HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-FD-A3B8-01A	537CA5D1-5B26-496F-B7B4-05FEA7B46353	Primary Tumor	Illumina HiSeq	c0aadcb9-2d54-45c7-9585-575ed21ea52f	Bladder	56	9A27AA84-D541-4FA3-A798-D7559A5AE70C	582B2439-02F1-4E2A-9A4E-771603658FB5	TCGA-FD-A3B8-01A-31D-A210-26	HG19_Broad_variant	TCGA-FD-A3B8	TCGA-BLCA	NA	s3296	MD Anderson - Institute for Applied Cancer Science	BLN - University Of Chicago	United States	NO	T2b	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage II	A210-26	TRUE
13722.58cfa832e4b0c9d6adf6ce18	58cfa832e4b0c9d6adf6ce18	TCGA-FD-A3B5-01A-11D-A210_120912_SN1120_0192_AC18ALACXX_s_1_rg.sorted.filtered.	WGS	TCGA-FD-A3B5-01A-11D-A210_120912_SN1120_0192_AC18ALACXX_s_1_rg.sorted	TCGA-FD-A3B5-01A-11D-A210_120912_SN1120_0192_AC18ALACXX_s_1_rg.sorted.bam	33.2	NA	0.17	58cfa832e4b0c9d6adf6ce18	TCGA-FD-A3B5-01A-11D-A210_120912_SN1120_0192_AC18ALACXX_s_1_rg.sorted.bam	Dead	MALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-FD-A3B5-01A	462D5A6B-9F39-4AAE-A35B-D06A7811D053	Primary Tumor	Illumina HiSeq	d7af6a65-2c95-4a83-8e6f-756aef5309bd	Bladder	86	F9DEDC8C-327D-456A-9C0B-E1EC58AE3169	0D51FF4C-41D7-4296-BDDC-F9DB7F41276A	TCGA-FD-A3B5-01A-11D-A210-26	HG19_Broad_variant	TCGA-FD-A3B5	TCGA-BLCA	272	s2721	MD Anderson - Institute for Applied Cancer Science	BLN - University Of Chicago	United States	NO	T2b	N1	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV	A210-26	TRUE
13722.58cfa832e4b0c9d6adf6ce6a	58cfa832e4b0c9d6adf6ce6a	TCGA-H2-A26U-01A-11D-A16N_121204_SN208_0442_BC1F7YACXX_s_5_rg.sorted.filtered.	WGS	TCGA-H2-A26U-01A-11D-A16N_121204_SN208_0442_BC1F7YACXX_s_5_rg.sorted	TCGA-H2-A26U-01A-11D-A16N_121204_SN208_0442_BC1F7YACXX_s_5_rg.sorted.bam	65.58	1.91	0.17	58cfa832e4b0c9d6adf6ce6a	TCGA-H2-A26U-01A-11D-A16N_121204_SN208_0442_BC1F7YACXX_s_5_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-H2-A26U-01A	E61FB24B-613A-4B6D-BB2B-00CCEDBD3DBC	Primary Tumor	Illumina HiSeq	91b791c7-9ac1-4a55-bb8a-110046b81a61	Thyroid	54	A4240AB1-970E-4A99-989E-8968903E3A25	79850C4D-71D0-4905-946A-F309DCDDA59F	TCGA-H2-A26U-01A-11D-A16N-02	HG19_Broad_variant	TCGA-H2-A26U	TCGA-THCA	NA	s12762	Harvard Medical School	Christiana Healthcare	United States	NO	T3	N0	Thyroid Papillary Carcinoma - Classical/usual	Stage III	A16N-02	TRUE
13722.58cfa832e4b0c9d6adf6cea9	58cfa832e4b0c9d6adf6cea9	TCGA-EJ-5516-01A-01D-1572_130131_SN1120_0235_BD1TAFACXX_s_3_rg.sorted.filtered.	WGS	TCGA-EJ-5516-01A-01D-1572_130131_SN1120_0235_BD1TAFACXX_s_3_rg.sorted	TCGA-EJ-5516-01A-01D-1572_130131_SN1120_0235_BD1TAFACXX_s_3_rg.sorted.bam	197.7	1.9	0.16	58cfa832e4b0c9d6adf6cea9	TCGA-EJ-5516-01A-01D-1572_130131_SN1120_0235_BD1TAFACXX_s_3_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-EJ-5516-01A	1FD06207-54E0-4ABA-819C-C7F671871F39	Primary Tumor	Illumina HiSeq	80ba9751-2e29-4949-a07f-6e3542df8770	Prostate	49	84D2D822-204E-4031-AF83-E188BB72F3AF	7DBAAFC9-A93D-4FFB-9FF0-85FACD567555	TCGA-EJ-5516-01A-01D-1572-02	HG19_Broad_variant	TCGA-EJ-5516	TCGA-PRAD	NA	s4136	Harvard Medical School	University of Pittsburgh	United States	NO	T3a	N0	Prostate Adenocarcinoma Acinar Type	Not available	1572-02	TRUE
13722.58cfa832e4b0c9d6adf6cf48	58cfa832e4b0c9d6adf6cf48	TCGA-HC-7075-01A-11D-1957_130412_SN590_0224_BC1YMJACXX_s_4_rg.sorted.filtered.	WGS	TCGA-HC-7075-01A-11D-1957_130412_SN590_0224_BC1YMJACXX_s_4_rg.sorted	TCGA-HC-7075-01A-11D-1957_130412_SN590_0224_BC1YMJACXX_s_4_rg.sorted.bam	242.7	NA	0.15	58cfa832e4b0c9d6adf6cf48	TCGA-HC-7075-01A-11D-1957_130412_SN590_0224_BC1YMJACXX_s_4_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-HC-7075-01A	5DD69C3E-9A3D-450C-9F10-10B4D6DAEEBA	Primary Tumor	Illumina HiSeq	7fee8465-32e2-4bef-bd48-102b2534003a	Prostate	63	1FA3E5C2-E415-42FA-AEA3-F6C84959522A	CFC425B3-7570-4FD2-8DB6-611EF4D627DF	TCGA-HC-7075-01A-11D-1957-02	HG19_Broad_variant	TCGA-HC-7075	TCGA-PRAD	NA	s3811	Harvard Medical School	International Genomics Consortium	United States	NO	T2a	Not available	Prostate Adenocarcinoma Acinar Type	Not available	1957-02	TRUE
13722.58cfa832e4b0c9d6adf6cefc	58cfa832e4b0c9d6adf6cefc	TCGA-H4-A2HQ-01A-11D-A17R_120921_SN208_0430_AC18CWACXX_s_5_rg.sorted.filtered.	WGS	TCGA-H4-A2HQ-01A-11D-A17R_120921_SN208_0430_AC18CWACXX_s_5_rg.sorted	TCGA-H4-A2HQ-01A-11D-A17R_120921_SN208_0430_AC18CWACXX_s_5_rg.sorted.bam	54.46	NA	0.15	58cfa832e4b0c9d6adf6cefc	TCGA-H4-A2HQ-01A-11D-A17R_120921_SN208_0430_AC18CWACXX_s_5_rg.sorted.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-H4-A2HQ-01A	CEDE5274-279D-4021-8ACA-5ECC4BF94D66	Primary Tumor	Illumina HiSeq	46adb3c9-ac82-4284-b0d1-f95b10435695	Bladder	64	CBEDC0DB-39FD-4661-9531-CC24D422FAC4	CD60EBC2-EF2A-4B47-8D42-C864AA095B8D	TCGA-H4-A2HQ-01A-11D-A17R-02	HG19_Broad_variant	TCGA-H4-A2HQ	TCGA-BLCA	NA	s2735	Harvard Medical School	Medical College of Georgia	United States	NO	Not available	NX	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV	A17R-02	TRUE
13722.58cfa832e4b0c9d6adf6cf86	58cfa832e4b0c9d6adf6cf86	TCGA-G9-6343-01A-21D-1957_130329_SN590_0221_BD1WHDACXX_s_8_rg.sorted.filtered.	WGS	TCGA-G9-6343-01A-21D-1957_130329_SN590_0221_BD1WHDACXX_s_8_rg.sorted	TCGA-G9-6343-01A-21D-1957_130329_SN590_0221_BD1WHDACXX_s_8_rg.sorted.bam	108.7	1.9	0.14	58cfa832e4b0c9d6adf6cf86	TCGA-G9-6343-01A-21D-1957_130329_SN590_0221_BD1WHDACXX_s_8_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-G9-6343-01A	36B87D12-9F96-460F-A3B5-A4C08CBF5B07	Primary Tumor	Illumina HiSeq	e413f861-4cba-4bf6-a805-aff9ecf4eb3b	Prostate	62	084C6D1F-047E-4B0E-9034-3B0FC18D510D	CB58EB3E-4769-4050-BB51-AE248D0FABAA	TCGA-G9-6343-01A-21D-1957-02	HG19_Broad_variant	TCGA-G9-6343	TCGA-PRAD	NA	s3453	Harvard Medical School	Roswell Park	United States	NO	T2c	Not available	Prostate Adenocarcinoma Acinar Type	Not available	1957-02	TRUE
13722.58cfa832e4b0c9d6adf6ce92	58cfa832e4b0c9d6adf6ce92	TCGA-G2-A2EJ-01A-11D-A17R_120921_SN208_0430_AC18CWACXX_s_3_rg.sorted.filtered.	WGS	TCGA-G2-A2EJ-01A-11D-A17R_120921_SN208_0430_AC18CWACXX_s_3_rg.sorted	TCGA-G2-A2EJ-01A-11D-A17R_120921_SN208_0430_AC18CWACXX_s_3_rg.sorted.bam	36.89	NA	0.16	58cfa832e4b0c9d6adf6ce92	TCGA-G2-A2EJ-01A-11D-A17R_120921_SN208_0430_AC18CWACXX_s_3_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-G2-A2EJ-01A	C6227D39-D9E8-4E28-9E70-D7F720AB25E4	Primary Tumor	Illumina HiSeq	18abb4d7-25d0-477e-bda6-011263e96364	Bladder	56	FBAD20BA-EE08-4D46-825B-870126AAD539	8D99E3A4-DECB-49D7-9727-C5D7606D60DF	TCGA-G2-A2EJ-01A-11D-A17R-02	HG19_Broad_variant	TCGA-G2-A2EJ	TCGA-BLCA	NA	s3304	Harvard Medical School	MD Anderson	United States	NO	Not available	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage II	A17R-02	TRUE
13722.58cfa832e4b0c9d6adf6cf1a	58cfa832e4b0c9d6adf6cf1a	TCGA-H7-7774-01A-21D-2317_120623_SN1222_0119_BC0WLLACXX_s_4_rg.sorted.filtered.	WGS	TCGA-H7-7774-01A-21D-2317_120623_SN1222_0119_BC0WLLACXX_s_4_rg.sorted	TCGA-H7-7774-01A-21D-2317_120623_SN1222_0119_BC0WLLACXX_s_4_rg.sorted.bam	52.73	NA	0.15	58cfa832e4b0c9d6adf6cf1a	TCGA-H7-7774-01A-21D-2317_120623_SN1222_0119_BC0WLLACXX_s_4_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-H7-7774-01A	EEAE67AC-C9E0-468D-AAD6-052501F7B982	Primary Tumor	Illumina HiSeq	ab347312-e135-4dd6-9be3-fa5fdebbcd68	Head and Neck	75	50F6615A-49CC-4E14-B5DD-54784B66C27B	B9B2B6F5-57EB-4DD6-8FE2-1E8669840DAB	TCGA-H7-7774-01A-21D-2317-26	HG19_Broad_variant	TCGA-H7-7774	TCGA-HNSC	NA	s16209	MD Anderson - Institute for Applied Cancer Science	ABS - IUPUI	United States	NO	T4a	N0	Head and Neck Squamous Cell Carcinoma	Stage IVA	2317-26	TRUE
13722.58cfa832e4b0c9d6adf6d01c	58cfa832e4b0c9d6adf6d01c	TCGA-FU-A3TX-01A-11D-A232_140124_SN1120_0291_AC2PHAACXX_s_4_rg.sorted.filtered.	WGS	TCGA-FU-A3TX-01A-11D-A232_140124_SN1120_0291_AC2PHAACXX_s_4_rg.sorted	TCGA-FU-A3TX-01A-11D-A232_140124_SN1120_0291_AC2PHAACXX_s_4_rg.sorted.bam	57.65	NA	0.16	58cfa832e4b0c9d6adf6d01c	TCGA-FU-A3TX-01A-11D-A232_140124_SN1120_0291_AC2PHAACXX_s_4_rg.sorted.bam	Alive	FEMALE	Not available	Not available	Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-FU-A3TX-01A	B75644C2-B515-41CE-9B03-842EF5208A17	Primary Tumor	Illumina HiSeq	3692ce0d-daf2-4076-a86f-4d8e9ea25745	Cervix	78	D9146847-1E6A-4963-9BC2-C2041B36A84C	14CDA56B-E939-4F52-8F22-00F3E5EA0DA6	TCGA-FU-A3TX-01A-11D-A232-26	HG19_Broad_variant	TCGA-FU-A3TX	TCGA-CESC	NA	s1371	MD Anderson - Institute for Applied Cancer Science	International Genomics Consortium	United States	NO	T1b2	N0	Cervical Squamous Cell Carcinoma	Not available	A232-26	TRUE
13722.58cfa832e4b0c9d6adf6d036	58cfa832e4b0c9d6adf6d036	TCGA-FU-A3WB-01A-11D-A232_140124_SN1120_0291_AC2PHAACXX_s_5_rg.sorted.filtered.	WGS	TCGA-FU-A3WB-01A-11D-A232_140124_SN1120_0291_AC2PHAACXX_s_5_rg.sorted	TCGA-FU-A3WB-01A-11D-A232_140124_SN1120_0291_AC2PHAACXX_s_5_rg.sorted.bam	44.44	NA	0.16	58cfa832e4b0c9d6adf6d036	TCGA-FU-A3WB-01A-11D-A232_140124_SN1120_0291_AC2PHAACXX_s_5_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-FU-A3WB-01A	6868BA1D-B612-454C-8146-74AF2F573D76	Primary Tumor	Illumina HiSeq	39124a1d-9323-40ae-aee5-6fb32cf4a565	Cervix	43	0334B0B7-115E-40A0-960B-6A3365CDA3AD	52C1B6D6-A160-4FFB-945C-6FB3B29EFEF9	TCGA-FU-A3WB-01A-11D-A232-26	HG19_Broad_variant	TCGA-FU-A3WB	TCGA-CESC	NA	s1203	MD Anderson - Institute for Applied Cancer Science	International Genomics Consortium	United States	NO	T2a2	N0	Cervical Squamous Cell Carcinoma	Not available	A232-26	TRUE
13722.58cfa832e4b0c9d6adf6d078	58cfa832e4b0c9d6adf6d078	TCGA-HC-7081-01A-11D-1957_130422_SN590_0225_BD23TLACXX_s_4_rg.sorted.filtered.	WGS	TCGA-HC-7081-01A-11D-1957_130422_SN590_0225_BD23TLACXX_s_4_rg.sorted	TCGA-HC-7081-01A-11D-1957_130422_SN590_0225_BD23TLACXX_s_4_rg.sorted.bam	130.7	NA	0.14	58cfa832e4b0c9d6adf6d078	TCGA-HC-7081-01A-11D-1957_130422_SN590_0225_BD23TLACXX_s_4_rg.sorted.bam	Alive	MALE	WHITE	Not available	Prostate Adenocarcinoma	Aligned reads	TCGA-HC-7081-01A	3DA2E90E-6450-4286-8C74-08DBECBFD788	Primary Tumor	Illumina HiSeq	f44b51c1-3e9f-49b0-817b-b31a58264c39	Prostate	62	D4EAA3C5-A0F0-4CD7-8B93-73DFB09B359A	AA4E666F-E577-4F00-82A7-EBC3B8739960	TCGA-HC-7081-01A-11D-1957-02	HG19_Broad_variant	TCGA-HC-7081	TCGA-PRAD	NA	s3805	Harvard Medical School	International Genomics Consortium	United States	NO	T3b	Not available	Prostate Adenocarcinoma Acinar Type	Not available	1957-02	TRUE
13722.58cfa832e4b0c9d6adf6d0ac	58cfa832e4b0c9d6adf6d0ac	TCGA-IG-A3I8-01A-11D-A248_130101_SN590_0206_AC1H8RACXX_s_5_rg.sorted.filtered.	WGS	TCGA-IG-A3I8-01A-11D-A248_130101_SN590_0206_AC1H8RACXX_s_5_rg.sorted	TCGA-IG-A3I8-01A-11D-A248_130101_SN590_0206_AC1H8RACXX_s_5_rg.sorted.bam	64.11	NA	0.16	58cfa832e4b0c9d6adf6d0ac	TCGA-IG-A3I8-01A-11D-A248_130101_SN590_0206_AC1H8RACXX_s_5_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Esophageal Carcinoma	Aligned reads	TCGA-IG-A3I8-01A	7BF3F18B-A013-48D2-A743-26A57FDBE4C4	Primary Tumor	Illumina HiSeq	d45e0e39-36b5-4628-9dae-7a185f129e6b	Esophagus	51	944A68B7-51D4-4831-88D4-D647BE17BC13	3A1FBCCE-BAB6-466C-AE4C-AADC4E5D357F	TCGA-IG-A3I8-01A-11D-A248-26	HG19_Broad_variant	TCGA-IG-A3I8	TCGA-ESCA	NA	s1621	MD Anderson - Institute for Applied Cancer Science	Asterand	Russia	NO	T3	N0	Not available	Stage IIA	A248-26	TRUE
13722.58cfa832e4b0c9d6adf6d0d0	58cfa832e4b0c9d6adf6d0d0	TCGA-IG-A3YA-01A-11D-A248_121211_SN208_0443_BC1H55ACXX_s_1_rg.sorted.filtered.	WGS	TCGA-IG-A3YA-01A-11D-A248_121211_SN208_0443_BC1H55ACXX_s_1_rg.sorted	TCGA-IG-A3YA-01A-11D-A248_121211_SN208_0443_BC1H55ACXX_s_1_rg.sorted.bam	41.16	NA	0.16	58cfa832e4b0c9d6adf6d0d0	TCGA-IG-A3YA-01A-11D-A248_121211_SN208_0443_BC1H55ACXX_s_1_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Esophageal Carcinoma	Aligned reads	TCGA-IG-A3YA-01A	7AB6DE57-D659-47F1-A70F-1B67650E99D7	Primary Tumor	Illumina HiSeq	d20d3af7-3c79-446f-834f-9be861dc1490	Esophagus	53	AAADB48E-3C60-4AE4-B6EB-7B5F9C9D6544	A389CF30-6460-43E5-A895-6EBFC9555AF2	TCGA-IG-A3YA-01A-11D-A248-26	HG19_Broad_variant	TCGA-IG-A3YA	TCGA-ESCA	NA	s1819	MD Anderson - Institute for Applied Cancer Science	Asterand	Russia	NO	T4	N0	Not available	Stage IIIA	A248-26	TRUE
13722.58cfa832e4b0c9d6adf6d0f0	58cfa832e4b0c9d6adf6d0f0	TCGA-HC-7077-01A-11D-1957_130412_SN590_0224_BC1YMJACXX_s_6_rg.sorted.filtered.	WGS	TCGA-HC-7077-01A-11D-1957_130412_SN590_0224_BC1YMJACXX_s_6_rg.sorted	TCGA-HC-7077-01A-11D-1957_130412_SN590_0224_BC1YMJACXX_s_6_rg.sorted.bam	192.7	NA	0.15	58cfa832e4b0c9d6adf6d0f0	TCGA-HC-7077-01A-11D-1957_130412_SN590_0224_BC1YMJACXX_s_6_rg.sorted.bam	Alive	MALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-HC-7077-01A	92252560-5984-41F6-A4B5-A3AA8654C0C8	Primary Tumor	Illumina HiSeq	bea10bd4-1049-4162-bb70-0bf5073199c6	Prostate	64	F3E4CC00-D6FE-4291-BB07-8E501E772CE1	EFC4EC34-58ED-40DE-8E0D-BCBA6320BF4C	TCGA-HC-7077-01A-11D-1957-02	HG19_Broad_variant	TCGA-HC-7077	TCGA-PRAD	NA	s4154	Harvard Medical School	International Genomics Consortium	United States	NO	T3a	Not available	Prostate Adenocarcinoma Acinar Type	Not available	1957-02	TRUE
13722.58cfa832e4b0c9d6adf6d0f2	58cfa832e4b0c9d6adf6d0f2	TCGA-HC-7213-01A-11D-2111_130517_SN590_0230_AD24B4ACXX_s_6_rg.sorted.filtered.	WGS	TCGA-HC-7213-01A-11D-2111_130517_SN590_0230_AD24B4ACXX_s_6_rg.sorted	TCGA-HC-7213-01A-11D-2111_130517_SN590_0230_AD24B4ACXX_s_6_rg.sorted.bam	408.3	NA	0.15	58cfa832e4b0c9d6adf6d0f2	TCGA-HC-7213-01A-11D-2111_130517_SN590_0230_AD24B4ACXX_s_6_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-HC-7213-01A	26EEFAA1-1666-4CE1-8CF4-F6FABFF81FD2	Primary Tumor	Illumina HiSeq	14482ee6-0af5-43ad-bc2b-c9574446f6b9	Prostate	53	0CB3DFFD-1521-4887-B19C-94DCD340D306	6D368C2B-4F13-4006-A487-7DB0ADA55C6A	TCGA-HC-7213-01A-11D-2111-02	HG19_Broad_variant	TCGA-HC-7213	TCGA-PRAD	NA	s3812	Harvard Medical School	International Genomics Consortium	United States	NO	T3b	N0	Prostate Adenocarcinoma Acinar Type	Not available	2111-02	TRUE
13722.58cfa832e4b0c9d6adf6d12e	58cfa832e4b0c9d6adf6d12e	TCGA-G2-A3IB-01A-11D-A210_120912_SN1222_0149_BD1CW3ACXX_s_1_rg.sorted.filtered.	WGS	TCGA-G2-A3IB-01A-11D-A210_120912_SN1222_0149_BD1CW3ACXX_s_1_rg.sorted	TCGA-G2-A3IB-01A-11D-A210_120912_SN1222_0149_BD1CW3ACXX_s_1_rg.sorted.bam	39.31	NA	0.15	58cfa832e4b0c9d6adf6d12e	TCGA-G2-A3IB-01A-11D-A210_120912_SN1222_0149_BD1CW3ACXX_s_1_rg.sorted.bam	Alive	MALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-G2-A3IB-01A	AF53D51E-0B5C-437F-A1C0-EC5F55C49364	Primary Tumor	Illumina HiSeq	f78443a3-8c1b-429a-93c3-fcd93f3c6d55	Bladder	66	791E4058-E872-4AF8-A431-F5782811F02A	80F634F1-C34C-40CD-9F9B-BBFC18E9DE6E	TCGA-G2-A3IB-01A-11D-A210-26	HG19_Broad_variant	TCGA-G2-A3IB	TCGA-BLCA	NA	s2726	MD Anderson - Institute for Applied Cancer Science	MD Anderson	United States	NO	Not available	NX	Muscle invasive urothelial carcinoma (pT2 or above)	Stage II	A210-26	TRUE
13722.58cfa832e4b0c9d6adf6d174	58cfa832e4b0c9d6adf6d174	TCGA-HC-7231-01A-11D-2111_130517_SN590_0231_BC24V6ACXX_s_2_rg.sorted.filtered.	WGS	TCGA-HC-7231-01A-11D-2111_130517_SN590_0231_BC24V6ACXX_s_2_rg.sorted	TCGA-HC-7231-01A-11D-2111_130517_SN590_0231_BC24V6ACXX_s_2_rg.sorted.bam	61.3	NA	0.17	58cfa832e4b0c9d6adf6d174	TCGA-HC-7231-01A-11D-2111_130517_SN590_0231_BC24V6ACXX_s_2_rg.sorted.bam	Alive	MALE	WHITE	Not available	Prostate Adenocarcinoma	Aligned reads	TCGA-HC-7231-01A	B182BDA9-3D9F-4958-96EB-BD6CC441830C	Primary Tumor	Illumina HiSeq	4b0f4fcc-c7c6-44bc-95d3-e693b0fbc7c7	Prostate	66	6AC7857C-5446-4297-95A9-5F2C11C28220	9826D5D9-D6D3-4216-9CA1-FE010711E13E	TCGA-HC-7231-01A-11D-2111-02	HG19_Broad_variant	TCGA-HC-7231	TCGA-PRAD	NA	s3806	Harvard Medical School	International Genomics Consortium	United States	NO	T2c	Not available	Prostate Adenocarcinoma Acinar Type	Not available	2111-02	TRUE
13722.58cfa832e4b0c9d6adf6d158	58cfa832e4b0c9d6adf6d158	TCGA-IR-A3LF-01A-21D-A232_140124_SN1120_0292_BD2F1HACXX_s_7_rg.sorted.filtered.	WGS	TCGA-IR-A3LF-01A-21D-A232_140124_SN1120_0292_BD2F1HACXX_s_7_rg.sorted	TCGA-IR-A3LF-01A-21D-A232_140124_SN1120_0292_BD2F1HACXX_s_7_rg.sorted.bam	36.63	NA	0.15	58cfa832e4b0c9d6adf6d158	TCGA-IR-A3LF-01A-21D-A232_140124_SN1120_0292_BD2F1HACXX_s_7_rg.sorted.bam	Alive	FEMALE	WHITE	Not available	Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-IR-A3LF-01A	785DDEA1-399D-47D8-B2B0-39E95EAA24B5	Primary Tumor	Illumina HiSeq	aba44461-5b2e-40f7-9e8e-262aee825e6c	Cervix	64	B6A74A02-CD3B-4F0A-BB2F-F90C1D3F6D14	02D65CAC-E751-493F-A4FB-3DDB1400EFAC	TCGA-IR-A3LF-01A-21D-A232-26	HG19_Broad_variant	TCGA-IR-A3LF	TCGA-CESC	NA	s1216	MD Anderson - Institute for Applied Cancer Science	Memorial Sloan Kettering	United States	NO	T1b1	N0	Endocervical Adenocarcinoma of the Usual Type	Not available	A232-26	TRUE
13722.58cfa832e4b0c9d6adf6d034	58cfa832e4b0c9d6adf6d034	TCGA-GC-A3RD-01A-12D-A233_120905_SN1120_0187_AD1E4NACXX_s_7_rg.sorted.filtered.	WGS	TCGA-GC-A3RD-01A-12D-A233_120905_SN1120_0187_AD1E4NACXX_s_7_rg.sorted	TCGA-GC-A3RD-01A-12D-A233_120905_SN1120_0187_AD1E4NACXX_s_7_rg.sorted.bam	46.83	NA	0.16	58cfa832e4b0c9d6adf6d034	TCGA-GC-A3RD-01A-12D-A233_120905_SN1120_0187_AD1E4NACXX_s_7_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-GC-A3RD-01A	6A2155B3-915C-41B1-B730-32E55E0C1FBD	Primary Tumor	Illumina HiSeq	27573bf6-b72d-47e6-93f7-38d2887d8b32	Bladder	83	1C60F60E-A3C6-43A1-A56E-BA68801D2D90	C9E9DC46-2917-47BE-92DA-9C40C6F13500	TCGA-GC-A3RD-01A-12D-A233-26	HG19_Broad_variant	TCGA-GC-A3RD	TCGA-BLCA	NA	s2731	MD Anderson - Institute for Applied Cancer Science	International Genomics Consortium	United States	NO	T3a	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage III	A233-26	TRUE
13722.58cfa832e4b0c9d6adf6d170	58cfa832e4b0c9d6adf6d170	TCGA-J8-A3YH-01A-11D-A23Q_120927_SN208_0432_AC188LACXX_s_3_rg.sorted.filtered.	WGS	TCGA-J8-A3YH-01A-11D-A23Q_120927_SN208_0432_AC188LACXX_s_3_rg.sorted	TCGA-J8-A3YH-01A-11D-A23Q_120927_SN208_0432_AC188LACXX_s_3_rg.sorted.bam	48.6	NA	0.15	58cfa832e4b0c9d6adf6d170	TCGA-J8-A3YH-01A-11D-A23Q_120927_SN208_0432_AC188LACXX_s_3_rg.sorted.bam	Alive	MALE	WHITE	Not available	Thyroid Carcinoma	Aligned reads	TCGA-J8-A3YH-01A	A09B20B5-C187-4632-B996-0D5314A9885C	Primary Tumor	Illumina HiSeq	f6ec340c-1c9c-4c8d-9266-4728709a90e6	Thyroid	39	EFDAD0C2-A44D-48F8-A908-E8C9747E78B8	BF118D4C-A2DF-4617-92E2-3475E07D9BE7	TCGA-J8-A3YH-01A-11D-A23Q-26	HG19_Broad_variant	TCGA-J8-A3YH	TCGA-THCA	NA	s12535	MD Anderson - Institute for Applied Cancer Science	Mayo Clinic	United States	NO	T3	N1b	Thyroid Papillary Carcinoma - Classical/usual	Stage I	A23Q-26	TRUE
13722.58cfa832e4b0c9d6adf6d655	58cfa832e4b0c9d6adf6d655	TCGA-LN-A49O-01A-11D-A248_130101_SN590_0206_AC1H8RACXX_s_1_rg.sorted.filtered.	WGS	TCGA-LN-A49O-01A-11D-A248_130101_SN590_0206_AC1H8RACXX_s_1_rg.sorted	TCGA-LN-A49O-01A-11D-A248_130101_SN590_0206_AC1H8RACXX_s_1_rg.sorted.bam	20.64	NA	0.16	58cfa832e4b0c9d6adf6d655	TCGA-LN-A49O-01A-11D-A248_130101_SN590_0206_AC1H8RACXX_s_1_rg.sorted.bam	Alive	MALE	ASIAN	NOT HISPANIC OR LATINO	Esophageal Carcinoma	Aligned reads	TCGA-LN-A49O-01A	3DF1B9DB-D900-47D2-839D-3900829CB2A9	Primary Tumor	Illumina HiSeq	e460c5ae-4179-406e-a1fd-fb7b1c7403ae	Esophagus	47	37A1045E-A566-4BC0-88CA-A54C5426A96D	C5253C04-01D3-40D9-85A2-155F9D0360C3	TCGA-LN-A49O-01A-11D-A248-26	HG19_Broad_variant	TCGA-LN-A49O	TCGA-ESCA	NA	s1863	MD Anderson - Institute for Applied Cancer Science	ILSbio	Vietnam	NO	T3	N0	Not available	Stage IIA	A248-26	TRUE
13722.58cfa82de4b0c9d6adf6a70e	58cfa82de4b0c9d6adf6a70e	G12518.TCGA-34-2596-01A-01D-0963-08.1.filtered.	WGS	G12518.TCGA-34-2596-01A-01D-0963-08.1	G12518.TCGA-34-2596-01A-01D-0963-08.1.bam	77.3	1.9	0.14	58cfa82de4b0c9d6adf6a70e	G12518.TCGA-34-2596-01A-01D-0963-08.1.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-34-2596-01A	7D3E77CC-9603-4722-8E39-1912B678871B	Primary Tumor	Illumina HiSeq	1fb42274-b17f-4050-9559-5d39557227d6	Lung	70	C07C8C94-150B-40A2-8830-5BE34DD99554	692DFA4F-45E5-4183-B5DA-6650A1FBCABD	TCGA-34-2596-01A-01D-0963-08	HG19_Broad_variant	TCGA-34-2596	TCGA-LUSC	80	s10356	Broad Institute of MIT and Harvard	University of Pittsburgh	United States	NO	T2	N1	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage IIB	0963-08	FALSE
13722.58cfa82de4b0c9d6adf6a75c	58cfa82de4b0c9d6adf6a75c	G14083.TCGA-21-1082-01A-01D-1521-08.3.filtered.	WGS	G14083.TCGA-21-1082-01A-01D-1521-08.3	G14083.TCGA-21-1082-01A-01D-1521-08.3.bam	233.7	1.9	0.05	58cfa82de4b0c9d6adf6a75c	G14083.TCGA-21-1082-01A-01D-1521-08.3.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-21-1082-01A	0E2EE54A-51C9-4868-842D-A2A1C1CFB016	Primary Tumor	Illumina HiSeq	94c61492-d5ca-462e-84cf-6d6d690fe431	Lung	61	F091C76E-5D01-4F4B-8F6F-463C9F302930	1C3DF485-8E75-4378-87F6-C6463A520624	TCGA-21-1082-01A-01D-1521-08	HG19_Broad_variant	TCGA-21-1082	TCGA-LUSC	NA	s10247	Broad Institute of MIT and Harvard	Fox Chase Cancer Center	United States	NO	T2	N0	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage IB	1521-08	TRUE
13722.58cfa82de4b0c9d6adf6a750	58cfa82de4b0c9d6adf6a750	G14082.TCGA-21-1076-01A-02D-1521-08.2.filtered.	WGS	G14082.TCGA-21-1076-01A-02D-1521-08.2	G14082.TCGA-21-1076-01A-02D-1521-08.2.bam	423.7	1.9	0.05	58cfa82de4b0c9d6adf6a750	G14082.TCGA-21-1076-01A-02D-1521-08.2.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-21-1076-01A	220BE009-8F1E-4A77-AB04-3220B5F87EA6	Primary Tumor	Illumina HiSeq	f960f40f-32d5-4ab1-a88c-0e199b9d1969	Lung	54	22BE9844-4D9E-4372-A46A-B5C64480E5AA	504D4CB0-D2DD-420D-82E6-9EC14434A0FC	TCGA-21-1076-01A-02D-1521-08	HG19_Broad_variant	TCGA-21-1076	TCGA-LUSC	NA	s10358	Broad Institute of MIT and Harvard	Fox Chase Cancer Center	United States	NO	T2	N0	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage IB	1521-08	TRUE
13722.58cfa82ee4b0c9d6adf6a7e8	58cfa82ee4b0c9d6adf6a7e8	G25773.TCGA-75-5147-01A-01D-1625-08.2.filtered.	WGS	G25773.TCGA-75-5147-01A-01D-1625-08.2	G25773.TCGA-75-5147-01A-01D-1625-08.2.bam	817.7	1.9	0.05	58cfa82ee4b0c9d6adf6a7e8	G25773.TCGA-75-5147-01A-01D-1625-08.2.bam	Alive	FEMALE	Not available	Not available	Lung Adenocarcinoma	Aligned reads	TCGA-75-5147-01A	D2824E6D-3784-45C2-9B0F-52B17356B5DA	Primary Tumor	Illumina HiSeq	6ec725e2-6d00-4866-8473-fd1b02309066	Lung	NA	F9F9C1DD-8462-4560-82B8-AEA4309854C9	52910A60-BB15-4BA5-9D09-50D8EE6A445B	TCGA-75-5147-01A-01D-1625-08	HG19_Broad_variant	TCGA-75-5147	TCGA-LUAD	NA	s10974	Broad Institute of MIT and Harvard	Ontario Institute for Cancer Research (OICR)	Canada	NO	T2	N0	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage IB	1625-08	FALSE
13722.58cfa82ee4b0c9d6adf6a82c	58cfa82ee4b0c9d6adf6a82c	G35154.TCGA-FG-7643-01A-11D-A461-08.2.filtered.	WGS	G35154.TCGA-FG-7643-01A-11D-A461-08.2	G35154.TCGA-FG-7643-01A-11D-A461-08.2.bam	9.7	NA	0.09	58cfa82ee4b0c9d6adf6a82c	G35154.TCGA-FG-7643-01A-11D-A461-08.2.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-FG-7643-01A	B6F13250-31B3-46AD-B514-5A684F1094A9	Primary Tumor	Illumina HiSeq	ad52b277-d592-4ece-a72f-4d48f9394453	Brain	49	71F68BC7-2612-4D84-8948-5A06D30AF488	025B53E6-9687-4085-B5CC-3585CE87625D	TCGA-FG-7643-01A-11D-A461-08	HG19_Broad_variant	TCGA-FG-7643	TCGA-LGG	NA	s8327	Broad Institute of MIT and Harvard	Case Western	United States	NO	Not available	Not available	Oligoastrocytoma	Not available	A461-08	TRUE
13722.58cfa82ee4b0c9d6adf6a826	58cfa82ee4b0c9d6adf6a826	G35154.TCGA-DU-5872-01A-11D-A465-08.1.filtered.	WGS	G35154.TCGA-DU-5872-01A-11D-A465-08.1	G35154.TCGA-DU-5872-01A-11D-A465-08.1.bam	31.7	1.8	0.09	58cfa82ee4b0c9d6adf6a826	G35154.TCGA-DU-5872-01A-11D-A465-08.1.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-DU-5872-01A	48607130-C09A-491D-882F-7D2591D13182	Primary Tumor	Illumina HiSeq	359efa91-062f-491e-805a-0130efb943eb	Brain	43	048550EE-189D-483D-B07F-B77F10278420	0BCE913F-C4A0-4CC6-9A8B-A223F00CBA11	TCGA-DU-5872-01A-11D-A465-08	HG19_Broad_variant	TCGA-DU-5872	TCGA-LGG	NA	s8528	Broad Institute of MIT and Harvard	Henry Ford Hospital	United States	NO	Not available	Not available	Oligoastrocytoma	Not available	A465-08	FALSE
13722.58cfa82de4b0c9d6adf6a762	58cfa82de4b0c9d6adf6a762	G14856.TCGA-05-4432-01A-01D-1931-08.2.filtered.	WGS	G14856.TCGA-05-4432-01A-01D-1931-08.2	G14856.TCGA-05-4432-01A-01D-1931-08.2.bam	306.53	1.9	0.14	58cfa82de4b0c9d6adf6a762	G14856.TCGA-05-4432-01A-01D-1931-08.2.bam	Alive	MALE	Not available	Not available	Lung Adenocarcinoma	Aligned reads	TCGA-05-4432-01A	E737F650-B72D-44E7-B750-558A56716803	Primary Tumor	Illumina HiSeq	612f40cd-a773-4962-b831-73dc8d9fb669	Lung	66	2A675528-1ABC-4220-A61A-25109850CE0D	3FBF4DA2-16C9-49AF-A5B3-3DC6C928E75C	TCGA-05-4432-01A-01D-1931-08	HG19_Broad_variant	TCGA-05-4432	TCGA-LUAD	NA	s11425	Broad Institute of MIT and Harvard	Indivumed	Germany	NO	T2	N1	Lung Adenocarcinoma Mixed Subtype	Stage IIB	1931-08	TRUE
13722.58cfa82ee4b0c9d6adf6a8b3	58cfa82ee4b0c9d6adf6a8b3	G35154.TCGA-FG-A4MT-01A-11D-A461-08.3.filtered.	WGS	G35154.TCGA-FG-A4MT-01A-11D-A461-08.3	G35154.TCGA-FG-A4MT-01A-11D-A461-08.3.bam	24.05	NA	0.08	58cfa82ee4b0c9d6adf6a8b3	G35154.TCGA-FG-A4MT-01A-11D-A461-08.3.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-FG-A4MT-01A	E30F1994-3622-43D0-BEC2-6D7E2D9881D2	Primary Tumor	Illumina HiSeq	19c19563-8424-46b9-b88c-72e6dcc4ec23	Brain	27	18C49A42-5EB4-4A3F-9233-C2557EA684BF	1120B01A-0819-4C90-A1B4-C2B85108E786	TCGA-FG-A4MT-01A-11D-A461-08	HG19_Broad_variant	TCGA-FG-A4MT	TCGA-LGG	NA	s8740	Broad Institute of MIT and Harvard	Case Western	United States	NO	Not available	Not available	Oligodendroglioma	Not available	A461-08	TRUE
13722.58cfa82ee4b0c9d6adf6a8ca	58cfa82ee4b0c9d6adf6a8ca	G35154.TCGA-DH-A669-01A-12D-A31L-08.3.filtered.	WGS	G35154.TCGA-DH-A669-01A-12D-A31L-08.3	G35154.TCGA-DH-A669-01A-12D-A31L-08.3.bam	53.17	NA	0.07	58cfa82ee4b0c9d6adf6a8ca	G35154.TCGA-DH-A669-01A-12D-A31L-08.3.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-DH-A669-01A	76E54EF6-1799-4FD9-BEC3-0EA960E8461E	Primary Tumor	Illumina HiSeq	5ce3eb80-b2f7-4ebe-bcda-690bfbf4a5ba	Brain	70	78A57936-140F-4593-9BF4-30B850247FAB	425BF16E-AEB2-453A-932B-B3F59016B041	TCGA-DH-A669-01A-12D-A31L-08	HG19_Broad_variant	TCGA-DH-A669	TCGA-LGG	919	s8099	Broad Institute of MIT and Harvard	University of Florida	United States	NO	Not available	Not available	Oligodendroglioma	Not available	A31L-08	FALSE
13722.58cfa82ee4b0c9d6adf6a8d6	58cfa82ee4b0c9d6adf6a8d6	G23072.TCGA_BB_4225_01A_01D_2268_08.1.filtered.	WGS	G23072.TCGA_BB_4225_01A_01D_2268_08.1	G23072.TCGA_BB_4225_01A_01D_2268_08.1.bam	56.7	1.9	0.15	58cfa82ee4b0c9d6adf6a8d6	G23072.TCGA_BB_4225_01A_01D_2268_08.1.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-BB-4225-01A	C1F50A22-38DF-41CC-A1F4-F7985504A7AC	Primary Tumor	Illumina HiSeq	e43130ec-f2f3-4984-8ba9-8f0e641acce9	Head and Neck	73	AC42070B-F4D6-47BE-96AA-A713D66A0072	81598359-24D5-4A8B-A6E6-7A6F94289119	TCGA-BB-4225-01A-01D-2268-08	HG19_Broad_variant	TCGA-BB-4225	TCGA-HNSC	NA	s16163	Broad Institute of MIT and Harvard	Johns Hopkins	United States	NO	TX	NX	Head and Neck Squamous Cell Carcinoma	Not available	2268-08	TRUE
13722.58cfa82ee4b0c9d6adf6a8a4	58cfa82ee4b0c9d6adf6a8a4	G35154.TCGA-CS-6669-01A-11D-1893-08.5.filtered.	WGS	G35154.TCGA-CS-6669-01A-11D-1893-08.5	G35154.TCGA-CS-6669-01A-11D-1893-08.5.bam	11.7	1.9	0.05	58cfa82ee4b0c9d6adf6a8a4	G35154.TCGA-CS-6669-01A-11D-1893-08.5.bam	Alive	FEMALE	WHITE	Not available	Brain Lower Grade Glioma	Aligned reads	TCGA-CS-6669-01A	DC5BDD21-B23F-400E-BBE2-4C98A517FC9E	Primary Tumor	Illumina HiSeq	7069c071-1fef-4c6f-b741-c67ee56619bb	Brain	26	57FAE3BD-B822-4855-A4A1-AFDCC20F6071	218A9531-9264-43BC-8535-858D4CB0919E	TCGA-CS-6669-01A-11D-1893-08	HG19_Broad_variant	TCGA-CS-6669	TCGA-LGG	NA	s8523	Broad Institute of MIT and Harvard	Thomas Jefferson University	United States	NO	Not available	Not available	Oligodendroglioma	Not available	1893-08	FALSE
13722.58cfa82ee4b0c9d6adf6a85a	58cfa82ee4b0c9d6adf6a85a	G35154.TCGA-HT-7602-01A-21D-2086-08.4.filtered.	WGS	G35154.TCGA-HT-7602-01A-21D-2086-08.4	G35154.TCGA-HT-7602-01A-21D-2086-08.4.bam	15.13	NA	0.05	58cfa82ee4b0c9d6adf6a85a	G35154.TCGA-HT-7602-01A-21D-2086-08.4.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-HT-7602-01A	799E9106-E62E-4681-8861-137F474EE8B8	Primary Tumor	Illumina HiSeq	fdc7bab5-c807-4791-be95-6a588e86a4b8	Brain	21	0997BB1A-F0A4-4CB8-9714-5BAF9C391CE8	88395C0E-4AFE-434D-8B20-5A3EEF8B7F00	TCGA-HT-7602-01A-21D-2086-08	HG19_Broad_variant	TCGA-HT-7602	TCGA-LGG	NA	s8531	Broad Institute of MIT and Harvard	Case Western - St Joes	United States	NO	Not available	Not available	Oligodendroglioma	Not available	2086-08	FALSE
13722.58cfa82ee4b0c9d6adf6a956	58cfa82ee4b0c9d6adf6a956	G35154.TCGA-DU-6401-01A-11D-1705-08.2.filtered.	WGS	G35154.TCGA-DU-6401-01A-11D-1705-08.2	G35154.TCGA-DU-6401-01A-11D-1705-08.2.bam	124.3	1.9	0.05	58cfa82ee4b0c9d6adf6a956	G35154.TCGA-DU-6401-01A-11D-1705-08.2.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-DU-6401-01A	97CB8701-7D63-4142-B404-006FBB3ECB0B	Primary Tumor	Illumina HiSeq	f0537710-8458-4890-8a52-3f4457eb308f	Brain	31	680DBC4E-5CEC-4E76-848F-72BC0A2407C6	3A81F733-B3A3-4578-B925-A663612BC92C	TCGA-DU-6401-01A-11D-1705-08	HG19_Broad_variant	TCGA-DU-6401	TCGA-LGG	2660	s8536	Broad Institute of MIT and Harvard	Henry Ford Hospital	United States	NO	Not available	Not available	Oligodendroglioma	Not available	1705-08	FALSE
13722.58cfa82ee4b0c9d6adf6a9a0	58cfa82ee4b0c9d6adf6a9a0	G35154.TCGA-TM-A7CF-01A-11D-A32B-08.4.filtered.	WGS	G35154.TCGA-TM-A7CF-01A-11D-A32B-08.4	G35154.TCGA-TM-A7CF-01A-11D-A32B-08.4.bam	11.46	NA	0.08	58cfa82ee4b0c9d6adf6a9a0	G35154.TCGA-TM-A7CF-01A-11D-A32B-08.4.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-TM-A7CF-01A	033C1F48-9225-4159-B23B-7042272877DA	Primary Tumor	Illumina HiSeq	41c3ad23-569a-452e-8577-85a783c2a020	Brain	41	ABE68BC0-FE69-409E-851E-3CCF10C8AC94	979F7FD8-AB07-40A0-869A-D08FB8E598FF	TCGA-TM-A7CF-01A-11D-A32B-08	HG19_Broad_variant	TCGA-TM-A7CF	TCGA-LGG	NA	s8116	Broad Institute of MIT and Harvard	The University of New South Wales	Australia	NO	Not available	Not available	Astrocytoma	Not available	A32B-08	FALSE
13722.58cfa82ee4b0c9d6adf6a9ea	58cfa82ee4b0c9d6adf6a9ea	G25772.TCGA-38-4630-01A-01D-2364-08.3.filtered.	WGS	G25772.TCGA-38-4630-01A-01D-2364-08.3	G25772.TCGA-38-4630-01A-01D-2364-08.3.bam	339.9	1.9	0.05	58cfa82ee4b0c9d6adf6a9ea	G25772.TCGA-38-4630-01A-01D-2364-08.3.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-38-4630-01A	F1985735-A188-4567-A88A-530F9B80291B	Primary Tumor	Illumina HiSeq	1ece9db5-148a-413e-9dc4-bf65d88ecc5f	Lung	75	83D01FF9-D0A9-4606-80ED-9A417A980EF7	2282CF06-9C70-47F0-958C-C9E5697AC2C8	TCGA-38-4630-01A-01D-2364-08	HG19_Broad_variant	TCGA-38-4630	TCGA-LUAD	1073	s10975	Broad Institute of MIT and Harvard	UNC	United States	NO	T2	N0	Lung Papillary Adenocarcinoma	Stage IB	2364-08	FALSE
13722.58cfa82ee4b0c9d6adf6a99c	58cfa82ee4b0c9d6adf6a99c	G35154.TCGA-IK-7675-01A-11D-2086-08.6.filtered.	WGS	G35154.TCGA-IK-7675-01A-11D-2086-08.6	G35154.TCGA-IK-7675-01A-11D-2086-08.6.bam	224	NA	0.05	58cfa82ee4b0c9d6adf6a99c	G35154.TCGA-IK-7675-01A-11D-2086-08.6.bam	Dead	MALE	WHITE	HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-IK-7675-01A	A5F851C5-6130-4EA1-9F86-BE59331A92F7	Primary Tumor	Illumina HiSeq	19191a31-9d4e-43a8-a88e-aff919fd0f95	Brain	43	661F567E-3E63-4692-8EF8-B80A83E6C8DE	A78544D7-65C6-4778-AF62-CEEC24C14056	TCGA-IK-7675-01A-11D-2086-08	HG19_Broad_variant	TCGA-IK-7675	TCGA-LGG	578	s8552	Broad Institute of MIT and Harvard	Christiana Healthcare	United States	NO	Not available	Not available	Oligodendroglioma	Not available	2086-08	FALSE
13722.58cfa82ee4b0c9d6adf6ab0e	58cfa82ee4b0c9d6adf6ab0e	G35154.TCGA-HW-7486-01A-11D-2024-08.6.filtered.	WGS	G35154.TCGA-HW-7486-01A-11D-2024-08.6	G35154.TCGA-HW-7486-01A-11D-2024-08.6.bam	21	NA	0.05	58cfa82ee4b0c9d6adf6ab0e	G35154.TCGA-HW-7486-01A-11D-2024-08.6.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-HW-7486-01A	55A67639-ED05-4143-AF96-A377BC5489EE	Primary Tumor	Illumina HiSeq	77a6b9b7-4a25-4784-95e5-98346720dcef	Brain	37	F0C5DF7C-53AA-4D90-8189-44A2BB55A696	67F88CD9-AB77-4227-A8D7-5512246F9772	TCGA-HW-7486-01A-11D-2024-08	HG19_Broad_variant	TCGA-HW-7486	TCGA-LGG	NA	s8551	Broad Institute of MIT and Harvard	MSKCC	United States	NO	Not available	Not available	Oligodendroglioma	Not available	2024-08	FALSE
13722.58cfa82ee4b0c9d6adf6ab5f	58cfa82ee4b0c9d6adf6ab5f	G37566.TCGA-CH-5771-01A-21D-1576-08.1.filtered.	WGS	G37566.TCGA-CH-5771-01A-21D-1576-08.1	G37566.TCGA-CH-5771-01A-21D-1576-08.1.bam	30.7	1.9	0.05	58cfa82ee4b0c9d6adf6ab5f	G37566.TCGA-CH-5771-01A-21D-1576-08.1.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-CH-5771-01A	3ACD8328-76F7-4F43-9660-394B95748C3D	Primary Tumor	Illumina HiSeq	e5382b76-d2ee-4eab-b245-b0d58fda770e	Prostate	63	19C87DE2-7936-4277-8AA8-3942D36E7579	87E1FFEE-A8CD-4D75-937E-ED415CF43546	TCGA-CH-5771-01A-21D-1576-08	HG19_Broad_variant	TCGA-CH-5771	TCGA-PRAD	NA	s3759	Broad Institute of MIT and Harvard	Indivumed	Germany	NO	T2c	N0	Prostate Adenocarcinoma Acinar Type	Not available	1576-08	TRUE
13722.58cfa82ee4b0c9d6adf6a9fd	58cfa82ee4b0c9d6adf6a9fd	G32534.TCGA-DJ-A3US-01A-11D-A22D-08.3.filtered.	WGS	G32534.TCGA-DJ-A3US-01A-11D-A22D-08.3	G32534.TCGA-DJ-A3US-01A-11D-A22D-08.3.bam	47.65	NA	0.08	58cfa82ee4b0c9d6adf6a9fd	G32534.TCGA-DJ-A3US-01A-11D-A22D-08.3.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-DJ-A3US-01A	6EE95DC8-2BAC-4691-AFA2-8222E07506AD	Primary Tumor	Illumina HiSeq	dbbfcd8f-5283-4bf9-98f1-9211808bfed9	Thyroid	37	9F63C13D-6008-416E-9E6B-D4ED4210E569	AD874249-9964-4E48-AA3F-7E828EA28F3F	TCGA-DJ-A3US-01A-11D-A22D-08	HG19_Broad_variant	TCGA-DJ-A3US	TCGA-THCA	NA	s12730	Broad Institute of MIT and Harvard	Memorial Sloan Kettering	United States	NO	T1b	N0	Thyroid Papillary Carcinoma - Classical/usual	Stage I	A22D-08	TRUE
13722.58cfa82ee4b0c9d6adf6ab54	58cfa82ee4b0c9d6adf6ab54	G37566.TCGA-CH-5788-01A-11D-1576-08.4.filtered.	WGS	G37566.TCGA-CH-5788-01A-11D-1576-08.4	G37566.TCGA-CH-5788-01A-11D-1576-08.4.bam	257.7	1.9	0.05	58cfa82ee4b0c9d6adf6ab54	G37566.TCGA-CH-5788-01A-11D-1576-08.4.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-CH-5788-01A	C039014F-821C-43D6-9D3C-914F9C8D98FA	Primary Tumor	Illumina HiSeq	fc337685-dcbd-4e7f-9b5b-369121193a7a	Prostate	69	144E0265-C04E-4538-A721-94DEF2570486	9E272BEA-9193-4C10-A802-F7E18B2937A3	TCGA-CH-5788-01A-11D-1576-08	HG19_Broad_variant	TCGA-CH-5788	TCGA-PRAD	NA	s3579	Broad Institute of MIT and Harvard	Indivumed	Germany	NO	T3b	N1	Prostate Adenocarcinoma Acinar Type	Not available	1576-08	TRUE
13722.58cfa82ee4b0c9d6adf6ab7c	58cfa82ee4b0c9d6adf6ab7c	G37566.TCGA-G9-6336-01A-11D-1786-08.1.filtered.	WGS	G37566.TCGA-G9-6336-01A-11D-1786-08.1	G37566.TCGA-G9-6336-01A-11D-1786-08.1.bam	81.4	1.9	0.05	58cfa82ee4b0c9d6adf6ab7c	G37566.TCGA-G9-6336-01A-11D-1786-08.1.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-G9-6336-01A	59207BCD-F127-481F-B576-8716DA7D7D97	Primary Tumor	Illumina HiSeq	69760af4-102b-4920-92f4-1424ac8db32a	Prostate	57	34C8B195-ECAB-492B-AED2-43ACFEDEF708	AB318624-DB9D-41D8-B7B8-34712434F28F	TCGA-G9-6336-01A-11D-1786-08	HG19_Broad_variant	TCGA-G9-6336	TCGA-PRAD	NA	s3410	Broad Institute of MIT and Harvard	Roswell Park	United States	NO	Not available	N0	Prostate Adenocarcinoma Acinar Type	Not available	1786-08	FALSE
13722.58cfa82ee4b0c9d6adf6ab66	58cfa82ee4b0c9d6adf6ab66	G25779.TCGA-49-4512-01A-21D-1855-08.4.filtered.	WGS	G25779.TCGA-49-4512-01A-21D-1855-08.4	G25779.TCGA-49-4512-01A-21D-1855-08.4.bam	180.7	1.9	0.05	58cfa82ee4b0c9d6adf6ab66	G25779.TCGA-49-4512-01A-21D-1855-08.4.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-49-4512-01A	A1E65587-24C1-4B41-92A7-4E1F15FFFD78	Primary Tumor	Illumina HiSeq	5f8b200d-759a-4368-b604-2b51822122d3	Lung	69	D809A778-D1AC-4406-AB09-67CC70F1F0C2	FA6A60F5-8949-4E01-9435-D3117601627F	TCGA-49-4512-01A-21D-1855-08	HG19_Broad_variant	TCGA-49-4512	TCGA-LUAD	905	s10893	Broad Institute of MIT and Harvard	Johns Hopkins	United States	NO	T2	N2	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage IIIA	1855-08	FALSE
13722.58cfa82ee4b0c9d6adf6ab6e	58cfa82ee4b0c9d6adf6ab6e	G37566.TCGA-EJ-7791-01A-11D-2114-08.2.filtered.	WGS	G37566.TCGA-EJ-7791-01A-11D-2114-08.2	G37566.TCGA-EJ-7791-01A-11D-2114-08.2.bam	97.3	NA	0.05	58cfa82ee4b0c9d6adf6ab6e	G37566.TCGA-EJ-7791-01A-11D-2114-08.2.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-EJ-7791-01A	4FE004E5-49F9-4336-A690-6EBAD512C813	Primary Tumor	Illumina HiSeq	60424977-6a58-4b53-9607-4cf61abb2c55	Prostate	67	57ED8A64-46F9-4E1F-8550-CEF121A6BBC6	D32F41FB-0744-4A62-81F6-0260C4920049	TCGA-EJ-7791-01A-11D-2114-08	HG19_Broad_variant	TCGA-EJ-7791	TCGA-PRAD	NA	s3927	Broad Institute of MIT and Harvard	University of Pittsburgh	United States	NO	T2c	N0	Prostate Adenocarcinoma Acinar Type	Not available	2114-08	FALSE
13722.58cfa82ee4b0c9d6adf6aba8	58cfa82ee4b0c9d6adf6aba8	G35154.TCGA-TQ-A7RK-01A-11D-A33T-08.3.filtered.	WGS	G35154.TCGA-TQ-A7RK-01A-11D-A33T-08.3	G35154.TCGA-TQ-A7RK-01A-11D-A33T-08.3.bam	15.56	NA	0.08	58cfa82ee4b0c9d6adf6aba8	G35154.TCGA-TQ-A7RK-01A-11D-A33T-08.3.bam	Alive	MALE	WHITE	HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-TQ-A7RK-01A	2F8C789E-BBD8-4753-A48B-6894C21162F8	Primary Tumor	Illumina HiSeq	4b48a880-f86b-4e8b-9d21-65c14ba90284	Brain	29	5793003F-E131-4259-91CB-BE9B65B0E523	EE20C616-5CA0-4B81-81A0-FE1551E6F760	TCGA-TQ-A7RK-01A-11D-A33T-08	HG19_Broad_variant	TCGA-TQ-A7RK	TCGA-LGG	NA	s8745	Broad Institute of MIT and Harvard	University of Sao Paulo	Brazil	NO	Not available	Not available	Oligoastrocytoma	Not available	A33T-08	FALSE
13722.58cfa82ee4b0c9d6adf6aba0	58cfa82ee4b0c9d6adf6aba0	G37566.TCGA-EJ-5503-01A-01D-1576-08.2.filtered.	WGS	G37566.TCGA-EJ-5503-01A-01D-1576-08.2	G37566.TCGA-EJ-5503-01A-01D-1576-08.2.bam	172.7	1.9	0.05	58cfa82ee4b0c9d6adf6aba0	G37566.TCGA-EJ-5503-01A-01D-1576-08.2.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-EJ-5503-01A	AA252F78-EBF3-42F9-86AF-BB6E57345706	Primary Tumor	Illumina HiSeq	b6f47487-689c-45fe-9716-1aa948f2b2c4	Prostate	50	627B9FF8-2557-4470-824A-B76A8BCD1E9F	25C002F7-E972-421A-B32D-7DD675D81931	TCGA-EJ-5503-01A-01D-1576-08	HG19_Broad_variant	TCGA-EJ-5503	TCGA-PRAD	NA	s3581	Broad Institute of MIT and Harvard	University of Pittsburgh	United States	NO	T3a	N0	Prostate Adenocarcinoma Acinar Type	Not available	1576-08	TRUE
13722.58cfa82ee4b0c9d6adf6abd0	58cfa82ee4b0c9d6adf6abd0	G35154.TCGA-TQ-A7RV-01A-21D-A34A-08.3.filtered.	WGS	G35154.TCGA-TQ-A7RV-01A-21D-A34A-08.3	G35154.TCGA-TQ-A7RV-01A-21D-A34A-08.3.bam	8.31	NA	0.08	58cfa82ee4b0c9d6adf6abd0	G35154.TCGA-TQ-A7RV-01A-21D-A34A-08.3.bam	Alive	MALE	WHITE	HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-TQ-A7RV-01A	5A3EDEB6-133E-4116-9F80-2485BD70754D	Primary Tumor	Illumina HiSeq	90057127-5744-4f65-853a-66561166dcbc	Brain	27	06D89076-34D4-496D-A412-F8C3B46A3A4B	33B54500-B50B-4368-8406-71015C43B929	TCGA-TQ-A7RV-01A-21D-A34A-08	HG19_Broad_variant	TCGA-TQ-A7RV	TCGA-LGG	NA	s8124	Broad Institute of MIT and Harvard	University of Sao Paulo	Brazil	NO	Not available	Not available	Astrocytoma	Not available	A34A-08	FALSE
13722.58cfa82ee4b0c9d6adf6abf6	58cfa82ee4b0c9d6adf6abf6	G35154.TCGA-FG-8182-01A-11D-2253-08.3.filtered.	WGS	G35154.TCGA-FG-8182-01A-11D-2253-08.3	G35154.TCGA-FG-8182-01A-11D-2253-08.3.bam	58.6	NA	0.05	58cfa82ee4b0c9d6adf6abf6	G35154.TCGA-FG-8182-01A-11D-2253-08.3.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-FG-8182-01A	6A0BCF0C-FA4C-4119-99D2-F722B781D20F	Primary Tumor	Illumina HiSeq	de01f2de-931f-4b79-9abc-966eaee7ca0a	Brain	35	0CF6BE14-2F25-4361-ADE5-7E5B6CA1063E	2AEAAB9F-4459-4BE8-91E7-E0746CBD671C	TCGA-FG-8182-01A-11D-2253-08	HG19_Broad_variant	TCGA-FG-8182	TCGA-LGG	NA	s8112	Broad Institute of MIT and Harvard	Case Western	United States	NO	Not available	Not available	Oligodendroglioma	Not available	2253-08	FALSE
13722.58cfa82ee4b0c9d6adf6abd2	58cfa82ee4b0c9d6adf6abd2	G37566.TCGA-CH-5763-01A-11D-1576-08.1.filtered.	WGS	G37566.TCGA-CH-5763-01A-11D-1576-08.1	G37566.TCGA-CH-5763-01A-11D-1576-08.1.bam	172.7	1.9	0.05	58cfa82ee4b0c9d6adf6abd2	G37566.TCGA-CH-5763-01A-11D-1576-08.1.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-CH-5763-01A	18E79A01-07A2-4CD5-B700-71D41724E041	Primary Tumor	Illumina HiSeq	ba68ecb8-6421-467d-b680-850c82a0b95d	Prostate	66	F4192448-E5B3-4A9F-8354-9FE28503017A	581BE6CF-9778-49C3-9C77-1316EAA78929	TCGA-CH-5763-01A-11D-1576-08	HG19_Broad_variant	TCGA-CH-5763	TCGA-PRAD	NA	s3405	Broad Institute of MIT and Harvard	Indivumed	Germany	NO	T3a	N0	Prostate Adenocarcinoma Acinar Type	Not available	1576-08	TRUE
13722.58cfa82ee4b0c9d6adf6ac26	58cfa82ee4b0c9d6adf6ac26	G37566.TCGA-G9-6365-01A-11D-1786-08.1.filtered.	WGS	G37566.TCGA-G9-6365-01A-11D-1786-08.1	G37566.TCGA-G9-6365-01A-11D-1786-08.1.bam	59.4	1.9	0.05	58cfa82ee4b0c9d6adf6ac26	G37566.TCGA-G9-6365-01A-11D-1786-08.1.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-G9-6365-01A	6845076E-E940-4437-8618-81DB4A447544	Primary Tumor	Illumina HiSeq	9cc69179-2c77-45b6-b3b1-0b1042756f81	Prostate	71	95D6E1D3-91C1-40E5-986D-1C5ABB33A03F	769E2AC9-A121-4B2A-A0FD-5F755B579811	TCGA-G9-6365-01A-11D-1786-08	HG19_Broad_variant	TCGA-G9-6365	TCGA-PRAD	NA	s3412	Broad Institute of MIT and Harvard	Roswell Park	United States	NO	T4	N0	Prostate Adenocarcinoma Acinar Type	Not available	1786-08	FALSE
13722.58cfa82ee4b0c9d6adf6ac30	58cfa82ee4b0c9d6adf6ac30	G37566.TCGA-HC-7233-01A-11D-2114-08.2.filtered.	WGS	G37566.TCGA-HC-7233-01A-11D-2114-08.2	G37566.TCGA-HC-7233-01A-11D-2114-08.2.bam	207.3	NA	0.05	58cfa82ee4b0c9d6adf6ac30	G37566.TCGA-HC-7233-01A-11D-2114-08.2.bam	Alive	MALE	WHITE	Not available	Prostate Adenocarcinoma	Aligned reads	TCGA-HC-7233-01A	E2B33861-2247-413F-B2E5-9BE3B604666C	Primary Tumor	Illumina HiSeq	4e0a9ee2-a019-4269-90e4-b6c02d5b0091	Prostate	73	848C2C7B-918E-4A09-BAD9-3B3D59BBC101	0C9A5DBC-F7F3-43E7-83D1-77B9FB4B8B54	TCGA-HC-7233-01A-11D-2114-08	HG19_Broad_variant	TCGA-HC-7233	TCGA-PRAD	NA	s3765	Broad Institute of MIT and Harvard	International Genomics Consortium	Yemen	NO	T2a	N0	Prostate Adenocarcinoma Acinar Type	Not available	2114-08	FALSE
13722.58cfa82ee4b0c9d6adf6ac22	58cfa82ee4b0c9d6adf6ac22	G37566.TCGA-HC-7075-01A-11D-1961-08.2.filtered.	WGS	G37566.TCGA-HC-7075-01A-11D-1961-08.2	G37566.TCGA-HC-7075-01A-11D-1961-08.2.bam	242.7	NA	0.05	58cfa82ee4b0c9d6adf6ac22	G37566.TCGA-HC-7075-01A-11D-1961-08.2.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-HC-7075-01A	5DD69C3E-9A3D-450C-9F10-10B4D6DAEEBA	Primary Tumor	Illumina HiSeq	8f4cf0ab-38b1-49e1-8c15-82f9d02b5f9f	Prostate	63	1FA3E5C2-E415-42FA-AEA3-F6C84959522A	DDC422E4-87E2-4FC0-B56B-DDC2D6A92F58	TCGA-HC-7075-01A-11D-1961-08	HG19_Broad_variant	TCGA-HC-7075	TCGA-PRAD	NA	s3406	Broad Institute of MIT and Harvard	International Genomics Consortium	United States	NO	T2a	Not available	Prostate Adenocarcinoma Acinar Type	Not available	1961-08	FALSE
13722.58cfa82ee4b0c9d6adf6ac91	58cfa82ee4b0c9d6adf6ac91	G47088.TCGA-22-5477-01A-01D-1632-08.1.filtered.	WGS	G47088.TCGA-22-5477-01A-01D-1632-08.1	G47088.TCGA-22-5477-01A-01D-1632-08.1.bam	859.7	1.9	0.05	58cfa82ee4b0c9d6adf6ac91	G47088.TCGA-22-5477-01A-01D-1632-08.1.bam	Dead	MALE	WHITE	Not available	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-22-5477-01A	BD15F523-45C4-4D7C-A3CC-4FB56ABB0E54	Primary Tumor	Illumina HiSeq	198a167a-3034-46af-a58f-46712ddf3eb0	Lung	65	F9D568B1-6951-4EAF-8867-4C86BDAEAA04	E7EBC6FB-0926-4C8A-A67B-0C6B9C1FFABA	TCGA-22-5477-01A-01D-1632-08	HG19_Broad_variant	TCGA-22-5477	TCGA-LUSC	1346	s10500	Broad Institute of MIT and Harvard	Mayo Clinic - Rochester	United States	NO	T1	N0	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage IA	1632-08	FALSE
13722.58cfa82ee4b0c9d6adf6acae	58cfa82ee4b0c9d6adf6acae	G37568.TCGA-DK-A1AA-01A-11D-A13W-08.3.filtered.	WGS	G37568.TCGA-DK-A1AA-01A-11D-A13W-08.3	G37568.TCGA-DK-A1AA-01A-11D-A13W-08.3.bam	72.54	1.95	0.08	58cfa82ee4b0c9d6adf6acae	G37568.TCGA-DK-A1AA-01A-11D-A13W-08.3.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-DK-A1AA-01A	56D8A1B8-1268-4362-A7F1-77B76FBF1B59	Primary Tumor	Illumina HiSeq	0ff07006-7458-42f5-b1fd-d84db4c2f25d	Bladder	57	577700D1-C366-41EF-8A0D-E50DEEFB5E3C	804FFA2E-158B-447D-945C-707684134C87	TCGA-DK-A1AA-01A-11D-A13W-08	HG19_Broad_variant	TCGA-DK-A1AA	TCGA-BLCA	NA	s3079	Broad Institute of MIT and Harvard	Memorial Sloan Kettering	United States	NO	T3	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage III	A13W-08	TRUE
13722.58cfa82ee4b0c9d6adf6acbe	58cfa82ee4b0c9d6adf6acbe	G37566.TCGA-HI-7169-01A-11D-2114-08.2.filtered.	WGS	G37566.TCGA-HI-7169-01A-11D-2114-08.2	G37566.TCGA-HI-7169-01A-11D-2114-08.2.bam	54.6	NA	0.05	58cfa82ee4b0c9d6adf6acbe	G37566.TCGA-HI-7169-01A-11D-2114-08.2.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-HI-7169-01A	11FB5853-8EEB-4AD8-825D-3EAAF3FA08D6	Primary Tumor	Illumina HiSeq	4ec05d23-3f9f-473a-b292-63ddb0e7d37f	Prostate	55	AEEF0836-305C-465C-A9CA-6C1825353AE7	E1FC4226-40CE-43B7-B92E-AA7CECD0CF4D	TCGA-HI-7169-01A-11D-2114-08	HG19_Broad_variant	TCGA-HI-7169	TCGA-PRAD	NA	s3586	Broad Institute of MIT and Harvard	Fox Chase	United States	NO	T3a	N0	Prostate Adenocarcinoma Acinar Type	Not available	2114-08	FALSE
13722.58cfa82ee4b0c9d6adf6acb4	58cfa82ee4b0c9d6adf6acb4	G47088.TCGA-77-6843-01A-11D-1945-08.1.filtered.	WGS	G47088.TCGA-77-6843-01A-11D-1945-08.1	G47088.TCGA-77-6843-01A-11D-1945-08.1.bam	285.7	1.9	0.05	58cfa82ee4b0c9d6adf6acb4	G47088.TCGA-77-6843-01A-11D-1945-08.1.bam	Dead	MALE	WHITE	Not available	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-77-6843-01A	C2598334-F866-4CC3-93EC-2D2E8B85D319	Primary Tumor	Illumina HiSeq	8cc492fe-df3d-4eb2-a46e-ef531153cf54	Lung	74	8712518A-FE08-43FD-B497-620ECC0AA0AC	FAB3D6F4-DE1C-4D6C-BDEA-AC39A7884657	TCGA-77-6843-01A-11D-1945-08	HG19_Broad_variant	TCGA-77-6843	TCGA-LUSC	2224	s10363	Broad Institute of MIT and Harvard	Prince Charles Hospital	Australia	NO	T1	N1	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage IIA	1945-08	TRUE
13722.58cfa82ee4b0c9d6adf6ad30	58cfa82ee4b0c9d6adf6ad30	G49837.TCGA-43-5670-01A-21D-A320-08.1.filtered.	WGS	G49837.TCGA-43-5670-01A-21D-A320-08.1	G49837.TCGA-43-5670-01A-21D-A320-08.1.bam	559	NA	0.07	58cfa82ee4b0c9d6adf6ad30	G49837.TCGA-43-5670-01A-21D-A320-08.1.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-43-5670-01A	7D905F8F-3967-4EA8-96C8-17B1B03FBEC3	Primary Tumor	Illumina HiSeq	118f7a8c-af7e-4f0d-a235-99c5487eee74	Lung	70	6B829F48-BA74-40D7-B92F-41A2A2B7D136	369C06F2-8904-49CB-99D1-DD297ED0CD0C	TCGA-43-5670-01A-21D-A320-08	HG19_Broad_variant	TCGA-43-5670	TCGA-LUSC	NA	s10369	Broad Institute of MIT and Harvard	Christiana Healthcare	United States	NO	T2b	N0	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage IIA	A320-08	TRUE
13722.58cfa82ee4b0c9d6adf6ad57	58cfa82ee4b0c9d6adf6ad57	G8893.TCGA-66-2766-01A-01D-1180-08.4.filtered.	WGS	G8893.TCGA-66-2766-01A-01D-1180-08.4	G8893.TCGA-66-2766-01A-01D-1180-08.4.bam	564.3	1.9	0.14	58cfa82ee4b0c9d6adf6ad57	G8893.TCGA-66-2766-01A-01D-1180-08.4.bam	Alive	MALE	Not available	Not available	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-66-2766-01A	B913D254-8307-4B8A-8313-D978E32BB38F	Primary Tumor	Illumina HiSeq	cba17a86-671f-4744-a52b-a93f56b8ee16	Lung	54	09215E83-EDAC-472D-B849-9225C532358C	45E16B70-C3EC-493E-86D1-505FFDF5056C	TCGA-66-2766-01A-01D-1180-08	HG19_Broad_variant	TCGA-66-2766	TCGA-LUSC	NA	s10262	Broad Institute of MIT and Harvard	Indivumed	Germany	NO	T2	N2	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage IIIA	1180-08	FALSE
13722.58cfa82ee4b0c9d6adf6ad61	58cfa82ee4b0c9d6adf6ad61	G8892.TCGA-66-2757-01A-01D-1180-08.1.filtered.	WGS	G8892.TCGA-66-2757-01A-01D-1180-08.1	G8892.TCGA-66-2757-01A-01D-1180-08.1.bam	161.3	1.9	0.15	58cfa82ee4b0c9d6adf6ad61	G8892.TCGA-66-2757-01A-01D-1180-08.1.bam	Alive	FEMALE	Not available	Not available	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-66-2757-01A	A02932F3-5606-42A5-AEE4-E5B9F5AA1AAA	Primary Tumor	Illumina HiSeq	994d5f87-3d5a-4efb-badb-127ee3dd9480	Lung	65	7C727433-A8A8-44EB-AC11-DCB5EBD9250C	0E2DD8AA-7B45-4E26-BA3C-1A202FCB6BE3	TCGA-66-2757-01A-01D-1180-08	HG19_Broad_variant	TCGA-66-2757	TCGA-LUSC	NA	s10087	Broad Institute of MIT and Harvard	Indivumed	Germany	NO	T1	N0	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage IA	1180-08	FALSE
13722.58cfa82ee4b0c9d6adf6adb4	58cfa82ee4b0c9d6adf6adb4	G47088.TCGA-92-8064-01A-11D-2244-08.2.filtered.	WGS	G47088.TCGA-92-8064-01A-11D-2244-08.2	G47088.TCGA-92-8064-01A-11D-2244-08.2.bam	406.33	NA	0.05	58cfa82ee4b0c9d6adf6adb4	G47088.TCGA-92-8064-01A-11D-2244-08.2.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-92-8064-01A	DC6CEECE-EFAA-4B9D-9E12-D35863D7A902	Primary Tumor	Illumina HiSeq	8a33c586-703c-4354-9bde-caab929fcc59	Lung	58	014AD75E-86D2-423F-B9D3-84657D459A28	0E6654C9-CD5E-4F94-A6D4-54F2BB16DE1F	TCGA-92-8064-01A-11D-2244-08	HG19_Broad_variant	TCGA-92-8064	TCGA-LUSC	NA	s10077	Broad Institute of MIT and Harvard	Washington University - St. Louis	United States	NO	T2b	N0	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage IB	2244-08	FALSE
13722.58cfa82ee4b0c9d6adf6ace0	58cfa82ee4b0c9d6adf6ace0	G39020.TCGA-CG-5723-01A-11D-1600-08.1.filtered.	WGS	G39020.TCGA-CG-5723-01A-11D-1600-08.1	G39020.TCGA-CG-5723-01A-11D-1600-08.1.bam	224	1.9	0.05	58cfa82ee4b0c9d6adf6ace0	G39020.TCGA-CG-5723-01A-11D-1600-08.1.bam	Alive	MALE	Not available	Not available	Stomach Adenocarcinoma	Aligned reads	TCGA-CG-5723-01A	0F00AD32-E4BE-49D4-A02A-D233BFC913C5	Primary Tumor	Illumina HiSeq	2a8e56af-ea0b-4304-805e-db8a07ae73dc	Stomach	83	4CCD9CCB-BF50-44EB-AA55-133D8824C433	FFB4F42B-58E9-40C3-8963-11804F041375	TCGA-CG-5723-01A-11D-1600-08	HG19_Broad_variant	TCGA-CG-5723	TCGA-STAD	NA	s14810	Broad Institute of MIT and Harvard	Indivumed	Germany	NO	T2	N1	Stomach  Adenocarcinoma  Not Otherwise Specified (NOS)	Stage II	1600-08	TRUE
13722.58cfa82ee4b0c9d6adf6add4	58cfa82ee4b0c9d6adf6add4	G39020.TCGA-CG-5724-01A-11D-1600-08.3.filtered.	WGS	G39020.TCGA-CG-5724-01A-11D-1600-08.3	G39020.TCGA-CG-5724-01A-11D-1600-08.3.bam	362	1.9	0.05	58cfa82ee4b0c9d6adf6add4	G39020.TCGA-CG-5724-01A-11D-1600-08.3.bam	Dead	MALE	Not available	Not available	Stomach Adenocarcinoma	Aligned reads	TCGA-CG-5724-01A	0B4E8D73-459D-4930-9D1A-ABB8D53E1844	Primary Tumor	Illumina HiSeq	f2f2a0e8-364c-4603-8030-6f0f803fe21c	Stomach	59	4D624B21-5AEE-42B8-B192-8AFECB51434D	6DAC8CA0-F776-4EA2-85C4-AEFBA4966BE7	TCGA-CG-5724-01A-11D-1600-08	HG19_Broad_variant	TCGA-CG-5724	TCGA-STAD	366	s15174	Broad Institute of MIT and Harvard	Indivumed	Germany	NO	T3	N3	Stomach  Adenocarcinoma  Diffuse Type	Stage IV	1600-08	TRUE
13722.58cfa82ee4b0c9d6adf6adca	58cfa82ee4b0c9d6adf6adca	G39020.TCGA-BR-A4J4-01A-12D-A25D-08.3.filtered.	WGS	G39020.TCGA-BR-A4J4-01A-12D-A25D-08.3	G39020.TCGA-BR-A4J4-01A-12D-A25D-08.3.bam	25.07	NA	0.08	58cfa82ee4b0c9d6adf6adca	G39020.TCGA-BR-A4J4-01A-12D-A25D-08.3.bam	Alive	MALE	ASIAN	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-BR-A4J4-01A	8A24F1A3-4BAB-4591-9676-7BEE01D096C1	Primary Tumor	Illumina HiSeq	2cdabae0-c924-481e-ad7e-bbe3f72f5c79	Stomach	39	5A5C4538-D75D-4DA5-8E8C-DD92766FEE50	2C316B7E-6A82-4BA1-9F34-D8BFCF82D41E	TCGA-BR-A4J4-01A-12D-A25D-08	HG19_Broad_variant	TCGA-BR-A4J4	TCGA-STAD	NA	s14459	Broad Institute of MIT and Harvard	Asterand	Vietnam	NO	T4a	N2	Stomach  Adenocarcinoma  Not Otherwise Specified (NOS)	Stage IIIB	A25D-08	FALSE
13722.58cfa82ee4b0c9d6adf6ae36	58cfa82ee4b0c9d6adf6ae36	G49837.TCGA-90-7767-01A-11D-A320-08.3.filtered.	WGS	G49837.TCGA-90-7767-01A-11D-A320-08.3	G49837.TCGA-90-7767-01A-11D-A320-08.3.bam	263	NA	0.08	58cfa82ee4b0c9d6adf6ae36	G49837.TCGA-90-7767-01A-11D-A320-08.3.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-90-7767-01A	9DFF11CD-0784-4A60-9C77-43F8957D3DFA	Primary Tumor	Illumina HiSeq	667b4d6b-e888-4912-a5fd-74910e9b2f8e	Lung	56	609D3070-4B64-42EE-B071-42BE33DF7600	48F68F73-3AC0-44AC-BA12-B8889FCB7F38	TCGA-90-7767-01A-11D-A320-08	HG19_Broad_variant	TCGA-90-7767	TCGA-LUSC	NA	s9981	Broad Institute of MIT and Harvard	ABS - IUPUI	United States	NO	T2b	N1	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage IIB	A320-08	TRUE
13722.58cfa82ee4b0c9d6adf6ae5d	58cfa82ee4b0c9d6adf6ae5d	G49837.TCGA-37-4135-01A-01D-A320-08.2.filtered.	WGS	G49837.TCGA-37-4135-01A-01D-A320-08.2	G49837.TCGA-37-4135-01A-01D-A320-08.2.bam	968.93	1.9	0.07	58cfa82ee4b0c9d6adf6ae5d	G49837.TCGA-37-4135-01A-01D-A320-08.2.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-37-4135-01A	1F6B2ACA-7357-40D1-BA7A-99227D9900A2	Primary Tumor	Illumina HiSeq	00a52da3-1aca-4f65-b9ab-15fe28578557	Lung	68	5294476F-A200-453E-9D11-9C50F3C3FA5D	C48D7F4A-E98A-4077-A749-EB9F56F05B84	TCGA-37-4135-01A-01D-A320-08	HG19_Broad_variant	TCGA-37-4135	TCGA-LUSC	NA	s10504	Broad Institute of MIT and Harvard	Cureline	Russia	NO	T2a	N0	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage IB	A320-08	TRUE
13722.58cfa82ee4b0c9d6adf6aecd	58cfa82ee4b0c9d6adf6aecd	G37566.TCGA-HC-7744-01A-11D-2114-08.1.filtered.	WGS	G37566.TCGA-HC-7744-01A-11D-2114-08.1	G37566.TCGA-HC-7744-01A-11D-2114-08.1.bam	170.3	NA	0.05	58cfa82ee4b0c9d6adf6aecd	G37566.TCGA-HC-7744-01A-11D-2114-08.1.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-HC-7744-01A	F6381367-142C-45D0-92B3-C1727D1813CE	Primary Tumor	Illumina HiSeq	8589d977-d1ca-42ea-975f-c3e664d57eba	Prostate	46	41E0D8F7-E104-43C4-B3BB-FD0B5CB3C7B2	0192D529-7340-45D8-A5F0-249CBB11CA19	TCGA-HC-7744-01A-11D-2114-08	HG19_Broad_variant	TCGA-HC-7744	TCGA-PRAD	NA	s3925	Broad Institute of MIT and Harvard	International Genomics Consortium	None	NO	T3b	N0	Prostate Adenocarcinoma Acinar Type	Not available	2114-08	FALSE
13722.58cfa82de4b0c9d6adf6a73e	58cfa82de4b0c9d6adf6a73e	G14851.TCGA-05-4422-01A-01D-1931-08.2.filtered.	WGS	G14851.TCGA-05-4422-01A-01D-1931-08.2	G14851.TCGA-05-4422-01A-01D-1931-08.2.bam	631.63	1.9	0.15	58cfa82de4b0c9d6adf6a73e	G14851.TCGA-05-4422-01A-01D-1931-08.2.bam	Alive	MALE	Not available	Not available	Lung Adenocarcinoma	Aligned reads	TCGA-05-4422-01A	44DEC838-B653-42A7-A58B-A1FD232CD68C	Primary Tumor	Illumina HiSeq	b70e3630-efee-4b99-b77b-c3000baf9819	Lung	68	DACBC55D-25C6-4E86-BD1B-38345B4DF7A7	6D2B0633-5BE4-4026-920C-427D3AA7C763	TCGA-05-4422-01A-01D-1931-08	HG19_Broad_variant	TCGA-05-4422	TCGA-LUAD	NA	s11104	Broad Institute of MIT and Harvard	Indivumed	Germany	NO	T2	N0	Lung Adenocarcinoma Mixed Subtype	Stage IB	1931-08	TRUE
13722.58cfa82de4b0c9d6adf6a746	58cfa82de4b0c9d6adf6a746	G14848.TCGA-05-4398-01A-01D-1931-08.3.filtered.	WGS	G14848.TCGA-05-4398-01A-01D-1931-08.3	G14848.TCGA-05-4398-01A-01D-1931-08.3.bam	403.53	1.9	0.15	58cfa82de4b0c9d6adf6a746	G14848.TCGA-05-4398-01A-01D-1931-08.3.bam	Alive	FEMALE	Not available	Not available	Lung Adenocarcinoma	Aligned reads	TCGA-05-4398-01A	31C96E35-5E2F-429C-B12A-7BC5A497A300	Primary Tumor	Illumina HiSeq	fc9ee166-a6ea-4c5a-9978-b63277aec83e	Lung	47	DA010683-C537-478F-8F95-E606B05DBC5C	23D77176-DFED-4BEE-AC96-9934377D8D81	TCGA-05-4398-01A-01D-1931-08	HG19_Broad_variant	TCGA-05-4398	TCGA-LUAD	NA	s10625	Broad Institute of MIT and Harvard	Indivumed	Germany	NO	T4	N3	Lung Adenocarcinoma Mixed Subtype	Stage IIIB	1931-08	TRUE
13722.58cfa82ee4b0c9d6adf6af08	58cfa82ee4b0c9d6adf6af08	G39020.TCGA-D7-A4YX-01A-11D-A25D-08.2.filtered.	WGS	G39020.TCGA-D7-A4YX-01A-11D-A25D-08.2	G39020.TCGA-D7-A4YX-01A-11D-A25D-08.2.bam	42.47	NA	0.08	58cfa82ee4b0c9d6adf6af08	G39020.TCGA-D7-A4YX-01A-11D-A25D-08.2.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-D7-A4YX-01A	2B4F014F-74E9-4DDA-A1AD-ABCBD124FC44	Primary Tumor	Illumina HiSeq	004a24e0-0e6d-4811-aac1-344ce1d54320	Stomach	63	DCFF683D-629E-4E67-9E9F-CE5752A2B276	A4C838DF-6AC4-455A-8096-8EC680064374	TCGA-D7-A4YX-01A-11D-A25D-08	HG19_Broad_variant	TCGA-D7-A4YX	TCGA-STAD	NA	s14462	Broad Institute of MIT and Harvard	Greater Poland Cancer Center	Poland	NO	T3	N1	Stomach  Adenocarcinoma  Not Otherwise Specified (NOS)	Stage IIB	A25D-08	FALSE
13722.58cfa82ee4b0c9d6adf6af34	58cfa82ee4b0c9d6adf6af34	G37566.TCGA-G9-6370-01A-11D-1786-08.2.filtered.	WGS	G37566.TCGA-G9-6370-01A-11D-1786-08.2	G37566.TCGA-G9-6370-01A-11D-1786-08.2.bam	59.4	2	0.05	58cfa82ee4b0c9d6adf6af34	G37566.TCGA-G9-6370-01A-11D-1786-08.2.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-G9-6370-01A	F947B0BC-BDAC-44E8-B5B9-FFAE4147740A	Primary Tumor	Illumina HiSeq	48541dbc-810e-4dad-a90a-5d33e6df1766	Prostate	52	644E1E7D-DFD1-4F83-82DC-AE0C7E010F6F	9689CB33-8AC9-4EE5-800D-3900769988AF	TCGA-G9-6370-01A-11D-1786-08	HG19_Broad_variant	TCGA-G9-6370	TCGA-PRAD	NA	s3582	Broad Institute of MIT and Harvard	Roswell Park	United States	NO	T3b	N0	Prostate Adenocarcinoma Acinar Type	Not available	1786-08	FALSE
13722.58cfa82ee4b0c9d6adf6af82	58cfa82ee4b0c9d6adf6af82	G39020.TCGA-D7-6822-01A-11D-1882-08.3.filtered.	WGS	G39020.TCGA-D7-6822-01A-11D-1882-08.3	G39020.TCGA-D7-6822-01A-11D-1882-08.3.bam	442.7	1.9	0.05	58cfa82ee4b0c9d6adf6af82	G39020.TCGA-D7-6822-01A-11D-1882-08.3.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-D7-6822-01A	E2AAABD9-F4BA-4763-A28A-C14D46A4BC5D	Primary Tumor	Illumina HiSeq	6bbb2709-a3ca-451a-82c8-996e619878b9	Stomach	77	C30AFDA8-FC63-4228-A9A9-42BCDB562ACE	1021B60D-F7B2-43B0-B2CC-F282D619D533	TCGA-D7-6822-01A-11D-1882-08	HG19_Broad_variant	TCGA-D7-6822	TCGA-STAD	NA	s15097	Broad Institute of MIT and Harvard	Greater Poland Cancer Center	Poland	NO	T2	N0	Stomach  Intestinal Adenocarcinoma  Tubular Type	Stage IB	1882-08	FALSE
13722.58cfa82ee4b0c9d6adf6af86	58cfa82ee4b0c9d6adf6af86	G41960.TCGA-55-8299-01A-11D-2284-08.1.filtered.	WGS	G41960.TCGA-55-8299-01A-11D-2284-08.1	G41960.TCGA-55-8299-01A-11D-2284-08.1.bam	255.7	NA	0.05	58cfa82ee4b0c9d6adf6af86	G41960.TCGA-55-8299-01A-11D-2284-08.1.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-55-8299-01A	2CD8EA73-CB3F-4B17-9B97-FA12EB03B85B	Primary Tumor	Illumina HiSeq	0900edf4-dd21-4cc0-a6cb-6de863318729	Lung	61	5D0ED8D1-6E84-4F6C-8E0E-0317AA8B0E3F	15E097E3-E468-466C-8E57-B59FBA90BBF2	TCGA-55-8299-01A-11D-2284-08	HG19_Broad_variant	TCGA-55-8299	TCGA-LUAD	NA	s10765	Broad Institute of MIT and Harvard	International Genomics Consortium	United States	NO	T1b	N0	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage IA	2284-08	FALSE
13722.58cfa82ee4b0c9d6adf6afd8	58cfa82ee4b0c9d6adf6afd8	G48125.TCGA-10-0938-01A-02D-A312-08.2.filtered.	WGS	G48125.TCGA-10-0938-01A-02D-A312-08.2	G48125.TCGA-10-0938-01A-02D-A312-08.2.bam	115.67	1.9	0.07	58cfa82ee4b0c9d6adf6afd8	G48125.TCGA-10-0938-01A-02D-A312-08.2.bam	Dead	FEMALE	WHITE	Not available	Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-10-0938-01A	7CA97692-0BF5-4BBD-81CE-10A051D04BD5	Primary Tumor	Illumina HiSeq	6df8b7aa-5a5e-4a7c-bd82-de0c3fff4dda	Ovary	80	C11664E8-8883-4A0F-87C3-6FDC903860D5	8093649A-74D6-4832-9154-8CC0182FA381	TCGA-10-0938-01A-02D-A312-08	HG19_Broad_variant	TCGA-10-0938	TCGA-OV	636	s17481	Broad Institute of MIT and Harvard	MD Anderson Cancer Center	None	NO	Not available	Not available	Serous Cystadenocarcinoma	Not available	A312-08	TRUE
13722.58cfa82ee4b0c9d6adf6b070	58cfa82ee4b0c9d6adf6b070	G8890.TCGA-60-2722-01A-01D-1180-08.2.filtered.	WGS	G8890.TCGA-60-2722-01A-01D-1180-08.2	G8890.TCGA-60-2722-01A-01D-1180-08.2.bam	179	1.9	0.15	58cfa82ee4b0c9d6adf6b070	G8890.TCGA-60-2722-01A-01D-1180-08.2.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-60-2722-01A	6FD72426-F6C8-47CA-A500-D5D3600B9B15	Primary Tumor	Illumina HiSeq	417178a5-e706-47ee-92d7-de1eb647b4fc	Lung	66	060717AD-F034-46FA-8E9B-94A9422E4666	96DC785C-8417-4813-8D15-C32B22D78B74	TCGA-60-2722-01A-01D-1180-08	HG19_Broad_variant	TCGA-60-2722	TCGA-LUSC	NA	s9982	Broad Institute of MIT and Harvard	Roswell Park	United States	NO	T2	N1	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage IIB	1180-08	FALSE
13722.58cfa82fe4b0c9d6adf6b86a	58cfa82fe4b0c9d6adf6b86a	TCGA-A6-2680-01A-01D-1554-10_wgs_Illumina.filtered.	WGS	TCGA-A6-2680-01A-01D-1554-10_wgs_Illumina	TCGA-A6-2680-01A-01D-1554-10_wgs_Illumina.bam	38	1.9	0.05	58cfa82fe4b0c9d6adf6b86a	TCGA-A6-2680-01A-01D-1554-10_wgs_Illumina.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Colon Adenocarcinoma	Aligned reads	TCGA-A6-2680-01A	FF1407C6-9174-4BAE-A19B-D34CA71B898C	Primary Tumor	Illumina HiSeq	d43e0ed3-ab1d-486a-bbf5-91dabacf8220	Colorectal	72	D664F620-CFEE-4700-B00E-68B65387883C	2CDC4CCE-0877-4EC1-85F5-20C909912E65	TCGA-A6-2680-01A-01D-1554-10	GRCh37-lite	TCGA-A6-2680	TCGA-COAD	NA	s13172	Baylor College of Medicine	Christiana Healthcare	None	NO	T3	N0	Colon Adenocarcinoma	Stage II	1554-10	FALSE
13722.58cfa82fe4b0c9d6adf6b8fa	58cfa82fe4b0c9d6adf6b8fa	TCGA-AA-3518-01A-02D-1525-10_hg19_wgs_Illumina.filtered.	WGS	TCGA-AA-3518-01A-02D-1525-10_hg19_wgs_Illumina	TCGA-AA-3518-01A-02D-1525-10_hg19_wgs_Illumina.bam	3.86	1.9	0.05	58cfa82fe4b0c9d6adf6b8fa	TCGA-AA-3518-01A-02D-1525-10_hg19_wgs_Illumina.bam	Alive	FEMALE	Not available	Not available	Colon Adenocarcinoma	Aligned reads	TCGA-AA-3518-01A	C5C4A0A5-900D-483D-9282-475654D63265	Primary Tumor	Illumina HiSeq	e3929c47-b19b-4c57-9990-6448eb979647	Colorectal	81	BC08B757-ED0A-44C0-88CD-85496BB72A75	F4B9D98F-7B76-4EAA-9595-10B0973D5FF7	TCGA-AA-3518-01A-02D-1525-10	GRCh37-lite	TCGA-AA-3518	TCGA-COAD	NA	s13663	Baylor College of Medicine	Indivumed	Germany	NO	T3	N0	Colon Adenocarcinoma	Stage IIA	1525-10	TRUE
13722.58cfa82fe4b0c9d6adf6b952	58cfa82fe4b0c9d6adf6b952	TCGA-AA-3534-01A-01D-1525-10_hg19_wgs_Illumina.filtered.	WGS	TCGA-AA-3534-01A-01D-1525-10_hg19_wgs_Illumina	TCGA-AA-3534-01A-01D-1525-10_hg19_wgs_Illumina.bam	84.63	1.9	0.05	58cfa82fe4b0c9d6adf6b952	TCGA-AA-3534-01A-01D-1525-10_hg19_wgs_Illumina.bam	Alive	FEMALE	Not available	Not available	Colon Adenocarcinoma	Aligned reads	TCGA-AA-3534-01A	DF228C56-89AC-4122-93B3-6C0740C4EC09	Primary Tumor	Illumina HiSeq	6e533853-5822-49cf-95a8-d75c517521cc	Colorectal	78	ECADE2C1-9DE2-4B05-B30C-4C8B81C65AE1	66701395-5A53-41BB-866B-3BBF08BC33AB	TCGA-AA-3534-01A-01D-1525-10	GRCh37-lite	TCGA-AA-3534	TCGA-COAD	NA	s12861	Baylor College of Medicine	Indivumed	Germany	NO	T3	N0	Colon Adenocarcinoma	Stage IIA	1525-10	TRUE
13722.58cfa830e4b0c9d6adf6ba5d	58cfa830e4b0c9d6adf6ba5d	TCGA-AA-A00R-01A-01D-A126-10_hg19_wgs_Illumina.filtered.	WGS	TCGA-AA-A00R-01A-01D-A126-10_hg19_wgs_Illumina	TCGA-AA-A00R-01A-01D-A126-10_hg19_wgs_Illumina.bam	205.35	1.73	0.08	58cfa830e4b0c9d6adf6ba5d	TCGA-AA-A00R-01A-01D-A126-10_hg19_wgs_Illumina.bam	Alive	FEMALE	Not available	Not available	Colon Adenocarcinoma	Aligned reads	TCGA-AA-A00R-01A	CA22EDD4-EB7C-4677-84AA-6F0354459A19	Primary Tumor	Illumina HiSeq	6182870d-a572-4538-aaa5-06b4adad7bbe	Colorectal	64	F72EEAE9-F7F5-4576-A072-5021119117D6	05780D48-80E7-4D70-B00C-081F8A9519F2	TCGA-AA-A00R-01A-01D-A126-10	GRCh37-lite	TCGA-AA-A00R	TCGA-COAD	NA	s13677	Baylor College of Medicine	Indivumed	Germany	NO	T2	N0	Colon Adenocarcinoma	Stage I	A126-10	FALSE
13722.58cfa830e4b0c9d6adf6ba60	58cfa830e4b0c9d6adf6ba60	TCGA-A3-3372-01A-01D-2094-10_Illumina.filtered.	WGS	TCGA-A3-3372-01A-01D-2094-10_Illumina	TCGA-A3-3372-01A-01D-2094-10_Illumina.bam	595.87	1.9	0.15	58cfa830e4b0c9d6adf6ba60	TCGA-A3-3372-01A-01D-2094-10_Illumina.bam	Alive	MALE	WHITE	Not available	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-A3-3372-01A	11AB53C8-6366-4BC9-B60D-23E6ED2D1CAE	Primary Tumor	Illumina HiSeq	0dc73f18-4553-49e0-b22e-8bc863c7b907	Kidney	64	D3280297-5674-4AE6-AB57-8D820543901E	F64E9609-D75D-400C-A92D-D77FD54D6C29	TCGA-A3-3372-01A-01D-2094-10	GRCh37-lite	TCGA-A3-3372	TCGA-KIRC	NA	s9155	Baylor College of Medicine	International Genomics Consortium	United States	NO	T3	NX	Kidney Clear Cell Renal Carcinoma	Stage III	2094-10	FALSE
13722.58cfa830e4b0c9d6adf6bb7c	58cfa830e4b0c9d6adf6bb7c	TCGA-AA-A01R-01A-21D-A17O-10_wgs_Illumina.filtered.	WGS	TCGA-AA-A01R-01A-21D-A17O-10_wgs_Illumina	TCGA-AA-A01R-01A-21D-A17O-10_wgs_Illumina.bam	75.21	1.8	0.07	58cfa830e4b0c9d6adf6bb7c	TCGA-AA-A01R-01A-21D-A17O-10_wgs_Illumina.bam	Alive	MALE	Not available	Not available	Colon Adenocarcinoma	Aligned reads	TCGA-AA-A01R-01A	97F6C8D3-09A0-4128-8F10-41E736648A5F	Primary Tumor	Illumina HiSeq	5b6c9797-7cfe-4bd0-a656-74dd069d72d9	Colorectal	47	73EE34E8-422D-4AB1-B0F0-DA8A5A2DD9AB	303ABBE5-4155-4A0D-BC3B-F8995261CA52	TCGA-AA-A01R-01A-21D-A17O-10	GRCh37-lite	TCGA-AA-A01R	TCGA-COAD	NA	s13194	Baylor College of Medicine	Indivumed	Germany	NO	T3	N2	Colon Mucinous Adenocarcinoma	Stage III	A17O-10	TRUE
13722.58cfa830e4b0c9d6adf6bbfa	58cfa830e4b0c9d6adf6bbfa	TCGA-AG-3593-01A-01D-1525-10_hg19_wgs_Illumina.filtered.	WGS	TCGA-AG-3593-01A-01D-1525-10_hg19_wgs_Illumina	TCGA-AG-3593-01A-01D-1525-10_hg19_wgs_Illumina.bam	495.85	1.9	0.05	58cfa830e4b0c9d6adf6bbfa	TCGA-AG-3593-01A-01D-1525-10_hg19_wgs_Illumina.bam	Alive	FEMALE	Not available	Not available	Rectum Adenocarcinoma	Aligned reads	TCGA-AG-3593-01A	10290E91-9784-4F94-8DAA-B5D9A8B0EFB9	Primary Tumor	Illumina HiSeq	9275573a-23ac-40aa-b792-cff9ee5bca8c	Colorectal	72	EFFCA0F1-E81D-47CD-8287-392A2B6AB786	FAFF4626-615B-416A-B7A6-9D177DCC94A9	TCGA-AG-3593-01A-01D-1525-10	GRCh37-lite	TCGA-AG-3593	TCGA-READ	NA	s1953	Baylor College of Medicine	Indivumed	Germany	NO	T3	N0	Rectal Adenocarcinoma	Stage IIA	1525-10	TRUE
13722.58cfa830e4b0c9d6adf6bc8e	58cfa830e4b0c9d6adf6bc8e	TCGA-AG-3901-01A-01D-1989-10_wgs_Illumina.filtered.	WGS	TCGA-AG-3901-01A-01D-1989-10_wgs_Illumina	TCGA-AG-3901-01A-01D-1989-10_wgs_Illumina.bam	510.89	1.9	0.15	58cfa830e4b0c9d6adf6bc8e	TCGA-AG-3901-01A-01D-1989-10_wgs_Illumina.bam	Alive	FEMALE	Not available	Not available	Rectum Adenocarcinoma	Aligned reads	TCGA-AG-3901-01A	1586CB0A-081A-4364-9470-46F9D0F0167D	Primary Tumor	Illumina HiSeq	51acbe73-78d9-48e4-b937-42a159dfb5a5	Colorectal	67	93B755E6-5D6E-4542-8BAE-2121F44F590C	7D59205A-65EC-4341-9748-28639D82ED29	TCGA-AG-3901-01A-01D-1989-10	GRCh37-lite	TCGA-AG-3901	TCGA-READ	NA	s2160	Baylor College of Medicine	Indivumed	Germany	NO	T3	N1	Rectal Mucinous Adenocarcinoma	Stage IIIB	1989-10	TRUE
13722.58cfa830e4b0c9d6adf6bd5c	58cfa830e4b0c9d6adf6bd5c	TCGA-AA-3516-01A-02D-1554-10_wgs_Illumina.filtered.	WGS	TCGA-AA-3516-01A-02D-1554-10_wgs_Illumina	TCGA-AA-3516-01A-02D-1554-10_wgs_Illumina.bam	47.29	1.9	0.05	58cfa830e4b0c9d6adf6bd5c	TCGA-AA-3516-01A-02D-1554-10_wgs_Illumina.bam	Alive	FEMALE	Not available	Not available	Colon Adenocarcinoma	Aligned reads	TCGA-AA-3516-01A	D9D7F0D4-FA64-48F2-8037-52CBF0B34AD8	Primary Tumor	Illumina HiSeq	f25d539d-8289-4400-8da7-ddce46918578	Colorectal	74	4E4F7BEC-56AF-4888-B40B-A33218B010E8	EE25E9EF-5200-40F8-A16D-559D98BFC5EA	TCGA-AA-3516-01A-02D-1554-10	GRCh37-lite	TCGA-AA-3516	TCGA-COAD	NA	s13185	Baylor College of Medicine	Indivumed	Germany	NO	T3	N2	Colon Mucinous Adenocarcinoma	Stage III	1554-10	FALSE
13722.58cfa830e4b0c9d6adf6be4c	58cfa830e4b0c9d6adf6be4c	TCGA-AG-3890-01A-01D-1989-10_wgs_Illumina.filtered.	WGS	TCGA-AG-3890-01A-01D-1989-10_wgs_Illumina	TCGA-AG-3890-01A-01D-1989-10_wgs_Illumina.bam	614.89	1.9	0.15	58cfa830e4b0c9d6adf6be4c	TCGA-AG-3890-01A-01D-1989-10_wgs_Illumina.bam	Alive	MALE	Not available	Not available	Rectum Adenocarcinoma	Aligned reads	TCGA-AG-3890-01A	E2D395F8-BF13-4FE4-8031-683B0EEDD875	Primary Tumor	Illumina HiSeq	8df564e5-cdec-4714-b522-5f7356be8d5d	Colorectal	62	DB70A6DD-DE09-4ED7-916C-708B21734500	03CFF38D-7E29-4409-A508-749BDDB1B3DF	TCGA-AG-3890-01A-01D-1989-10	GRCh37-lite	TCGA-AG-3890	TCGA-READ	NA	s1975	Baylor College of Medicine	Indivumed	Germany	NO	T2	N0	Rectal Adenocarcinoma	Stage I	1989-10	TRUE
13722.58cfa830e4b0c9d6adf6be92	58cfa830e4b0c9d6adf6be92	TCGA-AG-4007-01A-01D-1989-10_wgs_Illumina.filtered.	WGS	TCGA-AG-4007-01A-01D-1989-10_wgs_Illumina	TCGA-AG-4007-01A-01D-1989-10_wgs_Illumina.bam	915.89	1.9	0.16	58cfa830e4b0c9d6adf6be92	TCGA-AG-4007-01A-01D-1989-10_wgs_Illumina.bam	Alive	MALE	Not available	Not available	Rectum Adenocarcinoma	Aligned reads	TCGA-AG-4007-01A	8E00E7E7-FFAF-44F0-91A7-172671F18E08	Primary Tumor	Illumina HiSeq	16ef1919-094b-44db-a49b-966c6bf84f33	Colorectal	87	E6FC3F28-1DE1-4587-9E0E-0861323E6772	8DA641E4-9B12-4163-BD1E-9D5AF91E5186	TCGA-AG-4007-01A-01D-1989-10	GRCh37-lite	TCGA-AG-4007	TCGA-READ	NA	s1981	Baylor College of Medicine	Indivumed	Germany	NO	T4	N2	Rectal Adenocarcinoma	Stage IV	1989-10	TRUE
13722.58cfa830e4b0c9d6adf6be9f	58cfa830e4b0c9d6adf6be9f	TCGA-AG-3896-01A-01D-1989-10_wgs_Illumina.filtered.	WGS	TCGA-AG-3896-01A-01D-1989-10_wgs_Illumina	TCGA-AG-3896-01A-01D-1989-10_wgs_Illumina.bam	913.89	1.9	0.15	58cfa830e4b0c9d6adf6be9f	TCGA-AG-3896-01A-01D-1989-10_wgs_Illumina.bam	Alive	FEMALE	Not available	Not available	Rectum Adenocarcinoma	Aligned reads	TCGA-AG-3896-01A	9AF35239-FFB9-4D4F-889E-F743DA271EEF	Primary Tumor	Illumina HiSeq	a9406c81-5dd3-4c50-8984-c81a85f67723	Colorectal	85	03B40342-3CCE-4A45-B2EC-8855AEB85100	14334AEA-2DAE-428C-9D4A-1A37878DFC3F	TCGA-AG-3896-01A-01D-1989-10	GRCh37-lite	TCGA-AG-3896	TCGA-READ	NA	s1992	Baylor College of Medicine	Indivumed	Germany	NO	T2	N0	Rectal Adenocarcinoma	Stage I	1989-10	TRUE
13722.58cfa830e4b0c9d6adf6c052	58cfa830e4b0c9d6adf6c052	TCGA-B2-4101-01A-02D-2096-10_Illumina.filtered.	WGS	TCGA-B2-4101-01A-02D-2096-10_Illumina	TCGA-B2-4101-01A-02D-2096-10_Illumina.bam	138.47	1.9	0.15	58cfa830e4b0c9d6adf6c052	TCGA-B2-4101-01A-02D-2096-10_Illumina.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-B2-4101-01A	CFC999AA-802E-4A0D-8B14-BE2B19FA2A17	Primary Tumor	Illumina HiSeq	06203d35-b4db-4e6b-9c54-14edb4129481	Kidney	52	A9947B6C-DBC7-4BA5-AF61-7647E11E2973	F3C1A125-06E9-41C4-9558-275A3E346CC5	TCGA-B2-4101-01A-02D-2096-10	GRCh37-lite	TCGA-B2-4101	TCGA-KIRC	NA	s9564	Baylor College of Medicine	Christiana Healthcare	None	NO	T2a	NX	Kidney Clear Cell Renal Carcinoma	Stage II	2096-10	FALSE
13722.58cfa830e4b0c9d6adf6c07e	58cfa830e4b0c9d6adf6c07e	TCGA-B1-A47M-01A-11D-A25F-10_wgs_Illumina.filtered.	WGS	TCGA-B1-A47M-01A-11D-A25F-10_wgs_Illumina	TCGA-B1-A47M-01A-11D-A25F-10_wgs_Illumina.bam	27.53	NA	0.08	58cfa830e4b0c9d6adf6c07e	TCGA-B1-A47M-01A-11D-A25F-10_wgs_Illumina.bam	Alive	MALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Kidney Renal Papillary Cell Carcinoma	Aligned reads	TCGA-B1-A47M-01A	072507CF-1249-4B28-86D4-3AB97822A74C	Primary Tumor	Illumina HiSeq	aa347261-ddce-4395-b3f2-84e8210d4d8a	Kidney	79	75658EDD-12F1-4BB3-BEA2-01C154CB6AE9	8FB7FCAC-6C1D-40C2-9309-B53821CBEF30	TCGA-B1-A47M-01A-11D-A25F-10	GRCh37-lite	TCGA-B1-A47M	TCGA-KIRP	NA	s11581	Baylor College of Medicine	University of Pittsburgh	United States	NO	T3a	NX	Kidney Papillary Renal Cell Carcinoma	Stage III	A25F-10	TRUE
13722.58cfa830e4b0c9d6adf6c149	58cfa830e4b0c9d6adf6c149	TCGA-BA-4076-01A-01D-2266-10_Illumina.filtered.	WGS	TCGA-BA-4076-01A-01D-2266-10_Illumina	TCGA-BA-4076-01A-01D-2266-10_Illumina.bam	333.33	1.9	0.05	58cfa830e4b0c9d6adf6c149	TCGA-BA-4076-01A-01D-2266-10_Illumina.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-BA-4076-01A	7DE19081-D5FD-468C-AD0D-F6E3E8B2AD70	Primary Tumor	Illumina HiSeq	62857418-5247-4ae1-8064-d900ef856428	Head and Neck	39	FD99FD83-4040-4738-8A5A-E42D36ECFE0E	E2B5C926-491D-430D-8D9C-5C73D7752D1B	TCGA-BA-4076-01A-01D-2266-10	GRCh37-lite	TCGA-BA-4076	TCGA-HNSC	415	s16171	Baylor College of Medicine	UNC	None	NO	TX	NX	Head and Neck Squamous Cell Carcinoma	Not available	2266-10	TRUE
13722.58cfa831e4b0c9d6adf6c490	58cfa831e4b0c9d6adf6c490	TCGA-CJ-6033-01A-11D-2104-10_Illumina.filtered.	WGS	TCGA-CJ-6033-01A-11D-2104-10_Illumina	TCGA-CJ-6033-01A-11D-2104-10_Illumina.bam	13.66	1.9	0.17	58cfa831e4b0c9d6adf6c490	TCGA-CJ-6033-01A-11D-2104-10_Illumina.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-CJ-6033-01A	4EDFF57F-4B0E-4770-BEAC-590DA7D7232C	Primary Tumor	Illumina HiSeq	42a6262a-a044-4cac-b1dd-a97139e7859b	Kidney	54	840633A2-9565-4096-AA67-584952FBD6AB	10D15B7A-16D1-4953-AAEF-F193FFA97F42	TCGA-CJ-6033-01A-11D-2104-10	GRCh37-lite	TCGA-CJ-6033	TCGA-KIRC	224	s9169	Baylor College of Medicine	MD Anderson Cancer Center	United States	NO	T3a	N0	Kidney Clear Cell Renal Carcinoma	Stage IV	2104-10	FALSE
13722.58cfa831e4b0c9d6adf6c6ee	58cfa831e4b0c9d6adf6c6ee	TCGA-CR-6467-01A-11D-2266-10_Illumina.filtered.	WGS	TCGA-CR-6467-01A-11D-2266-10_Illumina	TCGA-CR-6467-01A-11D-2266-10_Illumina.bam	319.7	1.9	0.05	58cfa831e4b0c9d6adf6c6ee	TCGA-CR-6467-01A-11D-2266-10_Illumina.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CR-6467-01A	89F91E36-FED8-4DA3-8A35-C761D6F65285	Primary Tumor	Illumina HiSeq	27f00d9e-af52-4af4-b29b-a75a506754a8	Head and Neck	59	5EF4D047-5A84-4E03-ACF5-02029D8A4CF2	EE963667-56B1-49BD-8896-E07B536D3014	TCGA-CR-6467-01A-11D-2266-10	GRCh37-lite	TCGA-CR-6467	TCGA-HNSC	NA	s15769	Baylor College of Medicine	Vanderbilt University	United States	NO	T2	N1	Head and Neck Squamous Cell Carcinoma	Stage III	2266-10	TRUE
13722.58cfa831e4b0c9d6adf6c845	58cfa831e4b0c9d6adf6c845	TCGA-CV-5442-01A-01D-2266-10_Illumina.filtered.	WGS	TCGA-CV-5442-01A-01D-2266-10_Illumina	TCGA-CV-5442-01A-01D-2266-10_Illumina.bam	323.7	1.9	0.05	58cfa831e4b0c9d6adf6c845	TCGA-CV-5442-01A-01D-2266-10_Illumina.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-5442-01A	3C975B68-4A6E-4C97-A8D1-B9A427D4957C	Primary Tumor	Illumina HiSeq	53f0ce53-95fe-4d6c-930d-f8427c0c46ec	Head and Neck	76	698208BB-7272-4AD5-9CC0-909CB669BDAF	46D35B82-E1B7-4D35-BE5E-3A70FD47E421	TCGA-CV-5442-01A-01D-2266-10	GRCh37-lite	TCGA-CV-5442	TCGA-HNSC	NA	s16336	Baylor College of Medicine	MD Anderson Cancer Center	None	NO	T4a	N2b	Head and Neck Squamous Cell Carcinoma	Stage IVA	2266-10	TRUE
13722.58cfa832e4b0c9d6adf6d1e0	58cfa832e4b0c9d6adf6d1e0	TCGA-KL-8323-01A-21D-2310-10_wgs_Illumina.filtered.	WGS	TCGA-KL-8323-01A-21D-2310-10_wgs_Illumina	TCGA-KL-8323-01A-21D-2310-10_wgs_Illumina.bam	4.8	NA	0.05	58cfa832e4b0c9d6adf6d1e0	TCGA-KL-8323-01A-21D-2310-10_wgs_Illumina.bam	Dead	FEMALE	WHITE	Not available	Kidney Chromophobe	Aligned reads	TCGA-KL-8323-01A	83B3060C-2449-4581-88EF-817D126E4525	Primary Tumor	Illumina HiSeq	8854b195-7eb9-4554-8702-96ed5dd9029f	Kidney	57	8AA1A5F6-3548-494A-857B-E08124AEB9A9	FAE88D21-171C-4DF4-B258-3C5948A1034B	TCGA-KL-8323-01A-21D-2310-10	GRCh37-lite	TCGA-KL-8323	TCGA-KICH	1158	s16471	Baylor College of Medicine	MSKCC	United States	NO	T3b	NX	Kidney Chromophobe	Stage III	2310-10	TRUE
13722.58cfa832e4b0c9d6adf6d2dc	58cfa832e4b0c9d6adf6d2dc	TCGA-KL-8342-01A-11D-2310-10_wgs_Illumina.filtered.	WGS	TCGA-KL-8342-01A-11D-2310-10_wgs_Illumina	TCGA-KL-8342-01A-11D-2310-10_wgs_Illumina.bam	71.3	NA	0.05	58cfa832e4b0c9d6adf6d2dc	TCGA-KL-8342-01A-11D-2310-10_wgs_Illumina.bam	Alive	FEMALE	WHITE	Not available	Kidney Chromophobe	Aligned reads	TCGA-KL-8342-01A	C689AE1D-4A6B-45DB-B4D1-6B34C5C61522	Primary Tumor	Illumina HiSeq	1f1d17e4-280b-4955-97a5-75180878dc8e	Kidney	45	BC04E860-2CB8-4D90-BC17-F3A4D6A09881	F38FC6AC-2AF8-4D89-A514-4E2C5FDF08DE	TCGA-KL-8342-01A-11D-2310-10	GRCh37-lite	TCGA-KL-8342	TCGA-KICH	NA	s16483	Baylor College of Medicine	MSKCC	United States	NO	T2b	N0	Kidney Chromophobe	Stage II	2310-10	TRUE
13722.58cfa832e4b0c9d6adf6d326	58cfa832e4b0c9d6adf6d326	TCGA-KO-8407-01A-11D-2310-10_wgs_Illumina.filtered.	WGS	TCGA-KO-8407-01A-11D-2310-10_wgs_Illumina	TCGA-KO-8407-01A-11D-2310-10_wgs_Illumina.bam	150.2	NA	0.05	58cfa832e4b0c9d6adf6d326	TCGA-KO-8407-01A-11D-2310-10_wgs_Illumina.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Kidney Chromophobe	Aligned reads	TCGA-KO-8407-01A	151F07F5-1529-4FCD-912C-E55B2FF8ABEF	Primary Tumor	Illumina HiSeq	33c518fb-d4b6-4ec8-8125-6fd6c0032563	Kidney	42	24992BE3-78D6-4193-ACF3-F0A5AC959BB6	64F696A6-58B2-40A8-B848-FD775CD52529	TCGA-KO-8407-01A-11D-2310-10	GRCh37-lite	TCGA-KO-8407	TCGA-KICH	NA	s16438	Baylor College of Medicine	MD Anderson Cancer Center	United States	NO	T2	N0	Kidney Chromophobe	Stage II	2310-10	TRUE
13722.58cfa82de4b0c9d6adf6a73c	58cfa82de4b0c9d6adf6a73c	G13228.TCGA-43-3920-01A-01D-1553-08.4.filtered.	WGS	G13228.TCGA-43-3920-01A-01D-1553-08.4	G13228.TCGA-43-3920-01A-01D-1553-08.4.bam	835.37	1.9	0.05	58cfa82de4b0c9d6adf6a73c	G13228.TCGA-43-3920-01A-01D-1553-08.4.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-43-3920-01A	9293E197-E38A-4E19-A7D0-1B45D1AD48BD	Primary Tumor	Illumina HiSeq	3281e662-29ac-4441-86e2-07a71d47196c	Lung	71	BBC07C89-5540-4217-AA56-3608539983C2	A762DD44-A8AC-4269-8163-BBF6D0F8D4B3	TCGA-43-3920-01A-01D-1553-08	HG19_Broad_variant	TCGA-43-3920	TCGA-LUSC	NA	s10157	Broad Institute of MIT and Harvard	Christiana Healthcare	United States	NO	T2	N0	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage IB	1553-08	FALSE
13722.58cfa82de4b0c9d6adf6a738	58cfa82de4b0c9d6adf6a738	G14681.TCGA-60-2719-01A-01D-1522-08.1.filtered.	WGS	G14681.TCGA-60-2719-01A-01D-1522-08.1	G14681.TCGA-60-2719-01A-01D-1522-08.1.bam	604.3	1.9	0.05	58cfa82de4b0c9d6adf6a738	G14681.TCGA-60-2719-01A-01D-1522-08.1.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-60-2719-01A	585E6487-B0A3-4828-8A06-46BEE01DFF74	Primary Tumor	Illumina HiSeq	f600dac8-9a96-4214-a398-c9e40ed580ec	Lung	83	DD32EF9A-246B-47C9-A0E3-60A110E9047C	EE6CC68E-8D2A-41EE-82C6-0FECDF7E6259	TCGA-60-2719-01A-01D-1522-08	HG19_Broad_variant	TCGA-60-2719	TCGA-LUSC	NA	s10495	Broad Institute of MIT and Harvard	Roswell Park	United States	NO	T1	N0	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage IB	1522-08	TRUE
13722.58cfa82de4b0c9d6adf6a74c	58cfa82de4b0c9d6adf6a74c	G14084.TCGA-22-1016-01A-01D-1521-08.3.filtered.	WGS	G14084.TCGA-22-1016-01A-01D-1521-08.3	G14084.TCGA-22-1016-01A-01D-1521-08.3.bam	313	1.9	0.05	58cfa82de4b0c9d6adf6a74c	G14084.TCGA-22-1016-01A-01D-1521-08.3.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-22-1016-01A	037C57D1-B4A5-45DC-BDA4-0550461D321B	Primary Tumor	Illumina HiSeq	ec4da199-1467-4435-944a-7558f9ffd8ea	Lung	65	DDB395E5-4B12-4610-9755-01E444B35C2E	935B113E-F5ED-4A07-8E1D-1603DABA7F40	TCGA-22-1016-01A-01D-1521-08	HG19_Broad_variant	TCGA-22-1016	TCGA-LUSC	822	s9974	Broad Institute of MIT and Harvard	Mayo Clinic - Rochester	United States	NO	T2	N0	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage IB	1521-08	TRUE
13722.58cfa82de4b0c9d6adf6a763	58cfa82de4b0c9d6adf6a763	G13231.TCGA-60-2724-01A-01D-1522-08.3.filtered.	WGS	G13231.TCGA-60-2724-01A-01D-1522-08.3	G13231.TCGA-60-2724-01A-01D-1522-08.3.bam	508.3	1.9	0.05	58cfa82de4b0c9d6adf6a763	G13231.TCGA-60-2724-01A-01D-1522-08.3.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-60-2724-01A	A3E1AC67-A1F2-44FB-8343-A7E8239FC24A	Primary Tumor	Illumina HiSeq	fe7af73f-7704-440b-85f1-35dc1b30dea2	Lung	47	048E7EB0-57A4-4EED-A999-4E46D9FEF885	387C6519-6529-4074-A5AB-00F8052A5732	TCGA-60-2724-01A-01D-1522-08	HG19_Broad_variant	TCGA-60-2724	TCGA-LUSC	NA	s10155	Broad Institute of MIT and Harvard	Roswell Park	United States	NO	T3	N1	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage IIIA	1522-08	TRUE
13722.58cfa82de4b0c9d6adf6a794	58cfa82de4b0c9d6adf6a794	G14088.TCGA-60-2698-01A-01D-1522-08.1.filtered.	WGS	G14088.TCGA-60-2698-01A-01D-1522-08.1	G14088.TCGA-60-2698-01A-01D-1522-08.1.bam	258.3	1.9	0.05	58cfa82de4b0c9d6adf6a794	G14088.TCGA-60-2698-01A-01D-1522-08.1.bam	Dead	MALE	WHITE	Not available	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-60-2698-01A	FD9EE494-65FE-4DE4-ADFF-7952A059B17F	Primary Tumor	Illumina HiSeq	31535197-5bd8-4176-8b52-4bd012f6cb0b	Lung	62	A908CE38-12E6-4EC6-BAAB-9D79221AB6EB	2045C788-9EA8-4EA5-A5E3-65FC16A62ADB	TCGA-60-2698-01A-01D-1522-08	HG19_Broad_variant	TCGA-60-2698	TCGA-LUSC	311	s10494	Broad Institute of MIT and Harvard	Roswell Park	United States	NO	T2	N1	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage IIB	1522-08	TRUE
13722.58cfa82ee4b0c9d6adf6a918	58cfa82ee4b0c9d6adf6a918	G25776.TCGA-75-6203-01A-11D-1753-08.1.filtered.	WGS	G25776.TCGA-75-6203-01A-11D-1753-08.1	G25776.TCGA-75-6203-01A-11D-1753-08.1.bam	49.4	1.9	0.05	58cfa82ee4b0c9d6adf6a918	G25776.TCGA-75-6203-01A-11D-1753-08.1.bam	Alive	FEMALE	Not available	Not available	Lung Adenocarcinoma	Aligned reads	TCGA-75-6203-01A	A8D6694C-A213-4544-AC0B-63BCE16D8F4E	Primary Tumor	Illumina HiSeq	976f4757-1570-44bb-9a05-7680fc9d30b6	Lung	NA	336EB991-5705-4BC0-A167-6D7F82F81697	D9CD7F95-07D3-4B87-BE83-87340B08D249	TCGA-75-6203-01A-11D-1753-08	HG19_Broad_variant	TCGA-75-6203	TCGA-LUAD	NA	s10892	Broad Institute of MIT and Harvard	Ontario Institute for Cancer Research (OICR)	Canada	NO	T2	N2	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage IIIA	1753-08	TRUE
13722.58cfa82ee4b0c9d6adf6a8f6	58cfa82ee4b0c9d6adf6a8f6	G35154.TCGA-FG-5965-01B-11D-1893-08.2.filtered.	WGS	G35154.TCGA-FG-5965-01B-11D-1893-08.2	G35154.TCGA-FG-5965-01B-11D-1893-08.2.bam	86.7	1.9	0.05	58cfa82ee4b0c9d6adf6a8f6	G35154.TCGA-FG-5965-01B-11D-1893-08.2.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-FG-5965-01B	2CFC07F3-A31C-41A2-A9E3-B708D2421A78	Primary Tumor	Illumina HiSeq	8e6db5b3-96e4-4a80-9604-99a9433a1bb5	Brain	39	93FBE6D3-2091-4151-9075-0ED2DD4B886F	0730868D-1FE9-4964-A0CC-A12A74D161E6	TCGA-FG-5965-01B-11D-1893-08	HG19_Broad_variant	TCGA-FG-5965	TCGA-LGG	NA	s8106	Broad Institute of MIT and Harvard	Case Western	United States	NO	Not available	Not available	Oligoastrocytoma	Not available	1893-08	FALSE
13722.58cfa82ee4b0c9d6adf6a7fa	58cfa82ee4b0c9d6adf6a7fa	G25780.TCGA-49-6742-01A-11D-1855-08.4.filtered.	WGS	G25780.TCGA-49-6742-01A-11D-1855-08.4	G25780.TCGA-49-6742-01A-11D-1855-08.4.bam	39.7	2	0.05	58cfa82ee4b0c9d6adf6a7fa	G25780.TCGA-49-6742-01A-11D-1855-08.4.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-49-6742-01A	21FB46F9-4BBB-441C-AF19-A687E9138344	Primary Tumor	Illumina HiSeq	2fdfd442-4aa3-49d0-82e8-7b21b059e7e3	Lung	70	F0A4AE58-D5BC-4AB0-B1CF-0D951EA91FC7	49DEC0C2-8E75-4F44-A253-82B2EA605890	TCGA-49-6742-01A-11D-1855-08	HG19_Broad_variant	TCGA-49-6742	TCGA-LUAD	NA	s10895	Broad Institute of MIT and Harvard	Johns Hopkins	United States	NO	T2a	N1	Mucinous (Colloid) Carcinoma	Stage IIA	1855-08	FALSE
13722.58cfa82ee4b0c9d6adf6a97e	58cfa82ee4b0c9d6adf6a97e	G35154.TCGA-DU-7013-01A-11D-A461-08.1.filtered.	WGS	G35154.TCGA-DU-7013-01A-11D-A461-08.1	G35154.TCGA-DU-7013-01A-11D-A461-08.1.bam	277.7	NA	0.08	58cfa82ee4b0c9d6adf6a97e	G35154.TCGA-DU-7013-01A-11D-A461-08.1.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-DU-7013-01A	D61B5D20-4D6D-4FDC-AFE8-4B100B686EDA	Primary Tumor	Illumina HiSeq	06158eca-e4b3-400e-806c-5342049e40aa	Brain	59	0F43B42C-EE65-4DF3-BDFF-2101E15B7C9B	344F8786-3383-446B-8662-DEA1FA3B6FF5	TCGA-DU-7013-01A-11D-A461-08	HG19_Broad_variant	TCGA-DU-7013	TCGA-LGG	269	s8533	Broad Institute of MIT and Harvard	Henry Ford Hospital	United States	NO	Not available	Not available	Astrocytoma	Not available	A461-08	TRUE
13722.58cfa82ee4b0c9d6adf6a9de	58cfa82ee4b0c9d6adf6a9de	G25782.TCGA-55-6982-01A-11D-1945-08.2.filtered.	WGS	G25782.TCGA-55-6982-01A-11D-1945-08.2	G25782.TCGA-55-6982-01A-11D-1945-08.2.bam	86.7	NA	0.05	58cfa82ee4b0c9d6adf6a9de	G25782.TCGA-55-6982-01A-11D-1945-08.2.bam	Dead	FEMALE	WHITE	Not available	Lung Adenocarcinoma	Aligned reads	TCGA-55-6982-01A	35CB7841-9B09-465A-90C5-E3B8A9FAAD49	Primary Tumor	Illumina HiSeq	c6027d22-f05d-42e4-a467-de21b4606751	Lung	79	3B284FC6-7DC4-46C2-8EC9-1121EF0B4308	B7F11036-7AC4-41BC-A9A4-64162725FDFC	TCGA-55-6982-01A-11D-1945-08	HG19_Broad_variant	TCGA-55-6982	TCGA-LUAD	995	s11109	Broad Institute of MIT and Harvard	International Genomics Consortium	United States	NO	T2	N1	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage IIB	1945-08	TRUE
13722.58cfa82ee4b0c9d6adf6aa82	58cfa82ee4b0c9d6adf6aa82	G25781.TCGA-50-6597-01A-11D-1855-08.4.filtered.	WGS	G25781.TCGA-50-6597-01A-11D-1855-08.4	G25781.TCGA-50-6597-01A-11D-1855-08.4.bam	12.7	1.9	0.05	58cfa82ee4b0c9d6adf6aa82	G25781.TCGA-50-6597-01A-11D-1855-08.4.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-50-6597-01A	0D66BF6C-EED0-4726-BD5B-3BF6D610B4E0	Primary Tumor	Illumina HiSeq	0e48684b-e0b4-4625-9f32-7e0331dfcefe	Lung	79	C5363830-3DB9-4C0C-AA47-B32FDC888C60	CD0AEED5-93A1-4287-8A88-FE6B7B5E3983	TCGA-50-6597-01A-11D-1855-08	HG19_Broad_variant	TCGA-50-6597	TCGA-LUAD	NA	s11110	Broad Institute of MIT and Harvard	University of Pittsburgh	United States	NO	T2	N0	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage IB	1855-08	FALSE
13722.58cfa82ee4b0c9d6adf6aa01	58cfa82ee4b0c9d6adf6aa01	G23078.TCGA_CR_6487_01A_11D_2268_08.2.filtered.	WGS	G23078.TCGA_CR_6487_01A_11D_2268_08.2	G23078.TCGA_CR_6487_01A_11D_2268_08.2.bam	287.7	1.9	0.14	58cfa82ee4b0c9d6adf6aa01	G23078.TCGA_CR_6487_01A_11D_2268_08.2.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CR-6487-01A	9AE5101B-6031-4AB1-BFCA-198C41AF3184	Primary Tumor	Illumina HiSeq	5efcbe11-0d48-4b66-abce-d78199fe8fd8	Head and Neck	50	027DEDD3-BD53-420E-B7F2-EB5B8C26BCDC	1DB83E80-BDF7-4D8D-8008-BD8406D641FC	TCGA-CR-6487-01A-11D-2268-08	HG19_Broad_variant	TCGA-CR-6487	TCGA-HNSC	NA	s15606	Broad Institute of MIT and Harvard	Vanderbilt University	United States	NO	T1	N0	Head and Neck Squamous Cell Carcinoma	Stage I	2268-08	TRUE
13722.58cfa82ee4b0c9d6adf6aa8a	58cfa82ee4b0c9d6adf6aa8a	G32523.TCGA-DJ-A2Q2-01A-11D-A19J-08.4.filtered.	WGS	G32523.TCGA-DJ-A2Q2-01A-11D-A19J-08.4	G32523.TCGA-DJ-A2Q2-01A-11D-A19J-08.4.bam	41.27	NA	0.08	58cfa82ee4b0c9d6adf6aa8a	G32523.TCGA-DJ-A2Q2-01A-11D-A19J-08.4.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-DJ-A2Q2-01A	A00DA907-E527-45F9-9AFB-2FAD2C7B0940	Primary Tumor	Illumina HiSeq	a59111e2-1f5e-429d-bb7f-4e413ed0baeb	Thyroid	57	A2E3CA88-9FF0-44AD-8C5A-CA4C7B404DE6	565E656C-D5E3-4FE4-A10C-2E9CA1E498B5	TCGA-DJ-A2Q2-01A-11D-A19J-08	HG19_Broad_variant	TCGA-DJ-A2Q2	TCGA-THCA	NA	s11972	Broad Institute of MIT and Harvard	Memorial Sloan Kettering	United States	NO	T3	N0	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	Stage III	A19J-08	FALSE
13722.58cfa82ee4b0c9d6adf6ab92	58cfa82ee4b0c9d6adf6ab92	G25790.TCGA-50-5066-01A-01D-1625-08.2.filtered.	WGS	G25790.TCGA-50-5066-01A-01D-1625-08.2	G25790.TCGA-50-5066-01A-01D-1625-08.2.bam	1182.7	1.9	0.05	58cfa82ee4b0c9d6adf6ab92	G25790.TCGA-50-5066-01A-01D-1625-08.2.bam	Alive	MALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-50-5066-01A	3199CFE5-3BE3-43CD-A36B-5CF2C7A9929F	Primary Tumor	Illumina HiSeq	a9a4ae39-4e53-45e6-b9c0-2df2afca64ee	Lung	72	478CC306-6AEE-4597-8834-1E5CF8B05A59	F5A97315-1906-4774-980E-0879C6AD368E	TCGA-50-5066-01A-01D-1625-08	HG19_Broad_variant	TCGA-50-5066	TCGA-LUAD	NA	s10894	Broad Institute of MIT and Harvard	University of Pittsburgh	United States	NO	T2	N0	Lung Adenocarcinoma Mixed Subtype	Stage IB	1625-08	FALSE
13722.58cfa82ee4b0c9d6adf6ab5e	58cfa82ee4b0c9d6adf6ab5e	G25785.TCGA-78-7143-01A-11D-2036-08.1.filtered.	WGS	G25785.TCGA-78-7143-01A-11D-2036-08.1	G25785.TCGA-78-7143-01A-11D-2036-08.1.bam	405.7	NA	0.05	58cfa82ee4b0c9d6adf6ab5e	G25785.TCGA-78-7143-01A-11D-2036-08.1.bam	Dead	FEMALE	WHITE	Not available	Lung Adenocarcinoma	Aligned reads	TCGA-78-7143-01A	54254F5A-50E8-4150-A9B7-56A0470D2A56	Primary Tumor	Illumina HiSeq	d0505bbf-c663-484b-93b6-a129883be59b	Lung	62	EE72F78D-E5DB-4C99-9034-0B5BBF6DF849	B710996C-8D35-4A2C-BC51-389B3E35B0F3	TCGA-78-7143-01A-11D-2036-08	HG19_Broad_variant	TCGA-78-7143	TCGA-LUAD	4961	s11107	Broad Institute of MIT and Harvard	Prince Charles Hospital	Australia	NO	T2	N0	Lung Bronchioloalveolar Carcinoma Nonmucinous	Stage IB	2036-08	TRUE
13722.58cfa82ee4b0c9d6adf6ab20	58cfa82ee4b0c9d6adf6ab20	G32543.TCGA-GN-A26C-01A-11D-A19A-08.5.filtered.	WGS	G32543.TCGA-GN-A26C-01A-11D-A19A-08.5	G32543.TCGA-GN-A26C-01A-11D-A19A-08.5.bam	55.8	NA	0.08	58cfa82ee4b0c9d6adf6ab20	G32543.TCGA-GN-A26C-01A-11D-A19A-08.5.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Skin Cutaneous Melanoma	Aligned reads	TCGA-GN-A26C-01A	FA099993-EF30-4EFF-A8FB-AA41B5EA671A	Primary Tumor	Illumina HiSeq	da9e3264-de3a-4fca-bfda-59022f9417d2	Skin	77	8288B632-9E64-401C-8F45-F268367F40E4	E2774050-1257-4C29-B201-D79CE70FE17E	TCGA-GN-A26C-01A-11D-A19A-08	HG19_Broad_variant	TCGA-GN-A26C	TCGA-SKCM	821	s7477	Broad Institute of MIT and Harvard	Roswell	United States	NO	T4b	N2b	Not available	Stage IIIC	A19A-08	TRUE
13722.58cfa82ee4b0c9d6adf6ac51	58cfa82ee4b0c9d6adf6ac51	G39020.TCGA-BR-6456-01A-11D-1800-08.3.filtered.	WGS	G39020.TCGA-BR-6456-01A-11D-1800-08.3	G39020.TCGA-BR-6456-01A-11D-1800-08.3.bam	282.7	1.9	0.05	58cfa82ee4b0c9d6adf6ac51	G39020.TCGA-BR-6456-01A-11D-1800-08.3.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-BR-6456-01A	1CA3C5E0-32B0-4467-8EC0-CA212E35D2B3	Primary Tumor	Illumina HiSeq	9830e4a0-d8b1-4166-8375-49851288cf1f	Stomach	74	53369A25-3BC4-48CB-9004-DA3507C4D478	C612570A-881D-421F-98B9-0E4563133744	TCGA-BR-6456-01A-11D-1800-08	HG19_Broad_variant	TCGA-BR-6456	TCGA-STAD	NA	s14876	Broad Institute of MIT and Harvard	Asterand	Russia	NO	T3	N1	Stomach  Adenocarcinoma  Not Otherwise Specified (NOS)	Stage IIB	1800-08	TRUE
13722.58cfa82ee4b0c9d6adf6ac75	58cfa82ee4b0c9d6adf6ac75	G47088.TCGA-21-5782-01A-01D-1632-08.1.filtered.	WGS	G47088.TCGA-21-5782-01A-01D-1632-08.1	G47088.TCGA-21-5782-01A-01D-1632-08.1.bam	384.7	1.9	0.05	58cfa82ee4b0c9d6adf6ac75	G47088.TCGA-21-5782-01A-01D-1632-08.1.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-21-5782-01A	E21964B8-47C7-4A5F-BFA7-7206222883D2	Primary Tumor	Illumina HiSeq	80a5fd2e-393b-43b1-9bbd-0e02bd6053a2	Lung	68	9ABF3A20-B34D-429B-9C13-0468DFC20700	4C2AD4A0-5D57-4E27-9F35-058B2F205F50	TCGA-21-5782-01A-01D-1632-08	HG19_Broad_variant	TCGA-21-5782	TCGA-LUSC	962	s10362	Broad Institute of MIT and Harvard	Fox Chase Cancer Center	United States	NO	T2	N0	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage IB	1632-08	FALSE
13722.58cfa82ee4b0c9d6adf6abc6	58cfa82ee4b0c9d6adf6abc6	G32540.TCGA-EL-A3CV-01A-11D-A19J-08.2.filtered.	WGS	G32540.TCGA-EL-A3CV-01A-11D-A19J-08.2	G32540.TCGA-EL-A3CV-01A-11D-A19J-08.2.bam	15.76	NA	0.08	58cfa82ee4b0c9d6adf6abc6	G32540.TCGA-EL-A3CV-01A-11D-A19J-08.2.bam	Alive	MALE	WHITE	HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-EL-A3CV-01A	FB83F7D7-2182-4FB7-8E3E-8AD7F1FEAC72	Primary Tumor	Illumina HiSeq	bd9e1da9-58f5-49d6-b838-2acffb8ee860	Thyroid	40	7BC433ED-7908-4297-AA5A-E033924BCED1	B1753E9C-29D0-4955-89D2-949CDABD1211	TCGA-EL-A3CV-01A-11D-A19J-08	HG19_Broad_variant	TCGA-EL-A3CV	TCGA-THCA	NA	s12727	Broad Institute of MIT and Harvard	MD Anderson	United States	NO	T3	N1b	Thyroid Papillary Carcinoma - Classical/usual	Stage I	A19J-08	FALSE
13722.58cfa82ee4b0c9d6adf6ac8b	58cfa82ee4b0c9d6adf6ac8b	G47088.TCGA-98-8022-01A-11D-2244-08.2.filtered.	WGS	G47088.TCGA-98-8022-01A-11D-2244-08.2	G47088.TCGA-98-8022-01A-11D-2244-08.2.bam	276.03	NA	0.05	58cfa82ee4b0c9d6adf6ac8b	G47088.TCGA-98-8022-01A-11D-2244-08.2.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-98-8022-01A	ADC853B1-B8BF-488C-A1E2-E95603459B55	Primary Tumor	Illumina HiSeq	490e3546-83cd-4a44-a792-f1c2e1530f4a	Lung	61	95933B01-06CA-4F3E-8995-EB2AB01A2C4C	6962BC97-FBB8-4220-A600-E3C251E245CB	TCGA-98-8022-01A-11D-2244-08	HG19_Broad_variant	TCGA-98-8022	TCGA-LUSC	NA	s10499	Broad Institute of MIT and Harvard	Washington University - Alabama	United States	NO	T1a	N0	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage IA	2244-08	FALSE
13722.58cfa82ee4b0c9d6adf6ac8f	58cfa82ee4b0c9d6adf6ac8f	G48125.TCGA-13-1477-01A-01D-A312-08.3.filtered.	WGS	G48125.TCGA-13-1477-01A-01D-A312-08.3	G48125.TCGA-13-1477-01A-01D-A312-08.3.bam	173.97	1.9	0.08	58cfa82ee4b0c9d6adf6ac8f	G48125.TCGA-13-1477-01A-01D-A312-08.3.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-13-1477-01A	13F5814C-1F99-4FFA-84A4-3BBD8979FAAE	Primary Tumor	Illumina HiSeq	20a1de59-1aa6-4045-a699-63a91e441931	Ovary	49	79908395-D442-44A3-8E91-97C3AE97DDD5	0AE2193F-0D68-485A-B8C2-7568CBCCE33E	TCGA-13-1477-01A-01D-A312-08	HG19_Broad_variant	TCGA-13-1477	TCGA-OV	1662	s18023	Broad Institute of MIT and Harvard	Memorial Sloan Kettering	None	NO	Not available	Not available	Serous Cystadenocarcinoma	Not available	A312-08	TRUE
13722.58cfa82ee4b0c9d6adf6ac73	58cfa82ee4b0c9d6adf6ac73	G47088.TCGA-85-8277-01A-11D-2293-08.1.filtered.	WGS	G47088.TCGA-85-8277-01A-11D-2293-08.1	G47088.TCGA-85-8277-01A-11D-2293-08.1.bam	270.3	NA	0.05	58cfa82ee4b0c9d6adf6ac73	G47088.TCGA-85-8277-01A-11D-2293-08.1.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-85-8277-01A	8E6020A1-68DF-4D57-AD4E-33ACC0861FB3	Primary Tumor	Illumina HiSeq	b6b09fc0-6713-4047-8081-3b8224052fec	Lung	70	5600CB1A-D0F4-468E-B8D2-E431B77496BF	649F2C20-5B50-40A8-A6FD-9A51F3D5B9DF	TCGA-85-8277-01A-11D-2293-08	HG19_Broad_variant	TCGA-85-8277	TCGA-LUSC	NA	s10075	Broad Institute of MIT and Harvard	Asterand	Russia	NO	T3	N1	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage IIIA	2293-08	FALSE
13722.58cfa82ee4b0c9d6adf6ac9e	58cfa82ee4b0c9d6adf6ac9e	G48125.TCGA-04-1542-01A-01D-A312-08.1.filtered.	WGS	G48125.TCGA-04-1542-01A-01D-A312-08.1	G48125.TCGA-04-1542-01A-01D-A312-08.1.bam	136.34	1.9	0.08	58cfa82ee4b0c9d6adf6ac9e	G48125.TCGA-04-1542-01A-01D-A312-08.1.bam	Dead	FEMALE	WHITE	Not available	Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-04-1542-01A	0C1A2E7D-E7E4-481E-A012-EF214C444497	Primary Tumor	Illumina HiSeq	b959ed10-2767-48bb-8031-f7a331c04f91	Ovary	52	D33FD264-13DB-4642-AFCA-37125751CC28	A0BBB3B1-E774-4C75-9301-BA43FB803F20	TCGA-04-1542-01A-01D-A312-08	HG19_Broad_variant	TCGA-04-1542	TCGA-OV	2561	s18019	Broad Institute of MIT and Harvard	Gynecologic Oncology Group	None	NO	Not available	Not available	Serous Cystadenocarcinoma	Not available	A312-08	TRUE
13722.58cfa82ee4b0c9d6adf6ac97	58cfa82ee4b0c9d6adf6ac97	G48125.TCGA-13-1487-01A-01D-A312-08.2.filtered.	WGS	G48125.TCGA-13-1487-01A-01D-A312-08.2	G48125.TCGA-13-1487-01A-01D-A312-08.2.bam	298.97	1.9	0.07	58cfa82ee4b0c9d6adf6ac97	G48125.TCGA-13-1487-01A-01D-A312-08.2.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-13-1487-01A	C9E28934-8379-4511-817C-D787F2C4CA3A	Primary Tumor	Illumina HiSeq	3ce95963-7650-4fe7-9cbc-554ee9d56aa7	Ovary	74	BFF12F06-DABC-4424-AC53-65CA01D0A406	44EEBC04-C027-45AE-BECA-C4012B494F29	TCGA-13-1487-01A-01D-A312-08	HG19_Broad_variant	TCGA-13-1487	TCGA-OV	681	s17280	Broad Institute of MIT and Harvard	Memorial Sloan Kettering	None	NO	Not available	Not available	Serous Cystadenocarcinoma	Not available	A312-08	TRUE
13722.58cfa82ee4b0c9d6adf6aca8	58cfa82ee4b0c9d6adf6aca8	G39020.TCGA-HU-A4H0-01A-11D-A25D-08.1.filtered.	WGS	G39020.TCGA-HU-A4H0-01A-11D-A25D-08.1	G39020.TCGA-HU-A4H0-01A-11D-A25D-08.1.bam	42.83	NA	0.08	58cfa82ee4b0c9d6adf6aca8	G39020.TCGA-HU-A4H0-01A-11D-A25D-08.1.bam	Alive	MALE	ASIAN	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-HU-A4H0-01A	FE45EAEE-FF0C-4D52-B18C-04DC2D64D3B4	Primary Tumor	Illumina HiSeq	787fd694-c915-406f-a8a1-0ca998d01d93	Stomach	72	568CBF5F-86DA-4420-9C70-324D11B8E481	7116CC90-F465-4E7E-AA27-48A83ED258E9	TCGA-HU-A4H0-01A-11D-A25D-08	HG19_Broad_variant	TCGA-HU-A4H0	TCGA-STAD	NA	s14394	Broad Institute of MIT and Harvard	National Cancer Center Korea	Korea South	NO	T4a	N3b	Stomach  Adenocarcinoma  Diffuse Type	Stage IIIC	A25D-08	FALSE
13722.58cfa82ee4b0c9d6adf6acbc	58cfa82ee4b0c9d6adf6acbc	G37566.TCGA-HC-8258-01A-11D-2260-08.3.filtered.	WGS	G37566.TCGA-HC-8258-01A-11D-2260-08.3	G37566.TCGA-HC-8258-01A-11D-2260-08.3.bam	103.3	NA	0.05	58cfa82ee4b0c9d6adf6acbc	G37566.TCGA-HC-8258-01A-11D-2260-08.3.bam	Alive	MALE	Not available	Not available	Prostate Adenocarcinoma	Aligned reads	TCGA-HC-8258-01A	DA5B0169-E4F4-4674-B348-220AF03FF4B5	Primary Tumor	Illumina HiSeq	696d5596-7630-4286-a1c4-8a3ea96ddf16	Prostate	56	B8881603-9353-4F63-93D7-E14EFED64AA6	597E4011-EA99-4356-B1D9-8CFE35DB7C3B	TCGA-HC-8258-01A-11D-2260-08	HG19_Broad_variant	TCGA-HC-8258	TCGA-PRAD	NA	s3583	Broad Institute of MIT and Harvard	International Genomics Consortium	United States	NO	T2c	N0	Prostate Adenocarcinoma Acinar Type	Not available	2260-08	FALSE
13722.58cfa82ee4b0c9d6adf6acaa	58cfa82ee4b0c9d6adf6acaa	G47088.TCGA-68-8250-01A-11D-2293-08.1.filtered.	WGS	G47088.TCGA-68-8250-01A-11D-2293-08.1	G47088.TCGA-68-8250-01A-11D-2293-08.1.bam	242.3	NA	0.05	58cfa82ee4b0c9d6adf6acaa	G47088.TCGA-68-8250-01A-11D-2293-08.1.bam	Alive	MALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-68-8250-01A	7B982D5E-3A7D-40AC-BD25-6044C62879B6	Primary Tumor	Illumina HiSeq	c923eeaa-1b36-49b3-97b7-f64875389d5f	Lung	66	A6A1A05E-9126-45CD-B7BE-C1C342FAF5AF	71A2B4A2-88DD-4911-A67E-70B3309C4A12	TCGA-68-8250-01A-11D-2293-08	HG19_Broad_variant	TCGA-68-8250	TCGA-LUSC	NA	s10252	Broad Institute of MIT and Harvard	Washington University - Cleveland Clinic	United States	NO	T1a	N0	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage IA	2293-08	FALSE
13722.58cfa82ee4b0c9d6adf6acb6	58cfa82ee4b0c9d6adf6acb6	G48125.TCGA-23-1118-01A-01D-A312-08.2.filtered.	WGS	G48125.TCGA-23-1118-01A-01D-A312-08.2	G48125.TCGA-23-1118-01A-01D-A312-08.2.bam	362.67	1.9	0.08	58cfa82ee4b0c9d6adf6acb6	G48125.TCGA-23-1118-01A-01D-A312-08.2.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-23-1118-01A	700E91BB-D675-41B2-BBBD-935767C7B447	Primary Tumor	Illumina HiSeq	be8b86e7-e6da-45ca-a286-471e3ef37950	Ovary	45	E1BE8AD9-1A52-4677-8436-3DA22AD12E9A	33EA81F2-DB2C-4567-BD7B-4CB9AADFEF88	TCGA-23-1118-01A-01D-A312-08	HG19_Broad_variant	TCGA-23-1118	TCGA-OV	NA	s18021	Broad Institute of MIT and Harvard	Cedars Sinai	None	NO	Not available	Not available	Serous Cystadenocarcinoma	Not available	A312-08	TRUE
13722.58cfa82ee4b0c9d6adf6accf	58cfa82ee4b0c9d6adf6accf	G48125.TCGA-24-1557-01A-01D-A312-08.2.filtered.	WGS	G48125.TCGA-24-1557-01A-01D-A312-08.2	G48125.TCGA-24-1557-01A-01D-A312-08.2.bam	115.97	1.9	0.08	58cfa82ee4b0c9d6adf6accf	G48125.TCGA-24-1557-01A-01D-A312-08.2.bam	Dead	FEMALE	WHITE	Not available	Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-24-1557-01A	7DCC809B-E33A-4453-B92A-C00786F48CB0	Primary Tumor	Illumina HiSeq	07bba28c-8d1a-4228-bd9e-1b27066ba518	Ovary	49	FA79B363-380E-48AE-BB82-DB395085353C	BFF518FB-6DA7-4DFC-AE4C-BD3F641028E2	TCGA-24-1557-01A-01D-A312-08	HG19_Broad_variant	TCGA-24-1557	TCGA-OV	1213	s17862	Broad Institute of MIT and Harvard	Washington University	None	NO	Not available	Not available	Serous Cystadenocarcinoma	Not available	A312-08	TRUE
13722.58cfa82ee4b0c9d6adf6acc8	58cfa82ee4b0c9d6adf6acc8	G39020.TCGA-D7-8570-01A-11D-2340-08.2.filtered.	WGS	G39020.TCGA-D7-8570-01A-11D-2340-08.2	G39020.TCGA-D7-8570-01A-11D-2340-08.2.bam	318.7	NA	0.05	58cfa82ee4b0c9d6adf6acc8	G39020.TCGA-D7-8570-01A-11D-2340-08.2.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-D7-8570-01A	1E1CDF72-820F-48A4-8FB6-89575D07CDE9	Primary Tumor	Illumina HiSeq	4b984072-ec9c-4924-a922-f7c4f5c2eacc	Stomach	44	E23E2A9C-5080-4276-8982-9CF078027A48	429AAD6F-816D-4739-BAA3-B0EBF2FCD501	TCGA-D7-8570-01A-11D-2340-08	HG19_Broad_variant	TCGA-D7-8570	TCGA-STAD	NA	s14877	Broad Institute of MIT and Harvard	Greater Poland Cancer Center	Poland	NO	T3	N3a	Stomach  Intestinal Adenocarcinoma  Tubular Type	Stage IIIB	2340-08	FALSE
13722.58cfa82ee4b0c9d6adf6aaec	58cfa82ee4b0c9d6adf6aaec	G32536.TCGA-EL-A3T0-01A-22D-A22D-08.4.filtered.	WGS	G32536.TCGA-EL-A3T0-01A-22D-A22D-08.4	G32536.TCGA-EL-A3T0-01A-22D-A22D-08.4.bam	25.01	NA	0.08	58cfa82ee4b0c9d6adf6aaec	G32536.TCGA-EL-A3T0-01A-22D-A22D-08.4.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-EL-A3T0-01A	861F94CE-45FF-4588-ADDB-E1EA48878C2E	Primary Tumor	Illumina HiSeq	5c6477ae-68e1-4407-8f81-53f64006df76	Thyroid	45	913D384C-657A-4AE0-9E8E-E9BDB77D140E	54426B1A-E0D3-4D8E-9E81-2D8E6B153B22	TCGA-EL-A3T0-01A-22D-A22D-08	HG19_Broad_variant	TCGA-EL-A3T0	TCGA-THCA	NA	s11975	Broad Institute of MIT and Harvard	MD Anderson	United States	NO	T3	N1	Thyroid Papillary Carcinoma - Classical/usual	Stage III	A22D-08	TRUE
13722.58cfa82ee4b0c9d6adf6ad04	58cfa82ee4b0c9d6adf6ad04	G49537.TCGA-EL-A3MY-01A-11D-A21A-08.1.filtered.	WGS	G49537.TCGA-EL-A3MY-01A-11D-A21A-08.1	G49537.TCGA-EL-A3MY-01A-11D-A21A-08.1.bam	37.42	NA	0.08	58cfa82ee4b0c9d6adf6ad04	G49537.TCGA-EL-A3MY-01A-11D-A21A-08.1.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-EL-A3MY-01A	7746BE87-7AD0-48A7-84FB-08A81B220BDB	Primary Tumor	Illumina HiSeq	961c7c05-824f-48c1-aed0-956b03c74c9f	Thyroid	81	E1C4D037-D70F-4AB1-BB34-554538C934CD	A9C29EDD-2EF1-46EF-93C6-796CF0332A2B	TCGA-EL-A3MY-01A-11D-A21A-08	HG19_Broad_variant	TCGA-EL-A3MY	TCGA-THCA	533	s12621	Broad Institute of MIT and Harvard	MD Anderson	United States	NO	T4	NX	Thyroid Papillary Carcinoma - Classical/usual	Stage IVC	A21A-08	TRUE
13722.58cfa82ee4b0c9d6adf6ad22	58cfa82ee4b0c9d6adf6ad22	G49537.TCGA-BJ-A28T-01A-11D-A33C-08.2.filtered.	WGS	G49537.TCGA-BJ-A28T-01A-11D-A33C-08.2	G49537.TCGA-BJ-A28T-01A-11D-A33C-08.2.bam	61.44	2	0.08	58cfa82ee4b0c9d6adf6ad22	G49537.TCGA-BJ-A28T-01A-11D-A33C-08.2.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-BJ-A28T-01A	A9D8F797-8A53-4BE5-B957-0F1F6D080390	Primary Tumor	Illumina HiSeq	e27094ec-2670-4ef1-a358-d36554e52da1	Thyroid	34	4CA4149A-E952-4A25-9163-8D4C15B09A62	1D97BA51-D981-4986-9F71-C2B6CB9961C3	TCGA-BJ-A28T-01A-11D-A33C-08	HG19_Broad_variant	TCGA-BJ-A28T	TCGA-THCA	NA	s12218	Broad Institute of MIT and Harvard	University of Pittsburgh	United States	NO	T1	N1a	Thyroid Papillary Carcinoma - Classical/usual	Stage I	A33C-08	FALSE
13722.58cfa82ee4b0c9d6adf6ad24	58cfa82ee4b0c9d6adf6ad24	G49837.TCGA-18-3408-01A-01D-A320-08.4.filtered.	WGS	G49837.TCGA-18-3408-01A-01D-A320-08.4	G49837.TCGA-18-3408-01A-01D-A320-08.4.bam	385.94	1.9	0.08	58cfa82ee4b0c9d6adf6ad24	G49837.TCGA-18-3408-01A-01D-A320-08.4.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-18-3408-01A	D4BC755A-2585-4529-AE36-7E1D88BDECFE	Primary Tumor	Illumina HiSeq	cea31b4d-7d33-4497-ae63-50688d12b045	Lung	77	EEFFADF9-2CCB-4937-AE1E-1D50ABA41C4D	24BADF07-8615-48A3-8D6E-45C3D783F18D	TCGA-18-3408-01A-01D-A320-08	HG19_Broad_variant	TCGA-18-3408	TCGA-LUSC	NA	s10257	Broad Institute of MIT and Harvard	Princess Margaret Hospital (Canada)	Canada	NO	T2	N0	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage IB	A320-08	TRUE
13722.58cfa82ee4b0c9d6adf6ad2e	58cfa82ee4b0c9d6adf6ad2e	G49837.TCGA-56-7582-01A-11D-A320-08.4.filtered.	WGS	G49837.TCGA-56-7582-01A-11D-A320-08.4	G49837.TCGA-56-7582-01A-11D-A320-08.4.bam	60	NA	0.08	58cfa82ee4b0c9d6adf6ad2e	G49837.TCGA-56-7582-01A-11D-A320-08.4.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-56-7582-01A	B5E2CBDA-BBFA-4EF8-A9C4-CB978BEF9B23	Primary Tumor	Illumina HiSeq	0a8f41dd-07fb-47be-b963-8d807c40760c	Lung	83	1220E8B3-E16E-454E-BC49-60F49F9FE090	89C48E53-C8A9-4518-B3B8-509CDCAFF52B	TCGA-56-7582-01A-11D-A320-08	HG19_Broad_variant	TCGA-56-7582	TCGA-LUSC	NA	s10163	Broad Institute of MIT and Harvard	International Genomics Consortium	United States	NO	T2a	N0	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage IB	A320-08	TRUE
13722.58cfa82ee4b0c9d6adf6ad33	58cfa82ee4b0c9d6adf6ad33	G49837.TCGA-66-2759-01A-01D-A320-08.2.filtered.	WGS	G49837.TCGA-66-2759-01A-01D-A320-08.2	G49837.TCGA-66-2759-01A-01D-A320-08.2.bam	604.93	1.9	0.08	58cfa82ee4b0c9d6adf6ad33	G49837.TCGA-66-2759-01A-01D-A320-08.2.bam	Alive	MALE	Not available	Not available	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-66-2759-01A	E6B72C24-1607-43B9-8B8A-7BF83EEA5895	Primary Tumor	Illumina HiSeq	38482025-33d2-4b12-a2f0-2654d26fe714	Lung	66	33918A59-C2B0-435E-BA63-8A39DA191712	7AC0B303-D685-4FA5-BFEC-34D2BA1DBC8E	TCGA-66-2759-01A-01D-A320-08	HG19_Broad_variant	TCGA-66-2759	TCGA-LUSC	NA	s10165	Broad Institute of MIT and Harvard	Indivumed	Germany	NO	T2	N2	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage IIIA	A320-08	TRUE
13722.58cfa82ee4b0c9d6adf6ad38	58cfa82ee4b0c9d6adf6ad38	G49537.TCGA-BJ-A28V-01A-11D-A19J-08.1.filtered.	WGS	G49537.TCGA-BJ-A28V-01A-11D-A19J-08.1	G49537.TCGA-BJ-A28V-01A-11D-A19J-08.1.bam	78.4	2	0.08	58cfa82ee4b0c9d6adf6ad38	G49537.TCGA-BJ-A28V-01A-11D-A19J-08.1.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-BJ-A28V-01A	BED1FB3C-4459-460E-8190-29211857FA73	Primary Tumor	Illumina HiSeq	68b5668a-a719-42b2-99bb-d26c59c19b2f	Thyroid	80	4862B699-580D-4F2E-97A0-BD8918537067	19233FD1-5229-466E-ACF3-5882165758E0	TCGA-BJ-A28V-01A-11D-A19J-08	HG19_Broad_variant	TCGA-BJ-A28V	TCGA-THCA	NA	s12617	Broad Institute of MIT and Harvard	University of Pittsburgh	United States	NO	T3	N0	Thyroid Papillary Carcinoma - Classical/usual	Stage III	A19J-08	FALSE
13722.58cfa82ee4b0c9d6adf6ad41	58cfa82ee4b0c9d6adf6ad41	G49837.TCGA-52-7812-01A-11D-A320-08.3.filtered.	WGS	G49837.TCGA-52-7812-01A-11D-A320-08.3	G49837.TCGA-52-7812-01A-11D-A320-08.3.bam	402	NA	0.08	58cfa82ee4b0c9d6adf6ad41	G49837.TCGA-52-7812-01A-11D-A320-08.3.bam	Dead	MALE	WHITE	HISPANIC OR LATINO	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-52-7812-01A	81B7CBC1-C037-426F-95B0-D729A30697DA	Primary Tumor	Illumina HiSeq	7beb10bf-82e5-4496-80a3-2e212fece28a	Lung	68	75384E41-370E-4972-870C-2845FB4DED2F	2FE2433B-9A55-431F-A869-2B5A63E8E8FC	TCGA-52-7812-01A-11D-A320-08	HG19_Broad_variant	TCGA-52-7812	TCGA-LUSC	835	s10258	Broad Institute of MIT and Harvard	University of Miami	United States	NO	T2	N2	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage IIA	A320-08	TRUE
13722.58cfa82ee4b0c9d6adf6ad63	58cfa82ee4b0c9d6adf6ad63	G49537.TCGA-BJ-A0Z2-01A-11D-A10S-08.2.filtered.	WGS	G49537.TCGA-BJ-A0Z2-01A-11D-A10S-08.2	G49537.TCGA-BJ-A0Z2-01A-11D-A10S-08.2.bam	89.84	1.92	0.07	58cfa82ee4b0c9d6adf6ad63	G49537.TCGA-BJ-A0Z2-01A-11D-A10S-08.2.bam	Alive	MALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-BJ-A0Z2-01A	F9CEFFC0-D544-418D-B4A9-BD3C84E37026	Primary Tumor	Illumina HiSeq	b84e6415-1014-4d91-a469-879b108fa3bb	Thyroid	57	B06B7493-F38A-493F-8B47-61E0FA4D111F	2DD5EEA1-42A1-4E8B-99AC-20399CC7E15C	TCGA-BJ-A0Z2-01A-11D-A10S-08	HG19_Broad_variant	TCGA-BJ-A0Z2	TCGA-THCA	NA	s12618	Broad Institute of MIT and Harvard	University of Pittsburgh	United States	NO	T2	N0	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	Stage IVC	A10S-08	TRUE
13722.58cfa82ee4b0c9d6adf6ad47	58cfa82ee4b0c9d6adf6ad47	G49837.TCGA-68-7755-01A-11D-A320-08.2.filtered.	WGS	G49837.TCGA-68-7755-01A-11D-A320-08.2	G49837.TCGA-68-7755-01A-11D-A320-08.2.bam	35	NA	0.08	58cfa82ee4b0c9d6adf6ad47	G49837.TCGA-68-7755-01A-11D-A320-08.2.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-68-7755-01A	3666BC65-8E40-409E-9A1F-41583DD6D978	Primary Tumor	Illumina HiSeq	2a201b20-3b01-4291-9e87-443bfb483c69	Lung	60	87D21E55-7F4A-4652-B7F7-1E64CB300FAE	84E601B7-DFA5-4CD5-9FEF-07F03967A0D4	TCGA-68-7755-01A-11D-A320-08	HG19_Broad_variant	TCGA-68-7755	TCGA-LUSC	NA	s10372	Broad Institute of MIT and Harvard	Washington University - Cleveland Clinic	United States	NO	T1b	N1	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage IIA	A320-08	TRUE
13722.58cfa82ee4b0c9d6adf6ad69	58cfa82ee4b0c9d6adf6ad69	G48125.TCGA-25-2400-01A-01D-A312-08.2.filtered.	WGS	G48125.TCGA-25-2400-01A-01D-A312-08.2	G48125.TCGA-25-2400-01A-01D-A312-08.2.bam	26.97	1.9	0.08	58cfa82ee4b0c9d6adf6ad69	G48125.TCGA-25-2400-01A-01D-A312-08.2.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-25-2400-01A	5C127332-5CA0-45F1-A5AC-4876AD94E491	Primary Tumor	Illumina HiSeq	8cee9d85-d13a-49d0-a53e-c44c00ed4e36	Ovary	76	B5E8849B-9002-4B65-A2EA-6A46C04ABA4A	D67CAD13-E849-48B0-926C-10B6046BA0B9	TCGA-25-2400-01A-01D-A312-08	HG19_Broad_variant	TCGA-25-2400	TCGA-OV	1278	s17800	Broad Institute of MIT and Harvard	Mayo Clinic - Rochester	None	NO	Not available	Not available	Serous Cystadenocarcinoma	Not available	A312-08	TRUE
13722.58cfa82ee4b0c9d6adf6ad3a	58cfa82ee4b0c9d6adf6ad3a	G49537.TCGA-BJ-A0ZB-01A-11D-A10S-08.1.filtered.	WGS	G49537.TCGA-BJ-A0ZB-01A-11D-A10S-08.1	G49537.TCGA-BJ-A0ZB-01A-11D-A10S-08.1.bam	79.63	2	0.08	58cfa82ee4b0c9d6adf6ad3a	G49537.TCGA-BJ-A0ZB-01A-11D-A10S-08.1.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-BJ-A0ZB-01A	DC4D8468-6F34-40CB-A826-8D582CD86FDE	Primary Tumor	Illumina HiSeq	da7e540d-041b-4d8e-9158-52775a1aad5f	Thyroid	66	145A474E-D262-468A-8DB7-EE9F1B7CE0A7	ADD0B0F6-B4A8-4B73-B634-C3600DC567D5	TCGA-BJ-A0ZB-01A-11D-A10S-08	HG19_Broad_variant	TCGA-BJ-A0ZB	TCGA-THCA	NA	s12221	Broad Institute of MIT and Harvard	University of Pittsburgh	United States	NO	T3	N1b	Thyroid Papillary Carcinoma - Classical/usual	Stage IVA	A10S-08	TRUE
13722.58cfa82ee4b0c9d6adf6ad8a	58cfa82ee4b0c9d6adf6ad8a	G39020.TCGA-BR-6564-01A-12D-1882-08.2.filtered.	WGS	G39020.TCGA-BR-6564-01A-12D-1882-08.2	G39020.TCGA-BR-6564-01A-12D-1882-08.2.bam	29.7	1.9	0.05	58cfa82ee4b0c9d6adf6ad8a	G39020.TCGA-BR-6564-01A-12D-1882-08.2.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-BR-6564-01A	AF1086CC-B330-4AD6-AE1C-3B5C7259949A	Primary Tumor	Illumina HiSeq	69520aa9-d9e7-49e5-a7a9-0b1e402a69c4	Stomach	46	B8355E52-D7A7-4711-BBA7-BC4D201741F2	2E66EB75-097C-4AD8-B2B3-9F5849DFD02F	TCGA-BR-6564-01A-12D-1882-08	HG19_Broad_variant	TCGA-BR-6564	TCGA-STAD	NA	s15037	Broad Institute of MIT and Harvard	Asterand	Russia	NO	T3	N2	Stomach  Adenocarcinoma  Diffuse Type	Stage IIIA	1882-08	FALSE
13722.58cfa82ee4b0c9d6adf6ad43	58cfa82ee4b0c9d6adf6ad43	G49837.TCGA-66-2744-01A-01D-A320-08.3.filtered.	WGS	G49837.TCGA-66-2744-01A-01D-A320-08.3	G49837.TCGA-66-2744-01A-01D-A320-08.3.bam	87.27	1.9	0.07	58cfa82ee4b0c9d6adf6ad43	G49837.TCGA-66-2744-01A-01D-A320-08.3.bam	Alive	MALE	Not available	Not available	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-66-2744-01A	1EE543D5-B8C0-4F79-8373-6BB6319F2EE2	Primary Tumor	Illumina HiSeq	8188fa37-2482-4c3a-bc2d-c8ead7d2171c	Lung	71	75E00DD8-0AD9-4447-9407-0AB6AC0A7173	706868B5-4920-433A-BEA3-92E9BF83059B	TCGA-66-2744-01A-01D-A320-08	HG19_Broad_variant	TCGA-66-2744	TCGA-LUSC	NA	s10082	Broad Institute of MIT and Harvard	Indivumed	Germany	NO	T2	N1	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage IIB	A320-08	TRUE
13722.58cfa82ee4b0c9d6adf6ad7a	58cfa82ee4b0c9d6adf6ad7a	G39020.TCGA-BR-8381-01A-11D-2394-08.2.filtered.	WGS	G39020.TCGA-BR-8381-01A-11D-2394-08.2	G39020.TCGA-BR-8381-01A-11D-2394-08.2.bam	329	NA	0.05	58cfa82ee4b0c9d6adf6ad7a	G39020.TCGA-BR-8381-01A-11D-2394-08.2.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-BR-8381-01A	AEF8D98F-7A1C-47F3-B5A7-A3CB299C70DE	Primary Tumor	Illumina HiSeq	8d5cdec5-779b-4ca8-a709-f2fbc527642b	Stomach	51	1DDC7F73-D793-4AE6-8A6A-851069892FAD	D6738C83-7B52-4224-846A-67BD085AAAB8	TCGA-BR-8381-01A-11D-2394-08	HG19_Broad_variant	TCGA-BR-8381	TCGA-STAD	NA	s15170	Broad Institute of MIT and Harvard	Asterand	Ukraine	NO	T3	N1	Stomach  Adenocarcinoma  Not Otherwise Specified (NOS)	Stage IIB	2394-08	TRUE
13722.58cfa82ee4b0c9d6adf6ad9a	58cfa82ee4b0c9d6adf6ad9a	G49837.TCGA-96-7545-01A-21D-A320-08.2.filtered.	WGS	G49837.TCGA-96-7545-01A-21D-A320-08.2	G49837.TCGA-96-7545-01A-21D-A320-08.2.bam	100	NA	0.08	58cfa82ee4b0c9d6adf6ad9a	G49837.TCGA-96-7545-01A-21D-A320-08.2.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-96-7545-01A	4CA13C92-84B4-4EDF-842A-B20B7E713415	Primary Tumor	Illumina HiSeq	dadefdff-15a7-4c69-8436-344e649bc017	Lung	73	59F2654E-7F41-480B-B59C-F0DB373B7160	B7A7D93B-38A7-4FC3-A433-3BB0A8CB7C42	TCGA-96-7545-01A-21D-A320-08	HG19_Broad_variant	TCGA-96-7545	TCGA-LUSC	NA	s10084	Broad Institute of MIT and Harvard	Washington University - NYU	United States	NO	T1	N0	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage IA	A320-08	TRUE
13722.58cfa82ee4b0c9d6adf6ada0	58cfa82ee4b0c9d6adf6ada0	G39020.TCGA-CD-5799-01A-11D-1600-08.1.filtered.	WGS	G39020.TCGA-CD-5799-01A-11D-1600-08.1	G39020.TCGA-CD-5799-01A-11D-1600-08.1.bam	177.7	2	0.05	58cfa82ee4b0c9d6adf6ada0	G39020.TCGA-CD-5799-01A-11D-1600-08.1.bam	Alive	MALE	ASIAN	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-CD-5799-01A	C991697F-77F9-412A-9BD1-0E47F7387CB2	Primary Tumor	Illumina HiSeq	4086df7e-765b-48a9-bece-369629691ae0	Stomach	45	A3180E0E-EB99-49DD-8252-5FEA05A9885F	EB59B79F-BD36-4BF4-83E3-2AF73BD1D30A	TCGA-CD-5799-01A-11D-1600-08	HG19_Broad_variant	TCGA-CD-5799	TCGA-STAD	NA	s14602	Broad Institute of MIT and Harvard	ILSBIO	Vietnam	NO	T2	N1	Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS)	Stage II	1600-08	TRUE
13722.58cfa82ee4b0c9d6adf6adda	58cfa82ee4b0c9d6adf6adda	G49837.TCGA-18-3415-01A-01D-A320-08.2.filtered.	WGS	G49837.TCGA-18-3415-01A-01D-A320-08.2	G49837.TCGA-18-3415-01A-01D-A320-08.2.bam	369.94	1.9	0.08	58cfa82ee4b0c9d6adf6adda	G49837.TCGA-18-3415-01A-01D-A320-08.2.bam	Alive	MALE	Not available	Not available	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-18-3415-01A	9A874B64-D0D6-416E-97BC-E9071ED0B16B	Primary Tumor	Illumina HiSeq	c83a2887-3d9e-4a59-9e29-39e05ea6378b	Lung	77	23327C39-2E21-4604-9EBA-15884AE356FC	34881C6B-F59F-42C0-9F29-9C5C47262AE6	TCGA-18-3415-01A-01D-A320-08	HG19_Broad_variant	TCGA-18-3415	TCGA-LUSC	NA	s10080	Broad Institute of MIT and Harvard	Princess Margaret Hospital (Canada)	Canada	NO	T2	N0	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage IB	A320-08	TRUE
13722.58cfa82ee4b0c9d6adf6add8	58cfa82ee4b0c9d6adf6add8	G48125.TCGA-25-1634-01A-01D-A312-08.4.filtered.	WGS	G48125.TCGA-25-1634-01A-01D-A312-08.4	G48125.TCGA-25-1634-01A-01D-A312-08.4.bam	303.97	1.9	0.08	58cfa82ee4b0c9d6adf6add8	G48125.TCGA-25-1634-01A-01D-A312-08.4.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-25-1634-01A	15556B28-C6BD-455A-87B6-4B7B3E33D0E4	Primary Tumor	Illumina HiSeq	ed70494d-da6d-45b7-ad0f-59cd3afa7d46	Ovary	75	C0091BB4-1079-4254-AD42-42AC1DDD7F1E	3A5EAED6-FCFD-437A-B61C-FD3725C64717	TCGA-25-1634-01A-01D-A312-08	HG19_Broad_variant	TCGA-25-1634	TCGA-OV	1091	s17863	Broad Institute of MIT and Harvard	Mayo Clinic - Rochester	None	NO	Not available	Not available	Serous Cystadenocarcinoma	Not available	A312-08	TRUE
13722.58cfa82ee4b0c9d6adf6adfc	58cfa82ee4b0c9d6adf6adfc	G49538.TCGA-06-0211-01A-01D-1491-08.1.filtered.	WGS	G49538.TCGA-06-0211-01A-01D-1491-08.1	G49538.TCGA-06-0211-01A-01D-1491-08.1.bam	0	1.88	0.05	58cfa82ee4b0c9d6adf6adfc	G49538.TCGA-06-0211-01A-01D-1491-08.1.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Glioblastoma Multiforme	Aligned reads	TCGA-06-0211-01A	5C984433-33CF-42FC-B3BA-511EFCDCAB19	Primary Tumor	Illumina HiSeq	c68adb10-306f-4541-92b1-c6b5baa25d00	Brain	47	83177103-6AE2-444E-8AE7-E1BF76B1351D	CAEF21A2-190E-456D-95C9-3927A0B250AC	TCGA-06-0211-01A-01D-1491-08	HG19_Broad_variant	TCGA-06-0211	TCGA-GBM	360	s13948	Broad Institute of MIT and Harvard	Henry Ford Hospital	None	NO	Not available	Not available	Untreated primary (de novo) GBM	Not available	1491-08	FALSE
13722.58cfa82ee4b0c9d6adf6ae46	58cfa82ee4b0c9d6adf6ae46	G49837.TCGA-33-4586-01A-01D-A320-08.2.filtered.	WGS	G49837.TCGA-33-4586-01A-01D-A320-08.2	G49837.TCGA-33-4586-01A-01D-A320-08.2.bam	362	1.9	0.07	58cfa82ee4b0c9d6adf6ae46	G49837.TCGA-33-4586-01A-01D-A320-08.2.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-33-4586-01A	376DFD27-68E8-4A1A-9C4F-5064279B2A9E	Primary Tumor	Illumina HiSeq	e894d311-bbc3-468a-bed1-2c6328ae7bda	Lung	57	A41992A4-D0F9-4D5B-8D05-0E3025D9C8FF	B88F014E-BC0F-4775-8228-39E0B471C3B0	TCGA-33-4586-01A-01D-A320-08	HG19_Broad_variant	TCGA-33-4586	TCGA-LUSC	428	s10162	Broad Institute of MIT and Harvard	Johns Hopkins	United States	NO	T2	N2	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage IIIA	A320-08	TRUE
13722.58cfa82ee4b0c9d6adf6ae1a	58cfa82ee4b0c9d6adf6ae1a	G49837.TCGA-66-2795-01A-02D-A320-08.4.filtered.	WGS	G49837.TCGA-66-2795-01A-02D-A320-08.4	G49837.TCGA-66-2795-01A-02D-A320-08.4.bam	612.94	1.9	0.08	58cfa82ee4b0c9d6adf6ae1a	G49837.TCGA-66-2795-01A-02D-A320-08.4.bam	Alive	MALE	Not available	Not available	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-66-2795-01A	DA93A143-5799-4856-A5F4-3FF3B9284311	Primary Tumor	Illumina HiSeq	ad1129fe-92b3-4515-b91f-4b415f4e371f	Lung	68	9DC330BF-ACBD-4419-B533-35CF59ACEC71	D18C6E64-9598-488A-8AB3-3652072F9277	TCGA-66-2795-01A-02D-A320-08	HG19_Broad_variant	TCGA-66-2795	TCGA-LUSC	NA	s10256	Broad Institute of MIT and Harvard	Indivumed	Germany	NO	T4	N1	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage IIIB	A320-08	TRUE
13722.58cfa82ee4b0c9d6adf6ae76	58cfa82ee4b0c9d6adf6ae76	G49537.TCGA-FE-A22Z-01A-11D-A35R-08.1.filtered.	WGS	G49537.TCGA-FE-A22Z-01A-11D-A35R-08.1	G49537.TCGA-FE-A22Z-01A-11D-A35R-08.1.bam	78.59	2.03	0.08	58cfa82ee4b0c9d6adf6ae76	G49537.TCGA-FE-A22Z-01A-11D-A35R-08.1.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-FE-A22Z-01A	78D14F86-896A-4F98-9274-B2E8E387ADD9	Primary Tumor	Illumina HiSeq	d881881c-7108-46ea-92a8-1b1d9c915d5b	Thyroid	61	D206D300-E0CE-4A40-AF1F-45A685346A6E	8845FCE6-E2B4-4929-942B-57096B0BBAFC	TCGA-FE-A22Z-01A-11D-A35R-08	HG19_Broad_variant	TCGA-FE-A22Z	TCGA-THCA	NA	s12737	Broad Institute of MIT and Harvard	Ohio State University	United States	NO	T4a	N1	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	Stage IVA	A35R-08	FALSE
13722.58cfa82ee4b0c9d6adf6ae3b	58cfa82ee4b0c9d6adf6ae3b	G49837.TCGA-77-7139-01A-11D-A320-08.3.filtered.	WGS	G49837.TCGA-77-7139-01A-11D-A320-08.3	G49837.TCGA-77-7139-01A-11D-A320-08.3.bam	403	NA	0.08	58cfa82ee4b0c9d6adf6ae3b	G49837.TCGA-77-7139-01A-11D-A320-08.3.bam	Alive	MALE	WHITE	Not available	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-77-7139-01A	EE850103-6314-41A3-9734-8B520DE95B40	Primary Tumor	Illumina HiSeq	af2dee93-083d-492d-87c8-73cb962d49a2	Lung	56	48F646FE-03C6-4E7B-ACF1-9869E379443E	AD41F1F3-E38E-4418-9C16-52BCA5719F39	TCGA-77-7139-01A-11D-A320-08	HG19_Broad_variant	TCGA-77-7139	TCGA-LUSC	NA	s10260	Broad Institute of MIT and Harvard	Prince Charles Hospital	Australia	NO	T2	N1	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage IIB	A320-08	TRUE
13722.58cfa82ee4b0c9d6adf6ae86	58cfa82ee4b0c9d6adf6ae86	G49538.TCGA-14-1034-01A-01D-1492-08.3.filtered.	WGS	G49538.TCGA-14-1034-01A-01D-1492-08.3	G49538.TCGA-14-1034-01A-01D-1492-08.3.bam	15	1.9	0.05	58cfa82ee4b0c9d6adf6ae86	G49538.TCGA-14-1034-01A-01D-1492-08.3.bam	Dead	FEMALE	Not available	Not available	Glioblastoma Multiforme	Aligned reads	TCGA-14-1034-01A	0078B0C4-68A9-483B-9AAB-61156D263213	Primary Tumor	Illumina HiSeq	08541db8-2e7a-44e8-af91-65a951e09952	Brain	60	F2FFA9FF-86D6-41EF-92E7-7F87E981985B	86CD18AE-6390-4669-A707-4E0E334C690A	TCGA-14-1034-01A-01D-1492-08	HG19_Broad_variant	TCGA-14-1034	TCGA-GBM	485	s13984	Broad Institute of MIT and Harvard	Emory University	None	NO	Not available	Not available	Untreated primary (de novo) GBM	Not available	1492-08	FALSE
13722.58cfa82ee4b0c9d6adf6ae81	58cfa82ee4b0c9d6adf6ae81	G49538.TCGA-06-0210-01A-01D-1491-08.1.filtered.	WGS	G49538.TCGA-06-0210-01A-01D-1491-08.1	G49538.TCGA-06-0210-01A-01D-1491-08.1.bam	195.7	1.89	0.05	58cfa82ee4b0c9d6adf6ae81	G49538.TCGA-06-0210-01A-01D-1491-08.1.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Glioblastoma Multiforme	Aligned reads	TCGA-06-0210-01A	DE7B7CAC-F094-4D59-8651-E991E34EA093	Primary Tumor	Illumina HiSeq	47e69676-3a06-4711-ab31-5c65c734e472	Brain	72	D56A1EB8-D47B-41C3-B5D0-F5632DF77B3F	E362F533-5394-4E4A-9E4A-375FFC5F427B	TCGA-06-0210-01A-01D-1491-08	HG19_Broad_variant	TCGA-06-0210	TCGA-GBM	225	s13986	Broad Institute of MIT and Harvard	Henry Ford Hospital	None	NO	Not available	Not available	Untreated primary (de novo) GBM	Not available	1491-08	FALSE
13722.58cfa82ee4b0c9d6adf6ae8a	58cfa82ee4b0c9d6adf6ae8a	G49537.TCGA-L6-A4ET-01A-11D-A257-08.2.filtered.	WGS	G49537.TCGA-L6-A4ET-01A-11D-A257-08.2	G49537.TCGA-L6-A4ET-01A-11D-A257-08.2.bam	42.4	NA	0.08	58cfa82ee4b0c9d6adf6ae8a	G49537.TCGA-L6-A4ET-01A-11D-A257-08.2.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-L6-A4ET-01A	E1FF7694-64E1-47ED-B0D8-34ACFB4FFEF1	Primary Tumor	Illumina HiSeq	1e492402-4405-430b-a336-e8043ef159c8	Thyroid	49	D6183BCA-9A4D-41AC-940D-0EAA23DECF56	546B97B0-AB82-42A1-BBD2-241523278EC3	TCGA-L6-A4ET-01A-11D-A257-08	HG19_Broad_variant	TCGA-L6-A4ET	TCGA-THCA	NA	s12743	Broad Institute of MIT and Harvard	National Institutes of Health	United States	NO	T3	NX	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	Stage IVC	A257-08	FALSE
13722.58cfa82ee4b0c9d6adf6ae91	58cfa82ee4b0c9d6adf6ae91	G49538.TCGA-06-0125-01A-01D-1490-08.2.filtered.	WGS	G49538.TCGA-06-0125-01A-01D-1490-08.2	G49538.TCGA-06-0125-01A-01D-1490-08.2.bam	43.8	1.87	0.05	58cfa82ee4b0c9d6adf6ae91	G49538.TCGA-06-0125-01A-01D-1490-08.2.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Glioblastoma Multiforme	Aligned reads	TCGA-06-0125-01A	8DA3103E-3E6C-4176-A583-D5FE5E60601E	Primary Tumor	Illumina HiSeq	759af811-403e-4320-a598-d3291f429679	Brain	63	3A30326B-7523-4565-9A7E-0F7B5536B1CA	0D2A3D87-8ED4-4B27-82EB-FDE852EDE1D7	TCGA-06-0125-01A-01D-1490-08	HG19_Broad_variant	TCGA-06-0125	TCGA-GBM	1448	s14373	Broad Institute of MIT and Harvard	Henry Ford Hospital	None	NO	Not available	Not available	Untreated primary (de novo) GBM	Not available	1490-08	FALSE
13722.58cfa82ee4b0c9d6adf6ae8b	58cfa82ee4b0c9d6adf6ae8b	G49537.TCGA-EM-A22O-01A-11D-A17V-08.1.filtered.	WGS	G49537.TCGA-EM-A22O-01A-11D-A17V-08.1	G49537.TCGA-EM-A22O-01A-11D-A17V-08.1.bam	89.61	1.91	0.09	58cfa82ee4b0c9d6adf6ae8b	G49537.TCGA-EM-A22O-01A-11D-A17V-08.1.bam	Alive	MALE	ASIAN	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-EM-A22O-01A	6ABC861A-376D-446B-ACEE-FB0F03A82C09	Primary Tumor	Illumina HiSeq	93872277-a7c8-4d30-999d-afa2db9d4986	Thyroid	75	AACF33BD-95CE-40FD-9828-1E78CBBB0E1B	13642CF8-9840-4A7D-A26A-95F65B2C70C3	TCGA-EM-A22O-01A-11D-A17V-08	HG19_Broad_variant	TCGA-EM-A22O	TCGA-THCA	NA	s12087	Broad Institute of MIT and Harvard	University Health Network	Canada	NO	T4a	N1a	Thyroid Papillary Carcinoma - Classical/usual	Stage IVA	A17V-08	TRUE
13722.58cfa82ee4b0c9d6adf6ae9a	58cfa82ee4b0c9d6adf6ae9a	G49537.TCGA-FK-A3SD-01A-11D-A22D-08.1.filtered.	WGS	G49537.TCGA-FK-A3SD-01A-11D-A22D-08.1	G49537.TCGA-FK-A3SD-01A-11D-A22D-08.1.bam	32.19	NA	0.07	58cfa82ee4b0c9d6adf6ae9a	G49537.TCGA-FK-A3SD-01A-11D-A22D-08.1.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-FK-A3SD-01A	63B01B43-A68A-4046-89B0-736BA4D08504	Primary Tumor	Illumina HiSeq	f713e001-9c18-4a72-a093-90bd147d414f	Thyroid	61	B48D226E-610A-40DC-B62A-6DB863A7366C	29578759-9CCB-4A24-B5B8-C45EBD4339D9	TCGA-FK-A3SD-01A-11D-A22D-08	HG19_Broad_variant	TCGA-FK-A3SD	TCGA-THCA	NA	s12739	Broad Institute of MIT and Harvard	Johns Hopkins	United States	NO	T1	N0	Thyroid Papillary Carcinoma - Classical/usual	Stage I	A22D-08	TRUE
13722.58cfa82ee4b0c9d6adf6aebe	58cfa82ee4b0c9d6adf6aebe	G49538.TCGA-06-0190-01A-01D-1491-08.1.filtered.	WGS	G49538.TCGA-06-0190-01A-01D-1491-08.1	G49538.TCGA-06-0190-01A-01D-1491-08.1.bam	73.7	1.9	0.05	58cfa82ee4b0c9d6adf6aebe	G49538.TCGA-06-0190-01A-01D-1491-08.1.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Glioblastoma Multiforme	Aligned reads	TCGA-06-0190-01A	74139255-A635-4C87-814D-3DD04ED630A8	Primary Tumor	Illumina HiSeq	e496b84b-9adf-462a-8d8f-7b336fa12626	Brain	62	5E92A5D5-77A4-401A-ADE3-E01C95302EC0	640AFBF7-7886-4A29-9505-DCF36B611A05	TCGA-06-0190-01A-01D-1491-08	HG19_Broad_variant	TCGA-06-0190	TCGA-GBM	317	s14094	Broad Institute of MIT and Harvard	Henry Ford Hospital	None	NO	Not available	Not available	Untreated primary (de novo) GBM	Not available	1491-08	FALSE
13722.58cfa82ee4b0c9d6adf6aea8	58cfa82ee4b0c9d6adf6aea8	G39020.TCGA-BR-8373-01A-11D-2340-08.3.filtered.	WGS	G39020.TCGA-BR-8373-01A-11D-2340-08.3	G39020.TCGA-BR-8373-01A-11D-2340-08.3.bam	188.7	NA	0.05	58cfa82ee4b0c9d6adf6aea8	G39020.TCGA-BR-8373-01A-11D-2340-08.3.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-BR-8373-01A	60879669-96C2-4710-82E0-0AE9D0E5B242	Primary Tumor	Illumina HiSeq	cbbdb4e0-d400-45ef-bb4f-790b2cc9cb87	Stomach	65	4370B4F3-4FD7-4558-BF59-DAAE486BADC3	1F2A8889-4374-4037-BB56-0F20733380E3	TCGA-BR-8373-01A-11D-2340-08	HG19_Broad_variant	TCGA-BR-8373	TCGA-STAD	NA	s15094	Broad Institute of MIT and Harvard	Asterand	Ukraine	NO	T4a	N1	Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS)	Stage IIIA	2340-08	FALSE
13722.58cfa82ee4b0c9d6adf6aab8	58cfa82ee4b0c9d6adf6aab8	G23079.TCGA_CR_6482_01A_11D_2268_08.2.filtered.	WGS	G23079.TCGA_CR_6482_01A_11D_2268_08.2	G23079.TCGA_CR_6482_01A_11D_2268_08.2.bam	68.7	1.9	0.14	58cfa82ee4b0c9d6adf6aab8	G23079.TCGA_CR_6482_01A_11D_2268_08.2.bam	Alive	MALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CR-6482-01A	468649E7-1525-4B8A-8AB5-DDB27DB5F022	Primary Tumor	Illumina HiSeq	47cd6984-3399-4fc7-a843-09a97b33bf4b	Head and Neck	62	92173F97-B46A-4950-8CD8-6729AB9522C5	7158C9FD-A633-4FEF-AA23-BD285F2A87A8	TCGA-CR-6482-01A-11D-2268-08	HG19_Broad_variant	TCGA-CR-6482	TCGA-HNSC	NA	s15866	Broad Institute of MIT and Harvard	Vanderbilt University	United States	NO	Not available	Not available	Head and Neck Squamous Cell Carcinoma	Not available	2268-08	TRUE
13722.58cfa82ee4b0c9d6adf6aea6	58cfa82ee4b0c9d6adf6aea6	G49537.TCGA-EM-A2OW-01A-11D-A202-08.1.filtered.	WGS	G49537.TCGA-EM-A2OW-01A-11D-A202-08.1	G49537.TCGA-EM-A2OW-01A-11D-A202-08.1.bam	36.94	NA	0.08	58cfa82ee4b0c9d6adf6aea6	G49537.TCGA-EM-A2OW-01A-11D-A202-08.1.bam	Alive	FEMALE	Not available	Not available	Thyroid Carcinoma	Aligned reads	TCGA-EM-A2OW-01A	A65EC434-9AE0-453F-B440-08BF25558FD1	Primary Tumor	Illumina HiSeq	c5097aad-061c-40d4-aa81-a97fe09d13f6	Thyroid	37	4D6A2D9E-EC25-4040-A696-2D8D5D5C392E	17A66D24-DE77-4F2A-A8AD-D2C6A69E7671	TCGA-EM-A2OW-01A-11D-A202-08	HG19_Broad_variant	TCGA-EM-A2OW	TCGA-THCA	NA	s12504	Broad Institute of MIT and Harvard	University Health Network	Canada	NO	T1b	NX	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	Stage I	A202-08	TRUE
13722.58cfa82ee4b0c9d6adf6aebf	58cfa82ee4b0c9d6adf6aebf	G49537.TCGA-DE-A0Y3-01B-11D-A10S-08.2.filtered.	WGS	G49537.TCGA-DE-A0Y3-01B-11D-A10S-08.2	G49537.TCGA-DE-A0Y3-01B-11D-A10S-08.2.bam	60.48	2.03	0.07	58cfa82ee4b0c9d6adf6aebf	G49537.TCGA-DE-A0Y3-01B-11D-A10S-08.2.bam	Alive	FEMALE	ASIAN	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-DE-A0Y3-01B	C31B3ADF-3FC6-4A72-83B0-BBC0F295B5E7	Primary Tumor	Illumina HiSeq	3c0140ae-22a1-4eff-8981-313aa5dd5315	Thyroid	60	3AE03B86-1473-409C-8118-A91A73A36F60	7DFCFE29-3900-4D7B-8067-60C51584B0B1	TCGA-DE-A0Y3-01B-11D-A10S-08	HG19_Broad_variant	TCGA-DE-A0Y3	TCGA-THCA	NA	s12219	Broad Institute of MIT and Harvard	University of North Carolina	United States	NO	T4a	N1b	Thyroid Papillary Carcinoma - Classical/usual	Stage IVC	A10S-08	TRUE
13722.58cfa82ee4b0c9d6adf6aeea	58cfa82ee4b0c9d6adf6aeea	G49537.TCGA-EM-A3FR-01A-11D-A21Z-08.1.filtered.	WGS	G49537.TCGA-EM-A3FR-01A-11D-A21Z-08.1	G49537.TCGA-EM-A3FR-01A-11D-A21Z-08.1.bam	45.93	NA	0.08	58cfa82ee4b0c9d6adf6aeea	G49537.TCGA-EM-A3FR-01A-11D-A21Z-08.1.bam	Alive	FEMALE	Not available	Not available	Thyroid Carcinoma	Aligned reads	TCGA-EM-A3FR-01A	2B84CFBC-7CF6-4CB1-A1E3-BA85DAFB89F4	Primary Tumor	Illumina HiSeq	edb95f67-9483-47e8-9b1f-0aad36f1a1ac	Thyroid	55	319E3498-D5FB-4142-A09F-ABA779DBC094	4BAE2F08-DA75-4991-ACB8-5BA9912F9131	TCGA-EM-A3FR-01A-11D-A21Z-08	HG19_Broad_variant	TCGA-EM-A3FR	TCGA-THCA	NA	s11983	Broad Institute of MIT and Harvard	University Health Network	Canada	NO	T2	N1a	Thyroid Papillary Carcinoma - Classical/usual	Stage III	A21Z-08	TRUE
13722.58cfa82ee4b0c9d6adf6af26	58cfa82ee4b0c9d6adf6af26	G48125.TCGA-24-1562-01A-01D-A312-08.2.filtered.	WGS	G48125.TCGA-24-1562-01A-01D-A312-08.2	G48125.TCGA-24-1562-01A-01D-A312-08.2.bam	222.67	1.9	0.07	58cfa82ee4b0c9d6adf6af26	G48125.TCGA-24-1562-01A-01D-A312-08.2.bam	Dead	FEMALE	WHITE	Not available	Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-24-1562-01A	4C18D9CF-4AF4-4A86-8B1C-F78795FBBD7E	Primary Tumor	Illumina HiSeq	b0fd1893-f409-4444-b014-3667fdc22720	Ovary	67	A323F2F5-B250-40A6-A318-084A3933E829	E9D98643-01EE-40C3-A617-E004559625CD	TCGA-24-1562-01A-01D-A312-08	HG19_Broad_variant	TCGA-24-1562	TCGA-OV	1384	s18022	Broad Institute of MIT and Harvard	Washington University	None	NO	Not available	Not available	Serous Cystadenocarcinoma	Not available	A312-08	TRUE
13722.58cfa82ee4b0c9d6adf6af2a	58cfa82ee4b0c9d6adf6af2a	G39020.TCGA-HU-8608-01A-11D-2394-08.2.filtered.	WGS	G39020.TCGA-HU-8608-01A-11D-2394-08.2	G39020.TCGA-HU-8608-01A-11D-2394-08.2.bam	200	NA	0.05	58cfa82ee4b0c9d6adf6af2a	G39020.TCGA-HU-8608-01A-11D-2394-08.2.bam	Alive	MALE	ASIAN	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-HU-8608-01A	C6316FB5-99A7-4ADF-832F-DCE44DDCD3AA	Primary Tumor	Illumina HiSeq	58876087-e158-4469-af68-c91fe264ca8e	Stomach	70	E70FE3AD-F9FA-4097-B472-86606C241D26	A2EE5DDE-4342-4E78-88C5-3C9A8E10CBF5	TCGA-HU-8608-01A-11D-2394-08	HG19_Broad_variant	TCGA-HU-8608	TCGA-STAD	NA	s15298	Broad Institute of MIT and Harvard	National Cancer Center Korea	Korea South	NO	T4a	N2	Stomach  Adenocarcinoma  Diffuse Type	Stage IIIB	2394-08	TRUE
13722.58cfa82ee4b0c9d6adf6af4a	58cfa82ee4b0c9d6adf6af4a	G47088.TCGA-66-2793-01A-01D-1267-08.1.filtered.	WGS	G47088.TCGA-66-2793-01A-01D-1267-08.1	G47088.TCGA-66-2793-01A-01D-1267-08.1.bam	195.33	1.9	0.16	58cfa82ee4b0c9d6adf6af4a	G47088.TCGA-66-2793-01A-01D-1267-08.1.bam	Dead	MALE	Not available	Not available	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-66-2793-01A	9AF6ED4E-8CDC-4F49-84E9-BA1053B5B3CA	Primary Tumor	Illumina HiSeq	ca861e94-4779-4f5f-b97c-4310ed2d7702	Lung	68	DAA128EB-BF5A-4C2C-A7DC-E6E06B6AEB85	7DC5F8BA-0080-43D3-8426-BD527A970761	TCGA-66-2793-01A-01D-1267-08	HG19_Broad_variant	TCGA-66-2793	TCGA-LUSC	306	s10158	Broad Institute of MIT and Harvard	Indivumed	Germany	NO	T4	N1	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage IIIB	1267-08	FALSE
13722.58cfa82ee4b0c9d6adf6af1c	58cfa82ee4b0c9d6adf6af1c	G39020.TCGA-FP-7998-01A-11D-2201-08.2.filtered.	WGS	G39020.TCGA-FP-7998-01A-11D-2201-08.2	G39020.TCGA-FP-7998-01A-11D-2201-08.2.bam	278.7	NA	0.05	58cfa82ee4b0c9d6adf6af1c	G39020.TCGA-FP-7998-01A-11D-2201-08.2.bam	Alive	MALE	WHITE	HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-FP-7998-01A	B2E2D35C-7A79-4165-97A5-82D5C37D94F2	Primary Tumor	Illumina HiSeq	d124dc46-96b0-4101-b8a6-3e4ebf4862c9	Stomach	77	0A95BD32-539E-43F3-9694-A7D033A6FA84	172C9864-C26D-4E9B-947A-E8CE761E996D	TCGA-FP-7998-01A-11D-2201-08	HG19_Broad_variant	TCGA-FP-7998	TCGA-STAD	NA	s15369	Broad Institute of MIT and Harvard	International Genomics Consortium	United States	NO	T4a	N3a	Stomach  Adenocarcinoma  Diffuse Type	Stage IIIC	2201-08	FALSE
13722.58cfa82ee4b0c9d6adf6af4c	58cfa82ee4b0c9d6adf6af4c	G47088.TCGA-18-4721-01A-01D-1441-08.2.filtered.	WGS	G47088.TCGA-18-4721-01A-01D-1441-08.2	G47088.TCGA-18-4721-01A-01D-1441-08.2.bam	305.7	1.9	0.05	58cfa82ee4b0c9d6adf6af4c	G47088.TCGA-18-4721-01A-01D-1441-08.2.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-18-4721-01A	19F0CB8C-2E57-4310-967F-A9890F1605DB	Primary Tumor	Illumina HiSeq	cc99a2ed-feab-46b5-86eb-27fa81408f7c	Lung	74	1BAC4FF6-E35B-40F6-BBE4-705AB672D102	D2AB2555-7288-47A4-A80C-BF62D65B67B8	TCGA-18-4721-01A-01D-1441-08	HG19_Broad_variant	TCGA-18-4721	TCGA-LUSC	NA	s10078	Broad Institute of MIT and Harvard	Princess Margaret Hospital (Canada)	Canada	NO	T1	N0	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage IA	1441-08	FALSE
13722.58cfa82ee4b0c9d6adf6af7e	58cfa82ee4b0c9d6adf6af7e	G48125.TCGA-25-1632-01A-01D-A312-08.2.filtered.	WGS	G48125.TCGA-25-1632-01A-01D-A312-08.2	G48125.TCGA-25-1632-01A-01D-A312-08.2.bam	432.97	1.9	0.08	58cfa82ee4b0c9d6adf6af7e	G48125.TCGA-25-1632-01A-01D-A312-08.2.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-25-1632-01A	C435627C-159D-4A6D-A819-30ABAC24BF4D	Primary Tumor	Illumina HiSeq	541a0820-9b52-430b-9fca-5eaaeb06eb4a	Ovary	68	ED9C97D8-4DF2-4ED3-B455-4955D72901A8	FF3FE4A3-7D19-4D4D-81B6-AAA41BA5BF39	TCGA-25-1632-01A-01D-A312-08	HG19_Broad_variant	TCGA-25-1632	TCGA-OV	1799	s17406	Broad Institute of MIT and Harvard	Mayo Clinic - Rochester	None	NO	Not available	Not available	Serous Cystadenocarcinoma	Not available	A312-08	TRUE
13722.58cfa82ee4b0c9d6adf6af6c	58cfa82ee4b0c9d6adf6af6c	G48125.TCGA-13-0906-01A-01D-A312-08.2.filtered.	WGS	G48125.TCGA-13-0906-01A-01D-A312-08.2	G48125.TCGA-13-0906-01A-01D-A312-08.2.bam	35.67	1.9	0.08	58cfa82ee4b0c9d6adf6af6c	G48125.TCGA-13-0906-01A-01D-A312-08.2.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-13-0906-01A	E43D3769-E25F-4FB7-9080-EA26DEFAF094	Primary Tumor	Illumina HiSeq	aee22c2b-6ab3-4982-b343-b10b89c4b98b	Ovary	50	A0C48680-3CAF-49BD-B495-C9FD3A9CBE76	42AF8F74-FD4B-486D-BC11-DB53CC471D62	TCGA-13-0906-01A-01D-A312-08	HG19_Broad_variant	TCGA-13-0906	TCGA-OV	NA	s17760	Broad Institute of MIT and Harvard	Memorial Sloan Kettering	None	NO	Not available	Not available	Serous Cystadenocarcinoma	Not available	A312-08	TRUE
13722.58cfa82ee4b0c9d6adf6af68	58cfa82ee4b0c9d6adf6af68	G47088.TCGA-22-5492-01A-01D-1632-08.1.filtered.	WGS	G47088.TCGA-22-5492-01A-01D-1632-08.1	G47088.TCGA-22-5492-01A-01D-1632-08.1.bam	871.7	1.9	0.05	58cfa82ee4b0c9d6adf6af68	G47088.TCGA-22-5492-01A-01D-1632-08.1.bam	Dead	FEMALE	Not available	Not available	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-22-5492-01A	422A46B2-A67C-4A7E-923F-9B651CED96F8	Primary Tumor	Illumina HiSeq	ee7c69ad-64c9-44bd-8856-35ef192a2b61	Lung	73	8A0B8A54-D4F7-4911-A692-6731D089EBA2	ABC94013-71F5-4AC6-88A4-01B4EF9F9D2F	TCGA-22-5492-01A-01D-1632-08	HG19_Broad_variant	TCGA-22-5492	TCGA-LUSC	506	s10253	Broad Institute of MIT and Harvard	Mayo Clinic - Rochester	United States	NO	T2a	N2	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage IIIA	1632-08	FALSE
13722.58cfa82ee4b0c9d6adf6afb0	58cfa82ee4b0c9d6adf6afb0	G48125.TCGA-24-1544-01A-01D-A312-08.2.filtered.	WGS	G48125.TCGA-24-1544-01A-01D-A312-08.2	G48125.TCGA-24-1544-01A-01D-A312-08.2.bam	141.97	1.9	0.08	58cfa82ee4b0c9d6adf6afb0	G48125.TCGA-24-1544-01A-01D-A312-08.2.bam	Dead	FEMALE	BLACK OR AFRICAN AMERICAN	Not available	Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-24-1544-01A	21F6BF91-DFC6-4A59-8B76-88A0F95C7B47	Primary Tumor	Illumina HiSeq	d293d826-e945-45a9-8e15-cc375fcf4063	Ovary	71	CF7B9151-6479-41AF-986C-D9DB10E33CA6	052665D1-AB75-4F40-BE5A-B88154C8BEED	TCGA-24-1544-01A-01D-A312-08	HG19_Broad_variant	TCGA-24-1544	TCGA-OV	820	s17761	Broad Institute of MIT and Harvard	Washington University	None	NO	Not available	Not available	Serous Cystadenocarcinoma	Not available	A312-08	TRUE
13722.58cfa82fe4b0c9d6adf6b5fe	58cfa82fe4b0c9d6adf6b5fe	TCGA-36-1574-01A-01D-A324-10_wgs_Illumina.filtered.	WGS	TCGA-36-1574-01A-01D-A324-10_wgs_Illumina	TCGA-36-1574-01A-01D-A324-10_wgs_Illumina.bam	475.97	1.9	0.08	58cfa82fe4b0c9d6adf6b5fe	TCGA-36-1574-01A-01D-A324-10_wgs_Illumina.bam	Alive	FEMALE	ASIAN	Not available	Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-36-1574-01A	EEB9D147-608D-4692-8ADF-2F601D23A8FF	Primary Tumor	Illumina HiSeq	e3ba53fc-a70c-4bd4-8dc4-60969af737fa	Ovary	48	353B6C00-EBFE-4650-8379-F46C8FE3E9CF	80F02AEC-C07A-4BCB-B547-E60F8C33A7B1	TCGA-36-1574-01A-01D-A324-10	GRCh37-lite	TCGA-36-1574	TCGA-OV	NA	s17538	Baylor College of Medicine	BC Cancer Agency	None	NO	Not available	Not available	Serous Cystadenocarcinoma	Not available	A324-10	TRUE
13722.58cfa82ee4b0c9d6adf6affa	58cfa82ee4b0c9d6adf6affa	G48125.TCGA-13-0727-01A-01D-A312-08.2.filtered.	WGS	G48125.TCGA-13-0727-01A-01D-A312-08.2	G48125.TCGA-13-0727-01A-01D-A312-08.2.bam	36.64	1.9	0.08	58cfa82ee4b0c9d6adf6affa	G48125.TCGA-13-0727-01A-01D-A312-08.2.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-13-0727-01A	90F4B65C-CFD4-4066-A5B9-842885C172E2	Primary Tumor	Illumina HiSeq	e58e09a0-fb52-490e-baf9-19502ff4232d	Ovary	71	6FCD7BB8-6CB0-4797-A5B5-D3EC4911A279	16DF7888-2480-4394-8856-D57A6EF371D2	TCGA-13-0727-01A-01D-A312-08	HG19_Broad_variant	TCGA-13-0727	TCGA-OV	462	s17116	Broad Institute of MIT and Harvard	Memorial Sloan Kettering	None	NO	Not available	Not available	Serous Cystadenocarcinoma	Not available	A312-08	TRUE
13722.58cfa82fe4b0c9d6adf6b8d8	58cfa82fe4b0c9d6adf6b8d8	TCGA-A6-6781-01A-22D-1924-10_wgs_Illumina.filtered.	WGS	TCGA-A6-6781-01A-22D-1924-10_wgs_Illumina	TCGA-A6-6781-01A-22D-1924-10_wgs_Illumina.bam	190.3	1.9	0.05	58cfa82fe4b0c9d6adf6b8d8	TCGA-A6-6781-01A-22D-1924-10_wgs_Illumina.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Colon Adenocarcinoma	Aligned reads	TCGA-A6-6781-01A	B54865B6-824E-4163-B759-21A6EACC98CE	Primary Tumor	Illumina HiSeq	bee0f5f3-5654-4349-b3dd-afe0b89cc488	Colorectal	43	F1B2CA40-F20A-42DE-ABA2-4F730D7CCC09	2182CE2C-5941-4B65-9419-FC7966D5E6D5	TCGA-A6-6781-01A-22D-1924-10	GRCh37-lite	TCGA-A6-6781	TCGA-COAD	NA	s13354	Baylor College of Medicine	Christiana Healthcare	United States	NO	T4b	N1b	Colon Mucinous Adenocarcinoma	Stage IIIC	1924-10	FALSE
13722.58cfa82fe4b0c9d6adf6b961	58cfa82fe4b0c9d6adf6b961	TCGA-AA-3529-01A-02D-1554-10_wgs_Illumina.filtered.	WGS	TCGA-AA-3529-01A-02D-1554-10_wgs_Illumina	TCGA-AA-3529-01A-02D-1554-10_wgs_Illumina.bam	109.29	1.9	0.05	58cfa82fe4b0c9d6adf6b961	TCGA-AA-3529-01A-02D-1554-10_wgs_Illumina.bam	Dead	FEMALE	Not available	Not available	Colon Adenocarcinoma	Aligned reads	TCGA-AA-3529-01A	BFB07784-693B-4C25-874E-4AD6E04A5D46	Primary Tumor	Illumina HiSeq	510f1886-9023-432a-bc19-46aee37ea8a4	Colorectal	78	B083E3CB-0AF1-44EA-854D-85FD99B75AD5	9E5F0A23-E184-4611-B42B-E882DCF23ACD	TCGA-AA-3529-01A-02D-1554-10	GRCh37-lite	TCGA-AA-3529	TCGA-COAD	0	s12863	Baylor College of Medicine	Indivumed	Germany	NO	T3	N2	Colon Adenocarcinoma	Stage IIIC	1554-10	FALSE
13722.58cfa82fe4b0c9d6adf6b9e0	58cfa82fe4b0c9d6adf6b9e0	TCGA-AA-3977-01A-01D-1024-10_wgs_Illumina.filtered.	WGS	TCGA-AA-3977-01A-01D-1024-10_wgs_Illumina	TCGA-AA-3977-01A-01D-1024-10_wgs_Illumina.bam	540	1.9	0.15	58cfa82fe4b0c9d6adf6b9e0	TCGA-AA-3977-01A-01D-1024-10_wgs_Illumina.bam	Alive	MALE	Not available	Not available	Colon Adenocarcinoma	Aligned reads	TCGA-AA-3977-01A	33E989B9-FAC4-47D8-B429-269044AC772A	Primary Tumor	Illumina HiSeq	34a6b8b6-5a24-4e03-9f20-8b51e27033c5	Colorectal	65	56DD63CB-CF0A-48C3-BCCC-C5094F8D8AC0	93FF786E-0165-4B02-8D27-806D422E93FC	TCGA-AA-3977-01A-01D-1024-10	GRCh37-lite	TCGA-AA-3977	TCGA-COAD	NA	s13028	Baylor College of Medicine	Indivumed	Germany	NO	T2	N0	Colon Adenocarcinoma	Not available	1024-10	FALSE
13722.58cfa82fe4b0c9d6adf6b920	58cfa82fe4b0c9d6adf6b920	TCGA-A4-A48D-01A-11D-A25F-10_wgs_Illumina.filtered.	WGS	TCGA-A4-A48D-01A-11D-A25F-10_wgs_Illumina	TCGA-A4-A48D-01A-11D-A25F-10_wgs_Illumina.bam	21	NA	0.08	58cfa82fe4b0c9d6adf6b920	TCGA-A4-A48D-01A-11D-A25F-10_wgs_Illumina.bam	Alive	MALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Kidney Renal Papillary Cell Carcinoma	Aligned reads	TCGA-A4-A48D-01A	925AE8FF-3200-4564-BE76-94DB0984B027	Primary Tumor	Illumina HiSeq	ca65f407-1de9-4171-8ae5-67e4d85f5beb	Kidney	84	4DDC37D4-35B8-4A5D-BBF1-6DBF0548852B	5ECC88F7-8391-4168-AF11-07A6BF9B3652	TCGA-A4-A48D-01A-11D-A25F-10	GRCh37-lite	TCGA-A4-A48D	TCGA-KIRP	NA	s11850	Baylor College of Medicine	International Genomics Consortium	United States	NO	T1b	NX	Kidney Papillary Renal Cell Carcinoma	Stage I	A25F-10	TRUE
13722.58cfa830e4b0c9d6adf6ba9e	58cfa830e4b0c9d6adf6ba9e	TCGA-AA-A01X-01A-21D-A17O-10_wgs_Illumina.filtered.	WGS	TCGA-AA-A01X-01A-21D-A17O-10_wgs_Illumina	TCGA-AA-A01X-01A-21D-A17O-10_wgs_Illumina.bam	71	1.92	0.07	58cfa830e4b0c9d6adf6ba9e	TCGA-AA-A01X-01A-21D-A17O-10_wgs_Illumina.bam	Alive	FEMALE	Not available	Not available	Colon Adenocarcinoma	Aligned reads	TCGA-AA-A01X-01A	2E386E48-B99B-4806-A3E3-081D72A606E7	Primary Tumor	Illumina HiSeq	4b96a6ce-adbd-45b8-9c53-ea1850f0731c	Colorectal	80	0225A318-9BB2-4340-A34A-99FCBC563E0A	B7F2E85A-3C6A-48B7-8A4F-2DEC1D85359D	TCGA-AA-A01X-01A-21D-A17O-10	GRCh37-lite	TCGA-AA-A01X	TCGA-COAD	NA	s12880	Baylor College of Medicine	Indivumed	Germany	NO	T2	N1	Colon Adenocarcinoma	Stage III	A17O-10	TRUE
13722.58cfa830e4b0c9d6adf6bad6	58cfa830e4b0c9d6adf6bad6	TCGA-A6-6141-01A-11D-1771-10_wgs_Illumina.filtered.	WGS	TCGA-A6-6141-01A-11D-1771-10_wgs_Illumina	TCGA-A6-6141-01A-11D-1771-10_wgs_Illumina.bam	315.4	1.9	0.05	58cfa830e4b0c9d6adf6bad6	TCGA-A6-6141-01A-11D-1771-10_wgs_Illumina.bam	Alive	MALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Colon Adenocarcinoma	Aligned reads	TCGA-A6-6141-01A	58FACEDB-FCB8-4ECF-8338-2BFA4947ACEF	Primary Tumor	Illumina HiSeq	6fd83764-dbd4-43ec-bab9-c2950c46cf59	Colorectal	31	D67FC406-7974-433E-896D-57197ECED52B	00AA769D-622C-433E-8A8A-63FB5C41EA42	TCGA-A6-6141-01A-11D-1771-10	GRCh37-lite	TCGA-A6-6141	TCGA-COAD	NA	s13355	Baylor College of Medicine	Christiana Healthcare	United States	NO	T3	N0	Colon Adenocarcinoma	Stage IIA	1771-10	FALSE
13722.58cfa82fe4b0c9d6adf6ba26	58cfa82fe4b0c9d6adf6ba26	TCGA-A3-3370-01A-02D-2099-10_Illumina.filtered.	WGS	TCGA-A3-3370-01A-02D-2099-10_Illumina	TCGA-A3-3370-01A-02D-2099-10_Illumina.bam	152.4	1.9	0.14	58cfa82fe4b0c9d6adf6ba26	TCGA-A3-3370-01A-02D-2099-10_Illumina.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-A3-3370-01A	9F632FC3-2241-469A-A14A-CD537350155F	Primary Tumor	Illumina HiSeq	2bf569a0-5698-4304-b006-f61284e72aef	Kidney	48	1B2DF3FD-183C-4099-A387-5908C8B44F57	D7F1DB09-8BA0-4B76-BCD2-01C14165F0D5	TCGA-A3-3370-01A-02D-2099-10	GRCh37-lite	TCGA-A3-3370	TCGA-KIRC	NA	s9563	Baylor College of Medicine	International Genomics Consortium	United States	NO	T1b	N0	Kidney Clear Cell Renal Carcinoma	Stage I	2099-10	FALSE
13722.58cfa830e4b0c9d6adf6bb79	58cfa830e4b0c9d6adf6bb79	TCGA-AA-3685-01A-02D-1981-10_wgs_Illumina.filtered.	WGS	TCGA-AA-3685-01A-02D-1981-10_wgs_Illumina	TCGA-AA-3685-01A-02D-1981-10_wgs_Illumina.bam	417.96	1.9	0.15	58cfa830e4b0c9d6adf6bb79	TCGA-AA-3685-01A-02D-1981-10_wgs_Illumina.bam	Alive	MALE	Not available	Not available	Colon Adenocarcinoma	Aligned reads	TCGA-AA-3685-01A	DCA004BF-9C14-45A1-B186-AB3759F6C7FE	Primary Tumor	Illumina HiSeq	e8516b3d-fcff-4f10-94a4-993b059ac4aa	Colorectal	69	A2DD99BF-3A02-42CD-9AA8-80A018584EE6	85E29049-A5E8-49FA-A576-E113C7B2C2E3	TCGA-AA-3685-01A-02D-1981-10	GRCh37-lite	TCGA-AA-3685	TCGA-COAD	NA	s13515	Baylor College of Medicine	Indivumed	Germany	NO	T3	N0	Colon Adenocarcinoma	Stage II	1981-10	FALSE
13722.58cfa830e4b0c9d6adf6bb82	58cfa830e4b0c9d6adf6bb82	TCGA-A3-3308-01A-01D-2094-10_Illumina.filtered.	WGS	TCGA-A3-3308-01A-01D-2094-10_Illumina	TCGA-A3-3308-01A-01D-2094-10_Illumina.bam	591.9	1.9	0.17	58cfa830e4b0c9d6adf6bb82	TCGA-A3-3308-01A-01D-2094-10_Illumina.bam	Alive	FEMALE	WHITE	Not available	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-A3-3308-01A	3CBCA837-F5A7-4A87-8F02-C59EAC232D5A	Primary Tumor	Illumina HiSeq	ff863b55-b221-4580-b322-d2f1c9137279	Kidney	77	0B935ADB-0E19-4FCC-9BB0-B9D95872BCEF	68B7FDB1-22B5-4152-9E69-A41151640CD8	TCGA-A3-3308-01A-01D-2094-10	GRCh37-lite	TCGA-A3-3308	TCGA-KIRC	NA	s9000	Baylor College of Medicine	International Genomics Consortium	None	NO	T3b	N0	Kidney Clear Cell Renal Carcinoma	Stage III	2094-10	FALSE
13722.58cfa830e4b0c9d6adf6bbc0	58cfa830e4b0c9d6adf6bbc0	TCGA-AG-A002-01A-01D-A183-10_wgs_Illumina.filtered.	WGS	TCGA-AG-A002-01A-01D-A183-10_wgs_Illumina	TCGA-AG-A002-01A-01D-A183-10_wgs_Illumina.bam	228.5	1.72	0.08	58cfa830e4b0c9d6adf6bbc0	TCGA-AG-A002-01A-01D-A183-10_wgs_Illumina.bam	Alive	MALE	Not available	Not available	Rectum Adenocarcinoma	Aligned reads	TCGA-AG-A002-01A	CB005C69-7301-41CE-B534-C9751F1436C5	Primary Tumor	Illumina HiSeq	23b2dbcf-d83f-448a-8e6a-e3395344bc03	Colorectal	35	B918B56C-5C78-4CEE-85A7-7C88501E88AD	567C8810-DAEF-4FE7-AA45-E70DB20B9F01	TCGA-AG-A002-01A-01D-A183-10	GRCh37-lite	TCGA-AG-A002	TCGA-READ	NA	s2313	Baylor College of Medicine	Indivumed	Germany	NO	T2	N0	Rectal Adenocarcinoma	Stage I	A183-10	TRUE
13722.58cfa830e4b0c9d6adf6bc0e	58cfa830e4b0c9d6adf6bc0e	TCGA-AG-4008-01A-01D-1989-10_wgs_Illumina.filtered.	WGS	TCGA-AG-4008-01A-01D-1989-10_wgs_Illumina	TCGA-AG-4008-01A-01D-1989-10_wgs_Illumina.bam	624.89	1.9	0.14	58cfa830e4b0c9d6adf6bc0e	TCGA-AG-4008-01A-01D-1989-10_wgs_Illumina.bam	Alive	MALE	Not available	Not available	Rectum Adenocarcinoma	Aligned reads	TCGA-AG-4008-01A	72802851-9340-4C5F-A90B-23B7AFD7577A	Primary Tumor	Illumina HiSeq	673cc168-5c3a-4eec-b299-8de319725cc6	Colorectal	63	D803F092-3340-485D-9964-D6554D210E2E	428C100F-D7D0-4860-A8FC-2BAE6A4BBA95	TCGA-AG-4008-01A-01D-1989-10	GRCh37-lite	TCGA-AG-4008	TCGA-READ	NA	s1990	Baylor College of Medicine	Indivumed	Germany	NO	T3	N0	Rectal Adenocarcinoma	Stage IIA	1989-10	TRUE
13722.58cfa830e4b0c9d6adf6ba74	58cfa830e4b0c9d6adf6ba74	TCGA-AA-3555-01A-01D-0959-10_wgs_Illumina.filtered.	WGS	TCGA-AA-3555-01A-01D-0959-10_wgs_Illumina	TCGA-AA-3555-01A-01D-0959-10_wgs_Illumina.bam	949.56	1.9	0.13	58cfa830e4b0c9d6adf6ba74	TCGA-AA-3555-01A-01D-0959-10_wgs_Illumina.bam	Alive	FEMALE	Not available	Not available	Colon Adenocarcinoma	Aligned reads	TCGA-AA-3555-01A	36EAF209-C332-4321-B6AA-51A3368ECD79	Primary Tumor	Illumina HiSeq	6843fb20-8f01-4121-9e2c-823e5ce9da98	Colorectal	81	9F9961F0-4EE2-4471-AE4A-A0122D630A28	154F80BD-984C-4792-BB89-20C4DA0C08E0	TCGA-AA-3555-01A-01D-0959-10	GRCh37-lite	TCGA-AA-3555	TCGA-COAD	NA	s13182	Baylor College of Medicine	Indivumed	Germany	NO	T3	N0	Colon Mucinous Adenocarcinoma	Stage IIA	0959-10	FALSE
13722.58cfa830e4b0c9d6adf6bcb5	58cfa830e4b0c9d6adf6bcb5	TCGA-AZ-6601-01A-11D-1771-10_wgs_Illumina.filtered.	WGS	TCGA-AZ-6601-01A-11D-1771-10_wgs_Illumina	TCGA-AZ-6601-01A-11D-1771-10_wgs_Illumina.bam	286.4	1.9	0.05	58cfa830e4b0c9d6adf6bcb5	TCGA-AZ-6601-01A-11D-1771-10_wgs_Illumina.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Colon Adenocarcinoma	Aligned reads	TCGA-AZ-6601-01A	7AD0617E-BC4A-4869-8419-744F04D9B7A3	Primary Tumor	Illumina HiSeq	ae0bedfc-1ef9-4999-8ff2-c0eb8e421ef3	Colorectal	68	DC23BAFB-2CFB-4C1B-9E66-B9CAB22AE855	34348062-073E-40AA-9CA0-4B0CDAAF7177	TCGA-AZ-6601-01A-11D-1771-10	GRCh37-lite	TCGA-AZ-6601	TCGA-COAD	3042	s13215	Baylor College of Medicine	University of Pittsburgh	United States	NO	T3	N0	Colon Adenocarcinoma	Stage II	1771-10	FALSE
13722.58cfa830e4b0c9d6adf6bc64	58cfa830e4b0c9d6adf6bc64	TCGA-AF-3913-01A-02D-1459-10_wgs_Illumina.filtered.	WGS	TCGA-AF-3913-01A-02D-1459-10_wgs_Illumina	TCGA-AF-3913-01A-02D-1459-10_wgs_Illumina.bam	452.29	1.8	0.05	58cfa830e4b0c9d6adf6bc64	TCGA-AF-3913-01A-02D-1459-10_wgs_Illumina.bam	Dead	MALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Rectum Adenocarcinoma	Aligned reads	TCGA-AF-3913-01A	03A9DD9D-62AE-4ACD-9272-389274858F3D	Primary Tumor	Illumina HiSeq	13fc1d5a-7c67-4646-953d-ad0f22571017	Colorectal	60	B01C6CD1-68DA-437F-90E4-9A645E8F3470	2B2C1A0B-EAC3-4A6A-9C19-7141CBD573A7	TCGA-AF-3913-01A-02D-1459-10	GRCh37-lite	TCGA-AF-3913	TCGA-READ	316	s2134	Baylor College of Medicine	Christiana Healthcare	None	NO	T3	N1	Rectal Adenocarcinoma	Stage IV	1459-10	FALSE
13722.58cfa830e4b0c9d6adf6bcfc	58cfa830e4b0c9d6adf6bcfc	TCGA-AD-6964-01A-11D-1924-10_wgs_Illumina.filtered.	WGS	TCGA-AD-6964-01A-11D-1924-10_wgs_Illumina	TCGA-AD-6964-01A-11D-1924-10_wgs_Illumina.bam	177.7	NA	0.05	58cfa830e4b0c9d6adf6bcfc	TCGA-AD-6964-01A-11D-1924-10_wgs_Illumina.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Colon Adenocarcinoma	Aligned reads	TCGA-AD-6964-01A	5E7074A6-5011-4DC5-950C-41365DBC6D09	Primary Tumor	Illumina HiSeq	67abf892-45e8-4468-a1fd-8446401b3f55	Colorectal	58	4D16E41A-B100-4080-A759-1F62E54C1C91	42D20028-0DDC-4DAC-9F05-D674F8915F21	TCGA-AD-6964-01A-11D-1924-10	GRCh37-lite	TCGA-AD-6964	TCGA-COAD	NA	s13536	Baylor College of Medicine	International Genomics Consortium	United States	NO	T4a	N2b	Colon Adenocarcinoma	Not available	1924-10	FALSE
13722.58cfa830e4b0c9d6adf6bd38	58cfa830e4b0c9d6adf6bd38	TCGA-AA-A00N-01A-02D-A17O-10_wgs_Illumina.filtered.	WGS	TCGA-AA-A00N-01A-02D-A17O-10_wgs_Illumina	TCGA-AA-A00N-01A-02D-A17O-10_wgs_Illumina.bam	149.57	1.79	0.08	58cfa830e4b0c9d6adf6bd38	TCGA-AA-A00N-01A-02D-A17O-10_wgs_Illumina.bam	Dead	MALE	Not available	Not available	Colon Adenocarcinoma	Aligned reads	TCGA-AA-A00N-01A	E457344D-76FB-46BF-B362-61A6E811D131	Primary Tumor	Illumina HiSeq	d83f0731-9567-4d26-83ed-42e1c4e01ef0	Colorectal	75	D52F3D05-1850-473E-8E1E-AB2B4F88AF2A	6CA5C1BB-275B-4D05-948A-3C6C7D03FAB9	TCGA-AA-A00N-01A-02D-A17O-10	GRCh37-lite	TCGA-AA-A00N	TCGA-COAD	122	s13516	Baylor College of Medicine	Indivumed	Germany	NO	T4	N0	Colon Mucinous Adenocarcinoma	Stage IIB	A17O-10	TRUE
13722.58cfa830e4b0c9d6adf6c046	58cfa830e4b0c9d6adf6c046	TCGA-B2-4102-01A-02D-2095-10_wgs_Illumina.filtered.	WGS	TCGA-B2-4102-01A-02D-2095-10_wgs_Illumina	TCGA-B2-4102-01A-02D-2095-10_wgs_Illumina.bam	142.77	1.9	0.16	58cfa830e4b0c9d6adf6c046	TCGA-B2-4102-01A-02D-2095-10_wgs_Illumina.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-B2-4102-01A	BBBCE1BA-C739-43BA-B9CF-A4F746491AE3	Primary Tumor	Illumina HiSeq	08200438-3da7-446b-99d7-c23e7cbfb2b5	Kidney	61	0A187E9E-FAE3-4B9F-B6ED-23CF0FFCB39E	39C55051-E1BC-4081-962A-17205645DE45	TCGA-B2-4102-01A-02D-2095-10	GRCh37-lite	TCGA-B2-4102	TCGA-KIRC	NA	s9734	Baylor College of Medicine	Christiana Healthcare	None	NO	T1b	NX	Kidney Clear Cell Renal Carcinoma	Stage I	2095-10	FALSE
13722.58cfa830e4b0c9d6adf6c020	58cfa830e4b0c9d6adf6c020	TCGA-B1-A47O-01A-11D-A25F-10_wgs_Illumina.filtered.	WGS	TCGA-B1-A47O-01A-11D-A25F-10_wgs_Illumina	TCGA-B1-A47O-01A-11D-A25F-10_wgs_Illumina.bam	16.46	NA	0.09	58cfa830e4b0c9d6adf6c020	TCGA-B1-A47O-01A-11D-A25F-10_wgs_Illumina.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Papillary Cell Carcinoma	Aligned reads	TCGA-B1-A47O-01A	6A6C1569-1045-4ED3-ACDB-5C45E47614CA	Primary Tumor	Illumina HiSeq	3b1d3bea-7b97-415b-ad61-4c84d3bd88e2	Kidney	54	EBADE9FD-DCE5-4EC9-A483-9F165823D9B6	CA2B9FE2-97E0-4D4F-AFD7-A5ACF638800F	TCGA-B1-A47O-01A-11D-A25F-10	GRCh37-lite	TCGA-B1-A47O	TCGA-KIRP	NA	s11768	Baylor College of Medicine	University of Pittsburgh	United States	NO	T1b	N0	Kidney Papillary Renal Cell Carcinoma	Stage I	A25F-10	TRUE
13722.58cfa830e4b0c9d6adf6c13e	58cfa830e4b0c9d6adf6c13e	TCGA-B9-A44B-01A-11D-A25F-10_wgs_Illumina.filtered.	WGS	TCGA-B9-A44B-01A-11D-A25F-10_wgs_Illumina	TCGA-B9-A44B-01A-11D-A25F-10_wgs_Illumina.bam	19.16	NA	0.08	58cfa830e4b0c9d6adf6c13e	TCGA-B9-A44B-01A-11D-A25F-10_wgs_Illumina.bam	Alive	MALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Kidney Renal Papillary Cell Carcinoma	Aligned reads	TCGA-B9-A44B-01A	B809C2F2-185C-496A-A1D4-589294443A1D	Primary Tumor	Illumina HiSeq	148c4a68-bab6-4ff6-bcd7-fc69c33bea94	Kidney	70	07C08E8F-4DCA-42E4-9954-C62C32FED225	88E35D25-D98D-4576-8EBE-1CD74010ECD8	TCGA-B9-A44B-01A-11D-A25F-10	GRCh37-lite	TCGA-B9-A44B	TCGA-KIRP	NA	s11860	Baylor College of Medicine	UNC	United States	NO	T3b	NX	Kidney Papillary Renal Cell Carcinoma	Stage III	A25F-10	TRUE
13722.58cfa82ee4b0c9d6adf6aeee	58cfa82ee4b0c9d6adf6aeee	G49537.TCGA-FE-A233-01A-11D-A33C-08.1.filtered.	WGS	G49537.TCGA-FE-A233-01A-11D-A33C-08.1	G49537.TCGA-FE-A233-01A-11D-A33C-08.1.bam	92.7	2.05	0.09	58cfa82ee4b0c9d6adf6aeee	G49537.TCGA-FE-A233-01A-11D-A33C-08.1.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-FE-A233-01A	E70FEAFD-1390-4F4C-A635-DA65C1A7DAEB	Primary Tumor	Illumina HiSeq	d7f3aea8-ea8e-4400-b8b3-cc40582e70cd	Thyroid	18	76A6F76D-F33E-4B4A-B0EE-FB863345F194	473FE833-FCC6-485E-93D2-95E662C3EF53	TCGA-FE-A233-01A-11D-A33C-08	HG19_Broad_variant	TCGA-FE-A233	TCGA-THCA	NA	s12224	Broad Institute of MIT and Harvard	Ohio State University	United States	NO	T2	NX	Thyroid Papillary Carcinoma - Classical/usual	Stage I	A33C-08	FALSE
13722.58cfa831e4b0c9d6adf6c430	58cfa831e4b0c9d6adf6c430	TCGA-CJ-4918-01A-01D-2101-10_Illumina.filtered.	WGS	TCGA-CJ-4918-01A-01D-2101-10_Illumina	TCGA-CJ-4918-01A-01D-2101-10_Illumina.bam	41.4	1.9	0.16	58cfa831e4b0c9d6adf6c430	TCGA-CJ-4918-01A-01D-2101-10_Illumina.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-CJ-4918-01A	267FF78B-BCEB-466E-8582-C560FE227FF0	Primary Tumor	Illumina HiSeq	6b97d11a-5289-440f-a2df-5c10c9cb91fc	Kidney	64	8262BF2A-F944-4101-8E43-51658B580747	81D0D6BB-7319-4B67-BCF7-36DF24E76B43	TCGA-CJ-4918-01A-01D-2101-10	GRCh37-lite	TCGA-CJ-4918	TCGA-KIRC	93	s9305	Baylor College of Medicine	MD Anderson Cancer Center	None	NO	T3a	N0	Kidney Clear Cell Renal Carcinoma	Stage IV	2101-10	FALSE
13722.58cfa831e4b0c9d6adf6c41a	58cfa831e4b0c9d6adf6c41a	TCGA-CJ-4899-01A-01D-2100-10_Illumina.filtered.	WGS	TCGA-CJ-4899-01A-01D-2100-10_Illumina	TCGA-CJ-4899-01A-01D-2100-10_Illumina.bam	109.4	1.9	0.16	58cfa831e4b0c9d6adf6c41a	TCGA-CJ-4899-01A-01D-2100-10_Illumina.bam	Alive	MALE	ASIAN	NOT HISPANIC OR LATINO	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-CJ-4899-01A	900B5F21-E8FB-4A3F-B8E3-EF098716E508	Primary Tumor	Illumina HiSeq	ad992cd4-c4d5-4f87-b721-a2cbdf70f57d	Kidney	42	E2D40747-F751-4CCB-A45C-A60B06046DB1	9C181313-5B4C-41C5-9AD5-A5A86FE609AA	TCGA-CJ-4899-01A-01D-2100-10	GRCh37-lite	TCGA-CJ-4899	TCGA-KIRC	NA	s9568	Baylor College of Medicine	MD Anderson Cancer Center	None	NO	T1b	NX	Kidney Clear Cell Renal Carcinoma	Stage I	2100-10	FALSE
13722.58cfa831e4b0c9d6adf6c608	58cfa831e4b0c9d6adf6c608	TCGA-CN-5365-01A-01D-2276-10_Illumina.filtered.	WGS	TCGA-CN-5365-01A-01D-2276-10_Illumina	TCGA-CN-5365-01A-01D-2276-10_Illumina.bam	305.73	1.9	0.05	58cfa831e4b0c9d6adf6c608	TCGA-CN-5365-01A-01D-2276-10_Illumina.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CN-5365-01A	4CFFEA0B-90A7-4C86-A73F-BB8FECA3ADA7	Primary Tumor	Illumina HiSeq	84352351-1bc3-4c62-93be-29c899ff9811	Head and Neck	38	665D4BFF-603C-497B-816F-C98784665D0F	A0FE80E0-E3AC-485B-8A1A-4C80C101B874	TCGA-CN-5365-01A-01D-2276-10	GRCh37-lite	TCGA-CN-5365	TCGA-HNSC	351	s16033	Baylor College of Medicine	University of Pittsburgh	None	NO	T2	N3	Head and Neck Squamous Cell Carcinoma	Stage IVB	2276-10	TRUE
13722.58cfa831e4b0c9d6adf6c682	58cfa831e4b0c9d6adf6c682	TCGA-CR-5250-01A-01D-2276-10_Illumina.filtered.	WGS	TCGA-CR-5250-01A-01D-2276-10_Illumina	TCGA-CR-5250-01A-01D-2276-10_Illumina.bam	261.73	1.9	0.05	58cfa831e4b0c9d6adf6c682	TCGA-CR-5250-01A-01D-2276-10_Illumina.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CR-5250-01A	9E178D80-FE90-4998-9DAE-726C4BECEEF7	Primary Tumor	Illumina HiSeq	486d7653-48d6-47cc-b04b-362d1b0e485b	Head and Neck	71	13AE9411-E63F-4093-A80E-8B64837C001D	29FC38AA-F367-46A3-A14D-A5F657AD0CAA	TCGA-CR-5250-01A-01D-2276-10	GRCh37-lite	TCGA-CR-5250	TCGA-HNSC	NA	s16039	Baylor College of Medicine	Vanderbilt University	None	NO	TX	NX	Head and Neck Squamous Cell Carcinoma	Not available	2276-10	TRUE
13722.58cfa830e4b0c9d6adf6c2a3	58cfa830e4b0c9d6adf6c2a3	TCGA-B1-A47N-01A-11D-A25F-10_wgs_Illumina.filtered.	WGS	TCGA-B1-A47N-01A-11D-A25F-10_wgs_Illumina	TCGA-B1-A47N-01A-11D-A25F-10_wgs_Illumina.bam	32.02	NA	0.08	58cfa830e4b0c9d6adf6c2a3	TCGA-B1-A47N-01A-11D-A25F-10_wgs_Illumina.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Papillary Cell Carcinoma	Aligned reads	TCGA-B1-A47N-01A	F1EC5A7B-0973-4C38-9908-862196DF9541	Primary Tumor	Illumina HiSeq	57987e56-d118-4f55-98c4-340866fcf3e8	Kidney	62	C5EDE5F5-35D2-4059-9F0C-6736ABC6F899	BD2CC59D-F5CE-46ED-BEB0-4C80B24CBE71	TCGA-B1-A47N-01A-11D-A25F-10	GRCh37-lite	TCGA-B1-A47N	TCGA-KIRP	NA	s11855	Baylor College of Medicine	University of Pittsburgh	United States	NO	T1a	NX	Kidney Papillary Renal Cell Carcinoma	Stage I	A25F-10	TRUE
13722.58cfa831e4b0c9d6adf6c6b2	58cfa831e4b0c9d6adf6c6b2	TCGA-CR-5249-01A-01D-2276-10_wgs_Illumina.filtered.	WGS	TCGA-CR-5249-01A-01D-2276-10_wgs_Illumina	TCGA-CR-5249-01A-01D-2276-10_wgs_Illumina.bam	213.73	1.9	0.05	58cfa831e4b0c9d6adf6c6b2	TCGA-CR-5249-01A-01D-2276-10_wgs_Illumina.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CR-5249-01A	C7DF3466-B9A7-4818-883B-D0CD08483570	Primary Tumor	Illumina HiSeq	cef48339-6b24-4da9-b25d-55a64c71d0dc	Head and Neck	35	6697DD71-5A58-4862-B26E-EA16DCC383F2	C0812962-A345-48B7-AEC0-01336C2D1EED	TCGA-CR-5249-01A-01D-2276-10	GRCh37-lite	TCGA-CR-5249	TCGA-HNSC	NA	s15894	Baylor College of Medicine	Vanderbilt University	None	NO	T2	N0	Head and Neck Squamous Cell Carcinoma	Stage II	2276-10	TRUE
13722.58cfa831e4b0c9d6adf6c456	58cfa831e4b0c9d6adf6c456	TCGA-CA-6717-01A-11D-1835-10_wgs_Illumina.filtered.	WGS	TCGA-CA-6717-01A-11D-1835-10_wgs_Illumina	TCGA-CA-6717-01A-11D-1835-10_wgs_Illumina.bam	201	1.9	0.05	58cfa831e4b0c9d6adf6c456	TCGA-CA-6717-01A-11D-1835-10_wgs_Illumina.bam	Alive	MALE	ASIAN	NOT HISPANIC OR LATINO	Colon Adenocarcinoma	Aligned reads	TCGA-CA-6717-01A	268C01B3-D2CE-44C0-A2FE-EA846A1253CC	Primary Tumor	Illumina HiSeq	da552d40-23e1-469c-9fe7-ff2904a35ebe	Colorectal	57	D412011F-061C-43D6-8FA7-F917DA658AFF	2DF02F2B-9F1C-4249-B3B4-B03079CD97D9	TCGA-CA-6717-01A-11D-1835-10	GRCh37-lite	TCGA-CA-6717	TCGA-COAD	NA	s13038	Baylor College of Medicine	ILSbio	Vietnam	NO	T3	N0	Colon Mucinous Adenocarcinoma	Stage IIA	1835-10	FALSE
13722.58cfa831e4b0c9d6adf6c79a	58cfa831e4b0c9d6adf6c79a	TCGA-CV-7255-01A-11D-2276-10_Illumina.filtered.	WGS	TCGA-CV-7255-01A-11D-2276-10_Illumina	TCGA-CV-7255-01A-11D-2276-10_Illumina.bam	143.73	NA	0.05	58cfa831e4b0c9d6adf6c79a	TCGA-CV-7255-01A-11D-2276-10_Illumina.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-7255-01A	534F85F2-B9EB-45BE-87D5-C3DFFD13D541	Primary Tumor	Illumina HiSeq	7f307e2b-3164-4bb0-aa04-90c538b8bb46	Head and Neck	32	45A42060-1F1C-45FF-9717-9BE2F7FDF3F7	1AFF91A6-1B0F-4575-8F4B-4E064A50B886	TCGA-CV-7255-01A-11D-2276-10	GRCh37-lite	TCGA-CV-7255	TCGA-HNSC	64	s16051	Baylor College of Medicine	MD Anderson Cancer Center	United States	NO	T4a	N0	Head and Neck Squamous Cell Carcinoma	Stage IVA	2276-10	TRUE
13722.58cfa831e4b0c9d6adf6c78f	58cfa831e4b0c9d6adf6c78f	TCGA-CZ-4856-01A-02D-2101-10_Illumina.filtered.	WGS	TCGA-CZ-4856-01A-02D-2101-10_Illumina	TCGA-CZ-4856-01A-02D-2101-10_Illumina.bam	34.73	1.9	0.15	58cfa831e4b0c9d6adf6c78f	TCGA-CZ-4856-01A-02D-2101-10_Illumina.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-CZ-4856-01A	FCECAFA8-8B8B-4AE6-81BC-73ACF05B211A	Primary Tumor	Illumina HiSeq	5cf38428-0ee7-4a06-8f49-c41a19ad6f74	Kidney	62	6F6C9F00-D6E5-452F-BA04-F77B146B780B	9FB40473-74CB-43CB-9A54-C990B8BBDE17	TCGA-CZ-4856-01A-02D-2101-10	GRCh37-lite	TCGA-CZ-4856	TCGA-KIRC	NA	s9453	Baylor College of Medicine	Harvard	None	NO	T1b	N0	Kidney Clear Cell Renal Carcinoma	Stage I	2101-10	FALSE
13722.58cfa831e4b0c9d6adf6c81d	58cfa831e4b0c9d6adf6c81d	TCGA-CV-6433-01A-11D-2276-10_Illumina.filtered.	WGS	TCGA-CV-6433-01A-11D-2276-10_Illumina	TCGA-CV-6433-01A-11D-2276-10_Illumina.bam	207.03	1.9	0.05	58cfa831e4b0c9d6adf6c81d	TCGA-CV-6433-01A-11D-2276-10_Illumina.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-6433-01A	D5EEDFB5-4FA3-4A1E-AD0D-EA550B22A5BA	Primary Tumor	Illumina HiSeq	0fc542ae-619e-45f5-9496-dcf6f31f4c32	Head and Neck	57	47EC5010-4353-493B-AB28-C95BC2CB026C	0E6CA8DC-0F31-4675-95B1-5920576DAEFF	TCGA-CV-6433-01A-11D-2276-10	GRCh37-lite	TCGA-CV-6433	TCGA-HNSC	NA	s15511	Baylor College of Medicine	MD Anderson Cancer Center	United States	NO	T2	N0	Head and Neck Squamous Cell Carcinoma	Stage II	2276-10	TRUE
13722.58cfa831e4b0c9d6adf6c88e	58cfa831e4b0c9d6adf6c88e	TCGA-D5-6540-01A-11D-1719-10_wgs_Illumina.filtered.	WGS	TCGA-D5-6540-01A-11D-1719-10_wgs_Illumina	TCGA-D5-6540-01A-11D-1719-10_wgs_Illumina.bam	473	1.9	0.05	58cfa831e4b0c9d6adf6c88e	TCGA-D5-6540-01A-11D-1719-10_wgs_Illumina.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Colon Adenocarcinoma	Aligned reads	TCGA-D5-6540-01A	B08B5F49-9434-4653-9772-097EC29B2CA3	Primary Tumor	Illumina HiSeq	ea4fb044-493b-4e48-ac28-28ba39b8be21	Colorectal	66	201B6B48-418F-48A3-A568-6E851F85C25E	EC43C4B5-FB72-4A4A-AF03-10C2D05FF159	TCGA-D5-6540-01A-11D-1719-10	GRCh37-lite	TCGA-D5-6540	TCGA-COAD	NA	s13396	Baylor College of Medicine	Greater Poland Cancer Center	Poland	NO	T2	N0	Colon Mucinous Adenocarcinoma	Stage I	1719-10	FALSE
13722.58cfa831e4b0c9d6adf6c966	58cfa831e4b0c9d6adf6c966	TCGA-CN-5374-01A-01D-2266-10_Illumina.filtered.	WGS	TCGA-CN-5374-01A-01D-2266-10_Illumina	TCGA-CN-5374-01A-01D-2266-10_Illumina.bam	384.7	1.9	0.05	58cfa831e4b0c9d6adf6c966	TCGA-CN-5374-01A-01D-2266-10_Illumina.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CN-5374-01A	D7641CA1-A062-4DD2-9414-447AF7311A84	Primary Tumor	Illumina HiSeq	3713f8c9-23d7-490a-bec2-99cb7ab55eac	Head and Neck	56	617DF1E0-B075-4610-B6D5-8850786FEA70	AB923DB7-54E8-4A50-B7FD-C2B4B300041E	TCGA-CN-5374-01A-01D-2266-10	GRCh37-lite	TCGA-CN-5374	TCGA-HNSC	NA	s15768	Baylor College of Medicine	University of Pittsburgh	None	NO	T2	N2	Head and Neck Squamous Cell Carcinoma	Stage IVA	2266-10	TRUE
13722.58cfa831e4b0c9d6adf6c83b	58cfa831e4b0c9d6adf6c83b	TCGA-CV-7180-01A-11D-2266-10_Illumina.filtered.	WGS	TCGA-CV-7180-01A-11D-2266-10_Illumina	TCGA-CV-7180-01A-11D-2266-10_Illumina.bam	52.7	NA	0.05	58cfa831e4b0c9d6adf6c83b	TCGA-CV-7180-01A-11D-2266-10_Illumina.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-7180-01A	D2CA9A4D-C14C-40C0-871C-88794A02E4AA	Primary Tumor	Illumina HiSeq	b66083b7-e0ae-4f6e-ab6a-76caf55a13bc	Head and Neck	34	551B5AC7-41E8-42BC-B64D-20E7E156DBBC	1727E88B-DF0A-4AF2-9191-8C6061D98AD0	TCGA-CV-7180-01A-11D-2266-10	GRCh37-lite	TCGA-CV-7180	TCGA-HNSC	327	s15648	Baylor College of Medicine	MD Anderson Cancer Center	United States	NO	T2	NX	Head and Neck Squamous Cell Carcinoma	Stage II	2266-10	TRUE
13722.58cfa831e4b0c9d6adf6ccb4	58cfa831e4b0c9d6adf6ccb4	TCGA-EI-6917-01A-11D-1924-10_wgs_Illumina.filtered.	WGS	TCGA-EI-6917-01A-11D-1924-10_wgs_Illumina	TCGA-EI-6917-01A-11D-1924-10_wgs_Illumina.bam	325	1.9	0.05	58cfa831e4b0c9d6adf6ccb4	TCGA-EI-6917-01A-11D-1924-10_wgs_Illumina.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Rectum Adenocarcinoma	Aligned reads	TCGA-EI-6917-01A	0CB21FB0-520F-4105-99EC-697A335115B5	Primary Tumor	Illumina HiSeq	e00d5548-a577-4019-9f7c-5bad23811d4e	Colorectal	33	37BB8CE7-6C55-4237-A7AD-ADC42E6FF6A8	8853CBEE-7931-49A6-B063-A806943A10AD	TCGA-EI-6917-01A-11D-1924-10	GRCh37-lite	TCGA-EI-6917	TCGA-READ	NA	s2011	Baylor College of Medicine	Greater Poland Cancer Center	Poland	NO	T3	N1	Rectal Adenocarcinoma	Stage IIIA	1924-10	FALSE
13722.58cfa831e4b0c9d6adf6cd6e	58cfa831e4b0c9d6adf6cd6e	TCGA-F5-6814-01A-31D-1924-10_wgs_Illumina.filtered.	WGS	TCGA-F5-6814-01A-31D-1924-10_wgs_Illumina	TCGA-F5-6814-01A-31D-1924-10_wgs_Illumina.bam	336.7	NA	0.05	58cfa831e4b0c9d6adf6cd6e	TCGA-F5-6814-01A-31D-1924-10_wgs_Illumina.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Rectum Adenocarcinoma	Aligned reads	TCGA-F5-6814-01A	8FEB0E8F-D09B-437D-8651-0CDECFE776BF	Primary Tumor	Illumina HiSeq	4980286e-15f8-4cb0-b7f7-8e68f04c699f	Colorectal	57	81AB66E0-6470-409B-AA27-846C869D2C8F	14C5B81D-DA49-4DB1-9834-77711C2B1D38	TCGA-F5-6814-01A-31D-1924-10	GRCh37-lite	TCGA-F5-6814	TCGA-READ	NA	s2012	Baylor College of Medicine	Asterand	Russia	NO	T2	N0	Rectal Adenocarcinoma	Stage IIA	1924-10	FALSE
13722.58cfa832e4b0c9d6adf6d144	58cfa832e4b0c9d6adf6d144	TCGA-KL-8325-01A-11D-2310-10_wgs_Illumina.filtered.	WGS	TCGA-KL-8325-01A-11D-2310-10_wgs_Illumina	TCGA-KL-8325-01A-11D-2310-10_wgs_Illumina.bam	258.3	NA	0.05	58cfa832e4b0c9d6adf6d144	TCGA-KL-8325-01A-11D-2310-10_wgs_Illumina.bam	Dead	FEMALE	WHITE	Not available	Kidney Chromophobe	Aligned reads	TCGA-KL-8325-01A	6101FFE6-2EF6-4256-9D6B-A7C545836995	Primary Tumor	Illumina HiSeq	61d8317e-d85d-4447-8c11-18c8f719fbdd	Kidney	56	79C48BEA-33E0-49E6-84F7-6103DA654642	9FC0E0E8-1B0F-400C-B4CF-126193283695	TCGA-KL-8325-01A-11D-2310-10	GRCh37-lite	TCGA-KL-8325	TCGA-KICH	725	s16423	Baylor College of Medicine	MSKCC	United States	NO	T2	NX	Kidney Chromophobe	Stage II	2310-10	TRUE
13722.58cfa832e4b0c9d6adf6d2bd	58cfa832e4b0c9d6adf6d2bd	TCGA-KL-8341-01A-11D-2310-10_wgs_Illumina.filtered.	WGS	TCGA-KL-8341-01A-11D-2310-10_wgs_Illumina	TCGA-KL-8341-01A-11D-2310-10_wgs_Illumina.bam	167	NA	0.05	58cfa832e4b0c9d6adf6d2bd	TCGA-KL-8341-01A-11D-2310-10_wgs_Illumina.bam	Dead	MALE	ASIAN	Not available	Kidney Chromophobe	Aligned reads	TCGA-KL-8341-01A	70E306EE-9584-49D6-81A1-A49D837AB6AA	Primary Tumor	Illumina HiSeq	507c9643-76a6-4c30-9802-a174ce2a0c8f	Kidney	41	EDF08A41-2AD2-4D1A-B567-5BE518A33469	E9032DF3-8692-4146-A867-B9B64C9B310A	TCGA-KL-8341-01A-11D-2310-10	GRCh37-lite	TCGA-KL-8341	TCGA-KICH	754	s16481	Baylor College of Medicine	MSKCC	United States	NO	T3b	N2	Kidney Chromophobe	Stage IV	2310-10	TRUE
13722.58cfa832e4b0c9d6adf6d2f5	58cfa832e4b0c9d6adf6d2f5	TCGA-KN-8424-01A-11D-2310-10_wgs_Illumina.filtered.	WGS	TCGA-KN-8424-01A-11D-2310-10_wgs_Illumina	TCGA-KN-8424-01A-11D-2310-10_wgs_Illumina.bam	71.3	NA	0.05	58cfa832e4b0c9d6adf6d2f5	TCGA-KN-8424-01A-11D-2310-10_wgs_Illumina.bam	Alive	FEMALE	WHITE	Not available	Kidney Chromophobe	Aligned reads	TCGA-KN-8424-01A	8C9E1F60-1838-4AA4-A667-C1CEF7DDDBDF	Primary Tumor	Illumina HiSeq	5c114c89-2e86-497d-a02e-e309eee59dc0	Kidney	42	93B1AE00-43E1-466C-BBC1-8755CB1A1A0C	1E8AE8DD-74C1-44D5-A74E-BFDCE801C736	TCGA-KN-8424-01A-11D-2310-10	GRCh37-lite	TCGA-KN-8424	TCGA-KICH	NA	s16524	Baylor College of Medicine	Harvard	United States	NO	T1b	N0	Kidney Chromophobe	Stage I	2310-10	TRUE
13722.58cfa832e4b0c9d6adf6d300	58cfa832e4b0c9d6adf6d300	TCGA-KM-8440-01A-11D-2310-10_wgs_Illumina.filtered.	WGS	TCGA-KM-8440-01A-11D-2310-10_wgs_Illumina	TCGA-KM-8440-01A-11D-2310-10_wgs_Illumina.bam	38.6	NA	0.05	58cfa832e4b0c9d6adf6d300	TCGA-KM-8440-01A-11D-2310-10_wgs_Illumina.bam	Alive	MALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Kidney Chromophobe	Aligned reads	TCGA-KM-8440-01A	872092B3-D31E-44D7-BD03-E29F52F8AB5A	Primary Tumor	Illumina HiSeq	e0e06c60-542a-4e20-928f-7fed440fcd2a	Kidney	37	614E4163-7DA8-4F77-A58D-405B004BE3E0	CDF313C8-59F9-41C6-9BD2-F47CB4287DA5	TCGA-KM-8440-01A-11D-2310-10	GRCh37-lite	TCGA-KM-8440	TCGA-KICH	NA	s16478	Baylor College of Medicine	NCI Urologic Oncology Branch	United States	NO	T3a	NX	Kidney Chromophobe	Stage III	2310-10	TRUE
13722.58cfa832e4b0c9d6adf6d319	58cfa832e4b0c9d6adf6d319	TCGA-KN-8429-01A-11D-2310-10_wgs_Illumina.filtered.	WGS	TCGA-KN-8429-01A-11D-2310-10_wgs_Illumina	TCGA-KN-8429-01A-11D-2310-10_wgs_Illumina.bam	71.3	NA	0.05	58cfa832e4b0c9d6adf6d319	TCGA-KN-8429-01A-11D-2310-10_wgs_Illumina.bam	Alive	FEMALE	WHITE	Not available	Kidney Chromophobe	Aligned reads	TCGA-KN-8429-01A	366219B9-FDE3-4D2D-82D3-15FE6245AA98	Primary Tumor	Illumina HiSeq	a527b958-1e44-4a4f-99e9-ba45c80bd326	Kidney	38	B802658C-4715-4878-97CA-99576F08AF6A	58C7E9C3-1345-48C0-A758-0887358B8696	TCGA-KN-8429-01A-11D-2310-10	GRCh37-lite	TCGA-KN-8429	TCGA-KICH	NA	s16492	Baylor College of Medicine	Harvard	United States	NO	T3a	N0	Kidney Chromophobe	Stage III	2310-10	TRUE
13722.58cfa832e4b0c9d6adf6d31d	58cfa832e4b0c9d6adf6d31d	TCGA-KN-8434-01A-11D-2310-10_wgs_Illumina.filtered.	WGS	TCGA-KN-8434-01A-11D-2310-10_wgs_Illumina	TCGA-KN-8434-01A-11D-2310-10_wgs_Illumina.bam	71.3	NA	0.05	58cfa832e4b0c9d6adf6d31d	TCGA-KN-8434-01A-11D-2310-10_wgs_Illumina.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Kidney Chromophobe	Aligned reads	TCGA-KN-8434-01A	E1E15226-9F8E-4035-8F08-EB1FED57080E	Primary Tumor	Illumina HiSeq	46dd26b0-c7e3-4280-b67c-5141df9048cf	Kidney	65	F75DE9FC-5DE8-4CAE-B1E1-8C37D1915C17	24F887E1-CE82-40F3-9674-11102BD076C0	TCGA-KN-8434-01A-11D-2310-10	GRCh37-lite	TCGA-KN-8434	TCGA-KICH	NA	s16488	Baylor College of Medicine	Harvard	United States	NO	T2	NX	Kidney Chromophobe	Stage II	2310-10	TRUE
13722.58cfa832e4b0c9d6adf6d36c	58cfa832e4b0c9d6adf6d36c	TCGA-KN-8418-01A-11D-2310-10_wgs_Illumina.filtered.	WGS	TCGA-KN-8418-01A-11D-2310-10_wgs_Illumina	TCGA-KN-8418-01A-11D-2310-10_wgs_Illumina.bam	106.3	NA	0.05	58cfa832e4b0c9d6adf6d36c	TCGA-KN-8418-01A-11D-2310-10_wgs_Illumina.bam	Alive	FEMALE	WHITE	Not available	Kidney Chromophobe	Aligned reads	TCGA-KN-8418-01A	F3BA1CF8-AC67-4DA8-96F3-8680DC55F247	Primary Tumor	Illumina HiSeq	29118d80-8a70-4ed3-8742-d2c69bbeffb7	Kidney	41	D6F68966-D6A2-4B24-B1D5-15CB8F4ACB8F	9A90F951-AD96-4883-B97F-AC43395DAE5D	TCGA-KN-8418-01A-11D-2310-10	GRCh37-lite	TCGA-KN-8418	TCGA-KICH	NA	s16396	Baylor College of Medicine	Harvard	United States	NO	T2	N0	Kidney Chromophobe	Stage II	2310-10	TRUE
13722.58cfa832e4b0c9d6adf6d3c2	58cfa832e4b0c9d6adf6d3c2	TCGA-KO-8406-01A-11D-2310-10_wgs_Illumina.filtered.	WGS	TCGA-KO-8406-01A-11D-2310-10_wgs_Illumina	TCGA-KO-8406-01A-11D-2310-10_wgs_Illumina.bam	131.2	NA	0.05	58cfa832e4b0c9d6adf6d3c2	TCGA-KO-8406-01A-11D-2310-10_wgs_Illumina.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Kidney Chromophobe	Aligned reads	TCGA-KO-8406-01A	9AA02D46-294B-4E99-B9EE-56EDCBFB5275	Primary Tumor	Illumina HiSeq	1980f1bf-6afb-4a53-97a5-f069b4200e14	Kidney	17	2141972F-8CA9-4E82-B410-B1E3BBB2934A	C29F6ED6-880D-4F03-977E-1087738E5E60	TCGA-KO-8406-01A-11D-2310-10	GRCh37-lite	TCGA-KO-8406	TCGA-KICH	NA	s16408	Baylor College of Medicine	MD Anderson Cancer Center	United States	NO	T1	N0	Kidney Chromophobe	Stage I	2310-10	TRUE
13722.58cfa832e4b0c9d6adf6d3d3	58cfa832e4b0c9d6adf6d3d3	TCGA-KO-8417-01A-11D-2310-10_wgs_Illumina.filtered.	WGS	TCGA-KO-8417-01A-11D-2310-10_wgs_Illumina	TCGA-KO-8417-01A-11D-2310-10_wgs_Illumina.bam	186.5	NA	0.05	58cfa832e4b0c9d6adf6d3d3	TCGA-KO-8417-01A-11D-2310-10_wgs_Illumina.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Kidney Chromophobe	Aligned reads	TCGA-KO-8417-01A	0B77657A-0297-4CEE-B9F2-5DE72E182016	Primary Tumor	Illumina HiSeq	c1d96592-c2a1-4638-8ee3-0515f3a8c96a	Kidney	30	C6D5A991-4018-4D78-BF0C-4D240E7987B5	0C7AF04B-E171-47C4-8BE5-5DB33F20148E	TCGA-KO-8417-01A-11D-2310-10	GRCh37-lite	TCGA-KO-8417	TCGA-KICH	NA	s16574	Baylor College of Medicine	MD Anderson Cancer Center	United States	NO	T1	N0	Kidney Chromophobe	Stage I	2310-10	TRUE
13722.58cfa832e4b0c9d6adf6d394	58cfa832e4b0c9d6adf6d394	TCGA-KO-8411-01A-11D-2310-10_wgs_Illumina.filtered.	WGS	TCGA-KO-8411-01A-11D-2310-10_wgs_Illumina	TCGA-KO-8411-01A-11D-2310-10_wgs_Illumina.bam	133.2	NA	0.05	58cfa832e4b0c9d6adf6d394	TCGA-KO-8411-01A-11D-2310-10_wgs_Illumina.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Kidney Chromophobe	Aligned reads	TCGA-KO-8411-01A	EE8C1919-17A9-4DF1-8AA5-79546621B23C	Primary Tumor	Illumina HiSeq	bcee9ae3-609f-4f6c-bf6e-9bf33233592d	Kidney	58	9E2CDD77-110D-498A-83E8-DF2E044303D6	9DFCBABF-2BC0-43A2-BDDE-D0B2AACA3F6B	TCGA-KO-8411-01A-11D-2310-10	GRCh37-lite	TCGA-KO-8411	TCGA-KICH	NA	s16402	Baylor College of Medicine	MD Anderson Cancer Center	United States	NO	T1b	NX	Kidney Chromophobe	Stage I	2310-10	TRUE
13722.58cfa832e4b0c9d6adf6d356	58cfa832e4b0c9d6adf6d356	TCGA-KO-8416-01A-11D-2310-10_wgs_Illumina.filtered.	WGS	TCGA-KO-8416-01A-11D-2310-10_wgs_Illumina	TCGA-KO-8416-01A-11D-2310-10_wgs_Illumina.bam	74.8	NA	0.05	58cfa832e4b0c9d6adf6d356	TCGA-KO-8416-01A-11D-2310-10_wgs_Illumina.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Kidney Chromophobe	Aligned reads	TCGA-KO-8416-01A	0EC3CAA1-7C51-417B-A89C-18E9FCEB80C4	Primary Tumor	Illumina HiSeq	3f5f5abf-4e3b-409e-9e2b-c8543d51100b	Kidney	41	545486B9-EF3E-45AD-810A-F4594A2DB883	9D29543E-8601-4FD0-8E76-3DF3DE465CAB	TCGA-KO-8416-01A-11D-2310-10	GRCh37-lite	TCGA-KO-8416	TCGA-KICH	NA	s16576	Baylor College of Medicine	MD Anderson Cancer Center	United States	NO	T3a	N0	Kidney Chromophobe	Stage III	2310-10	TRUE
13722.58cfa831e4b0c9d6adf6c7c6	58cfa831e4b0c9d6adf6c7c6	TCGA-CW-6087-01A-11D-2279-10_wgs_Illumina.filtered.	WGS	TCGA-CW-6087-01A-11D-2279-10_wgs_Illumina	TCGA-CW-6087-01A-11D-2279-10_wgs_Illumina.bam	47.4	1.9	0.05	58cfa831e4b0c9d6adf6c7c6	TCGA-CW-6087-01A-11D-2279-10_wgs_Illumina.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-CW-6087-01A	BBDAA931-E922-49BE-BFBF-FA0C2AE27D7A	Primary Tumor	Illumina HiSeq	efcf45d7-17bb-4653-908f-773b5045531c	Kidney	61	B4F9B73B-94DB-4E0F-AF55-CF0583318A4A	2C581A74-7716-4C20-B366-A8E1D9A901F6	TCGA-CW-6087-01A-11D-2279-10	GRCh37-lite	TCGA-CW-6087	TCGA-KIRC	41	s9452	Baylor College of Medicine	Mayo Clinic - Rochester	United States	NO	T3a	N1	Kidney Clear Cell Renal Carcinoma	Stage IV	2279-10	FALSE
13722.58cfa82ee4b0c9d6adf6aed4	58cfa82ee4b0c9d6adf6aed4	G49537.TCGA-EM-A2CP-01A-11D-A17V-08.1.filtered.	WGS	G49537.TCGA-EM-A2CP-01A-11D-A17V-08.1	G49537.TCGA-EM-A2CP-01A-11D-A17V-08.1.bam	53.65	NA	0.07	58cfa82ee4b0c9d6adf6aed4	G49537.TCGA-EM-A2CP-01A-11D-A17V-08.1.bam	Alive	FEMALE	Not available	Not available	Thyroid Carcinoma	Aligned reads	TCGA-EM-A2CP-01A	2F59F12D-CA0C-4AC6-9718-98A6D455AF46	Primary Tumor	Illumina HiSeq	3bca46e2-dbce-4b1c-8aec-37cc8615d471	Thyroid	26	043765F1-FFBD-4AC9-B0AE-733C3643083D	B8CD6882-BE27-4742-BC63-3227D31BF704	TCGA-EM-A2CP-01A-11D-A17V-08	HG19_Broad_variant	TCGA-EM-A2CP	TCGA-THCA	NA	s12095	Broad Institute of MIT and Harvard	University Health Network	Canada	NO	T2	N0	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	Stage I	A17V-08	TRUE
13722.58cfa831e4b0c9d6adf6c7e1	58cfa831e4b0c9d6adf6c7e1	TCGA-CV-7090-01A-11D-2276-10_Illumina.filtered.	WGS	TCGA-CV-7090-01A-11D-2276-10_Illumina	TCGA-CV-7090-01A-11D-2276-10_Illumina.bam	158.73	NA	0.05	58cfa831e4b0c9d6adf6c7e1	TCGA-CV-7090-01A-11D-2276-10_Illumina.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-7090-01A	05FBD98C-28BD-41BC-AE60-16AC0C16C723	Primary Tumor	Illumina HiSeq	30e23a3f-f6eb-45e4-9d14-bddafc4fab6d	Head and Neck	39	E8BD9DCB-A9C7-4361-9724-24922A5E613B	A8041E86-071E-46CD-8FB5-7ECDC1AB0553	TCGA-CV-7090-01A-11D-2276-10	GRCh37-lite	TCGA-CV-7090	TCGA-HNSC	NA	s15646	Baylor College of Medicine	MD Anderson Cancer Center	United States	NO	T2	NX	Head and Neck Squamous Cell Carcinoma	Stage II	2276-10	TRUE
13722.58cfa832e4b0c9d6adf6d33e	58cfa832e4b0c9d6adf6d33e	TCGA-KN-8435-01A-11D-2310-10_wgs_Illumina.filtered.	WGS	TCGA-KN-8435-01A-11D-2310-10_wgs_Illumina	TCGA-KN-8435-01A-11D-2310-10_wgs_Illumina.bam	134	NA	0.05	58cfa832e4b0c9d6adf6d33e	TCGA-KN-8435-01A-11D-2310-10_wgs_Illumina.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Kidney Chromophobe	Aligned reads	TCGA-KN-8435-01A	F2B58595-DEC0-4194-AB33-7C7DC6C058A6	Primary Tumor	Illumina HiSeq	28eaaad9-76f1-4c47-9af6-d8dc853ae96c	Kidney	59	B2D2BE13-C233-409A-A793-21D9CD3CFCE7	715F59DD-A80F-422D-988C-F73F4B987BAF	TCGA-KN-8435-01A-11D-2310-10	GRCh37-lite	TCGA-KN-8435	TCGA-KICH	NA	s16489	Baylor College of Medicine	Harvard	United States	NO	T2	NX	Kidney Chromophobe	Stage II	2310-10	TRUE
13722.58cfa82ee4b0c9d6adf6ae64	58cfa82ee4b0c9d6adf6ae64	TCGA-05-4396-01A-21D-1853_111204_SN208_0256_C0562ACXX_s_1_rg.sorted.filtered.	WGS	TCGA-05-4396-01A-21D-1853_111204_SN208_0256_C0562ACXX_s_1_rg.sorted	TCGA-05-4396-01A-21D-1853_111204_SN208_0256_C0562ACXX_s_1_rg.sorted.bam	301.7	1.9	0.16	58cfa82ee4b0c9d6adf6ae64	TCGA-05-4396-01A-21D-1853_111204_SN208_0256_C0562ACXX_s_1_rg.sorted.bam	Dead	MALE	Not available	Not available	Lung Adenocarcinoma	Aligned reads	TCGA-05-4396-01A	9F81C602-8AFA-4588-B0B6-6E5A1A128D5A	Primary Tumor	Illumina HiSeq	61bb72a1-5c87-411d-af04-3e058c2beab2	Lung	76	4D85772B-287E-4790-B1E8-CD1C0E88AD48	1F0C98A3-3EED-45E0-BF81-78632C02D375	TCGA-05-4396-01A-21D-1853-02	HG19_Broad_variant	TCGA-05-4396	TCGA-LUAD	303	s10640	Harvard Medical School	Indivumed	Germany	NO	T4	N1	Lung Adenocarcinoma Mixed Subtype	Stage IIIB	1853-02	TRUE
13722.58cfa82ee4b0c9d6adf6af9e	58cfa82ee4b0c9d6adf6af9e	TCGA-05-4427-01A-21D-1853_111207_SN590_0112_D09CDACXX_s_3_rg.sorted.filtered.	WGS	TCGA-05-4427-01A-21D-1853_111207_SN590_0112_D09CDACXX_s_3_rg.sorted	TCGA-05-4427-01A-21D-1853_111207_SN590_0112_D09CDACXX_s_3_rg.sorted.bam	290.7	1.8	0.17	58cfa82ee4b0c9d6adf6af9e	TCGA-05-4427-01A-21D-1853_111207_SN590_0112_D09CDACXX_s_3_rg.sorted.bam	Alive	FEMALE	Not available	Not available	Lung Adenocarcinoma	Aligned reads	TCGA-05-4427-01A	78A24C56-576C-4245-BB42-6603B3D19897	Primary Tumor	Illumina HiSeq	10c44e9b-d94b-4f27-b275-2dab46a863c6	Lung	65	785B0C56-BED5-4D19-B7B3-D1A0CEB5D648	6B6663FE-F439-4546-B256-0024F66F748D	TCGA-05-4427-01A-21D-1853-02	HG19_Broad_variant	TCGA-05-4427	TCGA-LUAD	NA	s11225	Harvard Medical School	Indivumed	Germany	NO	T2	N1	Lung Adenocarcinoma Mixed Subtype	Stage IIB	1853-02	TRUE
13722.58cfa82fe4b0c9d6adf6b687	58cfa82fe4b0c9d6adf6b687	TCGA-44-6148-01A-11D-1751_110927_SN208_0243_BC00TKACXX_s_6_rg.sorted.filtered.	WGS	TCGA-44-6148-01A-11D-1751_110927_SN208_0243_BC00TKACXX_s_6_rg.sorted	TCGA-44-6148-01A-11D-1751_110927_SN208_0243_BC00TKACXX_s_6_rg.sorted.bam	164.4	1.9	0.16	58cfa82fe4b0c9d6adf6b687	TCGA-44-6148-01A-11D-1751_110927_SN208_0243_BC00TKACXX_s_6_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-44-6148-01A	8994C8C4-9EA0-46CB-B4A5-0055D7DA5BFA	Primary Tumor	Illumina HiSeq	e3f95d46-09ce-43a0-a2c7-581cb9fe8da9	Lung	60	C0FE5FFE-C0A3-4E62-AA55-2BC18788E505	F8A1C395-E730-48F9-BF82-E8931E4AF154	TCGA-44-6148-01A-11D-1751-02	HG19_Broad_variant	TCGA-44-6148	TCGA-LUAD	NA	s10995	Harvard Medical School	Christiana Healthcare	United States	NO	T1b	N0	Lung Mucinous Adenocarcinoma	Stage IA	1751-02	TRUE
13722.58cfa82ee4b0c9d6adf6ae54	58cfa82ee4b0c9d6adf6ae54	TCGA-05-4250-01A-01D-1103_110729_SN208_0215_BD0CLPABXX_s_2_rg.sorted.filtered.	WGS	TCGA-05-4250-01A-01D-1103_110729_SN208_0215_BD0CLPABXX_s_2_rg.sorted	TCGA-05-4250-01A-01D-1103_110729_SN208_0215_BD0CLPABXX_s_2_rg.sorted.bam	282.93	1.9	0.15	58cfa82ee4b0c9d6adf6ae54	TCGA-05-4250-01A-01D-1103_110729_SN208_0215_BD0CLPABXX_s_2_rg.sorted.bam	Dead	FEMALE	Not available	Not available	Lung Adenocarcinoma	Aligned reads	TCGA-05-4250-01A	F98ECD8A-B878-4F53-B911-20CD8E17281C	Primary Tumor	Illumina HiSeq	b7bbb240-9e61-41e0-a669-1744d0bda12b	Lung	79	8F274178-7A8E-46B6-8D2C-900338BBB946	A444B1E8-9FE9-492B-A361-93CAAB3681BC	TCGA-05-4250-01A-01D-1103-02	HG19_Broad_variant	TCGA-05-4250	TCGA-LUAD	121	s11441	Harvard Medical School	Indivumed	Germany	NO	T3	N1	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage IIIA	1103-02	TRUE
13722.58cfa82ee4b0c9d6adf6b0a5	58cfa82ee4b0c9d6adf6b0a5	TCGA-05-4249-01A-01D-1103_110729_SN208_0215_BD0CLPABXX_s_1_rg.sorted.filtered.	WGS	TCGA-05-4249-01A-01D-1103_110729_SN208_0215_BD0CLPABXX_s_1_rg.sorted	TCGA-05-4249-01A-01D-1103_110729_SN208_0215_BD0CLPABXX_s_1_rg.sorted.bam	64.93	1.9	0.15	58cfa82ee4b0c9d6adf6b0a5	TCGA-05-4249-01A-01D-1103_110729_SN208_0215_BD0CLPABXX_s_1_rg.sorted.bam	Alive	MALE	Not available	Not available	Lung Adenocarcinoma	Aligned reads	TCGA-05-4249-01A	4ADDF05F-3668-4B3F-A17F-C0227329CA52	Primary Tumor	Illumina HiSeq	94e6a5cd-7ba5-4f3e-bf83-7d07522963b4	Lung	67	80F196FE-1EAF-40CB-AB58-C84795ACC5C7	E3F50937-D6CF-423B-9DD3-31D715892FC7	TCGA-05-4249-01A-01D-1103-02	HG19_Broad_variant	TCGA-05-4249	TCGA-LUAD	NA	s10642	Harvard Medical School	Indivumed	Germany	NO	T2	N0	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage IB	1103-02	TRUE
13722.58cfa82fe4b0c9d6adf6b80c	58cfa82fe4b0c9d6adf6b80c	TCGA-44-4112-01A-01D-1103_120318_SN1120_0124_AC0HNPACXX_s_1_rg.sorted.filtered.	WGS	TCGA-44-4112-01A-01D-1103_120318_SN1120_0124_AC0HNPACXX_s_1_rg.sorted	TCGA-44-4112-01A-01D-1103_120318_SN1120_0124_AC0HNPACXX_s_1_rg.sorted.bam	452.63	1.9	0.15	58cfa82fe4b0c9d6adf6b80c	TCGA-44-4112-01A-01D-1103_120318_SN1120_0124_AC0HNPACXX_s_1_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-44-4112-01A	68B86559-38B2-41F2-B66E-C3C2B628B14D	Primary Tumor	Illumina HiSeq	7c0e7b16-7643-4891-96de-63f2106bfb1a	Lung	60	6C206676-E511-4281-91F5-BFE91B3279A4	68185A4B-CC12-494D-99F5-84F5888A24F9	TCGA-44-4112-01A-01D-1103-02	HG19_Broad_variant	TCGA-44-4112	TCGA-LUAD	NA	s10651	Harvard Medical School	Christiana Healthcare	None	NO	T2a	N0	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage IB	1103-02	TRUE
13722.58cfa82fe4b0c9d6adf6b88f	58cfa82fe4b0c9d6adf6b88f	TCGA-73-4676-01A-01D-1751_120309_SN208_0274_AD0R6DACXX_s_7_rg.sorted.filtered.	WGS	TCGA-73-4676-01A-01D-1751_120309_SN208_0274_AD0R6DACXX_s_7_rg.sorted	TCGA-73-4676-01A-01D-1751_120309_SN208_0274_AD0R6DACXX_s_7_rg.sorted.bam	216	1.9	0.15	58cfa82fe4b0c9d6adf6b88f	TCGA-73-4676-01A-01D-1751_120309_SN208_0274_AD0R6DACXX_s_7_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-73-4676-01A	195A5AFB-B79F-44D2-9D12-884487630C2B	Primary Tumor	Illumina HiSeq	a2b68d59-a4d4-4793-9e6c-72ccaf7c242b	Lung	45	22434A49-EB8A-43AC-8C08-AE6DCBE6FBB8	A79111BF-CB9D-4790-AE9F-6CB13C9334E2	TCGA-73-4676-01A-01D-1751-02	HG19_Broad_variant	TCGA-73-4676	TCGA-LUAD	NA	s11465	Harvard Medical School	Roswell Park	United States	NO	T2a	N1	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage IIA	1751-02	TRUE
13722.58cfa82fe4b0c9d6adf6b991	58cfa82fe4b0c9d6adf6b991	TCGA-50-6597-01A-11D-1853_120312_SN1120_0121_BD0RHPACXX_s_3_rg.sorted.filtered.	WGS	TCGA-50-6597-01A-11D-1853_120312_SN1120_0121_BD0RHPACXX_s_3_rg.sorted	TCGA-50-6597-01A-11D-1853_120312_SN1120_0121_BD0RHPACXX_s_3_rg.sorted.bam	12.7	1.9	0.15	58cfa82fe4b0c9d6adf6b991	TCGA-50-6597-01A-11D-1853_120312_SN1120_0121_BD0RHPACXX_s_3_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-50-6597-01A	0D66BF6C-EED0-4726-BD5B-3BF6D610B4E0	Primary Tumor	Illumina HiSeq	e7110ba5-6000-459a-8128-32b420e21194	Lung	79	C5363830-3DB9-4C0C-AA47-B32FDC888C60	84D15DBA-6689-4A93-B2CA-999BF7F97E96	TCGA-50-6597-01A-11D-1853-02	HG19_Broad_variant	TCGA-50-6597	TCGA-LUAD	NA	s11553	Harvard Medical School	University of Pittsburgh	United States	NO	T2	N0	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage IB	1853-02	TRUE
13722.58cfa82fe4b0c9d6adf6ba42	58cfa82fe4b0c9d6adf6ba42	TCGA-AA-A01R-01A-21D-A079-02_110402_SN208_0200_BB02BTABXX_s_3.rg.sorted.filtered.	WGS	TCGA-AA-A01R-01A-21D-A079-02_110402_SN208_0200_BB02BTABXX_s_3.rg.sorted	TCGA-AA-A01R-01A-21D-A079-02_110402_SN208_0200_BB02BTABXX_s_3.rg.sorted.bam	75.21	1.8	0.14	58cfa82fe4b0c9d6adf6ba42	TCGA-AA-A01R-01A-21D-A079-02_110402_SN208_0200_BB02BTABXX_s_3.rg.sorted.bam	Alive	MALE	Not available	Not available	Colon Adenocarcinoma	Aligned reads	TCGA-AA-A01R-01A	97F6C8D3-09A0-4128-8F10-41E736648A5F	Primary Tumor	Illumina HiSeq	dc5cfaa9-514c-4e4d-b882-21df489668aa	Colorectal	47	73EE34E8-422D-4AB1-B0F0-DA8A5A2DD9AB	F8021A03-B35B-4E6C-B196-2948789AFCF3	TCGA-AA-A01R-01A-21D-A079-02	HG18_Broad_variant	TCGA-AA-A01R	TCGA-COAD	NA	s12876	Harvard Medical School	Indivumed	Germany	NO	T3	N2	Colon Mucinous Adenocarcinoma	Stage III	A079-02	TRUE
13722.58cfa82fe4b0c9d6adf6b8e2	58cfa82fe4b0c9d6adf6b8e2	TCGA-A7-A26F-01B-04D-A22S_120816_SN1222_0144_AD16PUACXX_s_1_rg.sorted.filtered.	WGS	TCGA-A7-A26F-01B-04D-A22S_120816_SN1222_0144_AD16PUACXX_s_1_rg.sorted	TCGA-A7-A26F-01B-04D-A22S_120816_SN1222_0144_AD16PUACXX_s_1_rg.sorted.bam	8.32	NA	0.14	58cfa82fe4b0c9d6adf6b8e2	TCGA-A7-A26F-01B-04D-A22S_120816_SN1222_0144_AD16PUACXX_s_1_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-A7-A26F-01B	3B7B9C1E-A84C-47ED-983C-9E4B00CBF01A	Primary Tumor	Illumina HiSeq	4925c013-4605-47d0-9c97-2e8a69233aa4	Breast	55	29619D1E-E8B4-411E-BBBA-07F2CFB69E8A	A723DE1E-A9E0-487D-8D86-7AA4A062A1C2	TCGA-A7-A26F-01B-04D-A22S-26	HG19_Broad_variant	TCGA-A7-A26F	TCGA-BRCA	NA	s6916	MD Anderson - Institute for Applied Cancer Science	Christiana Healthcare	United States	YES	T1	N0	Other  specify	Stage IA	A22S-26	FALSE
13722.58cfa830e4b0c9d6adf6ba54	58cfa830e4b0c9d6adf6ba54	TCGA-AA-A01Q-01A-01D-A077_110402_SN208_0200_BB02BTABXX_s_4_rg.sorted.filtered.	WGS	TCGA-AA-A01Q-01A-01D-A077_110402_SN208_0200_BB02BTABXX_s_4_rg.sorted	TCGA-AA-A01Q-01A-01D-A077_110402_SN208_0200_BB02BTABXX_s_4_rg.sorted.bam	237.45	1.73	0.15	58cfa830e4b0c9d6adf6ba54	TCGA-AA-A01Q-01A-01D-A077_110402_SN208_0200_BB02BTABXX_s_4_rg.sorted.bam	Alive	FEMALE	Not available	Not available	Colon Adenocarcinoma	Aligned reads	TCGA-AA-A01Q-01A	4BE66108-E72A-406B-BB4B-F58FF2877336	Primary Tumor	Illumina HiSeq	f50b391c-a832-4938-86aa-0ae2e8261a9e	Colorectal	48	5D1D7C40-F636-46C6-9540-4DF11A466B15	D84E59D4-7777-4922-990F-622BD246A9F1	TCGA-AA-A01Q-01A-01D-A077-02	HG18_Broad_variant	TCGA-AA-A01Q	TCGA-COAD	NA	s13032	Harvard Medical School	Indivumed	Germany	NO	T3	N0	Colon Adenocarcinoma	Stage II	A077-02	TRUE
13722.58cfa830e4b0c9d6adf6bb7e	58cfa830e4b0c9d6adf6bb7e	TCGA-A5-A0GB-01A-11D-A043_120324_SN1120_0127_BC0L80ACXX_s_2_rg.sorted.filtered.	WGS	TCGA-A5-A0GB-01A-11D-A043_120324_SN1120_0127_BC0L80ACXX_s_2_rg.sorted	TCGA-A5-A0GB-01A-11D-A043_120324_SN1120_0127_BC0L80ACXX_s_2_rg.sorted.bam	52.54	2	0.16	58cfa830e4b0c9d6adf6bb7e	TCGA-A5-A0GB-01A-11D-A043_120324_SN1120_0127_BC0L80ACXX_s_2_rg.sorted.bam	Alive	FEMALE	WHITE	Not available	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-A5-A0GB-01A	2F4458B6-3CAF-4E33-890E-A04722BADD1B	Primary Tumor	Illumina HiSeq	c4dd9407-812c-41b2-9953-baec8808ddbd	Uterus	65	130744CA-A9A2-4C99-8ABB-20FE76E0A955	A025733C-E300-4C47-B2EF-D9C978B58BFD	TCGA-A5-A0GB-01A-11D-A043-02	HG19_Broad_variant	TCGA-A5-A0GB	TCGA-UCEC	NA	s4585	Harvard Medical School	Cedars Sinai	None	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A043-02	TRUE
13722.58cfa830e4b0c9d6adf6bad4	58cfa830e4b0c9d6adf6bad4	TCGA-AA-A01V-01A-23D-A079-02_110402_SN208_0200_BB02BTABXX_s_7.rg.sorted.filtered.	WGS	TCGA-AA-A01V-01A-23D-A079-02_110402_SN208_0200_BB02BTABXX_s_7.rg.sorted	TCGA-AA-A01V-01A-23D-A079-02_110402_SN208_0200_BB02BTABXX_s_7.rg.sorted.bam	86.94	2	0.15	58cfa830e4b0c9d6adf6bad4	TCGA-AA-A01V-01A-23D-A079-02_110402_SN208_0200_BB02BTABXX_s_7.rg.sorted.bam	Alive	MALE	Not available	Not available	Colon Adenocarcinoma	Aligned reads	TCGA-AA-A01V-01A	0CB0DAC8-4CE2-444A-B1AE-1550E065B4D9	Primary Tumor	Illumina HiSeq	f9fde040-dea2-4d98-8a28-05cb13efa1c2	Colorectal	59	8816F14D-9FBB-4033-9CA4-6CA0DB66161A	D13F4522-90DC-41C8-A274-FBD9C0CD2E60	TCGA-AA-A01V-01A-23D-A079-02	HG18_Broad_variant	TCGA-AA-A01V	TCGA-COAD	NA	s13683	Harvard Medical School	Indivumed	Germany	NO	T2	N0	Colon Adenocarcinoma	Stage I	A079-02	TRUE
13722.58cfa830e4b0c9d6adf6bc4e	58cfa830e4b0c9d6adf6bc4e	TCGA-AP-A05P-01A-11D-A043_120214_SN590_0139_BC0DYEACXX_s_5_rg.sorted.filtered.	WGS	TCGA-AP-A05P-01A-11D-A043_120214_SN590_0139_BC0DYEACXX_s_5_rg.sorted	TCGA-AP-A05P-01A-11D-A043_120214_SN590_0139_BC0DYEACXX_s_5_rg.sorted.bam	55.61	2.3	0.14	58cfa830e4b0c9d6adf6bc4e	TCGA-AP-A05P-01A-11D-A043_120214_SN590_0139_BC0DYEACXX_s_5_rg.sorted.bam	Alive	FEMALE	ASIAN	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-AP-A05P-01A	3CB83517-78A4-47B8-8B1E-57E765DBDD2E	Primary Tumor	Illumina HiSeq	a12cb33f-6f29-4068-a6c8-3e20520bc2e0	Uterus	54	F51F7B0E-3EA6-4232-9DE4-A4DD63B23BB5	E08A6886-B019-4920-ACC3-73A4CAF18E3F	TCGA-AP-A05P-01A-11D-A043-02	HG19_Broad_variant	TCGA-AP-A05P	TCGA-UCEC	NA	s5385	Harvard Medical School	MSKCC	None	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A043-02	TRUE
13722.58cfa830e4b0c9d6adf6bd8f	58cfa830e4b0c9d6adf6bd8f	TCGA-BB-4223-01A-01D-1431_120423_SN590_0154_AC0JBHACXX_s_7_rg.sorted.filtered.	WGS	TCGA-BB-4223-01A-01D-1431_120423_SN590_0154_AC0JBHACXX_s_7_rg.sorted	TCGA-BB-4223-01A-01D-1431_120423_SN590_0154_AC0JBHACXX_s_7_rg.sorted.bam	11.7	2	0.14	58cfa830e4b0c9d6adf6bd8f	TCGA-BB-4223-01A-01D-1431_120423_SN590_0154_AC0JBHACXX_s_7_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-BB-4223-01A	05F01280-BF77-4682-A7A8-20DD0EAC77BD	Primary Tumor	Illumina HiSeq	e8bc6546-004a-4702-9289-b5c90582298e	Head and Neck	48	82DB742D-885D-4788-B509-474715AE183B	007F0F41-C370-45F9-8053-2C774ADDED49	TCGA-BB-4223-01A-01D-1431-02	HG19_Broad_variant	TCGA-BB-4223	TCGA-HNSC	NA	s15490	Harvard Medical School	Johns Hopkins	United States	NO	T2	N2b	Head and Neck Squamous Cell Carcinoma	Stage IVA	1431-02	TRUE
13722.58cfa830e4b0c9d6adf6babc	58cfa830e4b0c9d6adf6babc	TCGA-AA-A01T-01A-21D-A079-02_110402_SN208_0200_BB02BTABXX_s_5.rg.sorted.filtered.	WGS	TCGA-AA-A01T-01A-21D-A079-02_110402_SN208_0200_BB02BTABXX_s_5.rg.sorted	TCGA-AA-A01T-01A-21D-A079-02_110402_SN208_0200_BB02BTABXX_s_5.rg.sorted.bam	80.04	2.03	0.14	58cfa830e4b0c9d6adf6babc	TCGA-AA-A01T-01A-21D-A079-02_110402_SN208_0200_BB02BTABXX_s_5.rg.sorted.bam	Alive	FEMALE	Not available	Not available	Colon Adenocarcinoma	Aligned reads	TCGA-AA-A01T-01A	F87C6DCC-1A9E-4DF5-962C-1F946E2611F8	Primary Tumor	Illumina HiSeq	0dd44906-041d-4af2-8f42-a1bed185e1c6	Colorectal	63	BFC99C6D-7791-4037-9C74-A74BE68E616A	8F61B113-0E19-403E-9637-48E9D9733692	TCGA-AA-A01T-01A-21D-A079-02	HG18_Broad_variant	TCGA-AA-A01T	TCGA-COAD	NA	s13839	Harvard Medical School	Indivumed	Germany	NO	T3	N1	Colon Adenocarcinoma	Stage III	A079-02	TRUE
13722.58cfa830e4b0c9d6adf6bd2e	58cfa830e4b0c9d6adf6bd2e	TCGA-AA-A01P-01A-21D-A079-02_IlluminaHiSeq-DNASeq_whole.filtered.	WGS	TCGA-AA-A01P-01A-21D-A079-02_IlluminaHiSeq-DNASeq_whole	TCGA-AA-A01P-01A-21D-A079-02_IlluminaHiSeq-DNASeq_whole.bam	76.48	1.86	0.16	58cfa830e4b0c9d6adf6bd2e	TCGA-AA-A01P-01A-21D-A079-02_IlluminaHiSeq-DNASeq_whole.bam	Dead	FEMALE	Not available	Not available	Colon Adenocarcinoma	Aligned reads	TCGA-AA-A01P-01A	13AE9D83-A22F-451F-88BB-686051725CF3	Primary Tumor	Illumina HiSeq	bd44a9e2-a1a2-43a2-bfca-3a7d028fd86c	Colorectal	80	133C13DE-6C6B-45E2-A611-A5C5A4AEBAA6	7788130D-F341-4900-B7E0-95EAD3063A9F	TCGA-AA-A01P-01A-21D-A079-02	HG18	TCGA-AA-A01P	TCGA-COAD	1158	s13527	Harvard Medical School	Indivumed	Germany	NO	T3	N1	Colon Adenocarcinoma	Stage III	A079-02	TRUE
13722.58cfa830e4b0c9d6adf6bdc4	58cfa830e4b0c9d6adf6bdc4	TCGA-BG-A18A-01A-21D-A12F_120626_SN590_0163_AC0VU5ACXX_s_7_rg.sorted.filtered.	WGS	TCGA-BG-A18A-01A-21D-A12F_120626_SN590_0163_AC0VU5ACXX_s_7_rg.sorted	TCGA-BG-A18A-01A-21D-A12F_120626_SN590_0163_AC0VU5ACXX_s_7_rg.sorted.bam	21.93	1.96	0.17	58cfa830e4b0c9d6adf6bdc4	TCGA-BG-A18A-01A-21D-A12F_120626_SN590_0163_AC0VU5ACXX_s_7_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-BG-A18A-01A	FEB3E930-3638-44B4-AC0F-A5DCB01FED76	Primary Tumor	Illumina HiSeq	cf06b397-1811-4a38-93b4-05f1457e9882	Uterus	74	8FD0971D-40BA-46C2-B3C4-8E48A3E6C122	518AFA21-9E19-49DE-A2A6-387828A10837	TCGA-BG-A18A-01A-21D-A12F-02	HG19_Broad_variant	TCGA-BG-A18A	TCGA-UCEC	NA	s4789	Harvard Medical School	University of Pittsburgh	None	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A12F-02	TRUE
13722.58cfa830e4b0c9d6adf6be01	58cfa830e4b0c9d6adf6be01	TCGA-BG-A0M8-01A-12D-A101_120330_SN1120_0129_BD0UCLACXX_s_3_rg.sorted.filtered.	WGS	TCGA-BG-A0M8-01A-12D-A101_120330_SN1120_0129_BD0UCLACXX_s_3_rg.sorted	TCGA-BG-A0M8-01A-12D-A101_120330_SN1120_0129_BD0UCLACXX_s_3_rg.sorted.bam	67.61	2	0.15	58cfa830e4b0c9d6adf6be01	TCGA-BG-A0M8-01A-12D-A101_120330_SN1120_0129_BD0UCLACXX_s_3_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-BG-A0M8-01A	E055DB71-F3DA-43D3-A9B2-2F65DFB23D3E	Primary Tumor	Illumina HiSeq	f354958c-ea56-472d-b145-a7e2895af8e2	Uterus	50	9CFB7290-EF60-4FDA-ABD7-9552AE11E4E7	D45D62ED-7BC6-4682-BB4B-2CA6EBBCE717	TCGA-BG-A0M8-01A-12D-A101-02	HG19_Broad_variant	TCGA-BG-A0M8	TCGA-UCEC	NA	s4434	Harvard Medical School	University of Pittsburgh	None	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A101-02	TRUE
13722.58cfa830e4b0c9d6adf6be06	58cfa830e4b0c9d6adf6be06	TCGA-BG-A0MQ-01A-11D-A101_120330_SN1120_0129_BD0UCLACXX_s_6_rg.sorted.filtered.	WGS	TCGA-BG-A0MQ-01A-11D-A101_120330_SN1120_0129_BD0UCLACXX_s_6_rg.sorted	TCGA-BG-A0MQ-01A-11D-A101_120330_SN1120_0129_BD0UCLACXX_s_6_rg.sorted.bam	87.16	2	0.14	58cfa830e4b0c9d6adf6be06	TCGA-BG-A0MQ-01A-11D-A101_120330_SN1120_0129_BD0UCLACXX_s_6_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-BG-A0MQ-01A	12D36A1D-9922-4311-BBDA-71F32AC2C03B	Primary Tumor	Illumina HiSeq	d1e9cdb8-f8a6-43da-9afb-28a6e6d72b6a	Uterus	71	3D1FA321-D2E8-4460-AE87-356AB1CA6281	08F01B17-0386-4C7E-B926-1736CEC043D2	TCGA-BG-A0MQ-01A-11D-A101-02	HG19_Broad_variant	TCGA-BG-A0MQ	TCGA-UCEC	NA	s4253	Harvard Medical School	University of Pittsburgh	None	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A101-02	TRUE
13722.58cfa830e4b0c9d6adf6be04	58cfa830e4b0c9d6adf6be04	TCGA-BG-A0M9-01A-21D-A101_120330_SN1120_0129_BD0UCLACXX_s_4_rg.sorted.filtered.	WGS	TCGA-BG-A0M9-01A-21D-A101_120330_SN1120_0129_BD0UCLACXX_s_4_rg.sorted	TCGA-BG-A0M9-01A-21D-A101_120330_SN1120_0129_BD0UCLACXX_s_4_rg.sorted.bam	133.79	2	0.17	58cfa830e4b0c9d6adf6be04	TCGA-BG-A0M9-01A-21D-A101_120330_SN1120_0129_BD0UCLACXX_s_4_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-BG-A0M9-01A	4FD1CB59-6C50-4355-9D37-A341E1F4FAD9	Primary Tumor	Illumina HiSeq	633f3cff-14c3-45f7-b568-caa86760d863	Uterus	73	DC487BBF-555B-423B-B7C0-3E92DEFA5A79	3D712314-6FDC-41C7-9CE1-5F9BB85929EE	TCGA-BG-A0M9-01A-21D-A101-02	HG19_Broad_variant	TCGA-BG-A0M9	TCGA-UCEC	NA	s4603	Harvard Medical School	University of Pittsburgh	None	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A101-02	TRUE
13722.58cfa830e4b0c9d6adf6be2e	58cfa830e4b0c9d6adf6be2e	TCGA-BG-A0MS-01A-11D-A101_120330_SN1120_0129_BD0UCLACXX_s_7_rg.sorted.filtered.	WGS	TCGA-BG-A0MS-01A-11D-A101_120330_SN1120_0129_BD0UCLACXX_s_7_rg.sorted	TCGA-BG-A0MS-01A-11D-A101_120330_SN1120_0129_BD0UCLACXX_s_7_rg.sorted.bam	76.64	1.97	0.15	58cfa830e4b0c9d6adf6be2e	TCGA-BG-A0MS-01A-11D-A101_120330_SN1120_0129_BD0UCLACXX_s_7_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-BG-A0MS-01A	A798A8CC-4E72-4A8C-9E20-74A14DEAFD12	Primary Tumor	Illumina HiSeq	71c1fd79-298f-43fd-82ba-a1a2228aaa51	Uterus	53	EF7F78EB-314B-4CF2-B45B-810C84C6AA7B	463D0533-A168-4F50-8EA9-7812D01B5115	TCGA-BG-A0MS-01A-11D-A101-02	HG19_Broad_variant	TCGA-BG-A0MS	TCGA-UCEC	NA	s5392	Harvard Medical School	University of Pittsburgh	None	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A101-02	TRUE
13722.58cfa830e4b0c9d6adf6be78	58cfa830e4b0c9d6adf6be78	TCGA-BL-A3JM-01A-12D-A21C_120914_SN590_0180_BC19KDACXX_s_3_rg.sorted.filtered.	WGS	TCGA-BL-A3JM-01A-12D-A21C_120914_SN590_0180_BC19KDACXX_s_3_rg.sorted	TCGA-BL-A3JM-01A-12D-A21C_120914_SN590_0180_BC19KDACXX_s_3_rg.sorted.bam	24.07	NA	0.16	58cfa830e4b0c9d6adf6be78	TCGA-BL-A3JM-01A-12D-A21C_120914_SN590_0180_BC19KDACXX_s_3_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-BL-A3JM-01A	0F4FB205-B13C-4A85-97B3-779429E6CCDD	Primary Tumor	Illumina HiSeq	5cd881b7-caa0-43ad-9ba8-f9696fdf7403	Bladder	62	110ACEE1-915F-43A2-B382-5D0AF1FC167F	6ABBBA00-C322-4EDE-91A4-85D0D3E886F9	TCGA-BL-A3JM-01A-12D-A21C-26	HG19_Broad_variant	TCGA-BL-A3JM	TCGA-BLCA	205	s2691	MD Anderson - Institute for Applied Cancer Science	Christiana Healthcare	United States	NO	T3	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage III	A21C-26	TRUE
13722.58cfa830e4b0c9d6adf6be6e	58cfa830e4b0c9d6adf6be6e	TCGA-BJ-A190-01A-11D-A13U_120711_SN1120_0173_AC0WN6ACXX_s_6_rg.sorted.filtered.	WGS	TCGA-BJ-A190-01A-11D-A13U_120711_SN1120_0173_AC0WN6ACXX_s_6_rg.sorted	TCGA-BJ-A190-01A-11D-A13U_120711_SN1120_0173_AC0WN6ACXX_s_6_rg.sorted.bam	53.09	1.95	0.16	58cfa830e4b0c9d6adf6be6e	TCGA-BJ-A190-01A-11D-A13U_120711_SN1120_0173_AC0WN6ACXX_s_6_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-BJ-A190-01A	04FFF86A-B6F5-4900-9E37-C1F0B881B160	Primary Tumor	Illumina HiSeq	a9f1f6de-8f02-48c6-a9e2-6cef21cd8438	Thyroid	55	2EB89D79-861E-41C2-BDD5-6F16D2A84B25	42FE4D84-B54D-42B8-81F8-92191723D057	TCGA-BJ-A190-01A-11D-A13U-02	HG19_Broad_variant	TCGA-BJ-A190	TCGA-THCA	NA	s12234	Harvard Medical School	University of Pittsburgh	United States	NO	T2	N0	Thyroid Papillary Carcinoma - Classical/usual	Stage II	A13U-02	TRUE
13722.58cfa830e4b0c9d6adf6c16a	58cfa830e4b0c9d6adf6c16a	TCGA-BH-A0HK-01A-11D-A060_130807_SN590_0236_BC291KACXX_s_1_rg.sorted.filtered.	WGS	TCGA-BH-A0HK-01A-11D-A060_130807_SN590_0236_BC291KACXX_s_1_rg.sorted	TCGA-BH-A0HK-01A-11D-A060_130807_SN590_0236_BC291KACXX_s_1_rg.sorted.bam	22.97	1.94	0.13	58cfa830e4b0c9d6adf6c16a	TCGA-BH-A0HK-01A-11D-A060_130807_SN590_0236_BC291KACXX_s_1_rg.sorted.bam	Alive	FEMALE	WHITE	Not available	Breast Invasive Carcinoma	Aligned reads	TCGA-BH-A0HK-01A	24334AC1-28A3-4B61-B590-3F51E375B247	Primary Tumor	Illumina HiSeq	c4f3a9e0-4b45-4e06-9320-171c27d9e28d	Breast	81	8835B20E-9343-4266-A356-E0343C657130	B96AE5EC-0139-4B8D-8136-B5BFA7AF8987	TCGA-BH-A0HK-01A-11D-A060-02	HG19_Broad_variant	TCGA-BH-A0HK	TCGA-BRCA	NA	s5642	Harvard Medical School	University of Pittsburgh	None	NO	T2	N1	Infiltrating Ductal Carcinoma	Stage IIB	A060-02	TRUE
13722.58cfa830e4b0c9d6adf6c16c	58cfa830e4b0c9d6adf6c16c	TCGA-BA-5557-01A-01D-1509_120420_SN1120_0135_BD0T5FACXX_s_4_rg.sorted.filtered.	WGS	TCGA-BA-5557-01A-01D-1509_120420_SN1120_0135_BD0T5FACXX_s_4_rg.sorted	TCGA-BA-5557-01A-01D-1509_120420_SN1120_0135_BD0T5FACXX_s_4_rg.sorted.bam	52.7	1.9	0.16	58cfa830e4b0c9d6adf6c16c	TCGA-BA-5557-01A-01D-1509_120420_SN1120_0135_BD0T5FACXX_s_4_rg.sorted.bam	Alive	FEMALE	Not available	HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-BA-5557-01A	7E0575CE-670B-4035-8A90-4D35279707B2	Primary Tumor	Illumina HiSeq	bb531fb4-064f-47dd-8231-bd6131866968	Head and Neck	41	67D75889-E868-41F2-8255-5D5D1AA0A854	0DDC26B3-2D83-4539-A934-4B0FEF8D1F69	TCGA-BA-5557-01A-01D-1509-02	HG19_Broad_variant	TCGA-BA-5557	TCGA-HNSC	NA	s15617	Harvard Medical School	UNC	None	NO	T1	N1	Head and Neck Squamous Cell Carcinoma	Stage III	1509-02	TRUE
13722.58cfa830e4b0c9d6adf6bb3e	58cfa830e4b0c9d6adf6bb3e	TCGA-AA-A01S-01A-21D-A079_110402_SN208_0200_BB02BTABXX_s_6_rg.sorted.filtered.	WGS	TCGA-AA-A01S-01A-21D-A079_110402_SN208_0200_BB02BTABXX_s_6_rg.sorted	TCGA-AA-A01S-01A-21D-A079_110402_SN208_0200_BB02BTABXX_s_6_rg.sorted.bam	89.57	1.8	0.13	58cfa830e4b0c9d6adf6bb3e	TCGA-AA-A01S-01A-21D-A079_110402_SN208_0200_BB02BTABXX_s_6_rg.sorted.bam	Alive	FEMALE	Not available	Not available	Colon Adenocarcinoma	Aligned reads	TCGA-AA-A01S-01A	84E34CF2-B3BB-4A1A-8FB7-6C2C604C4008	Primary Tumor	Illumina HiSeq	fe7c227a-1329-4956-b9bf-08bbb6fe161d	Colorectal	47	5743700C-CBD3-4F87-8109-6349A96EB605	DC9E606A-12D6-4AA6-9780-1D999EB72C5A	TCGA-AA-A01S-01A-21D-A079-02	HG18_Broad_variant	TCGA-AA-A01S	TCGA-COAD	NA	s13206	Harvard Medical School	Indivumed	Germany	NO	T3	N1	Colon Adenocarcinoma	Stage III	A079-02	TRUE
13722.58cfa830e4b0c9d6adf6c17e	58cfa830e4b0c9d6adf6c17e	TCGA-BA-4074-01A-01D-1431_120310_SN590_0145_BD0RGYACXX_s_1_rg.sorted.filtered.	WGS	TCGA-BA-4074-01A-01D-1431_120310_SN590_0145_BD0RGYACXX_s_1_rg.sorted	TCGA-BA-4074-01A-01D-1431_120310_SN590_0145_BD0RGYACXX_s_1_rg.sorted.bam	598.33	1.9	0.16	58cfa830e4b0c9d6adf6c17e	TCGA-BA-4074-01A-01D-1431_120310_SN590_0145_BD0RGYACXX_s_1_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-BA-4074-01A	A63CA97D-EF31-4118-9547-A6730967290F	Primary Tumor	Illumina HiSeq	da78e5e3-ea94-4ac2-8b21-69809cabb0c7	Head and Neck	69	7BC6B159-19B4-4711-961D-830BC9E56493	4786A24C-D127-43FB-9D9C-FF59622B7B24	TCGA-BA-4074-01A-01D-1431-02	HG19_Broad_variant	TCGA-BA-4074	TCGA-HNSC	462	s16168	Harvard Medical School	UNC	None	NO	T2	N2c	Head and Neck Squamous Cell Carcinoma	Stage IVA	1431-02	TRUE
13722.58cfa830e4b0c9d6adf6c1db	58cfa830e4b0c9d6adf6c1db	TCGA-BB-4224-01A-01D-1431_120423_SN590_0153_BC0KJ3ACXX_s_1_rg.sorted.filtered.	WGS	TCGA-BB-4224-01A-01D-1431_120423_SN590_0153_BC0KJ3ACXX_s_1_rg.sorted	TCGA-BB-4224-01A-01D-1431_120423_SN590_0153_BC0KJ3ACXX_s_1_rg.sorted.bam	16.7	1.9	0.13	58cfa830e4b0c9d6adf6c1db	TCGA-BB-4224-01A-01D-1431_120423_SN590_0153_BC0KJ3ACXX_s_1_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-BB-4224-01A	58574E35-8A30-4207-B127-59FFF7C87A43	Primary Tumor	Illumina HiSeq	44a7ef3f-57df-49e2-80b9-1f0dca51067f	Head and Neck	52	077ACD68-8C30-41A6-BB7E-5B014866B807	E2FF93EB-AE22-4C6B-B4D5-181B9393BC64	TCGA-BB-4224-01A-01D-1431-02	HG19_Broad_variant	TCGA-BB-4224	TCGA-HNSC	NA	s15876	Harvard Medical School	Johns Hopkins	United States	NO	T2	N2b	Head and Neck Squamous Cell Carcinoma	Stage IVA	1431-02	TRUE
13722.58cfa830e4b0c9d6adf6c2e0	58cfa830e4b0c9d6adf6c2e0	TCGA-BT-A20P-01A-11D-A14U_120926_SN1222_0152_AC187DACXX_s_3_rg.sorted.filtered.	WGS	TCGA-BT-A20P-01A-11D-A14U_120926_SN1222_0152_AC187DACXX_s_3_rg.sorted	TCGA-BT-A20P-01A-11D-A14U_120926_SN1222_0152_AC187DACXX_s_3_rg.sorted.bam	75.72	2.03	0.15	58cfa830e4b0c9d6adf6c2e0	TCGA-BT-A20P-01A-11D-A14U_120926_SN1222_0152_AC187DACXX_s_3_rg.sorted.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-BT-A20P-01A	F48937ED-E294-41F0-8872-7010391167A9	Primary Tumor	Illumina HiSeq	814688fe-5071-40b6-bb89-643389543580	Bladder	81	6B43EEEC-4FEB-4062-827A-E63ED8CE3820	022AEFEC-CBAC-46C1-9F17-AC087BD7164E	TCGA-BT-A20P-01A-11D-A14U-02	HG19_Broad_variant	TCGA-BT-A20P	TCGA-BLCA	544	s3272	Harvard Medical School	University of Pittsburgh	United States	NO	T3a	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage III	A14U-02	TRUE
13722.58cfa831e4b0c9d6adf6c375	58cfa831e4b0c9d6adf6c375	TCGA-CG-4477-01A-01D-1154_121212_SN1120_0205_AC1F18ACXX_s_2_rg.sorted.filtered.	WGS	TCGA-CG-4477-01A-01D-1154_121212_SN1120_0205_AC1F18ACXX_s_2_rg.sorted	TCGA-CG-4477-01A-01D-1154_121212_SN1120_0205_AC1F18ACXX_s_2_rg.sorted.bam	281.2	1.9	0.14	58cfa831e4b0c9d6adf6c375	TCGA-CG-4477-01A-01D-1154_121212_SN1120_0205_AC1F18ACXX_s_2_rg.sorted.bam	Alive	FEMALE	Not available	Not available	Stomach Adenocarcinoma	Aligned reads	TCGA-CG-4477-01A	18D0AAE7-9694-4252-B8FE-16E62DADAB07	Primary Tumor	Illumina HiSeq	854ac518-e119-4ce6-97c4-b123e75a99ee	Stomach	58	6D7C7B4E-6913-487D-9DC3-DDA901434192	3AE56504-30EE-4C03-9F69-C5B415DE6738	TCGA-CG-4477-01A-01D-1154-02	HG19_Broad_variant	TCGA-CG-4477	TCGA-STAD	NA	s14907	Harvard Medical School	Indivumed	Germany	NO	T2a	N0	Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS)	Stage IB	1154-02	TRUE
13722.58cfa831e4b0c9d6adf6c356	58cfa831e4b0c9d6adf6c356	TCGA-CG-4477-01A-01D-1154_130815_VM001_0007_VMR0007CXX_s_2_rg.sorted.filtered.	WGS	TCGA-CG-4477-01A-01D-1154_130815_VM001_0007_VMR0007CXX_s_2_rg.sorted	TCGA-CG-4477-01A-01D-1154_130815_VM001_0007_VMR0007CXX_s_2_rg.sorted.bam	281.2	1.9	0.14	58cfa831e4b0c9d6adf6c356	TCGA-CG-4477-01A-01D-1154_130815_VM001_0007_VMR0007CXX_s_2_rg.sorted.bam	Alive	FEMALE	Not available	Not available	Stomach Adenocarcinoma	Aligned reads	TCGA-CG-4477-01A	18D0AAE7-9694-4252-B8FE-16E62DADAB07	Primary Tumor	Illumina HiSeq	6fb461b5-4d42-4cba-bc62-bb8f68c3deed	Stomach	58	6D7C7B4E-6913-487D-9DC3-DDA901434192	3AE56504-30EE-4C03-9F69-C5B415DE6738	TCGA-CG-4477-01A-01D-1154-02	HG19_Broad_variant	TCGA-CG-4477	TCGA-STAD	NA	s14637	Harvard Medical School	Indivumed	Germany	NO	T2a	N0	Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS)	Stage IB	1154-02	TRUE
13722.58cfa831e4b0c9d6adf6c3cb	58cfa831e4b0c9d6adf6c3cb	TCGA-C5-A3HD-01B-11D-A20X_140117_SN590_0245_AC371LACXX_s_1_rg.sorted.filtered.	WGS	TCGA-C5-A3HD-01B-11D-A20X_140117_SN590_0245_AC371LACXX_s_1_rg.sorted	TCGA-C5-A3HD-01B-11D-A20X_140117_SN590_0245_AC371LACXX_s_1_rg.sorted.bam	60.19	NA	0.16	58cfa831e4b0c9d6adf6c3cb	TCGA-C5-A3HD-01B-11D-A20X_140117_SN590_0245_AC371LACXX_s_1_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-C5-A3HD-01B	12427B02-6E3F-461C-B271-6AB230F628E7	Primary Tumor	Illumina HiSeq	475d850b-49e8-4f15-9f59-8d65bf9cf22d	Cervix	51	56AA88C8-AF6D-42BE-8672-074476F6575A	03576AE9-4222-48C3-A428-D85AEC400BD6	TCGA-C5-A3HD-01B-11D-A20X-26	HG19_Broad_variant	TCGA-C5-A3HD	TCGA-CESC	NA	s1171	MD Anderson - Institute for Applied Cancer Science	Medical College of Wisconsin	United States	NO	Not available	Not available	Cervical Squamous Cell Carcinoma	Not available	A20X-26	TRUE
13722.58cfa831e4b0c9d6adf6c3c2	58cfa831e4b0c9d6adf6c3c2	TCGA-BT-A20Q-01A-11D-A14U_120926_SN1222_0152_AC187DACXX_s_5_rg.sorted.filtered.	WGS	TCGA-BT-A20Q-01A-11D-A14U_120926_SN1222_0152_AC187DACXX_s_5_rg.sorted	TCGA-BT-A20Q-01A-11D-A14U_120926_SN1222_0152_AC187DACXX_s_5_rg.sorted.bam	56.34	2.11	0.15	58cfa831e4b0c9d6adf6c3c2	TCGA-BT-A20Q-01A-11D-A14U_120926_SN1222_0152_AC187DACXX_s_5_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-BT-A20Q-01A	419DEAAC-EA45-4BDD-9FA0-B5CD8429B44F	Primary Tumor	Illumina HiSeq	9d2dc2d3-8995-42b8-9bee-010c8bce06e0	Bladder	73	F3906CD4-31C7-48A8-935B-5B7FAFEC1AE7	72AF980B-98A8-4572-8AF9-EFD4294700F9	TCGA-BT-A20Q-01A-11D-A14U-02	HG19_Broad_variant	TCGA-BT-A20Q	TCGA-BLCA	593	s3083	Harvard Medical School	University of Pittsburgh	United States	NO	T3b	N2	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV	A14U-02	TRUE
13722.58cfa831e4b0c9d6adf6c4a2	58cfa831e4b0c9d6adf6c4a2	TCGA-CG-5732-01A-11D-1598_121023_SN208_0436_AC1CMBACXX_s_2_rg.sorted.filtered.	WGS	TCGA-CG-5732-01A-11D-1598_121023_SN208_0436_AC1CMBACXX_s_2_rg.sorted	TCGA-CG-5732-01A-11D-1598_121023_SN208_0436_AC1CMBACXX_s_2_rg.sorted.bam	180	1.9	0.16	58cfa831e4b0c9d6adf6c4a2	TCGA-CG-5732-01A-11D-1598_121023_SN208_0436_AC1CMBACXX_s_2_rg.sorted.bam	Alive	MALE	Not available	Not available	Stomach Adenocarcinoma	Aligned reads	TCGA-CG-5732-01A	E62D5F3C-0A99-4932-A589-BFF4FA02B1D3	Primary Tumor	Illumina HiSeq	3bc07391-1ef5-4bbf-9614-e3f31b8448c9	Stomach	66	5295412B-3D28-4774-85D8-3D38C682C343	E09E88E6-7697-4A1F-BF79-6DE9BE6E0960	TCGA-CG-5732-01A-11D-1598-02	HG19_Broad_variant	TCGA-CG-5732	TCGA-STAD	NA	s14491	Harvard Medical School	Indivumed	Germany	NO	T2	N3	Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS)	Stage IV	1598-02	TRUE
13722.58cfa831e4b0c9d6adf6c4d0	58cfa831e4b0c9d6adf6c4d0	TCGA-BT-A3PJ-01A-21D-A221_120906_SN208_0426_BC194HACXX_s_1_rg.sorted.filtered.	WGS	TCGA-BT-A3PJ-01A-21D-A221_120906_SN208_0426_BC194HACXX_s_1_rg.sorted	TCGA-BT-A3PJ-01A-21D-A221_120906_SN208_0426_BC194HACXX_s_1_rg.sorted.bam	55.89	NA	0.15	58cfa831e4b0c9d6adf6c4d0	TCGA-BT-A3PJ-01A-21D-A221_120906_SN208_0426_BC194HACXX_s_1_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-BT-A3PJ-01A	CB664EEF-BE6F-44EF-AA90-6F6DA0E6440A	Primary Tumor	Illumina HiSeq	cac436d2-b3cb-4351-953e-084c7a431f0f	Bladder	76	29D79B83-FA80-490E-A8A1-C51C9AD061FE	4BAD319F-9A5F-4257-863A-BCD8ED983EFE	TCGA-BT-A3PJ-01A-21D-A221-26	HG19_Broad_variant	TCGA-BT-A3PJ	TCGA-BLCA	NA	s2698	MD Anderson - Institute for Applied Cancer Science	University of Pittsburgh	United States	NO	T3a	N3	Muscle invasive urothelial carcinoma (pT2 or above)	Stage III	A221-26	TRUE
13722.58cfa831e4b0c9d6adf6c522	58cfa831e4b0c9d6adf6c522	TCGA-CN-4731-01A-01D-1431_120513_SN590_0157_AD0PU3ACXX_s_7_rg.sorted.filtered.	WGS	TCGA-CN-4731-01A-01D-1431_120513_SN590_0157_AD0PU3ACXX_s_7_rg.sorted	TCGA-CN-4731-01A-01D-1431_120513_SN590_0157_AD0PU3ACXX_s_7_rg.sorted.bam	31.7	1.9	0.14	58cfa831e4b0c9d6adf6c522	TCGA-CN-4731-01A-01D-1431_120513_SN590_0157_AD0PU3ACXX_s_7_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CN-4731-01A	50E25A4B-2EB2-4770-9A2D-8922A1E0AB56	Primary Tumor	Illumina HiSeq	50e66965-d2d5-49dd-a113-8b1751d6f7b7	Head and Neck	63	CD4E9D8C-B1F9-486A-ADCD-BD4B77A50326	981D992B-B92F-4E42-AA43-FC48068648A8	TCGA-CN-4731-01A-01D-1431-02	HG19_Broad_variant	TCGA-CN-4731	TCGA-HNSC	NA	s15753	Harvard Medical School	University of Pittsburgh	None	NO	T4a	N2c	Head and Neck Squamous Cell Carcinoma	Stage IVA	1431-02	TRUE
13722.58cfa831e4b0c9d6adf6c5d8	58cfa831e4b0c9d6adf6c5d8	TCGA-CN-5363-01A-01D-1431_120418_SN1222_0098_BD0T68ACXX_s_3_rg.sorted.filtered.	WGS	TCGA-CN-5363-01A-01D-1431_120418_SN1222_0098_BD0T68ACXX_s_3_rg.sorted	TCGA-CN-5363-01A-01D-1431_120418_SN1222_0098_BD0T68ACXX_s_3_rg.sorted.bam	197.7	1.9	0.15	58cfa831e4b0c9d6adf6c5d8	TCGA-CN-5363-01A-01D-1431_120418_SN1222_0098_BD0T68ACXX_s_3_rg.sorted.bam	Dead	MALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CN-5363-01A	291B069C-9DDE-4E1E-8430-85146BC94338	Primary Tumor	Illumina HiSeq	624b1e50-b5bd-4a3f-98fd-4514bff3244d	Head and Neck	48	5E4E1E21-8016-4E27-8F72-2411714203E8	BEB17091-BD47-4666-8E3A-7A397977EA41	TCGA-CN-5363-01A-01D-1431-02	HG19_Broad_variant	TCGA-CN-5363	TCGA-HNSC	253	s15891	Harvard Medical School	University of Pittsburgh	None	NO	T4a	N3	Head and Neck Squamous Cell Carcinoma	Stage IVB	1431-02	TRUE
13722.58cfa831e4b0c9d6adf6c60c	58cfa831e4b0c9d6adf6c60c	TCGA-CN-5360-01A-01D-1431_120418_SN1222_0098_BD0T68ACXX_s_1_rg.sorted.filtered.	WGS	TCGA-CN-5360-01A-01D-1431_120418_SN1222_0098_BD0T68ACXX_s_1_rg.sorted	TCGA-CN-5360-01A-01D-1431_120418_SN1222_0098_BD0T68ACXX_s_1_rg.sorted.bam	449.7	1.9	0.15	58cfa831e4b0c9d6adf6c60c	TCGA-CN-5360-01A-01D-1431_120418_SN1222_0098_BD0T68ACXX_s_1_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CN-5360-01A	5793879B-F663-4A10-9BD9-1ACD2E189650	Primary Tumor	Illumina HiSeq	56414402-7420-42b7-a93d-3d1f88308155	Head and Neck	68	0C00768E-8B13-4B8E-80FC-B344740845F1	7EE362C2-86AD-462C-B478-21255D96ED90	TCGA-CN-5360-01A-01D-1431-02	HG19_Broad_variant	TCGA-CN-5360	TCGA-HNSC	NA	s15883	Harvard Medical School	University of Pittsburgh	None	NO	T4a	N0	Head and Neck Squamous Cell Carcinoma	Stage IVA	1431-02	TRUE
13722.58cfa831e4b0c9d6adf6c5fc	58cfa831e4b0c9d6adf6c5fc	TCGA-CN-5369-01A-01D-1431_120420_SN1120_0134_AC0J8YACXX_s_3_rg.sorted.filtered.	WGS	TCGA-CN-5369-01A-01D-1431_120420_SN1120_0134_AC0J8YACXX_s_3_rg.sorted	TCGA-CN-5369-01A-01D-1431_120420_SN1120_0134_AC0J8YACXX_s_3_rg.sorted.bam	345.7	1.9	0.15	58cfa831e4b0c9d6adf6c5fc	TCGA-CN-5369-01A-01D-1431_120420_SN1120_0134_AC0J8YACXX_s_3_rg.sorted.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CN-5369-01A	B98867D7-7D5A-4C58-8878-37BEE6F2F4FA	Primary Tumor	Illumina HiSeq	bd85b141-d240-412f-9b74-379c4e3797d2	Head and Neck	90	B4C02606-0F86-46E4-9DAF-DC7DBCD60D78	1A532CA9-E72F-4906-867B-272A18CFEC79	TCGA-CN-5369-01A-01D-1431-02	HG19_Broad_variant	TCGA-CN-5369	TCGA-HNSC	380	s16323	Harvard Medical School	University of Pittsburgh	None	NO	T4a	N0	Head and Neck Squamous Cell Carcinoma	Stage IVA	1431-02	TRUE
13722.58cfa831e4b0c9d6adf6c60e	58cfa831e4b0c9d6adf6c60e	TCGA-CQ-6219-01A-11D-1911_120504_SN1222_0101_AC0UMDACXX_s_7_rg.sorted.filtered.	WGS	TCGA-CQ-6219-01A-11D-1911_120504_SN1222_0101_AC0UMDACXX_s_7_rg.sorted	TCGA-CQ-6219-01A-11D-1911_120504_SN1222_0101_AC0UMDACXX_s_7_rg.sorted.bam	187.7	1.9	0.16	58cfa831e4b0c9d6adf6c60e	TCGA-CQ-6219-01A-11D-1911_120504_SN1222_0101_AC0UMDACXX_s_7_rg.sorted.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CQ-6219-01A	0CA3D25A-22E9-4E40-834B-65F402535005	Primary Tumor	Illumina HiSeq	e1a5a3ec-64d9-4348-8104-4f08021e914e	Head and Neck	50	2AAD293C-B3ED-4BD7-971D-EA8A5EFC66AD	215B7B8C-E4D0-4CD2-B2B8-9CDC222EBF25	TCGA-CQ-6219-01A-11D-1911-02	HG19_Broad_variant	TCGA-CQ-6219	TCGA-HNSC	479	s15632	Harvard Medical School	University Health Network, Toronto	Canada	NO	T3	N2a	Head and Neck Squamous Cell Carcinoma	Stage IVA	1911-02	TRUE
13722.58cfa831e4b0c9d6adf6c661	58cfa831e4b0c9d6adf6c661	TCGA-CG-4443-01A-01D-1154_130815_VM001_0004_VMR0004CXX_s_3_rg.sorted.filtered.	WGS	TCGA-CG-4443-01A-01D-1154_130815_VM001_0004_VMR0004CXX_s_3_rg.sorted	TCGA-CG-4443-01A-01D-1154_130815_VM001_0004_VMR0004CXX_s_3_rg.sorted.bam	261.2	1.9	0.15	58cfa831e4b0c9d6adf6c661	TCGA-CG-4443-01A-01D-1154_130815_VM001_0004_VMR0004CXX_s_3_rg.sorted.bam	Alive	MALE	Not available	Not available	Stomach Adenocarcinoma	Aligned reads	TCGA-CG-4443-01A	8CB0144B-BE6B-40A1-86A2-708F96D9B615	Primary Tumor	Illumina HiSeq	d15f98aa-3849-4230-aea5-46a959ece810	Stomach	68	F4FB736A-42C9-4367-A327-D0D1C4CBA359	0FCF9057-D05B-480B-A17F-5FE35BFEB0CA	TCGA-CG-4443-01A-01D-1154-02	HG19_Broad_variant	TCGA-CG-4443	TCGA-STAD	NA	s15245	Harvard Medical School	Indivumed	Germany	NO	T1	N0	Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS)	Stage IA	1154-02	TRUE
13722.58cfa831e4b0c9d6adf6c5de	58cfa831e4b0c9d6adf6c5de	TCGA-CN-5364-01A-01D-1431_120418_SN1222_0098_BD0T68ACXX_s_4_rg.sorted.filtered.	WGS	TCGA-CN-5364-01A-01D-1431_120418_SN1222_0098_BD0T68ACXX_s_4_rg.sorted	TCGA-CN-5364-01A-01D-1431_120418_SN1222_0098_BD0T68ACXX_s_4_rg.sorted.bam	172.7	1.9	0.14	58cfa831e4b0c9d6adf6c5de	TCGA-CN-5364-01A-01D-1431_120418_SN1222_0098_BD0T68ACXX_s_4_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CN-5364-01A	13F63218-0949-41E6-A661-C844414C45B5	Primary Tumor	Illumina HiSeq	c408c80c-a712-46f0-8945-22511233d2bf	Head and Neck	55	38A4AC42-BE08-4187-98C2-AF861218C3DB	6CE3D597-51F1-4807-A28F-271F25F95ED4	TCGA-CN-5364-01A-01D-1431-02	HG19_Broad_variant	TCGA-CN-5364	TCGA-HNSC	493	s15767	Harvard Medical School	University of Pittsburgh	None	NO	T4a	N2c	Head and Neck Squamous Cell Carcinoma	Stage IVA	1431-02	TRUE
13722.58cfa831e4b0c9d6adf6c67d	58cfa831e4b0c9d6adf6c67d	TCGA-CG-4469-01A-01D-1154_121026_SN1120_0197_AC1878ACXX_s_3_rg.sorted.filtered.	WGS	TCGA-CG-4469-01A-01D-1154_121026_SN1120_0197_AC1878ACXX_s_3_rg.sorted	TCGA-CG-4469-01A-01D-1154_121026_SN1120_0197_AC1878ACXX_s_3_rg.sorted.bam	298.2	1.9	0.14	58cfa831e4b0c9d6adf6c67d	TCGA-CG-4469-01A-01D-1154_121026_SN1120_0197_AC1878ACXX_s_3_rg.sorted.bam	Dead	MALE	Not available	Not available	Stomach Adenocarcinoma	Aligned reads	TCGA-CG-4469-01A	2AC986F6-CD6F-4CA5-90CC-7A105CFE85EA	Primary Tumor	Illumina HiSeq	dcd0352b-a451-4eaa-840e-14884d08bd89	Stomach	70	2A3D7538-D377-4D94-BB61-BF77BA56BE1B	9BAFEA4B-CCC4-4F5D-8BFE-BD13D56741F6	TCGA-CG-4469-01A-01D-1154-02	HG19_Broad_variant	TCGA-CG-4469	TCGA-STAD	215	s14831	Harvard Medical School	Indivumed	Germany	NO	T3	N3	Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS)	Stage IV	1154-02	TRUE
13722.58cfa831e4b0c9d6adf6c66d	58cfa831e4b0c9d6adf6c66d	TCGA-CU-A0YN-01A-21D-A10R_120926_SN590_0182_BD1EAGACXX_s_3_rg.sorted.filtered.	WGS	TCGA-CU-A0YN-01A-21D-A10R_120926_SN590_0182_BD1EAGACXX_s_3_rg.sorted	TCGA-CU-A0YN-01A-21D-A10R_120926_SN590_0182_BD1EAGACXX_s_3_rg.sorted.bam	82.02	2	0.16	58cfa831e4b0c9d6adf6c66d	TCGA-CU-A0YN-01A-21D-A10R_120926_SN590_0182_BD1EAGACXX_s_3_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-CU-A0YN-01A	679A6869-2CE9-4472-8DB1-8869E2C1A440	Primary Tumor	Illumina HiSeq	89fcc222-6a37-406f-a641-b3d857104f9f	Bladder	60	DBCC2FCB-A103-46DA-9893-6EC689D2F98E	98E994A3-9823-472B-AED1-38876DEA7F24	TCGA-CU-A0YN-01A-21D-A10R-02	HG19_Broad_variant	TCGA-CU-A0YN	TCGA-BLCA	393	s3276	Harvard Medical School	UNC	United States	NO	T3a	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage III	A10R-02	TRUE
13722.58cfa831e4b0c9d6adf6c698	58cfa831e4b0c9d6adf6c698	TCGA-CN-5366-01A-01D-1431_120420_SN1120_0134_AC0J8YACXX_s_1_rg.sorted.filtered.	WGS	TCGA-CN-5366-01A-01D-1431_120420_SN1120_0134_AC0J8YACXX_s_1_rg.sorted	TCGA-CN-5366-01A-01D-1431_120420_SN1120_0134_AC0J8YACXX_s_1_rg.sorted.bam	313.7	1.9	0.16	58cfa831e4b0c9d6adf6c698	TCGA-CN-5366-01A-01D-1431_120420_SN1120_0134_AC0J8YACXX_s_1_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CN-5366-01A	30EB06A5-8E88-4C46-BEBB-FB93CA07F108	Primary Tumor	Illumina HiSeq	0a7fb0ab-3302-4187-a567-58bc19979dc5	Head and Neck	51	62FDF8F3-A028-453F-B27C-C2506BE68CBE	AE791AB1-78E2-4E8B-AB05-4435D9C67AA3	TCGA-CN-5366-01A-01D-1431-02	HG19_Broad_variant	TCGA-CN-5366	TCGA-HNSC	360	s15497	Harvard Medical School	University of Pittsburgh	None	NO	T4a	N2c	Head and Neck Squamous Cell Carcinoma	Stage IVA	1431-02	TRUE
13722.58cfa831e4b0c9d6adf6c718	58cfa831e4b0c9d6adf6c718	TCGA-D7-6528-01A-11D-1798_130218_SN208_0453_AC1T26ACXX_s_5_rg.sorted.filtered.	WGS	TCGA-D7-6528-01A-11D-1798_130218_SN208_0453_AC1T26ACXX_s_5_rg.sorted	TCGA-D7-6528-01A-11D-1798_130218_SN208_0453_AC1T26ACXX_s_5_rg.sorted.bam	303.4	1.9	0.15	58cfa831e4b0c9d6adf6c718	TCGA-D7-6528-01A-11D-1798_130218_SN208_0453_AC1T26ACXX_s_5_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-D7-6528-01A	35496E4E-598F-4FFC-B11E-8EDAEB676079	Primary Tumor	Illumina HiSeq	478ea84f-df8f-4d1b-a7da-ab1ac7751e97	Stomach	70	DF817250-9A2C-42E8-AD90-0D9E13FE37B3	7DA37A25-E2DE-4193-AD71-2182B6DA5C26	TCGA-D7-6528-01A-11D-1798-02	HG19_Broad_variant	TCGA-D7-6528	TCGA-STAD	NA	s14562	Harvard Medical School	Greater Poland Cancer Center	Poland	NO	T2	N0	Stomach  Intestinal Adenocarcinoma  Tubular Type	Stage IB	1798-02	TRUE
13722.58cfa831e4b0c9d6adf6c6c2	58cfa831e4b0c9d6adf6c6c2	TCGA-CN-4740-01A-01D-1431_120412_SN208_0283_AD0V1GACXX_s_5_rg.sorted.filtered.	WGS	TCGA-CN-4740-01A-01D-1431_120412_SN208_0283_AD0V1GACXX_s_5_rg.sorted	TCGA-CN-4740-01A-01D-1431_120412_SN208_0283_AD0V1GACXX_s_5_rg.sorted.bam	78.7	1.9	0.14	58cfa831e4b0c9d6adf6c6c2	TCGA-CN-4740-01A-01D-1431_120412_SN208_0283_AD0V1GACXX_s_5_rg.sorted.bam	Alive	FEMALE	WHITE	Not available	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CN-4740-01A	E37C83DC-C2C4-4E5F-A57B-39FFCF9AA3CF	Primary Tumor	Illumina HiSeq	c1580763-a5d9-4753-b80c-f8d5498a7494	Head and Neck	79	2311DEEC-8DBC-4449-BE09-FCD4E3BAFD87	9DD678DF-BCE7-46C2-8454-3DE815FB85ED	TCGA-CN-4740-01A-01D-1431-02	HG19_Broad_variant	TCGA-CN-4740	TCGA-HNSC	NA	s15884	Harvard Medical School	University of Pittsburgh	None	NO	T4a	N0	Head and Neck Squamous Cell Carcinoma	Stage IVA	1431-02	TRUE
13722.58cfa831e4b0c9d6adf6c75a	58cfa831e4b0c9d6adf6c75a	TCGA-D6-6515-01A-21D-1868_120530_SN1222_0110_AC0VLAACXX_s_7_rg.sorted.filtered.	WGS	TCGA-D6-6515-01A-21D-1868_120530_SN1222_0110_AC0VLAACXX_s_7_rg.sorted	TCGA-D6-6515-01A-21D-1868_120530_SN1222_0110_AC0VLAACXX_s_7_rg.sorted.bam	127.7	1.9	0.15	58cfa831e4b0c9d6adf6c75a	TCGA-D6-6515-01A-21D-1868_120530_SN1222_0110_AC0VLAACXX_s_7_rg.sorted.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-D6-6515-01A	8E0E456E-85EE-4DE5-8F0B-72393D6ACDE0	Primary Tumor	Illumina HiSeq	5a79073a-b6a0-41df-b26b-247649784d4d	Head and Neck	82	4453D224-F846-4CEE-972F-8438C964913B	D6E287D9-D7C4-496C-829F-F7D7980D77A2	TCGA-D6-6515-01A-21D-1868-02	HG19_Broad_variant	TCGA-D6-6515	TCGA-HNSC	403	s15914	Harvard Medical School	Greater Poland Cancer Center	Poland	NO	T2	N0	Head and Neck Squamous Cell Carcinoma	Stage II	1868-02	TRUE
13722.58cfa831e4b0c9d6adf6c774	58cfa831e4b0c9d6adf6c774	TCGA-D1-A174-01A-11D-A12F_120522_SN208_0301_BC0VNWACXX_s_3_rg.sorted.filtered.	WGS	TCGA-D1-A174-01A-11D-A12F_120522_SN208_0301_BC0VNWACXX_s_3_rg.sorted	TCGA-D1-A174-01A-11D-A12F_120522_SN208_0301_BC0VNWACXX_s_3_rg.sorted.bam	124.95	1.37	0.15	58cfa831e4b0c9d6adf6c774	TCGA-D1-A174-01A-11D-A12F_120522_SN208_0301_BC0VNWACXX_s_3_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-D1-A174-01A	FC7315B0-9F48-4206-B197-2268C0518EB4	Primary Tumor	Illumina HiSeq	6ec3f35d-55a7-439a-b179-8a4aebcab751	Uterus	51	AD5A9CB6-B3F9-4651-B6D1-13C78010BD88	D661CFB9-248A-49E6-B0DB-865CA257E8DC	TCGA-D1-A174-01A-11D-A12F-02	HG19_Broad_variant	TCGA-D1-A174	TCGA-UCEC	NA	s4614	Harvard Medical School	Mayo Clinic	None	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A12F-02	TRUE
13722.58cfa831e4b0c9d6adf6c778	58cfa831e4b0c9d6adf6c778	TCGA-D1-A17D-01A-12D-A12F_120522_SN208_0301_BC0VNWACXX_s_4_rg.sorted.filtered.	WGS	TCGA-D1-A17D-01A-12D-A12F_120522_SN208_0301_BC0VNWACXX_s_4_rg.sorted	TCGA-D1-A17D-01A-12D-A12F_120522_SN208_0301_BC0VNWACXX_s_4_rg.sorted.bam	99.41	2	0.15	58cfa831e4b0c9d6adf6c778	TCGA-D1-A17D-01A-12D-A12F_120522_SN208_0301_BC0VNWACXX_s_4_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-D1-A17D-01A	7DDEDDD1-B2AD-425F-94A2-9C476B959F2A	Primary Tumor	Illumina HiSeq	9d6f1593-568e-447d-b4f7-10048102ce8f	Uterus	58	9EC5A25B-9CE1-4FDE-9341-13DA39BC74B0	0F6ECDCA-5659-426A-8DAC-3211183597BD	TCGA-D1-A17D-01A-12D-A12F-02	HG19_Broad_variant	TCGA-D1-A17D	TCGA-UCEC	NA	s4443	Harvard Medical School	Mayo Clinic	None	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A12F-02	TRUE
13722.58cfa831e4b0c9d6adf6c87c	58cfa831e4b0c9d6adf6c87c	TCGA-CV-7414-01A-11D-2317_120730_SN1222_0140_AC11GKACXX_s_8_rg.sorted.filtered.	WGS	TCGA-CV-7414-01A-11D-2317_120730_SN1222_0140_AC11GKACXX_s_8_rg.sorted	TCGA-CV-7414-01A-11D-2317_120730_SN1222_0140_AC11GKACXX_s_8_rg.sorted.bam	79.73	NA	0.16	58cfa831e4b0c9d6adf6c87c	TCGA-CV-7414-01A-11D-2317_120730_SN1222_0140_AC11GKACXX_s_8_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-7414-01A	C3B2C38D-81A3-42FD-A41E-6F6DE3934007	Primary Tumor	Illumina HiSeq	d2264558-e25d-4169-9e22-8f3c23b50ad9	Head and Neck	78	7BE274D5-D5A0-4EF9-A65A-4127ED864F0C	A78CD28C-EDAF-4439-905B-44B4616DF078	TCGA-CV-7414-01A-11D-2317-26	HG19_Broad_variant	TCGA-CV-7414	TCGA-HNSC	14	s15523	MD Anderson - Institute for Applied Cancer Science	MD Anderson Cancer Center	United States	NO	T4a	N2b	Head and Neck Squamous Cell Carcinoma	Stage IVA	2317-26	TRUE
13722.58cfa831e4b0c9d6adf6c8b0	58cfa831e4b0c9d6adf6c8b0	TCGA-CV-7432-01A-11D-2317_120730_SN1222_0141_BC115GACXX_s_1_rg.sorted.filtered.	WGS	TCGA-CV-7432-01A-11D-2317_120730_SN1222_0141_BC115GACXX_s_1_rg.sorted	TCGA-CV-7432-01A-11D-2317_120730_SN1222_0141_BC115GACXX_s_1_rg.sorted.bam	222.73	NA	0.15	58cfa831e4b0c9d6adf6c8b0	TCGA-CV-7432-01A-11D-2317_120730_SN1222_0141_BC115GACXX_s_1_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-7432-01A	EAF674DD-9909-4879-B9A3-74253169EDDD	Primary Tumor	Illumina HiSeq	d1f8d81a-4553-4c26-9d59-534aa2475dca	Head and Neck	79	9213AB13-AFC6-40B9-B278-98DD05C92934	541FB07A-7568-4CFC-9FCD-C5B403C619BA	TCGA-CV-7432-01A-11D-2317-26	HG19_Broad_variant	TCGA-CV-7432	TCGA-HNSC	2570	s15783	MD Anderson - Institute for Applied Cancer Science	MD Anderson Cancer Center	United States	NO	T2	N0	Head and Neck Squamous Cell Carcinoma	Stage II	2317-26	TRUE
13722.58cfa831e4b0c9d6adf6c7e5	58cfa831e4b0c9d6adf6c7e5	TCGA-D1-A169-01A-11D-A12F_120522_SN208_0301_BC0VNWACXX_s_1_rg.sorted.filtered.	WGS	TCGA-D1-A169-01A-11D-A12F_120522_SN208_0301_BC0VNWACXX_s_1_rg.sorted	TCGA-D1-A169-01A-11D-A12F_120522_SN208_0301_BC0VNWACXX_s_1_rg.sorted.bam	68.97	1.95	0.15	58cfa831e4b0c9d6adf6c7e5	TCGA-D1-A169-01A-11D-A12F_120522_SN208_0301_BC0VNWACXX_s_1_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-D1-A169-01A	9A599F57-0E8D-4E1F-A181-791F5FDEADB7	Primary Tumor	Illumina HiSeq	43a5a914-7913-4e5e-9d2f-42fcec7bab2f	Uterus	63	9B36F264-55C3-4E08-A151-4B356871520C	B3A7C237-92C3-448A-A87E-8C8B1061A79F	TCGA-D1-A169-01A-11D-A12F-02	HG19_Broad_variant	TCGA-D1-A169	TCGA-UCEC	NA	s4796	Harvard Medical School	Mayo Clinic	None	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A12F-02	TRUE
13722.58cfa831e4b0c9d6adf6c988	58cfa831e4b0c9d6adf6c988	TCGA-DJ-A1QE-01A-21D-A14U_120711_SN1120_0173_AC0WN6ACXX_s_2_rg.sorted.filtered.	WGS	TCGA-DJ-A1QE-01A-21D-A14U_120711_SN1120_0173_AC0WN6ACXX_s_2_rg.sorted	TCGA-DJ-A1QE-01A-21D-A14U_120711_SN1120_0173_AC0WN6ACXX_s_2_rg.sorted.bam	36.64	2.05	0.17	58cfa831e4b0c9d6adf6c988	TCGA-DJ-A1QE-01A-21D-A14U_120711_SN1120_0173_AC0WN6ACXX_s_2_rg.sorted.bam	Alive	FEMALE	WHITE	Not available	Thyroid Carcinoma	Aligned reads	TCGA-DJ-A1QE-01A	DCCBA97D-4E81-42FB-93B3-90BE68A034FB	Primary Tumor	Illumina HiSeq	b2380599-45dd-48d5-840c-f6e358db7169	Thyroid	62	E8BF40C4-8F4D-4032-B18B-D61A87A2DD1A	FB93D33F-510B-45BD-8E70-8FD3A0EA5DBE	TCGA-DJ-A1QE-01A-21D-A14U-02	HG19_Broad_variant	TCGA-DJ-A1QE	TCGA-THCA	NA	s12635	Harvard Medical School	Memorial Sloan Kettering	United States	NO	T3	N0	Thyroid Papillary Carcinoma - Classical/usual	Stage III	A14U-02	TRUE
13722.58cfa831e4b0c9d6adf6c998	58cfa831e4b0c9d6adf6c998	TCGA-DK-A1A7-01A-11D-A13U_121025_SN590_0188_AC190CACXX_s_1_rg.sorted.filtered.	WGS	TCGA-DK-A1A7-01A-11D-A13U_121025_SN590_0188_AC190CACXX_s_1_rg.sorted	TCGA-DK-A1A7-01A-11D-A13U_121025_SN590_0188_AC190CACXX_s_1_rg.sorted.bam	35.04	2	0.15	58cfa831e4b0c9d6adf6c998	TCGA-DK-A1A7-01A-11D-A13U_121025_SN590_0188_AC190CACXX_s_1_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-DK-A1A7-01A	3ED614E7-F356-4D87-985B-D3BBBAE3BB40	Primary Tumor	Illumina HiSeq	4c14028a-f15d-42f9-ad5f-19f0dca3984e	Bladder	67	D68D16F7-6117-4D3D-8347-CF5CD3F23AE4	2DDD46A0-5304-4CA3-9AE3-AC3787D3C86A	TCGA-DK-A1A7-01A-11D-A13U-02	HG19_Broad_variant	TCGA-DK-A1A7	TCGA-BLCA	NA	s3280	Harvard Medical School	Memorial Sloan Kettering	United States	NO	T3	N2	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV	A13U-02	TRUE
13722.58cfa831e4b0c9d6adf6c9a8	58cfa831e4b0c9d6adf6c9a8	TCGA-DK-A1AG-01A-11D-A13U_121025_SN590_0188_AC190CACXX_s_7_rg.sorted.filtered.	WGS	TCGA-DK-A1AG-01A-11D-A13U_121025_SN590_0188_AC190CACXX_s_7_rg.sorted	TCGA-DK-A1AG-01A-11D-A13U_121025_SN590_0188_AC190CACXX_s_7_rg.sorted.bam	70.38	1.89	0.17	58cfa831e4b0c9d6adf6c9a8	TCGA-DK-A1AG-01A-11D-A13U_121025_SN590_0188_AC190CACXX_s_7_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-DK-A1AG-01A	F8C0A69C-DF53-4A0A-A30E-4424C0CE3DD5	Primary Tumor	Illumina HiSeq	4043eef2-fcc6-411c-a6a3-ddd71f3852d8	Bladder	65	64668AA0-DDE5-4534-8CD0-378881E4A4E4	69A3B1DB-3463-456C-B3D1-6BE1FD7EE1D9	TCGA-DK-A1AG-01A-11D-A13U-02	HG19_Broad_variant	TCGA-DK-A1AG	TCGA-BLCA	NA	s2885	Harvard Medical School	Memorial Sloan Kettering	United States	NO	T3	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage III	A13U-02	TRUE
13722.58cfa831e4b0c9d6adf6c9a0	58cfa831e4b0c9d6adf6c9a0	TCGA-DO-A1K0-01A-11D-A13U_120706_SN1222_0123_BD1488ACXX_s_3_rg.sorted.filtered.	WGS	TCGA-DO-A1K0-01A-11D-A13U_120706_SN1222_0123_BD1488ACXX_s_3_rg.sorted	TCGA-DO-A1K0-01A-11D-A13U_120706_SN1222_0123_BD1488ACXX_s_3_rg.sorted.bam	80.19	1.78	0.16	58cfa831e4b0c9d6adf6c9a0	TCGA-DO-A1K0-01A-11D-A13U_120706_SN1222_0123_BD1488ACXX_s_3_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-DO-A1K0-01A	B7A01148-5BAB-4268-986A-A9CF7BCA967F	Primary Tumor	Illumina HiSeq	52d6a725-e64a-4e5b-88cb-c4845dc97057	Thyroid	30	C25AED9B-A1B7-48A9-8587-8D218F6A9562	7BC99883-45C3-4ADF-8761-40B4836552F2	TCGA-DO-A1K0-01A-11D-A13U-02	HG19_Broad_variant	TCGA-DO-A1K0	TCGA-THCA	NA	s12245	Harvard Medical School	Medical College of Georgia	United States	NO	T3	N1b	Thyroid Papillary Carcinoma - Classical/usual	Stage I	A13U-02	TRUE
13722.58cfa831e4b0c9d6adf6c9b4	58cfa831e4b0c9d6adf6c9b4	TCGA-DJ-A13S-01A-11D-A10R_120711_SN1120_0174_BD13R2ACXX_s_6_rg.sorted.filtered.	WGS	TCGA-DJ-A13S-01A-11D-A10R_120711_SN1120_0174_BD13R2ACXX_s_6_rg.sorted	TCGA-DJ-A13S-01A-11D-A10R_120711_SN1120_0174_BD13R2ACXX_s_6_rg.sorted.bam	58.89	1.97	0.13	58cfa831e4b0c9d6adf6c9b4	TCGA-DJ-A13S-01A-11D-A10R_120711_SN1120_0174_BD13R2ACXX_s_6_rg.sorted.bam	Alive	FEMALE	WHITE	HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-DJ-A13S-01A	8AA99F35-C644-4F91-9EFF-A5D3FAE758B0	Primary Tumor	Illumina HiSeq	a19c2149-887d-4a36-992f-2a0ebb46072c	Thyroid	19	17952842-3447-4A38-90F4-D25B90C3233A	3C630C3D-343D-4F9F-8067-43B66466D382	TCGA-DJ-A13S-01A-11D-A10R-02	HG19_Broad_variant	TCGA-DJ-A13S	TCGA-THCA	NA	s12239	Harvard Medical School	Memorial Sloan Kettering	United States	NO	T1b	N0	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	Stage I	A10R-02	TRUE
13722.58cfa831e4b0c9d6adf6ca43	58cfa831e4b0c9d6adf6ca43	TCGA-DJ-A1QL-01A-11D-A14U_120711_SN1120_0173_AC0WN6ACXX_s_1_rg.sorted.filtered.	WGS	TCGA-DJ-A1QL-01A-11D-A14U_120711_SN1120_0173_AC0WN6ACXX_s_1_rg.sorted	TCGA-DJ-A1QL-01A-11D-A14U_120711_SN1120_0173_AC0WN6ACXX_s_1_rg.sorted.bam	77.76	1.96	0.18	58cfa831e4b0c9d6adf6ca43	TCGA-DJ-A1QL-01A-11D-A14U_120711_SN1120_0173_AC0WN6ACXX_s_1_rg.sorted.bam	Alive	MALE	Not available	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-DJ-A1QL-01A	E4B08E66-0772-4956-8670-E5C6553EECBE	Primary Tumor	Illumina HiSeq	115df95b-61fb-4fef-a23f-df0ade71c646	Thyroid	70	62B6D426-E1E4-48E8-BC8F-6B07C67CC0D0	C5B8FBAE-98B5-437B-A8BD-D695C5E8CB4F	TCGA-DJ-A1QL-01A-11D-A14U-02	HG19_Broad_variant	TCGA-DJ-A1QL	TCGA-THCA	NA	s12373	Harvard Medical School	Memorial Sloan Kettering	United States	NO	T2	N0	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	Stage II	A14U-02	TRUE
13722.58cfa831e4b0c9d6adf6cad2	58cfa831e4b0c9d6adf6cad2	TCGA-DI-A1BU-01A-11D-A133_120511_SN1120_0141_BC0VK9ACXX_s_7_rg.sorted.filtered.	WGS	TCGA-DI-A1BU-01A-11D-A133_120511_SN1120_0141_BC0VK9ACXX_s_7_rg.sorted	TCGA-DI-A1BU-01A-11D-A133_120511_SN1120_0141_BC0VK9ACXX_s_7_rg.sorted.bam	88.64	1.98	0.17	58cfa831e4b0c9d6adf6cad2	TCGA-DI-A1BU-01A-11D-A133_120511_SN1120_0141_BC0VK9ACXX_s_7_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-DI-A1BU-01A	53245616-E095-4616-89BB-6062669122DA	Primary Tumor	Illumina HiSeq	1a6e5cca-d65a-40c4-b8ce-b7b282493459	Uterus	55	241BFB1F-5CF8-458D-B335-18BABF507E85	085C72D3-C295-4D9B-A5CC-08F76CFF2284	TCGA-DI-A1BU-01A-11D-A133-02	HG19_Broad_variant	TCGA-DI-A1BU	TCGA-UCEC	NA	s4805	Harvard Medical School	MD Anderson	United States	NO	Not available	Not available	Mixed serous and endometrioid	Not available	A133-02	FALSE
13722.58cfa831e4b0c9d6adf6cb1a	58cfa831e4b0c9d6adf6cb1a	TCGA-E7-A3X6-01A-12D-A233_120829_SN1120_0184_BD1DRAACXX_s_5_rg.sorted.filtered.	WGS	TCGA-E7-A3X6-01A-12D-A233_120829_SN1120_0184_BD1DRAACXX_s_5_rg.sorted	TCGA-E7-A3X6-01A-12D-A233_120829_SN1120_0184_BD1DRAACXX_s_5_rg.sorted.bam	39.5	NA	0.15	58cfa831e4b0c9d6adf6cb1a	TCGA-E7-A3X6-01A-12D-A233_120829_SN1120_0184_BD1DRAACXX_s_5_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-E7-A3X6-01A	C871EA6B-FBD2-4E6F-AB29-F43F6E3DDCBB	Primary Tumor	Illumina HiSeq	548e206a-eaec-49d3-a405-664cf76d0e16	Bladder	70	554AE735-9991-4CB3-AFE8-4951490BD709	AE6DC0A6-7405-44C2-886F-E10BAD336295	TCGA-E7-A3X6-01A-12D-A233-26	HG19_Broad_variant	TCGA-E7-A3X6	TCGA-BLCA	NA	s3291	MD Anderson - Institute for Applied Cancer Science	Asterand	Ukraine	NO	T2	NX	Muscle invasive urothelial carcinoma (pT2 or above)	Stage II	A233-26	TRUE
13722.58cfa831e4b0c9d6adf6cc16	58cfa831e4b0c9d6adf6cc16	TCGA-DU-7294-01A-11D-2022_130911_SN1222_0218_BC2A1NACXX_s_3_rg.sorted.filtered.	WGS	TCGA-DU-7294-01A-11D-2022_130911_SN1222_0218_BC2A1NACXX_s_3_rg.sorted	TCGA-DU-7294-01A-11D-2022_130911_SN1222_0218_BC2A1NACXX_s_3_rg.sorted.bam	62.7	NA	0.17	58cfa831e4b0c9d6adf6cc16	TCGA-DU-7294-01A-11D-2022_130911_SN1222_0218_BC2A1NACXX_s_3_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-DU-7294-01A	3F6FFB08-32A9-4555-BFD1-243B7F526105	Primary Tumor	Illumina HiSeq	2df0ab9f-8d32-40e9-883d-f5afad653272	Brain	53	C2D0A3C8-2354-475C-9027-5DF9523391CE	E6552DAE-BDEA-4945-9BA9-9C88D34CEBBC	TCGA-DU-7294-01A-11D-2022-02	HG19_Broad_variant	TCGA-DU-7294	TCGA-LGG	NA	s8362	Harvard Medical School	Henry Ford Hospital	United States	NO	Not available	Not available	Oligodendroglioma	Not available	2022-02	TRUE
13722.58cfa831e4b0c9d6adf6cbd0	58cfa831e4b0c9d6adf6cbd0	TCGA-EJ-7125-01A-11D-1957_130221_SN1120_0239_BD1V59ACXX_s_7_rg.sorted.filtered.	WGS	TCGA-EJ-7125-01A-11D-1957_130221_SN1120_0239_BD1V59ACXX_s_7_rg.sorted	TCGA-EJ-7125-01A-11D-1957_130221_SN1120_0239_BD1V59ACXX_s_7_rg.sorted.bam	118.7	NA	0.15	58cfa831e4b0c9d6adf6cbd0	TCGA-EJ-7125-01A-11D-1957_130221_SN1120_0239_BD1V59ACXX_s_7_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-EJ-7125-01A	ACA312AB-6DBD-4183-8B22-8F37834F3426	Primary Tumor	Illumina HiSeq	c476525e-5147-4afb-bed0-f9ad34226240	Prostate	44	08E17DE6-FE0D-4FF0-B588-1CF1AB03F594	4BAD4379-B8AB-4D28-968E-5729602757EB	TCGA-EJ-7125-01A-11D-1957-02	HG19_Broad_variant	TCGA-EJ-7125	TCGA-PRAD	NA	s3442	Harvard Medical School	University of Pittsburgh	United States	NO	T2c	N0	Prostate Adenocarcinoma Acinar Type	Not available	1957-02	TRUE
13722.58cfa831e4b0c9d6adf6cc87	58cfa831e4b0c9d6adf6cc87	TCGA-EM-A3O6-01A-11D-A221_120524_SN1120_0144_AC0VNCACXX_s_1_rg.sorted.filtered.	WGS	TCGA-EM-A3O6-01A-11D-A221_120524_SN1120_0144_AC0VNCACXX_s_1_rg.sorted	TCGA-EM-A3O6-01A-11D-A221_120524_SN1120_0144_AC0VNCACXX_s_1_rg.sorted.bam	44.88	NA	0.15	58cfa831e4b0c9d6adf6cc87	TCGA-EM-A3O6-01A-11D-A221_120524_SN1120_0144_AC0VNCACXX_s_1_rg.sorted.bam	Alive	FEMALE	Not available	Not available	Thyroid Carcinoma	Aligned reads	TCGA-EM-A3O6-01A	398D5C2E-F877-4BBF-A10C-486B8523C9CE	Primary Tumor	Illumina HiSeq	efd1fae6-df5c-4d7d-9579-296f0077b186	Thyroid	54	B3E6F726-256B-450B-B3F5-A1BB9AAB9C15	FA63C656-1DD5-4A92-9AE8-36B3408E00C7	TCGA-EM-A3O6-01A-11D-A221-26	HG19_Broad_variant	TCGA-EM-A3O6	TCGA-THCA	NA	s12114	MD Anderson - Institute for Applied Cancer Science	University Health Network	Canada	NO	T2	NX	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	Stage II	A221-26	TRUE
13722.58cfa831e4b0c9d6adf6ccc6	58cfa831e4b0c9d6adf6ccc6	TCGA-EM-A1CS-01A-11D-A13U_120711_SN1120_0173_AC0WN6ACXX_s_5_rg.sorted.filtered.	WGS	TCGA-EM-A1CS-01A-11D-A13U_120711_SN1120_0173_AC0WN6ACXX_s_5_rg.sorted	TCGA-EM-A1CS-01A-11D-A13U_120711_SN1120_0173_AC0WN6ACXX_s_5_rg.sorted.bam	69.84	1.88	0.18	58cfa831e4b0c9d6adf6ccc6	TCGA-EM-A1CS-01A-11D-A13U_120711_SN1120_0173_AC0WN6ACXX_s_5_rg.sorted.bam	Alive	FEMALE	Not available	Not available	Thyroid Carcinoma	Aligned reads	TCGA-EM-A1CS-01A	E92BDB0D-969A-4D98-ADA8-5DFEC68119B5	Primary Tumor	Illumina HiSeq	b6cf1366-a645-4bd9-ac5f-0e8c5d18a4ca	Thyroid	55	C1DAF740-06E2-4509-86BE-5BFCC52B508A	67082C81-DE62-42A4-82B7-CB6BE2C961D3	TCGA-EM-A1CS-01A-11D-A13U-02	HG19_Broad_variant	TCGA-EM-A1CS	TCGA-THCA	NA	s12251	Harvard Medical School	University Health Network	Canada	NO	T1	N0	Thyroid Papillary Carcinoma - Classical/usual	Stage I	A13U-02	TRUE
13722.58cfa831e4b0c9d6adf6cd12	58cfa831e4b0c9d6adf6cd12	TCGA-FD-A3SJ-01A-12D-A233_120830_SN208_0423_AC190AACXX_s_1_rg.sorted.filtered.	WGS	TCGA-FD-A3SJ-01A-12D-A233_120830_SN208_0423_AC190AACXX_s_1_rg.sorted	TCGA-FD-A3SJ-01A-12D-A233_120830_SN208_0423_AC190AACXX_s_1_rg.sorted.bam	30.78	NA	0.17	58cfa831e4b0c9d6adf6cd12	TCGA-FD-A3SJ-01A-12D-A233_120830_SN208_0423_AC190AACXX_s_1_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-FD-A3SJ-01A	6D8D8169-0C1A-4CDB-BE6F-9761C981A369	Primary Tumor	Illumina HiSeq	2635ae0a-878a-4237-ad5c-5f0092134ee3	Bladder	59	491A8898-7CC5-45D9-9502-FD24399C239D	E9F8EE08-E951-41A8-88AB-E7A98618EECC	TCGA-FD-A3SJ-01A-12D-A233-26	HG19_Broad_variant	TCGA-FD-A3SJ	TCGA-BLCA	739	s2909	MD Anderson - Institute for Applied Cancer Science	BLN - University Of Chicago	United States	NO	T2b	N2	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV	A233-26	TRUE
13722.58cfa831e4b0c9d6adf6cd1e	58cfa831e4b0c9d6adf6cd1e	TCGA-EX-A1H6-01B-11D-A232_140124_SN208_0506_BC2PD5ACXX_s_3_rg.sorted.filtered.	WGS	TCGA-EX-A1H6-01B-11D-A232_140124_SN208_0506_BC2PD5ACXX_s_3_rg.sorted	TCGA-EX-A1H6-01B-11D-A232_140124_SN208_0506_BC2PD5ACXX_s_3_rg.sorted.bam	47.39	NA	0.16	58cfa831e4b0c9d6adf6cd1e	TCGA-EX-A1H6-01B-11D-A232_140124_SN208_0506_BC2PD5ACXX_s_3_rg.sorted.bam	Alive	FEMALE	WHITE	Not available	Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-EX-A1H6-01B	1FE594D9-4240-49EE-8AFD-C7D16A377181	Primary Tumor	Illumina HiSeq	32948425-770d-4a87-8c3d-ade77ab0391d	Cervix	38	FE018D31-EEE8-4335-96A1-95ECEABFADF1	DD730721-CEC0-4034-B18D-588A200D4D76	TCGA-EX-A1H6-01B-11D-A232-26	HG19_Broad_variant	TCGA-EX-A1H6	TCGA-CESC	NA	s1197	MD Anderson - Institute for Applied Cancer Science	University of North Carolina	United States	NO	T1b1	N0	Endocervical Type of Adenocarcinoma	Not available	A232-26	TRUE
13722.58cfa831e4b0c9d6adf6cd39	58cfa831e4b0c9d6adf6cd39	TCGA-ET-A25L-01A-11D-A16N_120718_SN590_0169_AC0WL7ACXX_s_6_rg.sorted.filtered.	WGS	TCGA-ET-A25L-01A-11D-A16N_120718_SN590_0169_AC0WL7ACXX_s_6_rg.sorted	TCGA-ET-A25L-01A-11D-A16N_120718_SN590_0169_AC0WL7ACXX_s_6_rg.sorted.bam	63.41	1.93	0.17	58cfa831e4b0c9d6adf6cd39	TCGA-ET-A25L-01A-11D-A16N_120718_SN590_0169_AC0WL7ACXX_s_6_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-ET-A25L-01A	4481D84D-109E-44A0-BCB4-E6E61BDCE796	Primary Tumor	Illumina HiSeq	bd558097-490f-4ee3-af4a-093fd4aebaf1	Thyroid	52	7D90939F-BAB7-4A39-8D57-79540142BB63	3490DBDC-8BFC-476F-BC1F-2D142365D9A2	TCGA-ET-A25L-01A-11D-A16N-02	HG19_Broad_variant	TCGA-ET-A25L	TCGA-THCA	NA	s12524	Harvard Medical School	Johns Hopkins	United States	NO	T3	N1b	Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features)	Stage IVA	A16N-02	TRUE
13722.58cfa831e4b0c9d6adf6cd64	58cfa831e4b0c9d6adf6cd64	TCGA-FD-A3SS-01A-12D-A233_120905_SN1120_0187_AD1E4NACXX_s_1_rg.sorted.filtered.	WGS	TCGA-FD-A3SS-01A-12D-A233_120905_SN1120_0187_AD1E4NACXX_s_1_rg.sorted	TCGA-FD-A3SS-01A-12D-A233_120905_SN1120_0187_AD1E4NACXX_s_1_rg.sorted.bam	37.16	NA	0.15	58cfa831e4b0c9d6adf6cd64	TCGA-FD-A3SS-01A-12D-A233_120905_SN1120_0187_AD1E4NACXX_s_1_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-FD-A3SS-01A	7B98B829-FDC7-4719-BEE9-C83F6154019C	Primary Tumor	Illumina HiSeq	23aab0ed-a2ae-43db-9050-527db1729aa5	Bladder	66	015E6B08-AB3C-4D1D-99E4-77B5E10BD7FC	315B09D3-D014-4EF1-9CAC-AD5F63F6024A	TCGA-FD-A3SS-01A-12D-A233-26	HG19_Broad_variant	TCGA-FD-A3SS	TCGA-BLCA	NA	s3302	MD Anderson - Institute for Applied Cancer Science	BLN - University Of Chicago	United States	NO	T4	N3	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV	A233-26	TRUE
13722.58cfa831e4b0c9d6adf6cd7e	58cfa831e4b0c9d6adf6cd7e	TCGA-FE-A3PD-01A-11D-A221_120611_SN1222_0115_BD141KACXX_s_7_rg.sorted.filtered.	WGS	TCGA-FE-A3PD-01A-11D-A221_120611_SN1222_0115_BD141KACXX_s_7_rg.sorted	TCGA-FE-A3PD-01A-11D-A221_120611_SN1222_0115_BD141KACXX_s_7_rg.sorted.bam	59.24	NA	0.15	58cfa831e4b0c9d6adf6cd7e	TCGA-FE-A3PD-01A-11D-A221_120611_SN1222_0115_BD141KACXX_s_7_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-FE-A3PD-01A	39D90499-8549-4DA5-B391-C421F18FACF1	Primary Tumor	Illumina HiSeq	66155739-2eb1-4230-8b24-645dca4e0c0d	Thyroid	17	A6C23CA9-E6F4-4A2C-BB86-25EF76076381	3F63EB17-5F71-4EEC-AEF5-1D4FF328043C	TCGA-FE-A3PD-01A-11D-A221-26	HG19_Broad_variant	TCGA-FE-A3PD	TCGA-THCA	NA	s12390	MD Anderson - Institute for Applied Cancer Science	Ohio State University	United States	NO	T2	N0	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	Stage I	A221-26	TRUE
13722.58cfa831e4b0c9d6adf6cd90	58cfa831e4b0c9d6adf6cd90	TCGA-FE-A3PA-01A-12D-A221_120611_SN1222_0114_AC0WL3ACXX_s_1_rg.sorted.filtered.	WGS	TCGA-FE-A3PA-01A-12D-A221_120611_SN1222_0114_AC0WL3ACXX_s_1_rg.sorted	TCGA-FE-A3PA-01A-12D-A221_120611_SN1222_0114_AC0WL3ACXX_s_1_rg.sorted.bam	44.72	NA	0.15	58cfa831e4b0c9d6adf6cd90	TCGA-FE-A3PA-01A-12D-A221_120611_SN1222_0114_AC0WL3ACXX_s_1_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-FE-A3PA-01A	10BDAFBB-831D-48B5-B9A3-AD374FC50235	Primary Tumor	Illumina HiSeq	0d67cded-ff5a-4b7c-bc1e-2bda8ee44700	Thyroid	16	D37BED2A-BF63-43E0-91D0-6C95E4CA2D45	DBD2621E-9F39-45C6-B9AE-67873AECA03D	TCGA-FE-A3PA-01A-12D-A221-26	HG19_Broad_variant	TCGA-FE-A3PA	TCGA-THCA	NA	s12760	MD Anderson - Institute for Applied Cancer Science	Ohio State University	United States	NO	T4	N0	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	Stage II	A221-26	TRUE
13722.58cfa832e4b0c9d6adf6cef7	58cfa832e4b0c9d6adf6cef7	TCGA-IG-A5B8-01A-11D-A28P_131120_SN1222_0230_BC29YPACXX_s_3_rg.sorted.filtered.	WGS	TCGA-IG-A5B8-01A-11D-A28P_131120_SN1222_0230_BC29YPACXX_s_3_rg.sorted	TCGA-IG-A5B8-01A-11D-A28P_131120_SN1222_0230_BC29YPACXX_s_3_rg.sorted.bam	23.16	NA	0.14	58cfa832e4b0c9d6adf6cef7	TCGA-IG-A5B8-01A-11D-A28P_131120_SN1222_0230_BC29YPACXX_s_3_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Esophageal Carcinoma	Aligned reads	TCGA-IG-A5B8-01A	A4D36E09-5D8E-4006-855C-E466682B6813	Primary Tumor	Illumina HiSeq	948983f4-15f3-4b59-983e-18a248b1f4d9	Esophagus	72	C7E7425E-1F33-42B3-A2A2-ADDAAE6365E9	09D7FAFF-2E10-4C45-BB7E-E58B50911EFE	TCGA-IG-A5B8-01A-11D-A28P-26	HG19_Broad_variant	TCGA-IG-A5B8	TCGA-ESCA	24	s1817	MD Anderson - Institute for Applied Cancer Science	Asterand	Ukraine	NO	T3	N0	Not available	Stage IB	A28P-26	TRUE
13722.58cfa832e4b0c9d6adf6ceba	58cfa832e4b0c9d6adf6ceba	TCGA-FD-A3B4-01A-12D-A204_121002_SN1222_0155_BD1ERHACXX_s_3_rg.sorted.filtered.	WGS	TCGA-FD-A3B4-01A-12D-A204_121002_SN1222_0155_BD1ERHACXX_s_3_rg.sorted	TCGA-FD-A3B4-01A-12D-A204_121002_SN1222_0155_BD1ERHACXX_s_3_rg.sorted.bam	41.92	NA	0.16	58cfa832e4b0c9d6adf6ceba	TCGA-FD-A3B4-01A-12D-A204_121002_SN1222_0155_BD1ERHACXX_s_3_rg.sorted.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-FD-A3B4-01A	899F8D52-4C3A-4371-90EB-1F106001EDDC	Primary Tumor	Illumina HiSeq	54b70ff2-6c53-438c-934a-97fe2837620e	Bladder	55	6895A68F-0EFD-4B0E-8CF2-9195833DBBA1	7E975842-6EB5-4D66-A2F1-7EA7E8E989FC	TCGA-FD-A3B4-01A-12D-A204-02	HG19_Broad_variant	TCGA-FD-A3B4	TCGA-BLCA	NA	s3111	Harvard Medical School	BLN - University Of Chicago	United States	NO	T4a	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage III	A204-02	TRUE
13722.58cfa832e4b0c9d6adf6ce42	58cfa832e4b0c9d6adf6ce42	TCGA-ET-A25J-01A-11D-A16N_120718_SN590_0169_AC0WL7ACXX_s_1_rg.sorted.filtered.	WGS	TCGA-ET-A25J-01A-11D-A16N_120718_SN590_0169_AC0WL7ACXX_s_1_rg.sorted	TCGA-ET-A25J-01A-11D-A16N_120718_SN590_0169_AC0WL7ACXX_s_1_rg.sorted.bam	57.24	2	0.17	58cfa832e4b0c9d6adf6ce42	TCGA-ET-A25J-01A-11D-A16N_120718_SN590_0169_AC0WL7ACXX_s_1_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-ET-A25K-01A	2F9ED09D-2626-4C23-BA47-1850D36F812A	Primary Tumor	Illumina HiSeq	970a6dab-c1e4-4446-968a-4b37d1506eeb	Thyroid	36	343311B1-D586-4F92-9984-32AF1AFB1F62	663173D3-A9EE-4E73-8444-52F01727BE6D	TCGA-ET-A25K-01A-11D-A16N-02	HG19_Broad_variant	TCGA-ET-A25K	TCGA-THCA	NA	s12757	Harvard Medical School	Johns Hopkins	United States	NO	T2	N1a	Thyroid Papillary Carcinoma - Classical/usual	Stage I	A16N-02	TRUE
13722.58cfa832e4b0c9d6adf6ce5a	58cfa832e4b0c9d6adf6ce5a	TCGA-GV-A3QG-01A-11D-A221_120830_SN590_0178_AD143RACXX_s_3_rg.sorted.filtered.	WGS	TCGA-GV-A3QG-01A-11D-A221_120830_SN590_0178_AD143RACXX_s_3_rg.sorted	TCGA-GV-A3QG-01A-11D-A221_120830_SN590_0178_AD143RACXX_s_3_rg.sorted.bam	32.14	NA	0.15	58cfa832e4b0c9d6adf6ce5a	TCGA-GV-A3QG-01A-11D-A221_120830_SN590_0178_AD143RACXX_s_3_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-GV-A3QG-01A	79F23A0E-5AAE-4618-8191-7DD7C0552408	Primary Tumor	Illumina HiSeq	2102b9a0-6afe-47a9-89ae-9778452a6dcd	Bladder	65	FB9B1639-242F-4019-937F-DD13C40D9C2B	27EDCB5C-D1E4-4683-A967-A436E22D1958	TCGA-GV-A3QG-01A-11D-A221-26	HG19_Broad_variant	TCGA-GV-A3QG	TCGA-BLCA	NA	s3309	MD Anderson - Institute for Applied Cancer Science	BLN - Cleveland Clinic	United States	NO	T3a	N3	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV	A221-26	TRUE
13722.58cfa832e4b0c9d6adf6cefe	58cfa832e4b0c9d6adf6cefe	TCGA-H2-A3RI-01A-11D-A221_120610_SN1120_0152_BD13TDACXX_s_2_rg.sorted.filtered.	WGS	TCGA-H2-A3RI-01A-11D-A221_120610_SN1120_0152_BD13TDACXX_s_2_rg.sorted	TCGA-H2-A3RI-01A-11D-A221_120610_SN1120_0152_BD13TDACXX_s_2_rg.sorted.bam	58.31	NA	0.15	58cfa832e4b0c9d6adf6cefe	TCGA-H2-A3RI-01A-11D-A221_120610_SN1120_0152_BD13TDACXX_s_2_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-H2-A3RI-01A	BF193C4F-FBAC-41BC-B1AF-19B6CE856F0F	Primary Tumor	Illumina HiSeq	24a690e4-62f0-4e09-bbb1-ec78dafcf3cd	Thyroid	29	EAAE1A05-7D7E-406A-A02B-282A8B66F95C	5E15CB1B-B0D3-4FB9-9B30-3AEBE4DFC96B	TCGA-H2-A3RI-01A-11D-A221-26	HG19_Broad_variant	TCGA-H2-A3RI	TCGA-THCA	NA	s12259	MD Anderson - Institute for Applied Cancer Science	Christiana Healthcare	United States	NO	T3	N0	Thyroid Papillary Carcinoma - Classical/usual	Stage I	A221-26	TRUE
13722.58cfa832e4b0c9d6adf6cf94	58cfa832e4b0c9d6adf6cf94	TCGA-FU-A3NI-01A-11D-A245_140124_SN1440_0178_AC2PL6ACXX_s_8_rg.sorted.filtered.	WGS	TCGA-FU-A3NI-01A-11D-A245_140124_SN1440_0178_AC2PL6ACXX_s_8_rg.sorted	TCGA-FU-A3NI-01A-11D-A245_140124_SN1440_0178_AC2PL6ACXX_s_8_rg.sorted.bam	36.82	NA	0.16	58cfa832e4b0c9d6adf6cf94	TCGA-FU-A3NI-01A-11D-A245_140124_SN1440_0178_AC2PL6ACXX_s_8_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-FU-A3NI-01A	DAC27C24-CDBF-4527-9214-178FDE3D098A	Primary Tumor	Illumina HiSeq	e3d152ec-0ab5-4fb6-b2ca-ecdb79e43095	Cervix	45	C75C6FD3-79EF-48B8-B3BD-D097EF2A73AD	90DC57B8-74B7-4FB0-9EE7-52A4264D395F	TCGA-FU-A3NI-01A-11D-A245-26	HG19_Broad_variant	TCGA-FU-A3NI	TCGA-CESC	NA	s1204	MD Anderson - Institute for Applied Cancer Science	International Genomics Consortium	United States	NO	T1b1	N1	Cervical Squamous Cell Carcinoma	Not available	A245-26	TRUE
13722.58cfa832e4b0c9d6adf6cf97	58cfa832e4b0c9d6adf6cf97	TCGA-G9-6362-01A-11D-1784_130215_SN590_0211_AC1UJWACXX_s_3_rg.sorted.filtered.	WGS	TCGA-G9-6362-01A-11D-1784_130215_SN590_0211_AC1UJWACXX_s_3_rg.sorted	TCGA-G9-6362-01A-11D-1784_130215_SN590_0211_AC1UJWACXX_s_3_rg.sorted.bam	385.4	1.8	0.13	58cfa832e4b0c9d6adf6cf97	TCGA-G9-6362-01A-11D-1784_130215_SN590_0211_AC1UJWACXX_s_3_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-G9-6362-01A	F228EF91-ECFB-4D1E-8E6A-B43D2185270E	Primary Tumor	Illumina HiSeq	04834dec-1ae4-4a26-956a-f51c69d6c324	Prostate	57	1A626C6C-3DD9-4D87-BB93-CB2FEB82FBE8	A9B195C5-0441-4C98-8314-C50ECA082994	TCGA-G9-6362-01A-11D-1784-02	HG19_Broad_variant	TCGA-G9-6362	TCGA-PRAD	NA	s4149	Harvard Medical School	Roswell Park	United States	NO	T3a	N0	Prostate Adenocarcinoma Acinar Type	Not available	1784-02	TRUE
13722.58cfa832e4b0c9d6adf6cfa8	58cfa832e4b0c9d6adf6cfa8	TCGA-GV-A3JV-01A-11D-A221_120830_SN590_0178_AD143RACXX_s_1_rg.sorted.filtered.	WGS	TCGA-GV-A3JV-01A-11D-A221_120830_SN590_0178_AD143RACXX_s_1_rg.sorted	TCGA-GV-A3JV-01A-11D-A221_120830_SN590_0178_AD143RACXX_s_1_rg.sorted.bam	63.27	NA	0.14	58cfa832e4b0c9d6adf6cfa8	TCGA-GV-A3JV-01A-11D-A221_120830_SN590_0178_AD143RACXX_s_1_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-GV-A3JV-01A	01EE41EF-1894-4408-9E96-A22A1F068190	Primary Tumor	Illumina HiSeq	8f626567-33e0-4b6a-974f-6b41b341c60e	Bladder	66	55072935-CD20-4355-897B-F60F77A18847	E5863D29-E61D-4EE2-B04E-FE61C9B9CA5E	TCGA-GV-A3JV-01A-11D-A221-26	HG19_Broad_variant	TCGA-GV-A3JV	TCGA-BLCA	NA	s3308	MD Anderson - Institute for Applied Cancer Science	BLN - Cleveland Clinic	United States	NO	T3b	N1	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV	A221-26	TRUE
13722.58cfa832e4b0c9d6adf6cff5	58cfa832e4b0c9d6adf6cff5	TCGA-G9-6370-01A-11D-1784_130215_SN590_0212_BC1NP2ACXX_s_5_rg.sorted.filtered.	WGS	TCGA-G9-6370-01A-11D-1784_130215_SN590_0212_BC1NP2ACXX_s_5_rg.sorted	TCGA-G9-6370-01A-11D-1784_130215_SN590_0212_BC1NP2ACXX_s_5_rg.sorted.bam	59.4	2	0.14	58cfa832e4b0c9d6adf6cff5	TCGA-G9-6370-01A-11D-1784_130215_SN590_0212_BC1NP2ACXX_s_5_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-G9-6370-01A	F947B0BC-BDAC-44E8-B5B9-FFAE4147740A	Primary Tumor	Illumina HiSeq	7b80e96d-c20b-4080-9382-26a778397c15	Prostate	52	644E1E7D-DFD1-4F83-82DC-AE0C7E010F6F	D97C0E4A-EB95-49BC-B430-EE0122726442	TCGA-G9-6370-01A-11D-1784-02	HG19_Broad_variant	TCGA-G9-6370	TCGA-PRAD	NA	s3449	Harvard Medical School	Roswell Park	United States	NO	T3b	N0	Prostate Adenocarcinoma Acinar Type	Not available	1784-02	TRUE
13722.58cfa832e4b0c9d6adf6d01a	58cfa832e4b0c9d6adf6d01a	TCGA-G9-6353-01A-11D-1957_130405_SN590_0222_BD21LGACXX_s_4_rg.sorted.filtered.	WGS	TCGA-G9-6353-01A-11D-1957_130405_SN590_0222_BD21LGACXX_s_4_rg.sorted	TCGA-G9-6353-01A-11D-1957_130405_SN590_0222_BD21LGACXX_s_4_rg.sorted.bam	144.7	1.9	0.15	58cfa832e4b0c9d6adf6d01a	TCGA-G9-6353-01A-11D-1957_130405_SN590_0222_BD21LGACXX_s_4_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-G9-6353-01A	BCC94953-CE79-428E-99C1-632E42C1B9BC	Primary Tumor	Illumina HiSeq	86ec03a4-f08e-474e-b887-c5e06822b414	Prostate	58	4CBA0BA5-58C3-455C-9CD5-7D9428D27F8C	758712E3-95F1-4BB5-A83A-D01C4844122D	TCGA-G9-6353-01A-11D-1957-02	HG19_Broad_variant	TCGA-G9-6353	TCGA-PRAD	NA	s3970	Harvard Medical School	Roswell Park	United States	NO	T3a	Not available	Prostate Adenocarcinoma Acinar Type	Not available	1957-02	TRUE
13722.58cfa832e4b0c9d6adf6d010	58cfa832e4b0c9d6adf6d010	TCGA-G9-6338-01A-12D-1957_130222_SN1222_0174_BC1RNEACXX_s_5_rg.sorted.filtered.	WGS	TCGA-G9-6338-01A-12D-1957_130222_SN1222_0174_BC1RNEACXX_s_5_rg.sorted	TCGA-G9-6338-01A-12D-1957_130222_SN1222_0174_BC1RNEACXX_s_5_rg.sorted.bam	218.7	NA	0.16	58cfa832e4b0c9d6adf6d010	TCGA-G9-6338-01A-12D-1957_130222_SN1222_0174_BC1RNEACXX_s_5_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-G9-6338-01A	2C48B1BF-4E49-4869-874B-F08787FA04B5	Primary Tumor	Illumina HiSeq	3c22fc65-7067-4d13-a148-5e953f3a7097	Prostate	61	21FC7F0F-FCB3-422F-AA73-0E09FD06DA35	BF3CC12E-1835-40C8-B29F-C685B828AB18	TCGA-G9-6338-01A-12D-1957-02	HG19_Broad_variant	TCGA-G9-6338	TCGA-PRAD	NA	s3451	Harvard Medical School	Roswell Park	United States	NO	T3a	N0	Prostate Adenocarcinoma Acinar Type	Not available	1957-02	TRUE
13722.58cfa832e4b0c9d6adf6d020	58cfa832e4b0c9d6adf6d020	TCGA-GV-A3JZ-01A-11D-A21C_120830_SN590_0178_AD143RACXX_s_7_rg.sorted.filtered.	WGS	TCGA-GV-A3JZ-01A-11D-A21C_120830_SN590_0178_AD143RACXX_s_7_rg.sorted	TCGA-GV-A3JZ-01A-11D-A21C_120830_SN590_0178_AD143RACXX_s_7_rg.sorted.bam	63.92	NA	0.14	58cfa832e4b0c9d6adf6d020	TCGA-GV-A3JZ-01A-11D-A21C_120830_SN590_0178_AD143RACXX_s_7_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-GV-A3JZ-01A	9CC92795-7A24-4875-87F0-3EFCCBFCC970	Primary Tumor	Illumina HiSeq	d4d5d34c-9665-4291-a3d6-14bc9b48f2fa	Bladder	55	449E18FB-CBC0-4365-AEEC-EDC6A6B276BD	5A651606-6D92-445B-AA0B-B73CC9329402	TCGA-GV-A3JZ-01A-11D-A21C-26	HG19_Broad_variant	TCGA-GV-A3JZ	TCGA-BLCA	NA	s2738	MD Anderson - Institute for Applied Cancer Science	BLN - Cleveland Clinic	United States	NO	T4a	N3	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV	A21C-26	TRUE
13722.58cfa832e4b0c9d6adf6d086	58cfa832e4b0c9d6adf6d086	TCGA-HC-7212-01A-11D-2111_130517_SN590_0230_AD24B4ACXX_s_4_rg.sorted.filtered.	WGS	TCGA-HC-7212-01A-11D-2111_130517_SN590_0230_AD24B4ACXX_s_4_rg.sorted	TCGA-HC-7212-01A-11D-2111_130517_SN590_0230_AD24B4ACXX_s_4_rg.sorted.bam	333.3	NA	0.15	58cfa832e4b0c9d6adf6d086	TCGA-HC-7212-01A-11D-2111_130517_SN590_0230_AD24B4ACXX_s_4_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-HC-7212-01A	907B64D6-A26A-4092-A247-AC9AF444D1C7	Primary Tumor	Illumina HiSeq	4ff229a3-6637-4fdc-a3b6-079e28773187	Prostate	56	92888479-B534-432D-8F70-CAE857E0074B	9BF25BFC-4E07-4979-9169-F6CDADDB3A90	TCGA-HC-7212-01A-11D-2111-02	HG19_Broad_variant	TCGA-HC-7212	TCGA-PRAD	NA	s4153	Harvard Medical School	International Genomics Consortium	United States	NO	T2a	N0	Prostate Adenocarcinoma Acinar Type	Not available	2111-02	TRUE
13722.58cfa832e4b0c9d6adf6d155	58cfa832e4b0c9d6adf6d155	TCGA-G9-6361-01A-21D-1957_130405_SN590_0222_BD21LGACXX_s_6_rg.sorted.filtered.	WGS	TCGA-G9-6361-01A-21D-1957_130405_SN590_0222_BD21LGACXX_s_6_rg.sorted	TCGA-G9-6361-01A-21D-1957_130405_SN590_0222_BD21LGACXX_s_6_rg.sorted.bam	19.7	1.9	0.15	58cfa832e4b0c9d6adf6d155	TCGA-G9-6361-01A-21D-1957_130405_SN590_0222_BD21LGACXX_s_6_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-G9-6361-01A	71D14304-CCB0-4A4C-B935-8C014CA75FD0	Primary Tumor	Illumina HiSeq	4fc66c05-8bf3-4a56-8bfe-6d20c3195258	Prostate	61	A369C190-964E-471C-878A-D8FADE7CF992	54B8E171-9BCC-469D-9315-114FE2C57DC1	TCGA-G9-6361-01A-21D-1957-02	HG19_Broad_variant	TCGA-G9-6361	TCGA-PRAD	NA	s3795	Harvard Medical School	Roswell Park	United States	NO	T3a	N0	Prostate Adenocarcinoma Acinar Type	Not available	1957-02	TRUE
13722.58cfa832e4b0c9d6adf6d186	58cfa832e4b0c9d6adf6d186	TCGA-IR-A3L7-01A-21D-A20X_140117_SN590_0245_AC371LACXX_s_3_rg.sorted.filtered.	WGS	TCGA-IR-A3L7-01A-21D-A20X_140117_SN590_0245_AC371LACXX_s_3_rg.sorted	TCGA-IR-A3L7-01A-21D-A20X_140117_SN590_0245_AC371LACXX_s_3_rg.sorted.bam	59.39	NA	0.15	58cfa832e4b0c9d6adf6d186	TCGA-IR-A3L7-01A-21D-A20X_140117_SN590_0245_AC371LACXX_s_3_rg.sorted.bam	Alive	FEMALE	WHITE	Not available	Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-IR-A3L7-01A	66229DD6-C771-4455-A90C-C66FB40CF7FE	Primary Tumor	Illumina HiSeq	c50ab1fa-015d-4420-a67f-b023a5377b16	Cervix	37	F571523C-758C-4F34-A44B-F8E6A3EEBE0F	27168C7B-D67E-4B11-B5BA-A79FB523400B	TCGA-IR-A3L7-01A-21D-A20X-26	HG19_Broad_variant	TCGA-IR-A3L7	TCGA-CESC	NA	s1211	MD Anderson - Institute for Applied Cancer Science	Memorial Sloan Kettering	United States	NO	T1b1	N0	Cervical Squamous Cell Carcinoma	Not available	A20X-26	TRUE
13722.58cfa832e4b0c9d6adf6d25a	58cfa832e4b0c9d6adf6d25a	TCGA-IQ-7632-01A-11D-2317_120730_SN1222_0141_BC115GACXX_s_2_rg.sorted.filtered.	WGS	TCGA-IQ-7632-01A-11D-2317_120730_SN1222_0141_BC115GACXX_s_2_rg.sorted	TCGA-IQ-7632-01A-11D-2317_120730_SN1222_0141_BC115GACXX_s_2_rg.sorted.bam	9.33	NA	0.14	58cfa832e4b0c9d6adf6d25a	TCGA-IQ-7632-01A-11D-2317_120730_SN1222_0141_BC115GACXX_s_2_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-IQ-7632-01A	601A4146-8093-4F20-9A0A-A97916C9E7F6	Primary Tumor	Illumina HiSeq	9f8feb9c-6c20-4997-afcf-24177e9a7829	Head and Neck	68	CD989471-A9CF-4FAD-A321-C01764BB85D7	614C0F1F-C677-44ED-B3E1-0FA9DE03F591	TCGA-IQ-7632-01A-11D-2317-26	HG19_Broad_variant	TCGA-IQ-7632	TCGA-HNSC	NA	s16062	MD Anderson - RPPA Core Facility (Proteomics)	University of Miami	United States	NO	T4a	N0	Head and Neck Squamous Cell Carcinoma	Stage IVA	2317-26	TRUE
13722.58cfa832e4b0c9d6adf6d44e	58cfa832e4b0c9d6adf6d44e	TCGA-VD-A8KG-01A-11D-A40D_140731_SN208_0522_AC59K7ACXX_s_4_rg.sorted.filtered.	WGS	TCGA-VD-A8KG-01A-11D-A40D_140731_SN208_0522_AC59K7ACXX_s_4_rg.sorted	TCGA-VD-A8KG-01A-11D-A40D_140731_SN208_0522_AC59K7ACXX_s_4_rg.sorted.bam	43.78	NA	0.17	58cfa832e4b0c9d6adf6d44e	TCGA-VD-A8KG-01A-11D-A40D_140731_SN208_0522_AC59K7ACXX_s_4_rg.sorted.bam	Alive	FEMALE	Not available	Not available	Uveal Melanoma	Aligned reads	TCGA-VD-A8KG-01A	9F57834A-4DC4-45ED-97DE-ED4DA9D0598D	Primary Tumor	Illumina HiSeq	4a7b8d85-7b0f-4e37-b941-e61363166648	Eye	47	75A06E1E-CF06-418C-BFB7-3B9147D19078	376A6943-6FCC-406B-B543-4C0C385D2E22	TCGA-VD-A8KG-01A-11D-A40D-26	HG19_Broad_variant	TCGA-VD-A8KG	TCGA-UVM	NA	s272	MD Anderson - Institute for Applied Cancer Science	University of Liverpool	United Kingdom	NO	T2a	NX	Not available	Stage IIA	A40D-26	TRUE
13722.58cfa832e4b0c9d6adf6d40e	58cfa832e4b0c9d6adf6d40e	TCGA-VD-A8KF-01A-11D-A40D_140731_SN208_0522_AC59K7ACXX_s_3_rg.sorted.filtered.	WGS	TCGA-VD-A8KF-01A-11D-A40D_140731_SN208_0522_AC59K7ACXX_s_3_rg.sorted	TCGA-VD-A8KF-01A-11D-A40D_140731_SN208_0522_AC59K7ACXX_s_3_rg.sorted.bam	45.75	NA	0.16	58cfa832e4b0c9d6adf6d40e	TCGA-VD-A8KF-01A-11D-A40D_140731_SN208_0522_AC59K7ACXX_s_3_rg.sorted.bam	Dead	MALE	Not available	Not available	Uveal Melanoma	Aligned reads	TCGA-VD-A8KF-01A	78039723-94A9-4903-8BB4-C00852E8E889	Primary Tumor	Illumina HiSeq	29607312-d3fc-46a7-97ec-8515bd642e3a	Eye	68	B48C5179-16E6-47F1-87C7-EE8B71989BF9	8EB5960A-3FDC-4641-AF72-C80755429C8D	TCGA-VD-A8KF-01A-11D-A40D-26	HG19_Broad_variant	TCGA-VD-A8KF	TCGA-UVM	40	s266	MD Anderson - Institute for Applied Cancer Science	University of Liverpool	United Kingdom	NO	T4b	NX	Not available	Stage IIIB	A40D-26	TRUE
13722.58cfa832e4b0c9d6adf6d478	58cfa832e4b0c9d6adf6d478	TCGA-VD-A8KD-01A-11D-A40D_140731_SN208_0522_AC59K7ACXX_s_1_rg.sorted.filtered.	WGS	TCGA-VD-A8KD-01A-11D-A40D_140731_SN208_0522_AC59K7ACXX_s_1_rg.sorted	TCGA-VD-A8KD-01A-11D-A40D_140731_SN208_0522_AC59K7ACXX_s_1_rg.sorted.bam	49.59	NA	0.17	58cfa832e4b0c9d6adf6d478	TCGA-VD-A8KD-01A-11D-A40D_140731_SN208_0522_AC59K7ACXX_s_1_rg.sorted.bam	Dead	MALE	Not available	Not available	Uveal Melanoma	Aligned reads	TCGA-VD-A8KD-01A	73B3E4DD-C53D-4FE3-8607-EE462C9CBBD1	Primary Tumor	Illumina HiSeq	32e66b83-1d91-4ed8-b672-cc125bbe3b57	Eye	72	4F0319B2-722C-48E1-A5E1-798463E9EA02	347DBA4E-7CA8-4432-A0F7-90F9009F8AA3	TCGA-VD-A8KD-01A-11D-A40D-26	HG19_Broad_variant	TCGA-VD-A8KD	TCGA-UVM	114	s270	MD Anderson - Institute for Applied Cancer Science	University of Liverpool	United Kingdom	NO	T4a	NX	Not available	Stage IV	A40D-26	TRUE
13722.58cfa832e4b0c9d6adf6d40a	58cfa832e4b0c9d6adf6d40a	TCGA-V4-A9F3-01A-11D-A40D_140715_SN1440_0193_BC4K41ACXX_s_3_rg.sorted.filtered.	WGS	TCGA-V4-A9F3-01A-11D-A40D_140715_SN1440_0193_BC4K41ACXX_s_3_rg.sorted	TCGA-V4-A9F3-01A-11D-A40D_140715_SN1440_0193_BC4K41ACXX_s_3_rg.sorted.bam	49.28	NA	0.16	58cfa832e4b0c9d6adf6d40a	TCGA-V4-A9F3-01A-11D-A40D_140715_SN1440_0193_BC4K41ACXX_s_3_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uveal Melanoma	Aligned reads	TCGA-V4-A9F3-01A	E21D8018-8FE9-4C92-8B36-28D7D3F7DF2B	Primary Tumor	Illumina HiSeq	cae118e4-484b-45f4-b225-3d7297583648	Eye	49	6805D6DB-775C-4817-9F1B-5BE44AE2DA45	395ECE1C-9831-48BF-A933-A4A94566CD9D	TCGA-V4-A9F3-01A-11D-A40D-26	HG19_Broad_variant	TCGA-V4-A9F3	TCGA-UVM	NA	s229	MD Anderson - Institute for Applied Cancer Science	Institut Curie	France	NO	T4a	N0	Not available	Stage IIIA	A40D-26	TRUE
13722.58cfa832e4b0c9d6adf6d4da	58cfa832e4b0c9d6adf6d4da	TCGA-VD-A8KE-01A-11D-A40D_140731_SN208_0522_AC59K7ACXX_s_2_rg.sorted.filtered.	WGS	TCGA-VD-A8KE-01A-11D-A40D_140731_SN208_0522_AC59K7ACXX_s_2_rg.sorted	TCGA-VD-A8KE-01A-11D-A40D_140731_SN208_0522_AC59K7ACXX_s_2_rg.sorted.bam	35.8	NA	0.15	58cfa832e4b0c9d6adf6d4da	TCGA-VD-A8KE-01A-11D-A40D_140731_SN208_0522_AC59K7ACXX_s_2_rg.sorted.bam	Alive	FEMALE	Not available	Not available	Uveal Melanoma	Aligned reads	TCGA-VD-A8KE-01A	C9BFC2A7-0914-4080-A0A3-1C6A4E58E1AB	Primary Tumor	Illumina HiSeq	54db22ce-0562-4448-825c-d4e883f4aca6	Eye	74	35DFEB9D-1F64-4D51-B27A-24AD8AA3327B	119B486A-77DF-49A2-80A0-19555DEB7573	TCGA-VD-A8KE-01A-11D-A40D-26	HG19_Broad_variant	TCGA-VD-A8KE	TCGA-UVM	NA	s279	MD Anderson - Institute for Applied Cancer Science	University of Liverpool	United Kingdom	NO	T2a	NX	Not available	Stage IIA	A40D-26	TRUE
13722.58cfa832e4b0c9d6adf6d576	58cfa832e4b0c9d6adf6d576	TCGA-V4-A9EZ-01A-11D-A40D_140714_SN1440_0192_AC3RUUACXX_s_3_rg.sorted.filtered.	WGS	TCGA-V4-A9EZ-01A-11D-A40D_140714_SN1440_0192_AC3RUUACXX_s_3_rg.sorted	TCGA-V4-A9EZ-01A-11D-A40D_140714_SN1440_0192_AC3RUUACXX_s_3_rg.sorted.bam	34.26	NA	0.16	58cfa832e4b0c9d6adf6d576	TCGA-V4-A9EZ-01A-11D-A40D_140714_SN1440_0192_AC3RUUACXX_s_3_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uveal Melanoma	Aligned reads	TCGA-V4-A9EZ-01A	39E494BC-7710-4F9F-98B0-0F509F7AEF1A	Primary Tumor	Illumina HiSeq	5c8725d3-7d4e-4fa4-9626-127c91f5ea5c	Eye	78	9FEE606B-30E8-4BD6-B4C3-E21EFE64870C	6C22A928-CD61-4D62-B401-A4BE19418177	TCGA-V4-A9EZ-01A-11D-A40D-26	HG19_Broad_variant	TCGA-V4-A9EZ	TCGA-UVM	NA	s225	MD Anderson - Institute for Applied Cancer Science	Institut Curie	France	NO	T3a	N0	Not available	Stage IIB	A40D-26	TRUE
13722.58cfa82ee4b0c9d6adf6b00e	58cfa82ee4b0c9d6adf6b00e	TCGA-05-4422-01A-01D-1203_120316_SN208_0275_BD0PL2ACXX_s_5_rg.sorted.filtered.	WGS	TCGA-05-4422-01A-01D-1203_120316_SN208_0275_BD0PL2ACXX_s_5_rg.sorted	TCGA-05-4422-01A-01D-1203_120316_SN208_0275_BD0PL2ACXX_s_5_rg.sorted.bam	631.63	1.9	0.15	58cfa82ee4b0c9d6adf6b00e	TCGA-05-4422-01A-01D-1203_120316_SN208_0275_BD0PL2ACXX_s_5_rg.sorted.bam	Alive	MALE	Not available	Not available	Lung Adenocarcinoma	Aligned reads	TCGA-05-4422-01A	44DEC838-B653-42A7-A58B-A1FD232CD68C	Primary Tumor	Illumina HiSeq	9fcb53c6-7d0c-4468-8a77-40e6ea3d43d8	Lung	68	DACBC55D-25C6-4E86-BD1B-38345B4DF7A7	09DD9098-5702-44A6-B9EA-F148ECE1E264	TCGA-05-4422-01A-01D-1203-02	HG19_Broad_variant	TCGA-05-4422	TCGA-LUAD	NA	s11223	Harvard Medical School	Indivumed	Germany	NO	T2	N0	Lung Adenocarcinoma Mixed Subtype	Stage IB	1203-02	TRUE
13722.58cfa82fe4b0c9d6adf6b5cc	58cfa82fe4b0c9d6adf6b5cc	TCGA-38-4628-01A-01D-1203_110804_SN208_0217_BC03EKABXX_s_8_rg.sorted.filtered.	WGS	TCGA-38-4628-01A-01D-1203_110804_SN208_0217_BC03EKABXX_s_8_rg.sorted	TCGA-38-4628-01A-01D-1203_110804_SN208_0217_BC03EKABXX_s_8_rg.sorted.bam	32.52	1.9	0.13	58cfa82fe4b0c9d6adf6b5cc	TCGA-38-4628-01A-01D-1203_110804_SN208_0217_BC03EKABXX_s_8_rg.sorted.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-38-4628-01A	CC4BD56A-25C5-4C48-B583-AC3AEB778CA6	Primary Tumor	Illumina HiSeq	f215f323-8551-4bdc-bce7-17bc9bd45bf4	Lung	65	A74F6423-B5D3-4AE2-B61F-3EE04B1073BF	606E6830-C9FB-4107-8BD4-253C193D56B6	TCGA-38-4628-01A-01D-1203-02	HG19_Broad_variant	TCGA-38-4628	TCGA-LUAD	1492	s10652	Harvard Medical School	UNC	United States	NO	T2	N1	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage IIB	1203-02	TRUE
13722.58cfa82fe4b0c9d6adf6b7b4	58cfa82fe4b0c9d6adf6b7b4	TCGA-50-5930-01A-11D-1751_111007_SN590_0110_C003AACXX_s_1_rg.sorted.filtered.	WGS	TCGA-50-5930-01A-11D-1751_111007_SN590_0110_C003AACXX_s_1_rg.sorted	TCGA-50-5930-01A-11D-1751_111007_SN590_0110_C003AACXX_s_1_rg.sorted.bam	181.4	2	0.16	58cfa82fe4b0c9d6adf6b7b4	TCGA-50-5930-01A-11D-1751_111007_SN590_0110_C003AACXX_s_1_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-50-5930-01A	368E23F0-E573-4547-BF5A-14080BAF737B	Primary Tumor	Illumina HiSeq	09c8fefe-47f0-44eb-b4f4-160944e2991a	Lung	47	3E30DBD1-10BF-4450-8D19-6F44D3284E02	31047F3B-8F9D-47D9-87D3-BB2F8CF7E1EF	TCGA-50-5930-01A-11D-1751-02	HG19_Broad_variant	TCGA-50-5930	TCGA-LUAD	282	s11347	Harvard Medical School	University of Pittsburgh	United States	NO	T2	N2	Lung Adenocarcinoma Mixed Subtype	Stage IIIA	1751-02	TRUE
13722.58cfa830e4b0c9d6adf6bc0a	58cfa830e4b0c9d6adf6bc0a	TCGA-A5-A0GV-01A-31D-A043_120214_SN590_0139_BC0DYEACXX_s_3_rg.sorted.filtered.	WGS	TCGA-A5-A0GV-01A-31D-A043_120214_SN590_0139_BC0DYEACXX_s_3_rg.sorted	TCGA-A5-A0GV-01A-31D-A043_120214_SN590_0139_BC0DYEACXX_s_3_rg.sorted.bam	42.49	2.13	0.16	58cfa830e4b0c9d6adf6bc0a	TCGA-A5-A0GV-01A-31D-A043_120214_SN590_0139_BC0DYEACXX_s_3_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-A5-A0GV-01A	5E3B981E-73FE-4CC9-8C89-B420E8E2F426	Primary Tumor	Illumina HiSeq	c99f6cb7-44cc-4045-a0f6-4fec580e964c	Uterus	67	339926E1-61E6-4256-A808-F931AA2C17D2	721D7961-15F0-4A52-8D2C-885278D3B579	TCGA-A5-A0GV-01A-31D-A043-02	HG19_Broad_variant	TCGA-A5-A0GV	TCGA-UCEC	NA	s4987	Harvard Medical School	Cedars Sinai	None	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A043-02	TRUE
13722.58cfa831e4b0c9d6adf6cd16	58cfa831e4b0c9d6adf6cd16	TCGA-FD-A3SL-01A-21D-A233_120830_SN208_0423_AC190AACXX_s_3_rg.sorted.filtered.	WGS	TCGA-FD-A3SL-01A-21D-A233_120830_SN208_0423_AC190AACXX_s_3_rg.sorted	TCGA-FD-A3SL-01A-21D-A233_120830_SN208_0423_AC190AACXX_s_3_rg.sorted.bam	18.6	NA	0.16	58cfa831e4b0c9d6adf6cd16	TCGA-FD-A3SL-01A-21D-A233_120830_SN208_0423_AC190AACXX_s_3_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-FD-A3SL-01A	4570B6E2-D430-41CA-AAB1-CE4D14C36463	Primary Tumor	Illumina HiSeq	764ae567-a7b6-4d13-bef1-8cc55afb4524	Bladder	60	0A1E88E0-3593-40BA-86E5-751074885578	2BF89FED-C215-4893-BA35-2FE0C7DD5DD0	TCGA-FD-A3SL-01A-21D-A233-26	HG19_Broad_variant	TCGA-FD-A3SL	TCGA-BLCA	NA	s2720	MD Anderson - Institute for Applied Cancer Science	BLN - University Of Chicago	United States	NO	T4a	N2	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV	A233-26	TRUE
13722.58cfa82fe4b0c9d6adf6b72a	58cfa82fe4b0c9d6adf6b72a	TCGA-49-6767-01A-11D-1853_120205_SN590_0136_BD0LRYACXX_s_7_rg.sorted.filtered.	WGS	TCGA-49-6767-01A-11D-1853_120205_SN590_0136_BD0LRYACXX_s_7_rg.sorted	TCGA-49-6767-01A-11D-1853_120205_SN590_0136_BD0LRYACXX_s_7_rg.sorted.bam	291.7	1.9	0.14	58cfa82fe4b0c9d6adf6b72a	TCGA-49-6767-01A-11D-1853_120205_SN590_0136_BD0LRYACXX_s_7_rg.sorted.bam	Alive	FEMALE	WHITE	Not available	Lung Adenocarcinoma	Aligned reads	TCGA-49-6767-01A	6BFFE800-EC2B-4638-9333-97FE85DCD91C	Primary Tumor	Illumina HiSeq	759c1dd3-0f7d-4ba7-8c8e-c276faf0255b	Lung	46	708A8742-F6D6-411D-9340-2C6C25885D22	FBCE84D6-2880-45F5-BD6F-B079C33C353E	TCGA-49-6767-01A-11D-1853-02	HG19_Broad_variant	TCGA-49-6767	TCGA-LUAD	NA	s11233	Harvard Medical School	Johns Hopkins	United States	NO	T3	N0	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage IIB	1853-02	TRUE
13722.58cfa82fe4b0c9d6adf6b7f6	58cfa82fe4b0c9d6adf6b7f6	TCGA-73-4677-01A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.filtered.	WGS	TCGA-73-4677-01A-01D-1203-02_IlluminaHiSeq-DNASeq_whole	TCGA-73-4677-01A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.bam	153	1.9	0.15	58cfa82fe4b0c9d6adf6b7f6	TCGA-73-4677-01A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-73-4677-01A	03C3409A-9D16-41D0-9E26-F9FC2547A4C8	Primary Tumor	Illumina HiSeq	5dd207d7-c666-46ae-8154-cb0c0cd6467f	Lung	74	EF88B85A-61EE-44E1-BB63-1B4CE9154BFB	2E41BAD5-941E-4EE8-A1DC-5BBA14E89141	TCGA-73-4677-01A-01D-1203-02	GRCh37	TCGA-73-4677	TCGA-LUAD	38	s10914	Harvard Medical School	Roswell Park	United States	NO	T2a	N0	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage IA	1203-02	TRUE
13722.58cfa82fe4b0c9d6adf6b8bc	58cfa82fe4b0c9d6adf6b8bc	TCGA-73-4668-01A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.filtered.	WGS	TCGA-73-4668-01A-01D-1203-02_IlluminaHiSeq-DNASeq_whole	TCGA-73-4668-01A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.bam	311.9	1.9	0.15	58cfa82fe4b0c9d6adf6b8bc	TCGA-73-4668-01A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.bam	Alive	FEMALE	AMERICAN INDIAN OR ALASKA NATIVE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-73-4668-01A	B2285924-9813-4F46-BB8F-91A0EFD8A9B6	Primary Tumor	Illumina HiSeq	c3c82aae-4b64-4f65-b4ed-048053aef739	Lung	66	FDBFDF52-C0CD-4FBB-A910-B747516DFEF4	DC227D17-FED3-489A-B5C6-3D4C910310FF	TCGA-73-4668-01A-01D-1203-02	GRCh37	TCGA-73-4668	TCGA-LUAD	NA	s10795	Harvard Medical School	Roswell Park	United States	NO	T2	N1	Lung Micropapillary Adenocarcinoma	Stage IIB	1203-02	TRUE
13722.58cfa82ee4b0c9d6adf6b034	58cfa82ee4b0c9d6adf6b034	TCGA-05-4426-01A-01D-1203_111013_SN208_0253_B00PJACXX_s_8_rg.sorted.filtered.	WGS	TCGA-05-4426-01A-01D-1203_111013_SN208_0253_B00PJACXX_s_8_rg.sorted	TCGA-05-4426-01A-01D-1203_111013_SN208_0253_B00PJACXX_s_8_rg.sorted.bam	666.2	1.9	0.14	58cfa82ee4b0c9d6adf6b034	TCGA-05-4426-01A-01D-1203_111013_SN208_0253_B00PJACXX_s_8_rg.sorted.bam	Alive	MALE	Not available	Not available	Lung Adenocarcinoma	Aligned reads	TCGA-05-4426-01A	36BF02F8-C1C8-49F9-A417-ADF88A205C70	Primary Tumor	Illumina HiSeq	63037227-adb0-4505-bd71-2527743ec736	Lung	71	0C06CF85-61EB-4E6D-AE54-B8F5CBAB9B63	EA6C652F-4896-4D57-978D-7528578BB153	TCGA-05-4426-01A-01D-1203-02	HG19_Broad_variant	TCGA-05-4426	TCGA-LUAD	NA	s10645	Harvard Medical School	Indivumed	Germany	NO	T2	N0	Lung Adenocarcinoma Mixed Subtype	Stage IB	1203-02	TRUE
13722.58cfa82fe4b0c9d6adf6ba00	58cfa82fe4b0c9d6adf6ba00	TCGA-AA-3555-01A-01D-1637-02_IlluminaHiSeq-DNASeq_whole.filtered.	WGS	TCGA-AA-3555-01A-01D-1637-02_IlluminaHiSeq-DNASeq_whole	TCGA-AA-3555-01A-01D-1637-02_IlluminaHiSeq-DNASeq_whole.bam	949.56	1.9	0.13	58cfa82fe4b0c9d6adf6ba00	TCGA-AA-3555-01A-01D-1637-02_IlluminaHiSeq-DNASeq_whole.bam	Alive	FEMALE	Not available	Not available	Colon Adenocarcinoma	Aligned reads	TCGA-AA-3555-01A	36EAF209-C332-4321-B6AA-51A3368ECD79	Primary Tumor	Illumina HiSeq	4abf3b47-09b2-46e1-8bca-eb46790b3930	Colorectal	81	9F9961F0-4EE2-4471-AE4A-A0122D630A28	099EA705-3D94-4746-AF72-E21B31D0425A	TCGA-AA-3555-01A-01D-1637-02	HG18	TCGA-AA-3555	TCGA-COAD	NA	s13513	Harvard Medical School	Indivumed	Germany	NO	T3	N0	Colon Mucinous Adenocarcinoma	Stage IIA	1637-02	FALSE
13722.58cfa82fe4b0c9d6adf6b9c8	58cfa82fe4b0c9d6adf6b9c8	TCGA-AA-A00Q-01A-01D-A077-02_IlluminaHiSeq-DNASeq_whole.filtered.	WGS	TCGA-AA-A00Q-01A-01D-A077-02_IlluminaHiSeq-DNASeq_whole	TCGA-AA-A00Q-01A-01D-A077-02_IlluminaHiSeq-DNASeq_whole.bam	212.1	1.72	0.15	58cfa82fe4b0c9d6adf6b9c8	TCGA-AA-A00Q-01A-01D-A077-02_IlluminaHiSeq-DNASeq_whole.bam	Alive	FEMALE	Not available	Not available	Colon Adenocarcinoma	Aligned reads	TCGA-AA-A00Q-01A	62D39BE5-F029-4EB8-8B00-46470E06A755	Primary Tumor	Illumina HiSeq	5ccd68f8-a32c-47e2-805b-e3721dbb395d	Colorectal	66	89FC5DB9-EDFF-480F-8FC4-ADDD28C6D615	D458CE34-22B1-41F7-9CE7-659107AD6F77	TCGA-AA-A00Q-01A-01D-A077-02	HG18	TCGA-AA-A00Q	TCGA-COAD	NA	s13523	Harvard Medical School	Indivumed	Germany	NO	T4	N1	Colon Adenocarcinoma	Stage IIIB	A077-02	TRUE
13722.58cfa82fe4b0c9d6adf6b9cc	58cfa82fe4b0c9d6adf6b9cc	TCGA-AA-A00Z-01A-01D-A077-02_IlluminaHiSeq-DNASeq_whole.filtered.	WGS	TCGA-AA-A00Z-01A-01D-A077-02_IlluminaHiSeq-DNASeq_whole	TCGA-AA-A00Z-01A-01D-A077-02_IlluminaHiSeq-DNASeq_whole.bam	264.6	1.73	0.15	58cfa82fe4b0c9d6adf6b9cc	TCGA-AA-A00Z-01A-01D-A077-02_IlluminaHiSeq-DNASeq_whole.bam	Alive	MALE	Not available	Not available	Colon Adenocarcinoma	Aligned reads	TCGA-AA-A00Z-01A	AF3A0634-4292-45BD-B948-6B6BD2D58090	Primary Tumor	Illumina HiSeq	9701e2c0-3702-4d55-9816-940f128d19e0	Colorectal	70	75A6A64E-11F0-41C8-9CBA-179AE3333621	DF16D4D9-DD5E-4614-AE58-465EC09F2992	TCGA-AA-A00Z-01A-01D-A077-02	HG18	TCGA-AA-A00Z	TCGA-COAD	NA	s13198	Harvard Medical School	Indivumed	Germany	NO	T3	N0	Colon Adenocarcinoma	Stage IIA	A077-02	TRUE
13722.58cfa82fe4b0c9d6adf6ba16	58cfa82fe4b0c9d6adf6ba16	TCGA-AA-3549-01A-02D-1167-02_IlluminaHiSeq-DNASeq_whole.filtered.	WGS	TCGA-AA-3549-01A-02D-1167-02_IlluminaHiSeq-DNASeq_whole	TCGA-AA-3549-01A-02D-1167-02_IlluminaHiSeq-DNASeq_whole.bam	431.56	1.9	0.17	58cfa82fe4b0c9d6adf6ba16	TCGA-AA-3549-01A-02D-1167-02_IlluminaHiSeq-DNASeq_whole.bam	Alive	MALE	Not available	Not available	Colon Adenocarcinoma	Aligned reads	TCGA-AA-3549-01A	E6EC5A68-7555-4F26-BD7E-9CDB4C5F7004	Primary Tumor	Illumina HiSeq	cff80dc2-c080-4905-afce-cfd06a84f6c9	Colorectal	69	86158696-60A3-45B7-8351-D800F57EF23B	C5D50597-F0E1-4C34-AB95-3718566AF540	TCGA-AA-3549-01A-02D-1167-02	HG18	TCGA-AA-3549	TCGA-COAD	NA	s13358	Harvard Medical School	Indivumed	Germany	NO	T2	N0	Colon Adenocarcinoma	Stage I	1167-02	TRUE
13722.58cfa830e4b0c9d6adf6baf8	58cfa830e4b0c9d6adf6baf8	TCGA-AA-3514-01A-02D-1547_110525_SN590_0091_AC02W2ABXX_s_1.rg.sorted.filtered.	WGS	TCGA-AA-3514-01A-02D-1547_110525_SN590_0091_AC02W2ABXX_s_1.rg.sorted	TCGA-AA-3514-01A-02D-1547_110525_SN590_0091_AC02W2ABXX_s_1.rg.sorted.bam	263.29	1.9	0.15	58cfa830e4b0c9d6adf6baf8	TCGA-AA-3514-01A-02D-1547_110525_SN590_0091_AC02W2ABXX_s_1.rg.sorted.bam	Alive	FEMALE	Not available	Not available	Colon Adenocarcinoma	Aligned reads	TCGA-AA-3514-01A	DDF69ED9-4C53-48B8-9F01-495BD60C3425	Primary Tumor	Illumina HiSeq	3737ce68-bbb0-4ecc-849f-0fd049fe4d85	Colorectal	81	A657AFDB-5322-454F-8DD7-8397291401C5	C0486DD0-5BE4-4B64-8A8F-3CF47BD5A330	TCGA-AA-3514-01A-02D-1547-02	HG18_Broad_variant	TCGA-AA-3514	TCGA-COAD	NA	s13361	Harvard Medical School	Indivumed	Germany	NO	T2	N0	Colon Adenocarcinoma	Stage I	1547-02	FALSE
13722.58cfa830e4b0c9d6adf6ba75	58cfa830e4b0c9d6adf6ba75	TCGA-AA-3812-01A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.filtered.	WGS	TCGA-AA-3812-01A-01D-1167-02_IlluminaHiSeq-DNASeq_whole	TCGA-AA-3812-01A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.bam	270.96	1.9	0.15	58cfa830e4b0c9d6adf6ba75	TCGA-AA-3812-01A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.bam	Alive	FEMALE	Not available	Not available	Colon Adenocarcinoma	Aligned reads	TCGA-AA-3812-01A	4563E4E0-A661-46DE-AD25-9C86A621E147	Primary Tumor	Illumina HiSeq	92316171-5ae2-4812-b824-183f14adf90a	Colorectal	82	98AD41D5-FD77-4F30-94B5-03BF7B9C69B9	B4AA0837-42E8-41B7-B44B-F84D48155C3E	TCGA-AA-3812-01A-01D-1167-02	HG18	TCGA-AA-3812	TCGA-COAD	NA	s13188	Harvard Medical School	Indivumed	Germany	NO	T3	N0	Colon Adenocarcinoma	Stage IIA	1167-02	TRUE
13722.58cfa830e4b0c9d6adf6bbc8	58cfa830e4b0c9d6adf6bbc8	TCGA-AG-4015-01A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.filtered.	WGS	TCGA-AG-4015-01A-01D-1115-02_IlluminaHiSeq-DNASeq_whole	TCGA-AG-4015-01A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.bam	610.89	1.9	0.14	58cfa830e4b0c9d6adf6bbc8	TCGA-AG-4015-01A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.bam	Alive	FEMALE	Not available	Not available	Rectum Adenocarcinoma	Aligned reads	TCGA-AG-4015-01A	1388BBA1-02BA-40DF-93E5-C3D58B7BBAE0	Primary Tumor	Illumina HiSeq	70efc59a-8909-43e4-961b-76a7a3633927	Colorectal	85	3C910093-DF83-485B-86EF-26A0991D9A0B	2E183A8C-5755-4DC7-AEAB-6F7E9A9A5D1A	TCGA-AG-4015-01A-01D-1115-02	HG18	TCGA-AG-4015	TCGA-READ	NA	s1986	Harvard Medical School	Indivumed	Germany	NO	T3	N0	Rectal Adenocarcinoma	Stage IIA	1115-02	TRUE
13722.58cfa830e4b0c9d6adf6bc1c	58cfa830e4b0c9d6adf6bc1c	TCGA-AG-A020-01A-21D-A079-02_110409_SN590_0077_BB04EHABXX_s_1.rg.sorted.filtered.	WGS	TCGA-AG-A020-01A-21D-A079-02_110409_SN590_0077_BB04EHABXX_s_1.rg.sorted	TCGA-AG-A020-01A-21D-A079-02_110409_SN590_0077_BB04EHABXX_s_1.rg.sorted.bam	125.63	1.96	0.17	58cfa830e4b0c9d6adf6bc1c	TCGA-AG-A020-01A-21D-A079-02_110409_SN590_0077_BB04EHABXX_s_1.rg.sorted.bam	Alive	FEMALE	Not available	Not available	Rectum Adenocarcinoma	Aligned reads	TCGA-AG-A020-01A	19E46A3D-18C5-4927-8501-2265E2D617B8	Primary Tumor	Illumina HiSeq	1aa43549-776a-4daf-b60e-f0b8c3287077	Colorectal	57	EEC9C9E3-6CB3-4589-B3A8-EA2337878599	140B186D-B7EC-4A31-8FE0-A490BBDAE19B	TCGA-AG-A020-01A-21D-A079-02	HG18_Broad_variant	TCGA-AG-A020	TCGA-READ	NA	s2003	Harvard Medical School	Indivumed	Germany	NO	T3	N1	Rectal Mucinous Adenocarcinoma	Stage III	A079-02	TRUE
13722.58cfa830e4b0c9d6adf6bc46	58cfa830e4b0c9d6adf6bc46	TCGA-AO-A0JF-01A-11D-A060_130719_SN1120_0270_AC2CVRACXX_s_1_rg.sorted.filtered.	WGS	TCGA-AO-A0JF-01A-11D-A060_130719_SN1120_0270_AC2CVRACXX_s_1_rg.sorted	TCGA-AO-A0JF-01A-11D-A060_130719_SN1120_0270_AC2CVRACXX_s_1_rg.sorted.bam	16.97	1.91	0.13	58cfa830e4b0c9d6adf6bc46	TCGA-AO-A0JF-01A-11D-A060_130719_SN1120_0270_AC2CVRACXX_s_1_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-AO-A0JF-01A	F357FE19-5359-4662-8CE9-AA996132283B	Primary Tumor	Illumina HiSeq	031ab51d-07d0-4afe-a9dd-222889f5c32b	Breast	68	DDEE0B07-2771-40C7-BDDA-C1100958F0D8	BDAA1600-1B4F-4BBA-B4D6-A4D169B029D6	TCGA-AO-A0JF-01A-11D-A060-02	HG19_Broad_variant	TCGA-AO-A0JF	TCGA-BRCA	NA	s5491	Harvard Medical School	MSKCC	None	NO	T1c	N1a	Infiltrating Ductal Carcinoma	Stage IIA	A060-02	TRUE
13722.58cfa830e4b0c9d6adf6bc6c	58cfa830e4b0c9d6adf6bc6c	TCGA-AG-4007-01A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.filtered.	WGS	TCGA-AG-4007-01A-01D-1115-02_IlluminaHiSeq-DNASeq_whole	TCGA-AG-4007-01A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.bam	915.89	1.9	0.16	58cfa830e4b0c9d6adf6bc6c	TCGA-AG-4007-01A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.bam	Alive	MALE	Not available	Not available	Rectum Adenocarcinoma	Aligned reads	TCGA-AG-4007-01A	8E00E7E7-FFAF-44F0-91A7-172671F18E08	Primary Tumor	Illumina HiSeq	5f015b15-7286-4700-88d4-e7c460f68336	Colorectal	87	E6FC3F28-1DE1-4587-9E0E-0861323E6772	E9D7A5C4-3E98-4C98-A953-B75EA555DD7D	TCGA-AG-4007-01A-01D-1115-02	HG18	TCGA-AG-4007	TCGA-READ	NA	s1985	Harvard Medical School	Indivumed	Germany	NO	T4	N2	Rectal Adenocarcinoma	Stage IV	1115-02	TRUE
13722.58cfa830e4b0c9d6adf6bcb2	58cfa830e4b0c9d6adf6bcb2	TCGA-AZ-4684-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.filtered.	WGS	TCGA-AZ-4684-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole	TCGA-AZ-4684-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.bam	275.02	1.9	0.15	58cfa830e4b0c9d6adf6bcb2	TCGA-AZ-4684-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Colon Adenocarcinoma	Aligned reads	TCGA-AZ-4684-01A	CAC80259-3A26-4A99-B0D3-13454068E6ED	Primary Tumor	Illumina HiSeq	bab439b0-f1d3-41c2-98dd-a660818851fe	Colorectal	49	37AD61EA-96D1-40F1-B77A-56408E4243EA	6731F782-4435-497F-9626-C0199DAE8A8A	TCGA-AZ-4684-01A-01D-1405-02	HG18	TCGA-AZ-4684	TCGA-COAD	NA	s13391	Harvard Medical School	University of Pittsburgh	None	NO	T3	N2	Colon Adenocarcinoma	Stage IVA	1405-02	TRUE
13722.58cfa830e4b0c9d6adf6be13	58cfa830e4b0c9d6adf6be13	TCGA-BH-A0W5-01A-11D-A106_130719_SN1120_0270_AC2CVRACXX_s_3_rg.sorted.filtered.	WGS	TCGA-BH-A0W5-01A-11D-A106_130719_SN1120_0270_AC2CVRACXX_s_3_rg.sorted	TCGA-BH-A0W5-01A-11D-A106_130719_SN1120_0270_AC2CVRACXX_s_3_rg.sorted.bam	55.92	1.91	0.16	58cfa830e4b0c9d6adf6be13	TCGA-BH-A0W5-01A-11D-A106_130719_SN1120_0270_AC2CVRACXX_s_3_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-BH-A0W5-01A	DA9C10EA-C13F-4D88-8B94-A0CBC106D036	Primary Tumor	Illumina HiSeq	eeccc516-2d3d-4f41-a324-c90f92a6f944	Breast	77	050E66BB-438A-49D5-A005-7967A006B3F0	6C8B3A70-CD58-4BFC-9418-54182588CFCB	TCGA-BH-A0W5-01A-11D-A106-02	HG19_Broad_variant	TCGA-BH-A0W5	TCGA-BRCA	NA	s5803	Harvard Medical School	University of Pittsburgh	None	NO	T1c	N1a	Infiltrating Ductal Carcinoma	Stage IIA	A106-02	FALSE
13722.58cfa830e4b0c9d6adf6be2a	58cfa830e4b0c9d6adf6be2a	TCGA-B6-A0X4-01A-11D-A106_130719_SN1120_0270_AC2CVRACXX_s_7_rg.sorted.filtered.	WGS	TCGA-B6-A0X4-01A-11D-A106_130719_SN1120_0270_AC2CVRACXX_s_7_rg.sorted	TCGA-B6-A0X4-01A-11D-A106_130719_SN1120_0270_AC2CVRACXX_s_7_rg.sorted.bam	65.55	2.08	0.15	58cfa830e4b0c9d6adf6be2a	TCGA-B6-A0X4-01A-11D-A106_130719_SN1120_0270_AC2CVRACXX_s_7_rg.sorted.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-B6-A0X4-01A	4E42FDC5-2A8B-49E9-87EF-6DB7A6692D08	Primary Tumor	Illumina HiSeq	1973be6c-c5a9-40d1-bdd2-a752dd33d6d1	Breast	62	45C3BD72-D260-4663-9091-5058E58F352D	062A41CC-4B23-49E2-AFF8-3CFE34DE9A36	TCGA-B6-A0X4-01A-11D-A106-02	HG19_Broad_variant	TCGA-B6-A0X4	TCGA-BRCA	860	s6462	Harvard Medical School	Duke	United States	NO	T2	N1b	Infiltrating Ductal Carcinoma	Stage IIB	A106-02	FALSE
13722.58cfa82fe4b0c9d6adf6b96f	58cfa82fe4b0c9d6adf6b96f	TCGA-AA-3666-01A-02D-1167-02_IlluminaHiSeq-DNASeq_whole.filtered.	WGS	TCGA-AA-3666-01A-02D-1167-02_IlluminaHiSeq-DNASeq_whole	TCGA-AA-3666-01A-02D-1167-02_IlluminaHiSeq-DNASeq_whole.bam	554.96	1.9	0.17	58cfa82fe4b0c9d6adf6b96f	TCGA-AA-3666-01A-02D-1167-02_IlluminaHiSeq-DNASeq_whole.bam	Dead	MALE	Not available	Not available	Colon Adenocarcinoma	Aligned reads	TCGA-AA-3666-01A	A512701F-88BB-4B05-8C94-FD285B9DD13E	Primary Tumor	Illumina HiSeq	0bc29a5e-10c6-4c45-8cb6-2284ab7be445	Colorectal	68	F1064663-1462-4901-8BF7-9F50DA5EE7B1	CAD86B88-04E5-400F-B3EB-43D31A2D8358	TCGA-AA-3666-01A-02D-1167-02	HG18	TCGA-AA-3666	TCGA-COAD	61	s13363	Harvard Medical School	Indivumed	Germany	NO	T3	N1	Colon Adenocarcinoma	Stage III	1167-02	TRUE
13722.58cfa830e4b0c9d6adf6bd44	58cfa830e4b0c9d6adf6bd44	TCGA-AP-A054-01A-11D-A043_120209_SN1120_0114_BC0DFVACXX_s_1_rg.sorted.filtered.	WGS	TCGA-AP-A054-01A-11D-A043_120209_SN1120_0114_BC0DFVACXX_s_1_rg.sorted	TCGA-AP-A054-01A-11D-A043_120209_SN1120_0114_BC0DFVACXX_s_1_rg.sorted.bam	117.13	2.03	0.16	58cfa830e4b0c9d6adf6bd44	TCGA-AP-A054-01A-11D-A043_120209_SN1120_0114_BC0DFVACXX_s_1_rg.sorted.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-AP-A054-01A	D77E4DBC-B239-4742-8CB7-EFD427010D13	Primary Tumor	Illumina HiSeq	a8fe0928-3d0c-4d16-be11-a5dd077bdb2c	Uterus	64	DDFFB9C7-185F-402F-99B8-8058B40086D9	F5A9F85D-4E8E-4400-A109-C227D6B4C0A4	TCGA-AP-A054-01A-11D-A043-02	HG19_Broad_variant	TCGA-AP-A054	TCGA-UCEC	709	s4590	Harvard Medical School	MSKCC	None	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A043-02	TRUE
13722.58cfa830e4b0c9d6adf6bea9	58cfa830e4b0c9d6adf6bea9	TCGA-AG-3909-01A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.filtered.	WGS	TCGA-AG-3909-01A-01D-1115-02_IlluminaHiSeq-DNASeq_whole	TCGA-AG-3909-01A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.bam	208.89	1.9	0.14	58cfa830e4b0c9d6adf6bea9	TCGA-AG-3909-01A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.bam	Alive	FEMALE	Not available	Not available	Rectum Adenocarcinoma	Aligned reads	TCGA-AG-3909-01A	769880AE-34D9-405E-8EA7-33BA47CF2DD2	Primary Tumor	Illumina HiSeq	f11e5abe-82c7-4b53-bc65-7bde2dbc2bb1	Colorectal	69	12A43BEB-EDB6-4ABC-8322-CA8246D64B3F	F168205F-B2ED-4563-A211-DA59223830AB	TCGA-AG-3909-01A-01D-1115-02	HG18	TCGA-AG-3909	TCGA-READ	NA	s1987	Harvard Medical School	Indivumed	Germany	NO	T3	N1	Rectal Adenocarcinoma	Stage IIIB	1115-02	TRUE
13722.58cfa830e4b0c9d6adf6bf16	58cfa830e4b0c9d6adf6bf16	TCGA-BR-4257-01A-01D-1128_130110_SN1222_0167_AC1JPDACXX_s_3_rg.sorted.filtered.	WGS	TCGA-BR-4257-01A-01D-1128_130110_SN1222_0167_AC1JPDACXX_s_3_rg.sorted	TCGA-BR-4257-01A-01D-1128_130110_SN1222_0167_AC1JPDACXX_s_3_rg.sorted.bam	106.9	1.9	0.16	58cfa830e4b0c9d6adf6bf16	TCGA-BR-4257-01A-01D-1128_130110_SN1222_0167_AC1JPDACXX_s_3_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-BR-4257-01A	DA112431-5579-4FD1-A230-9144B359B0E9	Primary Tumor	Illumina HiSeq	5e38d8b4-97fb-407a-ab06-2f002456472d	Stomach	79	97B44B05-97EB-486C-94DB-42838831DE0B	465E5E4D-A801-4BBC-9E1C-004C7718571F	TCGA-BR-4257-01A-01D-1128-02	HG19_Broad_variant	TCGA-BR-4257	TCGA-STAD	NA	s15048	Harvard Medical School	Asterand	Russia	NO	TX	NX	Stomach  Adenocarcinoma  Not Otherwise Specified (NOS)	Not available	1128-02	TRUE
13722.58cfa830e4b0c9d6adf6be44	58cfa830e4b0c9d6adf6be44	TCGA-AF-2691-01A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.filtered.	WGS	TCGA-AF-2691-01A-01D-1167-02_IlluminaHiSeq-DNASeq_whole	TCGA-AF-2691-01A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.bam	406.94	1.9	0.15	58cfa830e4b0c9d6adf6be44	TCGA-AF-2691-01A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Rectum Adenocarcinoma	Aligned reads	TCGA-AF-2691-01A	830FD359-ABD4-4C99-89E4-2D6BB9CE5637	Primary Tumor	Illumina HiSeq	92f1a7a8-08ff-487e-bd7d-8146bc0109c6	Colorectal	48	CE252C3D-5CF3-46BC-A181-3714D1C65E4E	64EDFE90-619C-42A0-BBE1-EB78B4D5C26D	TCGA-AF-2691-01A-01D-1167-02	HG18	TCGA-AF-2691	TCGA-READ	NA	s2131	Harvard Medical School	Christiana Healthcare	None	NO	T1	N0	Rectal Adenocarcinoma	Stage I	1167-02	TRUE
13722.58cfa830e4b0c9d6adf6bf3c	58cfa830e4b0c9d6adf6bf3c	TCGA-BR-4256-01A-01D-1128_130110_SN1222_0167_AC1JPDACXX_s_1_rg.sorted.filtered.	WGS	TCGA-BR-4256-01A-01D-1128_130110_SN1222_0167_AC1JPDACXX_s_1_rg.sorted	TCGA-BR-4256-01A-01D-1128_130110_SN1222_0167_AC1JPDACXX_s_1_rg.sorted.bam	67.9	1.9	0.15	58cfa830e4b0c9d6adf6bf3c	TCGA-BR-4256-01A-01D-1128_130110_SN1222_0167_AC1JPDACXX_s_1_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-BR-4256-01A	7B0D69CA-13A6-46E0-839C-E433BBEDE3AD	Primary Tumor	Illumina HiSeq	6e990147-2463-4d38-a785-6c76ae1dbc25	Stomach	80	61C7AAB0-51D9-4706-A37C-D5058007DAF1	30AF7950-11F7-43BF-9A1D-98A57F416397	TCGA-BR-4256-01A-01D-1128-02	HG19_Broad_variant	TCGA-BR-4256	TCGA-STAD	NA	s14396	Harvard Medical School	Asterand	Russia	NO	TX	N1	Stomach  Adenocarcinoma  Not Otherwise Specified (NOS)	Not available	1128-02	TRUE
13722.58cfa830e4b0c9d6adf6bf72	58cfa830e4b0c9d6adf6bf72	TCGA-BR-4363-01A-01D-1154_130815_VM001_0001_VMR0001CXX_s_7_rg.sorted.filtered.	WGS	TCGA-BR-4363-01A-01D-1154_130815_VM001_0001_VMR0001CXX_s_7_rg.sorted	TCGA-BR-4363-01A-01D-1154_130815_VM001_0001_VMR0001CXX_s_7_rg.sorted.bam	264.2	1.9	0.15	58cfa830e4b0c9d6adf6bf72	TCGA-BR-4363-01A-01D-1154_130815_VM001_0001_VMR0001CXX_s_7_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-BR-4363-01A	66BCA2F8-F269-454D-ABE2-CE51A0704645	Primary Tumor	Illumina HiSeq	ab5af808-6239-48fa-ba17-b80aa3fc5e14	Stomach	60	06EC6231-EE0E-4C15-AF9F-5B9E5BF557B8	D62228AE-B0AB-4C31-9FD7-F9D48B140CDC	TCGA-BR-4363-01A-01D-1154-02	HG19_Broad_variant	TCGA-BR-4363	TCGA-STAD	NA	s14528	Harvard Medical School	Asterand	Russia	NO	T3	NX	Stomach  Adenocarcinoma  Not Otherwise Specified (NOS)	Not available	1154-02	TRUE
13722.58cfa830e4b0c9d6adf6bf6a	58cfa830e4b0c9d6adf6bf6a	TCGA-BR-6452-01A-12D-1798_130115_SN1222_0169_BD1K2PACXX_s_2_rg.sorted.filtered.	WGS	TCGA-BR-6452-01A-12D-1798_130115_SN1222_0169_BD1K2PACXX_s_2_rg.sorted	TCGA-BR-6452-01A-12D-1798_130115_SN1222_0169_BD1K2PACXX_s_2_rg.sorted.bam	409.4	1.9	0.16	58cfa830e4b0c9d6adf6bf6a	TCGA-BR-6452-01A-12D-1798_130115_SN1222_0169_BD1K2PACXX_s_2_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-BR-6452-01A	27988B3E-CDE1-4F4B-82A1-6D8AD08DB8E9	Primary Tumor	Illumina HiSeq	cfd9aa7a-7f3d-4b70-9359-2c93f0238361	Stomach	78	76144F2F-2498-430D-B33C-F000394C427E	460DE564-5AAB-46B0-8174-36AF18D2DF4C	TCGA-BR-6452-01A-12D-1798-02	HG19_Broad_variant	TCGA-BR-6452	TCGA-STAD	NA	s14744	Harvard Medical School	Asterand	Russia	NO	T3	N0	Stomach  Adenocarcinoma  Not Otherwise Specified (NOS)	Stage IIA	1798-02	TRUE
13722.58cfa830e4b0c9d6adf6bf80	58cfa830e4b0c9d6adf6bf80	TCGA-BR-6455-01A-11D-1798_130115_SN1222_0169_BD1K2PACXX_s_8_rg.sorted.filtered.	WGS	TCGA-BR-6455-01A-11D-1798_130115_SN1222_0169_BD1K2PACXX_s_8_rg.sorted	TCGA-BR-6455-01A-11D-1798_130115_SN1222_0169_BD1K2PACXX_s_8_rg.sorted.bam	324.7	1.9	0.15	58cfa830e4b0c9d6adf6bf80	TCGA-BR-6455-01A-11D-1798_130115_SN1222_0169_BD1K2PACXX_s_8_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-BR-6455-01A	75A29059-4705-4A55-BC3D-F5923B24B358	Primary Tumor	Illumina HiSeq	719ee3a5-cfe9-48cb-9e48-e11e49bd217c	Stomach	59	59BD0192-A50B-4672-A17F-4DF138F58988	6C038E7C-8B03-4AB6-A31A-00C3C6CE6204	TCGA-BR-6455-01A-11D-1798-02	HG19_Broad_variant	TCGA-BR-6455	TCGA-STAD	NA	s14470	Harvard Medical School	Asterand	Russia	NO	T3	N1	Stomach  Adenocarcinoma  Not Otherwise Specified (NOS)	Stage IIB	1798-02	TRUE
13722.58cfa830e4b0c9d6adf6bec5	58cfa830e4b0c9d6adf6bec5	TCGA-AG-A032-01A-01D-A077-02_IlluminaHiSeq-DNASeq_whole.filtered.	WGS	TCGA-AG-A032-01A-01D-A077-02_IlluminaHiSeq-DNASeq_whole	TCGA-AG-A032-01A-01D-A077-02_IlluminaHiSeq-DNASeq_whole.bam	237.12	1.85	0.15	58cfa830e4b0c9d6adf6bec5	TCGA-AG-A032-01A-01D-A077-02_IlluminaHiSeq-DNASeq_whole.bam	Alive	MALE	Not available	Not available	Rectum Adenocarcinoma	Aligned reads	TCGA-AG-A032-01A	0BB786EE-07CF-4853-9B49-EC95CD14E282	Primary Tumor	Illumina HiSeq	16a2716c-9563-4403-9a4b-8d4856022741	Colorectal	68	AE3C8931-C06F-466A-B6BF-440007E13387	AF7D94D6-C414-4812-A329-8856C086087E	TCGA-AG-A032-01A-01D-A077-02	HG18	TCGA-AG-A032	TCGA-READ	NA	s2175	Harvard Medical School	Indivumed	Germany	NO	T3	N1	Rectal Adenocarcinoma	Stage IIIB	A077-02	TRUE
13722.58cfa830e4b0c9d6adf6bfa8	58cfa830e4b0c9d6adf6bfa8	TCGA-BR-6454-01A-11D-1798_130115_SN1222_0169_BD1K2PACXX_s_6_rg.sorted.filtered.	WGS	TCGA-BR-6454-01A-11D-1798_130115_SN1222_0169_BD1K2PACXX_s_6_rg.sorted	TCGA-BR-6454-01A-11D-1798_130115_SN1222_0169_BD1K2PACXX_s_6_rg.sorted.bam	478.4	1.9	0.14	58cfa830e4b0c9d6adf6bfa8	TCGA-BR-6454-01A-11D-1798_130115_SN1222_0169_BD1K2PACXX_s_6_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-BR-6454-01A	AC2CBCE4-4BA8-42C9-AC61-70F42995588E	Primary Tumor	Illumina HiSeq	e344c34d-da8c-4145-8a02-b9ae248ca3a3	Stomach	58	E7D94421-7A3B-4100-9CBF-1B1F2EC07737	6F5506E4-8375-4F62-8B85-64FD729C6136	TCGA-BR-6454-01A-11D-1798-02	HG19_Broad_variant	TCGA-BR-6454	TCGA-STAD	NA	s14619	Harvard Medical School	Asterand	Russia	NO	T3	N0	Stomach  Adenocarcinoma  Not Otherwise Specified (NOS)	Stage IIA	1798-02	TRUE
13722.58cfa830e4b0c9d6adf6bfd6	58cfa830e4b0c9d6adf6bfd6	TCGA-AG-3728-01A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.filtered.	WGS	TCGA-AG-3728-01A-01D-1115-02_IlluminaHiSeq-DNASeq_whole	TCGA-AG-3728-01A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.bam	650.31	1.9	0.14	58cfa830e4b0c9d6adf6bfd6	TCGA-AG-3728-01A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.bam	Alive	MALE	Not available	Not available	Rectum Adenocarcinoma	Aligned reads	TCGA-AG-3728-01A	856A490C-C6DA-48FE-88B5-9FDE0F481365	Primary Tumor	Illumina HiSeq	d36f782a-483a-478d-a9a6-22f626b032bb	Colorectal	73	019EB82B-4A2D-4E67-99A6-FE10B0ABCB70	DF699DEA-C800-47D0-A526-A6C7A610041A	TCGA-AG-3728-01A-01D-1115-02	HG18	TCGA-AG-3728	TCGA-READ	NA	s2137	Harvard Medical School	Indivumed	Germany	NO	T3	N1	Rectal Adenocarcinoma	Stage IIIB	1115-02	TRUE
13722.58cfa830e4b0c9d6adf6c010	58cfa830e4b0c9d6adf6c010	TCGA-B5-A0K0-01A-11D-A043_120209_SN1120_0114_BC0DFVACXX_s_7_rg.sorted.filtered.	WGS	TCGA-B5-A0K0-01A-11D-A043_120209_SN1120_0114_BC0DFVACXX_s_7_rg.sorted	TCGA-B5-A0K0-01A-11D-A043_120209_SN1120_0114_BC0DFVACXX_s_7_rg.sorted.bam	106.93	1.95	0.16	58cfa830e4b0c9d6adf6c010	TCGA-B5-A0K0-01A-11D-A043_120209_SN1120_0114_BC0DFVACXX_s_7_rg.sorted.bam	Alive	FEMALE	WHITE	Not available	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-B5-A0K0-01A	29C8F468-5AC1-4D6C-8376-E36E6D246926	Primary Tumor	Illumina HiSeq	e5550bf6-3edf-480e-9dc5-6d590e837e5e	Uterus	48	11C43948-E7C9-4436-A654-82FA8033B625	3296C785-7C20-487D-BAEC-C66022E77E53	TCGA-B5-A0K0-01A-11D-A043-02	HG19_Broad_variant	TCGA-B5-A0K0	TCGA-UCEC	NA	s4598	Harvard Medical School	Duke	United States	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A043-02	TRUE
13722.58cfa830e4b0c9d6adf6c024	58cfa830e4b0c9d6adf6c024	TCGA-AX-A0J1-01A-11D-A043_120403_SN1222_0094_BD0UKBACXX_s_4_rg.sorted.filtered.	WGS	TCGA-AX-A0J1-01A-11D-A043_120403_SN1222_0094_BD0UKBACXX_s_4_rg.sorted	TCGA-AX-A0J1-01A-11D-A043_120403_SN1222_0094_BD0UKBACXX_s_4_rg.sorted.bam	87.89	1.88	0.15	58cfa830e4b0c9d6adf6c024	TCGA-AX-A0J1-01A-11D-A043_120403_SN1222_0094_BD0UKBACXX_s_4_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-AX-A0J1-01A	EC7A9D74-8B3F-4747-8926-1739A016AB2B	Primary Tumor	Illumina HiSeq	7bce686e-1ac7-49b4-9b2f-c76eec80a77c	Uterus	80	AC14E378-2DE1-458A-B8CD-7C60131AA927	3612DB54-D93C-47FB-A5E7-3BA3CE404A3C	TCGA-AX-A0J1-01A-11D-A043-02	HG19_Broad_variant	TCGA-AX-A0J1	TCGA-UCEC	NA	s4594	Harvard Medical School	Gynecologic Oncology Group	None	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A043-02	TRUE
13722.58cfa830e4b0c9d6adf6c05e	58cfa830e4b0c9d6adf6c05e	TCGA-AG-3999-01A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.filtered.	WGS	TCGA-AG-3999-01A-01D-1115-02_IlluminaHiSeq-DNASeq_whole	TCGA-AG-3999-01A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.bam	651.89	1.9	0.14	58cfa830e4b0c9d6adf6c05e	TCGA-AG-3999-01A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.bam	Alive	FEMALE	Not available	Not available	Rectum Adenocarcinoma	Aligned reads	TCGA-AG-3999-01A	60778DA8-D99E-4E51-96A2-3E900B3978D9	Primary Tumor	Illumina HiSeq	3d30dbe4-9c61-402a-afcd-c869123af4c6	Colorectal	61	022BA0B0-F8CC-474C-9FB9-7928B45FD756	1C65913D-665D-455E-9F40-8464E5EA0D55	TCGA-AG-3999-01A-01D-1115-02	HG18	TCGA-AG-3999	TCGA-READ	NA	s2161	Harvard Medical School	Indivumed	Germany	NO	T3	N2	Rectal Adenocarcinoma	Stage IIIC	1115-02	TRUE
13722.58cfa830e4b0c9d6adf6c106	58cfa830e4b0c9d6adf6c106	TCGA-BS-A0TJ-01A-11D-A101_120407_SN590_0152_AC0C7LACXX_s_6_rg.sorted.filtered.	WGS	TCGA-BS-A0TJ-01A-11D-A101_120407_SN590_0152_AC0C7LACXX_s_6_rg.sorted	TCGA-BS-A0TJ-01A-11D-A101_120407_SN590_0152_AC0C7LACXX_s_6_rg.sorted.bam	96.9	1.86	0.16	58cfa830e4b0c9d6adf6c106	TCGA-BS-A0TJ-01A-11D-A101_120407_SN590_0152_AC0C7LACXX_s_6_rg.sorted.bam	Alive	FEMALE	ASIAN	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-BS-A0TJ-01A	F74DA4C6-4291-46D2-ABD4-7D7F6EF03B00	Primary Tumor	Illumina HiSeq	d9625d1c-df48-4532-994d-9ab3a3c8f8b6	Uterus	59	AC35307B-AC7F-49FC-A237-5E03AB2E2276	C20AA17E-3866-4864-A4AE-44ACFD746221	TCGA-BS-A0TJ-01A-11D-A101-02	HG19_Broad_variant	TCGA-BS-A0TJ	TCGA-UCEC	NA	s5012	Harvard Medical School	University of Hawaii	None	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A101-02	TRUE
13722.58cfa830e4b0c9d6adf6c11c	58cfa830e4b0c9d6adf6c11c	TCGA-BS-A0TD-01A-11D-A101_120407_SN590_0152_AC0C7LACXX_s_2_rg.sorted.filtered.	WGS	TCGA-BS-A0TD-01A-11D-A101_120407_SN590_0152_AC0C7LACXX_s_2_rg.sorted	TCGA-BS-A0TD-01A-11D-A101_120407_SN590_0152_AC0C7LACXX_s_2_rg.sorted.bam	96.72	1.83	0.13	58cfa830e4b0c9d6adf6c11c	TCGA-BS-A0TD-01A-11D-A101_120407_SN590_0152_AC0C7LACXX_s_2_rg.sorted.bam	Alive	FEMALE	ASIAN	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-BS-A0TD-01A	FFAA98A0-2B69-46DC-AEE5-C5C3F2ABBC38	Primary Tumor	Illumina HiSeq	8f5ee5b5-1b1c-4af7-a179-4b71cc7c9f12	Uterus	65	8BB3A057-8958-4F62-AF81-976DA2E92DF7	3EF9C5ED-860A-4FF2-AA76-C53E9EB2453E	TCGA-BS-A0TD-01A-11D-A101-02	HG19_Broad_variant	TCGA-BS-A0TD	TCGA-UCEC	NA	s5219	Harvard Medical School	University of Hawaii	None	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A101-02	TRUE
13722.58cfa830e4b0c9d6adf6c1ba	58cfa830e4b0c9d6adf6c1ba	TCGA-BS-A0UT-01A-11D-A101_120407_SN590_0151_BC0KKJACXX_s_4_rg.sorted.filtered.	WGS	TCGA-BS-A0UT-01A-11D-A101_120407_SN590_0151_BC0KKJACXX_s_4_rg.sorted	TCGA-BS-A0UT-01A-11D-A101_120407_SN590_0151_BC0KKJACXX_s_4_rg.sorted.bam	65.26	1.97	0.13	58cfa830e4b0c9d6adf6c1ba	TCGA-BS-A0UT-01A-11D-A101_120407_SN590_0151_BC0KKJACXX_s_4_rg.sorted.bam	Alive	FEMALE	ASIAN	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-BS-A0UT-01A	E2B1D0DE-5221-44A1-8FAD-9708A3CADA14	Primary Tumor	Illumina HiSeq	ca5a88b7-6801-435a-aeef-b9ca9d963c17	Uterus	62	824D0DBC-293F-4893-A68C-24DEDD437EA5	12674687-D555-40DB-ACC9-7638F85D0661	TCGA-BS-A0UT-01A-11D-A101-02	HG19_Broad_variant	TCGA-BS-A0UT	TCGA-UCEC	NA	s4608	Harvard Medical School	University of Hawaii	None	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A101-02	TRUE
13722.58cfa830e4b0c9d6adf6c13a	58cfa830e4b0c9d6adf6c13a	TCGA-BS-A0U8-01A-11D-A101_120407_SN590_0152_AC0C7LACXX_s_8_rg.sorted.filtered.	WGS	TCGA-BS-A0U8-01A-11D-A101_120407_SN590_0152_AC0C7LACXX_s_8_rg.sorted	TCGA-BS-A0U8-01A-11D-A101_120407_SN590_0152_AC0C7LACXX_s_8_rg.sorted.bam	116.56	1.88	0.15	58cfa830e4b0c9d6adf6c13a	TCGA-BS-A0U8-01A-11D-A101_120407_SN590_0152_AC0C7LACXX_s_8_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-BS-A0U8-01A	FB7475DF-30CC-4316-B9AC-37CBEEB6BA2B	Primary Tumor	Illumina HiSeq	44c78212-4860-4cf3-bd54-0e8e150cd0b1	Uterus	55	E3E23393-8597-4091-A343-CD544111C63B	89AB037F-B001-486F-A7EB-37AF8FBD0677	TCGA-BS-A0U8-01A-11D-A101-02	HG19_Broad_variant	TCGA-BS-A0U8	TCGA-UCEC	NA	s4261	Harvard Medical School	University of Hawaii	None	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A101-02	TRUE
13722.58cfa830e4b0c9d6adf6c1b2	58cfa830e4b0c9d6adf6c1b2	TCGA-BG-A0MO-01A-11D-A043_120327_SN590_0148_BC0LM8ACXX_s_1_rg.sorted.filtered.	WGS	TCGA-BG-A0MO-01A-11D-A043_120327_SN590_0148_BC0LM8ACXX_s_1_rg.sorted	TCGA-BG-A0MO-01A-11D-A043_120327_SN590_0148_BC0LM8ACXX_s_1_rg.sorted.bam	37.97	2	0.16	58cfa830e4b0c9d6adf6c1b2	TCGA-BG-A0MO-01A-11D-A043_120327_SN590_0148_BC0LM8ACXX_s_1_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-BG-A0MO-01A	734EF97F-807C-480E-8DF9-FEAF041032D2	Primary Tumor	Illumina HiSeq	e165d17d-a860-4111-9ae9-3fb19605cd21	Uterus	63	7582CBB9-42D3-496C-991D-D76BEA4C434C	9AD06738-F4A2-47A8-972E-BF8C817326A6	TCGA-BG-A0MO-01A-11D-A043-02	HG19_Broad_variant	TCGA-BG-A0MO	TCGA-UCEC	NA	s5215	Harvard Medical School	University of Pittsburgh	None	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A043-02	TRUE
13722.58cfa830e4b0c9d6adf6c167	58cfa830e4b0c9d6adf6c167	TCGA-BJ-A0Z9-01A-11D-A10R_120616_SN1120_0153_AC0WMJACXX_s_7_rg.sorted.filtered.	WGS	TCGA-BJ-A0Z9-01A-11D-A10R_120616_SN1120_0153_AC0WMJACXX_s_7_rg.sorted	TCGA-BJ-A0Z9-01A-11D-A10R_120616_SN1120_0153_AC0WMJACXX_s_7_rg.sorted.bam	75.83	2.17	0.13	58cfa830e4b0c9d6adf6c167	TCGA-BJ-A0Z9-01A-11D-A10R_120616_SN1120_0153_AC0WMJACXX_s_7_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-BJ-A0Z9-01A	86F9ECA0-D1EA-4375-A6BC-055E44B3198A	Primary Tumor	Illumina HiSeq	2fcaeaf0-3a03-4b60-975a-31ac8afe58aa	Thyroid	57	AA8578FE-EDB2-4137-B363-FEB2C27D475A	B761F912-BDF6-4F1F-8CD0-0AE9DFC57A59	TCGA-BJ-A0Z9-01A-11D-A10R-02	HG19_Broad_variant	TCGA-BJ-A0Z9	TCGA-THCA	NA	s12099	Harvard Medical School	University of Pittsburgh	United States	NO	T3	N0	Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features)	Stage III	A10R-02	TRUE
13722.58cfa830e4b0c9d6adf6c064	58cfa830e4b0c9d6adf6c064	TCGA-AG-4005-01A-01D-1115_101122_SN177_0123_B20APUABXX_s_3_rg.sorted.filtered.	WGS	TCGA-AG-4005-01A-01D-1115_101122_SN177_0123_B20APUABXX_s_3_rg.sorted	TCGA-AG-4005-01A-01D-1115_101122_SN177_0123_B20APUABXX_s_3_rg.sorted.bam	618.89	1.9	0.15	58cfa830e4b0c9d6adf6c064	TCGA-AG-4005-01A-01D-1115_101122_SN177_0123_B20APUABXX_s_3_rg.sorted.bam	Alive	MALE	Not available	Not available	Rectum Adenocarcinoma	Aligned reads	TCGA-AG-4005-01A	866DE12B-E4DF-4F19-B62E-E3FD85D4EC08	Primary Tumor	Illumina HiSeq	06bb3e36-d2de-48c4-a23d-89eae00ec7e5	Colorectal	64	5B98C136-7BC3-411C-B07D-F0CF657F834D	284653D0-67A2-4ABF-9F75-1F045D0DAA70	TCGA-AG-4005-01A-01D-1115-02	HG18_Broad_variant	TCGA-AG-4005	TCGA-READ	NA	s1999	Harvard Medical School	Indivumed	Germany	NO	T3	N2	Rectal Adenocarcinoma	Stage IV	1115-02	TRUE
13722.58cfa830e4b0c9d6adf6c107	58cfa830e4b0c9d6adf6c107	TCGA-BS-A0TA-01A-11D-A101_120403_SN1222_0094_BD0UKBACXX_s_1_rg.sorted.filtered.	WGS	TCGA-BS-A0TA-01A-11D-A101_120403_SN1222_0094_BD0UKBACXX_s_1_rg.sorted	TCGA-BS-A0TA-01A-11D-A101_120403_SN1222_0094_BD0UKBACXX_s_1_rg.sorted.bam	95.02	2.03	0.15	58cfa830e4b0c9d6adf6c107	TCGA-BS-A0TA-01A-11D-A101_120403_SN1222_0094_BD0UKBACXX_s_1_rg.sorted.bam	Alive	FEMALE	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-BS-A0TA-01A	AD3D8420-F562-4CBE-AC82-C968BD4F782D	Primary Tumor	Illumina HiSeq	ee69554a-eb4c-482a-b37e-a643758f27e5	Uterus	58	B6A042B6-F94A-4ACC-98CB-A1A2FE72B9AD	896590DE-B00E-40A3-912D-D625F3581AD8	TCGA-BS-A0TA-01A-11D-A101-02	HG19_Broad_variant	TCGA-BS-A0TA	TCGA-UCEC	NA	s4437	Harvard Medical School	University of Hawaii	None	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A101-02	TRUE
13722.58cfa830e4b0c9d6adf6c20b	58cfa830e4b0c9d6adf6c20b	TCGA-BA-4078-01A-01D-1431_120423_SN590_0154_AC0JBHACXX_s_1_rg.sorted.filtered.	WGS	TCGA-BA-4078-01A-01D-1431_120423_SN590_0154_AC0JBHACXX_s_1_rg.sorted	TCGA-BA-4078-01A-01D-1431_120423_SN590_0154_AC0JBHACXX_s_1_rg.sorted.bam	747.33	1.9	0.16	58cfa830e4b0c9d6adf6c20b	TCGA-BA-4078-01A-01D-1431_120423_SN590_0154_AC0JBHACXX_s_1_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-BA-4078-01A	C7353D6A-82A2-4A0D-8CD4-8C8957943EDB	Primary Tumor	Illumina HiSeq	aaa9123e-a827-4226-9b51-0b04709fadb2	Head and Neck	83	2027EDE3-13F5-40F6-BEF6-16704981D676	66A9CFF2-397E-415E-BF54-9A75CCC80BDE	TCGA-BA-4078-01A-01D-1431-02	HG19_Broad_variant	TCGA-BA-4078	TCGA-HNSC	276	s15493	Harvard Medical School	UNC	None	NO	Not available	Not available	Head and Neck Squamous Cell Carcinoma	Not available	1431-02	TRUE
13722.58cfa830e4b0c9d6adf6c258	58cfa830e4b0c9d6adf6c258	TCGA-BJ-A0Z5-01A-11D-A10R_120616_SN1120_0153_AC0WMJACXX_s_1_rg.sorted.filtered.	WGS	TCGA-BJ-A0Z5-01A-11D-A10R_120616_SN1120_0153_AC0WMJACXX_s_1_rg.sorted	TCGA-BJ-A0Z5-01A-11D-A10R_120616_SN1120_0153_AC0WMJACXX_s_1_rg.sorted.bam	95.63	2.11	0.16	58cfa830e4b0c9d6adf6c258	TCGA-BJ-A0Z5-01A-11D-A10R_120616_SN1120_0153_AC0WMJACXX_s_1_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-BJ-A0Z5-01A	0FE3B19A-F5E4-497E-92DA-32FF6C77B066	Primary Tumor	Illumina HiSeq	84ec4e2b-c502-4348-b6ce-ae4a912e603c	Thyroid	58	D17746B4-EDEA-45DB-9AD1-5EE4973F007C	0AB5F114-C3CC-4DB4-87DF-1B339DDC54C2	TCGA-BJ-A0Z5-01A-11D-A10R-02	HG19_Broad_variant	TCGA-BJ-A0Z5	TCGA-THCA	NA	s12352	Harvard Medical School	University of Pittsburgh	United States	NO	T3	N1a	Thyroid Papillary Carcinoma - Classical/usual	Stage III	A10R-02	TRUE
13722.58cfa830e4b0c9d6adf6c226	58cfa830e4b0c9d6adf6c226	TCGA-BS-A0UV-01A-11D-A101_120407_SN590_0151_BC0KKJACXX_s_5_rg.sorted.filtered.	WGS	TCGA-BS-A0UV-01A-11D-A101_120407_SN590_0151_BC0KKJACXX_s_5_rg.sorted	TCGA-BS-A0UV-01A-11D-A101_120407_SN590_0151_BC0KKJACXX_s_5_rg.sorted.bam	96.07	1.92	0.15	58cfa830e4b0c9d6adf6c226	TCGA-BS-A0UV-01A-11D-A101_120407_SN590_0151_BC0KKJACXX_s_5_rg.sorted.bam	Alive	FEMALE	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-BS-A0UV-01A	B19425AB-A82F-4C2A-BF58-D1BD30511D74	Primary Tumor	Illumina HiSeq	91fbcf9b-f514-49ff-925b-08d6244293f7	Uterus	55	30945527-528A-448E-8DB4-2E0C31C9016D	A0F51177-4C00-4F97-8CD4-2E05B63B00DE	TCGA-BS-A0UV-01A-11D-A101-02	HG19_Broad_variant	TCGA-BS-A0UV	TCGA-UCEC	NA	s5222	Harvard Medical School	University of Hawaii	None	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A101-02	TRUE
13722.58cfa831e4b0c9d6adf6c392	58cfa831e4b0c9d6adf6c392	TCGA-CD-5799-01A-11D-1598_121025_SN590_0187_BC191FACXX_s_4_rg.sorted.filtered.	WGS	TCGA-CD-5799-01A-11D-1598_121025_SN590_0187_BC191FACXX_s_4_rg.sorted	TCGA-CD-5799-01A-11D-1598_121025_SN590_0187_BC191FACXX_s_4_rg.sorted.bam	177.7	2	0.17	58cfa831e4b0c9d6adf6c392	TCGA-CD-5799-01A-11D-1598_121025_SN590_0187_BC191FACXX_s_4_rg.sorted.bam	Alive	MALE	ASIAN	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-CD-5799-01A	C991697F-77F9-412A-9BD1-0E47F7387CB2	Primary Tumor	Illumina HiSeq	a59236bd-649f-4f2d-a702-4fb190d7f92c	Stomach	45	A3180E0E-EB99-49DD-8252-5FEA05A9885F	74F06FDA-C4D0-4542-AC92-68677B595800	TCGA-CD-5799-01A-11D-1598-02	HG19_Broad_variant	TCGA-CD-5799	TCGA-STAD	NA	s14633	Harvard Medical School	ILSbio	Vietnam	NO	T2	N1	Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS)	Stage II	1598-02	TRUE
13722.58cfa831e4b0c9d6adf6c4f9	58cfa831e4b0c9d6adf6c4f9	TCGA-BR-4369-01A-01D-1154_130815_VM001_0002_VMR0002CXX_s_7_rg.sorted.filtered.	WGS	TCGA-BR-4369-01A-01D-1154_130815_VM001_0002_VMR0002CXX_s_7_rg.sorted	TCGA-BR-4369-01A-01D-1154_130815_VM001_0002_VMR0002CXX_s_7_rg.sorted.bam	161.2	1.9	0.14	58cfa831e4b0c9d6adf6c4f9	TCGA-BR-4369-01A-01D-1154_130815_VM001_0002_VMR0002CXX_s_7_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-BR-4369-01A	FE9A5FCF-FF99-4DD1-8CC7-ED9F4B9D952B	Primary Tumor	Illumina HiSeq	cbba5183-9ada-4363-8f98-bf406b64f6d6	Stomach	75	39B440B3-F888-488A-A0CC-D7410DC73093	7220D8C0-DF8F-4A72-8338-795181BD8A47	TCGA-BR-4369-01A-01D-1154-02	HG19_Broad_variant	TCGA-BR-4369	TCGA-STAD	NA	s14966	Harvard Medical School	Asterand	Russia	NO	TX	NX	Stomach  Adenocarcinoma  Not Otherwise Specified (NOS)	Not available	1154-02	TRUE
13722.58cfa831e4b0c9d6adf6c3a8	58cfa831e4b0c9d6adf6c3a8	TCGA-CD-5798-01A-11D-1598_121025_SN590_0187_BC191FACXX_s_3_rg.sorted.filtered.	WGS	TCGA-CD-5798-01A-11D-1598_121025_SN590_0187_BC191FACXX_s_3_rg.sorted	TCGA-CD-5798-01A-11D-1598_121025_SN590_0187_BC191FACXX_s_3_rg.sorted.bam	44	1.9	0.13	58cfa831e4b0c9d6adf6c3a8	TCGA-CD-5798-01A-11D-1598_121025_SN590_0187_BC191FACXX_s_3_rg.sorted.bam	Alive	MALE	ASIAN	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-CD-5798-01A	E42F45C6-FD00-44CF-A210-C8803DA326A1	Primary Tumor	Illumina HiSeq	5b2c6e2f-0b61-49e1-bef5-6d7408918d47	Stomach	82	72855D36-60BE-498F-96E9-0F10DC05B3A0	F9D13E07-70F4-48F3-B49E-06984C9E39EE	TCGA-CD-5798-01A-11D-1598-02	HG19_Broad_variant	TCGA-CD-5798	TCGA-STAD	NA	s15455	Harvard Medical School	ILSbio	Vietnam	NO	T3	N0	Stomach Intestinal Adenocarcinoma Mucinous Type	Stage II	1598-02	TRUE
13722.58cfa831e4b0c9d6adf6c4d6	58cfa831e4b0c9d6adf6c4d6	TCGA-CF-A3MF-01A-12D-A21C_120914_SN590_0180_BC19KDACXX_s_1_rg.sorted.filtered.	WGS	TCGA-CF-A3MF-01A-12D-A21C_120914_SN590_0180_BC19KDACXX_s_1_rg.sorted	TCGA-CF-A3MF-01A-12D-A21C_120914_SN590_0180_BC19KDACXX_s_1_rg.sorted.bam	55.07	NA	0.16	58cfa831e4b0c9d6adf6c4d6	TCGA-CF-A3MF-01A-12D-A21C_120914_SN590_0180_BC19KDACXX_s_1_rg.sorted.bam	Alive	MALE	ASIAN	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-CF-A3MF-01A	1E308B12-0590-4DAE-94D0-A539FCF25DF7	Primary Tumor	Illumina HiSeq	57be2848-15e4-489c-b122-a660f03c68dd	Bladder	34	E9889071-4C6E-4761-9D65-06C6B5989FB7	6646401F-5235-4847-A4E6-006F98CAFE85	TCGA-CF-A3MF-01A-12D-A21C-26	HG19_Broad_variant	TCGA-CF-A3MF	TCGA-BLCA	NA	s3092	MD Anderson - Institute for Applied Cancer Science	ILSbio	Vietnam	NO	T3	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage III	A21C-26	TRUE
13722.58cfa831e4b0c9d6adf6c4fd	58cfa831e4b0c9d6adf6c4fd	TCGA-CD-5800-01A-11D-1598_121025_SN590_0187_BC191FACXX_s_5_rg.sorted.filtered.	WGS	TCGA-CD-5800-01A-11D-1598_121025_SN590_0187_BC191FACXX_s_5_rg.sorted	TCGA-CD-5800-01A-11D-1598_121025_SN590_0187_BC191FACXX_s_5_rg.sorted.bam	389	2	0.17	58cfa831e4b0c9d6adf6c4fd	TCGA-CD-5800-01A-11D-1598_121025_SN590_0187_BC191FACXX_s_5_rg.sorted.bam	Alive	FEMALE	ASIAN	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-CD-5800-01A	EEB114EA-ECEE-49EE-A162-B3B7BC0A60CD	Primary Tumor	Illumina HiSeq	e62fc018-7ddb-4d26-b187-0781aa2ba772	Stomach	51	B23E2D58-E61B-4B94-B4D8-407418351167	5EF4C8F7-B17A-48DA-AAF2-EF2FA32619A9	TCGA-CD-5800-01A-11D-1598-02	HG19_Broad_variant	TCGA-CD-5800	TCGA-STAD	NA	s14753	Harvard Medical School	ILSbio	Vietnam	NO	T3	N0	Stomach Intestinal Adenocarcinoma Papillary Type	Stage II	1598-02	TRUE
13722.58cfa830e4b0c9d6adf6c31b	58cfa830e4b0c9d6adf6c31b	TCGA-BS-A0TI-01A-11D-A101_120407_SN590_0152_AC0C7LACXX_s_5_rg.sorted.filtered.	WGS	TCGA-BS-A0TI-01A-11D-A101_120407_SN590_0152_AC0C7LACXX_s_5_rg.sorted	TCGA-BS-A0TI-01A-11D-A101_120407_SN590_0152_AC0C7LACXX_s_5_rg.sorted.bam	82.74	1.89	0.17	58cfa830e4b0c9d6adf6c31b	TCGA-BS-A0TI-01A-11D-A101_120407_SN590_0152_AC0C7LACXX_s_5_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-BS-A0TI-01A	DF857BC6-FD6A-4713-BEF9-6EE1301E5FB1	Primary Tumor	Illumina HiSeq	ea49ec05-391f-4ccc-8dbf-11ec80154839	Uterus	64	2F52C850-8E70-4EAB-88F3-D35DC55E385B	E1707EDD-FAC5-4213-BA50-2538F9F90EE5	TCGA-BS-A0TI-01A-11D-A101-02	HG19_Broad_variant	TCGA-BS-A0TI	TCGA-UCEC	NA	s5010	Harvard Medical School	University of Hawaii	None	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A101-02	TRUE
13722.58cfa831e4b0c9d6adf6c548	58cfa831e4b0c9d6adf6c548	TCGA-CM-4747-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.filtered.	WGS	TCGA-CM-4747-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole	TCGA-CM-4747-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.bam	541	1.9	0.15	58cfa831e4b0c9d6adf6c548	TCGA-CM-4747-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Colon Adenocarcinoma	Aligned reads	TCGA-CM-4747-01A	56EB96A4-D2C2-42FB-B26C-1A80012BCB8E	Primary Tumor	Illumina HiSeq	e66cdfc9-e0b0-4ca4-bbcc-9ae23d9d663f	Colorectal	47	D3DAA95A-19B5-4822-BCBE-35CEEC12FDF1	7E2021D4-E528-4EB1-A7A0-71D6BE77A71D	TCGA-CM-4747-01A-01D-1405-02	HG18	TCGA-CM-4747	TCGA-COAD	NA	s13217	Harvard Medical School	MSKCC	None	NO	T4a	N1b	Colon Adenocarcinoma	Stage IVA	1405-02	TRUE
13722.58cfa831e4b0c9d6adf6c5f0	58cfa831e4b0c9d6adf6c5f0	TCGA-CG-4440-01A-01D-A326_131002_SN208_0497_AC2CLVACXX_s_5_rg.sorted.filtered.	WGS	TCGA-CG-4440-01A-01D-A326_131002_SN208_0497_AC2CLVACXX_s_5_rg.sorted	TCGA-CG-4440-01A-01D-A326_131002_SN208_0497_AC2CLVACXX_s_5_rg.sorted.bam	126.2	1.9	0.14	58cfa831e4b0c9d6adf6c5f0	TCGA-CG-4440-01A-01D-A326_131002_SN208_0497_AC2CLVACXX_s_5_rg.sorted.bam	Dead	FEMALE	Not available	Not available	Stomach Adenocarcinoma	Aligned reads	TCGA-CG-4440-01A	8CA597DB-AC21-43D1-9329-586B2EAF6982	Primary Tumor	Illumina HiSeq	d72343ff-91f0-4705-a398-914c5d2344d9	Stomach	68	C7B05D36-0386-4B2C-9E8B-2C7502CC4F21	8743D838-FD82-47D4-9BD0-0BAC137FE644	TCGA-CG-4440-01A-01D-A326-26	HG19_Broad_variant	TCGA-CG-4440	TCGA-STAD	122	s15397	MD Anderson - Institute for Applied Cancer Science	Indivumed	Germany	NO	T3	N3	Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS)	Stage IV	A326-26	TRUE
13722.58cfa831e4b0c9d6adf6c588	58cfa831e4b0c9d6adf6c588	TCGA-CM-4748-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.filtered.	WGS	TCGA-CM-4748-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole	TCGA-CM-4748-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.bam	227.02	1.9	0.13	58cfa831e4b0c9d6adf6c588	TCGA-CM-4748-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Colon Adenocarcinoma	Aligned reads	TCGA-CM-4748-01A	CD845618-4CC4-49C2-9055-C171D4C24EE1	Primary Tumor	Illumina HiSeq	f3119dfa-63bb-4098-9ea9-874f04789d12	Colorectal	53	1A465792-4DA7-4D37-9352-73E76ECFF4D2	3E7170B8-B0ED-4077-A65A-B6E399719A93	TCGA-CM-4748-01A-01D-1405-02	HG18	TCGA-CM-4748	TCGA-COAD	NA	s13392	Harvard Medical School	MSKCC	None	NO	T4a	N1a	Colon Mucinous Adenocarcinoma	Stage IIIB	1405-02	TRUE
13722.58cfa831e4b0c9d6adf6c605	58cfa831e4b0c9d6adf6c605	TCGA-CQ-5329-01A-01D-1681_120425_SN1222_0100_BD0T1VACXX_s_3_rg.sorted.filtered.	WGS	TCGA-CQ-5329-01A-01D-1681_120425_SN1222_0100_BD0T1VACXX_s_3_rg.sorted	TCGA-CQ-5329-01A-01D-1681_120425_SN1222_0100_BD0T1VACXX_s_3_rg.sorted.bam	687	1.9	0.14	58cfa831e4b0c9d6adf6c605	TCGA-CQ-5329-01A-01D-1681_120425_SN1222_0100_BD0T1VACXX_s_3_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CQ-5329-01A	02DCC11F-4F0E-4C9E-8D96-D22D47BEEF5D	Primary Tumor	Illumina HiSeq	b54a3eac-9c58-453d-9db1-395601ae82ea	Head and Neck	46	D22E9B65-495B-4D42-926A-01BF2C436D76	63CE8A9C-2CC5-41D9-B24D-3FB88343B693	TCGA-CQ-5329-01A-01D-1681-02	HG19_Broad_variant	TCGA-CQ-5329	TCGA-HNSC	NA	s15772	Harvard Medical School	University Health Network, Toronto	Canada	NO	T2	N0	Head and Neck Squamous Cell Carcinoma	Stage II	1681-02	TRUE
13722.58cfa831e4b0c9d6adf6c61f	58cfa831e4b0c9d6adf6c61f	TCGA-CG-4436-01A-01D-1154_130815_VM001_0003_VMR0003CXX_s_5_rg.sorted.filtered.	WGS	TCGA-CG-4436-01A-01D-1154_130815_VM001_0003_VMR0003CXX_s_5_rg.sorted	TCGA-CG-4436-01A-01D-1154_130815_VM001_0003_VMR0003CXX_s_5_rg.sorted.bam	336.2	1.9	0.13	58cfa831e4b0c9d6adf6c61f	TCGA-CG-4436-01A-01D-1154_130815_VM001_0003_VMR0003CXX_s_5_rg.sorted.bam	Alive	MALE	Not available	Not available	Stomach Adenocarcinoma	Aligned reads	TCGA-CG-4436-01A	7938CA55-766E-4277-9E7E-603FFA02E570	Primary Tumor	Illumina HiSeq	0b869c68-28bb-4675-ba6c-6d20a89a1a49	Stomach	57	21F40CF9-D89F-4FEC-BE65-1740AB39DAE4	9215C180-AC30-4585-9AF3-4EF1D718E187	TCGA-CG-4436-01A-01D-1154-02	HG19_Broad_variant	TCGA-CG-4436	TCGA-STAD	NA	s14980	Harvard Medical School	Indivumed	Germany	NO	T2	N0	Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS)	Stage IB	1154-02	TRUE
13722.58cfa831e4b0c9d6adf6c6d2	58cfa831e4b0c9d6adf6c6d2	TCGA-CS-4938-01B-11D-1891_130919_SN590_0238_AC29TRACXX_s_1_rg.sorted.filtered.	WGS	TCGA-CS-4938-01B-11D-1891_130919_SN590_0238_AC29TRACXX_s_1_rg.sorted	TCGA-CS-4938-01B-11D-1891_130919_SN590_0238_AC29TRACXX_s_1_rg.sorted.bam	19.7	1.9	0.15	58cfa831e4b0c9d6adf6c6d2	TCGA-CS-4938-01B-11D-1891_130919_SN590_0238_AC29TRACXX_s_1_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-CS-4938-01B	334F715E-08DC-4A29-B8E4-B010B829C478	Primary Tumor	Illumina HiSeq	8b9dc3cd-2c99-405c-8306-3b388ad5bdf6	Brain	31	99104139-6CB5-44F7-8314-A4DDF02DE7D4	7FE72196-9DE8-4A43-87F2-D2E8F74B0007	TCGA-CS-4938-01B-11D-1891-02	HG19_Broad_variant	TCGA-CS-4938	TCGA-LGG	NA	s8553	Harvard Medical School	Thomas Jefferson University	United States	NO	Not available	Not available	Astrocytoma	Not available	1891-02	TRUE
13722.58cfa831e4b0c9d6adf6c655	58cfa831e4b0c9d6adf6c655	TCGA-CG-4444-01A-01D-A326_131002_SN208_0497_AC2CLVACXX_s_7_rg.sorted.filtered.	WGS	TCGA-CG-4444-01A-01D-A326_131002_SN208_0497_AC2CLVACXX_s_7_rg.sorted	TCGA-CG-4444-01A-01D-A326_131002_SN208_0497_AC2CLVACXX_s_7_rg.sorted.bam	51.2	1.9	0.14	58cfa831e4b0c9d6adf6c655	TCGA-CG-4444-01A-01D-A326_131002_SN208_0497_AC2CLVACXX_s_7_rg.sorted.bam	Alive	MALE	Not available	Not available	Stomach Adenocarcinoma	Aligned reads	TCGA-CG-4444-01A	5C087D33-0BD3-407D-8350-FABBA6AEC597	Primary Tumor	Illumina HiSeq	37421315-54a7-4a59-9939-4706dcd66019	Stomach	76	8563E95B-8E50-4E23-95D1-25AE8437B1DB	37738374-DDCD-4710-A1CC-BF86868C252A	TCGA-CG-4444-01A-01D-A326-26	HG19_Broad_variant	TCGA-CG-4444	TCGA-STAD	NA	s15192	MD Anderson - Institute for Applied Cancer Science	Indivumed	Germany	NO	T2b	N2	Stomach  Adenocarcinoma  Diffuse Type	Stage IIIA	A326-26	TRUE
13722.58cfa831e4b0c9d6adf6c646	58cfa831e4b0c9d6adf6c646	TCGA-CQ-5327-01A-01D-1681_120425_SN1222_0100_BD0T1VACXX_s_2_rg.sorted.filtered.	WGS	TCGA-CQ-5327-01A-01D-1681_120425_SN1222_0100_BD0T1VACXX_s_2_rg.sorted	TCGA-CQ-5327-01A-01D-1681_120425_SN1222_0100_BD0T1VACXX_s_2_rg.sorted.bam	234	1.9	0.15	58cfa831e4b0c9d6adf6c646	TCGA-CQ-5327-01A-01D-1681_120425_SN1222_0100_BD0T1VACXX_s_2_rg.sorted.bam	Alive	FEMALE	ASIAN	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CQ-5327-01A	5A03E2B6-4C8B-479A-9036-9859AF031DA4	Primary Tumor	Illumina HiSeq	3482a15d-acdc-4fcf-86a5-b015e57faefd	Head and Neck	61	93D283A7-E866-4F23-81F7-942DEE5009B8	55F0F300-E472-4254-9BDA-76AD94EA8C13	TCGA-CQ-5327-01A-01D-1681-02	HG19_Broad_variant	TCGA-CQ-5327	TCGA-HNSC	NA	s15638	Harvard Medical School	University Health Network, Toronto	Canada	NO	T3	N2c	Head and Neck Squamous Cell Carcinoma	Stage IVA	1681-02	TRUE
13722.58cfa831e4b0c9d6adf6c526	58cfa831e4b0c9d6adf6c526	TCGA-CM-4746-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.filtered.	WGS	TCGA-CM-4746-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole	TCGA-CM-4746-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.bam	516	1.9	0.15	58cfa831e4b0c9d6adf6c526	TCGA-CM-4746-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.bam	Alive	MALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Colon Adenocarcinoma	Aligned reads	TCGA-CM-4746-01A	C0B8C55C-B993-481D-AEEA-9EBFA64EE20E	Primary Tumor	Illumina HiSeq	cba07266-002c-406e-bfb3-5fc3483bb04b	Colorectal	61	85991716-6807-4F31-BE63-BF80CEC40CC2	32AAA8D7-1ABF-4AEF-8067-BE801C95D30B	TCGA-CM-4746-01A-01D-1405-02	HG18	TCGA-CM-4746	TCGA-COAD	NA	s12892	Harvard Medical School	MSKCC	None	NO	T2	N0	Colon Adenocarcinoma	Stage I	1405-02	TRUE
13722.58cfa831e4b0c9d6adf6c726	58cfa831e4b0c9d6adf6c726	TCGA-D6-6825-01A-21D-1911_120518_SN1120_0143_BC0VN6ACXX_s_2_rg.sorted.filtered.	WGS	TCGA-D6-6825-01A-21D-1911_120518_SN1120_0143_BC0VN6ACXX_s_2_rg.sorted	TCGA-D6-6825-01A-21D-1911_120518_SN1120_0143_BC0VN6ACXX_s_2_rg.sorted.bam	288.7	1.9	0.14	58cfa831e4b0c9d6adf6c726	TCGA-D6-6825-01A-21D-1911_120518_SN1120_0143_BC0VN6ACXX_s_2_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-D6-6825-01A	42BC2336-2408-441A-83B9-AADC9700F750	Primary Tumor	Illumina HiSeq	e785062a-dcec-4a1d-aa67-6089980c9e35	Head and Neck	73	D9E2F5AA-A6E2-491A-9DBC-E5D10B4ABA58	8B36C904-50A1-4B17-94A2-F9331A5FED1E	TCGA-D6-6825-01A-21D-1911-02	HG19_Broad_variant	TCGA-D6-6825	TCGA-HNSC	NA	s15529	Harvard Medical School	Greater Poland Cancer Center	Poland	NO	T1	N0	Head and Neck Squamous Cell Carcinoma	Stage I	1911-02	TRUE
13722.58cfa831e4b0c9d6adf6c95a	58cfa831e4b0c9d6adf6c95a	TCGA-DJ-A1QF-01A-12D-A14U_120629_SN1120_0167_AC0WMBACXX_s_4_rg.sorted.filtered.	WGS	TCGA-DJ-A1QF-01A-12D-A14U_120629_SN1120_0167_AC0WMBACXX_s_4_rg.sorted	TCGA-DJ-A1QF-01A-12D-A14U_120629_SN1120_0167_AC0WMBACXX_s_4_rg.sorted.bam	14.32	1.97	0.15	58cfa831e4b0c9d6adf6c95a	TCGA-DJ-A1QF-01A-12D-A14U_120629_SN1120_0167_AC0WMBACXX_s_4_rg.sorted.bam	Alive	FEMALE	WHITE	Not available	Thyroid Carcinoma	Aligned reads	TCGA-DJ-A1QF-01A	FCA0C7D9-5E6F-4AA7-BA04-5DF2EB8BA398	Primary Tumor	Illumina HiSeq	267d7caa-22fc-41bc-8ea9-ee910a0ac510	Thyroid	61	E4B53CA1-D395-4FEA-A962-DFBD2B373A6B	FA0BE982-CE22-449F-9D2B-E688196BA8AE	TCGA-DJ-A1QF-01A-12D-A14U-02	HG19_Broad_variant	TCGA-DJ-A1QF	TCGA-THCA	NA	s11991	Harvard Medical School	Memorial Sloan Kettering	United States	NO	T2	N0	Thyroid Papillary Carcinoma - Classical/usual	Stage II	A14U-02	TRUE
13722.58cfa831e4b0c9d6adf6c7ff	58cfa831e4b0c9d6adf6c7ff	TCGA-D1-A16X-01A-11D-A12F_120413_SN1120_0132_AD0T6RACXX_s_4_rg.sorted.filtered.	WGS	TCGA-D1-A16X-01A-11D-A12F_120413_SN1120_0132_AD0T6RACXX_s_4_rg.sorted	TCGA-D1-A16X-01A-11D-A12F_120413_SN1120_0132_AD0T6RACXX_s_4_rg.sorted.bam	91.84	2.11	0.16	58cfa831e4b0c9d6adf6c7ff	TCGA-D1-A16X-01A-11D-A12F_120413_SN1120_0132_AD0T6RACXX_s_4_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-D1-A16X-01A	22618073-4EF0-4C3A-97B9-90BA1CAA1D72	Primary Tumor	Illumina HiSeq	8f166eb0-a44e-4848-ae7a-4e174f470d5b	Uterus	54	6421D807-9BEC-4AD4-8B75-8F9DD594A977	E652FF84-B885-4245-86E5-70ADE972FD67	TCGA-D1-A16X-01A-11D-A12F-02	HG19_Broad_variant	TCGA-D1-A16X	TCGA-UCEC	NA	s5023	Harvard Medical School	Mayo Clinic	None	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A12F-02	TRUE
13722.58cfa831e4b0c9d6adf6c97a	58cfa831e4b0c9d6adf6c97a	TCGA-DJ-A1QN-01A-11D-A14U_120629_SN1120_0168_BD1454ACXX_s_1_rg.sorted.filtered.	WGS	TCGA-DJ-A1QN-01A-11D-A14U_120629_SN1120_0168_BD1454ACXX_s_1_rg.sorted	TCGA-DJ-A1QN-01A-11D-A14U_120629_SN1120_0168_BD1454ACXX_s_1_rg.sorted.bam	94.75	1.91	0.17	58cfa831e4b0c9d6adf6c97a	TCGA-DJ-A1QN-01A-11D-A14U_120629_SN1120_0168_BD1454ACXX_s_1_rg.sorted.bam	Alive	FEMALE	Not available	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-DJ-A1QN-01A	2012869D-C169-4CEA-AA09-C892FB79BBAA	Primary Tumor	Illumina HiSeq	5cfa9ea5-2e72-4f40-96be-d6accc8482a8	Thyroid	42	884C1978-00CF-4E48-BEF8-F03CA67D6C02	F5D0FC17-824D-42F7-931B-E23CD68B9E2F	TCGA-DJ-A1QN-01A-11D-A14U-02	HG19_Broad_variant	TCGA-DJ-A1QN	TCGA-THCA	NA	s12640	Harvard Medical School	Memorial Sloan Kettering	United States	NO	T1b	N0	Thyroid Papillary Carcinoma - Classical/usual	Stage I	A14U-02	TRUE
13722.58cfa831e4b0c9d6adf6c94b	58cfa831e4b0c9d6adf6c94b	TCGA-DJ-A1QO-01A-11D-A14U_120629_SN1120_0168_BD1454ACXX_s_6_rg.sorted.filtered.	WGS	TCGA-DJ-A1QO-01A-11D-A14U_120629_SN1120_0168_BD1454ACXX_s_6_rg.sorted	TCGA-DJ-A1QO-01A-11D-A14U_120629_SN1120_0168_BD1454ACXX_s_6_rg.sorted.bam	43.74	1.8	0.18	58cfa831e4b0c9d6adf6c94b	TCGA-DJ-A1QO-01A-11D-A14U_120629_SN1120_0168_BD1454ACXX_s_6_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-DJ-A1QO-01A	F2AD720E-579F-4E2C-A3F0-17877CA91067	Primary Tumor	Illumina HiSeq	1ac10023-1615-4727-ac8d-23b842c19d3c	Thyroid	69	03811796-0ECE-4408-82F7-B449A631D2FB	9E0C97ED-7482-4400-B66A-72AB48BA11A2	TCGA-DJ-A1QO-01A-11D-A14U-02	HG19_Broad_variant	TCGA-DJ-A1QO	TCGA-THCA	NA	s12372	Harvard Medical School	Memorial Sloan Kettering	United States	NO	T3	N0	Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features)	Stage III	A14U-02	TRUE
13722.58cfa831e4b0c9d6adf6c9c9	58cfa831e4b0c9d6adf6c9c9	TCGA-DJ-A1QH-01A-21D-A14U_120629_SN1222_0121_BD143UACXX_s_7_rg.sorted.filtered.	WGS	TCGA-DJ-A1QH-01A-21D-A14U_120629_SN1222_0121_BD143UACXX_s_7_rg.sorted	TCGA-DJ-A1QH-01A-21D-A14U_120629_SN1222_0121_BD143UACXX_s_7_rg.sorted.bam	51.98	1.61	0.16	58cfa831e4b0c9d6adf6c9c9	TCGA-DJ-A1QH-01A-21D-A14U_120629_SN1222_0121_BD143UACXX_s_7_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-DJ-A1QH-01A	F3C73DC9-6280-4619-A629-B575FDBDB0CA	Primary Tumor	Illumina HiSeq	0e84405e-6687-4f5d-89c9-c507d3c0bba0	Thyroid	58	B1775A45-D30D-42C3-91D8-53C662B4A974	31F3AA22-9E90-4FF7-872C-0EED3DB18545	TCGA-DJ-A1QH-01A-21D-A14U-02	HG19_Broad_variant	TCGA-DJ-A1QH	TCGA-THCA	NA	s12376	Harvard Medical School	Memorial Sloan Kettering	United States	NO	T3	N1a	Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features)	Stage III	A14U-02	TRUE
13722.58cfa831e4b0c9d6adf6cab0	58cfa831e4b0c9d6adf6cab0	TCGA-DJ-A13U-01A-11D-A10R_120616_SN1120_0153_AC0WMJACXX_s_3_rg.sorted.filtered.	WGS	TCGA-DJ-A13U-01A-11D-A10R_120616_SN1120_0153_AC0WMJACXX_s_3_rg.sorted	TCGA-DJ-A13U-01A-11D-A10R_120616_SN1120_0153_AC0WMJACXX_s_3_rg.sorted.bam	76.6	1.95	0.16	58cfa831e4b0c9d6adf6cab0	TCGA-DJ-A13U-01A-11D-A10R_120616_SN1120_0153_AC0WMJACXX_s_3_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-DJ-A13U-01A	8C5AEF43-341E-4A37-84EB-FD730EB957C7	Primary Tumor	Illumina HiSeq	c717fac6-b3b3-4335-8ee8-5862d742ea16	Thyroid	60	CD19D6BB-21A4-409A-A7BA-A4521A03ABD3	B80A7146-1AB2-49BD-A3B2-7F6650840195	TCGA-DJ-A13U-01A-11D-A10R-02	HG19_Broad_variant	TCGA-DJ-A13U	TCGA-THCA	NA	s12104	Harvard Medical School	Memorial Sloan Kettering	United States	NO	T3	N0	Thyroid Papillary Carcinoma - Classical/usual	Stage III	A10R-02	TRUE
13722.58cfa831e4b0c9d6adf6c9ed	58cfa831e4b0c9d6adf6c9ed	TCGA-DJ-A13P-01A-11D-A10R_120617_SN1222_0117_BD1414ACXX_s_5_rg.sorted.filtered.	WGS	TCGA-DJ-A13P-01A-11D-A10R_120617_SN1222_0117_BD1414ACXX_s_5_rg.sorted	TCGA-DJ-A13P-01A-11D-A10R_120617_SN1222_0117_BD1414ACXX_s_5_rg.sorted.bam	104.83	1.95	0.16	58cfa831e4b0c9d6adf6c9ed	TCGA-DJ-A13P-01A-11D-A10R_120617_SN1222_0117_BD1414ACXX_s_5_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-DJ-A13P-01A	CA95A11C-B54C-409E-B9A0-DA850945033D	Primary Tumor	Illumina HiSeq	5d993dc5-0dfb-4f12-bd8b-c21a2c64577d	Thyroid	52	EFAD8B07-B295-468F-A836-F94029AEC777	528EC19A-8218-4E8F-B1E7-8A149F54A6BE	TCGA-DJ-A13P-01A-11D-A10R-02	HG19_Broad_variant	TCGA-DJ-A13P	TCGA-THCA	NA	s11995	Harvard Medical School	Memorial Sloan Kettering	United States	NO	T2	N0	Thyroid Papillary Carcinoma - Classical/usual	Stage II	A10R-02	TRUE
13722.58cfa831e4b0c9d6adf6cada	58cfa831e4b0c9d6adf6cada	TCGA-DU-6542-01A-11D-1891_130919_SN590_0238_AC29TRACXX_s_2_rg.sorted.filtered.	WGS	TCGA-DU-6542-01A-11D-1891_130919_SN590_0238_AC29TRACXX_s_2_rg.sorted	TCGA-DU-6542-01A-11D-1891_130919_SN590_0238_AC29TRACXX_s_2_rg.sorted.bam	424.7	1.9	0.14	58cfa831e4b0c9d6adf6cada	TCGA-DU-6542-01A-11D-1891_130919_SN590_0238_AC29TRACXX_s_2_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-DU-6542-01A	CD69D509-A652-4257-A8D3-767296BBB4EC	Primary Tumor	Illumina HiSeq	4b6cb752-5ed6-42e5-aed5-c8bdc6b95945	Brain	25	D00791AB-AA9D-406B-934C-E6946A430BB2	6EF0AE20-9197-4162-9A35-E235071A83B5	TCGA-DU-6542-01A-11D-1891-02	HG19_Broad_variant	TCGA-DU-6542	TCGA-LGG	NA	s8143	Harvard Medical School	Henry Ford Hospital	United States	NO	Not available	Not available	Oligoastrocytoma	Not available	1891-02	TRUE
13722.58cfa831e4b0c9d6adf6caa0	58cfa831e4b0c9d6adf6caa0	TCGA-DJ-A1QM-01A-11D-A14U_120629_SN1120_0167_AC0WMBACXX_s_3_rg.sorted.filtered.	WGS	TCGA-DJ-A1QM-01A-11D-A14U_120629_SN1120_0167_AC0WMBACXX_s_3_rg.sorted	TCGA-DJ-A1QM-01A-11D-A14U_120629_SN1120_0167_AC0WMBACXX_s_3_rg.sorted.bam	41.49	1.86	0.16	58cfa831e4b0c9d6adf6caa0	TCGA-DJ-A1QM-01A-11D-A14U_120629_SN1120_0167_AC0WMBACXX_s_3_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-DJ-A1QM-01A	3597AF5E-65FF-40A7-95FC-DACC26CBCA14	Primary Tumor	Illumina HiSeq	e98815fd-cd95-4af1-af17-129186e4a00a	Thyroid	42	B4215B1F-3918-43D6-8862-380C35F891EC	A070BCA4-DDFA-4BE7-A635-69A2BA97FFE9	TCGA-DJ-A1QM-01A-11D-A14U-02	HG19_Broad_variant	TCGA-DJ-A1QM	TCGA-THCA	NA	s12243	Harvard Medical School	Memorial Sloan Kettering	United States	NO	T1a	N0	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	Stage I	A14U-02	TRUE
13722.58cfa831e4b0c9d6adf6cd18	58cfa831e4b0c9d6adf6cd18	TCGA-ET-A25N-01A-11D-A16N_120718_SN590_0169_AC0WL7ACXX_s_7_rg.sorted.filtered.	WGS	TCGA-ET-A25N-01A-11D-A16N_120718_SN590_0169_AC0WL7ACXX_s_7_rg.sorted	TCGA-ET-A25N-01A-11D-A16N_120718_SN590_0169_AC0WL7ACXX_s_7_rg.sorted.bam	26.49	1.71	0.15	58cfa831e4b0c9d6adf6cd18	TCGA-ET-A25N-01A-11D-A16N_120718_SN590_0169_AC0WL7ACXX_s_7_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-ET-A25N-01A	EBCCFB5F-C0A8-4263-AAFF-B5DD83585191	Primary Tumor	Illumina HiSeq	2e9fb20e-cc3d-4aa3-a188-6695dc2532a3	Thyroid	28	0CD93B1F-1CBB-4C1E-A4F6-940F95C41683	1A00F009-28F5-406B-8F47-4BB9D55D25D6	TCGA-ET-A25N-01A-11D-A16N-02	HG19_Broad_variant	TCGA-ET-A25N	TCGA-THCA	NA	s12525	Harvard Medical School	Johns Hopkins	United States	NO	T2	N1a	Thyroid Papillary Carcinoma - Classical/usual	Stage I	A16N-02	TRUE
13722.58cfa831e4b0c9d6adf6cd74	58cfa831e4b0c9d6adf6cd74	TCGA-ET-A25K-01A-11D-A16N_120717_SN1120_0176_BC1178ACXX_s_7_rg.sorted.filtered.	WGS	TCGA-ET-A25K-01A-11D-A16N_120717_SN1120_0176_BC1178ACXX_s_7_rg.sorted	TCGA-ET-A25K-01A-11D-A16N_120717_SN1120_0176_BC1178ACXX_s_7_rg.sorted.bam	57.24	2	0.17	58cfa831e4b0c9d6adf6cd74	TCGA-ET-A25K-01A-11D-A16N_120717_SN1120_0176_BC1178ACXX_s_7_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-ET-A25K-01A	2F9ED09D-2626-4C23-BA47-1850D36F812A	Primary Tumor	Illumina HiSeq	81720382-db9a-41e3-814e-ee8ec59ce22d	Thyroid	36	343311B1-D586-4F92-9984-32AF1AFB1F62	663173D3-A9EE-4E73-8444-52F01727BE6D	TCGA-ET-A25K-01A-11D-A16N-02	HG19_Broad_variant	TCGA-ET-A25K	TCGA-THCA	NA	s12115	Harvard Medical School	Johns Hopkins	United States	NO	T2	N1a	Thyroid Papillary Carcinoma - Classical/usual	Stage I	A16N-02	TRUE
13722.58cfa831e4b0c9d6adf6cdb8	58cfa831e4b0c9d6adf6cdb8	TCGA-FG-6691-01A-11D-1891_130919_SN590_0238_AC29TRACXX_s_8_rg.sorted.filtered.	WGS	TCGA-FG-6691-01A-11D-1891_130919_SN590_0238_AC29TRACXX_s_8_rg.sorted	TCGA-FG-6691-01A-11D-1891_130919_SN590_0238_AC29TRACXX_s_8_rg.sorted.bam	105.7	1.9	0.16	58cfa831e4b0c9d6adf6cdb8	TCGA-FG-6691-01A-11D-1891_130919_SN590_0238_AC29TRACXX_s_8_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-FG-6691-01A	E4D9B696-3311-44E7-9191-FDE56C080A00	Primary Tumor	Illumina HiSeq	b404ac67-1c7f-4b01-8038-7432d3d6e489	Brain	23	87800B98-1FD3-4A09-AC98-3125962BFA72	B4968770-4D21-4C51-9ECA-47E23D5C240E	TCGA-FG-6691-01A-11D-1891-02	HG19_Broad_variant	TCGA-FG-6691	TCGA-LGG	NA	s8368	Harvard Medical School	Case Western	United States	NO	Not available	Not available	Astrocytoma	Not available	1891-02	TRUE
13722.58cfa831e4b0c9d6adf6cda0	58cfa831e4b0c9d6adf6cda0	TCGA-FE-A233-01A-11D-A14U_120629_SN1222_0121_BD143UACXX_s_3_rg.sorted.filtered.	WGS	TCGA-FE-A233-01A-11D-A14U_120629_SN1222_0121_BD143UACXX_s_3_rg.sorted	TCGA-FE-A233-01A-11D-A14U_120629_SN1222_0121_BD143UACXX_s_3_rg.sorted.bam	92.7	2.05	0.18	58cfa831e4b0c9d6adf6cda0	TCGA-FE-A233-01A-11D-A14U_120629_SN1222_0121_BD143UACXX_s_3_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-FE-A233-01A	E70FEAFD-1390-4F4C-A635-DA65C1A7DAEB	Primary Tumor	Illumina HiSeq	3609a0f8-b027-4392-adea-96eab2e1d78f	Thyroid	18	76A6F76D-F33E-4B4A-B0EE-FB863345F194	4336BC49-7D28-4EB6-8B41-F43127ED8EC1	TCGA-FE-A233-01A-11D-A14U-02	HG19_Broad_variant	TCGA-FE-A233	TCGA-THCA	NA	s12758	Harvard Medical School	Ohio State University	United States	NO	T2	NX	Thyroid Papillary Carcinoma - Classical/usual	Stage I	A14U-02	TRUE
13722.58cfa831e4b0c9d6adf6cd82	58cfa831e4b0c9d6adf6cd82	TCGA-FE-A230-01A-11D-A14U_120629_SN1120_0168_BD1454ACXX_s_2_rg.sorted.filtered.	WGS	TCGA-FE-A230-01A-11D-A14U_120629_SN1120_0168_BD1454ACXX_s_2_rg.sorted	TCGA-FE-A230-01A-11D-A14U_120629_SN1120_0168_BD1454ACXX_s_2_rg.sorted.bam	73.25	2.05	0.17	58cfa831e4b0c9d6adf6cd82	TCGA-FE-A230-01A-11D-A14U_120629_SN1120_0168_BD1454ACXX_s_2_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-FE-A230-01A	B1D71782-2443-43F3-BD0E-8B7220515CB6	Primary Tumor	Illumina HiSeq	5aeaadf5-f228-4383-97ce-9048120f8b41	Thyroid	30	12FC3F30-08FB-47C6-92F1-009D961C1E94	001C6478-B20D-40D8-AF62-C45C64269129	TCGA-FE-A230-01A-11D-A14U-02	HG19_Broad_variant	TCGA-FE-A230	TCGA-THCA	NA	s12389	Harvard Medical School	Ohio State University	United States	NO	T3	N1a	Thyroid Papillary Carcinoma - Classical/usual	Stage I	A14U-02	TRUE
13722.58cfa831e4b0c9d6adf6cdcc	58cfa831e4b0c9d6adf6cdcc	TCGA-FG-6689-01A-11D-1891_130923_SN1222_0220_BC2DUUACXX_s_1_rg.sorted.filtered.	WGS	TCGA-FG-6689-01A-11D-1891_130923_SN1222_0220_BC2DUUACXX_s_1_rg.sorted	TCGA-FG-6689-01A-11D-1891_130923_SN1222_0220_BC2DUUACXX_s_1_rg.sorted.bam	86.7	1.9	0.16	58cfa831e4b0c9d6adf6cdcc	TCGA-FG-6689-01A-11D-1891_130923_SN1222_0220_BC2DUUACXX_s_1_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-FG-6689-01A	8D07B1E8-5D1D-4A43-B616-D29DD58CE5FE	Primary Tumor	Illumina HiSeq	9e07a7ab-1033-43c4-a4f4-49ba35319fea	Brain	30	D81C3F19-BBCF-4071-8BA4-CB8C505307D7	2FD05E93-48E8-460E-80E0-C3262EAEE72B	TCGA-FG-6689-01A-11D-1891-02	HG19_Broad_variant	TCGA-FG-6689	TCGA-LGG	NA	s8144	Harvard Medical School	Case Western	United States	NO	Not available	Not available	Astrocytoma	Not available	1891-02	TRUE
13722.58cfa832e4b0c9d6adf6ce20	58cfa832e4b0c9d6adf6ce20	TCGA-FG-6688-01A-11D-1891_130919_SN590_0238_AC29TRACXX_s_5_rg.sorted.filtered.	WGS	TCGA-FG-6688-01A-11D-1891_130919_SN590_0238_AC29TRACXX_s_5_rg.sorted	TCGA-FG-6688-01A-11D-1891_130919_SN590_0238_AC29TRACXX_s_5_rg.sorted.bam	62.7	2	0.17	58cfa832e4b0c9d6adf6ce20	TCGA-FG-6688-01A-11D-1891_130919_SN590_0238_AC29TRACXX_s_5_rg.sorted.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-FG-6688-01A	DADD7428-9E4D-4652-9469-AB521B88D529	Primary Tumor	Illumina HiSeq	3b45431a-1066-4467-bc8a-f1aa3342c5f0	Brain	59	8594744F-F317-4022-991B-21891DA7F80A	5977877C-7B55-4666-AC08-54FEF233FB2F	TCGA-FG-6688-01A-11D-1891-02	HG19_Broad_variant	TCGA-FG-6688	TCGA-LGG	NA	s8570	Harvard Medical School	Case Western	United States	NO	Not available	Not available	Astrocytoma	Not available	1891-02	TRUE
13722.58cfa832e4b0c9d6adf6ce97	58cfa832e4b0c9d6adf6ce97	TCGA-G2-A2EF-01A-12D-A18D_120912_SN1222_0148_AC188PACXX_s_7_rg.sorted.filtered.	WGS	TCGA-G2-A2EF-01A-12D-A18D_120912_SN1222_0148_AC188PACXX_s_7_rg.sorted	TCGA-G2-A2EF-01A-12D-A18D_120912_SN1222_0148_AC188PACXX_s_7_rg.sorted.bam	40.86	NA	0.15	58cfa832e4b0c9d6adf6ce97	TCGA-G2-A2EF-01A-12D-A18D_120912_SN1222_0148_AC188PACXX_s_7_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-G2-A2EF-01A	2A142731-119C-495D-AD30-EB0B48BACB46	Primary Tumor	Illumina HiSeq	ac16538b-bd5d-496e-bccc-6f3374d226c6	Bladder	50	981F581E-32AF-486B-9B60-0C8F1047C879	CE2F4DE7-C8AE-4103-8084-5F783B1087A7	TCGA-G2-A2EF-01A-12D-A18D-02	HG19_Broad_variant	TCGA-G2-A2EF	TCGA-BLCA	NA	s3118	Harvard Medical School	MD Anderson	United States	NO	Not available	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage II	A18D-02	TRUE
13722.58cfa832e4b0c9d6adf6cedf	58cfa832e4b0c9d6adf6cedf	TCGA-EM-A1YD-01A-11D-A14U_120629_SN1120_0168_BD1454ACXX_s_5_rg.sorted.filtered.	WGS	TCGA-EM-A1YD-01A-11D-A14U_120629_SN1120_0168_BD1454ACXX_s_5_rg.sorted	TCGA-EM-A1YD-01A-11D-A14U_120629_SN1120_0168_BD1454ACXX_s_5_rg.sorted.bam	41.17	1.98	0.17	58cfa832e4b0c9d6adf6cedf	TCGA-EM-A1YD-01A-11D-A14U_120629_SN1120_0168_BD1454ACXX_s_5_rg.sorted.bam	Alive	FEMALE	Not available	Not available	Thyroid Carcinoma	Aligned reads	TCGA-EM-A1YD-01A	8A3659A8-2A85-4BAB-8BF3-55795922474C	Primary Tumor	Illumina HiSeq	76d6fe1c-fb49-412c-bf6f-43229f7b7df6	Thyroid	53	AD5054BB-96D0-47CC-BB8C-F36E58784A31	CD27AF7E-F458-49BA-8C82-D18BDE252DB2	TCGA-EM-A1YD-01A-11D-A14U-02	HG19_Broad_variant	TCGA-EM-A1YD	TCGA-THCA	NA	s12381	Harvard Medical School	University Health Network	Canada	NO	T2	N0	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	Stage II	A14U-02	TRUE
13722.58cfa832e4b0c9d6adf6cf6a	58cfa832e4b0c9d6adf6cf6a	TCGA-GC-A3OO-01A-11D-A233_120905_SN1120_0187_AD1E4NACXX_s_5_rg.sorted.filtered.	WGS	TCGA-GC-A3OO-01A-11D-A233_120905_SN1120_0187_AD1E4NACXX_s_5_rg.sorted	TCGA-GC-A3OO-01A-11D-A233_120905_SN1120_0187_AD1E4NACXX_s_5_rg.sorted.bam	11.56	NA	0.16	58cfa832e4b0c9d6adf6cf6a	TCGA-GC-A3OO-01A-11D-A233_120905_SN1120_0187_AD1E4NACXX_s_5_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-GC-A3OO-01A	1FF60FD9-3CA3-43BE-92A8-8DBA2CD4D4DF	Primary Tumor	Illumina HiSeq	8c665767-edb1-4860-b26a-4171237962fa	Bladder	79	91E7F41C-17B3-4724-96EF-D3C207B964E1	67B2932F-8C9D-4D38-8791-D4D8AAB7F3B2	TCGA-GC-A3OO-01A-11D-A233-26	HG19_Broad_variant	TCGA-GC-A3OO	TCGA-BLCA	NA	s3306	MD Anderson - Institute for Applied Cancer Science	International Genomics Consortium	United States	NO	T2b	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage II	A233-26	TRUE
13722.58cfa832e4b0c9d6adf6cf91	58cfa832e4b0c9d6adf6cf91	TCGA-G9-6365-01A-11D-1784_130215_SN590_0212_BC1NP2ACXX_s_1_rg.sorted.filtered.	WGS	TCGA-G9-6365-01A-11D-1784_130215_SN590_0212_BC1NP2ACXX_s_1_rg.sorted	TCGA-G9-6365-01A-11D-1784_130215_SN590_0212_BC1NP2ACXX_s_1_rg.sorted.bam	59.4	1.9	0.17	58cfa832e4b0c9d6adf6cf91	TCGA-G9-6365-01A-11D-1784_130215_SN590_0212_BC1NP2ACXX_s_1_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-G9-6365-01A	6845076E-E940-4437-8618-81DB4A447544	Primary Tumor	Illumina HiSeq	9d7979c6-8197-4347-806d-4bb667d5cb2b	Prostate	71	95D6E1D3-91C1-40E5-986D-1C5ABB33A03F	CD30C4FA-8BBF-4A8A-A1F7-4FA0D45CA380	TCGA-G9-6365-01A-11D-1784-02	HG19_Broad_variant	TCGA-G9-6365	TCGA-PRAD	NA	s3973	Harvard Medical School	Roswell Park	United States	NO	T4	N0	Prostate Adenocarcinoma Acinar Type	Not available	1784-02	TRUE
13722.58cfa832e4b0c9d6adf6cf6e	58cfa832e4b0c9d6adf6cf6e	TCGA-G9-6384-01A-11D-1784_130301_SN590_0217_BC1UHMACXX_s_5_rg.sorted.filtered.	WGS	TCGA-G9-6384-01A-11D-1784_130301_SN590_0217_BC1UHMACXX_s_5_rg.sorted	TCGA-G9-6384-01A-11D-1784_130301_SN590_0217_BC1UHMACXX_s_5_rg.sorted.bam	146.4	1.9	0.15	58cfa832e4b0c9d6adf6cf6e	TCGA-G9-6384-01A-11D-1784_130301_SN590_0217_BC1UHMACXX_s_5_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-G9-6384-01A	A279D5AA-51F7-4E75-9E14-B206B97EC4BD	Primary Tumor	Illumina HiSeq	75df59ac-7525-45fc-843a-5210bd036dca	Prostate	53	1ABCBE00-5A6F-4E0F-A61C-D158545C2293	1F750885-56C4-4953-8D22-BC7719F57F9F	TCGA-G9-6384-01A-11D-1784-02	HG19_Broad_variant	TCGA-G9-6384	TCGA-PRAD	NA	s4152	Harvard Medical School	Roswell Park	United States	NO	T3a	N0	Prostate Adenocarcinoma Acinar Type	Not available	1784-02	TRUE
13722.58cfa832e4b0c9d6adf6d160	58cfa832e4b0c9d6adf6d160	TCGA-IG-A4P3-01A-11D-A267_131018_SN590_0240_AC2MW5ACXX_s_3_rg.sorted.filtered.	WGS	TCGA-IG-A4P3-01A-11D-A267_131018_SN590_0240_AC2MW5ACXX_s_3_rg.sorted	TCGA-IG-A4P3-01A-11D-A267_131018_SN590_0240_AC2MW5ACXX_s_3_rg.sorted.bam	40.74	NA	0.15	58cfa832e4b0c9d6adf6d160	TCGA-IG-A4P3-01A-11D-A267_131018_SN590_0240_AC2MW5ACXX_s_3_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Esophageal Carcinoma	Aligned reads	TCGA-IG-A4P3-01A	6594ACD5-4D2A-4CC5-8CF8-4064E252C5F6	Primary Tumor	Illumina HiSeq	a5b7767c-9dba-49bf-8711-9a76a0ab0e4f	Esophagus	48	784021B2-5F94-48F9-9DF7-854B4FBDF802	84882FB6-6ED6-42E8-9179-90CE089C4664	TCGA-IG-A4P3-01A-11D-A267-26	HG19_Broad_variant	TCGA-IG-A4P3	TCGA-ESCA	NA	s1826	MD Anderson - Institute for Applied Cancer Science	Asterand	Ukraine	NO	T2	N1	Not available	Stage IIB	A267-26	TRUE
13722.58cfa832e4b0c9d6adf6d374	58cfa832e4b0c9d6adf6d374	TCGA-LN-A49M-01A-21D-A267_131001_SN1222_0222_BC2CN2ACXX_s_1_rg.sorted.filtered.	WGS	TCGA-LN-A49M-01A-21D-A267_131001_SN1222_0222_BC2CN2ACXX_s_1_rg.sorted	TCGA-LN-A49M-01A-21D-A267_131001_SN1222_0222_BC2CN2ACXX_s_1_rg.sorted.bam	23.64	NA	0.16	58cfa832e4b0c9d6adf6d374	TCGA-LN-A49M-01A-21D-A267_131001_SN1222_0222_BC2CN2ACXX_s_1_rg.sorted.bam	Alive	MALE	ASIAN	NOT HISPANIC OR LATINO	Esophageal Carcinoma	Aligned reads	TCGA-LN-A49M-01A	B3E248B5-5D40-495C-BD10-90ECF0ED6A95	Primary Tumor	Illumina HiSeq	821eaabe-92ee-4e30-9254-77b2ce89ea42	Esophagus	62	E6BEF2C0-1C6A-4137-A099-920F1F811489	9C284314-4356-44EA-8087-E64F5A614179	TCGA-LN-A49M-01A-21D-A267-26	HG19_Broad_variant	TCGA-LN-A49M	TCGA-ESCA	NA	s1862	MD Anderson - Institute for Applied Cancer Science	ILSbio	Vietnam	NO	T2	N0	Not available	Stage IIA	A267-26	TRUE
13722.58cfa832e4b0c9d6adf6d3ee	58cfa832e4b0c9d6adf6d3ee	TCGA-V4-A9ES-01A-11D-A40D_140808_SN590_0253_AC499NACXX_s_4_rg.sorted.filtered.	WGS	TCGA-V4-A9ES-01A-11D-A40D_140808_SN590_0253_AC499NACXX_s_4_rg.sorted	TCGA-V4-A9ES-01A-11D-A40D_140808_SN590_0253_AC499NACXX_s_4_rg.sorted.bam	57.9	NA	0.15	58cfa832e4b0c9d6adf6d3ee	TCGA-V4-A9ES-01A-11D-A40D_140808_SN590_0253_AC499NACXX_s_4_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uveal Melanoma	Aligned reads	TCGA-V4-A9ES-01A	C510A423-6AB1-431E-9248-D2AC91FDEDBA	Primary Tumor	Illumina HiSeq	0edc5349-7b58-4f3e-ae40-3c517bcc8d47	Eye	54	1BC52C96-A28E-4E9C-AD3F-0797234C5A12	B16AE1A2-403B-4573-A6B0-9CBB05CEA149	TCGA-V4-A9ES-01A-11D-A40D-26	HG19_Broad_variant	TCGA-V4-A9ES	TCGA-UVM	NA	s201	MD Anderson - Institute for Applied Cancer Science	Institut Curie	France	NO	T3b	N0	Not available	Stage IIIA	A40D-26	TRUE
13722.58cfa832e4b0c9d6adf6d42e	58cfa832e4b0c9d6adf6d42e	TCGA-VD-A8K8-01A-11D-A40D_140716_SN208_0518_AC59RNACXX_s_1_rg.sorted.filtered.	WGS	TCGA-VD-A8K8-01A-11D-A40D_140716_SN208_0518_AC59RNACXX_s_1_rg.sorted	TCGA-VD-A8K8-01A-11D-A40D_140716_SN208_0518_AC59RNACXX_s_1_rg.sorted.bam	51.97	NA	0.15	58cfa832e4b0c9d6adf6d42e	TCGA-VD-A8K8-01A-11D-A40D_140716_SN208_0518_AC59RNACXX_s_1_rg.sorted.bam	Alive	FEMALE	Not available	Not available	Uveal Melanoma	Aligned reads	TCGA-VD-A8K8-01A	9B1ECFB2-9DFB-4E71-B51A-D2A0C5A7940E	Primary Tumor	Illumina HiSeq	874e4766-c478-4406-91cf-977d43d9ed07	Eye	56	F23780FD-DFEB-472B-B747-84ECE2A6226D	E0DBB55F-2753-4B23-B621-F8003B05D814	TCGA-VD-A8K8-01A-11D-A40D-26	HG19_Broad_variant	TCGA-VD-A8K8	TCGA-UVM	NA	s283	MD Anderson - Institute for Applied Cancer Science	University of Liverpool	United Kingdom	NO	T3a	NX	Not available	Stage IIB	A40D-26	TRUE
13722.58cfa832e4b0c9d6adf6d4b4	58cfa832e4b0c9d6adf6d4b4	TCGA-V4-A9EV-01A-11D-A40D_140808_SN590_0253_AC499NACXX_s_7_rg.sorted.filtered.	WGS	TCGA-V4-A9EV-01A-11D-A40D_140808_SN590_0253_AC499NACXX_s_7_rg.sorted	TCGA-V4-A9EV-01A-11D-A40D_140808_SN590_0253_AC499NACXX_s_7_rg.sorted.bam	56.76	NA	0.15	58cfa832e4b0c9d6adf6d4b4	TCGA-V4-A9EV-01A-11D-A40D_140808_SN590_0253_AC499NACXX_s_7_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uveal Melanoma	Aligned reads	TCGA-V4-A9EV-01A	DA6F0ED2-A6D5-4D87-823E-122EBD59AABA	Primary Tumor	Illumina HiSeq	463c617e-a31f-4ebe-9bb0-bdf35b3823f8	Eye	59	42BBB13B-DA94-44FF-A01C-4776A74AEA6F	A08A9A90-323B-48AB-89C8-4805FE59BC70	TCGA-V4-A9EV-01A-11D-A40D-26	HG19_Broad_variant	TCGA-V4-A9EV	TCGA-UVM	NA	s204	MD Anderson - Institute for Applied Cancer Science	Institut Curie	France	NO	T4a	N0	Not available	Stage IIIA	A40D-26	TRUE
13722.58cfa832e4b0c9d6adf6d514	58cfa832e4b0c9d6adf6d514	TCGA-V4-A9EU-01A-11D-A40D_140808_SN590_0253_AC499NACXX_s_6_rg.sorted.filtered.	WGS	TCGA-V4-A9EU-01A-11D-A40D_140808_SN590_0253_AC499NACXX_s_6_rg.sorted	TCGA-V4-A9EU-01A-11D-A40D_140808_SN590_0253_AC499NACXX_s_6_rg.sorted.bam	49	NA	0.14	58cfa832e4b0c9d6adf6d514	TCGA-V4-A9EU-01A-11D-A40D_140808_SN590_0253_AC499NACXX_s_6_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uveal Melanoma	Aligned reads	TCGA-V4-A9EU-01A	DF685F8C-645A-47AE-A471-63BF1973A0AE	Primary Tumor	Illumina HiSeq	929aff65-5561-439c-9850-a5ce595efc28	Eye	83	2DAC7136-D3A0-4FFD-B22D-7F1F9B8B8E4C	4C43B0FD-D2D3-456F-AFDD-EC90DBBD5FBA	TCGA-V4-A9EU-01A-11D-A40D-26	HG19_Broad_variant	TCGA-V4-A9EU	TCGA-UVM	NA	s213	MD Anderson - Institute for Applied Cancer Science	Institut Curie	France	NO	T4d	N0	Not available	Stage IIIC	A40D-26	TRUE
13722.58cfa832e4b0c9d6adf6d4fe	58cfa832e4b0c9d6adf6d4fe	TCGA-L5-A4OG-01A-11D-A267_131001_SN1120_0280_BD2FDEACXX_s_7_rg.sorted.filtered.	WGS	TCGA-L5-A4OG-01A-11D-A267_131001_SN1120_0280_BD2FDEACXX_s_7_rg.sorted	TCGA-L5-A4OG-01A-11D-A267_131001_SN1120_0280_BD2FDEACXX_s_7_rg.sorted.bam	40.59	NA	0.16	58cfa832e4b0c9d6adf6d4fe	TCGA-L5-A4OG-01A-11D-A267_131001_SN1120_0280_BD2FDEACXX_s_7_rg.sorted.bam	Alive	FEMALE	WHITE	Not available	Esophageal Carcinoma	Aligned reads	TCGA-L5-A4OG-01A	EB4AD376-4CC1-4D2C-9B93-AD2B082C77C4	Primary Tumor	Illumina HiSeq	cef87877-7e34-43b9-9599-f98660d7b833	Esophagus	79	E8E44C65-B4E4-4688-A217-206905E68A7F	04C91C91-E55A-4075-B08A-F80568BB4A7B	TCGA-L5-A4OG-01A-11D-A267-26	HG19_Broad_variant	TCGA-L5-A4OG	TCGA-ESCA	NA	s1926	MD Anderson - Institute for Applied Cancer Science	University of Michigan	United States	NO	T1	N0	Not available	Stage I	A267-26	TRUE
13722.58cfa832e4b0c9d6adf6d52e	58cfa832e4b0c9d6adf6d52e	TCGA-LN-A4A8-01A-32D-A267_131018_SN590_0241_BC30HBACXX_s_5_rg.sorted.filtered.	WGS	TCGA-LN-A4A8-01A-32D-A267_131018_SN590_0241_BC30HBACXX_s_5_rg.sorted	TCGA-LN-A4A8-01A-32D-A267_131018_SN590_0241_BC30HBACXX_s_5_rg.sorted.bam	34.22	NA	0.15	58cfa832e4b0c9d6adf6d52e	TCGA-LN-A4A8-01A-32D-A267_131018_SN590_0241_BC30HBACXX_s_5_rg.sorted.bam	Alive	MALE	ASIAN	NOT HISPANIC OR LATINO	Esophageal Carcinoma	Aligned reads	TCGA-LN-A4A8-01A	AA364B98-0097-43A4-976D-742FAA0276DF	Primary Tumor	Illumina HiSeq	fd30434f-5a9a-4128-99f1-85d8d06ead73	Esophagus	52	0C0582CA-A181-4EFB-8486-C4312B250BA9	E42ECB6E-825E-407C-9CC7-C153C8F40DDC	TCGA-LN-A4A8-01A-32D-A267-26	HG19_Broad_variant	TCGA-LN-A4A8	TCGA-ESCA	NA	s1935	MD Anderson - Institute for Applied Cancer Science	ILSbio	Vietnam	NO	T2	N0	Not available	Stage IIA	A267-26	TRUE
13722.58cfa832e4b0c9d6adf6d5bc	58cfa832e4b0c9d6adf6d5bc	TCGA-LN-A4A4-01A-11D-A267_131001_SN1222_0222_BC2CN2ACXX_s_3_rg.sorted.filtered.	WGS	TCGA-LN-A4A4-01A-11D-A267_131001_SN1222_0222_BC2CN2ACXX_s_3_rg.sorted	TCGA-LN-A4A4-01A-11D-A267_131001_SN1222_0222_BC2CN2ACXX_s_3_rg.sorted.bam	24.3	NA	0.16	58cfa832e4b0c9d6adf6d5bc	TCGA-LN-A4A4-01A-11D-A267_131001_SN1222_0222_BC2CN2ACXX_s_3_rg.sorted.bam	Alive	MALE	ASIAN	NOT HISPANIC OR LATINO	Esophageal Carcinoma	Aligned reads	TCGA-LN-A4A4-01A	E89D7900-915D-4936-B1B2-CAC3670EA2F4	Primary Tumor	Illumina HiSeq	8f2d7e64-e129-494b-9068-ad15dcb9457e	Esophagus	36	C7A31A25-A496-4D26-A9D2-C42ADB22BB45	655BFF55-E213-442B-8C1F-A1A959E89CDB	TCGA-LN-A4A4-01A-11D-A267-26	HG19_Broad_variant	TCGA-LN-A4A4	TCGA-ESCA	NA	s1778	MD Anderson - Institute for Applied Cancer Science	ILSbio	Vietnam	NO	T3	N1	Not available	Stage III	A267-26	TRUE
13722.58cfa832e4b0c9d6adf6d5d0	58cfa832e4b0c9d6adf6d5d0	TCGA-L7-A56G-01A-21D-A267_131001_SN1120_0280_BD2FDEACXX_s_3_rg.sorted.filtered.	WGS	TCGA-L7-A56G-01A-21D-A267_131001_SN1120_0280_BD2FDEACXX_s_3_rg.sorted	TCGA-L7-A56G-01A-21D-A267_131001_SN1120_0280_BD2FDEACXX_s_3_rg.sorted.bam	26.05	NA	0.15	58cfa832e4b0c9d6adf6d5d0	TCGA-L7-A56G-01A-21D-A267_131001_SN1120_0280_BD2FDEACXX_s_3_rg.sorted.bam	Alive	MALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Esophageal Carcinoma	Aligned reads	TCGA-L7-A56G-01A	70C5CE85-4022-46C0-8BD0-F5E9009DDF41	Primary Tumor	Illumina HiSeq	8e835c63-a680-469e-82b7-850d8f01da57	Esophagus	65	3DD6751A-6FA6-4365-8E5E-FCB3D17910F6	6AD8F7F3-2EEC-47F7-9176-B10EBEB78F7E	TCGA-L7-A56G-01A-21D-A267-26	HG19_Broad_variant	TCGA-L7-A56G	TCGA-ESCA	NA	s1851	MD Anderson - Institute for Applied Cancer Science	Christiana Care	United States	NO	Not available	Not available	Not available	Not available	A267-26	TRUE
13722.58cfa832e4b0c9d6adf6d604	58cfa832e4b0c9d6adf6d604	TCGA-LN-A49W-01A-11D-A267_131018_SN590_0240_AC2MW5ACXX_s_5_rg.sorted.filtered.	WGS	TCGA-LN-A49W-01A-11D-A267_131018_SN590_0240_AC2MW5ACXX_s_5_rg.sorted	TCGA-LN-A49W-01A-11D-A267_131018_SN590_0240_AC2MW5ACXX_s_5_rg.sorted.bam	22.73	NA	0.15	58cfa832e4b0c9d6adf6d604	TCGA-LN-A49W-01A-11D-A267_131018_SN590_0240_AC2MW5ACXX_s_5_rg.sorted.bam	Alive	MALE	ASIAN	Not available	Esophageal Carcinoma	Aligned reads	TCGA-LN-A49W-01A	DAF211F2-941E-4244-8CF5-D31492269443	Primary Tumor	Illumina HiSeq	30b9eb80-84d4-4582-aa2d-a826faadd2f2	Esophagus	73	25E6A27B-B015-4936-B57E-CF39DD5AF9BA	38678D1B-A9D9-4231-95B8-95D5AB4D64F2	TCGA-LN-A49W-01A-11D-A267-26	HG19_Broad_variant	TCGA-LN-A49W	TCGA-ESCA	NA	s1772	MD Anderson - Institute for Applied Cancer Science	ILSbio	Vietnam	NO	T3	N1	Not available	Stage III	A267-26	TRUE
13722.58cfa832e4b0c9d6adf6d608	58cfa832e4b0c9d6adf6d608	TCGA-LN-A5U5-01A-21D-A28P_140122_SN1222_0236_BD2CT4ACXX_s_4_rg.sorted.filtered.	WGS	TCGA-LN-A5U5-01A-21D-A28P_140122_SN1222_0236_BD2CT4ACXX_s_4_rg.sorted	TCGA-LN-A5U5-01A-21D-A28P_140122_SN1222_0236_BD2CT4ACXX_s_4_rg.sorted.bam	66.44	NA	0.15	58cfa832e4b0c9d6adf6d608	TCGA-LN-A5U5-01A-21D-A28P_140122_SN1222_0236_BD2CT4ACXX_s_4_rg.sorted.bam	Alive	MALE	ASIAN	NOT HISPANIC OR LATINO	Esophageal Carcinoma	Aligned reads	TCGA-LN-A5U5-01A	656E3C14-1FC6-473A-813E-719753E7B408	Primary Tumor	Illumina HiSeq	d3861f7c-bb4e-48be-b15b-0c082a3b6ff5	Esophagus	57	945DA36D-32AD-4996-9D77-BE6D09B858F9	E9CE892D-BF42-4445-B566-A8D7AC73AED0	TCGA-LN-A5U5-01A-21D-A28P-26	HG19_Broad_variant	TCGA-LN-A5U5	TCGA-ESCA	NA	s1682	MD Anderson - Institute for Applied Cancer Science	ILSbio	Vietnam	NO	T3	N1	Not available	Stage IV	A28P-26	TRUE
13722.58cfa832e4b0c9d6adf6d5e3	58cfa832e4b0c9d6adf6d5e3	TCGA-LN-A49U-01A-31D-A267_131001_SN1222_0222_BC2CN2ACXX_s_7_rg.sorted.filtered.	WGS	TCGA-LN-A49U-01A-31D-A267_131001_SN1222_0222_BC2CN2ACXX_s_7_rg.sorted	TCGA-LN-A49U-01A-31D-A267_131001_SN1222_0222_BC2CN2ACXX_s_7_rg.sorted.bam	24.19	NA	0.15	58cfa832e4b0c9d6adf6d5e3	TCGA-LN-A49U-01A-31D-A267_131001_SN1222_0222_BC2CN2ACXX_s_7_rg.sorted.bam	Alive	MALE	ASIAN	NOT HISPANIC OR LATINO	Esophageal Carcinoma	Aligned reads	TCGA-LN-A49U-01A	931A50FF-3149-4C4A-9456-45ED3A9DD457	Primary Tumor	Illumina HiSeq	c075129e-527d-4603-9336-8b26a5ce10d2	Esophagus	62	9B3E9E79-52EB-40F7-87EC-E1CB360004E6	FF6F10D6-874C-4281-AB3B-79FF2440A901	TCGA-LN-A49U-01A-31D-A267-26	HG19_Broad_variant	TCGA-LN-A49U	TCGA-ESCA	NA	s1777	MD Anderson - Institute for Applied Cancer Science	ILSbio	Vietnam	NO	T3	N0	Not available	Stage IIA	A267-26	TRUE
13722.58cfa82ee4b0c9d6adf6b001	58cfa82ee4b0c9d6adf6b001	TCGA-05-4430-01A-02D-1203_111013_SN208_0253_B00PJACXX_s_6_rg.sorted.filtered.	WGS	TCGA-05-4430-01A-02D-1203_111013_SN208_0253_B00PJACXX_s_6_rg.sorted	TCGA-05-4430-01A-02D-1203_111013_SN208_0253_B00PJACXX_s_6_rg.sorted.bam	342.2	1.9	0.15	58cfa82ee4b0c9d6adf6b001	TCGA-05-4430-01A-02D-1203_111013_SN208_0253_B00PJACXX_s_6_rg.sorted.bam	Alive	FEMALE	Not available	Not available	Lung Adenocarcinoma	Aligned reads	TCGA-05-4430-01A	3A23CDB5-2327-45AC-B0B5-D4AFE038C757	Primary Tumor	Illumina HiSeq	e4ae6498-889f-4900-a73c-2e61a6e154d1	Lung	59	122AAA4F-8FD5-4C41-BFF8-8A45BDFB3F81	C14A77D1-DB59-434E-BD3C-DBBE647D790C	TCGA-05-4430-01A-02D-1203-02	HG19_Broad_variant	TCGA-05-4430	TCGA-LUAD	NA	s10646	Harvard Medical School	Indivumed	Germany	NO	T2	N0	Lung Adenocarcinoma Mixed Subtype	Stage IB	1203-02	TRUE
13722.58cfa82ee4b0c9d6adf6b020	58cfa82ee4b0c9d6adf6b020	TCGA-05-4432-01A-01D-1203_111013_SN208_0253_B00PJACXX_s_4_rg.sorted.filtered.	WGS	TCGA-05-4432-01A-01D-1203_111013_SN208_0253_B00PJACXX_s_4_rg.sorted	TCGA-05-4432-01A-01D-1203_111013_SN208_0253_B00PJACXX_s_4_rg.sorted.bam	306.53	1.9	0.14	58cfa82ee4b0c9d6adf6b020	TCGA-05-4432-01A-01D-1203_111013_SN208_0253_B00PJACXX_s_4_rg.sorted.bam	Alive	MALE	Not available	Not available	Lung Adenocarcinoma	Aligned reads	TCGA-05-4432-01A	E737F650-B72D-44E7-B750-558A56716803	Primary Tumor	Illumina HiSeq	6110bc85-6f14-48d5-b166-2b3f42776573	Lung	66	2A675528-1ABC-4220-A61A-25109850CE0D	A4E437A5-1603-4AE4-89C2-CD741FDE5015	TCGA-05-4432-01A-01D-1203-02	HG19_Broad_variant	TCGA-05-4432	TCGA-LUAD	NA	s11334	Harvard Medical School	Indivumed	Germany	NO	T2	N1	Lung Adenocarcinoma Mixed Subtype	Stage IIB	1203-02	TRUE
13722.58cfa82fe4b0c9d6adf6b676	58cfa82fe4b0c9d6adf6b676	TCGA-73-4666-01A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.filtered.	WGS	TCGA-73-4666-01A-01D-1203-02_IlluminaHiSeq-DNASeq_whole	TCGA-73-4666-01A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.bam	375.23	1.9	0.16	58cfa82fe4b0c9d6adf6b676	TCGA-73-4666-01A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-73-4666-01A	4C31127E-D095-4978-9DAC-35153C27F6ED	Primary Tumor	Illumina HiSeq	7af89597-2a6c-4030-acf6-4bd33963a3f3	Lung	52	5BAE2E45-6DBC-458C-A66F-702EB1AF7357	AC0D75F8-B4C5-40A8-9044-0B74722424D8	TCGA-73-4666-01A-01D-1203-02	GRCh37	TCGA-73-4666	TCGA-LUAD	NA	s11461	Harvard Medical School	Roswell Park	United States	NO	T1	N0	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage IV	1203-02	TRUE
13722.58cfa82fe4b0c9d6adf6b678	58cfa82fe4b0c9d6adf6b678	TCGA-73-4670-01A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.filtered.	WGS	TCGA-73-4670-01A-01D-1203-02_IlluminaHiSeq-DNASeq_whole	TCGA-73-4670-01A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.bam	343.9	1.9	0.16	58cfa82fe4b0c9d6adf6b678	TCGA-73-4670-01A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-73-4670-01A	1B354837-4925-4480-AC32-6B44D0957314	Primary Tumor	Illumina HiSeq	8e4449ab-641c-44ea-af17-a681182f7299	Lung	69	646402AF-BA5F-438C-AE63-213EBD58B16D	D2FFA731-14A2-4A83-964E-C9969080263C	TCGA-73-4670-01A-01D-1203-02	GRCh37	TCGA-73-4670	TCGA-LUAD	NA	s11356	Harvard Medical School	Roswell Park	United States	NO	T2	N0	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage IV	1203-02	TRUE
13722.58cfa82fe4b0c9d6adf6b6f6	58cfa82fe4b0c9d6adf6b6f6	TCGA-50-6591-01A-11D-1751_111111_SN208_0254_B0160ACXX_s_5_rg.sorted.filtered.	WGS	TCGA-50-6591-01A-11D-1751_111111_SN208_0254_B0160ACXX_s_5_rg.sorted	TCGA-50-6591-01A-11D-1751_111111_SN208_0254_B0160ACXX_s_5_rg.sorted.bam	351.4	1.8	0.14	58cfa82fe4b0c9d6adf6b6f6	TCGA-50-6591-01A-11D-1751_111111_SN208_0254_B0160ACXX_s_5_rg.sorted.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-50-6591-01A	9B132E4F-7E35-4CC5-8711-43AD62B906D0	Primary Tumor	Illumina HiSeq	c1731efd-11ec-47b9-bb3c-32eab31d3552	Lung	63	0791E7AA-E97C-4DD0-9615-09EC7090F684	C57EF4F0-5BE8-4761-9763-5052EFDFD7D5	TCGA-50-6591-01A-11D-1751-02	HG19_Broad_variant	TCGA-50-6591	TCGA-LUAD	119	s10784	Harvard Medical School	University of Pittsburgh	United States	NO	T2	N0	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage IV	1751-02	TRUE
13722.58cfa82fe4b0c9d6adf6b834	58cfa82fe4b0c9d6adf6b834	TCGA-A5-A0RA-01A-21D-A101_120403_SN1222_0093_AC0L7VACXX_s_6_rg.sorted.filtered.	WGS	TCGA-A5-A0RA-01A-21D-A101_120403_SN1222_0093_AC0L7VACXX_s_6_rg.sorted	TCGA-A5-A0RA-01A-21D-A101_120403_SN1222_0093_AC0L7VACXX_s_6_rg.sorted.bam	85.83	2.23	0.16	58cfa82fe4b0c9d6adf6b834	TCGA-A5-A0RA-01A-21D-A101_120403_SN1222_0093_AC0L7VACXX_s_6_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-A5-A0RA-01A	AFD710B8-D172-4AC4-9973-E969DB1ED231	Primary Tumor	Illumina HiSeq	d644ff0f-6dc7-4922-a46d-3223823e8118	Uterus	68	4ED231EE-0E54-4AC5-8278-1061AD3972A2	01EFCC42-CCFA-4D41-87BE-CA8F1C551823	TCGA-A5-A0RA-01A-21D-A101-02	HG19_Broad_variant	TCGA-A5-A0RA	TCGA-UCEC	NA	s5195	Harvard Medical School	Cedars Sinai	None	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A101-02	TRUE
13722.58cfa82fe4b0c9d6adf6b84e	58cfa82fe4b0c9d6adf6b84e	TCGA-A5-A0R8-01A-11D-A101_120403_SN1222_0093_AC0L7VACXX_s_4_rg.sorted.filtered.	WGS	TCGA-A5-A0R8-01A-11D-A101_120403_SN1222_0093_AC0L7VACXX_s_4_rg.sorted	TCGA-A5-A0R8-01A-11D-A101_120403_SN1222_0093_AC0L7VACXX_s_4_rg.sorted.bam	80.74	2.11	0.16	58cfa82fe4b0c9d6adf6b84e	TCGA-A5-A0R8-01A-11D-A101_120403_SN1222_0093_AC0L7VACXX_s_4_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-A5-A0R8-01A	06D16B6B-9CA6-4CEC-A785-F27AA4323CEC	Primary Tumor	Illumina HiSeq	ed11d53d-5cbb-44e2-b4d2-1603cef4ec13	Uterus	81	5B5CC2BA-6A10-4279-A0AA-8DDAE94D56EA	289CE7E4-AF92-4857-9D07-7CF334C40542	TCGA-A5-A0R8-01A-11D-A101-02	HG19_Broad_variant	TCGA-A5-A0R8	TCGA-UCEC	NA	s4420	Harvard Medical School	Cedars Sinai	None	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A101-02	TRUE
13722.58cfa82fe4b0c9d6adf6b86c	58cfa82fe4b0c9d6adf6b86c	TCGA-A5-A0VP-01A-21D-A101_120407_SN590_0151_BC0KKJACXX_s_6_rg.sorted.filtered.	WGS	TCGA-A5-A0VP-01A-21D-A101_120407_SN590_0151_BC0KKJACXX_s_6_rg.sorted	TCGA-A5-A0VP-01A-21D-A101_120407_SN590_0151_BC0KKJACXX_s_6_rg.sorted.bam	77.93	2.03	0.16	58cfa82fe4b0c9d6adf6b86c	TCGA-A5-A0VP-01A-21D-A101_120407_SN590_0151_BC0KKJACXX_s_6_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-A5-A0VP-01A	2DB0FB62-64CE-457C-9E22-DD05EF59F684	Primary Tumor	Illumina HiSeq	26cc510d-e8a9-4782-9488-478373dbc1df	Uterus	74	F1FBE4AC-F3FD-4609-9A2B-507820ABE77E	E23FE404-0449-453D-971C-6E940B546119	TCGA-A5-A0VP-01A-21D-A101-02	HG19_Broad_variant	TCGA-A5-A0VP	TCGA-UCEC	NA	s4992	Harvard Medical School	Cedars Sinai	None	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A101-02	TRUE
13722.58cfa82fe4b0c9d6adf6b882	58cfa82fe4b0c9d6adf6b882	TCGA-A6-2678-01A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.filtered.	WGS	TCGA-A6-2678-01A-01D-1167-02_IlluminaHiSeq-DNASeq_whole	TCGA-A6-2678-01A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.bam	493.29	1.9	0.15	58cfa82fe4b0c9d6adf6b882	TCGA-A6-2678-01A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Colon Adenocarcinoma	Aligned reads	TCGA-A6-2678-01A	3A785E32-7960-4C72-84C4-FB42C4DD86F1	Primary Tumor	Illumina HiSeq	31675676-aba0-4d34-a2dc-0356129ceaa2	Colorectal	43	20ECCD8A-DFAF-40E4-8128-D77AA41680C4	83E77250-E68B-4ECA-9592-4424151E0D79	TCGA-A6-2678-01A-01D-1167-02	HG18	TCGA-A6-2678	TCGA-COAD	NA	s12856	Harvard Medical School	Christiana Healthcare	None	NO	T3	N1	Colon Adenocarcinoma	Stage IIIB	1167-02	TRUE
13722.58cfa82fe4b0c9d6adf6b892	58cfa82fe4b0c9d6adf6b892	TCGA-A6-2681-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.filtered.	WGS	TCGA-A6-2681-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole	TCGA-A6-2681-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.bam	308	1.9	0.15	58cfa82fe4b0c9d6adf6b892	TCGA-A6-2681-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Colon Adenocarcinoma	Aligned reads	TCGA-A6-2681-01A	7D8EAB0A-E6C8-4449-9EBF-50C41DB94A06	Primary Tumor	Illumina HiSeq	eda754a1-3a13-47a5-8e0e-49ef1384646d	Colorectal	73	0537BAD8-0E85-4B05-91B3-FD965E96D0D7	BFF8CDA3-3C4B-416F-AF46-6811B139D670	TCGA-A6-2681-01A-01D-1405-02	HG18	TCGA-A6-2681	TCGA-COAD	NA	s12860	Harvard Medical School	Christiana Healthcare	United States	NO	T3	N0	Colon Adenocarcinoma	Stage IIA	1405-02	TRUE
13722.58cfa82fe4b0c9d6adf6b95e	58cfa82fe4b0c9d6adf6b95e	TCGA-AA-3548-01A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.filtered.	WGS	TCGA-AA-3548-01A-01D-1167-02_IlluminaHiSeq-DNASeq_whole	TCGA-AA-3548-01A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.bam	628.56	1.9	0.16	58cfa82fe4b0c9d6adf6b95e	TCGA-AA-3548-01A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.bam	Alive	FEMALE	Not available	Not available	Colon Adenocarcinoma	Aligned reads	TCGA-AA-3548-01A	2DCED66C-1F0D-4039-A5E5-54CCA77C16E9	Primary Tumor	Illumina HiSeq	362e7b19-891a-4eba-9cba-97d157a94152	Colorectal	71	633AFC4C-4A35-420E-9CE6-FF4670E28395	B5E87744-9963-4DBA-84C8-B61048169517	TCGA-AA-3548-01A-01D-1167-02	HG18	TCGA-AA-3548	TCGA-COAD	NA	s13669	Harvard Medical School	Indivumed	Germany	NO	T3	N2	Colon Adenocarcinoma	Stage IIIC	1167-02	TRUE
13722.58cfa82fe4b0c9d6adf6b965	58cfa82fe4b0c9d6adf6b965	TCGA-AA-3529-01A-02D-1547-02_IlluminaHiSeq-DNASeq_whole.filtered.	WGS	TCGA-AA-3529-01A-02D-1547-02_IlluminaHiSeq-DNASeq_whole	TCGA-AA-3529-01A-02D-1547-02_IlluminaHiSeq-DNASeq_whole.bam	109.29	1.9	0.13	58cfa82fe4b0c9d6adf6b965	TCGA-AA-3529-01A-02D-1547-02_IlluminaHiSeq-DNASeq_whole.bam	Dead	FEMALE	Not available	Not available	Colon Adenocarcinoma	Aligned reads	TCGA-AA-3529-01A	BFB07784-693B-4C25-874E-4AD6E04A5D46	Primary Tumor	Illumina HiSeq	8d96c289-9e08-45f8-a5dc-8c089ca7eb93	Colorectal	78	B083E3CB-0AF1-44EA-854D-85FD99B75AD5	B8C9B915-BD7E-41FA-B5E1-4A28478EDC6E	TCGA-AA-3529-01A-02D-1547-02	HG18	TCGA-AA-3529	TCGA-COAD	0	s13364	Harvard Medical School	Indivumed	Germany	NO	T3	N2	Colon Adenocarcinoma	Stage IIIC	1547-02	FALSE
13722.58cfa82fe4b0c9d6adf6b97e	58cfa82fe4b0c9d6adf6b97e	TCGA-AA-3681-01A-01D-1637-02_IlluminaHiSeq-DNASeq_whole.filtered.	WGS	TCGA-AA-3681-01A-01D-1637-02_IlluminaHiSeq-DNASeq_whole	TCGA-AA-3681-01A-01D-1637-02_IlluminaHiSeq-DNASeq_whole.bam	353.96	1.9	0.15	58cfa82fe4b0c9d6adf6b97e	TCGA-AA-3681-01A-01D-1637-02_IlluminaHiSeq-DNASeq_whole.bam	Alive	FEMALE	Not available	Not available	Colon Adenocarcinoma	Aligned reads	TCGA-AA-3681-01A	ABB0D53F-F74E-45DC-8FBB-40863016F3C6	Primary Tumor	Illumina HiSeq	4a7f8872-1280-4a05-8448-a62ee6de1108	Colorectal	77	190FECAB-1EF1-43FA-87A2-104014EB2CE2	85305E56-627C-4471-BD16-6818AD3751C2	TCGA-AA-3681-01A-01D-1637-02	HG18	TCGA-AA-3681	TCGA-COAD	NA	s13029	Harvard Medical School	Indivumed	Germany	NO	T3	N1	Colon Adenocarcinoma	Stage III	1637-02	FALSE
13722.58cfa82fe4b0c9d6adf6b982	58cfa82fe4b0c9d6adf6b982	TCGA-AA-3861-01A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.filtered.	WGS	TCGA-AA-3861-01A-01D-1167-02_IlluminaHiSeq-DNASeq_whole	TCGA-AA-3861-01A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.bam	294	1.9	0.15	58cfa82fe4b0c9d6adf6b982	TCGA-AA-3861-01A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.bam	Alive	MALE	Not available	Not available	Colon Adenocarcinoma	Aligned reads	TCGA-AA-3861-01A	5DA56982-6DE7-4994-AA9E-3B01200B2959	Primary Tumor	Illumina HiSeq	041d683a-798a-4869-a98d-b7abfe977709	Colorectal	72	390070D8-EF9B-46FE-93EE-9CF01A642A92	3FF478FA-97AF-4122-AC93-1BF1DD21BCB3	TCGA-AA-3861-01A-01D-1167-02	HG18	TCGA-AA-3861	TCGA-COAD	NA	s13186	Harvard Medical School	Indivumed	Germany	NO	T3	N0	Colon Adenocarcinoma	Stage IIA	1167-02	TRUE
13722.58cfa830e4b0c9d6adf6ba6c	58cfa830e4b0c9d6adf6ba6c	TCGA-AA-A010-01A-01D-A077-02_IlluminaHiSeq-DNASeq_whole.filtered.	WGS	TCGA-AA-A010-01A-01D-A077-02_IlluminaHiSeq-DNASeq_whole	TCGA-AA-A010-01A-01D-A077-02_IlluminaHiSeq-DNASeq_whole.bam	113.85	1.65	0.15	58cfa830e4b0c9d6adf6ba6c	TCGA-AA-A010-01A-01D-A077-02_IlluminaHiSeq-DNASeq_whole.bam	Alive	FEMALE	Not available	Not available	Colon Adenocarcinoma	Aligned reads	TCGA-AA-A010-01A	0712566E-3371-4715-95F1-5B792E72D758	Primary Tumor	Illumina HiSeq	ea0e92bb-7617-4183-82be-773e8cc15dca	Colorectal	46	46FB1711-E385-49A4-BF15-7990123CBE6B	30FCD977-8C62-4925-BC84-5894A12BABDB	TCGA-AA-A010-01A-01D-A077-02	HG18	TCGA-AA-A010	TCGA-COAD	NA	s13200	Harvard Medical School	Indivumed	Germany	NO	T4	N0	Colon Adenocarcinoma	Stage IIB	A077-02	TRUE
13722.58cfa830e4b0c9d6adf6bbe4	58cfa830e4b0c9d6adf6bbe4	TCGA-AG-A002-01A-01D-A077-02_110217_SN208_0190_B81CLKABXX_s_1.rg.sorted.filtered.	WGS	TCGA-AG-A002-01A-01D-A077-02_110217_SN208_0190_B81CLKABXX_s_1.rg.sorted	TCGA-AG-A002-01A-01D-A077-02_110217_SN208_0190_B81CLKABXX_s_1.rg.sorted.bam	228.5	1.72	0.15	58cfa830e4b0c9d6adf6bbe4	TCGA-AG-A002-01A-01D-A077-02_110217_SN208_0190_B81CLKABXX_s_1.rg.sorted.bam	Alive	MALE	Not available	Not available	Rectum Adenocarcinoma	Aligned reads	TCGA-AG-A002-01A	CB005C69-7301-41CE-B534-C9751F1436C5	Primary Tumor	Illumina HiSeq	90021059-77d3-4362-9cc9-f14fcfba46c9	Colorectal	35	B918B56C-5C78-4CEE-85A7-7C88501E88AD	901C5D59-CE0A-44AE-91AE-9C253E99B68E	TCGA-AG-A002-01A-01D-A077-02	HG18_Broad_variant	TCGA-AG-A002	TCGA-READ	NA	s1991	Harvard Medical School	Indivumed	Germany	NO	T2	N0	Rectal Adenocarcinoma	Stage I	A077-02	TRUE
13722.58cfa831e4b0c9d6adf6c52c	58cfa831e4b0c9d6adf6c52c	TCGA-CK-4951-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.filtered.	WGS	TCGA-CK-4951-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole	TCGA-CK-4951-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.bam	36.02	1.9	0.17	58cfa831e4b0c9d6adf6c52c	TCGA-CK-4951-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Colon Adenocarcinoma	Aligned reads	TCGA-CK-4951-01A	2DB3C23D-C591-4EA0-B0A8-ED9C4343C80E	Primary Tumor	Illumina HiSeq	7dcee63f-adaa-46d6-a48c-750143760f41	Colorectal	79	EA9E7E8C-4151-4CFC-8631-5880C6F1A21F	C501681C-26B5-4385-AE24-BEC8FB230C51	TCGA-CK-4951-01A-01D-1405-02	HG18	TCGA-CK-4951	TCGA-COAD	NA	s13040	Harvard Medical School	Harvard	None	NO	T3	N0	Colon Mucinous Adenocarcinoma	Stage IIA	1405-02	TRUE
13722.58cfa82de4b0c9d6adf6a6fa	58cfa82de4b0c9d6adf6a6fa	9ae1429cc5f7f8e4692281baf49e4ff5.filtered.	WGS	9ae1429cc5f7f8e4692281baf49e4ff5	9ae1429cc5f7f8e4692281baf49e4ff5.bam	55.4	1.9	0.08	58cfa82de4b0c9d6adf6a6fa	9ae1429cc5f7f8e4692281baf49e4ff5.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-B6-A0RT-01A	4BF50455-9AB7-4521-A791-089F66D3B877	Primary Tumor	Illumina HiSeq	0058348e-638c-426a-9fba-b26a3143c45b	Breast	39	C2300B5B-43A7-43B8-8CD1-22FF7E89A21A	1BB3A1C7-4D7B-4FB6-B54D-E94CBD0E32AA	TCGA-B6-A0RT-01A-21D-A128-09	GRCh37-lite	TCGA-B6-A0RT	TCGA-BRCA	NA	s5635	Washington University School of Medicine	Duke	United States	NO	T3	N1	Infiltrating Ductal Carcinoma	Stage IIIA	A128-09	TRUE
13722.58cfa82de4b0c9d6adf6a5ee	58cfa82de4b0c9d6adf6a5ee	6979f0583ba67718dda7c5ddb907abd8.filtered.	WGS	6979f0583ba67718dda7c5ddb907abd8	6979f0583ba67718dda7c5ddb907abd8.bam	77.7	2.03	0.08	58cfa82de4b0c9d6adf6a5ee	6979f0583ba67718dda7c5ddb907abd8.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-AO-A0J2-01A	D2F2560C-EC80-4FEA-9474-C47A2E85EA95	Primary Tumor	Illumina HiSeq	46cbf954-a4fb-4060-818c-a60666ae41d3	Breast	41	4F5E142F-D936-469D-ABAA-37BAF6F045AF	207F8A42-5B05-4876-B0AE-EBFAEEA27844	TCGA-AO-A0J2-01A-11D-A19H-09	GRCh37-lite	TCGA-AO-A0J2	TCGA-BRCA	NA	s6459	Washington University School of Medicine	MSKCC	None	NO	T1c	N0 (i-)	Infiltrating Ductal Carcinoma	Stage IA	A19H-09	TRUE
13722.58cfa82de4b0c9d6adf6a72e	58cfa82de4b0c9d6adf6a72e	G13226.TCGA-21-1078-01A-01D-1521-08.1.filtered.	WGS	G13226.TCGA-21-1078-01A-01D-1521-08.1	G13226.TCGA-21-1078-01A-01D-1521-08.1.bam	586.7	1.8	0.05	58cfa82de4b0c9d6adf6a72e	G13226.TCGA-21-1078-01A-01D-1521-08.1.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-21-1078-01A	0AB8D063-62B4-4D47-82AA-E3351A60029D	Primary Tumor	Illumina HiSeq	646caf62-8b1b-43c0-a9c6-471110de099c	Lung	77	EFACAC80-9428-4482-9AEA-6B57FD172D49	8CF9B32D-3D6F-4898-8C7A-89511B754021	TCGA-21-1078-01A-01D-1521-08	HG19_Broad_variant	TCGA-21-1078	TCGA-LUSC	474	s10248	Broad Institute of MIT and Harvard	Fox Chase Cancer Center	United States	NO	T2	N0	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage IB	1521-08	TRUE
13722.58cfa82de4b0c9d6adf6a742	58cfa82de4b0c9d6adf6a742	G14580.TCGA-64-1678-01A-01D-1040-01.2.filtered.	WGS	G14580.TCGA-64-1678-01A-01D-1040-01.2	G14580.TCGA-64-1678-01A-01D-1040-01.2.bam	482.23	1.9	0.15	58cfa82de4b0c9d6adf6a742	G14580.TCGA-64-1678-01A-01D-1040-01.2.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-64-1678-01A	F77CF4D3-9829-4FD3-95A1-B29AED9E94B8	Primary Tumor	Illumina HiSeq	3abe422b-51c0-4fb1-932d-f9e07cdb2150	Lung	70	0A2D9FAD-C5DF-46C1-BF96-529C7C92DFBA	53BB7112-3E38-45FE-A9C4-1B0871BABF4A	TCGA-64-1678-01A-01D-1040-01	HG19_Broad_variant	TCGA-64-1678	TCGA-LUAD	NA	s11207	Broad Institute of MIT and Harvard	Fox Chase	United States	NO	T2b	N0	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage IIA	1040-01	FALSE
13722.58cfa82de4b0c9d6adf6a74a	58cfa82de4b0c9d6adf6a74a	G13227.TCGA-43-3394-01A-01D-1553-08.1.filtered.	WGS	G13227.TCGA-43-3394-01A-01D-1553-08.1	G13227.TCGA-43-3394-01A-01D-1553-08.1.bam	532.37	1.9	0.05	58cfa82de4b0c9d6adf6a74a	G13227.TCGA-43-3394-01A-01D-1553-08.1.bam	Alive	MALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-43-3394-01A	CE8612AB-3149-4A6A-B424-29C0C21C9B8B	Primary Tumor	Illumina HiSeq	bc49e74a-6128-4677-93fa-776314b3caef	Lung	52	D8F165AF-1DF5-4876-ABF8-7596E52A3BC3	EFE4D5DD-FFFB-41DF-AB86-BE06CC16646F	TCGA-43-3394-01A-01D-1553-08	HG19_Broad_variant	TCGA-43-3394	TCGA-LUSC	NA	s10073	Broad Institute of MIT and Harvard	Christiana Healthcare	United States	NO	T2a	N0	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage IB	1553-08	FALSE
13722.58cfa82de4b0c9d6adf6a759	58cfa82de4b0c9d6adf6a759	G13230.TCGA-60-2713-01A-01D-1522-08.3.filtered.	WGS	G13230.TCGA-60-2713-01A-01D-1522-08.3	G13230.TCGA-60-2713-01A-01D-1522-08.3.bam	661.3	1.9	0.05	58cfa82de4b0c9d6adf6a759	G13230.TCGA-60-2713-01A-01D-1522-08.3.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-60-2713-01A	E58E8850-154F-4695-BEE0-005C76410327	Primary Tumor	Illumina HiSeq	34149172-2cd5-402b-a1c6-c4fd3919f717	Lung	64	88A9B60F-89DD-4C2B-B13B-5EF5E10B94AB	79EB7BBA-F0D8-462C-ADD7-20A2FB7843E1	TCGA-60-2713-01A-01D-1522-08	HG19_Broad_variant	TCGA-60-2713	TCGA-LUSC	NA	s10074	Broad Institute of MIT and Harvard	Roswell Park	United States	NO	T2	N0	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage IB	1522-08	TRUE
13722.58cfa82de4b0c9d6adf6a49e	58cfa82de4b0c9d6adf6a49e	3d2308f4fcb270a0468e663dc68d9a50.filtered.	WGS	3d2308f4fcb270a0468e663dc68d9a50	3d2308f4fcb270a0468e663dc68d9a50.bam	60.36	1.92	0.07	58cfa82de4b0c9d6adf6a49e	3d2308f4fcb270a0468e663dc68d9a50.bam	Alive	FEMALE	Not available	Not available	Breast Invasive Carcinoma	Aligned reads	TCGA-A8-A094-01A	993103B1-E5A1-4C33-8629-BE53EBC41D64	Primary Tumor	Illumina HiSeq	d706598d-75e8-4df1-94b7-da37b3361303	Breast	75	A36231AA-F304-4BBF-AA86-B9547916C097	DB45D81F-695C-4F99-BEEA-6DBEC1FF47FC	TCGA-A8-A094-01A-11D-A19H-09	GRCh37-lite	TCGA-A8-A094	TCGA-BRCA	NA	s6618	Washington University School of Medicine	Indivumed	Germany	NO	T2	N0	Infiltrating Ductal Carcinoma	Stage IIA	A19H-09	TRUE
13722.58cfa82de4b0c9d6adf6a74e	58cfa82de4b0c9d6adf6a74e	G13229.TCGA-56-1622-01A-01D-1521-08.1.filtered.	WGS	G13229.TCGA-56-1622-01A-01D-1521-08.1	G13229.TCGA-56-1622-01A-01D-1521-08.1.bam	338.7	1.9	0.05	58cfa82de4b0c9d6adf6a74e	G13229.TCGA-56-1622-01A-01D-1521-08.1.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-56-1622-01A	3EDF933A-BE1A-46E8-BFB0-ACDFF30E64A0	Primary Tumor	Illumina HiSeq	7fdda717-3cf6-4e4d-a2c7-8b7691ce09b2	Lung	58	4083DE2F-3FF5-487B-A27B-783D51C4F853	0BBC7EDE-5022-4084-925C-D65BAAF7ABC2	TCGA-56-1622-01A-01D-1521-08	HG19_Broad_variant	TCGA-56-1622	TCGA-LUSC	881	s10071	Broad Institute of MIT and Harvard	International Genomics Consortium	United States	NO	T2	N0	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage IB	1521-08	TRUE
13722.58cfa82de4b0c9d6adf6a778	58cfa82de4b0c9d6adf6a778	G14849.TCGA-44-2659-01A-01D-1931-08.5.filtered.	WGS	G14849.TCGA-44-2659-01A-01D-1931-08.5	G14849.TCGA-44-2659-01A-01D-1931-08.5.bam	82.96	1.9	0.15	58cfa82de4b0c9d6adf6a778	G14849.TCGA-44-2659-01A-01D-1931-08.5.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-44-2659-01A	BF15F7AD-9D92-473B-91D1-F24AA373AB97	Primary Tumor	Illumina HiSeq	bcdd7201-d7f2-45f5-bbaf-e0ca63b987c4	Lung	65	42208BA8-F465-4D62-9ED9-5DBFAA525913	2BDE43E2-FD4E-413E-ADC7-C50BCA75D358	TCGA-44-2659-01A-01D-1931-08	HG19_Broad_variant	TCGA-44-2659	TCGA-LUAD	NA	s10626	Broad Institute of MIT and Harvard	Christiana Healthcare	United States	NO	T1	N1	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage IIB	1931-08	TRUE
13722.58cfa82de4b0c9d6adf6a776	58cfa82de4b0c9d6adf6a776	G14853.TCGA-05-4420-01A-01D-1931-08.1.filtered.	WGS	G14853.TCGA-05-4420-01A-01D-1931-08.1	G14853.TCGA-05-4420-01A-01D-1931-08.1.bam	651.3	1.9	0.16	58cfa82de4b0c9d6adf6a776	G14853.TCGA-05-4420-01A-01D-1931-08.1.bam	Alive	MALE	Not available	Not available	Lung Adenocarcinoma	Aligned reads	TCGA-05-4420-01A	3D2AA654-1B5F-4EB4-A1C2-AF31F5760069	Primary Tumor	Illumina HiSeq	aa05f7cb-814c-4ddf-a639-50291fa19a95	Lung	41	4B202550-9744-4C6C-AD17-97F764EA3F18	DE614A3E-1C0D-49C7-A2F1-28BC58E6E5C7	TCGA-05-4420-01A-01D-1931-08	HG19_Broad_variant	TCGA-05-4420	TCGA-LUAD	NA	s11315	Broad Institute of MIT and Harvard	Indivumed	Germany	NO	T2	N0	Lung Adenocarcinoma Mixed Subtype	Stage IB	1931-08	TRUE
13722.58cfa82de4b0c9d6adf6a77c	58cfa82de4b0c9d6adf6a77c	G14852.TCGA-49-4510-01A-01D-1931-08.3.filtered.	WGS	G14852.TCGA-49-4510-01A-01D-1931-08.3	G14852.TCGA-49-4510-01A-01D-1931-08.3.bam	177.53	1.9	0.14	58cfa82de4b0c9d6adf6a77c	G14852.TCGA-49-4510-01A-01D-1931-08.3.bam	Dead	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-49-4510-01A	F77B6930-A1CE-446E-A15D-C018CBBECFEE	Primary Tumor	Illumina HiSeq	25c363b3-3a56-4365-8fec-10ccb8618909	Lung	51	9A479D32-13A4-46C2-B26D-34CB6051A891	3E680217-92C1-4C6F-BF67-CA64E469B4A4	TCGA-49-4510-01A-01D-1931-08	HG19_Broad_variant	TCGA-49-4510	TCGA-LUAD	896	s11212	Broad Institute of MIT and Harvard	Johns Hopkins	United States	NO	T2	N1	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage IIB	1931-08	TRUE
13722.58cfa82de4b0c9d6adf6a77a	58cfa82de4b0c9d6adf6a77a	G12520.TCGA-60-2711-01A-01D-0963-08.1.filtered.	WGS	G12520.TCGA-60-2711-01A-01D-0963-08.1	G12520.TCGA-60-2711-01A-01D-0963-08.1.bam	620.3	1.9	0.15	58cfa82de4b0c9d6adf6a77a	G12520.TCGA-60-2711-01A-01D-0963-08.1.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-60-2711-01A	1F11DE87-A5FE-49FD-80C1-E279B2BC69DE	Primary Tumor	Illumina HiSeq	53773d17-2e17-4544-845d-b784120af48d	Lung	64	8A3A376A-A4DB-4D4F-85CE-A894A2AA60BB	D54CA81C-1BCC-41EA-B17A-9F7249EBE9C1	TCGA-60-2711-01A-01D-0963-08	HG19_Broad_variant	TCGA-60-2711	TCGA-LUSC	NA	s10496	Broad Institute of MIT and Harvard	Roswell Park	United States	NO	T2	N0	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage IB	0963-08	FALSE
13722.58cfa82ee4b0c9d6adf6a7cf	58cfa82ee4b0c9d6adf6a7cf	G25249.TCGA-CR-7391-01A-11D-2334-08.1.filtered.	WGS	G25249.TCGA-CR-7391-01A-11D-2334-08.1	G25249.TCGA-CR-7391-01A-11D-2334-08.1.bam	85.7	NA	0.05	58cfa82ee4b0c9d6adf6a7cf	G25249.TCGA-CR-7391-01A-11D-2334-08.1.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CR-7391-01A	832316EE-08AB-412B-9E4D-8A57FF84BC11	Primary Tumor	Illumina HiSeq	ef4db578-e4b8-4047-b761-df26ecf7a41e	Head and Neck	36	54B7DB2E-F0DD-469D-81BB-4E2A86EBEA9D	C121DE15-78F7-4698-91BF-FD0485C466C2	TCGA-CR-7391-01A-11D-2334-08	HG19_Broad_variant	TCGA-CR-7391	TCGA-HNSC	NA	s15862	Broad Institute of MIT and Harvard	Vanderbilt University	United States	NO	T1	N0	Head and Neck Squamous Cell Carcinoma	Stage I	2334-08	FALSE
13722.58cfa82ee4b0c9d6adf6a7d6	58cfa82ee4b0c9d6adf6a7d6	G23064.TCGA_CR_6472_01A_11D_2268_08.1.filtered.	WGS	G23064.TCGA_CR_6472_01A_11D_2268_08.1	G23064.TCGA_CR_6472_01A_11D_2268_08.1.bam	118	1.9	0.15	58cfa82ee4b0c9d6adf6a7d6	G23064.TCGA_CR_6472_01A_11D_2268_08.1.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CR-6472-01A	0956BC67-DD55-4C54-A56A-F22F2856662A	Primary Tumor	Illumina HiSeq	8bf4b442-c0d0-4794-b87d-990df38dfce7	Head and Neck	59	76095F05-CD2B-4973-800A-10FE58EE1609	5193A482-6ED9-4504-BD7C-C8B9E4103577	TCGA-CR-6472-01A-11D-2268-08	HG19_Broad_variant	TCGA-CR-6472	TCGA-HNSC	NA	s15603	Broad Institute of MIT and Harvard	Vanderbilt University	United States	NO	Not available	Not available	Head and Neck Squamous Cell Carcinoma	Not available	2268-08	TRUE
13722.58cfa82ee4b0c9d6adf6a876	58cfa82ee4b0c9d6adf6a876	G26391.TCGA-26-5135-01A-01D-1486-08.1.filtered.	WGS	G26391.TCGA-26-5135-01A-01D-1486-08.1	G26391.TCGA-26-5135-01A-01D-1486-08.1.bam	443.73	1.9	0.05	58cfa82ee4b0c9d6adf6a876	G26391.TCGA-26-5135-01A-01D-1486-08.1.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Glioblastoma Multiforme	Aligned reads	TCGA-26-5135-01A	69D56F2D-6924-409B-9D1E-C8D69B400270	Primary Tumor	Illumina HiSeq	1fec68bf-4fbd-4cbf-bf2e-e540dd2bc143	Brain	72	8CFB4C3F-B25F-412C-91C7-997C64EA2D75	2CE48F01-2F61-49D9-A56A-7438BF4A37D7	TCGA-26-5135-01A-01D-1486-08	HG19_Broad_variant	TCGA-26-5135	TCGA-GBM	270	s14173	Broad Institute of MIT and Harvard	University of Florida	None	NO	Not available	Not available	Untreated primary (de novo) GBM	Not available	1486-08	FALSE
13722.58cfa82ee4b0c9d6adf6a89a	58cfa82ee4b0c9d6adf6a89a	G35154.TCGA-HT-8104-01A-11D-A461-08.2.filtered.	WGS	G35154.TCGA-HT-8104-01A-11D-A461-08.2	G35154.TCGA-HT-8104-01A-11D-A461-08.2.bam	129.6	NA	0.08	58cfa82ee4b0c9d6adf6a89a	G35154.TCGA-HT-8104-01A-11D-A461-08.2.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-HT-8104-01A	5DE6FD84-ED02-4C27-9947-DB57F05FAF6D	Primary Tumor	Illumina HiSeq	85f4a2b5-246f-41da-9777-57d2ceaf1b70	Brain	51	13845BA9-5FC0-408A-8CA9-AC32511765B7	3139DEFD-0311-4F2A-9AD4-A9903F481832	TCGA-HT-8104-01A-11D-A461-08	HG19_Broad_variant	TCGA-HT-8104	TCGA-LGG	NA	s8334	Broad Institute of MIT and Harvard	Case Western - St Joes	United States	NO	Not available	Not available	Astrocytoma	Not available	A461-08	TRUE
13722.58cfa82ee4b0c9d6adf6a81a	58cfa82ee4b0c9d6adf6a81a	G23062.TCGA_BA_4077_01B_01D_2268_08.2.filtered.	WGS	G23062.TCGA_BA_4077_01B_01D_2268_08.2	G23062.TCGA_BA_4077_01B_01D_2268_08.2.bam	246.33	1.9	0.15	58cfa82ee4b0c9d6adf6a81a	G23062.TCGA_BA_4077_01B_01D_2268_08.2.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-BA-4077-01B	4BFBCE2B-9D0B-4E8A-950F-FD8E0BA3E05A	Primary Tumor	Illumina HiSeq	6533e56c-b5b8-4c85-862b-a5526c5c2e0a	Head and Neck	45	327BBCA7-FA25-4A92-BE27-21A4C184C760	268D9CDB-CCCF-491A-A9BB-2E3D6B85951F	TCGA-BA-4077-01B-01D-2268-08	HG19_Broad_variant	TCGA-BA-4077	TCGA-HNSC	1134	s16017	Broad Institute of MIT and Harvard	UNC	None	NO	T4a	N0	Head and Neck Squamous Cell Carcinoma	Stage IVA	2268-08	TRUE
13722.58cfa82ee4b0c9d6adf6a8da	58cfa82ee4b0c9d6adf6a8da	G25786.TCGA-78-7146-01A-11D-2036-08.2.filtered.	WGS	G25786.TCGA-78-7146-01A-11D-2036-08.2	G25786.TCGA-78-7146-01A-11D-2036-08.2.bam	113.7	NA	0.05	58cfa82ee4b0c9d6adf6a8da	G25786.TCGA-78-7146-01A-11D-2036-08.2.bam	Dead	FEMALE	WHITE	Not available	Lung Adenocarcinoma	Aligned reads	TCGA-78-7146-01A	FF9DEF3D-17E5-4EF6-B74E-933F11ED6F00	Primary Tumor	Illumina HiSeq	17e2078c-ad94-4ecc-ba36-9a8e9e4e237e	Lung	71	98A8D751-4EFD-442E-A242-0FE399C2586F	7692E684-4AF2-4892-80AD-1F417B6B38FA	TCGA-78-7146-01A-11D-2036-08	HG19_Broad_variant	TCGA-78-7146	TCGA-LUAD	173	s11108	Broad Institute of MIT and Harvard	Prince Charles Hospital	Australia	NO	T2	N2	Lung Adenocarcinoma Mixed Subtype	Stage IIIA	2036-08	TRUE
13722.58cfa82ee4b0c9d6adf6a89c	58cfa82ee4b0c9d6adf6a89c	G25775.TCGA-44-6148-01A-11D-1753-08.1.filtered.	WGS	G25775.TCGA-44-6148-01A-11D-1753-08.1	G25775.TCGA-44-6148-01A-11D-1753-08.1.bam	164.4	1.9	0.05	58cfa82ee4b0c9d6adf6a89c	G25775.TCGA-44-6148-01A-11D-1753-08.1.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-44-6148-01A	8994C8C4-9EA0-46CB-B4A5-0055D7DA5BFA	Primary Tumor	Illumina HiSeq	85617ab0-26a0-468d-b153-3e62d6b86c64	Lung	60	C0FE5FFE-C0A3-4E62-AA55-2BC18788E505	9C7B3AC8-1352-49CD-8A8C-DF6B19F6FD64	TCGA-44-6148-01A-11D-1753-08	HG19_Broad_variant	TCGA-44-6148	TCGA-LUAD	NA	s11320	Broad Institute of MIT and Harvard	Christiana Healthcare	United States	NO	T1b	N0	Lung Mucinous Adenocarcinoma	Stage IA	1753-08	TRUE
13722.58cfa82ee4b0c9d6adf6a8e2	58cfa82ee4b0c9d6adf6a8e2	G35154.TCGA-DU-5870-01A-11D-A461-08.3.filtered.	WGS	G35154.TCGA-DU-5870-01A-11D-A461-08.3	G35154.TCGA-DU-5870-01A-11D-A461-08.3.bam	55.6	1.9	0.08	58cfa82ee4b0c9d6adf6a8e2	G35154.TCGA-DU-5870-01A-11D-A461-08.3.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-DU-5870-01A	EB42625E-FBBB-4BEE-BBE9-315B3CA2138A	Primary Tumor	Illumina HiSeq	781639a0-ea42-4e90-8e48-2dd0de69143f	Brain	34	25E75875-4A84-4C29-9030-0E0922BD6567	8EFA4E9E-F222-4CCB-BF34-32443183BD7F	TCGA-DU-5870-01A-11D-A461-08	HG19_Broad_variant	TCGA-DU-5870	TCGA-LGG	NA	s8318	Broad Institute of MIT and Harvard	Henry Ford Hospital	United States	NO	Not available	Not available	Oligodendroglioma	Not available	A461-08	TRUE
13722.58cfa82ee4b0c9d6adf6a90a	58cfa82ee4b0c9d6adf6a90a	G32457.TCGA-FD-A3N6-01A-11D-A21A-08.1.filtered.	WGS	G32457.TCGA-FD-A3N6-01A-11D-A21A-08.1	G32457.TCGA-FD-A3N6-01A-11D-A21A-08.1.bam	47.84	NA	0.08	58cfa82ee4b0c9d6adf6a90a	G32457.TCGA-FD-A3N6-01A-11D-A21A-08.1.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-FD-A3N6-01A	8C1DD7F7-B74A-4FA2-B6A7-86F0348D2567	Primary Tumor	Illumina HiSeq	d881868c-a616-4a4c-bbb7-4fbda95e1323	Bladder	43	6CD6D1F4-D8E4-47F9-812F-EB7FEC925F8D	D4615CA0-B5C7-4A5C-8593-BD50034A78AE	TCGA-FD-A3N6-01A-11D-A21A-08	HG19_Broad_variant	TCGA-FD-A3N6	TCGA-BLCA	NA	s2849	Broad Institute of MIT and Harvard	BLN - University Of Chicago	United States	NO	T2b	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage II	A21A-08	TRUE
13722.58cfa82ee4b0c9d6adf6a8fd	58cfa82ee4b0c9d6adf6a8fd	G26370.TCGA-27-1831-01A-01D-1494-08.1.filtered.	WGS	G26370.TCGA-27-1831-01A-01D-1494-08.1	G26370.TCGA-27-1831-01A-01D-1494-08.1.bam	564.7	1.93	0.05	58cfa82ee4b0c9d6adf6a8fd	G26370.TCGA-27-1831-01A-01D-1494-08.1.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Glioblastoma Multiforme	Aligned reads	TCGA-27-1831-01A	F45F4A30-6B4C-4F15-9140-959D6A25A45F	Primary Tumor	Illumina HiSeq	c2dc8176-a9d4-4f93-877b-c6d55f074569	Brain	66	9BB49615-6F5E-471C-B68B-866E6199CEB7	9880C3C9-5685-42A7-8FE9-7585EA1A1D37	TCGA-27-1831-01A-01D-1494-08	HG19_Broad_variant	TCGA-27-1831	TCGA-GBM	505	s14091	Broad Institute of MIT and Harvard	Milan - Italy, Fondazione IRCCS Instituto Neuroligico C. Besta	None	NO	Not available	Not available	Untreated primary (de novo) GBM	Not available	1494-08	TRUE
13722.58cfa82ee4b0c9d6adf6a960	58cfa82ee4b0c9d6adf6a960	G35154.TCGA-DU-6404-01A-11D-A461-08.3.filtered.	WGS	G35154.TCGA-DU-6404-01A-11D-A461-08.3	G35154.TCGA-DU-6404-01A-11D-A461-08.3.bam	202.6	1.9	0.07	58cfa82ee4b0c9d6adf6a960	G35154.TCGA-DU-6404-01A-11D-A461-08.3.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-DU-6404-01A	C0D47E0F-4918-4E06-9DB6-201671B1259C	Primary Tumor	Illumina HiSeq	e8c73506-ba8e-44dc-87cd-4305bdb6b7f9	Brain	24	1F5A0C14-D1C1-4E88-BC19-ABFAFFF97445	E24BC524-4F82-4FC8-AA20-0B64C9B74762	TCGA-DU-6404-01A-11D-A461-08	HG19_Broad_variant	TCGA-DU-6404	TCGA-LGG	4068	s8104	Broad Institute of MIT and Harvard	Henry Ford Hospital	United States	NO	Not available	Not available	Oligodendroglioma	Not available	A461-08	TRUE
13722.58cfa82ee4b0c9d6adf6a95e	58cfa82ee4b0c9d6adf6a95e	G35154.TCGA-DU-6397-01A-11D-A461-08.3.filtered.	WGS	G35154.TCGA-DU-6397-01A-11D-A461-08.3	G35154.TCGA-DU-6397-01A-11D-A461-08.3.bam	140.6	1.9	0.07	58cfa82ee4b0c9d6adf6a95e	G35154.TCGA-DU-6397-01A-11D-A461-08.3.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-DU-6397-01A	E695B780-17F4-4E71-9120-7C6BCAFAA3A7	Primary Tumor	Illumina HiSeq	24c6f54a-e7a2-4148-8335-045e3c74096e	Brain	45	AEB67AEA-F2AA-4181-8E25-7653341A0B61	77909413-9323-4916-BB9F-A8E578342333	TCGA-DU-6397-01A-11D-A461-08	HG19_Broad_variant	TCGA-DU-6397	TCGA-LGG	1401	s8113	Broad Institute of MIT and Harvard	Henry Ford Hospital	United States	NO	Not available	Not available	Oligodendroglioma	Not available	A461-08	TRUE
13722.58cfa82ee4b0c9d6adf6a911	58cfa82ee4b0c9d6adf6a911	G16921.TCGA-BP-4977-01A-01D-2048-08.1.filtered.	WGS	G16921.TCGA-BP-4977-01A-01D-2048-08.1	G16921.TCGA-BP-4977-01A-01D-2048-08.1.bam	26.1	1.9	0.16	58cfa82ee4b0c9d6adf6a911	G16921.TCGA-BP-4977-01A-01D-2048-08.1.bam	Alive	MALE	WHITE	Not available	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-BP-4977-01A	CC353686-E2B6-46A1-8095-48E2BC44B11F	Primary Tumor	Illumina HiSeq	eb47b3fe-95b7-490e-99d4-9e326b44d448	Kidney	57	35C747C0-38BB-4D2E-A428-8E24106ADFAB	1E046AB9-FA4C-4C15-8D78-ED0048C80EBF	TCGA-BP-4977-01A-01D-2048-08	HG19_Broad_variant	TCGA-BP-4977	TCGA-KIRC	NA	s8831	Broad Institute of MIT and Harvard	MSKCC	None	NO	T1b	NX	Kidney Clear Cell Renal Carcinoma	Stage I	2048-08	FALSE
13722.58cfa82ee4b0c9d6adf6a9ae	58cfa82ee4b0c9d6adf6a9ae	G16919.TCGA-A3-3308-01A-01D-2048-08.1.filtered.	WGS	G16919.TCGA-A3-3308-01A-01D-2048-08.1	G16919.TCGA-A3-3308-01A-01D-2048-08.1.bam	591.9	1.9	0.17	58cfa82ee4b0c9d6adf6a9ae	G16919.TCGA-A3-3308-01A-01D-2048-08.1.bam	Alive	FEMALE	WHITE	Not available	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-A3-3308-01A	3CBCA837-F5A7-4A87-8F02-C59EAC232D5A	Primary Tumor	Illumina HiSeq	6208ef74-033a-4d92-ad2e-96de84ea4784	Kidney	77	0B935ADB-0E19-4FCC-9BB0-B9D95872BCEF	EFD9E8D3-7803-4996-85D3-8A9449B3C1AC	TCGA-A3-3308-01A-01D-2048-08	HG19_Broad_variant	TCGA-A3-3308	TCGA-KIRC	NA	s9441	Broad Institute of MIT and Harvard	International Genomics Consortium	None	NO	T3b	N0	Kidney Clear Cell Renal Carcinoma	Stage III	2048-08	FALSE
13722.58cfa82ee4b0c9d6adf6a922	58cfa82ee4b0c9d6adf6a922	G26380.TCGA-06-0744-01A-01D-1492-08.1.filtered.	WGS	G26380.TCGA-06-0744-01A-01D-1492-08.1	G26380.TCGA-06-0744-01A-01D-1492-08.1.bam	108.57	1.91	0.05	58cfa82ee4b0c9d6adf6a922	G26380.TCGA-06-0744-01A-01D-1492-08.1.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Glioblastoma Multiforme	Aligned reads	TCGA-06-0744-01A	5613F5F6-086D-470B-8F77-6DCB7F8625B7	Primary Tumor	Illumina HiSeq	fec78208-6a76-43eb-9c8c-a3d7c5d55fed	Brain	66	C01952D4-AE81-48E2-8818-0E438E66B516	914421D2-898E-433E-BB66-B1710EAAE2C7	TCGA-06-0744-01A-01D-1492-08	HG19_Broad_variant	TCGA-06-0744	TCGA-GBM	NA	s14138	Broad Institute of MIT and Harvard	Henry Ford Hospital	None	NO	Not available	Not available	Untreated primary (de novo) GBM	Not available	1492-08	FALSE
13722.58cfa82ee4b0c9d6adf6a9a6	58cfa82ee4b0c9d6adf6a9a6	G25789.TCGA-78-7535-01A-11D-2063-08.1.filtered.	WGS	G25789.TCGA-78-7535-01A-11D-2063-08.1	G25789.TCGA-78-7535-01A-11D-2063-08.1.bam	314.3	NA	0.05	58cfa82ee4b0c9d6adf6a9a6	G25789.TCGA-78-7535-01A-11D-2063-08.1.bam	Dead	MALE	WHITE	Not available	Lung Adenocarcinoma	Aligned reads	TCGA-78-7535-01A	46592B7B-6968-42A6-83AF-0917C9F4A9A5	Primary Tumor	Illumina HiSeq	c7601721-da6e-403a-9b43-7971f6513153	Lung	45	C0A8C73C-35BA-4724-B13A-9A9986AF36C0	FA8844F8-C4B6-487A-8187-E30C12A7A453	TCGA-78-7535-01A-11D-2063-08	HG19_Broad_variant	TCGA-78-7535	TCGA-LUAD	949	s10759	Broad Institute of MIT and Harvard	Prince Charles Hospital	Australia	NO	T2	N0	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage IB	2063-08	FALSE
13722.58cfa82ee4b0c9d6adf6a9c4	58cfa82ee4b0c9d6adf6a9c4	G23076.TCGA_CV_5443_01A_01D_2268_08.1.filtered.	WGS	G23076.TCGA_CV_5443_01A_01D_2268_08.1	G23076.TCGA_CV_5443_01A_01D_2268_08.1.bam	385	1.9	0.15	58cfa82ee4b0c9d6adf6a9c4	G23076.TCGA_CV_5443_01A_01D_2268_08.1.bam	Alive	MALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-5443-01A	180036A2-3B56-405E-A1FE-D5932517B6C7	Primary Tumor	Illumina HiSeq	9e76f187-2863-42f5-9540-da82b815d6c0	Head and Neck	63	746322C7-FE75-4B9F-9309-93E9CFA4CB5A	D4B80307-ABBD-48BB-B52C-6DCD409699A2	TCGA-CV-5443-01A-01D-2268-08	HG19_Broad_variant	TCGA-CV-5443	TCGA-HNSC	NA	s15742	Broad Institute of MIT and Harvard	MD Anderson Cancer Center	None	NO	T3	N0	Head and Neck Squamous Cell Carcinoma	Stage III	2268-08	TRUE
13722.58cfa82ee4b0c9d6adf6a9d5	58cfa82ee4b0c9d6adf6a9d5	G25788.TCGA-55-7281-01A-11D-2036-08.1.filtered.	WGS	G25788.TCGA-55-7281-01A-11D-2036-08.1	G25788.TCGA-55-7281-01A-11D-2036-08.1.bam	196.7	NA	0.05	58cfa82ee4b0c9d6adf6a9d5	G25788.TCGA-55-7281-01A-11D-2036-08.1.bam	Alive	FEMALE	WHITE	Not available	Lung Adenocarcinoma	Aligned reads	TCGA-55-7281-01A	659668E8-F0D9-4FF2-BBC8-9246F2EF49AB	Primary Tumor	Illumina HiSeq	19c6ac35-62fd-4db0-8641-22abc19d0b52	Lung	70	AFEC3B25-C3F7-4E48-8FB0-6FB4DD581081	D5443922-FEA5-4FF0-BD6E-8CE04E1951D8	TCGA-55-7281-01A-11D-2036-08	HG19_Broad_variant	TCGA-55-7281	TCGA-LUAD	NA	s11213	Broad Institute of MIT and Harvard	International Genomics Consortium	United States	NO	T1b	N0	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage IA	2036-08	TRUE
13722.58cfa82ee4b0c9d6adf6a9e7	58cfa82ee4b0c9d6adf6a9e7	G25771.TCGA-05-4395-01A-01D-2364-08.1.filtered.	WGS	G25771.TCGA-05-4395-01A-01D-2364-08.1	G25771.TCGA-05-4395-01A-01D-2364-08.1.bam	385.2	1.9	0.05	58cfa82ee4b0c9d6adf6a9e7	G25771.TCGA-05-4395-01A-01D-2364-08.1.bam	Dead	MALE	Not available	Not available	Lung Adenocarcinoma	Aligned reads	TCGA-05-4395-01A	762DEA8A-5B41-4058-979A-B7876ED13D7E	Primary Tumor	Illumina HiSeq	e32c5a48-a697-44eb-8628-35528945fdf2	Lung	76	9DED6605-39A3-4C0F-AD2E-7F6863960DBE	BCE88385-4A1B-4A8C-920C-060F6A2675D4	TCGA-05-4395-01A-01D-2364-08	HG19_Broad_variant	TCGA-05-4395	TCGA-LUAD	0	s11216	Broad Institute of MIT and Harvard	Indivumed	Germany	NO	T4	N2	Lung Adenocarcinoma Mixed Subtype	Stage IIIB	2364-08	FALSE
13722.58cfa82ee4b0c9d6adf6aa04	58cfa82ee4b0c9d6adf6aa04	G25250.TCGA-CR-6470-01A-11D-2334-08.1.filtered.	WGS	G25250.TCGA-CR-6470-01A-11D-2334-08.1	G25250.TCGA-CR-6470-01A-11D-2334-08.1.bam	137.7	1.9	0.05	58cfa82ee4b0c9d6adf6aa04	G25250.TCGA-CR-6470-01A-11D-2334-08.1.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CR-6470-01A	CD032DDB-55F2-4C77-8DCF-E4E630F7DE6F	Primary Tumor	Illumina HiSeq	1a71c849-3daa-48f9-b309-4c340a01def2	Head and Neck	38	AFB7EA63-2959-4E53-95EA-7A032DCB5A8B	02C6A893-49C5-49D1-8EB1-195021E70D52	TCGA-CR-6470-01A-11D-2334-08	HG19_Broad_variant	TCGA-CR-6470	TCGA-HNSC	NA	s16019	Broad Institute of MIT and Harvard	Vanderbilt University	United States	NO	T2	N0	Head and Neck Squamous Cell Carcinoma	Stage II	2334-08	FALSE
13722.58cfa82ee4b0c9d6adf6aa06	58cfa82ee4b0c9d6adf6aa06	G23074.TCGA_CN_4741_01A_01D_2268_08.1.filtered.	WGS	G23074.TCGA_CN_4741_01A_01D_2268_08.1	G23074.TCGA_CN_4741_01A_01D_2268_08.1.bam	215.7	1.9	0.14	58cfa82ee4b0c9d6adf6aa06	G23074.TCGA_CN_4741_01A_01D_2268_08.1.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CN-4741-01A	277B02E9-DED5-4980-845D-AF53690000AC	Primary Tumor	Illumina HiSeq	b508fa53-d86f-4e56-9703-6cdb7095ed0b	Head and Neck	75	03C9108A-5139-4BAC-9641-C7DBBEDEF420	F652367A-D6C9-4A0A-AADE-1AB988BE3BE6	TCGA-CN-4741-01A-01D-2268-08	HG19_Broad_variant	TCGA-CN-4741	TCGA-HNSC	NA	s15745	Broad Institute of MIT and Harvard	University of Pittsburgh	None	NO	T4a	N0	Head and Neck Squamous Cell Carcinoma	Stage IVA	2268-08	TRUE
13722.58cfa82ee4b0c9d6adf6aa44	58cfa82ee4b0c9d6adf6aa44	G25251.TCGA-CR-7404-01A-11D-2334-08.1.filtered.	WGS	G25251.TCGA-CR-7404-01A-11D-2334-08.1	G25251.TCGA-CR-7404-01A-11D-2334-08.1.bam	181.7	NA	0.05	58cfa82ee4b0c9d6adf6aa44	G25251.TCGA-CR-7404-01A-11D-2334-08.1.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CR-7404-01A	D189A6C6-210F-4957-B500-457D5CE3F867	Primary Tumor	Illumina HiSeq	f8742c2f-2e32-467e-9347-f0dd0959da6b	Head and Neck	53	A39131B9-E7C7-4385-A1B9-D8A0A0950337	83ECA7B5-45BB-44C0-8AFE-36F8988D0078	TCGA-CR-7404-01A-11D-2334-08	HG19_Broad_variant	TCGA-CR-7404	TCGA-HNSC	NA	s15602	Broad Institute of MIT and Harvard	Vanderbilt University	United States	NO	TX	NX	Head and Neck Squamous Cell Carcinoma	Not available	2334-08	FALSE
13722.58cfa82ee4b0c9d6adf6aa3c	58cfa82ee4b0c9d6adf6aa3c	G23081.TCGA_CV_6961_01A_21D_2268_08.2.filtered.	WGS	G23081.TCGA_CV_6961_01A_21D_2268_08.2	G23081.TCGA_CV_6961_01A_21D_2268_08.2.bam	52.7	1.9	0.14	58cfa82ee4b0c9d6adf6aa3c	G23081.TCGA_CV_6961_01A_21D_2268_08.2.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-6961-01A	4075717B-2240-4842-A00A-0C4DBCB910C4	Primary Tumor	Illumina HiSeq	4b9344a0-a7c6-453a-b184-87e94c97920a	Head and Neck	61	BE0A6A2B-A306-4AC6-8BF8-EA6AF16EAA5A	DFA20D2D-1BA3-476A-B4B9-21D21470BEE2	TCGA-CV-6961-01A-21D-2268-08	HG19_Broad_variant	TCGA-CV-6961	TCGA-HNSC	76	s15744	Broad Institute of MIT and Harvard	MD Anderson Cancer Center	United States	NO	T2	N0	Head and Neck Squamous Cell Carcinoma	Stage II	2268-08	TRUE
13722.58cfa82ee4b0c9d6adf6aa4c	58cfa82ee4b0c9d6adf6aa4c	G35154.TCGA-TQ-A8XE-01A-11D-A36O-08.2.filtered.	WGS	G35154.TCGA-TQ-A8XE-01A-11D-A36O-08.2	G35154.TCGA-TQ-A8XE-01A-11D-A36O-08.2.bam	12.75	NA	0.07	58cfa82ee4b0c9d6adf6aa4c	G35154.TCGA-TQ-A8XE-01A-11D-A36O-08.2.bam	Dead	FEMALE	WHITE	HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-TQ-A8XE-01A	135A149A-D153-465E-AA58-06D47BB18E00	Primary Tumor	Illumina HiSeq	3bc46ccf-d9f8-41bd-a003-42e547c7d758	Brain	42	7C60D0DE-B913-4454-BF9F-C554810911B5	4AAEBADF-13D2-4865-8AB5-CC989D80A261	TCGA-TQ-A8XE-01A-11D-A36O-08	HG19_Broad_variant	TCGA-TQ-A8XE	TCGA-LGG	954	s8339	Broad Institute of MIT and Harvard	University of Sao Paulo	Brazil	NO	Not available	Not available	Oligodendroglioma	Not available	A36O-08	TRUE
13722.58cfa82ee4b0c9d6adf6aa72	58cfa82ee4b0c9d6adf6aa72	G26387.TCGA-19-2620-01A-01D-1495-08.2.filtered.	WGS	G26387.TCGA-19-2620-01A-01D-1495-08.2	G26387.TCGA-19-2620-01A-01D-1495-08.2.bam	648.1	1.9	0.05	58cfa82ee4b0c9d6adf6aa72	G26387.TCGA-19-2620-01A-01D-1495-08.2.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Glioblastoma Multiforme	Aligned reads	TCGA-19-2620-01A	352768F9-3CE1-419C-BEEF-6515C78F5D7A	Primary Tumor	Illumina HiSeq	57c2175a-25d3-4859-9eab-ecf3563510e9	Brain	70	2ED6BBB4-C2FB-42BF-A0B6-8687A73B3B7B	6DE41AC1-229B-40B9-A494-5588C284351D	TCGA-19-2620-01A-01D-1495-08	HG19_Broad_variant	TCGA-19-2620	TCGA-GBM	148	s14368	Broad Institute of MIT and Harvard	Case Western	None	NO	Not available	Not available	Untreated primary (de novo) GBM	Not available	1495-08	FALSE
13722.58cfa82ee4b0c9d6adf6aa50	58cfa82ee4b0c9d6adf6aa50	G23069.TCGA_CR_6480_01A_11D_2268_08.2.filtered.	WGS	G23069.TCGA_CR_6480_01A_11D_2268_08.2	G23069.TCGA_CR_6480_01A_11D_2268_08.2.bam	158.7	1.9	0.15	58cfa82ee4b0c9d6adf6aa50	G23069.TCGA_CR_6480_01A_11D_2268_08.2.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CR-6480-01A	BA9D4568-71A8-41FC-A2BE-0BF784E36D6A	Primary Tumor	Illumina HiSeq	cf0a07e0-8d0a-4c16-8d48-7efb9bf38f8a	Head and Neck	53	0C6B4631-381E-4B73-AC9E-62BBC1849FF4	EF673D3D-2031-4036-BA25-4BC7EF04075B	TCGA-CR-6480-01A-11D-2268-08	HG19_Broad_variant	TCGA-CR-6480	TCGA-HNSC	NA	s16166	Broad Institute of MIT and Harvard	Vanderbilt University	United States	NO	Not available	Not available	Head and Neck Squamous Cell Carcinoma	Not available	2268-08	TRUE
13722.58cfa82ee4b0c9d6adf6aa78	58cfa82ee4b0c9d6adf6aa78	G32451.TCGA-BT-A20T-01A-11D-A14W-08.1.filtered.	WGS	G32451.TCGA-BT-A20T-01A-11D-A14W-08.1	G32451.TCGA-BT-A20T-01A-11D-A14W-08.1.bam	59.68	2.07	0.09	58cfa82ee4b0c9d6adf6aa78	G32451.TCGA-BT-A20T-01A-11D-A14W-08.1.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-BT-A20T-01A	096B4F32-10C1-4737-A0DD-CAE04C54EE33	Primary Tumor	Illumina HiSeq	7d40d139-a746-424d-9f90-d5d3da5e98cb	Bladder	63	52F538EF-B05D-4C76-9976-CE6D49158016	301D6CE3-4099-4C1D-8E50-C04B7CE91450	TCGA-BT-A20T-01A-11D-A14W-08	HG19_Broad_variant	TCGA-BT-A20T	TCGA-BLCA	453	s2674	Broad Institute of MIT and Harvard	University of Pittsburgh	United States	NO	T3b	N1	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV	A14W-08	TRUE
13722.58cfa82ee4b0c9d6adf6aa4d	58cfa82ee4b0c9d6adf6aa4d	G26368.TCGA-19-2629-01A-01D-1495-08.1.filtered.	WGS	G26368.TCGA-19-2629-01A-01D-1495-08.1	G26368.TCGA-19-2629-01A-01D-1495-08.1.bam	169.1	1.9	0.05	58cfa82ee4b0c9d6adf6aa4d	G26368.TCGA-19-2629-01A-01D-1495-08.1.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Glioblastoma Multiforme	Aligned reads	TCGA-19-2629-01A	E17A6048-7A72-42C0-AD3F-97CBFF02BC9F	Primary Tumor	Illumina HiSeq	f54e5ef9-adae-4612-98af-8247a3499567	Brain	60	B89A4D5D-EE24-4052-B454-B67169328737	56FFAA35-814C-4C0B-B3C6-D4514D34FEC2	TCGA-19-2629-01A-01D-1495-08	HG19_Broad_variant	TCGA-19-2629	TCGA-GBM	737	s14367	Broad Institute of MIT and Harvard	Case Western	None	NO	Not available	Not available	Untreated primary (de novo) GBM	Not available	1495-08	FALSE
13722.58cfa82ee4b0c9d6adf6ab16	58cfa82ee4b0c9d6adf6ab16	G25783.TCGA-55-6986-01A-11D-1945-08.2.filtered.	WGS	G25783.TCGA-55-6986-01A-11D-1945-08.2	G25783.TCGA-55-6986-01A-11D-1945-08.2.bam	62	NA	0.05	58cfa82ee4b0c9d6adf6ab16	G25783.TCGA-55-6986-01A-11D-1945-08.2.bam	Alive	FEMALE	WHITE	Not available	Lung Adenocarcinoma	Aligned reads	TCGA-55-6986-01A	028E99E9-5B9A-4954-BB6E-6D4709A3CEA8	Primary Tumor	Illumina HiSeq	ee88a53a-b82b-4bd8-b13b-da8f5da9e39c	Lung	74	9622C370-68D0-48DA-A7E0-5EB4765B6F27	5A7F3C88-EF02-4E97-8009-5622245B6A09	TCGA-55-6986-01A-11D-1945-08	HG19_Broad_variant	TCGA-55-6986	TCGA-LUAD	NA	s11106	Broad Institute of MIT and Harvard	International Genomics Consortium	United States	NO	T2	N0	Lung Bronchioloalveolar Carcinoma Nonmucinous	Stage IB	1945-08	TRUE
13722.58cfa82ee4b0c9d6adf6aac9	58cfa82ee4b0c9d6adf6aac9	G25778.TCGA-05-4396-01A-21D-1855-08.2.filtered.	WGS	G25778.TCGA-05-4396-01A-21D-1855-08.2	G25778.TCGA-05-4396-01A-21D-1855-08.2.bam	301.7	1.9	0.05	58cfa82ee4b0c9d6adf6aac9	G25778.TCGA-05-4396-01A-21D-1855-08.2.bam	Dead	MALE	Not available	Not available	Lung Adenocarcinoma	Aligned reads	TCGA-05-4396-01A	9F81C602-8AFA-4588-B0B6-6E5A1A128D5A	Primary Tumor	Illumina HiSeq	80ae7a4a-81b6-4887-b708-cbff2cae5d94	Lung	76	4D85772B-287E-4790-B1E8-CD1C0E88AD48	0176CF1D-0760-4769-A493-277F4BB7585E	TCGA-05-4396-01A-21D-1855-08	HG19_Broad_variant	TCGA-05-4396	TCGA-LUAD	303	s11215	Broad Institute of MIT and Harvard	Indivumed	Germany	NO	T4	N1	Lung Adenocarcinoma Mixed Subtype	Stage IIIB	1855-08	FALSE
13722.58cfa82ee4b0c9d6adf6ab02	58cfa82ee4b0c9d6adf6ab02	G23071.TCGA_CV_7100_01A_11D_2268_08.1.filtered.	WGS	G23071.TCGA_CV_7100_01A_11D_2268_08.1	G23071.TCGA_CV_7100_01A_11D_2268_08.1.bam	335.7	NA	0.14	58cfa82ee4b0c9d6adf6ab02	G23071.TCGA_CV_7100_01A_11D_2268_08.1.bam	Dead	MALE	WHITE	Not available	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-7100-01A	90A8D2CB-1F31-45F9-8575-EED3CB9A7798	Primary Tumor	Illumina HiSeq	4e9d6eec-9af8-4de3-b449-1d56dd8ba30f	Head and Neck	66	08C3093D-4100-4BFC-92FC-A11F1393868F	FECCC27E-5C2E-4339-8746-0945FEE93C1E	TCGA-CV-7100-01A-11D-2268-08	HG19_Broad_variant	TCGA-CV-7100	TCGA-HNSC	274	s16312	Broad Institute of MIT and Harvard	MD Anderson Cancer Center	United States	NO	T2	N1	Head and Neck Squamous Cell Carcinoma	Stage III	2268-08	TRUE
13722.58cfa82ee4b0c9d6adf6ab88	58cfa82ee4b0c9d6adf6ab88	G37566.TCGA-CH-5750-01A-11D-1576-08.2.filtered.	WGS	G37566.TCGA-CH-5750-01A-11D-1576-08.2	G37566.TCGA-CH-5750-01A-11D-1576-08.2.bam	300.7	1.9	0.05	58cfa82ee4b0c9d6adf6ab88	G37566.TCGA-CH-5750-01A-11D-1576-08.2.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-CH-5750-01A	DC40CF49-B208-4F59-B5F0-CFBDD02970B2	Primary Tumor	Illumina HiSeq	84c3a2f5-0cac-4bc2-8734-3269860bd2c0	Prostate	72	0386D0E9-7BD8-467F-BA97-A379C1D67A83	E1B169C3-44E0-43E5-9EE3-2DF7A678A5EA	TCGA-CH-5750-01A-11D-1576-08	HG19_Broad_variant	TCGA-CH-5750	TCGA-PRAD	NA	s3580	Broad Institute of MIT and Harvard	Indivumed	Germany	NO	T2c	N0	Prostate Adenocarcinoma Acinar Type	Not available	1576-08	TRUE
13722.58cfa82ee4b0c9d6adf6ab9c	58cfa82ee4b0c9d6adf6ab9c	G25777.TCGA-67-6215-01A-11D-1753-08.1.filtered.	WGS	G25777.TCGA-67-6215-01A-11D-1753-08.1	G25777.TCGA-67-6215-01A-11D-1753-08.1.bam	292.4	1.9	0.05	58cfa82ee4b0c9d6adf6ab9c	G25777.TCGA-67-6215-01A-11D-1753-08.1.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-67-6215-01A	DBD5B0DE-94C9-45DD-AFB3-6820A7ECACA2	Primary Tumor	Illumina HiSeq	70835707-2b01-4434-88b9-57b2c434b88e	Lung	52	3BA5F6B9-6458-44E2-A0AA-B5C7E5FCD632	68C2A355-862C-4657-B296-5776ED8447B0	TCGA-67-6215-01A-11D-1753-08	HG19_Broad_variant	TCGA-67-6215	TCGA-LUAD	NA	s10633	Broad Institute of MIT and Harvard	St Joseph's Medical Center (MD)	United States	NO	T2a	N0	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage IB	1753-08	TRUE
13722.58cfa82ee4b0c9d6adf6ab99	58cfa82ee4b0c9d6adf6ab99	G26397.TCGA-19-5960-01A-11D-1696-08.2.filtered.	WGS	G26397.TCGA-19-5960-01A-11D-1696-08.2	G26397.TCGA-19-5960-01A-11D-1696-08.2.bam	513.03	1.9	0.05	58cfa82ee4b0c9d6adf6ab99	G26397.TCGA-19-5960-01A-11D-1696-08.2.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Glioblastoma Multiforme	Aligned reads	TCGA-19-5960-01A	93ED7A2B-B0CB-4A84-871F-5C34A0B6A640	Primary Tumor	Illumina HiSeq	264b0e2f-a66b-477b-90af-7dd319a8d4b8	Brain	56	86C6A232-F5AB-47CD-B91B-4CAD6AA1D0F1	B8151614-B08F-49A3-AB6F-2E780F765A17	TCGA-19-5960-01A-11D-1696-08	HG19_Broad_variant	TCGA-19-5960	TCGA-GBM	NA	s14347	Broad Institute of MIT and Harvard	Case Western	None	NO	Not available	Not available	Untreated primary (de novo) GBM	Not available	1696-08	FALSE
13722.58cfa82ee4b0c9d6adf6ab8a	58cfa82ee4b0c9d6adf6ab8a	G26372.TCGA-26-5132-01A-01D-1486-08.2.filtered.	WGS	G26372.TCGA-26-5132-01A-01D-1486-08.2	G26372.TCGA-26-5132-01A-01D-1486-08.2.bam	568.73	1.9	0.05	58cfa82ee4b0c9d6adf6ab8a	G26372.TCGA-26-5132-01A-01D-1486-08.2.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Glioblastoma Multiforme	Aligned reads	TCGA-26-5132-01A	2C5FA2D4-8E35-42E4-8BCA-9FB3371A19C8	Primary Tumor	Illumina HiSeq	68345c45-66a1-48a6-a6a5-ed29b8525b04	Brain	74	AC7EA2F0-A526-4B9A-8E81-2736EA38F53B	D1132127-1250-43AF-9C16-425798A3D1A7	TCGA-26-5132-01A-01D-1486-08	HG19_Broad_variant	TCGA-26-5132	TCGA-GBM	NA	s13890	Broad Institute of MIT and Harvard	University of Florida	None	NO	Not available	Not available	Untreated primary (de novo) GBM	Not available	1486-08	FALSE
13722.58cfa82ee4b0c9d6adf6abb0	58cfa82ee4b0c9d6adf6abb0	G26366.TCGA-06-0686-01A-01D-1492-08.2.filtered.	WGS	G26366.TCGA-06-0686-01A-01D-1492-08.2	G26366.TCGA-06-0686-01A-01D-1492-08.2.bam	420.57	1.91	0.05	58cfa82ee4b0c9d6adf6abb0	G26366.TCGA-06-0686-01A-01D-1492-08.2.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Glioblastoma Multiforme	Aligned reads	TCGA-06-0686-01A	C931F3BD-74C5-4EBD-BC0F-C7C6BECD25AB	Primary Tumor	Illumina HiSeq	4d80b67a-08f2-45cf-84b2-9aabce938c2f	Brain	53	7AF6D7A5-B550-42D9-983A-241EC76FD7F4	2C71D542-1653-4D97-8752-F2FD05C7E75D	TCGA-06-0686-01A-01D-1492-08	HG19_Broad_variant	TCGA-06-0686	TCGA-GBM	NA	s14344	Broad Institute of MIT and Harvard	Henry Ford Hospital	None	NO	Not available	Not available	Untreated primary (de novo) GBM	Not available	1492-08	FALSE
13722.58cfa82ee4b0c9d6adf6abc4	58cfa82ee4b0c9d6adf6abc4	G37566.TCGA-EJ-5506-01A-01D-1576-08.1.filtered.	WGS	G37566.TCGA-EJ-5506-01A-01D-1576-08.1	G37566.TCGA-EJ-5506-01A-01D-1576-08.1.bam	238.7	1.9	0.05	58cfa82ee4b0c9d6adf6abc4	G37566.TCGA-EJ-5506-01A-01D-1576-08.1.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-EJ-5506-01A	E5E4D3B6-8E58-4DCF-8F67-A00E656A8E27	Primary Tumor	Illumina HiSeq	b7db243f-ae86-4f3d-b5f1-38ba6363bd78	Prostate	67	9EBDA113-B0FC-4233-87AC-DAD0E7D033DE	9F5E6063-D19E-4F56-B3F9-5C2260D3BFC9	TCGA-EJ-5506-01A-01D-1576-08	HG19_Broad_variant	TCGA-EJ-5506	TCGA-PRAD	NA	s3757	Broad Institute of MIT and Harvard	University of Pittsburgh	United States	NO	T3b	N1	Prostate Adenocarcinoma Acinar Type	Not available	1576-08	TRUE
13722.58cfa82ee4b0c9d6adf6ac20	58cfa82ee4b0c9d6adf6ac20	G37566.TCGA-CH-5789-01A-11D-1576-08.1.filtered.	WGS	G37566.TCGA-CH-5789-01A-11D-1576-08.1	G37566.TCGA-CH-5789-01A-11D-1576-08.1.bam	148.7	1.9	0.05	58cfa82ee4b0c9d6adf6ac20	G37566.TCGA-CH-5789-01A-11D-1576-08.1.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-CH-5789-01A	BE5411DC-3CAA-4B25-9B94-CE463E8E52B4	Primary Tumor	Illumina HiSeq	93287c07-09e0-4643-b170-08b49803c218	Prostate	61	3C42EB4B-DB63-4F81-8D28-A439E932C716	B68C5EC2-0875-4D77-B4B7-738D2B2F313C	TCGA-CH-5789-01A-11D-1576-08	HG19_Broad_variant	TCGA-CH-5789	TCGA-PRAD	NA	s3761	Broad Institute of MIT and Harvard	Indivumed	Germany	NO	T3a	N0	Prostate Adenocarcinoma Acinar Type	Not available	1576-08	TRUE
13722.58cfa82ee4b0c9d6adf6ac1c	58cfa82ee4b0c9d6adf6ac1c	G37566.TCGA-HC-7079-01A-11D-1961-08.2.filtered.	WGS	G37566.TCGA-HC-7079-01A-11D-1961-08.2	G37566.TCGA-HC-7079-01A-11D-1961-08.2.bam	133	NA	0.05	58cfa82ee4b0c9d6adf6ac1c	G37566.TCGA-HC-7079-01A-11D-1961-08.2.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-HC-7079-01A	10FBE481-F111-4F88-AE45-4D67CB265567	Primary Tumor	Illumina HiSeq	75a8bf78-150a-4c1f-99fa-41db038cf5a5	Prostate	51	190EF71A-5B5D-4009-B707-68F10147CB65	7F1CA00A-84BA-4B26-A1A5-4D83C363AC69	TCGA-HC-7079-01A-11D-1961-08	HG19_Broad_variant	TCGA-HC-7079	TCGA-PRAD	NA	s3924	Broad Institute of MIT and Harvard	International Genomics Consortium	United States	NO	T3a	N0	Prostate Adenocarcinoma Acinar Type	Not available	1961-08	FALSE
13722.58cfa82ee4b0c9d6adf6ac1e	58cfa82ee4b0c9d6adf6ac1e	G37566.TCGA-G9-7522-01A-11D-2260-08.1.filtered.	WGS	G37566.TCGA-G9-7522-01A-11D-2260-08.1	G37566.TCGA-G9-7522-01A-11D-2260-08.1.bam	146.7	NA	0.05	58cfa82ee4b0c9d6adf6ac1e	G37566.TCGA-G9-7522-01A-11D-2260-08.1.bam	Alive	MALE	Not available	Not available	Prostate Adenocarcinoma	Aligned reads	TCGA-G9-7522-01A	87959988-BB25-47EE-AFC1-9AF92592BBE7	Primary Tumor	Illumina HiSeq	07b2c012-7fce-49d8-a6b8-6d5eb4907508	Prostate	49	10BFE256-C4A2-4D88-B907-56F86EF63DE9	F54442D1-80FA-4678-AC94-C3AD03BC37FB	TCGA-G9-7522-01A-11D-2260-08	HG19_Broad_variant	TCGA-G9-7522	TCGA-PRAD	NA	s3923	Broad Institute of MIT and Harvard	Roswell Park	United States	NO	T2c	N0	Prostate Adenocarcinoma Acinar Type	Not available	2260-08	FALSE
13722.58cfa82ee4b0c9d6adf6ac27	58cfa82ee4b0c9d6adf6ac27	G37566.TCGA-HC-7737-01A-11D-2114-08.3.filtered.	WGS	G37566.TCGA-HC-7737-01A-11D-2114-08.3	G37566.TCGA-HC-7737-01A-11D-2114-08.3.bam	205.3	NA	0.05	58cfa82ee4b0c9d6adf6ac27	G37566.TCGA-HC-7737-01A-11D-2114-08.3.bam	Alive	MALE	BLACK OR AFRICAN AMERICAN	Not available	Prostate Adenocarcinoma	Aligned reads	TCGA-HC-7737-01A	73F875CB-BCFC-43BA-AB97-4E94CAF836D4	Primary Tumor	Illumina HiSeq	855b7ac8-18b6-4ec4-9471-8d12a802bf46	Prostate	55	47B6E89A-EA86-475A-9F1D-02001069C895	DCF98ACC-736B-4AF6-BDCA-A320A413165A	TCGA-HC-7737-01A-11D-2114-08	HG19_Broad_variant	TCGA-HC-7737	TCGA-PRAD	NA	s3407	Broad Institute of MIT and Harvard	International Genomics Consortium	United States	NO	T2c	N1	Prostate Adenocarcinoma Acinar Type	Not available	2114-08	FALSE
13722.58cfa82ee4b0c9d6adf6ac9a	58cfa82ee4b0c9d6adf6ac9a	G41960.TCGA-91-6847-01A-11D-1945-08.1.filtered.	WGS	G41960.TCGA-91-6847-01A-11D-1945-08.1	G41960.TCGA-91-6847-01A-11D-1945-08.1.bam	528.7	1.9	0.05	58cfa82ee4b0c9d6adf6ac9a	G41960.TCGA-91-6847-01A-11D-1945-08.1.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-91-6847-01A	97831D28-AB41-4C18-BFC2-C4C6BC757D13	Primary Tumor	Illumina HiSeq	7d8d3882-a579-44c1-b63d-eabff64671d1	Lung	62	96A05D4B-3731-4B98-B38F-A6B33CD6ED96	020FAB36-C7DE-4933-B2BF-DC7B019A1326	TCGA-91-6847-01A-11D-1945-08	HG19_Broad_variant	TCGA-91-6847	TCGA-LUAD	NA	s10635	Broad Institute of MIT and Harvard	ABS - IUPUI	United States	NO	T2	N0	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage IB	1945-08	TRUE
13722.58cfa82ee4b0c9d6adf6ac88	58cfa82ee4b0c9d6adf6ac88	G47088.TCGA-34-5240-01A-01D-1441-08.1.filtered.	WGS	G47088.TCGA-34-5240-01A-01D-1441-08.1	G47088.TCGA-34-5240-01A-01D-1441-08.1.bam	715.7	1.9	0.05	58cfa82ee4b0c9d6adf6ac88	G47088.TCGA-34-5240-01A-01D-1441-08.1.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-34-5240-01A	E7D1B042-5B1C-4C29-B501-A5EF4810ECD2	Primary Tumor	Illumina HiSeq	8c136698-e283-46dc-83d9-44916f08fe6b	Lung	73	49395D22-CD07-4AB7-BDF3-CFA56687BA43	4C3840DF-9824-40DB-879E-6D24ADC8C155	TCGA-34-5240-01A-01D-1441-08	HG19_Broad_variant	TCGA-34-5240	TCGA-LUSC	NA	s10361	Broad Institute of MIT and Harvard	University of Pittsburgh	United States	NO	T2	N1	Lung Basaloid Squamous Cell Carcinoma	Stage IIB	1441-08	FALSE
13722.58cfa82ee4b0c9d6adf6acac	58cfa82ee4b0c9d6adf6acac	G37566.TCGA-HC-7740-01A-11D-2114-08.2.filtered.	WGS	G37566.TCGA-HC-7740-01A-11D-2114-08.2	G37566.TCGA-HC-7740-01A-11D-2114-08.2.bam	31.3	NA	0.05	58cfa82ee4b0c9d6adf6acac	G37566.TCGA-HC-7740-01A-11D-2114-08.2.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-HC-7740-01A	91E249A6-B0B0-487E-9FAD-0E9F5798DCAE	Primary Tumor	Illumina HiSeq	dd2df8bb-8035-4f08-b3d4-d9ee910fd0ea	Prostate	59	54D1CF0E-5D54-486C-A863-733B5EDC5986	7303F9FE-88BB-48BA-B9B4-EBF9E4770C1C	TCGA-HC-7740-01A-11D-2114-08	HG19_Broad_variant	TCGA-HC-7740	TCGA-PRAD	NA	s3762	Broad Institute of MIT and Harvard	International Genomics Consortium	United States	NO	T2c	N0	Prostate Adenocarcinoma Acinar Type	Not available	2114-08	FALSE
13722.58cfa82ee4b0c9d6adf6accb	58cfa82ee4b0c9d6adf6accb	G39020.TCGA-D7-6815-01A-11D-1882-08.1.filtered.	WGS	G39020.TCGA-D7-6815-01A-11D-1882-08.1	G39020.TCGA-D7-6815-01A-11D-1882-08.1.bam	457	1.9	0.05	58cfa82ee4b0c9d6adf6accb	G39020.TCGA-D7-6815-01A-11D-1882-08.1.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-D7-6815-01A	53086E20-A727-40D6-B42D-8030109B5130	Primary Tumor	Illumina HiSeq	6265f1bc-c42b-4073-b83d-4f13fbe9da6c	Stomach	70	B5F3D9A1-46B5-4A63-8F7D-9C993FE9340D	9536F736-63BC-4099-BD54-740F5910F4A8	TCGA-D7-6815-01A-11D-1882-08	HG19_Broad_variant	TCGA-D7-6815	TCGA-STAD	NA	s14682	Broad Institute of MIT and Harvard	Greater Poland Cancer Center	Poland	NO	T2	N2	Stomach  Intestinal Adenocarcinoma  Tubular Type	Stage IIB	1882-08	FALSE
13722.58cfa82ee4b0c9d6adf6acd3	58cfa82ee4b0c9d6adf6acd3	G39020.TCGA-D7-6528-01A-11D-1800-08.2.filtered.	WGS	G39020.TCGA-D7-6528-01A-11D-1800-08.2	G39020.TCGA-D7-6528-01A-11D-1800-08.2.bam	303.4	1.9	0.05	58cfa82ee4b0c9d6adf6acd3	G39020.TCGA-D7-6528-01A-11D-1800-08.2.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-D7-6528-01A	35496E4E-598F-4FFC-B11E-8EDAEB676079	Primary Tumor	Illumina HiSeq	afbd806d-5a24-4b55-ba74-c8fef8aba22c	Stomach	70	DF817250-9A2C-42E8-AD90-0D9E13FE37B3	153A64EE-6322-4F2E-B3DF-77EF7D3A4CF0	TCGA-D7-6528-01A-11D-1800-08	HG19_Broad_variant	TCGA-D7-6528	TCGA-STAD	NA	s15232	Broad Institute of MIT and Harvard	Greater Poland Cancer Center	Poland	NO	T2	N0	Stomach  Intestinal Adenocarcinoma  Tubular Type	Stage IB	1800-08	TRUE
13722.58cfa82ee4b0c9d6adf6acdb	58cfa82ee4b0c9d6adf6acdb	G39020.TCGA-D7-6519-01A-11D-1800-08.2.filtered.	WGS	G39020.TCGA-D7-6519-01A-11D-1800-08.2	G39020.TCGA-D7-6519-01A-11D-1800-08.2.bam	266.4	1.9	0.05	58cfa82ee4b0c9d6adf6acdb	G39020.TCGA-D7-6519-01A-11D-1800-08.2.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-D7-6519-01A	E37CAE9E-0656-4B89-B326-739A5CC859E0	Primary Tumor	Illumina HiSeq	8f8b5fc2-7fb8-4a30-968b-375bf038514e	Stomach	64	FA7426E1-FCFB-4B08-AD50-1D9E903A81FB	A2E67393-50D7-4BCC-9BBD-C695086A936A	TCGA-D7-6519-01A-11D-1800-08	HG19_Broad_variant	TCGA-D7-6519	TCGA-STAD	NA	s14683	Broad Institute of MIT and Harvard	Greater Poland Cancer Center	Poland	NO	T2	N1	Stomach  Adenocarcinoma  Diffuse Type	Stage IIIB	1800-08	TRUE
13722.58cfa82ee4b0c9d6adf6ad0e	58cfa82ee4b0c9d6adf6ad0e	G37568.TCGA-DK-A1AE-01A-11D-A13W-08.2.filtered.	WGS	G37568.TCGA-DK-A1AE-01A-11D-A13W-08.2	G37568.TCGA-DK-A1AE-01A-11D-A13W-08.2.bam	76.27	1.91	0.08	58cfa82ee4b0c9d6adf6ad0e	G37568.TCGA-DK-A1AE-01A-11D-A13W-08.2.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-DK-A1AE-01A	493A4FF2-37A5-4B79-928D-83DBFE534556	Primary Tumor	Illumina HiSeq	2722f260-d3b4-4088-860d-7a5070921255	Bladder	84	67865453-D515-4D63-84E8-CFB2686A211D	ABD2D959-D5ED-4EB3-9759-67EB1AA23325	TCGA-DK-A1AE-01A-11D-A13W-08	HG19_Broad_variant	TCGA-DK-A1AE	TCGA-BLCA	NA	s2688	Broad Institute of MIT and Harvard	Memorial Sloan Kettering	United States	NO	T3	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage III	A13W-08	TRUE
13722.58cfa82ee4b0c9d6adf6ad66	58cfa82ee4b0c9d6adf6ad66	G35154.TCGA-HT-A5R7-01A-11D-A461-08.2.filtered.	WGS	G35154.TCGA-HT-A5R7-01A-11D-A461-08.2	G35154.TCGA-HT-A5R7-01A-11D-A461-08.2.bam	17.75	NA	0.08	58cfa82ee4b0c9d6adf6ad66	G35154.TCGA-HT-A5R7-01A-11D-A461-08.2.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-HT-A5R7-01A	7E41BABA-7EF6-4030-B595-D95CD96336B5	Primary Tumor	Illumina HiSeq	c239bee2-d22d-4390-be44-ed4be0395f57	Brain	33	7BA53D9A-FE20-487A-B4BB-84451E207755	C71F8C39-653F-42F2-AD3E-439CF86A0738	TCGA-HT-A5R7-01A-11D-A461-08	HG19_Broad_variant	TCGA-HT-A5R7	TCGA-LGG	NA	s8119	Broad Institute of MIT and Harvard	Case Western - St Joes	United States	NO	Not available	Not available	Astrocytoma	Not available	A461-08	TRUE
13722.58cfa82ee4b0c9d6adf6ad7c	58cfa82ee4b0c9d6adf6ad7c	G26401.TCGA-15-1444-01A-02D-1696-08.1.filtered.	WGS	G26401.TCGA-15-1444-01A-02D-1696-08.1	G26401.TCGA-15-1444-01A-02D-1696-08.1.bam	294.03	1.9	0.05	58cfa82ee4b0c9d6adf6ad7c	G26401.TCGA-15-1444-01A-02D-1696-08.1.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Glioblastoma Multiforme	Aligned reads	TCGA-15-1444-01A	4C42DC4E-66B7-40BF-9FBE-B92543248198	Primary Tumor	Illumina HiSeq	15eb38d5-3d01-48d9-bea4-3b6868b9dee9	Brain	21	07DA260D-EF04-4A23-BDAD-5CEB98A673CA	CBD4D4E7-F1C4-446C-8DBC-CE06C872EC14	TCGA-15-1444-01A-02D-1696-08	HG19_Broad_variant	TCGA-15-1444	TCGA-GBM	1537	s14141	Broad Institute of MIT and Harvard	Mayo Clinic - Rochester	None	NO	Not available	Not available	Glioblastoma Multiforme (GBM)	Not available	1696-08	FALSE
13722.58cfa82ee4b0c9d6adf6ac7c	58cfa82ee4b0c9d6adf6ac7c	G41960.TCGA-50-6591-01A-11D-1753-08.3.filtered.	WGS	G41960.TCGA-50-6591-01A-11D-1753-08.3	G41960.TCGA-50-6591-01A-11D-1753-08.3.bam	351.4	1.8	0.05	58cfa82ee4b0c9d6adf6ac7c	G41960.TCGA-50-6591-01A-11D-1753-08.3.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-50-6591-01A	9B132E4F-7E35-4CC5-8711-43AD62B906D0	Primary Tumor	Illumina HiSeq	3d4858b4-9af4-47f2-84d2-6618c7a21581	Lung	63	0791E7AA-E97C-4DD0-9615-09EC7090F684	BF7462A2-394F-4838-BCB6-4D0126FA48B1	TCGA-50-6591-01A-11D-1753-08	HG19_Broad_variant	TCGA-50-6591	TCGA-LUAD	119	s10637	Broad Institute of MIT and Harvard	University of Pittsburgh	United States	NO	T2	N0	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage IV	1753-08	TRUE
13722.58cfa82ee4b0c9d6adf6af6a	58cfa82ee4b0c9d6adf6af6a	G41960.TCGA-55-6972-01A-11D-1945-08.1.filtered.	WGS	G41960.TCGA-55-6972-01A-11D-1945-08.1	G41960.TCGA-55-6972-01A-11D-1945-08.1.bam	520.7	NA	0.05	58cfa82ee4b0c9d6adf6af6a	G41960.TCGA-55-6972-01A-11D-1945-08.1.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-55-6972-01A	C4D1E105-28B7-48DF-ABEF-FBE09782FDB2	Primary Tumor	Illumina HiSeq	30f0b521-90e2-41a2-9dcc-97b6702a46fc	Lung	72	38C83B40-FBA4-48D4-AD6E-93768CB6139F	46693A2B-5105-4770-A9E1-031DFEDEB694	TCGA-55-6972-01A-11D-1945-08	HG19_Broad_variant	TCGA-55-6972	TCGA-LUAD	NA	s11113	Broad Institute of MIT and Harvard	International Genomics Consortium	United States	NO	T2	N0	Lung Papillary Adenocarcinoma	Stage IB	1945-08	TRUE
13722.58cfa82ee4b0c9d6adf6b0c4	58cfa82ee4b0c9d6adf6b0c4	G8891.TCGA-66-2756-01A-01D-1180-08.1.filtered.	WGS	G8891.TCGA-66-2756-01A-01D-1180-08.1	G8891.TCGA-66-2756-01A-01D-1180-08.1.bam	184.3	1.9	0.15	58cfa82ee4b0c9d6adf6b0c4	G8891.TCGA-66-2756-01A-01D-1180-08.1.bam	Alive	MALE	Not available	Not available	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-66-2756-01A	43ABE847-4BA7-466E-8283-5D7B80B999A7	Primary Tumor	Illumina HiSeq	2cc59bf0-d2ce-42b3-a587-574633628139	Lung	68	D80486CD-F054-4527-A886-CF9446381B9F	25224AA0-CFDD-48EC-92E5-8F3992A3E574	TCGA-66-2756-01A-01D-1180-08	HG19_Broad_variant	TCGA-66-2756	TCGA-LUSC	NA	s10261	Broad Institute of MIT and Harvard	Indivumed	Germany	NO	T4	N0	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage IIIB	1180-08	FALSE
13722.58cfa82ee4b0c9d6adf6af76	58cfa82ee4b0c9d6adf6af76	G41960.TCGA-50-5930-01A-11D-1753-08.3.filtered.	WGS	G41960.TCGA-50-5930-01A-11D-1753-08.3	G41960.TCGA-50-5930-01A-11D-1753-08.3.bam	181.4	2	0.05	58cfa82ee4b0c9d6adf6af76	G41960.TCGA-50-5930-01A-11D-1753-08.3.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-50-5930-01A	368E23F0-E573-4547-BF5A-14080BAF737B	Primary Tumor	Illumina HiSeq	7ef1f666-79cc-4c94-90b9-49c32631ba72	Lung	47	3E30DBD1-10BF-4450-8D19-6F44D3284E02	BD3E88B3-B37C-4641-85FA-D8125BA324CA	TCGA-50-5930-01A-11D-1753-08	HG19_Broad_variant	TCGA-50-5930	TCGA-LUAD	282	s10638	Broad Institute of MIT and Harvard	University of Pittsburgh	United States	NO	T2	N2	Lung Adenocarcinoma Mixed Subtype	Stage IIIA	1753-08	TRUE
13722.58cfa82fe4b0c9d6adf6b8a5	58cfa82fe4b0c9d6adf6b8a5	TCGA-A6-2683-01A-01D-1554-10_wgs_Illumina.filtered.	WGS	TCGA-A6-2683-01A-01D-1554-10_wgs_Illumina	TCGA-A6-2683-01A-01D-1554-10_wgs_Illumina.bam	467.29	1.9	0.05	58cfa82fe4b0c9d6adf6b8a5	TCGA-A6-2683-01A-01D-1554-10_wgs_Illumina.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Colon Adenocarcinoma	Aligned reads	TCGA-A6-2683-01A	FAFD4576-0709-49E1-926F-AD1EE09907EC	Primary Tumor	Illumina HiSeq	9e91b702-c4fb-4c6e-9060-987e5ff14421	Colorectal	57	C24759F8-566B-42DA-A26D-BB0BF51EE15F	FC453F67-6623-4E8C-B519-0BD79E4D4651	TCGA-A6-2683-01A-01D-1554-10	GRCh37-lite	TCGA-A6-2683	TCGA-COAD	NA	s13015	Baylor College of Medicine	Christiana Healthcare	None	NO	T4	N0	Colon Adenocarcinoma	Stage IV	1554-10	FALSE
13722.58cfa82fe4b0c9d6adf6ba06	58cfa82fe4b0c9d6adf6ba06	TCGA-AA-3956-01A-02D-1981-10_wgs_Illumina.filtered.	WGS	TCGA-AA-3956-01A-02D-1981-10_wgs_Illumina	TCGA-AA-3956-01A-02D-1981-10_wgs_Illumina.bam	282.86	1.9	0.14	58cfa82fe4b0c9d6adf6ba06	TCGA-AA-3956-01A-02D-1981-10_wgs_Illumina.bam	Alive	MALE	Not available	Not available	Colon Adenocarcinoma	Aligned reads	TCGA-AA-3956-01A	7B47489F-C3CC-4388-B5D7-C7C02790A5F6	Primary Tumor	Illumina HiSeq	72141594-ac11-437d-896e-d1ae66162764	Colorectal	65	DC1FFDA5-5B8F-4227-BE04-321643F73731	3C019B2F-52EC-40A8-99B5-98C1423CE627	TCGA-AA-3956-01A-02D-1981-10	GRCh37-lite	TCGA-AA-3956	TCGA-COAD	NA	s12870	Baylor College of Medicine	Indivumed	Germany	NO	T3	N0	Colon Adenocarcinoma	Stage IIA	1981-10	FALSE
13722.58cfa82fe4b0c9d6adf6b8c8	58cfa82fe4b0c9d6adf6b8c8	TCGA-A6-2681-01A-01D-1554-10_wgs_Illumina.filtered.	WGS	TCGA-A6-2681-01A-01D-1554-10_wgs_Illumina	TCGA-A6-2681-01A-01D-1554-10_wgs_Illumina.bam	308	1.9	0.05	58cfa82fe4b0c9d6adf6b8c8	TCGA-A6-2681-01A-01D-1554-10_wgs_Illumina.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Colon Adenocarcinoma	Aligned reads	TCGA-A6-2681-01A	7D8EAB0A-E6C8-4449-9EBF-50C41DB94A06	Primary Tumor	Illumina HiSeq	11d59d80-a10a-4e78-b8a8-64a9569a9e32	Colorectal	73	0537BAD8-0E85-4B05-91B3-FD965E96D0D7	D3DAF373-1485-455E-A0A1-8E33D215D623	TCGA-A6-2681-01A-01D-1554-10	GRCh37-lite	TCGA-A6-2681	TCGA-COAD	NA	s13650	Baylor College of Medicine	Christiana Healthcare	United States	NO	T3	N0	Colon Adenocarcinoma	Stage IIA	1554-10	FALSE
13722.58cfa830e4b0c9d6adf6ba4a	58cfa830e4b0c9d6adf6ba4a	TCGA-A6-3807-01A-01D-1459-10_wgs_Illumina.filtered.	WGS	TCGA-A6-3807-01A-01D-1459-10_wgs_Illumina	TCGA-A6-3807-01A-01D-1459-10_wgs_Illumina.bam	380	1.9	0.05	58cfa830e4b0c9d6adf6ba4a	TCGA-A6-3807-01A-01D-1459-10_wgs_Illumina.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Colon Adenocarcinoma	Aligned reads	TCGA-A6-3807-01A	5116E3B4-2BAC-40F5-8046-B9C1783FAAA5	Primary Tumor	Illumina HiSeq	b5897ed2-6c9b-4c6e-b131-41b62e60ecb9	Colorectal	53	1EB2A255-6EDD-4ADB-B52D-99DCEC590C5D	F38B5D2E-5CAB-45C7-BB0A-38B2EFC5C156	TCGA-A6-3807-01A-01D-1459-10	GRCh37-lite	TCGA-A6-3807	TCGA-COAD	NA	s13652	Baylor College of Medicine	Christiana Healthcare	None	NO	T3	N2	Colon Adenocarcinoma	Stage IIIC	1459-10	FALSE
13722.58cfa830e4b0c9d6adf6baa2	58cfa830e4b0c9d6adf6baa2	TCGA-AA-3514-01A-02D-1554-10_wgs_Illumina.filtered.	WGS	TCGA-AA-3514-01A-02D-1554-10_wgs_Illumina	TCGA-AA-3514-01A-02D-1554-10_wgs_Illumina.bam	263.29	1.9	0.05	58cfa830e4b0c9d6adf6baa2	TCGA-AA-3514-01A-02D-1554-10_wgs_Illumina.bam	Alive	FEMALE	Not available	Not available	Colon Adenocarcinoma	Aligned reads	TCGA-AA-3514-01A	DDF69ED9-4C53-48B8-9F01-495BD60C3425	Primary Tumor	Illumina HiSeq	2c81df5f-0948-463a-a303-3beb5bd5205b	Colorectal	81	A657AFDB-5322-454F-8DD7-8397291401C5	A0F94565-9169-49EE-8E6A-21BDC43D9DE6	TCGA-AA-3514-01A-02D-1554-10	GRCh37-lite	TCGA-AA-3514	TCGA-COAD	NA	s13667	Baylor College of Medicine	Indivumed	Germany	NO	T2	N0	Colon Adenocarcinoma	Stage I	1554-10	FALSE
13722.58cfa830e4b0c9d6adf6bc11	58cfa830e4b0c9d6adf6bc11	TCGA-AG-3727-01A-01D-1989-10_wgs_Illumina.filtered.	WGS	TCGA-AG-3727-01A-01D-1989-10_wgs_Illumina	TCGA-AG-3727-01A-01D-1989-10_wgs_Illumina.bam	489.31	1.9	0.15	58cfa830e4b0c9d6adf6bc11	TCGA-AG-3727-01A-01D-1989-10_wgs_Illumina.bam	Alive	FEMALE	Not available	Not available	Rectum Adenocarcinoma	Aligned reads	TCGA-AG-3727-01A	E6827400-0D95-46B0-8874-6CE9E9D5011B	Primary Tumor	Illumina HiSeq	70d6fce9-139d-448e-8f5f-14b10832d66b	Colorectal	78	DA1CA84F-6C55-4536-9449-3C87E51EF85A	786FC3E4-E2BF-4914-9251-41C800EBB2FA	TCGA-AG-3727-01A-01D-1989-10	GRCh37-lite	TCGA-AG-3727	TCGA-READ	NA	s2142	Baylor College of Medicine	Indivumed	Germany	NO	T3	N1	Rectal Adenocarcinoma	Stage III	1989-10	TRUE
13722.58cfa830e4b0c9d6adf6bc84	58cfa830e4b0c9d6adf6bc84	TCGA-AG-A032-01A-01D-A183-10_wgs_Illumina.filtered.	WGS	TCGA-AG-A032-01A-01D-A183-10_wgs_Illumina	TCGA-AG-A032-01A-01D-A183-10_wgs_Illumina.bam	237.12	1.85	0.08	58cfa830e4b0c9d6adf6bc84	TCGA-AG-A032-01A-01D-A183-10_wgs_Illumina.bam	Alive	MALE	Not available	Not available	Rectum Adenocarcinoma	Aligned reads	TCGA-AG-A032-01A	0BB786EE-07CF-4853-9B49-EC95CD14E282	Primary Tumor	Illumina HiSeq	3d3bf209-70e8-4882-99c7-6e20c03cccea	Colorectal	68	AE3C8931-C06F-466A-B6BF-440007E13387	CD3D7559-B583-4474-81DF-4BF9232DE3C2	TCGA-AG-A032-01A-01D-A183-10	GRCh37-lite	TCGA-AG-A032	TCGA-READ	NA	s2170	Baylor College of Medicine	Indivumed	Germany	NO	T3	N1	Rectal Adenocarcinoma	Stage IIIB	A183-10	TRUE
13722.58cfa830e4b0c9d6adf6bb4c	58cfa830e4b0c9d6adf6bb4c	TCGA-AA-A01T-01A-21D-A17O-10_wgs_Illumina.filtered.	WGS	TCGA-AA-A01T-01A-21D-A17O-10_wgs_Illumina	TCGA-AA-A01T-01A-21D-A17O-10_wgs_Illumina.bam	80.04	2.03	0.07	58cfa830e4b0c9d6adf6bb4c	TCGA-AA-A01T-01A-21D-A17O-10_wgs_Illumina.bam	Alive	FEMALE	Not available	Not available	Colon Adenocarcinoma	Aligned reads	TCGA-AA-A01T-01A	F87C6DCC-1A9E-4DF5-962C-1F946E2611F8	Primary Tumor	Illumina HiSeq	abefb6f0-6456-48a1-b9d2-3789849aaea6	Colorectal	63	BFC99C6D-7791-4037-9C74-A74BE68E616A	75AD15B9-8F9C-40C1-9CA6-1E8454FBD310	TCGA-AA-A01T-01A-21D-A17O-10	GRCh37-lite	TCGA-AA-A01T	TCGA-COAD	NA	s13681	Baylor College of Medicine	Indivumed	Germany	NO	T3	N1	Colon Adenocarcinoma	Stage III	A17O-10	TRUE
13722.58cfa830e4b0c9d6adf6bb72	58cfa830e4b0c9d6adf6bb72	TCGA-AA-A01V-01A-23D-A17O-10_wgs_Illumina.filtered.	WGS	TCGA-AA-A01V-01A-23D-A17O-10_wgs_Illumina	TCGA-AA-A01V-01A-23D-A17O-10_wgs_Illumina.bam	86.94	2	0.08	58cfa830e4b0c9d6adf6bb72	TCGA-AA-A01V-01A-23D-A17O-10_wgs_Illumina.bam	Alive	MALE	Not available	Not available	Colon Adenocarcinoma	Aligned reads	TCGA-AA-A01V-01A	0CB0DAC8-4CE2-444A-B1AE-1550E065B4D9	Primary Tumor	Illumina HiSeq	12678e03-e8e4-4074-91b0-68bb57767c2d	Colorectal	59	8816F14D-9FBB-4033-9CA4-6CA0DB66161A	31F02F48-44A4-445E-AC3D-E9BF3D8D25A2	TCGA-AA-A01V-01A-23D-A17O-10	GRCh37-lite	TCGA-AA-A01V	TCGA-COAD	NA	s13379	Baylor College of Medicine	Indivumed	Germany	NO	T2	N0	Colon Adenocarcinoma	Stage I	A17O-10	TRUE
13722.58cfa830e4b0c9d6adf6bbdd	58cfa830e4b0c9d6adf6bbdd	TCGA-AG-4015-01A-01D-1989-10_wgs_Illumina.filtered.	WGS	TCGA-AG-4015-01A-01D-1989-10_wgs_Illumina	TCGA-AG-4015-01A-01D-1989-10_wgs_Illumina.bam	610.89	1.9	0.14	58cfa830e4b0c9d6adf6bbdd	TCGA-AG-4015-01A-01D-1989-10_wgs_Illumina.bam	Alive	FEMALE	Not available	Not available	Rectum Adenocarcinoma	Aligned reads	TCGA-AG-4015-01A	1388BBA1-02BA-40DF-93E5-C3D58B7BBAE0	Primary Tumor	Illumina HiSeq	ba539625-e278-4166-9667-ec8f68d0b5a0	Colorectal	85	3C910093-DF83-485B-86EF-26A0991D9A0B	AA06AE46-2336-4666-A3AF-FC790DAF8DA4	TCGA-AG-4015-01A-01D-1989-10	GRCh37-lite	TCGA-AG-4015	TCGA-READ	NA	s2169	Baylor College of Medicine	Indivumed	Germany	NO	T3	N0	Rectal Adenocarcinoma	Stage IIA	1989-10	TRUE
13722.58cfa82de4b0c9d6adf6a4d6	58cfa82de4b0c9d6adf6a4d6	4042a719096f3096b3cbb539a45e6492.filtered.	WGS	4042a719096f3096b3cbb539a45e6492	4042a719096f3096b3cbb539a45e6492.bam	47.52	2	0.07	58cfa82de4b0c9d6adf6a4d6	4042a719096f3096b3cbb539a45e6492.bam	Alive	FEMALE	Not available	HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-AO-A0JM-01A	44BEC761-B603-49C0-8634-F6BFE0319BB1	Primary Tumor	Illumina HiSeq	456682bf-18d1-4383-96ba-6e06fe7dd669	Breast	40	7EC2C455-D90F-4CD5-9BBB-AEDBF21ECA00	AACABA97-ECDE-440B-AAE0-0E9C608C4B24	TCGA-AO-A0JM-01A-21D-A19H-09	GRCh37-lite	TCGA-AO-A0JM	TCGA-BRCA	NA	s5628	Washington University School of Medicine	MSKCC	None	NO	T2	N1	Infiltrating Ductal Carcinoma	Stage IIB	A19H-09	TRUE
13722.58cfa830e4b0c9d6adf6be46	58cfa830e4b0c9d6adf6be46	TCGA-AF-2691-01A-01D-1989-10_wgs_Illumina.filtered.	WGS	TCGA-AF-2691-01A-01D-1989-10_wgs_Illumina	TCGA-AF-2691-01A-01D-1989-10_wgs_Illumina.bam	406.94	1.9	0.15	58cfa830e4b0c9d6adf6be46	TCGA-AF-2691-01A-01D-1989-10_wgs_Illumina.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Rectum Adenocarcinoma	Aligned reads	TCGA-AF-2691-01A	830FD359-ABD4-4C99-89E4-2D6BB9CE5637	Primary Tumor	Illumina HiSeq	51fe9202-95ee-418b-a143-fe84f4b20380	Colorectal	48	CE252C3D-5CF3-46BC-A181-3714D1C65E4E	81B1E78C-6032-4FF4-B52A-83456B9450EA	TCGA-AF-2691-01A-01D-1989-10	GRCh37-lite	TCGA-AF-2691	TCGA-READ	NA	s1956	Baylor College of Medicine	Christiana Healthcare	None	NO	T1	N0	Rectal Adenocarcinoma	Stage I	1989-10	TRUE
13722.58cfa83ce4b0c9d6adf730b4	58cfa83ce4b0c9d6adf730b4	fae749c6bcfc193aa1b9126628a2cf23.filtered.	WGS	fae749c6bcfc193aa1b9126628a2cf23	fae749c6bcfc193aa1b9126628a2cf23.bam	116.59	1.95	0.07	58cfa83ce4b0c9d6adf730b4	fae749c6bcfc193aa1b9126628a2cf23.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-B6-A0IJ-01A	2C86C3EA-D926-4D39-A5AE-39ECE4774287	Primary Tumor	Illumina HiSeq	b665cc0b-5952-419e-87a4-d97d3298f607	Breast	42	9EF8142A-8627-4DCF-8C87-15B1BC2BFEA2	B7FAC67C-EB7A-485C-A9B3-3E36388D02B1	TCGA-B6-A0IJ-01A-11D-A128-09	GRCh37-lite	TCGA-B6-A0IJ	TCGA-BRCA	NA	s6907	Washington University School of Medicine	Duke	United States	NO	T3	N0 (i-)	Infiltrating Ductal Carcinoma	Stage IIB	A128-09	TRUE
13722.58cfa83ce4b0c9d6adf73104	58cfa83ce4b0c9d6adf73104	bbb8b1b82e376eb4e8ac399b06def113.filtered.	WGS	bbb8b1b82e376eb4e8ac399b06def113	bbb8b1b82e376eb4e8ac399b06def113.bam	64.8	2.03	0.08	58cfa83ce4b0c9d6adf73104	bbb8b1b82e376eb4e8ac399b06def113.bam	Dead	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-B6-A0I6-01A	045C13EF-3DB7-4ADF-B0A3-23338F0479F3	Primary Tumor	Illumina HiSeq	aea89793-bb38-432a-ab2c-b5b9e7e93b1c	Breast	49	14423610-4958-43F4-9A75-1A61C1293024	A876398C-5B1D-444F-A360-5FE2DB697480	TCGA-B6-A0I6-01A-11D-A128-09	GRCh37-lite	TCGA-B6-A0I6	TCGA-BRCA	991	s5621	Washington University School of Medicine	Duke	United States	NO	T1c	N1	Infiltrating Ductal Carcinoma	Stage IIA	A128-09	TRUE
13722.58cfa82de4b0c9d6adf6a712	58cfa82de4b0c9d6adf6a712	G14854.TCGA-38-4628-01A-01D-1931-08.5.filtered.	WGS	G14854.TCGA-38-4628-01A-01D-1931-08.5	G14854.TCGA-38-4628-01A-01D-1931-08.5.bam	32.52	1.9	0.13	58cfa82de4b0c9d6adf6a712	G14854.TCGA-38-4628-01A-01D-1931-08.5.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-38-4628-01A	CC4BD56A-25C5-4C48-B583-AC3AEB778CA6	Primary Tumor	Illumina HiSeq	2fb6e0f6-487d-4404-9958-6ca019a21395	Lung	65	A74F6423-B5D3-4AE2-B61F-3EE04B1073BF	C437535B-2ACC-4236-BEAE-94E2C1336830	TCGA-38-4628-01A-01D-1931-08	HG19_Broad_variant	TCGA-38-4628	TCGA-LUAD	1492	s10627	Broad Institute of MIT and Harvard	UNC	United States	NO	T2	N1	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage IIB	1931-08	TRUE
13722.58cfa82de4b0c9d6adf6a720	58cfa82de4b0c9d6adf6a720	G13232.TCGA-60-2726-01A-01D-1522-08.2.filtered.	WGS	G13232.TCGA-60-2726-01A-01D-1522-08.2	G13232.TCGA-60-2726-01A-01D-1522-08.2.bam	741.3	1.9	0.05	58cfa82de4b0c9d6adf6a720	G13232.TCGA-60-2726-01A-01D-1522-08.2.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-60-2726-01A	3D1F4059-2220-45B4-A4D2-B14F76CEC96A	Primary Tumor	Illumina HiSeq	f4213e44-6813-4ccc-a6aa-9213ff594b0b	Lung	56	91A60807-2D0F-474E-B02F-18FEA788B319	A96EDDFC-3AFB-4BF8-A440-C91778113FBD	TCGA-60-2726-01A-01D-1522-08	HG19_Broad_variant	TCGA-60-2726	TCGA-LUSC	358	s10250	Broad Institute of MIT and Harvard	Roswell Park	United States	NO	T2	N1	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage IIA	1522-08	TRUE
13722.58cfa82ee4b0c9d6adf6abe7	58cfa82ee4b0c9d6adf6abe7	G32538.TCGA-EM-A2CU-01A-12D-A17V-08.4.filtered.	WGS	G32538.TCGA-EM-A2CU-01A-12D-A17V-08.4	G32538.TCGA-EM-A2CU-01A-12D-A17V-08.4.bam	27.26	NA	0.08	58cfa82ee4b0c9d6adf6abe7	G32538.TCGA-EM-A2CU-01A-12D-A17V-08.4.bam	Alive	FEMALE	Not available	Not available	Thyroid Carcinoma	Aligned reads	TCGA-EM-A2CU-01A	667EB7F6-1D36-49BB-9D7B-C9D167B64619	Primary Tumor	Illumina HiSeq	ef836a6f-dd3c-40ed-af7d-87b77a209877	Thyroid	47	5F75F169-6835-4B42-AF77-AB64CBFB5EF3	788FBFAA-51BF-42A4-AFA6-5B87ED04C2D5	TCGA-EM-A2CU-01A-12D-A17V-08	HG19_Broad_variant	TCGA-EM-A2CU	TCGA-THCA	NA	s12341	Broad Institute of MIT and Harvard	University Health Network	Canada	NO	T2	N1a	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	Stage III	A17V-08	TRUE
13722.58cfa82ee4b0c9d6adf6ac7e	58cfa82ee4b0c9d6adf6ac7e	G47088.TCGA-85-8052-01A-11D-2244-08.3.filtered.	WGS	G47088.TCGA-85-8052-01A-11D-2244-08.3	G47088.TCGA-85-8052-01A-11D-2244-08.3.bam	56.03	NA	0.05	58cfa82ee4b0c9d6adf6ac7e	G47088.TCGA-85-8052-01A-11D-2244-08.3.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-85-8052-01A	395BABB3-3F5D-4E71-A675-AF4443F23028	Primary Tumor	Illumina HiSeq	541bd2eb-5c99-4a8c-a9d3-c05c470d15f8	Lung	53	9248B38E-EC7B-4C7C-BCB0-E942CE3C4847	43AA4123-0FE2-4071-8A81-CBDD0410B917	TCGA-85-8052-01A-11D-2244-08	HG19_Broad_variant	TCGA-85-8052	TCGA-LUSC	NA	s10498	Broad Institute of MIT and Harvard	Asterand	Russia	NO	T3	N0	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage IIB	2244-08	FALSE
13722.58cfa82ee4b0c9d6adf6ac7a	58cfa82ee4b0c9d6adf6ac7a	G39020.TCGA-IN-7806-01A-11D-2053-08.3.filtered.	WGS	G39020.TCGA-IN-7806-01A-11D-2053-08.3	G39020.TCGA-IN-7806-01A-11D-2053-08.3.bam	341.7	NA	0.05	58cfa82ee4b0c9d6adf6ac7a	G39020.TCGA-IN-7806-01A-11D-2053-08.3.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-IN-7806-01A	87C217D4-66F4-46CA-8244-7856CE658FD3	Primary Tumor	Illumina HiSeq	65b3a7db-195a-47e8-804b-a1d4a5df79aa	Stomach	50	9B864C79-BF5C-4430-86E8-D8479ED90D25	576A1741-8C65-40DA-9F0F-B2CA805D70F3	TCGA-IN-7806-01A-11D-2053-08	HG19_Broad_variant	TCGA-IN-7806	TCGA-STAD	NA	s15297	Broad Institute of MIT and Harvard	University of Pittsburgh	United States	NO	T3	N1	Stomach  Adenocarcinoma  Diffuse Type	Stage IIB	2053-08	FALSE
13722.58cfa82ee4b0c9d6adf6ac9c	58cfa82ee4b0c9d6adf6ac9c	G47088.TCGA-21-1083-01A-01D-1521-08.3.filtered.	WGS	G47088.TCGA-21-1083-01A-01D-1521-08.3	G47088.TCGA-21-1083-01A-01D-1521-08.3.bam	532	1.9	0.05	58cfa82ee4b0c9d6adf6ac9c	G47088.TCGA-21-1083-01A-01D-1521-08.3.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-21-1083-01A	0398EAE1-7216-4595-80A5-6B117D96E070	Primary Tumor	Illumina HiSeq	365def90-a1fd-45b6-a3ab-749e13d4833d	Lung	75	300CB22F-ACB4-4ACD-8D64-FE8DCDF64801	FB0C6353-A90C-45E2-9355-7CD16CF756FF	TCGA-21-1083-01A-01D-1521-08	HG19_Broad_variant	TCGA-21-1083	TCGA-LUSC	1315	s9978	Broad Institute of MIT and Harvard	Fox Chase Cancer Center	United States	NO	T1	N0	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage IA	1521-08	TRUE
13722.58cfa82ee4b0c9d6adf6acec	58cfa82ee4b0c9d6adf6acec	G49537.TCGA-DE-A3KN-01A-11D-A20C-08.2.filtered.	WGS	G49537.TCGA-DE-A3KN-01A-11D-A20C-08.2	G49537.TCGA-DE-A3KN-01A-11D-A20C-08.2.bam	47.57	NA	0.08	58cfa82ee4b0c9d6adf6acec	G49537.TCGA-DE-A3KN-01A-11D-A20C-08.2.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-DE-A3KN-01A	085FFCDC-8600-42E2-852A-506465F716A2	Primary Tumor	Illumina HiSeq	62705306-2ad4-4287-ac8d-ca27cf525430	Thyroid	49	620B21C9-AC06-4154-A941-2532C775C6D8	07A7C634-BD9A-4FC2-B9FE-87B060EC3D1F	TCGA-DE-A3KN-01A-11D-A20C-08	HG19_Broad_variant	TCGA-DE-A3KN	TCGA-THCA	NA	s11984	Broad Institute of MIT and Harvard	University of North Carolina	United States	NO	T3	N1b	Thyroid Papillary Carcinoma - Classical/usual	Stage IVA	A20C-08	FALSE
13722.58cfa82ee4b0c9d6adf6acef	58cfa82ee4b0c9d6adf6acef	G49537.TCGA-DJ-A4UT-01A-11D-A257-08.1.filtered.	WGS	G49537.TCGA-DJ-A4UT-01A-11D-A257-08.1	G49537.TCGA-DJ-A4UT-01A-11D-A257-08.1.bam	37.91	NA	0.08	58cfa82ee4b0c9d6adf6acef	G49537.TCGA-DJ-A4UT-01A-11D-A257-08.1.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-DJ-A4UT-01A	ACB80B76-2394-4250-8687-60E40E16E83B	Primary Tumor	Illumina HiSeq	3f6de736-5ec7-4e27-85a6-a39f216ce0bf	Thyroid	32	4D6855A8-076D-4F95-B6CE-2B250CE3087D	64A17D5B-8F40-4CCF-8F2F-E68C5FE6B1FF	TCGA-DJ-A4UT-01A-11D-A257-08	HG19_Broad_variant	TCGA-DJ-A4UT	TCGA-THCA	NA	s11980	Broad Institute of MIT and Harvard	Memorial Sloan Kettering	United States	NO	T1a	N0	Thyroid Papillary Carcinoma - Classical/usual	Stage I	A257-08	FALSE
13722.58cfa82ee4b0c9d6adf6acf8	58cfa82ee4b0c9d6adf6acf8	G49537.TCGA-EL-A3T9-01A-21D-A22D-08.2.filtered.	WGS	G49537.TCGA-EL-A3T9-01A-21D-A22D-08.2	G49537.TCGA-EL-A3T9-01A-21D-A22D-08.2.bam	33.29	NA	0.08	58cfa82ee4b0c9d6adf6acf8	G49537.TCGA-EL-A3T9-01A-21D-A22D-08.2.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-EL-A3T9-01A	8A233B01-2959-467F-8950-02BE16309156	Primary Tumor	Illumina HiSeq	2ef29dae-4708-441b-ab7f-4f8ef4462a47	Thyroid	69	5297F55C-3A46-47ED-8ACC-03333AC26473	D692ECD0-2433-426B-9AF2-A30C44A80F7C	TCGA-EL-A3T9-01A-21D-A22D-08	HG19_Broad_variant	TCGA-EL-A3T9	TCGA-THCA	174	s12499	Broad Institute of MIT and Harvard	MD Anderson	United States	NO	T4	N1	Thyroid Papillary Carcinoma - Classical/usual	Stage IV	A22D-08	TRUE
13722.58cfa82ee4b0c9d6adf6ad00	58cfa82ee4b0c9d6adf6ad00	G49537.TCGA-E8-A418-01A-11D-A23M-08.1.filtered.	WGS	G49537.TCGA-E8-A418-01A-11D-A23M-08.1	G49537.TCGA-E8-A418-01A-11D-A23M-08.1.bam	30.97	NA	0.08	58cfa82ee4b0c9d6adf6ad00	G49537.TCGA-E8-A418-01A-11D-A23M-08.1.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-E8-A418-01A	EBBD54AD-7B97-4081-AD11-7F7F3CE74EEF	Primary Tumor	Illumina HiSeq	dcbb2120-b24f-4bc5-a07f-706d58345c05	Thyroid	75	979CBB75-28D9-4D33-8083-077C25BDDFD6	63EA274B-D42B-4787-9C54-8EE95EA376EC	TCGA-E8-A418-01A-11D-A23M-08	HG19_Broad_variant	TCGA-E8-A418	TCGA-THCA	NA	s12088	Broad Institute of MIT and Harvard	Asterand	Russia	NO	T4a	N0	Thyroid Papillary Carcinoma - Classical/usual	Stage IVA	A23M-08	FALSE
13722.58cfa82ee4b0c9d6adf6ad02	58cfa82ee4b0c9d6adf6ad02	G49537.TCGA-E8-A416-01A-11D-A23M-08.2.filtered.	WGS	G49537.TCGA-E8-A416-01A-11D-A23M-08.2	G49537.TCGA-E8-A416-01A-11D-A23M-08.2.bam	16.01	NA	0.08	58cfa82ee4b0c9d6adf6ad02	G49537.TCGA-E8-A416-01A-11D-A23M-08.2.bam	Alive	FEMALE	ASIAN	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-E8-A416-01A	86B82345-6F4D-44FD-A9DB-6F107DE62F53	Primary Tumor	Illumina HiSeq	d49de1af-8dd9-4fdb-8a60-87bd8894395b	Thyroid	51	AF7B5868-2C11-4C74-8033-E914C987ECE6	C8381701-31CB-465A-BDF2-1B8132BE7A14	TCGA-E8-A416-01A-11D-A23M-08	HG19_Broad_variant	TCGA-E8-A416	TCGA-THCA	NA	s12623	Broad Institute of MIT and Harvard	Asterand	Vietnam	NO	T1b	N0	Thyroid Papillary Carcinoma - Classical/usual	Stage I	A23M-08	FALSE
13722.58cfa82ee4b0c9d6adf6ad1c	58cfa82ee4b0c9d6adf6ad1c	G49537.TCGA-BJ-A45K-01A-11D-A23U-08.3.filtered.	WGS	G49537.TCGA-BJ-A45K-01A-11D-A23U-08.3	G49537.TCGA-BJ-A45K-01A-11D-A23U-08.3.bam	27.47	NA	0.08	58cfa82ee4b0c9d6adf6ad1c	G49537.TCGA-BJ-A45K-01A-11D-A23U-08.3.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-BJ-A45K-01A	8CFB88F6-7B37-4F1E-882B-3A368B604167	Primary Tumor	Illumina HiSeq	9a38b46c-3b59-40ad-9d22-d0d153c211a1	Thyroid	33	29B4816D-4CFB-45F0-BCD2-6B948245F3A4	77EBE6D2-6537-49D3-849D-FE93E2CF52AF	TCGA-BJ-A45K-01A-11D-A23U-08	HG19_Broad_variant	TCGA-BJ-A45K	TCGA-THCA	NA	s12615	Broad Institute of MIT and Harvard	University of Pittsburgh	United States	NO	T2	N0	Thyroid Papillary Carcinoma - Classical/usual	Stage I	A23U-08	FALSE
13722.58cfa82ee4b0c9d6adf6ad12	58cfa82ee4b0c9d6adf6ad12	G49537.TCGA-DE-A2OL-01A-11D-A18F-08.2.filtered.	WGS	G49537.TCGA-DE-A2OL-01A-11D-A18F-08.2	G49537.TCGA-DE-A2OL-01A-11D-A18F-08.2.bam	71.37	NA	0.08	58cfa82ee4b0c9d6adf6ad12	G49537.TCGA-DE-A2OL-01A-11D-A18F-08.2.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-DE-A2OL-01A	77BB90F0-E923-4E28-BB88-4D6B420E0B5C	Primary Tumor	Illumina HiSeq	60e1b538-0f36-45ea-892a-a8b64734f42b	Thyroid	44	6CBA95AD-2702-4F50-8B1E-BECDAF014B83	FC812906-D3B6-4210-A842-96F095280CBF	TCGA-DE-A2OL-01A-11D-A18F-08	HG19_Broad_variant	TCGA-DE-A2OL	TCGA-THCA	NA	s12350	Broad Institute of MIT and Harvard	University of North Carolina	United States	NO	T2	NX	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	Stage I	A18F-08	FALSE
13722.58cfa82ee4b0c9d6adf6ad18	58cfa82ee4b0c9d6adf6ad18	G49537.TCGA-EM-A2OV-01A-11D-A202-08.1.filtered.	WGS	G49537.TCGA-EM-A2OV-01A-11D-A202-08.1	G49537.TCGA-EM-A2OV-01A-11D-A202-08.1.bam	24.95	NA	0.08	58cfa82ee4b0c9d6adf6ad18	G49537.TCGA-EM-A2OV-01A-11D-A202-08.1.bam	Alive	FEMALE	ASIAN	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-EM-A2OV-01A	55E03FFC-F006-4EC8-8E5D-A738FF091F8A	Primary Tumor	Illumina HiSeq	6c8370c6-102f-4bde-84ce-bf930800ac6a	Thyroid	64	1183BCB5-50A7-4CC0-A94C-732636B7EE7D	2DFE70FD-2650-49C0-B6EB-67DF585D063B	TCGA-EM-A2OV-01A-11D-A202-08	HG19_Broad_variant	TCGA-EM-A2OV	TCGA-THCA	NA	s12347	Broad Institute of MIT and Harvard	University Health Network	Canada	NO	T2	N0	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	Stage II	A202-08	TRUE
13722.58cfa82ee4b0c9d6adf6ad1f	58cfa82ee4b0c9d6adf6ad1f	G39020.TCGA-BR-8486-01A-31D-2394-08.2.filtered.	WGS	G39020.TCGA-BR-8486-01A-31D-2394-08.2	G39020.TCGA-BR-8486-01A-31D-2394-08.2.bam	280	NA	0.05	58cfa82ee4b0c9d6adf6ad1f	G39020.TCGA-BR-8486-01A-31D-2394-08.2.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-BR-8486-01A	B8A1C8C7-3945-4D84-8F58-3A1A1EB10730	Primary Tumor	Illumina HiSeq	09ea179f-e2fc-479c-9b04-7c3ae8034874	Stomach	90	65FA5F32-8747-41B7-8287-061587DC22DE	6A7CDAF6-211E-4EB8-A70E-1153D69C45E4	TCGA-BR-8486-01A-31D-2394-08	HG19_Broad_variant	TCGA-BR-8486	TCGA-STAD	NA	s14678	Broad Institute of MIT and Harvard	Asterand	Russia	NO	T1b	N0	Stomach  Adenocarcinoma  Not Otherwise Specified (NOS)	Stage IA	2394-08	TRUE
13722.58cfa82ee4b0c9d6adf6adac	58cfa82ee4b0c9d6adf6adac	G39020.TCGA-CD-8529-01A-11D-2340-08.2.filtered.	WGS	G39020.TCGA-CD-8529-01A-11D-2340-08.2	G39020.TCGA-CD-8529-01A-11D-2340-08.2.bam	200.7	NA	0.05	58cfa82ee4b0c9d6adf6adac	G39020.TCGA-CD-8529-01A-11D-2340-08.2.bam	Alive	MALE	ASIAN	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-CD-8529-01A	5B7E557A-6AEE-4077-B3CD-C96179E643AE	Primary Tumor	Illumina HiSeq	65281f4c-9277-4d03-8566-75feb73c114d	Stomach	65	EB18C784-32F7-4570-A661-E4DF8F55378C	931B24DA-5D6D-4C2D-8DE9-EF32D6EB8565	TCGA-CD-8529-01A-11D-2340-08	HG19_Broad_variant	TCGA-CD-8529	TCGA-STAD	NA	s14958	Broad Institute of MIT and Harvard	ILSbio	Vietnam	NO	T4	N0	Stomach Intestinal Adenocarcinoma Mucinous Type	Stage IV	2340-08	FALSE
13722.58cfa82ee4b0c9d6adf6add6	58cfa82ee4b0c9d6adf6add6	G39020.TCGA-BR-8690-01A-11D-2394-08.4.filtered.	WGS	G39020.TCGA-BR-8690-01A-11D-2394-08.4	G39020.TCGA-BR-8690-01A-11D-2394-08.4.bam	390	NA	0.05	58cfa82ee4b0c9d6adf6add6	G39020.TCGA-BR-8690-01A-11D-2394-08.4.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-BR-8690-01A	337819D2-5281-4B41-9583-A476924BC837	Primary Tumor	Illumina HiSeq	4a0c62bb-6857-41e2-8933-37b5cb32f6b7	Stomach	54	0F7EBFFA-D119-45D6-8AF1-2048ECA173E7	EDC8839F-FA6B-41E0-AD49-F688073730BD	TCGA-BR-8690-01A-11D-2394-08	HG19_Broad_variant	TCGA-BR-8690	TCGA-STAD	NA	s14390	Broad Institute of MIT and Harvard	Asterand	Ukraine	NO	T3	N3a	Stomach  Adenocarcinoma  Not Otherwise Specified (NOS)	Stage IIIB	2394-08	TRUE
13722.58cfa82ee4b0c9d6adf6ae16	58cfa82ee4b0c9d6adf6ae16	G49837.TCGA-94-7943-01A-11D-A320-08.2.filtered.	WGS	G49837.TCGA-94-7943-01A-11D-A320-08.2	G49837.TCGA-94-7943-01A-11D-A320-08.2.bam	203	NA	0.08	58cfa82ee4b0c9d6adf6ae16	G49837.TCGA-94-7943-01A-11D-A320-08.2.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-94-7943-01A	AECF85CC-058C-46F3-9CDC-3573AC3B8438	Primary Tumor	Illumina HiSeq	f0eef218-f0af-4e9d-8f67-cdfc840480bc	Lung	80	E447DA47-227D-4956-9F46-AD1F81B73EBA	7731EF7F-25BD-42F5-9A20-BE249306A711	TCGA-94-7943-01A-11D-A320-08	HG19_Broad_variant	TCGA-94-7943	TCGA-LUSC	NA	s10509	Broad Institute of MIT and Harvard	Washington University - Emory	United States	NO	T1b	NX	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage IA	A320-08	TRUE
13722.58cfa82ee4b0c9d6adf6ae5a	58cfa82ee4b0c9d6adf6ae5a	TCGA-04-1514-01A-01D-A324-10_wgs_Illumina.filtered.	WGS	TCGA-04-1514-01A-01D-A324-10_wgs_Illumina	TCGA-04-1514-01A-01D-A324-10_wgs_Illumina.bam	279.67	1.9	0.07	58cfa82ee4b0c9d6adf6ae5a	TCGA-04-1514-01A-01D-A324-10_wgs_Illumina.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-04-1514-01A	E9483296-CB91-497A-B955-39A3C3289DAC	Primary Tumor	Illumina HiSeq	07a37a5e-5fa5-415b-9814-363bf0a7bc48	Ovary	45	18E0F4ED-43E2-451F-82BD-102260A30AAA	C691D6B3-8E70-4951-8551-2EE4E4D0D10B	TCGA-04-1514-01A-01D-A324-10	GRCh37-lite	TCGA-04-1514	TCGA-OV	1720	s17412	Baylor College of Medicine	Gynecologic Oncology Group	None	NO	Not available	Not available	Serous Cystadenocarcinoma	Not available	A324-10	TRUE
13722.58cfa82ee4b0c9d6adf6ade4	58cfa82ee4b0c9d6adf6ade4	G49837.TCGA-66-2789-01A-01D-A320-08.2.filtered.	WGS	G49837.TCGA-66-2789-01A-01D-A320-08.2	G49837.TCGA-66-2789-01A-01D-A320-08.2.bam	379.94	1.8	0.07	58cfa82ee4b0c9d6adf6ade4	G49837.TCGA-66-2789-01A-01D-A320-08.2.bam	Dead	MALE	Not available	Not available	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-66-2789-01A	87AC0AD4-8C9D-409E-9A86-1D201D01769D	Primary Tumor	Illumina HiSeq	52b8139f-9275-441d-b6ee-e7d29d66fc68	Lung	73	A633A5CA-C207-45BE-8903-93527DE31C22	9623D295-C23D-4F2F-827C-69F767A26F1F	TCGA-66-2789-01A-01D-A320-08	HG19_Broad_variant	TCGA-66-2789	TCGA-LUSC	123	s10164	Broad Institute of MIT and Harvard	Indivumed	Germany	NO	T1	N3	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage IIIB	A320-08	TRUE
13722.58cfa82ee4b0c9d6adf6ad92	58cfa82ee4b0c9d6adf6ad92	G39020.TCGA-D7-6527-01A-11D-1800-08.2.filtered.	WGS	G39020.TCGA-D7-6527-01A-11D-1800-08.2	G39020.TCGA-D7-6527-01A-11D-1800-08.2.bam	84.4	1.9	0.05	58cfa82ee4b0c9d6adf6ad92	G39020.TCGA-D7-6527-01A-11D-1800-08.2.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-D7-6527-01A	CB622CD6-776D-4681-8A67-4ADDD61C66B8	Primary Tumor	Illumina HiSeq	869f3603-32f9-4e4d-a862-211f1bb624b8	Stomach	62	8461CE68-3A6F-4343-8977-78448123F373	DC537FCF-D910-4C4B-8AF9-E7DA429F2633	TCGA-D7-6527-01A-11D-1800-08	HG19_Broad_variant	TCGA-D7-6527	TCGA-STAD	NA	s15229	Broad Institute of MIT and Harvard	Greater Poland Cancer Center	Poland	NO	T2	N1	Stomach Intestinal Adenocarcinoma Papillary Type	Stage II	1800-08	TRUE
13722.58cfa82ee4b0c9d6adf6aeaa	58cfa82ee4b0c9d6adf6aeaa	G49537.TCGA-ET-A4KN-01A-11D-A257-08.1.filtered.	WGS	G49537.TCGA-ET-A4KN-01A-11D-A257-08.1	G49537.TCGA-ET-A4KN-01A-11D-A257-08.1.bam	32.52	NA	0.07	58cfa82ee4b0c9d6adf6aeaa	G49537.TCGA-ET-A4KN-01A-11D-A257-08.1.bam	Alive	FEMALE	WHITE	Not available	Thyroid Carcinoma	Aligned reads	TCGA-ET-A4KN-01A	7629F864-A009-4AA9-BF7E-2D99E00D294E	Primary Tumor	Illumina HiSeq	82a795da-f726-45af-a15f-a778695d466a	Thyroid	51	E01D507C-8E8E-45C6-B4EF-193177A382C4	178D0486-CB0D-4979-8BDF-BB3FE99149BD	TCGA-ET-A4KN-01A-11D-A257-08	HG19_Broad_variant	TCGA-ET-A4KN	TCGA-THCA	NA	s12619	Broad Institute of MIT and Harvard	Johns Hopkins	United States	NO	T3	N0	Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features)	Stage III	A257-08	FALSE
13722.58cfa82ee4b0c9d6adf6aea0	58cfa82ee4b0c9d6adf6aea0	G49537.TCGA-FY-A2QD-01A-11D-A19J-08.1.filtered.	WGS	G49537.TCGA-FY-A2QD-01A-11D-A19J-08.1	G49537.TCGA-FY-A2QD-01A-11D-A19J-08.1.bam	37.07	NA	0.08	58cfa82ee4b0c9d6adf6aea0	G49537.TCGA-FY-A2QD-01A-11D-A19J-08.1.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-FY-A2QD-01A	B0CB6ED7-3D9F-4D5E-8DF5-EDCC921C43B4	Primary Tumor	Illumina HiSeq	102342da-d9ce-4eb4-8c20-dda6ce072830	Thyroid	61	08D3CB3B-9A80-4034-B06D-B37DD38C8B9B	E7335A24-E5FC-4558-9EBA-511C5A802320	TCGA-FY-A2QD-01A-11D-A19J-08	HG19_Broad_variant	TCGA-FY-A2QD	TCGA-THCA	NA	s12226	Broad Institute of MIT and Harvard	International Genomics Consortium	United States	NO	T1	N0	Thyroid Papillary Carcinoma - Classical/usual	Not available	A19J-08	FALSE
13722.58cfa82ee4b0c9d6adf6aedb	58cfa82ee4b0c9d6adf6aedb	G49537.TCGA-DJ-A2Q1-01A-22D-A19J-08.1.filtered.	WGS	G49537.TCGA-DJ-A2Q1-01A-22D-A19J-08.1	G49537.TCGA-DJ-A2Q1-01A-22D-A19J-08.1.bam	27.76	NA	0.09	58cfa82ee4b0c9d6adf6aedb	G49537.TCGA-DJ-A2Q1-01A-22D-A19J-08.1.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-DJ-A2Q1-01A	E35B2928-8784-45D0-A71A-A2DF161542FA	Primary Tumor	Illumina HiSeq	0cac59ec-55cb-4769-ba6d-92c08a076186	Thyroid	44	D1361CB2-6758-4A8C-AE97-8AD5192572FC	007AAB66-2F07-459D-8952-3041D6EA24A8	TCGA-DJ-A2Q1-01A-22D-A19J-08	HG19_Broad_variant	TCGA-DJ-A2Q1	TCGA-THCA	NA	s11981	Broad Institute of MIT and Harvard	Memorial Sloan Kettering	United States	NO	T1b	N1b	Thyroid Papillary Carcinoma - Classical/usual	Stage I	A19J-08	FALSE
13722.58cfa82ee4b0c9d6adf6aeb6	58cfa82ee4b0c9d6adf6aeb6	G49537.TCGA-EM-A2CN-01A-11D-A19J-08.2.filtered.	WGS	G49537.TCGA-EM-A2CN-01A-11D-A19J-08.2	G49537.TCGA-EM-A2CN-01A-11D-A19J-08.2.bam	65.79	NA	0.09	58cfa82ee4b0c9d6adf6aeb6	G49537.TCGA-EM-A2CN-01A-11D-A19J-08.2.bam	Alive	MALE	Not available	Not available	Thyroid Carcinoma	Aligned reads	TCGA-EM-A2CN-01A	4AED5116-D27B-4911-B310-05C2248B861F	Primary Tumor	Illumina HiSeq	2dc0d4bf-c927-40fc-bc8e-fbdc5e1da355	Thyroid	62	4548D9EE-668F-495B-845F-8B9FC798EA38	5C02D399-07AF-4573-A568-BC1B256BC8F8	TCGA-EM-A2CN-01A-11D-A19J-08	HG19_Broad_variant	TCGA-EM-A2CN	TCGA-THCA	NA	s12089	Broad Institute of MIT and Harvard	University Health Network	Canada	NO	T3	N0	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	Stage IVC	A19J-08	FALSE
13722.58cfa82ee4b0c9d6adf6af3e	58cfa82ee4b0c9d6adf6af3e	G47088.TCGA-22-5485-01A-01D-1632-08.2.filtered.	WGS	G47088.TCGA-22-5485-01A-01D-1632-08.2	G47088.TCGA-22-5485-01A-01D-1632-08.2.bam	342.7	1.9	0.05	58cfa82ee4b0c9d6adf6af3e	G47088.TCGA-22-5485-01A-01D-1632-08.2.bam	Dead	FEMALE	WHITE	Not available	Lung Squamous Cell Carcinoma	Aligned reads	TCGA-22-5485-01A	305F72A8-069B-410B-BBE4-4ECB761C748D	Primary Tumor	Illumina HiSeq	c56332b3-4ccb-4b34-80c3-ffa0b28c5690	Lung	58	ABC3A25F-D5BC-469E-8C3E-8E6F5B129E8F	448AF8B4-E071-48B0-A65B-B4AD17AFDC0C	TCGA-22-5485-01A-01D-1632-08	HG19_Broad_variant	TCGA-22-5485	TCGA-LUSC	916	s10593	Broad Institute of MIT and Harvard	Mayo Clinic - Rochester	United States	NO	T1a	N0	Lung Squamous Cell Carcinoma- Not Otherwise Specified (NOS)	Stage IA	1632-08	FALSE
13722.58cfa82ee4b0c9d6adf6af4e	58cfa82ee4b0c9d6adf6af4e	G49537.TCGA-EL-A4K6-01A-12D-A257-08.2.filtered.	WGS	G49537.TCGA-EL-A4K6-01A-12D-A257-08.2	G49537.TCGA-EL-A4K6-01A-12D-A257-08.2.bam	55.8	NA	0.08	58cfa82ee4b0c9d6adf6af4e	G49537.TCGA-EL-A4K6-01A-12D-A257-08.2.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-EL-A4K6-01A	4FC8E011-4433-4537-B03F-457A3A70240F	Primary Tumor	Illumina HiSeq	3fa6f792-4048-42a5-990b-a50e3e20fa7a	Thyroid	75	BB98FF62-4CD8-46D6-9A85-8439265BE40B	66EB4833-1B87-4FD9-A53D-26DC7AD6DE29	TCGA-EL-A4K6-01A-12D-A257-08	HG19_Broad_variant	TCGA-EL-A4K6	TCGA-THCA	NA	s12498	Broad Institute of MIT and Harvard	MD Anderson	United States	NO	T4	N1	Thyroid Papillary Carcinoma - Classical/usual	Stage IV	A257-08	FALSE
13722.58cfa82ee4b0c9d6adf6aec4	58cfa82ee4b0c9d6adf6aec4	G49537.TCGA-DJ-A13R-01A-11D-A10S-08.1.filtered.	WGS	G49537.TCGA-DJ-A13R-01A-11D-A10S-08.1	G49537.TCGA-DJ-A13R-01A-11D-A10S-08.1.bam	78.88	1.95	0.08	58cfa82ee4b0c9d6adf6aec4	G49537.TCGA-DJ-A13R-01A-11D-A10S-08.1.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-DJ-A13R-01A	3E787A0E-B5D2-401E-B1E5-077376090B3A	Primary Tumor	Illumina HiSeq	af5f8467-77af-435f-b962-db1a207085e3	Thyroid	50	27B0FF79-4213-4B57-B6E0-A393B8983D20	3F039593-91D1-43CB-A06B-41E92F7E8D20	TCGA-DJ-A13R-01A-11D-A10S-08	HG19_Broad_variant	TCGA-DJ-A13R	TCGA-THCA	NA	s12503	Broad Institute of MIT and Harvard	Memorial Sloan Kettering	United States	NO	T3	N0	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	Stage III	A10S-08	TRUE
13722.58cfa82ee4b0c9d6adf6af7c	58cfa82ee4b0c9d6adf6af7c	TCGA-04-1331-01A-01D-A324-10_wgs_Illumina.filtered.	WGS	TCGA-04-1331-01A-01D-A324-10_wgs_Illumina	TCGA-04-1331-01A-01D-A324-10_wgs_Illumina.bam	417.67	1.9	0.08	58cfa82ee4b0c9d6adf6af7c	TCGA-04-1331-01A-01D-A324-10_wgs_Illumina.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-04-1331-01A	6D10D4EE-6331-4BBA-93BC-A7B64CC0B22A	Primary Tumor	Illumina HiSeq	d7ce51ee-6050-45ea-ad60-5209ad11625a	Ovary	78	A1EC9279-C1A6-4E58-97ED-9EC1F36187C5	C9959F68-C385-4C1F-9188-8203844D288E	TCGA-04-1331-01A-01D-A324-10	GRCh37-lite	TCGA-04-1331	TCGA-OV	1336	s17654	Baylor College of Medicine	Gynecologic Oncology Group	None	NO	Not available	Not available	Serous Cystadenocarcinoma	Not available	A324-10	TRUE
13722.58cfa82ee4b0c9d6adf6aff6	58cfa82ee4b0c9d6adf6aff6	TCGA-10-0937-01A-02D-A324-10_wgs_Illumina.filtered.	WGS	TCGA-10-0937-01A-02D-A324-10_wgs_Illumina	TCGA-10-0937-01A-02D-A324-10_wgs_Illumina.bam	272.34	1.9	0.07	58cfa82ee4b0c9d6adf6aff6	TCGA-10-0937-01A-02D-A324-10_wgs_Illumina.bam	Dead	FEMALE	WHITE	Not available	Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-10-0937-01A	A5030259-CF9C-4A58-8710-B9DA8EE59320	Primary Tumor	Illumina HiSeq	ba32f721-1816-4462-b3f7-f496ee3d8c84	Ovary	44	8585D596-4D6B-4F6C-BB46-A2661F9CA05A	8A69F3CA-4E17-4DAA-8722-A36316E345BA	TCGA-10-0937-01A-02D-A324-10	GRCh37-lite	TCGA-10-0937	TCGA-OV	608	s17910	Baylor College of Medicine	MD Anderson Cancer Center	None	NO	Not available	Not available	Serous Cystadenocarcinoma	Not available	A324-10	TRUE
13722.58cfa82ee4b0c9d6adf6b028	58cfa82ee4b0c9d6adf6b028	TCGA-04-1347-01A-01D-A324-10_wgs_Illumina.filtered.	WGS	TCGA-04-1347-01A-01D-A324-10_wgs_Illumina	TCGA-04-1347-01A-01D-A324-10_wgs_Illumina.bam	602.67	1.9	0.07	58cfa82ee4b0c9d6adf6b028	TCGA-04-1347-01A-01D-A324-10_wgs_Illumina.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-04-1347-01A	F0C353FD-947C-41E2-B643-3ECC0D69796C	Primary Tumor	Illumina HiSeq	bbcc4096-ca91-49bb-b631-a4db1ca7ab8b	Ovary	81	4C4747D9-C0BC-486E-B88C-5C1B8214D4DE	1DC9E7FD-FC62-4B32-9619-4E02A266A385	TCGA-04-1347-01A-01D-A324-10	GRCh37-lite	TCGA-04-1347	TCGA-OV	NA	s18085	Baylor College of Medicine	Gynecologic Oncology Group	None	NO	Not available	Not available	Serous Cystadenocarcinoma	Not available	A324-10	TRUE
13722.58cfa82ee4b0c9d6adf6af6e	58cfa82ee4b0c9d6adf6af6e	G39020.TCGA-F1-6875-01A-11D-2053-08.3.filtered.	WGS	G39020.TCGA-F1-6875-01A-11D-2053-08.3	G39020.TCGA-F1-6875-01A-11D-2053-08.3.bam	583.7	NA	0.05	58cfa82ee4b0c9d6adf6af6e	G39020.TCGA-F1-6875-01A-11D-2053-08.3.bam	Dead	MALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-F1-6875-01A	283776CD-32E8-4A79-BED1-1411C9D3A9E0	Primary Tumor	Illumina HiSeq	b6dcf3d5-80e4-40e1-a164-4697d1de7670	Stomach	79	4E5FDD56-C807-4493-A331-359577C31514	EA1CAC20-88C1-4257-9CDB-D2890EB2E123	TCGA-F1-6875-01A-11D-2053-08	HG19_Broad_variant	TCGA-F1-6875	TCGA-STAD	2197	s14461	Broad Institute of MIT and Harvard	UNC	United States	NO	T2	N0	Stomach  Adenocarcinoma  Not Otherwise Specified (NOS)	Stage IA	2053-08	FALSE
13722.58cfa82ee4b0c9d6adf6b004	58cfa82ee4b0c9d6adf6b004	G49537.TCGA-EM-A3FL-01A-11D-A21A-08.2.filtered.	WGS	G49537.TCGA-EM-A3FL-01A-11D-A21A-08.2	G49537.TCGA-EM-A3FL-01A-11D-A21A-08.2.bam	8.35	NA	0.08	58cfa82ee4b0c9d6adf6b004	G49537.TCGA-EM-A3FL-01A-11D-A21A-08.2.bam	Alive	FEMALE	Not available	Not available	Thyroid Carcinoma	Aligned reads	TCGA-EM-A3FL-01A	CFDD2155-57A9-499C-92E1-FB82B577B050	Primary Tumor	Illumina HiSeq	477abd20-1834-4af2-8091-7566a4d68578	Thyroid	63	56E31332-09FB-4305-8EE8-ADC568B393F3	1BBB522D-E224-4B3F-9E10-3A47D06B2B05	TCGA-EM-A3FL-01A-11D-A21A-08	HG19_Broad_variant	TCGA-EM-A3FL	TCGA-THCA	NA	s12225	Broad Institute of MIT and Harvard	University Health Network	Canada	NO	T1b	NX	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	Stage I	A21A-08	TRUE
13722.58cfa82ee4b0c9d6adf6afc7	58cfa82ee4b0c9d6adf6afc7	G49537.TCGA-DJ-A13L-01A-11D-A21Z-08.1.filtered.	WGS	G49537.TCGA-DJ-A13L-01A-11D-A21Z-08.1	G49537.TCGA-DJ-A13L-01A-11D-A21Z-08.1.bam	32.87	NA	0.08	58cfa82ee4b0c9d6adf6afc7	G49537.TCGA-DJ-A13L-01A-11D-A21Z-08.1.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-DJ-A13L-01A	C7A2F394-3E3F-4C90-9F1E-F2BE3E5B0D6B	Primary Tumor	Illumina HiSeq	56cad7af-d64e-4a7f-9d2e-206cbb921c3f	Thyroid	85	AB13FB1A-8B7F-4D84-84A9-C4F7EE59CAF8	1924D200-6929-4EEF-8A7F-317F8FBAB915	TCGA-DJ-A13L-01A-11D-A21Z-08	HG19_Broad_variant	TCGA-DJ-A13L	TCGA-THCA	NA	s12501	Broad Institute of MIT and Harvard	Memorial Sloan Kettering	United States	NO	T1b	N0	Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features)	Stage I	A21Z-08	TRUE
13722.58cfa82fe4b0c9d6adf6b290	58cfa82fe4b0c9d6adf6b290	TCGA-09-2045-01A-01D-A324-10_wgs_Illumina.filtered.	WGS	TCGA-09-2045-01A-01D-A324-10_wgs_Illumina	TCGA-09-2045-01A-01D-A324-10_wgs_Illumina.bam	598.97	1.9	0.08	58cfa82fe4b0c9d6adf6b290	TCGA-09-2045-01A-01D-A324-10_wgs_Illumina.bam	Dead	FEMALE	ASIAN	NOT HISPANIC OR LATINO	Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-09-2045-01A	3768D34F-1527-40DB-B116-CD80CEE5EC3A	Primary Tumor	Illumina HiSeq	51ef343e-2d9c-48c4-9a6f-6c4f0dcac50d	Ovary	50	4D5AAF12-A500-4709-9C99-5B9FEF2C79B1	6797443C-EB4A-4654-B957-C0056E5A4206	TCGA-09-2045-01A-01D-A324-10	GRCh37-lite	TCGA-09-2045	TCGA-OV	1069	s17170	Baylor College of Medicine	UCSF	None	NO	Not available	Not available	Serous Cystadenocarcinoma	Not available	A324-10	TRUE
13722.58cfa82fe4b0c9d6adf6b3a2	58cfa82fe4b0c9d6adf6b3a2	TCGA-24-1419-01A-01D-A324-10_wgs_Illumina.filtered.	WGS	TCGA-24-1419-01A-01D-A324-10_wgs_Illumina	TCGA-24-1419-01A-01D-A324-10_wgs_Illumina.bam	589.97	1.9	0.09	58cfa82fe4b0c9d6adf6b3a2	TCGA-24-1419-01A-01D-A324-10_wgs_Illumina.bam	Alive	FEMALE	WHITE	Not available	Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-24-1419-01A	5E18B17D-4626-4B6D-8AC6-E560CEE0376C	Primary Tumor	Illumina HiSeq	915b863a-f427-4e28-8809-4e9f244f9f4d	Ovary	62	92D562DF-4A58-43DA-8811-843D3D3C9438	2F2EAECC-6509-423F-B63A-8C3BEA1BA4A4	TCGA-24-1419-01A-01D-A324-10	GRCh37-lite	TCGA-24-1419	TCGA-OV	NA	s17620	Baylor College of Medicine	Washington University	None	NO	Not available	Not available	Serous Cystadenocarcinoma	Not available	A324-10	TRUE
13722.58cfa82ee4b0c9d6adf6b197	58cfa82ee4b0c9d6adf6b197	TCGA-09-1666-01A-01D-A324-10_wgs_Illumina.filtered.	WGS	TCGA-09-1666-01A-01D-A324-10_wgs_Illumina	TCGA-09-1666-01A-01D-A324-10_wgs_Illumina.bam	788.97	1.9	0.08	58cfa82ee4b0c9d6adf6b197	TCGA-09-1666-01A-01D-A324-10_wgs_Illumina.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-09-1666-01A	4EAC2C98-86D2-4EE6-A1D3-157D013C78DC	Primary Tumor	Illumina HiSeq	6d2f46e9-b19b-431a-aa4e-c409eb1787dc	Ovary	57	77AB9685-021C-4D99-8980-79BEC534828E	127B0F7D-D24E-48B7-AC25-D3F14A43952D	TCGA-09-1666-01A-01D-A324-10	GRCh37-lite	TCGA-09-1666	TCGA-OV	NA	s17490	Baylor College of Medicine	UCSF	None	NO	Not available	Not available	Serous Cystadenocarcinoma	Not available	A324-10	TRUE
13722.58cfa82fe4b0c9d6adf6b384	58cfa82fe4b0c9d6adf6b384	TCGA-24-2024-01A-02D-A324-10_wgs_Illumina.filtered.	WGS	TCGA-24-2024-01A-02D-A324-10_wgs_Illumina	TCGA-24-2024-01A-02D-A324-10_wgs_Illumina.bam	798.27	1.8	0.07	58cfa82fe4b0c9d6adf6b384	TCGA-24-2024-01A-02D-A324-10_wgs_Illumina.bam	Dead	FEMALE	BLACK OR AFRICAN AMERICAN	Not available	Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-24-2024-01A	0A48873A-092A-4B25-822B-B0B3C18C08A8	Primary Tumor	Illumina HiSeq	03e36495-9e80-442c-bc07-456ee80a47ca	Ovary	72	A3F8DCAD-C42A-4070-80C4-782627BBACA2	46F19B5C-3EBA-4B23-A1AB-9748090CA4E5	TCGA-24-2024-01A-02D-A324-10	GRCh37-lite	TCGA-24-2024	TCGA-OV	1769	s17944	Baylor College of Medicine	Washington University	None	NO	Not available	Not available	Serous Cystadenocarcinoma	Not available	A324-10	TRUE
13722.58cfa82fe4b0c9d6adf6b2be	58cfa82fe4b0c9d6adf6b2be	TCGA-23-1110-01A-01D-A324-10_wgs_Illumina.filtered.	WGS	TCGA-23-1110-01A-01D-A324-10_wgs_Illumina	TCGA-23-1110-01A-01D-A324-10_wgs_Illumina.bam	572.67	1.9	0.08	58cfa82fe4b0c9d6adf6b2be	TCGA-23-1110-01A-01D-A324-10_wgs_Illumina.bam	Alive	FEMALE	WHITE	HISPANIC OR LATINO	Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-23-1110-01A	9FB1BA57-2007-4477-B000-2D36F163EFD2	Primary Tumor	Illumina HiSeq	1a385700-67e4-4e15-95ac-102406f8fe18	Ovary	42	5ADCA90E-F8AE-4A74-9C7F-A2B64FDA2B31	1292E13B-D7C6-447B-A227-9A8113215580	TCGA-23-1110-01A-01D-A324-10	GRCh37-lite	TCGA-23-1110	TCGA-OV	NA	s17716	Baylor College of Medicine	Cedars Sinai	None	NO	Not available	Not available	Serous Cystadenocarcinoma	Not available	A324-10	TRUE
13722.58cfa82fe4b0c9d6adf6b408	58cfa82fe4b0c9d6adf6b408	TCGA-24-1558-01A-01D-A324-10_wgs_Illumina.filtered.	WGS	TCGA-24-1558-01A-01D-A324-10_wgs_Illumina	TCGA-24-1558-01A-01D-A324-10_wgs_Illumina.bam	326.97	1.9	0.08	58cfa82fe4b0c9d6adf6b408	TCGA-24-1558-01A-01D-A324-10_wgs_Illumina.bam	Dead	FEMALE	WHITE	Not available	Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-24-1558-01A	BA68F2CF-9271-41FD-9655-1FAC7681F588	Primary Tumor	Illumina HiSeq	ff5c5c7d-21a4-4a46-b611-efb7750a4316	Ovary	73	3E8BD387-4FDA-4623-924E-314267C55EEA	9020B6A5-8325-4B0D-84D9-04371C857910	TCGA-24-1558-01A-01D-A324-10	GRCh37-lite	TCGA-24-1558	TCGA-OV	594	s18117	Baylor College of Medicine	Washington University	None	NO	Not available	Not available	Serous Cystadenocarcinoma	Not available	A324-10	TRUE
13722.58cfa82fe4b0c9d6adf6b3fa	58cfa82fe4b0c9d6adf6b3fa	TCGA-24-1552-01A-01D-A324-10_wgs_Illumina.filtered.	WGS	TCGA-24-1552-01A-01D-A324-10_wgs_Illumina	TCGA-24-1552-01A-01D-A324-10_wgs_Illumina.bam	719.67	1.9	0.08	58cfa82fe4b0c9d6adf6b3fa	TCGA-24-1552-01A-01D-A324-10_wgs_Illumina.bam	Dead	FEMALE	WHITE	Not available	Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-24-1552-01A	62379BE5-13F0-474B-94D3-6F944EC4EE96	Primary Tumor	Illumina HiSeq	5549fe8c-2ced-4cb8-826b-b212f6ba24d5	Ovary	77	411B4C26-FCC4-438A-8731-D0CF5DD6C74F	14ED7388-41ED-43D4-AFB2-04CD6410D5D2	TCGA-24-1552-01A-01D-A324-10	GRCh37-lite	TCGA-24-1552	TCGA-OV	1259	s17300	Baylor College of Medicine	Washington University	None	NO	Not available	Not available	Serous Cystadenocarcinoma	Not available	A324-10	TRUE
13722.58cfa82fe4b0c9d6adf6b541	58cfa82fe4b0c9d6adf6b541	TCGA-25-2391-01A-01D-A324-10_wgs_Illumina.filtered.	WGS	TCGA-25-2391-01A-01D-A324-10_wgs_Illumina	TCGA-25-2391-01A-01D-A324-10_wgs_Illumina.bam	896.97	1.9	0.07	58cfa82fe4b0c9d6adf6b541	TCGA-25-2391-01A-01D-A324-10_wgs_Illumina.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-25-2391-01A	F5033D52-EC36-4E67-88D8-B6D898B81B2F	Primary Tumor	Illumina HiSeq	4c0ed657-169e-4ee1-b8b9-4544a43ed2ee	Ovary	57	2179798C-4FD4-4434-B1D5-1453F6054FA2	58FAF969-BF37-4180-8807-2F44F2CC8EDA	TCGA-25-2391-01A-01D-A324-10	GRCh37-lite	TCGA-25-2391	TCGA-OV	1492	s17137	Baylor College of Medicine	Mayo Clinic - Rochester	None	NO	Not available	Not available	Serous Cystadenocarcinoma	Not available	A324-10	TRUE
13722.58cfa82fe4b0c9d6adf6b440	58cfa82fe4b0c9d6adf6b440	TCGA-24-2290-01A-01D-A324-10_wgs_Illumina.filtered.	WGS	TCGA-24-2290-01A-01D-A324-10_wgs_Illumina	TCGA-24-2290-01A-01D-A324-10_wgs_Illumina.bam	683.97	1.9	0.08	58cfa82fe4b0c9d6adf6b440	TCGA-24-2290-01A-01D-A324-10_wgs_Illumina.bam	Dead	FEMALE	WHITE	Not available	Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-24-2290-01A	2B14123B-8FCD-402C-9399-4E7C47F20252	Primary Tumor	Illumina HiSeq	f1ffb755-85ec-4449-b604-8e9cd194d527	Ovary	56	BBFED693-79E1-4DC7-896E-15B98FC7DBAC	FEA5827B-251D-474B-8713-FC76DB995FE7	TCGA-24-2290-01A-01D-A324-10	GRCh37-lite	TCGA-24-2290	TCGA-OV	1102	s17878	Baylor College of Medicine	Washington University	None	NO	Not available	Not available	Serous Cystadenocarcinoma	Not available	A324-10	TRUE
13722.58cfa82fe4b0c9d6adf6b8ca	58cfa82fe4b0c9d6adf6b8ca	TCGA-A4-A4ZT-01A-11D-A26P-10_wgs_Illumina.filtered.	WGS	TCGA-A4-A4ZT-01A-11D-A26P-10_wgs_Illumina	TCGA-A4-A4ZT-01A-11D-A26P-10_wgs_Illumina.bam	55.16	NA	0.09	58cfa82fe4b0c9d6adf6b8ca	TCGA-A4-A4ZT-01A-11D-A26P-10_wgs_Illumina.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Papillary Cell Carcinoma	Aligned reads	TCGA-A4-A4ZT-01A	8B3C068D-5090-4030-8E7E-39DA005DEE79	Primary Tumor	Illumina HiSeq	90b348f5-ec38-4672-a60b-2bf4add19464	Kidney	71	460188E7-2A1E-4C3F-9C96-48C59A3FA9A0	483BB781-0179-42E1-BF9C-487B240769B8	TCGA-A4-A4ZT-01A-11D-A26P-10	GRCh37-lite	TCGA-A4-A4ZT	TCGA-KIRP	NA	s11635	Baylor College of Medicine	International Genomics Consortium	United States	NO	T1b	NX	Kidney Papillary Renal Cell Carcinoma	Stage I	A26P-10	TRUE
13722.58cfa82fe4b0c9d6adf6b691	58cfa82fe4b0c9d6adf6b691	TCGA-36-1570-01A-01D-A324-10_wgs_Illumina.filtered.	WGS	TCGA-36-1570-01A-01D-A324-10_wgs_Illumina	TCGA-36-1570-01A-01D-A324-10_wgs_Illumina.bam	286.97	1.9	0.09	58cfa82fe4b0c9d6adf6b691	TCGA-36-1570-01A-01D-A324-10_wgs_Illumina.bam	Alive	FEMALE	WHITE	Not available	Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-36-1570-01A	0F530B3E-5B6D-4892-9EBD-9138D76FDCA7	Primary Tumor	Illumina HiSeq	7bd2e9c4-4e02-4a02-83d2-c1da3a047b3a	Ovary	49	22B7E0E2-334C-419C-A243-358BA22E479A	A2F38E9E-48B2-4463-B2E3-61CC8475257F	TCGA-36-1570-01A-01D-A324-10	GRCh37-lite	TCGA-36-1570	TCGA-OV	NA	s18070	Baylor College of Medicine	BC Cancer Agency	None	NO	Not available	Not available	Serous Cystadenocarcinoma	Not available	A324-10	TRUE
13722.58cfa82fe4b0c9d6adf6b89b	58cfa82fe4b0c9d6adf6b89b	TCGA-A6-A566-01A-11D-A28G-10_wgs_Illumina.filtered.	WGS	TCGA-A6-A566-01A-11D-A28G-10_wgs_Illumina	TCGA-A6-A566-01A-11D-A28G-10_wgs_Illumina.bam	17.81	NA	0.08	58cfa82fe4b0c9d6adf6b89b	TCGA-A6-A566-01A-11D-A28G-10_wgs_Illumina.bam	Dead	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Colon Adenocarcinoma	Aligned reads	TCGA-A6-A566-01A	790266BC-C252-43F4-85D1-1B06EE529CF8	Primary Tumor	Illumina HiSeq	dd970455-c925-43f6-b58d-24982c846bdd	Colorectal	55	615FDEE9-637E-45C6-8909-36B9201A8EB7	492B4E58-12E2-47B2-BD47-28F8607072FA	TCGA-A6-A566-01A-11D-A28G-10	GRCh37-lite	TCGA-A6-A566	TCGA-COAD	758	s13351	Baylor College of Medicine	Christiana Healthcare	United States	NO	T4	N1	Colon Mucinous Adenocarcinoma	Stage IIIB	A28G-10	TRUE
13722.58cfa82fe4b0c9d6adf6b8d2	58cfa82fe4b0c9d6adf6b8d2	TCGA-61-2000-01A-01D-A324-10_wgs_Illumina.filtered.	WGS	TCGA-61-2000-01A-01D-A324-10_wgs_Illumina	TCGA-61-2000-01A-01D-A324-10_wgs_Illumina.bam	730.97	1.9	0.08	58cfa82fe4b0c9d6adf6b8d2	TCGA-61-2000-01A-01D-A324-10_wgs_Illumina.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-61-2000-01A	29949B65-2913-4C86-BBD7-B85C5DF6F15E	Primary Tumor	Illumina HiSeq	19381aa5-278b-49eb-87b8-c53fac7ee2e4	Ovary	67	FDB8966D-55C9-49BE-80DD-369246604AAD	B243ADB4-B3E7-4E0E-BC0D-625AA8DBB1BE	TCGA-61-2000-01A-01D-A324-10	GRCh37-lite	TCGA-61-2000	TCGA-OV	NA	s17798	Baylor College of Medicine	University of Pittsburgh	None	NO	Not available	Not available	Serous Cystadenocarcinoma	Not available	A324-10	TRUE
13722.58cfa82fe4b0c9d6adf6b92e	58cfa82fe4b0c9d6adf6b92e	TCGA-A4-A57E-01A-11D-A26P-10_wgs_Illumina.filtered.	WGS	TCGA-A4-A57E-01A-11D-A26P-10_wgs_Illumina	TCGA-A4-A57E-01A-11D-A26P-10_wgs_Illumina.bam	37.08	NA	0.08	58cfa82fe4b0c9d6adf6b92e	TCGA-A4-A57E-01A-11D-A26P-10_wgs_Illumina.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Papillary Cell Carcinoma	Aligned reads	TCGA-A4-A57E-01A	D80F601B-1064-4FF0-9C51-7F6AFB22D1F5	Primary Tumor	Illumina HiSeq	8e29468f-f3dd-48a6-9c1a-3bd0083bae2d	Kidney	59	341EA198-C8A2-4675-8077-2C450E9925E1	2DEB8F9A-9E0A-46D1-BCB5-902DB3B5C8AC	TCGA-A4-A57E-01A-11D-A26P-10	GRCh37-lite	TCGA-A4-A57E	TCGA-KIRP	NA	s11637	Baylor College of Medicine	International Genomics Consortium	United States	NO	T2a	N0	Kidney Papillary Renal Cell Carcinoma	Stage IV	A26P-10	TRUE
13722.58cfa830e4b0c9d6adf6bb02	58cfa830e4b0c9d6adf6bb02	TCGA-A6-A567-01A-31D-A28G-10_wgs_Illumina.filtered.	WGS	TCGA-A6-A567-01A-31D-A28G-10_wgs_Illumina	TCGA-A6-A567-01A-31D-A28G-10_wgs_Illumina.bam	29.22	NA	0.08	58cfa830e4b0c9d6adf6bb02	TCGA-A6-A567-01A-31D-A28G-10_wgs_Illumina.bam	Dead	MALE	BLACK OR AFRICAN AMERICAN	Not available	Colon Adenocarcinoma	Aligned reads	TCGA-A6-A567-01A	857A5889-19E7-4208-8362-F1377C408037	Primary Tumor	Illumina HiSeq	062aa65c-624a-4bc6-97bc-6c35e7dc0ba3	Colorectal	56	ED37A5C0-341C-4ECC-8FB8-4B705E76E2AF	05486349-24A4-4931-BF5F-C9FEFE369AF2	TCGA-A6-A567-01A-31D-A28G-10	GRCh37-lite	TCGA-A6-A567	TCGA-COAD	1881	s12854	Baylor College of Medicine	Christiana Healthcare	United States	NO	T3	N1	Colon Adenocarcinoma	Stage IV	A28G-10	TRUE
13722.58cfa82fe4b0c9d6adf6b80a	58cfa82fe4b0c9d6adf6b80a	TCGA-36-1571-01A-01D-A324-10_wgs_Illumina.filtered.	WGS	TCGA-36-1571-01A-01D-A324-10_wgs_Illumina	TCGA-36-1571-01A-01D-A324-10_wgs_Illumina.bam	740.97	1.9	0.07	58cfa82fe4b0c9d6adf6b80a	TCGA-36-1571-01A-01D-A324-10_wgs_Illumina.bam	Dead	FEMALE	WHITE	Not available	Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-36-1571-01A	12581634-EEBB-4841-8498-71DC9D78C546	Primary Tumor	Illumina HiSeq	9c491361-7721-46fe-ae77-f268796b5b9a	Ovary	53	A1D026C2-4D7A-4454-A8E3-30E5C243ABA0	BA577913-356C-4488-8F9D-C45778E7B9E1	TCGA-36-1571-01A-01D-A324-10	GRCh37-lite	TCGA-36-1571	TCGA-OV	695	s17463	Baylor College of Medicine	BC Cancer Agency	None	NO	Not available	Not available	Serous Cystadenocarcinoma	Not available	A324-10	TRUE
13722.58cfa830e4b0c9d6adf6bc36	58cfa830e4b0c9d6adf6bc36	TCGA-AL-3467-01A-02D-1402-10_wgs_Illumina.filtered.	WGS	TCGA-AL-3467-01A-02D-1402-10_wgs_Illumina	TCGA-AL-3467-01A-02D-1402-10_wgs_Illumina.bam	305.07	1.9	0.05	58cfa830e4b0c9d6adf6bc36	TCGA-AL-3467-01A-02D-1402-10_wgs_Illumina.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Papillary Cell Carcinoma	Aligned reads	TCGA-AL-3467-01A	4D02010E-9E69-40D3-9BF0-3D4510AA0614	Primary Tumor	Illumina HiSeq	23233f91-10b3-48ca-9864-1ed41832b031	Kidney	54	70E32971-74E6-4C92-8424-D10541D39360	74C4C45F-818F-43A6-82A0-8E3E4EFDA26B	TCGA-AL-3467-01A-02D-1402-10	GRCh37-lite	TCGA-AL-3467	TCGA-KIRP	NA	s11580	Baylor College of Medicine	Fox Chase	None	NO	T1b	NX	Kidney Papillary Renal Cell Carcinoma	Not available	1402-10	FALSE
13722.58cfa82fe4b0c9d6adf6b8e1	58cfa82fe4b0c9d6adf6b8e1	TCGA-A6-A56B-01A-31D-A28G-10_wgs_Illumina.filtered.	WGS	TCGA-A6-A56B-01A-31D-A28G-10_wgs_Illumina	TCGA-A6-A56B-01A-31D-A28G-10_wgs_Illumina.bam	38.26	NA	0.08	58cfa82fe4b0c9d6adf6b8e1	TCGA-A6-A56B-01A-31D-A28G-10_wgs_Illumina.bam	Alive	MALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Colon Adenocarcinoma	Aligned reads	TCGA-A6-A56B-01A	74A0264D-1D31-430D-9A88-E7334C8AA96C	Primary Tumor	Illumina HiSeq	319d9aec-3e76-4b48-b4a8-9ffcb0f3acc4	Colorectal	57	4425892C-8C35-4F6C-B531-1EC510AD19D2	D3D65DB3-36F9-41C7-8E5E-1683CE94DFCB	TCGA-A6-A56B-01A-31D-A28G-10	GRCh37-lite	TCGA-A6-A56B	TCGA-COAD	NA	s13353	Baylor College of Medicine	Christiana Healthcare	United States	NO	T3	N1	Colon Adenocarcinoma	Stage IIIB	A28G-10	TRUE
13722.58cfa82fe4b0c9d6adf6ba25	58cfa82fe4b0c9d6adf6ba25	TCGA-A3-3363-01A-01D-2094-10_wgs_Illumina.filtered.	WGS	TCGA-A3-3363-01A-01D-2094-10_wgs_Illumina	TCGA-A3-3363-01A-01D-2094-10_wgs_Illumina.bam	864.57	1.9	0.14	58cfa82fe4b0c9d6adf6ba25	TCGA-A3-3363-01A-01D-2094-10_wgs_Illumina.bam	Alive	MALE	ASIAN	Not available	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-A3-3363-01A	659294B9-DED9-498A-BC00-C1D4D456AA4A	Primary Tumor	Illumina HiSeq	cbce285a-a226-46dc-9f92-dfe98700c750	Kidney	50	605E86AC-58F6-47D4-8BDE-15EB23C857CC	0F53E757-1823-409F-A0EA-249270728E15	TCGA-A3-3363-01A-01D-2094-10	GRCh37-lite	TCGA-A3-3363	TCGA-KIRC	NA	s9301	Baylor College of Medicine	International Genomics Consortium	None	NO	T2	N0	Kidney Clear Cell Renal Carcinoma	Stage II	2094-10	FALSE
13722.58cfa830e4b0c9d6adf6bb0d	58cfa830e4b0c9d6adf6bb0d	TCGA-A6-A565-01A-31D-A28G-10_wgs_Illumina.filtered.	WGS	TCGA-A6-A565-01A-31D-A28G-10_wgs_Illumina	TCGA-A6-A565-01A-31D-A28G-10_wgs_Illumina.bam	27.34	NA	0.08	58cfa830e4b0c9d6adf6bb0d	TCGA-A6-A565-01A-31D-A28G-10_wgs_Illumina.bam	Dead	FEMALE	BLACK OR AFRICAN AMERICAN	Not available	Colon Adenocarcinoma	Aligned reads	TCGA-A6-A565-01A	DD7A53EE-CB08-40C4-9935-51D1CA17E9E8	Primary Tumor	Illumina HiSeq	94ddbe0f-9753-4acc-abe8-2bfda86dd8b2	Colorectal	34	87A57810-8B62-4AF1-ADB9-4715A71ED632	63BC376E-5A3D-44FD-8D77-686DFC41E458	TCGA-A6-A565-01A-31D-A28G-10	GRCh37-lite	TCGA-A6-A565	TCGA-COAD	494	s13657	Baylor College of Medicine	Christiana Healthcare	United States	NO	T3	N2	Colon Mucinous Adenocarcinoma	Stage IIIC	A28G-10	TRUE
13722.58cfa830e4b0c9d6adf6bc4c	58cfa830e4b0c9d6adf6bc4c	TCGA-AL-3473-01A-01D-1253-10_wgs_Illumina.filtered.	WGS	TCGA-AL-3473-01A-01D-1253-10_wgs_Illumina	TCGA-AL-3473-01A-01D-1253-10_wgs_Illumina.bam	543	1.9	0.14	58cfa830e4b0c9d6adf6bc4c	TCGA-AL-3473-01A-01D-1253-10_wgs_Illumina.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Papillary Cell Carcinoma	Aligned reads	TCGA-AL-3473-01A	A7BF785F-0539-4899-AC21-47D1FC347EE8	Primary Tumor	Illumina HiSeq	7f8267f9-4d48-48c6-aebb-a596aaf7755c	Kidney	55	DE88A41B-8A32-40D6-9C0B-1FE2303D8AD2	14DD86C1-DFB3-4124-A453-4D64223BC048	TCGA-AL-3473-01A-01D-1253-10	GRCh37-lite	TCGA-AL-3473	TCGA-KIRP	NA	s11638	Baylor College of Medicine	Fox Chase	None	NO	T2	N0	Kidney Papillary Renal Cell Carcinoma	Stage II	1253-10	FALSE
13722.58cfa830e4b0c9d6adf6bc4a	58cfa830e4b0c9d6adf6bc4a	TCGA-AL-3468-01A-02D-1402-10_wgs_Illumina.filtered.	WGS	TCGA-AL-3468-01A-02D-1402-10_wgs_Illumina	TCGA-AL-3468-01A-02D-1402-10_wgs_Illumina.bam	171.07	1.9	0.05	58cfa830e4b0c9d6adf6bc4a	TCGA-AL-3468-01A-02D-1402-10_wgs_Illumina.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Papillary Cell Carcinoma	Aligned reads	TCGA-AL-3468-01A	2272C592-B9B6-4483-9F7F-6E185699B900	Primary Tumor	Illumina HiSeq	2cdb23d3-23d0-4aef-9ab9-0f01c712eafa	Kidney	74	2E825CE0-8121-4D0F-B876-905A1DF66D46	19D6CF34-1CD7-4242-A4D1-5D3E11F428AA	TCGA-AL-3468-01A-02D-1402-10	GRCh37-lite	TCGA-AL-3468	TCGA-KIRP	NA	s11578	Baylor College of Medicine	Fox Chase	United States	NO	T2	NX	Kidney Papillary Renal Cell Carcinoma	Stage II	1402-10	FALSE
13722.58cfa830e4b0c9d6adf6bdba	58cfa830e4b0c9d6adf6bdba	TCGA-BC-A10Q-01A-11D-A12Z-10_wgs_Illumina.filtered.	WGS	TCGA-BC-A10Q-01A-11D-A12Z-10_wgs_Illumina	TCGA-BC-A10Q-01A-11D-A12Z-10_wgs_Illumina.bam	43.79	1.91	0.08	58cfa830e4b0c9d6adf6bdba	TCGA-BC-A10Q-01A-11D-A12Z-10_wgs_Illumina.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Liver Hepatocellular Carcinoma	Aligned reads	TCGA-BC-A10Q-01A	DFA15FBE-BB14-40CE-AFC6-70694112E3E2	Primary Tumor	Illumina HiSeq	64b40e86-f174-43b5-8a08-7ad687b13815	Liver	72	BF225DC1-4309-4304-849E-CBCC23C8442C	F7E9EED5-7A0B-4B2D-BEA3-FD8C42A3B90E	TCGA-BC-A10Q-01A-11D-A12Z-10	GRCh37-lite	TCGA-BC-A10Q	TCGA-LIHC	1135	s16670	Baylor College of Medicine	UNC	United States	NO	T2	NX	Hepatocellular Carcinoma	Not available	A12Z-10	TRUE
13722.58cfa830e4b0c9d6adf6be71	58cfa830e4b0c9d6adf6be71	TCGA-BP-4326-01A-01D-2097-10_wgs_Illumina.filtered.	WGS	TCGA-BP-4326-01A-01D-2097-10_wgs_Illumina	TCGA-BP-4326-01A-01D-2097-10_wgs_Illumina.bam	109	1.9	0.14	58cfa830e4b0c9d6adf6be71	TCGA-BP-4326-01A-01D-2097-10_wgs_Illumina.bam	Alive	FEMALE	WHITE	Not available	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-BP-4326-01A	7664C241-B369-4D76-9CD1-7F2BDC1D267F	Primary Tumor	Illumina HiSeq	8d64ee9c-1973-46e9-8ad7-1d9c3a96a47c	Kidney	53	068BFE4D-341C-49F7-B7A9-5D070DE00AB3	54842328-9432-4820-8976-7964BF9BF147	TCGA-BP-4326-01A-01D-2097-10	GRCh37-lite	TCGA-BP-4326	TCGA-KIRC	NA	s9163	Baylor College of Medicine	MSKCC	None	NO	T1b	N0	Kidney Clear Cell Renal Carcinoma	Stage I	2097-10	FALSE
13722.58cfa830e4b0c9d6adf6be22	58cfa830e4b0c9d6adf6be22	TCGA-B9-4113-01A-01D-1253-10_wgs_Illumina.filtered.	WGS	TCGA-B9-4113-01A-01D-1253-10_wgs_Illumina	TCGA-B9-4113-01A-01D-1253-10_wgs_Illumina.bam	0	1.9	0.15	58cfa830e4b0c9d6adf6be22	TCGA-B9-4113-01A-01D-1253-10_wgs_Illumina.bam	Dead	MALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Kidney Renal Papillary Cell Carcinoma	Aligned reads	TCGA-B9-4113-01A	5C9A6C40-982E-45C7-98D3-AEB6CAD16986	Primary Tumor	Illumina HiSeq	946b3469-d936-4438-8fc4-3075da99cd4d	Kidney	64	DDDC5575-D88F-4F4E-B591-96F11403184B	F03330DD-C616-4AD5-ABC3-6D6B0445E9E9	TCGA-B9-4113-01A-01D-1253-10	GRCh37-lite	TCGA-B9-4113	TCGA-KIRP	1536	s11585	Baylor College of Medicine	UNC	None	NO	T1	NX	Kidney Papillary Renal Cell Carcinoma	Stage I	1253-10	FALSE
13722.58cfa830e4b0c9d6adf6bca2	58cfa830e4b0c9d6adf6bca2	TCGA-AZ-4315-01A-01W-1461-10_wgs_Illumina.filtered.	WGS	TCGA-AZ-4315-01A-01W-1461-10_wgs_Illumina	TCGA-AZ-4315-01A-01W-1461-10_wgs_Illumina.bam	171	NA	0.5	58cfa830e4b0c9d6adf6bca2	TCGA-AZ-4315-01A-01W-1461-10_wgs_Illumina.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Colon Adenocarcinoma	Aligned reads	TCGA-AZ-4315-01A	DE287A25-981D-49F8-81AF-FE0300E4CD31	Primary Tumor	Illumina HiSeq	707a2d43-0ea1-4012-8f29-4202690c6608	Colorectal	61	BA9E5603-BB1D-4AA8-93E4-40043164F143	A9D1B074-7F36-4A04-B270-A2061249FF20	TCGA-AZ-4315-01A-01W-1461-10	GRCh37-lite	TCGA-AZ-4315	TCGA-COAD	NA	s13211	Baylor College of Medicine	University of Pittsburgh	None	NO	T3	N0	Colon Adenocarcinoma	Stage IIA	1461-10	FALSE
13722.58cfa830e4b0c9d6adf6bcb3	58cfa830e4b0c9d6adf6bcb3	TCGA-B0-5695-01A-11D-2103-10_wgs_Illumina.filtered.	WGS	TCGA-B0-5695-01A-11D-2103-10_wgs_Illumina	TCGA-B0-5695-01A-11D-2103-10_wgs_Illumina.bam	239.4	1.9	0.15	58cfa830e4b0c9d6adf6bcb3	TCGA-B0-5695-01A-11D-2103-10_wgs_Illumina.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-B0-5695-01A	FB9BAFA5-7133-4955-8156-4EB6763DC8E1	Primary Tumor	Illumina HiSeq	a8ffeac5-01c4-4dac-92b8-413f4009f4fa	Kidney	61	86E4862C-7405-40B5-B73F-BE0C6C52EA6D	B6365BDB-E6D5-4615-95B3-DB12A0C2F3D9	TCGA-B0-5695-01A-11D-2103-10	GRCh37-lite	TCGA-B0-5695	TCGA-KIRC	NA	s8833	Baylor College of Medicine	University of Pittsburgh	None	NO	T1b	N0	Kidney Clear Cell Renal Carcinoma	Stage I	2103-10	FALSE
13722.58cfa830e4b0c9d6adf6becd	58cfa830e4b0c9d6adf6becd	TCGA-AL-A5DJ-01A-11D-A26P-10_wgs_Illumina.filtered.	WGS	TCGA-AL-A5DJ-01A-11D-A26P-10_wgs_Illumina	TCGA-AL-A5DJ-01A-11D-A26P-10_wgs_Illumina.bam	26.68	NA	0.07	58cfa830e4b0c9d6adf6becd	TCGA-AL-A5DJ-01A-11D-A26P-10_wgs_Illumina.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Papillary Cell Carcinoma	Aligned reads	TCGA-AL-A5DJ-01A	B06CDF61-61C9-4035-A55D-1EF21DC21069	Primary Tumor	Illumina HiSeq	0fd919c5-b847-49f4-b928-4dd15a94c3a0	Kidney	54	BD6B7CBE-57B6-45B9-96F6-4D39B8303407	B4F515CE-5BEE-4E40-A66A-01F41E92181E	TCGA-AL-A5DJ-01A-11D-A26P-10	GRCh37-lite	TCGA-AL-A5DJ	TCGA-KIRP	NA	s11579	Baylor College of Medicine	Fox Chase	United States	NO	T3a	NX	Kidney Papillary Renal Cell Carcinoma	Stage III	A26P-10	TRUE
13722.58cfa830e4b0c9d6adf6bed5	58cfa830e4b0c9d6adf6bed5	TCGA-BP-4756-01A-01D-2097-10_wgs_Illumina.filtered.	WGS	TCGA-BP-4756-01A-01D-2097-10_wgs_Illumina	TCGA-BP-4756-01A-01D-2097-10_wgs_Illumina.bam	133	1.9	0.14	58cfa830e4b0c9d6adf6bed5	TCGA-BP-4756-01A-01D-2097-10_wgs_Illumina.bam	Alive	FEMALE	ASIAN	Not available	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-BP-4756-01A	9ECDDE9C-2179-4830-BD10-C4FA40F26066	Primary Tumor	Illumina HiSeq	21f5c572-343f-4923-af48-99ee2a4ccbdf	Kidney	62	98D425BE-4D70-4260-8C4F-B0EB89E0E4A6	DB4592FB-13C2-4D61-9DC3-A5D43DEF8D4B	TCGA-BP-4756-01A-01D-2097-10	GRCh37-lite	TCGA-BP-4756	TCGA-KIRC	NA	s9164	Baylor College of Medicine	MSKCC	None	NO	T1b	N0	Kidney Clear Cell Renal Carcinoma	Stage I	2097-10	FALSE
13722.58cfa830e4b0c9d6adf6bf19	58cfa830e4b0c9d6adf6bf19	TCGA-AY-A54L-01A-11D-A28G-10_wgs_Illumina.filtered.	WGS	TCGA-AY-A54L-01A-11D-A28G-10_wgs_Illumina	TCGA-AY-A54L-01A-11D-A28G-10_wgs_Illumina.bam	62.42	NA	0.07	58cfa830e4b0c9d6adf6bf19	TCGA-AY-A54L-01A-11D-A28G-10_wgs_Illumina.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	Not available	Colon Adenocarcinoma	Aligned reads	TCGA-AY-A54L-01A	D8E9EA52-FF28-4626-BAA3-71350FD53DDF	Primary Tumor	Illumina HiSeq	709d8bea-f505-4558-b12a-7bd4322e75ea	Colorectal	74	52EFBEB4-7B23-4C49-92F9-931A3EB99055	080ECC31-756A-4A1B-A51E-D632AC8219F7	TCGA-AY-A54L-01A-11D-A28G-10	GRCh37-lite	TCGA-AY-A54L	TCGA-COAD	NA	s13542	Baylor College of Medicine	UNC	United States	NO	T2	N0	Colon Adenocarcinoma	Stage I	A28G-10	TRUE
13722.58cfa830e4b0c9d6adf6c000	58cfa830e4b0c9d6adf6c000	TCGA-B3-4104-01A-02D-1402-10_wgs_Illumina.filtered.	WGS	TCGA-B3-4104-01A-02D-1402-10_wgs_Illumina	TCGA-B3-4104-01A-02D-1402-10_wgs_Illumina.bam	198.07	1.9	0.05	58cfa830e4b0c9d6adf6c000	TCGA-B3-4104-01A-02D-1402-10_wgs_Illumina.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Papillary Cell Carcinoma	Aligned reads	TCGA-B3-4104-01A	E15A108E-0B32-426F-926A-3FB1AF0A82D3	Primary Tumor	Illumina HiSeq	bf671eff-6fe3-4498-b767-06041f20c7e5	Kidney	75	BB0EFB98-DB70-499D-BC72-56AF138C419C	8E0F02B3-2BC5-4E1B-BA7E-809CB7FDB58C	TCGA-B3-4104-01A-02D-1402-10	GRCh37-lite	TCGA-B3-4104	TCGA-KIRP	NA	s11642	Baylor College of Medicine	Christiana Healthcare	None	NO	T2	NX	Kidney Papillary Renal Cell Carcinoma	Stage II	1402-10	FALSE
13722.58cfa830e4b0c9d6adf6c005	58cfa830e4b0c9d6adf6c005	TCGA-B3-4103-01A-02D-1402-10_wgs_Illumina.filtered.	WGS	TCGA-B3-4103-01A-02D-1402-10_wgs_Illumina	TCGA-B3-4103-01A-02D-1402-10_wgs_Illumina.bam	216.07	1.9	0.05	58cfa830e4b0c9d6adf6c005	TCGA-B3-4103-01A-02D-1402-10_wgs_Illumina.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Papillary Cell Carcinoma	Aligned reads	TCGA-B3-4103-01A	1A726069-0B44-42AD-9A20-0EE90B31796B	Primary Tumor	Illumina HiSeq	e00b0cfe-8b23-4f21-998f-957efbc26955	Kidney	56	3829FA12-FDD5-4829-8F00-BDFBB057F23E	1DA96C26-20A5-435A-8CA3-9F698B8652A2	TCGA-B3-4103-01A-02D-1402-10	GRCh37-lite	TCGA-B3-4103	TCGA-KIRP	NA	s11853	Baylor College of Medicine	Christiana Healthcare	None	NO	T1a	NX	Kidney Papillary Renal Cell Carcinoma	Stage I	1402-10	FALSE
13722.58cfa830e4b0c9d6adf6c140	58cfa830e4b0c9d6adf6c140	TCGA-BA-6872-01A-11D-A32X-10_wgs_Illumina.filtered.	WGS	TCGA-BA-6872-01A-11D-A32X-10_wgs_Illumina	TCGA-BA-6872-01A-11D-A32X-10_wgs_Illumina.bam	89.7	1.9	0.07	58cfa830e4b0c9d6adf6c140	TCGA-BA-6872-01A-11D-A32X-10_wgs_Illumina.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-BA-6872-01A	3E5F451A-5882-4914-AE1A-95C898C2BCCA	Primary Tumor	Illumina HiSeq	28a6e3a3-207f-4df1-bdb3-c63373ce9ba2	Head and Neck	47	04107A58-667D-4712-B972-61837EFF6029	C76F7FCC-2748-4B6D-805E-D21652DD5E3A	TCGA-BA-6872-01A-11D-A32X-10	GRCh37-lite	TCGA-BA-6872	TCGA-HNSC	384	s16028	Baylor College of Medicine	UNC	United States	NO	TX	NX	Head and Neck Squamous Cell Carcinoma	Not available	A32X-10	TRUE
13722.58cfa830e4b0c9d6adf6c00e	58cfa830e4b0c9d6adf6c00e	TCGA-B3-3926-01A-02D-1402-10_wgs_Illumina.filtered.	WGS	TCGA-B3-3926-01A-02D-1402-10_wgs_Illumina	TCGA-B3-3926-01A-02D-1402-10_wgs_Illumina.bam	191.07	1.9	0.05	58cfa830e4b0c9d6adf6c00e	TCGA-B3-3926-01A-02D-1402-10_wgs_Illumina.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Papillary Cell Carcinoma	Aligned reads	TCGA-B3-3926-01A	2666AB3E-F2B9-4B3D-BFCE-AAC2A4BAFE62	Primary Tumor	Illumina HiSeq	7825c6ac-6e33-4e1d-82cc-35cf60c16253	Kidney	59	3BB75DF9-E710-4F3D-B1B1-A4D459EB376F	72293A70-9DC8-4E4A-ACDC-C74587A90420	TCGA-B3-3926-01A-02D-1402-10	GRCh37-lite	TCGA-B3-3926	TCGA-KIRP	NA	s11582	Baylor College of Medicine	Christiana Healthcare	None	NO	T1	NX	Kidney Papillary Renal Cell Carcinoma	Stage I	1402-10	FALSE
13722.58cfa830e4b0c9d6adf6c14d	58cfa830e4b0c9d6adf6c14d	TCGA-BA-5556-01A-01D-A32X-10_wgs_Illumina.filtered.	WGS	TCGA-BA-5556-01A-01D-A32X-10_wgs_Illumina	TCGA-BA-5556-01A-01D-A32X-10_wgs_Illumina.bam	116.7	1.9	0.08	58cfa830e4b0c9d6adf6c14d	TCGA-BA-5556-01A-01D-A32X-10_wgs_Illumina.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-BA-5556-01A	70741B73-9683-42BD-87FC-6A021A70103B	Primary Tumor	Illumina HiSeq	e855f092-899d-469a-981c-5094b07c31ac	Head and Neck	58	C00EEDDB-6AE2-48BA-8677-C174E579A724	8294A969-59A1-4D3B-895B-F07E96BF9F7A	TCGA-BA-5556-01A-01D-A32X-10	GRCh37-lite	TCGA-BA-5556	TCGA-HNSC	NA	s16319	Baylor College of Medicine	UNC	None	NO	T2	N0	Head and Neck Squamous Cell Carcinoma	Stage II	A32X-10	TRUE
13722.58cfa830e4b0c9d6adf6c048	58cfa830e4b0c9d6adf6c048	TCGA-B3-3925-01A-02D-1402-10_wgs_Illumina.filtered.	WGS	TCGA-B3-3925-01A-02D-1402-10_wgs_Illumina	TCGA-B3-3925-01A-02D-1402-10_wgs_Illumina.bam	241.07	1.9	0.05	58cfa830e4b0c9d6adf6c048	TCGA-B3-3925-01A-02D-1402-10_wgs_Illumina.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Papillary Cell Carcinoma	Aligned reads	TCGA-B3-3925-01A	75A53BFF-BF0F-4AD8-9B8E-14A27914D4F2	Primary Tumor	Illumina HiSeq	9130f58c-9250-4f4f-a60d-028366b76852	Kidney	52	16223531-33C3-4D2C-8715-FA9899CEE168	42F88B95-FA12-47C7-93F1-CF72F207291C	TCGA-B3-3925-01A-02D-1402-10	GRCh37-lite	TCGA-B3-3925	TCGA-KIRP	NA	s11770	Baylor College of Medicine	Christiana Healthcare	None	NO	T3a	NX	Kidney Papillary Renal Cell Carcinoma	Stage III	1402-10	FALSE
13722.58cfa830e4b0c9d6adf6c156	58cfa830e4b0c9d6adf6c156	TCGA-B9-4117-01A-02D-1402-10_wgs_Illumina.filtered.	WGS	TCGA-B9-4117-01A-02D-1402-10_wgs_Illumina	TCGA-B9-4117-01A-02D-1402-10_wgs_Illumina.bam	155.07	1.9	0.05	58cfa830e4b0c9d6adf6c156	TCGA-B9-4117-01A-02D-1402-10_wgs_Illumina.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Kidney Renal Papillary Cell Carcinoma	Aligned reads	TCGA-B9-4117-01A	71B35CD8-ECEE-4599-BB24-B1EF78118423	Primary Tumor	Illumina HiSeq	4d9a1f84-a989-4caa-84d2-36d42c950675	Kidney	48	F3871637-192D-4324-9C59-CECFFF436356	6BA5F81A-B7A0-4C18-A112-2E11094EEC85	TCGA-B9-4117-01A-02D-1402-10	GRCh37-lite	TCGA-B9-4117	TCGA-KIRP	NA	s11776	Baylor College of Medicine	UNC	None	NO	T2	NX	Kidney Papillary Renal Cell Carcinoma	Not available	1402-10	FALSE
13722.58cfa830e4b0c9d6adf6c15e	58cfa830e4b0c9d6adf6c15e	TCGA-BA-6869-01A-11D-A32X-10_wgs_Illumina.filtered.	WGS	TCGA-BA-6869-01A-11D-A32X-10_wgs_Illumina	TCGA-BA-6869-01A-11D-A32X-10_wgs_Illumina.bam	379.7	1.9	0.07	58cfa830e4b0c9d6adf6c15e	TCGA-BA-6869-01A-11D-A32X-10_wgs_Illumina.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-BA-6869-01A	FAFD6F5B-1D76-4537-BD1C-E0BD7B4E2166	Primary Tumor	Illumina HiSeq	e35c380b-a1ee-47e3-b382-139ed8640d98	Head and Neck	62	F4ED2C84-39F8-4AB3-8762-A9920ACC2432	3E604A1C-B95F-44FF-9723-E2FAC845DA3B	TCGA-BA-6869-01A-11D-A32X-10	GRCh37-lite	TCGA-BA-6869	TCGA-HNSC	NA	s15615	Baylor College of Medicine	UNC	United States	NO	T3	N0	Head and Neck Squamous Cell Carcinoma	Stage III	A32X-10	TRUE
13722.58cfa830e4b0c9d6adf6c198	58cfa830e4b0c9d6adf6c198	TCGA-B9-4116-01A-02D-1402-10_wgs_Illumina.filtered.	WGS	TCGA-B9-4116-01A-02D-1402-10_wgs_Illumina	TCGA-B9-4116-01A-02D-1402-10_wgs_Illumina.bam	149.07	1.8	0.05	58cfa830e4b0c9d6adf6c198	TCGA-B9-4116-01A-02D-1402-10_wgs_Illumina.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Kidney Renal Papillary Cell Carcinoma	Aligned reads	TCGA-B9-4116-01A	4EDD92E1-5DA5-49A3-80E4-FA456AA425B8	Primary Tumor	Illumina HiSeq	23059106-498b-44b7-a1a9-72b42dcd751c	Kidney	75	DAC245C0-39A0-40D3-8FE1-E33F97B95D27	E6801359-D1D7-4871-B2FB-180674A2E469	TCGA-B9-4116-01A-02D-1402-10	GRCh37-lite	TCGA-B9-4116	TCGA-KIRP	NA	s11772	Baylor College of Medicine	UNC	None	NO	T2a	NX	Kidney Papillary Renal Cell Carcinoma	Not available	1402-10	FALSE
13722.58cfa830e4b0c9d6adf6bc5e	58cfa830e4b0c9d6adf6bc5e	TCGA-AL-3472-01A-01D-1253-10_wgs_Illumina.filtered.	WGS	TCGA-AL-3472-01A-01D-1253-10_wgs_Illumina	TCGA-AL-3472-01A-01D-1253-10_wgs_Illumina.bam	543	1.9	0.13	58cfa830e4b0c9d6adf6bc5e	TCGA-AL-3472-01A-01D-1253-10_wgs_Illumina.bam	Alive	MALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Kidney Renal Papillary Cell Carcinoma	Aligned reads	TCGA-AL-3472-01A	42D044AE-1416-477D-AC80-779C49BC8D35	Primary Tumor	Illumina HiSeq	8f19974d-a670-4221-82fc-60d3918c19e0	Kidney	57	7EEA5C2A-F1A2-432E-88A2-E96B809E15D9	63D0C49D-918D-41FB-808A-1F8001981917	TCGA-AL-3472-01A-01D-1253-10	GRCh37-lite	TCGA-AL-3472	TCGA-KIRP	NA	s11852	Baylor College of Medicine	Fox Chase	None	NO	T2	N0	Kidney Papillary Renal Cell Carcinoma	Not available	1253-10	FALSE
13722.58cfa830e4b0c9d6adf6c1c8	58cfa830e4b0c9d6adf6c1c8	TCGA-BC-A217-01A-11D-A152-10_wgs_Illumina.filtered.	WGS	TCGA-BC-A217-01A-11D-A152-10_wgs_Illumina	TCGA-BC-A217-01A-11D-A152-10_wgs_Illumina.bam	102.31	1.74	0.09	58cfa830e4b0c9d6adf6c1c8	TCGA-BC-A217-01A-11D-A152-10_wgs_Illumina.bam	Alive	FEMALE	WHITE	Not available	Liver Hepatocellular Carcinoma	Aligned reads	TCGA-BC-A217-01A	6DCFC418-AB28-4365-95EA-C1AE254F2341	Primary Tumor	Illumina HiSeq	a8b86f30-113b-4e02-98d3-b1dae29380d3	Liver	75	C827A8B9-359C-4A6F-B950-839B3FB0C097	2BFF30D5-BE79-4686-8164-7A7D9619D3C0	TCGA-BC-A217-01A-11D-A152-10	GRCh37-lite	TCGA-BC-A217	TCGA-LIHC	NA	s17057	Baylor College of Medicine	UNC	United States	NO	T2	NX	Hepatocellular Carcinoma	Stage II	A152-10	TRUE
13722.58cfa830e4b0c9d6adf6c1e6	58cfa830e4b0c9d6adf6c1e6	TCGA-AL-3466-01A-02D-1402-10_wgs_Illumina.filtered.	WGS	TCGA-AL-3466-01A-02D-1402-10_wgs_Illumina	TCGA-AL-3466-01A-02D-1402-10_wgs_Illumina.bam	151.07	1.9	0.05	58cfa830e4b0c9d6adf6c1e6	TCGA-AL-3466-01A-02D-1402-10_wgs_Illumina.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Papillary Cell Carcinoma	Aligned reads	TCGA-AL-3466-01A	9FC40B03-0B56-4B1F-93ED-DBC455AE3FD9	Primary Tumor	Illumina HiSeq	e3c3f7d5-b1b3-4a59-be19-a675fd939ad5	Kidney	41	D74C7152-798F-4913-95D3-67AC834204F0	642E1379-1061-40BC-9A4C-F7C191E84D9D	TCGA-AL-3466-01A-02D-1402-10	GRCh37-lite	TCGA-AL-3466	TCGA-KIRP	293	s11766	Baylor College of Medicine	Fox Chase	None	NO	T3b	N1	Kidney Papillary Renal Cell Carcinoma	Stage IV	1402-10	FALSE
13722.58cfa830e4b0c9d6adf6c178	58cfa830e4b0c9d6adf6c178	TCGA-B9-4115-01A-01D-1554-10_wgs_Illumina.filtered.	WGS	TCGA-B9-4115-01A-01D-1554-10_wgs_Illumina	TCGA-B9-4115-01A-01D-1554-10_wgs_Illumina.bam	374.67	1.9	0.05	58cfa830e4b0c9d6adf6c178	TCGA-B9-4115-01A-01D-1554-10_wgs_Illumina.bam	Alive	MALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Kidney Renal Papillary Cell Carcinoma	Aligned reads	TCGA-B9-4115-01A	A121406A-30B2-4717-AE96-EDCB17D911E2	Primary Tumor	Illumina HiSeq	4971043f-212e-4a2c-a9db-7e10c9203ce1	Kidney	53	31769C98-8882-44E9-B61B-417903B3E4F5	0ED63D84-D3FE-4289-9255-35F4A03B703B	TCGA-B9-4115-01A-01D-1554-10	GRCh37-lite	TCGA-B9-4115	TCGA-KIRP	NA	s11858	Baylor College of Medicine	UNC	None	NO	T1a	NX	Kidney Papillary Renal Cell Carcinoma	Stage I	1554-10	FALSE
13722.58cfa830e4b0c9d6adf6c1d6	58cfa830e4b0c9d6adf6c1d6	TCGA-BC-A216-01A-11D-A152-10_wgs_Illumina.filtered.	WGS	TCGA-BC-A216-01A-11D-A152-10_wgs_Illumina	TCGA-BC-A216-01A-11D-A152-10_wgs_Illumina.bam	85.26	1.85	0.09	58cfa830e4b0c9d6adf6c1d6	TCGA-BC-A216-01A-11D-A152-10_wgs_Illumina.bam	Alive	FEMALE	WHITE	Not available	Liver Hepatocellular Carcinoma	Aligned reads	TCGA-BC-A216-01A	4BBDBE77-F3CB-4B64-9826-72DEBB734784	Primary Tumor	Illumina HiSeq	b808f3c9-f5be-4c4d-af62-4389365badbb	Liver	62	F8B5247F-5276-4189-9041-2D914482D539	C1D9ED06-7498-4C6C-A0DE-DBF28E868109	TCGA-BC-A216-01A-11D-A152-10	GRCh37-lite	TCGA-BC-A216	TCGA-LIHC	NA	s16672	Baylor College of Medicine	UNC	United States	NO	T3	NX	Hepatocellular Carcinoma	Stage IIIA	A152-10	TRUE
13722.58cfa830e4b0c9d6adf6c2a2	58cfa830e4b0c9d6adf6c2a2	TCGA-BP-4807-01A-01D-2098-10_wgs_Illumina.filtered.	WGS	TCGA-BP-4807-01A-01D-2098-10_wgs_Illumina	TCGA-BP-4807-01A-01D-2098-10_wgs_Illumina.bam	91.4	1.9	0.16	58cfa830e4b0c9d6adf6c2a2	TCGA-BP-4807-01A-01D-2098-10_wgs_Illumina.bam	Alive	MALE	WHITE	Not available	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-BP-4807-01A	33CF0893-0411-4758-AA90-602BFEDF0850	Primary Tumor	Illumina HiSeq	929b4e29-102f-48e2-a919-ff967127437e	Kidney	42	26307437-2F30-4647-81AC-F6BAE5BE6113	A54AAC0E-4108-49CF-BF50-687031C7CDA6	TCGA-BP-4807-01A-01D-2098-10	GRCh37-lite	TCGA-BP-4807	TCGA-KIRC	NA	s9447	Baylor College of Medicine	MSKCC	None	NO	T1a	NX	Kidney Clear Cell Renal Carcinoma	Stage I	2098-10	TRUE
13722.58cfa830e4b0c9d6adf6c23e	58cfa830e4b0c9d6adf6c23e	TCGA-BW-A5NQ-01A-11D-A27I-10_wgs_Illumina.filtered.	WGS	TCGA-BW-A5NQ-01A-11D-A27I-10_wgs_Illumina	TCGA-BW-A5NQ-01A-11D-A27I-10_wgs_Illumina.bam	66.53	NA	0.07	58cfa830e4b0c9d6adf6c23e	TCGA-BW-A5NQ-01A-11D-A27I-10_wgs_Illumina.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Liver Hepatocellular Carcinoma	Aligned reads	TCGA-BW-A5NQ-01A	C7F1B389-AEC7-4993-8AFB-B7A56064F8FC	Primary Tumor	Illumina HiSeq	4bbd34a1-0024-44aa-9e51-9ac4c51c7f1d	Liver	63	C8FFE03A-62C3-4B47-9DEA-CB3377F59ABB	E30C64D5-E796-4CFC-8DC8-6E62BF97822F	TCGA-BW-A5NQ-01A-11D-A27I-10	GRCh37-lite	TCGA-BW-A5NQ	TCGA-LIHC	NA	s16848	Baylor College of Medicine	St Joseph's Medical Center (MD)	United States	NO	T1	NX	Hepatocellular Carcinoma	Stage I	A27I-10	TRUE
13722.58cfa830e4b0c9d6adf6c28c	58cfa830e4b0c9d6adf6c28c	TCGA-AD-A5EJ-01A-11D-A28G-10_wgs_Illumina.filtered.	WGS	TCGA-AD-A5EJ-01A-11D-A28G-10_wgs_Illumina	TCGA-AD-A5EJ-01A-11D-A28G-10_wgs_Illumina.bam	40.09	NA	0.07	58cfa830e4b0c9d6adf6c28c	TCGA-AD-A5EJ-01A-11D-A28G-10_wgs_Illumina.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Colon Adenocarcinoma	Aligned reads	TCGA-AD-A5EJ-01A	613AA3E8-A70B-45A9-9C08-0C2346C8BF00	Primary Tumor	Illumina HiSeq	ce0bf9ea-efa0-4c54-8970-a703051d667e	Colorectal	74	F675116A-BFEC-47AE-AC24-9B61DD3CC6C1	711C8A16-3CF8-42D8-B29E-FD1E9EF1C82B	TCGA-AD-A5EJ-01A-11D-A28G-10	GRCh37-lite	TCGA-AD-A5EJ	TCGA-COAD	NA	s13538	Baylor College of Medicine	International Genomics Consortium	United States	NO	T3	N0	Colon Adenocarcinoma	Stage IIA	A28G-10	TRUE
13722.58cfa831e4b0c9d6adf6c3e3	58cfa831e4b0c9d6adf6c3e3	TCGA-CC-5260-01A-01D-A12Z-10_wgs_Illumina.filtered.	WGS	TCGA-CC-5260-01A-01D-A12Z-10_wgs_Illumina	TCGA-CC-5260-01A-01D-A12Z-10_wgs_Illumina.bam	91.26	1.95	0.08	58cfa831e4b0c9d6adf6c3e3	TCGA-CC-5260-01A-01D-A12Z-10_wgs_Illumina.bam	Alive	FEMALE	ASIAN	NOT HISPANIC OR LATINO	Liver Hepatocellular Carcinoma	Aligned reads	TCGA-CC-5260-01A	CA8AFB2C-BE3D-41E8-8DBC-19FE7AB6154B	Primary Tumor	Illumina HiSeq	94aaf939-2195-4c49-b867-778f3670e7ff	Liver	61	7F347680-CD4D-4289-8F8F-3B0541381A42	3BACC189-01B8-46CC-A442-F393C0F428C6	TCGA-CC-5260-01A-01D-A12Z-10	GRCh37-lite	TCGA-CC-5260	TCGA-LIHC	NA	s16581	Baylor College of Medicine	ILSbio	None	NO	T4	N0	Hepatocellular Carcinoma	Stage IIIC	A12Z-10	TRUE
13722.58cfa831e4b0c9d6adf6c3b6	58cfa831e4b0c9d6adf6c3b6	TCGA-CC-5262-01A-01D-A21X-10_wgs_Illumina.filtered.	WGS	TCGA-CC-5262-01A-01D-A21X-10_wgs_Illumina	TCGA-CC-5262-01A-01D-A21X-10_wgs_Illumina.bam	73.73	1.92	0.07	58cfa831e4b0c9d6adf6c3b6	TCGA-CC-5262-01A-01D-A21X-10_wgs_Illumina.bam	Alive	MALE	ASIAN	NOT HISPANIC OR LATINO	Liver Hepatocellular Carcinoma	Aligned reads	TCGA-CC-5262-01A	1B428ADA-EB3F-40C2-B4BF-1BBF6B61729D	Primary Tumor	Illumina HiSeq	c98a5543-b4b7-42ad-807e-73cdbbf77345	Liver	67	DC595EED-D459-40FD-8417-6A1C56759EC8	47E5FF56-9534-4FCF-A593-33027E877F93	TCGA-CC-5262-01A-01D-A21X-10	GRCh37-lite	TCGA-CC-5262	TCGA-LIHC	NA	s16851	Baylor College of Medicine	ILSbio	None	NO	T4	N0	Hepatocellular Carcinoma	Stage IIIC	A21X-10	FALSE
13722.58cfa831e4b0c9d6adf6c3a6	58cfa831e4b0c9d6adf6c3a6	TCGA-CC-A1HT-01A-11D-A12Z-10_wgs_Illumina.filtered.	WGS	TCGA-CC-A1HT-01A-11D-A12Z-10_wgs_Illumina	TCGA-CC-A1HT-01A-11D-A12Z-10_wgs_Illumina.bam	75.65	1.95	0.08	58cfa831e4b0c9d6adf6c3a6	TCGA-CC-A1HT-01A-11D-A12Z-10_wgs_Illumina.bam	Alive	MALE	ASIAN	NOT HISPANIC OR LATINO	Liver Hepatocellular Carcinoma	Aligned reads	TCGA-CC-A1HT-01A	670C1CBC-4494-45F1-BB8B-18DB82D4F7E0	Primary Tumor	Illumina HiSeq	f7c13bc4-5edc-4964-8267-e7956bf2fdd0	Liver	50	96F911ED-2064-4745-AD07-6C47B0A0C7CD	6B25A78F-20DC-4CCC-B4C0-F9885D16725D	TCGA-CC-A1HT-01A-11D-A12Z-10	GRCh37-lite	TCGA-CC-A1HT	TCGA-LIHC	NA	s16850	Baylor College of Medicine	ILSbio	Vietnam	NO	T3	N0	Hepatocellular Carcinoma	Stage IIIA	A12Z-10	TRUE
13722.58cfa831e4b0c9d6adf6c3be	58cfa831e4b0c9d6adf6c3be	TCGA-CC-5261-01A-01D-A12Z-10_wgs_Illumina.filtered.	WGS	TCGA-CC-5261-01A-01D-A12Z-10_wgs_Illumina	TCGA-CC-5261-01A-01D-A12Z-10_wgs_Illumina.bam	125.45	1.93	0.08	58cfa831e4b0c9d6adf6c3be	TCGA-CC-5261-01A-01D-A12Z-10_wgs_Illumina.bam	Alive	MALE	ASIAN	NOT HISPANIC OR LATINO	Liver Hepatocellular Carcinoma	Aligned reads	TCGA-CC-5261-01A	1AD7F17E-B3B8-40E9-AAB8-5A17E0AEC408	Primary Tumor	Illumina HiSeq	43047cdb-fea6-4e20-9248-30ae5624c5a7	Liver	44	538998F3-5230-4963-8B67-D34DE695E97D	A2F143D6-BA07-4FF0-960D-B29C3C716665	TCGA-CC-5261-01A-01D-A12Z-10	GRCh37-lite	TCGA-CC-5261	TCGA-LIHC	NA	s16582	Baylor College of Medicine	ILSbio	None	NO	T2	N0	Hepatocellular Carcinoma	Stage II	A12Z-10	TRUE
13722.58cfa831e4b0c9d6adf6c422	58cfa831e4b0c9d6adf6c422	TCGA-BW-A5NP-01A-11D-A27I-10_wgs_Illumina.filtered.	WGS	TCGA-BW-A5NP-01A-11D-A27I-10_wgs_Illumina	TCGA-BW-A5NP-01A-11D-A27I-10_wgs_Illumina.bam	62.92	NA	0.08	58cfa831e4b0c9d6adf6c422	TCGA-BW-A5NP-01A-11D-A27I-10_wgs_Illumina.bam	Alive	FEMALE	WHITE	HISPANIC OR LATINO	Liver Hepatocellular Carcinoma	Aligned reads	TCGA-BW-A5NP-01A	56A82A56-0241-4D3D-9DE2-696B0C36DF91	Primary Tumor	Illumina HiSeq	ce91806d-fb1a-452a-ad2e-51c7bdfbeb15	Liver	26	C13884B6-EAEF-4E1C-8FA7-5FE76548D32F	1C00925B-7328-4DB0-B930-04AAB2D80719	TCGA-BW-A5NP-01A-11D-A27I-10	GRCh37-lite	TCGA-BW-A5NP	TCGA-LIHC	NA	s16972	Baylor College of Medicine	St Joseph's Medical Center (MD)	United States	NO	T2	N0	Hepatocellular Carcinoma	Stage IV	A27I-10	TRUE
13722.58cfa831e4b0c9d6adf6c418	58cfa831e4b0c9d6adf6c418	TCGA-CJ-4878-01A-01D-2098-10_wgs_Illumina.filtered.	WGS	TCGA-CJ-4878-01A-01D-2098-10_wgs_Illumina	TCGA-CJ-4878-01A-01D-2098-10_wgs_Illumina.bam	215.7	1.9	0.15	58cfa831e4b0c9d6adf6c418	TCGA-CJ-4878-01A-01D-2098-10_wgs_Illumina.bam	Alive	FEMALE	WHITE	HISPANIC OR LATINO	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-CJ-4878-01A	7CA06DBE-F073-4AEE-86FF-A545FAD5EA93	Primary Tumor	Illumina HiSeq	cb7f204c-4503-4691-b1c7-fe363b44f4de	Kidney	71	24814EED-FDDB-475A-822E-EFFF92202954	DE4C3F91-D164-47DF-9971-FEBA840D247C	TCGA-CJ-4878-01A-01D-2098-10	GRCh37-lite	TCGA-CJ-4878	TCGA-KIRC	NA	s9567	Baylor College of Medicine	MD Anderson Cancer Center	None	NO	T3a	NX	Kidney Clear Cell Renal Carcinoma	Stage III	2098-10	TRUE
13722.58cfa831e4b0c9d6adf6c43a	58cfa831e4b0c9d6adf6c43a	TCGA-CJ-4870-01A-01D-2098-10_wgs_Illumina.filtered.	WGS	TCGA-CJ-4870-01A-01D-2098-10_wgs_Illumina	TCGA-CJ-4870-01A-01D-2098-10_wgs_Illumina.bam	85.7	1.9	0.15	58cfa831e4b0c9d6adf6c43a	TCGA-CJ-4870-01A-01D-2098-10_wgs_Illumina.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-CJ-4870-01A	78048432-2DE1-498C-9CF1-9C5BD43DAA39	Primary Tumor	Illumina HiSeq	22d3d6f1-5686-493f-b205-6ecc2602d2b8	Kidney	58	F7D03CD3-2D55-400A-BB29-F86CCAE475EC	267A9862-17BD-4056-BA4A-1F373736FFBB	TCGA-CJ-4870-01A-01D-2098-10	GRCh37-lite	TCGA-CJ-4870	TCGA-KIRC	NA	s9566	Baylor College of Medicine	MD Anderson Cancer Center	None	NO	T3a	NX	Kidney Clear Cell Renal Carcinoma	Stage III	2098-10	TRUE
13722.58cfa831e4b0c9d6adf6c45e	58cfa831e4b0c9d6adf6c45e	TCGA-CJ-5681-01A-11D-1534-10_wgs_Illumina.filtered.	WGS	TCGA-CJ-5681-01A-11D-1534-10_wgs_Illumina	TCGA-CJ-5681-01A-11D-1534-10_wgs_Illumina.bam	253.4	1.9	0.05	58cfa831e4b0c9d6adf6c45e	TCGA-CJ-5681-01A-11D-1534-10_wgs_Illumina.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-CJ-5681-01A	2939C03A-6F3F-4F7B-B246-34361BAADEB9	Primary Tumor	Illumina HiSeq	7efcb420-d7ac-41f1-847f-17a9ec6d10d5	Kidney	44	252836BE-AFF6-4967-8887-D93B178A4FF9	9AE0744A-9BC1-4CD7-B7CF-C6569ED9E4AA	TCGA-CJ-5681-01A-11D-1534-10	GRCh37-lite	TCGA-CJ-5681	TCGA-KIRC	552	s9170	Baylor College of Medicine	MD Anderson Cancer Center	None	NO	T3a	NX	Kidney Clear Cell Renal Carcinoma	Stage IV	1534-10	FALSE
13722.58cfa830e4b0c9d6adf6c1ae	58cfa830e4b0c9d6adf6c1ae	TCGA-B9-4617-01A-01D-1253-10_wgs_Illumina.filtered.	WGS	TCGA-B9-4617-01A-01D-1253-10_wgs_Illumina	TCGA-B9-4617-01A-01D-1253-10_wgs_Illumina.bam	45.94	1.9	0.15	58cfa830e4b0c9d6adf6c1ae	TCGA-B9-4617-01A-01D-1253-10_wgs_Illumina.bam	Alive	MALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Kidney Renal Papillary Cell Carcinoma	Aligned reads	TCGA-B9-4617-01A	A6E960AF-3CA5-42FB-B546-451C2583282D	Primary Tumor	Illumina HiSeq	dbbf365c-a7c9-4093-8ffb-acf0b6eabf20	Kidney	41	605B6DD3-552B-403C-98D9-C8B441B37A90	BEF23192-57CD-4301-B7A7-5E82CA62482D	TCGA-B9-4617-01A-01D-1253-10	GRCh37-lite	TCGA-B9-4617	TCGA-KIRP	NA	s11586	Baylor College of Medicine	UNC	None	NO	T1a	NX	Kidney Papillary Renal Cell Carcinoma	Not available	1253-10	FALSE
13722.58cfa831e4b0c9d6adf6c450	58cfa831e4b0c9d6adf6c450	TCGA-BW-A5NO-01A-11D-A27I-10_wgs_Illumina.filtered.	WGS	TCGA-BW-A5NO-01A-11D-A27I-10_wgs_Illumina	TCGA-BW-A5NO-01A-11D-A27I-10_wgs_Illumina.bam	61.1	NA	0.08	58cfa831e4b0c9d6adf6c450	TCGA-BW-A5NO-01A-11D-A27I-10_wgs_Illumina.bam	Alive	MALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Liver Hepatocellular Carcinoma	Aligned reads	TCGA-BW-A5NO-01A	EE63C44B-91F4-4004-8DEA-192EAB527036	Primary Tumor	Illumina HiSeq	b36db6ae-5ff9-4608-9db1-8dd5dc62fd82	Liver	50	3CBD785D-CAD5-4299-8FE8-695CA8DB726D	81A8B064-E735-455F-B2DB-AF7AE11DAAC4	TCGA-BW-A5NO-01A-11D-A27I-10	GRCh37-lite	TCGA-BW-A5NO	TCGA-LIHC	NA	s16580	Baylor College of Medicine	St Joseph's Medical Center (MD)	United States	NO	T3a	NX	Hepatocellular Carcinoma	Stage IIIA	A27I-10	TRUE
13722.58cfa831e4b0c9d6adf6c612	58cfa831e4b0c9d6adf6c612	TCGA-CQ-6228-01A-11D-A32X-10_wgs_Illumina.filtered.	WGS	TCGA-CQ-6228-01A-11D-A32X-10_wgs_Illumina	TCGA-CQ-6228-01A-11D-A32X-10_wgs_Illumina.bam	338.7	1.9	0.07	58cfa831e4b0c9d6adf6c612	TCGA-CQ-6228-01A-11D-A32X-10_wgs_Illumina.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CQ-6228-01A	E303B8C4-6428-4134-BB9D-A95DC1D8E35E	Primary Tumor	Illumina HiSeq	c8e6d97c-8cc3-45f6-99a2-d20b8bc3b2d6	Head and Neck	71	62E8F535-CF5E-4F90-AFCD-1E0136066820	C2124BB2-30E1-4093-9A8A-3A188A6DC0A9	TCGA-CQ-6228-01A-11D-A32X-10	GRCh37-lite	TCGA-CQ-6228	TCGA-HNSC	456	s15634	Baylor College of Medicine	University Health Network, Toronto	Canada	NO	T1	N2b	Head and Neck Squamous Cell Carcinoma	Stage IVA	A32X-10	TRUE
13722.58cfa831e4b0c9d6adf6c630	58cfa831e4b0c9d6adf6c630	TCGA-CN-4737-01A-01D-2266-10_Illumina.filtered.	WGS	TCGA-CN-4737-01A-01D-2266-10_Illumina	TCGA-CN-4737-01A-01D-2266-10_Illumina.bam	142	1.9	0.05	58cfa831e4b0c9d6adf6c630	TCGA-CN-4737-01A-01D-2266-10_Illumina.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CN-4737-01A	1F744ADA-6DE1-446D-B62C-76A7FC8B40AF	Primary Tumor	Illumina HiSeq	cd1138ab-45a7-4da9-a78d-142e2e75f255	Head and Neck	19	BA5D40F5-56A2-438B-92B8-6EB7DB6D6AFA	878A7FE7-20FF-4651-9587-B4D6FD42E929	TCGA-CN-4737-01A-01D-2266-10	GRCh37-lite	TCGA-CN-4737	TCGA-HNSC	NA	s16030	Baylor College of Medicine	University of Pittsburgh	None	NO	T2	N2b	Head and Neck Squamous Cell Carcinoma	Stage IVA	2266-10	TRUE
13722.58cfa831e4b0c9d6adf6c470	58cfa831e4b0c9d6adf6c470	TCGA-CA-6718-01A-11D-1835-10_wgs_Illumina.filtered.	WGS	TCGA-CA-6718-01A-11D-1835-10_wgs_Illumina	TCGA-CA-6718-01A-11D-1835-10_wgs_Illumina.bam	376.7	1.9	0.05	58cfa831e4b0c9d6adf6c470	TCGA-CA-6718-01A-11D-1835-10_wgs_Illumina.bam	Alive	MALE	ASIAN	NOT HISPANIC OR LATINO	Colon Adenocarcinoma	Aligned reads	TCGA-CA-6718-01A	DF5AB6CC-6F68-4B6B-95E2-954C6B57BA9C	Primary Tumor	Illumina HiSeq	3f12f1a7-45cc-4500-b7e1-8ac12465fbfe	Colorectal	46	F235AFBB-DC2A-41DD-B373-77C0AACEFB37	0980E7FD-051D-45E9-9CA6-2BAF073DA4E8	TCGA-CA-6718-01A-11D-1835-10	GRCh37-lite	TCGA-CA-6718	TCGA-COAD	NA	s13037	Baylor College of Medicine	ILSbio	Vietnam	NO	T3	N0	Colon Adenocarcinoma	Stage IIA	1835-10	FALSE
13722.58cfa831e4b0c9d6adf6c6b9	58cfa831e4b0c9d6adf6c6b9	TCGA-CQ-6225-01A-11D-A32X-10_wgs_Illumina.filtered.	WGS	TCGA-CQ-6225-01A-11D-A32X-10_wgs_Illumina	TCGA-CQ-6225-01A-11D-A32X-10_wgs_Illumina.bam	191.7	1.9	0.08	58cfa831e4b0c9d6adf6c6b9	TCGA-CQ-6225-01A-11D-A32X-10_wgs_Illumina.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CQ-6225-01A	90F44998-3C05-44B2-9501-BBD0F43C5147	Primary Tumor	Illumina HiSeq	4bedf81d-7024-4c95-8d97-32aa6de7578e	Head and Neck	65	E907D8D4-C4C6-441F-9F19-FF3746E5D13E	AFA4344E-2252-4EF9-8B8A-14AAE14ACC9C	TCGA-CQ-6225-01A-11D-A32X-10	GRCh37-lite	TCGA-CQ-6225	TCGA-HNSC	403	s15503	Baylor College of Medicine	University Health Network, Toronto	Canada	NO	T3	N0	Head and Neck Squamous Cell Carcinoma	Stage III	A32X-10	TRUE
13722.58cfa831e4b0c9d6adf6c706	58cfa831e4b0c9d6adf6c706	TCGA-CV-5431-01A-01D-A32X-10_wgs_Illumina.filtered.	WGS	TCGA-CV-5431-01A-01D-A32X-10_wgs_Illumina	TCGA-CV-5431-01A-01D-A32X-10_wgs_Illumina.bam	464.7	1.8	0.08	58cfa831e4b0c9d6adf6c706	TCGA-CV-5431-01A-01D-A32X-10_wgs_Illumina.bam	Dead	MALE	WHITE	HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-5431-01A	64BB5550-2735-4401-A0DB-58EC1020A32D	Primary Tumor	Illumina HiSeq	cbfa9144-8087-42ab-9497-71bfeddc55ae	Head and Neck	73	BE567C0A-3833-45D7-B846-D229A8E16E16	DE8EF60B-4DBE-4AA8-ADEF-6F58CDFADA29	TCGA-CV-5431-01A-01D-A32X-10	GRCh37-lite	TCGA-CV-5431	TCGA-HNSC	522	s16192	Baylor College of Medicine	MD Anderson Cancer Center	None	NO	T3	N2c	Head and Neck Squamous Cell Carcinoma	Stage IVA	A32X-10	TRUE
13722.58cfa831e4b0c9d6adf6c66a	58cfa831e4b0c9d6adf6c66a	TCGA-CR-7382-01A-11D-A32X-10_wgs_Illumina.filtered.	WGS	TCGA-CR-7382-01A-11D-A32X-10_wgs_Illumina	TCGA-CR-7382-01A-11D-A32X-10_wgs_Illumina.bam	170.7	NA	0.08	58cfa831e4b0c9d6adf6c66a	TCGA-CR-7382-01A-11D-A32X-10_wgs_Illumina.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CR-7382-01A	F030E410-2585-461E-AD23-9FDF026AC06C	Primary Tumor	Illumina HiSeq	ab5f1c0e-d07d-49b4-9fc2-b74f3c4928a6	Head and Neck	49	A8D8886B-B422-4C66-B0B4-4C9F0546B1B3	B86E88E7-0D5F-4B32-A35F-DC97251AB990	TCGA-CR-7382-01A-11D-A32X-10	GRCh37-lite	TCGA-CR-7382	TCGA-HNSC	NA	s16328	Baylor College of Medicine	Vanderbilt University	United States	NO	T2	N2c	Head and Neck Squamous Cell Carcinoma	Stage IVA	A32X-10	TRUE
13722.58cfa831e4b0c9d6adf6c7ba	58cfa831e4b0c9d6adf6c7ba	TCGA-CN-6011-01A-11D-A32X-10_wgs_Illumina.filtered.	WGS	TCGA-CN-6011-01A-11D-A32X-10_wgs_Illumina	TCGA-CN-6011-01A-11D-A32X-10_wgs_Illumina.bam	193	1.9	0.08	58cfa831e4b0c9d6adf6c7ba	TCGA-CN-6011-01A-11D-A32X-10_wgs_Illumina.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CN-6011-01A	E7D49212-E9CB-4CD7-923A-BDFC82A4A150	Primary Tumor	Illumina HiSeq	33680362-5ef1-477f-9dbc-64dc2ed0d5a8	Head and Neck	57	AFBF3020-1715-4E74-8224-05E316796999	21205681-A0C7-48D0-81D4-0B7EF31158CF	TCGA-CN-6011-01A-11D-A32X-10	GRCh37-lite	TCGA-CN-6011	TCGA-HNSC	NA	s15500	Baylor College of Medicine	University of Pittsburgh	None	NO	T4a	N0	Head and Neck Squamous Cell Carcinoma	Stage IVA	A32X-10	TRUE
13722.58cfa830e4b0c9d6adf6c2c4	58cfa830e4b0c9d6adf6c2c4	TCGA-AD-A5EK-01A-11D-A28G-10_wgs_Illumina.filtered.	WGS	TCGA-AD-A5EK-01A-11D-A28G-10_wgs_Illumina	TCGA-AD-A5EK-01A-11D-A28G-10_wgs_Illumina.bam	58.87	NA	0.08	58cfa830e4b0c9d6adf6c2c4	TCGA-AD-A5EK-01A-11D-A28G-10_wgs_Illumina.bam	Alive	MALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Colon Adenocarcinoma	Aligned reads	TCGA-AD-A5EK-01A	E8EC26BD-C88D-42B9-AC8A-AB121B8140F8	Primary Tumor	Illumina HiSeq	e84aec8b-4304-43e0-96c7-d605fc64dd11	Colorectal	51	C48314EE-C778-4B82-8E5A-4923DF4C8413	D0A0D845-32E2-4590-B909-29BD27B92900	TCGA-AD-A5EK-01A-11D-A28G-10	GRCh37-lite	TCGA-AD-A5EK	TCGA-COAD	NA	s13537	Baylor College of Medicine	International Genomics Consortium	United States	NO	T2	N0	Colon Adenocarcinoma	Stage I	A28G-10	TRUE
13722.58cfa831e4b0c9d6adf6c6c6	58cfa831e4b0c9d6adf6c6c6	TCGA-CV-5432-01A-02D-A32X-10_wgs_Illumina.filtered.	WGS	TCGA-CV-5432-01A-02D-A32X-10_wgs_Illumina	TCGA-CV-5432-01A-02D-A32X-10_wgs_Illumina.bam	341	1.9	0.08	58cfa831e4b0c9d6adf6c6c6	TCGA-CV-5432-01A-02D-A32X-10_wgs_Illumina.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-5432-01A	D89B1FD6-BEF4-4803-8ED3-3B442BE600B6	Primary Tumor	Illumina HiSeq	6d564719-34a3-4b79-bf57-a5c8f73d7436	Head and Neck	68	B4A36114-80D3-4F28-B85A-077DC31EB485	9988EB07-01F6-4F83-8699-BB63E0525F08	TCGA-CV-5432-01A-02D-A32X-10	GRCh37-lite	TCGA-CV-5432	TCGA-HNSC	NA	s16196	Baylor College of Medicine	MD Anderson Cancer Center	None	NO	T3	N0	Head and Neck Squamous Cell Carcinoma	Stage III	A32X-10	TRUE
13722.58cfa831e4b0c9d6adf6c7be	58cfa831e4b0c9d6adf6c7be	TCGA-CV-6956-01A-21D-A32X-10_wgs_Illumina.filtered.	WGS	TCGA-CV-6956-01A-21D-A32X-10_wgs_Illumina	TCGA-CV-6956-01A-21D-A32X-10_wgs_Illumina.bam	124.43	NA	0.07	58cfa831e4b0c9d6adf6c7be	TCGA-CV-6956-01A-21D-A32X-10_wgs_Illumina.bam	Dead	MALE	WHITE	HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-6956-01A	8C238D30-DF8E-4E6B-98FC-21696269A294	Primary Tumor	Illumina HiSeq	f9762350-aee5-49d2-a5de-165317ff2bd3	Head and Neck	67	8B9F33FA-04EF-4767-93D1-98F6E420D037	5046F1B4-9D95-4841-BA30-691FA44719A2	TCGA-CV-6956-01A-21D-A32X-10	GRCh37-lite	TCGA-CV-6956	TCGA-HNSC	217	s16201	Baylor College of Medicine	MD Anderson Cancer Center	United States	NO	T3	N1	Head and Neck Squamous Cell Carcinoma	Stage III	A32X-10	TRUE
13722.58cfa831e4b0c9d6adf6c6b0	58cfa831e4b0c9d6adf6c6b0	TCGA-CR-6491-01A-11D-A32X-10_wgs_Illumina.filtered.	WGS	TCGA-CR-6491-01A-11D-A32X-10_wgs_Illumina	TCGA-CR-6491-01A-11D-A32X-10_wgs_Illumina.bam	78.7	1.9	0.08	58cfa831e4b0c9d6adf6c6b0	TCGA-CR-6491-01A-11D-A32X-10_wgs_Illumina.bam	Alive	MALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CR-6491-01A	5FCE954C-11B9-41F4-9471-4B5BDC0EFA7F	Primary Tumor	Illumina HiSeq	85a87fce-1144-4d78-8495-597c211a5312	Head and Neck	60	E23D2F8B-ACA4-43C2-876E-F8C6E1CA2D93	A315B798-F037-48D5-91ED-E733E3BBD6EE	TCGA-CR-6491-01A-11D-A32X-10	GRCh37-lite	TCGA-CR-6491	TCGA-HNSC	NA	s15504	Baylor College of Medicine	Vanderbilt University	United States	NO	T4a	N2b	Head and Neck Squamous Cell Carcinoma	Stage IVA	A32X-10	TRUE
13722.58cfa831e4b0c9d6adf6c89e	58cfa831e4b0c9d6adf6c89e	TCGA-DD-A1EG-01A-11D-A20W-10_wgs_Illumina.filtered.	WGS	TCGA-DD-A1EG-01A-11D-A20W-10_wgs_Illumina	TCGA-DD-A1EG-01A-11D-A20W-10_wgs_Illumina.bam	24.35	NA	0.08	58cfa831e4b0c9d6adf6c89e	TCGA-DD-A1EG-01A-11D-A20W-10_wgs_Illumina.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Liver Hepatocellular Carcinoma	Aligned reads	TCGA-DD-A1EG-01A	6C79F64B-63FE-46F5-BF7B-77208231B0F2	Primary Tumor	Illumina HiSeq	cf962035-7148-470e-a820-f252e162e9ef	Liver	76	E8B59658-06C6-46B7-B51F-ED52DE0C403E	50EE360C-E3DF-4888-9999-EBB88E271D08	TCGA-DD-A1EG-01A-11D-A20W-10	GRCh37-lite	TCGA-DD-A1EG	TCGA-LIHC	1372	s16585	Baylor College of Medicine	Mayo Clinic - Rochester	United States	NO	T1	N0	Hepatocellular Carcinoma	Stage I	A20W-10	FALSE
13722.58cfa831e4b0c9d6adf6c8a8	58cfa831e4b0c9d6adf6c8a8	TCGA-CZ-5453-01A-01D-2102-10_wgs_Illumina.filtered.	WGS	TCGA-CZ-5453-01A-01D-2102-10_wgs_Illumina	TCGA-CZ-5453-01A-01D-2102-10_wgs_Illumina.bam	156.4	1.9	0.15	58cfa831e4b0c9d6adf6c8a8	TCGA-CZ-5453-01A-01D-2102-10_wgs_Illumina.bam	Alive	MALE	WHITE	Not available	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-CZ-5453-01A	577847B9-F9B6-4954-868F-3D5AB2B4F694	Primary Tumor	Illumina HiSeq	28e40615-1ae0-420f-b7c0-ca99eaa91361	Kidney	67	5C1B955D-9D60-4975-A1E6-C4D531E79190	64446AEC-C125-4C81-B9CC-62482CB1AAED	TCGA-CZ-5453-01A-01D-2102-10	GRCh37-lite	TCGA-CZ-5453	TCGA-KIRC	NA	s9307	Baylor College of Medicine	Harvard	None	NO	T2	NX	Kidney Clear Cell Renal Carcinoma	Stage II	2102-10	FALSE
13722.58cfa831e4b0c9d6adf6c8b2	58cfa831e4b0c9d6adf6c8b2	TCGA-DD-A3A7-01A-11D-A22F-10_wgs_Illumina.filtered.	WGS	TCGA-DD-A3A7-01A-11D-A22F-10_wgs_Illumina	TCGA-DD-A3A7-01A-11D-A22F-10_wgs_Illumina.bam	41.76	NA	0.08	58cfa831e4b0c9d6adf6c8b2	TCGA-DD-A3A7-01A-11D-A22F-10_wgs_Illumina.bam	Dead	MALE	Not available	Not available	Liver Hepatocellular Carcinoma	Aligned reads	TCGA-DD-A3A7-01A	614C0ECF-6A84-4C86-8706-79BE5BB00991	Primary Tumor	Illumina HiSeq	48ae1497-c89f-4b1e-a0c4-1c6bd49c39b7	Liver	67	1EF290A3-D054-4E3A-9683-8F99A2010E3E	29B92B51-7BA3-42A9-97D3-6A9B5E43F928	TCGA-DD-A3A7-01A-11D-A22F-10	GRCh37-lite	TCGA-DD-A3A7	TCGA-LIHC	419	s16852	Baylor College of Medicine	Mayo Clinic - Rochester	United States	NO	T3b	N0	Hepatocellular Carcinoma	Stage IIIB	A22F-10	TRUE
13722.58cfa831e4b0c9d6adf6c89a	58cfa831e4b0c9d6adf6c89a	TCGA-DD-A1EH-01A-11D-A12Z-10_wgs_Illumina.filtered.	WGS	TCGA-DD-A1EH-01A-11D-A12Z-10_wgs_Illumina	TCGA-DD-A1EH-01A-11D-A12Z-10_wgs_Illumina.bam	38.71	1.93	0.08	58cfa831e4b0c9d6adf6c89a	TCGA-DD-A1EH-01A-11D-A12Z-10_wgs_Illumina.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Liver Hepatocellular Carcinoma	Aligned reads	TCGA-DD-A1EH-01A	CAB5B264-ABAB-4BDB-816E-9D2C0AC30629	Primary Tumor	Illumina HiSeq	6126a7f9-c6d2-4361-9420-37af4bfafb5f	Liver	23	44C98B82-ADCB-4597-A9DB-83E7D2A0E2F9	B9F03936-1DE5-4330-8B0F-6D0AB533876E	TCGA-DD-A1EH-01A-11D-A12Z-10	GRCh37-lite	TCGA-DD-A1EH	TCGA-LIHC	NA	s16776	Baylor College of Medicine	Mayo Clinic - Rochester	United States	NO	T3	N0	Hepatocellular Carcinoma	Stage III	A12Z-10	TRUE
13722.58cfa831e4b0c9d6adf6c8e1	58cfa831e4b0c9d6adf6c8e1	TCGA-CW-5585-01A-01D-2103-10_wgs_Illumina.filtered.	WGS	TCGA-CW-5585-01A-01D-2103-10_wgs_Illumina	TCGA-CW-5585-01A-01D-2103-10_wgs_Illumina.bam	288.4	1.88	0.15	58cfa831e4b0c9d6adf6c8e1	TCGA-CW-5585-01A-01D-2103-10_wgs_Illumina.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Clear Cell Carcinoma	Aligned reads	TCGA-CW-5585-01A	0487FC41-386C-4D76-9084-DAF959BF5E98	Primary Tumor	Illumina HiSeq	ff078c8b-f861-46f7-ac62-eb5ff21a805c	Kidney	51	B5040DA2-0D96-422A-9760-98A95C136FE8	3FEAC02A-C99F-4DD9-9EFF-E4F5E87F7DC5	TCGA-CW-5585-01A-01D-2103-10	GRCh37-lite	TCGA-CW-5585	TCGA-KIRC	NA	s9306	Baylor College of Medicine	Mayo Clinic - Rochester	United States	NO	T3b	N0	Kidney Clear Cell Renal Carcinoma	Stage IV	2103-10	FALSE
13722.58cfa831e4b0c9d6adf6c8e4	58cfa831e4b0c9d6adf6c8e4	TCGA-CX-7086-01A-11D-A32X-10_wgs_Illumina.filtered.	WGS	TCGA-CX-7086-01A-11D-A32X-10_wgs_Illumina	TCGA-CX-7086-01A-11D-A32X-10_wgs_Illumina.bam	464.7	NA	0.08	58cfa831e4b0c9d6adf6c8e4	TCGA-CX-7086-01A-11D-A32X-10_wgs_Illumina.bam	Alive	MALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CX-7086-01A	AD6C9D09-2C03-4786-A72D-DD2AA5F603D4	Primary Tumor	Illumina HiSeq	2c64cb1b-6ae4-4191-9b2c-e5c13e267e83	Head and Neck	53	B293A736-9A82-4AD9-BF7E-9E2CEA09DDBC	E52FFA79-557A-4024-81F3-F3826C227EC5	TCGA-CX-7086-01A-11D-A32X-10	GRCh37-lite	TCGA-CX-7086	TCGA-HNSC	NA	s16343	Baylor College of Medicine	Medical College of Georgia	United States	NO	T3	N1	Head and Neck Squamous Cell Carcinoma	Stage III	A32X-10	TRUE
13722.58cfa831e4b0c9d6adf6c8fe	58cfa831e4b0c9d6adf6c8fe	TCGA-CN-6994-01A-11D-A32X-10_wgs_Illumina.filtered.	WGS	TCGA-CN-6994-01A-11D-A32X-10_wgs_Illumina	TCGA-CN-6994-01A-11D-A32X-10_wgs_Illumina.bam	267.7	NA	0.07	58cfa831e4b0c9d6adf6c8fe	TCGA-CN-6994-01A-11D-A32X-10_wgs_Illumina.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CN-6994-01A	6909302D-358A-46CD-8052-EEDB09C83C83	Primary Tumor	Illumina HiSeq	165171a0-a11e-4c82-b718-897ca9741478	Head and Neck	67	1A5AF8E2-61B4-4A04-B4B6-EA41FC34C89A	190EB791-383D-4E27-870D-E470630843E7	TCGA-CN-6994-01A-11D-A32X-10	GRCh37-lite	TCGA-CN-6994	TCGA-HNSC	NA	s16325	Baylor College of Medicine	University of Pittsburgh	United States	NO	T4a	N0	Head and Neck Squamous Cell Carcinoma	Stage IVA	A32X-10	TRUE
13722.58cfa831e4b0c9d6adf6c8b8	58cfa831e4b0c9d6adf6c8b8	TCGA-DD-A4NG-01A-11D-A27I-10_wgs_Illumina.filtered.	WGS	TCGA-DD-A4NG-01A-11D-A27I-10_wgs_Illumina	TCGA-DD-A4NG-01A-11D-A27I-10_wgs_Illumina.bam	15.95	NA	0.07	58cfa831e4b0c9d6adf6c8b8	TCGA-DD-A4NG-01A-11D-A27I-10_wgs_Illumina.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Liver Hepatocellular Carcinoma	Aligned reads	TCGA-DD-A4NG-01A	89791F8F-DC06-4A04-B166-AFBFD6CF53DE	Primary Tumor	Illumina HiSeq	ef6dfbd5-d562-4452-9843-9c3db280717c	Liver	77	38507EDD-DFB4-4931-9895-2C0482BD4555	03C88506-D72E-4A44-A34E-A7F0564F1799	TCGA-DD-A4NG-01A-11D-A27I-10	GRCh37-lite	TCGA-DD-A4NG	TCGA-LIHC	NA	s16856	Baylor College of Medicine	Mayo Clinic - Rochester	United States	NO	T3a	NX	Hepatocellular Carcinoma	Stage IIIA	A27I-10	TRUE
13722.58cfa831e4b0c9d6adf6c934	58cfa831e4b0c9d6adf6c934	TCGA-DD-A4ND-01A-11D-A25V-10_wgs_Illumina.filtered.	WGS	TCGA-DD-A4ND-01A-11D-A25V-10_wgs_Illumina	TCGA-DD-A4ND-01A-11D-A25V-10_wgs_Illumina.bam	24.52	NA	0.07	58cfa831e4b0c9d6adf6c934	TCGA-DD-A4ND-01A-11D-A25V-10_wgs_Illumina.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Liver Hepatocellular Carcinoma	Aligned reads	TCGA-DD-A4ND-01A	C0BF9278-9CBB-4361-B4D8-AB172B67E276	Primary Tumor	Illumina HiSeq	7b8d29e8-a5ac-4b38-9ac0-77398a23286f	Liver	56	4282039E-396B-44D8-B4EC-AC14C46DDEF6	D9C5493E-F969-4C04-A646-9A3134011021	TCGA-DD-A4ND-01A-11D-A25V-10	GRCh37-lite	TCGA-DD-A4ND	TCGA-LIHC	NA	s16857	Baylor College of Medicine	Mayo Clinic - Rochester	United States	NO	T1	N0	Hepatocellular Carcinoma	Stage I	A25V-10	TRUE
13722.58cfa831e4b0c9d6adf6c954	58cfa831e4b0c9d6adf6c954	TCGA-DQ-5629-01A-01D-A32X-10_wgs_Illumina.filtered.	WGS	TCGA-DQ-5629-01A-01D-A32X-10_wgs_Illumina	TCGA-DQ-5629-01A-01D-A32X-10_wgs_Illumina.bam	233.7	1.9	0.08	58cfa831e4b0c9d6adf6c954	TCGA-DQ-5629-01A-01D-A32X-10_wgs_Illumina.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-DQ-5629-01A	E95E9E7D-A1ED-46EB-9CF8-1D355BF0577F	Primary Tumor	Illumina HiSeq	3fb0505f-e847-4658-93f1-0af7d8617e66	Head and Neck	64	57EA3EED-F8E2-4310-90C0-50D89F818A12	2AFB198A-D4AA-4544-BDCE-85695E185869	TCGA-DQ-5629-01A-01D-A32X-10	GRCh37-lite	TCGA-DQ-5629	TCGA-HNSC	NA	s16345	Baylor College of Medicine	University of Michigan	United States	NO	TX	NX	Head and Neck Squamous Cell Carcinoma	Not available	A32X-10	TRUE
13722.58cfa831e4b0c9d6adf6c9a2	58cfa831e4b0c9d6adf6c9a2	TCGA-DD-A3A8-01A-11D-A22F-10_wgs_Illumina.filtered.	WGS	TCGA-DD-A3A8-01A-11D-A22F-10_wgs_Illumina	TCGA-DD-A3A8-01A-11D-A22F-10_wgs_Illumina.bam	34.18	NA	0.07	58cfa831e4b0c9d6adf6c9a2	TCGA-DD-A3A8-01A-11D-A22F-10_wgs_Illumina.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Liver Hepatocellular Carcinoma	Aligned reads	TCGA-DD-A3A8-01A	69D6881B-9E9A-407B-8B02-BAD5FC2455BF	Primary Tumor	Illumina HiSeq	772bc588-a4c5-4f9a-a1d8-be943b521c76	Liver	75	93D007F8-84D9-427D-A1E9-54919605F7B3	4CFF8590-559E-4204-8635-96E11BFEDA68	TCGA-DD-A3A8-01A-11D-A22F-10	GRCh37-lite	TCGA-DD-A3A8	TCGA-LIHC	11	s16976	Baylor College of Medicine	Mayo Clinic - Rochester	United States	NO	T2	N0	Hepatocellular Carcinoma	Stage II	A22F-10	TRUE
13722.58cfa831e4b0c9d6adf6c903	58cfa831e4b0c9d6adf6c903	TCGA-DD-A3A6-01A-11D-A22F-10_wgs_Illumina.filtered.	WGS	TCGA-DD-A3A6-01A-11D-A22F-10_wgs_Illumina	TCGA-DD-A3A6-01A-11D-A22F-10_wgs_Illumina.bam	38.07	NA	0.08	58cfa831e4b0c9d6adf6c903	TCGA-DD-A3A6-01A-11D-A22F-10_wgs_Illumina.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Liver Hepatocellular Carcinoma	Aligned reads	TCGA-DD-A3A6-01A	C4C4820B-6F4C-4CDD-B233-4D22F5933FD9	Primary Tumor	Illumina HiSeq	e78847a6-5647-480c-8eb3-a41842fa2139	Liver	72	8BBFEEAB-FF99-4BD0-B407-E1E532BD04FC	7F03CB4B-60B1-460C-B761-402E7CA09B0D	TCGA-DD-A3A6-01A-11D-A22F-10	GRCh37-lite	TCGA-DD-A3A6	TCGA-LIHC	3258	s16854	Baylor College of Medicine	Mayo Clinic - Rochester	United States	NO	T2	N0	Hepatocellular Carcinoma	Stage II	A22F-10	TRUE
13722.58cfa831e4b0c9d6adf6c8f4	58cfa831e4b0c9d6adf6c8f4	TCGA-CV-7432-01A-11D-A32X-10_wgs_Illumina.filtered.	WGS	TCGA-CV-7432-01A-11D-A32X-10_wgs_Illumina	TCGA-CV-7432-01A-11D-A32X-10_wgs_Illumina.bam	222.73	NA	0.08	58cfa831e4b0c9d6adf6c8f4	TCGA-CV-7432-01A-11D-A32X-10_wgs_Illumina.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-7432-01A	EAF674DD-9909-4879-B9A3-74253169EDDD	Primary Tumor	Illumina HiSeq	b0ae59a2-ff3b-4c06-a046-3138e659d051	Head and Neck	79	9213AB13-AFC6-40B9-B278-98DD05C92934	D25A4C65-9CB4-4611-909E-E68F93408D84	TCGA-CV-7432-01A-11D-A32X-10	GRCh37-lite	TCGA-CV-7432	TCGA-HNSC	2570	s15785	Baylor College of Medicine	MD Anderson Cancer Center	United States	NO	T2	N0	Head and Neck Squamous Cell Carcinoma	Stage II	A32X-10	TRUE
13722.58cfa831e4b0c9d6adf6c977	58cfa831e4b0c9d6adf6c977	TCGA-DD-A1EL-01A-11D-A152-10_wgs_Illumina.filtered.	WGS	TCGA-DD-A1EL-01A-11D-A152-10_wgs_Illumina	TCGA-DD-A1EL-01A-11D-A152-10_wgs_Illumina.bam	63.8	1.71	0.08	58cfa831e4b0c9d6adf6c977	TCGA-DD-A1EL-01A-11D-A152-10_wgs_Illumina.bam	Dead	MALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Liver Hepatocellular Carcinoma	Aligned reads	TCGA-DD-A1EL-01A	2854FFE8-1F77-497A-BF49-11E0189FEE35	Primary Tumor	Illumina HiSeq	a4594690-fa54-40f6-bd78-08ffa730aa84	Liver	23	5A756B40-6C08-47E8-9B25-9B3FFFF39606	D252F328-4583-4E97-9A71-BB2885F06F73	TCGA-DD-A1EL-01A-11D-A152-10	GRCh37-lite	TCGA-DD-A1EL	TCGA-LIHC	415	s16676	Baylor College of Medicine	Mayo Clinic - Rochester	United States	NO	T2	N0	Hepatocellular Carcinoma	Stage II	A152-10	TRUE
13722.58cfa831e4b0c9d6adf6c9a4	58cfa831e4b0c9d6adf6c9a4	TCGA-DD-A1ED-01A-11D-A152-10_wgs_Illumina.filtered.	WGS	TCGA-DD-A1ED-01A-11D-A152-10_wgs_Illumina	TCGA-DD-A1ED-01A-11D-A152-10_wgs_Illumina.bam	38.22	1.7	0.08	58cfa831e4b0c9d6adf6c9a4	TCGA-DD-A1ED-01A-11D-A152-10_wgs_Illumina.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Liver Hepatocellular Carcinoma	Aligned reads	TCGA-DD-A1ED-01A	0FF6364A-E6F4-47CA-A7E7-14705BF0A8DF	Primary Tumor	Illumina HiSeq	baa8f20c-66ac-448e-9ca3-b1302905fa30	Liver	68	1CF84C3E-E7E2-43A6-B9AF-E0042312F02F	4C3EDA94-56F4-46D3-8C88-50D476E773F6	TCGA-DD-A1ED-01A-11D-A152-10	GRCh37-lite	TCGA-DD-A1ED	TCGA-LIHC	NA	s16977	Baylor College of Medicine	Mayo Clinic - Rochester	United States	NO	T1	N0	Hepatocellular Carcinoma	Stage I	A152-10	TRUE
13722.58cfa831e4b0c9d6adf6c9bf	58cfa831e4b0c9d6adf6c9bf	TCGA-DD-A1EJ-01A-11D-A152-10_wgs_Illumina.filtered.	WGS	TCGA-DD-A1EJ-01A-11D-A152-10_wgs_Illumina	TCGA-DD-A1EJ-01A-11D-A152-10_wgs_Illumina.bam	51.74	1.45	0.08	58cfa831e4b0c9d6adf6c9bf	TCGA-DD-A1EJ-01A-11D-A152-10_wgs_Illumina.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Liver Hepatocellular Carcinoma	Aligned reads	TCGA-DD-A1EJ-01A	52292FFC-0902-4D97-B461-20723987A177	Primary Tumor	Illumina HiSeq	65b1f0b7-fec9-4ee4-8634-583e00af7202	Liver	71	2D549BB0-9E98-40C7-8B33-545C481DD105	9C681CD9-25FB-42AC-AA6B-BB962882FA22	TCGA-DD-A1EJ-01A-11D-A152-10	GRCh37-lite	TCGA-DD-A1EJ	TCGA-LIHC	NA	s16586	Baylor College of Medicine	Mayo Clinic - Rochester	United States	NO	T1	N1	Hepatocellular Carcinoma	Stage IIIC	A152-10	TRUE
13722.58cfa831e4b0c9d6adf6c8ca	58cfa831e4b0c9d6adf6c8ca	TCGA-CV-5973-01A-11D-A32X-10_wgs_Illumina.filtered.	WGS	TCGA-CV-5973-01A-11D-A32X-10_wgs_Illumina	TCGA-CV-5973-01A-11D-A32X-10_wgs_Illumina.bam	115	1.9	0.08	58cfa831e4b0c9d6adf6c8ca	TCGA-CV-5973-01A-11D-A32X-10_wgs_Illumina.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-5973-01A	8FC1F1BE-D2D5-4B3A-9973-F4D964018BEB	Primary Tumor	Illumina HiSeq	91b47661-f43d-4fb8-a616-e40ed72329d3	Head and Neck	62	5078222F-B257-4286-A29A-BC1E395149BC	7E584FF6-0B81-4F85-81DA-B8117AFEE326	TCGA-CV-5973-01A-11D-A32X-10	GRCh37-lite	TCGA-CV-5973	TCGA-HNSC	NA	s16042	Baylor College of Medicine	MD Anderson Cancer Center	None	NO	T3	N1	Head and Neck Squamous Cell Carcinoma	Stage III	A32X-10	TRUE
13722.58cfa831e4b0c9d6adf6c9ca	58cfa831e4b0c9d6adf6c9ca	TCGA-DD-A1EB-01A-11D-A12Z-10_wgs_Illumina.filtered.	WGS	TCGA-DD-A1EB-01A-11D-A12Z-10_wgs_Illumina	TCGA-DD-A1EB-01A-11D-A12Z-10_wgs_Illumina.bam	45.15	1.98	0.08	58cfa831e4b0c9d6adf6c9ca	TCGA-DD-A1EB-01A-11D-A12Z-10_wgs_Illumina.bam	Alive	FEMALE	Not available	Not available	Liver Hepatocellular Carcinoma	Aligned reads	TCGA-DD-A1EB-01A	68015CC7-D3A1-4C90-B8FB-5D14143D9960	Primary Tumor	Illumina HiSeq	df20c59b-843a-4f42-babb-7205e75d0a32	Liver	72	FEE48A64-CF2F-4AE9-B3CF-315410D8E8AE	90611290-E44C-438E-91AA-F3B83DAE3B71	TCGA-DD-A1EB-01A-11D-A12Z-10	GRCh37-lite	TCGA-DD-A1EB	TCGA-LIHC	NA	s16675	Baylor College of Medicine	Mayo Clinic - Rochester	United States	NO	T1	N0	Hepatocellular Carcinoma	Stage I	A12Z-10	TRUE
13722.58cfa831e4b0c9d6adf6c9db	58cfa831e4b0c9d6adf6c9db	TCGA-DD-A3A9-01A-11D-A25V-10_wgs_Illumina.filtered.	WGS	TCGA-DD-A3A9-01A-11D-A25V-10_wgs_Illumina	TCGA-DD-A3A9-01A-11D-A25V-10_wgs_Illumina.bam	36.73	NA	0.08	58cfa831e4b0c9d6adf6c9db	TCGA-DD-A3A9-01A-11D-A25V-10_wgs_Illumina.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Liver Hepatocellular Carcinoma	Aligned reads	TCGA-DD-A3A9-01A	457CCA7C-A8B4-414E-A3C0-7FCCF0EE2034	Primary Tumor	Illumina HiSeq	f40faf20-3443-4f29-85be-0107c0d838aa	Liver	64	9BFBC85E-86E0-4AC5-9304-84B1EB32B9CC	96517058-18D2-4847-8085-768CA8AA1565	TCGA-DD-A3A9-01A-11D-A25V-10	GRCh37-lite	TCGA-DD-A3A9	TCGA-LIHC	931	s16587	Baylor College of Medicine	Mayo Clinic - Rochester	United States	NO	T4	N0	Hepatocellular Carcinoma	Stage IVB	A25V-10	TRUE
13722.58cfa831e4b0c9d6adf6c9f6	58cfa831e4b0c9d6adf6c9f6	TCGA-DD-A4NB-01A-12D-A25V-10_wgs_Illumina.filtered.	WGS	TCGA-DD-A4NB-01A-12D-A25V-10_wgs_Illumina	TCGA-DD-A4NB-01A-12D-A25V-10_wgs_Illumina.bam	9.12	NA	0.07	58cfa831e4b0c9d6adf6c9f6	TCGA-DD-A4NB-01A-12D-A25V-10_wgs_Illumina.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Liver Hepatocellular Carcinoma	Aligned reads	TCGA-DD-A4NB-01A	1983FADE-44F1-41E0-8983-F2CE8D649655	Primary Tumor	Illumina HiSeq	a3509f59-4d19-4a9b-afd1-dc57f8f871dd	Liver	25	0A79C3EE-9DD0-4FF7-B079-C9A0AEB08E1F	5D58B984-E0B8-4237-A576-0E9D4079599E	TCGA-DD-A4NB-01A-12D-A25V-10	GRCh37-lite	TCGA-DD-A4NB	TCGA-LIHC	NA	s16855	Baylor College of Medicine	Mayo Clinic - Rochester	United States	NO	T1	N0	Fibrolamellar Carcinoma	Stage I	A25V-10	TRUE
13722.58cfa831e4b0c9d6adf6ca23	58cfa831e4b0c9d6adf6ca23	TCGA-DD-A1EI-01A-11D-A12Z-10_wgs_Illumina.filtered.	WGS	TCGA-DD-A1EI-01A-11D-A12Z-10_wgs_Illumina	TCGA-DD-A1EI-01A-11D-A12Z-10_wgs_Illumina.bam	51.84	1.86	0.08	58cfa831e4b0c9d6adf6ca23	TCGA-DD-A1EI-01A-11D-A12Z-10_wgs_Illumina.bam	Alive	MALE	ASIAN	NOT HISPANIC OR LATINO	Liver Hepatocellular Carcinoma	Aligned reads	TCGA-DD-A1EI-01A	3ACF7438-FD65-442C-8A30-68B6714537F3	Primary Tumor	Illumina HiSeq	3578b4d9-a65f-4096-bb30-1b3509f8a918	Liver	46	65FB618A-9296-47AD-BBA9-A93FC3F88E68	C016D025-3C92-41C5-B846-493B1FCCE79E	TCGA-DD-A1EI-01A-11D-A12Z-10	GRCh37-lite	TCGA-DD-A1EI	TCGA-LIHC	NA	s16975	Baylor College of Medicine	Mayo Clinic - Rochester	United States	NO	T1	N0	Hepatocellular Carcinoma	Stage I	A12Z-10	TRUE
13722.58cfa831e4b0c9d6adf6cae4	58cfa831e4b0c9d6adf6cae4	TCGA-DQ-5625-01A-01D-A32X-10_wgs_Illumina.filtered.	WGS	TCGA-DQ-5625-01A-01D-A32X-10_wgs_Illumina	TCGA-DQ-5625-01A-01D-A32X-10_wgs_Illumina.bam	154.7	1.9	0.08	58cfa831e4b0c9d6adf6cae4	TCGA-DQ-5625-01A-01D-A32X-10_wgs_Illumina.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-DQ-5625-01A	53D9A130-4A3A-4491-85CD-9A44415A1632	Primary Tumor	Illumina HiSeq	cb931cae-83da-428c-86f1-59df36c9af80	Head and Neck	52	74856E66-109F-4A68-A496-8FA66729FE1F	D3709EEA-CA2A-49AC-B79C-871A5473D450	TCGA-DQ-5625-01A-01D-A32X-10	GRCh37-lite	TCGA-DQ-5625	TCGA-HNSC	NA	s16061	Baylor College of Medicine	University of Michigan	United States	NO	TX	NX	Head and Neck Squamous Cell Carcinoma	Not available	A32X-10	TRUE
13722.58cfa831e4b0c9d6adf6ca58	58cfa831e4b0c9d6adf6ca58	TCGA-DD-A4NA-01A-11D-A25V-10_wgs_Illumina.filtered.	WGS	TCGA-DD-A4NA-01A-11D-A25V-10_wgs_Illumina	TCGA-DD-A4NA-01A-11D-A25V-10_wgs_Illumina.bam	38.33	NA	0.08	58cfa831e4b0c9d6adf6ca58	TCGA-DD-A4NA-01A-11D-A25V-10_wgs_Illumina.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Liver Hepatocellular Carcinoma	Aligned reads	TCGA-DD-A4NA-01A	BEE9D6C8-948F-4B76-97CA-B985064249EF	Primary Tumor	Illumina HiSeq	9011fbab-0082-4675-98d0-33225253f93c	Liver	67	1E7C53F1-DFB6-4A50-BD83-F8062B1306F2	5EAD73FE-1C34-48ED-B20D-89FC3C82DBD6	TCGA-DD-A4NA-01A-11D-A25V-10	GRCh37-lite	TCGA-DD-A4NA	TCGA-LIHC	NA	s17059	Baylor College of Medicine	Mayo Clinic - Rochester	United States	NO	T2	N1	Hepatocellular Carcinoma	Stage IIIC	A25V-10	TRUE
13722.58cfa831e4b0c9d6adf6ca63	58cfa831e4b0c9d6adf6ca63	TCGA-CN-6989-01A-11D-A32X-10_wgs_Illumina.filtered.	WGS	TCGA-CN-6989-01A-11D-A32X-10_wgs_Illumina	TCGA-CN-6989-01A-11D-A32X-10_wgs_Illumina.bam	182.7	NA	0.08	58cfa831e4b0c9d6adf6ca63	TCGA-CN-6989-01A-11D-A32X-10_wgs_Illumina.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CN-6989-01A	F33AA93F-B32D-4C4F-9A71-1E5AB69C6899	Primary Tumor	Illumina HiSeq	190e57a0-694b-46ca-a944-0bf0e9d732c2	Head and Neck	64	7AC8FB22-0A09-4B16-AF8C-B5C2E90A968A	08227616-02A5-46E8-9DB1-F2D1D691AB23	TCGA-CN-6989-01A-11D-A32X-10	GRCh37-lite	TCGA-CN-6989	TCGA-HNSC	NA	s16177	Baylor College of Medicine	University of Pittsburgh	United States	NO	T3	N2c	Head and Neck Squamous Cell Carcinoma	Stage IVA	A32X-10	TRUE
13722.58cfa831e4b0c9d6adf6ca17	58cfa831e4b0c9d6adf6ca17	TCGA-DD-A4NE-01A-11D-A27I-10_wgs_Illumina.filtered.	WGS	TCGA-DD-A4NE-01A-11D-A27I-10_wgs_Illumina	TCGA-DD-A4NE-01A-11D-A27I-10_wgs_Illumina.bam	36.93	NA	0.07	58cfa831e4b0c9d6adf6ca17	TCGA-DD-A4NE-01A-11D-A27I-10_wgs_Illumina.bam	Dead	FEMALE	WHITE	HISPANIC OR LATINO	Liver Hepatocellular Carcinoma	Aligned reads	TCGA-DD-A4NE-01A	BCE25281-502E-4599-9679-32DC8462FFB1	Primary Tumor	Illumina HiSeq	fde02df3-c43e-4d99-bb67-57c883818892	Liver	75	C8CB1326-7AB9-4E3D-BDC9-9CE42715DAC7	343FCBC2-F30C-4FFA-A0B3-F5BB21E5E70B	TCGA-DD-A4NE-01A-11D-A27I-10	GRCh37-lite	TCGA-DD-A4NE	TCGA-LIHC	660	s16588	Baylor College of Medicine	Mayo Clinic - Rochester	United States	NO	T3a	N0	Hepatocellular Carcinoma	Stage IIIA	A27I-10	TRUE
13722.58cfa831e4b0c9d6adf6cc3c	58cfa831e4b0c9d6adf6cc3c	TCGA-EP-A2KB-01A-11D-A183-10_wgs_Illumina.filtered.	WGS	TCGA-EP-A2KB-01A-11D-A183-10_wgs_Illumina	TCGA-EP-A2KB-01A-11D-A183-10_wgs_Illumina.bam	51.77	NA	0.08	58cfa831e4b0c9d6adf6cc3c	TCGA-EP-A2KB-01A-11D-A183-10_wgs_Illumina.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Liver Hepatocellular Carcinoma	Aligned reads	TCGA-EP-A2KB-01A	18C08546-BED3-4ED9-B223-479AFE633C8E	Primary Tumor	Illumina HiSeq	41e9afd1-d090-475a-ba8a-48976ddc9d52	Liver	46	E2895132-DA4F-4DB5-B417-510E99FCE776	305A5074-5384-45A0-985D-289B178D09F6	TCGA-EP-A2KB-01A-11D-A183-10	GRCh37-lite	TCGA-EP-A2KB	TCGA-LIHC	NA	s16781	Baylor College of Medicine	Christiana Healthcare	United States	NO	T1	NX	Hepatocellular Carcinoma	Stage I	A183-10	TRUE
13722.58cfa831e4b0c9d6adf6cbe9	58cfa831e4b0c9d6adf6cbe9	TCGA-ED-A459-01A-11D-A25V-10_wgs_Illumina.filtered.	WGS	TCGA-ED-A459-01A-11D-A25V-10_wgs_Illumina	TCGA-ED-A459-01A-11D-A25V-10_wgs_Illumina.bam	19.74	NA	0.08	58cfa831e4b0c9d6adf6cbe9	TCGA-ED-A459-01A-11D-A25V-10_wgs_Illumina.bam	Alive	MALE	ASIAN	NOT HISPANIC OR LATINO	Liver Hepatocellular Carcinoma	Aligned reads	TCGA-ED-A459-01A	56403463-1727-4C23-A709-DE5F168C4073	Primary Tumor	Illumina HiSeq	eefae457-c645-4b48-b599-b479b7be4414	Liver	47	97FA4D8B-1C05-41A6-97C4-0B27DC70EB4C	7FC7B316-F3D3-4E71-9417-423FE334E6BC	TCGA-ED-A459-01A-11D-A25V-10	GRCh37-lite	TCGA-ED-A459	TCGA-LIHC	NA	s16980	Baylor College of Medicine	Asterand	Vietnam	NO	T2	N0	Hepatocellular Carcinoma	Stage II	A25V-10	TRUE
13722.58cfa831e4b0c9d6adf6cc38	58cfa831e4b0c9d6adf6cc38	TCGA-EP-A26S-01A-11D-A16V-10_wgs_Illumina.filtered.	WGS	TCGA-EP-A26S-01A-11D-A16V-10_wgs_Illumina	TCGA-EP-A26S-01A-11D-A16V-10_wgs_Illumina.bam	64	NA	0.07	58cfa831e4b0c9d6adf6cc38	TCGA-EP-A26S-01A-11D-A16V-10_wgs_Illumina.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Liver Hepatocellular Carcinoma	Aligned reads	TCGA-EP-A26S-01A	B7D6621C-8BCE-4A01-8588-9D7761D9372B	Primary Tumor	Illumina HiSeq	e3122147-a994-4b8f-aa05-ddb36413802a	Liver	70	A0B2FF38-E6BF-4F27-98AB-5CF924B0E236	463BF060-8BA6-4A73-8173-172025F7B527	TCGA-EP-A26S-01A-11D-A16V-10	GRCh37-lite	TCGA-EP-A26S	TCGA-LIHC	NA	s16982	Baylor College of Medicine	Christiana Healthcare	United States	NO	T1	N0	Hepatocellular Carcinoma	Stage I	A16V-10	TRUE
13722.58cfa831e4b0c9d6adf6cde4	58cfa831e4b0c9d6adf6cde4	TCGA-ES-A2HS-01A-11D-A183-10_wgs_Illumina.filtered.	WGS	TCGA-ES-A2HS-01A-11D-A183-10_wgs_Illumina	TCGA-ES-A2HS-01A-11D-A183-10_wgs_Illumina.bam	48.99	NA	0.09	58cfa831e4b0c9d6adf6cde4	TCGA-ES-A2HS-01A-11D-A183-10_wgs_Illumina.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Liver Hepatocellular Carcinoma	Aligned reads	TCGA-ES-A2HS-01A	728AEDB3-551A-4C16-9BE3-7733A9539E9E	Primary Tumor	Illumina HiSeq	a3182ffa-89ac-4c42-a051-93cb3aa08207	Liver	80	A06FE860-8D5F-4ED0-B7FC-72F74567FB7E	DCF45005-7E6D-4C26-9994-F973DA7E814F	TCGA-ES-A2HS-01A-11D-A183-10	GRCh37-lite	TCGA-ES-A2HS	TCGA-LIHC	695	s16984	Baylor College of Medicine	University of Florida	United States	NO	T1	NX	Hepatocellular Carcinoma	Stage I	A183-10	TRUE
13722.58cfa831e4b0c9d6adf6cb2c	58cfa831e4b0c9d6adf6cb2c	TCGA-ED-A4XI-01A-11D-A25V-10_wgs_Illumina.filtered.	WGS	TCGA-ED-A4XI-01A-11D-A25V-10_wgs_Illumina	TCGA-ED-A4XI-01A-11D-A25V-10_wgs_Illumina.bam	23.36	NA	0.08	58cfa831e4b0c9d6adf6cb2c	TCGA-ED-A4XI-01A-11D-A25V-10_wgs_Illumina.bam	Alive	MALE	ASIAN	NOT HISPANIC OR LATINO	Liver Hepatocellular Carcinoma	Aligned reads	TCGA-ED-A4XI-01A	C52ABAC9-07DA-4B3D-BF8A-2161CACF9682	Primary Tumor	Illumina HiSeq	a2c23e6e-f1ad-454f-999a-c07f31a63536	Liver	58	25EB5AFD-E7A6-4F3C-82B4-A3DE1F8F9BE1	670F971F-A525-4EF8-91BA-610CFBAEB914	TCGA-ED-A4XI-01A-11D-A25V-10	GRCh37-lite	TCGA-ED-A4XI	TCGA-LIHC	NA	s16589	Baylor College of Medicine	Asterand	Vietnam	NO	T2	N0	Hepatocellular Carcinoma	Stage II	A25V-10	TRUE
13722.58cfa831e4b0c9d6adf6cc1c	58cfa831e4b0c9d6adf6cc1c	TCGA-EP-A2KA-01A-11D-A183-10_wgs_Illumina.filtered.	WGS	TCGA-EP-A2KA-01A-11D-A183-10_wgs_Illumina	TCGA-EP-A2KA-01A-11D-A183-10_wgs_Illumina.bam	69.11	NA	0.07	58cfa831e4b0c9d6adf6cc1c	TCGA-EP-A2KA-01A-11D-A183-10_wgs_Illumina.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Liver Hepatocellular Carcinoma	Aligned reads	TCGA-EP-A2KA-01A	440375D7-CDCD-418A-8992-0A8CA42D290D	Primary Tumor	Illumina HiSeq	e0364f92-b574-4946-8ba1-2504614f0845	Liver	52	E6E1BF11-DA29-4052-85A1-584401F0FA3D	484A41C8-FCAF-488D-97DC-BFE6A4B88A95	TCGA-EP-A2KA-01A-11D-A183-10	GRCh37-lite	TCGA-EP-A2KA	TCGA-LIHC	NA	s16983	Baylor College of Medicine	Christiana Healthcare	United States	NO	T3a	NX	Hepatocellular Carcinoma	Stage IIIA	A183-10	TRUE
13722.58cfa832e4b0c9d6adf6ce3a	58cfa832e4b0c9d6adf6ce3a	TCGA-ES-A2HT-01A-12D-A183-10_wgs_Illumina.filtered.	WGS	TCGA-ES-A2HT-01A-12D-A183-10_wgs_Illumina	TCGA-ES-A2HT-01A-12D-A183-10_wgs_Illumina.bam	11.86	NA	0.08	58cfa832e4b0c9d6adf6ce3a	TCGA-ES-A2HT-01A-12D-A183-10_wgs_Illumina.bam	Dead	MALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Liver Hepatocellular Carcinoma	Aligned reads	TCGA-ES-A2HT-01A	7DD3BDA9-3A0A-46FA-B052-A6D24B847804	Primary Tumor	Illumina HiSeq	f5b5c206-8657-4209-bc75-e3f064cecdd0	Liver	54	9B68C72D-30D4-4A7A-ADE7-A2BDE50A84F2	D6CCFD6F-2EA9-499D-A25D-4BA9D4A9258E	TCGA-ES-A2HT-01A-12D-A183-10	GRCh37-lite	TCGA-ES-A2HT	TCGA-LIHC	438	s16783	Baylor College of Medicine	University of Florida	United States	NO	T1	NX	Hepatocellular Carcinoma	Stage I	A183-10	TRUE
13722.58cfa831e4b0c9d6adf6cd8d	58cfa831e4b0c9d6adf6cd8d	TCGA-FF-8062-01A-11D-2210-10_wgs_Illumina.filtered.	WGS	TCGA-FF-8062-01A-11D-2210-10_wgs_Illumina	TCGA-FF-8062-01A-11D-2210-10_wgs_Illumina.bam	612.7	NA	0.05	58cfa831e4b0c9d6adf6cd8d	TCGA-FF-8062-01A-11D-2210-10_wgs_Illumina.bam	Alive	FEMALE	ASIAN	NOT HISPANIC OR LATINO	Lymphoid Neoplasm Diffuse Large B-cell Lymphoma	Aligned reads	TCGA-FF-8062-01A	0E9FCCCC-0630-408D-A121-2C6413824CB7	Primary Tumor	Illumina HiSeq	6b814375-f839-4dc0-a4a2-d495b55c5f64	Lymph Nodes	60	A1DACFBB-042B-496E-94A4-046DC04E27B5	BD403458-5154-488B-931A-A7E737A6BF8C	TCGA-FF-8062-01A-11D-2210-10	GRCh37-lite	TCGA-FF-8062	TCGA-DLBC	NA	s1112	Baylor College of Medicine	SingHealth	Singapore	NO	Not available	Not available	Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal)	Not available	2210-10	TRUE
13722.58cfa832e4b0c9d6adf6ce68	58cfa832e4b0c9d6adf6ce68	TCGA-G3-A25V-01A-11D-A16V-10_wgs_Illumina.filtered.	WGS	TCGA-G3-A25V-01A-11D-A16V-10_wgs_Illumina	TCGA-G3-A25V-01A-11D-A16V-10_wgs_Illumina.bam	62.02	1.79	0.08	58cfa832e4b0c9d6adf6ce68	TCGA-G3-A25V-01A-11D-A16V-10_wgs_Illumina.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Liver Hepatocellular Carcinoma	Aligned reads	TCGA-G3-A25V-01A	F435EC00-0DB8-46B4-96BF-890A9D931DF3	Primary Tumor	Illumina HiSeq	ddbeb5de-c37a-4565-8b8d-8965c09eb657	Liver	68	634AB666-0845-4B62-A2A1-ABD408D8B829	4624FD20-E2AD-4826-B606-A694B04E1076	TCGA-G3-A25V-01A-11D-A16V-10	GRCh37-lite	TCGA-G3-A25V	TCGA-LIHC	NA	s16688	Baylor College of Medicine	Alberta Health Services	Canada	NO	T1	N0	Hepatocellular Carcinoma	Stage I	A16V-10	TRUE
13722.58cfa832e4b0c9d6adf6ce70	58cfa832e4b0c9d6adf6ce70	TCGA-FV-A496-01A-11D-A25V-10_wgs_Illumina.filtered.	WGS	TCGA-FV-A496-01A-11D-A25V-10_wgs_Illumina	TCGA-FV-A496-01A-11D-A25V-10_wgs_Illumina.bam	36.61	NA	0.07	58cfa832e4b0c9d6adf6ce70	TCGA-FV-A496-01A-11D-A25V-10_wgs_Illumina.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Liver Hepatocellular Carcinoma	Aligned reads	TCGA-FV-A496-01A	8AFA3140-DCBD-44C0-AB13-4ADA6A0444D4	Primary Tumor	Illumina HiSeq	62727522-1644-478e-a555-06a870b68bab	Liver	84	FD1E3B28-C143-4EF6-A699-3A61CB20A5ED	6E6AD1A2-F1EB-44D1-9852-F5752AFCF5EB	TCGA-FV-A496-01A-11D-A25V-10	GRCh37-lite	TCGA-FV-A496	TCGA-LIHC	NA	s16787	Baylor College of Medicine	International Genomics Consortium	United States	NO	T1	NX	Hepatocellular Carcinoma	Stage I	A25V-10	TRUE
13722.58cfa832e4b0c9d6adf6ce7e	58cfa832e4b0c9d6adf6ce7e	TCGA-FV-A495-01A-11D-A25V-10_wgs_Illumina.filtered.	WGS	TCGA-FV-A495-01A-11D-A25V-10_wgs_Illumina	TCGA-FV-A495-01A-11D-A25V-10_wgs_Illumina.bam	17.43	NA	0.08	58cfa832e4b0c9d6adf6ce7e	TCGA-FV-A495-01A-11D-A25V-10_wgs_Illumina.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Liver Hepatocellular Carcinoma	Aligned reads	TCGA-FV-A495-01A	BD48FA5E-0152-46F0-A4FA-8CF723FF2DCD	Primary Tumor	Illumina HiSeq	bd95350e-cf5e-48c9-929a-3e397b36cd21	Liver	51	B7FC877D-6055-4A28-BBDF-50CE7236B7BF	84FE77B4-F6CC-49BF-A6B9-1621EC9394F8	TCGA-FV-A495-01A-11D-A25V-10	GRCh37-lite	TCGA-FV-A495	TCGA-LIHC	NA	s16591	Baylor College of Medicine	International Genomics Consortium	United States	NO	T2	NX	Hepatocellular Carcinoma	Stage II	A25V-10	TRUE
13722.58cfa832e4b0c9d6adf6ce6c	58cfa832e4b0c9d6adf6ce6c	TCGA-G3-A3CK-01A-11D-A20W-10_wgs_Illumina.filtered.	WGS	TCGA-G3-A3CK-01A-11D-A20W-10_wgs_Illumina	TCGA-G3-A3CK-01A-11D-A20W-10_wgs_Illumina.bam	43.11	NA	0.08	58cfa832e4b0c9d6adf6ce6c	TCGA-G3-A3CK-01A-11D-A20W-10_wgs_Illumina.bam	Alive	MALE	ASIAN	NOT HISPANIC OR LATINO	Liver Hepatocellular Carcinoma	Aligned reads	TCGA-G3-A3CK-01A	39EB1DB0-2722-4AF4-8254-D0E10256C64D	Primary Tumor	Illumina HiSeq	210fd1fb-0012-410b-bfc8-bf53607bfe12	Liver	61	2F38C711-639F-4611-9076-DC99A1DB8239	1127B561-EA40-4D5E-95DF-DAA0A5EBC1E4	TCGA-G3-A3CK-01A-11D-A20W-10	GRCh37-lite	TCGA-G3-A3CK	TCGA-LIHC	NA	s16988	Baylor College of Medicine	Alberta Health Services	Canada	NO	T1	N0	Hepatocellular Carcinoma	Stage I	A20W-10	FALSE
13722.58cfa832e4b0c9d6adf6ce6f	58cfa832e4b0c9d6adf6ce6f	TCGA-GL-A4EM-01A-11D-A25F-10_wgs_Illumina.filtered.	WGS	TCGA-GL-A4EM-01A-11D-A25F-10_wgs_Illumina	TCGA-GL-A4EM-01A-11D-A25F-10_wgs_Illumina.bam	11.47	NA	0.08	58cfa832e4b0c9d6adf6ce6f	TCGA-GL-A4EM-01A-11D-A25F-10_wgs_Illumina.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Papillary Cell Carcinoma	Aligned reads	TCGA-GL-A4EM-01A	2C084454-18E9-4837-9BBA-7E91A73A48E0	Primary Tumor	Illumina HiSeq	39550a3d-400e-427e-871c-7749ae5dc2f3	Kidney	61	353CDF9B-F87E-45ED-8263-B1720FAE4EEA	7815397B-AA39-4B79-BCAA-6859A3F115F8	TCGA-GL-A4EM-01A-11D-A25F-10	GRCh37-lite	TCGA-GL-A4EM	TCGA-KIRP	NA	s11777	Baylor College of Medicine	ABS - IUPUI	United States	NO	T1b	NX	Kidney Papillary Renal Cell Carcinoma	Stage I	A25F-10	TRUE
13722.58cfa832e4b0c9d6adf6ce87	58cfa832e4b0c9d6adf6ce87	TCGA-FV-A3R3-01A-11D-A22F-10_wgs_Illumina.filtered.	WGS	TCGA-FV-A3R3-01A-11D-A22F-10_wgs_Illumina	TCGA-FV-A3R3-01A-11D-A22F-10_wgs_Illumina.bam	16.97	NA	0.08	58cfa832e4b0c9d6adf6ce87	TCGA-FV-A3R3-01A-11D-A22F-10_wgs_Illumina.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Liver Hepatocellular Carcinoma	Aligned reads	TCGA-FV-A3R3-01A	3DD7C93D-8194-44EE-8014-10DD81EF6441	Primary Tumor	Illumina HiSeq	0f95ee88-7930-46cd-a565-bf3d91f5f505	Liver	38	8ABDA02F-AEDF-4599-9407-E253207D5D4C	C285C2FA-24B4-47A1-874D-86E74B002B05	TCGA-FV-A3R3-01A-11D-A22F-10	GRCh37-lite	TCGA-FV-A3R3	TCGA-LIHC	NA	s16685	Baylor College of Medicine	International Genomics Consortium	United States	NO	T1	NX	Hepatocellular Carcinoma	Stage I	A22F-10	TRUE
13722.58cfa831e4b0c9d6adf6cc59	58cfa831e4b0c9d6adf6cc59	TCGA-EP-A3RK-01A-11D-A22F-10_wgs_Illumina.filtered.	WGS	TCGA-EP-A3RK-01A-11D-A22F-10_wgs_Illumina	TCGA-EP-A3RK-01A-11D-A22F-10_wgs_Illumina.bam	46.15	NA	0.08	58cfa831e4b0c9d6adf6cc59	TCGA-EP-A3RK-01A-11D-A22F-10_wgs_Illumina.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Liver Hepatocellular Carcinoma	Aligned reads	TCGA-EP-A3RK-01A	F15279DD-5D12-460B-9BD1-B4F95681CA65	Primary Tumor	Illumina HiSeq	3b2093f5-b5ba-4e57-b4a1-47a180f9bb81	Liver	73	253DA6EE-8786-4A20-A0DC-58816A8A9C39	0D259AC2-03D1-4814-9B0B-D05E3A6029B7	TCGA-EP-A3RK-01A-11D-A22F-10	GRCh37-lite	TCGA-EP-A3RK	TCGA-LIHC	NA	s16682	Baylor College of Medicine	Christiana Healthcare	United States	NO	T3a	NX	Hepatocellular Carcinoma	Stage IIIA	A22F-10	TRUE
13722.58cfa832e4b0c9d6adf6ce7c	58cfa832e4b0c9d6adf6ce7c	TCGA-G3-A5SL-01A-11D-A27I-10_wgs_Illumina.filtered.	WGS	TCGA-G3-A5SL-01A-11D-A27I-10_wgs_Illumina	TCGA-G3-A5SL-01A-11D-A27I-10_wgs_Illumina.bam	50.54	NA	0.07	58cfa832e4b0c9d6adf6ce7c	TCGA-G3-A5SL-01A-11D-A27I-10_wgs_Illumina.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Liver Hepatocellular Carcinoma	Aligned reads	TCGA-G3-A5SL-01A	9A56D8A8-DADD-442E-BC09-732CD619AEF7	Primary Tumor	Illumina HiSeq	f55def89-845d-40d8-a532-eb471f2c04d3	Liver	70	5AF5519D-73EE-481B-A47C-06F54DBD372F	70422E6D-CB1F-4284-8BE9-1D4517FFAD60	TCGA-G3-A5SL-01A-11D-A27I-10	GRCh37-lite	TCGA-G3-A5SL	TCGA-LIHC	NA	s17064	Baylor College of Medicine	Alberta Health Services	Canada	NO	T2	NX	Hepatocellular Carcinoma	Stage II	A27I-10	TRUE
13722.58cfa832e4b0c9d6adf6ce6e	58cfa832e4b0c9d6adf6ce6e	TCGA-FV-A3R2-01A-11D-A22F-10_wgs_Illumina.filtered.	WGS	TCGA-FV-A3R2-01A-11D-A22F-10_wgs_Illumina	TCGA-FV-A3R2-01A-11D-A22F-10_wgs_Illumina.bam	43.8	NA	0.07	58cfa832e4b0c9d6adf6ce6e	TCGA-FV-A3R2-01A-11D-A22F-10_wgs_Illumina.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Liver Hepatocellular Carcinoma	Aligned reads	TCGA-FV-A3R2-01A	17833039-0D7E-47F0-90E6-8CABAE94C124	Primary Tumor	Illumina HiSeq	b20c4bf4-6780-4ba0-ae12-ae33d48a60d2	Liver	75	04BECA9F-830C-4CA8-A947-1BF2D7DF1B26	B9098B7C-EAB0-4EF5-B968-8D3024BF32F7	TCGA-FV-A3R2-01A-11D-A22F-10	GRCh37-lite	TCGA-FV-A3R2	TCGA-LIHC	194	s16784	Baylor College of Medicine	International Genomics Consortium	United States	NO	T1	NX	Hepatocellular Carcinoma	Stage I	A22F-10	TRUE
13722.58cfa832e4b0c9d6adf6cef0	58cfa832e4b0c9d6adf6cef0	TCGA-FF-8043-01A-11D-2210-10_wgs_Illumina.filtered.	WGS	TCGA-FF-8043-01A-11D-2210-10_wgs_Illumina	TCGA-FF-8043-01A-11D-2210-10_wgs_Illumina.bam	464.7	NA	0.05	58cfa832e4b0c9d6adf6cef0	TCGA-FF-8043-01A-11D-2210-10_wgs_Illumina.bam	Alive	FEMALE	ASIAN	NOT HISPANIC OR LATINO	Lymphoid Neoplasm Diffuse Large B-cell Lymphoma	Aligned reads	TCGA-FF-8043-01A	A8E2DF1E-4042-42AF-9231-3A00E83489F0	Primary Tumor	Illumina HiSeq	a5e8328e-363d-44ee-b7f7-43594627c249	Lymph Nodes	70	DEC7125D-7E6C-4D05-9911-C3FF2A8E2B73	E89E9C69-FFCD-4A4C-818D-1DEE43DDC76A	TCGA-FF-8043-01A-11D-2210-10	GRCh37-lite	TCGA-FF-8043	TCGA-DLBC	NA	s1110	Baylor College of Medicine	SingHealth	Singapore	NO	Not available	Not available	Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal)	Not available	2210-10	TRUE
13722.58cfa832e4b0c9d6adf6cefa	58cfa832e4b0c9d6adf6cefa	TCGA-HE-A5NH-01A-11D-A26P-10_wgs_Illumina.filtered.	WGS	TCGA-HE-A5NH-01A-11D-A26P-10_wgs_Illumina	TCGA-HE-A5NH-01A-11D-A26P-10_wgs_Illumina.bam	20.02	NA	0.08	58cfa832e4b0c9d6adf6cefa	TCGA-HE-A5NH-01A-11D-A26P-10_wgs_Illumina.bam	Alive	MALE	Not available	Not available	Kidney Renal Papillary Cell Carcinoma	Aligned reads	TCGA-HE-A5NH-01A	98A639C2-D615-4DC1-98F0-298752B69B09	Primary Tumor	Illumina HiSeq	7d7c81dd-4888-4bac-a7d7-0859f946423b	Kidney	62	E8CD0D5D-2AF6-444F-B8B9-05B1874EDAE2	33B7E799-AD10-498F-9948-8CE433311539	TCGA-HE-A5NH-01A-11D-A26P-10	GRCh37-lite	TCGA-HE-A5NH	TCGA-KIRP	NA	s11591	Baylor College of Medicine	Ontario Institute for Cancer Research (OICR)	Canada	NO	T1a	NX	Kidney Papillary Renal Cell Carcinoma	Stage I	A26P-10	TRUE
13722.58cfa832e4b0c9d6adf6ce62	58cfa832e4b0c9d6adf6ce62	TCGA-FV-A2QQ-01A-11D-A22F-10_wgs_Illumina.filtered.	WGS	TCGA-FV-A2QQ-01A-11D-A22F-10_wgs_Illumina	TCGA-FV-A2QQ-01A-11D-A22F-10_wgs_Illumina.bam	36.18	NA	0.08	58cfa832e4b0c9d6adf6ce62	TCGA-FV-A2QQ-01A-11D-A22F-10_wgs_Illumina.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Liver Hepatocellular Carcinoma	Aligned reads	TCGA-FV-A2QQ-01A	D680DF09-368E-42B5-B540-45C41ED31042	Primary Tumor	Illumina HiSeq	5e2beb4b-957f-4d8e-956f-798a63355329	Liver	80	A0096AF4-ABD3-4F6E-A6AC-2CF2E57C7BD9	4904D56F-0FE7-4482-8F6D-9E54D261F399	TCGA-FV-A2QQ-01A-11D-A22F-10	GRCh37-lite	TCGA-FV-A2QQ	TCGA-LIHC	NA	s16861	Baylor College of Medicine	International Genomics Consortium	United States	NO	T1	N1	Hepatocellular Carcinoma	Stage IVA	A22F-10	TRUE
13722.58cfa832e4b0c9d6adf6cf76	58cfa832e4b0c9d6adf6cf76	TCGA-FV-A23B-01A-11D-A16V-10_wgs_Illumina.filtered.	WGS	TCGA-FV-A23B-01A-11D-A16V-10_wgs_Illumina	TCGA-FV-A23B-01A-11D-A16V-10_wgs_Illumina.bam	76.29	1.85	0.08	58cfa832e4b0c9d6adf6cf76	TCGA-FV-A23B-01A-11D-A16V-10_wgs_Illumina.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Liver Hepatocellular Carcinoma	Aligned reads	TCGA-FV-A23B-01A	C95ED407-BCC2-44AA-BC59-BF7549F2D665	Primary Tumor	Illumina HiSeq	1727600d-b6d6-4ab4-9eb1-03b214f5be2c	Liver	70	D056433D-C3E2-467A-8151-DDF2A6D8683A	63ADC09C-E1B1-40DD-9C35-2F8276B656FC	TCGA-FV-A23B-01A-11D-A16V-10	GRCh37-lite	TCGA-FV-A23B	TCGA-LIHC	NA	s16786	Baylor College of Medicine	International Genomics Consortium	United States	NO	T2	N0	Hepatocellular Carcinoma	Stage II	A16V-10	TRUE
13722.58cfa832e4b0c9d6adf6d011	58cfa832e4b0c9d6adf6d011	TCGA-G3-A25Y-01A-11D-A16V-10_wgs_Illumina.filtered.	WGS	TCGA-G3-A25Y-01A-11D-A16V-10_wgs_Illumina	TCGA-G3-A25Y-01A-11D-A16V-10_wgs_Illumina.bam	84.29	1.88	0.08	58cfa832e4b0c9d6adf6d011	TCGA-G3-A25Y-01A-11D-A16V-10_wgs_Illumina.bam	Dead	FEMALE	ASIAN	NOT HISPANIC OR LATINO	Liver Hepatocellular Carcinoma	Aligned reads	TCGA-G3-A25Y-01A	239B4298-B090-480A-A19F-9758A827AA30	Primary Tumor	Illumina HiSeq	e3c5b76f-1e3c-4536-92be-2851b2d6f589	Liver	52	433DF923-691A-41F8-8718-6F9783F59873	6B50391F-D890-4CA0-B942-BEAB0F8BF1C9	TCGA-G3-A25Y-01A-11D-A16V-10	GRCh37-lite	TCGA-G3-A25Y	TCGA-LIHC	452	s16864	Baylor College of Medicine	Alberta Health Services	Canada	NO	T1	N0	Hepatocellular Carcinoma	Stage I	A16V-10	TRUE
13722.58cfa832e4b0c9d6adf6d027	58cfa832e4b0c9d6adf6d027	TCGA-HE-A5NJ-01A-11D-A26P-10_wgs_Illumina.filtered.	WGS	TCGA-HE-A5NJ-01A-11D-A26P-10_wgs_Illumina	TCGA-HE-A5NJ-01A-11D-A26P-10_wgs_Illumina.bam	54.68	NA	0.07	58cfa832e4b0c9d6adf6d027	TCGA-HE-A5NJ-01A-11D-A26P-10_wgs_Illumina.bam	Alive	MALE	Not available	Not available	Kidney Renal Papillary Cell Carcinoma	Aligned reads	TCGA-HE-A5NJ-01A	8D28F586-3DE5-4033-A9FD-4F67BE406FB4	Primary Tumor	Illumina HiSeq	ac395d4f-83c9-44e8-af57-fc5266ebef92	Kidney	58	DDB72D04-48F5-4AD5-95A7-8D2614BA0AE0	A9DBD55C-5DCC-48DB-8785-6BAEF3FDD7DB	TCGA-HE-A5NJ-01A-11D-A26P-10	GRCh37-lite	TCGA-HE-A5NJ	TCGA-KIRP	NA	s11652	Baylor College of Medicine	Ontario Institute for Cancer Research (OICR)	Canada	NO	T1b	NX	Kidney Papillary Renal Cell Carcinoma	Not available	A26P-10	TRUE
13722.58cfa832e4b0c9d6adf6d04c	58cfa832e4b0c9d6adf6d04c	TCGA-HE-A5NK-01A-11D-A26P-10_wgs_Illumina.filtered.	WGS	TCGA-HE-A5NK-01A-11D-A26P-10_wgs_Illumina	TCGA-HE-A5NK-01A-11D-A26P-10_wgs_Illumina.bam	18.38	NA	0.07	58cfa832e4b0c9d6adf6d04c	TCGA-HE-A5NK-01A-11D-A26P-10_wgs_Illumina.bam	Alive	MALE	Not available	Not available	Kidney Renal Papillary Cell Carcinoma	Aligned reads	TCGA-HE-A5NK-01A	F9306CB1-C4E4-42EB-8AA9-EE906C408E10	Primary Tumor	Illumina HiSeq	5f1b89ba-b8f2-47c1-962e-8ae688b53555	Kidney	82	A3EDB023-35B4-4FB5-98A0-FF51C0348187	73F57B92-A6E6-4472-940B-579C22D208BF	TCGA-HE-A5NK-01A-11D-A26P-10	GRCh37-lite	TCGA-HE-A5NK	TCGA-KIRP	NA	s11780	Baylor College of Medicine	Ontario Institute for Cancer Research (OICR)	Canada	NO	T1b	NX	Kidney Papillary Renal Cell Carcinoma	Not available	A26P-10	TRUE
13722.58cfa832e4b0c9d6adf6d07e	58cfa832e4b0c9d6adf6d07e	TCGA-HE-A5NF-01A-11D-A26P-10_wgs_Illumina.filtered.	WGS	TCGA-HE-A5NF-01A-11D-A26P-10_wgs_Illumina	TCGA-HE-A5NF-01A-11D-A26P-10_wgs_Illumina.bam	17.39	NA	0.08	58cfa832e4b0c9d6adf6d07e	TCGA-HE-A5NF-01A-11D-A26P-10_wgs_Illumina.bam	Alive	MALE	Not available	Not available	Kidney Renal Papillary Cell Carcinoma	Aligned reads	TCGA-HE-A5NF-01A	36B46540-472F-4A4D-A801-B8B6AE660DC9	Primary Tumor	Illumina HiSeq	ccad1f55-76d4-41fc-abf9-9409c743d7e8	Kidney	58	7C6B9F49-9EA0-4532-BDCE-F8987786BF5A	C14407AD-670E-4D1E-9417-2B76F4810FFF	TCGA-HE-A5NF-01A-11D-A26P-10	GRCh37-lite	TCGA-HE-A5NF	TCGA-KIRP	NA	s11779	Baylor College of Medicine	Ontario Institute for Cancer Research (OICR)	Canada	NO	T1a	NX	Kidney Papillary Renal Cell Carcinoma	Stage I	A26P-10	TRUE
13722.58cfa832e4b0c9d6adf6d112	58cfa832e4b0c9d6adf6d112	TCGA-FV-A3I0-01A-11D-A22F-10_wgs_Illumina.filtered.	WGS	TCGA-FV-A3I0-01A-11D-A22F-10_wgs_Illumina	TCGA-FV-A3I0-01A-11D-A22F-10_wgs_Illumina.bam	32.65	NA	0.07	58cfa832e4b0c9d6adf6d112	TCGA-FV-A3I0-01A-11D-A22F-10_wgs_Illumina.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Liver Hepatocellular Carcinoma	Aligned reads	TCGA-FV-A3I0-01A	A8C2AA08-9156-4845-AD77-5E060858C757	Primary Tumor	Illumina HiSeq	63861662-f89c-47c7-80f6-165f38ed4253	Liver	76	810D65B3-59D9-4815-AA41-0C21A0D17AC2	5DF489BC-6178-49E4-8A42-506F70300DFF	TCGA-FV-A3I0-01A-11D-A22F-10	GRCh37-lite	TCGA-FV-A3I0	TCGA-LIHC	NA	s16593	Baylor College of Medicine	International Genomics Consortium	United States	NO	T2	NX	Hepatocholangiocarcinoma (Mixed)	Stage II	A22F-10	TRUE
13722.58cfa832e4b0c9d6adf6d0d8	58cfa832e4b0c9d6adf6d0d8	TCGA-G3-A25S-01A-11D-A16V-10_wgs_Illumina.filtered.	WGS	TCGA-G3-A25S-01A-11D-A16V-10_wgs_Illumina	TCGA-G3-A25S-01A-11D-A16V-10_wgs_Illumina.bam	82.14	1.93	0.08	58cfa832e4b0c9d6adf6d0d8	TCGA-G3-A25S-01A-11D-A16V-10_wgs_Illumina.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Liver Hepatocellular Carcinoma	Aligned reads	TCGA-G3-A25S-01A	B865DEC4-F051-4FBE-9405-F832FF2010D7	Primary Tumor	Illumina HiSeq	95c222bc-3817-42a2-b237-911c68ec0cf0	Liver	64	D12BE3F6-68BC-4583-9478-FC01A0EB9387	C05ADC19-2E01-4712-A35A-69EEE4D40998	TCGA-G3-A25S-01A-11D-A16V-10	GRCh37-lite	TCGA-G3-A25S	TCGA-LIHC	NA	s16686	Baylor College of Medicine	Alberta Health Services	Canada	NO	T1	N0	Hepatocellular Carcinoma	Stage I	A16V-10	TRUE
13722.58cfa832e4b0c9d6adf6cfd2	58cfa832e4b0c9d6adf6cfd2	TCGA-GL-A59R-01A-11D-A26P-10_wgs_Illumina.filtered.	WGS	TCGA-GL-A59R-01A-11D-A26P-10_wgs_Illumina	TCGA-GL-A59R-01A-11D-A26P-10_wgs_Illumina.bam	21.08	NA	0.08	58cfa832e4b0c9d6adf6cfd2	TCGA-GL-A59R-01A-11D-A26P-10_wgs_Illumina.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Papillary Cell Carcinoma	Aligned reads	TCGA-GL-A59R-01A	78412F82-CC55-43D5-96CA-1D02CF957725	Primary Tumor	Illumina HiSeq	78730e13-6aeb-4c56-8ac4-4a73dcd37bbd	Kidney	79	6F084D86-6CE0-431A-87D7-0E543392EA15	C504D5A9-29B0-4B7E-AC7B-5E543449A0F4	TCGA-GL-A59R-01A-11D-A26P-10	GRCh37-lite	TCGA-GL-A59R	TCGA-KIRP	NA	s11647	Baylor College of Medicine	ABS - IUPUI	United States	NO	T3c	N0	Kidney Papillary Renal Cell Carcinoma	Stage III	A26P-10	TRUE
13722.58cfa832e4b0c9d6adf6d029	58cfa832e4b0c9d6adf6d029	TCGA-HE-A5NI-01A-11D-A26P-10_wgs_Illumina.filtered.	WGS	TCGA-HE-A5NI-01A-11D-A26P-10_wgs_Illumina	TCGA-HE-A5NI-01A-11D-A26P-10_wgs_Illumina.bam	27.28	NA	0.08	58cfa832e4b0c9d6adf6d029	TCGA-HE-A5NI-01A-11D-A26P-10_wgs_Illumina.bam	Alive	MALE	Not available	Not available	Kidney Renal Papillary Cell Carcinoma	Aligned reads	TCGA-HE-A5NI-01A	D61E22D8-C3CE-4237-83D7-DA188B9FD456	Primary Tumor	Illumina HiSeq	b85a3000-296d-44e9-8c6b-9a5db0104583	Kidney	73	520E4C08-E7C6-407F-94CD-A07681BC24A8	40A609BB-2C8F-4146-83C4-E7B0D1B23619	TCGA-HE-A5NI-01A-11D-A26P-10	GRCh37-lite	TCGA-HE-A5NI	TCGA-KIRP	NA	s11651	Baylor College of Medicine	Ontario Institute for Cancer Research (OICR)	Canada	NO	T1a	NX	Kidney Papillary Renal Cell Carcinoma	Stage I	A26P-10	TRUE
13722.58cfa832e4b0c9d6adf6d0a2	58cfa832e4b0c9d6adf6d0a2	TCGA-IA-A40X-01A-11D-A25F-10_wgs_Illumina.filtered.	WGS	TCGA-IA-A40X-01A-11D-A25F-10_wgs_Illumina	TCGA-IA-A40X-01A-11D-A25F-10_wgs_Illumina.bam	35.98	NA	0.08	58cfa832e4b0c9d6adf6d0a2	TCGA-IA-A40X-01A-11D-A25F-10_wgs_Illumina.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Kidney Renal Papillary Cell Carcinoma	Aligned reads	TCGA-IA-A40X-01A	0C151271-2CF9-43F4-9E9B-FE927DE43131	Primary Tumor	Illumina HiSeq	0d27ff83-40ce-4ea3-8368-b9f9f3b4fe26	Kidney	49	863393ED-42BB-4232-93F4-2B5759D9822C	E1217EBE-1826-41A9-B6C4-702100A66F5E	TCGA-IA-A40X-01A-11D-A25F-10	GRCh37-lite	TCGA-IA-A40X	TCGA-KIRP	NA	s11862	Baylor College of Medicine	Cleveland Clinic	United States	NO	T1a	NX	Kidney Papillary Renal Cell Carcinoma	Stage I	A25F-10	TRUE
13722.58cfa832e4b0c9d6adf6d11e	58cfa832e4b0c9d6adf6d11e	TCGA-FV-A4ZQ-01A-11D-A25V-10_wgs_Illumina.filtered.	WGS	TCGA-FV-A4ZQ-01A-11D-A25V-10_wgs_Illumina	TCGA-FV-A4ZQ-01A-11D-A25V-10_wgs_Illumina.bam	41.34	NA	0.08	58cfa832e4b0c9d6adf6d11e	TCGA-FV-A4ZQ-01A-11D-A25V-10_wgs_Illumina.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Liver Hepatocellular Carcinoma	Aligned reads	TCGA-FV-A4ZQ-01A	65E430E1-0C9A-4045-83A9-653B7CFF811D	Primary Tumor	Illumina HiSeq	34884ff9-c16b-4800-9b84-dd3ec001b261	Liver	52	56DAAD30-A336-4311-9FEB-26CF3E48C734	D02597F8-3AC7-4165-A65F-0E134E5D215B	TCGA-FV-A4ZQ-01A-11D-A25V-10	GRCh37-lite	TCGA-FV-A4ZQ	TCGA-LIHC	NA	s16592	Baylor College of Medicine	International Genomics Consortium	United States	NO	T1	NX	Hepatocellular Carcinoma	Stage I	A25V-10	TRUE
13722.58cfa832e4b0c9d6adf6d168	58cfa832e4b0c9d6adf6d168	TCGA-KL-8328-01A-11D-2310-10_wgs_Illumina.filtered.	WGS	TCGA-KL-8328-01A-11D-2310-10_wgs_Illumina	TCGA-KL-8328-01A-11D-2310-10_wgs_Illumina.bam	110.3	NA	0.05	58cfa832e4b0c9d6adf6d168	TCGA-KL-8328-01A-11D-2310-10_wgs_Illumina.bam	Alive	MALE	WHITE	Not available	Kidney Chromophobe	Aligned reads	TCGA-KL-8328-01A	452135F2-6DE6-4593-A091-DDF6344EE431	Primary Tumor	Illumina HiSeq	c5c55965-aec9-4c64-9d09-4dbba956669c	Kidney	60	BBCD6B07-862B-4DA1-8880-9D98B643898C	2CCD028D-E7E0-4F77-A512-F658A31819A4	TCGA-KL-8328-01A-11D-2310-10	GRCh37-lite	TCGA-KL-8328	TCGA-KICH	NA	s16518	Baylor College of Medicine	MSKCC	United States	NO	T2b	N0	Kidney Chromophobe	Stage II	2310-10	TRUE
13722.58cfa832e4b0c9d6adf6d164	58cfa832e4b0c9d6adf6d164	TCGA-KL-8327-01A-11D-2310-10_wgs_Illumina.filtered.	WGS	TCGA-KL-8327-01A-11D-2310-10_wgs_Illumina	TCGA-KL-8327-01A-11D-2310-10_wgs_Illumina.bam	112.3	NA	0.05	58cfa832e4b0c9d6adf6d164	TCGA-KL-8327-01A-11D-2310-10_wgs_Illumina.bam	Alive	FEMALE	WHITE	Not available	Kidney Chromophobe	Aligned reads	TCGA-KL-8327-01A	02979422-5149-4750-AD5F-483E0BEC6AC5	Primary Tumor	Illumina HiSeq	791eea87-33dd-4932-9e4e-d31487fc9a39	Kidney	46	F35E66EC-7AA5-477C-ABF7-07C35C90F7DE	D72A7338-C144-4C62-A70E-2177A3B4B77E	TCGA-KL-8327-01A-11D-2310-10	GRCh37-lite	TCGA-KL-8327	TCGA-KICH	NA	s16521	Baylor College of Medicine	MSKCC	United States	NO	T1b	N0	Kidney Chromophobe	Stage I	2310-10	TRUE
13722.58cfa832e4b0c9d6adf6d1b9	58cfa832e4b0c9d6adf6d1b9	TCGA-HE-A5NL-01A-11D-A26P-10_wgs_Illumina.filtered.	WGS	TCGA-HE-A5NL-01A-11D-A26P-10_wgs_Illumina	TCGA-HE-A5NL-01A-11D-A26P-10_wgs_Illumina.bam	35.01	NA	0.07	58cfa832e4b0c9d6adf6d1b9	TCGA-HE-A5NL-01A-11D-A26P-10_wgs_Illumina.bam	Alive	MALE	Not available	Not available	Kidney Renal Papillary Cell Carcinoma	Aligned reads	TCGA-HE-A5NL-01A	E4245FFF-1281-40E5-87B4-4E42A18A3A63	Primary Tumor	Illumina HiSeq	14b775e3-8ff9-4815-bb25-ebfc6c526e2f	Kidney	51	21B630BE-466D-46A3-801A-7EB593BDDDB6	A441697C-4CA0-4EAB-9B01-B9CB50223CE2	TCGA-HE-A5NL-01A-11D-A26P-10	GRCh37-lite	TCGA-HE-A5NL	TCGA-KIRP	NA	s11589	Baylor College of Medicine	Ontario Institute for Cancer Research (OICR)	Canada	NO	T1a	NX	Kidney Papillary Renal Cell Carcinoma	Stage I	A26P-10	TRUE
13722.58cfa832e4b0c9d6adf6d1bf	58cfa832e4b0c9d6adf6d1bf	TCGA-HP-A5MZ-01A-21D-A27I-10_wgs_Illumina.filtered.	WGS	TCGA-HP-A5MZ-01A-21D-A27I-10_wgs_Illumina	TCGA-HP-A5MZ-01A-21D-A27I-10_wgs_Illumina.bam	32.76	NA	0.08	58cfa832e4b0c9d6adf6d1bf	TCGA-HP-A5MZ-01A-21D-A27I-10_wgs_Illumina.bam	Dead	MALE	Not available	Not available	Liver Hepatocellular Carcinoma	Aligned reads	TCGA-HP-A5MZ-01A	2D00F09F-0074-46C8-B357-B5F33567762A	Primary Tumor	Illumina HiSeq	bb9234a0-b13c-43f2-8d45-2ec940f73d34	Liver	78	9EC5013E-AABB-487A-87D7-49B4B6BD0F6A	C36213E4-C057-46F5-ADA5-F1F921855BB4	TCGA-HP-A5MZ-01A-21D-A27I-10	GRCh37-lite	TCGA-HP-A5MZ	TCGA-LIHC	91	s16789	Baylor College of Medicine	Ontario Institute for Cancer Research (OICR)	Canada	NO	T1	NX	Hepatocellular Carcinoma	Stage I	A27I-10	TRUE
13722.58cfa832e4b0c9d6adf6d1c1	58cfa832e4b0c9d6adf6d1c1	TCGA-FF-8061-01A-11D-2210-10_wgs_Illumina.filtered.	WGS	TCGA-FF-8061-01A-11D-2210-10_wgs_Illumina	TCGA-FF-8061-01A-11D-2210-10_wgs_Illumina.bam	443.7	NA	0.05	58cfa832e4b0c9d6adf6d1c1	TCGA-FF-8061-01A-11D-2210-10_wgs_Illumina.bam	Alive	MALE	ASIAN	NOT HISPANIC OR LATINO	Lymphoid Neoplasm Diffuse Large B-cell Lymphoma	Aligned reads	TCGA-FF-8061-01A	C8CDE9EA-89E9-4EE8-8A46-417A48F6D3AB	Primary Tumor	Illumina HiSeq	649ff853-287a-4f0d-94db-0842347bf98c	Lymph Nodes	42	047CAECB-6829-4943-BBC5-F45EED3979B6	A29278AF-7ECF-403E-B6A9-623EA7879D05	TCGA-FF-8061-01A-11D-2210-10	GRCh37-lite	TCGA-FF-8061	TCGA-DLBC	NA	s1103	Baylor College of Medicine	SingHealth	Singapore	NO	Not available	Not available	Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal)	Not available	2210-10	TRUE
13722.58cfa832e4b0c9d6adf6d1ee	58cfa832e4b0c9d6adf6d1ee	TCGA-FF-8046-01A-11D-2210-10_wgs_Illumina.filtered.	WGS	TCGA-FF-8046-01A-11D-2210-10_wgs_Illumina	TCGA-FF-8046-01A-11D-2210-10_wgs_Illumina.bam	445.7	NA	0.05	58cfa832e4b0c9d6adf6d1ee	TCGA-FF-8046-01A-11D-2210-10_wgs_Illumina.bam	Alive	MALE	ASIAN	NOT HISPANIC OR LATINO	Lymphoid Neoplasm Diffuse Large B-cell Lymphoma	Aligned reads	TCGA-FF-8046-01A	67325322-483F-443F-9FFA-2A20D108A2FB	Primary Tumor	Illumina HiSeq	872155f2-6470-47b1-af0b-1a04950e187e	Lymph Nodes	51	6C8A582B-70B0-4C94-98C8-E800A95AE112	AA847C3D-D3A7-46AA-A81B-DB5099A458FB	TCGA-FF-8046-01A-11D-2210-10	GRCh37-lite	TCGA-FF-8046	TCGA-DLBC	NA	s1101	Baylor College of Medicine	SingHealth	Singapore	NO	Not available	Not available	Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal)	Not available	2210-10	TRUE
13722.58cfa832e4b0c9d6adf6d1f0	58cfa832e4b0c9d6adf6d1f0	TCGA-FF-8042-01A-11D-2210-10_wgs_Illumina.filtered.	WGS	TCGA-FF-8042-01A-11D-2210-10_wgs_Illumina	TCGA-FF-8042-01A-11D-2210-10_wgs_Illumina.bam	439.7	NA	0.05	58cfa832e4b0c9d6adf6d1f0	TCGA-FF-8042-01A-11D-2210-10_wgs_Illumina.bam	Alive	FEMALE	ASIAN	NOT HISPANIC OR LATINO	Lymphoid Neoplasm Diffuse Large B-cell Lymphoma	Aligned reads	TCGA-FF-8042-01A	F0A326D2-1F3E-4A5D-BCA8-32AACCC52338	Primary Tumor	Illumina HiSeq	fbeb4f92-2f36-4ebf-8684-0327679f0a2f	Lymph Nodes	57	562F76EB-CD16-4EEC-9B31-3E5DEEE3497C	897A4500-6FB8-4E81-AA07-021A26D632FB	TCGA-FF-8042-01A-11D-2210-10	GRCh37-lite	TCGA-FF-8042	TCGA-DLBC	NA	s1108	Baylor College of Medicine	SingHealth	Singapore	NO	Not available	Not available	Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal)	Not available	2210-10	TRUE
13722.58cfa832e4b0c9d6adf6d130	58cfa832e4b0c9d6adf6d130	TCGA-FV-A3I1-01A-11D-A22F-10_wgs_Illumina.filtered.	WGS	TCGA-FV-A3I1-01A-11D-A22F-10_wgs_Illumina	TCGA-FV-A3I1-01A-11D-A22F-10_wgs_Illumina.bam	39.14	NA	0.08	58cfa832e4b0c9d6adf6d130	TCGA-FV-A3I1-01A-11D-A22F-10_wgs_Illumina.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Liver Hepatocellular Carcinoma	Aligned reads	TCGA-FV-A3I1-01A	BFD20D71-18A5-4F01-8D56-84378AD92359	Primary Tumor	Illumina HiSeq	137dd060-0c76-4ad8-b447-bcf55d593f0c	Liver	81	A744BE68-D008-4847-A11D-89918A419A5F	992D9566-B1DA-421A-BF36-D23382B115FA	TCGA-FV-A3I1-01A-11D-A22F-10	GRCh37-lite	TCGA-FV-A3I1	TCGA-LIHC	NA	s16986	Baylor College of Medicine	International Genomics Consortium	United States	NO	T2	N0	Hepatocellular Carcinoma	Stage II	A22F-10	TRUE
13722.58cfa832e4b0c9d6adf6d062	58cfa832e4b0c9d6adf6d062	TCGA-G3-A25T-01A-11D-A16V-10_wgs_Illumina.filtered.	WGS	TCGA-G3-A25T-01A-11D-A16V-10_wgs_Illumina	TCGA-G3-A25T-01A-11D-A16V-10_wgs_Illumina.bam	80.84	2.02	0.08	58cfa832e4b0c9d6adf6d062	TCGA-G3-A25T-01A-11D-A16V-10_wgs_Illumina.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Liver Hepatocellular Carcinoma	Aligned reads	TCGA-G3-A25T-01A	F6E5979D-D6A9-4408-BD1B-1B37D1064E83	Primary Tumor	Illumina HiSeq	97875fbb-c05a-4e3b-89e6-28f20a7eb82f	Liver	45	D42D6E07-8E0E-4345-B1B9-1B8B4574D042	41840DC1-5EA2-4F01-A0D4-8B65ADD641C8	TCGA-G3-A25T-01A-11D-A16V-10	GRCh37-lite	TCGA-G3-A25T	TCGA-LIHC	NA	s16690	Baylor College of Medicine	Alberta Health Services	Canada	NO	T3	N0	Hepatocellular Carcinoma	Stage IIIA	A16V-10	TRUE
13722.58cfa832e4b0c9d6adf6d1f2	58cfa832e4b0c9d6adf6d1f2	TCGA-FF-8047-01A-11D-2210-10_wgs_Illumina.filtered.	WGS	TCGA-FF-8047-01A-11D-2210-10_wgs_Illumina	TCGA-FF-8047-01A-11D-2210-10_wgs_Illumina.bam	361.7	NA	0.05	58cfa832e4b0c9d6adf6d1f2	TCGA-FF-8047-01A-11D-2210-10_wgs_Illumina.bam	Alive	FEMALE	ASIAN	NOT HISPANIC OR LATINO	Lymphoid Neoplasm Diffuse Large B-cell Lymphoma	Aligned reads	TCGA-FF-8047-01A	F978CB0F-D319-4C01-B4C5-23AE1403A106	Primary Tumor	Illumina HiSeq	59fecb70-aec2-4deb-b598-543c4dd843e1	Lymph Nodes	38	A592550C-97B4-4A82-A088-14A5AC6BF084	1B1780D5-06DA-40EE-9E15-02631A68027B	TCGA-FF-8047-01A-11D-2210-10	GRCh37-lite	TCGA-FF-8047	TCGA-DLBC	NA	s1100	Baylor College of Medicine	SingHealth	Singapore	NO	Not available	Not available	Diffuse large B-cell lymphoma (DLBCL) NOS (any anatomic site nodal or extranodal)	Not available	2210-10	TRUE
13722.58cfa832e4b0c9d6adf6d1b2	58cfa832e4b0c9d6adf6d1b2	TCGA-FF-8041-01A-11D-2210-10_wgs_Illumina.filtered.	WGS	TCGA-FF-8041-01A-11D-2210-10_wgs_Illumina	TCGA-FF-8041-01A-11D-2210-10_wgs_Illumina.bam	454.7	NA	0.05	58cfa832e4b0c9d6adf6d1b2	TCGA-FF-8041-01A-11D-2210-10_wgs_Illumina.bam	Alive	FEMALE	ASIAN	NOT HISPANIC OR LATINO	Lymphoid Neoplasm Diffuse Large B-cell Lymphoma	Aligned reads	TCGA-FF-8041-01A	1F971AF1-6772-4FE6-8D35-BBE527A037FE	Primary Tumor	Illumina HiSeq	90920dc3-b0bd-48f3-a446-87f757968eab	Lymph Nodes	28	738A6FD7-D8E1-4FC3-9F73-AD6C9B67DA2A	FA676301-902F-473F-8313-5BFF34AE549A	TCGA-FF-8041-01A-11D-2210-10	GRCh37-lite	TCGA-FF-8041	TCGA-DLBC	NA	s1109	Baylor College of Medicine	SingHealth	Singapore	NO	Not available	Not available	Primary mediastinal (thymic) DLBCL	Not available	2210-10	TRUE
13722.58cfa832e4b0c9d6adf6d291	58cfa832e4b0c9d6adf6d291	TCGA-KL-8340-01A-11D-2310-10_wgs_Illumina.filtered.	WGS	TCGA-KL-8340-01A-11D-2310-10_wgs_Illumina	TCGA-KL-8340-01A-11D-2310-10_wgs_Illumina.bam	71.3	NA	0.05	58cfa832e4b0c9d6adf6d291	TCGA-KL-8340-01A-11D-2310-10_wgs_Illumina.bam	Alive	MALE	WHITE	Not available	Kidney Chromophobe	Aligned reads	TCGA-KL-8340-01A	3129E869-BB2F-423A-BD20-D0DAAE33B11A	Primary Tumor	Illumina HiSeq	24326cad-efd9-4017-90e3-2ae8ac037b99	Kidney	34	07C3C6E6-D297-4D80-9C28-974FA470A132	D113CE88-04AB-4675-B363-92F80C28DE34	TCGA-KL-8340-01A-11D-2310-10	GRCh37-lite	TCGA-KL-8340	TCGA-KICH	NA	s16477	Baylor College of Medicine	MSKCC	United States	NO	T2	N0	Kidney Chromophobe	Stage II	2310-10	TRUE
13722.58cfa832e4b0c9d6adf6d29a	58cfa832e4b0c9d6adf6d29a	TCGA-KL-8343-01A-11D-2310-10_wgs_Illumina.filtered.	WGS	TCGA-KL-8343-01A-11D-2310-10_wgs_Illumina	TCGA-KL-8343-01A-11D-2310-10_wgs_Illumina.bam	71.3	NA	0.05	58cfa832e4b0c9d6adf6d29a	TCGA-KL-8343-01A-11D-2310-10_wgs_Illumina.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Kidney Chromophobe	Aligned reads	TCGA-KL-8343-01A	B4A0BF74-1381-4C17-B97D-206810D9E59A	Primary Tumor	Illumina HiSeq	a7a4a6a6-4a0b-4611-9bd4-1d86b0ddf49c	Kidney	72	FFE4DFE1-B2FE-448E-8664-8299484FC809	34739BD6-B3BE-441D-8CDB-E4233BF14080	TCGA-KL-8343-01A-11D-2310-10	GRCh37-lite	TCGA-KL-8343	TCGA-KICH	NA	s16394	Baylor College of Medicine	MSKCC	United States	NO	T3	N0	Kidney Chromophobe	Stage III	2310-10	TRUE
13722.58cfa832e4b0c9d6adf6d296	58cfa832e4b0c9d6adf6d296	TCGA-KM-8439-01A-11D-2310-10_wgs_Illumina.filtered.	WGS	TCGA-KM-8439-01A-11D-2310-10_wgs_Illumina	TCGA-KM-8439-01A-11D-2310-10_wgs_Illumina.bam	96.3	NA	0.05	58cfa832e4b0c9d6adf6d296	TCGA-KM-8439-01A-11D-2310-10_wgs_Illumina.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Kidney Chromophobe	Aligned reads	TCGA-KM-8439-01A	739DEED4-D1DC-458F-BD0F-1E24D2BFD305	Primary Tumor	Illumina HiSeq	1da1e41d-ec72-4c5f-9c1f-50f9606970e1	Kidney	30	A59051E9-5155-4073-A4D6-C9A8C54AD118	9D3B0B87-5FC5-4D09-9C63-4D5FC4BC46D0	TCGA-KM-8439-01A-11D-2310-10	GRCh37-lite	TCGA-KM-8439	TCGA-KICH	NA	s16484	Baylor College of Medicine	NCI Urologic Oncology Branch	United States	NO	T1b	NX	Kidney Chromophobe	Stage I	2310-10	TRUE
13722.58cfa832e4b0c9d6adf6d2a0	58cfa832e4b0c9d6adf6d2a0	TCGA-KM-8477-01A-11D-2310-10_wgs_Illumina.filtered.	WGS	TCGA-KM-8477-01A-11D-2310-10_wgs_Illumina	TCGA-KM-8477-01A-11D-2310-10_wgs_Illumina.bam	26.3	NA	0.05	58cfa832e4b0c9d6adf6d2a0	TCGA-KM-8477-01A-11D-2310-10_wgs_Illumina.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Kidney Chromophobe	Aligned reads	TCGA-KM-8477-01A	9680B5FF-1882-434F-9981-E8AC33764B93	Primary Tumor	Illumina HiSeq	af92bfa8-a70f-4436-b545-46899487c859	Kidney	56	50DA0237-8E9D-4C08-AE44-F32103E8F095	4ECBFD89-393F-4126-AA1C-951A2C23EF89	TCGA-KM-8477-01A-11D-2310-10	GRCh37-lite	TCGA-KM-8477	TCGA-KICH	NA	s16397	Baylor College of Medicine	NCI Urologic Oncology Branch	United States	NO	T1a	NX	Kidney Chromophobe	Stage I	2310-10	TRUE
13722.58cfa832e4b0c9d6adf6d246	58cfa832e4b0c9d6adf6d246	TCGA-IA-A40Y-01A-11D-A25F-10_wgs_Illumina.filtered.	WGS	TCGA-IA-A40Y-01A-11D-A25F-10_wgs_Illumina	TCGA-IA-A40Y-01A-11D-A25F-10_wgs_Illumina.bam	22.07	NA	0.08	58cfa832e4b0c9d6adf6d246	TCGA-IA-A40Y-01A-11D-A25F-10_wgs_Illumina.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Papillary Cell Carcinoma	Aligned reads	TCGA-IA-A40Y-01A	1DB41963-A520-47F0-828C-ED5C626507B1	Primary Tumor	Illumina HiSeq	2157f13c-f876-4b2f-91eb-f3ada3c0b2e7	Kidney	60	05ACDAC8-480B-43B6-82F5-B0DDC4A1C36F	AD9455E9-7147-489E-9B1F-3540C457C260	TCGA-IA-A40Y-01A-11D-A25F-10	GRCh37-lite	TCGA-IA-A40Y	TCGA-KIRP	NA	s11863	Baylor College of Medicine	Cleveland Clinic	United States	NO	T3a	N1	Kidney Papillary Renal Cell Carcinoma	Stage III	A25F-10	TRUE
13722.58cfa832e4b0c9d6adf6d29d	58cfa832e4b0c9d6adf6d29d	TCGA-KM-8438-01A-11D-2310-10_wgs_Illumina.filtered.	WGS	TCGA-KM-8438-01A-11D-2310-10_wgs_Illumina	TCGA-KM-8438-01A-11D-2310-10_wgs_Illumina.bam	40.3	NA	0.05	58cfa832e4b0c9d6adf6d29d	TCGA-KM-8438-01A-11D-2310-10_wgs_Illumina.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Kidney Chromophobe	Aligned reads	TCGA-KM-8438-01A	23656226-2D99-4548-959F-5C2EED803E33	Primary Tumor	Illumina HiSeq	171af111-4e87-4e89-af1b-ee3fbed93db6	Kidney	45	3CBDEE56-19F7-4A7A-850E-A7664E67C919	148536CE-EE2A-4952-A19D-10D6F44146B9	TCGA-KM-8438-01A-11D-2310-10	GRCh37-lite	TCGA-KM-8438	TCGA-KICH	NA	s16399	Baylor College of Medicine	NCI Urologic Oncology Branch	United States	NO	T2	N0	Kidney Chromophobe	Stage II	2310-10	TRUE
13722.58cfa832e4b0c9d6adf6d2b8	58cfa832e4b0c9d6adf6d2b8	TCGA-KL-8331-01A-11D-2310-10_wgs_Illumina.filtered.	WGS	TCGA-KL-8331-01A-11D-2310-10_wgs_Illumina	TCGA-KL-8331-01A-11D-2310-10_wgs_Illumina.bam	125.3	NA	0.05	58cfa832e4b0c9d6adf6d2b8	TCGA-KL-8331-01A-11D-2310-10_wgs_Illumina.bam	Alive	FEMALE	WHITE	Not available	Kidney Chromophobe	Aligned reads	TCGA-KL-8331-01A	8AC7F218-BD7B-4DDA-8879-2CEC49748E42	Primary Tumor	Illumina HiSeq	30f11cbf-417b-4a4a-b440-1c22bfc3b225	Kidney	48	EEA84BEB-0F41-4120-A350-6F31EC8712BB	7087A2B6-7FC4-45B0-8C48-248864F03DEB	TCGA-KL-8331-01A-11D-2310-10	GRCh37-lite	TCGA-KL-8331	TCGA-KICH	NA	s16421	Baylor College of Medicine	MSKCC	United States	NO	T2	N0	Kidney Chromophobe	Stage II	2310-10	TRUE
13722.58cfa832e4b0c9d6adf6d2d4	58cfa832e4b0c9d6adf6d2d4	TCGA-KL-8346-01A-11D-2310-10_wgs_Illumina.filtered.	WGS	TCGA-KL-8346-01A-11D-2310-10_wgs_Illumina	TCGA-KL-8346-01A-11D-2310-10_wgs_Illumina.bam	69.8	NA	0.05	58cfa832e4b0c9d6adf6d2d4	TCGA-KL-8346-01A-11D-2310-10_wgs_Illumina.bam	Alive	MALE	WHITE	Not available	Kidney Chromophobe	Aligned reads	TCGA-KL-8346-01A	A122D361-835E-4CF2-850F-AF7864AA112C	Primary Tumor	Illumina HiSeq	bed80d0d-f127-4c4f-9a1f-2c032aa9b498	Kidney	62	ABCF54FE-D93E-4C3B-ACD0-757CDD6A3D3B	BD2EC47B-A120-4B3B-B10D-AEE09805AB33	TCGA-KL-8346-01A-11D-2310-10	GRCh37-lite	TCGA-KL-8346	TCGA-KICH	NA	s16429	Baylor College of Medicine	MSKCC	United States	NO	T2b	N0	Kidney Chromophobe	Stage II	2310-10	TRUE
13722.58cfa832e4b0c9d6adf6d2c4	58cfa832e4b0c9d6adf6d2c4	TCGA-KL-8337-01A-11D-2310-10_wgs_Illumina.filtered.	WGS	TCGA-KL-8337-01A-11D-2310-10_wgs_Illumina	TCGA-KL-8337-01A-11D-2310-10_wgs_Illumina.bam	168.3	NA	0.05	58cfa832e4b0c9d6adf6d2c4	TCGA-KL-8337-01A-11D-2310-10_wgs_Illumina.bam	Alive	MALE	BLACK OR AFRICAN AMERICAN	Not available	Kidney Chromophobe	Aligned reads	TCGA-KL-8337-01A	5F633C79-FCF8-47DA-B349-ADA3FB794819	Primary Tumor	Illumina HiSeq	283efb4c-4edf-48c2-975a-9578517c0270	Kidney	26	988D64CE-EE26-4837-8161-86C4831BE203	A3FD2EE0-3DD0-4992-9A9F-75E487B43441	TCGA-KL-8337-01A-11D-2310-10	GRCh37-lite	TCGA-KL-8337	TCGA-KICH	NA	s16390	Baylor College of Medicine	MSKCC	United States	NO	T2	N0	Kidney Chromophobe	Stage II	2310-10	TRUE
13722.58cfa832e4b0c9d6adf6d2b6	58cfa832e4b0c9d6adf6d2b6	TCGA-KL-8332-01A-11D-2310-10_wgs_Illumina.filtered.	WGS	TCGA-KL-8332-01A-11D-2310-10_wgs_Illumina	TCGA-KL-8332-01A-11D-2310-10_wgs_Illumina.bam	71.3	NA	0.05	58cfa832e4b0c9d6adf6d2b6	TCGA-KL-8332-01A-11D-2310-10_wgs_Illumina.bam	Alive	MALE	WHITE	Not available	Kidney Chromophobe	Aligned reads	TCGA-KL-8332-01A	3EC3BCB3-492C-4942-BE02-76A67F57E38F	Primary Tumor	Illumina HiSeq	b51b4316-5d7e-4f98-96f9-01d644b87e6d	Kidney	55	CD734D15-92C6-4B43-A5D3-EC823F6B9DC2	C6D6F49E-6E95-4E41-8388-71F6FE017D80	TCGA-KL-8332-01A-11D-2310-10	GRCh37-lite	TCGA-KL-8332	TCGA-KICH	NA	s16520	Baylor College of Medicine	MSKCC	United States	NO	T1b	N0	Kidney Chromophobe	Stage I	2310-10	TRUE
13722.58cfa832e4b0c9d6adf6d2d0	58cfa832e4b0c9d6adf6d2d0	TCGA-KL-8333-01A-11D-2310-10_wgs_Illumina.filtered.	WGS	TCGA-KL-8333-01A-11D-2310-10_wgs_Illumina	TCGA-KL-8333-01A-11D-2310-10_wgs_Illumina.bam	46.3	NA	0.05	58cfa832e4b0c9d6adf6d2d0	TCGA-KL-8333-01A-11D-2310-10_wgs_Illumina.bam	Alive	MALE	WHITE	Not available	Kidney Chromophobe	Aligned reads	TCGA-KL-8333-01A	02EC7A3A-2812-4A65-93CD-07BF655CC91B	Primary Tumor	Illumina HiSeq	824e5509-79ee-455a-8650-3c757cdf6fbf	Kidney	69	77186D62-B354-49A4-8A2A-12F5F6B938F6	C56505CB-E150-408D-9DF6-3AF4E608C376	TCGA-KL-8333-01A-11D-2310-10	GRCh37-lite	TCGA-KL-8333	TCGA-KICH	NA	s16434	Baylor College of Medicine	MSKCC	United States	NO	T2	N0	Kidney Chromophobe	Stage II	2310-10	TRUE
13722.58cfa832e4b0c9d6adf6d2da	58cfa832e4b0c9d6adf6d2da	TCGA-KL-8334-01A-11D-2310-10_wgs_Illumina.filtered.	WGS	TCGA-KL-8334-01A-11D-2310-10_wgs_Illumina	TCGA-KL-8334-01A-11D-2310-10_wgs_Illumina.bam	71.3	NA	0.05	58cfa832e4b0c9d6adf6d2da	TCGA-KL-8334-01A-11D-2310-10_wgs_Illumina.bam	Alive	FEMALE	WHITE	Not available	Kidney Chromophobe	Aligned reads	TCGA-KL-8334-01A	9AABCBD7-A26A-49B1-ABF1-02C0DC3ADCF2	Primary Tumor	Illumina HiSeq	8f7d6dce-86ff-4bee-b2df-12b2ff95f653	Kidney	37	E9938C51-8FC6-4ED0-9201-E51C0E943D1F	94434272-4CBD-4B4D-BD98-44F18526DD69	TCGA-KL-8334-01A-11D-2310-10	GRCh37-lite	TCGA-KL-8334	TCGA-KICH	NA	s16485	Baylor College of Medicine	MSKCC	United States	NO	T3a	N0	Kidney Chromophobe	Stage III	2310-10	TRUE
13722.58cfa832e4b0c9d6adf6d2e0	58cfa832e4b0c9d6adf6d2e0	TCGA-KL-8330-01A-11D-2310-10_wgs_Illumina.filtered.	WGS	TCGA-KL-8330-01A-11D-2310-10_wgs_Illumina	TCGA-KL-8330-01A-11D-2310-10_wgs_Illumina.bam	210.3	NA	0.05	58cfa832e4b0c9d6adf6d2e0	TCGA-KL-8330-01A-11D-2310-10_wgs_Illumina.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Kidney Chromophobe	Aligned reads	TCGA-KL-8330-01A	0F3C4F8F-0766-46B0-81B4-18CA4F6EA20A	Primary Tumor	Illumina HiSeq	ee57fec3-c6dc-4fef-9340-d24a48421fe8	Kidney	44	81431ED0-D762-4131-895B-852B2F78786D	09537DCE-C797-4B60-962A-D4C3CD6AB00A	TCGA-KL-8330-01A-11D-2310-10	GRCh37-lite	TCGA-KL-8330	TCGA-KICH	NA	s16522	Baylor College of Medicine	MSKCC	United States	NO	T2b	N0	Kidney Chromophobe	Stage II	2310-10	TRUE
13722.58cfa832e4b0c9d6adf6d2f9	58cfa832e4b0c9d6adf6d2f9	TCGA-KN-8426-01A-11D-2310-10_wgs_Illumina.filtered.	WGS	TCGA-KN-8426-01A-11D-2310-10_wgs_Illumina	TCGA-KN-8426-01A-11D-2310-10_wgs_Illumina.bam	110.3	NA	0.05	58cfa832e4b0c9d6adf6d2f9	TCGA-KN-8426-01A-11D-2310-10_wgs_Illumina.bam	Alive	MALE	WHITE	Not available	Kidney Chromophobe	Aligned reads	TCGA-KN-8426-01A	B08DFBA8-6AFB-4217-9259-72BE6F1F3363	Primary Tumor	Illumina HiSeq	d5461fca-308e-41be-a207-bdb698350564	Kidney	50	8A7FAD85-8756-4411-BE2B-A87159B843A5	A3DEAFCB-B54F-4B7E-89AC-C92C16FB919F	TCGA-KN-8426-01A-11D-2310-10	GRCh37-lite	TCGA-KN-8426	TCGA-KICH	NA	s16473	Baylor College of Medicine	Harvard	United States	NO	T3a	NX	Kidney Chromophobe	Stage IV	2310-10	TRUE
13722.58cfa832e4b0c9d6adf6d2e6	58cfa832e4b0c9d6adf6d2e6	TCGA-KM-8476-01A-11D-2310-10_wgs_Illumina.filtered.	WGS	TCGA-KM-8476-01A-11D-2310-10_wgs_Illumina	TCGA-KM-8476-01A-11D-2310-10_wgs_Illumina.bam	50.3	NA	0.05	58cfa832e4b0c9d6adf6d2e6	TCGA-KM-8476-01A-11D-2310-10_wgs_Illumina.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Kidney Chromophobe	Aligned reads	TCGA-KM-8476-01A	4E4FAF51-2CBF-4910-A093-186660E4A19B	Primary Tumor	Illumina HiSeq	bcb52a60-30eb-4af3-8ec1-512d6157e6be	Kidney	47	450DFCB0-F059-4427-9A72-EA51DC48956E	5BEBC389-DE0D-45B8-9D2F-6476988C358A	TCGA-KM-8476-01A-11D-2310-10	GRCh37-lite	TCGA-KM-8476	TCGA-KICH	NA	s16391	Baylor College of Medicine	NCI Urologic Oncology Branch	United States	NO	T1	NX	Kidney Chromophobe	Stage I	2310-10	TRUE
13722.58cfa832e4b0c9d6adf6d2e2	58cfa832e4b0c9d6adf6d2e2	TCGA-KL-8344-01A-11D-2310-10_wgs_Illumina.filtered.	WGS	TCGA-KL-8344-01A-11D-2310-10_wgs_Illumina	TCGA-KL-8344-01A-11D-2310-10_wgs_Illumina.bam	156.3	NA	0.05	58cfa832e4b0c9d6adf6d2e2	TCGA-KL-8344-01A-11D-2310-10_wgs_Illumina.bam	Alive	MALE	WHITE	Not available	Kidney Chromophobe	Aligned reads	TCGA-KL-8344-01A	A5AF1391-89D3-4F41-930E-7E8272AFEC98	Primary Tumor	Illumina HiSeq	85c6bd93-8e9d-43f8-ad70-a8d080e1c284	Kidney	51	4CEA843F-80AE-4284-B70F-8989717EEE7C	3ACE181A-23BD-424E-A87E-E0C01A2A2CB8	TCGA-KL-8344-01A-11D-2310-10	GRCh37-lite	TCGA-KL-8344	TCGA-KICH	NA	s16474	Baylor College of Medicine	MSKCC	United States	NO	T3a	N0	Kidney Chromophobe	Stage III	2310-10	TRUE
13722.58cfa832e4b0c9d6adf6d2fa	58cfa832e4b0c9d6adf6d2fa	TCGA-KM-8443-01A-11D-2310-10_wgs_Illumina.filtered.	WGS	TCGA-KM-8443-01A-11D-2310-10_wgs_Illumina	TCGA-KM-8443-01A-11D-2310-10_wgs_Illumina.bam	71.3	NA	0.05	58cfa832e4b0c9d6adf6d2fa	TCGA-KM-8443-01A-11D-2310-10_wgs_Illumina.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Kidney Chromophobe	Aligned reads	TCGA-KM-8443-01A	2F1C4DB6-88A7-4A5D-A5FE-94D85F569440	Primary Tumor	Illumina HiSeq	eecb2ae5-92c3-432e-be0c-d7463b8efbb1	Kidney	57	F606FE9C-7D9F-4615-AB16-0BB4C796ADEA	C00DE7A0-0B09-4E07-988C-EF2A7F8E932A	TCGA-KM-8443-01A-11D-2310-10	GRCh37-lite	TCGA-KM-8443	TCGA-KICH	NA	s16528	Baylor College of Medicine	NCI Urologic Oncology Branch	United States	NO	T2	N0	Kidney Chromophobe	Stage II	2310-10	TRUE
13722.58cfa832e4b0c9d6adf6d2fe	58cfa832e4b0c9d6adf6d2fe	TCGA-KM-8441-01A-11D-2310-10_wgs_Illumina.filtered.	WGS	TCGA-KM-8441-01A-11D-2310-10_wgs_Illumina	TCGA-KM-8441-01A-11D-2310-10_wgs_Illumina.bam	28.3	NA	0.05	58cfa832e4b0c9d6adf6d2fe	TCGA-KM-8441-01A-11D-2310-10_wgs_Illumina.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Kidney Chromophobe	Aligned reads	TCGA-KM-8441-01A	F31BA8EC-A3DD-4DD8-8D15-F6C5975EBE44	Primary Tumor	Illumina HiSeq	a15ce5fc-4e2f-4fe0-b799-1be690aa31b9	Kidney	61	566A0F2C-743C-4F18-B14E-1667A8666008	97C1A300-978D-4DF1-9E97-CE2F92B9EFF1	TCGA-KM-8441-01A-11D-2310-10	GRCh37-lite	TCGA-KM-8441	TCGA-KICH	NA	s16570	Baylor College of Medicine	NCI Urologic Oncology Branch	United States	NO	T1b	NX	Kidney Chromophobe	Stage I	2310-10	TRUE
13722.58cfa832e4b0c9d6adf6d2fc	58cfa832e4b0c9d6adf6d2fc	TCGA-KM-8442-01A-11D-2310-10_wgs_Illumina.filtered.	WGS	TCGA-KM-8442-01A-11D-2310-10_wgs_Illumina	TCGA-KM-8442-01A-11D-2310-10_wgs_Illumina.bam	71.3	NA	0.05	58cfa832e4b0c9d6adf6d2fc	TCGA-KM-8442-01A-11D-2310-10_wgs_Illumina.bam	Alive	MALE	Not available	HISPANIC OR LATINO	Kidney Chromophobe	Aligned reads	TCGA-KM-8442-01A	40F79CFE-A51F-497B-B06E-7A4F9004F092	Primary Tumor	Illumina HiSeq	7555ac98-9d69-49ff-a604-7ee15dbf1190	Kidney	38	839592BE-2687-4996-ACF8-0BFDE2B2BE22	9FB73D89-F7C4-47B2-810B-3CE37CD8A3C9	TCGA-KM-8442-01A-11D-2310-10	GRCh37-lite	TCGA-KM-8442	TCGA-KICH	NA	s16392	Baylor College of Medicine	NCI Urologic Oncology Branch	United States	NO	T2	NX	Kidney Chromophobe	Stage II	2310-10	TRUE
13722.58cfa832e4b0c9d6adf6d320	58cfa832e4b0c9d6adf6d320	TCGA-KN-8425-01A-11D-2310-10_wgs_Illumina.filtered.	WGS	TCGA-KN-8425-01A-11D-2310-10_wgs_Illumina	TCGA-KN-8425-01A-11D-2310-10_wgs_Illumina.bam	71.3	NA	0.05	58cfa832e4b0c9d6adf6d320	TCGA-KN-8425-01A-11D-2310-10_wgs_Illumina.bam	Alive	MALE	WHITE	Not available	Kidney Chromophobe	Aligned reads	TCGA-KN-8425-01A	CC316FAF-DCB1-4DEA-B8B0-A17D000FF40F	Primary Tumor	Illumina HiSeq	60135711-8234-4e49-8d15-e9a5a0726f68	Kidney	53	84ED1792-CEC8-4F98-9988-74B3F5F6F516	81BB13FC-F082-4C0B-8066-1729F11EF617	TCGA-KN-8425-01A-11D-2310-10	GRCh37-lite	TCGA-KN-8425	TCGA-KICH	NA	s16527	Baylor College of Medicine	Harvard	United States	NO	T1b	N0	Kidney Chromophobe	Stage I	2310-10	TRUE
13722.58cfa832e4b0c9d6adf6d30e	58cfa832e4b0c9d6adf6d30e	TCGA-KN-8431-01A-11D-2310-10_wgs_Illumina.filtered.	WGS	TCGA-KN-8431-01A-11D-2310-10_wgs_Illumina	TCGA-KN-8431-01A-11D-2310-10_wgs_Illumina.bam	71.3	NA	0.05	58cfa832e4b0c9d6adf6d30e	TCGA-KN-8431-01A-11D-2310-10_wgs_Illumina.bam	Alive	FEMALE	Not available	Not available	Kidney Chromophobe	Aligned reads	TCGA-KN-8431-01A	04E9A63A-D742-488C-8564-BF9D79AA2091	Primary Tumor	Illumina HiSeq	335b2e98-ed12-462c-8a68-11724a840ad0	Kidney	35	2BBA3FAA-8D55-4AEC-863D-AAE1CEA6FEAB	93B51C61-6EEA-4228-A102-840A2E118522	TCGA-KN-8431-01A-11D-2310-10	GRCh37-lite	TCGA-KN-8431	TCGA-KICH	NA	s16403	Baylor College of Medicine	Harvard	United States	NO	T2	NX	Kidney Chromophobe	Stage II	2310-10	TRUE
13722.58cfa832e4b0c9d6adf6d317	58cfa832e4b0c9d6adf6d317	TCGA-KN-8428-01A-11D-2310-10_wgs_Illumina.filtered.	WGS	TCGA-KN-8428-01A-11D-2310-10_wgs_Illumina	TCGA-KN-8428-01A-11D-2310-10_wgs_Illumina.bam	260.3	NA	0.05	58cfa832e4b0c9d6adf6d317	TCGA-KN-8428-01A-11D-2310-10_wgs_Illumina.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Kidney Chromophobe	Aligned reads	TCGA-KN-8428-01A	455FD7D4-5FF4-423F-83CE-4630AEF89BB7	Primary Tumor	Illumina HiSeq	1b52b2f7-d6a9-41f9-870c-f1456fda197e	Kidney	71	FFE3D692-7B81-45D9-BE76-2C580A091539	322F0B01-2118-4DBE-ABA1-3875A54EE71B	TCGA-KN-8428-01A-11D-2310-10	GRCh37-lite	TCGA-KN-8428	TCGA-KICH	1590	s16538	Baylor College of Medicine	Harvard	United States	NO	T2	N0	Kidney Chromophobe	Stage II	2310-10	TRUE
13722.58cfa832e4b0c9d6adf6d332	58cfa832e4b0c9d6adf6d332	TCGA-KN-8432-01A-11D-2310-10_wgs_Illumina.filtered.	WGS	TCGA-KN-8432-01A-11D-2310-10_wgs_Illumina	TCGA-KN-8432-01A-11D-2310-10_wgs_Illumina.bam	205.3	NA	0.05	58cfa832e4b0c9d6adf6d332	TCGA-KN-8432-01A-11D-2310-10_wgs_Illumina.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Kidney Chromophobe	Aligned reads	TCGA-KN-8432-01A	AF1111AF-9384-4E37-9B16-227D38007EBD	Primary Tumor	Illumina HiSeq	be9bfce6-c244-4dcb-b5df-36fab219e0f6	Kidney	86	F27E987E-DA76-40C2-B7B8-5DEE724D7EB7	85ED2434-DA94-4333-90CA-6CA4691CBDD3	TCGA-KN-8432-01A-11D-2310-10	GRCh37-lite	TCGA-KN-8432	TCGA-KICH	NA	s16406	Baylor College of Medicine	Harvard	United States	NO	T2b	NX	Kidney Chromophobe	Stage II	2310-10	TRUE
13722.58cfa832e4b0c9d6adf6d338	58cfa832e4b0c9d6adf6d338	TCGA-KN-8427-01A-11D-2310-10_wgs_Illumina.filtered.	WGS	TCGA-KN-8427-01A-11D-2310-10_wgs_Illumina	TCGA-KN-8427-01A-11D-2310-10_wgs_Illumina.bam	198.3	NA	0.05	58cfa832e4b0c9d6adf6d338	TCGA-KN-8427-01A-11D-2310-10_wgs_Illumina.bam	Alive	MALE	WHITE	Not available	Kidney Chromophobe	Aligned reads	TCGA-KN-8427-01A	955D428C-8FE8-456B-B86D-65EA6C2A1B18	Primary Tumor	Illumina HiSeq	1ab3dc9e-2973-4b02-bf13-e2f1f27c0f05	Kidney	54	8719FECD-7AB5-4468-A978-5C6BF1D4A1D7	07E0E938-F61F-477A-92A2-5B7E74B78943	TCGA-KN-8427-01A-11D-2310-10	GRCh37-lite	TCGA-KN-8427	TCGA-KICH	NA	s16442	Baylor College of Medicine	Harvard	United States	NO	T4	N1	Kidney Chromophobe	Stage IV	2310-10	TRUE
13722.58cfa832e4b0c9d6adf6d32e	58cfa832e4b0c9d6adf6d32e	TCGA-KN-8421-01A-11D-2310-10_wgs_Illumina.filtered.	WGS	TCGA-KN-8421-01A-11D-2310-10_wgs_Illumina	TCGA-KN-8421-01A-11D-2310-10_wgs_Illumina.bam	112.3	NA	0.05	58cfa832e4b0c9d6adf6d32e	TCGA-KN-8421-01A-11D-2310-10_wgs_Illumina.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Kidney Chromophobe	Aligned reads	TCGA-KN-8421-01A	2FC175D1-9D95-44FD-A53E-820F6F404551	Primary Tumor	Illumina HiSeq	2b4a72cf-171d-4cea-ac2a-528687128d7c	Kidney	47	D4694662-8330-4F19-A25D-9A12751C1B57	BA686386-8113-4885-B20F-6AD09A295604	TCGA-KN-8421-01A-11D-2310-10	GRCh37-lite	TCGA-KN-8421	TCGA-KICH	NA	s16476	Baylor College of Medicine	Harvard	United States	NO	T2	N0	Kidney Chromophobe	Stage II	2310-10	TRUE
13722.58cfa832e4b0c9d6adf6d334	58cfa832e4b0c9d6adf6d334	TCGA-KM-8639-01A-11D-2397-10_wgs_Illumina.filtered.	WGS	TCGA-KM-8639-01A-11D-2397-10_wgs_Illumina	TCGA-KM-8639-01A-11D-2397-10_wgs_Illumina.bam	157	NA	0.05	58cfa832e4b0c9d6adf6d334	TCGA-KM-8639-01A-11D-2397-10_wgs_Illumina.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Kidney Chromophobe	Aligned reads	TCGA-KM-8639-01A	2EA84E23-6A0A-4C5D-9C70-D5355A85DF35	Primary Tumor	Illumina HiSeq	f1dafc21-d5b0-48e6-ab3e-2fffa2d599e4	Kidney	67	E1D3EE37-402B-4727-8E27-B797D42F46BA	0B811C6A-8F05-44BD-AC33-FB720D189E71	TCGA-KM-8639-01A-11D-2397-10	GRCh37-lite	TCGA-KM-8639	TCGA-KICH	NA	s16572	Baylor College of Medicine	NCI Urologic Oncology Branch	United States	NO	T1a	NX	Kidney Chromophobe	Stage I	2397-10	FALSE
13722.58cfa832e4b0c9d6adf6d354	58cfa832e4b0c9d6adf6d354	TCGA-KO-8409-01A-11D-2310-10_wgs_Illumina.filtered.	WGS	TCGA-KO-8409-01A-11D-2310-10_wgs_Illumina	TCGA-KO-8409-01A-11D-2310-10_wgs_Illumina.bam	151.2	NA	0.05	58cfa832e4b0c9d6adf6d354	TCGA-KO-8409-01A-11D-2310-10_wgs_Illumina.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Kidney Chromophobe	Aligned reads	TCGA-KO-8409-01A	08A96DEC-E658-493A-9308-83F7ACE3B3B6	Primary Tumor	Illumina HiSeq	a6a7348b-80db-4f3a-b7eb-77e0575ab072	Kidney	69	56B3AC6B-BD6E-4960-8610-292CF154A705	8DF1EEB4-DFC9-4A0A-8F93-98460C3AB489	TCGA-KO-8409-01A-11D-2310-10	GRCh37-lite	TCGA-KO-8409	TCGA-KICH	NA	s16445	Baylor College of Medicine	MD Anderson Cancer Center	United States	NO	T2b	N0	Kidney Chromophobe	Stage II	2310-10	TRUE
13722.58cfa832e4b0c9d6adf6d33a	58cfa832e4b0c9d6adf6d33a	TCGA-KN-8430-01A-11D-2310-10_wgs_Illumina.filtered.	WGS	TCGA-KN-8430-01A-11D-2310-10_wgs_Illumina	TCGA-KN-8430-01A-11D-2310-10_wgs_Illumina.bam	155.3	NA	0.05	58cfa832e4b0c9d6adf6d33a	TCGA-KN-8430-01A-11D-2310-10_wgs_Illumina.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Kidney Chromophobe	Aligned reads	TCGA-KN-8430-01A	9F8AA332-E625-46F7-B77B-1FCB3CA99EE2	Primary Tumor	Illumina HiSeq	1722dad6-e2ed-4881-9193-2569f9b36201	Kidney	75	85339F51-85C1-4C2E-966E-CDE3D0CFAC91	70FD4434-02C9-4016-BB89-86BEC4317489	TCGA-KN-8430-01A-11D-2310-10	GRCh37-lite	TCGA-KN-8430	TCGA-KICH	NA	s16401	Baylor College of Medicine	Harvard	United States	NO	T1b	N0	Kidney Chromophobe	Stage I	2310-10	TRUE
13722.58cfa832e4b0c9d6adf6d17e	58cfa832e4b0c9d6adf6d17e	TCGA-HD-7753-01A-11D-A32X-10_wgs_Illumina.filtered.	WGS	TCGA-HD-7753-01A-11D-A32X-10_wgs_Illumina	TCGA-HD-7753-01A-11D-A32X-10_wgs_Illumina.bam	103.73	NA	0.07	58cfa832e4b0c9d6adf6d17e	TCGA-HD-7753-01A-11D-A32X-10_wgs_Illumina.bam	Alive	MALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-HD-7753-01A	E8AC39E6-377A-412C-B18D-F6C4FC654EC6	Primary Tumor	Illumina HiSeq	393b4af8-b44d-4c3f-b5ca-f7032b687a16	Head and Neck	62	E723F1BB-73A3-4D65-BD25-DE76138515E9	54E78DE0-D357-4125-A904-AB35E461572B	TCGA-HD-7753-01A-11D-A32X-10	GRCh37-lite	TCGA-HD-7753	TCGA-HNSC	NA	s15534	Baylor College of Medicine	International Genomics Consortium	United States	NO	T1	N0	Head and Neck Squamous Cell Carcinoma	Stage I	A32X-10	TRUE
13722.58cfa832e4b0c9d6adf6d3ad	58cfa832e4b0c9d6adf6d3ad	TCGA-NH-A50V-01A-11D-A28G-10_wgs_Illumina.filtered.	WGS	TCGA-NH-A50V-01A-11D-A28G-10_wgs_Illumina	TCGA-NH-A50V-01A-11D-A28G-10_wgs_Illumina.bam	33.86	NA	0.08	58cfa832e4b0c9d6adf6d3ad	TCGA-NH-A50V-01A-11D-A28G-10_wgs_Illumina.bam	Alive	MALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Colon Adenocarcinoma	Aligned reads	TCGA-NH-A50V-01A	D3B7ADA6-5395-4212-A921-8E97C92B605D	Primary Tumor	Illumina HiSeq	80f9989d-1696-49b8-a893-f045bc8615ea	Colorectal	69	A7A71B11-5E34-49A4-8D54-BE27D9C8DAF0	55345803-83D4-4FDB-B0EE-328753801DA1	TCGA-NH-A50V-01A-11D-A28G-10	GRCh37-lite	TCGA-NH-A50V	TCGA-COAD	NA	s13043	Baylor College of Medicine	Candler	United States	NO	T3	N2a	Colon Adenocarcinoma	Stage IIIB	A28G-10	TRUE
13722.58cfa832e4b0c9d6adf6d43a	58cfa832e4b0c9d6adf6d43a	TCGA-QG-A5YV-01A-11D-A28G-10_wgs_Illumina.filtered.	WGS	TCGA-QG-A5YV-01A-11D-A28G-10_wgs_Illumina	TCGA-QG-A5YV-01A-11D-A28G-10_wgs_Illumina.bam	62.92	NA	0.07	58cfa832e4b0c9d6adf6d43a	TCGA-QG-A5YV-01A-11D-A28G-10_wgs_Illumina.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Colon Adenocarcinoma	Aligned reads	TCGA-QG-A5YV-01A	C83D38FC-E011-4F75-A100-96513611F3E9	Primary Tumor	Illumina HiSeq	fc951188-ba57-4cd7-a209-28726710bb92	Colorectal	64	69EF3E70-5D7A-4E30-ABDE-0F9F76EA3141	E3EF5CAD-4D6E-4F04-BABB-A908EE02644B	TCGA-QG-A5YV-01A-11D-A28G-10	GRCh37-lite	TCGA-QG-A5YV	TCGA-COAD	NA	s13220	Baylor College of Medicine	BLN - Baylor	United States	NO	T4b	N1a	Colon Adenocarcinoma	Stage IIIC	A28G-10	TRUE
13722.58cfa832e4b0c9d6adf6d448	58cfa832e4b0c9d6adf6d448	TCGA-QG-A5YW-01A-11D-A28G-10_wgs_Illumina.filtered.	WGS	TCGA-QG-A5YW-01A-11D-A28G-10_wgs_Illumina	TCGA-QG-A5YW-01A-11D-A28G-10_wgs_Illumina.bam	63.92	NA	0.08	58cfa832e4b0c9d6adf6d448	TCGA-QG-A5YW-01A-11D-A28G-10_wgs_Illumina.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Colon Adenocarcinoma	Aligned reads	TCGA-QG-A5YW-01A	9F45A227-1FD5-478C-A194-4A5C61B68CC3	Primary Tumor	Illumina HiSeq	32a205bb-36f6-42a4-8bc1-42318eeccd0f	Colorectal	55	D8DCE266-1073-4BF2-A714-748E7E942635	4CFB0AEE-6661-478A-8694-9D8BA15E46B7	TCGA-QG-A5YW-01A-11D-A28G-10	GRCh37-lite	TCGA-QG-A5YW	TCGA-COAD	NA	s12894	Baylor College of Medicine	BLN - Baylor	United States	NO	T3	N2b	Colon Mucinous Adenocarcinoma	Stage IIIC	A28G-10	TRUE
13722.58cfa832e4b0c9d6adf6d437	58cfa832e4b0c9d6adf6d437	TCGA-QG-A5Z1-01A-11D-A28G-10_wgs_Illumina.filtered.	WGS	TCGA-QG-A5Z1-01A-11D-A28G-10_wgs_Illumina	TCGA-QG-A5Z1-01A-11D-A28G-10_wgs_Illumina.bam	39.63	NA	0.08	58cfa832e4b0c9d6adf6d437	TCGA-QG-A5Z1-01A-11D-A28G-10_wgs_Illumina.bam	Alive	MALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Colon Adenocarcinoma	Aligned reads	TCGA-QG-A5Z1-01A	9C45EAEC-D854-4F51-80A3-2D80D6B4AEBC	Primary Tumor	Illumina HiSeq	cc89a29c-287c-4a64-87c1-40ea6c90f58a	Colorectal	71	95601410-9608-4DDA-BA3F-462BE0E8C35F	D3AFF5D3-23C0-43AE-9C01-8DDD776B530B	TCGA-QG-A5Z1-01A-11D-A28G-10	GRCh37-lite	TCGA-QG-A5Z1	TCGA-COAD	NA	s13041	Baylor College of Medicine	BLN - Baylor	United States	NO	T3	N1b	Colon Adenocarcinoma	Stage IIIB	A28G-10	TRUE
13722.58cfa832e4b0c9d6adf6d51c	58cfa832e4b0c9d6adf6d51c	TCGA-KO-8405-01A-11D-2310-10_wgs_Illumina.filtered.	WGS	TCGA-KO-8405-01A-11D-2310-10_wgs_Illumina	TCGA-KO-8405-01A-11D-2310-10_wgs_Illumina.bam	91.2	NA	0.05	58cfa832e4b0c9d6adf6d51c	TCGA-KO-8405-01A-11D-2310-10_wgs_Illumina.bam	Alive	MALE	WHITE	HISPANIC OR LATINO	Kidney Chromophobe	Aligned reads	TCGA-KO-8405-01A	D52C3CB6-921E-4F26-B49C-E6E4F11F9C06	Primary Tumor	Illumina HiSeq	f0e77d93-bf81-460d-b8ea-9f6189208a33	Kidney	29	415C8373-535F-4CDD-883B-C7BD7CEB426E	6400C324-2C94-477D-ACB9-669D4EA46F1E	TCGA-KO-8405-01A-11D-2310-10	GRCh37-lite	TCGA-KO-8405	TCGA-KICH	NA	s16535	Baylor College of Medicine	MD Anderson Cancer Center	United States	NO	T3a	N0	Kidney Chromophobe	Stage III	2310-10	TRUE
13722.58cfa832e4b0c9d6adf6d4fc	58cfa832e4b0c9d6adf6d4fc	TCGA-KN-8437-01A-11D-2310-10_wgs_Illumina.filtered.	WGS	TCGA-KN-8437-01A-11D-2310-10_wgs_Illumina	TCGA-KN-8437-01A-11D-2310-10_wgs_Illumina.bam	88.3	NA	0.05	58cfa832e4b0c9d6adf6d4fc	TCGA-KN-8437-01A-11D-2310-10_wgs_Illumina.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Kidney Chromophobe	Aligned reads	TCGA-KN-8437-01A	F1C1502E-1BD6-425A-B651-454363809668	Primary Tumor	Illumina HiSeq	b4d37e4e-5f70-4f9f-8577-67d22eef75a4	Kidney	42	05CC0766-7ED0-458E-B1D7-732B632C05A4	345A06D6-FA5C-4674-A847-88A6B537CF3C	TCGA-KN-8437-01A-11D-2310-10	GRCh37-lite	TCGA-KN-8437	TCGA-KICH	NA	s16410	Baylor College of Medicine	Harvard	United States	NO	T1a	NX	Kidney Chromophobe	Stage I	2310-10	TRUE
13722.58cfa832e4b0c9d6adf6d517	58cfa832e4b0c9d6adf6d517	TCGA-PD-A5DF-01A-11D-A27I-10_wgs_Illumina.filtered.	WGS	TCGA-PD-A5DF-01A-11D-A27I-10_wgs_Illumina	TCGA-PD-A5DF-01A-11D-A27I-10_wgs_Illumina.bam	28.25	NA	0.08	58cfa832e4b0c9d6adf6d517	TCGA-PD-A5DF-01A-11D-A27I-10_wgs_Illumina.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Liver Hepatocellular Carcinoma	Aligned reads	TCGA-PD-A5DF-01A	1987B453-F97D-45C7-9C89-B9A33313D645	Primary Tumor	Illumina HiSeq	b1a68eac-e070-4718-a0a6-095bb77bfeea	Liver	58	0B88D087-50FB-4893-AE37-2FC5990A5B15	F1A4F60A-5228-47CD-883F-FF8D2DFE1633	TCGA-PD-A5DF-01A-11D-A27I-10	GRCh37-lite	TCGA-PD-A5DF	TCGA-LIHC	639	s16865	Baylor College of Medicine	Fox Chase	United States	NO	T4	N0	Hepatocellular Carcinoma	Stage IIIB	A27I-10	TRUE
13722.58cfa832e4b0c9d6adf6d48a	58cfa832e4b0c9d6adf6d48a	TCGA-NH-A50T-01A-11D-A28G-10_wgs_Illumina.filtered.	WGS	TCGA-NH-A50T-01A-11D-A28G-10_wgs_Illumina	TCGA-NH-A50T-01A-11D-A28G-10_wgs_Illumina.bam	43.71	NA	0.08	58cfa832e4b0c9d6adf6d48a	TCGA-NH-A50T-01A-11D-A28G-10_wgs_Illumina.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Colon Adenocarcinoma	Aligned reads	TCGA-NH-A50T-01A	490EABCA-4575-4BD6-9604-6B6E23D069CE	Primary Tumor	Illumina HiSeq	2893d404-6a2e-482b-86f7-eb3ae051faf4	Colorectal	68	9F5AD422-C94D-4914-B6F0-071596ECB589	8A929C55-35A6-4645-BB70-4B85D281B139	TCGA-NH-A50T-01A-11D-A28G-10	GRCh37-lite	TCGA-NH-A50T	TCGA-COAD	NA	s13547	Baylor College of Medicine	Candler	United States	NO	T3	N0	Colon Adenocarcinoma	Stage IIA	A28G-10	TRUE
13722.58cfa832e4b0c9d6adf6d523	58cfa832e4b0c9d6adf6d523	TCGA-KN-8419-01A-11D-2310-10_wgs_Illumina.filtered.	WGS	TCGA-KN-8419-01A-11D-2310-10_wgs_Illumina	TCGA-KN-8419-01A-11D-2310-10_wgs_Illumina.bam	17.3	NA	0.05	58cfa832e4b0c9d6adf6d523	TCGA-KN-8419-01A-11D-2310-10_wgs_Illumina.bam	Alive	MALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Kidney Chromophobe	Aligned reads	TCGA-KN-8419-01A	DC04B82C-E1E8-4917-BA19-C2FEA4A1B69A	Primary Tumor	Illumina HiSeq	14e44071-dc94-49f8-a105-4012aa8e1767	Kidney	43	65256F5D-63A8-49D3-9D76-A3D7E3DDC0E6	A592E80A-3B1A-46AA-BE30-BCD87D6BCA6F	TCGA-KN-8419-01A-11D-2310-10	GRCh37-lite	TCGA-KN-8419	TCGA-KICH	NA	s16533	Baylor College of Medicine	Harvard	United States	NO	T2	N0	Kidney Chromophobe	Stage II	2310-10	TRUE
13722.58cfa832e4b0c9d6adf6d59a	58cfa832e4b0c9d6adf6d59a	TCGA-MH-A55W-01A-11D-A26P-10_wgs_Illumina.filtered.	WGS	TCGA-MH-A55W-01A-11D-A26P-10_wgs_Illumina	TCGA-MH-A55W-01A-11D-A26P-10_wgs_Illumina.bam	41.46	NA	0.07	58cfa832e4b0c9d6adf6d59a	TCGA-MH-A55W-01A-11D-A26P-10_wgs_Illumina.bam	Alive	MALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Kidney Renal Papillary Cell Carcinoma	Aligned reads	TCGA-MH-A55W-01A	2030E10B-A4C2-460F-9E29-90C8A76EA05E	Primary Tumor	Illumina HiSeq	02bc7316-2306-488a-9d16-c7a439636912	Kidney	50	7846E991-0D5F-4E97-ABE1-945C3BE9C9F9	2425A532-F562-423A-88F5-228642F53875	TCGA-MH-A55W-01A-11D-A26P-10	GRCh37-lite	TCGA-MH-A55W	TCGA-KIRP	NA	s11593	Baylor College of Medicine	BLN - Baylor	United States	NO	T1b	NX	Kidney Papillary Renal Cell Carcinoma	Stage I	A26P-10	TRUE
13722.58cfa832e4b0c9d6adf6d59c	58cfa832e4b0c9d6adf6d59c	TCGA-MH-A562-01A-11D-A26P-10_wgs_Illumina.filtered.	WGS	TCGA-MH-A562-01A-11D-A26P-10_wgs_Illumina	TCGA-MH-A562-01A-11D-A26P-10_wgs_Illumina.bam	34.1	NA	0.08	58cfa832e4b0c9d6adf6d59c	TCGA-MH-A562-01A-11D-A26P-10_wgs_Illumina.bam	Alive	MALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Kidney Renal Papillary Cell Carcinoma	Aligned reads	TCGA-MH-A562-01A	45BDCFD6-1E3F-4BE8-B843-AE949E8E43EB	Primary Tumor	Illumina HiSeq	6eae65c7-1a89-44c9-a3c5-b7af6d633f1b	Kidney	57	4306E07D-6FC1-4C69-ACB8-00A1DC78CAD8	DDDEA2E4-B8C3-4157-9D92-6DE472E8375A	TCGA-MH-A562-01A-11D-A26P-10	GRCh37-lite	TCGA-MH-A562	TCGA-KIRP	NA	s11782	Baylor College of Medicine	BLN - Baylor	United States	NO	T1a	NX	Kidney Papillary Renal Cell Carcinoma	Stage I	A26P-10	TRUE
13722.58cfa832e4b0c9d6adf6d470	58cfa832e4b0c9d6adf6d470	TCGA-QG-A5Z2-01A-11D-A28G-10_wgs_Illumina.filtered.	WGS	TCGA-QG-A5Z2-01A-11D-A28G-10_wgs_Illumina	TCGA-QG-A5Z2-01A-11D-A28G-10_wgs_Illumina.bam	58.77	NA	0.07	58cfa832e4b0c9d6adf6d470	TCGA-QG-A5Z2-01A-11D-A28G-10_wgs_Illumina.bam	Alive	MALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Colon Adenocarcinoma	Aligned reads	TCGA-QG-A5Z2-01A	84959E50-17F5-4F2B-8E0C-5EBB139D2C3A	Primary Tumor	Illumina HiSeq	2113677f-10e1-4987-bde0-35d29025de2e	Colorectal	61	3D753B5B-8E33-4307-9321-E4AD4821F3BF	31E63F89-A6A9-40FB-823D-F41587BD73D8	TCGA-QG-A5Z2-01A-11D-A28G-10	GRCh37-lite	TCGA-QG-A5Z2	TCGA-COAD	NA	s13042	Baylor College of Medicine	BLN - Baylor	United States	NO	T2	N0	Colon Adenocarcinoma	Stage I	A28G-10	TRUE
13722.58cfa832e4b0c9d6adf6d5a2	58cfa832e4b0c9d6adf6d5a2	TCGA-MH-A560-01A-11D-A26P-10_wgs_Illumina.filtered.	WGS	TCGA-MH-A560-01A-11D-A26P-10_wgs_Illumina	TCGA-MH-A560-01A-11D-A26P-10_wgs_Illumina.bam	8.04	NA	0.07	58cfa832e4b0c9d6adf6d5a2	TCGA-MH-A560-01A-11D-A26P-10_wgs_Illumina.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Kidney Renal Papillary Cell Carcinoma	Aligned reads	TCGA-MH-A560-01A	A40BEABE-496E-4324-A1D1-5A7D8B002AAB	Primary Tumor	Illumina HiSeq	b1efdb03-f6ae-443f-85cc-d545d7710c21	Kidney	62	2697D1DE-3D7E-4BD6-9EDE-7516BD10A701	CF5DEB22-F7EB-409D-A0E4-882716199C39	TCGA-MH-A560-01A-11D-A26P-10	GRCh37-lite	TCGA-MH-A560	TCGA-KIRP	NA	s11594	Baylor College of Medicine	BLN - Baylor	United States	NO	T1a	NX	Kidney Papillary Renal Cell Carcinoma	Stage I	A26P-10	TRUE
13722.58cfa832e4b0c9d6adf6d58e	58cfa832e4b0c9d6adf6d58e	TCGA-MR-A520-01A-11D-A25V-10_wgs_Illumina.filtered.	WGS	TCGA-MR-A520-01A-11D-A25V-10_wgs_Illumina	TCGA-MR-A520-01A-11D-A25V-10_wgs_Illumina.bam	24.04	NA	0.08	58cfa832e4b0c9d6adf6d58e	TCGA-MR-A520-01A-11D-A25V-10_wgs_Illumina.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Liver Hepatocellular Carcinoma	Aligned reads	TCGA-MR-A520-01A	25E893AD-A0FD-45AE-9AA9-9BCD7C2EC8E5	Primary Tumor	Illumina HiSeq	aa52c229-8251-4890-a772-fac2f7c1b7ca	Liver	58	D7F0E432-C20B-4B2B-8D73-2A235F339BE7	352FBBB4-88A5-4354-B1FA-3A01DA3FBFA7	TCGA-MR-A520-01A-11D-A25V-10	GRCh37-lite	TCGA-MR-A520	TCGA-LIHC	NA	s16790	Baylor College of Medicine	University of Minnesota	United States	NO	T1	NX	Hepatocellular Carcinoma	Stage I	A25V-10	TRUE
13722.58cfa832e4b0c9d6adf6d5b8	58cfa832e4b0c9d6adf6d5b8	TCGA-KO-8410-01A-11D-2310-10_wgs_Illumina.filtered.	WGS	TCGA-KO-8410-01A-11D-2310-10_wgs_Illumina	TCGA-KO-8410-01A-11D-2310-10_wgs_Illumina.bam	71.2	NA	0.05	58cfa832e4b0c9d6adf6d5b8	TCGA-KO-8410-01A-11D-2310-10_wgs_Illumina.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Kidney Chromophobe	Aligned reads	TCGA-KO-8410-01A	B5F6A0E3-F9AC-475F-9A34-B8B8834F1779	Primary Tumor	Illumina HiSeq	ccebf6d6-dff4-4e8b-b33c-391cf464f5ab	Kidney	74	3751E3F9-C61F-4D5A-8054-B08590539820	798BD17B-69B7-40D7-92FF-7C2389EDCCCF	TCGA-KO-8410-01A-11D-2310-10	GRCh37-lite	TCGA-KO-8410	TCGA-KICH	NA	s16409	Baylor College of Medicine	MD Anderson Cancer Center	United States	NO	T1b	N0	Kidney Chromophobe	Stage I	2310-10	TRUE
13722.58cfa832e4b0c9d6adf6d5af	58cfa832e4b0c9d6adf6d5af	TCGA-MH-A561-01A-11D-A26P-10_wgs_Illumina.filtered.	WGS	TCGA-MH-A561-01A-11D-A26P-10_wgs_Illumina	TCGA-MH-A561-01A-11D-A26P-10_wgs_Illumina.bam	42.2	NA	0.08	58cfa832e4b0c9d6adf6d5af	TCGA-MH-A561-01A-11D-A26P-10_wgs_Illumina.bam	Alive	MALE	WHITE	HISPANIC OR LATINO	Kidney Renal Papillary Cell Carcinoma	Aligned reads	TCGA-MH-A561-01A	E6E6A773-B155-45A9-989F-75C12CE1702A	Primary Tumor	Illumina HiSeq	49516926-9793-4b88-bfa8-c631918a9b7a	Kidney	66	9E93686E-D150-404A-BD88-1DD4D2999ED3	2E8AD1CD-D5D5-4BB4-8BBD-E9BEF45088DA	TCGA-MH-A561-01A-11D-A26P-10	GRCh37-lite	TCGA-MH-A561	TCGA-KIRP	NA	s11592	Baylor College of Medicine	BLN - Baylor	United States	NO	T1a	NX	Kidney Papillary Renal Cell Carcinoma	Stage I	A26P-10	TRUE
13722.58cfa832e4b0c9d6adf6d2aa	58cfa832e4b0c9d6adf6d2aa	TCGA-KL-8326-01A-11D-2310-10_wgs_Illumina.filtered.	WGS	TCGA-KL-8326-01A-11D-2310-10_wgs_Illumina	TCGA-KL-8326-01A-11D-2310-10_wgs_Illumina.bam	71.3	NA	0.05	58cfa832e4b0c9d6adf6d2aa	TCGA-KL-8326-01A-11D-2310-10_wgs_Illumina.bam	Alive	MALE	WHITE	Not available	Kidney Chromophobe	Aligned reads	TCGA-KL-8326-01A	03F3DD32-E1D1-485B-A968-3F55798F4D46	Primary Tumor	Illumina HiSeq	b96eaa8e-2627-4ac2-a3fb-1140269babf6	Kidney	69	59703768-8BE1-47A7-8C7D-D794C0936019	4729FE4B-C1AC-489B-A67E-91E5C5E3FF8C	TCGA-KL-8326-01A-11D-2310-10	GRCh37-lite	TCGA-KL-8326	TCGA-KICH	NA	s16519	Baylor College of Medicine	MSKCC	United States	NO	T3a	N0	Kidney Chromophobe	Stage III	2310-10	TRUE
13722.58cfa832e4b0c9d6adf6d5ad	58cfa832e4b0c9d6adf6d5ad	TCGA-MH-A55Z-01A-11D-A26P-10_wgs_Illumina.filtered.	WGS	TCGA-MH-A55Z-01A-11D-A26P-10_wgs_Illumina	TCGA-MH-A55Z-01A-11D-A26P-10_wgs_Illumina.bam	53.89	NA	0.07	58cfa832e4b0c9d6adf6d5ad	TCGA-MH-A55Z-01A-11D-A26P-10_wgs_Illumina.bam	Alive	MALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Kidney Renal Papillary Cell Carcinoma	Aligned reads	TCGA-MH-A55Z-01A	F0F7E57F-1E9D-4F24-A685-A0811AACBBED	Primary Tumor	Illumina HiSeq	44cc1ed1-021d-4a1e-9a42-c6cb01ad7781	Kidney	65	1FC5BF90-235F-411C-AC1D-AEDC4DF1746F	B19EC4CD-2876-4A2B-BCB9-B3C8DB54FC15	TCGA-MH-A55Z-01A-11D-A26P-10	GRCh37-lite	TCGA-MH-A55Z	TCGA-KIRP	NA	s11866	Baylor College of Medicine	BLN - Baylor	United States	NO	T1b	NX	Kidney Papillary Renal Cell Carcinoma	Stage I	A26P-10	TRUE
13722.58cfa82ee4b0c9d6adf6ade1	58cfa82ee4b0c9d6adf6ade1	G39020.TCGA-BR-8682-01A-11D-2394-08.3.filtered.	WGS	G39020.TCGA-BR-8682-01A-11D-2394-08.3	G39020.TCGA-BR-8682-01A-11D-2394-08.3.bam	231	NA	0.05	58cfa82ee4b0c9d6adf6ade1	G39020.TCGA-BR-8682-01A-11D-2394-08.3.bam	Alive	MALE	ASIAN	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-BR-8682-01A	D5EFCDE2-21E6-4071-9AA4-3C5688A45B3F	Primary Tumor	Illumina HiSeq	36f56254-f585-4353-89b4-00cb5cfa20eb	Stomach	52	4E6BBC3C-BB9E-46C0-8B22-60F9725DB516	EA2055D1-7B8B-4AAF-9A70-8802F4DEEF9B	TCGA-BR-8682-01A-11D-2394-08	HG19_Broad_variant	TCGA-BR-8682	TCGA-STAD	NA	s15038	Broad Institute of MIT and Harvard	Asterand	Vietnam	NO	T4a	N0	Stomach Intestinal Adenocarcinoma Mucinous Type	Stage IIB	2394-08	TRUE
13722.58cfa82fe4b0c9d6adf6b657	58cfa82fe4b0c9d6adf6b657	TCGA-64-5778-01A-01D-1623_110824_SN208_0222_BB0164ACXX_s_3_rg.sorted.filtered.	WGS	TCGA-64-5778-01A-01D-1623_110824_SN208_0222_BB0164ACXX_s_3_rg.sorted	TCGA-64-5778-01A-01D-1623_110824_SN208_0222_BB0164ACXX_s_3_rg.sorted.bam	702.7	1.9	0.15	58cfa82fe4b0c9d6adf6b657	TCGA-64-5778-01A-01D-1623_110824_SN208_0222_BB0164ACXX_s_3_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-64-5778-01A	8FDBD88F-19AE-4AB8-BCD7-6BFA1BBDE742	Primary Tumor	Illumina HiSeq	bd5570f2-ed45-408a-a615-0a6808c31d84	Lung	60	92514FD2-A178-42E8-8929-0910558E7F87	BC8FFDB4-AB99-44B7-95B0-7BC2F8110B76	TCGA-64-5778-01A-01D-1623-02	HG19_Broad_variant	TCGA-64-5778	TCGA-LUAD	NA	s10796	Harvard Medical School	Fox Chase	United States	NO	T2	N0	Lung Bronchioloalveolar Carcinoma Nonmucinous	Stage IB	1623-02	TRUE
13722.58cfa82fe4b0c9d6adf6b664	58cfa82fe4b0c9d6adf6b664	TCGA-50-6594-01A-11D-1751_120105_SN1120_0107_AC054PACXX_s_1_rg.sorted.filtered.	WGS	TCGA-50-6594-01A-11D-1751_120105_SN1120_0107_AC054PACXX_s_1_rg.sorted	TCGA-50-6594-01A-11D-1751_120105_SN1120_0107_AC054PACXX_s_1_rg.sorted.bam	193.4	1.8	0.13	58cfa82fe4b0c9d6adf6b664	TCGA-50-6594-01A-11D-1751_120105_SN1120_0107_AC054PACXX_s_1_rg.sorted.bam	Dead	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-50-6594-01A	8504FD86-A70A-4CBA-9EC8-25C9E60CA549	Primary Tumor	Illumina HiSeq	e9b1ca6e-b0f0-48d8-ba44-ebfcec8cd171	Lung	79	DAB00804-E92F-43F1-9348-16F3015B5DCE	9AED6934-5553-4BAC-AD76-BA2DDAE0DC72	TCGA-50-6594-01A-11D-1751-02	HG19_Broad_variant	TCGA-50-6594	TCGA-LUAD	370	s11350	Harvard Medical School	University of Pittsburgh	United States	NO	T3	N2	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage IIIA	1751-02	TRUE
13722.58cfa82fe4b0c9d6adf6b6b7	58cfa82fe4b0c9d6adf6b6b7	TCGA-64-5781-01A-01D-1623_110824_SN208_0222_BB0164ACXX_s_7_rg.sorted.filtered.	WGS	TCGA-64-5781-01A-01D-1623_110824_SN208_0222_BB0164ACXX_s_7_rg.sorted	TCGA-64-5781-01A-01D-1623_110824_SN208_0222_BB0164ACXX_s_7_rg.sorted.bam	555.7	1.9	0.15	58cfa82fe4b0c9d6adf6b6b7	TCGA-64-5781-01A-01D-1623_110824_SN208_0222_BB0164ACXX_s_7_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-64-5781-01A	41C4C704-825E-49F5-9D54-DBD7D30725E0	Primary Tumor	Illumina HiSeq	901f4776-2659-4626-abec-5a9323e6f75e	Lung	55	B32F509D-91E5-4601-B8B3-4B0A5212C22B	69DEF564-A4D8-4820-9ED6-F17AF2CAB0A7	TCGA-64-5781-01A-01D-1623-02	HG19_Broad_variant	TCGA-64-5781	TCGA-LUAD	NA	s11352	Harvard Medical School	Fox Chase	United States	NO	T2	N0	Lung Adenocarcinoma Mixed Subtype	Stage IB	1623-02	TRUE
13722.58cfa82fe4b0c9d6adf6b852	58cfa82fe4b0c9d6adf6b852	TCGA-A5-A0R9-01A-11D-A101_120403_SN1222_0093_AC0L7VACXX_s_5_rg.sorted.filtered.	WGS	TCGA-A5-A0R9-01A-11D-A101_120403_SN1222_0093_AC0L7VACXX_s_5_rg.sorted	TCGA-A5-A0R9-01A-11D-A101_120403_SN1222_0093_AC0L7VACXX_s_5_rg.sorted.bam	112.95	1.93	0.17	58cfa82fe4b0c9d6adf6b852	TCGA-A5-A0R9-01A-11D-A101_120403_SN1222_0093_AC0L7VACXX_s_5_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-A5-A0R9-01A	284174FD-1320-4617-9E99-75BD75DF9BF3	Primary Tumor	Illumina HiSeq	4139f46d-ae94-47a2-a3ae-0b96262c6a89	Uterus	51	986AC6AC-087F-412B-BB0C-9BE10D104989	6BBEF031-7106-4D36-86A9-F8A2333448BB	TCGA-A5-A0R9-01A-11D-A101-02	HG19_Broad_variant	TCGA-A5-A0R9	TCGA-UCEC	NA	s4419	Harvard Medical School	Cedars Sinai	None	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A101-02	TRUE
13722.58cfa82fe4b0c9d6adf6b85e	58cfa82fe4b0c9d6adf6b85e	TCGA-A6-2680-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.filtered.	WGS	TCGA-A6-2680-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole	TCGA-A6-2680-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.bam	38	1.9	0.16	58cfa82fe4b0c9d6adf6b85e	TCGA-A6-2680-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Colon Adenocarcinoma	Aligned reads	TCGA-A6-2680-01A	FF1407C6-9174-4BAE-A19B-D34CA71B898C	Primary Tumor	Illumina HiSeq	b2bf326b-6022-44c8-87fd-c3777c1ab858	Colorectal	72	D664F620-CFEE-4700-B00E-68B65387883C	22A3FC8C-A661-4B3D-A4BA-B35DFDBE24BC	TCGA-A6-2680-01A-01D-1405-02	HG18	TCGA-A6-2680	TCGA-COAD	NA	s13356	Harvard Medical School	Christiana Healthcare	None	NO	T3	N0	Colon Adenocarcinoma	Stage II	1405-02	TRUE
13722.58cfa82fe4b0c9d6adf6b86e	58cfa82fe4b0c9d6adf6b86e	TCGA-A6-2671-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.filtered.	WGS	TCGA-A6-2671-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole	TCGA-A6-2671-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.bam	243	1.9	0.15	58cfa82fe4b0c9d6adf6b86e	TCGA-A6-2671-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Colon Adenocarcinoma	Aligned reads	TCGA-A6-2671-01A	565E2726-4942-4726-89D3-C5E3797F7204	Primary Tumor	Illumina HiSeq	866dc7b9-86cd-4842-ad2f-1d5e7c714ccb	Colorectal	85	81505915-6C01-4299-AE89-964DC20D93CB	82E23BAF-DA11-4175-BEE0-81C0C0137D72	TCGA-A6-2671-01A-01D-1405-02	HG18	TCGA-A6-2671	TCGA-COAD	NA	s13649	Harvard Medical School	Christiana Healthcare	None	NO	T3	N2	Colon Adenocarcinoma	Stage IV	1405-02	TRUE
13722.58cfa82fe4b0c9d6adf6b866	58cfa82fe4b0c9d6adf6b866	TCGA-A6-2682-01A-01D-1405_110114_SN177_0133_A809KVABXX_s_8_rg.sorted.filtered.	WGS	TCGA-A6-2682-01A-01D-1405_110114_SN177_0133_A809KVABXX_s_8_rg.sorted	TCGA-A6-2682-01A-01D-1405_110114_SN177_0133_A809KVABXX_s_8_rg.sorted.bam	618	1.9	0.16	58cfa82fe4b0c9d6adf6b866	TCGA-A6-2682-01A-01D-1405_110114_SN177_0133_A809KVABXX_s_8_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Colon Adenocarcinoma	Aligned reads	TCGA-A6-2682-01A	77A44132-AF22-4115-9FA2-78F2F74BF687	Primary Tumor	Illumina HiSeq	dd9a1c6d-4344-4fed-a29f-b60afcfaa5eb	Colorectal	70	F10F139D-1D7F-4923-8129-F103F5D3163B	F8B17713-D431-4418-A6F7-DC6DE3077212	TCGA-A6-2682-01A-01D-1405-02	HG18_Broad_variant	TCGA-A6-2682	TCGA-COAD	424	s13651	Harvard Medical School	Christiana Healthcare	United States	NO	T4b	N1	Colon Adenocarcinoma	Stage IV	1405-02	TRUE
13722.58cfa82fe4b0c9d6adf6b874	58cfa82fe4b0c9d6adf6b874	TCGA-A5-A0VQ-01A-11D-A101_120407_SN590_0151_BC0KKJACXX_s_2_rg.sorted.filtered.	WGS	TCGA-A5-A0VQ-01A-11D-A101_120407_SN590_0151_BC0KKJACXX_s_2_rg.sorted	TCGA-A5-A0VQ-01A-11D-A101_120407_SN590_0151_BC0KKJACXX_s_2_rg.sorted.bam	105.24	2	0.15	58cfa82fe4b0c9d6adf6b874	TCGA-A5-A0VQ-01A-11D-A101_120407_SN590_0151_BC0KKJACXX_s_2_rg.sorted.bam	Alive	FEMALE	Not available	HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-A5-A0VQ-01A	23489245-48D7-4F19-8A42-E23B1181412B	Primary Tumor	Illumina HiSeq	b4dd6449-2e78-432b-86c6-348339f37763	Uterus	62	952CB6A5-7527-470A-978E-EDD44E3A368F	97FE43D0-30DF-45A1-83F0-B4ED5EDF76AE	TCGA-A5-A0VQ-01A-11D-A101-02	HG19_Broad_variant	TCGA-A5-A0VQ	TCGA-UCEC	NA	s5381	Harvard Medical School	Cedars Sinai	None	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A101-02	TRUE
13722.58cfa82fe4b0c9d6adf6b938	58cfa82fe4b0c9d6adf6b938	TCGA-64-5779-01A-01D-1623_110824_SN208_0222_BB0164ACXX_s_5_rg.sorted.filtered.	WGS	TCGA-64-5779-01A-01D-1623_110824_SN208_0222_BB0164ACXX_s_5_rg.sorted	TCGA-64-5779-01A-01D-1623_110824_SN208_0222_BB0164ACXX_s_5_rg.sorted.bam	439.7	1.9	0.15	58cfa82fe4b0c9d6adf6b938	TCGA-64-5779-01A-01D-1623_110824_SN208_0222_BB0164ACXX_s_5_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-64-5779-01A	1C58D9B8-17A2-4FC6-9898-FE6F47BD2C2A	Primary Tumor	Illumina HiSeq	40156a89-cb76-4ae2-b73d-ec06c1cbd7bb	Lung	61	4131DA8F-3C6C-43E1-A7EB-81CB8988F524	AE15BEF8-478B-432E-B429-643A75BD2EB8	TCGA-64-5779-01A-01D-1623-02	HG19_Broad_variant	TCGA-64-5779	TCGA-LUAD	NA	s11463	Harvard Medical School	Fox Chase	United States	NO	T2	N2	Lung Acinar Adenocarcinoma	Stage IIIA	1623-02	TRUE
13722.58cfa82fe4b0c9d6adf6b8c4	58cfa82fe4b0c9d6adf6b8c4	TCGA-49-4510-01A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.filtered.	WGS	TCGA-49-4510-01A-01D-1203-02_IlluminaHiSeq-DNASeq_whole	TCGA-49-4510-01A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.bam	177.53	1.9	0.14	58cfa82fe4b0c9d6adf6b8c4	TCGA-49-4510-01A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.bam	Dead	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-49-4510-01A	F77B6930-A1CE-446E-A15D-C018CBBECFEE	Primary Tumor	Illumina HiSeq	abe8920d-80b9-4fc8-a249-5bf0a4a06ac7	Lung	51	9A479D32-13A4-46C2-B26D-34CB6051A891	3324FA3E-B195-4974-A15B-0C8D8AC2EFA9	TCGA-49-4510-01A-01D-1203-02	GRCh37	TCGA-49-4510	TCGA-LUAD	896	s11338	Harvard Medical School	Johns Hopkins	United States	NO	T2	N1	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage IIB	1203-02	TRUE
13722.58cfa82fe4b0c9d6adf6ba02	58cfa82fe4b0c9d6adf6ba02	TCGA-AA-A01I-01A-02D-A077-02_IlluminaHiSeq-DNASeq_whole.filtered.	WGS	TCGA-AA-A01I-01A-02D-A077-02_IlluminaHiSeq-DNASeq_whole	TCGA-AA-A01I-01A-02D-A077-02_IlluminaHiSeq-DNASeq_whole.bam	237.83	1.78	0.15	58cfa82fe4b0c9d6adf6ba02	TCGA-AA-A01I-01A-02D-A077-02_IlluminaHiSeq-DNASeq_whole.bam	Alive	MALE	Not available	Not available	Colon Adenocarcinoma	Aligned reads	TCGA-AA-A01I-01A	86D18004-9478-4E46-83B4-4FBE445CCB70	Primary Tumor	Illumina HiSeq	397e6c0b-1bf2-43ff-b659-15147ee8be30	Colorectal	76	FBA03796-B9C8-4042-9720-F21660CFEC28	DAED1A71-909A-42D8-87B4-6760B54D91AF	TCGA-AA-A01I-01A-02D-A077-02	HG18	TCGA-AA-A01I	TCGA-COAD	NA	s13201	Harvard Medical School	Indivumed	Germany	NO	T2	N0	Colon Adenocarcinoma	Stage I	A077-02	TRUE
13722.58cfa830e4b0c9d6adf6baaa	58cfa830e4b0c9d6adf6baaa	TCGA-A5-A0GD-01A-11D-A043_120209_SN1120_0114_BC0DFVACXX_s_3_rg.sorted.filtered.	WGS	TCGA-A5-A0GD-01A-11D-A043_120209_SN1120_0114_BC0DFVACXX_s_3_rg.sorted	TCGA-A5-A0GD-01A-11D-A043_120209_SN1120_0114_BC0DFVACXX_s_3_rg.sorted.bam	96.48	1.95	0.14	58cfa830e4b0c9d6adf6baaa	TCGA-A5-A0GD-01A-11D-A043_120209_SN1120_0114_BC0DFVACXX_s_3_rg.sorted.bam	Alive	FEMALE	WHITE	Not available	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-A5-A0GD-01A	1486A031-B74D-4976-8B0B-4569E6978F49	Primary Tumor	Illumina HiSeq	98b5ea92-9e57-4d1f-937d-8bb0dd2a3cf2	Uterus	75	F449F50A-7664-4DDC-87AA-6A061EE7190C	069406A8-56D7-4E93-8570-7880A99D6C2D	TCGA-A5-A0GD-01A-11D-A043-02	HG19_Broad_variant	TCGA-A5-A0GD	TCGA-UCEC	NA	s4771	Harvard Medical School	Cedars Sinai	None	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A043-02	TRUE
13722.58cfa830e4b0c9d6adf6bbc2	58cfa830e4b0c9d6adf6bbc2	TCGA-AG-4008-01A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.filtered.	WGS	TCGA-AG-4008-01A-01D-1115-02_IlluminaHiSeq-DNASeq_whole	TCGA-AG-4008-01A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.bam	624.89	1.9	0.14	58cfa830e4b0c9d6adf6bbc2	TCGA-AG-4008-01A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.bam	Alive	MALE	Not available	Not available	Rectum Adenocarcinoma	Aligned reads	TCGA-AG-4008-01A	72802851-9340-4C5F-A90B-23B7AFD7577A	Primary Tumor	Illumina HiSeq	95360a98-f3fd-40d4-b451-5973fe934b51	Colorectal	63	D803F092-3340-485D-9964-D6554D210E2E	CD36B70F-6819-4136-ADB5-8024E27B05A6	TCGA-AG-4008-01A-01D-1115-02	HG18	TCGA-AG-4008	TCGA-READ	NA	s2312	Harvard Medical School	Indivumed	Germany	NO	T3	N0	Rectal Adenocarcinoma	Stage IIA	1115-02	TRUE
13722.58cfa830e4b0c9d6adf6bc92	58cfa830e4b0c9d6adf6bc92	TCGA-AG-3902-01A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.filtered.	WGS	TCGA-AG-3902-01A-01D-1115-02_IlluminaHiSeq-DNASeq_whole	TCGA-AG-3902-01A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.bam	500.89	1.9	0.14	58cfa830e4b0c9d6adf6bc92	TCGA-AG-3902-01A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.bam	Alive	MALE	Not available	Not available	Rectum Adenocarcinoma	Aligned reads	TCGA-AG-3902-01A	BCFE4FE9-D090-49F9-85A7-2B472E0F7453	Primary Tumor	Illumina HiSeq	66b629b3-3801-4c84-966b-4b01243390f0	Colorectal	61	F52423C2-7780-4470-8E27-5982201CCB83	A8A88775-9775-4087-8C03-9B5BC771F983	TCGA-AG-3902-01A-01D-1115-02	HG18	TCGA-AG-3902	TCGA-READ	NA	s2159	Harvard Medical School	Indivumed	Germany	NO	T3	N0	Rectal Adenocarcinoma	Stage IIA	1115-02	TRUE
13722.58cfa830e4b0c9d6adf6bd3c	58cfa830e4b0c9d6adf6bd3c	TCGA-AG-3892-01A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.filtered.	WGS	TCGA-AG-3892-01A-01D-1115-02_IlluminaHiSeq-DNASeq_whole	TCGA-AG-3892-01A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.bam	728.89	1.9	0.15	58cfa830e4b0c9d6adf6bd3c	TCGA-AG-3892-01A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.bam	Alive	FEMALE	Not available	Not available	Rectum Adenocarcinoma	Aligned reads	TCGA-AG-3892-01A	DED3FEB2-1079-4520-A7CA-F5B5FC73D7C5	Primary Tumor	Illumina HiSeq	adde3886-c16e-4d0c-8186-1a253ffca559	Colorectal	57	D5B6919D-5654-486F-95B0-D89CB1893614	8B81AA70-5B77-4BE9-8438-AE0928339E21	TCGA-AG-3892-01A-01D-1115-02	HG18	TCGA-AG-3892	TCGA-READ	NA	s1998	Harvard Medical School	Indivumed	Germany	NO	T1	N0	Rectal Adenocarcinoma	Stage I	1115-02	TRUE
13722.58cfa830e4b0c9d6adf6bd7c	58cfa830e4b0c9d6adf6bd7c	TCGA-BF-A1PV-01A-11D-A18Z_120517_SN208_0300_BC0VYMACXX_s_1_rg.sorted.filtered.	WGS	TCGA-BF-A1PV-01A-11D-A18Z_120517_SN208_0300_BC0VYMACXX_s_1_rg.sorted	TCGA-BF-A1PV-01A-11D-A18Z_120517_SN208_0300_BC0VYMACXX_s_1_rg.sorted.bam	78.67	NA	0.17	58cfa830e4b0c9d6adf6bd7c	TCGA-BF-A1PV-01A-11D-A18Z_120517_SN208_0300_BC0VYMACXX_s_1_rg.sorted.bam	Alive	FEMALE	WHITE	Not available	Skin Cutaneous Melanoma	Aligned reads	TCGA-BF-A1PV-01A	EFF78AF6-0F68-49B9-866B-0D511606F2B1	Primary Tumor	Illumina HiSeq	a219d21e-e657-407a-8e8f-aba8b0190425	Skin	74	090DEBB2-290D-49DD-B642-7F01C99A795C	BC0B690D-7C05-4B68-B2F2-5D38EA621A02	TCGA-BF-A1PV-01A-11D-A18Z-02	HG19_Broad_variant	TCGA-BF-A1PV	TCGA-SKCM	NA	s7491	Harvard Medical School	Cureline	Russia	NO	T4b	N0	Not available	Stage IIC	A18Z-02	TRUE
13722.58cfa830e4b0c9d6adf6be10	58cfa830e4b0c9d6adf6be10	TCGA-BH-A0HX-01A-21D-A060_130807_SN590_0236_BC291KACXX_s_7_rg.sorted.filtered.	WGS	TCGA-BH-A0HX-01A-21D-A060_130807_SN590_0236_BC291KACXX_s_7_rg.sorted	TCGA-BH-A0HX-01A-21D-A060_130807_SN590_0236_BC291KACXX_s_7_rg.sorted.bam	19.84	1.95	0.16	58cfa830e4b0c9d6adf6be10	TCGA-BH-A0HX-01A-21D-A060_130807_SN590_0236_BC291KACXX_s_7_rg.sorted.bam	Alive	FEMALE	WHITE	Not available	Breast Invasive Carcinoma	Aligned reads	TCGA-BH-A0HX-01A	3B01D064-8C00-4972-9F07-407EAC8E7534	Primary Tumor	Illumina HiSeq	06f7db86-540c-401d-bbd9-0b88698c5f36	Breast	54	989C2DF5-5183-4DAA-A8DA-FC9AB18A437C	11821020-0E93-4479-85F8-306976DE6722	TCGA-BH-A0HX-01A-21D-A060-02	HG19_Broad_variant	TCGA-BH-A0HX	TCGA-BRCA	NA	s6126	Harvard Medical School	University of Pittsburgh	None	NO	T2	N1a	Infiltrating Ductal Carcinoma	Stage IIB	A060-02	TRUE
13722.58cfa830e4b0c9d6adf6be3a	58cfa830e4b0c9d6adf6be3a	TCGA-BJ-A18Z-01A-21D-A13U_120712_SN1222_0125_BD13TPACXX_s_1_rg.sorted.filtered.	WGS	TCGA-BJ-A18Z-01A-21D-A13U_120712_SN1222_0125_BD13TPACXX_s_1_rg.sorted	TCGA-BJ-A18Z-01A-21D-A13U_120712_SN1222_0125_BD13TPACXX_s_1_rg.sorted.bam	45.3	1.98	0.17	58cfa830e4b0c9d6adf6be3a	TCGA-BJ-A18Z-01A-21D-A13U_120712_SN1222_0125_BD13TPACXX_s_1_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-BJ-A18Z-01A	0D497FAF-2C1C-4173-A5FE-770CCA73323C	Primary Tumor	Illumina HiSeq	a740c90f-9cbc-4ff1-8cad-c78d4dbb92cf	Thyroid	58	19DEE039-9C98-4D4A-8BAF-EEA1B6DDA8EB	815C53C3-8ADD-4612-B93C-3ED4BFA530AA	TCGA-BJ-A18Z-01A-21D-A13U-02	HG19_Broad_variant	TCGA-BJ-A18Z	TCGA-THCA	NA	s12354	Harvard Medical School	University of Pittsburgh	United States	NO	T3	N1b	Thyroid Papillary Carcinoma - Classical/usual	Stage IVA	A13U-02	TRUE
13722.58cfa830e4b0c9d6adf6be3c	58cfa830e4b0c9d6adf6be3c	TCGA-BJ-A18Y-01A-11D-A13U_120706_SN1222_0122_AC0WPYACXX_s_1_rg.sorted.filtered.	WGS	TCGA-BJ-A18Y-01A-11D-A13U_120706_SN1222_0122_AC0WPYACXX_s_1_rg.sorted	TCGA-BJ-A18Y-01A-11D-A13U_120706_SN1222_0122_AC0WPYACXX_s_1_rg.sorted.bam	77.56	2	0.18	58cfa830e4b0c9d6adf6be3c	TCGA-BJ-A18Y-01A-11D-A13U_120706_SN1222_0122_AC0WPYACXX_s_1_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-BJ-A18Y-01A	ACB3B9DB-16E9-40F5-87A9-9DF9D4CEEE54	Primary Tumor	Illumina HiSeq	0074a697-0800-4872-9a48-48945f46d18d	Thyroid	29	5D1D84D0-9A03-4381-9CF1-E460B3617AAA	56D2A069-7969-40F1-A237-E4FE7E62C84C	TCGA-BJ-A18Y-01A-11D-A13U-02	HG19_Broad_variant	TCGA-BJ-A18Y	TCGA-THCA	NA	s12351	Harvard Medical School	University of Pittsburgh	United States	NO	T1b	N0	Thyroid Papillary Carcinoma - Classical/usual	Stage I	A13U-02	TRUE
13722.58cfa830e4b0c9d6adf6bdf4	58cfa830e4b0c9d6adf6bdf4	TCGA-AG-A014-01A-02D-A077_110504_SN590_0081_BB0BM5ABXX_s_6_rg.sorted.filtered.	WGS	TCGA-AG-A014-01A-02D-A077_110504_SN590_0081_BB0BM5ABXX_s_6_rg.sorted	TCGA-AG-A014-01A-02D-A077_110504_SN590_0081_BB0BM5ABXX_s_6_rg.sorted.bam	223.31	1.73	0.15	58cfa830e4b0c9d6adf6bdf4	TCGA-AG-A014-01A-02D-A077_110504_SN590_0081_BB0BM5ABXX_s_6_rg.sorted.bam	Alive	MALE	Not available	Not available	Rectum Adenocarcinoma	Aligned reads	TCGA-AG-A014-01A	51C37449-6A2E-4C3D-A7CC-06F901E1224F	Primary Tumor	Illumina HiSeq	b165eaa6-faee-4f3f-967e-55f2b4b0bba2	Colorectal	86	FBFA61FE-4FB7-4B2A-9BF0-33140FD41873	7771CB7E-1405-4B8E-86B5-0E06A0EB7FD1	TCGA-AG-A014-01A-02D-A077-02	HG18_Broad_variant	TCGA-AG-A014	TCGA-READ	NA	s2000	Harvard Medical School	Indivumed	Germany	NO	T2	N0	Rectal Adenocarcinoma	Stage I	A077-02	TRUE
13722.58cfa830e4b0c9d6adf6bdc0	58cfa830e4b0c9d6adf6bdc0	TCGA-BG-A186-01A-11D-A12F_120413_SN1120_0132_AD0T6RACXX_s_1_rg.sorted.filtered.	WGS	TCGA-BG-A186-01A-11D-A12F_120413_SN1120_0132_AD0T6RACXX_s_1_rg.sorted	TCGA-BG-A186-01A-11D-A12F_120413_SN1120_0132_AD0T6RACXX_s_1_rg.sorted.bam	79.77	1.93	0.17	58cfa830e4b0c9d6adf6bdc0	TCGA-BG-A186-01A-11D-A12F_120413_SN1120_0132_AD0T6RACXX_s_1_rg.sorted.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-BG-A186-01A	FE4DB898-3A9F-4DFF-ADCB-7B8C30137350	Primary Tumor	Illumina HiSeq	f65268ef-b937-4d49-922e-a5e3ebc0eab8	Uterus	61	B1645A83-57B7-4357-B977-63A5B6AEE39E	ECF410AD-B160-4F00-A165-38529FAE974B	TCGA-BG-A186-01A-11D-A12F-02	HG19_Broad_variant	TCGA-BG-A186	TCGA-UCEC	NA	s4792	Harvard Medical School	University of Pittsburgh	None	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A12F-02	TRUE
13722.58cfa830e4b0c9d6adf6bbc4	58cfa830e4b0c9d6adf6bbc4	TCGA-AG-A008-01A-01D-A077-02_110217_SN208_0190_B81CLKABXX_s_7.rg.sorted.filtered.	WGS	TCGA-AG-A008-01A-01D-A077-02_110217_SN208_0190_B81CLKABXX_s_7.rg.sorted	TCGA-AG-A008-01A-01D-A077-02_110217_SN208_0190_B81CLKABXX_s_7.rg.sorted.bam	174.93	1.72	0.15	58cfa830e4b0c9d6adf6bbc4	TCGA-AG-A008-01A-01D-A077-02_110217_SN208_0190_B81CLKABXX_s_7.rg.sorted.bam	Alive	FEMALE	Not available	Not available	Rectum Adenocarcinoma	Aligned reads	TCGA-AG-A008-01A	E7503A51-6647-4CC2-80DD-645D0DF4DB43	Primary Tumor	Illumina HiSeq	e31d4ba3-4d48-4e50-9932-05a2978a90df	Colorectal	50	AC02CD55-BC05-4329-8845-E09D088E3CB4	999D82E8-B92F-4397-A9F9-9AFBFD8A249C	TCGA-AG-A008-01A-01D-A077-02	HG18_Broad_variant	TCGA-AG-A008	TCGA-READ	NA	s1995	Harvard Medical School	Indivumed	Germany	NO	T2	N0	Rectal Mucinous Adenocarcinoma	Stage I	A077-02	TRUE
13722.58cfa830e4b0c9d6adf6be8d	58cfa830e4b0c9d6adf6be8d	TCGA-BK-A0CB-01A-32D-A101_120330_SN208_0280_AD0UKLACXX_s_1_rg.sorted.filtered.	WGS	TCGA-BK-A0CB-01A-32D-A101_120330_SN208_0280_AD0UKLACXX_s_1_rg.sorted	TCGA-BK-A0CB-01A-32D-A101_120330_SN208_0280_AD0UKLACXX_s_1_rg.sorted.bam	79.7	1.9	0.16	58cfa830e4b0c9d6adf6be8d	TCGA-BK-A0CB-01A-32D-A101_120330_SN208_0280_AD0UKLACXX_s_1_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-BK-A0CB-01A	59E9029A-8DDD-4447-B35A-72BC39F82A30	Primary Tumor	Illumina HiSeq	2c466122-c49e-4866-b9d4-faf31dde999c	Uterus	60	7678C70D-A298-4472-89A0-427AF1E93D28	F186159C-DCE6-467C-AAAF-BB08FBAE6827	TCGA-BK-A0CB-01A-32D-A101-02	HG19_Broad_variant	TCGA-BK-A0CB	TCGA-UCEC	NA	s5006	Harvard Medical School	Christiana Healthcare	None	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A101-02	TRUE
13722.58cfa830e4b0c9d6adf6bee6	58cfa830e4b0c9d6adf6bee6	TCGA-AX-A0IU-01A-11D-A101_120330_SN208_0280_AD0UKLACXX_s_2_rg.sorted.filtered.	WGS	TCGA-AX-A0IU-01A-11D-A101_120330_SN208_0280_AD0UKLACXX_s_2_rg.sorted	TCGA-AX-A0IU-01A-11D-A101_120330_SN208_0280_AD0UKLACXX_s_2_rg.sorted.bam	117.75	2.28	0.16	58cfa830e4b0c9d6adf6bee6	TCGA-AX-A0IU-01A-11D-A101_120330_SN208_0280_AD0UKLACXX_s_2_rg.sorted.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-AX-A0IU-01A	7E64EA6C-A3DB-48EB-91BE-131361510A92	Primary Tumor	Illumina HiSeq	927c6e80-e2e3-4198-98a4-77a79159fb8a	Uterus	79	DC4B3695-CE62-48D5-9F1D-7DD70D049C97	24746F36-88BC-44B0-955A-55A2CC98E17C	TCGA-AX-A0IU-01A-11D-A101-02	HG19_Broad_variant	TCGA-AX-A0IU	TCGA-UCEC	NA	s4999	Harvard Medical School	Gynecologic Oncology Group	None	NO	Not available	Not available	Serous endometrial adenocarcinoma	Not available	A101-02	TRUE
13722.58cfa830e4b0c9d6adf6bec0	58cfa830e4b0c9d6adf6bec0	TCGA-AR-A0TU-01A-31D-A106_130719_SN1120_0270_AC2CVRACXX_s_5_rg.sorted.filtered.	WGS	TCGA-AR-A0TU-01A-31D-A106_130719_SN1120_0270_AC2CVRACXX_s_5_rg.sorted	TCGA-AR-A0TU-01A-31D-A106_130719_SN1120_0270_AC2CVRACXX_s_5_rg.sorted.bam	73.2	1.9	0.15	58cfa830e4b0c9d6adf6bec0	TCGA-AR-A0TU-01A-31D-A106_130719_SN1120_0270_AC2CVRACXX_s_5_rg.sorted.bam	Alive	FEMALE	Not available	Not available	Breast Invasive Carcinoma	Aligned reads	TCGA-AR-A0TU-01A	DFE6DB17-CF45-488E-BD3C-B8433D7343CA	Primary Tumor	Illumina HiSeq	fb34c291-904a-4613-80cd-9788ff446157	Breast	35	1E629A73-68CD-449D-A1C0-B856BE4143E6	E00819A1-4A65-4289-9DDE-0800FC6C69F6	TCGA-AR-A0TU-01A-31D-A106-02	HG19_Broad_variant	TCGA-AR-A0TU	TCGA-BRCA	NA	s6630	Harvard Medical School	Mayo	None	NO	T2	N0	Infiltrating Ductal Carcinoma	Stage IIA	A106-02	FALSE
13722.58cfa830e4b0c9d6adf6bf83	58cfa830e4b0c9d6adf6bf83	TCGA-BR-6453-01A-11D-1798_130115_SN1222_0169_BD1K2PACXX_s_4_rg.sorted.filtered.	WGS	TCGA-BR-6453-01A-11D-1798_130115_SN1222_0169_BD1K2PACXX_s_4_rg.sorted	TCGA-BR-6453-01A-11D-1798_130115_SN1222_0169_BD1K2PACXX_s_4_rg.sorted.bam	93.7	1.9	0.15	58cfa830e4b0c9d6adf6bf83	TCGA-BR-6453-01A-11D-1798_130115_SN1222_0169_BD1K2PACXX_s_4_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-BR-6453-01A	AE633E83-303F-4A90-AC3B-34458FD9BEEF	Primary Tumor	Illumina HiSeq	e92977c9-6880-4f84-842a-9152e558d0b1	Stomach	54	A8F3B148-5929-4025-81A1-6595D49F2279	EE3446DC-7278-47AF-8F65-F63A1D423644	TCGA-BR-6453-01A-11D-1798-02	HG19_Broad_variant	TCGA-BR-6453	TCGA-STAD	NA	s15305	Harvard Medical School	Asterand	Russia	NO	T2	N1	Stomach  Adenocarcinoma  Not Otherwise Specified (NOS)	Stage IIA	1798-02	TRUE
13722.58cfa830e4b0c9d6adf6bf30	58cfa830e4b0c9d6adf6bf30	TCGA-BR-4191-01A-02D-1128_120805_SN1222_0143_BD172BACXX_s_3_rg.sorted.filtered.	WGS	TCGA-BR-4191-01A-02D-1128_120805_SN1222_0143_BD172BACXX_s_3_rg.sorted	TCGA-BR-4191-01A-02D-1128_120805_SN1222_0143_BD172BACXX_s_3_rg.sorted.bam	266.9	1.9	0.15	58cfa830e4b0c9d6adf6bf30	TCGA-BR-4191-01A-02D-1128_120805_SN1222_0143_BD172BACXX_s_3_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-BR-4191-01A	74F859CF-6DF5-4E96-AE6B-CFAAB691D5FD	Primary Tumor	Illumina HiSeq	d71fa3ea-a7fb-40af-a7b9-64ceca39e135	Stomach	72	E5A1A598-5896-46F9-8DCA-BA19AC138D14	125C563B-A1CE-4FFC-8D8D-19C7CA2E1049	TCGA-BR-4191-01A-02D-1128-02	HG19_Broad_variant	TCGA-BR-4191	TCGA-STAD	NA	s14608	Harvard Medical School	Asterand	Russia	NO	TX	N1	Stomach  Adenocarcinoma  Not Otherwise Specified (NOS)	Not available	1128-02	TRUE
13722.58cfa830e4b0c9d6adf6bfa4	58cfa830e4b0c9d6adf6bfa4	TCGA-BR-6457-01A-21D-1798_130116_SN208_0448_AC1J58ACXX_s_3_rg.sorted.filtered.	WGS	TCGA-BR-6457-01A-21D-1798_130116_SN208_0448_AC1J58ACXX_s_3_rg.sorted	TCGA-BR-6457-01A-21D-1798_130116_SN208_0448_AC1J58ACXX_s_3_rg.sorted.bam	77.4	1.9	0.15	58cfa830e4b0c9d6adf6bfa4	TCGA-BR-6457-01A-21D-1798_130116_SN208_0448_AC1J58ACXX_s_3_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-BR-6457-01A	05CE16D4-A999-491A-91AD-9449A57228FF	Primary Tumor	Illumina HiSeq	695f7145-7735-48f7-98e8-99b86bb936f4	Stomach	69	BADB9AE0-9C44-41D4-848B-EE03B6FCA503	85EEEBBE-BDBB-4FE7-8CCD-401E818EEB29	TCGA-BR-6457-01A-21D-1798-02	HG19_Broad_variant	TCGA-BR-6457	TCGA-STAD	NA	s14618	Harvard Medical School	Asterand	Ukraine	NO	T3	N0	Stomach  Adenocarcinoma  Not Otherwise Specified (NOS)	Stage IIA	1798-02	TRUE
13722.58cfa830e4b0c9d6adf6bfa9	58cfa830e4b0c9d6adf6bfa9	TCGA-BR-6456-01A-11D-1798_130116_SN208_0448_AC1J58ACXX_s_1_rg.sorted.filtered.	WGS	TCGA-BR-6456-01A-11D-1798_130116_SN208_0448_AC1J58ACXX_s_1_rg.sorted	TCGA-BR-6456-01A-11D-1798_130116_SN208_0448_AC1J58ACXX_s_1_rg.sorted.bam	282.7	1.9	0.15	58cfa830e4b0c9d6adf6bfa9	TCGA-BR-6456-01A-11D-1798_130116_SN208_0448_AC1J58ACXX_s_1_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-BR-6456-01A	1CA3C5E0-32B0-4467-8EC0-CA212E35D2B3	Primary Tumor	Illumina HiSeq	a772744a-8f77-4f03-adaf-cbd5db4ba399	Stomach	74	53369A25-3BC4-48CB-9004-DA3507C4D478	B2D5157F-5D0A-451C-8E78-AFFFC67B2F68	TCGA-BR-6456-01A-11D-1798-02	HG19_Broad_variant	TCGA-BR-6456	TCGA-STAD	NA	s14399	Harvard Medical School	Asterand	Russia	NO	T3	N1	Stomach  Adenocarcinoma  Not Otherwise Specified (NOS)	Stage IIB	1798-02	TRUE
13722.58cfa830e4b0c9d6adf6bf74	58cfa830e4b0c9d6adf6bf74	TCGA-AP-A0LD-01A-11D-A043_120330_SN1120_0128_AC0L52ACXX_s_6_rg.sorted.filtered.	WGS	TCGA-AP-A0LD-01A-11D-A043_120330_SN1120_0128_AC0L52ACXX_s_6_rg.sorted	TCGA-AP-A0LD-01A-11D-A043_120330_SN1120_0128_AC0L52ACXX_s_6_rg.sorted.bam	84.77	1.86	0.16	58cfa830e4b0c9d6adf6bf74	TCGA-AP-A0LD-01A-11D-A043_120330_SN1120_0128_AC0L52ACXX_s_6_rg.sorted.bam	Alive	FEMALE	WHITE	Not available	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-AP-A0LD-01A	1200C8B7-A058-4C01-BBE2-04EC09A65245	Primary Tumor	Illumina HiSeq	aa90984a-1483-43a2-8b20-f1654e3f601e	Uterus	63	649DADDA-5823-4B0D-B5A2-49F501ADC029	3D587F43-D9C5-4E3B-B245-60BB0AE92808	TCGA-AP-A0LD-01A-11D-A043-02	HG19_Broad_variant	TCGA-AP-A0LD	TCGA-UCEC	NA	s5199	Harvard Medical School	MSKCC	None	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A043-02	TRUE
13722.58cfa82fe4b0c9d6adf6b700	58cfa82fe4b0c9d6adf6b700	TCGA-64-5775-01A-01D-1623_110824_SN208_0222_BB0164ACXX_s_1_rg.sorted.filtered.	WGS	TCGA-64-5775-01A-01D-1623_110824_SN208_0222_BB0164ACXX_s_1_rg.sorted	TCGA-64-5775-01A-01D-1623_110824_SN208_0222_BB0164ACXX_s_1_rg.sorted.bam	360.7	1.9	0.14	58cfa82fe4b0c9d6adf6b700	TCGA-64-5775-01A-01D-1623_110824_SN208_0222_BB0164ACXX_s_1_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-64-5775-01A	C8544FB3-B26E-4672-BB81-A271DB724B04	Primary Tumor	Illumina HiSeq	af9f3482-e78b-4fe4-ac01-64f69b84d78d	Lung	71	5449BCED-1356-4DE5-9352-349725656C5C	11AEF70D-D22B-4936-BD8C-863BDBD4940E	TCGA-64-5775-01A-01D-1623-02	HG19_Broad_variant	TCGA-64-5775	TCGA-LUAD	62	s10664	Harvard Medical School	Fox Chase	United States	NO	T4	N0	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage IIIA	1623-02	TRUE
13722.58cfa830e4b0c9d6adf6bfc0	58cfa830e4b0c9d6adf6bfc0	TCGA-B5-A0JS-01A-11D-A101_120330_SN208_0280_AD0UKLACXX_s_4_rg.sorted.filtered.	WGS	TCGA-B5-A0JS-01A-11D-A101_120330_SN208_0280_AD0UKLACXX_s_4_rg.sorted	TCGA-B5-A0JS-01A-11D-A101_120330_SN208_0280_AD0UKLACXX_s_4_rg.sorted.bam	61.49	1.87	0.17	58cfa830e4b0c9d6adf6bfc0	TCGA-B5-A0JS-01A-11D-A101_120330_SN208_0280_AD0UKLACXX_s_4_rg.sorted.bam	Alive	FEMALE	WHITE	Not available	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-B5-A0JS-01A	0DA7BBD4-ED8D-474B-B494-CB93C5FA811E	Primary Tumor	Illumina HiSeq	06607d3e-b9f0-4332-aee8-7001d26e7d12	Uterus	54	D0B88B1C-150D-4ABC-9F9E-8C51CB208EFA	D2DD7ED4-03F6-463E-94BD-6CF98D80E8FD	TCGA-B5-A0JS-01A-11D-A101-02	HG19_Broad_variant	TCGA-B5-A0JS	TCGA-UCEC	NA	s5208	Harvard Medical School	Duke	United States	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A101-02	TRUE
13722.58cfa830e4b0c9d6adf6bffc	58cfa830e4b0c9d6adf6bffc	TCGA-AG-3890-01A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.filtered.	WGS	TCGA-AG-3890-01A-01D-1115-02_IlluminaHiSeq-DNASeq_whole	TCGA-AG-3890-01A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.bam	614.89	1.9	0.15	58cfa830e4b0c9d6adf6bffc	TCGA-AG-3890-01A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.bam	Alive	MALE	Not available	Not available	Rectum Adenocarcinoma	Aligned reads	TCGA-AG-3890-01A	E2D395F8-BF13-4FE4-8031-683B0EEDD875	Primary Tumor	Illumina HiSeq	b4bf7544-0816-4940-aa9f-d770f09f35f3	Colorectal	62	DB70A6DD-DE09-4ED7-916C-708B21734500	12064771-AE96-441D-BE8B-EE49B63F1E4E	TCGA-AG-3890-01A-01D-1115-02	HG18	TCGA-AG-3890	TCGA-READ	NA	s2145	Harvard Medical School	Indivumed	Germany	NO	T2	N0	Rectal Adenocarcinoma	Stage I	1115-02	TRUE
13722.58cfa830e4b0c9d6adf6c022	58cfa830e4b0c9d6adf6c022	TCGA-BJ-A0ZE-01A-11D-A10R_120617_SN1222_0117_BD1414ACXX_s_4_rg.sorted.filtered.	WGS	TCGA-BJ-A0ZE-01A-11D-A10R_120617_SN1222_0117_BD1414ACXX_s_4_rg.sorted	TCGA-BJ-A0ZE-01A-11D-A10R_120617_SN1222_0117_BD1414ACXX_s_4_rg.sorted.bam	36.9	2.03	0.15	58cfa830e4b0c9d6adf6c022	TCGA-BJ-A0ZE-01A-11D-A10R_120617_SN1222_0117_BD1414ACXX_s_4_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-BJ-A0ZE-01A	AB8C9101-ADEB-4C43-A8BB-B089EBD711F6	Primary Tumor	Illumina HiSeq	b215d9c2-6a64-45cf-8e4b-0e2b87207119	Thyroid	63	695C5627-F442-4A86-9702-EF35DEFD8C8C	ED0B1C86-A516-422F-92C4-7C535E709989	TCGA-BJ-A0ZE-01A-11D-A10R-02	HG19_Broad_variant	TCGA-BJ-A0ZE	TCGA-THCA	NA	s12231	Harvard Medical School	University of Pittsburgh	United States	NO	T3	N0	Thyroid Papillary Carcinoma - Classical/usual	Stage III	A10R-02	TRUE
13722.58cfa830e4b0c9d6adf6c12f	58cfa830e4b0c9d6adf6c12f	TCGA-BG-A0MU-01A-11D-A101_120403_SN1222_0093_AC0L7VACXX_s_1_rg.sorted.filtered.	WGS	TCGA-BG-A0MU-01A-11D-A101_120403_SN1222_0093_AC0L7VACXX_s_1_rg.sorted	TCGA-BG-A0MU-01A-11D-A101_120403_SN1222_0093_AC0L7VACXX_s_1_rg.sorted.bam	74.26	2.08	0.16	58cfa830e4b0c9d6adf6c12f	TCGA-BG-A0MU-01A-11D-A101_120403_SN1222_0093_AC0L7VACXX_s_1_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-BG-A0MU-01A	A7329910-B1C7-4A18-B28E-8FAD79121339	Primary Tumor	Illumina HiSeq	c676fa46-db3a-402d-804d-9717141fdae6	Uterus	78	F0AF3F30-3D64-4BD8-9A8F-7FF7AB9BB7B0	0BB10C9F-C337-4E2E-A661-9CE12C8BEB35	TCGA-BG-A0MU-01A-11D-A101-02	HG19_Broad_variant	TCGA-BG-A0MU	TCGA-UCEC	NA	s5393	Harvard Medical School	University of Pittsburgh	None	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A101-02	TRUE
13722.58cfa830e4b0c9d6adf6bff8	58cfa830e4b0c9d6adf6bff8	TCGA-AG-3887-01A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.filtered.	WGS	TCGA-AG-3887-01A-01D-1115-02_IlluminaHiSeq-DNASeq_whole	TCGA-AG-3887-01A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.bam	745.89	1.9	0.15	58cfa830e4b0c9d6adf6bff8	TCGA-AG-3887-01A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.bam	Alive	MALE	Not available	Not available	Rectum Adenocarcinoma	Aligned reads	TCGA-AG-3887-01A	8C7CCDB0-7653-4A8D-86B6-DE39AFC40765	Primary Tumor	Illumina HiSeq	0041b462-7ad7-4a4d-8fea-1942532341ed	Colorectal	68	7F10DD13-E2C3-4F27-8673-FF5CD1632B2B	5986038D-2696-4F89-A5F5-C8173BA7D70F	TCGA-AG-3887-01A-01D-1115-02	HG18	TCGA-AG-3887	TCGA-READ	NA	s2136	Harvard Medical School	Indivumed	Germany	NO	T3	N0	Rectal Mucinous Adenocarcinoma	Stage IIA	1115-02	TRUE
13722.58cfa830e4b0c9d6adf6c164	58cfa830e4b0c9d6adf6c164	TCGA-BA-5151-01A-01D-1431_120423_SN590_0154_AC0JBHACXX_s_3_rg.sorted.filtered.	WGS	TCGA-BA-5151-01A-01D-1431_120423_SN590_0154_AC0JBHACXX_s_3_rg.sorted	TCGA-BA-5151-01A-01D-1431_120423_SN590_0154_AC0JBHACXX_s_3_rg.sorted.bam	227.7	1.9	0.15	58cfa830e4b0c9d6adf6c164	TCGA-BA-5151-01A-01D-1431_120423_SN590_0154_AC0JBHACXX_s_3_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-BA-5151-01A	A55FB87D-F606-48A5-82F5-09EACBACF41B	Primary Tumor	Illumina HiSeq	d1067ce4-863a-49f4-9061-d2e677695382	Head and Neck	72	63384A6A-9686-44EE-8C8F-22923968C9DE	5B29B8E2-23E6-4E6E-815C-B8D0EF534B14	TCGA-BA-5151-01A-01D-1431-02	HG19_Broad_variant	TCGA-BA-5151	TCGA-HNSC	NA	s15488	Harvard Medical School	UNC	None	NO	T4a	N0	Head and Neck Squamous Cell Carcinoma	Stage IVA	1431-02	TRUE
13722.58cfa830e4b0c9d6adf6c1cc	58cfa830e4b0c9d6adf6c1cc	TCGA-BF-A1PU-01A-11D-A18Z_120517_SN208_0300_BC0VYMACXX_s_5_rg.sorted.filtered.	WGS	TCGA-BF-A1PU-01A-11D-A18Z_120517_SN208_0300_BC0VYMACXX_s_5_rg.sorted	TCGA-BF-A1PU-01A-11D-A18Z_120517_SN208_0300_BC0VYMACXX_s_5_rg.sorted.bam	55.01	NA	0.18	58cfa830e4b0c9d6adf6c1cc	TCGA-BF-A1PU-01A-11D-A18Z_120517_SN208_0300_BC0VYMACXX_s_5_rg.sorted.bam	Alive	FEMALE	WHITE	Not available	Skin Cutaneous Melanoma	Aligned reads	TCGA-BF-A1PU-01A	3DD5A206-D7F3-42F1-B9CC-4B31C76D495D	Primary Tumor	Illumina HiSeq	26c2ab51-9411-4718-8733-1c3c5ba19602	Skin	46	D9C8128A-5990-43C8-AC08-CBDF035213D6	AAC0230D-759F-4B2E-9904-3F7822E6B13C	TCGA-BF-A1PU-01A-11D-A18Z-02	HG19_Broad_variant	TCGA-BF-A1PU	TCGA-SKCM	NA	s7667	Harvard Medical School	Cureline	Russia	NO	T4b	N0	Not available	Stage IIC	A18Z-02	TRUE
13722.58cfa830e4b0c9d6adf6c21a	58cfa830e4b0c9d6adf6c21a	TCGA-BA-5153-01A-01D-1431_120423_SN590_0154_AC0JBHACXX_s_5_rg.sorted.filtered.	WGS	TCGA-BA-5153-01A-01D-1431_120423_SN590_0154_AC0JBHACXX_s_5_rg.sorted	TCGA-BA-5153-01A-01D-1431_120423_SN590_0154_AC0JBHACXX_s_5_rg.sorted.bam	422.7	1.9	0.15	58cfa830e4b0c9d6adf6c21a	TCGA-BA-5153-01A-01D-1431_120423_SN590_0154_AC0JBHACXX_s_5_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-BA-5153-01A	B3631718-9E0A-454C-BEE1-8F36EBC509D8	Primary Tumor	Illumina HiSeq	3bd56918-8f2b-4486-86ea-e479c2cab413	Head and Neck	51	2DC7070A-9C70-4BB1-9634-8C934BB9C8D1	F14D0AA8-E7BB-4E0E-B887-DA7B6FA0BC86	TCGA-BA-5153-01A-01D-1431-02	HG19_Broad_variant	TCGA-BA-5153	TCGA-HNSC	1762	s16316	Harvard Medical School	UNC	None	NO	T2	NX	Head and Neck Squamous Cell Carcinoma	Not available	1431-02	TRUE
13722.58cfa831e4b0c9d6adf6c36c	58cfa831e4b0c9d6adf6c36c	TCGA-CD-5803-01A-11D-1598_121025_SN590_0187_BC191FACXX_s_8_rg.sorted.filtered.	WGS	TCGA-CD-5803-01A-11D-1598_121025_SN590_0187_BC191FACXX_s_8_rg.sorted	TCGA-CD-5803-01A-11D-1598_121025_SN590_0187_BC191FACXX_s_8_rg.sorted.bam	193.3	1.9	0.14	58cfa831e4b0c9d6adf6c36c	TCGA-CD-5803-01A-11D-1598_121025_SN590_0187_BC191FACXX_s_8_rg.sorted.bam	Alive	FEMALE	ASIAN	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-CD-5803-01A	33901C6F-9180-4A19-866C-F4AC6BEC76DA	Primary Tumor	Illumina HiSeq	1002025d-03b9-46ab-988a-576f59957cac	Stomach	78	EB71264D-C896-4910-BF46-D6F129B83941	EABD49CE-0F0C-443D-9BF4-0ADD2C2532B2	TCGA-CD-5803-01A-11D-1598-02	HG19_Broad_variant	TCGA-CD-5803	TCGA-STAD	NA	s15118	Harvard Medical School	ILSbio	Vietnam	NO	T3	N0	Stomach  Adenocarcinoma  Not Otherwise Specified (NOS)	Stage II	1598-02	TRUE
13722.58cfa830e4b0c9d6adf6c2ca	58cfa830e4b0c9d6adf6c2ca	TCGA-BG-A0RY-01A-11D-A101_120403_SN1222_0093_AC0L7VACXX_s_7_rg.sorted.filtered.	WGS	TCGA-BG-A0RY-01A-11D-A101_120403_SN1222_0093_AC0L7VACXX_s_7_rg.sorted	TCGA-BG-A0RY-01A-11D-A101_120403_SN1222_0093_AC0L7VACXX_s_7_rg.sorted.bam	73.32	1.95	0.16	58cfa830e4b0c9d6adf6c2ca	TCGA-BG-A0RY-01A-11D-A101_120403_SN1222_0093_AC0L7VACXX_s_7_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-BG-A0RY-01A	F299AD43-BB16-46CE-9617-48CC6C6F29E7	Primary Tumor	Illumina HiSeq	5464e1b6-9efc-49a0-bd5b-4fcd152a7718	Uterus	68	260692E1-9B2C-4F8B-952D-1B95C042E659	8DB9ED84-C708-4075-B93D-CC58E84E6D99	TCGA-BG-A0RY-01A-11D-A101-02	HG19_Broad_variant	TCGA-BG-A0RY	TCGA-UCEC	NA	s4258	Harvard Medical School	University of Pittsburgh	None	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A101-02	TRUE
13722.58cfa830e4b0c9d6adf6c03c	58cfa830e4b0c9d6adf6c03c	TCGA-AG-4001-01A-02D-1115-02_IlluminaHiSeq-DNASeq_whole.filtered.	WGS	TCGA-AG-4001-01A-02D-1115-02_IlluminaHiSeq-DNASeq_whole	TCGA-AG-4001-01A-02D-1115-02_IlluminaHiSeq-DNASeq_whole.bam	420.89	1.9	0.15	58cfa830e4b0c9d6adf6c03c	TCGA-AG-4001-01A-02D-1115-02_IlluminaHiSeq-DNASeq_whole.bam	Alive	FEMALE	Not available	Not available	Rectum Adenocarcinoma	Aligned reads	TCGA-AG-4001-01A	D846228F-67AF-4B3B-9796-DBC263C2054C	Primary Tumor	Illumina HiSeq	53c6af7e-4876-4559-b1b1-d7dc58c2b702	Colorectal	74	6160C363-B050-4B3B-9909-4EBC33ED3A1A	05B6BA78-DDE8-4E68-9622-7B618A083CC8	TCGA-AG-4001-01A-02D-1115-02	HG18	TCGA-AG-4001	TCGA-READ	NA	s2164	Harvard Medical School	Indivumed	Germany	NO	T3	N0	Rectal Adenocarcinoma	Stage IIA	1115-02	TRUE
13722.58cfa831e4b0c9d6adf6c3d4	58cfa831e4b0c9d6adf6c3d4	TCGA-C5-A3HF-01A-11D-A20X_140117_SN590_0246_BC37BDACXX_s_1_rg.sorted.filtered.	WGS	TCGA-C5-A3HF-01A-11D-A20X_140117_SN590_0246_BC37BDACXX_s_1_rg.sorted	TCGA-C5-A3HF-01A-11D-A20X_140117_SN590_0246_BC37BDACXX_s_1_rg.sorted.bam	62.13	NA	0.16	58cfa831e4b0c9d6adf6c3d4	TCGA-C5-A3HF-01A-11D-A20X_140117_SN590_0246_BC37BDACXX_s_1_rg.sorted.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-C5-A3HF-01A	085DF27C-9BC2-425A-9A49-547D692EA028	Primary Tumor	Illumina HiSeq	4b4bea19-4db4-4996-8037-4129a4494419	Cervix	24	79C43439-BC01-4033-85FA-3191A79277C6	0C08A31F-1414-42E3-986A-00BAF9C926F8	TCGA-C5-A3HF-01A-11D-A20X-26	HG19_Broad_variant	TCGA-C5-A3HF	TCGA-CESC	543	s1358	MD Anderson - Institute for Applied Cancer Science	Medical College of Wisconsin	United States	NO	Not available	Not available	Mucinous Adenocarcinoma of Endocervical Type	Not available	A20X-26	TRUE
13722.58cfa831e4b0c9d6adf6c4d2	58cfa831e4b0c9d6adf6c4d2	TCGA-CF-A3MG-01A-11D-A210_120914_SN590_0180_BC19KDACXX_s_7_rg.sorted.filtered.	WGS	TCGA-CF-A3MG-01A-11D-A210_120914_SN590_0180_BC19KDACXX_s_7_rg.sorted	TCGA-CF-A3MG-01A-11D-A210_120914_SN590_0180_BC19KDACXX_s_7_rg.sorted.bam	66.73	NA	0.14	58cfa831e4b0c9d6adf6c4d2	TCGA-CF-A3MG-01A-11D-A210_120914_SN590_0180_BC19KDACXX_s_7_rg.sorted.bam	Alive	MALE	ASIAN	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-CF-A3MG-01A	39EFA06A-FFE5-40B3-8F8A-A2D7071BC9E3	Primary Tumor	Illumina HiSeq	695ed631-423c-4381-ae8f-4a70fd6266b9	Bladder	48	1ACF91C8-4971-4893-AC27-64EA4A4C3023	99993BCD-8555-407A-A918-3F51D57BA720	TCGA-CF-A3MG-01A-11D-A210-26	HG19_Broad_variant	TCGA-CF-A3MG	TCGA-BLCA	NA	s3095	MD Anderson - Institute for Applied Cancer Science	ILSbio	Vietnam	NO	T2	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage II	A210-26	TRUE
13722.58cfa831e4b0c9d6adf6c560	58cfa831e4b0c9d6adf6c560	TCGA-CH-5767-01A-11D-1784_130329_SN590_0221_BD1WHDACXX_s_6_rg.sorted.filtered.	WGS	TCGA-CH-5767-01A-11D-1784_130329_SN590_0221_BD1WHDACXX_s_6_rg.sorted	TCGA-CH-5767-01A-11D-1784_130329_SN590_0221_BD1WHDACXX_s_6_rg.sorted.bam	200.4	1.9	0.16	58cfa831e4b0c9d6adf6c560	TCGA-CH-5767-01A-11D-1784_130329_SN590_0221_BD1WHDACXX_s_6_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-CH-5767-01A	8DC53431-44AB-485E-B4E6-C3D06509506D	Primary Tumor	Illumina HiSeq	4ec6dbff-5194-4938-949c-d5ae0ec6a882	Prostate	66	A87E6352-C469-484D-87FC-FABDBA237D01	02D28407-4AE4-4DA6-ABB5-6D6A4BB3D8D3	TCGA-CH-5767-01A-11D-1784-02	HG19_Broad_variant	TCGA-CH-5767	TCGA-PRAD	NA	s4129	Harvard Medical School	Indivumed	Germany	NO	T2c	N0	Prostate Adenocarcinoma Acinar Type	Not available	1784-02	TRUE
13722.58cfa831e4b0c9d6adf6c4b4	58cfa831e4b0c9d6adf6c4b4	TCGA-CE-A13K-01A-11D-A10R_120616_SN1120_0154_BD142VACXX_s_1_rg.sorted.filtered.	WGS	TCGA-CE-A13K-01A-11D-A10R_120616_SN1120_0154_BD142VACXX_s_1_rg.sorted	TCGA-CE-A13K-01A-11D-A10R_120616_SN1120_0154_BD142VACXX_s_1_rg.sorted.bam	88.59	2.02	0.17	58cfa831e4b0c9d6adf6c4b4	TCGA-CE-A13K-01A-11D-A10R_120616_SN1120_0154_BD142VACXX_s_1_rg.sorted.bam	Alive	FEMALE	ASIAN	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-CE-A13K-01A	A1227FFA-2733-4A43-BA82-834755453870	Primary Tumor	Illumina HiSeq	7f979498-38e3-4b28-b84a-c3eede43fa06	Thyroid	30	DAF2A444-AB89-48D4-9DA7-888AC3099AB7	7CEF35A1-E530-47C9-9A86-3EA2C970FCD3	TCGA-CE-A13K-01A-11D-A10R-02	HG19_Broad_variant	TCGA-CE-A13K	TCGA-THCA	NA	s12632	Harvard Medical School	ILSbio	Vietnam	NO	T3	N1	Thyroid Papillary Carcinoma - Classical/usual	Stage I	A10R-02	TRUE
13722.58cfa831e4b0c9d6adf6c4e9	58cfa831e4b0c9d6adf6c4e9	TCGA-AZ-4682-01B-01D-1405-02_IlluminaHiSeq-DNASeq_whole.filtered.	WGS	TCGA-AZ-4682-01B-01D-1405-02_IlluminaHiSeq-DNASeq_whole	TCGA-AZ-4682-01B-01D-1405-02_IlluminaHiSeq-DNASeq_whole.bam	752.02	1.9	0.15	58cfa831e4b0c9d6adf6c4e9	TCGA-AZ-4682-01B-01D-1405-02_IlluminaHiSeq-DNASeq_whole.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Colon Adenocarcinoma	Aligned reads	TCGA-AZ-4682-01B	E588714A-7753-4C3C-ABB6-EAF1AAB53AB3	Primary Tumor	Illumina HiSeq	fb93cdea-2ff1-454c-9fac-523a4bb11d62	Colorectal	61	A2412F6F-324E-4EF2-BD46-0D33596A033B	2007180A-F4AC-4300-A560-903ACEAC4F71	TCGA-AZ-4682-01B-01D-1405-02	HG18	TCGA-AZ-4682	TCGA-COAD	680	s13390	Harvard Medical School	University of Pittsburgh	None	NO	T3	N0	Colon Adenocarcinoma	Stage IVA	1405-02	TRUE
13722.58cfa831e4b0c9d6adf6c5e4	58cfa831e4b0c9d6adf6c5e4	TCGA-CG-4437-01A-01D-1798_130116_SN208_0449_BD1RNWACXX_s_4_rg.sorted.filtered.	WGS	TCGA-CG-4437-01A-01D-1798_130116_SN208_0449_BD1RNWACXX_s_4_rg.sorted	TCGA-CG-4437-01A-01D-1798_130116_SN208_0449_BD1RNWACXX_s_4_rg.sorted.bam	215.4	1.9	0.14	58cfa831e4b0c9d6adf6c5e4	TCGA-CG-4437-01A-01D-1798_130116_SN208_0449_BD1RNWACXX_s_4_rg.sorted.bam	Alive	MALE	Not available	Not available	Stomach Adenocarcinoma	Aligned reads	TCGA-CG-4437-01A	6244E506-D163-4D34-8FEC-6158191679CB	Primary Tumor	Illumina HiSeq	ff02c427-3a7b-4e29-9ddc-0b8034807ad6	Stomach	83	A882F6C0-D12D-4D49-9A2A-3850EA736C37	B6D1C576-6AB8-4759-B1B0-6E18DC162962	TCGA-CG-4437-01A-01D-1798-02	HG19_Broad_variant	TCGA-CG-4437	TCGA-STAD	NA	s14553	Harvard Medical School	Indivumed	Germany	NO	T2	N1	Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS)	Stage II	1798-02	TRUE
13722.58cfa831e4b0c9d6adf6c62c	58cfa831e4b0c9d6adf6c62c	TCGA-CG-4301-01A-01D-A326_131002_SN208_0497_AC2CLVACXX_s_1_rg.sorted.filtered.	WGS	TCGA-CG-4301-01A-01D-A326_131002_SN208_0497_AC2CLVACXX_s_1_rg.sorted	TCGA-CG-4301-01A-01D-A326_131002_SN208_0497_AC2CLVACXX_s_1_rg.sorted.bam	84.9	1.9	0.15	58cfa831e4b0c9d6adf6c62c	TCGA-CG-4301-01A-01D-A326_131002_SN208_0497_AC2CLVACXX_s_1_rg.sorted.bam	Alive	FEMALE	Not available	Not available	Stomach Adenocarcinoma	Aligned reads	TCGA-CG-4301-01A	7E13FE2A-3D6E-487F-900D-F5891D986AA2	Primary Tumor	Illumina HiSeq	7d1cd13f-5ac5-457f-8e7b-89cabb2463c6	Stomach	75	F8CCC777-65A2-41FA-95AC-AB33C3E9AD9A	55F814EC-D386-4277-8CF1-245313CF373D	TCGA-CG-4301-01A-01D-A326-26	HG19_Broad_variant	TCGA-CG-4301	TCGA-STAD	NA	s15456	MD Anderson - Institute for Applied Cancer Science	Indivumed	Germany	NO	T4	N1	Stomach  Adenocarcinoma  Not Otherwise Specified (NOS)	Stage IV	A326-26	TRUE
13722.58cfa831e4b0c9d6adf6c604	58cfa831e4b0c9d6adf6c604	TCGA-CQ-5330-01A-01D-1681_120425_SN1222_0100_BD0T1VACXX_s_4_rg.sorted.filtered.	WGS	TCGA-CQ-5330-01A-01D-1681_120425_SN1222_0100_BD0T1VACXX_s_4_rg.sorted	TCGA-CQ-5330-01A-01D-1681_120425_SN1222_0100_BD0T1VACXX_s_4_rg.sorted.bam	258	1.9	0.14	58cfa831e4b0c9d6adf6c604	TCGA-CQ-5330-01A-01D-1681_120425_SN1222_0100_BD0T1VACXX_s_4_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CQ-5330-01A	9FFA79FA-D2D8-48E1-8FD6-4B020ECF357C	Primary Tumor	Illumina HiSeq	a37f15ec-e0df-4bcd-8275-88312d0a1566	Head and Neck	69	A70301B0-F66D-49B7-B420-C1F56B90002D	AB6DC814-ECE0-497C-BC58-5FECE5D3DCE6	TCGA-CQ-5330-01A-01D-1681-02	HG19_Broad_variant	TCGA-CQ-5330	TCGA-HNSC	NA	s15640	Harvard Medical School	University Health Network, Toronto	Canada	NO	T3	N2b	Head and Neck Squamous Cell Carcinoma	Stage IVA	1681-02	TRUE
13722.58cfa831e4b0c9d6adf6c68a	58cfa831e4b0c9d6adf6c68a	TCGA-CU-A0YR-01A-12D-A10R_120926_SN590_0182_BD1EAGACXX_s_7_rg.sorted.filtered.	WGS	TCGA-CU-A0YR-01A-12D-A10R_120926_SN590_0182_BD1EAGACXX_s_7_rg.sorted	TCGA-CU-A0YR-01A-12D-A10R_120926_SN590_0182_BD1EAGACXX_s_7_rg.sorted.bam	36.74	1.82	0.16	58cfa831e4b0c9d6adf6c68a	TCGA-CU-A0YR-01A-12D-A10R_120926_SN590_0182_BD1EAGACXX_s_7_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-CU-A0YR-01A	811B3950-36E7-485F-BC48-ACA1EEE2DDEF	Primary Tumor	Illumina HiSeq	197d19a7-07c1-4cd3-b41d-a8233c9d8a42	Bladder	83	B362FCFA-4E31-4321-9E17-11A8BAE839C3	0CB51232-CFEA-4F4F-A26A-173B1094A64B	TCGA-CU-A0YR-01A-12D-A10R-02	HG19_Broad_variant	TCGA-CU-A0YR	TCGA-BLCA	NA	s3096	Harvard Medical School	UNC	United States	NO	T2	N2	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV	A10R-02	TRUE
13722.58cfa831e4b0c9d6adf6c678	58cfa831e4b0c9d6adf6c678	TCGA-CQ-5325-01A-01D-1681_120425_SN1222_0100_BD0T1VACXX_s_1_rg.sorted.filtered.	WGS	TCGA-CQ-5325-01A-01D-1681_120425_SN1222_0100_BD0T1VACXX_s_1_rg.sorted	TCGA-CQ-5325-01A-01D-1681_120425_SN1222_0100_BD0T1VACXX_s_1_rg.sorted.bam	166	1.9	0.14	58cfa831e4b0c9d6adf6c678	TCGA-CQ-5325-01A-01D-1681_120425_SN1222_0100_BD0T1VACXX_s_1_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CQ-5325-01A	408C5D54-7888-4955-8386-BF8819B48A6C	Primary Tumor	Illumina HiSeq	a7440672-d797-4ad6-979a-c0835f0c2768	Head and Neck	65	8394A7F6-1BF6-473E-A155-3DA1A3DE244F	FFB4F8E1-B683-4A35-A5E7-15DBF610AE47	TCGA-CQ-5325-01A-01D-1681-02	HG19_Broad_variant	TCGA-CQ-5325	TCGA-HNSC	654	s16331	Harvard Medical School	University Health Network, Toronto	Canada	NO	T1	N0	Head and Neck Squamous Cell Carcinoma	Stage I	1681-02	TRUE
13722.58cfa831e4b0c9d6adf6c6c3	58cfa831e4b0c9d6adf6c6c3	TCGA-CU-A3QU-01A-11D-A233_120829_SN1120_0183_AC18U8ACXX_s_1_rg.sorted.filtered.	WGS	TCGA-CU-A3QU-01A-11D-A233_120829_SN1120_0183_AC18U8ACXX_s_1_rg.sorted	TCGA-CU-A3QU-01A-11D-A233_120829_SN1120_0183_AC18U8ACXX_s_1_rg.sorted.bam	73.31	NA	0.15	58cfa831e4b0c9d6adf6c6c3	TCGA-CU-A3QU-01A-11D-A233_120829_SN1120_0183_AC18U8ACXX_s_1_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-CU-A3QU-01A	AE6D853B-A7F0-4465-B7BF-5A45006AB3B3	Primary Tumor	Illumina HiSeq	c4c9ea17-be51-4e92-8cdc-0d5880def11c	Bladder	58	75448068-DED8-42F0-BB99-6D1C4B3FFA4E	98A4CFCF-34FE-433A-A598-4191742DC977	TCGA-CU-A3QU-01A-11D-A233-26	HG19_Broad_variant	TCGA-CU-A3QU	TCGA-BLCA	NA	s3278	MD Anderson - Institute for Applied Cancer Science	UNC	United States	NO	T2b	N1	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV	A233-26	TRUE
13722.58cfa831e4b0c9d6adf6c662	58cfa831e4b0c9d6adf6c662	TCGA-CM-4750-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.filtered.	WGS	TCGA-CM-4750-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole	TCGA-CM-4750-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.bam	450.02	1.9	0.14	58cfa831e4b0c9d6adf6c662	TCGA-CM-4750-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Colon Adenocarcinoma	Aligned reads	TCGA-CM-4750-01A	C777A777-373A-4773-9566-6C373261F00A	Primary Tumor	Illumina HiSeq	eae74e76-b630-469d-9ad7-549fbfe64297	Colorectal	34	463D4B1E-2068-45DD-9631-FB9C7268FE6C	EE814BA4-311A-4ABC-B7A6-F32C68C50F2A	TCGA-CM-4750-01A-01D-1405-02	HG18	TCGA-CM-4750	TCGA-COAD	NA	s12891	Harvard Medical School	MSKCC	United States	NO	T1	N1b	Colon Adenocarcinoma	Stage IIIA	1405-02	TRUE
13722.58cfa831e4b0c9d6adf6c794	58cfa831e4b0c9d6adf6c794	TCGA-CN-6017-01A-11D-1681_120425_SN1222_0099_AC0JCEACXX_s_2_rg.sorted.filtered.	WGS	TCGA-CN-6017-01A-11D-1681_120425_SN1222_0099_AC0JCEACXX_s_2_rg.sorted	TCGA-CN-6017-01A-11D-1681_120425_SN1222_0099_AC0JCEACXX_s_2_rg.sorted.bam	69	1.9	0.15	58cfa831e4b0c9d6adf6c794	TCGA-CN-6017-01A-11D-1681_120425_SN1222_0099_AC0JCEACXX_s_2_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CN-6017-01A	23C4E2EB-142B-4FCC-A974-9A248AEC3F37	Primary Tumor	Illumina HiSeq	e0dae8a5-f74f-4e25-98c2-238e28c54863	Head and Neck	55	6C07CD48-2269-4D42-9879-309EA4CD3A74	48A22F9A-2A18-4FCA-8271-44B3F7C3A628	TCGA-CN-6017-01A-11D-1681-02	HG19_Broad_variant	TCGA-CN-6017	TCGA-HNSC	NA	s16181	Harvard Medical School	University of Pittsburgh	United States	NO	T3	N2b	Head and Neck Squamous Cell Carcinoma	Stage IVA	1681-02	TRUE
13722.58cfa831e4b0c9d6adf6c7ac	58cfa831e4b0c9d6adf6c7ac	TCGA-D6-6827-01A-11D-1911_120518_SN1120_0143_BC0VN6ACXX_s_4_rg.sorted.filtered.	WGS	TCGA-D6-6827-01A-11D-1911_120518_SN1120_0143_BC0VN6ACXX_s_4_rg.sorted	TCGA-D6-6827-01A-11D-1911_120518_SN1120_0143_BC0VN6ACXX_s_4_rg.sorted.bam	262.7	1.9	0.14	58cfa831e4b0c9d6adf6c7ac	TCGA-D6-6827-01A-11D-1911_120518_SN1120_0143_BC0VN6ACXX_s_4_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-D6-6827-01A	3C5BC678-41E9-46B3-9686-5CD95659AB71	Primary Tumor	Illumina HiSeq	849f41d7-0557-40ce-bca0-8a54c496fef2	Head and Neck	55	C53D6135-C614-45F4-8F41-49B20ED4A549	E2CDC496-8A62-4501-98C0-2AF2CCF48988	TCGA-D6-6827-01A-11D-1911-02	HG19_Broad_variant	TCGA-D6-6827	TCGA-HNSC	NA	s16057	Harvard Medical School	Greater Poland Cancer Center	Poland	NO	T1	N0	Head and Neck Squamous Cell Carcinoma	Stage I	1911-02	TRUE
13722.58cfa831e4b0c9d6adf6c804	58cfa831e4b0c9d6adf6c804	TCGA-D1-A2G6-01A-11D-A17E_120511_SN208_0299_BD12J9ACXX_s_7_rg.sorted.filtered.	WGS	TCGA-D1-A2G6-01A-11D-A17E_120511_SN208_0299_BD12J9ACXX_s_7_rg.sorted	TCGA-D1-A2G6-01A-11D-A17E_120511_SN208_0299_BD12J9ACXX_s_7_rg.sorted.bam	60.54	NA	0.18	58cfa831e4b0c9d6adf6c804	TCGA-D1-A2G6-01A-11D-A17E_120511_SN208_0299_BD12J9ACXX_s_7_rg.sorted.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-D1-A2G6-01A	46CD8DED-F8A1-4F8C-A4C2-2D5B51C04F18	Primary Tumor	Illumina HiSeq	4ac2b259-f781-4a71-b271-2d326472c965	Uterus	53	2127E58B-BD7B-490E-B34B-4F626B2A4053	079C1D47-95AC-456B-8DD5-C89B4076E578	TCGA-D1-A2G6-01A-11D-A17E-02	HG19_Broad_variant	TCGA-D1-A2G6	TCGA-UCEC	258	s5230	Harvard Medical School	Mayo Clinic	United States	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A17E-02	TRUE
13722.58cfa831e4b0c9d6adf6c7ce	58cfa831e4b0c9d6adf6c7ce	TCGA-CV-7434-01A-11D-2317_120730_SN1222_0141_BC115GACXX_s_3_rg.sorted.filtered.	WGS	TCGA-CV-7434-01A-11D-2317_120730_SN1222_0141_BC115GACXX_s_3_rg.sorted	TCGA-CV-7434-01A-11D-2317_120730_SN1222_0141_BC115GACXX_s_3_rg.sorted.bam	274.73	NA	0.14	58cfa831e4b0c9d6adf6c7ce	TCGA-CV-7434-01A-11D-2317_120730_SN1222_0141_BC115GACXX_s_3_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-7434-01A	63B50E1C-7948-464F-BFF1-8E0E5DAAFCC5	Primary Tumor	Illumina HiSeq	c645c62d-79d3-478c-a9c4-16294daad71c	Head and Neck	64	2CB75C6E-CA4F-4A88-9679-812A51C7B832	4A4BF5E3-272F-492C-9755-BBFE14D3BEE1	TCGA-CV-7434-01A-11D-2317-26	HG19_Broad_variant	TCGA-CV-7434	TCGA-HNSC	218	s15528	MD Anderson - Institute for Applied Cancer Science	MD Anderson Cancer Center	United States	NO	T4a	N1	Head and Neck Squamous Cell Carcinoma	Stage IVA	2317-26	TRUE
13722.58cfa831e4b0c9d6adf6c876	58cfa831e4b0c9d6adf6c876	TCGA-D6-6826-01A-11D-1911_120518_SN1120_0143_BC0VN6ACXX_s_3_rg.sorted.filtered.	WGS	TCGA-D6-6826-01A-11D-1911_120518_SN1120_0143_BC0VN6ACXX_s_3_rg.sorted	TCGA-D6-6826-01A-11D-1911_120518_SN1120_0143_BC0VN6ACXX_s_3_rg.sorted.bam	275.7	1.9	0.14	58cfa831e4b0c9d6adf6c876	TCGA-D6-6826-01A-11D-1911_120518_SN1120_0143_BC0VN6ACXX_s_3_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-D6-6826-01A	31243867-8E9F-46E9-A213-B83544EB8028	Primary Tumor	Illumina HiSeq	377f848a-3e59-4eee-bd9d-87fdc1a898bb	Head and Neck	64	1737989D-8463-4761-B111-53E4FD396375	07759CEA-B923-4D20-96DB-7952D50314C7	TCGA-D6-6826-01A-11D-1911-02	HG19_Broad_variant	TCGA-D6-6826	TCGA-HNSC	NA	s15912	Harvard Medical School	Greater Poland Cancer Center	Poland	NO	T4a	N2b	Head and Neck Squamous Cell Carcinoma	Stage IVA	1911-02	TRUE
13722.58cfa831e4b0c9d6adf6c7bc	58cfa831e4b0c9d6adf6c7bc	TCGA-CN-6019-01A-11D-1681_120425_SN1222_0099_AC0JCEACXX_s_4_rg.sorted.filtered.	WGS	TCGA-CN-6019-01A-11D-1681_120425_SN1222_0099_AC0JCEACXX_s_4_rg.sorted	TCGA-CN-6019-01A-11D-1681_120425_SN1222_0099_AC0JCEACXX_s_4_rg.sorted.bam	172	1.9	0.15	58cfa831e4b0c9d6adf6c7bc	TCGA-CN-6019-01A-11D-1681_120425_SN1222_0099_AC0JCEACXX_s_4_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CN-6019-01A	EE3061EC-273C-4BEF-A325-35E9C469BF01	Primary Tumor	Illumina HiSeq	e7b9cb7d-0a1a-4461-ab89-108d02821762	Head and Neck	61	AC349695-2219-4A67-ADD5-A94FF85794E1	2C509E96-12D7-4DBB-A02F-DCDCC6F76952	TCGA-CN-6019-01A-11D-1681-02	HG19_Broad_variant	TCGA-CN-6019	TCGA-HNSC	NA	s16178	Harvard Medical School	University of Pittsburgh	United States	NO	T4a	N0	Head and Neck Squamous Cell Carcinoma	Stage IVA	1681-02	TRUE
13722.58cfa831e4b0c9d6adf6c866	58cfa831e4b0c9d6adf6c866	TCGA-D6-6823-01A-11D-1911_120518_SN1120_0143_BC0VN6ACXX_s_1_rg.sorted.filtered.	WGS	TCGA-D6-6823-01A-11D-1911_120518_SN1120_0143_BC0VN6ACXX_s_1_rg.sorted	TCGA-D6-6823-01A-11D-1911_120518_SN1120_0143_BC0VN6ACXX_s_1_rg.sorted.bam	384.7	1.9	0.14	58cfa831e4b0c9d6adf6c866	TCGA-D6-6823-01A-11D-1911_120518_SN1120_0143_BC0VN6ACXX_s_1_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-D6-6823-01A	FBDAB01C-191C-4AEF-9451-CA3AFEC55FA1	Primary Tumor	Illumina HiSeq	250e5855-f3af-4c16-9efe-918be02bf754	Head and Neck	50	2DA83450-04C2-44D0-AB8A-9CC876242D5A	FE15C318-C3B1-4541-A0DA-4E41D7E99FBB	TCGA-D6-6823-01A-11D-1911-02	HG19_Broad_variant	TCGA-D6-6823	TCGA-HNSC	NA	s15531	Harvard Medical School	Greater Poland Cancer Center	Poland	NO	T2	N0	Head and Neck Squamous Cell Carcinoma	Stage II	1911-02	TRUE
13722.58cfa831e4b0c9d6adf6c896	58cfa831e4b0c9d6adf6c896	TCGA-DJ-A13V-01A-11D-A10R_120616_SN1120_0154_BD142VACXX_s_2_rg.sorted.filtered.	WGS	TCGA-DJ-A13V-01A-11D-A10R_120616_SN1120_0154_BD142VACXX_s_2_rg.sorted	TCGA-DJ-A13V-01A-11D-A10R_120616_SN1120_0154_BD142VACXX_s_2_rg.sorted.bam	80.38	1.94	0.14	58cfa831e4b0c9d6adf6c896	TCGA-DJ-A13V-01A-11D-A10R_120616_SN1120_0154_BD142VACXX_s_2_rg.sorted.bam	Alive	FEMALE	Not available	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-DJ-A13V-01A	99AC4F2E-2E63-4F1E-AF0F-8F23A2CAF999	Primary Tumor	Illumina HiSeq	a3620988-3968-488b-88e7-9ae555459dc7	Thyroid	21	A870F5CA-F049-48C1-AFAC-B788A3111086	DB0AC00C-ABED-4D02-B05B-A3CD87DCA75F	TCGA-DJ-A13V-01A-11D-A10R-02	HG19_Broad_variant	TCGA-DJ-A13V	TCGA-THCA	NA	s12634	Harvard Medical School	Memorial Sloan Kettering	United States	NO	T3	N1a	Thyroid Papillary Carcinoma - Classical/usual	Stage I	A10R-02	TRUE
13722.58cfa831e4b0c9d6adf6c8e0	58cfa831e4b0c9d6adf6c8e0	TCGA-DK-A3IV-01A-22D-A21C_120830_SN590_0177_BD141PACXX_s_7_rg.sorted.filtered.	WGS	TCGA-DK-A3IV-01A-22D-A21C_120830_SN590_0177_BD141PACXX_s_7_rg.sorted	TCGA-DK-A3IV-01A-22D-A21C_120830_SN590_0177_BD141PACXX_s_7_rg.sorted.bam	71.23	NA	0.16	58cfa831e4b0c9d6adf6c8e0	TCGA-DK-A3IV-01A-22D-A21C_120830_SN590_0177_BD141PACXX_s_7_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-DK-A3IV-01A	F953DC5D-58BF-4936-B9FE-74B45E8C00E5	Primary Tumor	Illumina HiSeq	5bf5cb9d-7592-4967-8440-fe80dfe9c2a6	Bladder	60	BC065247-1179-4FC2-B45C-8EFB13AADE65	62148C98-8E6F-4CA0-9EC6-C7FD7F96495D	TCGA-DK-A3IV-01A-22D-A21C-26	HG19_Broad_variant	TCGA-DK-A3IV	TCGA-BLCA	294	s3108	MD Anderson - Institute for Applied Cancer Science	Memorial Sloan Kettering	United States	NO	Not available	NX	Muscle invasive urothelial carcinoma (pT2 or above)	Stage II	A21C-26	TRUE
13722.58cfa831e4b0c9d6adf6c8da	58cfa831e4b0c9d6adf6c8da	TCGA-D1-A168-01A-31D-A12F_120413_SN1120_0133_BC0J8UACXX_s_6_rg.sorted.filtered.	WGS	TCGA-D1-A168-01A-31D-A12F_120413_SN1120_0133_BC0J8UACXX_s_6_rg.sorted	TCGA-D1-A168-01A-31D-A12F_120413_SN1120_0133_BC0J8UACXX_s_6_rg.sorted.bam	60.13	1.98	0.15	58cfa831e4b0c9d6adf6c8da	TCGA-D1-A168-01A-31D-A12F_120413_SN1120_0133_BC0J8UACXX_s_6_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-D1-A168-01A	41893E97-7E90-4B03-B738-260F288ADE4C	Primary Tumor	Illumina HiSeq	f7d0c63d-0a01-4ff3-b721-3c10692581ca	Uterus	67	B44C673E-9560-4B59-9FF3-34CE230CAD1C	4593D11C-3A35-4269-80EC-D282497CF71C	TCGA-D1-A168-01A-31D-A12F-02	HG19_Broad_variant	TCGA-D1-A168	TCGA-UCEC	NA	s4438	Harvard Medical School	Mayo Clinic	None	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A12F-02	TRUE
13722.58cfa831e4b0c9d6adf6c958	58cfa831e4b0c9d6adf6c958	TCGA-DK-A3IK-01A-32D-A21C_120914_SN590_0179_AD13PPACXX_s_3_rg.sorted.filtered.	WGS	TCGA-DK-A3IK-01A-32D-A21C_120914_SN590_0179_AD13PPACXX_s_3_rg.sorted	TCGA-DK-A3IK-01A-32D-A21C_120914_SN590_0179_AD13PPACXX_s_3_rg.sorted.bam	35.88	NA	0.16	58cfa831e4b0c9d6adf6c958	TCGA-DK-A3IK-01A-32D-A21C_120914_SN590_0179_AD13PPACXX_s_3_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-DK-A3IK-01A	3F0A0748-9ACC-4D0B-BA18-7C08BD183F86	Primary Tumor	Illumina HiSeq	6c286798-955c-487f-b541-72f253866ada	Bladder	87	4FF20C48-29EE-4101-B409-C4573E38CF92	B13B80DE-1722-44D3-888D-EEE8677F205C	TCGA-DK-A3IK-01A-32D-A21C-26	HG19_Broad_variant	TCGA-DK-A3IK	TCGA-BLCA	NA	s2887	MD Anderson - Institute for Applied Cancer Science	Memorial Sloan Kettering	United States	NO	T3	N2	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV	A21C-26	TRUE
13722.58cfa831e4b0c9d6adf6c949	58cfa831e4b0c9d6adf6c949	TCGA-DJ-A13O-01A-11D-A10R_120617_SN1222_0116_AC0WMMACXX_s_5_rg.sorted.filtered.	WGS	TCGA-DJ-A13O-01A-11D-A10R_120617_SN1222_0116_AC0WMMACXX_s_5_rg.sorted	TCGA-DJ-A13O-01A-11D-A10R_120617_SN1222_0116_AC0WMMACXX_s_5_rg.sorted.bam	21.24	1.93	0.16	58cfa831e4b0c9d6adf6c949	TCGA-DJ-A13O-01A-11D-A10R_120617_SN1222_0116_AC0WMMACXX_s_5_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-DJ-A13O-01A	77D5B246-33BA-4A96-9D73-06ACA797653E	Primary Tumor	Illumina HiSeq	ae4a78d9-4c9a-40f7-9612-17d11799ea67	Thyroid	56	457B11C0-3C36-4907-8C76-60E3861EBABB	EC713290-9998-489B-9D1E-CC9D33CF5428	TCGA-DJ-A13O-01A-11D-A10R-02	HG19_Broad_variant	TCGA-DJ-A13O	TCGA-THCA	NA	s12241	Harvard Medical School	Memorial Sloan Kettering	United States	NO	T1b	N0	Thyroid Papillary Carcinoma - Classical/usual	Stage I	A10R-02	TRUE
13722.58cfa831e4b0c9d6adf6c9b0	58cfa831e4b0c9d6adf6c9b0	TCGA-DJ-A13M-01A-11D-A10R_120616_SN1120_0154_BD142VACXX_s_6_rg.sorted.filtered.	WGS	TCGA-DJ-A13M-01A-11D-A10R_120616_SN1120_0154_BD142VACXX_s_6_rg.sorted	TCGA-DJ-A13M-01A-11D-A10R_120616_SN1120_0154_BD142VACXX_s_6_rg.sorted.bam	24.89	1.93	0.14	58cfa831e4b0c9d6adf6c9b0	TCGA-DJ-A13M-01A-11D-A10R_120616_SN1120_0154_BD142VACXX_s_6_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-DJ-A13M-01A	BA9DEC81-FFC0-453A-9621-94BEBA45FAB1	Primary Tumor	Illumina HiSeq	6d7b5f3b-5fba-469e-a651-31a4569d7877	Thyroid	28	28913C64-8637-4537-AF8C-7315097A5AD1	8C708D3B-B312-4C27-898B-A0FE87110474	TCGA-DJ-A13M-01A-11D-A10R-02	HG19_Broad_variant	TCGA-DJ-A13M	TCGA-THCA	NA	s12369	Harvard Medical School	Memorial Sloan Kettering	United States	NO	T1b	N0	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	Stage I	A10R-02	TRUE
13722.58cfa831e4b0c9d6adf6c99c	58cfa831e4b0c9d6adf6c99c	TCGA-DK-A3WX-01A-22D-A233_120829_SN1120_0183_AC18U8ACXX_s_5_rg.sorted.filtered.	WGS	TCGA-DK-A3WX-01A-22D-A233_120829_SN1120_0183_AC18U8ACXX_s_5_rg.sorted	TCGA-DK-A3WX-01A-22D-A233_120829_SN1120_0183_AC18U8ACXX_s_5_rg.sorted.bam	36.57	NA	0.16	58cfa831e4b0c9d6adf6c99c	TCGA-DK-A3WX-01A-22D-A233_120829_SN1120_0183_AC18U8ACXX_s_5_rg.sorted.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-DK-A3WX-01A	D63C186D-ADD6-492E-8250-E83F46D39D00	Primary Tumor	Illumina HiSeq	12365344-0a7a-4ef2-a651-2f1f3a15f6a1	Bladder	67	FED73C89-75F1-45C9-B14B-7840C52C305F	A6D2A8FB-6A01-4625-AEB9-FFA9476B658E	TCGA-DK-A3WX-01A-22D-A233-26	HG19_Broad_variant	TCGA-DK-A3WX	TCGA-BLCA	321	s2899	MD Anderson - Institute for Applied Cancer Science	Memorial Sloan Kettering	United States	NO	T3	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage III	A233-26	TRUE
13722.58cfa831e4b0c9d6adf6c730	58cfa831e4b0c9d6adf6c730	TCGA-D1-A17N-01A-11D-A12F_120413_SN1120_0132_AD0T6RACXX_s_6_rg.sorted.filtered.	WGS	TCGA-D1-A17N-01A-11D-A12F_120413_SN1120_0132_AD0T6RACXX_s_6_rg.sorted	TCGA-D1-A17N-01A-11D-A12F_120413_SN1120_0132_AD0T6RACXX_s_6_rg.sorted.bam	98.78	1.87	0.17	58cfa831e4b0c9d6adf6c730	TCGA-D1-A17N-01A-11D-A12F_120413_SN1120_0132_AD0T6RACXX_s_6_rg.sorted.bam	Alive	FEMALE	Not available	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-D1-A17N-01A	001E0309-9C50-42B0-9E38-347883EE2CD3	Primary Tumor	Illumina HiSeq	610d595a-df00-4af9-9644-d750501c1737	Uterus	46	F93931BA-8333-4E22-A430-CA02D9DA3FFC	DB0F8EE9-33A0-46CC-8218-59E18B2F824F	TCGA-D1-A17N-01A-11D-A12F-02	HG19_Broad_variant	TCGA-D1-A17N	TCGA-UCEC	NA	s5226	Harvard Medical School	Mayo Clinic	None	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A12F-02	TRUE
13722.58cfa831e4b0c9d6adf6c9e7	58cfa831e4b0c9d6adf6c9e7	TCGA-DJ-A1QQ-01A-11D-A14U_120629_SN1222_0120_AC0WKWACXX_s_4_rg.sorted.filtered.	WGS	TCGA-DJ-A1QQ-01A-11D-A14U_120629_SN1222_0120_AC0WKWACXX_s_4_rg.sorted	TCGA-DJ-A1QQ-01A-11D-A14U_120629_SN1222_0120_AC0WKWACXX_s_4_rg.sorted.bam	48.48	1.91	0.16	58cfa831e4b0c9d6adf6c9e7	TCGA-DJ-A1QQ-01A-11D-A14U_120629_SN1222_0120_AC0WKWACXX_s_4_rg.sorted.bam	Alive	MALE	ASIAN	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-DJ-A1QQ-01A	99EF2FEC-5A3C-4E42-8F78-7EAF9877E26D	Primary Tumor	Illumina HiSeq	091bb28f-4fe0-41e6-b7c5-b952dc370506	Thyroid	43	64D1F58A-986F-4D4B-962E-DA59A48C988B	DDE34A05-A208-4F86-9803-0FB1EB858947	TCGA-DJ-A1QQ-01A-11D-A14U-02	HG19_Broad_variant	TCGA-DJ-A1QQ	TCGA-THCA	NA	s12639	Harvard Medical School	Memorial Sloan Kettering	United States	NO	T3	N0	Thyroid Papillary Carcinoma - Classical/usual	Stage I	A14U-02	TRUE
13722.58cfa831e4b0c9d6adf6c9ce	58cfa831e4b0c9d6adf6c9ce	TCGA-DK-A3WY-01A-11D-A233_120829_SN1120_0183_AC18U8ACXX_s_7_rg.sorted.filtered.	WGS	TCGA-DK-A3WY-01A-11D-A233_120829_SN1120_0183_AC18U8ACXX_s_7_rg.sorted	TCGA-DK-A3WY-01A-11D-A233_120829_SN1120_0183_AC18U8ACXX_s_7_rg.sorted.bam	13.9	NA	0.15	58cfa831e4b0c9d6adf6c9ce	TCGA-DK-A3WY-01A-11D-A233_120829_SN1120_0183_AC18U8ACXX_s_7_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-DK-A3WY-01A	9BB5D187-033E-4E86-A76E-E1A6D20488F7	Primary Tumor	Illumina HiSeq	ae1b3911-b342-4886-b75a-3e9be21dae41	Bladder	67	33D579B3-198D-46CA-B2CF-574A0673E26F	ABA3AF01-2CBD-4450-9CCB-698DF8982E91	TCGA-DK-A3WY-01A-11D-A233-26	HG19_Broad_variant	TCGA-DK-A3WY	TCGA-BLCA	NA	s2895	MD Anderson - Institute for Applied Cancer Science	Memorial Sloan Kettering	United States	NO	T3	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage III	A233-26	TRUE
13722.58cfa831e4b0c9d6adf6ca25	58cfa831e4b0c9d6adf6ca25	TCGA-DE-A0Y2-01A-11D-A10R_120617_SN1222_0116_AC0WMMACXX_s_3_rg.sorted.filtered.	WGS	TCGA-DE-A0Y2-01A-11D-A10R_120617_SN1222_0116_AC0WMMACXX_s_3_rg.sorted	TCGA-DE-A0Y2-01A-11D-A10R_120617_SN1222_0116_AC0WMMACXX_s_3_rg.sorted.bam	63	2.03	0.14	58cfa831e4b0c9d6adf6ca25	TCGA-DE-A0Y2-01A-11D-A10R_120617_SN1222_0116_AC0WMMACXX_s_3_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-DE-A0Y2-01A	6AD260AD-769A-4F3C-BD07-927ADF6B2338	Primary Tumor	Illumina HiSeq	eaf940db-08d0-4dc4-b390-0576523fb2f5	Thyroid	30	EB4FEEBB-293E-43E3-A2ED-344B17D180B3	E86091EB-6DCC-479B-BAFD-3DABA65787EC	TCGA-DE-A0Y2-01A-11D-A10R-02	HG19_Broad_variant	TCGA-DE-A0Y2	TCGA-THCA	NA	s12514	Harvard Medical School	University of North Carolina	United States	NO	T2	N1a	Thyroid Papillary Carcinoma - Classical/usual	Stage I	A10R-02	TRUE
13722.58cfa831e4b0c9d6adf6ca5e	58cfa831e4b0c9d6adf6ca5e	TCGA-DJ-A1QG-01A-11D-A14U_120629_SN1222_0121_BD143UACXX_s_1_rg.sorted.filtered.	WGS	TCGA-DJ-A1QG-01A-11D-A14U_120629_SN1222_0121_BD143UACXX_s_1_rg.sorted	TCGA-DJ-A1QG-01A-11D-A14U_120629_SN1222_0121_BD143UACXX_s_1_rg.sorted.bam	73.27	1.98	0.17	58cfa831e4b0c9d6adf6ca5e	TCGA-DJ-A1QG-01A-11D-A14U_120629_SN1222_0121_BD143UACXX_s_1_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-DJ-A1QG-01A	CB29E795-7618-4882-A7E0-69D39787B80C	Primary Tumor	Illumina HiSeq	cd7d52cc-20ac-4fa7-a821-231d15f926fc	Thyroid	62	D0A669AF-1A0A-451D-9D6F-9EEE15F7264C	EF88FE61-36C4-43CF-BD57-D15F7E264DF0	TCGA-DJ-A1QG-01A-11D-A14U-02	HG19_Broad_variant	TCGA-DJ-A1QG	TCGA-THCA	NA	s12240	Harvard Medical School	Memorial Sloan Kettering	United States	NO	T1b	N0	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	Stage I	A14U-02	TRUE
13722.58cfa831e4b0c9d6adf6cb30	58cfa831e4b0c9d6adf6cb30	TCGA-EA-A3HQ-01A-11D-A20X_140131_SN590_0247_AC3FDBACXX_s_3_rg.sorted.filtered.	WGS	TCGA-EA-A3HQ-01A-11D-A20X_140131_SN590_0247_AC3FDBACXX_s_3_rg.sorted	TCGA-EA-A3HQ-01A-11D-A20X_140131_SN590_0247_AC3FDBACXX_s_3_rg.sorted.bam	14.36	NA	0.15	58cfa831e4b0c9d6adf6cb30	TCGA-EA-A3HQ-01A-11D-A20X_140131_SN590_0247_AC3FDBACXX_s_3_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-EA-A3HQ-01A	6BF00B63-89F8-420C-8D36-F680FB0908B1	Primary Tumor	Illumina HiSeq	33c80031-f923-4aa0-adfa-9e229f413f83	Cervix	60	E4B391D9-2F3E-474C-AFA0-FDF4FD11FDF9	0032959A-5D7B-4D74-927E-25F79EF25D49	TCGA-EA-A3HQ-01A-11D-A20X-26	HG19_Broad_variant	TCGA-EA-A3HQ	TCGA-CESC	NA	s1180	MD Anderson - Institute for Applied Cancer Science	Asterand	Russia	NO	T2a	N0	Cervical Squamous Cell Carcinoma	Not available	A20X-26	TRUE
13722.58cfa831e4b0c9d6adf6ca60	58cfa831e4b0c9d6adf6ca60	TCGA-CN-6013-01A-11D-1681_120425_SN1222_0099_AC0JCEACXX_s_1_rg.sorted.filtered.	WGS	TCGA-CN-6013-01A-11D-1681_120425_SN1222_0099_AC0JCEACXX_s_1_rg.sorted	TCGA-CN-6013-01A-11D-1681_120425_SN1222_0099_AC0JCEACXX_s_1_rg.sorted.bam	354	1.9	0.15	58cfa831e4b0c9d6adf6ca60	TCGA-CN-6013-01A-11D-1681_120425_SN1222_0099_AC0JCEACXX_s_1_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CN-6013-01A	714496C5-D221-4397-9C5A-CD2D22603E6F	Primary Tumor	Illumina HiSeq	2ca5ef3f-76f6-4db9-85e7-d32249cd642f	Head and Neck	56	D018CD44-6B01-44F2-9181-81153225AAB8	2DE7DBC6-2A3E-4E67-BB96-552E27137618	TCGA-CN-6013-01A-11D-1681-02	HG19_Broad_variant	TCGA-CN-6013	TCGA-HNSC	NA	s15629	Harvard Medical School	University of Pittsburgh	United States	NO	T4a	N2b	Head and Neck Squamous Cell Carcinoma	Stage IVA	1681-02	TRUE
13722.58cfa831e4b0c9d6adf6cb5e	58cfa831e4b0c9d6adf6cb5e	TCGA-DU-7018-01A-11D-2022_130910_SN208_0495_BD2FGNACXX_s_5_rg.sorted.filtered.	WGS	TCGA-DU-7018-01A-11D-2022_130910_SN208_0495_BD2FGNACXX_s_5_rg.sorted	TCGA-DU-7018-01A-11D-2022_130910_SN208_0495_BD2FGNACXX_s_5_rg.sorted.bam	193.7	NA	0.15	58cfa831e4b0c9d6adf6cb5e	TCGA-DU-7018-01A-11D-2022_130910_SN208_0495_BD2FGNACXX_s_5_rg.sorted.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-DU-7018-01A	F18DAB99-26B0-4727-89A9-7F16BD382356	Primary Tumor	Illumina HiSeq	2736e751-ccc3-4721-b516-238f987ad26f	Brain	57	FE98F78B-2C80-4999-B430-E1D95A53F356	02FCFCBB-05D7-4671-BDDF-DED65316FCC6	TCGA-DU-7018-01A-11D-2022-02	HG19_Broad_variant	TCGA-DU-7018	TCGA-LGG	933	s8567	Harvard Medical School	Henry Ford Hospital	United States	NO	Not available	Not available	Oligodendroglioma	Not available	2022-02	TRUE
13722.58cfa831e4b0c9d6adf6cb58	58cfa831e4b0c9d6adf6cb58	TCGA-EB-A299-01A-21D-A18Y_120730_SN208_0420_BC12YJACXX_s_5_rg.sorted.filtered.	WGS	TCGA-EB-A299-01A-21D-A18Y_120730_SN208_0420_BC12YJACXX_s_5_rg.sorted	TCGA-EB-A299-01A-21D-A18Y_120730_SN208_0420_BC12YJACXX_s_5_rg.sorted.bam	56.25	NA	0.15	58cfa831e4b0c9d6adf6cb58	TCGA-EB-A299-01A-21D-A18Y_120730_SN208_0420_BC12YJACXX_s_5_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Skin Cutaneous Melanoma	Aligned reads	TCGA-EB-A299-01A	90402C32-9548-432E-85B8-A4F80E14401E	Primary Tumor	Illumina HiSeq	8780c547-110c-4e3a-88fa-1feeb9a57ad0	Skin	63	5678AE8F-382C-4167-839E-A160CE6710C7	C164DE0A-E762-48BE-B940-9E5EA31AD026	TCGA-EB-A299-01A-21D-A18Y-02	HG19_Broad_variant	TCGA-EB-A299	TCGA-SKCM	NA	s7844	Harvard Medical School	Asterand	Russia	NO	T2b	N0	Not available	Stage IIA	A18Y-02	TRUE
13722.58cfa831e4b0c9d6adf6cc4a	58cfa831e4b0c9d6adf6cc4a	TCGA-EB-A24C-01A-11D-A18Y_120730_SN208_0420_BC12YJACXX_s_3_rg.sorted.filtered.	WGS	TCGA-EB-A24C-01A-11D-A18Y_120730_SN208_0420_BC12YJACXX_s_3_rg.sorted	TCGA-EB-A24C-01A-11D-A18Y_120730_SN208_0420_BC12YJACXX_s_3_rg.sorted.bam	54.37	NA	0.17	58cfa831e4b0c9d6adf6cc4a	TCGA-EB-A24C-01A-11D-A18Y_120730_SN208_0420_BC12YJACXX_s_3_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Skin Cutaneous Melanoma	Aligned reads	TCGA-EB-A24C-01A	2F1BBE96-49D9-417B-BC9C-A09992489340	Primary Tumor	Illumina HiSeq	536296fc-5bec-4776-8ce4-7eee8581fbc3	Skin	56	67D59A46-5944-4B23-AA7B-9561C6F7B956	B48D03D1-E323-4119-B62E-1952163AAB2A	TCGA-EB-A24C-01A-11D-A18Y-02	HG19_Broad_variant	TCGA-EB-A24C	TCGA-SKCM	NA	s7333	Harvard Medical School	Asterand	Ukraine	NO	T4b	NX	Not available	Not available	A18Y-02	TRUE
13722.58cfa831e4b0c9d6adf6cc4e	58cfa831e4b0c9d6adf6cc4e	TCGA-DU-7007-01A-11D-2022_130910_SN208_0494_AC2A1DACXX_s_7_rg.sorted.filtered.	WGS	TCGA-DU-7007-01A-11D-2022_130910_SN208_0494_AC2A1DACXX_s_7_rg.sorted	TCGA-DU-7007-01A-11D-2022_130910_SN208_0494_AC2A1DACXX_s_7_rg.sorted.bam	200.7	NA	0.17	58cfa831e4b0c9d6adf6cc4e	TCGA-DU-7007-01A-11D-2022_130910_SN208_0494_AC2A1DACXX_s_7_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-DU-7007-01A	8E2DCC00-9F7E-4DEE-B24D-43C8B30294C5	Primary Tumor	Illumina HiSeq	84edb90d-0a24-46dd-bed3-126c5fdcda42	Brain	33	E8E363D0-D9EA-478F-880C-7ADED5846237	A15321DD-20AE-4D64-9D89-C64A92468ECA	TCGA-DU-7007-01A-11D-2022-02	HG19_Broad_variant	TCGA-DU-7007	TCGA-LGG	1915	s8352	Harvard Medical School	Henry Ford Hospital	United States	NO	Not available	Not available	Astrocytoma	Not available	2022-02	TRUE
13722.58cfa831e4b0c9d6adf6cc66	58cfa831e4b0c9d6adf6cc66	TCGA-EB-A24D-01A-11D-A18Y_120730_SN208_0420_BC12YJACXX_s_4_rg.sorted.filtered.	WGS	TCGA-EB-A24D-01A-11D-A18Y_120730_SN208_0420_BC12YJACXX_s_4_rg.sorted	TCGA-EB-A24D-01A-11D-A18Y_120730_SN208_0420_BC12YJACXX_s_4_rg.sorted.bam	62.95	NA	0.16	58cfa831e4b0c9d6adf6cc66	TCGA-EB-A24D-01A-11D-A18Y_120730_SN208_0420_BC12YJACXX_s_4_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Skin Cutaneous Melanoma	Aligned reads	TCGA-EB-A24D-01A	D7EE2693-39A8-4E3A-B6F6-E4729800E34E	Primary Tumor	Illumina HiSeq	44c42419-04e6-439f-aceb-e330fd514f35	Skin	72	A74E2FEC-291C-4967-AFE3-101955578225	0FD8F30A-936E-4A72-AA69-4DAC1E4BCE49	TCGA-EB-A24D-01A-11D-A18Y-02	HG19_Broad_variant	TCGA-EB-A24D	TCGA-SKCM	NA	s7508	Harvard Medical School	Asterand	Ukraine	NO	T4a	N2b	Not available	Stage IIIB	A18Y-02	TRUE
13722.58cfa831e4b0c9d6adf6cdb1	58cfa831e4b0c9d6adf6cdb1	TCGA-FG-6692-01A-11D-1891_130919_SN590_0238_AC29TRACXX_s_6_rg.sorted.filtered.	WGS	TCGA-FG-6692-01A-11D-1891_130919_SN590_0238_AC29TRACXX_s_6_rg.sorted	TCGA-FG-6692-01A-11D-1891_130919_SN590_0238_AC29TRACXX_s_6_rg.sorted.bam	270.7	1.9	0.15	58cfa831e4b0c9d6adf6cdb1	TCGA-FG-6692-01A-11D-1891_130919_SN590_0238_AC29TRACXX_s_6_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-FG-6692-01A	5F10CD91-1E03-4016-B35A-8629A1A8FCC9	Primary Tumor	Illumina HiSeq	66eb8fac-6ead-47b2-be40-effbb245f499	Brain	63	FDDB3709-5F1C-40C8-A39A-48329DFE9C97	5BB5BFCC-DB34-474C-95E6-3A84C3A7DBAA	TCGA-FG-6692-01A-11D-1891-02	HG19_Broad_variant	TCGA-FG-6692	TCGA-LGG	NA	s8367	Harvard Medical School	Case Western	United States	NO	Not available	Not available	Oligodendroglioma	Not available	1891-02	TRUE
13722.58cfa831e4b0c9d6adf6ccdc	58cfa831e4b0c9d6adf6ccdc	TCGA-EM-A1YC-01A-11D-A14U_120629_SN1120_0167_AC0WMBACXX_s_7_rg.sorted.filtered.	WGS	TCGA-EM-A1YC-01A-11D-A14U_120629_SN1120_0167_AC0WMBACXX_s_7_rg.sorted	TCGA-EM-A1YC-01A-11D-A14U_120629_SN1120_0167_AC0WMBACXX_s_7_rg.sorted.bam	43.33	1.93	0.17	58cfa831e4b0c9d6adf6ccdc	TCGA-EM-A1YC-01A-11D-A14U_120629_SN1120_0167_AC0WMBACXX_s_7_rg.sorted.bam	Alive	FEMALE	Not available	Not available	Thyroid Carcinoma	Aligned reads	TCGA-EM-A1YC-01A	0AD2A2B3-C1BB-4597-B28E-A6385F93D09C	Primary Tumor	Illumina HiSeq	256cee86-6dd3-4d12-bb0b-e3ab680044aa	Thyroid	71	17610B7B-F2EC-4B55-808C-1C2219A0D1BA	3D02FB7F-EB7D-49F9-BD40-20E9BDA1FBAB	TCGA-EM-A1YC-01A-11D-A14U-02	HG19_Broad_variant	TCGA-EM-A1YC	TCGA-THCA	NA	s12752	Harvard Medical School	University Health Network	Canada	NO	T3	N0	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	Stage III	A14U-02	TRUE
13722.58cfa831e4b0c9d6adf6cd9e	58cfa831e4b0c9d6adf6cd9e	TCGA-FE-A238-01A-11D-A16N_120718_SN590_0169_AC0WL7ACXX_s_5_rg.sorted.filtered.	WGS	TCGA-FE-A238-01A-11D-A16N_120718_SN590_0169_AC0WL7ACXX_s_5_rg.sorted	TCGA-FE-A238-01A-11D-A16N_120718_SN590_0169_AC0WL7ACXX_s_5_rg.sorted.bam	71.81	1.88	0.16	58cfa831e4b0c9d6adf6cd9e	TCGA-FE-A238-01A-11D-A16N_120718_SN590_0169_AC0WL7ACXX_s_5_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-FE-A238-01A	DFFC4F7A-C67A-4AC5-A338-717DFFDE686D	Primary Tumor	Illumina HiSeq	004a2d8a-2dac-4e95-b287-dde59c5f0561	Thyroid	36	D68C3B99-CB82-48BD-A1F8-BEE0A9A9E8C3	BA986EBD-8E2D-4BAF-AC16-FCEB1286F590	TCGA-FE-A238-01A-11D-A16N-02	HG19_Broad_variant	TCGA-FE-A238	TCGA-THCA	NA	s12004	Harvard Medical School	Ohio State University	United States	NO	T3	N0	Thyroid Papillary Carcinoma - Classical/usual	Stage I	A16N-02	TRUE
13722.58cfa831e4b0c9d6adf6cdc4	58cfa831e4b0c9d6adf6cdc4	TCGA-FG-6690-01A-11D-1891_130919_SN590_0238_AC29TRACXX_s_7_rg.sorted.filtered.	WGS	TCGA-FG-6690-01A-11D-1891_130919_SN590_0238_AC29TRACXX_s_7_rg.sorted	TCGA-FG-6690-01A-11D-1891_130919_SN590_0238_AC29TRACXX_s_7_rg.sorted.bam	113.7	1.9	0.16	58cfa831e4b0c9d6adf6cdc4	TCGA-FG-6690-01A-11D-1891_130919_SN590_0238_AC29TRACXX_s_7_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-FG-6690-01A	AD202887-88B3-4E0F-A4C3-7E135D4CB258	Primary Tumor	Illumina HiSeq	e33fa79f-3d33-4f0b-81d9-705ab9c8a19c	Brain	70	F6C7B8C5-02DF-4B89-B527-F647762A98B7	BA96EFD0-90DE-4458-89DE-8B16639760B8	TCGA-FG-6690-01A-11D-1891-02	HG19_Broad_variant	TCGA-FG-6690	TCGA-LGG	NA	s8146	Harvard Medical School	Case Western	United States	NO	Not available	Not available	Oligodendroglioma	Not available	1891-02	TRUE
13722.58cfa832e4b0c9d6adf6ce0e	58cfa832e4b0c9d6adf6ce0e	TCGA-FD-A3N5-01A-11D-A21C_120830_SN590_0177_BD141PACXX_s_5_rg.sorted.filtered.	WGS	TCGA-FD-A3N5-01A-11D-A21C_120830_SN590_0177_BD141PACXX_s_5_rg.sorted	TCGA-FD-A3N5-01A-11D-A21C_120830_SN590_0177_BD141PACXX_s_5_rg.sorted.bam	30.45	NA	0.15	58cfa832e4b0c9d6adf6ce0e	TCGA-FD-A3N5-01A-11D-A21C_120830_SN590_0177_BD141PACXX_s_5_rg.sorted.bam	Alive	MALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-FD-A3N5-01A	A658BECF-3934-49F2-9E74-291DCA61D4BB	Primary Tumor	Illumina HiSeq	b9214ac8-956d-471d-8cad-a44ddc8825e8	Bladder	69	66559B5F-AB2F-406B-9EDB-0F5085EEC7C5	BA548041-624F-4357-A9F9-3BE29A3FF4FD	TCGA-FD-A3N5-01A-11D-A21C-26	HG19_Broad_variant	TCGA-FD-A3N5	TCGA-BLCA	NA	s2907	MD Anderson - Institute for Applied Cancer Science	BLN - University Of Chicago	United States	NO	T2b	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage II	A21C-26	TRUE
13722.58cfa831e4b0c9d6adf6cdb4	58cfa831e4b0c9d6adf6cdb4	TCGA-FE-A231-01A-11D-A14U_120629_SN1222_0120_AC0WKWACXX_s_1_rg.sorted.filtered.	WGS	TCGA-FE-A231-01A-11D-A14U_120629_SN1222_0120_AC0WKWACXX_s_1_rg.sorted	TCGA-FE-A231-01A-11D-A14U_120629_SN1222_0120_AC0WKWACXX_s_1_rg.sorted.bam	101.76	2.16	0.16	58cfa831e4b0c9d6adf6cdb4	TCGA-FE-A231-01A-11D-A14U_120629_SN1222_0120_AC0WKWACXX_s_1_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-FE-A231-01A	7044DEE0-FD6C-4E75-B731-DC60A386A1AB	Primary Tumor	Illumina HiSeq	2983a837-7d6a-4e9d-a68a-a3aa674fbb8b	Thyroid	70	96C298EB-0699-42AE-B2EA-63A192353D69	056B3922-279A-4869-A933-0C53C1137450	TCGA-FE-A231-01A-11D-A14U-02	HG19_Broad_variant	TCGA-FE-A231	TCGA-THCA	NA	s12256	Harvard Medical School	Ohio State University	United States	NO	T3	N1b	Thyroid Papillary Carcinoma - Classical/usual	Stage IVA	A14U-02	TRUE
13722.58cfa832e4b0c9d6adf6ce11	58cfa832e4b0c9d6adf6ce11	TCGA-EM-A1YE-01A-11D-A14U_120629_SN1222_0120_AC0WKWACXX_s_3_rg.sorted.filtered.	WGS	TCGA-EM-A1YE-01A-11D-A14U_120629_SN1222_0120_AC0WKWACXX_s_3_rg.sorted	TCGA-EM-A1YE-01A-11D-A14U_120629_SN1222_0120_AC0WKWACXX_s_3_rg.sorted.bam	72.49	1.98	0.17	58cfa832e4b0c9d6adf6ce11	TCGA-EM-A1YE-01A-11D-A14U_120629_SN1222_0120_AC0WKWACXX_s_3_rg.sorted.bam	Alive	FEMALE	Not available	Not available	Thyroid Carcinoma	Aligned reads	TCGA-EM-A1YE-01A	E632B443-CF6A-4592-96C6-C3493EC86FEA	Primary Tumor	Illumina HiSeq	a16ef214-00f5-4385-81e9-e66da356395c	Thyroid	47	A5DE766B-9CCC-4B56-8D9B-25704C1C91D0	4AE46D2E-BA86-426F-A127-4C1AAF92AB5B	TCGA-EM-A1YE-01A-11D-A14U-02	HG19_Broad_variant	TCGA-EM-A1YE	TCGA-THCA	NA	s12519	Harvard Medical School	University Health Network	Canada	NO	T2	N0	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	Stage II	A14U-02	TRUE
13722.58cfa832e4b0c9d6adf6ce34	58cfa832e4b0c9d6adf6ce34	TCGA-ER-A19T-01A-11D-A18Z_120516_SN1222_0107_BD12HYACXX_s_8_rg.sorted.filtered.	WGS	TCGA-ER-A19T-01A-11D-A18Z_120516_SN1222_0107_BD12HYACXX_s_8_rg.sorted	TCGA-ER-A19T-01A-11D-A18Z_120516_SN1222_0107_BD12HYACXX_s_8_rg.sorted.bam	76.29	NA	0.18	58cfa832e4b0c9d6adf6ce34	TCGA-ER-A19T-01A-11D-A18Z_120516_SN1222_0107_BD12HYACXX_s_8_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Skin Cutaneous Melanoma	Aligned reads	TCGA-ER-A19T-01A	B85B14D7-3B5A-4800-AF12-622EC03B9FE5	Primary Tumor	Illumina HiSeq	f16ac608-e77d-4717-aeea-b71439dc385a	Skin	51	11E2F891-251A-4813-AA90-E944F350C54D	9C1427B0-B112-4BB7-89B3-27934F92E077	TCGA-ER-A19T-01A-11D-A18Z-02	HG19_Broad_variant	TCGA-ER-A19T	TCGA-SKCM	270	s8022	Harvard Medical School	University of Pittsburgh	United States	NO	T4a	N3	Not available	Stage IV	A18Z-02	TRUE
13722.58cfa832e4b0c9d6adf6cf3c	58cfa832e4b0c9d6adf6cf3c	TCGA-G9-6373-01A-11D-1784_130301_SN590_0217_BC1UHMACXX_s_1_rg.sorted.filtered.	WGS	TCGA-G9-6373-01A-11D-1784_130301_SN590_0217_BC1UHMACXX_s_1_rg.sorted	TCGA-G9-6373-01A-11D-1784_130301_SN590_0217_BC1UHMACXX_s_1_rg.sorted.bam	59.4	2	0.15	58cfa832e4b0c9d6adf6cf3c	TCGA-G9-6373-01A-11D-1784_130301_SN590_0217_BC1UHMACXX_s_1_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-G9-6373-01A	C3A509C6-35A6-4D17-A9FD-0AA8884B33A0	Primary Tumor	Illumina HiSeq	b8d1f15f-e927-4a6e-8154-620ccb08e6f5	Prostate	68	18365C1F-9BC0-4865-B40D-DEF3EE73331C	A0563516-591D-4FC2-AF37-8BA62A071C58	TCGA-G9-6373-01A-11D-1784-02	HG19_Broad_variant	TCGA-G9-6373	TCGA-PRAD	NA	s3976	Harvard Medical School	Roswell Park	United States	NO	T3a	Not available	Prostate Adenocarcinoma Acinar Type	Not available	1784-02	TRUE
13722.58cfa832e4b0c9d6adf6cee6	58cfa832e4b0c9d6adf6cee6	TCGA-FI-A2D0-01A-11D-A17E_120511_SN1120_0140_AD12J0ACXX_s_3_rg.sorted.filtered.	WGS	TCGA-FI-A2D0-01A-11D-A17E_120511_SN1120_0140_AD12J0ACXX_s_3_rg.sorted	TCGA-FI-A2D0-01A-11D-A17E_120511_SN1120_0140_AD12J0ACXX_s_3_rg.sorted.bam	65.38	NA	0.17	58cfa832e4b0c9d6adf6cee6	TCGA-FI-A2D0-01A-11D-A17E_120511_SN1120_0140_AD12J0ACXX_s_3_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-FI-A2D0-01A	1B35D083-F7C9-47D2-9A9E-718788F9E39A	Primary Tumor	Illumina HiSeq	5d8357bd-6f87-41b8-af0f-a2bdcb483e07	Uterus	55	A2D2A29A-5ABC-48C3-AC17-76B8B9EE1717	9406B9B9-CC2D-470D-BFB6-2118C0B84982	TCGA-FI-A2D0-01A-11D-A17E-02	HG19_Broad_variant	TCGA-FI-A2D0	TCGA-UCEC	NA	s5399	Harvard Medical School	Washington University	United States	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A17E-02	TRUE
13722.58cfa832e4b0c9d6adf6cf4e	58cfa832e4b0c9d6adf6cf4e	TCGA-G9-6356-01A-11D-1784_130215_SN590_0211_AC1UJWACXX_s_1_rg.sorted.filtered.	WGS	TCGA-G9-6356-01A-11D-1784_130215_SN590_0211_AC1UJWACXX_s_1_rg.sorted	TCGA-G9-6356-01A-11D-1784_130215_SN590_0211_AC1UJWACXX_s_1_rg.sorted.bam	144.4	1.9	0.15	58cfa832e4b0c9d6adf6cf4e	TCGA-G9-6356-01A-11D-1784_130215_SN590_0211_AC1UJWACXX_s_1_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-G9-6356-01A	1D7FFBE7-6139-412B-8739-8082A63A2B33	Primary Tumor	Illumina HiSeq	4c78b0a9-d4e9-4656-95bf-0306c7bb406e	Prostate	60	C6E0F83F-ABA3-4705-ABAC-C81C885B53BA	E43C07B2-F48D-4780-9766-15CC08CE6FE2	TCGA-G9-6356-01A-11D-1784-02	HG19_Broad_variant	TCGA-G9-6356	TCGA-PRAD	NA	s4146	Harvard Medical School	Roswell Park	United States	NO	T3b	N0	Prostate Adenocarcinoma Acinar Type	Not available	1784-02	TRUE
13722.58cfa832e4b0c9d6adf6cf6c	58cfa832e4b0c9d6adf6cf6c	TCGA-G9-6496-01A-11D-1784_130131_SN1120_0234_AD1PVUACXX_s_3_rg.sorted.filtered.	WGS	TCGA-G9-6496-01A-11D-1784_130131_SN1120_0234_AD1PVUACXX_s_3_rg.sorted	TCGA-G9-6496-01A-11D-1784_130131_SN1120_0234_AD1PVUACXX_s_3_rg.sorted.bam	223.4	1.9	0.14	58cfa832e4b0c9d6adf6cf6c	TCGA-G9-6496-01A-11D-1784_130131_SN1120_0234_AD1PVUACXX_s_3_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-G9-6496-01A	CE2B7E17-424E-4954-8A68-19D7F98D2E7E	Primary Tumor	Illumina HiSeq	9bf9f3ef-b79e-4a93-8df6-ab2b9a3f24aa	Prostate	61	ECE85143-957D-4AD1-BFCC-B71307EFB911	10BB38BE-9E75-4793-89B5-7BB19D7AA4F8	TCGA-G9-6496-01A-11D-1784-02	HG19_Broad_variant	TCGA-G9-6496	TCGA-PRAD	NA	s3619	Harvard Medical School	Roswell Park	United States	NO	T2c	N0	Prostate Adenocarcinoma Acinar Type	Not available	1784-02	TRUE
13722.58cfa832e4b0c9d6adf6cfc9	58cfa832e4b0c9d6adf6cfc9	TCGA-FU-A3HZ-01A-11D-A20X_140106_SN590_0243_AC371BACXX_s_4_rg.sorted.filtered.	WGS	TCGA-FU-A3HZ-01A-11D-A20X_140106_SN590_0243_AC371BACXX_s_4_rg.sorted	TCGA-FU-A3HZ-01A-11D-A20X_140106_SN590_0243_AC371BACXX_s_4_rg.sorted.bam	19.8	NA	0.16	58cfa832e4b0c9d6adf6cfc9	TCGA-FU-A3HZ-01A-11D-A20X_140106_SN590_0243_AC371BACXX_s_4_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-FU-A3HZ-01A	6FF12A54-10DA-4941-BFEA-7B66E19B4BE9	Primary Tumor	Illumina HiSeq	40af9367-bd77-4c64-98d6-d2e2c6e5c11a	Cervix	64	6408A1F5-F5F7-40C8-A2EE-CB8038C15C95	230B8BFA-EBC7-4058-AA0C-78CA7DD01386	TCGA-FU-A3HZ-01A-11D-A20X-26	HG19_Broad_variant	TCGA-FU-A3HZ	TCGA-CESC	NA	s1202	MD Anderson - Institute for Applied Cancer Science	International Genomics Consortium	United States	NO	T2a2	N0	Cervical Squamous Cell Carcinoma	Not available	A20X-26	TRUE
13722.58cfa832e4b0c9d6adf6d02e	58cfa832e4b0c9d6adf6d02e	TCGA-G9-6367-01A-11D-1784_130215_SN590_0212_BC1NP2ACXX_s_3_rg.sorted.filtered.	WGS	TCGA-G9-6367-01A-11D-1784_130215_SN590_0212_BC1NP2ACXX_s_3_rg.sorted	TCGA-G9-6367-01A-11D-1784_130215_SN590_0212_BC1NP2ACXX_s_3_rg.sorted.bam	59.4	1.9	0.14	58cfa832e4b0c9d6adf6d02e	TCGA-G9-6367-01A-11D-1784_130215_SN590_0212_BC1NP2ACXX_s_3_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-G9-6367-01A	9F751C9D-AD41-4F02-B7F8-12423857D418	Primary Tumor	Illumina HiSeq	d4203e0e-c16e-4638-a239-378ffed98124	Prostate	60	5BC98578-E4C7-4BE8-89DF-F26AA5D545A9	9667EB66-775F-4C37-9309-FF73E55D553B	TCGA-G9-6367-01A-11D-1784-02	HG19_Broad_variant	TCGA-G9-6367	TCGA-PRAD	NA	s3612	Harvard Medical School	Roswell Park	United States	NO	T3a	N0	Prostate Adenocarcinoma Acinar Type	Not available	1784-02	TRUE
13722.58cfa832e4b0c9d6adf6d0c9	58cfa832e4b0c9d6adf6d0c9	TCGA-IG-A3YB-01A-11D-A248_121207_SN1222_0162_BD1MA7ACXX_s_3_rg.sorted.filtered.	WGS	TCGA-IG-A3YB-01A-11D-A248_121207_SN1222_0162_BD1MA7ACXX_s_3_rg.sorted	TCGA-IG-A3YB-01A-11D-A248_121207_SN1222_0162_BD1MA7ACXX_s_3_rg.sorted.bam	34.41	NA	0.15	58cfa832e4b0c9d6adf6d0c9	TCGA-IG-A3YB-01A-11D-A248_121207_SN1222_0162_BD1MA7ACXX_s_3_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Esophageal Carcinoma	Aligned reads	TCGA-IG-A3YB-01A	A1A233EA-5DDA-4EEB-BD92-6667E8B3EF57	Primary Tumor	Illumina HiSeq	6b51ea9f-5ca3-4973-bc0f-8df5ae95abbd	Esophagus	61	F936DE42-1441-4C4C-882A-DC67D332C125	335AAD40-B278-4EEC-BEE6-FC4F77C63370	TCGA-IG-A3YB-01A-11D-A248-26	HG19_Broad_variant	TCGA-IG-A3YB	TCGA-ESCA	NA	s1911	MD Anderson - Institute for Applied Cancer Science	Asterand	Russia	NO	T3	N1	Not available	Stage IIIA	A248-26	TRUE
13722.58cfa832e4b0c9d6adf6d0c8	58cfa832e4b0c9d6adf6d0c8	TCGA-FS-A1ZN-01A-11D-A18Y_120605_SN1222_0112_AC0WJJACXX_s_2_rg.sorted.filtered.	WGS	TCGA-FS-A1ZN-01A-11D-A18Y_120605_SN1222_0112_AC0WJJACXX_s_2_rg.sorted	TCGA-FS-A1ZN-01A-11D-A18Y_120605_SN1222_0112_AC0WJJACXX_s_2_rg.sorted.bam	65.89	NA	0.15	58cfa832e4b0c9d6adf6d0c8	TCGA-FS-A1ZN-01A-11D-A18Y_120605_SN1222_0112_AC0WJJACXX_s_2_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Skin Cutaneous Melanoma	Aligned reads	TCGA-FS-A1ZN-01A	9D86940D-50FB-4D2F-8B1E-539196885F46	Primary Tumor	Illumina HiSeq	497c930e-47cd-4669-a434-af770d331308	Skin	43	C6C66FAF-676B-4302-B825-143E1E72D04D	507A59F5-70A6-464C-ADA3-3E686414045A	TCGA-FS-A1ZN-01A-11D-A18Y-02	HG19_Broad_variant	TCGA-FS-A1ZN	TCGA-SKCM	730	s7372	Harvard Medical School	Essen	Germany	NO	T4b	N1a	Not available	Stage IIIA	A18Y-02	TRUE
13722.58cfa832e4b0c9d6adf6cfe8	58cfa832e4b0c9d6adf6cfe8	TCGA-GV-A3JX-01A-11D-A210_120912_SN1222_0148_AC188PACXX_s_1_rg.sorted.filtered.	WGS	TCGA-GV-A3JX-01A-11D-A210_120912_SN1222_0148_AC188PACXX_s_1_rg.sorted	TCGA-GV-A3JX-01A-11D-A210_120912_SN1222_0148_AC188PACXX_s_1_rg.sorted.bam	67.04	NA	0.15	58cfa832e4b0c9d6adf6cfe8	TCGA-GV-A3JX-01A-11D-A210_120912_SN1222_0148_AC188PACXX_s_1_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-GV-A3JX-01A	D9DCBB57-F6C2-4465-8A60-AFE876E113CA	Primary Tumor	Illumina HiSeq	317cc3f0-7a98-402b-bb1f-81a0437fbaf8	Bladder	59	CE32612D-F504-4164-AE50-04C4AC2999FB	A8636E11-C752-46F4-A6A8-42D5B7DCBD02	TCGA-GV-A3JX-01A-11D-A210-26	HG19_Broad_variant	TCGA-GV-A3JX	TCGA-BLCA	NA	s2736	MD Anderson - Institute for Applied Cancer Science	BLN - Cleveland Clinic	United States	NO	T3b	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage III	A210-26	TRUE
13722.58cfa832e4b0c9d6adf6d0e2	58cfa832e4b0c9d6adf6d0e2	TCGA-IG-A3YC-01A-11D-A248_121207_SN1222_0161_AC1HJ0ACXX_s_5_rg.sorted.filtered.	WGS	TCGA-IG-A3YC-01A-11D-A248_121207_SN1222_0161_AC1HJ0ACXX_s_5_rg.sorted	TCGA-IG-A3YC-01A-11D-A248_121207_SN1222_0161_AC1HJ0ACXX_s_5_rg.sorted.bam	24.61	NA	0.15	58cfa832e4b0c9d6adf6d0e2	TCGA-IG-A3YC-01A-11D-A248_121207_SN1222_0161_AC1HJ0ACXX_s_5_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Esophageal Carcinoma	Aligned reads	TCGA-IG-A3YC-01A	6A05288E-D051-40A5-9F4E-864AB806A5DC	Primary Tumor	Illumina HiSeq	a1261941-39f5-47ec-a6a4-ab07b298fb93	Esophagus	62	C754C363-924A-404A-9D60-4CA2A3930D2A	44EE541C-5657-43A9-9D56-6D88319E4617	TCGA-IG-A3YC-01A-11D-A248-26	HG19_Broad_variant	TCGA-IG-A3YC	TCGA-ESCA	NA	s1622	MD Anderson - Institute for Applied Cancer Science	Asterand	Russia	NO	T3	N1	Not available	Stage IIIA	A248-26	TRUE
13722.58cfa832e4b0c9d6adf6d126	58cfa832e4b0c9d6adf6d126	TCGA-FY-A3ON-01A-11D-A221_120610_SN1120_0152_BD13TDACXX_s_1_rg.sorted.filtered.	WGS	TCGA-FY-A3ON-01A-11D-A221_120610_SN1120_0152_BD13TDACXX_s_1_rg.sorted	TCGA-FY-A3ON-01A-11D-A221_120610_SN1120_0152_BD13TDACXX_s_1_rg.sorted.bam	44.16	NA	0.14	58cfa832e4b0c9d6adf6d126	TCGA-FY-A3ON-01A-11D-A221_120610_SN1120_0152_BD13TDACXX_s_1_rg.sorted.bam	Alive	MALE	WHITE	HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-FY-A3ON-01A	4D1AEC67-C345-4721-8EE8-356B0DFF009B	Primary Tumor	Illumina HiSeq	276539e6-e471-4dc2-96e7-0c80fb486af1	Thyroid	20	1392A49C-87BC-45E7-B7D2-ACD53E921467	68FEC551-495D-47E6-BF85-FBD422FC68D6	TCGA-FY-A3ON-01A-11D-A221-26	HG19_Broad_variant	TCGA-FY-A3ON	TCGA-THCA	NA	s12121	MD Anderson - Institute for Applied Cancer Science	International Genomics Consortium	United States	NO	T2	N1	Thyroid Papillary Carcinoma - Classical/usual	Stage I	A221-26	TRUE
13722.58cfa832e4b0c9d6adf6d1a8	58cfa832e4b0c9d6adf6d1a8	TCGA-HT-7472-01A-11D-2022_130911_SN1222_0218_BC2A1NACXX_s_7_rg.sorted.filtered.	WGS	TCGA-HT-7472-01A-11D-2022_130911_SN1222_0218_BC2A1NACXX_s_7_rg.sorted	TCGA-HT-7472-01A-11D-2022_130911_SN1222_0218_BC2A1NACXX_s_7_rg.sorted.bam	62.7	NA	0.17	58cfa832e4b0c9d6adf6d1a8	TCGA-HT-7472-01A-11D-2022_130911_SN1222_0218_BC2A1NACXX_s_7_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-HT-7472-01A	482D4078-7576-48CF-BF7C-29014935FD47	Primary Tumor	Illumina HiSeq	518f9b23-97da-447f-90e5-a03c5ae09642	Brain	38	F05081A2-2465-4EA4-9EC3-319810FE2D45	A68374D7-4782-4FF5-B921-35D45468A4D1	TCGA-HT-7472-01A-11D-2022-02	HG19_Broad_variant	TCGA-HT-7472	TCGA-LGG	NA	s8574	Harvard Medical School	Case Western - St Joes	United States	NO	Not available	Not available	Oligodendroglioma	Not available	2022-02	TRUE
13722.58cfa832e4b0c9d6adf6d196	58cfa832e4b0c9d6adf6d196	TCGA-K4-A3WV-01A-11D-A23Q_120926_SN1222_0153_BD1D4MACXX_s_6_rg.sorted.filtered.	WGS	TCGA-K4-A3WV-01A-11D-A23Q_120926_SN1222_0153_BD1D4MACXX_s_6_rg.sorted	TCGA-K4-A3WV-01A-11D-A23Q_120926_SN1222_0153_BD1D4MACXX_s_6_rg.sorted.bam	33.77	NA	0.15	58cfa832e4b0c9d6adf6d196	TCGA-K4-A3WV-01A-11D-A23Q_120926_SN1222_0153_BD1D4MACXX_s_6_rg.sorted.bam	Alive	FEMALE	WHITE	HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-K4-A3WV-01A	D53EADE8-A845-4252-AECE-92F3573486A7	Primary Tumor	Illumina HiSeq	ca7a6b06-a6fa-4314-80ef-725b81781598	Bladder	77	3ADFA409-A9F8-4EDB-AAF7-C5285AE5F895	9A7CA3A1-631F-41BA-A490-04D470C4AF8E	TCGA-K4-A3WV-01A-11D-A23Q-26	HG19_Broad_variant	TCGA-K4-A3WV	TCGA-BLCA	NA	s2937	MD Anderson - Institute for Applied Cancer Science	ABS - Lahey Clinic	United States	NO	T2b	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage II	A23Q-26	TRUE
13722.58cfa832e4b0c9d6adf6d2a6	58cfa832e4b0c9d6adf6d2a6	TCGA-IR-A3LL-01A-11D-A20X_140117_SN590_0245_AC371LACXX_s_4_rg.sorted.filtered.	WGS	TCGA-IR-A3LL-01A-11D-A20X_140117_SN590_0245_AC371LACXX_s_4_rg.sorted	TCGA-IR-A3LL-01A-11D-A20X_140117_SN590_0245_AC371LACXX_s_4_rg.sorted.bam	66.26	NA	0.15	58cfa832e4b0c9d6adf6d2a6	TCGA-IR-A3LL-01A-11D-A20X_140117_SN590_0245_AC371LACXX_s_4_rg.sorted.bam	Alive	FEMALE	WHITE	Not available	Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-IR-A3LL-01A	7C4AB1CA-4BDD-4EF7-9A42-F6C0C7136D26	Primary Tumor	Illumina HiSeq	817ccf3b-ceaa-45cf-a938-67e531a9f57a	Cervix	60	A0FB972A-CE8F-441F-8707-C3CC1081DEE0	5457562E-E184-4D13-B11C-49728B689275	TCGA-IR-A3LL-01A-11D-A20X-26	HG19_Broad_variant	TCGA-IR-A3LL	TCGA-CESC	NA	s1378	MD Anderson - Institute for Applied Cancer Science	Memorial Sloan Kettering	United States	NO	T1b1	N0	Cervical Squamous Cell Carcinoma	Not available	A20X-26	TRUE
13722.58cfa832e4b0c9d6adf6d362	58cfa832e4b0c9d6adf6d362	TCGA-L5-A4OH-01A-11D-A267_131001_SN1222_0222_BC2CN2ACXX_s_5_rg.sorted.filtered.	WGS	TCGA-L5-A4OH-01A-11D-A267_131001_SN1222_0222_BC2CN2ACXX_s_5_rg.sorted	TCGA-L5-A4OH-01A-11D-A267_131001_SN1222_0222_BC2CN2ACXX_s_5_rg.sorted.bam	43.66	NA	0.17	58cfa832e4b0c9d6adf6d362	TCGA-L5-A4OH-01A-11D-A267_131001_SN1222_0222_BC2CN2ACXX_s_5_rg.sorted.bam	Alive	MALE	WHITE	Not available	Esophageal Carcinoma	Aligned reads	TCGA-L5-A4OH-01A	3FA7FC16-49DA-4BF6-90C4-74DF5CF68B65	Primary Tumor	Illumina HiSeq	ba83865e-0ba3-48ab-841f-de07856ee9bc	Esophagus	71	4029F7BA-1D2D-49B8-A37B-4D4A5D0ACB79	C886B6DD-1595-49DD-B4DA-B69AA9C813E4	TCGA-L5-A4OH-01A-11D-A267-26	HG19_Broad_variant	TCGA-L5-A4OH	TCGA-ESCA	NA	s1747	MD Anderson - Institute for Applied Cancer Science	University of Michigan	United States	NO	T1	N0	Not available	Stage I	A267-26	TRUE
13722.58cfa832e4b0c9d6adf6d388	58cfa832e4b0c9d6adf6d388	TCGA-L5-A4OP-01A-11D-A267_131001_SN1120_0280_BD2FDEACXX_s_1_rg.sorted.filtered.	WGS	TCGA-L5-A4OP-01A-11D-A267_131001_SN1120_0280_BD2FDEACXX_s_1_rg.sorted	TCGA-L5-A4OP-01A-11D-A267_131001_SN1120_0280_BD2FDEACXX_s_1_rg.sorted.bam	41.04	NA	0.17	58cfa832e4b0c9d6adf6d388	TCGA-L5-A4OP-01A-11D-A267_131001_SN1120_0280_BD2FDEACXX_s_1_rg.sorted.bam	Alive	FEMALE	WHITE	Not available	Esophageal Carcinoma	Aligned reads	TCGA-L5-A4OP-01A	97031483-1185-41D6-9722-0A03B63CAA19	Primary Tumor	Illumina HiSeq	940f64ee-414a-4190-9fc9-c697ad112dfe	Esophagus	67	BA02D5B4-9CA9-4455-81D4-E5F2C8C0DF74	5D8E8DA5-04FF-4548-96EC-AE1E80C57CD1	TCGA-L5-A4OP-01A-11D-A267-26	HG19_Broad_variant	TCGA-L5-A4OP	TCGA-ESCA	NA	s1923	MD Anderson - Institute for Applied Cancer Science	University of Michigan	United States	NO	T1	N0	Not available	Stage IA	A267-26	TRUE
13722.58cfa832e4b0c9d6adf6d386	58cfa832e4b0c9d6adf6d386	TCGA-LN-A4A3-01A-11D-A267_131001_SN1120_0280_BD2FDEACXX_s_5_rg.sorted.filtered.	WGS	TCGA-LN-A4A3-01A-11D-A267_131001_SN1120_0280_BD2FDEACXX_s_5_rg.sorted	TCGA-LN-A4A3-01A-11D-A267_131001_SN1120_0280_BD2FDEACXX_s_5_rg.sorted.bam	20.45	NA	0.16	58cfa832e4b0c9d6adf6d386	TCGA-LN-A4A3-01A-11D-A267_131001_SN1120_0280_BD2FDEACXX_s_5_rg.sorted.bam	Alive	MALE	ASIAN	NOT HISPANIC OR LATINO	Esophageal Carcinoma	Aligned reads	TCGA-LN-A4A3-01A	3C0BB5E2-AD33-4D91-A31E-2A18F1C94D2D	Primary Tumor	Illumina HiSeq	e04a9b3d-9bc4-4857-9030-288efed94e80	Esophagus	61	3C85B0AB-C83E-4371-9F53-6A71D3763F3F	5402975D-7AE7-46FC-847A-4EE7DEBCD553	TCGA-LN-A4A3-01A-11D-A267-26	HG19_Broad_variant	TCGA-LN-A4A3	TCGA-ESCA	NA	s1770	MD Anderson - Institute for Applied Cancer Science	ILSbio	Vietnam	NO	T3	N1	Not available	Stage III	A267-26	TRUE
13722.58cfa832e4b0c9d6adf6d418	58cfa832e4b0c9d6adf6d418	TCGA-V4-A9F2-01A-11D-A40D_140715_SN1440_0193_BC4K41ACXX_s_2_rg.sorted.filtered.	WGS	TCGA-V4-A9F2-01A-11D-A40D_140715_SN1440_0193_BC4K41ACXX_s_2_rg.sorted	TCGA-V4-A9F2-01A-11D-A40D_140715_SN1440_0193_BC4K41ACXX_s_2_rg.sorted.bam	38.01	NA	0.16	58cfa832e4b0c9d6adf6d418	TCGA-V4-A9F2-01A-11D-A40D_140715_SN1440_0193_BC4K41ACXX_s_2_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uveal Melanoma	Aligned reads	TCGA-V4-A9F2-01A	411DDF79-FE92-44AD-8D10-EEB703F11BE7	Primary Tumor	Illumina HiSeq	c4fcd1a4-5246-4a6b-b5b0-45b8b838edf2	Eye	78	2F2FF6C7-9568-47E4-AB09-6050F84BBF5C	87781EA6-C3E9-476A-B5D2-E58FC557FC7A	TCGA-V4-A9F2-01A-11D-A40D-26	HG19_Broad_variant	TCGA-V4-A9F2	TCGA-UVM	NA	s207	MD Anderson - Institute for Applied Cancer Science	Institut Curie	France	NO	T3b	N0	Not available	Stage IIIA	A40D-26	TRUE
13722.58cfa832e4b0c9d6adf6d474	58cfa832e4b0c9d6adf6d474	TCGA-V4-A9EI-01A-11D-A40D_140725_SN590_0251_AC41YJACXX_s_6_rg.sorted.filtered.	WGS	TCGA-V4-A9EI-01A-11D-A40D_140725_SN590_0251_AC41YJACXX_s_6_rg.sorted	TCGA-V4-A9EI-01A-11D-A40D_140725_SN590_0251_AC41YJACXX_s_6_rg.sorted.bam	32.62	NA	0.17	58cfa832e4b0c9d6adf6d474	TCGA-V4-A9EI-01A-11D-A40D_140725_SN590_0251_AC41YJACXX_s_6_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Uveal Melanoma	Aligned reads	TCGA-V4-A9EI-01A	B533E555-90CF-4657-80C6-15B67DA8AD26	Primary Tumor	Illumina HiSeq	ffc1ec43-7da7-4a9b-ab87-1ad3a3ba5c42	Eye	78	0077CCB8-615D-4725-95E7-72708732E963	B0CCF5D2-B334-4B7C-858E-53005B6FD0D7	TCGA-V4-A9EI-01A-11D-A40D-26	HG19_Broad_variant	TCGA-V4-A9EI	TCGA-UVM	389	s203	MD Anderson - Institute for Applied Cancer Science	Institut Curie	France	NO	T4c	N0	Not available	Stage IIIB	A40D-26	TRUE
13722.58cfa832e4b0c9d6adf6d416	58cfa832e4b0c9d6adf6d416	TCGA-VD-A8K9-01A-11D-A40D_140716_SN208_0518_AC59RNACXX_s_2_rg.sorted.filtered.	WGS	TCGA-VD-A8K9-01A-11D-A40D_140716_SN208_0518_AC59RNACXX_s_2_rg.sorted	TCGA-VD-A8K9-01A-11D-A40D_140716_SN208_0518_AC59RNACXX_s_2_rg.sorted.bam	33.22	NA	0.15	58cfa832e4b0c9d6adf6d416	TCGA-VD-A8K9-01A-11D-A40D_140716_SN208_0518_AC59RNACXX_s_2_rg.sorted.bam	Alive	FEMALE	Not available	Not available	Uveal Melanoma	Aligned reads	TCGA-VD-A8K9-01A	FA9089FA-9AF9-4932-8AB7-0E7F2FD6B121	Primary Tumor	Illumina HiSeq	bd825a81-851e-4e11-a617-ff32ec721c33	Eye	71	25BDDCB7-2759-42F7-A8EB-D67F0D973802	03211DE4-51EB-4AB9-84CB-30D7A6F12025	TCGA-VD-A8K9-01A-11D-A40D-26	HG19_Broad_variant	TCGA-VD-A8K9	TCGA-UVM	NA	s277	MD Anderson - Institute for Applied Cancer Science	University of Liverpool	United Kingdom	NO	T2a	NX	Not available	Stage IIA	A40D-26	TRUE
13722.58cfa832e4b0c9d6adf6d4aa	58cfa832e4b0c9d6adf6d4aa	TCGA-V4-A9ET-01A-11D-A40D_140808_SN590_0253_AC499NACXX_s_5_rg.sorted.filtered.	WGS	TCGA-V4-A9ET-01A-11D-A40D_140808_SN590_0253_AC499NACXX_s_5_rg.sorted	TCGA-V4-A9ET-01A-11D-A40D_140808_SN590_0253_AC499NACXX_s_5_rg.sorted.bam	57.02	NA	0.17	58cfa832e4b0c9d6adf6d4aa	TCGA-V4-A9ET-01A-11D-A40D_140808_SN590_0253_AC499NACXX_s_5_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Uveal Melanoma	Aligned reads	TCGA-V4-A9ET-01A	5383FB57-69C2-4B34-AF7F-C67208EFB2B5	Primary Tumor	Illumina HiSeq	98f43560-a2c1-4edb-a936-9c84114cf0c2	Eye	57	C16B2576-AB56-4BEB-B621-22EA9FC4E898	D544884F-7E0D-4029-B778-55E14B5C2C38	TCGA-V4-A9ET-01A-11D-A40D-26	HG19_Broad_variant	TCGA-V4-A9ET	TCGA-UVM	NA	s244	MD Anderson - Institute for Applied Cancer Science	Institut Curie	France	NO	T4b	N0	Not available	Stage IIIB	A40D-26	TRUE
13722.58cfa832e4b0c9d6adf6d426	58cfa832e4b0c9d6adf6d426	TCGA-V4-A9F0-01A-11D-A40D_140714_SN1440_0192_AC3RUUACXX_s_4_rg.sorted.filtered.	WGS	TCGA-V4-A9F0-01A-11D-A40D_140714_SN1440_0192_AC3RUUACXX_s_4_rg.sorted	TCGA-V4-A9F0-01A-11D-A40D_140714_SN1440_0192_AC3RUUACXX_s_4_rg.sorted.bam	54.63	NA	0.15	58cfa832e4b0c9d6adf6d426	TCGA-V4-A9F0-01A-11D-A40D_140714_SN1440_0192_AC3RUUACXX_s_4_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Uveal Melanoma	Aligned reads	TCGA-V4-A9F0-01A	92FCA97D-6123-46A7-9C34-7A6F877FE612	Primary Tumor	Illumina HiSeq	96f55937-5d74-4e04-8ab5-f928a9a23da4	Eye	59	62859C7E-4B8D-4122-9365-B1595E944C42	C752F975-1E44-4EDF-87BA-4823698AC3F5	TCGA-V4-A9F0-01A-11D-A40D-26	HG19_Broad_variant	TCGA-V4-A9F0	TCGA-UVM	NA	s227	MD Anderson - Institute for Applied Cancer Science	Institut Curie	France	NO	T4b	N0	Not available	Stage IIIB	A40D-26	TRUE
13722.58cfa832e4b0c9d6adf6d4a6	58cfa832e4b0c9d6adf6d4a6	TCGA-V4-A9EW-01A-11D-A40D_140808_SN590_0253_AC499NACXX_s_8_rg.sorted.filtered.	WGS	TCGA-V4-A9EW-01A-11D-A40D_140808_SN590_0253_AC499NACXX_s_8_rg.sorted	TCGA-V4-A9EW-01A-11D-A40D_140808_SN590_0253_AC499NACXX_s_8_rg.sorted.bam	43.67	NA	0.16	58cfa832e4b0c9d6adf6d4a6	TCGA-V4-A9EW-01A-11D-A40D_140808_SN590_0253_AC499NACXX_s_8_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uveal Melanoma	Aligned reads	TCGA-V4-A9EW-01A	6BE5176C-4980-4663-ADFF-D04F05737DA0	Primary Tumor	Illumina HiSeq	3dd4d560-67ce-426b-9eeb-63fec58eaf05	Eye	44	685D5387-B35F-40EE-8F14-491CE212F0DE	6B52C651-649F-41C5-B0DD-197F77F2AA10	TCGA-V4-A9EW-01A-11D-A40D-26	HG19_Broad_variant	TCGA-V4-A9EW	TCGA-UVM	NA	s216	MD Anderson - Institute for Applied Cancer Science	Institut Curie	France	NO	T4a	N0	Not available	Stage IIIA	A40D-26	TRUE
13722.58cfa832e4b0c9d6adf6d4c6	58cfa832e4b0c9d6adf6d4c6	TCGA-VD-A8KA-01B-11D-A40D_140716_SN208_0518_AC59RNACXX_s_3_rg.sorted.filtered.	WGS	TCGA-VD-A8KA-01B-11D-A40D_140716_SN208_0518_AC59RNACXX_s_3_rg.sorted	TCGA-VD-A8KA-01B-11D-A40D_140716_SN208_0518_AC59RNACXX_s_3_rg.sorted.bam	26.17	NA	0.16	58cfa832e4b0c9d6adf6d4c6	TCGA-VD-A8KA-01B-11D-A40D_140716_SN208_0518_AC59RNACXX_s_3_rg.sorted.bam	Alive	MALE	Not available	Not available	Uveal Melanoma	Aligned reads	TCGA-VD-A8KA-01B	AF04CA52-8B71-497E-8135-6DDFCA9AB221	Primary Tumor	Illumina HiSeq	c48413ae-339d-4a00-8615-5fbb50dad7b2	Eye	22	F028A8C2-1AD9-4CCD-9EF4-076F90D73806	CE40220B-D109-4A14-9C17-3C7DFD0A737A	TCGA-VD-A8KA-01B-11D-A40D-26	HG19_Broad_variant	TCGA-VD-A8KA	TCGA-UVM	NA	s262	MD Anderson - Institute for Applied Cancer Science	University of Liverpool	United Kingdom	NO	T3a	NX	Not available	Stage IIB	A40D-26	TRUE
13722.58cfa832e4b0c9d6adf6d4ca	58cfa832e4b0c9d6adf6d4ca	TCGA-V4-A9F5-01A-11D-A40D_140716_SN208_0519_BC5946ACXX_s_1_rg.sorted.filtered.	WGS	TCGA-V4-A9F5-01A-11D-A40D_140716_SN208_0519_BC5946ACXX_s_1_rg.sorted	TCGA-V4-A9F5-01A-11D-A40D_140716_SN208_0519_BC5946ACXX_s_1_rg.sorted.bam	57.62	NA	0.17	58cfa832e4b0c9d6adf6d4ca	TCGA-V4-A9F5-01A-11D-A40D_140716_SN208_0519_BC5946ACXX_s_1_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uveal Melanoma	Aligned reads	TCGA-V4-A9F5-01A	BBF07E1F-8C17-4C2E-89ED-38332D82E455	Primary Tumor	Illumina HiSeq	11ec05e6-4b9a-4abf-8b47-45f259c5eaf3	Eye	85	16FCA21C-963E-4D77-8B5A-3C178DAC6168	38812469-1716-4B6F-8DBE-822654AC13F6	TCGA-V4-A9F5-01A-11D-A40D-26	HG19_Broad_variant	TCGA-V4-A9F5	TCGA-UVM	NA	s245	MD Anderson - Institute for Applied Cancer Science	Institut Curie	France	NO	T4e	N0	Not available	Stage IV	A40D-26	TRUE
13722.58cfa832e4b0c9d6adf6d54e	58cfa832e4b0c9d6adf6d54e	TCGA-L5-A4OS-01A-11D-A28P_140122_SN1222_0236_BD2CT4ACXX_s_3_rg.sorted.filtered.	WGS	TCGA-L5-A4OS-01A-11D-A28P_140122_SN1222_0236_BD2CT4ACXX_s_3_rg.sorted	TCGA-L5-A4OS-01A-11D-A28P_140122_SN1222_0236_BD2CT4ACXX_s_3_rg.sorted.bam	26.15	NA	0.16	58cfa832e4b0c9d6adf6d54e	TCGA-L5-A4OS-01A-11D-A28P_140122_SN1222_0236_BD2CT4ACXX_s_3_rg.sorted.bam	Alive	FEMALE	WHITE	Not available	Esophageal Carcinoma	Aligned reads	TCGA-L5-A4OS-01A	D5AC647F-0C6D-40D7-87A8-FAA1CC968C82	Primary Tumor	Illumina HiSeq	5c0f7af4-2359-4784-8db9-a4acac6fbb09	Esophagus	86	8734680B-CA7B-49F4-A539-0182B45454F3	C3CAE2EF-E23F-4D72-8B4F-E9F9AF08340D	TCGA-L5-A4OS-01A-11D-A28P-26	HG19_Broad_variant	TCGA-L5-A4OS	TCGA-ESCA	NA	s1849	MD Anderson - Institute for Applied Cancer Science	University of Michigan	United States	NO	T2	N1	Not available	Stage IIB	A28P-26	TRUE
13722.58cfa832e4b0c9d6adf6d528	58cfa832e4b0c9d6adf6d528	TCGA-L5-A4OJ-01A-11D-A267_131018_SN590_0241_BC30HBACXX_s_1_rg.sorted.filtered.	WGS	TCGA-L5-A4OJ-01A-11D-A267_131018_SN590_0241_BC30HBACXX_s_1_rg.sorted	TCGA-L5-A4OJ-01A-11D-A267_131018_SN590_0241_BC30HBACXX_s_1_rg.sorted.bam	44.72	NA	0.17	58cfa832e4b0c9d6adf6d528	TCGA-L5-A4OJ-01A-11D-A267_131018_SN590_0241_BC30HBACXX_s_1_rg.sorted.bam	Alive	FEMALE	WHITE	Not available	Esophageal Carcinoma	Aligned reads	TCGA-L5-A4OJ-01A	CB419344-6148-43D4-B549-570BD09B3E05	Primary Tumor	Illumina HiSeq	b8117191-ea00-451f-85ca-53357a42b44f	Esophagus	70	4F03824A-79D6-40E8-A9E0-4079B1209F38	74221A72-4B40-4943-877D-7979EB4BD268	TCGA-L5-A4OJ-01A-11D-A267-26	HG19_Broad_variant	TCGA-L5-A4OJ	TCGA-ESCA	NA	s1651	MD Anderson - Institute for Applied Cancer Science	University of Michigan	United States	NO	T1	N0	Not available	Stage I	A267-26	TRUE
13722.58cfa832e4b0c9d6adf6d4f8	58cfa832e4b0c9d6adf6d4f8	TCGA-L5-A4OT-01A-11D-A28P_140122_SN1222_0236_BD2CT4ACXX_s_7_rg.sorted.filtered.	WGS	TCGA-L5-A4OT-01A-11D-A28P_140122_SN1222_0236_BD2CT4ACXX_s_7_rg.sorted	TCGA-L5-A4OT-01A-11D-A28P_140122_SN1222_0236_BD2CT4ACXX_s_7_rg.sorted.bam	28.48	NA	0.14	58cfa832e4b0c9d6adf6d4f8	TCGA-L5-A4OT-01A-11D-A28P_140122_SN1222_0236_BD2CT4ACXX_s_7_rg.sorted.bam	Dead	MALE	WHITE	Not available	Esophageal Carcinoma	Aligned reads	TCGA-L5-A4OT-01A	9559F579-5D9A-4C96-9836-8A039D394795	Primary Tumor	Illumina HiSeq	7d4e10aa-fe0f-4c18-800f-98fde94f819b	Esophagus	77	6671C9B7-5445-40F1-ADB6-FCC8BAD25301	79E420D7-8852-45A0-BBEB-CAEEC5BE685F	TCGA-L5-A4OT-01A-11D-A28P-26	HG19_Broad_variant	TCGA-L5-A4OT	TCGA-ESCA	149	s1927	MD Anderson - Institute for Applied Cancer Science	University of Michigan	United States	NO	T3	N1	Not available	Stage IV	A28P-26	TRUE
13722.58cfa832e4b0c9d6adf6d5a8	58cfa832e4b0c9d6adf6d5a8	TCGA-LN-A49S-01A-11D-A248_121207_SN1222_0162_BD1MA7ACXX_s_5_rg.sorted.filtered.	WGS	TCGA-LN-A49S-01A-11D-A248_121207_SN1222_0162_BD1MA7ACXX_s_5_rg.sorted	TCGA-LN-A49S-01A-11D-A248_121207_SN1222_0162_BD1MA7ACXX_s_5_rg.sorted.bam	29.69	NA	0.17	58cfa832e4b0c9d6adf6d5a8	TCGA-LN-A49S-01A-11D-A248_121207_SN1222_0162_BD1MA7ACXX_s_5_rg.sorted.bam	Alive	MALE	ASIAN	NOT HISPANIC OR LATINO	Esophageal Carcinoma	Aligned reads	TCGA-LN-A49S-01A	E9F82800-647A-4D61-BD1F-2C17C4CCAFBA	Primary Tumor	Illumina HiSeq	f173addf-1b74-441d-b167-5eb17cdfe1c3	Esophagus	59	A83FF623-8AF0-44A9-8468-95457A017E5A	151B9A13-9D3D-4AF2-A779-24F62A13975B	TCGA-LN-A49S-01A-11D-A248-26	HG19_Broad_variant	TCGA-LN-A49S	TCGA-ESCA	NA	s1680	MD Anderson - Institute for Applied Cancer Science	ILSbio	Vietnam	NO	T3	N0	Not available	Stage IIA	A248-26	TRUE
13722.58cfa832e4b0c9d6adf6d4fa	58cfa832e4b0c9d6adf6d4fa	TCGA-L5-A4OE-01A-11D-A267_131001_SN1120_0279_AC2DKPACXX_s_1_rg.sorted.filtered.	WGS	TCGA-L5-A4OE-01A-11D-A267_131001_SN1120_0279_AC2DKPACXX_s_1_rg.sorted	TCGA-L5-A4OE-01A-11D-A267_131001_SN1120_0279_AC2DKPACXX_s_1_rg.sorted.bam	43.86	NA	0.16	58cfa832e4b0c9d6adf6d4fa	TCGA-L5-A4OE-01A-11D-A267_131001_SN1120_0279_AC2DKPACXX_s_1_rg.sorted.bam	Alive	MALE	WHITE	Not available	Esophageal Carcinoma	Aligned reads	TCGA-L5-A4OE-01A	0A466142-C513-4257-85D4-4BD7CFD0EF29	Primary Tumor	Illumina HiSeq	49822c02-a9e7-4e7e-bd12-f1756b639beb	Esophagus	81	BD8CADB2-1382-4BF5-A68F-C5A71837FE95	C5F599A9-1398-4E49-9CC7-77129658E143	TCGA-L5-A4OE-01A-11D-A267-26	HG19_Broad_variant	TCGA-L5-A4OE	TCGA-ESCA	NA	s1838	MD Anderson - Institute for Applied Cancer Science	University of Michigan	United States	NO	T3	N2	Not available	Stage IIIB	A267-26	TRUE
13722.58cfa831e4b0c9d6adf6c485	58cfa831e4b0c9d6adf6c485	TCGA-CM-4752-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.filtered.	WGS	TCGA-CM-4752-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole	TCGA-CM-4752-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.bam	846.02	1.9	0.15	58cfa831e4b0c9d6adf6c485	TCGA-CM-4752-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.bam	Alive	MALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Colon Adenocarcinoma	Aligned reads	TCGA-CM-4752-01A	7EA546CE-F48A-4D9C-96B4-A0124C692870	Primary Tumor	Illumina HiSeq	ad469933-d84b-4305-85e2-a7d919298b71	Colorectal	58	5703F0D8-DB96-40CE-8009-51D2EC188ABF	43756C1F-6ED2-468B-B0AD-D44A447C7709	TCGA-CM-4752-01A-01D-1405-02	HG18	TCGA-CM-4752	TCGA-COAD	NA	s13219	Harvard Medical School	MSKCC	None	NO	T3	N0	Colon Adenocarcinoma	Stage IIA	1405-02	TRUE
13722.58cfa831e4b0c9d6adf6ca05	58cfa831e4b0c9d6adf6ca05	TCGA-DE-A0Y3-01B-11D-A10R_120617_SN1222_0117_BD1414ACXX_s_3_rg.sorted.filtered.	WGS	TCGA-DE-A0Y3-01B-11D-A10R_120617_SN1222_0117_BD1414ACXX_s_3_rg.sorted	TCGA-DE-A0Y3-01B-11D-A10R_120617_SN1222_0117_BD1414ACXX_s_3_rg.sorted.bam	60.48	2.03	0.14	58cfa831e4b0c9d6adf6ca05	TCGA-DE-A0Y3-01B-11D-A10R_120617_SN1222_0117_BD1414ACXX_s_3_rg.sorted.bam	Alive	FEMALE	ASIAN	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-DE-A0Y3-01B	C31B3ADF-3FC6-4A72-83B0-BBC0F295B5E7	Primary Tumor	Illumina HiSeq	e17f6c8d-d069-4561-8371-8138731e3dd2	Thyroid	60	3AE03B86-1473-409C-8118-A91A73A36F60	F3099D9B-DBBE-46CB-BA22-DAD7F9428C4F	TCGA-DE-A0Y3-01B-11D-A10R-02	HG19_Broad_variant	TCGA-DE-A0Y3	TCGA-THCA	NA	s12848	Harvard Medical School	University of North Carolina	United States	NO	T4a	N1b	Thyroid Papillary Carcinoma - Classical/usual	Stage IVC	A10R-02	TRUE
13722.58cfa82de4b0c9d6adf6a534	58cfa82de4b0c9d6adf6a534	49320cdd49b83c21082251cf7413af62.filtered.	WGS	49320cdd49b83c21082251cf7413af62	49320cdd49b83c21082251cf7413af62.bam	NA	NA	0.08	58cfa82de4b0c9d6adf6a534	49320cdd49b83c21082251cf7413af62.bam	Alive	FEMALE	WHITE	Not available	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-AP-A051-01A	B045F24B-F822-4DF9-9FFA-47308EDCEC8C	Primary Tumor	Illumina HiSeq	16685246-b33b-4810-9cef-2ec37924f621	Uterus	69	417CFF62-B034-4197-9CFD-E640D55F3094	BCF858FD-CC3B-4FDE-AB10-EB96216F4366	TCGA-AP-A051-01A-21D-A013-09	GRCh37-lite	TCGA-AP-A051	TCGA-UCEC	NA	s5190	Washington University School of Medicine	MSKCC	None	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A013-09	TRUE
13722.58cfa82de4b0c9d6adf6a577	58cfa82de4b0c9d6adf6a577	4d55b306c9f948c74d83dd41705f0440.filtered.	WGS	4d55b306c9f948c74d83dd41705f0440	4d55b306c9f948c74d83dd41705f0440.bam	91.17	1.76	0.08	58cfa82de4b0c9d6adf6a577	4d55b306c9f948c74d83dd41705f0440.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-C5-A1MQ-01A	EB59CF69-1997-41B9-BF69-69AD7DA292A1	Primary Tumor	Illumina HiSeq	6eef85cb-d9eb-495a-b69a-6944cbd18483	Cervix	35	F5FC27D9-4949-43E9-B358-78CB69D87A3C	A67F4531-99EF-43DF-82F5-F6ABC4B11826	TCGA-C5-A1MQ-01A-11D-A200-09	GRCh37-lite	TCGA-C5-A1MQ	TCGA-CESC	NA	s1163	Washington University School of Medicine	Medical College of Wisconsin	United States	NO	T2b	N0	Cervical Squamous Cell Carcinoma	Not available	A200-09	TRUE
13722.58cfa82de4b0c9d6adf6a666	58cfa82de4b0c9d6adf6a666	804182419c4c4708dc5058194c29d6d2.filtered.	WGS	804182419c4c4708dc5058194c29d6d2	804182419c4c4708dc5058194c29d6d2.bam	22.3	NA	0.08	58cfa82de4b0c9d6adf6a666	804182419c4c4708dc5058194c29d6d2.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Sarcoma	Aligned reads	TCGA-DX-A3LT-01A	E7A72F7E-77B1-4D95-8F37-39A6CFFC35DC	Primary Tumor	Illumina HiSeq	3daa0a7d-91d3-4cad-a48a-5a08bdd32529	Mesenchymal	62	32F8354A-7D2F-467B-AFED-E7F91369615F	A2F02FF7-8433-4CB5-9324-34F13EDEACA1	TCGA-DX-A3LT-01A-12D-A21Q-09	GRCh37-lite	TCGA-DX-A3LT	TCGA-SARC	NA	s2490	Washington University School of Medicine	Memorial Sloan Kettering	United States	NO	Not available	Not available	Not available	Not available	A21Q-09	TRUE
13722.58cfa82ee4b0c9d6adf6aaa8	58cfa82ee4b0c9d6adf6aaa8	G32463.TCGA-DK-A1A5-01A-11D-A13W-08.3.filtered.	WGS	G32463.TCGA-DK-A1A5-01A-11D-A13W-08.3	G32463.TCGA-DK-A1A5-01A-11D-A13W-08.3.bam	59.04	1.91	0.08	58cfa82ee4b0c9d6adf6aaa8	G32463.TCGA-DK-A1A5-01A-11D-A13W-08.3.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-DK-A1A5-01A	904A8757-E0C5-41EF-B583-C8F170CAAAC1	Primary Tumor	Illumina HiSeq	bc2dfa86-f2b0-4747-beb4-8940c4a6c000	Bladder	79	A9EF3EC5-B1C1-481F-89CF-1729FAB50173	448FE471-3F4E-4DC8-A4E0-6F147DC93ABE	TCGA-DK-A1A5-01A-11D-A13W-08	HG19_Broad_variant	TCGA-DK-A1A5	TCGA-BLCA	65	s3253	Broad Institute of MIT and Harvard	Memorial Sloan Kettering	United States	NO	T2b	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage II	A13W-08	TRUE
13722.58cfa82ee4b0c9d6adf6ab36	58cfa82ee4b0c9d6adf6ab36	G32557.TCGA-ER-A19T-01A-11D-A19A-08.3.filtered.	WGS	G32557.TCGA-ER-A19T-01A-11D-A19A-08.3	G32557.TCGA-ER-A19T-01A-11D-A19A-08.3.bam	76.29	NA	0.09	58cfa82ee4b0c9d6adf6ab36	G32557.TCGA-ER-A19T-01A-11D-A19A-08.3.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Skin Cutaneous Melanoma	Aligned reads	TCGA-ER-A19T-01A	B85B14D7-3B5A-4800-AF12-622EC03B9FE5	Primary Tumor	Illumina HiSeq	7967a744-2db3-4cec-86e2-524388a325e5	Skin	51	11E2F891-251A-4813-AA90-E944F350C54D	D1942D67-3C90-474E-9164-E76DDF9E335A	TCGA-ER-A19T-01A-11D-A19A-08	HG19_Broad_variant	TCGA-ER-A19T	TCGA-SKCM	270	s7307	Broad Institute of MIT and Harvard	University of Pittsburgh	United States	NO	T4a	N3	Not available	Stage IV	A19A-08	TRUE
13722.58cfa82fe4b0c9d6adf6b8e0	58cfa82fe4b0c9d6adf6b8e0	TCGA-A7-A0CE-01A-11D-A12L-09_IlluminaGA-DNASeq_whole_1.filtered.	WGS	TCGA-A7-A0CE-01A-11D-A12L-09_IlluminaGA-DNASeq_whole_1	TCGA-A7-A0CE-01A-11D-A12L-09_IlluminaGA-DNASeq_whole_1.bam	40.39	1.89	0.07	58cfa82fe4b0c9d6adf6b8e0	TCGA-A7-A0CE-01A-11D-A12L-09_IlluminaGA-DNASeq_whole_1.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-A7-A0CE-01A	9D95A65B-E41D-4F93-92D4-99DCE29FF40D	Primary Tumor	Illumina HiSeq	d744c7c6-690c-4f5e-968e-532936b3696a	Breast	57	9DC315CE-3B76-4754-B103-2C2580CDE4AB	7B08E810-F3C9-4155-AC11-F45A3A4F8B41	TCGA-A7-A0CE-01A-11D-A12L-09	GRCh37-lite	TCGA-A7-A0CE	TCGA-BRCA	NA	s5490	Washington University School of Medicine	Christiana Healthcare	None	NO	T2	N0 (i-)	Infiltrating Ductal Carcinoma	Stage IIA	A12L-09	FALSE
13722.58cfa82fe4b0c9d6adf6b948	58cfa82fe4b0c9d6adf6b948	TCGA-A2-A04T-01A-21D-A128-09_IlluminaGA-DNASeq_whole.filtered.	WGS	TCGA-A2-A04T-01A-21D-A128-09_IlluminaGA-DNASeq_whole	TCGA-A2-A04T-01A-21D-A128-09_IlluminaGA-DNASeq_whole.bam	91.2	1.92	0.08	58cfa82fe4b0c9d6adf6b948	TCGA-A2-A04T-01A-21D-A128-09_IlluminaGA-DNASeq_whole.bam	Alive	FEMALE	WHITE	Not available	Breast Invasive Carcinoma	Aligned reads	TCGA-A2-A04T-01A	B58AD350-5140-4FA8-BC2C-24BCA8395F3A	Primary Tumor	Illumina HiSeq	6dd42df3-896f-418a-9f13-468ac66d69bc	Breast	62	6DD4870F-1EC2-484B-8703-6397D8E67DAA	B752B444-F033-4BE4-9D24-E5E80B4181AF	TCGA-A2-A04T-01A-21D-A128-09	GRCh37-lite	TCGA-A2-A04T	TCGA-BRCA	NA	s5637	Washington University School of Medicine	Walter Reed	None	NO	T2	N0 (i-)	Infiltrating Ductal Carcinoma	Stage IIA	A128-09	TRUE
13722.58cfa82fe4b0c9d6adf6b958	58cfa82fe4b0c9d6adf6b958	TCGA-AA-3534-01A-01D-1525-10_Illumina.filtered.	WGS	TCGA-AA-3534-01A-01D-1525-10_Illumina	TCGA-AA-3534-01A-01D-1525-10_Illumina.bam	84.63	1.9	0.05	58cfa82fe4b0c9d6adf6b958	TCGA-AA-3534-01A-01D-1525-10_Illumina.bam	Alive	FEMALE	Not available	Not available	Colon Adenocarcinoma	Aligned reads	TCGA-AA-3534-01A	DF228C56-89AC-4122-93B3-6C0740C4EC09	Primary Tumor	Illumina HiSeq	a3cf0d96-684b-4e42-ac5f-e1e6813123de	Colorectal	78	ECADE2C1-9DE2-4B05-B30C-4C8B81C65AE1	66701395-5A53-41BB-866B-3BBF08BC33AB	TCGA-AA-3534-01A-01D-1525-10	NCBI36_BCM_variant	TCGA-AA-3534	TCGA-COAD	NA	s13509	Baylor College of Medicine	Indivumed	Germany	NO	T3	N0	Colon Adenocarcinoma	Stage IIA	1525-10	TRUE
13722.58cfa830e4b0c9d6adf6bc2c	58cfa830e4b0c9d6adf6bc2c	TCGA-AO-A0J4-01A-11D-A128-09_IlluminaGA-DNASeq_whole.filtered.	WGS	TCGA-AO-A0J4-01A-11D-A128-09_IlluminaGA-DNASeq_whole	TCGA-AO-A0J4-01A-11D-A128-09_IlluminaGA-DNASeq_whole.bam	78.64	1.86	0.08	58cfa830e4b0c9d6adf6bc2c	TCGA-AO-A0J4-01A-11D-A128-09_IlluminaGA-DNASeq_whole.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-AO-A0J4-01A	A9B7D7FE-BE31-4F71-AFEE-C1BFDF511888	Primary Tumor	Illumina HiSeq	b518df9f-2eae-4c82-92e3-3eb196cdd3a5	Breast	41	CF11642A-EB96-4B37-B914-371C71F8E0CA	110B5F05-DED7-45EC-B0F6-A941C92D77DD	TCGA-AO-A0J4-01A-11D-A128-09	GRCh37-lite	TCGA-AO-A0J4	TCGA-BRCA	NA	s5960	Washington University School of Medicine	MSKCC	None	NO	T1c	N0 (i-)	Infiltrating Ductal Carcinoma	Stage IA	A128-09	TRUE
13722.58cfa830e4b0c9d6adf6bbae	58cfa830e4b0c9d6adf6bbae	TCGA-A2-A0D2-01A-21D-A128-09_IlluminaGA-DNASeq_whole.filtered.	WGS	TCGA-A2-A0D2-01A-21D-A128-09_IlluminaGA-DNASeq_whole	TCGA-A2-A0D2-01A-21D-A128-09_IlluminaGA-DNASeq_whole.bam	61.59	1.89	0.08	58cfa830e4b0c9d6adf6bbae	TCGA-A2-A0D2-01A-21D-A128-09_IlluminaGA-DNASeq_whole.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-A2-A0D2-01A	99E32C59-AA73-43FA-88C9-399DDADB2C72	Primary Tumor	Illumina HiSeq	221d4b81-a70e-4647-8a9a-ce4866538392	Breast	45	72439E36-3C17-4A90-B3E1-8F6CCFD3DCD4	51A5A15A-1551-469F-A5B0-09581EC47975	TCGA-A2-A0D2-01A-21D-A128-09	GRCh37-lite	TCGA-A2-A0D2	TCGA-BRCA	NA	s5488	Washington University School of Medicine	Walter Reed	None	NO	T2	N0 (i+)	Infiltrating Ductal Carcinoma	Stage IIA	A128-09	TRUE
13722.58cfa830e4b0c9d6adf6bdc6	58cfa830e4b0c9d6adf6bdc6	TCGA-BH-A0B3-01A-11D-A128-09_IlluminaGA-DNASeq_whole.filtered.	WGS	TCGA-BH-A0B3-01A-11D-A128-09_IlluminaGA-DNASeq_whole	TCGA-BH-A0B3-01A-11D-A128-09_IlluminaGA-DNASeq_whole.bam	52.29	1.9	0.08	58cfa830e4b0c9d6adf6bdc6	TCGA-BH-A0B3-01A-11D-A128-09_IlluminaGA-DNASeq_whole.bam	Alive	FEMALE	WHITE	Not available	Breast Invasive Carcinoma	Aligned reads	TCGA-BH-A0B3-01A	18EB4DFC-556F-4BF3-A411-4780209ED1E0	Primary Tumor	Illumina HiSeq	82535082-739b-4a9b-8609-4724bbdd27ee	Breast	53	FC1F0AD4-8412-4143-8EBF-FA6592F396E9	43F7A2E0-FEC9-4E43-872D-18C6C946FA17	TCGA-BH-A0B3-01A-11D-A128-09	GRCh37-lite	TCGA-BH-A0B3	TCGA-BRCA	NA	s6464	Washington University School of Medicine	University of Pittsburgh	None	NO	T2	N1a	Infiltrating Ductal Carcinoma	Stage IIB	A128-09	TRUE
13722.58cfa830e4b0c9d6adf6bdd8	58cfa830e4b0c9d6adf6bdd8	TCGA-BH-A0E0-01A-11D-A128-09_IlluminaGA-DNASeq_whole.filtered.	WGS	TCGA-BH-A0E0-01A-11D-A128-09_IlluminaGA-DNASeq_whole	TCGA-BH-A0E0-01A-11D-A128-09_IlluminaGA-DNASeq_whole.bam	55.87	1.93	0.08	58cfa830e4b0c9d6adf6bdd8	TCGA-BH-A0E0-01A-11D-A128-09_IlluminaGA-DNASeq_whole.bam	Alive	FEMALE	WHITE	Not available	Breast Invasive Carcinoma	Aligned reads	TCGA-BH-A0E0-01A	20E8106B-1290-4735-ABE4-7621E08E3DC8	Primary Tumor	Illumina HiSeq	fc737335-21e7-4997-b267-04d3f91043f5	Breast	38	662CC11C-DA31-4E31-8E77-46011B38EA96	E8392F20-C9E3-4649-B64F-5B266C393A76	TCGA-BH-A0E0-01A-11D-A128-09	GRCh37-lite	TCGA-BH-A0E0	TCGA-BRCA	NA	s5804	Washington University School of Medicine	University of Pittsburgh	None	NO	T3	N3a	Infiltrating Ductal Carcinoma	Stage IIIC	A128-09	TRUE
13722.58cfa830e4b0c9d6adf6c1ea	58cfa830e4b0c9d6adf6c1ea	TCGA-AO-A0J6-01A-11D-A128-09_IlluminaGA-DNASeq_whole.filtered.	WGS	TCGA-AO-A0J6-01A-11D-A128-09_IlluminaGA-DNASeq_whole	TCGA-AO-A0J6-01A-11D-A128-09_IlluminaGA-DNASeq_whole.bam	73.05	2	0.08	58cfa830e4b0c9d6adf6c1ea	TCGA-AO-A0J6-01A-11D-A128-09_IlluminaGA-DNASeq_whole.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-AO-A0J6-01A	E9F4F373-37A5-48AD-A1A0-B0D47820111A	Primary Tumor	Illumina HiSeq	71b1d18c-e0ab-473a-b4ee-55ebb68cfda8	Breast	61	0C12EA89-EEB4-4865-91EB-10CF75884C21	F69E5057-EDA6-4391-BA9A-AEDBF6B572DA	TCGA-AO-A0J6-01A-11D-A128-09	GRCh37-lite	TCGA-AO-A0J6	TCGA-BRCA	NA	s5798	Washington University School of Medicine	MSKCC	None	NO	T2	N0 (i-)	Infiltrating Ductal Carcinoma	Stage IIA	A128-09	TRUE
13722.58cfa83ce4b0c9d6adf72efc	58cfa83ce4b0c9d6adf72efc	bc77bc34a99fd3e3ca9ff72ebb9852f8.filtered.	WGS	bc77bc34a99fd3e3ca9ff72ebb9852f8	bc77bc34a99fd3e3ca9ff72ebb9852f8.bam	21.25	NA	0.08	58cfa83ce4b0c9d6adf72efc	bc77bc34a99fd3e3ca9ff72ebb9852f8.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Sarcoma	Aligned reads	TCGA-HB-A5W3-01A	C5B0E6BE-48B5-40E5-9D90-F9112050AA88	Primary Tumor	Illumina HiSeq	49c1bf65-391c-43e5-97fe-2f34ca184442	Mesenchymal	58	E7E97623-5C8A-42B4-ABC6-E7B424816713	4D4EFF82-EDE0-47F1-B49A-ADA025952114	TCGA-HB-A5W3-01A-11D-A29N-09	GRCh37-lite	TCGA-HB-A5W3	TCGA-SARC	384	s2669	Washington University School of Medicine	University of North Carolina	United States	NO	Not available	Not available	Not available	Not available	A29N-09	FALSE
13722.58cfa83ce4b0c9d6adf72f0f	58cfa83ce4b0c9d6adf72f0f	d70abbce939febed4d88a2f3041db471.filtered.	WGS	d70abbce939febed4d88a2f3041db471	d70abbce939febed4d88a2f3041db471.bam	97.91	1.93	0.08	58cfa83ce4b0c9d6adf72f0f	d70abbce939febed4d88a2f3041db471.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-D1-A1NU-01A	E56491AF-718F-4CA1-B3CD-0E5B3154697B	Primary Tumor	Illumina HiSeq	55250c6d-b9fb-4613-8463-59123f4e2065	Uterus	74	7901F084-C220-4865-A034-DA0144D63A28	FD504153-3CF6-44B9-99D5-21961EBAC188	TCGA-D1-A1NU-01A-11D-A34H-09	GRCh37-lite	TCGA-D1-A1NU	TCGA-UCEC	NA	s4399	Washington University School of Medicine	Mayo Clinic	United States	NO	Not available	Not available	Serous endometrial adenocarcinoma	Not available	A34H-09	TRUE
13722.58cfa82ee4b0c9d6adf6ae6a	58cfa82ee4b0c9d6adf6ae6a	TCGA-05-4398-01A-01D-1203_120316_SN208_0275_BD0PL2ACXX_s_1_rg.sorted.filtered.	WGS	TCGA-05-4398-01A-01D-1203_120316_SN208_0275_BD0PL2ACXX_s_1_rg.sorted	TCGA-05-4398-01A-01D-1203_120316_SN208_0275_BD0PL2ACXX_s_1_rg.sorted.bam	403.53	1.9	0.15	58cfa82ee4b0c9d6adf6ae6a	TCGA-05-4398-01A-01D-1203_120316_SN208_0275_BD0PL2ACXX_s_1_rg.sorted.bam	Alive	FEMALE	Not available	Not available	Lung Adenocarcinoma	Aligned reads	TCGA-05-4398-01A	31C96E35-5E2F-429C-B12A-7BC5A497A300	Primary Tumor	Illumina HiSeq	af507e03-fa73-4b22-88ae-8d5d9cee85dc	Lung	47	DA010683-C537-478F-8F95-E606B05DBC5C	CC8C5E2D-1878-49EC-9D63-D65EB4FE8256	TCGA-05-4398-01A-01D-1203-02	HG19_Broad_variant	TCGA-05-4398	TCGA-LUAD	NA	s10981	Harvard Medical School	Indivumed	Germany	NO	T4	N3	Lung Adenocarcinoma Mixed Subtype	Stage IIIB	1203-02	TRUE
13722.58cfa82ee4b0c9d6adf6ae50	58cfa82ee4b0c9d6adf6ae50	TCGA-05-4382-01A-01D-1203_120318_SN1120_0124_AC0HNPACXX_s_3_rg.sorted.filtered.	WGS	TCGA-05-4382-01A-01D-1203_120318_SN1120_0124_AC0HNPACXX_s_3_rg.sorted	TCGA-05-4382-01A-01D-1203_120318_SN1120_0124_AC0HNPACXX_s_3_rg.sorted.bam	445.53	1.9	0.14	58cfa82ee4b0c9d6adf6ae50	TCGA-05-4382-01A-01D-1203_120318_SN1120_0124_AC0HNPACXX_s_3_rg.sorted.bam	Alive	MALE	Not available	Not available	Lung Adenocarcinoma	Aligned reads	TCGA-05-4382-01A	3434B91A-C05F-460F-A078-7B1BB6E7085D	Primary Tumor	Illumina HiSeq	42d76c95-55a7-4160-b22f-4338315e6146	Lung	68	CCE6D71F-369E-467F-BD7E-03D20E97B7F3	EE1D241A-B371-433A-9AF7-F1C9074C155F	TCGA-05-4382-01A-01D-1203-02	HG19_Broad_variant	TCGA-05-4382	TCGA-LUAD	NA	s11435	Harvard Medical School	Indivumed	None	NO	T2	N0	Lung Adenocarcinoma Mixed Subtype	Stage IB	1203-02	TRUE
13722.58cfa82ee4b0c9d6adf6b02c	58cfa82ee4b0c9d6adf6b02c	TCGA-05-4420-01A-01D-1203_120316_SN208_0275_BD0PL2ACXX_s_3_rg.sorted.filtered.	WGS	TCGA-05-4420-01A-01D-1203_120316_SN208_0275_BD0PL2ACXX_s_3_rg.sorted	TCGA-05-4420-01A-01D-1203_120316_SN208_0275_BD0PL2ACXX_s_3_rg.sorted.bam	651.3	1.9	0.16	58cfa82ee4b0c9d6adf6b02c	TCGA-05-4420-01A-01D-1203_120316_SN208_0275_BD0PL2ACXX_s_3_rg.sorted.bam	Alive	MALE	Not available	Not available	Lung Adenocarcinoma	Aligned reads	TCGA-05-4420-01A	3D2AA654-1B5F-4EB4-A1C2-AF31F5760069	Primary Tumor	Illumina HiSeq	067a9600-61b8-4de1-ac32-914605c3033e	Lung	41	4B202550-9744-4C6C-AD17-97F764EA3F18	A50583F2-BB90-4848-9A5F-EAF4656A1866	TCGA-05-4420-01A-01D-1203-02	HG19_Broad_variant	TCGA-05-4420	TCGA-LUAD	NA	s11332	Harvard Medical School	Indivumed	Germany	NO	T2	N0	Lung Adenocarcinoma Mixed Subtype	Stage IB	1203-02	TRUE
13722.58cfa82fe4b0c9d6adf6b64a	58cfa82fe4b0c9d6adf6b64a	TCGA-73-4662-01A-01D-1203_110629_SN208_0211_AB0BP8ABXX_s_5_rg.sorted.filtered.	WGS	TCGA-73-4662-01A-01D-1203_110629_SN208_0211_AB0BP8ABXX_s_5_rg.sorted	TCGA-73-4662-01A-01D-1203_110629_SN208_0211_AB0BP8ABXX_s_5_rg.sorted.bam	337.2	1.9	0.15	58cfa82fe4b0c9d6adf6b64a	TCGA-73-4662-01A-01D-1203_110629_SN208_0211_AB0BP8ABXX_s_5_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-73-4662-01A	294FF941-AEA1-4588-9A0E-E9F5393E2BB6	Primary Tumor	Illumina HiSeq	bb68d6e1-efca-4ccb-bbd6-45c4da207bb7	Lung	65	C7D727B6-47C6-4339-B9DD-5BAF41527BD4	DCC0A32E-EF17-4AA8-8321-A03137A61D72	TCGA-73-4662-01A-01D-1203-02	HG19_Broad_variant	TCGA-73-4662	TCGA-LUAD	NA	s10663	Harvard Medical School	Roswell Park	United States	NO	T1	N0	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage IA	1203-02	TRUE
13722.58cfa82fe4b0c9d6adf6b659	58cfa82fe4b0c9d6adf6b659	TCGA-50-6592-01A-11D-1751_111111_SN208_0254_B0160ACXX_s_7_rg.sorted.filtered.	WGS	TCGA-50-6592-01A-11D-1751_111111_SN208_0254_B0160ACXX_s_7_rg.sorted	TCGA-50-6592-01A-11D-1751_111111_SN208_0254_B0160ACXX_s_7_rg.sorted.bam	254.4	1.9	0.13	58cfa82fe4b0c9d6adf6b659	TCGA-50-6592-01A-11D-1751_111111_SN208_0254_B0160ACXX_s_7_rg.sorted.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-50-6592-01A	09918B81-4696-4CBA-A45A-5FE7407C2337	Primary Tumor	Illumina HiSeq	207da806-7a0b-406f-aaa6-b5bb17f7f28a	Lung	71	01F94091-EB70-40D3-9D56-70C4F847CB4C	F61D3411-6EED-4EDE-8BBA-A40AF0C9DA84	TCGA-50-6592-01A-11D-1751-02	HG19_Broad_variant	TCGA-50-6592	TCGA-LUAD	777	s10793	Harvard Medical School	University of Pittsburgh	United States	NO	T2	N0	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage IB	1751-02	TRUE
13722.58cfa82fe4b0c9d6adf6b66c	58cfa82fe4b0c9d6adf6b66c	TCGA-50-5946-01A-11D-1751_111111_SN208_0254_B0160ACXX_s_3_rg.sorted.filtered.	WGS	TCGA-50-5946-01A-11D-1751_111111_SN208_0254_B0160ACXX_s_3_rg.sorted	TCGA-50-5946-01A-11D-1751_111111_SN208_0254_B0160ACXX_s_3_rg.sorted.bam	242.4	1.9	0.14	58cfa82fe4b0c9d6adf6b66c	TCGA-50-5946-01A-11D-1751_111111_SN208_0254_B0160ACXX_s_3_rg.sorted.bam	Alive	MALE	WHITE	Not available	Lung Adenocarcinoma	Aligned reads	TCGA-50-5946-01A	C95957A7-1A1A-4C8D-BB61-7C99B500F224	Primary Tumor	Illumina HiSeq	b7f024ff-9569-4d31-b652-ffc2ceaa2789	Lung	62	AD9A794F-52DD-4572-BF29-CD3D11BA6C24	F9F38A15-2964-4AE0-90AA-E5F3F7461AB3	TCGA-50-5946-01A-11D-1751-02	HG19_Broad_variant	TCGA-50-5946	TCGA-LUAD	NA	s10790	Harvard Medical School	University of Pittsburgh	United States	NO	T1	N0	Lung Adenocarcinoma Mixed Subtype	Stage IA	1751-02	TRUE
13722.58cfa82ee4b0c9d6adf6ae52	58cfa82ee4b0c9d6adf6ae52	TCGA-05-4389-01A-01D-1203_120318_SN1120_0124_AC0HNPACXX_s_5_rg.sorted.filtered.	WGS	TCGA-05-4389-01A-01D-1203_120318_SN1120_0124_AC0HNPACXX_s_5_rg.sorted	TCGA-05-4389-01A-01D-1203_120318_SN1120_0124_AC0HNPACXX_s_5_rg.sorted.bam	372.53	1.9	0.14	58cfa82ee4b0c9d6adf6ae52	TCGA-05-4389-01A-01D-1203_120318_SN1120_0124_AC0HNPACXX_s_5_rg.sorted.bam	Alive	MALE	Not available	Not available	Lung Adenocarcinoma	Aligned reads	TCGA-05-4389-01A	A3DE401D-91FE-49A2-BB07-81C1A06506E6	Primary Tumor	Illumina HiSeq	63a06f9b-e1c2-495a-8f7e-88e19c550049	Lung	70	ED61AC6A-F21F-4B88-928A-029340D4AEBD	575D4BEF-5610-41F4-B219-C9BBBA72F047	TCGA-05-4389-01A-01D-1203-02	HG19_Broad_variant	TCGA-05-4389	TCGA-LUAD	NA	s10769	Harvard Medical School	Indivumed	Germany	NO	T1	N0	Lung Adenocarcinoma Mixed Subtype	Stage IA	1203-02	TRUE
13722.58cfa82fe4b0c9d6adf6b6ba	58cfa82fe4b0c9d6adf6b6ba	TCGA-44-6778-01A-11D-1853_120312_SN1120_0120_AD0PYGACXX_s_5_rg.sorted.filtered.	WGS	TCGA-44-6778-01A-11D-1853_120312_SN1120_0120_AD0PYGACXX_s_5_rg.sorted	TCGA-44-6778-01A-11D-1853_120312_SN1120_0120_AD0PYGACXX_s_5_rg.sorted.bam	227.7	1.9	0.15	58cfa82fe4b0c9d6adf6b6ba	TCGA-44-6778-01A-11D-1853_120312_SN1120_0120_AD0PYGACXX_s_5_rg.sorted.bam	Alive	MALE	BLACK OR AFRICAN AMERICAN	Not available	Lung Adenocarcinoma	Aligned reads	TCGA-44-6778-01A	5D5CC436-6E57-4D23-A164-7F5153C2E666	Primary Tumor	Illumina HiSeq	8d0de456-4a8c-48ad-bfc5-fa6e66ba6e0d	Lung	59	15321297-7110-4E79-8D6F-94C95BC83C94	737A7A30-1F60-4D88-B94D-B5FCD996FED2	TCGA-44-6778-01A-11D-1853-02	HG19_Broad_variant	TCGA-44-6778	TCGA-LUAD	NA	s11126	Harvard Medical School	Christiana Healthcare	United States	NO	T1	N0	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage IA	1853-02	TRUE
13722.58cfa82fe4b0c9d6adf6b704	58cfa82fe4b0c9d6adf6b704	TCGA-73-4659-01A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.filtered.	WGS	TCGA-73-4659-01A-01D-1203-02_IlluminaHiSeq-DNASeq_whole	TCGA-73-4659-01A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.bam	665.52	1.9	0.15	58cfa82fe4b0c9d6adf6b704	TCGA-73-4659-01A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-73-4659-01A	CD0DC947-B708-464E-BEB7-954C9D4583E7	Primary Tumor	Illumina HiSeq	37276b21-3a00-4b58-b1df-cc2199584cb0	Lung	66	C35A5ED1-1821-4077-BA1E-B972DFA3233B	277D2F7F-1A7F-4D39-BD15-0334CC02840E	TCGA-73-4659-01A-01D-1203-02	GRCh37	TCGA-73-4659	TCGA-LUAD	711	s11246	Harvard Medical School	Roswell Park	United States	NO	T2	N2	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage IIIA	1203-02	TRUE
13722.58cfa82fe4b0c9d6adf6b6aa	58cfa82fe4b0c9d6adf6b6aa	TCGA-44-6774-01A-21D-1853_111204_SN208_0256_C0562ACXX_s_7_rg.sorted.filtered.	WGS	TCGA-44-6774-01A-21D-1853_111204_SN208_0256_C0562ACXX_s_7_rg.sorted	TCGA-44-6774-01A-21D-1853_111204_SN208_0256_C0562ACXX_s_7_rg.sorted.bam	62.7	1.9	0.17	58cfa82fe4b0c9d6adf6b6aa	TCGA-44-6774-01A-21D-1853_111204_SN208_0256_C0562ACXX_s_7_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-44-6774-01A	33C71EAD-4C2A-476D-85EF-885DBBFC2CBD	Primary Tumor	Illumina HiSeq	5ff8e7e5-3b91-49af-b384-9d870bd9e425	Lung	56	79CF84B5-84FF-42E5-B438-697B35D272FC	6B977266-994D-4440-BC09-59FD8737F2D0	TCGA-44-6774-01A-21D-1853-02	HG19_Broad_variant	TCGA-44-6774	TCGA-LUAD	NA	s10996	Harvard Medical School	Christiana Healthcare	United States	NO	T1	N2	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage IIIA	1853-02	TRUE
13722.58cfa82fe4b0c9d6adf6b64b	58cfa82fe4b0c9d6adf6b64b	TCGA-75-5126-01A-01D-1751_120309_SN208_0273_BC0HEAACXX_s_5_rg.sorted.filtered.	WGS	TCGA-75-5126-01A-01D-1751_120309_SN208_0273_BC0HEAACXX_s_5_rg.sorted	TCGA-75-5126-01A-01D-1751_120309_SN208_0273_BC0HEAACXX_s_5_rg.sorted.bam	392.4	1.9	0.15	58cfa82fe4b0c9d6adf6b64b	TCGA-75-5126-01A-01D-1751_120309_SN208_0273_BC0HEAACXX_s_5_rg.sorted.bam	Alive	FEMALE	Not available	Not available	Lung Adenocarcinoma	Aligned reads	TCGA-75-5126-01A	93766482-2F20-4C8F-BBD8-BDD203C37D5A	Primary Tumor	Illumina HiSeq	8c670948-9cf1-4db3-82d5-39ed824c61ff	Lung	NA	39509EA1-E728-4350-B444-798C72ADE33A	7BCB1D5A-871F-472E-A964-9B68259D9716	TCGA-75-5126-01A-01D-1751-02	HG19_Broad_variant	TCGA-75-5126	TCGA-LUAD	NA	s11251	Harvard Medical School	Ontario Institute for Cancer Research (OICR)	Canada	NO	T3	N2	Lung Papillary Adenocarcinoma	Stage IIIA	1751-02	TRUE
13722.58cfa82fe4b0c9d6adf6b790	58cfa82fe4b0c9d6adf6b790	TCGA-44-6146-01A-11D-1751_110927_SN208_0243_BC00TKACXX_s_3_rg.sorted.filtered.	WGS	TCGA-44-6146-01A-11D-1751_110927_SN208_0243_BC00TKACXX_s_3_rg.sorted	TCGA-44-6146-01A-11D-1751_110927_SN208_0243_BC00TKACXX_s_3_rg.sorted.bam	72	1.9	0.16	58cfa82fe4b0c9d6adf6b790	TCGA-44-6146-01A-11D-1751_110927_SN208_0243_BC00TKACXX_s_3_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-44-6146-01A	0C0B610E-FE4C-406D-A5ED-5CC3B11DABF5	Primary Tumor	Illumina HiSeq	99148000-be38-4da1-aeaa-4b0271725662	Lung	64	AD66185F-983D-4416-B705-25D3D4D8B5A5	2D5C6425-E3F4-4389-9DDF-FDE694B4227E	TCGA-44-6146-01A-11D-1751-02	HG19_Broad_variant	TCGA-44-6146	TCGA-LUAD	NA	s11337	Harvard Medical School	Christiana Healthcare	United States	NO	T3	N0	Lung Mucinous Adenocarcinoma	Stage IIB	1751-02	TRUE
13722.58cfa82fe4b0c9d6adf6b7b6	58cfa82fe4b0c9d6adf6b7b6	TCGA-44-3918-01A-01D-1103_110729_SN208_0215_BD0CLPABXX_s_6_rg.sorted.filtered.	WGS	TCGA-44-3918-01A-01D-1103_110729_SN208_0215_BD0CLPABXX_s_6_rg.sorted	TCGA-44-3918-01A-01D-1103_110729_SN208_0215_BD0CLPABXX_s_6_rg.sorted.bam	467.53	1.9	0.16	58cfa82fe4b0c9d6adf6b7b6	TCGA-44-3918-01A-01D-1103_110729_SN208_0215_BD0CLPABXX_s_6_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-44-3918-01A	6E3B6B72-142D-4B8D-A462-28A205796E41	Primary Tumor	Illumina HiSeq	96ae9138-6a97-4b93-9d28-35ec09a8d772	Lung	60	2FF8BAFD-2AC5-4BFD-8C60-81519CD44166	81D8D7E2-65FA-4E92-B064-0D7D41C54E7F	TCGA-44-3918-01A-01D-1103-02	HG19_Broad_variant	TCGA-44-3918	TCGA-LUAD	NA	s11122	Harvard Medical School	Christiana Healthcare	United States	NO	T1	N0	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage IA	1103-02	TRUE
13722.58cfa82fe4b0c9d6adf6b868	58cfa82fe4b0c9d6adf6b868	TCGA-A5-A0R7-01A-31D-A101_120403_SN1222_0093_AC0L7VACXX_s_3_rg.sorted.filtered.	WGS	TCGA-A5-A0R7-01A-31D-A101_120403_SN1222_0093_AC0L7VACXX_s_3_rg.sorted	TCGA-A5-A0R7-01A-31D-A101_120403_SN1222_0093_AC0L7VACXX_s_3_rg.sorted.bam	88.28	1.87	0.17	58cfa82fe4b0c9d6adf6b868	TCGA-A5-A0R7-01A-31D-A101_120403_SN1222_0093_AC0L7VACXX_s_3_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-A5-A0R7-01A	02B25675-094D-4098-96DA-51D121380FEC	Primary Tumor	Illumina HiSeq	daa92f08-7339-46a6-8a74-e6756c170ed5	Uterus	55	550C6341-260A-4156-B00C-0AE9031D647F	4C9B54D0-A58E-44CF-8937-913A34F0788C	TCGA-A5-A0R7-01A-31D-A101-02	HG19_Broad_variant	TCGA-A5-A0R7	TCGA-UCEC	NA	s4777	Harvard Medical School	Cedars Sinai	None	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A101-02	TRUE
13722.58cfa82fe4b0c9d6adf6b8fe	58cfa82fe4b0c9d6adf6b8fe	TCGA-49-6744-01A-11D-1853_111218_SN208_0258_C054RACXX_s_5_rg.sorted.filtered.	WGS	TCGA-49-6744-01A-11D-1853_111218_SN208_0258_C054RACXX_s_5_rg.sorted	TCGA-49-6744-01A-11D-1853_111218_SN208_0258_C054RACXX_s_5_rg.sorted.bam	62.7	1.9	0.15	58cfa82fe4b0c9d6adf6b8fe	TCGA-49-6744-01A-11D-1853_111218_SN208_0258_C054RACXX_s_5_rg.sorted.bam	Alive	FEMALE	WHITE	Not available	Lung Adenocarcinoma	Aligned reads	TCGA-49-6744-01A	15340DD3-84AE-49FB-989A-EB212F3E73DA	Primary Tumor	Illumina HiSeq	8290093a-0193-41fa-8e87-71960e0e640e	Lung	64	A9D69D7E-298C-4AB6-B64F-1EDC58832CCD	7455D0A5-45DB-461F-9026-5A0FE3D55A6A	TCGA-49-6744-01A-11D-1853-02	HG19_Broad_variant	TCGA-49-6744	TCGA-LUAD	NA	s10656	Harvard Medical School	Johns Hopkins	United States	NO	T2a	N1	Lung Adenocarcinoma Mixed Subtype	Stage IIA	1853-02	TRUE
13722.58cfa82fe4b0c9d6adf6b8b3	58cfa82fe4b0c9d6adf6b8b3	TCGA-50-5051-01A-21D-1853_120322_SN208_0277_AD0PL1ACXX_s_7_rg.sorted.filtered.	WGS	TCGA-50-5051-01A-21D-1853_120322_SN208_0277_AD0PL1ACXX_s_7_rg.sorted	TCGA-50-5051-01A-21D-1853_120322_SN208_0277_AD0PL1ACXX_s_7_rg.sorted.bam	416.7	1.9	0.15	58cfa82fe4b0c9d6adf6b8b3	TCGA-50-5051-01A-21D-1853_120322_SN208_0277_AD0PL1ACXX_s_7_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-50-5051-01A	E1C55BAC-BB41-4964-ADD5-ECD6BA04B58D	Primary Tumor	Illumina HiSeq	fd2a1c20-3ed6-4057-8fb5-4027ce0eec74	Lung	42	180EB213-0DDC-4F10-AB0E-B3AF92CDE3C3	80170E98-4886-4A34-BC88-F2B2F84743B2	TCGA-50-5051-01A-21D-1853-02	HG19_Broad_variant	TCGA-50-5051	TCGA-LUAD	NA	s10789	Harvard Medical School	University of Pittsburgh	United States	NO	T2	N2	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage IIIA	1853-02	TRUE
13722.58cfa82fe4b0c9d6adf6b90e	58cfa82fe4b0c9d6adf6b90e	TCGA-49-4507-01A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.filtered.	WGS	TCGA-49-4507-01A-01D-1203-02_IlluminaHiSeq-DNASeq_whole	TCGA-49-4507-01A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.bam	289.2	1.9	0.14	58cfa82fe4b0c9d6adf6b90e	TCGA-49-4507-01A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-49-4507-01A	50B2C647-AECD-4C81-AF22-0D8116593552	Primary Tumor	Illumina HiSeq	557606c6-d245-45ba-b9f0-adc05c6a5f4f	Lung	73	962F85FF-1F27-49E4-8C3D-798FACEA122F	EF299B98-6A9F-4022-8683-A9C830E7263C	TCGA-49-4507-01A-01D-1203-02	GRCh37	TCGA-49-4507	TCGA-LUAD	268	s11453	Harvard Medical School	Johns Hopkins	United States	NO	T3	N1	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage IIIA	1203-02	TRUE
13722.58cfa82fe4b0c9d6adf6b912	58cfa82fe4b0c9d6adf6b912	TCGA-49-4506-01A-01D-1203_110729_SN208_0215_BD0CLPABXX_s_7_rg.sorted.filtered.	WGS	TCGA-49-4506-01A-01D-1203_110729_SN208_0215_BD0CLPABXX_s_7_rg.sorted	TCGA-49-4506-01A-01D-1203_110729_SN208_0215_BD0CLPABXX_s_7_rg.sorted.bam	258.2	1.9	0.13	58cfa82fe4b0c9d6adf6b912	TCGA-49-4506-01A-01D-1203_110729_SN208_0215_BD0CLPABXX_s_7_rg.sorted.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-49-4506-01A	B61ABDFD-B7A0-4E1A-B570-D1EAECAD3A9E	Primary Tumor	Illumina HiSeq	b07f7ea8-c74b-4559-97d3-987f1985f2e9	Lung	68	9EDEA53D-AD06-4B5D-BFF0-48E834C3684F	2270ABD6-565B-46B6-8154-505C5659A7C3	TCGA-49-4506-01A-01D-1203-02	HG19_Broad_variant	TCGA-49-4506	TCGA-LUAD	999	s11234	Harvard Medical School	Johns Hopkins	United States	NO	T2	N1	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage IIB	1203-02	TRUE
13722.58cfa82fe4b0c9d6adf6ba10	58cfa82fe4b0c9d6adf6ba10	TCGA-AA-A01G-01A-01D-A077-02_IlluminaHiSeq-DNASeq_whole.filtered.	WGS	TCGA-AA-A01G-01A-01D-A077-02_IlluminaHiSeq-DNASeq_whole	TCGA-AA-A01G-01A-01D-A077-02_IlluminaHiSeq-DNASeq_whole.bam	233.25	1.69	0.15	58cfa82fe4b0c9d6adf6ba10	TCGA-AA-A01G-01A-01D-A077-02_IlluminaHiSeq-DNASeq_whole.bam	Alive	MALE	Not available	Not available	Colon Adenocarcinoma	Aligned reads	TCGA-AA-A01G-01A	6F2B5A14-569C-4084-8C67-B1A44D787897	Primary Tumor	Illumina HiSeq	efd511ca-ff06-4cbe-afe2-2c025120233e	Colorectal	63	A09ABC20-4F93-4130-A23A-8413E6C32FE5	D7D83B15-9EE5-4206-805D-AC3E5914BCC6	TCGA-AA-A01G-01A-01D-A077-02	HG18	TCGA-AA-A01G	TCGA-COAD	NA	s13205	Harvard Medical School	Indivumed	Germany	NO	T3	N0	Colon Mucinous Adenocarcinoma	Stage IIA	A077-02	TRUE
13722.58cfa830e4b0c9d6adf6bc52	58cfa830e4b0c9d6adf6bc52	TCGA-AG-A011-01A-01D-A077-02_110409_SN590_0076_AB04G5ABXX_s_1.rg.sorted.filtered.	WGS	TCGA-AG-A011-01A-01D-A077-02_110409_SN590_0076_AB04G5ABXX_s_1.rg.sorted	TCGA-AG-A011-01A-01D-A077-02_110409_SN590_0076_AB04G5ABXX_s_1.rg.sorted.bam	217.29	1.72	0.15	58cfa830e4b0c9d6adf6bc52	TCGA-AG-A011-01A-01D-A077-02_110409_SN590_0076_AB04G5ABXX_s_1.rg.sorted.bam	Alive	MALE	Not available	Not available	Rectum Adenocarcinoma	Aligned reads	TCGA-AG-A011-01A	3BE106BC-BA42-4C70-9B50-697D89DB617D	Primary Tumor	Illumina HiSeq	af371ab1-77bf-4408-860e-ccc4386c99aa	Colorectal	80	B5DD8F49-26FC-48D9-A964-D8EBDCCA9E19	8C282A6C-3D47-4F9E-96C4-2C0852E7785B	TCGA-AG-A011-01A-01D-A077-02	HG18_Broad_variant	TCGA-AG-A011	TCGA-READ	NA	s2001	Harvard Medical School	Indivumed	Germany	NO	T3	N0	Rectal Adenocarcinoma	Stage IIA	A077-02	TRUE
13722.58cfa830e4b0c9d6adf6bc62	58cfa830e4b0c9d6adf6bc62	TCGA-AG-A00Y-01A-02D-A077-02_110405_SN590_0074_AB04EUABXX_s_7.rg.sorted.filtered.	WGS	TCGA-AG-A00Y-01A-02D-A077-02_110405_SN590_0074_AB04EUABXX_s_7.rg.sorted	TCGA-AG-A00Y-01A-02D-A077-02_110405_SN590_0074_AB04EUABXX_s_7.rg.sorted.bam	150.39	1.72	0.15	58cfa830e4b0c9d6adf6bc62	TCGA-AG-A00Y-01A-02D-A077-02_110405_SN590_0074_AB04EUABXX_s_7.rg.sorted.bam	Alive	MALE	Not available	Not available	Rectum Adenocarcinoma	Aligned reads	TCGA-AG-A00Y-01A	C7E09161-60D6-4DFF-A840-7CEC3BB7A30A	Primary Tumor	Illumina HiSeq	2c284389-2d4d-4e3b-9b5b-a37212874f6e	Colorectal	68	8EC6ADED-026E-47F5-91F1-2A75F07BD8D0	27B036A3-5277-4C0F-93EE-593FDA1441DC	TCGA-AG-A00Y-01A-02D-A077-02	HG18_Broad_variant	TCGA-AG-A00Y	TCGA-READ	NA	s1983	Harvard Medical School	Indivumed	Germany	NO	T3	N0	Rectal Adenocarcinoma	Stage IIA	A077-02	TRUE
13722.58cfa830e4b0c9d6adf6bc8c	58cfa830e4b0c9d6adf6bc8c	TCGA-AG-3896-01A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.filtered.	WGS	TCGA-AG-3896-01A-01D-1115-02_IlluminaHiSeq-DNASeq_whole	TCGA-AG-3896-01A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.bam	913.89	1.9	0.15	58cfa830e4b0c9d6adf6bc8c	TCGA-AG-3896-01A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.bam	Alive	FEMALE	Not available	Not available	Rectum Adenocarcinoma	Aligned reads	TCGA-AG-3896-01A	9AF35239-FFB9-4D4F-889E-F743DA271EEF	Primary Tumor	Illumina HiSeq	5666993b-483e-4cb2-ac08-c5f26b31b9cd	Colorectal	85	03B40342-3CCE-4A45-B2EC-8855AEB85100	D33D46C5-F3FD-4FD5-9CE2-06839BF33A37	TCGA-AG-3896-01A-01D-1115-02	HG18	TCGA-AG-3896	TCGA-READ	NA	s1988	Harvard Medical School	Indivumed	Germany	NO	T2	N0	Rectal Adenocarcinoma	Stage I	1115-02	TRUE
13722.58cfa830e4b0c9d6adf6bc90	58cfa830e4b0c9d6adf6bc90	TCGA-AZ-4308-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.filtered.	WGS	TCGA-AZ-4308-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole	TCGA-AZ-4308-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.bam	414.02	1.9	0.15	58cfa830e4b0c9d6adf6bc90	TCGA-AZ-4308-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Colon Adenocarcinoma	Aligned reads	TCGA-AZ-4308-01A	3D8FD9B2-9AA2-4C81-8843-535AE66D6140	Primary Tumor	Illumina HiSeq	562ea734-bcd1-499a-8054-f710f2de3e41	Colorectal	47	6F0E65B2-7CA0-4F10-8952-B64900009001	1C7E82B6-A8EB-4593-B329-5299BC05140E	TCGA-AZ-4308-01A-01D-1405-02	HG18	TCGA-AZ-4308	TCGA-COAD	NA	s13540	Harvard Medical School	University of Pittsburgh	None	NO	T3	N1	Colon Adenocarcinoma	Stage IIIB	1405-02	TRUE
13722.58cfa830e4b0c9d6adf6bd64	58cfa830e4b0c9d6adf6bd64	TCGA-AA-A00R-01A-01D-A077-02_IlluminaHiSeq-DNASeq_whole.filtered.	WGS	TCGA-AA-A00R-01A-01D-A077-02_IlluminaHiSeq-DNASeq_whole	TCGA-AA-A00R-01A-01D-A077-02_IlluminaHiSeq-DNASeq_whole.bam	205.35	1.73	0.15	58cfa830e4b0c9d6adf6bd64	TCGA-AA-A00R-01A-01D-A077-02_IlluminaHiSeq-DNASeq_whole.bam	Alive	FEMALE	Not available	Not available	Colon Adenocarcinoma	Aligned reads	TCGA-AA-A00R-01A	CA22EDD4-EB7C-4677-84AA-6F0354459A19	Primary Tumor	Illumina HiSeq	f8afa471-fd74-43ef-8cc5-58a4f3788e31	Colorectal	64	F72EEAE9-F7F5-4576-A072-5021119117D6	AC9F45EC-C004-475F-8537-8977F20B0DE8	TCGA-AA-A00R-01A-01D-A077-02	HG18	TCGA-AA-A00R	TCGA-COAD	NA	s13517	Harvard Medical School	Indivumed	Germany	NO	T2	N0	Colon Adenocarcinoma	Stage I	A077-02	TRUE
13722.58cfa830e4b0c9d6adf6bd8c	58cfa830e4b0c9d6adf6bd8c	TCGA-BG-A0M0-01A-11D-A101_120330_SN208_0279_BC0L73ACXX_s_6_rg.sorted.filtered.	WGS	TCGA-BG-A0M0-01A-11D-A101_120330_SN208_0279_BC0L73ACXX_s_6_rg.sorted	TCGA-BG-A0M0-01A-11D-A101_120330_SN208_0279_BC0L73ACXX_s_6_rg.sorted.bam	94.25	2.11	0.15	58cfa830e4b0c9d6adf6bd8c	TCGA-BG-A0M0-01A-11D-A101_120330_SN208_0279_BC0L73ACXX_s_6_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-BG-A0M0-01A	8BF0B156-6EB4-45E8-9CBB-0979EFBEA898	Primary Tumor	Illumina HiSeq	bedca351-a4f7-4fbd-af8e-d49f3d9b2c37	Uterus	66	E3F599DB-19CF-4086-8E5D-D3527119120F	78D21C64-205B-4C9C-A862-8A70348D2602	TCGA-BG-A0M0-01A-11D-A101-02	HG19_Broad_variant	TCGA-BG-A0M0	TCGA-UCEC	NA	s5216	Harvard Medical School	University of Pittsburgh	None	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A101-02	TRUE
13722.58cfa830e4b0c9d6adf6bda8	58cfa830e4b0c9d6adf6bda8	TCGA-BF-A1Q0-01A-21D-A18Z_120520_SN590_0158_AC0J99ACXX_s_5_rg.sorted.filtered.	WGS	TCGA-BF-A1Q0-01A-21D-A18Z_120520_SN590_0158_AC0J99ACXX_s_5_rg.sorted	TCGA-BF-A1Q0-01A-21D-A18Z_120520_SN590_0158_AC0J99ACXX_s_5_rg.sorted.bam	66.95	NA	0.16	58cfa830e4b0c9d6adf6bda8	TCGA-BF-A1Q0-01A-21D-A18Z_120520_SN590_0158_AC0J99ACXX_s_5_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Skin Cutaneous Melanoma	Aligned reads	TCGA-BF-A1Q0-01A	633DDC04-C424-42C8-8E54-673968B130A7	Primary Tumor	Illumina HiSeq	44801af7-d042-441d-afc9-4c0d7b493b01	Skin	80	B68CFB6B-4249-4855-8278-B18C0F561EFD	C94F7E24-8073-4786-BFC0-C45A37D85B2F	TCGA-BF-A1Q0-01A-21D-A18Z-02	HG19_Broad_variant	TCGA-BF-A1Q0	TCGA-SKCM	NA	s7320	Harvard Medical School	Cureline	Russia	NO	T4b	N0	Not available	Stage IIC	A18Z-02	TRUE
13722.58cfa830e4b0c9d6adf6bded	58cfa830e4b0c9d6adf6bded	TCGA-BH-A0DK-01A-21D-A060_130807_SN590_0236_BC291KACXX_s_5_rg.sorted.filtered.	WGS	TCGA-BH-A0DK-01A-21D-A060_130807_SN590_0236_BC291KACXX_s_5_rg.sorted	TCGA-BH-A0DK-01A-21D-A060_130807_SN590_0236_BC291KACXX_s_5_rg.sorted.bam	43.73	2.05	0.16	58cfa830e4b0c9d6adf6bded	TCGA-BH-A0DK-01A-21D-A060_130807_SN590_0236_BC291KACXX_s_5_rg.sorted.bam	Alive	FEMALE	WHITE	Not available	Breast Invasive Carcinoma	Aligned reads	TCGA-BH-A0DK-01A	F2BBFA9D-9A9D-4F46-9FDE-378E4C44E2AD	Primary Tumor	Illumina HiSeq	71acb20b-f186-44d4-a92e-a2751f845fe3	Breast	49	1ACAE6E0-3100-4DE8-A436-E15CDBE1322B	92245807-8B1B-4E96-8567-6CFE5E70ADE4	TCGA-BH-A0DK-01A-21D-A060-02	HG19_Broad_variant	TCGA-BH-A0DK	TCGA-BRCA	NA	s5493	Harvard Medical School	University of Pittsburgh	None	NO	T2	N0 (i-)	Infiltrating Ductal Carcinoma	Stage IIA	A060-02	TRUE
13722.58cfa830e4b0c9d6adf6bd9b	58cfa830e4b0c9d6adf6bd9b	TCGA-BG-A0M3-01A-11D-A101_120330_SN208_0279_BC0L73ACXX_s_8_rg.sorted.filtered.	WGS	TCGA-BG-A0M3-01A-11D-A101_120330_SN208_0279_BC0L73ACXX_s_8_rg.sorted	TCGA-BG-A0M3-01A-11D-A101_120330_SN208_0279_BC0L73ACXX_s_8_rg.sorted.bam	101.93	1.88	0.15	58cfa830e4b0c9d6adf6bd9b	TCGA-BG-A0M3-01A-11D-A101_120330_SN208_0279_BC0L73ACXX_s_8_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-BG-A0M3-01A	8BDD4E0E-5BEC-43F2-B9FA-D6E94A72FE05	Primary Tumor	Illumina HiSeq	d3fa774f-c50e-499c-ad6e-1a5f67dd2be3	Uterus	74	1802CD6B-4D4A-45FA-B839-7450071E41EE	04E49830-378E-4EB2-B77C-70D6955627F7	TCGA-BG-A0M3-01A-11D-A101-02	HG19_Broad_variant	TCGA-BG-A0M3	TCGA-UCEC	NA	s5394	Harvard Medical School	University of Pittsburgh	None	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A101-02	TRUE
13722.58cfa830e4b0c9d6adf6be7e	58cfa830e4b0c9d6adf6be7e	TCGA-BJ-A192-01A-31D-A13U_120706_SN1120_0170_BD1422ACXX_s_4_rg.sorted.filtered.	WGS	TCGA-BJ-A192-01A-31D-A13U_120706_SN1120_0170_BD1422ACXX_s_4_rg.sorted	TCGA-BJ-A192-01A-31D-A13U_120706_SN1120_0170_BD1422ACXX_s_4_rg.sorted.bam	32.81	2.02	0.17	58cfa830e4b0c9d6adf6be7e	TCGA-BJ-A192-01A-31D-A13U_120706_SN1120_0170_BD1422ACXX_s_4_rg.sorted.bam	Alive	FEMALE	WHITE	Not available	Thyroid Carcinoma	Aligned reads	TCGA-BJ-A192-01A	B55375C3-9EF2-4D2F-9C29-224E746931C4	Primary Tumor	Illumina HiSeq	9218178e-761c-40ac-b3ca-044bf37f8686	Thyroid	54	582C3030-1F23-4535-9C8B-6B594E656AF4	6D770754-E14D-4E47-AE33-BE0FC9B40CE9	TCGA-BJ-A192-01A-31D-A13U-02	HG19_Broad_variant	TCGA-BJ-A192	TCGA-THCA	NA	s12235	Harvard Medical School	University of Pittsburgh	United States	NO	T3	NX	Thyroid Papillary Carcinoma - Classical/usual	Stage III	A13U-02	TRUE
13722.58cfa830e4b0c9d6adf6be84	58cfa830e4b0c9d6adf6be84	TCGA-BJ-A191-01A-11D-A13U_120706_SN1120_0170_BD1422ACXX_s_1_rg.sorted.filtered.	WGS	TCGA-BJ-A191-01A-11D-A13U_120706_SN1120_0170_BD1422ACXX_s_1_rg.sorted	TCGA-BJ-A191-01A-11D-A13U_120706_SN1120_0170_BD1422ACXX_s_1_rg.sorted.bam	110.16	1.93	0.17	58cfa830e4b0c9d6adf6be84	TCGA-BJ-A191-01A-11D-A13U_120706_SN1120_0170_BD1422ACXX_s_1_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-BJ-A191-01A	2501EE46-8D38-448B-8765-E9C9706CBBE8	Primary Tumor	Illumina HiSeq	fb73296b-b8ef-4ff9-a954-fab7d29ab101	Thyroid	49	C92FC4E3-7A96-4000-A969-AA894CA58A33	B3EDF2BC-5E8F-435A-ADA1-F292722EDD9C	TCGA-BJ-A191-01A-11D-A13U-02	HG19_Broad_variant	TCGA-BJ-A191	TCGA-THCA	NA	s12237	Harvard Medical School	University of Pittsburgh	United States	NO	T1b	N0	Other  specify	Stage I	A13U-02	TRUE
13722.58cfa830e4b0c9d6adf6bec9	58cfa830e4b0c9d6adf6bec9	TCGA-AP-A0LP-01A-12D-A101_120330_SN208_0279_BC0L73ACXX_s_4_rg.sorted.filtered.	WGS	TCGA-AP-A0LP-01A-12D-A101_120330_SN208_0279_BC0L73ACXX_s_4_rg.sorted	TCGA-AP-A0LP-01A-12D-A101_120330_SN208_0279_BC0L73ACXX_s_4_rg.sorted.bam	109.58	1.91	0.16	58cfa830e4b0c9d6adf6bec9	TCGA-AP-A0LP-01A-12D-A101_120330_SN208_0279_BC0L73ACXX_s_4_rg.sorted.bam	Alive	FEMALE	WHITE	Not available	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-AP-A0LP-01A	EFAE3940-D3CC-4988-BDB4-FA05D977AFF5	Primary Tumor	Illumina HiSeq	369f32c0-ebb9-490e-baa4-0735e0efa092	Uterus	76	D67450C1-8848-4B28-9C16-83AA7132E8C8	C7A70C11-A05E-473D-929E-59A260FFBD97	TCGA-AP-A0LP-01A-12D-A101-02	HG19_Broad_variant	TCGA-AP-A0LP	TCGA-UCEC	NA	s5202	Harvard Medical School	MSKCC	None	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A101-02	TRUE
13722.58cfa830e4b0c9d6adf6bf21	58cfa830e4b0c9d6adf6bf21	TCGA-BR-4279-01A-01D-1128_121127_SN208_0441_BC1F8CACXX_s_1_rg.sorted.filtered.	WGS	TCGA-BR-4279-01A-01D-1128_121127_SN208_0441_BC1F8CACXX_s_1_rg.sorted	TCGA-BR-4279-01A-01D-1128_121127_SN208_0441_BC1F8CACXX_s_1_rg.sorted.bam	7.9	1.9	0.16	58cfa830e4b0c9d6adf6bf21	TCGA-BR-4279-01A-01D-1128_121127_SN208_0441_BC1F8CACXX_s_1_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-BR-4279-01A	117EB38B-0C62-4336-A866-FA5BD013256A	Primary Tumor	Illumina HiSeq	0fa8a7d6-6636-4135-82f6-21c9df279b16	Stomach	43	84AD647D-76B8-4EDA-8603-40220089BE34	01DC88B7-45FC-464C-A613-9793CD0C068B	TCGA-BR-4279-01A-01D-1128-02	HG19_Broad_variant	TCGA-BR-4279	TCGA-STAD	NA	s14814	Harvard Medical School	Asterand	Russia	NO	T2a	N1	Stomach  Adenocarcinoma  Not Otherwise Specified (NOS)	Stage II	1128-02	TRUE
13722.58cfa830e4b0c9d6adf6bead	58cfa830e4b0c9d6adf6bead	TCGA-AG-3901-01A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.filtered.	WGS	TCGA-AG-3901-01A-01D-1115-02_IlluminaHiSeq-DNASeq_whole	TCGA-AG-3901-01A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.bam	510.89	1.9	0.15	58cfa830e4b0c9d6adf6bead	TCGA-AG-3901-01A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.bam	Alive	FEMALE	Not available	Not available	Rectum Adenocarcinoma	Aligned reads	TCGA-AG-3901-01A	1586CB0A-081A-4364-9470-46F9D0F0167D	Primary Tumor	Illumina HiSeq	c8ff4c94-25ea-4468-8ae0-06cb92ffa025	Colorectal	67	93B755E6-5D6E-4542-8BAE-2121F44F590C	F5D4395A-5E00-4616-A402-CDCAD8702E1B	TCGA-AG-3901-01A-01D-1115-02	HG18	TCGA-AG-3901	TCGA-READ	NA	s2148	Harvard Medical School	Indivumed	Germany	NO	T3	N1	Rectal Mucinous Adenocarcinoma	Stage IIIB	1115-02	TRUE
13722.58cfa830e4b0c9d6adf6bf9f	58cfa830e4b0c9d6adf6bf9f	TCGA-BR-6458-01A-11D-1798_130116_SN208_0448_AC1J58ACXX_s_5_rg.sorted.filtered.	WGS	TCGA-BR-6458-01A-11D-1798_130116_SN208_0448_AC1J58ACXX_s_5_rg.sorted	TCGA-BR-6458-01A-11D-1798_130116_SN208_0448_AC1J58ACXX_s_5_rg.sorted.bam	306.4	1.9	0.15	58cfa830e4b0c9d6adf6bf9f	TCGA-BR-6458-01A-11D-1798_130116_SN208_0448_AC1J58ACXX_s_5_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-BR-6458-01A	E516880B-C4E5-43CD-A358-BE0DB88564D7	Primary Tumor	Illumina HiSeq	545acf44-8e16-46b9-b35a-c860c08b416b	Stomach	57	A30B45F5-C6E4-4975-A912-8313D93DFD27	2DD3E59B-4DBB-49B4-9DC4-A949FE48AA17	TCGA-BR-6458-01A-11D-1798-02	HG19_Broad_variant	TCGA-BR-6458	TCGA-STAD	NA	s14613	Harvard Medical School	Asterand	Ukraine	NO	T3	N1	Stomach  Adenocarcinoma  Not Otherwise Specified (NOS)	Stage IIB	1798-02	TRUE
13722.58cfa830e4b0c9d6adf6bfe8	58cfa830e4b0c9d6adf6bfe8	TCGA-BR-6565-01A-11D-1798_130116_SN208_0448_AC1J58ACXX_s_7_rg.sorted.filtered.	WGS	TCGA-BR-6565-01A-11D-1798_130116_SN208_0448_AC1J58ACXX_s_7_rg.sorted	TCGA-BR-6565-01A-11D-1798_130116_SN208_0448_AC1J58ACXX_s_7_rg.sorted.bam	338.7	1.9	0.14	58cfa830e4b0c9d6adf6bfe8	TCGA-BR-6565-01A-11D-1798_130116_SN208_0448_AC1J58ACXX_s_7_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-BR-6565-01A	DAECEA36-B379-46CE-8AE9-A38D22556CE2	Primary Tumor	Illumina HiSeq	8cfafa49-f561-4e59-98c5-b9a816534417	Stomach	67	1D7AAE07-2453-4DC3-A26D-D67161172648	E5F188AD-28C2-4AD0-89DD-C13493CE4B03	TCGA-BR-6565-01A-11D-1798-02	HG19_Broad_variant	TCGA-BR-6565	TCGA-STAD	NA	s14881	Harvard Medical School	Asterand	Russia	NO	T4a	N0	Stomach  Adenocarcinoma  Not Otherwise Specified (NOS)	Stage IIB	1798-02	TRUE
13722.58cfa830e4b0c9d6adf6c01e	58cfa830e4b0c9d6adf6c01e	TCGA-BJ-A0Z2-01A-11D-A10R_120711_SN208_0414_BD13L5ACXX_s_1_rg.sorted.filtered.	WGS	TCGA-BJ-A0Z2-01A-11D-A10R_120711_SN208_0414_BD13L5ACXX_s_1_rg.sorted	TCGA-BJ-A0Z2-01A-11D-A10R_120711_SN208_0414_BD13L5ACXX_s_1_rg.sorted.bam	89.84	1.92	0.14	58cfa830e4b0c9d6adf6c01e	TCGA-BJ-A0Z2-01A-11D-A10R_120711_SN208_0414_BD13L5ACXX_s_1_rg.sorted.bam	Alive	MALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-BJ-A0Z2-01A	F9CEFFC0-D544-418D-B4A9-BD3C84E37026	Primary Tumor	Illumina HiSeq	9493c81d-440a-4066-975b-c6265b7641a6	Thyroid	57	B06B7493-F38A-493F-8B47-61E0FA4D111F	D8B6F131-76CA-45D3-8934-A6CDEA8153AD	TCGA-BJ-A0Z2-01A-11D-A10R-02	HG19_Broad_variant	TCGA-BJ-A0Z2	TCGA-THCA	NA	s12353	Harvard Medical School	University of Pittsburgh	United States	NO	T2	N0	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	Stage IVC	A10R-02	TRUE
13722.58cfa830e4b0c9d6adf6c01c	58cfa830e4b0c9d6adf6c01c	TCGA-B5-A0K7-01A-11D-A101_120330_SN208_0280_AD0UKLACXX_s_8_rg.sorted.filtered.	WGS	TCGA-B5-A0K7-01A-11D-A101_120330_SN208_0280_AD0UKLACXX_s_8_rg.sorted	TCGA-B5-A0K7-01A-11D-A101_120330_SN208_0280_AD0UKLACXX_s_8_rg.sorted.bam	106.4	2	0.15	58cfa830e4b0c9d6adf6c01c	TCGA-B5-A0K7-01A-11D-A101_120330_SN208_0280_AD0UKLACXX_s_8_rg.sorted.bam	Alive	FEMALE	WHITE	Not available	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-B5-A0K7-01A	2F0640BC-598C-4714-9E9B-7E0F2CA4567F	Primary Tumor	Illumina HiSeq	b1ac8e27-775c-4d91-8a4d-9d096cde589d	Uterus	64	51E8577D-6849-422E-8F37-2EA8C400BBE5	ED30E619-1EBE-4CCE-B7FD-93B552953B65	TCGA-B5-A0K7-01A-11D-A101-02	HG19_Broad_variant	TCGA-B5-A0K7	TCGA-UCEC	NA	s5390	Harvard Medical School	Duke	United States	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A101-02	TRUE
13722.58cfa830e4b0c9d6adf6c026	58cfa830e4b0c9d6adf6c026	TCGA-BJ-A0ZB-01A-11D-A10R_120617_SN1222_0116_AC0WMMACXX_s_4_rg.sorted.filtered.	WGS	TCGA-BJ-A0ZB-01A-11D-A10R_120617_SN1222_0116_AC0WMMACXX_s_4_rg.sorted	TCGA-BJ-A0ZB-01A-11D-A10R_120617_SN1222_0116_AC0WMMACXX_s_4_rg.sorted.bam	79.63	2	0.16	58cfa830e4b0c9d6adf6c026	TCGA-BJ-A0ZB-01A-11D-A10R_120617_SN1222_0116_AC0WMMACXX_s_4_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-BJ-A0ZB-01A	DC4D8468-6F34-40CB-A826-8D582CD86FDE	Primary Tumor	Illumina HiSeq	72ce31c8-5889-450a-ac21-159c97d9b125	Thyroid	66	145A474E-D262-468A-8DB7-EE9F1B7CE0A7	EBAA6AE4-66C0-49A7-938C-620E24564846	TCGA-BJ-A0ZB-01A-11D-A10R-02	HG19_Broad_variant	TCGA-BJ-A0ZB	TCGA-THCA	NA	s12097	Harvard Medical School	University of Pittsburgh	United States	NO	T3	N1b	Thyroid Papillary Carcinoma - Classical/usual	Stage IVA	A10R-02	TRUE
13722.58cfa830e4b0c9d6adf6c050	58cfa830e4b0c9d6adf6c050	TCGA-B5-A0K6-01A-11D-A043_120327_SN590_0149_AD0U12ACXX_s_5_rg.sorted.filtered.	WGS	TCGA-B5-A0K6-01A-11D-A043_120327_SN590_0149_AD0U12ACXX_s_5_rg.sorted	TCGA-B5-A0K6-01A-11D-A043_120327_SN590_0149_AD0U12ACXX_s_5_rg.sorted.bam	110.74	2.06	0.14	58cfa830e4b0c9d6adf6c050	TCGA-B5-A0K6-01A-11D-A043_120327_SN590_0149_AD0U12ACXX_s_5_rg.sorted.bam	Alive	FEMALE	WHITE	Not available	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-B5-A0K6-01A	5CBA9441-6812-49C0-A0F6-7928ED4E5B81	Primary Tumor	Illumina HiSeq	06cd1c7f-2531-4a07-bf4f-c086f7a954a0	Uterus	58	69BF0D3A-B7AE-4EE1-B7D1-18A32FCFA67C	A4364F57-81A8-4B96-BA31-1D8B1CC78C5D	TCGA-B5-A0K6-01A-11D-A043-02	HG19_Broad_variant	TCGA-B5-A0K6	TCGA-UCEC	NA	s4247	Harvard Medical School	Duke	United States	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A043-02	TRUE
13722.58cfa830e4b0c9d6adf6c066	58cfa830e4b0c9d6adf6c066	TCGA-AG-3894-01A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.filtered.	WGS	TCGA-AG-3894-01A-01D-1115-02_IlluminaHiSeq-DNASeq_whole	TCGA-AG-3894-01A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.bam	710.89	1.9	0.15	58cfa830e4b0c9d6adf6c066	TCGA-AG-3894-01A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.bam	Alive	MALE	Not available	Not available	Rectum Adenocarcinoma	Aligned reads	TCGA-AG-3894-01A	065B26FC-6827-44D5-83D8-1100C63FCDA6	Primary Tumor	Illumina HiSeq	8db01c5c-36a6-4060-ada7-3d57682daaf6	Colorectal	65	D6B7E2F3-01AD-4E77-87BB-9CBAEF03A5FB	339E9078-1166-45F6-A6BD-A2818B8918A1	TCGA-AG-3894-01A-01D-1115-02	HG18	TCGA-AG-3894	TCGA-READ	NA	s2163	Harvard Medical School	Indivumed	Germany	NO	T3	N0	Rectal Adenocarcinoma	Stage IIA	1115-02	TRUE
13722.58cfa830e4b0c9d6adf6c044	58cfa830e4b0c9d6adf6c044	TCGA-AG-3893-01A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.filtered.	WGS	TCGA-AG-3893-01A-01D-1115-02_IlluminaHiSeq-DNASeq_whole	TCGA-AG-3893-01A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.bam	551.89	1.9	0.15	58cfa830e4b0c9d6adf6c044	TCGA-AG-3893-01A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.bam	Alive	MALE	Not available	Not available	Rectum Adenocarcinoma	Aligned reads	TCGA-AG-3893-01A	ADD567B7-29EF-4122-8A54-57D36F735E78	Primary Tumor	Illumina HiSeq	d98305fc-80c0-4336-b35c-0c47d8c297b8	Colorectal	74	7E16AFE9-DA05-451B-BD8C-86D75C8E475C	5815181B-A53B-4AAF-9817-168AC41DAD2A	TCGA-AG-3893-01A-01D-1115-02	HG18	TCGA-AG-3893	TCGA-READ	NA	s2152	Harvard Medical School	Indivumed	Germany	NO	T3	N1	Rectal Adenocarcinoma	Stage IIIB	1115-02	TRUE
13722.58cfa830e4b0c9d6adf6c1b8	58cfa830e4b0c9d6adf6c1b8	TCGA-BF-A1PZ-01A-11D-A18Z_120612_SN590_0162_BC0VNGACXX_s_5_rg.sorted.filtered.	WGS	TCGA-BF-A1PZ-01A-11D-A18Z_120612_SN590_0162_BC0VNGACXX_s_5_rg.sorted	TCGA-BF-A1PZ-01A-11D-A18Z_120612_SN590_0162_BC0VNGACXX_s_5_rg.sorted.bam	64.32	NA	0.18	58cfa830e4b0c9d6adf6c1b8	TCGA-BF-A1PZ-01A-11D-A18Z_120612_SN590_0162_BC0VNGACXX_s_5_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Skin Cutaneous Melanoma	Aligned reads	TCGA-BF-A1PZ-01A	455F982C-A067-46AC-BF89-3E535D0FFCA0	Primary Tumor	Illumina HiSeq	61217185-aa8a-467c-ba89-48231f6a81cc	Skin	71	2A5EE782-122E-432B-98E0-0849B6F9A3D9	25D65D8B-ED75-47D6-B7F6-95CF26CCBE06	TCGA-BF-A1PZ-01A-11D-A18Z-02	HG19_Broad_variant	TCGA-BF-A1PZ	TCGA-SKCM	NA	s7319	Harvard Medical School	Cureline	Russia	NO	T4a	N0	Not available	Stage IIB	A18Z-02	TRUE
13722.58cfa830e4b0c9d6adf6c1fc	58cfa830e4b0c9d6adf6c1fc	TCGA-BG-A0M2-01A-11D-A101_120330_SN208_0279_BC0L73ACXX_s_7_rg.sorted.filtered.	WGS	TCGA-BG-A0M2-01A-11D-A101_120330_SN208_0279_BC0L73ACXX_s_7_rg.sorted	TCGA-BG-A0M2-01A-11D-A101_120330_SN208_0279_BC0L73ACXX_s_7_rg.sorted.bam	63.57	1.97	0.15	58cfa830e4b0c9d6adf6c1fc	TCGA-BG-A0M2-01A-11D-A101_120330_SN208_0279_BC0L73ACXX_s_7_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-BG-A0M2-01A	9731E0B3-C62D-43CB-8AE7-8F973D69AB19	Primary Tumor	Illumina HiSeq	9dcd7360-a8dc-49cb-bf13-8fb36c436e30	Uterus	62	2AF18345-2A71-4574-AC8E-83DDEED3AD57	E59EB8B5-DA68-44B3-BB18-8C42F583B2BA	TCGA-BG-A0M2-01A-11D-A101-02	HG19_Broad_variant	TCGA-BG-A0M2	TCGA-UCEC	NA	s4604	Harvard Medical School	University of Pittsburgh	None	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A101-02	TRUE
13722.58cfa830e4b0c9d6adf6c23c	58cfa830e4b0c9d6adf6c23c	TCGA-BT-A2LB-01A-11D-A18D_120904_SN1120_0186_BC1911ACXX_s_6_rg.sorted.filtered.	WGS	TCGA-BT-A2LB-01A-11D-A18D_120904_SN1120_0186_BC1911ACXX_s_6_rg.sorted	TCGA-BT-A2LB-01A-11D-A18D_120904_SN1120_0186_BC1911ACXX_s_6_rg.sorted.bam	51.24	NA	0.18	58cfa830e4b0c9d6adf6c23c	TCGA-BT-A2LB-01A-11D-A18D_120904_SN1120_0186_BC1911ACXX_s_6_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-BT-A2LB-01A	D17A5AB1-3789-4652-AFF5-D8F4F2291F9C	Primary Tumor	Illumina HiSeq	de67212f-594e-409c-bd19-3d40f013b89a	Bladder	73	7C6178A6-6D4C-4DEF-B4AC-A064AB4A6C8A	FAD087E0-3752-4144-960B-659B59312C92	TCGA-BT-A2LB-01A-11D-A18D-02	HG19_Broad_variant	TCGA-BT-A2LB	TCGA-BLCA	NA	s3087	Harvard Medical School	University of Pittsburgh	United States	NO	T3a	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage III	A18D-02	TRUE
13722.58cfa830e4b0c9d6adf6c260	58cfa830e4b0c9d6adf6c260	TCGA-C5-A3HL-01A-11D-A20X_140117_SN590_0246_BC37BDACXX_s_7_rg.sorted.filtered.	WGS	TCGA-C5-A3HL-01A-11D-A20X_140117_SN590_0246_BC37BDACXX_s_7_rg.sorted	TCGA-C5-A3HL-01A-11D-A20X_140117_SN590_0246_BC37BDACXX_s_7_rg.sorted.bam	48.29	NA	0.14	58cfa830e4b0c9d6adf6c260	TCGA-C5-A3HL-01A-11D-A20X_140117_SN590_0246_BC37BDACXX_s_7_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-C5-A3HL-01A	09329A53-D58D-4480-95D8-32043E40DE6E	Primary Tumor	Illumina HiSeq	84c6e022-f737-4fae-a2c7-812ef4f00adf	Cervix	76	2A3CC87B-B120-49EC-93E6-8BDDBAE5C97C	04FC6219-3EAC-4BB8-82CA-CD0AA6B0ACE3	TCGA-C5-A3HL-01A-11D-A20X-26	HG19_Broad_variant	TCGA-C5-A3HL	TCGA-CESC	NA	s1516	MD Anderson - Institute for Applied Cancer Science	Medical College of Wisconsin	United States	NO	T1b2	N0	Cervical Squamous Cell Carcinoma	Not available	A20X-26	TRUE
13722.58cfa830e4b0c9d6adf6c29e	58cfa830e4b0c9d6adf6c29e	TCGA-BR-4366-01A-01D-1154_130815_VM001_0002_VMR0002CXX_s_1_rg.sorted.filtered.	WGS	TCGA-BR-4366-01A-01D-1154_130815_VM001_0002_VMR0002CXX_s_1_rg.sorted	TCGA-BR-4366-01A-01D-1154_130815_VM001_0002_VMR0002CXX_s_1_rg.sorted.bam	194.2	1.9	0.15	58cfa830e4b0c9d6adf6c29e	TCGA-BR-4366-01A-01D-1154_130815_VM001_0002_VMR0002CXX_s_1_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-BR-4366-01A	525A6978-2D7B-4F3A-AC68-13FE8CBBBDCC	Primary Tumor	Illumina HiSeq	c4b9424f-d0da-48ae-8723-69cbccfdefc6	Stomach	87	8C2D2CCE-E071-42E8-89B2-77C56B4F3472	5AF4101A-F7F6-4014-BC9C-02446DA9CBDC	TCGA-BR-4366-01A-01D-1154-02	HG19_Broad_variant	TCGA-BR-4366	TCGA-STAD	NA	s15235	Harvard Medical School	Asterand	Russia	NO	TX	NX	Stomach  Adenocarcinoma  Not Otherwise Specified (NOS)	Not available	1154-02	TRUE
13722.58cfa830e4b0c9d6adf6c272	58cfa830e4b0c9d6adf6c272	TCGA-BJ-A0ZA-01A-11D-A10R_120616_SN1120_0154_BD142VACXX_s_5_rg.sorted.filtered.	WGS	TCGA-BJ-A0ZA-01A-11D-A10R_120616_SN1120_0154_BD142VACXX_s_5_rg.sorted	TCGA-BJ-A0ZA-01A-11D-A10R_120616_SN1120_0154_BD142VACXX_s_5_rg.sorted.bam	34.66	1.95	0.15	58cfa830e4b0c9d6adf6c272	TCGA-BJ-A0ZA-01A-11D-A10R_120616_SN1120_0154_BD142VACXX_s_5_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-BJ-A0ZA-01A	4C513413-263E-4C7B-B997-7B688C47B698	Primary Tumor	Illumina HiSeq	787aed3e-08d4-4fa8-93e1-c04216a9875f	Thyroid	67	A61A9EC7-B893-44A5-AB6F-A390C168BE88	F3A353BB-07C3-49D1-BED2-2F8F5A328E1C	TCGA-BJ-A0ZA-01A-11D-A10R-02	HG19_Broad_variant	TCGA-BJ-A0ZA	TCGA-THCA	NA	s12744	Harvard Medical School	University of Pittsburgh	United States	NO	T2	N0	Thyroid Papillary Carcinoma - Classical/usual	Stage II	A10R-02	TRUE
13722.58cfa830e4b0c9d6adf6c2da	58cfa830e4b0c9d6adf6c2da	TCGA-BR-4370-01A-01D-1154_130815_VM001_0003_VMR0003CXX_s_1_rg.sorted.filtered.	WGS	TCGA-BR-4370-01A-01D-1154_130815_VM001_0003_VMR0003CXX_s_1_rg.sorted	TCGA-BR-4370-01A-01D-1154_130815_VM001_0003_VMR0003CXX_s_1_rg.sorted.bam	179.2	1.9	0.15	58cfa830e4b0c9d6adf6c2da	TCGA-BR-4370-01A-01D-1154_130815_VM001_0003_VMR0003CXX_s_1_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-BR-4370-01A	A2A71CB0-9DBD-45CC-8867-DA84500515E7	Primary Tumor	Illumina HiSeq	a1feb789-c851-4608-a5c1-382bb432c4c7	Stomach	74	CFB7901B-E4E1-42FE-802D-DCD34F8C4912	B27FAC46-97C3-4262-B8CB-6E15AA75483A	TCGA-BR-4370-01A-01D-1154-02	HG19_Broad_variant	TCGA-BR-4370	TCGA-STAD	NA	s14883	Harvard Medical School	Asterand	Russia	NO	TX	NX	Stomach  Adenocarcinoma  Not Otherwise Specified (NOS)	Not available	1154-02	TRUE
13722.58cfa830e4b0c9d6adf6c2ec	58cfa830e4b0c9d6adf6c2ec	TCGA-BR-6566-01A-11D-1798_130116_SN208_0449_BD1RNWACXX_s_2_rg.sorted.filtered.	WGS	TCGA-BR-6566-01A-11D-1798_130116_SN208_0449_BD1RNWACXX_s_2_rg.sorted	TCGA-BR-6566-01A-11D-1798_130116_SN208_0449_BD1RNWACXX_s_2_rg.sorted.bam	118.7	1.9	0.15	58cfa830e4b0c9d6adf6c2ec	TCGA-BR-6566-01A-11D-1798_130116_SN208_0449_BD1RNWACXX_s_2_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-BR-6566-01A	43F0421C-6578-4D77-9314-EF0305C7EFBD	Primary Tumor	Illumina HiSeq	ae711b74-3be9-4959-addd-03427c07f35b	Stomach	64	EEB8703E-5F0A-429D-9A5C-7C5227EB7A01	7BAAEED3-AA68-4825-84F1-0516B543C762	TCGA-BR-6566-01A-11D-1798-02	HG19_Broad_variant	TCGA-BR-6566	TCGA-STAD	NA	s14884	Harvard Medical School	Asterand	Russia	NO	T3	N0	Stomach  Adenocarcinoma  Not Otherwise Specified (NOS)	Stage IIA	1798-02	TRUE
13722.58cfa831e4b0c9d6adf6c384	58cfa831e4b0c9d6adf6c384	TCGA-CD-5801-01A-11D-1598_121025_SN590_0187_BC191FACXX_s_6_rg.sorted.filtered.	WGS	TCGA-CD-5801-01A-11D-1598_121025_SN590_0187_BC191FACXX_s_6_rg.sorted	TCGA-CD-5801-01A-11D-1598_121025_SN590_0187_BC191FACXX_s_6_rg.sorted.bam	374	2	0.17	58cfa831e4b0c9d6adf6c384	TCGA-CD-5801-01A-11D-1598_121025_SN590_0187_BC191FACXX_s_6_rg.sorted.bam	Alive	MALE	ASIAN	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-CD-5801-01A	DF822EA3-E0E6-4AD3-A228-E20E3A737DAC	Primary Tumor	Illumina HiSeq	5196b0dd-1d41-47f4-84a8-999f211443f4	Stomach	69	9D0DF8D7-8D59-4983-9BBF-C6C106BDEFEC	F32CB4AA-D842-427A-8B7E-371764308512	TCGA-CD-5801-01A-11D-1598-02	HG19_Broad_variant	TCGA-CD-5801	TCGA-STAD	NA	s15317	Harvard Medical School	ILSbio	Vietnam	NO	T3	N1	Stomach  Adenocarcinoma  Not Otherwise Specified (NOS)	Stage IIIA	1598-02	TRUE
13722.58cfa831e4b0c9d6adf6c498	58cfa831e4b0c9d6adf6c498	TCGA-CN-4722-01A-01D-1431_120423_SN590_0153_BC0KJ3ACXX_s_7_rg.sorted.filtered.	WGS	TCGA-CN-4722-01A-01D-1431_120423_SN590_0153_BC0KJ3ACXX_s_7_rg.sorted	TCGA-CN-4722-01A-01D-1431_120423_SN590_0153_BC0KJ3ACXX_s_7_rg.sorted.bam	52.7	1.9	0.16	58cfa831e4b0c9d6adf6c498	TCGA-CN-4722-01A-01D-1431_120423_SN590_0153_BC0KJ3ACXX_s_7_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CN-4722-01A	B64BFCA1-033C-4501-A900-103AC105C084	Primary Tumor	Illumina HiSeq	3723e20c-1e27-4158-8bc5-1768c49ee5e5	Head and Neck	61	6E767FC9-0F5A-49EC-999A-CDA2DAEBA6FF	0CA196A7-5A71-4E70-8FA6-9506E1883032	TCGA-CN-4722-01A-01D-1431-02	HG19_Broad_variant	TCGA-CN-4722	TCGA-HNSC	NA	s15758	Harvard Medical School	University of Pittsburgh	None	NO	T2	N0	Head and Neck Squamous Cell Carcinoma	Stage II	1431-02	TRUE
13722.58cfa831e4b0c9d6adf6c424	58cfa831e4b0c9d6adf6c424	TCGA-CN-4725-01A-01D-1431_120504_SN590_0155_AC0KTHACXX_s_3_rg.sorted.filtered.	WGS	TCGA-CN-4725-01A-01D-1431_120504_SN590_0155_AC0KTHACXX_s_3_rg.sorted	TCGA-CN-4725-01A-01D-1431_120504_SN590_0155_AC0KTHACXX_s_3_rg.sorted.bam	52.7	1.9	0.17	58cfa831e4b0c9d6adf6c424	TCGA-CN-4725-01A-01D-1431_120504_SN590_0155_AC0KTHACXX_s_3_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CN-4725-01A	3BE2ACE5-1C2A-49E9-8DA9-CEED6119530B	Primary Tumor	Illumina HiSeq	7ddc2537-f164-4a40-befe-6e0a3deed186	Head and Neck	60	DD42AB2F-E936-4ACE-93D8-60375E03F2FE	C8B71532-685F-47AC-B019-B898A8D1670D	TCGA-CN-4725-01A-01D-1431-02	HG19_Broad_variant	TCGA-CN-4725	TCGA-HNSC	NA	s15755	Harvard Medical School	University of Pittsburgh	None	NO	T2	N0	Head and Neck Squamous Cell Carcinoma	Stage II	1431-02	TRUE
13722.58cfa831e4b0c9d6adf6c4e4	58cfa831e4b0c9d6adf6c4e4	TCGA-C5-A2LZ-01A-11D-A20X_140106_SN590_0244_BC384EACXX_s_2_rg.sorted.filtered.	WGS	TCGA-C5-A2LZ-01A-11D-A20X_140106_SN590_0244_BC384EACXX_s_2_rg.sorted	TCGA-C5-A2LZ-01A-11D-A20X_140106_SN590_0244_BC384EACXX_s_2_rg.sorted.bam	58.89	NA	0.17	58cfa831e4b0c9d6adf6c4e4	TCGA-C5-A2LZ-01A-11D-A20X_140106_SN590_0244_BC384EACXX_s_2_rg.sorted.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-C5-A2LZ-01A	BE8FA67D-C2D3-4FFF-82FE-A46BA1FA8DF0	Primary Tumor	Illumina HiSeq	19f84215-7f5d-4cf8-a6f5-e135327ccd50	Cervix	65	6B9F4254-DBD3-4D82-BAE8-D43A4915A7CD	837B293C-0843-4002-A8AB-3A945E040C75	TCGA-C5-A2LZ-01A-11D-A20X-26	HG19_Broad_variant	TCGA-C5-A2LZ	TCGA-CESC	3046	s1173	MD Anderson - Institute for Applied Cancer Science	Medical College of Wisconsin	United States	NO	Not available	Not available	Cervical Squamous Cell Carcinoma	Not available	A20X-26	TRUE
13722.58cfa831e4b0c9d6adf6c4a4	58cfa831e4b0c9d6adf6c4a4	TCGA-CF-A1HR-01A-11D-A13U_121011_SN590_0184_BC192GACXX_s_3_rg.sorted.filtered.	WGS	TCGA-CF-A1HR-01A-11D-A13U_121011_SN590_0184_BC192GACXX_s_3_rg.sorted	TCGA-CF-A1HR-01A-11D-A13U_121011_SN590_0184_BC192GACXX_s_3_rg.sorted.bam	37.6	2	0.16	58cfa831e4b0c9d6adf6c4a4	TCGA-CF-A1HR-01A-11D-A13U_121011_SN590_0184_BC192GACXX_s_3_rg.sorted.bam	Alive	MALE	ASIAN	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-CF-A1HR-01A	39EA19E1-4959-4F1B-9934-54BDAF766842	Primary Tumor	Illumina HiSeq	65dee943-f41b-4f59-a5bb-2477053d1079	Bladder	62	6E77AB45-9C53-4A74-9581-043005C3E685	B048E28D-38FC-4E37-9C54-9C56526AD0E3	TCGA-CF-A1HR-01A-11D-A13U-02	HG19_Broad_variant	TCGA-CF-A1HR	TCGA-BLCA	NA	s2872	Harvard Medical School	ILSbio	Vietnam	NO	T3	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage III	A13U-02	TRUE
13722.58cfa831e4b0c9d6adf6c514	58cfa831e4b0c9d6adf6c514	TCGA-CN-4735-01A-01D-1431_120412_SN208_0283_AD0V1GACXX_s_2_rg.sorted.filtered.	WGS	TCGA-CN-4735-01A-01D-1431_120412_SN208_0283_AD0V1GACXX_s_2_rg.sorted	TCGA-CN-4735-01A-01D-1431_120412_SN208_0283_AD0V1GACXX_s_2_rg.sorted.bam	52.7	1.9	0.13	58cfa831e4b0c9d6adf6c514	TCGA-CN-4735-01A-01D-1431_120412_SN208_0283_AD0V1GACXX_s_2_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CN-4735-01A	FE844945-3EA9-449E-993C-DF392FABCFD0	Primary Tumor	Illumina HiSeq	b8913a67-9dd4-41f9-8888-c998df0a0a23	Head and Neck	52	FBB300FA-8793-42DA-A68E-4570AE2E5186	F759672A-62CA-49DC-BC4F-643E8A885787	TCGA-CN-4735-01A-01D-1431-02	HG19_Broad_variant	TCGA-CN-4735	TCGA-HNSC	NA	s16032	Harvard Medical School	University of Pittsburgh	None	NO	T3	N2b	Head and Neck Squamous Cell Carcinoma	Stage IVA	1431-02	TRUE
13722.58cfa831e4b0c9d6adf6c57e	58cfa831e4b0c9d6adf6c57e	TCGA-CN-4729-01A-01D-1431_120513_SN590_0157_AD0PU3ACXX_s_3_rg.sorted.filtered.	WGS	TCGA-CN-4729-01A-01D-1431_120513_SN590_0157_AD0PU3ACXX_s_3_rg.sorted	TCGA-CN-4729-01A-01D-1431_120513_SN590_0157_AD0PU3ACXX_s_3_rg.sorted.bam	99.7	1.9	0.15	58cfa831e4b0c9d6adf6c57e	TCGA-CN-4729-01A-01D-1431_120513_SN590_0157_AD0PU3ACXX_s_3_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CN-4729-01A	2FC960BD-01B0-422D-AD33-34520FA3DF0E	Primary Tumor	Illumina HiSeq	8b48a937-18eb-4e54-95d1-680ce9284b60	Head and Neck	73	1DA8FE25-AEE2-45FD-A1F3-3239A42E54B2	A49670C2-95A6-4DEB-BFC5-59B0FF37389E	TCGA-CN-4729-01A-01D-1431-02	HG19_Broad_variant	TCGA-CN-4729	TCGA-HNSC	NA	s15620	Harvard Medical School	University of Pittsburgh	None	NO	T2	N1	Head and Neck Squamous Cell Carcinoma	Stage III	1431-02	TRUE
13722.58cfa830e4b0c9d6adf6c102	58cfa830e4b0c9d6adf6c102	TCGA-B5-A0K9-01A-21D-A101_120330_SN208_0279_BC0L73ACXX_s_1_rg.sorted.filtered.	WGS	TCGA-B5-A0K9-01A-21D-A101_120330_SN208_0279_BC0L73ACXX_s_1_rg.sorted	TCGA-B5-A0K9-01A-21D-A101_120330_SN208_0279_BC0L73ACXX_s_1_rg.sorted.bam	97.15	2.16	0.13	58cfa830e4b0c9d6adf6c102	TCGA-B5-A0K9-01A-21D-A101_120330_SN208_0279_BC0L73ACXX_s_1_rg.sorted.bam	Alive	FEMALE	WHITE	Not available	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-B5-A0K9-01A	4485CC98-5D58-4EB4-8325-7D1A617B6461	Primary Tumor	Illumina HiSeq	71c016d1-ab89-4d8f-acb9-92767959d603	Uterus	88	52A96216-708F-43F2-A923-130A1C35922D	30D94271-91F3-4CF5-83C0-4708662115D0	TCGA-B5-A0K9-01A-21D-A101-02	HG19_Broad_variant	TCGA-B5-A0K9	TCGA-UCEC	NA	s5210	Harvard Medical School	Duke	United States	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A101-02	TRUE
13722.58cfa831e4b0c9d6adf6c63a	58cfa831e4b0c9d6adf6c63a	TCGA-CG-4304-01A-01D-A326_131002_SN208_0497_AC2CLVACXX_s_3_rg.sorted.filtered.	WGS	TCGA-CG-4304-01A-01D-A326_131002_SN208_0497_AC2CLVACXX_s_3_rg.sorted	TCGA-CG-4304-01A-01D-A326_131002_SN208_0497_AC2CLVACXX_s_3_rg.sorted.bam	286.2	1.9	0.16	58cfa831e4b0c9d6adf6c63a	TCGA-CG-4304-01A-01D-A326_131002_SN208_0497_AC2CLVACXX_s_3_rg.sorted.bam	Alive	MALE	Not available	Not available	Stomach Adenocarcinoma	Aligned reads	TCGA-CG-4304-01A	8E005891-D6FE-4FEE-A699-971FEE4E70F1	Primary Tumor	Illumina HiSeq	4fbdbad3-32cb-45de-990a-1337f32a25fa	Stomach	84	CC852701-8996-4C8B-828D-5C4AC1F4CFD4	46FB2601-D210-4528-B7D9-BE054DD54BFD	TCGA-CG-4304-01A-01D-A326-26	HG19_Broad_variant	TCGA-CG-4304	TCGA-STAD	NA	s14549	MD Anderson - Institute for Applied Cancer Science	Indivumed	Germany	NO	T2a	N0	Stomach  Adenocarcinoma  Not Otherwise Specified (NOS)	Stage IB	A326-26	TRUE
13722.58cfa831e4b0c9d6adf6c651	58cfa831e4b0c9d6adf6c651	TCGA-CN-4736-01A-01D-1431_120412_SN208_0283_AD0V1GACXX_s_3_rg.sorted.filtered.	WGS	TCGA-CN-4736-01A-01D-1431_120412_SN208_0283_AD0V1GACXX_s_3_rg.sorted	TCGA-CN-4736-01A-01D-1431_120412_SN208_0283_AD0V1GACXX_s_3_rg.sorted.bam	52.7	1.9	0.15	58cfa831e4b0c9d6adf6c651	TCGA-CN-4736-01A-01D-1431_120412_SN208_0283_AD0V1GACXX_s_3_rg.sorted.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CN-4736-01A	0FB3E5FF-54F0-43C5-9322-541BB7825E7F	Primary Tumor	Illumina HiSeq	45c5cea2-56a4-43af-9c53-19302867f2d9	Head and Neck	70	6DB0B6EE-23B3-43BF-8AA9-FDF641AFC673	8141905F-DE66-4DB2-A9F9-5819C953A465	TCGA-CN-4736-01A-01D-1431-02	HG19_Broad_variant	TCGA-CN-4736	TCGA-HNSC	395	s15881	Harvard Medical School	University of Pittsburgh	None	NO	T1	NX	Head and Neck Squamous Cell Carcinoma	Not available	1431-02	TRUE
13722.58cfa831e4b0c9d6adf6c696	58cfa831e4b0c9d6adf6c696	TCGA-CS-6186-01A-12D-2022_130910_SN208_0494_AC2A1DACXX_s_3_rg.sorted.filtered.	WGS	TCGA-CS-6186-01A-12D-2022_130910_SN208_0494_AC2A1DACXX_s_3_rg.sorted	TCGA-CS-6186-01A-12D-2022_130910_SN208_0494_AC2A1DACXX_s_3_rg.sorted.bam	324.7	NA	0.15	58cfa831e4b0c9d6adf6c696	TCGA-CS-6186-01A-12D-2022_130910_SN208_0494_AC2A1DACXX_s_3_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-CS-6186-01A	9EE6E821-3AF2-42D7-9D14-F0CA455F338C	Primary Tumor	Illumina HiSeq	5660aee8-60eb-40d1-9083-d4fc781e8ddc	Brain	58	5F73FA4E-FC7D-4FC0-8436-2241E57B9B69	4143FB11-BA46-4129-8543-F72C015AE5C4	TCGA-CS-6186-01A-12D-2022-02	HG19_Broad_variant	TCGA-CS-6186	TCGA-LGG	538	s8556	Harvard Medical School	Thomas Jefferson University	United States	NO	Not available	Not available	Oligoastrocytoma	Not available	2022-02	TRUE
13722.58cfa831e4b0c9d6adf6c68f	58cfa831e4b0c9d6adf6c68f	TCGA-CU-A3YL-01A-11D-A233_120829_SN1120_0183_AC18U8ACXX_s_3_rg.sorted.filtered.	WGS	TCGA-CU-A3YL-01A-11D-A233_120829_SN1120_0183_AC18U8ACXX_s_3_rg.sorted	TCGA-CU-A3YL-01A-11D-A233_120829_SN1120_0183_AC18U8ACXX_s_3_rg.sorted.bam	42.41	NA	0.15	58cfa831e4b0c9d6adf6c68f	TCGA-CU-A3YL-01A-11D-A233_120829_SN1120_0183_AC18U8ACXX_s_3_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-CU-A3YL-01A	087A7F70-2FA8-4A16-B130-4DF10A70C662	Primary Tumor	Illumina HiSeq	8753d7f5-4d92-4781-8d19-d44710fa4f45	Bladder	67	F66AD788-E2D8-4688-820F-49A609701533	CAD008C4-3B53-4E9D-8730-9807E4753DDD	TCGA-CU-A3YL-01A-11D-A233-26	HG19_Broad_variant	TCGA-CU-A3YL	TCGA-BLCA	NA	s3274	MD Anderson - Institute for Applied Cancer Science	UNC	United States	NO	T4a	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage III	A233-26	TRUE
13722.58cfa831e4b0c9d6adf6c741	58cfa831e4b0c9d6adf6c741	TCGA-CV-7247-01A-11D-2317_120730_SN1222_0140_AC11GKACXX_s_7_rg.sorted.filtered.	WGS	TCGA-CV-7247-01A-11D-2317_120730_SN1222_0140_AC11GKACXX_s_7_rg.sorted	TCGA-CV-7247-01A-11D-2317_120730_SN1222_0140_AC11GKACXX_s_7_rg.sorted.bam	52.73	NA	0.13	58cfa831e4b0c9d6adf6c741	TCGA-CV-7247-01A-11D-2317_120730_SN1222_0140_AC11GKACXX_s_7_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-7247-01A	5E25AB76-A8AB-4779-AA03-8DE658F18DA1	Primary Tumor	Illumina HiSeq	0b4ae8f3-7acd-4d37-a39f-cb4fc2b537b4	Head and Neck	55	F84AE44B-4BB7-4841-AEE0-139CD79B9680	A5BA905A-C959-4118-B1C9-F6466CB5541A	TCGA-CV-7247-01A-11D-2317-26	HG19_Broad_variant	TCGA-CV-7247	TCGA-HNSC	577	s15904	MD Anderson - Institute for Applied Cancer Science	MD Anderson Cancer Center	United States	NO	T3	N0	Head and Neck Squamous Cell Carcinoma	Stage III	2317-26	TRUE
13722.58cfa831e4b0c9d6adf6c810	58cfa831e4b0c9d6adf6c810	TCGA-D1-A2G0-01A-11D-A17E_120511_SN1120_0140_AD12J0ACXX_s_5_rg.sorted.filtered.	WGS	TCGA-D1-A2G0-01A-11D-A17E_120511_SN1120_0140_AD12J0ACXX_s_5_rg.sorted	TCGA-D1-A2G0-01A-11D-A17E_120511_SN1120_0140_AD12J0ACXX_s_5_rg.sorted.bam	59.69	NA	0.17	58cfa831e4b0c9d6adf6c810	TCGA-D1-A2G0-01A-11D-A17E_120511_SN1120_0140_AD12J0ACXX_s_5_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-D1-A2G0-01A	6F661F0D-F08B-486E-8BD7-4306E1593EB9	Primary Tumor	Illumina HiSeq	675cc0ce-f2e1-4e4c-a337-4bc31fcb46c5	Uterus	70	134CD317-CBEB-4633-B540-B639454615F7	DF417E78-8258-40C2-8305-2FE14DCC8035	TCGA-D1-A2G0-01A-11D-A17E-02	HG19_Broad_variant	TCGA-D1-A2G0	TCGA-UCEC	NA	s4803	Harvard Medical School	Mayo Clinic	United States	NO	Not available	Not available	Mixed serous and endometrioid	Not available	A17E-02	TRUE
13722.58cfa831e4b0c9d6adf6c77e	58cfa831e4b0c9d6adf6c77e	TCGA-CS-5396-01A-02D-1465_130906_SN1440_0166_BC2A68ACXX_s_4_rg.sorted.filtered.	WGS	TCGA-CS-5396-01A-02D-1465_130906_SN1440_0166_BC2A68ACXX_s_4_rg.sorted	TCGA-CS-5396-01A-02D-1465_130906_SN1440_0166_BC2A68ACXX_s_4_rg.sorted.bam	152.7	1.9	0.15	58cfa831e4b0c9d6adf6c77e	TCGA-CS-5396-01A-02D-1465_130906_SN1440_0166_BC2A68ACXX_s_4_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-CS-5396-01A	B6C2C9BD-625B-4A98-830C-49C344F6CB5F	Primary Tumor	Illumina HiSeq	3d26b7bb-4cc9-4d9b-8c42-6fbd2ea9b590	Brain	53	CE1ED4B3-AF89-4BBD-B9A6-EEFA007E4368	F2F5E5EE-B807-4CAF-99B3-68270C1F305E	TCGA-CS-5396-01A-02D-1465-02	HG19_Broad_variant	TCGA-CS-5396	TCGA-LGG	NA	s8342	Harvard Medical School	Thomas Jefferson University	United States	NO	Not available	Not available	Oligodendroglioma	Not available	1465-02	TRUE
13722.58cfa831e4b0c9d6adf6c830	58cfa831e4b0c9d6adf6c830	TCGA-CV-7407-01A-11D-2317_120710_SN590_0166_AC0VNFACXX_s_8_rg.sorted.filtered.	WGS	TCGA-CV-7407-01A-11D-2317_120710_SN590_0166_AC0VNFACXX_s_8_rg.sorted	TCGA-CV-7407-01A-11D-2317_120710_SN590_0166_AC0VNFACXX_s_8_rg.sorted.bam	131.73	NA	0.16	58cfa831e4b0c9d6adf6c830	TCGA-CV-7407-01A-11D-2317_120710_SN590_0166_AC0VNFACXX_s_8_rg.sorted.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-7407-01A	8B63BE59-9CE6-45A0-80D9-4D20F4918CB9	Primary Tumor	Illumina HiSeq	e5709830-4141-4354-94f0-94f576fe84c9	Head and Neck	67	6ABAF81A-B228-4AFE-B931-BC1FC39CD265	4CC9AD85-2F84-4657-8F3E-6C5DD69F1B30	TCGA-CV-7407-01A-11D-2317-26	HG19_Broad_variant	TCGA-CV-7407	TCGA-HNSC	1081	s15909	MD Anderson - Institute for Applied Cancer Science	MD Anderson Cancer Center	United States	NO	T2	NX	Head and Neck Squamous Cell Carcinoma	Stage II	2317-26	TRUE
13722.58cfa831e4b0c9d6adf6c8d6	58cfa831e4b0c9d6adf6c8d6	TCGA-D1-A16B-01A-11D-A12F_120511_SN208_0299_BD12J9ACXX_s_1_rg.sorted.filtered.	WGS	TCGA-D1-A16B-01A-11D-A12F_120511_SN208_0299_BD12J9ACXX_s_1_rg.sorted	TCGA-D1-A16B-01A-11D-A12F_120511_SN208_0299_BD12J9ACXX_s_1_rg.sorted.bam	93.6	1.92	0.15	58cfa831e4b0c9d6adf6c8d6	TCGA-D1-A16B-01A-11D-A12F_120511_SN208_0299_BD12J9ACXX_s_1_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-D1-A16B-01A	BCA1057A-1E96-404D-8A37-5A8DC1944EE7	Primary Tumor	Illumina HiSeq	fee88e21-5479-4b67-8933-80c22e6fa222	Uterus	64	6A59FF6E-7CC6-4D46-8983-7D9E6A48CC19	D581BCAA-4EA7-4364-840B-E2D24F1916E4	TCGA-D1-A16B-01A-11D-A12F-02	HG19_Broad_variant	TCGA-D1-A16B	TCGA-UCEC	NA	s5017	Harvard Medical School	Mayo Clinic	None	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A12F-02	TRUE
13722.58cfa831e4b0c9d6adf6c8ba	58cfa831e4b0c9d6adf6c8ba	TCGA-DK-A3IM-01A-11D-A210_120906_SN208_0425_AD1CU2ACXX_s_7_rg.sorted.filtered.	WGS	TCGA-DK-A3IM-01A-11D-A210_120906_SN208_0425_AD1CU2ACXX_s_7_rg.sorted	TCGA-DK-A3IM-01A-11D-A210_120906_SN208_0425_AD1CU2ACXX_s_7_rg.sorted.bam	26.41	NA	0.15	58cfa831e4b0c9d6adf6c8ba	TCGA-DK-A3IM-01A-11D-A210_120906_SN208_0425_AD1CU2ACXX_s_7_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-DK-A3IM-01A	41B59716-116F-4942-8B63-409870A87E26	Primary Tumor	Illumina HiSeq	27ca0d22-3ef8-4c3c-814a-94dfb76c3289	Bladder	76	7A37AE7C-6B46-410D-AE2B-12FD868C25B3	CDAC6FE7-FB06-4F9A-86D0-DF0DF26FD558	TCGA-DK-A3IM-01A-11D-A210-26	HG19_Broad_variant	TCGA-DK-A3IM	TCGA-BLCA	NA	s2882	MD Anderson - Institute for Applied Cancer Science	Memorial Sloan Kettering	United States	NO	T3	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage III	A210-26	TRUE
13722.58cfa831e4b0c9d6adf6c8ce	58cfa831e4b0c9d6adf6c8ce	TCGA-D1-A16Q-01A-12D-A12F_120511_SN208_0299_BD12J9ACXX_s_5_rg.sorted.filtered.	WGS	TCGA-D1-A16Q-01A-12D-A12F_120511_SN208_0299_BD12J9ACXX_s_5_rg.sorted	TCGA-D1-A16Q-01A-12D-A12F_120511_SN208_0299_BD12J9ACXX_s_5_rg.sorted.bam	74.24	1.92	0.14	58cfa831e4b0c9d6adf6c8ce	TCGA-D1-A16Q-01A-12D-A12F_120511_SN208_0299_BD12J9ACXX_s_5_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-D1-A16Q-01A	7F4F3AED-69AF-421E-817B-B258DCC0BAC5	Primary Tumor	Illumina HiSeq	c23e5f4d-d7be-44b1-a19e-c949819d58c9	Uterus	54	BFE3DA05-506E-4837-AC72-A285FE079C58	23DF790A-0AB3-4EFB-AD9D-62AF1B79D941	TCGA-D1-A16Q-01A-12D-A12F-02	HG19_Broad_variant	TCGA-D1-A16Q	TCGA-UCEC	NA	s5024	Harvard Medical School	Mayo Clinic	None	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A12F-02	TRUE
13722.58cfa831e4b0c9d6adf6c9da	58cfa831e4b0c9d6adf6c9da	TCGA-DJ-A13T-01A-11D-A10R_120629_SN1120_0167_AC0WMBACXX_s_1_rg.sorted.filtered.	WGS	TCGA-DJ-A13T-01A-11D-A10R_120629_SN1120_0167_AC0WMBACXX_s_1_rg.sorted	TCGA-DJ-A13T-01A-11D-A10R_120629_SN1120_0167_AC0WMBACXX_s_1_rg.sorted.bam	48.83	2	0.16	58cfa831e4b0c9d6adf6c9da	TCGA-DJ-A13T-01A-11D-A10R_120629_SN1120_0167_AC0WMBACXX_s_1_rg.sorted.bam	Alive	FEMALE	WHITE	Not available	Thyroid Carcinoma	Aligned reads	TCGA-DJ-A13T-01A	0B170ED4-D919-466B-B765-47878B865AED	Primary Tumor	Illumina HiSeq	f42aa2a6-4acd-4650-aea7-c83fbddf27d2	Thyroid	37	6883BA87-9184-40D7-840B-603B15D73F7A	76DCBA6C-0992-44BB-9492-3023A2430CC4	TCGA-DJ-A13T-01A-11D-A10R-02	HG19_Broad_variant	TCGA-DJ-A13T	TCGA-THCA	NA	s12513	Harvard Medical School	Memorial Sloan Kettering	United States	NO	T2	N0	Thyroid Papillary Carcinoma - Classical/usual	Stage I	A10R-02	TRUE
13722.58cfa831e4b0c9d6adf6c9e6	58cfa831e4b0c9d6adf6c9e6	TCGA-DK-A3X1-01A-12D-A233_120829_SN1120_0184_BD1DRAACXX_s_1_rg.sorted.filtered.	WGS	TCGA-DK-A3X1-01A-12D-A233_120829_SN1120_0184_BD1DRAACXX_s_1_rg.sorted	TCGA-DK-A3X1-01A-12D-A233_120829_SN1120_0184_BD1DRAACXX_s_1_rg.sorted.bam	47.57	NA	0.16	58cfa831e4b0c9d6adf6c9e6	TCGA-DK-A3X1-01A-12D-A233_120829_SN1120_0184_BD1DRAACXX_s_1_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-DK-A3X1-01A	6BDDAFDE-7004-49B6-80CF-8081CD4B7D44	Primary Tumor	Illumina HiSeq	4c8de054-fd6d-4ebd-8a6e-b5061ef5913b	Bladder	78	3D440A83-214E-432F-89D2-B523BFE7C6EF	4A8B5117-AF70-40AB-9698-B736EF20F3DE	TCGA-DK-A3X1-01A-12D-A233-26	HG19_Broad_variant	TCGA-DK-A3X1	TCGA-BLCA	NA	s3286	MD Anderson - Institute for Applied Cancer Science	Memorial Sloan Kettering	United States	NO	T3	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage III	A233-26	TRUE
13722.58cfa831e4b0c9d6adf6c96a	58cfa831e4b0c9d6adf6c96a	TCGA-DJ-A1QI-01A-11D-A14U_120717_SN1120_0175_AC1179ACXX_s_5_rg.sorted.filtered.	WGS	TCGA-DJ-A1QI-01A-11D-A14U_120717_SN1120_0175_AC1179ACXX_s_5_rg.sorted	TCGA-DJ-A1QI-01A-11D-A14U_120717_SN1120_0175_AC1179ACXX_s_5_rg.sorted.bam	97.61	1.98	0.17	58cfa831e4b0c9d6adf6c96a	TCGA-DJ-A1QI-01A-11D-A14U_120717_SN1120_0175_AC1179ACXX_s_5_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-DJ-A1QI-01A	3B1E2BD6-3D32-40F7-9B32-0DF32DFCBC72	Primary Tumor	Illumina HiSeq	e0052e53-2d8c-45ba-8d2c-db4eab61a141	Thyroid	63	C58506A1-8C6B-4CE8-99E0-F2D1234F95F5	3C049586-BD3C-490D-93DB-E344BD6A1AE8	TCGA-DJ-A1QI-01A-11D-A14U-02	HG19_Broad_variant	TCGA-DJ-A1QI	TCGA-THCA	NA	s12641	Harvard Medical School	Memorial Sloan Kettering	United States	NO	T2	N0	Thyroid Papillary Carcinoma - Classical/usual	Stage II	A14U-02	TRUE
13722.58cfa831e4b0c9d6adf6ca0f	58cfa831e4b0c9d6adf6ca0f	TCGA-DK-A3X2-01A-11D-A233_120829_SN1120_0184_BD1DRAACXX_s_3_rg.sorted.filtered.	WGS	TCGA-DK-A3X2-01A-11D-A233_120829_SN1120_0184_BD1DRAACXX_s_3_rg.sorted	TCGA-DK-A3X2-01A-11D-A233_120829_SN1120_0184_BD1DRAACXX_s_3_rg.sorted.bam	51.32	NA	0.15	58cfa831e4b0c9d6adf6ca0f	TCGA-DK-A3X2-01A-11D-A233_120829_SN1120_0184_BD1DRAACXX_s_3_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-DK-A3X2-01A	40551D53-388B-4067-9341-76E94D023703	Primary Tumor	Illumina HiSeq	a8b7a158-32d0-421e-82bd-edb6a44d69e0	Bladder	85	3B816277-91CB-413E-BC7C-BA33CD72B67D	5D13DEBC-82D6-45EA-A9EA-A85B85CF659F	TCGA-DK-A3X2-01A-11D-A233-26	HG19_Broad_variant	TCGA-DK-A3X2	TCGA-BLCA	547	s2716	MD Anderson - Institute for Applied Cancer Science	Memorial Sloan Kettering	United States	NO	T3	N2	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV	A233-26	TRUE
13722.58cfa831e4b0c9d6adf6ca37	58cfa831e4b0c9d6adf6ca37	TCGA-DB-5279-01A-01D-1465_130806_SN1440_0159_BC29Y3ACXX_s_7_rg.sorted.filtered.	WGS	TCGA-DB-5279-01A-01D-1465_130806_SN1440_0159_BC29Y3ACXX_s_7_rg.sorted	TCGA-DB-5279-01A-01D-1465_130806_SN1440_0159_BC29Y3ACXX_s_7_rg.sorted.bam	81	1.9	0.14	58cfa831e4b0c9d6adf6ca37	TCGA-DB-5279-01A-01D-1465_130806_SN1440_0159_BC29Y3ACXX_s_7_rg.sorted.bam	Alive	MALE	Not available	Not available	Brain Lower Grade Glioma	Aligned reads	TCGA-DB-5279-01A	85F77526-791E-47CD-904D-D1DBB49EAEAB	Primary Tumor	Illumina HiSeq	1c15ff7e-3cbc-41b1-b814-1cf03f1f5a27	Brain	59	0096C7FB-34E3-4D0F-BA81-3559CC00080A	109052DB-CACF-4E14-8258-500E90B6B476	TCGA-DB-5279-01A-01D-1465-02	HG19_Broad_variant	TCGA-DB-5279	TCGA-LGG	NA	s8559	Harvard Medical School	Mayo Clinic - Rochester	United States	NO	Not available	Not available	Oligodendroglioma	Not available	1465-02	TRUE
13722.58cfa831e4b0c9d6adf6ca54	58cfa831e4b0c9d6adf6ca54	TCGA-DB-5280-01A-01D-1465_130906_SN1440_0166_BC2A68ACXX_s_5_rg.sorted.filtered.	WGS	TCGA-DB-5280-01A-01D-1465_130906_SN1440_0166_BC2A68ACXX_s_5_rg.sorted	TCGA-DB-5280-01A-01D-1465_130906_SN1440_0166_BC2A68ACXX_s_5_rg.sorted.bam	325.7	1.9	0.15	58cfa831e4b0c9d6adf6ca54	TCGA-DB-5280-01A-01D-1465_130906_SN1440_0166_BC2A68ACXX_s_5_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-DB-5280-01A	4797C600-F024-42FE-B287-D919B24DCB79	Primary Tumor	Illumina HiSeq	47363648-94bb-4221-a905-4832396ef90e	Brain	43	D9B929FD-335C-46B1-B60D-B846C372AA6A	677B8F71-325E-49F9-B3D7-B6ADB6831ED5	TCGA-DB-5280-01A-01D-1465-02	HG19_Broad_variant	TCGA-DB-5280	TCGA-LGG	NA	s8130	Harvard Medical School	Mayo Clinic - Rochester	United States	NO	Not available	Not available	Oligoastrocytoma	Not available	1465-02	TRUE
13722.58cfa831e4b0c9d6adf6ca7c	58cfa831e4b0c9d6adf6ca7c	TCGA-DJ-A13X-01A-11D-A10R_120617_SN1222_0117_BD1414ACXX_s_1_rg.sorted.filtered.	WGS	TCGA-DJ-A13X-01A-11D-A10R_120617_SN1222_0117_BD1414ACXX_s_1_rg.sorted	TCGA-DJ-A13X-01A-11D-A10R_120617_SN1222_0117_BD1414ACXX_s_1_rg.sorted.bam	52.8	1.95	0.16	58cfa831e4b0c9d6adf6ca7c	TCGA-DJ-A13X-01A-11D-A10R_120617_SN1222_0117_BD1414ACXX_s_1_rg.sorted.bam	Alive	FEMALE	Not available	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-DJ-A13X-01A	3B3C99AB-5336-4433-B682-E1A590221611	Primary Tumor	Illumina HiSeq	a3b0754a-92ca-4ef2-b612-4e5bf2f74048	Thyroid	51	AC52BED3-FDD6-4281-89DE-D2F125BA038E	3E92A45C-FFFB-4C07-BD81-DB3EBF41841F	TCGA-DJ-A13X-01A-11D-A10R-02	HG19_Broad_variant	TCGA-DJ-A13X	TCGA-THCA	NA	s12748	Harvard Medical School	Memorial Sloan Kettering	United States	NO	T3	N0	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	Stage III	A10R-02	TRUE
13722.58cfa831e4b0c9d6adf6caaa	58cfa831e4b0c9d6adf6caaa	TCGA-D1-A16D-01A-11D-A12F_120511_SN208_0299_BD12J9ACXX_s_3_rg.sorted.filtered.	WGS	TCGA-D1-A16D-01A-11D-A12F_120511_SN208_0299_BD12J9ACXX_s_3_rg.sorted	TCGA-D1-A16D-01A-11D-A12F_120511_SN208_0299_BD12J9ACXX_s_3_rg.sorted.bam	64.8	1.88	0.16	58cfa831e4b0c9d6adf6caaa	TCGA-D1-A16D-01A-11D-A12F_120511_SN208_0299_BD12J9ACXX_s_3_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-D1-A16D-01A	5693302A-4548-4C0B-8725-0CB7C67BC4F8	Primary Tumor	Illumina HiSeq	c72febd1-cbf3-4ba1-9e3e-35d65e99aa5e	Uterus	49	007BDFD3-81B6-42C3-A4A6-C4DDAF1BE0AE	DCA0D1DE-E9A0-45CF-B709-A492D513C1C4	TCGA-D1-A16D-01A-11D-A12F-02	HG19_Broad_variant	TCGA-D1-A16D	TCGA-UCEC	NA	s4613	Harvard Medical School	Mayo Clinic	None	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A12F-02	TRUE
13722.58cfa831e4b0c9d6adf6c9dc	58cfa831e4b0c9d6adf6c9dc	TCGA-DU-6392-01A-11D-1703_130906_SN1440_0166_BC2A68ACXX_s_6_rg.sorted.filtered.	WGS	TCGA-DU-6392-01A-11D-1703_130906_SN1440_0166_BC2A68ACXX_s_6_rg.sorted	TCGA-DU-6392-01A-11D-1703_130906_SN1440_0166_BC2A68ACXX_s_6_rg.sorted.bam	16	2	0.13	58cfa831e4b0c9d6adf6c9dc	TCGA-DU-6392-01A-11D-1703_130906_SN1440_0166_BC2A68ACXX_s_6_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-DU-6392-01A	FCD9E1C4-BDDB-4856-844C-03DF48FBA499	Primary Tumor	Illumina HiSeq	8f4eff17-77e1-4e7d-9fc7-83ae4db50b3a	Brain	35	14780BB2-67A9-4ACA-BCE4-12793FB1808E	E7B36F2D-9AB1-4A46-B669-65367B841752	TCGA-DU-6392-01A-11D-1703-02	HG19_Broad_variant	TCGA-DU-6392	TCGA-LGG	NA	s8561	Harvard Medical School	Henry Ford Hospital	United States	NO	Not available	Not available	Astrocytoma	Not available	1703-02	TRUE
13722.58cfa831e4b0c9d6adf6caf8	58cfa831e4b0c9d6adf6caf8	TCGA-EA-A3HR-01A-11D-A20X_140417_SN590_0248_AC3EUFACXX_s_1_rg.sorted.filtered.	WGS	TCGA-EA-A3HR-01A-11D-A20X_140417_SN590_0248_AC3EUFACXX_s_1_rg.sorted	TCGA-EA-A3HR-01A-11D-A20X_140417_SN590_0248_AC3EUFACXX_s_1_rg.sorted.bam	47.83	NA	0.16	58cfa831e4b0c9d6adf6caf8	TCGA-EA-A3HR-01A-11D-A20X_140417_SN590_0248_AC3EUFACXX_s_1_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-EA-A3HR-01A	638035F6-2909-4A44-980F-468AC5D74E18	Primary Tumor	Illumina HiSeq	a2c5a51a-5933-4597-b207-2c761c54f7c2	Cervix	57	1FBFA952-F272-4531-9F9D-1B8BD1DD0845	2B1D8BBD-0F37-40D4-AF38-C78C4BB556BB	TCGA-EA-A3HR-01A-11D-A20X-26	HG19_Broad_variant	TCGA-EA-A3HR	TCGA-CESC	NA	s1179	MD Anderson - Institute for Applied Cancer Science	Asterand	Russia	NO	T2a	N0	Cervical Squamous Cell Carcinoma	Not available	A20X-26	TRUE
13722.58cfa831e4b0c9d6adf6caf0	58cfa831e4b0c9d6adf6caf0	TCGA-DU-7006-01A-11D-2022_130910_SN208_0494_AC2A1DACXX_s_5_rg.sorted.filtered.	WGS	TCGA-DU-7006-01A-11D-2022_130910_SN208_0494_AC2A1DACXX_s_5_rg.sorted	TCGA-DU-7006-01A-11D-2022_130910_SN208_0494_AC2A1DACXX_s_5_rg.sorted.bam	301.7	NA	0.16	58cfa831e4b0c9d6adf6caf0	TCGA-DU-7006-01A-11D-2022_130910_SN208_0494_AC2A1DACXX_s_5_rg.sorted.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-DU-7006-01A	215E117C-4D76-463C-8F8A-FD6A28D23929	Primary Tumor	Illumina HiSeq	a423d9b3-2389-45d5-b834-d5cf57e5e647	Brain	60	21E471E0-6B87-4D98-A7E0-DE0F34598460	FDA752F3-371F-460B-8D81-216E0AC53B0E	TCGA-DU-7006-01A-11D-2022-02	HG19_Broad_variant	TCGA-DU-7006	TCGA-LGG	349	s8357	Harvard Medical School	Henry Ford Hospital	United States	NO	Not available	Not available	Astrocytoma	Not available	2022-02	TRUE
13722.58cfa831e4b0c9d6adf6cad6	58cfa831e4b0c9d6adf6cad6	TCGA-DU-6408-01A-11D-1703_130813_SN1440_0160_AD2B87ACXX_s_8_rg.sorted.filtered.	WGS	TCGA-DU-6408-01A-11D-1703_130813_SN1440_0160_AD2B87ACXX_s_8_rg.sorted	TCGA-DU-6408-01A-11D-1703_130813_SN1440_0160_AD2B87ACXX_s_8_rg.sorted.bam	157.3	1.9	0.15	58cfa831e4b0c9d6adf6cad6	TCGA-DU-6408-01A-11D-1703_130813_SN1440_0160_AD2B87ACXX_s_8_rg.sorted.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-DU-6408-01A	14375753-A69F-41E0-B910-2BB8E84CC43A	Primary Tumor	Illumina HiSeq	f441e949-5e27-4235-a0db-39c77aacdb5c	Brain	23	F68159AD-A0E9-4F9F-AD68-A29D53772982	57952871-E6FE-4C1F-87FE-404FADFC67C1	TCGA-DU-6408-01A-11D-1703-02	HG19_Broad_variant	TCGA-DU-6408	TCGA-LGG	3470	s8757	Harvard Medical School	Henry Ford Hospital	United States	NO	Not available	Not available	Oligodendroglioma	Not available	1703-02	TRUE
13722.58cfa831e4b0c9d6adf6cb28	58cfa831e4b0c9d6adf6cb28	TCGA-E7-A3Y1-01A-11D-A233_120829_SN1120_0184_BD1DRAACXX_s_7_rg.sorted.filtered.	WGS	TCGA-E7-A3Y1-01A-11D-A233_120829_SN1120_0184_BD1DRAACXX_s_7_rg.sorted	TCGA-E7-A3Y1-01A-11D-A233_120829_SN1120_0184_BD1DRAACXX_s_7_rg.sorted.bam	43.56	NA	0.17	58cfa831e4b0c9d6adf6cb28	TCGA-E7-A3Y1-01A-11D-A233_120829_SN1120_0184_BD1DRAACXX_s_7_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-E7-A3Y1-01A	F7C891EB-3B09-4E01-BB8A-53D570518CBE	Primary Tumor	Illumina HiSeq	aaeb4857-84bb-4a72-9e0d-81280de1ca61	Bladder	57	FABE5B98-4586-445D-9513-598BB7FD1909	46542747-5AF3-4F7E-AE97-7E0689976D0A	TCGA-E7-A3Y1-01A-11D-A233-26	HG19_Broad_variant	TCGA-E7-A3Y1	TCGA-BLCA	NA	s3109	MD Anderson - Institute for Applied Cancer Science	Asterand	Ukraine	NO	Not available	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage II	A233-26	TRUE
13722.58cfa831e4b0c9d6adf6cc15	58cfa831e4b0c9d6adf6cc15	TCGA-DU-7290-01A-11D-2022_130910_SN208_0495_BD2FGNACXX_s_7_rg.sorted.filtered.	WGS	TCGA-DU-7290-01A-11D-2022_130910_SN208_0495_BD2FGNACXX_s_7_rg.sorted	TCGA-DU-7290-01A-11D-2022_130910_SN208_0495_BD2FGNACXX_s_7_rg.sorted.bam	157.7	NA	0.14	58cfa831e4b0c9d6adf6cc15	TCGA-DU-7290-01A-11D-2022_130910_SN208_0495_BD2FGNACXX_s_7_rg.sorted.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-DU-7290-01A	E00A9855-C15E-46EF-988F-25CA64EC4717	Primary Tumor	Illumina HiSeq	827baf09-e242-460a-8d97-75059c6c3a98	Brain	45	942B676C-CCFD-4005-A564-C48F558D5D3B	9A452E24-A4D1-4229-9256-6A30800A5DDF	TCGA-DU-7290-01A-11D-2022-02	HG19_Broad_variant	TCGA-DU-7290	TCGA-LGG	315	s8353	Harvard Medical School	Henry Ford Hospital	United States	NO	Not available	Not available	Astrocytoma	Not available	2022-02	TRUE
13722.58cfa831e4b0c9d6adf6cc1e	58cfa831e4b0c9d6adf6cc1e	TCGA-EM-A3OB-01A-11D-A221_120610_SN1120_0152_BD13TDACXX_s_7_rg.sorted.filtered.	WGS	TCGA-EM-A3OB-01A-11D-A221_120610_SN1120_0152_BD13TDACXX_s_7_rg.sorted	TCGA-EM-A3OB-01A-11D-A221_120610_SN1120_0152_BD13TDACXX_s_7_rg.sorted.bam	51.44	NA	0.15	58cfa831e4b0c9d6adf6cc1e	TCGA-EM-A3OB-01A-11D-A221_120610_SN1120_0152_BD13TDACXX_s_7_rg.sorted.bam	Alive	FEMALE	Not available	Not available	Thyroid Carcinoma	Aligned reads	TCGA-EM-A3OB-01A	8CFC2589-B0AD-4FE6-8420-8F6FE0178BCC	Primary Tumor	Illumina HiSeq	2d07ef47-3523-49c8-9f8e-64e984c3ceda	Thyroid	33	8133FCFE-ECC4-4503-B81E-00FDF6F87426	F90A631C-4556-43E2-8AA2-1114326B6984	TCGA-EM-A3OB-01A-11D-A221-26	HG19_Broad_variant	TCGA-EM-A3OB	TCGA-THCA	NA	s12384	MD Anderson - Institute for Applied Cancer Science	University Health Network	Canada	NO	T2	N0	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	Stage I	A221-26	TRUE
13722.58cfa831e4b0c9d6adf6cc63	58cfa831e4b0c9d6adf6cc63	TCGA-EA-A3HU-01A-11D-A20X_140106_SN590_0244_BC384EACXX_s_3_rg.sorted.filtered.	WGS	TCGA-EA-A3HU-01A-11D-A20X_140106_SN590_0244_BC384EACXX_s_3_rg.sorted	TCGA-EA-A3HU-01A-11D-A20X_140106_SN590_0244_BC384EACXX_s_3_rg.sorted.bam	40.2	NA	0.16	58cfa831e4b0c9d6adf6cc63	TCGA-EA-A3HU-01A-11D-A20X_140106_SN590_0244_BC384EACXX_s_3_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-EA-A3HU-01A	9912432E-74BC-4846-93B4-FA2BF8070BD1	Primary Tumor	Illumina HiSeq	4f5312e3-89a9-41d7-a296-8b90e22cb408	Cervix	43	05409DA8-60DC-4073-91F0-F91832F3A607	B66F8B97-9149-4C12-A66E-4BC7D1352269	TCGA-EA-A3HU-01A-11D-A20X-26	HG19_Broad_variant	TCGA-EA-A3HU	TCGA-CESC	NA	s1520	MD Anderson - Institute for Applied Cancer Science	Asterand	Russia	NO	T2a2	N0	Cervical Squamous Cell Carcinoma	Not available	A20X-26	TRUE
13722.58cfa831e4b0c9d6adf6cc7c	58cfa831e4b0c9d6adf6cc7c	TCGA-EM-A1CU-01A-11D-A13U_120706_SN1120_0170_BD1422ACXX_s_3_rg.sorted.filtered.	WGS	TCGA-EM-A1CU-01A-11D-A13U_120706_SN1120_0170_BD1422ACXX_s_3_rg.sorted	TCGA-EM-A1CU-01A-11D-A13U_120706_SN1120_0170_BD1422ACXX_s_3_rg.sorted.bam	50.69	1.91	0.18	58cfa831e4b0c9d6adf6cc7c	TCGA-EM-A1CU-01A-11D-A13U_120706_SN1120_0170_BD1422ACXX_s_3_rg.sorted.bam	Alive	MALE	Not available	Not available	Thyroid Carcinoma	Aligned reads	TCGA-EM-A1CU-01A	4E80F403-0E10-4725-854D-F023C12EE1E2	Primary Tumor	Illumina HiSeq	a03be55f-c2fb-41d6-88ae-f1063ed587f6	Thyroid	31	C285C3AC-26D7-4481-BAAF-769F49AED55A	A9886789-6859-4FC9-812A-D9813FD1C20D	TCGA-EM-A1CU-01A-11D-A13U-02	HG19_Broad_variant	TCGA-EM-A1CU	TCGA-THCA	NA	s12379	Harvard Medical School	University Health Network	Canada	NO	T3	N1a	Thyroid Papillary Carcinoma - Classical/usual	Stage I	A13U-02	TRUE
13722.58cfa831e4b0c9d6adf6cc3e	58cfa831e4b0c9d6adf6cc3e	TCGA-EM-A3FR-01A-11D-A221_120610_SN1120_0152_BD13TDACXX_s_6_rg.sorted.filtered.	WGS	TCGA-EM-A3FR-01A-11D-A221_120610_SN1120_0152_BD13TDACXX_s_6_rg.sorted	TCGA-EM-A3FR-01A-11D-A221_120610_SN1120_0152_BD13TDACXX_s_6_rg.sorted.bam	45.93	NA	0.15	58cfa831e4b0c9d6adf6cc3e	TCGA-EM-A3FR-01A-11D-A221_120610_SN1120_0152_BD13TDACXX_s_6_rg.sorted.bam	Alive	FEMALE	Not available	Not available	Thyroid Carcinoma	Aligned reads	TCGA-EM-A3FR-01A	2B84CFBC-7CF6-4CB1-A1E3-BA85DAFB89F4	Primary Tumor	Illumina HiSeq	0430ed44-5b5d-4b22-b78a-9b9ecd259736	Thyroid	55	319E3498-D5FB-4142-A09F-ABA779DBC094	FEA6D565-EDBC-4FB7-ADB8-090914F4259E	TCGA-EM-A3FR-01A-11D-A221-26	HG19_Broad_variant	TCGA-EM-A3FR	TCGA-THCA	NA	s12247	MD Anderson - Institute for Applied Cancer Science	University Health Network	Canada	NO	T2	N1a	Thyroid Papillary Carcinoma - Classical/usual	Stage III	A221-26	TRUE
13722.58cfa831e4b0c9d6adf6cc9c	58cfa831e4b0c9d6adf6cc9c	TCGA-FD-A3SM-01A-11D-A233_120830_SN208_0423_AC190AACXX_s_5_rg.sorted.filtered.	WGS	TCGA-FD-A3SM-01A-11D-A233_120830_SN208_0423_AC190AACXX_s_5_rg.sorted	TCGA-FD-A3SM-01A-11D-A233_120830_SN208_0423_AC190AACXX_s_5_rg.sorted.bam	22.6	NA	0.16	58cfa831e4b0c9d6adf6cc9c	TCGA-FD-A3SM-01A-11D-A233_120830_SN208_0423_AC190AACXX_s_5_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-FD-A3SM-01A	474582F2-8DEC-4FBC-803F-4FD9BA2E0957	Primary Tumor	Illumina HiSeq	bacf3136-6605-4a66-a869-8d91e4003a0d	Bladder	70	5F7DE481-C011-43A8-844B-F47569499F0D	AF7DFCCA-999E-4EA2-A14B-1E923C2ECE38	TCGA-FD-A3SM-01A-11D-A233-26	HG19_Broad_variant	TCGA-FD-A3SM	TCGA-BLCA	NA	s3299	MD Anderson - Institute for Applied Cancer Science	BLN - University Of Chicago	United States	NO	T3a	N2	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV	A233-26	TRUE
13722.58cfa831e4b0c9d6adf6ccd0	58cfa831e4b0c9d6adf6ccd0	TCGA-EM-A1YA-01A-11D-A14U_120629_SN1222_0121_BD143UACXX_s_2_rg.sorted.filtered.	WGS	TCGA-EM-A1YA-01A-11D-A14U_120629_SN1222_0121_BD143UACXX_s_2_rg.sorted	TCGA-EM-A1YA-01A-11D-A14U_120629_SN1222_0121_BD143UACXX_s_2_rg.sorted.bam	45.94	1.87	0.18	58cfa831e4b0c9d6adf6ccd0	TCGA-EM-A1YA-01A-11D-A14U_120629_SN1222_0121_BD143UACXX_s_2_rg.sorted.bam	Alive	FEMALE	Not available	Not available	Thyroid Carcinoma	Aligned reads	TCGA-EM-A1YA-01A	567E4D90-5C5A-44F0-A462-90C831F3C096	Primary Tumor	Illumina HiSeq	69cba75e-7be6-4707-b524-255288547622	Thyroid	74	D0880877-36CF-4DED-87B2-898C3446F90D	D1BD818E-62BF-4375-A171-ED388341014F	TCGA-EM-A1YA-01A-11D-A14U-02	HG19_Broad_variant	TCGA-EM-A1YA	TCGA-THCA	NA	s12754	Harvard Medical School	University Health Network	Canada	NO	T2	NX	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	Stage II	A14U-02	TRUE
13722.58cfa831e4b0c9d6adf6ccd2	58cfa831e4b0c9d6adf6ccd2	TCGA-EM-A3OA-01A-11D-A221_120610_SN1120_0151_AC0WN0ACXX_s_6_rg.sorted.filtered.	WGS	TCGA-EM-A3OA-01A-11D-A221_120610_SN1120_0151_AC0WN0ACXX_s_6_rg.sorted	TCGA-EM-A3OA-01A-11D-A221_120610_SN1120_0151_AC0WN0ACXX_s_6_rg.sorted.bam	47.85	NA	0.16	58cfa831e4b0c9d6adf6ccd2	TCGA-EM-A3OA-01A-11D-A221_120610_SN1120_0151_AC0WN0ACXX_s_6_rg.sorted.bam	Alive	FEMALE	Not available	Not available	Thyroid Carcinoma	Aligned reads	TCGA-EM-A3OA-01A	24CF6397-60EF-4635-81F0-78A67157AAC0	Primary Tumor	Illumina HiSeq	ddf917ff-6b4d-45ca-a503-8d6449f76e72	Thyroid	55	8B048263-6C2F-4BF6-8F37-C69DA9F3839F	2604E6C9-A117-49DC-A06E-082E63859DCA	TCGA-EM-A3OA-01A-11D-A221-26	HG19_Broad_variant	TCGA-EM-A3OA	TCGA-THCA	NA	s12249	MD Anderson - Institute for Applied Cancer Science	University Health Network	Canada	NO	T2	N0	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	Stage II	A221-26	TRUE
13722.58cfa831e4b0c9d6adf6cd3c	58cfa831e4b0c9d6adf6cd3c	TCGA-ET-A25M-01A-11D-A16N_120718_SN590_0170_BD141RACXX_s_6_rg.sorted.filtered.	WGS	TCGA-ET-A25M-01A-11D-A16N_120718_SN590_0170_BD141RACXX_s_6_rg.sorted	TCGA-ET-A25M-01A-11D-A16N_120718_SN590_0170_BD141RACXX_s_6_rg.sorted.bam	54.33	1.96	0.17	58cfa831e4b0c9d6adf6cd3c	TCGA-ET-A25M-01A-11D-A16N_120718_SN590_0170_BD141RACXX_s_6_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-ET-A25M-01A	8023D4C9-B56D-417A-9A52-D45B59C756ED	Primary Tumor	Illumina HiSeq	893b646b-2fc5-4163-905e-37bfeb036280	Thyroid	33	0C601625-ED21-47E5-BC3D-A0057D6A148F	7DE80DCB-BBFD-4D87-AD80-EE29258EFFD1	TCGA-ET-A25M-01A-11D-A16N-02	HG19_Broad_variant	TCGA-ET-A25M	TCGA-THCA	NA	s12002	Harvard Medical School	Johns Hopkins	United States	NO	T2	N1	Thyroid Papillary Carcinoma - Classical/usual	Stage I	A16N-02	TRUE
13722.58cfa831e4b0c9d6adf6cdc0	58cfa831e4b0c9d6adf6cdc0	TCGA-FI-A2CY-01A-11D-A17E_120511_SN1120_0140_AD12J0ACXX_s_1_rg.sorted.filtered.	WGS	TCGA-FI-A2CY-01A-11D-A17E_120511_SN1120_0140_AD12J0ACXX_s_1_rg.sorted	TCGA-FI-A2CY-01A-11D-A17E_120511_SN1120_0140_AD12J0ACXX_s_1_rg.sorted.bam	72.14	NA	0.16	58cfa831e4b0c9d6adf6cdc0	TCGA-FI-A2CY-01A-11D-A17E_120511_SN1120_0140_AD12J0ACXX_s_1_rg.sorted.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-FI-A2CY-01A	B9AB4AB9-BA9C-4A01-9F61-55C82B924936	Primary Tumor	Illumina HiSeq	d1004865-f030-4d10-90a0-3d6d105408a0	Uterus	60	047B688C-AA29-4A63-B555-9275AF4B0CEE	4BCC9DA0-4F58-4BB8-B660-D8591AD1CE18	TCGA-FI-A2CY-01A-11D-A17E-02	HG19_Broad_variant	TCGA-FI-A2CY	TCGA-UCEC	NA	s5398	Harvard Medical School	Washington University	United States	NO	Not available	Not available	Mixed serous and endometrioid	Not available	A17E-02	TRUE
13722.58cfa831e4b0c9d6adf6cdab	58cfa831e4b0c9d6adf6cdab	TCGA-FE-A234-01A-11D-A14U_120717_SN1120_0175_AC1179ACXX_s_2_rg.sorted.filtered.	WGS	TCGA-FE-A234-01A-11D-A14U_120717_SN1120_0175_AC1179ACXX_s_2_rg.sorted	TCGA-FE-A234-01A-11D-A14U_120717_SN1120_0175_AC1179ACXX_s_2_rg.sorted.bam	101.34	2.14	0.18	58cfa831e4b0c9d6adf6cdab	TCGA-FE-A234-01A-11D-A14U_120717_SN1120_0175_AC1179ACXX_s_2_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-FE-A234-01A	E4C85BDD-7B7C-414F-9503-647D9B825915	Primary Tumor	Illumina HiSeq	f1eeb2ea-cc97-40b1-ac5b-fa027012fff2	Thyroid	26	8765B072-83E1-40B2-B1C9-15F38D799FC3	D4A41A96-02D5-455E-BB12-7225EBEA15A5	TCGA-FE-A234-01A-11D-A14U-02	HG19_Broad_variant	TCGA-FE-A234	TCGA-THCA	NA	s12388	Harvard Medical School	Ohio State University	United States	NO	T2	N1	Thyroid Papillary Carcinoma - Classical/usual	Stage I	A14U-02	TRUE
13722.58cfa832e4b0c9d6adf6cea0	58cfa832e4b0c9d6adf6cea0	TCGA-ER-A2NF-01A-11D-A18Z_120516_SN1222_0107_BD12HYACXX_s_7_rg.sorted.filtered.	WGS	TCGA-ER-A2NF-01A-11D-A18Z_120516_SN1222_0107_BD12HYACXX_s_7_rg.sorted	TCGA-ER-A2NF-01A-11D-A18Z_120516_SN1222_0107_BD12HYACXX_s_7_rg.sorted.bam	52.36	NA	0.16	58cfa832e4b0c9d6adf6cea0	TCGA-ER-A2NF-01A-11D-A18Z_120516_SN1222_0107_BD12HYACXX_s_7_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Skin Cutaneous Melanoma	Aligned reads	TCGA-ER-A2NF-01A	D32A4219-4CCA-470F-B6B3-11447D9F5E0B	Primary Tumor	Illumina HiSeq	cf624be8-7ec3-4fce-9ab0-1d9ac2fb1edb	Skin	53	52EDD1DB-F1C3-4B87-B959-B5B095E52463	DB2D94A9-5B22-4163-AE7A-1DA11F7037A6	TCGA-ER-A2NF-01A-11D-A18Z-02	HG19_Broad_variant	TCGA-ER-A2NF	TCGA-SKCM	NA	s7861	Harvard Medical School	University of Pittsburgh	None	NO	T4b	N3	Not available	Stage IIIC	A18Z-02	TRUE
13722.58cfa832e4b0c9d6adf6cf3d	58cfa832e4b0c9d6adf6cf3d	TCGA-G9-6378-01A-11D-1784_130301_SN590_0217_BC1UHMACXX_s_3_rg.sorted.filtered.	WGS	TCGA-G9-6378-01A-11D-1784_130301_SN590_0217_BC1UHMACXX_s_3_rg.sorted	TCGA-G9-6378-01A-11D-1784_130301_SN590_0217_BC1UHMACXX_s_3_rg.sorted.bam	245.4	1.9	0.13	58cfa832e4b0c9d6adf6cf3d	TCGA-G9-6378-01A-11D-1784_130301_SN590_0217_BC1UHMACXX_s_3_rg.sorted.bam	Alive	MALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-G9-6378-01A	12F225D0-CBFF-44EB-9183-BACC7F33B090	Primary Tumor	Illumina HiSeq	cc75d8b4-ea9f-4b89-9c12-d370ba7a227f	Prostate	54	940BBB5C-7280-41ED-9332-47C2072AE072	CA3B6408-29B5-4DB1-A56D-7B47F966177D	TCGA-G9-6378-01A-11D-1784-02	HG19_Broad_variant	TCGA-G9-6378	TCGA-PRAD	NA	s3801	Harvard Medical School	Roswell Park	United States	NO	T2c	Not available	Prostate Adenocarcinoma Acinar Type	Not available	1784-02	TRUE
13722.58cfa832e4b0c9d6adf6cfb6	58cfa832e4b0c9d6adf6cfb6	TCGA-G9-6342-01A-11D-1957_130222_SN1222_0174_BC1RNEACXX_s_7_rg.sorted.filtered.	WGS	TCGA-G9-6342-01A-11D-1957_130222_SN1222_0174_BC1RNEACXX_s_7_rg.sorted	TCGA-G9-6342-01A-11D-1957_130222_SN1222_0174_BC1RNEACXX_s_7_rg.sorted.bam	201.7	1.9	0.14	58cfa832e4b0c9d6adf6cfb6	TCGA-G9-6342-01A-11D-1957_130222_SN1222_0174_BC1RNEACXX_s_7_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-G9-6342-01A	00E41E6A-9FE7-44F9-978B-7B05B179506A	Primary Tumor	Illumina HiSeq	2e8198a3-6874-4ea2-9d85-405122d87da4	Prostate	61	2C85548B-D1FD-4FC8-9908-60205A42E080	0C765D21-A6AE-4FE8-9B80-7DEBA8459E76	TCGA-G9-6342-01A-11D-1957-02	HG19_Broad_variant	TCGA-G9-6342	TCGA-PRAD	NA	s3797	Harvard Medical School	Roswell Park	United States	NO	T3a	Not available	Prostate Adenocarcinoma Acinar Type	Not available	1957-02	TRUE
13722.58cfa832e4b0c9d6adf6cfea	58cfa832e4b0c9d6adf6cfea	TCGA-G9-6494-01A-11D-1784_130131_SN1120_0234_AD1PVUACXX_s_1_rg.sorted.filtered.	WGS	TCGA-G9-6494-01A-11D-1784_130131_SN1120_0234_AD1PVUACXX_s_1_rg.sorted	TCGA-G9-6494-01A-11D-1784_130131_SN1120_0234_AD1PVUACXX_s_1_rg.sorted.bam	129.4	1.9	0.13	58cfa832e4b0c9d6adf6cfea	TCGA-G9-6494-01A-11D-1784_130131_SN1120_0234_AD1PVUACXX_s_1_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-G9-6494-01A	0C459149-0DFE-4206-B50B-DB79180EBB57	Primary Tumor	Illumina HiSeq	d55338b0-a49a-4c6e-ba7d-757df0a55dfe	Prostate	66	45DB5303-BBAB-4F8C-A2A2-9A9A9BFA2FD1	5BCBE988-68F6-48D0-8F2A-B34369A5FBB9	TCGA-G9-6494-01A-11D-1784-02	HG19_Broad_variant	TCGA-G9-6494	TCGA-PRAD	NA	s3620	Harvard Medical School	Roswell Park	United States	NO	T4	N0	Prostate Adenocarcinoma Acinar Type	Not available	1784-02	TRUE
13722.58cfa832e4b0c9d6adf6cfc0	58cfa832e4b0c9d6adf6cfc0	TCGA-GF-A2C7-01A-11D-A18Y_120602_SN208_0304_BC0WTWACXX_s_3_rg.sorted.filtered.	WGS	TCGA-GF-A2C7-01A-11D-A18Y_120602_SN208_0304_BC0WTWACXX_s_3_rg.sorted	TCGA-GF-A2C7-01A-11D-A18Y_120602_SN208_0304_BC0WTWACXX_s_3_rg.sorted.bam	42.41	NA	0.16	58cfa832e4b0c9d6adf6cfc0	TCGA-GF-A2C7-01A-11D-A18Y_120602_SN208_0304_BC0WTWACXX_s_3_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Skin Cutaneous Melanoma	Aligned reads	TCGA-GF-A2C7-01A	285D8E2C-F183-49D5-BC1C-FD47C6670ACC	Primary Tumor	Illumina HiSeq	9e0dd24f-4e97-44c0-916f-03fc02fc29ac	Skin	48	053CAF96-E851-401D-A5CC-214DBA82FE05	12E86E5E-AA64-4E6F-B5BC-846DDCBF4A64	TCGA-GF-A2C7-01A-11D-A18Y-02	HG19_Broad_variant	TCGA-GF-A2C7	TCGA-SKCM	NA	s7374	Harvard Medical School	ABS - IUPUI	United States	NO	T4b	N0	Not available	Stage IIC	A18Y-02	TRUE
13722.58cfa832e4b0c9d6adf6d11f	58cfa832e4b0c9d6adf6d11f	TCGA-IR-A3LK-01A-12D-A20X_140417_SN590_0248_AC3EUFACXX_s_3_rg.sorted.filtered.	WGS	TCGA-IR-A3LK-01A-12D-A20X_140417_SN590_0248_AC3EUFACXX_s_3_rg.sorted	TCGA-IR-A3LK-01A-12D-A20X_140417_SN590_0248_AC3EUFACXX_s_3_rg.sorted.bam	71.39	NA	0.16	58cfa832e4b0c9d6adf6d11f	TCGA-IR-A3LK-01A-12D-A20X_140417_SN590_0248_AC3EUFACXX_s_3_rg.sorted.bam	Alive	FEMALE	WHITE	Not available	Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-IR-A3LK-01A	B79558C5-1DB2-4B1E-A7B8-EFBD19AA855E	Primary Tumor	Illumina HiSeq	1c6981be-5fe3-4898-ba63-e0cd0eecc5e5	Cervix	69	DCA9FF1F-DD32-43DD-8FD4-446D014F5DB8	9E7C0BE8-042F-4B5F-BFE9-E993081589AD	TCGA-IR-A3LK-01A-12D-A20X-26	HG19_Broad_variant	TCGA-IR-A3LK	TCGA-CESC	NA	s1376	MD Anderson - Institute for Applied Cancer Science	Memorial Sloan Kettering	United States	NO	T1b2	N0	Cervical Squamous Cell Carcinoma	Not available	A20X-26	TRUE
13722.58cfa832e4b0c9d6adf6d190	58cfa832e4b0c9d6adf6d190	TCGA-IR-A3LH-01A-21D-A20X_140117_SN590_0246_BC37BDACXX_s_8_rg.sorted.filtered.	WGS	TCGA-IR-A3LH-01A-21D-A20X_140117_SN590_0246_BC37BDACXX_s_8_rg.sorted	TCGA-IR-A3LH-01A-21D-A20X_140117_SN590_0246_BC37BDACXX_s_8_rg.sorted.bam	62.48	NA	0.15	58cfa832e4b0c9d6adf6d190	TCGA-IR-A3LH-01A-21D-A20X_140117_SN590_0246_BC37BDACXX_s_8_rg.sorted.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	Not available	Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-IR-A3LH-01A	F24ED9C0-92BB-4003-86D2-42AB26617A05	Primary Tumor	Illumina HiSeq	159f94e1-d4e4-45d7-9220-90578144802f	Cervix	49	D95E5389-DD55-4D55-AB01-6A770C66502F	7BDB76AA-01BA-48A8-A58A-29B118B8118A	TCGA-IR-A3LH-01A-21D-A20X-26	HG19_Broad_variant	TCGA-IR-A3LH	TCGA-CESC	NA	s1535	MD Anderson - Institute for Applied Cancer Science	Memorial Sloan Kettering	United States	NO	T2a1	N0	Cervical Squamous Cell Carcinoma	Not available	A20X-26	TRUE
13722.58cfa832e4b0c9d6adf6d19c	58cfa832e4b0c9d6adf6d19c	TCGA-HG-A2PA-01A-11D-A20X_140106_SN590_0244_BC384EACXX_s_4_rg.sorted.filtered.	WGS	TCGA-HG-A2PA-01A-11D-A20X_140106_SN590_0244_BC384EACXX_s_4_rg.sorted	TCGA-HG-A2PA-01A-11D-A20X_140106_SN590_0244_BC384EACXX_s_4_rg.sorted.bam	61.98	NA	0.15	58cfa832e4b0c9d6adf6d19c	TCGA-HG-A2PA-01A-11D-A20X_140106_SN590_0244_BC384EACXX_s_4_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-HG-A2PA-01A	E2FF7CFD-A101-45B9-895F-26F403E7BDFB	Primary Tumor	Illumina HiSeq	2c605f98-0c77-45ff-bcea-2fcf6094ca2d	Cervix	38	235DBD13-5052-4E19-9C1C-A72A1A9A79CE	ECE06317-01F9-4EF2-ACE0-E9B18C7F4DE1	TCGA-HG-A2PA-01A-11D-A20X-26	HG19_Broad_variant	TCGA-HG-A2PA	TCGA-CESC	NA	s1534	MD Anderson - Institute for Applied Cancer Science	Roswell Park	United States	NO	T1b2	N0	Cervical Squamous Cell Carcinoma	Not available	A20X-26	TRUE
13722.58cfa832e4b0c9d6adf6d19a	58cfa832e4b0c9d6adf6d19a	TCGA-IR-A3LC-01A-11D-A20X_140117_SN590_0246_BC37BDACXX_s_3_rg.sorted.filtered.	WGS	TCGA-IR-A3LC-01A-11D-A20X_140117_SN590_0246_BC37BDACXX_s_3_rg.sorted	TCGA-IR-A3LC-01A-11D-A20X_140117_SN590_0246_BC37BDACXX_s_3_rg.sorted.bam	81.15	NA	0.15	58cfa832e4b0c9d6adf6d19a	TCGA-IR-A3LC-01A-11D-A20X_140117_SN590_0246_BC37BDACXX_s_3_rg.sorted.bam	Alive	FEMALE	WHITE	Not available	Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-IR-A3LC-01A	58BDCACE-0047-456E-A225-68953EDAFE5E	Primary Tumor	Illumina HiSeq	8b84ea0a-0512-427e-8456-2facdcd978b9	Cervix	40	AC6D15A0-67CF-42AA-97DC-BA50D0E9F409	47A900B4-52E8-448E-B092-EEE4E394A309	TCGA-IR-A3LC-01A-11D-A20X-26	HG19_Broad_variant	TCGA-IR-A3LC	TCGA-CESC	NA	s1375	MD Anderson - Institute for Applied Cancer Science	Memorial Sloan Kettering	United States	NO	T1b1	N0	Cervical Squamous Cell Carcinoma	Not available	A20X-26	TRUE
13722.58cfa832e4b0c9d6adf6d1f4	58cfa832e4b0c9d6adf6d1f4	TCGA-IG-A51D-01A-11D-A267_131001_SN1120_0279_AC2DKPACXX_s_3_rg.sorted.filtered.	WGS	TCGA-IG-A51D-01A-11D-A267_131001_SN1120_0279_AC2DKPACXX_s_3_rg.sorted	TCGA-IG-A51D-01A-11D-A267_131001_SN1120_0279_AC2DKPACXX_s_3_rg.sorted.bam	23.75	NA	0.16	58cfa832e4b0c9d6adf6d1f4	TCGA-IG-A51D-01A-11D-A267_131001_SN1120_0279_AC2DKPACXX_s_3_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Esophageal Carcinoma	Aligned reads	TCGA-IG-A51D-01A	F8DBAB24-B9F4-4B8A-BFEA-57856CCF6364	Primary Tumor	Illumina HiSeq	c422f0b8-8f83-4d33-b800-bab29faa7b7b	Esophagus	63	3889C9FE-3777-4B3D-9CF1-12135D4D7F7D	02AA44BC-DD51-4A76-B94E-FF273011E904	TCGA-IG-A51D-01A-11D-A267-26	HG19_Broad_variant	TCGA-IG-A51D	TCGA-ESCA	NA	s1825	MD Anderson - Institute for Applied Cancer Science	Asterand	Russia	NO	T1	N1	Not available	Stage IIB	A267-26	TRUE
13722.58cfa832e4b0c9d6adf6d222	58cfa832e4b0c9d6adf6d222	TCGA-IR-A3LI-01A-11D-A20X_140131_SN590_0247_AC3FDBACXX_s_5_rg.sorted.filtered.	WGS	TCGA-IR-A3LI-01A-11D-A20X_140131_SN590_0247_AC3FDBACXX_s_5_rg.sorted	TCGA-IR-A3LI-01A-11D-A20X_140131_SN590_0247_AC3FDBACXX_s_5_rg.sorted.bam	19.9	NA	0.16	58cfa832e4b0c9d6adf6d222	TCGA-IR-A3LI-01A-11D-A20X_140131_SN590_0247_AC3FDBACXX_s_5_rg.sorted.bam	Alive	FEMALE	WHITE	Not available	Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-IR-A3LI-01A	75BC22D8-738D-45F8-B6C0-C664F5FEF47C	Primary Tumor	Illumina HiSeq	3a9d3f81-919f-44e3-a9cc-813b4dcaf027	Cervix	48	EBFA4682-49C9-4AC1-8147-E3860D852D28	689630AD-8262-403B-9983-B4BAE99B8A45	TCGA-IR-A3LI-01A-11D-A20X-26	HG19_Broad_variant	TCGA-IR-A3LI	TCGA-CESC	NA	s1210	MD Anderson - Institute for Applied Cancer Science	Memorial Sloan Kettering	United States	NO	T2b	N1	Endocervical Type of Adenocarcinoma	Not available	A20X-26	TRUE
13722.58cfa832e4b0c9d6adf6d20e	58cfa832e4b0c9d6adf6d20e	TCGA-HT-7468-01A-11D-2022_130911_SN1222_0218_BC2A1NACXX_s_5_rg.sorted.filtered.	WGS	TCGA-HT-7468-01A-11D-2022_130911_SN1222_0218_BC2A1NACXX_s_5_rg.sorted	TCGA-HT-7468-01A-11D-2022_130911_SN1222_0218_BC2A1NACXX_s_5_rg.sorted.bam	188	NA	0.13	58cfa832e4b0c9d6adf6d20e	TCGA-HT-7468-01A-11D-2022_130911_SN1222_0218_BC2A1NACXX_s_5_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-HT-7468-01A	E6C55BA6-4C8A-4EA4-8DDE-74D01915DB02	Primary Tumor	Illumina HiSeq	e1855a2f-1904-41ee-ba33-a27e1c202d99	Brain	30	D2775F99-CC96-4C72-94FF-E3BA985DC151	143CEFE3-F477-4CDE-AEA6-CE0610835570	TCGA-HT-7468-01A-11D-2022-02	HG19_Broad_variant	TCGA-HT-7468	TCGA-LGG	NA	s8759	Harvard Medical School	Case Western - St Joes	United States	NO	Not available	Not available	Oligodendroglioma	Not available	2022-02	TRUE
13722.58cfa832e4b0c9d6adf6d322	58cfa832e4b0c9d6adf6d322	TCGA-L5-A43C-01A-11D-A248_121207_SN1222_0161_AC1HJ0ACXX_s_1_rg.sorted.filtered.	WGS	TCGA-L5-A43C-01A-11D-A248_121207_SN1222_0161_AC1HJ0ACXX_s_1_rg.sorted	TCGA-L5-A43C-01A-11D-A248_121207_SN1222_0161_AC1HJ0ACXX_s_1_rg.sorted.bam	21.33	NA	0.16	58cfa832e4b0c9d6adf6d322	TCGA-L5-A43C-01A-11D-A248_121207_SN1222_0161_AC1HJ0ACXX_s_1_rg.sorted.bam	Alive	MALE	WHITE	Not available	Esophageal Carcinoma	Aligned reads	TCGA-L5-A43C-01A	A935DAEB-1EFD-4113-A614-A5E4D446C72B	Primary Tumor	Illumina HiSeq	f5b917a1-f719-4ee6-b994-c4bc7dbbc159	Esophagus	81	2DD3A5ED-42EF-4CA1-AC40-B2F486F0395A	74016C2E-EEC8-4FE9-A297-A4E64D797DEE	TCGA-L5-A43C-01A-11D-A248-26	HG19_Broad_variant	TCGA-L5-A43C	TCGA-ESCA	NA	s1646	MD Anderson - Institute for Applied Cancer Science	University of Michigan	United States	NO	Not available	Not available	Not available	Not available	A248-26	TRUE
13722.58cfa832e4b0c9d6adf6d3ea	58cfa832e4b0c9d6adf6d3ea	TCGA-V4-A9EO-01A-12D-A40D_140808_SN590_0253_AC499NACXX_s_3_rg.sorted.filtered.	WGS	TCGA-V4-A9EO-01A-12D-A40D_140808_SN590_0253_AC499NACXX_s_3_rg.sorted	TCGA-V4-A9EO-01A-12D-A40D_140808_SN590_0253_AC499NACXX_s_3_rg.sorted.bam	16.22	NA	0.17	58cfa832e4b0c9d6adf6d3ea	TCGA-V4-A9EO-01A-12D-A40D_140808_SN590_0253_AC499NACXX_s_3_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Uveal Melanoma	Aligned reads	TCGA-V4-A9EO-01A	BCB87378-9F43-45E4-BDF2-F6DFA6AC5B8C	Primary Tumor	Illumina HiSeq	e433357d-cafe-49f8-b481-e9b804bd4a06	Eye	74	C46DB8A8-DAF3-4E99-9307-E6C6CD8F79D5	B0A67E95-2ED2-43EB-9490-5F94BB8E21F4	TCGA-V4-A9EO-01A-12D-A40D-26	HG19_Broad_variant	TCGA-V4-A9EO	TCGA-UVM	NA	s240	MD Anderson - Institute for Applied Cancer Science	Institut Curie	France	NO	T4a	N0	Not available	Stage IIIA	A40D-26	TRUE
13722.58cfa832e4b0c9d6adf6d1fa	58cfa832e4b0c9d6adf6d1fa	TCGA-GV-A3JW-01A-11D-A210_120912_SN1222_0149_BD1CW3ACXX_s_7_rg.sorted.filtered.	WGS	TCGA-GV-A3JW-01A-11D-A210_120912_SN1222_0149_BD1CW3ACXX_s_7_rg.sorted	TCGA-GV-A3JW-01A-11D-A210_120912_SN1222_0149_BD1CW3ACXX_s_7_rg.sorted.bam	45.77	NA	0.15	58cfa832e4b0c9d6adf6d1fa	TCGA-GV-A3JW-01A-11D-A210_120912_SN1222_0149_BD1CW3ACXX_s_7_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-GV-A3JW-01A	3D644EAF-82FC-4BC7-93B7-3E600E8C6511	Primary Tumor	Illumina HiSeq	586abfdd-f50a-4834-8143-3bda5638ea60	Bladder	74	B02C03B6-24AA-42D3-9310-741DE1EF0D30	D7EFF32B-E9EB-4891-93D7-4C3D10BE21EA	TCGA-GV-A3JW-01A-11D-A210-26	HG19_Broad_variant	TCGA-GV-A3JW	TCGA-BLCA	NA	s2737	MD Anderson - Institute for Applied Cancer Science	BLN - Cleveland Clinic	United States	NO	T2	NX	Muscle invasive urothelial carcinoma (pT2 or above)	Stage II	A210-26	TRUE
13722.58cfa832e4b0c9d6adf6d414	58cfa832e4b0c9d6adf6d414	TCGA-VD-A8KB-01A-11D-A40D_140716_SN208_0518_AC59RNACXX_s_4_rg.sorted.filtered.	WGS	TCGA-VD-A8KB-01A-11D-A40D_140716_SN208_0518_AC59RNACXX_s_4_rg.sorted	TCGA-VD-A8KB-01A-11D-A40D_140716_SN208_0518_AC59RNACXX_s_4_rg.sorted.bam	41.19	NA	0.15	58cfa832e4b0c9d6adf6d414	TCGA-VD-A8KB-01A-11D-A40D_140716_SN208_0518_AC59RNACXX_s_4_rg.sorted.bam	Alive	FEMALE	Not available	Not available	Uveal Melanoma	Aligned reads	TCGA-VD-A8KB-01A	31771082-C094-4749-A9C7-80B67762F4D1	Primary Tumor	Illumina HiSeq	55fb2927-8427-4ec7-a0cd-d9250ff855be	Eye	66	3106274B-1330-4C1D-9D6F-EE36138BC929	DEE2EF23-9722-4006-AC98-0F262EB9ECF7	TCGA-VD-A8KB-01A-11D-A40D-26	HG19_Broad_variant	TCGA-VD-A8KB	TCGA-UVM	NA	s273	MD Anderson - Institute for Applied Cancer Science	University of Liverpool	United Kingdom	NO	T3a	NX	Not available	Stage IIB	A40D-26	TRUE
13722.58cfa832e4b0c9d6adf6d4be	58cfa832e4b0c9d6adf6d4be	TCGA-V4-A9F7-01A-11D-A40D_140716_SN208_0519_BC5946ACXX_s_2_rg.sorted.filtered.	WGS	TCGA-V4-A9F7-01A-11D-A40D_140716_SN208_0519_BC5946ACXX_s_2_rg.sorted	TCGA-V4-A9F7-01A-11D-A40D_140716_SN208_0519_BC5946ACXX_s_2_rg.sorted.bam	49.86	NA	0.16	58cfa832e4b0c9d6adf6d4be	TCGA-V4-A9F7-01A-11D-A40D_140716_SN208_0519_BC5946ACXX_s_2_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uveal Melanoma	Aligned reads	TCGA-V4-A9F7-01A	64422CC5-5E5B-4EF9-A9E2-214CEBF8DFBC	Primary Tumor	Illumina HiSeq	8388df36-e4c1-4450-bc87-acc118ce705e	Eye	78	44AD0268-6B48-4264-A1DD-58C2302224D7	07397855-A0D5-4287-A21B-5AB83A4E0DE0	TCGA-V4-A9F7-01A-11D-A40D-26	HG19_Broad_variant	TCGA-V4-A9F7	TCGA-UVM	NA	s257	MD Anderson - Institute for Applied Cancer Science	Institut Curie	France	NO	T3a	N0	Not available	Stage IIB	A40D-26	TRUE
13722.58cfa832e4b0c9d6adf6d498	58cfa832e4b0c9d6adf6d498	TCGA-V4-A9EF-01A-21D-A40D_140725_SN590_0251_AC41YJACXX_s_4_rg.sorted.filtered.	WGS	TCGA-V4-A9EF-01A-21D-A40D_140725_SN590_0251_AC41YJACXX_s_4_rg.sorted	TCGA-V4-A9EF-01A-21D-A40D_140725_SN590_0251_AC41YJACXX_s_4_rg.sorted.bam	37.33	NA	0.17	58cfa832e4b0c9d6adf6d498	TCGA-V4-A9EF-01A-21D-A40D_140725_SN590_0251_AC41YJACXX_s_4_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Uveal Melanoma	Aligned reads	TCGA-V4-A9EF-01A	A18D3BA3-E2F4-4144-9C25-2019CAD193F4	Primary Tumor	Illumina HiSeq	bf602ec4-fef9-41b6-9f28-a773493f4507	Eye	56	0966DF5C-5838-4E92-ADA6-304241CCAEF1	0CE78DDD-32D4-43DB-B7A4-FE7C3AD9563D	TCGA-V4-A9EF-01A-21D-A40D-26	HG19_Broad_variant	TCGA-V4-A9EF	TCGA-UVM	NA	s215	MD Anderson - Institute for Applied Cancer Science	Institut Curie	France	NO	T4b	N0	Not available	Stage IIIB	A40D-26	TRUE
13722.58cfa832e4b0c9d6adf6d4a7	58cfa832e4b0c9d6adf6d4a7	TCGA-VD-A8KH-01A-11D-A40D_140731_SN208_0522_AC59K7ACXX_s_5_rg.sorted.filtered.	WGS	TCGA-VD-A8KH-01A-11D-A40D_140731_SN208_0522_AC59K7ACXX_s_5_rg.sorted	TCGA-VD-A8KH-01A-11D-A40D_140731_SN208_0522_AC59K7ACXX_s_5_rg.sorted.bam	39.6	NA	0.17	58cfa832e4b0c9d6adf6d4a7	TCGA-VD-A8KH-01A-11D-A40D_140731_SN208_0522_AC59K7ACXX_s_5_rg.sorted.bam	Alive	MALE	Not available	Not available	Uveal Melanoma	Aligned reads	TCGA-VD-A8KH-01A	39AF6E0F-908C-4B2B-97B8-A4D1966E47E1	Primary Tumor	Illumina HiSeq	c1aaf5dd-316d-42b5-9471-88f8c886efd8	Eye	69	98A73F7B-83C7-4160-944E-7A19B07AD696	4A25E140-632B-481F-8D50-49433ECEF545	TCGA-VD-A8KH-01A-11D-A40D-26	HG19_Broad_variant	TCGA-VD-A8KH	TCGA-UVM	NA	s251	MD Anderson - Institute for Applied Cancer Science	University of Liverpool	United Kingdom	NO	T4b	NX	Not available	Stage IIIB	A40D-26	TRUE
13722.58cfa832e4b0c9d6adf6d56c	58cfa832e4b0c9d6adf6d56c	TCGA-V4-A9EY-01A-11D-A40D_140714_SN1440_0192_AC3RUUACXX_s_2_rg.sorted.filtered.	WGS	TCGA-V4-A9EY-01A-11D-A40D_140714_SN1440_0192_AC3RUUACXX_s_2_rg.sorted	TCGA-V4-A9EY-01A-11D-A40D_140714_SN1440_0192_AC3RUUACXX_s_2_rg.sorted.bam	24.77	NA	0.16	58cfa832e4b0c9d6adf6d56c	TCGA-V4-A9EY-01A-11D-A40D_140714_SN1440_0192_AC3RUUACXX_s_2_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uveal Melanoma	Aligned reads	TCGA-V4-A9EY-01A	15D19CCC-52B8-41F6-B1C1-2CC55691AED5	Primary Tumor	Illumina HiSeq	27c8b2d4-9133-49cb-a86b-84553dcf1c8e	Eye	66	E8C4DEFB-7781-4B3D-B209-7D444A1A1BB5	FDFEA8DC-451B-4493-B7ED-DBF97D7C1D78	TCGA-V4-A9EY-01A-11D-A40D-26	HG19_Broad_variant	TCGA-V4-A9EY	TCGA-UVM	NA	s218	MD Anderson - Institute for Applied Cancer Science	Institut Curie	France	NO	T4a	N0	Not available	Stage IIIA	A40D-26	TRUE
13722.58cfa832e4b0c9d6adf6d18e	58cfa832e4b0c9d6adf6d18e	TCGA-FI-A2D4-01A-12D-A17E_120511_SN1120_0140_AD12J0ACXX_s_7_rg.sorted.filtered.	WGS	TCGA-FI-A2D4-01A-12D-A17E_120511_SN1120_0140_AD12J0ACXX_s_7_rg.sorted	TCGA-FI-A2D4-01A-12D-A17E_120511_SN1120_0140_AD12J0ACXX_s_7_rg.sorted.bam	28.14	NA	0.16	58cfa832e4b0c9d6adf6d18e	TCGA-FI-A2D4-01A-12D-A17E_120511_SN1120_0140_AD12J0ACXX_s_7_rg.sorted.bam	Dead	FEMALE	WHITE	Not available	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-FI-A2D4-01A	490AE247-EE67-48D4-94ED-93DF5B9BBEFE	Primary Tumor	Illumina HiSeq	8f265179-0deb-4bbd-bd06-f6a211fae179	Uterus	44	A8393121-29DF-4525-BF4F-FCE0DEAF25F5	6DA2AADF-7B34-4F4F-93E4-0963248B3DEB	TCGA-FI-A2D4-01A-12D-A17E-02	HG19_Broad_variant	TCGA-FI-A2D4	TCGA-UCEC	243	s5232	Harvard Medical School	Washington University	United States	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A17E-02	TRUE
13722.58cfa832e4b0c9d6adf6d42a	58cfa832e4b0c9d6adf6d42a	TCGA-VD-AA8O-01A-11D-A40D_140807_SN1440_0194_AC5B5RACXX_s_3_rg.sorted.filtered.	WGS	TCGA-VD-AA8O-01A-11D-A40D_140807_SN1440_0194_AC5B5RACXX_s_3_rg.sorted	TCGA-VD-AA8O-01A-11D-A40D_140807_SN1440_0194_AC5B5RACXX_s_3_rg.sorted.bam	48.76	NA	0.16	58cfa832e4b0c9d6adf6d42a	TCGA-VD-AA8O-01A-11D-A40D_140807_SN1440_0194_AC5B5RACXX_s_3_rg.sorted.bam	Alive	MALE	Not available	Not available	Uveal Melanoma	Aligned reads	TCGA-VD-AA8O-01A	99D1BFCC-1989-4DD2-A5E9-78E08F6CE7CF	Primary Tumor	Illumina HiSeq	cfc969dd-923b-4187-808c-584f86e0c276	Eye	77	9C21476F-E62A-4259-BD84-52E539EB5806	9E3B6CA4-5102-4C1E-99FD-3E149D0E4B6D	TCGA-VD-AA8O-01A-11D-A40D-26	HG19_Broad_variant	TCGA-VD-AA8O	TCGA-UVM	NA	s269	MD Anderson - Institute for Applied Cancer Science	University of Liverpool	United Kingdom	NO	T3a	N0	Not available	Stage IIB	A40D-26	TRUE
13722.58cfa832e4b0c9d6adf6d4a2	58cfa832e4b0c9d6adf6d4a2	TCGA-V4-A9F8-01A-11D-A40D_140716_SN208_0519_BC5946ACXX_s_3_rg.sorted.filtered.	WGS	TCGA-V4-A9F8-01A-11D-A40D_140716_SN208_0519_BC5946ACXX_s_3_rg.sorted	TCGA-V4-A9F8-01A-11D-A40D_140716_SN208_0519_BC5946ACXX_s_3_rg.sorted.bam	54.24	NA	0.17	58cfa832e4b0c9d6adf6d4a2	TCGA-V4-A9F8-01A-11D-A40D_140716_SN208_0519_BC5946ACXX_s_3_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Uveal Melanoma	Aligned reads	TCGA-V4-A9F8-01A	64BD88BD-1D5A-4569-9F46-F668D448C336	Primary Tumor	Illumina HiSeq	05bff1f2-adb9-4252-892d-c86207753ca1	Eye	68	6B903079-A499-4AE3-B399-59276DCB9C70	5FABEAFA-9ADE-43AA-B4EB-979826FAE9BF	TCGA-V4-A9F8-01A-11D-A40D-26	HG19_Broad_variant	TCGA-V4-A9F8	TCGA-UVM	NA	s252	MD Anderson - Institute for Applied Cancer Science	Institut Curie	France	NO	T4a	N0	Not available	Stage IIIA	A40D-26	TRUE
13722.58cfa832e4b0c9d6adf6d4dc	58cfa832e4b0c9d6adf6d4dc	TCGA-VD-A8KN-01A-11D-A40D_140731_SN208_0522_AC59K7ACXX_s_8_rg.sorted.filtered.	WGS	TCGA-VD-A8KN-01A-11D-A40D_140731_SN208_0522_AC59K7ACXX_s_8_rg.sorted	TCGA-VD-A8KN-01A-11D-A40D_140731_SN208_0522_AC59K7ACXX_s_8_rg.sorted.bam	23.55	NA	0.15	58cfa832e4b0c9d6adf6d4dc	TCGA-VD-A8KN-01A-11D-A40D_140731_SN208_0522_AC59K7ACXX_s_8_rg.sorted.bam	Alive	FEMALE	Not available	Not available	Uveal Melanoma	Aligned reads	TCGA-VD-A8KN-01A	B26CB5F2-4FF0-4476-8D02-7256ACE7D8A3	Primary Tumor	Illumina HiSeq	48635af7-70bf-40ad-8bc3-2acb2a60ab81	Eye	60	3DD23C74-0B1D-40F4-8E8E-A5032CC7C87D	CBCBD0D3-2964-4D54-9872-0442D37D9D04	TCGA-VD-A8KN-01A-11D-A40D-26	HG19_Broad_variant	TCGA-VD-A8KN	TCGA-UVM	NA	s258	MD Anderson - Institute for Applied Cancer Science	University of Liverpool	United Kingdom	NO	T2a	NX	Not available	Stage IIA	A40D-26	TRUE
13722.58cfa82ee4b0c9d6adf6ae62	58cfa82ee4b0c9d6adf6ae62	TCGA-05-4395-01A-01D-1203_110913_SN208_0238_BC008YACXX_s_8_rg.sorted.filtered.	WGS	TCGA-05-4395-01A-01D-1203_110913_SN208_0238_BC008YACXX_s_8_rg.sorted	TCGA-05-4395-01A-01D-1203_110913_SN208_0238_BC008YACXX_s_8_rg.sorted.bam	385.2	1.9	0.14	58cfa82ee4b0c9d6adf6ae62	TCGA-05-4395-01A-01D-1203_110913_SN208_0238_BC008YACXX_s_8_rg.sorted.bam	Dead	MALE	Not available	Not available	Lung Adenocarcinoma	Aligned reads	TCGA-05-4395-01A	762DEA8A-5B41-4058-979A-B7876ED13D7E	Primary Tumor	Illumina HiSeq	dcb07672-8bde-427e-9d94-ac644e457e91	Lung	76	9DED6605-39A3-4C0F-AD2E-7F6863960DBE	5E9E0A0C-75C0-48AA-BD85-A2E102787EF9	TCGA-05-4395-01A-01D-1203-02	HG19_Broad_variant	TCGA-05-4395	TCGA-LUAD	0	s11115	Harvard Medical School	Indivumed	Germany	NO	T4	N2	Lung Adenocarcinoma Mixed Subtype	Stage IIIB	1203-02	TRUE
13722.58cfa82ee4b0c9d6adf6ae74	58cfa82ee4b0c9d6adf6ae74	TCGA-05-4402-01A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.filtered.	WGS	TCGA-05-4402-01A-01D-1203-02_IlluminaHiSeq-DNASeq_whole	TCGA-05-4402-01A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.bam	176.2	1.9	0.14	58cfa82ee4b0c9d6adf6ae74	TCGA-05-4402-01A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.bam	Dead	FEMALE	Not available	Not available	Lung Adenocarcinoma	Aligned reads	TCGA-05-4402-01A	722D6818-F1CB-49F4-B68A-FD0A31304681	Primary Tumor	Illumina HiSeq	603e16bf-9b05-49c9-a925-f409626c969a	Lung	57	07C1FCE4-EC48-47A4-8391-E553936B67F2	5E791B10-E5FD-412D-9F42-72CAC197F253	TCGA-05-4402-01A-01D-1203-02	GRCh37	TCGA-05-4402	TCGA-LUAD	244	s10900	Harvard Medical School	Indivumed	Germany	NO	T2	NX	Lung Adenocarcinoma Mixed Subtype	Stage IV	1203-02	TRUE
13722.58cfa82ee4b0c9d6adf6ae68	58cfa82ee4b0c9d6adf6ae68	TCGA-05-4403-01A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.filtered.	WGS	TCGA-05-4403-01A-01D-1203-02_IlluminaHiSeq-DNASeq_whole	TCGA-05-4403-01A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.bam	211.2	1.9	0.15	58cfa82ee4b0c9d6adf6ae68	TCGA-05-4403-01A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.bam	Alive	MALE	Not available	Not available	Lung Adenocarcinoma	Aligned reads	TCGA-05-4403-01A	CE15F31F-2BAD-4485-96FA-495BFA262E66	Primary Tumor	Illumina HiSeq	80e2118c-7ebf-42fc-8600-573afcbb3fe6	Lung	76	44B1D21C-0794-428C-BA01-82812D74DA2F	48F1FF7F-84F4-4420-96F9-DA1917577B6D	TCGA-05-4403-01A-01D-1203-02	GRCh37	TCGA-05-4403	TCGA-LUAD	NA	s10980	Harvard Medical School	Indivumed	Germany	NO	T2	N0	Lung Adenocarcinoma Mixed Subtype	Stage IB	1203-02	TRUE
13722.58cfa82ee4b0c9d6adf6afe6	58cfa82ee4b0c9d6adf6afe6	TCGA-05-4434-01A-01D-1203_111013_SN208_0253_B00PJACXX_s_2_rg.sorted.filtered.	WGS	TCGA-05-4434-01A-01D-1203_111013_SN208_0253_B00PJACXX_s_2_rg.sorted	TCGA-05-4434-01A-01D-1203_111013_SN208_0253_B00PJACXX_s_2_rg.sorted.bam	724.9	1.9	0.15	58cfa82ee4b0c9d6adf6afe6	TCGA-05-4434-01A-01D-1203_111013_SN208_0253_B00PJACXX_s_2_rg.sorted.bam	Dead	FEMALE	Not available	Not available	Lung Adenocarcinoma	Aligned reads	TCGA-05-4434-01A	D94FE32F-BEDD-4F4C-9FEB-FCB60D40F4BB	Primary Tumor	Illumina HiSeq	f43f1ef0-b383-4a17-a3cc-25c353416799	Lung	67	7A03048B-58B6-4CAE-B143-81C0A4977AC6	8A64C790-988A-4B51-8E5F-B4F746F2D9EB	TCGA-05-4434-01A-01D-1203-02	HG19_Broad_variant	TCGA-05-4434	TCGA-LUAD	457	s10644	Harvard Medical School	Indivumed	Germany	NO	T4	N1	Lung Adenocarcinoma Mixed Subtype	Stage IV	1203-02	TRUE
13722.58cfa82fe4b0c9d6adf6b624	58cfa82fe4b0c9d6adf6b624	TCGA-75-5146-01A-01D-1623_110913_SN208_0238_BC008YACXX_s_5_rg.sorted.filtered.	WGS	TCGA-75-5146-01A-01D-1623_110913_SN208_0238_BC008YACXX_s_5_rg.sorted	TCGA-75-5146-01A-01D-1623_110913_SN208_0238_BC008YACXX_s_5_rg.sorted.bam	692.7	1.9	0.15	58cfa82fe4b0c9d6adf6b624	TCGA-75-5146-01A-01D-1623_110913_SN208_0238_BC008YACXX_s_5_rg.sorted.bam	Alive	MALE	Not available	Not available	Lung Adenocarcinoma	Aligned reads	TCGA-75-5146-01A	1D276B62-5E64-48FB-B2CE-5192B511FE37	Primary Tumor	Illumina HiSeq	926ac8ca-ff8f-4822-bf62-819bf5525a5d	Lung	NA	373C5231-B6AE-49DB-AC0D-D674A0C9C100	2578C781-0BDF-4CA2-A8FA-8B624489818B	TCGA-75-5146-01A-01D-1623-02	HG19_Broad_variant	TCGA-75-5146	TCGA-LUAD	NA	s10668	Harvard Medical School	Ontario Institute for Cancer Research (OICR)	Canada	NO	T2	N0	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage IB	1623-02	TRUE
13722.58cfa82fe4b0c9d6adf6b5da	58cfa82fe4b0c9d6adf6b5da	TCGA-35-4123-01A-01D-1103_110913_SN208_0238_BC008YACXX_s_6_rg.sorted.filtered.	WGS	TCGA-35-4123-01A-01D-1103_110913_SN208_0238_BC008YACXX_s_6_rg.sorted	TCGA-35-4123-01A-01D-1103_110913_SN208_0238_BC008YACXX_s_6_rg.sorted.bam	766.93	1.9	0.16	58cfa82fe4b0c9d6adf6b5da	TCGA-35-4123-01A-01D-1103_110913_SN208_0238_BC008YACXX_s_6_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-35-4123-01A	6CF49CF0-DE4C-4C90-8358-EAE19C6206B0	Primary Tumor	Illumina HiSeq	c620a587-dd69-4a1c-81c9-5ae742181fbc	Lung	38	3AF63E86-157B-408C-9527-58A45107DDD2	D1765CB9-4A13-425F-8B2D-E632B656058B	TCGA-35-4123-01A-01D-1103-02	HG19_Broad_variant	TCGA-35-4123	TCGA-LUAD	NA	s11335	Harvard Medical School	Cureline	Russia	NO	T1	N0	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage IA	1103-02	TRUE
13722.58cfa82fe4b0c9d6adf6b5e4	58cfa82fe4b0c9d6adf6b5e4	TCGA-44-2661-01A-01D-1103_110913_SN208_0238_BC008YACXX_s_7_rg.sorted.filtered.	WGS	TCGA-44-2661-01A-01D-1103_110913_SN208_0238_BC008YACXX_s_7_rg.sorted	TCGA-44-2661-01A-01D-1103_110913_SN208_0238_BC008YACXX_s_7_rg.sorted.bam	735.66	1.9	0.15	58cfa82fe4b0c9d6adf6b5e4	TCGA-44-2661-01A-01D-1103_110913_SN208_0238_BC008YACXX_s_7_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-44-2661-01A	F3501466-CF32-4866-B5FB-E94DD32341BC	Primary Tumor	Illumina HiSeq	fbe0b7e0-45f4-4c61-9965-be52ae790251	Lung	69	48DD9724-8848-48C3-8628-7E78A24E3F2C	5F5307B5-02FF-4262-BB72-A215897B2EA7	TCGA-44-2661-01A-01D-1103-02	HG19_Broad_variant	TCGA-44-2661	TCGA-LUAD	NA	s10650	Harvard Medical School	Christiana Healthcare	United States	NO	T1	N0	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage IA	1103-02	TRUE
13722.58cfa82fe4b0c9d6adf6b617	58cfa82fe4b0c9d6adf6b617	TCGA-35-4122-01A-01D-1103_110804_SN208_0217_BC03EKABXX_s_3_rg.sorted.filtered.	WGS	TCGA-35-4122-01A-01D-1103_110804_SN208_0217_BC03EKABXX_s_3_rg.sorted	TCGA-35-4122-01A-01D-1103_110804_SN208_0217_BC03EKABXX_s_3_rg.sorted.bam	244.93	1.9	0.15	58cfa82fe4b0c9d6adf6b617	TCGA-35-4122-01A-01D-1103_110804_SN208_0217_BC03EKABXX_s_3_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-35-4122-01A	44ADF4CB-2829-4153-80FD-A8B7EE0E654A	Primary Tumor	Illumina HiSeq	3887aeb9-e6df-492e-ad08-f4037acba9aa	Lung	69	587F8383-3A48-49AF-8AC4-D86E6009C96B	DD8A0F54-0311-49FB-B270-ABF1AE9B56A5	TCGA-35-4122-01A-01D-1103-02	HG19_Broad_variant	TCGA-35-4122	TCGA-LUAD	NA	s11445	Harvard Medical School	Cureline	Russia	NO	T1	N0	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage IA	1103-02	TRUE
13722.58cfa82fe4b0c9d6adf6b67d	58cfa82fe4b0c9d6adf6b67d	TCGA-49-4486-01A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.filtered.	WGS	TCGA-49-4486-01A-01D-1203-02_IlluminaHiSeq-DNASeq_whole	TCGA-49-4486-01A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.bam	142.53	1.9	0.14	58cfa82fe4b0c9d6adf6b67d	TCGA-49-4486-01A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-49-4486-01A	61C655EC-52B5-453F-A6CC-B2ABA445B027	Primary Tumor	Illumina HiSeq	cb4d8cf1-9903-481c-8ba1-df0586b69916	Lung	72	5AE9B10F-347C-48C3-90CD-9290055CFE4B	EC0EE49C-D1D4-490D-BA82-CFAE6D451B8D	TCGA-49-4486-01A-01D-1203-02	GRCh37	TCGA-49-4486	TCGA-LUAD	2318	s10907	Harvard Medical School	Johns Hopkins	United States	NO	T1	N0	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage IA	1203-02	TRUE
13722.58cfa82fe4b0c9d6adf6b726	58cfa82fe4b0c9d6adf6b726	TCGA-75-5147-01A-01D-1623_110913_SN208_0238_BC008YACXX_s_4_rg.sorted.filtered.	WGS	TCGA-75-5147-01A-01D-1623_110913_SN208_0238_BC008YACXX_s_4_rg.sorted	TCGA-75-5147-01A-01D-1623_110913_SN208_0238_BC008YACXX_s_4_rg.sorted.bam	817.7	1.9	0.15	58cfa82fe4b0c9d6adf6b726	TCGA-75-5147-01A-01D-1623_110913_SN208_0238_BC008YACXX_s_4_rg.sorted.bam	Alive	FEMALE	Not available	Not available	Lung Adenocarcinoma	Aligned reads	TCGA-75-5147-01A	D2824E6D-3784-45C2-9B0F-52B17356B5DA	Primary Tumor	Illumina HiSeq	ca549b28-f771-489d-93fe-90211aa22391	Lung	NA	F9F9C1DD-8462-4560-82B8-AEA4309854C9	1291FD50-F1A9-4A2A-A2FD-2320ED01FB4E	TCGA-75-5147-01A-01D-1623-02	HG19_Broad_variant	TCGA-75-5147	TCGA-LUAD	NA	s11466	Harvard Medical School	Ontario Institute for Cancer Research (OICR)	Canada	NO	T2	N0	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage IB	1623-02	TRUE
13722.58cfa82fe4b0c9d6adf6b7b0	58cfa82fe4b0c9d6adf6b7b0	TCGA-49-4494-01A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.filtered.	WGS	TCGA-49-4494-01A-01D-1203-02_IlluminaHiSeq-DNASeq_whole	TCGA-49-4494-01A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.bam	245.2	1.9	0.16	58cfa82fe4b0c9d6adf6b7b0	TCGA-49-4494-01A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-49-4494-01A	C6D78E27-E510-4F57-ABAE-19EFA6105A8D	Primary Tumor	Illumina HiSeq	3cb48d09-95ac-452f-9c92-19d7f966aec0	Lung	77	7CA68089-C61F-4D31-8CC8-FB11AE70910A	8DF0AEB4-1455-4760-A230-54FE1551D08C	TCGA-49-4494-01A-01D-1203-02	GRCh37	TCGA-49-4494	TCGA-LUAD	1081	s10783	Harvard Medical School	Johns Hopkins	United States	NO	T3	N2	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage IIIA	1203-02	TRUE
13722.58cfa82fe4b0c9d6adf6b77c	58cfa82fe4b0c9d6adf6b77c	TCGA-44-5645-01A-01D-1623_110804_SN208_0216_AD0CLLABXX_s_5_rg.sorted.filtered.	WGS	TCGA-44-5645-01A-01D-1623_110804_SN208_0216_AD0CLLABXX_s_5_rg.sorted	TCGA-44-5645-01A-01D-1623_110804_SN208_0216_AD0CLLABXX_s_5_rg.sorted.bam	466.6	1.9	0.16	58cfa82fe4b0c9d6adf6b77c	TCGA-44-5645-01A-01D-1623_110804_SN208_0216_AD0CLLABXX_s_5_rg.sorted.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-44-5645-01A	DDEACCCF-0953-4952-8A4E-C2617F2E7BCC	Primary Tumor	Illumina HiSeq	e1f13e42-abbc-4a28-91d2-65b2a95b0018	Lung	61	37A8D3A5-BAA0-427C-AB43-48AE4B93633B	A35054A5-9324-47AD-841E-E2ADCD97126D	TCGA-44-5645-01A-01D-1623-02	HG19_Broad_variant	TCGA-44-5645	TCGA-LUAD	NA	s10993	Harvard Medical School	Christiana Healthcare	United States	NO	T1	NX	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage IA	1623-02	TRUE
13722.58cfa82fe4b0c9d6adf6b7d4	58cfa82fe4b0c9d6adf6b7d4	TCGA-44-3919-01A-02D-1103_110804_SN208_0217_BC03EKABXX_s_7_rg.sorted.filtered.	WGS	TCGA-44-3919-01A-02D-1103_110804_SN208_0217_BC03EKABXX_s_7_rg.sorted	TCGA-44-3919-01A-02D-1103_110804_SN208_0217_BC03EKABXX_s_7_rg.sorted.bam	427.33	1.9	0.15	58cfa82fe4b0c9d6adf6b7d4	TCGA-44-3919-01A-02D-1103_110804_SN208_0217_BC03EKABXX_s_7_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-44-3919-01A	66ED89F6-8BA2-49D0-AF0F-4B6EBF2381BF	Primary Tumor	Illumina HiSeq	14d2cfc2-f4ac-4ab1-93d3-0e178305e26f	Lung	71	9DE8D353-3442-41D8-8BFE-A08C4975EACA	9C982400-B6C3-4D00-9981-BA06775FEF4F	TCGA-44-3919-01A-02D-1103-02	HG19_Broad_variant	TCGA-44-3919	TCGA-LUAD	NA	s10994	Harvard Medical School	Christiana Healthcare	United States	NO	T1	N0	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage IA	1103-02	TRUE
13722.58cfa82fe4b0c9d6adf6b840	58cfa82fe4b0c9d6adf6b840	TCGA-A6-2679-01A-02D-1405-02_IlluminaHiSeq-DNASeq_whole.filtered.	WGS	TCGA-A6-2679-01A-02D-1405-02_IlluminaHiSeq-DNASeq_whole	TCGA-A6-2679-01A-02D-1405-02_IlluminaHiSeq-DNASeq_whole.bam	556	1.9	0.17	58cfa82fe4b0c9d6adf6b840	TCGA-A6-2679-01A-02D-1405-02_IlluminaHiSeq-DNASeq_whole.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Colon Adenocarcinoma	Aligned reads	TCGA-A6-2679-01A	0F74D992-00DA-4728-9564-086CA1B95921	Primary Tumor	Illumina HiSeq	6ba315a4-973a-47a1-b157-8f6ab62fdaef	Colorectal	73	1FCB9C83-18CB-42A4-8769-FDDB3541C95D	118D83B1-3464-40E3-8A77-270650CFED42	TCGA-A6-2679-01A-02D-1405-02	HG18	TCGA-A6-2679	TCGA-COAD	NA	s13014	Harvard Medical School	Christiana Healthcare	None	NO	T3	N0	Colon Adenocarcinoma	Stage IIB	1405-02	TRUE
13722.58cfa82fe4b0c9d6adf6b842	58cfa82fe4b0c9d6adf6b842	TCGA-A6-2674-01A-02D-1167-02_IlluminaHiSeq-DNASeq_whole.filtered.	WGS	TCGA-A6-2674-01A-02D-1167-02_IlluminaHiSeq-DNASeq_whole	TCGA-A6-2674-01A-02D-1167-02_IlluminaHiSeq-DNASeq_whole.bam	260.29	1.9	0.14	58cfa82fe4b0c9d6adf6b842	TCGA-A6-2674-01A-02D-1167-02_IlluminaHiSeq-DNASeq_whole.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Colon Adenocarcinoma	Aligned reads	TCGA-A6-2674-01A	57CDAA1C-4E94-4A28-AB3B-300C0457555F	Primary Tumor	Illumina HiSeq	92b3a16b-1a9e-47a3-9146-1a297c51c5a3	Colorectal	71	8ACA008C-F55A-420A-82C7-ACD2CCA77D85	9FDFC199-B878-4049-994E-B5CA384678FB	TCGA-A6-2674-01A-02D-1167-02	HG18	TCGA-A6-2674	TCGA-COAD	NA	s13013	Harvard Medical School	Christiana Healthcare	None	NO	T3	N2	Colon Mucinous Adenocarcinoma	Stage IV	1167-02	TRUE
13722.58cfa82fe4b0c9d6adf6b8e8	58cfa82fe4b0c9d6adf6b8e8	TCGA-AA-3510-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.filtered.	WGS	TCGA-AA-3510-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole	TCGA-AA-3510-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.bam	346	1.9	0.13	58cfa82fe4b0c9d6adf6b8e8	TCGA-AA-3510-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.bam	Alive	MALE	Not available	Not available	Colon Adenocarcinoma	Aligned reads	TCGA-AA-3510-01A	35C295C2-37D1-44B2-87A3-1039645E5BAE	Primary Tumor	Illumina HiSeq	0bb810fb-0134-4ea2-a821-41bbbdbd9155	Colorectal	70	C71C031C-3089-44E5-A49F-5284D7D300CE	DA2A173C-BBD3-4A90-8D1D-CD35CBE750F3	TCGA-AA-3510-01A-01D-1405-02	HG18	TCGA-AA-3510	TCGA-COAD	NA	s13666	Harvard Medical School	Indivumed	Germany	NO	T3	N0	Colon Adenocarcinoma	Stage II	1405-02	TRUE
13722.58cfa82fe4b0c9d6adf6b8b8	58cfa82fe4b0c9d6adf6b8b8	TCGA-73-4675-01A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.filtered.	WGS	TCGA-73-4675-01A-01D-1203-02_IlluminaHiSeq-DNASeq_whole	TCGA-73-4675-01A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.bam	482.2	1.9	0.16	58cfa82fe4b0c9d6adf6b8b8	TCGA-73-4675-01A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-73-4675-01A	AE39E358-08D7-4367-AE68-82B469E791E4	Primary Tumor	Illumina HiSeq	14b3ad66-64c9-4b39-a34e-5cb29788735a	Lung	59	1F5FA8FD-1DE8-4456-8935-71B5A8B54BD2	356D01E0-DF80-40C6-BA06-8CD4EDFBD1EC	TCGA-73-4675-01A-01D-1203-02	GRCh37	TCGA-73-4675	TCGA-LUAD	NA	s11013	Harvard Medical School	Roswell Park	United States	NO	T3	N1	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage IIIA	1203-02	TRUE
13722.58cfa82fe4b0c9d6adf6b898	58cfa82fe4b0c9d6adf6b898	TCGA-A6-2676-01A-01D-1167-02_101203_SN177_0125_B802RYABXX_s_1.rg.sorted.filtered.	WGS	TCGA-A6-2676-01A-01D-1167-02_101203_SN177_0125_B802RYABXX_s_1.rg.sorted	TCGA-A6-2676-01A-01D-1167-02_101203_SN177_0125_B802RYABXX_s_1.rg.sorted.bam	296.29	1.9	0.17	58cfa82fe4b0c9d6adf6b898	TCGA-A6-2676-01A-01D-1167-02_101203_SN177_0125_B802RYABXX_s_1.rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Colon Adenocarcinoma	Aligned reads	TCGA-A6-2676-01A	89A6384E-1CEA-440B-9F17-D57CB0805174	Primary Tumor	Illumina HiSeq	c175a01b-eba5-4c4d-b786-fc9f54a2fa60	Colorectal	75	CBBD1187-E8F7-4E63-A8E2-3C19863E89F5	D02407DB-AECE-475A-AA3F-00653B1E7BEE	TCGA-A6-2676-01A-01D-1167-02	HG18_Broad_variant	TCGA-A6-2676	TCGA-COAD	NA	s13022	Harvard Medical School	Christiana Healthcare	None	NO	T4	N0	Colon Adenocarcinoma	Stage IIB	1167-02	TRUE
13722.58cfa82fe4b0c9d6adf6b914	58cfa82fe4b0c9d6adf6b914	TCGA-49-4505-01A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.filtered.	WGS	TCGA-49-4505-01A-01D-1203-02_IlluminaHiSeq-DNASeq_whole	TCGA-49-4505-01A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.bam	129.53	1.9	0.14	58cfa82fe4b0c9d6adf6b914	TCGA-49-4505-01A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-49-4505-01A	088EDF89-D2B5-40C7-B066-DF3BD383F7EA	Primary Tumor	Illumina HiSeq	af550be6-0986-458b-8206-9c7cf928c215	Lung	61	D1FB0862-8D9C-4BC4-AAC6-81DC4EED66C9	30B77A0C-3439-44E2-A586-5DF68C0D0002	TCGA-49-4505-01A-01D-1203-02	GRCh37	TCGA-49-4505	TCGA-LUAD	428	s11125	Harvard Medical School	Johns Hopkins	United States	NO	T2	N1	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage IIB	1203-02	TRUE
13722.58cfa82fe4b0c9d6adf6b89a	58cfa82fe4b0c9d6adf6b89a	TCGA-A6-2683-01A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.filtered.	WGS	TCGA-A6-2683-01A-01D-1167-02_IlluminaHiSeq-DNASeq_whole	TCGA-A6-2683-01A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.bam	467.29	1.9	0.16	58cfa82fe4b0c9d6adf6b89a	TCGA-A6-2683-01A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Colon Adenocarcinoma	Aligned reads	TCGA-A6-2683-01A	FAFD4576-0709-49E1-926F-AD1EE09907EC	Primary Tumor	Illumina HiSeq	06c41745-bee7-471d-9c51-8886c6c8dd9c	Colorectal	57	C24759F8-566B-42DA-A26D-BB0BF51EE15F	B22E3766-3FC6-4E77-86D0-0A10A810D313	TCGA-A6-2683-01A-01D-1167-02	HG18	TCGA-A6-2683	TCGA-COAD	NA	s12852	Harvard Medical School	Christiana Healthcare	None	NO	T4	N0	Colon Adenocarcinoma	Stage IV	1167-02	TRUE
13722.58cfa82fe4b0c9d6adf6b974	58cfa82fe4b0c9d6adf6b974	TCGA-AA-3675-01A-02D-1109-02_IlluminaHiSeq-DNASeq_whole.filtered.	WGS	TCGA-AA-3675-01A-02D-1109-02_IlluminaHiSeq-DNASeq_whole	TCGA-AA-3675-01A-02D-1109-02_IlluminaHiSeq-DNASeq_whole.bam	570.96	1.9	0.14	58cfa82fe4b0c9d6adf6b974	TCGA-AA-3675-01A-02D-1109-02_IlluminaHiSeq-DNASeq_whole.bam	Alive	MALE	Not available	Not available	Colon Adenocarcinoma	Aligned reads	TCGA-AA-3675-01A	41658CF8-0DE1-4A97-BB60-0F0107C84E00	Primary Tumor	Illumina HiSeq	f57af06a-9d5a-4a69-888a-8d611982b88e	Colorectal	84	A4CE3727-4506-493B-95F4-2F11CEB09CEB	D611373E-EF0A-46E4-8D3E-0722F221E828	TCGA-AA-3675-01A-02D-1109-02	HG18	TCGA-AA-3675	TCGA-COAD	NA	s13672	Harvard Medical School	Indivumed	Germany	NO	T3	N0	Colon Adenocarcinoma	Stage II	1109-02	TRUE
13722.58cfa82fe4b0c9d6adf6b940	58cfa82fe4b0c9d6adf6b940	TCGA-A6-3808-01A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.filtered.	WGS	TCGA-A6-3808-01A-01D-1167-02_IlluminaHiSeq-DNASeq_whole	TCGA-A6-3808-01A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.bam	236	1.9	0.14	58cfa82fe4b0c9d6adf6b940	TCGA-A6-3808-01A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Colon Adenocarcinoma	Aligned reads	TCGA-A6-3808-01A	4F9775F2-B663-4DAF-AA9E-50915CAE9407	Primary Tumor	Illumina HiSeq	58504a37-4eb0-44ec-bb5d-83e955521de2	Colorectal	73	037BA047-2228-43DE-8DF8-32920A689ECA	2B2625B5-FBDD-41C3-9BB3-71566C5FBBA4	TCGA-A6-3808-01A-01D-1167-02	HG18	TCGA-A6-3808	TCGA-COAD	NA	s13173	Harvard Medical School	Christiana Healthcare	None	NO	T3	N0	Colon Adenocarcinoma	Stage IIA	1167-02	TRUE
13722.58cfa82fe4b0c9d6adf6b98e	58cfa82fe4b0c9d6adf6b98e	TCGA-50-5944-01A-11D-1751_111221_SN1120_0106_BD0M7HACXX_s_1_rg.sorted.filtered.	WGS	TCGA-50-5944-01A-11D-1751_111221_SN1120_0106_BD0M7HACXX_s_1_rg.sorted	TCGA-50-5944-01A-11D-1751_111221_SN1120_0106_BD0M7HACXX_s_1_rg.sorted.bam	115.4	1.9	0.14	58cfa82fe4b0c9d6adf6b98e	TCGA-50-5944-01A-11D-1751_111221_SN1120_0106_BD0M7HACXX_s_1_rg.sorted.bam	Alive	FEMALE	WHITE	Not available	Lung Adenocarcinoma	Aligned reads	TCGA-50-5944-01A	1C339545-C08A-4A77-B8E9-A7E49E53853F	Primary Tumor	Illumina HiSeq	c76f3861-5117-4ed7-9ca6-eecc10e949f3	Lung	69	BF8FDF82-62B4-4B5D-93E7-CE153576FE49	71CD46A8-30B0-4452-860D-3ED173C461A7	TCGA-50-5944-01A-11D-1751-02	HG19_Broad_variant	TCGA-50-5944	TCGA-LUAD	NA	s11348	Harvard Medical School	University of Pittsburgh	United States	NO	T1	N0	Lung Acinar Adenocarcinoma	Stage IA	1751-02	TRUE
13722.58cfa82fe4b0c9d6adf6b9ca	58cfa82fe4b0c9d6adf6b9ca	TCGA-AA-A00U-01A-01D-A077-02_IlluminaHiSeq-DNASeq_whole.filtered.	WGS	TCGA-AA-A00U-01A-01D-A077-02_IlluminaHiSeq-DNASeq_whole	TCGA-AA-A00U-01A-01D-A077-02_IlluminaHiSeq-DNASeq_whole.bam	232.95	1.72	0.15	58cfa82fe4b0c9d6adf6b9ca	TCGA-AA-A00U-01A-01D-A077-02_IlluminaHiSeq-DNASeq_whole.bam	Alive	MALE	Not available	Not available	Colon Adenocarcinoma	Aligned reads	TCGA-AA-A00U-01A	091E3084-04EE-4497-893C-D46226DEC78F	Primary Tumor	Illumina HiSeq	95f8b5f7-db6e-4a69-959f-dde28a98d4ed	Colorectal	50	2FC854D7-4F80-4C39-BD92-397E94FEE4A0	6765593B-17DC-4B0F-A20B-7F0FF67DFF64	TCGA-AA-A00U-01A-01D-A077-02	HG18	TCGA-AA-A00U	TCGA-COAD	NA	s13682	Harvard Medical School	Indivumed	Germany	NO	T3	N1	Colon Adenocarcinoma	Stage IIIB	A077-02	TRUE
13722.58cfa82fe4b0c9d6adf6ba0c	58cfa82fe4b0c9d6adf6ba0c	TCGA-AA-3970-01A-01D-1109-02_IlluminaHiSeq-DNASeq_whole.filtered.	WGS	TCGA-AA-3970-01A-01D-1109-02_IlluminaHiSeq-DNASeq_whole	TCGA-AA-3970-01A-01D-1109-02_IlluminaHiSeq-DNASeq_whole.bam	686.66	1.9	0.15	58cfa82fe4b0c9d6adf6ba0c	TCGA-AA-3970-01A-01D-1109-02_IlluminaHiSeq-DNASeq_whole.bam	Alive	MALE	Not available	Not available	Colon Adenocarcinoma	Aligned reads	TCGA-AA-3970-01A	733D8B6A-CA9D-4A69-8C9C-1F88733E8B68	Primary Tumor	Illumina HiSeq	9a7a59e0-b435-4e8b-b503-c49ce6f819e4	Colorectal	65	767A5260-34F4-4BED-9CDA-305BC431A402	0F57E6B4-FE51-4ACF-B65B-1FDB2CF9C6CB	TCGA-AA-3970-01A-01D-1109-02	HG18	TCGA-AA-3970	TCGA-COAD	NA	s13190	Harvard Medical School	Indivumed	Germany	NO	T3	N0	Colon Adenocarcinoma	Stage IIA	1109-02	TRUE
13722.58cfa82fe4b0c9d6adf6b9d8	58cfa82fe4b0c9d6adf6b9d8	TCGA-AA-3947-01A-01D-1167-02_101023_SN208_0167_B80L4DABXX_s_1.rg.sorted.filtered.	WGS	TCGA-AA-3947-01A-01D-1167-02_101023_SN208_0167_B80L4DABXX_s_1.rg.sorted	TCGA-AA-3947-01A-01D-1167-02_101023_SN208_0167_B80L4DABXX_s_1.rg.sorted.bam	880.86	1.9	0.14	58cfa82fe4b0c9d6adf6b9d8	TCGA-AA-3947-01A-01D-1167-02_101023_SN208_0167_B80L4DABXX_s_1.rg.sorted.bam	Alive	FEMALE	Not available	Not available	Colon Adenocarcinoma	Aligned reads	TCGA-AA-3947-01A	654C6F5C-3E5C-49F0-B53F-87CD9797D7C9	Primary Tumor	Illumina HiSeq	2d1ad0b4-c460-4a5b-ae6d-2926bfe40052	Colorectal	60	5241539D-65AC-434D-8EAA-AE57F702C8CE	EE2FCBCE-108F-46EC-8C7A-12D34142820A	TCGA-AA-3947-01A-01D-1167-02	HG18_Broad_variant	TCGA-AA-3947	TCGA-COAD	NA	s13679	Harvard Medical School	Indivumed	Germany	NO	T4	N0	Colon Mucinous Adenocarcinoma	Stage IIB	1167-02	TRUE
13722.58cfa82fe4b0c9d6adf6b9fe	58cfa82fe4b0c9d6adf6b9fe	TCGA-AA-3968-01A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.filtered.	WGS	TCGA-AA-3968-01A-01D-1167-02_IlluminaHiSeq-DNASeq_whole	TCGA-AA-3968-01A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.bam	756	1.9	0.15	58cfa82fe4b0c9d6adf6b9fe	TCGA-AA-3968-01A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.bam	Alive	FEMALE	Not available	Not available	Colon Adenocarcinoma	Aligned reads	TCGA-AA-3968-01A	CAB7BDBC-0A11-4901-97C3-26B884F79CB5	Primary Tumor	Illumina HiSeq	7c5f1648-b5c0-4e96-a5ca-38b2630f40ee	Colorectal	55	E950BC59-116F-4366-8524-F0731B1C9A3D	193F15A1-6BE4-4992-AC6E-EF34CBB3B57A	TCGA-AA-3968-01A-01D-1167-02	HG18	TCGA-AA-3968	TCGA-COAD	NA	s13030	Harvard Medical School	Indivumed	Germany	NO	T2	N0	Colon Adenocarcinoma	Stage I	1167-02	TRUE
13722.58cfa82fe4b0c9d6adf6ba1e	58cfa82fe4b0c9d6adf6ba1e	TCGA-AA-3664-01A-01D-1167_101023_SN208_0166_A808PFABXX_s_5_rg.sorted.filtered.	WGS	TCGA-AA-3664-01A-01D-1167_101023_SN208_0166_A808PFABXX_s_5_rg.sorted	TCGA-AA-3664-01A-01D-1167_101023_SN208_0166_A808PFABXX_s_5_rg.sorted.bam	338.96	1.9	0.16	58cfa82fe4b0c9d6adf6ba1e	TCGA-AA-3664-01A-01D-1167_101023_SN208_0166_A808PFABXX_s_5_rg.sorted.bam	Alive	FEMALE	Not available	Not available	Colon Adenocarcinoma	Aligned reads	TCGA-AA-3664-01A	A06C09A8-0951-49F4-A765-5147BBCAE109	Primary Tumor	Illumina HiSeq	1eb3d869-c9bd-4087-80cd-7fb426eb7997	Colorectal	74	D448668C-90F3-40FA-9961-88407090DA31	4B4C0EDF-1012-4A6A-B01E-CDEB130FF2E6	TCGA-AA-3664-01A-01D-1167-02	HG18_Broad_variant	TCGA-AA-3664	TCGA-COAD	NA	s12864	Harvard Medical School	Indivumed	Germany	NO	T3	N0	Colon Adenocarcinoma	Stage II	1167-02	TRUE
13722.58cfa830e4b0c9d6adf6ba6e	58cfa830e4b0c9d6adf6ba6e	TCGA-AA-A01D-01A-01D-A077-02_IlluminaHiSeq-DNASeq_whole.filtered.	WGS	TCGA-AA-A01D-01A-01D-A077-02_IlluminaHiSeq-DNASeq_whole	TCGA-AA-A01D-01A-01D-A077-02_IlluminaHiSeq-DNASeq_whole.bam	119.82	1.79	0.15	58cfa830e4b0c9d6adf6ba6e	TCGA-AA-A01D-01A-01D-A077-02_IlluminaHiSeq-DNASeq_whole.bam	Alive	FEMALE	Not available	Not available	Colon Adenocarcinoma	Aligned reads	TCGA-AA-A01D-01A	E2EDBF3F-25D8-49AA-B656-2A59C3B99AEB	Primary Tumor	Illumina HiSeq	dc156fb1-9b36-4d02-a6f0-54027775ed04	Colorectal	47	082DEF2F-4D99-4270-83E7-5A9A5C049C23	5BF3D0AB-D301-4EE7-84A1-83F596C29E6E	TCGA-AA-A01D-01A-01D-A077-02	HG18	TCGA-AA-A01D	TCGA-COAD	NA	s13525	Harvard Medical School	Indivumed	Germany	NO	T3	N2	Colon Mucinous Adenocarcinoma	Stage IIIC	A077-02	TRUE
13722.58cfa830e4b0c9d6adf6ba56	58cfa830e4b0c9d6adf6ba56	TCGA-AA-3966-01A-01D-1109-02_IlluminaHiSeq-DNASeq_whole.filtered.	WGS	TCGA-AA-3966-01A-01D-1109-02_IlluminaHiSeq-DNASeq_whole	TCGA-AA-3966-01A-01D-1109-02_IlluminaHiSeq-DNASeq_whole.bam	526.89	1.9	0.15	58cfa830e4b0c9d6adf6ba56	TCGA-AA-3966-01A-01D-1109-02_IlluminaHiSeq-DNASeq_whole.bam	Alive	FEMALE	Not available	Not available	Colon Adenocarcinoma	Aligned reads	TCGA-AA-3966-01A	BC42FE2D-1A33-428D-A601-B1871F4C8D9B	Primary Tumor	Illumina HiSeq	3a88f23b-5740-4937-be5d-a5aed2c4e962	Colorectal	89	8C5799BF-DB65-40F6-9A67-ABD4DA4025F2	F1E05BF6-0B98-45F8-9F97-10ABE5957C99	TCGA-AA-3966-01A-01D-1109-02	HG18	TCGA-AA-3966	TCGA-COAD	NA	s13674	Harvard Medical School	Indivumed	Germany	NO	T3	N0	Colon Mucinous Adenocarcinoma	Stage IIA	1109-02	TRUE
13722.58cfa830e4b0c9d6adf6ba50	58cfa830e4b0c9d6adf6ba50	TCGA-AA-A02K-01A-21D-A079_110401_SN177_0152_A819RJABXX_s_2.rg.sorted.filtered.	WGS	TCGA-AA-A02K-01A-21D-A079_110401_SN177_0152_A819RJABXX_s_2.rg.sorted	TCGA-AA-A02K-01A-21D-A079_110401_SN177_0152_A819RJABXX_s_2.rg.sorted.bam	28.83	1.9	0.15	58cfa830e4b0c9d6adf6ba50	TCGA-AA-A02K-01A-21D-A079_110401_SN177_0152_A819RJABXX_s_2.rg.sorted.bam	Dead	MALE	Not available	Not available	Colon Adenocarcinoma	Aligned reads	TCGA-AA-A02K-01A	10881458-55B2-41D1-8358-4EE6CCB8EC85	Primary Tumor	Illumina HiSeq	7942eab9-d80a-496e-b3cb-50b42bd23334	Colorectal	50	685DF015-1B7B-4993-BF05-E3206619DFBA	7CC17F3D-27F5-484A-8E22-C9D0B5B27836	TCGA-AA-A02K-01A-21D-A079-02	HG18_Broad_variant	TCGA-AA-A02K	TCGA-COAD	426	s13842	Harvard Medical School	Indivumed	Germany	NO	T4	N2	Colon Adenocarcinoma	Stage IV	A079-02	TRUE
13722.58cfa830e4b0c9d6adf6baa6	58cfa830e4b0c9d6adf6baa6	TCGA-AA-A03F-01A-11D-A079-02_IlluminaHiSeq-DNASeq_whole.filtered.	WGS	TCGA-AA-A03F-01A-11D-A079-02_IlluminaHiSeq-DNASeq_whole	TCGA-AA-A03F-01A-11D-A079-02_IlluminaHiSeq-DNASeq_whole.bam	124.44	1.85	0.17	58cfa830e4b0c9d6adf6baa6	TCGA-AA-A03F-01A-11D-A079-02_IlluminaHiSeq-DNASeq_whole.bam	Dead	FEMALE	Not available	Not available	Colon Adenocarcinoma	Aligned reads	TCGA-AA-A03F-01A	2A971E32-B0E7-4A3F-8C40-62D69C0307D8	Primary Tumor	Illumina HiSeq	93e089c5-c259-445d-9ffa-10073ad2d336	Colorectal	90	8ABA8350-B5EE-4CA2-BC99-5C7922A886C4	F445E8E6-6A82-4400-8307-1DE92AC03539	TCGA-AA-A03F-01A-11D-A079-02	HG18	TCGA-AA-A03F	TCGA-COAD	549	s13207	Harvard Medical School	Indivumed	Germany	NO	T3	N2	Colon Mucinous Adenocarcinoma	Stage III	A079-02	TRUE
13722.58cfa830e4b0c9d6adf6bb0a	58cfa830e4b0c9d6adf6bb0a	TCGA-A5-A0R6-01A-11D-A101_120403_SN1222_0093_AC0L7VACXX_s_2_rg.sorted.filtered.	WGS	TCGA-A5-A0R6-01A-11D-A101_120403_SN1222_0093_AC0L7VACXX_s_2_rg.sorted	TCGA-A5-A0R6-01A-11D-A101_120403_SN1222_0093_AC0L7VACXX_s_2_rg.sorted.bam	55.64	2.08	0.15	58cfa830e4b0c9d6adf6bb0a	TCGA-A5-A0R6-01A-11D-A101_120403_SN1222_0093_AC0L7VACXX_s_2_rg.sorted.bam	Alive	FEMALE	WHITE	HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-A5-A0R6-01A	39609D3C-F5D3-4BC4-B356-1403C6DD1CB5	Primary Tumor	Illumina HiSeq	7485f99f-a7fe-456f-873d-eb1be9fa04b1	Uterus	64	836BD487-091B-4728-BCD7-8065E5B76465	FBE6A365-A19A-42F1-9198-63549F77CD9B	TCGA-A5-A0R6-01A-11D-A101-02	HG19_Broad_variant	TCGA-A5-A0R6	TCGA-UCEC	NA	s4991	Harvard Medical School	Cedars Sinai	None	NO	Not available	Not available	Serous endometrial adenocarcinoma	Not available	A101-02	TRUE
13722.58cfa830e4b0c9d6adf6ba7c	58cfa830e4b0c9d6adf6ba7c	TCGA-AA-3509-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.filtered.	WGS	TCGA-AA-3509-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole	TCGA-AA-3509-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.bam	496	1.9	0.14	58cfa830e4b0c9d6adf6ba7c	TCGA-AA-3509-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.bam	Alive	FEMALE	Not available	Not available	Colon Adenocarcinoma	Aligned reads	TCGA-AA-3509-01A	80E677B1-5EBE-4069-A1A5-1538FFEE6642	Primary Tumor	Illumina HiSeq	41b8f6a5-58f8-4e97-bbd3-a2587a70e30d	Colorectal	54	BA6E3333-3651-450E-A6EA-4E47CF0D18BF	ACCC21A8-D026-40E4-AA2C-C0F998A1D370	TCGA-AA-3509-01A-01D-1405-02	HG18	TCGA-AA-3509	TCGA-COAD	NA	s13183	Harvard Medical School	Indivumed	Germany	NO	T3	N0	Colon Adenocarcinoma	Stage II	1405-02	TRUE
13722.58cfa830e4b0c9d6adf6bac2	58cfa830e4b0c9d6adf6bac2	TCGA-49-4501-01A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.filtered.	WGS	TCGA-49-4501-01A-01D-1203-02_IlluminaHiSeq-DNASeq_whole	TCGA-49-4501-01A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.bam	133.2	1.9	0.14	58cfa830e4b0c9d6adf6bac2	TCGA-49-4501-01A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-49-4501-01A	0780EB43-D5B5-4C3D-9825-BEACBA5CC723	Primary Tumor	Illumina HiSeq	2df919ad-215d-40a5-8e9d-e22862898cd7	Lung	67	FC511A67-5383-4877-AEEF-36C0B7934B77	FA521F2B-4BB1-4A15-9101-422B2B65489A	TCGA-49-4501-01A-01D-1203-02	GRCh37	TCGA-49-4501	TCGA-LUAD	1421	s11003	Harvard Medical School	Johns Hopkins	United States	NO	T2	N0	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage IB	1203-02	TRUE
13722.58cfa830e4b0c9d6adf6bb40	58cfa830e4b0c9d6adf6bb40	TCGA-AA-A02R-01A-01D-A077-02_IlluminaHiSeq-DNASeq_whole.filtered.	WGS	TCGA-AA-A02R-01A-01D-A077-02_IlluminaHiSeq-DNASeq_whole	TCGA-AA-A02R-01A-01D-A077-02_IlluminaHiSeq-DNASeq_whole.bam	146.73	1.77	0.15	58cfa830e4b0c9d6adf6bb40	TCGA-AA-A02R-01A-01D-A077-02_IlluminaHiSeq-DNASeq_whole.bam	Dead	FEMALE	Not available	Not available	Colon Adenocarcinoma	Aligned reads	TCGA-AA-A02R-01A	764C97C9-01D3-45CB-86BD-F8A52B5468DA	Primary Tumor	Illumina HiSeq	5affe933-9b26-4971-81d9-e380618fbfa0	Colorectal	84	197245F6-A310-4AF4-9231-0AFEFC547ECD	A803F2CD-F90D-4E51-8D90-1E6AF6897413	TCGA-AA-A02R-01A-01D-A077-02	HG18	TCGA-AA-A02R	TCGA-COAD	670	s13204	Harvard Medical School	Indivumed	Germany	NO	T3	N0	Colon Adenocarcinoma	Stage IIA	A077-02	TRUE
13722.58cfa830e4b0c9d6adf6bb48	58cfa830e4b0c9d6adf6bb48	TCGA-AA-A02Y-01A-43D-A079-02_IlluminaHiSeq-DNASeq_whole.filtered.	WGS	TCGA-AA-A02Y-01A-43D-A079-02_IlluminaHiSeq-DNASeq_whole	TCGA-AA-A02Y-01A-43D-A079-02_IlluminaHiSeq-DNASeq_whole.bam	84.8	1.91	0.16	58cfa830e4b0c9d6adf6bb48	TCGA-AA-A02Y-01A-43D-A079-02_IlluminaHiSeq-DNASeq_whole.bam	Alive	MALE	Not available	Not available	Colon Adenocarcinoma	Aligned reads	TCGA-AA-A02Y-01A	A435FDF4-A89A-499E-9006-CBB5693EAB26	Primary Tumor	Illumina HiSeq	faa460a7-9c39-4da6-93c1-22d5d99742f0	Colorectal	73	8537633B-6426-4B66-A2A3-FA942EEDF01B	CD188DB1-ED81-42A6-B550-07D4008143EE	TCGA-AA-A02Y-01A-43D-A079-02	HG18	TCGA-AA-A02Y	TCGA-COAD	NA	s13195	Harvard Medical School	Indivumed	Germany	NO	T2	N0	Colon Adenocarcinoma	Stage I	A079-02	TRUE
13722.58cfa830e4b0c9d6adf6bb5a	58cfa830e4b0c9d6adf6bb5a	TCGA-AA-3553-01A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.filtered.	WGS	TCGA-AA-3553-01A-01D-1167-02_IlluminaHiSeq-DNASeq_whole	TCGA-AA-3553-01A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.bam	1010.56	1.9	0.17	58cfa830e4b0c9d6adf6bb5a	TCGA-AA-3553-01A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.bam	Alive	FEMALE	Not available	Not available	Colon Adenocarcinoma	Aligned reads	TCGA-AA-3553-01A	D181C72B-843C-4B2D-B014-2A6DD1C3C1EC	Primary Tumor	Illumina HiSeq	b8e8f766-3a6f-4c2c-aeb0-ba7b926a3b99	Colorectal	61	B1DCD03C-3CDD-4C23-9391-C5ADEEBFF489	2159EE82-6427-4E1F-9C6F-28B48562DF0C	TCGA-AA-3553-01A-01D-1167-02	HG18	TCGA-AA-3553	TCGA-COAD	NA	s13362	Harvard Medical School	Indivumed	Germany	NO	T2	N0	Colon Adenocarcinoma	Stage I	1167-02	TRUE
13722.58cfa830e4b0c9d6adf6bba5	58cfa830e4b0c9d6adf6bba5	TCGA-AA-A02W-01A-01D-A077_110406_SN177_0153_A818P3ABXX_s_1_rg.sorted.filtered.	WGS	TCGA-AA-A02W-01A-01D-A077_110406_SN177_0153_A818P3ABXX_s_1_rg.sorted	TCGA-AA-A02W-01A-01D-A077_110406_SN177_0153_A818P3ABXX_s_1_rg.sorted.bam	226.38	1.78	0.15	58cfa830e4b0c9d6adf6bba5	TCGA-AA-A02W-01A-01D-A077_110406_SN177_0153_A818P3ABXX_s_1_rg.sorted.bam	Alive	FEMALE	Not available	Not available	Colon Adenocarcinoma	Aligned reads	TCGA-AA-A02W-01A	73448B56-A6C6-4C98-A153-AB704261E073	Primary Tumor	Illumina HiSeq	faf93a8d-56fb-4e28-97fa-1fcee234250c	Colorectal	73	B0F0EA02-B1DA-4613-A9B0-D18A07910010	4D2B2573-105C-4770-B8CF-9243B6D709EC	TCGA-AA-A02W-01A-01D-A077-02	HG18_Broad_variant	TCGA-AA-A02W	TCGA-COAD	NA	s13532	Harvard Medical School	Indivumed	Germany	NO	T2	N0	Colon Adenocarcinoma	Stage I	A077-02	TRUE
13722.58cfa830e4b0c9d6adf6bb5c	58cfa830e4b0c9d6adf6bb5c	TCGA-AA-3675-01A-02D-1167-02_IlluminaHiSeq-DNASeq_whole.filtered.	WGS	TCGA-AA-3675-01A-02D-1167-02_IlluminaHiSeq-DNASeq_whole	TCGA-AA-3675-01A-02D-1167-02_IlluminaHiSeq-DNASeq_whole.bam	570.96	1.9	0.14	58cfa830e4b0c9d6adf6bb5c	TCGA-AA-3675-01A-02D-1167-02_IlluminaHiSeq-DNASeq_whole.bam	Alive	MALE	Not available	Not available	Colon Adenocarcinoma	Aligned reads	TCGA-AA-3675-01A	41658CF8-0DE1-4A97-BB60-0F0107C84E00	Primary Tumor	Illumina HiSeq	971987d4-bd49-45d8-949e-4c2108a7cbc7	Colorectal	84	A4CE3727-4506-493B-95F4-2F11CEB09CEB	42AD4E5A-8E58-47EC-9D1F-F65D5C22DA49	TCGA-AA-3675-01A-02D-1167-02	HG18	TCGA-AA-3675	TCGA-COAD	NA	s13372	Harvard Medical School	Indivumed	Germany	NO	T3	N0	Colon Adenocarcinoma	Stage II	1167-02	TRUE
13722.58cfa830e4b0c9d6adf6bbac	58cfa830e4b0c9d6adf6bbac	TCGA-AA-A02O-01A-21D-A079-02_IlluminaHiSeq-DNASeq_whole.filtered.	WGS	TCGA-AA-A02O-01A-21D-A079-02_IlluminaHiSeq-DNASeq_whole	TCGA-AA-A02O-01A-21D-A079-02_IlluminaHiSeq-DNASeq_whole.bam	107.64	2.11	0.16	58cfa830e4b0c9d6adf6bbac	TCGA-AA-A02O-01A-21D-A079-02_IlluminaHiSeq-DNASeq_whole.bam	Alive	MALE	Not available	Not available	Colon Adenocarcinoma	Aligned reads	TCGA-AA-A02O-01A	6FA41234-9077-4D05-A295-6820F3BEDF5B	Primary Tumor	Illumina HiSeq	e53db54a-bb1b-4c60-8214-aaa269abd153	Colorectal	82	2151DC9E-F76A-4CFF-8A20-B7C107D59C27	519A6BBF-68D8-4275-854A-5216FC4DFD15	TCGA-AA-A02O-01A-21D-A079-02	HG18	TCGA-AA-A02O	TCGA-COAD	NA	s12873	Harvard Medical School	Indivumed	Germany	NO	T3	N0	Colon Adenocarcinoma	Stage II	A079-02	TRUE
13722.58cfa830e4b0c9d6adf6bb88	58cfa830e4b0c9d6adf6bb88	TCGA-AA-3956-01A-02D-1167-02_IlluminaHiSeq-DNASeq_whole.filtered.	WGS	TCGA-AA-3956-01A-02D-1167-02_IlluminaHiSeq-DNASeq_whole	TCGA-AA-3956-01A-02D-1167-02_IlluminaHiSeq-DNASeq_whole.bam	282.86	1.9	0.14	58cfa830e4b0c9d6adf6bb88	TCGA-AA-3956-01A-02D-1167-02_IlluminaHiSeq-DNASeq_whole.bam	Alive	MALE	Not available	Not available	Colon Adenocarcinoma	Aligned reads	TCGA-AA-3956-01A	7B47489F-C3CC-4388-B5D7-C7C02790A5F6	Primary Tumor	Illumina HiSeq	edcd6fc2-ca83-409b-957a-ff0199cedf0d	Colorectal	65	DC1FFDA5-5B8F-4227-BE04-321643F73731	63EEF7A5-A1CC-4BB6-BA02-464D2DE89E2A	TCGA-AA-3956-01A-02D-1167-02	HG18	TCGA-AA-3956	TCGA-COAD	NA	s13519	Harvard Medical School	Indivumed	Germany	NO	T3	N0	Colon Adenocarcinoma	Stage IIA	1167-02	TRUE
13722.58cfa830e4b0c9d6adf6bbfe	58cfa830e4b0c9d6adf6bbfe	TCGA-A6-2684-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.filtered.	WGS	TCGA-A6-2684-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole	TCGA-A6-2684-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.bam	463.6	1.9	0.15	58cfa830e4b0c9d6adf6bbfe	TCGA-A6-2684-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Colon Adenocarcinoma	Aligned reads	TCGA-A6-2684-01A	49929108-023E-4D35-B26D-50AB4D3AE581	Primary Tumor	Illumina HiSeq	1d127721-dd08-4127-af3b-0dfd623ea7bf	Colorectal	75	73B6994E-C9BF-41A8-A455-17D7BE309A9F	5A35E547-72DB-4B4E-8459-1264D0845506	TCGA-A6-2684-01A-01D-1405-02	HG18	TCGA-A6-2684	TCGA-COAD	NA	s13174	Harvard Medical School	Christiana Healthcare	None	NO	T2	N0	Colon Adenocarcinoma	Stage I	1405-02	TRUE
13722.58cfa830e4b0c9d6adf6bc1e	58cfa830e4b0c9d6adf6bc1e	TCGA-AG-A01Y-01A-41D-A079-02_IlluminaHiSeq-DNASeq_whole.filtered.	WGS	TCGA-AG-A01Y-01A-41D-A079-02_IlluminaHiSeq-DNASeq_whole	TCGA-AG-A01Y-01A-41D-A079-02_IlluminaHiSeq-DNASeq_whole.bam	100.13	2.07	0.17	58cfa830e4b0c9d6adf6bc1e	TCGA-AG-A01Y-01A-41D-A079-02_IlluminaHiSeq-DNASeq_whole.bam	Alive	FEMALE	Not available	Not available	Rectum Adenocarcinoma	Aligned reads	TCGA-AG-A01Y-01A	A91F7A8C-E0FE-403A-9EF0-F7679B2761CC	Primary Tumor	Illumina HiSeq	9b6deb45-fcab-4b6f-8c5d-225444c42154	Colorectal	49	28B76ABF-6A5F-4D3B-87FE-18EA7139DEDF	D295156A-3A31-4540-B295-0B620340E4DB	TCGA-AG-A01Y-01A-41D-A079-02	HG18	TCGA-AG-A01Y	TCGA-READ	NA	s2172	Harvard Medical School	Indivumed	Germany	NO	T3	N0	Rectal Adenocarcinoma	Stage II	A079-02	TRUE
13722.58cfa830e4b0c9d6adf6bc2a	58cfa830e4b0c9d6adf6bc2a	TCGA-AA-3994-01A-01D-1109-02_IlluminaHiSeq-DNASeq_whole.filtered.	WGS	TCGA-AA-3994-01A-01D-1109-02_IlluminaHiSeq-DNASeq_whole	TCGA-AA-3994-01A-01D-1109-02_IlluminaHiSeq-DNASeq_whole.bam	631.89	1.9	0.16	58cfa830e4b0c9d6adf6bc2a	TCGA-AA-3994-01A-01D-1109-02_IlluminaHiSeq-DNASeq_whole.bam	Alive	MALE	Not available	Not available	Colon Adenocarcinoma	Aligned reads	TCGA-AA-3994-01A	750770DB-53CF-4021-A8C2-5E0DDB97FEF5	Primary Tumor	Illumina HiSeq	dadc0f63-410b-4eb6-b287-c05bbc274608	Colorectal	69	41933A62-1325-4089-80B5-06E3EBB238DA	FED1DBB6-D332-4239-A878-8587A7CE4D05	TCGA-AA-3994-01A-01D-1109-02	HG18	TCGA-AA-3994	TCGA-COAD	NA	s13518	Harvard Medical School	Indivumed	Germany	NO	T3	N1	Colon Mucinous Adenocarcinoma	Stage IIIB	1109-02	TRUE
13722.58cfa830e4b0c9d6adf6bc38	58cfa830e4b0c9d6adf6bc38	TCGA-AA-A01C-01A-01D-A077-02_IlluminaHiSeq-DNASeq_whole.filtered.	WGS	TCGA-AA-A01C-01A-01D-A077-02_IlluminaHiSeq-DNASeq_whole	TCGA-AA-A01C-01A-01D-A077-02_IlluminaHiSeq-DNASeq_whole.bam	91.92	1.64	0.15	58cfa830e4b0c9d6adf6bc38	TCGA-AA-A01C-01A-01D-A077-02_IlluminaHiSeq-DNASeq_whole.bam	Alive	MALE	Not available	Not available	Colon Adenocarcinoma	Aligned reads	TCGA-AA-A01C-01A	80809D79-92E1-4D6C-BA2E-0A9589997792	Primary Tumor	Illumina HiSeq	a7b8c819-1f82-43d2-93aa-5c85e2710e7e	Colorectal	75	1E191EED-2238-450E-A384-26DF9C569FD0	77F9EF43-7202-4C9B-9556-F00F0A66D2D4	TCGA-AA-A01C-01A-01D-A077-02	HG18	TCGA-AA-A01C	TCGA-COAD	NA	s13199	Harvard Medical School	Indivumed	Germany	NO	T2	N1	Colon Adenocarcinoma	Stage IIIA	A077-02	TRUE
13722.58cfa830e4b0c9d6adf6bc26	58cfa830e4b0c9d6adf6bc26	TCGA-A6-3810-01A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.filtered.	WGS	TCGA-A6-3810-01A-01D-1167-02_IlluminaHiSeq-DNASeq_whole	TCGA-A6-3810-01A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.bam	420.6	1.9	0.16	58cfa830e4b0c9d6adf6bc26	TCGA-A6-3810-01A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Colon Adenocarcinoma	Aligned reads	TCGA-A6-3810-01A	B728E6E8-A0E4-496B-904C-6F07C12E901F	Primary Tumor	Illumina HiSeq	54687a8d-c693-4ae5-8451-4f4c80adca53	Colorectal	62	F2BD44D3-A53C-4A10-9AE1-A93E762F174C	AD4275F1-789D-471C-88DD-B6E76069D856	TCGA-A6-3810-01A-01D-1167-02	HG18	TCGA-A6-3810	TCGA-COAD	NA	s13016	Harvard Medical School	Christiana Healthcare	None	NO	T3	N0	Colon Adenocarcinoma	Stage IIA	1167-02	TRUE
13722.58cfa830e4b0c9d6adf6bcae	58cfa830e4b0c9d6adf6bcae	TCGA-AZ-4614-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.filtered.	WGS	TCGA-AZ-4614-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole	TCGA-AZ-4614-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.bam	449.02	1.9	0.16	58cfa830e4b0c9d6adf6bcae	TCGA-AZ-4614-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Colon Adenocarcinoma	Aligned reads	TCGA-AZ-4614-01A	3334201D-A3C0-45EC-A9ED-CF48CC8C38E8	Primary Tumor	Illumina HiSeq	50679ea1-6443-43b4-ab23-0f7542f4cb98	Colorectal	71	0C4DAF52-CC9F-4099-8825-33C484CED5B1	29DA0D99-6FD9-4CC0-84BE-E1670FC253E7	TCGA-AZ-4614-01A-01D-1405-02	HG18	TCGA-AZ-4614	TCGA-COAD	172	s12888	Harvard Medical School	University of Pittsburgh	None	NO	T4a	N1	Colon Adenocarcinoma	Stage IVA	1405-02	TRUE
13722.58cfa830e4b0c9d6adf6bc22	58cfa830e4b0c9d6adf6bc22	TCGA-AG-3727-01A-01D-1167_101105_SN208_0168_A80A3BABXX_s_3.rg.sorted.filtered.	WGS	TCGA-AG-3727-01A-01D-1167_101105_SN208_0168_A80A3BABXX_s_3.rg.sorted	TCGA-AG-3727-01A-01D-1167_101105_SN208_0168_A80A3BABXX_s_3.rg.sorted.bam	489.31	1.9	0.15	58cfa830e4b0c9d6adf6bc22	TCGA-AG-3727-01A-01D-1167_101105_SN208_0168_A80A3BABXX_s_3.rg.sorted.bam	Alive	FEMALE	Not available	Not available	Rectum Adenocarcinoma	Aligned reads	TCGA-AG-3727-01A	E6827400-0D95-46B0-8874-6CE9E9D5011B	Primary Tumor	Illumina HiSeq	c29d4836-8104-479e-98ce-a8c435a242d7	Colorectal	78	DA1CA84F-6C55-4536-9449-3C87E51EF85A	D8361FC2-8AB1-4D36-9009-237D905CF899	TCGA-AG-3727-01A-01D-1167-02	HG18_Broad_variant	TCGA-AG-3727	TCGA-READ	NA	s2141	Harvard Medical School	Indivumed	Germany	NO	T3	N1	Rectal Adenocarcinoma	Stage III	1167-02	TRUE
13722.58cfa830e4b0c9d6adf6bcc4	58cfa830e4b0c9d6adf6bcc4	TCGA-AZ-4313-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.filtered.	WGS	TCGA-AZ-4313-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole	TCGA-AZ-4313-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.bam	397.02	1.9	0.15	58cfa830e4b0c9d6adf6bcc4	TCGA-AZ-4313-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Colon Adenocarcinoma	Aligned reads	TCGA-AZ-4313-01A	1FD75C4D-E74C-410C-A150-814722C6C1CC	Primary Tumor	Illumina HiSeq	b8e9093c-1570-45c6-8278-f686c276ee91	Colorectal	51	475F161C-2F7F-43A2-B187-DE6038752F39	F64D4985-D460-435C-8EC0-477D313A895A	TCGA-AZ-4313-01A-01D-1405-02	HG18	TCGA-AZ-4313	TCGA-COAD	NA	s13212	Harvard Medical School	University of Pittsburgh	None	NO	T1	N0	Colon Adenocarcinoma	Stage I	1405-02	TRUE
13722.58cfa830e4b0c9d6adf6bd5d	58cfa830e4b0c9d6adf6bd5d	TCGA-AA-3516-01A-02D-1167-02_IlluminaHiSeq-DNASeq_whole.filtered.	WGS	TCGA-AA-3516-01A-02D-1167-02_IlluminaHiSeq-DNASeq_whole	TCGA-AA-3516-01A-02D-1167-02_IlluminaHiSeq-DNASeq_whole.bam	47.29	1.9	0.13	58cfa830e4b0c9d6adf6bd5d	TCGA-AA-3516-01A-02D-1167-02_IlluminaHiSeq-DNASeq_whole.bam	Alive	FEMALE	Not available	Not available	Colon Adenocarcinoma	Aligned reads	TCGA-AA-3516-01A	D9D7F0D4-FA64-48F2-8037-52CBF0B34AD8	Primary Tumor	Illumina HiSeq	99b382c5-00ca-4acd-81bc-0c46b9c7ccea	Colorectal	74	4E4F7BEC-56AF-4888-B40B-A33218B010E8	3F9A934E-C9BE-4A5F-A1F5-EB51BED8DCDD	TCGA-AA-3516-01A-02D-1167-02	HG18	TCGA-AA-3516	TCGA-COAD	NA	s13181	Harvard Medical School	Indivumed	Germany	NO	T3	N2	Colon Mucinous Adenocarcinoma	Stage III	1167-02	TRUE
13722.58cfa830e4b0c9d6adf6bcda	58cfa830e4b0c9d6adf6bcda	TCGA-AG-3574-01A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.filtered.	WGS	TCGA-AG-3574-01A-01D-1167-02_IlluminaHiSeq-DNASeq_whole	TCGA-AG-3574-01A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.bam	750.21	1.9	0.14	58cfa830e4b0c9d6adf6bcda	TCGA-AG-3574-01A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.bam	Alive	FEMALE	Not available	Not available	Rectum Adenocarcinoma	Aligned reads	TCGA-AG-3574-01A	0EDA7373-8335-455F-B90A-8C3540F28088	Primary Tumor	Illumina HiSeq	44e4b931-5188-44b9-aea5-fdff70c4c058	Colorectal	89	DA897A5D-B2CC-419F-ACD7-473B4928C5D5	5DAA6B90-B302-4B0E-A44B-0A6D3159DACE	TCGA-AG-3574-01A-01D-1167-02	HG18	TCGA-AG-3574	TCGA-READ	NA	s1955	Harvard Medical School	Indivumed	Germany	NO	T3	N0	Rectal Adenocarcinoma	Stage II	1167-02	TRUE
13722.58cfa830e4b0c9d6adf6bde2	58cfa830e4b0c9d6adf6bde2	TCGA-AG-A01N-01A-01D-A077_110406_SN177_0154_B818URABXX_s_3.rg.sorted.filtered.	WGS	TCGA-AG-A01N-01A-01D-A077_110406_SN177_0154_B818URABXX_s_3.rg.sorted	TCGA-AG-A01N-01A-01D-A077_110406_SN177_0154_B818URABXX_s_3.rg.sorted.bam	237.59	1.78	0.15	58cfa830e4b0c9d6adf6bde2	TCGA-AG-A01N-01A-01D-A077_110406_SN177_0154_B818URABXX_s_3.rg.sorted.bam	Alive	FEMALE	Not available	Not available	Rectum Adenocarcinoma	Aligned reads	TCGA-AG-A01N-01A	1118490D-75AA-43CC-B2A2-C2AF61829FFC	Primary Tumor	Illumina HiSeq	1e5467f7-e974-4244-b9fb-2afff5ed40b4	Colorectal	68	0350E0DE-7B86-485A-A057-50E77D899ED9	49977602-A81B-4DDD-9354-8949BC3208CF	TCGA-AG-A01N-01A-01D-A077-02	HG18_Broad_variant	TCGA-AG-A01N	TCGA-READ	NA	s2007	Harvard Medical School	Indivumed	Germany	NO	T2	N0	Rectal Adenocarcinoma	Stage IV	A077-02	TRUE
13722.58cfa830e4b0c9d6adf6bcc8	58cfa830e4b0c9d6adf6bcc8	TCGA-AG-3582-01A-01D-1167_101105_SN208_0168_A80A3BABXX_s_1_rg.sorted.filtered.	WGS	TCGA-AG-3582-01A-01D-1167_101105_SN208_0168_A80A3BABXX_s_1_rg.sorted	TCGA-AG-3582-01A-01D-1167_101105_SN208_0168_A80A3BABXX_s_1_rg.sorted.bam	747.21	1.9	0.15	58cfa830e4b0c9d6adf6bcc8	TCGA-AG-3582-01A-01D-1167_101105_SN208_0168_A80A3BABXX_s_1_rg.sorted.bam	Alive	MALE	Not available	Not available	Rectum Adenocarcinoma	Aligned reads	TCGA-AG-3582-01A	DB1E3104-8BFD-4353-854A-C478BA1F7D07	Primary Tumor	Illumina HiSeq	85a5fdbc-5a9a-4ddf-aac9-84a213ee17fd	Colorectal	75	1B1EF856-EA45-4857-8B4B-C4330FA930D8	CA0DD61C-D4F2-4ED9-91EF-11F7B1BE15AF	TCGA-AG-3582-01A-01D-1167-02	HG18_Broad_variant	TCGA-AG-3582	TCGA-READ	NA	s1973	Harvard Medical School	Indivumed	Germany	NO	T3	N1	Rectal Adenocarcinoma	Stage IV	1167-02	TRUE
13722.58cfa830e4b0c9d6adf6bdf5	58cfa830e4b0c9d6adf6bdf5	TCGA-AG-A01W-01A-21D-A079-02_IlluminaHiSeq-DNASeq_whole.filtered.	WGS	TCGA-AG-A01W-01A-21D-A079-02_IlluminaHiSeq-DNASeq_whole	TCGA-AG-A01W-01A-21D-A079-02_IlluminaHiSeq-DNASeq_whole.bam	140.75	2	0.15	58cfa830e4b0c9d6adf6bdf5	TCGA-AG-A01W-01A-21D-A079-02_IlluminaHiSeq-DNASeq_whole.bam	Alive	FEMALE	Not available	Not available	Rectum Adenocarcinoma	Aligned reads	TCGA-AG-A01W-01A	74543FA4-CE73-46E4-9C59-224E8242B4A2	Primary Tumor	Illumina HiSeq	66ffc729-68c6-4bd6-b4d2-e68e3989e252	Colorectal	67	C481ABBB-21EB-4393-AB8D-C27E3DA1B8F7	BC3C3340-5E36-4754-AF22-F08EF550BD07	TCGA-AG-A01W-01A-21D-A079-02	HG18	TCGA-AG-A01W	TCGA-READ	NA	s2171	Harvard Medical School	Indivumed	Germany	NO	T3	N0	Rectal Adenocarcinoma	Stage II	A079-02	TRUE
13722.58cfa830e4b0c9d6adf6be18	58cfa830e4b0c9d6adf6be18	TCGA-AZ-4615-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.filtered.	WGS	TCGA-AZ-4615-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole	TCGA-AZ-4615-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.bam	361.02	1.9	0.15	58cfa830e4b0c9d6adf6be18	TCGA-AZ-4615-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Colon Adenocarcinoma	Aligned reads	TCGA-AZ-4615-01A	BF69A4CE-EC7E-4752-A86D-DCC80E3C9A57	Primary Tumor	Illumina HiSeq	82dc215a-4234-4f8b-a4c0-50c8103dda6e	Colorectal	84	89811300-8202-4A82-8353-5B2B2B2ECFD4	90D11094-F492-4B05-81AB-E637AEC8F953	TCGA-AZ-4615-01A-01D-1405-02	HG18	TCGA-AZ-4615	TCGA-COAD	NA	s13216	Harvard Medical School	University of Pittsburgh	None	NO	T3	N1	Colon Adenocarcinoma	Stage IIIB	1405-02	TRUE
13722.58cfa830e4b0c9d6adf6bd00	58cfa830e4b0c9d6adf6bd00	TCGA-AF-2692-01A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.filtered.	WGS	TCGA-AF-2692-01A-01D-1167-02_IlluminaHiSeq-DNASeq_whole	TCGA-AF-2692-01A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.bam	2	1.9	0.15	58cfa830e4b0c9d6adf6bd00	TCGA-AF-2692-01A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Rectum Adenocarcinoma	Aligned reads	TCGA-AF-2692-01A	71A32FCA-D48F-4EA3-8DF7-69F9DDA8FA91	Primary Tumor	Illumina HiSeq	f19d4bca-a876-4c65-a830-4d5f12eb5803	Colorectal	54	3CA7589A-E887-4DA2-8D59-19FE5963AC21	CC1B3C2A-43B7-43CB-85F8-383A3C255D4B	TCGA-AF-2692-01A-01D-1167-02	HG18	TCGA-AF-2692	TCGA-READ	NA	s1972	Harvard Medical School	Christiana Healthcare	United States	NO	T3	N0	Not available	Stage IIA	1167-02	TRUE
13722.58cfa830e4b0c9d6adf6bea4	58cfa830e4b0c9d6adf6bea4	TCGA-AG-3898-01A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.filtered.	WGS	TCGA-AG-3898-01A-01D-1115-02_IlluminaHiSeq-DNASeq_whole	TCGA-AG-3898-01A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.bam	722.89	1.9	0.15	58cfa830e4b0c9d6adf6bea4	TCGA-AG-3898-01A-01D-1115-02_IlluminaHiSeq-DNASeq_whole.bam	Alive	MALE	Not available	Not available	Rectum Adenocarcinoma	Aligned reads	TCGA-AG-3898-01A	5A7D19F9-6BE2-45AC-9FFC-11E28594EEEE	Primary Tumor	Illumina HiSeq	846bcf47-2650-4479-be12-96589e587f3a	Colorectal	61	C782D6BF-AA57-4184-8276-E08D6B64E6B2	AA49029D-0F51-4836-BD7B-74CC0C2F9576	TCGA-AG-3898-01A-01D-1115-02	HG18	TCGA-AG-3898	TCGA-READ	NA	s2314	Harvard Medical School	Indivumed	Germany	NO	T3	N0	Rectal Adenocarcinoma	Stage IIA	1115-02	TRUE
13722.58cfa830e4b0c9d6adf6c02a	58cfa830e4b0c9d6adf6c02a	TCGA-AX-A0IW-01A-11D-A043_120327_SN590_0149_AD0U12ACXX_s_3_rg.sorted.filtered.	WGS	TCGA-AX-A0IW-01A-11D-A043_120327_SN590_0149_AD0U12ACXX_s_3_rg.sorted	TCGA-AX-A0IW-01A-11D-A043_120327_SN590_0149_AD0U12ACXX_s_3_rg.sorted.bam	112.67	1.79	0.14	58cfa830e4b0c9d6adf6c02a	TCGA-AX-A0IW-01A-11D-A043_120327_SN590_0149_AD0U12ACXX_s_3_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-AX-A0IW-01A	DB21FCCF-40CB-4235-A34D-336A03B8C8F4	Primary Tumor	Illumina HiSeq	26dfa889-ba7c-4cc0-8adc-59d5eb4e4026	Uterus	67	874A1C5C-229B-4BCE-B612-55EFF238D533	CFB35E8C-470B-4F9E-B7C1-63FCAA162F3C	TCGA-AX-A0IW-01A-11D-A043-02	HG19_Broad_variant	TCGA-AX-A0IW	TCGA-UCEC	NA	s4422	Harvard Medical School	Gynecologic Oncology Group	None	NO	Not available	Not available	Serous endometrial adenocarcinoma	Not available	A043-02	TRUE
13722.58cfa830e4b0c9d6adf6c11a	58cfa830e4b0c9d6adf6c11a	TCGA-BS-A0TE-01A-11D-A101_120407_SN590_0152_AC0C7LACXX_s_3_rg.sorted.filtered.	WGS	TCGA-BS-A0TE-01A-11D-A101_120407_SN590_0152_AC0C7LACXX_s_3_rg.sorted	TCGA-BS-A0TE-01A-11D-A101_120407_SN590_0152_AC0C7LACXX_s_3_rg.sorted.bam	53.44	1.91	0.17	58cfa830e4b0c9d6adf6c11a	TCGA-BS-A0TE-01A-11D-A101_120407_SN590_0152_AC0C7LACXX_s_3_rg.sorted.bam	Dead	FEMALE	ASIAN	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-BS-A0TE-01A	09066FBF-6A1D-46C9-A4C5-C53340C3D1BA	Primary Tumor	Illumina HiSeq	a687b0ac-0eda-43c1-ab2f-cf8b3d6ffb94	Uterus	35	2D1226A1-1C88-422B-9A8D-316BEBEB65FD	250BF272-4CCD-41DB-ABD1-4FE2E304AB21	TCGA-BS-A0TE-01A-11D-A101-02	HG19_Broad_variant	TCGA-BS-A0TE	TCGA-UCEC	146	s4607	Harvard Medical School	University of Hawaii	None	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A101-02	TRUE
13722.58cfa830e4b0c9d6adf6c147	58cfa830e4b0c9d6adf6c147	TCGA-B7-5818-01A-11D-1598_121025_SN590_0187_BC191FACXX_s_2_rg.sorted.filtered.	WGS	TCGA-B7-5818-01A-11D-1598_121025_SN590_0187_BC191FACXX_s_2_rg.sorted	TCGA-B7-5818-01A-11D-1598_121025_SN590_0187_BC191FACXX_s_2_rg.sorted.bam	411	1.9	0.14	58cfa830e4b0c9d6adf6c147	TCGA-B7-5818-01A-11D-1598_121025_SN590_0187_BC191FACXX_s_2_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-B7-5818-01A	6E03B415-84A1-4B91-8717-1A41EDD4A255	Primary Tumor	Illumina HiSeq	e2875187-aeca-43f4-85d8-13ecd0452ec3	Stomach	62	FD97CDF5-0F7F-48A2-B5DA-5C5F56A89166	0EBF1A63-C6E4-49FE-B21B-AE46FF14261D	TCGA-B7-5818-01A-11D-1598-02	HG19_Broad_variant	TCGA-B7-5818	TCGA-STAD	NA	s15372	Harvard Medical School	Cureline	Russia	NO	T2	N0	Stomach  Adenocarcinoma  Diffuse Type	Stage IB	1598-02	TRUE
13722.58cfa830e4b0c9d6adf6c124	58cfa830e4b0c9d6adf6c124	TCGA-BS-A0TC-01A-11D-A101_120407_SN590_0152_AC0C7LACXX_s_1_rg.sorted.filtered.	WGS	TCGA-BS-A0TC-01A-11D-A101_120407_SN590_0152_AC0C7LACXX_s_1_rg.sorted	TCGA-BS-A0TC-01A-11D-A101_120407_SN590_0152_AC0C7LACXX_s_1_rg.sorted.bam	60.12	1.87	0.14	58cfa830e4b0c9d6adf6c124	TCGA-BS-A0TC-01A-11D-A101_120407_SN590_0152_AC0C7LACXX_s_1_rg.sorted.bam	Alive	FEMALE	ASIAN	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-BS-A0TC-01A	7B7D2D2B-ABE6-4F32-ADD0-3715096995D1	Primary Tumor	Illumina HiSeq	402004c3-b5d0-41ad-990c-203cbf02ec5d	Uterus	69	C4C99327-B778-4E29-A111-75569AD38696	99E19D8C-EC6E-45D7-89E5-091D101BF466	TCGA-BS-A0TC-01A-11D-A101-02	HG19_Broad_variant	TCGA-BS-A0TC	TCGA-UCEC	NA	s5015	Harvard Medical School	University of Hawaii	None	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A101-02	TRUE
13722.58cfa830e4b0c9d6adf6c170	58cfa830e4b0c9d6adf6c170	TCGA-BS-A0TG-01A-32D-A101_120407_SN590_0152_AC0C7LACXX_s_4_rg.sorted.filtered.	WGS	TCGA-BS-A0TG-01A-32D-A101_120407_SN590_0152_AC0C7LACXX_s_4_rg.sorted	TCGA-BS-A0TG-01A-32D-A101_120407_SN590_0152_AC0C7LACXX_s_4_rg.sorted.bam	31.82	1.93	0.16	58cfa830e4b0c9d6adf6c170	TCGA-BS-A0TG-01A-32D-A101_120407_SN590_0152_AC0C7LACXX_s_4_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-BS-A0TG-01A	13F31BCB-BEFD-4ED2-ADC0-DC9E9CE52B75	Primary Tumor	Illumina HiSeq	bbb0de46-a395-47cf-938b-3a6a6c59b9ec	Uterus	60	36E44603-A1EE-4A5B-9506-49A9358BF8D0	FABEC5F4-2EF2-41CB-A728-E21D6C49F3F7	TCGA-BS-A0TG-01A-32D-A101-02	HG19_Broad_variant	TCGA-BS-A0TG	TCGA-UCEC	NA	s4795	Harvard Medical School	University of Hawaii	None	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A101-02	TRUE
13722.58cfa830e4b0c9d6adf6c070	58cfa830e4b0c9d6adf6c070	TCGA-AY-4070-01A-01D-1109-02_IlluminaHiSeq-DNASeq_whole.filtered.	WGS	TCGA-AY-4070-01A-01D-1109-02_IlluminaHiSeq-DNASeq_whole	TCGA-AY-4070-01A-01D-1109-02_IlluminaHiSeq-DNASeq_whole.bam	458.59	1.9	0.13	58cfa830e4b0c9d6adf6c070	TCGA-AY-4070-01A-01D-1109-02_IlluminaHiSeq-DNASeq_whole.bam	Dead	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Colon Adenocarcinoma	Aligned reads	TCGA-AY-4070-01A	6BAF61B6-AE5B-42F0-ADC9-0D26FDA231F7	Primary Tumor	Illumina HiSeq	c0679a4e-afc6-4b64-80a5-35bf5e446cb1	Colorectal	50	C35CB7B2-7A85-4320-89AC-3A395EF8C1BE	B9EFEB1A-FA1D-4917-8FC5-149ECAF26989	TCGA-AY-4070-01A-01D-1109-02	HG18	TCGA-AY-4070	TCGA-COAD	496	s13388	Harvard Medical School	UNC	None	NO	T3	N2	Colon Adenocarcinoma	Stage IIIC	1109-02	TRUE
13722.58cfa830e4b0c9d6adf6c172	58cfa830e4b0c9d6adf6c172	TCGA-BS-A0U7-01A-21D-A101_120407_SN590_0152_AC0C7LACXX_s_7_rg.sorted.filtered.	WGS	TCGA-BS-A0U7-01A-21D-A101_120407_SN590_0152_AC0C7LACXX_s_7_rg.sorted	TCGA-BS-A0U7-01A-21D-A101_120407_SN590_0152_AC0C7LACXX_s_7_rg.sorted.bam	86.95	1.93	0.17	58cfa830e4b0c9d6adf6c172	TCGA-BS-A0U7-01A-21D-A101_120407_SN590_0152_AC0C7LACXX_s_7_rg.sorted.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-BS-A0U7-01A	282DDC43-922D-4F1F-80C7-6BA2DE23B7BC	Primary Tumor	Illumina HiSeq	1d76b3a6-ff5e-4092-b273-cc2380e0810c	Uterus	63	803C6D51-0EBA-475A-9C3C-7B3401787907	652088F1-AB84-40C7-8B24-FD92A32DFA44	TCGA-BS-A0U7-01A-21D-A101-02	HG19_Broad_variant	TCGA-BS-A0U7	TCGA-UCEC	935	s4436	Harvard Medical School	University of Hawaii	None	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A101-02	TRUE
13722.58cfa830e4b0c9d6adf6c1bc	58cfa830e4b0c9d6adf6c1bc	TCGA-AG-A01L-01A-01D-A077_110406_SN177_0154_B818URABXX_s_1_rg.sorted.filtered.	WGS	TCGA-AG-A01L-01A-01D-A077_110406_SN177_0154_B818URABXX_s_1_rg.sorted	TCGA-AG-A01L-01A-01D-A077_110406_SN177_0154_B818URABXX_s_1_rg.sorted.bam	251.75	1.72	0.15	58cfa830e4b0c9d6adf6c1bc	TCGA-AG-A01L-01A-01D-A077_110406_SN177_0154_B818URABXX_s_1_rg.sorted.bam	Alive	MALE	Not available	Not available	Rectum Adenocarcinoma	Aligned reads	TCGA-AG-A01L-01A	848A5838-8A06-45A9-A3D6-E4ED47B824AB	Primary Tumor	Illumina HiSeq	f1b7cb66-3e14-4411-b17a-0ad856d8c686	Colorectal	58	B034C90B-D0BD-466A-88BA-B61EFD36C6E4	337F94D6-ECFB-4653-A63C-49F0D1893BF0	TCGA-AG-A01L-01A-01D-A077-02	HG18_Broad_variant	TCGA-AG-A01L	TCGA-READ	NA	s2002	Harvard Medical School	Indivumed	Germany	NO	T3	N1	Rectal Adenocarcinoma	Stage IIIB	A077-02	TRUE
13722.58cfa830e4b0c9d6adf6bffa	58cfa830e4b0c9d6adf6bffa	TCGA-AG-3878-01A-02D-1167-02_IlluminaHiSeq-DNASeq_whole.filtered.	WGS	TCGA-AG-3878-01A-02D-1167-02_IlluminaHiSeq-DNASeq_whole	TCGA-AG-3878-01A-02D-1167-02_IlluminaHiSeq-DNASeq_whole.bam	360.61	1.9	0.15	58cfa830e4b0c9d6adf6bffa	TCGA-AG-3878-01A-02D-1167-02_IlluminaHiSeq-DNASeq_whole.bam	Alive	MALE	Not available	Not available	Rectum Adenocarcinoma	Aligned reads	TCGA-AG-3878-01A	FDEEFF8E-1328-42A4-ACA0-A03B97421F1E	Primary Tumor	Illumina HiSeq	df3192f9-1041-4ef9-80aa-2f3e263fa968	Colorectal	64	D2F28259-87A7-4BD8-84BC-832E551C1ACE	8F233F73-550A-4708-9C2C-BEA9347969F7	TCGA-AG-3878-01A-02D-1167-02	HG18	TCGA-AG-3878	TCGA-READ	NA	s2127	Harvard Medical School	Indivumed	Germany	NO	T2	N0	Rectal Adenocarcinoma	Stage I	1167-02	TRUE
13722.58cfa830e4b0c9d6adf6c28a	58cfa830e4b0c9d6adf6c28a	TCGA-AF-3913-01A-02D-1115-02_IlluminaHiSeq-DNASeq_whole.filtered.	WGS	TCGA-AF-3913-01A-02D-1115-02_IlluminaHiSeq-DNASeq_whole	TCGA-AF-3913-01A-02D-1115-02_IlluminaHiSeq-DNASeq_whole.bam	452.29	1.8	0.16	58cfa830e4b0c9d6adf6c28a	TCGA-AF-3913-01A-02D-1115-02_IlluminaHiSeq-DNASeq_whole.bam	Dead	MALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Rectum Adenocarcinoma	Aligned reads	TCGA-AF-3913-01A	03A9DD9D-62AE-4ACD-9272-389274858F3D	Primary Tumor	Illumina HiSeq	6b7624bc-5e74-4fd2-9475-f916cbe9bc5f	Colorectal	60	B01C6CD1-68DA-437F-90E4-9A645E8F3470	44A5F915-BADF-4521-8102-1B353E302E80	TCGA-AF-3913-01A-02D-1115-02	HG18	TCGA-AF-3913	TCGA-READ	316	s2147	Harvard Medical School	Christiana Healthcare	None	NO	T3	N1	Rectal Adenocarcinoma	Stage IV	1115-02	TRUE
13722.58cfa831e4b0c9d6adf6c42c	58cfa831e4b0c9d6adf6c42c	TCGA-BT-A2LD-01A-12D-A210_120914_SN590_0180_BC19KDACXX_s_5_rg.sorted.filtered.	WGS	TCGA-BT-A2LD-01A-12D-A210_120914_SN590_0180_BC19KDACXX_s_5_rg.sorted	TCGA-BT-A2LD-01A-12D-A210_120914_SN590_0180_BC19KDACXX_s_5_rg.sorted.bam	16.84	NA	0.18	58cfa831e4b0c9d6adf6c42c	TCGA-BT-A2LD-01A-12D-A210_120914_SN590_0180_BC19KDACXX_s_5_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-BT-A2LD-01A	9DD97821-7AFD-4982-8B1D-F14F845B79F7	Primary Tumor	Illumina HiSeq	205bfe9f-2bc9-4236-930c-a862874ad8e0	Bladder	78	AEB379D5-B157-4BCE-82C5-0CD0077DB01F	BF6A16B2-9DC9-4E9A-A810-2EBA7E9B56A1	TCGA-BT-A2LD-01A-12D-A210-26	HG19_Broad_variant	TCGA-BT-A2LD	TCGA-BLCA	NA	s3089	MD Anderson - Institute for Applied Cancer Science	University of Pittsburgh	United States	NO	T3a	N1	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV	A210-26	TRUE
13722.58cfa831e4b0c9d6adf6c42a	58cfa831e4b0c9d6adf6c42a	TCGA-BT-A2LA-01A-11D-A18D_120912_SN1222_0148_AC188PACXX_s_3_rg.sorted.filtered.	WGS	TCGA-BT-A2LA-01A-11D-A18D_120912_SN1222_0148_AC188PACXX_s_3_rg.sorted	TCGA-BT-A2LA-01A-11D-A18D_120912_SN1222_0148_AC188PACXX_s_3_rg.sorted.bam	80.43	NA	0.15	58cfa831e4b0c9d6adf6c42a	TCGA-BT-A2LA-01A-11D-A18D_120912_SN1222_0148_AC188PACXX_s_3_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-BT-A2LA-01A	797A71EE-372D-41E5-AEEE-5AB3C4661110	Primary Tumor	Illumina HiSeq	587f05f3-8e6a-4a97-b59b-29371f2f8b74	Bladder	54	6ED52558-8039-4658-A245-78A29968CE2F	D08FDC4F-83B0-4885-A8CF-45F72E5E6BD2	TCGA-BT-A2LA-01A-11D-A18D-02	HG19_Broad_variant	TCGA-BT-A2LA	TCGA-BLCA	NA	s2860	Harvard Medical School	University of Pittsburgh	United States	NO	T3a	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage III	A18D-02	TRUE
13722.58cfa831e4b0c9d6adf6c4a6	58cfa831e4b0c9d6adf6c4a6	TCGA-BJ-A0ZJ-01A-11D-A10R_120616_SN1120_0153_AC0WMJACXX_s_2_rg.sorted.filtered.	WGS	TCGA-BJ-A0ZJ-01A-11D-A10R_120616_SN1120_0153_AC0WMJACXX_s_2_rg.sorted	TCGA-BJ-A0ZJ-01A-11D-A10R_120616_SN1120_0153_AC0WMJACXX_s_2_rg.sorted.bam	59.26	1.9	0.16	58cfa831e4b0c9d6adf6c4a6	TCGA-BJ-A0ZJ-01A-11D-A10R_120616_SN1120_0153_AC0WMJACXX_s_2_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-BJ-A0ZJ-01A	8877B479-B62A-4794-B71E-418DE96DFF23	Primary Tumor	Illumina HiSeq	649e17cb-1adf-40a9-a837-4980acc1a108	Thyroid	36	C6D64D80-C8AA-494A-8C0E-8640BEEBDFC9	D54FCA2A-0B8E-4A33-8B52-3FBF0E47D799	TCGA-BJ-A0ZJ-01A-11D-A10R-02	HG19_Broad_variant	TCGA-BJ-A0ZJ	TCGA-THCA	NA	s12629	Harvard Medical School	University of Pittsburgh	United States	NO	T2	N1a	Thyroid Papillary Carcinoma - Classical/usual	Stage I	A10R-02	TRUE
13722.58cfa830e4b0c9d6adf6c292	58cfa830e4b0c9d6adf6c292	TCGA-AY-4071-01A-01D-1109-02_IlluminaHiSeq-DNASeq_whole.filtered.	WGS	TCGA-AY-4071-01A-01D-1109-02_IlluminaHiSeq-DNASeq_whole	TCGA-AY-4071-01A-01D-1109-02_IlluminaHiSeq-DNASeq_whole.bam	504.59	1.9	0.15	58cfa830e4b0c9d6adf6c292	TCGA-AY-4071-01A-01D-1109-02_IlluminaHiSeq-DNASeq_whole.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Colon Adenocarcinoma	Aligned reads	TCGA-AY-4071-01A	315EF7F6-CA21-4D87-8F19-40BD455885EC	Primary Tumor	Illumina HiSeq	0335df8b-3dec-4304-95e5-47210ed06ba3	Colorectal	63	7D09112D-53F5-4B72-993A-337C55A0C902	8DE6361C-E9B5-45FF-A328-67B0DED836B9	TCGA-AY-4071-01A-01D-1109-02	HG18	TCGA-AY-4071	TCGA-COAD	29	s12887	Harvard Medical School	UNC	None	NO	T1	N0	Not available	Stage I	1109-02	TRUE
13722.58cfa831e4b0c9d6adf6c46a	58cfa831e4b0c9d6adf6c46a	TCGA-CA-5256-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.filtered.	WGS	TCGA-CA-5256-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole	TCGA-CA-5256-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.bam	806.02	1.9	0.13	58cfa831e4b0c9d6adf6c46a	TCGA-CA-5256-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.bam	Alive	FEMALE	ASIAN	Not available	Colon Adenocarcinoma	Aligned reads	TCGA-CA-5256-01A	17633A60-E12B-4A7C-BD8A-C16341DDC606	Primary Tumor	Illumina HiSeq	21c81645-36f0-4e4a-8f23-b589998bcb76	Colorectal	54	D4D5DEB6-6CFB-4E25-9824-8F7DC8D5B451	A8F8AAD6-F8C5-4133-A651-454C047A19D0	TCGA-CA-5256-01A-01D-1405-02	HG18	TCGA-CA-5256	TCGA-COAD	NA	s13544	Harvard Medical School	ILSbio	None	NO	T3	N0	Colon Adenocarcinoma	Stage IIA	1405-02	TRUE
13722.58cfa831e4b0c9d6adf6c5ab	58cfa831e4b0c9d6adf6c5ab	TCGA-CG-4462-01A-01D-1154_130815_VM001_0004_VMR0004CXX_s_7_rg.sorted.filtered.	WGS	TCGA-CG-4462-01A-01D-1154_130815_VM001_0004_VMR0004CXX_s_7_rg.sorted	TCGA-CG-4462-01A-01D-1154_130815_VM001_0004_VMR0004CXX_s_7_rg.sorted.bam	57.2	1.9	0.14	58cfa831e4b0c9d6adf6c5ab	TCGA-CG-4462-01A-01D-1154_130815_VM001_0004_VMR0004CXX_s_7_rg.sorted.bam	Dead	FEMALE	Not available	Not available	Stomach Adenocarcinoma	Aligned reads	TCGA-CG-4462-01A	E9EA3687-0DB3-47F3-8099-B4FC054397F1	Primary Tumor	Illumina HiSeq	bd5f9f37-7032-427b-a031-8789066620ac	Stomach	72	D4F28131-D917-449B-95DC-DC6BA2EEE81B	8CB261D0-2AF0-4D1B-895C-9D7F2404DBDC	TCGA-CG-4462-01A-01D-1154-02	HG19_Broad_variant	TCGA-CG-4462	TCGA-STAD	0	s14700	Harvard Medical School	Indivumed	Germany	NO	T3	N3	Stomach  Adenocarcinoma  Diffuse Type	Stage IV	1154-02	TRUE
13722.58cfa831e4b0c9d6adf6c524	58cfa831e4b0c9d6adf6c524	TCGA-CM-4744-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.filtered.	WGS	TCGA-CM-4744-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole	TCGA-CM-4744-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.bam	471	1.9	0.14	58cfa831e4b0c9d6adf6c524	TCGA-CM-4744-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Colon Adenocarcinoma	Aligned reads	TCGA-CM-4744-01A	CC15469C-7BAD-4E86-9DA3-AE0C72E9D380	Primary Tumor	Illumina HiSeq	e1403b52-6792-4d08-acad-95659ceeca82	Colorectal	69	A545FB9A-C386-4A80-9A25-660DC4F62904	6D073A6F-FB7B-4ED2-BD24-5233E019D64A	TCGA-CM-4744-01A-01D-1405-02	HG18	TCGA-CM-4744	TCGA-COAD	NA	s13689	Harvard Medical School	MSKCC	None	NO	T2	N0	Colon Adenocarcinoma	Stage I	1405-02	TRUE
13722.58cfa831e4b0c9d6adf6c5c2	58cfa831e4b0c9d6adf6c5c2	TCGA-CG-4462-01A-01D-1154_121023_SN208_0437_BD1H3FACXX_s_7_rg.sorted.filtered.	WGS	TCGA-CG-4462-01A-01D-1154_121023_SN208_0437_BD1H3FACXX_s_7_rg.sorted	TCGA-CG-4462-01A-01D-1154_121023_SN208_0437_BD1H3FACXX_s_7_rg.sorted.bam	57.2	1.9	0.14	58cfa831e4b0c9d6adf6c5c2	TCGA-CG-4462-01A-01D-1154_121023_SN208_0437_BD1H3FACXX_s_7_rg.sorted.bam	Dead	FEMALE	Not available	Not available	Stomach Adenocarcinoma	Aligned reads	TCGA-CG-4462-01A	E9EA3687-0DB3-47F3-8099-B4FC054397F1	Primary Tumor	Illumina HiSeq	1bcd6b3d-eeca-4c1e-bf6f-52c0a6b151ca	Stomach	72	D4F28131-D917-449B-95DC-DC6BA2EEE81B	8CB261D0-2AF0-4D1B-895C-9D7F2404DBDC	TCGA-CG-4462-01A-01D-1154-02	HG19_Broad_variant	TCGA-CG-4462	TCGA-STAD	0	s15124	Harvard Medical School	Indivumed	Germany	NO	T3	N3	Stomach  Adenocarcinoma  Diffuse Type	Stage IV	1154-02	TRUE
13722.58cfa831e4b0c9d6adf6c6d8	58cfa831e4b0c9d6adf6c6d8	TCGA-CG-4460-01A-01D-1154_120913_SN208_0429_AC187FACXX_s_8_rg.sorted.filtered.	WGS	TCGA-CG-4460-01A-01D-1154_120913_SN208_0429_AC187FACXX_s_8_rg.sorted	TCGA-CG-4460-01A-01D-1154_120913_SN208_0429_AC187FACXX_s_8_rg.sorted.bam	183.9	1.9	0.15	58cfa831e4b0c9d6adf6c6d8	TCGA-CG-4460-01A-01D-1154_120913_SN208_0429_AC187FACXX_s_8_rg.sorted.bam	Dead	FEMALE	Not available	Not available	Stomach Adenocarcinoma	Aligned reads	TCGA-CG-4460-01A	3C3D4EF0-019A-423E-89B2-4AC5A7B567AB	Primary Tumor	Illumina HiSeq	1d341d0a-b2f5-4f35-b60d-7c87f2a7dc78	Stomach	66	14FE3057-C82E-4D66-9798-BCD042CF64D6	1AE6944B-600D-40A8-ADD3-16F99982CDFE	TCGA-CG-4460-01A-01D-1154-02	HG19_Broad_variant	TCGA-CG-4460	TCGA-STAD	669	s15396	Harvard Medical School	Indivumed	Germany	NO	T4	N1	Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS)	Stage IV	1154-02	TRUE
13722.58cfa831e4b0c9d6adf6cadd	58cfa831e4b0c9d6adf6cadd	TCGA-E1-5305-01A-01D-1891_130919_SN590_0238_AC29TRACXX_s_3_rg.sorted.filtered.	WGS	TCGA-E1-5305-01A-01D-1891_130919_SN590_0238_AC29TRACXX_s_3_rg.sorted	TCGA-E1-5305-01A-01D-1891_130919_SN590_0238_AC29TRACXX_s_3_rg.sorted.bam	57.7	1.9	0.14	58cfa831e4b0c9d6adf6cadd	TCGA-E1-5305-01A-01D-1891_130919_SN590_0238_AC29TRACXX_s_3_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-E1-5305-01A	A0BC5147-D9B4-41FD-8DF3-A241D23722E8	Primary Tumor	Illumina HiSeq	0f660d53-1dae-499d-8a76-f591e1110acb	Brain	34	1B3185BF-9DEF-4B13-93F8-02CF3171464A	036EF90A-EACA-4105-9B7B-74C20BFA0BB9	TCGA-E1-5305-01A-01D-1891-02	HG19_Broad_variant	TCGA-E1-5305	TCGA-LGG	2433	s8354	Harvard Medical School	Duke	United States	NO	Not available	Not available	Astrocytoma	Not available	1891-02	TRUE
13722.58cfa831e4b0c9d6adf6cb2a	58cfa831e4b0c9d6adf6cb2a	TCGA-E1-5307-01A-01D-1891_130919_SN590_0238_AC29TRACXX_s_4_rg.sorted.filtered.	WGS	TCGA-E1-5307-01A-01D-1891_130919_SN590_0238_AC29TRACXX_s_4_rg.sorted	TCGA-E1-5307-01A-01D-1891_130919_SN590_0238_AC29TRACXX_s_4_rg.sorted.bam	138.7	1.9	0.14	58cfa831e4b0c9d6adf6cb2a	TCGA-E1-5307-01A-01D-1891_130919_SN590_0238_AC29TRACXX_s_4_rg.sorted.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-E1-5307-01A	A6EE311C-0A7B-4F47-86F1-F2164B128F9C	Primary Tumor	Illumina HiSeq	80d2e037-eb0e-4514-bdd4-caa1fc77176d	Brain	62	DED0F767-9CEE-4F1D-8E91-CB242D30B57E	A95622B9-01E0-4625-AAB8-2193C2594976	TCGA-E1-5307-01A-01D-1891-02	HG19_Broad_variant	TCGA-E1-5307	TCGA-LGG	1762	s8363	Harvard Medical School	Duke	United States	NO	Not available	Not available	Astrocytoma	Not available	1891-02	TRUE
13722.58cfa831e4b0c9d6adf6cda9	58cfa831e4b0c9d6adf6cda9	TCGA-FG-7636-01A-11D-2088_130923_SN1222_0220_BC2DUUACXX_s_3_rg.sorted.filtered.	WGS	TCGA-FG-7636-01A-11D-2088_130923_SN1222_0220_BC2DUUACXX_s_3_rg.sorted	TCGA-FG-7636-01A-11D-2088_130923_SN1222_0220_BC2DUUACXX_s_3_rg.sorted.bam	103.7	NA	0.15	58cfa831e4b0c9d6adf6cda9	TCGA-FG-7636-01A-11D-2088_130923_SN1222_0220_BC2DUUACXX_s_3_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-FG-7636-01A	B342E980-8383-4F1B-BF57-4098C37A536C	Primary Tumor	Illumina HiSeq	336bd48f-3c20-4a2f-a2ef-38bb94e30e11	Brain	48	BF70C0A6-CA2D-4355-B5BA-738094382E28	CE49A704-BECD-4A35-978B-4E21572CC5B2	TCGA-FG-7636-01A-11D-2088-02	HG19_Broad_variant	TCGA-FG-7636	TCGA-LGG	NA	s8573	Harvard Medical School	Case Western	United States	NO	Not available	Not available	Astrocytoma	Not available	2088-02	FALSE
13722.58cfa831e4b0c9d6adf6cd65	58cfa831e4b0c9d6adf6cd65	TCGA-FE-A232-01A-11D-A14U_120629_SN1222_0120_AC0WKWACXX_s_5_rg.sorted.filtered.	WGS	TCGA-FE-A232-01A-11D-A14U_120629_SN1222_0120_AC0WKWACXX_s_5_rg.sorted	TCGA-FE-A232-01A-11D-A14U_120629_SN1222_0120_AC0WKWACXX_s_5_rg.sorted.bam	72.56	2.05	0.18	58cfa831e4b0c9d6adf6cd65	TCGA-FE-A232-01A-11D-A14U_120629_SN1222_0120_AC0WKWACXX_s_5_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-FE-A232-01A	5EB0D577-223B-4409-89D1-5C5D196AFFC3	Primary Tumor	Illumina HiSeq	ca8aaa05-1546-46a2-aee9-1ad97cadf087	Thyroid	44	213BE6EE-1E61-4FA0-9B73-66B696086397	AD42DF5B-2665-4CA1-8049-943F684B6BFD	TCGA-FE-A232-01A-11D-A14U-02	HG19_Broad_variant	TCGA-FE-A232	TCGA-THCA	NA	s12530	Harvard Medical School	Ohio State University	United States	NO	T3	NX	Thyroid Papillary Carcinoma - Classical/usual	Stage I	A14U-02	TRUE
13722.58cfa832e4b0c9d6adf6ce19	58cfa832e4b0c9d6adf6ce19	TCGA-FD-A3N6-01A-11D-A21C_120830_SN590_0177_BD141PACXX_s_3_rg.sorted.filtered.	WGS	TCGA-FD-A3N6-01A-11D-A21C_120830_SN590_0177_BD141PACXX_s_3_rg.sorted	TCGA-FD-A3N6-01A-11D-A21C_120830_SN590_0177_BD141PACXX_s_3_rg.sorted.bam	47.84	NA	0.16	58cfa832e4b0c9d6adf6ce19	TCGA-FD-A3N6-01A-11D-A21C_120830_SN590_0177_BD141PACXX_s_3_rg.sorted.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-FD-A3N6-01A	8C1DD7F7-B74A-4FA2-B6A7-86F0348D2567	Primary Tumor	Illumina HiSeq	2beb0463-75e7-4244-b88e-022e447445f2	Bladder	43	6CD6D1F4-D8E4-47F9-812F-EB7FEC925F8D	C218A6A8-78F5-472B-A1CA-886E2331A688	TCGA-FD-A3N6-01A-11D-A21C-26	HG19_Broad_variant	TCGA-FD-A3N6	TCGA-BLCA	NA	s3292	MD Anderson - Institute for Applied Cancer Science	BLN - University Of Chicago	United States	NO	T2b	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage II	A21C-26	TRUE
13722.58cfa832e4b0c9d6adf6ce2a	58cfa832e4b0c9d6adf6ce2a	TCGA-FN-7833-01A-11D-2088_130923_SN1222_0220_BC2DUUACXX_s_4_rg.sorted.filtered.	WGS	TCGA-FN-7833-01A-11D-2088_130923_SN1222_0220_BC2DUUACXX_s_4_rg.sorted	TCGA-FN-7833-01A-11D-2088_130923_SN1222_0220_BC2DUUACXX_s_4_rg.sorted.bam	141.7	NA	0.14	58cfa832e4b0c9d6adf6ce2a	TCGA-FN-7833-01A-11D-2088_130923_SN1222_0220_BC2DUUACXX_s_4_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-FN-7833-01A	5B9D7565-A933-449D-8FFA-EC5F82DB2E77	Primary Tumor	Illumina HiSeq	91f0d100-c921-4319-9d82-98819189b525	Brain	25	CF2E4A0A-59C5-41DA-9F24-DE83EEB856E5	1C69F8E8-7D70-4BD1-8B42-7E93DC23DA7B	TCGA-FN-7833-01A-11D-2088-02	HG19_Broad_variant	TCGA-FN-7833	TCGA-LGG	NA	s8366	Harvard Medical School	International Genomics Consortium	United States	NO	Not available	Not available	Oligoastrocytoma	Not available	2088-02	FALSE
13722.58cfa832e4b0c9d6adf6d2a8	58cfa832e4b0c9d6adf6d2a8	TCGA-HT-7604-01A-11D-2088_130923_SN1222_0220_BC2DUUACXX_s_6_rg.sorted.filtered.	WGS	TCGA-HT-7604-01A-11D-2088_130923_SN1222_0220_BC2DUUACXX_s_6_rg.sorted	TCGA-HT-7604-01A-11D-2088_130923_SN1222_0220_BC2DUUACXX_s_6_rg.sorted.bam	175	NA	0.13	58cfa832e4b0c9d6adf6d2a8	TCGA-HT-7604-01A-11D-2088_130923_SN1222_0220_BC2DUUACXX_s_6_rg.sorted.bam	Alive	MALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-HT-7604-01A	019C5DE9-74FD-48B7-95A3-227532E16C5A	Primary Tumor	Illumina HiSeq	b3d0b563-b12d-4872-9a0c-f795ca13842f	Brain	50	9CA3488A-91F8-4EB2-8B03-24E8629757E1	31412731-7A51-4E73-BFC4-0098275D633B	TCGA-HT-7604-01A-11D-2088-02	HG19_Broad_variant	TCGA-HT-7604	TCGA-LGG	NA	s8575	Harvard Medical School	Case Western - St Joes	United States	NO	Not available	Not available	Astrocytoma	Not available	2088-02	FALSE
13722.58cfa832e4b0c9d6adf6d234	58cfa832e4b0c9d6adf6d234	TCGA-JX-A3Q8-01A-11D-A245_140206_SN1222_0239_BC2RAKACXX_s_3_rg.sorted.filtered.	WGS	TCGA-JX-A3Q8-01A-11D-A245_140206_SN1222_0239_BC2RAKACXX_s_3_rg.sorted	TCGA-JX-A3Q8-01A-11D-A245_140206_SN1222_0239_BC2RAKACXX_s_3_rg.sorted.bam	63.47	NA	0.14	58cfa832e4b0c9d6adf6d234	TCGA-JX-A3Q8-01A-11D-A245_140206_SN1222_0239_BC2RAKACXX_s_3_rg.sorted.bam	Alive	FEMALE	ASIAN	NOT HISPANIC OR LATINO	Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-JX-A3Q8-01A	34629EB8-0C5E-4910-8E13-BF7D6A1E337F	Primary Tumor	Illumina HiSeq	e8f02d77-0077-4817-a34b-ab4ddd64bbd5	Cervix	40	28954012-3732-40B0-8EA7-F48CBEEF4105	52CB86FE-6EFF-4FF4-BC53-FD82E04854FB	TCGA-JX-A3Q8-01A-11D-A245-26	HG19_Broad_variant	TCGA-JX-A3Q8	TCGA-CESC	NA	s1380	MD Anderson - Institute for Applied Cancer Science	Washington University	United States	NO	T1b1	N0	Endocervical Type of Adenocarcinoma	Not available	A245-26	TRUE
13722.58cfa832e4b0c9d6adf6d28b	58cfa832e4b0c9d6adf6d28b	TCGA-HT-7601-01A-11D-2088_130923_SN1222_0220_BC2DUUACXX_s_5_rg.sorted.filtered.	WGS	TCGA-HT-7601-01A-11D-2088_130923_SN1222_0220_BC2DUUACXX_s_5_rg.sorted	TCGA-HT-7601-01A-11D-2088_130923_SN1222_0220_BC2DUUACXX_s_5_rg.sorted.bam	56	NA	0.15	58cfa832e4b0c9d6adf6d28b	TCGA-HT-7601-01A-11D-2088_130923_SN1222_0220_BC2DUUACXX_s_5_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-HT-7601-01A	E7FDF164-A85D-4FF5-9676-D2215CA35403	Primary Tumor	Illumina HiSeq	5faa261d-a169-4ab5-a52b-de3b50c46299	Brain	30	7F6B5679-49E1-498D-BD1F-A757CD7DB4CC	5F766AF5-08F5-4E10-AAED-4B582275CFC1	TCGA-HT-7601-01A-11D-2088-02	HG19_Broad_variant	TCGA-HT-7601	TCGA-LGG	NA	s8153	Harvard Medical School	Case Western - St Joes	United States	NO	Not available	Not available	Astrocytoma	Not available	2088-02	FALSE
13722.58cfa832e4b0c9d6adf6d3f0	58cfa832e4b0c9d6adf6d3f0	TCGA-V4-A9ED-01A-11D-A40D_140725_SN590_0251_AC41YJACXX_s_2_rg.sorted.filtered.	WGS	TCGA-V4-A9ED-01A-11D-A40D_140725_SN590_0251_AC41YJACXX_s_2_rg.sorted	TCGA-V4-A9ED-01A-11D-A40D_140725_SN590_0251_AC41YJACXX_s_2_rg.sorted.bam	53.75	NA	0.17	58cfa832e4b0c9d6adf6d3f0	TCGA-V4-A9ED-01A-11D-A40D_140725_SN590_0251_AC41YJACXX_s_2_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Uveal Melanoma	Aligned reads	TCGA-V4-A9ED-01A	367869F9-BBE7-4E57-A16F-F2B63F2DE697	Primary Tumor	Illumina HiSeq	db951476-e1a5-4731-8c40-dbe710922b60	Eye	45	F1A146CE-B2C6-4CD5-9153-F640D38ABAF1	8CDB01C8-C2D9-40DB-84EE-00B50B9EC314	TCGA-V4-A9ED-01A-11D-A40D-26	HG19_Broad_variant	TCGA-V4-A9ED	TCGA-UVM	NA	s220	MD Anderson - Institute for Applied Cancer Science	Institut Curie	France	NO	T3b	N0	Not available	Stage IIIA	A40D-26	TRUE
13722.58cfa832e4b0c9d6adf6d3d7	58cfa832e4b0c9d6adf6d3d7	TCGA-V4-A9EJ-01A-11D-A40D_140725_SN590_0251_AC41YJACXX_s_7_rg.sorted.filtered.	WGS	TCGA-V4-A9EJ-01A-11D-A40D_140725_SN590_0251_AC41YJACXX_s_7_rg.sorted	TCGA-V4-A9EJ-01A-11D-A40D_140725_SN590_0251_AC41YJACXX_s_7_rg.sorted.bam	36.7	NA	0.17	58cfa832e4b0c9d6adf6d3d7	TCGA-V4-A9EJ-01A-11D-A40D_140725_SN590_0251_AC41YJACXX_s_7_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Uveal Melanoma	Aligned reads	TCGA-V4-A9EJ-01A	D9CCBA9B-6BF0-44D9-8097-A97AB747F0BD	Primary Tumor	Illumina HiSeq	9a75e8fd-7cbd-4d0f-a91b-22e52e02c00d	Eye	38	6D2FBFD2-E1BF-483E-B0A0-A308F93871D4	42B46C86-61F4-4C2E-9EC3-0ED0113F3EC3	TCGA-V4-A9EJ-01A-11D-A40D-26	HG19_Broad_variant	TCGA-V4-A9EJ	TCGA-UVM	NA	s206	MD Anderson - Institute for Applied Cancer Science	Institut Curie	France	NO	T3a	N0	Not available	Stage IIB	A40D-26	TRUE
13722.58cfa832e4b0c9d6adf6d400	58cfa832e4b0c9d6adf6d400	TCGA-V4-A9EK-01A-11D-A40D_140725_SN590_0251_AC41YJACXX_s_8_rg.sorted.filtered.	WGS	TCGA-V4-A9EK-01A-11D-A40D_140725_SN590_0251_AC41YJACXX_s_8_rg.sorted	TCGA-V4-A9EK-01A-11D-A40D_140725_SN590_0251_AC41YJACXX_s_8_rg.sorted.bam	48.23	NA	0.16	58cfa832e4b0c9d6adf6d400	TCGA-V4-A9EK-01A-11D-A40D_140725_SN590_0251_AC41YJACXX_s_8_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uveal Melanoma	Aligned reads	TCGA-V4-A9EK-01A	4464418C-EC35-4826-B3D5-152AC2A27A04	Primary Tumor	Illumina HiSeq	9f84d9e1-572c-43b9-8fa8-695decf3b44e	Eye	37	9F324851-EAAE-41B8-BB0E-5D5CEB9E5B23	01AA5AFA-5877-45CA-98DB-9547B99B30C5	TCGA-V4-A9EK-01A-11D-A40D-26	HG19_Broad_variant	TCGA-V4-A9EK	TCGA-UVM	NA	s234	MD Anderson - Institute for Applied Cancer Science	Institut Curie	France	NO	T3a	N0	Not available	Stage IIB	A40D-26	TRUE
13722.58cfa832e4b0c9d6adf6d4e4	58cfa832e4b0c9d6adf6d4e4	TCGA-V4-A9EE-01A-11D-A40D_140725_SN590_0251_AC41YJACXX_s_3_rg.sorted.filtered.	WGS	TCGA-V4-A9EE-01A-11D-A40D_140725_SN590_0251_AC41YJACXX_s_3_rg.sorted	TCGA-V4-A9EE-01A-11D-A40D_140725_SN590_0251_AC41YJACXX_s_3_rg.sorted.bam	37.61	NA	0.17	58cfa832e4b0c9d6adf6d4e4	TCGA-V4-A9EE-01A-11D-A40D_140725_SN590_0251_AC41YJACXX_s_3_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Uveal Melanoma	Aligned reads	TCGA-V4-A9EE-01A	EDBF6720-467E-4928-B1CB-0E7336358D18	Primary Tumor	Illumina HiSeq	88edb951-b2e0-476d-bc63-3f5883671a8f	Eye	86	1C5AB1BD-67EF-43AB-B46B-17E126DF2B82	0E1D56AE-4213-4443-BDD3-A652CFC60104	TCGA-V4-A9EE-01A-11D-A40D-26	HG19_Broad_variant	TCGA-V4-A9EE	TCGA-UVM	398	s223	MD Anderson - Institute for Applied Cancer Science	Institut Curie	France	NO	T3a	N0	Not available	Stage IIB	A40D-26	TRUE
13722.58cfa832e4b0c9d6adf6d47f	58cfa832e4b0c9d6adf6d47f	TCGA-V4-A9EC-01A-11D-A40D_140725_SN590_0251_AC41YJACXX_s_1_rg.sorted.filtered.	WGS	TCGA-V4-A9EC-01A-11D-A40D_140725_SN590_0251_AC41YJACXX_s_1_rg.sorted	TCGA-V4-A9EC-01A-11D-A40D_140725_SN590_0251_AC41YJACXX_s_1_rg.sorted.bam	44.61	NA	0.16	58cfa832e4b0c9d6adf6d47f	TCGA-V4-A9EC-01A-11D-A40D_140725_SN590_0251_AC41YJACXX_s_1_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uveal Melanoma	Aligned reads	TCGA-V4-A9EC-01A	EEAB0529-31E6-4EDB-BD2C-A21F2A169381	Primary Tumor	Illumina HiSeq	b19262ce-546a-4f20-b2c6-542d12745c33	Eye	75	3234E814-AD34-48F0-AEBD-19E1A694ED8E	3ED594C4-5AF5-4461-838D-367758D3BA55	TCGA-V4-A9EC-01A-11D-A40D-26	HG19_Broad_variant	TCGA-V4-A9EC	TCGA-UVM	NA	s232	MD Anderson - Institute for Applied Cancer Science	Institut Curie	France	NO	T3a	N0	Not available	Stage IIB	A40D-26	TRUE
13722.58cfa832e4b0c9d6adf6d4f4	58cfa832e4b0c9d6adf6d4f4	TCGA-V3-A9ZX-01A-11D-A40D_140715_SN590_0249_AC3M6CACXX_s_2_rg.sorted.filtered.	WGS	TCGA-V3-A9ZX-01A-11D-A40D_140715_SN590_0249_AC3M6CACXX_s_2_rg.sorted	TCGA-V3-A9ZX-01A-11D-A40D_140715_SN590_0249_AC3M6CACXX_s_2_rg.sorted.bam	47.71	NA	0.15	58cfa832e4b0c9d6adf6d4f4	TCGA-V3-A9ZX-01A-11D-A40D_140715_SN590_0249_AC3M6CACXX_s_2_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Uveal Melanoma	Aligned reads	TCGA-V3-A9ZX-01A	5019E7F1-DB46-4A07-9E7B-B6E5D1481B84	Primary Tumor	Illumina HiSeq	ad32c24c-f4fa-4356-95a8-15d394368122	Eye	56	A2DFEBBB-9A38-4CC2-A3F3-857C2A70DCF4	314EE286-7E1A-4CF8-A39D-D12E23C6DAAB	TCGA-V3-A9ZX-01A-11D-A40D-26	HG19_Broad_variant	TCGA-V3-A9ZX	TCGA-UVM	NA	s195	MD Anderson - Institute for Applied Cancer Science	Cleveland Clinic Foundation	United States	NO	T2b	NX	Not available	Stage IIB	A40D-26	TRUE
13722.58cfa832e4b0c9d6adf6d4f6	58cfa832e4b0c9d6adf6d4f6	TCGA-L5-A4OI-01A-11D-A267_131018_SN590_0240_AC2MW5ACXX_s_1_rg.sorted.filtered.	WGS	TCGA-L5-A4OI-01A-11D-A267_131018_SN590_0240_AC2MW5ACXX_s_1_rg.sorted	TCGA-L5-A4OI-01A-11D-A267_131018_SN590_0240_AC2MW5ACXX_s_1_rg.sorted.bam	40.07	NA	0.16	58cfa832e4b0c9d6adf6d4f6	TCGA-L5-A4OI-01A-11D-A267_131018_SN590_0240_AC2MW5ACXX_s_1_rg.sorted.bam	Alive	MALE	WHITE	Not available	Esophageal Carcinoma	Aligned reads	TCGA-L5-A4OI-01A	CB2AF13B-CBED-4657-8FD4-FED8DB375CBA	Primary Tumor	Illumina HiSeq	61f0c88a-c61d-400f-b8cf-b9cacd5fcada	Esophagus	79	1B1CBB34-DA71-4441-B1A1-C936E8F04C73	8D5A0D62-D9C1-46D1-9B81-685293B45E6B	TCGA-L5-A4OI-01A-11D-A267-26	HG19_Broad_variant	TCGA-L5-A4OI	TCGA-ESCA	NA	s1924	MD Anderson - Institute for Applied Cancer Science	University of Michigan	United States	NO	T3	N3	Not available	Stage IIIC	A267-26	TRUE
13722.58cfa832e4b0c9d6adf6d4d7	58cfa832e4b0c9d6adf6d4d7	TCGA-RZ-AB0B-01A-11D-A40D_140715_SN590_0249_AC3M6CACXX_s_1_rg.sorted.filtered.	WGS	TCGA-RZ-AB0B-01A-11D-A40D_140715_SN590_0249_AC3M6CACXX_s_1_rg.sorted	TCGA-RZ-AB0B-01A-11D-A40D_140715_SN590_0249_AC3M6CACXX_s_1_rg.sorted.bam	44.7	NA	0.14	58cfa832e4b0c9d6adf6d4d7	TCGA-RZ-AB0B-01A-11D-A40D_140715_SN590_0249_AC3M6CACXX_s_1_rg.sorted.bam	Dead	FEMALE	WHITE	Not available	Uveal Melanoma	Aligned reads	TCGA-RZ-AB0B-01A	2BF47A88-DF0A-4102-AF2E-998C3D252B9C	Primary Tumor	Illumina HiSeq	e284c77f-87fb-456b-8707-5f7b1219d267	Eye	47	78DA02B6-41D6-4911-8762-A71657F26F3C	B2D03978-B98B-4FB4-BA5C-50CE935C0056	TCGA-RZ-AB0B-01A-11D-A40D-26	HG19_Broad_variant	TCGA-RZ-AB0B	TCGA-UVM	149	s187	MD Anderson - Institute for Applied Cancer Science	Wills Eye Institute	United States	NO	T4b	Not available	Not available	Stage IV	A40D-26	TRUE
13722.58cfa832e4b0c9d6adf6d401	58cfa832e4b0c9d6adf6d401	TCGA-V4-A9EH-01A-11D-A40D_140725_SN590_0251_AC41YJACXX_s_5_rg.sorted.filtered.	WGS	TCGA-V4-A9EH-01A-11D-A40D_140725_SN590_0251_AC41YJACXX_s_5_rg.sorted	TCGA-V4-A9EH-01A-11D-A40D_140725_SN590_0251_AC41YJACXX_s_5_rg.sorted.bam	32.48	NA	0.17	58cfa832e4b0c9d6adf6d401	TCGA-V4-A9EH-01A-11D-A40D_140725_SN590_0251_AC41YJACXX_s_5_rg.sorted.bam	Alive	MALE	WHITE	HISPANIC OR LATINO	Uveal Melanoma	Aligned reads	TCGA-V4-A9EH-01A	5E54122F-1C4D-45CC-8842-CD1C1DF0EED8	Primary Tumor	Illumina HiSeq	f23ae536-eb5e-4d13-baf2-94a4eb03d083	Eye	53	A320EAC2-C0FB-44D0-9849-DD541C2428E1	AC2BA0CC-C007-44BF-8C99-4C88D55C022E	TCGA-V4-A9EH-01A-11D-A40D-26	HG19_Broad_variant	TCGA-V4-A9EH	TCGA-UVM	NA	s222	MD Anderson - Institute for Applied Cancer Science	Institut Curie	France	NO	T4c	N0	Not available	Stage IIIB	A40D-26	TRUE
13722.58cfa832e4b0c9d6adf6d582	58cfa832e4b0c9d6adf6d582	TCGA-V4-A9EA-01A-11D-A40D_140715_SN590_0249_AC3M6CACXX_s_8_rg.sorted.filtered.	WGS	TCGA-V4-A9EA-01A-11D-A40D_140715_SN590_0249_AC3M6CACXX_s_8_rg.sorted	TCGA-V4-A9EA-01A-11D-A40D_140715_SN590_0249_AC3M6CACXX_s_8_rg.sorted.bam	33.08	NA	0.17	58cfa832e4b0c9d6adf6d582	TCGA-V4-A9EA-01A-11D-A40D_140715_SN590_0249_AC3M6CACXX_s_8_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Uveal Melanoma	Aligned reads	TCGA-V4-A9EA-01A	A9FE64A9-6D22-4E9F-96F3-F16AF7D298F8	Primary Tumor	Illumina HiSeq	35b1a08b-2b90-4f04-887c-7e95542f287e	Eye	66	1A18A8C2-C00F-42B2-B5C6-3AAB27BCE06D	10EEDA0C-C4C3-4F47-A3AF-599FDFCD62DF	TCGA-V4-A9EA-01A-11D-A40D-26	HG19_Broad_variant	TCGA-V4-A9EA	TCGA-UVM	NA	s188	MD Anderson - Institute for Applied Cancer Science	Institut Curie	France	NO	T4a	N0	Not available	Stage IIIA	A40D-26	TRUE
13722.58cfa832e4b0c9d6adf6d58a	58cfa832e4b0c9d6adf6d58a	TCGA-V4-A9E9-01A-11D-A40D_140715_SN590_0249_AC3M6CACXX_s_7_rg.sorted.filtered.	WGS	TCGA-V4-A9E9-01A-11D-A40D_140715_SN590_0249_AC3M6CACXX_s_7_rg.sorted	TCGA-V4-A9E9-01A-11D-A40D_140715_SN590_0249_AC3M6CACXX_s_7_rg.sorted.bam	31.06	NA	0.16	58cfa832e4b0c9d6adf6d58a	TCGA-V4-A9E9-01A-11D-A40D_140715_SN590_0249_AC3M6CACXX_s_7_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Uveal Melanoma	Aligned reads	TCGA-V4-A9E9-01A	418152BD-7D33-4F0A-B890-2356B30D6F44	Primary Tumor	Illumina HiSeq	d8293c54-78cb-49a0-a69f-f36723632ddd	Eye	50	5CB8105A-6D8B-441B-A8F7-89308DD4FC92	3782E96A-456F-4747-B75B-A48597EDFD90	TCGA-V4-A9E9-01A-11D-A40D-26	HG19_Broad_variant	TCGA-V4-A9E9	TCGA-UVM	NA	s189	MD Anderson - Institute for Applied Cancer Science	Institut Curie	France	NO	T4a	N0	Not available	Stage IIIA	A40D-26	TRUE
13722.58cfa832e4b0c9d6adf6d586	58cfa832e4b0c9d6adf6d586	TCGA-V4-A9E8-01A-11D-A40D_140715_SN590_0249_AC3M6CACXX_s_6_rg.sorted.filtered.	WGS	TCGA-V4-A9E8-01A-11D-A40D_140715_SN590_0249_AC3M6CACXX_s_6_rg.sorted	TCGA-V4-A9E8-01A-11D-A40D_140715_SN590_0249_AC3M6CACXX_s_6_rg.sorted.bam	31.12	NA	0.16	58cfa832e4b0c9d6adf6d586	TCGA-V4-A9E8-01A-11D-A40D_140715_SN590_0249_AC3M6CACXX_s_6_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Uveal Melanoma	Aligned reads	TCGA-V4-A9E8-01A	DF941BC1-6356-4F2E-A3F5-AE190266B441	Primary Tumor	Illumina HiSeq	20fb461e-733f-4247-b4ad-e78418cd1866	Eye	49	7C95738B-C7F2-470F-AB95-88CDABBEEF21	F5FF03D8-69DA-49EC-8BF3-8132071649AC	TCGA-V4-A9E8-01A-11D-A40D-26	HG19_Broad_variant	TCGA-V4-A9E8	TCGA-UVM	808	s183	MD Anderson - Institute for Applied Cancer Science	Institut Curie	France	NO	T4a	N0	Not available	Stage IIIA	A40D-26	TRUE
13722.58cfa832e4b0c9d6adf6d590	58cfa832e4b0c9d6adf6d590	TCGA-V3-A9ZY-01A-11D-A40D_140715_SN590_0249_AC3M6CACXX_s_3_rg.sorted.filtered.	WGS	TCGA-V3-A9ZY-01A-11D-A40D_140715_SN590_0249_AC3M6CACXX_s_3_rg.sorted	TCGA-V3-A9ZY-01A-11D-A40D_140715_SN590_0249_AC3M6CACXX_s_3_rg.sorted.bam	50.6	NA	0.15	58cfa832e4b0c9d6adf6d590	TCGA-V3-A9ZY-01A-11D-A40D_140715_SN590_0249_AC3M6CACXX_s_3_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Uveal Melanoma	Aligned reads	TCGA-V3-A9ZY-01A	2112A42A-9B85-475A-A31B-4CE7751CDEB9	Primary Tumor	Illumina HiSeq	00a09c4d-5a88-4562-b9f3-e397798bdc18	Eye	54	E835BB77-E3EE-41B0-B8E0-D39E966F91A7	CD97490D-738A-48A2-B014-F9DB48DE45FA	TCGA-V3-A9ZY-01A-11D-A40D-26	HG19_Broad_variant	TCGA-V3-A9ZY	TCGA-UVM	NA	s192	MD Anderson - Institute for Applied Cancer Science	Cleveland Clinic Foundation	United States	NO	T3a	NX	Not available	Stage IIB	A40D-26	TRUE
13722.58cfa832e4b0c9d6adf6d58c	58cfa832e4b0c9d6adf6d58c	TCGA-V4-A9E7-01A-11D-A40D_140715_SN590_0249_AC3M6CACXX_s_5_rg.sorted.filtered.	WGS	TCGA-V4-A9E7-01A-11D-A40D_140715_SN590_0249_AC3M6CACXX_s_5_rg.sorted	TCGA-V4-A9E7-01A-11D-A40D_140715_SN590_0249_AC3M6CACXX_s_5_rg.sorted.bam	32.61	NA	0.16	58cfa832e4b0c9d6adf6d58c	TCGA-V4-A9E7-01A-11D-A40D_140715_SN590_0249_AC3M6CACXX_s_5_rg.sorted.bam	Dead	MALE	WHITE	Not available	Uveal Melanoma	Aligned reads	TCGA-V4-A9E7-01A	B5C516BA-4785-41DC-BD07-B129D47808DD	Primary Tumor	Illumina HiSeq	18accc0b-97a3-4386-b4c6-9213eeb4da3e	Eye	76	76AF65DC-CCCD-4257-8D05-38334D3110DA	3D700A8D-7760-4095-B537-1171444D1A5D	TCGA-V4-A9E7-01A-11D-A40D-26	HG19_Broad_variant	TCGA-V4-A9E7	TCGA-UVM	415	s193	MD Anderson - Institute for Applied Cancer Science	Institut Curie	France	NO	T4a	N0	Not available	Stage IIIA	A40D-26	TRUE
13722.58cfa832e4b0c9d6adf6d6a6	58cfa832e4b0c9d6adf6d6a6	TCGA-V4-A9E5-01A-11D-A40D_140715_SN590_0249_AC3M6CACXX_s_4_rg.sorted.filtered.	WGS	TCGA-V4-A9E5-01A-11D-A40D_140715_SN590_0249_AC3M6CACXX_s_4_rg.sorted	TCGA-V4-A9E5-01A-11D-A40D_140715_SN590_0249_AC3M6CACXX_s_4_rg.sorted.bam	30.36	NA	0.16	58cfa832e4b0c9d6adf6d6a6	TCGA-V4-A9E5-01A-11D-A40D_140715_SN590_0249_AC3M6CACXX_s_4_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uveal Melanoma	Aligned reads	TCGA-V4-A9E5-01A	029CC59C-60DF-4411-A044-3A2EEEE7B110	Primary Tumor	Illumina HiSeq	6d4c51c2-0829-4ab2-9c4e-0a4653d8b744	Eye	51	9FD9F385-A009-44AE-836F-F18BAD96628F	CE4927D1-2A65-4BEF-98E5-EDD02A341820	TCGA-V4-A9E5-01A-11D-A40D-26	HG19_Broad_variant	TCGA-V4-A9E5	TCGA-UVM	NA	s190	MD Anderson - Institute for Applied Cancer Science	Institut Curie	France	NO	T4b	N0	Not available	Stage IIIB	A40D-26	TRUE
13722.58cfa832e4b0c9d6adf6d61a	58cfa832e4b0c9d6adf6d61a	TCGA-LN-A49X-01A-31D-A267_131018_SN590_0241_BC30HBACXX_s_3_rg.sorted.filtered.	WGS	TCGA-LN-A49X-01A-31D-A267_131018_SN590_0241_BC30HBACXX_s_3_rg.sorted	TCGA-LN-A49X-01A-31D-A267_131018_SN590_0241_BC30HBACXX_s_3_rg.sorted.bam	16.61	NA	0.16	58cfa832e4b0c9d6adf6d61a	TCGA-LN-A49X-01A-31D-A267_131018_SN590_0241_BC30HBACXX_s_3_rg.sorted.bam	Alive	MALE	ASIAN	NOT HISPANIC OR LATINO	Esophageal Carcinoma	Aligned reads	TCGA-LN-A49X-01A	B05AEFC4-2D61-44B6-9451-E660D10D8A79	Primary Tumor	Illumina HiSeq	e3d2b395-b1fa-4edd-86a9-72ca75792159	Esophagus	44	F67F4ACC-E1DC-41F5-AF25-F4C03856B1AC	92F976C9-1D13-4347-ADDB-6C8F4C2E078F	TCGA-LN-A49X-01A-31D-A267-26	HG19_Broad_variant	TCGA-LN-A49X	TCGA-ESCA	NA	s1683	MD Anderson - Institute for Applied Cancer Science	ILSbio	Vietnam	NO	T3	N0	Not available	Stage IIA	A267-26	TRUE
13722.58cfa82ee4b0c9d6adf6afc4	58cfa82ee4b0c9d6adf6afc4	TCGA-05-4418-01A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.filtered.	WGS	TCGA-05-4418-01A-01D-1203-02_IlluminaHiSeq-DNASeq_whole	TCGA-05-4418-01A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.bam	313.3	1.9	0.15	58cfa82ee4b0c9d6adf6afc4	TCGA-05-4418-01A-01D-1203-02_IlluminaHiSeq-DNASeq_whole.bam	Dead	MALE	Not available	Not available	Lung Adenocarcinoma	Aligned reads	TCGA-05-4418-01A	D2C1E896-6886-4122-BB48-5FBCD3F641F4	Primary Tumor	Illumina HiSeq	961e7ff2-7efc-46b6-9fe6-3f19366eeab8	Lung	69	C9E092B2-D6C3-4161-BD9E-0FA4015BEBBB	AA7559AC-F8C0-40E5-A313-3914A6E4559A	TCGA-05-4418-01A-01D-1203-02	GRCh37	TCGA-05-4418	TCGA-LUAD	274	s11440	Harvard Medical School	Indivumed	Germany	NO	T3	N2	Lung Adenocarcinoma Mixed Subtype	Stage IIIA	1203-02	TRUE
13722.58cfa82fe4b0c9d6adf6ba20	58cfa82fe4b0c9d6adf6ba20	TCGA-AA-3664-01A-01D-1167_110111_SN208_0178_B818TTABXX_s_5.rg.sorted.filtered.	WGS	TCGA-AA-3664-01A-01D-1167_110111_SN208_0178_B818TTABXX_s_5.rg.sorted	TCGA-AA-3664-01A-01D-1167_110111_SN208_0178_B818TTABXX_s_5.rg.sorted.bam	338.96	1.9	0.16	58cfa82fe4b0c9d6adf6ba20	TCGA-AA-3664-01A-01D-1167_110111_SN208_0178_B818TTABXX_s_5.rg.sorted.bam	Alive	FEMALE	Not available	Not available	Colon Adenocarcinoma	Aligned reads	TCGA-AA-3664-01A	A06C09A8-0951-49F4-A765-5147BBCAE109	Primary Tumor	Illumina HiSeq	9caec406-c1d9-43df-a730-7226fd5880b0	Colorectal	74	D448668C-90F3-40FA-9961-88407090DA31	4B4C0EDF-1012-4A6A-B01E-CDEB130FF2E6	TCGA-AA-3664-01A-01D-1167-02	HG18_Broad_variant	TCGA-AA-3664	TCGA-COAD	NA	s13024	Harvard Medical School	Indivumed	Germany	NO	T3	N0	Colon Adenocarcinoma	Stage II	1167-02	TRUE
13722.58cfa830e4b0c9d6adf6bc00	58cfa830e4b0c9d6adf6bc00	TCGA-A6-3807-01A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.filtered.	WGS	TCGA-A6-3807-01A-01D-1167-02_IlluminaHiSeq-DNASeq_whole	TCGA-A6-3807-01A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.bam	380	1.9	0.15	58cfa830e4b0c9d6adf6bc00	TCGA-A6-3807-01A-01D-1167-02_IlluminaHiSeq-DNASeq_whole.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Colon Adenocarcinoma	Aligned reads	TCGA-A6-3807-01A	5116E3B4-2BAC-40F5-8046-B9C1783FAAA5	Primary Tumor	Illumina HiSeq	d5f643a5-b69b-499a-8aab-7fc6520f2e55	Colorectal	53	1EB2A255-6EDD-4ADB-B52D-99DCEC590C5D	3A4293C1-0860-42F9-9D64-26B7298C2CDB	TCGA-A6-3807-01A-01D-1167-02	HG18	TCGA-A6-3807	TCGA-COAD	NA	s13505	Harvard Medical School	Christiana Healthcare	None	NO	T3	N2	Colon Adenocarcinoma	Stage IIIC	1167-02	TRUE
13722.58cfa830e4b0c9d6adf6bca6	58cfa830e4b0c9d6adf6bca6	TCGA-AZ-4315-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.filtered.	WGS	TCGA-AZ-4315-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole	TCGA-AZ-4315-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.bam	524.02	1.9	0.15	58cfa830e4b0c9d6adf6bca6	TCGA-AZ-4315-01A-01D-1405-02_IlluminaHiSeq-DNASeq_whole.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Colon Adenocarcinoma	Aligned reads	TCGA-AZ-4315-01A	DE287A25-981D-49F8-81AF-FE0300E4CD31	Primary Tumor	Illumina HiSeq	8b6a06d6-c15c-4491-996c-2a012440f8a2	Colorectal	61	BA9E5603-BB1D-4AA8-93E4-40043164F143	FBEA9F07-A969-4396-8A17-A269BF1F8A2A	TCGA-AZ-4315-01A-01D-1405-02	HG18	TCGA-AZ-4315	TCGA-COAD	NA	s13389	Harvard Medical School	University of Pittsburgh	None	NO	T3	N0	Colon Adenocarcinoma	Stage IIA	1405-02	TRUE
13722.58cfa82ee4b0c9d6adf6ae48	58cfa82ee4b0c9d6adf6ae48	TCGA-05-4384-01A-01D-1751_120228_SN1120_0117_BC0DKWACXX_s_4_rg.sorted.filtered.	WGS	TCGA-05-4384-01A-01D-1751_120228_SN1120_0117_BC0DKWACXX_s_4_rg.sorted	TCGA-05-4384-01A-01D-1751_120228_SN1120_0117_BC0DKWACXX_s_4_rg.sorted.bam	486.4	1.9	0.15	58cfa82ee4b0c9d6adf6ae48	TCGA-05-4384-01A-01D-1751_120228_SN1120_0117_BC0DKWACXX_s_4_rg.sorted.bam	Alive	MALE	Not available	Not available	Lung Adenocarcinoma	Aligned reads	TCGA-05-4384-01A	9A50E7E4-831D-489F-87D2-979E987561CC	Primary Tumor	Illumina HiSeq	985192a3-1403-4393-895a-ca9a4d12268f	Lung	66	E4416303-50B0-4316-BFEE-030C7B29FAC6	5253B1A2-8C57-414A-8E19-6E8390A6C18D	TCGA-05-4384-01A-01D-1751-02	HG19_Broad_variant	TCGA-05-4384	TCGA-LUAD	NA	s10982	Harvard Medical School	Indivumed	Germany	NO	T2	N2	Lung Adenocarcinoma Mixed Subtype	Stage IIIA	1751-02	TRUE
13722.58cfa82fe4b0c9d6adf6b7de	58cfa82fe4b0c9d6adf6b7de	TCGA-50-5931-01A-11D-1751_110928_SN590_0108_BB01CWACXX_s_2_rg.sorted.filtered.	WGS	TCGA-50-5931-01A-11D-1751_110928_SN590_0108_BB01CWACXX_s_2_rg.sorted	TCGA-50-5931-01A-11D-1751_110928_SN590_0108_BB01CWACXX_s_2_rg.sorted.bam	345.4	1.9	0.15	58cfa82fe4b0c9d6adf6b7de	TCGA-50-5931-01A-11D-1751_110928_SN590_0108_BB01CWACXX_s_2_rg.sorted.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-50-5931-01A	12CCD581-A921-41BC-BCEE-4E9BE54532CC	Primary Tumor	Illumina HiSeq	ba1d7028-7d97-4a0b-917e-b861a8656748	Lung	75	16A2D381-75A0-423B-AAC2-D5710AFB183B	5EA8E18D-2D34-4C6E-A89D-36DE5E91E80C	TCGA-50-5931-01A-11D-1751-02	HG19_Broad_variant	TCGA-50-5931	TCGA-LUAD	434	s11458	Harvard Medical School	University of Pittsburgh	United States	NO	T2	N0	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage IB	1751-02	TRUE
13722.58cfa82fe4b0c9d6adf6b7fc	58cfa82fe4b0c9d6adf6b7fc	TCGA-38-6178-01A-11D-1751_120301_SN208_0270_AD0KLRACXX_s_3_rg.sorted.filtered.	WGS	TCGA-38-6178-01A-11D-1751_120301_SN208_0270_AD0KLRACXX_s_3_rg.sorted	TCGA-38-6178-01A-11D-1751_120301_SN208_0270_AD0KLRACXX_s_3_rg.sorted.bam	240.4	1.9	0.14	58cfa82fe4b0c9d6adf6b7fc	TCGA-38-6178-01A-11D-1751_120301_SN208_0270_AD0KLRACXX_s_3_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-38-6178-01A	EDF80622-AEA2-4B50-BB69-691D6708AA83	Primary Tumor	Illumina HiSeq	f309d501-6d91-40ce-839c-bef9a434bae1	Lung	70	81FB5FA9-D901-4FAA-B909-376B8676D2BC	DE9A3263-6ACD-4BBB-9F91-D4E7FCBEFA04	TCGA-38-6178-01A-11D-1751-02	HG19_Broad_variant	TCGA-38-6178	TCGA-LUAD	NA	s11119	Harvard Medical School	UNC	United States	NO	T2b	N2	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage IIIA	1751-02	TRUE
13722.58cfa82fe4b0c9d6adf6b800	58cfa82fe4b0c9d6adf6b800	TCGA-38-4632-01A-01D-1751_120305_SN1120_0118_AD0L4HACXX_s_7_rg.sorted.filtered.	WGS	TCGA-38-4632-01A-01D-1751_120305_SN1120_0118_AD0L4HACXX_s_7_rg.sorted	TCGA-38-4632-01A-01D-1751_120305_SN1120_0118_AD0L4HACXX_s_7_rg.sorted.bam	465.4	1.9	0.15	58cfa82fe4b0c9d6adf6b800	TCGA-38-4632-01A-01D-1751_120305_SN1120_0118_AD0L4HACXX_s_7_rg.sorted.bam	Dead	MALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-38-4632-01A	875333AB-9048-462D-AAA2-693AD127E3CC	Primary Tumor	Illumina HiSeq	ee38fc59-2812-43a0-b6c0-ab684daab63d	Lung	42	D994817A-474E-4F92-8A78-7586CAA85D52	77D4D914-9C77-401B-BD71-9CF71A58DCE7	TCGA-38-4632-01A-01D-1751-02	HG19_Broad_variant	TCGA-38-4632	TCGA-LUAD	1357	s11449	Harvard Medical School	UNC	United States	NO	T2	N1	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage IV	1751-02	TRUE
13722.58cfa82fe4b0c9d6adf6b756	58cfa82fe4b0c9d6adf6b756	TCGA-91-6835-01A-11D-1853_120310_SN590_0144_AD0PNFACXX_s_5_rg.sorted.filtered.	WGS	TCGA-91-6835-01A-11D-1853_120310_SN590_0144_AD0PNFACXX_s_5_rg.sorted	TCGA-91-6835-01A-11D-1853_120310_SN590_0144_AD0PNFACXX_s_5_rg.sorted.bam	328.7	1.9	0.14	58cfa82fe4b0c9d6adf6b756	TCGA-91-6835-01A-11D-1853_120310_SN590_0144_AD0PNFACXX_s_5_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-91-6835-01A	2F09479F-87FC-4C34-8E2C-333E970A3681	Primary Tumor	Illumina HiSeq	8c5e1a0f-e9a8-4ce4-b066-97b2040c5327	Lung	81	EFD3F14F-F785-4AEC-9EFD-6DD8E9C41EBA	A4DC40A6-EE0F-4637-937F-406F5FC8579F	TCGA-91-6835-01A-11D-1853-02	HG19_Broad_variant	TCGA-91-6835	TCGA-LUAD	NA	s10913	Harvard Medical School	ABS - IUPUI	United States	NO	T1	N0	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage IA	1853-02	TRUE
13722.58cfa82fe4b0c9d6adf6b9e2	58cfa82fe4b0c9d6adf6b9e2	TCGA-64-5815-01A-01D-1623_120228_SN1120_0117_BC0DKWACXX_s_3_rg.sorted.filtered.	WGS	TCGA-64-5815-01A-01D-1623_120228_SN1120_0117_BC0DKWACXX_s_3_rg.sorted	TCGA-64-5815-01A-01D-1623_120228_SN1120_0117_BC0DKWACXX_s_3_rg.sorted.bam	132.7	1.9	0.14	58cfa82fe4b0c9d6adf6b9e2	TCGA-64-5815-01A-01D-1623_120228_SN1120_0117_BC0DKWACXX_s_3_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-64-5815-01A	A65700C2-E58C-4FD4-AEB1-5686B8F4D212	Primary Tumor	Illumina HiSeq	d64bfa4e-ae37-494a-aabe-6787ac58054a	Lung	74	4420AAE3-3F44-4852-974D-74F155B99FE4	7DC45930-978E-42B5-8ECB-942F3C6DA727	TCGA-64-5815-01A-01D-1623-02	HG19_Broad_variant	TCGA-64-5815	TCGA-LUAD	NA	s11460	Harvard Medical School	Fox Chase	United States	NO	T2	N1	Lung Adenocarcinoma Mixed Subtype	Stage IIB	1623-02	TRUE
13722.58cfa830e4b0c9d6adf6bd86	58cfa830e4b0c9d6adf6bd86	TCGA-BG-A0LX-01A-11D-A043_120214_SN590_0138_AC0E8HACXX_s_7_rg.sorted.filtered.	WGS	TCGA-BG-A0LX-01A-11D-A043_120214_SN590_0138_AC0E8HACXX_s_7_rg.sorted	TCGA-BG-A0LX-01A-11D-A043_120214_SN590_0138_AC0E8HACXX_s_7_rg.sorted.bam	65.42	2.11	0.15	58cfa830e4b0c9d6adf6bd86	TCGA-BG-A0LX-01A-11D-A043_120214_SN590_0138_AC0E8HACXX_s_7_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-BG-A0LX-01A	AC1D3946-FE6C-4BD8-B02C-638799CB0F67	Primary Tumor	Illumina HiSeq	182220ca-d437-40a2-adeb-d4cb1ce2f284	Uterus	57	99CDF3A0-90DC-4992-B75A-11DD41928D43	B294F25A-93D9-49A6-8FD3-6D2B0BBEF27C	TCGA-BG-A0LX-01A-11D-A043-02	HG19_Broad_variant	TCGA-BG-A0LX	TCGA-UCEC	NA	s5218	Harvard Medical School	University of Pittsburgh	None	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A043-02	TRUE
13722.58cfa830e4b0c9d6adf6bdd6	58cfa830e4b0c9d6adf6bdd6	TCGA-BG-A0MC-01A-21D-A043_120530_SN1222_0110_AC0VLAACXX_s_1_rg.sorted.filtered.	WGS	TCGA-BG-A0MC-01A-21D-A043_120530_SN1222_0110_AC0VLAACXX_s_1_rg.sorted	TCGA-BG-A0MC-01A-21D-A043_120530_SN1222_0110_AC0VLAACXX_s_1_rg.sorted.bam	84.24	2.08	0.16	58cfa830e4b0c9d6adf6bdd6	TCGA-BG-A0MC-01A-21D-A043_120530_SN1222_0110_AC0VLAACXX_s_1_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-BG-A0MC-01A	884FD57D-BD8E-40E7-82F6-0BA1C71101A9	Primary Tumor	Illumina HiSeq	db9c9c51-2c42-4a56-a87d-9c01038c4e6f	Uterus	74	46B48BF8-346B-4F25-916E-26A3CDDFA00D	9376C8CD-BD9D-4576-BBE3-7D771914AFA3	TCGA-BG-A0MC-01A-21D-A043-02	HG19_Broad_variant	TCGA-BG-A0MC	TCGA-UCEC	NA	s4601	Harvard Medical School	University of Pittsburgh	None	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A043-02	TRUE
13722.58cfa830e4b0c9d6adf6bc5a	58cfa830e4b0c9d6adf6bc5a	TCGA-AP-A0LH-01A-11D-A043_120214_SN590_0138_AC0E8HACXX_s_1_rg.sorted.filtered.	WGS	TCGA-AP-A0LH-01A-11D-A043_120214_SN590_0138_AC0E8HACXX_s_1_rg.sorted	TCGA-AP-A0LH-01A-11D-A043_120214_SN590_0138_AC0E8HACXX_s_1_rg.sorted.bam	94.43	2	0.16	58cfa830e4b0c9d6adf6bc5a	TCGA-AP-A0LH-01A-11D-A043_120214_SN590_0138_AC0E8HACXX_s_1_rg.sorted.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-AP-A0LH-01A	7DCE4215-01F6-43E9-9378-9E22C26C23A2	Primary Tumor	Illumina HiSeq	4334c333-7627-4949-90aa-55897232ec49	Uterus	60	4C657AD4-2C53-4EA9-82B5-52996E74E3FF	FCA1C7F5-E456-4574-9716-79770E6DAE8C	TCGA-AP-A0LH-01A-11D-A043-02	HG19_Broad_variant	TCGA-AP-A0LH	TCGA-UCEC	1106	s5203	Harvard Medical School	MSKCC	None	NO	Not available	Not available	Mixed serous and endometrioid	Not available	A043-02	TRUE
13722.58cfa830e4b0c9d6adf6bec7	58cfa830e4b0c9d6adf6bec7	TCGA-AP-A0LJ-01A-11D-A043_120324_SN1120_0127_BC0L80ACXX_s_7_rg.sorted.filtered.	WGS	TCGA-AP-A0LJ-01A-11D-A043_120324_SN1120_0127_BC0L80ACXX_s_7_rg.sorted	TCGA-AP-A0LJ-01A-11D-A043_120324_SN1120_0127_BC0L80ACXX_s_7_rg.sorted.bam	83.32	2.09	0.15	58cfa830e4b0c9d6adf6bec7	TCGA-AP-A0LJ-01A-11D-A043_120324_SN1120_0127_BC0L80ACXX_s_7_rg.sorted.bam	Alive	FEMALE	WHITE	Not available	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-AP-A0LJ-01A	B4A520AE-F259-48C8-823E-C10B9B8A133A	Primary Tumor	Illumina HiSeq	c3705d55-9194-4d83-9162-41aae551e016	Uterus	42	BE3ED392-4D9F-4EAF-8A56-D251846DF4DA	2A88E054-E64F-4C5F-97F0-53F95D64FC04	TCGA-AP-A0LJ-01A-11D-A043-02	HG19_Broad_variant	TCGA-AP-A0LJ	TCGA-UCEC	NA	s4996	Harvard Medical School	MSKCC	None	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A043-02	TRUE
13722.58cfa830e4b0c9d6adf6be90	58cfa830e4b0c9d6adf6be90	TCGA-BL-A13I-01A-11D-A13U_121005_SN1120_0195_AC13RHACXX_s_4_rg.sorted.filtered.	WGS	TCGA-BL-A13I-01A-11D-A13U_121005_SN1120_0195_AC13RHACXX_s_4_rg.sorted	TCGA-BL-A13I-01A-11D-A13U_121005_SN1120_0195_AC13RHACXX_s_4_rg.sorted.bam	92.87	2	0.15	58cfa830e4b0c9d6adf6be90	TCGA-BL-A13I-01A-11D-A13U_121005_SN1120_0195_AC13RHACXX_s_4_rg.sorted.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-BL-A13I-01A	EBC094A6-CDC9-4C02-B8EC-A181B25A364D	Primary Tumor	Illumina HiSeq	b7cfe609-703a-4750-b9e7-5bda8e948cc4	Bladder	57	62C2BA8F-02E3-4100-86BC-5958038B4983	7C09CFF3-3162-4952-93AD-8A7D89F07266	TCGA-BL-A13I-01A-11D-A13U-02	HG19_Broad_variant	TCGA-BL-A13I	TCGA-BLCA	223	s2689	Harvard Medical School	Christiana Healthcare	United States	NO	T3	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage III	A13U-02	TRUE
13722.58cfa830e4b0c9d6adf6be76	58cfa830e4b0c9d6adf6be76	TCGA-BJ-A3PU-01A-11D-A221_120530_SN1222_0111_BD12L1ACXX_s_5_rg.sorted.filtered.	WGS	TCGA-BJ-A3PU-01A-11D-A221_120530_SN1222_0111_BD12L1ACXX_s_5_rg.sorted	TCGA-BJ-A3PU-01A-11D-A221_120530_SN1222_0111_BD12L1ACXX_s_5_rg.sorted.bam	52.74	NA	0.15	58cfa830e4b0c9d6adf6be76	TCGA-BJ-A3PU-01A-11D-A221_120530_SN1222_0111_BD12L1ACXX_s_5_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-BJ-A3PU-01A	4CCCC34B-DAF6-41CA-9BF8-F1614525EAC9	Primary Tumor	Illumina HiSeq	42209b7e-0b20-42c9-aa80-993445de4b03	Thyroid	52	0BE2571E-3572-4974-95CE-21B9972B24B2	C290C4E6-11FF-49B6-89A1-0332A8D8DD6B	TCGA-BJ-A3PU-01A-11D-A221-26	HG19_Broad_variant	TCGA-BJ-A3PU	TCGA-THCA	NA	s12361	MD Anderson - RPPA Core Facility (Proteomics)	University of Pittsburgh	United States	NO	T3	N1a	Thyroid Papillary Carcinoma - Classical/usual	Stage III	A221-26	TRUE
13722.58cfa830e4b0c9d6adf6bef8	58cfa830e4b0c9d6adf6bef8	TCGA-BJ-A28W-01A-11D-A16N_120805_SN208_0421_AC11HPACXX_s_2_rg.sorted.filtered.	WGS	TCGA-BJ-A28W-01A-11D-A16N_120805_SN208_0421_AC11HPACXX_s_2_rg.sorted	TCGA-BJ-A28W-01A-11D-A16N_120805_SN208_0421_AC11HPACXX_s_2_rg.sorted.bam	59.66	1.88	0.17	58cfa830e4b0c9d6adf6bef8	TCGA-BJ-A28W-01A-11D-A16N_120805_SN208_0421_AC11HPACXX_s_2_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-BJ-A28W-01A	A6D37F61-BECA-46EA-A59A-62257475AC77	Primary Tumor	Illumina HiSeq	32effbdc-7d3b-4ad8-9245-1a253cbe1ff3	Thyroid	32	32AEF736-82A4-4813-A272-86EF160E7D56	229AD821-4BB0-4046-B5E6-6193005D3C8A	TCGA-BJ-A28W-01A-11D-A16N-02	HG19_Broad_variant	TCGA-BJ-A28W	TCGA-THCA	NA	s12507	Harvard Medical School	University of Pittsburgh	United States	NO	T2	N0	Thyroid Papillary Carcinoma - Classical/usual	Stage I	A16N-02	TRUE
13722.58cfa830e4b0c9d6adf6bf60	58cfa830e4b0c9d6adf6bf60	TCGA-BR-4357-01A-01D-1154_130815_VM001_0001_VMR0001CXX_s_5_rg.sorted.filtered.	WGS	TCGA-BR-4357-01A-01D-1154_130815_VM001_0001_VMR0001CXX_s_5_rg.sorted	TCGA-BR-4357-01A-01D-1154_130815_VM001_0001_VMR0001CXX_s_5_rg.sorted.bam	197.2	1.9	0.16	58cfa830e4b0c9d6adf6bf60	TCGA-BR-4357-01A-01D-1154_130815_VM001_0001_VMR0001CXX_s_5_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-BR-4357-01A	BEC83DFF-2BBA-4467-92AA-5DC3DB9E0EAF	Primary Tumor	Illumina HiSeq	4bc9f55b-1edb-49c9-be1a-1d00a108b99b	Stomach	58	81C87C27-47C7-4DC7-BF92-E0037433DF30	93F60FA6-0D34-441E-8F61-80306E10D046	TCGA-BR-4357-01A-01D-1154-02	HG19_Broad_variant	TCGA-BR-4357	TCGA-STAD	NA	s15301	Harvard Medical School	Asterand	Russia	NO	T3	NX	Stomach  Adenocarcinoma  Not Otherwise Specified (NOS)	Not available	1154-02	TRUE
13722.58cfa830e4b0c9d6adf6bf8f	58cfa830e4b0c9d6adf6bf8f	TCGA-B5-A0K0-01A-11D-A043_120209_SN1120_0113_AC0DKVACXX_s_7_rg.sorted.filtered.	WGS	TCGA-B5-A0K0-01A-11D-A043_120209_SN1120_0113_AC0DKVACXX_s_7_rg.sorted	TCGA-B5-A0K0-01A-11D-A043_120209_SN1120_0113_AC0DKVACXX_s_7_rg.sorted.bam	106.93	1.95	0.16	58cfa830e4b0c9d6adf6bf8f	TCGA-B5-A0K0-01A-11D-A043_120209_SN1120_0113_AC0DKVACXX_s_7_rg.sorted.bam	Alive	FEMALE	WHITE	Not available	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-B5-A0K0-01A	29C8F468-5AC1-4D6C-8376-E36E6D246926	Primary Tumor	Illumina HiSeq	5de016ca-e694-4ebc-b06f-5d07f7523fda	Uterus	48	11C43948-E7C9-4436-A654-82FA8033B625	3296C785-7C20-487D-BAEC-C66022E77E53	TCGA-B5-A0K0-01A-11D-A043-02	HG19_Broad_variant	TCGA-B5-A0K0	TCGA-UCEC	NA	s5204	Harvard Medical School	Duke	United States	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A043-02	TRUE
13722.58cfa830e4b0c9d6adf6bf95	58cfa830e4b0c9d6adf6bf95	TCGA-BR-6564-01A-12D-1880_121220_SN1222_0163_AC1HA2ACXX_s_1_rg.sorted.filtered.	WGS	TCGA-BR-6564-01A-12D-1880_121220_SN1222_0163_AC1HA2ACXX_s_1_rg.sorted	TCGA-BR-6564-01A-12D-1880_121220_SN1222_0163_AC1HA2ACXX_s_1_rg.sorted.bam	29.7	1.9	0.13	58cfa830e4b0c9d6adf6bf95	TCGA-BR-6564-01A-12D-1880_121220_SN1222_0163_AC1HA2ACXX_s_1_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-BR-6564-01A	AF1086CC-B330-4AD6-AE1C-3B5C7259949A	Primary Tumor	Illumina HiSeq	6ee5a220-be0b-4909-bd37-5a6d8c53177d	Stomach	46	B8355E52-D7A7-4711-BBA7-BC4D201741F2	62E2C436-03DA-4B32-B43A-DF7AC992DD7C	TCGA-BR-6564-01A-12D-1880-02	HG19_Broad_variant	TCGA-BR-6564	TCGA-STAD	NA	s15051	Harvard Medical School	Asterand	Russia	NO	T3	N2	Stomach  Adenocarcinoma  Diffuse Type	Stage IIIA	1880-02	TRUE
13722.58cfa830e4b0c9d6adf6c1f2	58cfa830e4b0c9d6adf6c1f2	TCGA-BT-A20N-01A-11D-A14U_120921_SN208_0431_BD1D5FACXX_s_1_rg.sorted.filtered.	WGS	TCGA-BT-A20N-01A-11D-A14U_120921_SN208_0431_BD1D5FACXX_s_1_rg.sorted	TCGA-BT-A20N-01A-11D-A14U_120921_SN208_0431_BD1D5FACXX_s_1_rg.sorted.bam	70.31	1.91	0.17	58cfa830e4b0c9d6adf6c1f2	TCGA-BT-A20N-01A-11D-A14U_120921_SN208_0431_BD1D5FACXX_s_1_rg.sorted.bam	Dead	MALE	Not available	Not available	Bladder Urothelial Carcinoma	Aligned reads	TCGA-BT-A20N-01A	EBEDAB7C-DD7C-448E-8324-78C86F13BE8B	Primary Tumor	Illumina HiSeq	c7de2a6f-d24f-4be6-98af-307070063116	Bladder	72	89EC2DFD-7A0C-4631-958D-D5492BC89F8D	CE801D11-240F-4510-8010-E3D7DA8247FC	TCGA-BT-A20N-01A-11D-A14U-02	HG19_Broad_variant	TCGA-BT-A20N	TCGA-BLCA	795	s2697	Harvard Medical School	University of Pittsburgh	None	NO	T3a	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage III	A14U-02	TRUE
13722.58cfa830e4b0c9d6adf6bf14	58cfa830e4b0c9d6adf6bf14	TCGA-BR-4267-01A-01D-1128_120805_SN1120_0181_AD16WCACXX_s_3_rg.sorted.filtered.	WGS	TCGA-BR-4267-01A-01D-1128_120805_SN1120_0181_AD16WCACXX_s_3_rg.sorted	TCGA-BR-4267-01A-01D-1128_120805_SN1120_0181_AD16WCACXX_s_3_rg.sorted.bam	265.9	1.9	0.13	58cfa830e4b0c9d6adf6bf14	TCGA-BR-4267-01A-01D-1128_120805_SN1120_0181_AD16WCACXX_s_3_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-BR-4267-01A	0D0F0200-25B8-483B-B04A-82A7833B4D30	Primary Tumor	Illumina HiSeq	cd48e485-3a3f-4eec-92e7-f1c52c0866f1	Stomach	51	32D28ED3-2E33-4D83-8DE6-82E156B33211	F0DB5AF5-091F-4CDC-9917-BEFD658BF454	TCGA-BR-4267-01A-01D-1128-02	HG19_Broad_variant	TCGA-BR-4267	TCGA-STAD	NA	s15044	Harvard Medical School	Asterand	None	NO	T2a	N0	Stomach  Adenocarcinoma  Not Otherwise Specified (NOS)	Stage IB	1128-02	TRUE
13722.58cfa830e4b0c9d6adf6c1fa	58cfa830e4b0c9d6adf6c1fa	TCGA-BA-5559-01A-01D-1509_120420_SN1120_0135_BD0T5FACXX_s_6_rg.sorted.filtered.	WGS	TCGA-BA-5559-01A-01D-1509_120420_SN1120_0135_BD0T5FACXX_s_6_rg.sorted	TCGA-BA-5559-01A-01D-1509_120420_SN1120_0135_BD0T5FACXX_s_6_rg.sorted.bam	476.7	1.9	0.16	58cfa830e4b0c9d6adf6c1fa	TCGA-BA-5559-01A-01D-1509_120420_SN1120_0135_BD0T5FACXX_s_6_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-BA-5559-01A	17B17D91-C3DF-4B89-9C10-4DB069AFF656	Primary Tumor	Illumina HiSeq	a6749339-8b87-4219-84dd-8045857cbe79	Head and Neck	71	FBEA64F9-B46B-4AF1-BFB2-1791D93977B6	61532C84-EDD9-492D-AF89-99086F87381E	TCGA-BA-5559-01A-01D-1509-02	HG19_Broad_variant	TCGA-BA-5559	TCGA-HNSC	NA	s16320	Harvard Medical School	UNC	None	NO	TX	NX	Head and Neck Squamous Cell Carcinoma	Not available	1509-02	TRUE
13722.58cfa830e4b0c9d6adf6c224	58cfa830e4b0c9d6adf6c224	TCGA-C5-A2LS-01A-22D-A232_140124_SN1120_0291_AC2PHAACXX_s_1_rg.sorted.filtered.	WGS	TCGA-C5-A2LS-01A-22D-A232_140124_SN1120_0291_AC2PHAACXX_s_1_rg.sorted	TCGA-C5-A2LS-01A-22D-A232_140124_SN1120_0291_AC2PHAACXX_s_1_rg.sorted.bam	49.75	NA	0.15	58cfa830e4b0c9d6adf6c224	TCGA-C5-A2LS-01A-22D-A232_140124_SN1120_0291_AC2PHAACXX_s_1_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-C5-A2LS-01A	185E1520-92EE-4AF5-AF15-FBEEFB352C99	Primary Tumor	Illumina HiSeq	3c012d75-0d17-4b4d-834f-cd4767f6b023	Cervix	37	79248694-77E1-4FBE-8C94-64A308FC982D	DE7180EF-3E7E-43D5-8ACE-C7ED57992345	TCGA-C5-A2LS-01A-22D-A232-26	HG19_Broad_variant	TCGA-C5-A2LS	TCGA-CESC	NA	s1356	MD Anderson - Institute for Applied Cancer Science	Medical College of Wisconsin	United States	NO	T1b2	N0	Endocervical Adenocarcinoma of the Usual Type	Not available	A232-26	TRUE
13722.58cfa82fe4b0c9d6adf6b99a	58cfa82fe4b0c9d6adf6b99a	TCGA-64-5774-01A-01D-1623_120228_SN1120_0117_BC0DKWACXX_s_1_rg.sorted.filtered.	WGS	TCGA-64-5774-01A-01D-1623_120228_SN1120_0117_BC0DKWACXX_s_1_rg.sorted	TCGA-64-5774-01A-01D-1623_120228_SN1120_0117_BC0DKWACXX_s_1_rg.sorted.bam	877.7	1.9	0.15	58cfa82fe4b0c9d6adf6b99a	TCGA-64-5774-01A-01D-1623_120228_SN1120_0117_BC0DKWACXX_s_1_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-64-5774-01A	FD3FC273-C035-40EA-A459-FF4806F5D592	Primary Tumor	Illumina HiSeq	b5b4f9c8-7044-4c76-ae48-241c8c4dd953	Lung	60	252C5D60-7033-44C3-8AB5-4604670A80F4	83902D13-5FD4-4640-B20F-3A8110F6D5EC	TCGA-64-5774-01A-01D-1623-02	HG19_Broad_variant	TCGA-64-5774	TCGA-LUAD	NA	s10910	Harvard Medical School	Fox Chase	United States	NO	T2	N0	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage IB	1623-02	TRUE
13722.58cfa830e4b0c9d6adf6c290	58cfa830e4b0c9d6adf6c290	TCGA-BR-4294-01A-01D-1128_121204_SN590_0204_BC1H5VACXX_s_2_rg.sorted.filtered.	WGS	TCGA-BR-4294-01A-01D-1128_121204_SN590_0204_BC1H5VACXX_s_2_rg.sorted	TCGA-BR-4294-01A-01D-1128_121204_SN590_0204_BC1H5VACXX_s_2_rg.sorted.bam	42.9	1.9	0.14	58cfa830e4b0c9d6adf6c290	TCGA-BR-4294-01A-01D-1128_121204_SN590_0204_BC1H5VACXX_s_2_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-BR-4294-01A	ACAB1362-C8A0-448B-8533-0CD84D97959C	Primary Tumor	Illumina HiSeq	23c036ca-ac6a-45dc-9100-558b2249f3bc	Stomach	65	CB5D3EDE-205D-43F6-A3E3-DB287FB1783B	97DB8928-FACC-4095-984F-07C52A759DB4	TCGA-BR-4294-01A-01D-1128-02	HG19_Broad_variant	TCGA-BR-4294	TCGA-STAD	NA	s15374	Harvard Medical School	Asterand	Russia	NO	T2a	NX	Stomach  Intestinal Adenocarcinoma  Tubular Type	Not available	1128-02	TRUE
13722.58cfa830e4b0c9d6adf6c22c	58cfa830e4b0c9d6adf6c22c	TCGA-BT-A0S7-01A-11D-A10R_120920_SN1222_0150_AC1927ACXX_s_4_rg.sorted.filtered.	WGS	TCGA-BT-A0S7-01A-11D-A10R_120920_SN1222_0150_AC1927ACXX_s_4_rg.sorted	TCGA-BT-A0S7-01A-11D-A10R_120920_SN1222_0150_AC1927ACXX_s_4_rg.sorted.bam	12.85	1.87	0.15	58cfa830e4b0c9d6adf6c22c	TCGA-BT-A0S7-01A-11D-A10R_120920_SN1222_0150_AC1927ACXX_s_4_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-BT-A0S7-01A	68BC786E-07C7-4964-BC88-5E2A8633626A	Primary Tumor	Illumina HiSeq	55a63ec5-a803-44ee-905f-c7bfff9162d6	Bladder	75	A9B73851-4609-4DF7-8EB8-45A56F4B2DD6	F415813D-F975-492B-9E4E-55CE47C967B9	TCGA-BT-A0S7-01A-11D-A10R-02	HG19_Broad_variant	TCGA-BT-A0S7	TCGA-BLCA	200	s3269	Harvard Medical School	University of Pittsburgh	United States	NO	T4a	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage III	A10R-02	TRUE
13722.58cfa830e4b0c9d6adf6c2d0	58cfa830e4b0c9d6adf6c2d0	TCGA-CE-A27D-01A-11D-A16N_120805_SN208_0422_BD16VPACXX_s_1_rg.sorted.filtered.	WGS	TCGA-CE-A27D-01A-11D-A16N_120805_SN208_0422_BD16VPACXX_s_1_rg.sorted	TCGA-CE-A27D-01A-11D-A16N_120805_SN208_0422_BD16VPACXX_s_1_rg.sorted.bam	52.72	1.93	0.17	58cfa830e4b0c9d6adf6c2d0	TCGA-CE-A27D-01A-11D-A16N_120805_SN208_0422_BD16VPACXX_s_1_rg.sorted.bam	Alive	FEMALE	ASIAN	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-CE-A27D-01A	75A93F0E-CD41-43C6-A303-FF37E31395E9	Primary Tumor	Illumina HiSeq	c2d55126-05aa-44ef-97c3-ae2ac400c1b9	Thyroid	28	1807CEEE-28E1-4E8D-A1C4-6F6AD60EE310	CE991BB3-A63D-40C1-BFAF-3C4498D2C6EE	TCGA-CE-A27D-01A-11D-A16N-02	HG19_Broad_variant	TCGA-CE-A27D	TCGA-THCA	NA	s12362	Harvard Medical School	ILSbio	Vietnam	NO	T2	N1	Thyroid Papillary Carcinoma - Classical/usual	Stage I	A16N-02	TRUE
13722.58cfa830e4b0c9d6adf6c2d6	58cfa830e4b0c9d6adf6c2d6	TCGA-BR-6707-01A-11D-1880_121220_SN1222_0163_AC1HA2ACXX_s_7_rg.sorted.filtered.	WGS	TCGA-BR-6707-01A-11D-1880_121220_SN1222_0163_AC1HA2ACXX_s_7_rg.sorted	TCGA-BR-6707-01A-11D-1880_121220_SN1222_0163_AC1HA2ACXX_s_7_rg.sorted.bam	333.7	1.9	0.15	58cfa830e4b0c9d6adf6c2d6	TCGA-BR-6707-01A-11D-1880_121220_SN1222_0163_AC1HA2ACXX_s_7_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-BR-6707-01A	DF3DF249-86C2-43D4-ABE1-796CD7DF653F	Primary Tumor	Illumina HiSeq	e2babdbd-1849-48ed-8726-1e3788be6064	Stomach	75	36F691AA-B737-4369-AD62-84F987F697A6	AA430360-2BE7-4C92-A10C-52588D8A6061	TCGA-BR-6707-01A-11D-1880-02	HG19_Broad_variant	TCGA-BR-6707	TCGA-STAD	NA	s14890	Harvard Medical School	Asterand	Ukraine	NO	T3	N0	Stomach  Adenocarcinoma  Not Otherwise Specified (NOS)	Stage IIA	1880-02	TRUE
13722.58cfa830e4b0c9d6adf6c2e4	58cfa830e4b0c9d6adf6c2e4	TCGA-BR-6802-01A-11D-1880_121220_SN1222_0164_BC1HJ3ACXX_s_7_rg.sorted.filtered.	WGS	TCGA-BR-6802-01A-11D-1880_121220_SN1222_0164_BC1HJ3ACXX_s_7_rg.sorted	TCGA-BR-6802-01A-11D-1880_121220_SN1222_0164_BC1HJ3ACXX_s_7_rg.sorted.bam	487.7	1.9	0.14	58cfa830e4b0c9d6adf6c2e4	TCGA-BR-6802-01A-11D-1880_121220_SN1222_0164_BC1HJ3ACXX_s_7_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-BR-6802-01A	7C831A1D-3253-4AF4-A0FF-7FE9FF9AF1CE	Primary Tumor	Illumina HiSeq	73cec875-41a5-40bd-9d13-9e1ed4dd64d0	Stomach	65	E3BF04C2-961F-4511-AF63-5A0E8AE6377B	0B4F4B0B-EF5C-4717-875A-7B8C5342DBC4	TCGA-BR-6802-01A-11D-1880-02	HG19_Broad_variant	TCGA-BR-6802	TCGA-STAD	NA	s14885	Harvard Medical School	Asterand	Russia	NO	T3	N2	Stomach  Adenocarcinoma  Not Otherwise Specified (NOS)	Stage IIIA	1880-02	TRUE
13722.58cfa831e4b0c9d6adf6c350	58cfa831e4b0c9d6adf6c350	TCGA-CG-5717-01A-11D-1598_121029_SN208_0438_AC18NJACXX_s_5_rg.sorted.filtered.	WGS	TCGA-CG-5717-01A-11D-1598_121029_SN208_0438_AC18NJACXX_s_5_rg.sorted	TCGA-CG-5717-01A-11D-1598_121029_SN208_0438_AC18NJACXX_s_5_rg.sorted.bam	152	1.9	0.15	58cfa831e4b0c9d6adf6c350	TCGA-CG-5717-01A-11D-1598_121029_SN208_0438_AC18NJACXX_s_5_rg.sorted.bam	Dead	MALE	Not available	Not available	Stomach Adenocarcinoma	Aligned reads	TCGA-CG-5717-01A	BDC3899E-15AE-421F-829B-0E07FBD27C60	Primary Tumor	Illumina HiSeq	34ec4e75-2398-4904-adf0-34500892e1a5	Stomach	58	CEA37BBD-1BCC-4205-BE3D-DAFAC2E30256	64826993-D765-4895-BE39-BE5ECC72807B	TCGA-CG-5717-01A-11D-1598-02	HG19_Broad_variant	TCGA-CG-5717	TCGA-STAD	212	s14488	Harvard Medical School	Indivumed	Germany	NO	T2b	N1	Stomach  Adenocarcinoma  Not Otherwise Specified (NOS)	Stage II	1598-02	TRUE
13722.58cfa831e4b0c9d6adf6c3f8	58cfa831e4b0c9d6adf6c3f8	TCGA-CH-5771-01A-21D-1572_130104_SN208_0446_BD1KR5ACXX_s_7_rg.sorted.filtered.	WGS	TCGA-CH-5771-01A-21D-1572_130104_SN208_0446_BD1KR5ACXX_s_7_rg.sorted	TCGA-CH-5771-01A-21D-1572_130104_SN208_0446_BD1KR5ACXX_s_7_rg.sorted.bam	30.7	1.9	0.14	58cfa831e4b0c9d6adf6c3f8	TCGA-CH-5771-01A-21D-1572_130104_SN208_0446_BD1KR5ACXX_s_7_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-CH-5771-01A	3ACD8328-76F7-4F43-9660-394B95748C3D	Primary Tumor	Illumina HiSeq	93b110cf-3f4b-4f72-8025-320b77838b0a	Prostate	63	19C87DE2-7936-4277-8AA8-3942D36E7579	83F4BDB9-ED8B-4472-87BB-74C901B1A350	TCGA-CH-5771-01A-21D-1572-02	HG19_Broad_variant	TCGA-CH-5771	TCGA-PRAD	NA	s3931	Harvard Medical School	Indivumed	Germany	NO	T2c	N0	Prostate Adenocarcinoma Acinar Type	Not available	1572-02	TRUE
13722.58cfa831e4b0c9d6adf6c37a	58cfa831e4b0c9d6adf6c37a	TCGA-CD-5813-01A-11D-1598_121026_SN1120_0198_BC188JACXX_s_5_rg.sorted.filtered.	WGS	TCGA-CD-5813-01A-11D-1598_121026_SN1120_0198_BC188JACXX_s_5_rg.sorted	TCGA-CD-5813-01A-11D-1598_121026_SN1120_0198_BC188JACXX_s_5_rg.sorted.bam	46	1.9	0.17	58cfa831e4b0c9d6adf6c37a	TCGA-CD-5813-01A-11D-1598_121026_SN1120_0198_BC188JACXX_s_5_rg.sorted.bam	Alive	MALE	ASIAN	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-CD-5813-01A	152B9D8A-19FD-4665-B9E4-4FEDFB1608CD	Primary Tumor	Illumina HiSeq	ccc0d204-3529-43aa-b108-62d12f6465bd	Stomach	60	09E42E33-D2EC-406C-9A42-36D9D2EBD6C6	2118F0C5-3178-40EA-850D-C3F6F8752DD9	TCGA-CD-5813-01A-11D-1598-02	HG19_Broad_variant	TCGA-CD-5813	TCGA-STAD	NA	s14408	Harvard Medical School	ILSbio	Vietnam	NO	T3	N0	Stomach Intestinal Adenocarcinoma Mucinous Type	Stage II	1598-02	TRUE
13722.58cfa831e4b0c9d6adf6c3c4	58cfa831e4b0c9d6adf6c3c4	TCGA-BT-A20O-01A-21D-A14U_120921_SN208_0431_BD1D5FACXX_s_3_rg.sorted.filtered.	WGS	TCGA-BT-A20O-01A-21D-A14U_120921_SN208_0431_BD1D5FACXX_s_3_rg.sorted	TCGA-BT-A20O-01A-21D-A14U_120921_SN208_0431_BD1D5FACXX_s_3_rg.sorted.bam	63.78	1.88	0.16	58cfa831e4b0c9d6adf6c3c4	TCGA-BT-A20O-01A-21D-A14U_120921_SN208_0431_BD1D5FACXX_s_3_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-BT-A20O-01A	C0E7FBE7-B9CB-4E65-941B-CD7D581C54EC	Primary Tumor	Illumina HiSeq	c345a912-f3c8-4622-9793-88cf795fc964	Bladder	75	5ECD84AD-44FD-4599-BF3D-AB725E0404EC	13596E86-7CD8-4A07-941F-E936D0004F6B	TCGA-BT-A20O-01A-21D-A14U-02	HG19_Broad_variant	TCGA-BT-A20O	TCGA-BLCA	370	s3090	Harvard Medical School	University of Pittsburgh	United States	NO	T3a	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage III	A14U-02	TRUE
13722.58cfa831e4b0c9d6adf6c52e	58cfa831e4b0c9d6adf6c52e	TCGA-CH-5769-01A-11D-1572_130104_SN208_0446_BD1KR5ACXX_s_5_rg.sorted.filtered.	WGS	TCGA-CH-5769-01A-11D-1572_130104_SN208_0446_BD1KR5ACXX_s_5_rg.sorted	TCGA-CH-5769-01A-11D-1572_130104_SN208_0446_BD1KR5ACXX_s_5_rg.sorted.bam	75.7	1.9	0.15	58cfa831e4b0c9d6adf6c52e	TCGA-CH-5769-01A-11D-1572_130104_SN208_0446_BD1KR5ACXX_s_5_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-CH-5769-01A	A7B76662-8380-4F35-9307-99C0ACACB904	Primary Tumor	Illumina HiSeq	2fe51267-827f-4ffb-8aa8-42352e2352d5	Prostate	48	18606532-21D5-40BF-92CF-A42B027449A1	5488DCD8-EC8B-4E14-8F62-5F9931580B87	TCGA-CH-5769-01A-11D-1572-02	HG19_Broad_variant	TCGA-CH-5769	TCGA-PRAD	NA	s3424	Harvard Medical School	Indivumed	Germany	NO	T3b	N0	Prostate Adenocarcinoma Acinar Type	Not available	1572-02	TRUE
13722.58cfa831e4b0c9d6adf6c534	58cfa831e4b0c9d6adf6c534	TCGA-CH-5766-01A-11D-1572_130104_SN208_0446_BD1KR5ACXX_s_1_rg.sorted.filtered.	WGS	TCGA-CH-5766-01A-11D-1572_130104_SN208_0446_BD1KR5ACXX_s_1_rg.sorted	TCGA-CH-5766-01A-11D-1572_130104_SN208_0446_BD1KR5ACXX_s_1_rg.sorted.bam	273.7	1.9	0.15	58cfa831e4b0c9d6adf6c534	TCGA-CH-5766-01A-11D-1572_130104_SN208_0446_BD1KR5ACXX_s_1_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-CH-5766-01A	A5C77AB6-6E98-4A3D-81C8-F3D5FABD31D2	Primary Tumor	Illumina HiSeq	f778efd0-d2ed-48bc-ab57-e2bd12130169	Prostate	55	8477DA86-95BD-4B6D-A3E8-C16C9D61EA1F	ACAE8359-C2D0-4EB8-836B-D0BDF815F065	TCGA-CH-5766-01A-11D-1572-02	HG19_Broad_variant	TCGA-CH-5766	TCGA-PRAD	NA	s3421	Harvard Medical School	Indivumed	Germany	NO	T3a	N1	Prostate Adenocarcinoma Acinar Type	Not available	1572-02	TRUE
13722.58cfa831e4b0c9d6adf6c536	58cfa831e4b0c9d6adf6c536	TCGA-CH-5763-01A-11D-1572_130104_SN208_0445_AC1JWAACXX_s_3_rg.sorted.filtered.	WGS	TCGA-CH-5763-01A-11D-1572_130104_SN208_0445_AC1JWAACXX_s_3_rg.sorted	TCGA-CH-5763-01A-11D-1572_130104_SN208_0445_AC1JWAACXX_s_3_rg.sorted.bam	172.7	1.9	0.17	58cfa831e4b0c9d6adf6c536	TCGA-CH-5763-01A-11D-1572_130104_SN208_0445_AC1JWAACXX_s_3_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-CH-5763-01A	18E79A01-07A2-4CD5-B700-71D41724E041	Primary Tumor	Illumina HiSeq	25246d22-8217-4900-8b3c-c63126974b5c	Prostate	66	F4192448-E5B3-4A9F-8354-9FE28503017A	0B812175-D56C-4407-9745-8DA5B8E531B4	TCGA-CH-5763-01A-11D-1572-02	HG19_Broad_variant	TCGA-CH-5763	TCGA-PRAD	NA	s4126	Harvard Medical School	Indivumed	Germany	NO	T3a	N0	Prostate Adenocarcinoma Acinar Type	Not available	1572-02	TRUE
13722.58cfa831e4b0c9d6adf6c4ac	58cfa831e4b0c9d6adf6c4ac	TCGA-CF-A3MH-01A-11D-A210_120906_SN208_0425_AD1CU2ACXX_s_1_rg.sorted.filtered.	WGS	TCGA-CF-A3MH-01A-11D-A210_120906_SN208_0425_AD1CU2ACXX_s_1_rg.sorted	TCGA-CF-A3MH-01A-11D-A210_120906_SN208_0425_AD1CU2ACXX_s_1_rg.sorted.bam	63.16	NA	0.15	58cfa831e4b0c9d6adf6c4ac	TCGA-CF-A3MH-01A-11D-A210_120906_SN208_0425_AD1CU2ACXX_s_1_rg.sorted.bam	Alive	MALE	ASIAN	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-CF-A3MH-01A	B8A8D2FC-421B-4393-8D5A-946CF72CB496	Primary Tumor	Illumina HiSeq	f82c1606-fe81-428d-9889-58cafa1f29e4	Bladder	75	8CF68BB1-5966-40CD-A038-E9E91E608766	463978F0-D37A-4035-9D1C-8C0E7B0F721C	TCGA-CF-A3MH-01A-11D-A210-26	HG19_Broad_variant	TCGA-CF-A3MH	TCGA-BLCA	NA	s2874	MD Anderson - Institute for Applied Cancer Science	ILSbio	Vietnam	NO	T2	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage II	A210-26	TRUE
13722.58cfa831e4b0c9d6adf6c540	58cfa831e4b0c9d6adf6c540	TCGA-CH-5764-01A-21D-1572_130104_SN208_0445_AC1JWAACXX_s_5_rg.sorted.filtered.	WGS	TCGA-CH-5764-01A-21D-1572_130104_SN208_0445_AC1JWAACXX_s_5_rg.sorted	TCGA-CH-5764-01A-21D-1572_130104_SN208_0445_AC1JWAACXX_s_5_rg.sorted.bam	157.7	1.9	0.17	58cfa831e4b0c9d6adf6c540	TCGA-CH-5764-01A-21D-1572_130104_SN208_0445_AC1JWAACXX_s_5_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-CH-5764-01A	ED73F136-42E8-4100-B432-D10370D07E8B	Primary Tumor	Illumina HiSeq	036937fb-20a8-45df-a234-f7396aefb2d1	Prostate	66	48726D56-93A1-4730-A660-FCEEE0321084	F57D0D07-21B0-4901-9D81-C371C4673D4A	TCGA-CH-5764-01A-21D-1572-02	HG19_Broad_variant	TCGA-CH-5764	TCGA-PRAD	NA	s3777	Harvard Medical School	Indivumed	Germany	NO	T3b	N0	Prostate Adenocarcinoma Acinar Type	Not available	1572-02	TRUE
13722.58cfa831e4b0c9d6adf6c3a0	58cfa831e4b0c9d6adf6c3a0	TCGA-BT-A20U-01A-11D-A14U_120927_SN208_0433_BD1D5JACXX_s_7_rg.sorted.filtered.	WGS	TCGA-BT-A20U-01A-11D-A14U_120927_SN208_0433_BD1D5JACXX_s_7_rg.sorted	TCGA-BT-A20U-01A-11D-A14U_120927_SN208_0433_BD1D5JACXX_s_7_rg.sorted.bam	68.38	1.71	0.17	58cfa831e4b0c9d6adf6c3a0	TCGA-BT-A20U-01A-11D-A14U_120927_SN208_0433_BD1D5JACXX_s_7_rg.sorted.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-BT-A20U-01A	83B41D35-69B1-4218-BE1A-8821D8A6899C	Primary Tumor	Illumina HiSeq	9947c8cb-fa3d-4cc2-942e-b013f7a47faa	Bladder	70	D29E555F-8467-45C8-9124-0E6A757B1ADF	8D4442E9-3312-4607-A59F-49538B19FA71	TCGA-BT-A20U-01A-11D-A14U-02	HG19_Broad_variant	TCGA-BT-A20U	TCGA-BLCA	455	s3270	Harvard Medical School	University of Pittsburgh	United States	NO	T3a	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage III	A14U-02	TRUE
13722.58cfa831e4b0c9d6adf6c4b7	58cfa831e4b0c9d6adf6c4b7	TCGA-BR-4253-01A-01D-1128_120816_SN590_0175_AD16M6ACXX_s_7_rg.sorted.filtered.	WGS	TCGA-BR-4253-01A-01D-1128_120816_SN590_0175_AD16M6ACXX_s_7_rg.sorted	TCGA-BR-4253-01A-01D-1128_120816_SN590_0175_AD16M6ACXX_s_7_rg.sorted.bam	201.9	1.9	0.14	58cfa831e4b0c9d6adf6c4b7	TCGA-BR-4253-01A-01D-1128_120816_SN590_0175_AD16M6ACXX_s_7_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-BR-4253-01A	411257A4-A148-4606-8C8B-F9F1240E40ED	Primary Tumor	Illumina HiSeq	90590609-4f3e-48b4-98e5-963c1c97f057	Stomach	80	C536B8DF-6FE3-425E-82E8-36299A6BA2B9	B7CE561B-B51B-4C85-822D-58DF663DE8EA	TCGA-BR-4253-01A-01D-1128-02	HG19_Broad_variant	TCGA-BR-4253	TCGA-STAD	NA	s15104	Harvard Medical School	Asterand	Russia	NO	T3	N1	Stomach  Adenocarcinoma  Not Otherwise Specified (NOS)	Stage IIIA	1128-02	TRUE
13722.58cfa831e4b0c9d6adf6c552	58cfa831e4b0c9d6adf6c552	TCGA-CH-5762-01A-11D-1572_130104_SN208_0445_AC1JWAACXX_s_1_rg.sorted.filtered.	WGS	TCGA-CH-5762-01A-11D-1572_130104_SN208_0445_AC1JWAACXX_s_1_rg.sorted	TCGA-CH-5762-01A-11D-1572_130104_SN208_0445_AC1JWAACXX_s_1_rg.sorted.bam	211.7	1.9	0.15	58cfa831e4b0c9d6adf6c552	TCGA-CH-5762-01A-11D-1572_130104_SN208_0445_AC1JWAACXX_s_1_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-CH-5762-01A	D4FFAFDC-EE83-43DF-AA3B-7326503C6438	Primary Tumor	Illumina HiSeq	70b297c6-c1f6-4651-93c3-17888cf0b118	Prostate	60	6D1A2D44-72F3-4333-8506-E53CDC4E5185	25189A34-4C05-4D77-9A3B-212A475F66B1	TCGA-CH-5762-01A-11D-1572-02	HG19_Broad_variant	TCGA-CH-5762	TCGA-PRAD	NA	s3594	Harvard Medical School	Indivumed	Germany	NO	T3b	N0	Prostate Adenocarcinoma Acinar Type	Not available	1572-02	TRUE
13722.58cfa831e4b0c9d6adf6c542	58cfa831e4b0c9d6adf6c542	TCGA-CH-5754-01A-11D-1572_130103_SN1222_0166_BD1K7EACXX_s_5_rg.sorted.filtered.	WGS	TCGA-CH-5754-01A-11D-1572_130103_SN1222_0166_BD1K7EACXX_s_5_rg.sorted	TCGA-CH-5754-01A-11D-1572_130103_SN1222_0166_BD1K7EACXX_s_5_rg.sorted.bam	197.7	1.9	0.16	58cfa831e4b0c9d6adf6c542	TCGA-CH-5754-01A-11D-1572_130103_SN1222_0166_BD1K7EACXX_s_5_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-CH-5754-01A	0AAD0ABD-750A-400D-A34F-491DA996D46C	Primary Tumor	Illumina HiSeq	9b3dfe47-a8c3-4a73-8aa3-66af9d5001a2	Prostate	65	BE645D37-B3E1-4D09-91CB-6231E25ACEB8	2C0EF4A5-DC20-45E7-B8EE-7525D77128B6	TCGA-CH-5754-01A-11D-1572-02	HG19_Broad_variant	TCGA-CH-5754	TCGA-PRAD	NA	s3596	Harvard Medical School	Indivumed	Germany	NO	T3b	N1	Prostate Adenocarcinoma Acinar Type	Not available	1572-02	TRUE
13722.58cfa831e4b0c9d6adf6c556	58cfa831e4b0c9d6adf6c556	TCGA-CH-5752-01A-11D-1572_130103_SN1222_0166_BD1K7EACXX_s_1_rg.sorted.filtered.	WGS	TCGA-CH-5752-01A-11D-1572_130103_SN1222_0166_BD1K7EACXX_s_1_rg.sorted	TCGA-CH-5752-01A-11D-1572_130103_SN1222_0166_BD1K7EACXX_s_1_rg.sorted.bam	191.7	1.9	0.16	58cfa831e4b0c9d6adf6c556	TCGA-CH-5752-01A-11D-1572_130103_SN1222_0166_BD1K7EACXX_s_1_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-CH-5752-01A	D8F56D75-51AB-4A86-A502-C86E1DCD1EFF	Primary Tumor	Illumina HiSeq	d1bae4e7-eb79-4ede-abb5-19a328e4ad0c	Prostate	66	94A01526-7771-4A05-A9CE-9694B73DF3A7	490FC467-7E7E-40A1-98D0-ABA46EC71F53	TCGA-CH-5752-01A-11D-1572-02	HG19_Broad_variant	TCGA-CH-5752	TCGA-PRAD	NA	s3427	Harvard Medical School	Indivumed	Germany	NO	T3a	N0	Prostate Adenocarcinoma Acinar Type	Not available	1572-02	TRUE
13722.58cfa831e4b0c9d6adf6c562	58cfa831e4b0c9d6adf6c562	TCGA-CH-5761-01A-11D-1572_130103_SN1222_0166_BD1K7EACXX_s_7_rg.sorted.filtered.	WGS	TCGA-CH-5761-01A-11D-1572_130103_SN1222_0166_BD1K7EACXX_s_7_rg.sorted	TCGA-CH-5761-01A-11D-1572_130103_SN1222_0166_BD1K7EACXX_s_7_rg.sorted.bam	197.7	1.9	0.15	58cfa831e4b0c9d6adf6c562	TCGA-CH-5761-01A-11D-1572_130103_SN1222_0166_BD1K7EACXX_s_7_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-CH-5761-01A	854A481B-71A2-4F23-80AA-E91E9F4069B1	Primary Tumor	Illumina HiSeq	4d316299-7958-45e8-93ab-2150e05d3210	Prostate	61	332A54B1-2DF4-4BAA-84AC-2D95ABEF4064	F2F787DA-691C-4E73-A8B1-8D662781953E	TCGA-CH-5761-01A-11D-1572-02	HG19_Broad_variant	TCGA-CH-5761	TCGA-PRAD	NA	s3593	Harvard Medical School	Indivumed	Germany	NO	T3b	N0	Prostate Adenocarcinoma Acinar Type	Not available	1572-02	TRUE
13722.58cfa831e4b0c9d6adf6c56a	58cfa831e4b0c9d6adf6c56a	TCGA-CH-5765-01A-11D-1572_130104_SN208_0445_AC1JWAACXX_s_7_rg.sorted.filtered.	WGS	TCGA-CH-5765-01A-11D-1572_130104_SN208_0445_AC1JWAACXX_s_7_rg.sorted	TCGA-CH-5765-01A-11D-1572_130104_SN208_0445_AC1JWAACXX_s_7_rg.sorted.bam	256.7	1.9	0.16	58cfa831e4b0c9d6adf6c56a	TCGA-CH-5765-01A-11D-1572_130104_SN208_0445_AC1JWAACXX_s_7_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-CH-5765-01A	716EB429-D7AF-4D4F-BD8D-AFCFF1A323EE	Primary Tumor	Illumina HiSeq	265ff01e-199b-4908-acaa-62aa8986967a	Prostate	55	E2359111-B056-4676-A8B6-C5CEA259B478	B7EFFFED-73EC-4139-A359-41B239F2978D	TCGA-CH-5765-01A-11D-1572-02	HG19_Broad_variant	TCGA-CH-5765	TCGA-PRAD	NA	s3428	Harvard Medical School	Indivumed	Germany	NO	T3a	N0	Prostate Adenocarcinoma Acinar Type	Not available	1572-02	TRUE
13722.58cfa831e4b0c9d6adf6c632	58cfa831e4b0c9d6adf6c632	TCGA-CG-4441-01A-01D-1798_130214_SN1120_0236_AC1RPCACXX_s_1_rg.sorted.filtered.	WGS	TCGA-CG-4441-01A-01D-1798_130214_SN1120_0236_AC1RPCACXX_s_1_rg.sorted	TCGA-CG-4441-01A-01D-1798_130214_SN1120_0236_AC1RPCACXX_s_1_rg.sorted.bam	250	1.9	0.15	58cfa831e4b0c9d6adf6c632	TCGA-CG-4441-01A-01D-1798_130214_SN1120_0236_AC1RPCACXX_s_1_rg.sorted.bam	Dead	MALE	Not available	Not available	Stomach Adenocarcinoma	Aligned reads	TCGA-CG-4441-01A	37E22429-EFD7-4D6A-B79A-9D8C7BE2170C	Primary Tumor	Illumina HiSeq	d3542e45-2b25-406d-976d-5d4c63e4839e	Stomach	83	60937697-57BA-4D03-9545-B0E321215448	DE856FF9-FEF4-4AA8-9418-F29EB79932B0	TCGA-CG-4441-01A-01D-1798-02	HG19_Broad_variant	TCGA-CG-4441	TCGA-STAD	426	s14699	Harvard Medical School	Indivumed	Germany	NO	T2	N2	Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS)	Stage IIIA	1798-02	TRUE
13722.58cfa831e4b0c9d6adf6c6ce	58cfa831e4b0c9d6adf6c6ce	TCGA-CS-6290-01A-11D-1703_130808_SN208_0487_AC28U7ACXX_s_7_rg.sorted.filtered.	WGS	TCGA-CS-6290-01A-11D-1703_130808_SN208_0487_AC28U7ACXX_s_7_rg.sorted	TCGA-CS-6290-01A-11D-1703_130808_SN208_0487_AC28U7ACXX_s_7_rg.sorted.bam	95.3	1.9	0.15	58cfa831e4b0c9d6adf6c6ce	TCGA-CS-6290-01A-11D-1703_130808_SN208_0487_AC28U7ACXX_s_7_rg.sorted.bam	Alive	MALE	Not available	Not available	Brain Lower Grade Glioma	Aligned reads	TCGA-CS-6290-01A	42FE260F-520B-4FAC-8C09-D2B31AED59FB	Primary Tumor	Illumina HiSeq	dd2c0db0-5e68-43b9-a591-4efa9a782af1	Brain	31	6148F31E-CDBA-481B-BCD7-B3AEE05925B1	D31BD4D8-DF61-4B6B-9304-17B22FDD023B	TCGA-CS-6290-01A-11D-1703-02	HG19_Broad_variant	TCGA-CS-6290	TCGA-LGG	NA	s8555	Harvard Medical School	Thomas Jefferson University	United States	NO	Not available	Not available	Astrocytoma	Not available	1703-02	TRUE
13722.58cfa831e4b0c9d6adf6c67c	58cfa831e4b0c9d6adf6c67c	TCGA-CN-4739-01A-02D-1509_120420_SN1120_0135_BD0T5FACXX_s_8_rg.sorted.filtered.	WGS	TCGA-CN-4739-01A-02D-1509_120420_SN1120_0135_BD0T5FACXX_s_8_rg.sorted	TCGA-CN-4739-01A-02D-1509_120420_SN1120_0135_BD0T5FACXX_s_8_rg.sorted.bam	187.7	1.9	0.14	58cfa831e4b0c9d6adf6c67c	TCGA-CN-4739-01A-02D-1509_120420_SN1120_0135_BD0T5FACXX_s_8_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CN-4739-01A	7E3B90C1-8772-4E12-8050-A156558BEB82	Primary Tumor	Illumina HiSeq	796943be-2aa7-419f-801f-22c78459cc72	Head and Neck	71	F450DBE6-4972-4C49-AF97-963BCD0D0DA0	3B0BED92-ED76-451D-B605-A79FAE296DDE	TCGA-CN-4739-01A-02D-1509-02	HG19_Broad_variant	TCGA-CN-4739	TCGA-HNSC	NA	s15888	Harvard Medical School	University of Pittsburgh	None	NO	T4a	N0	Head and Neck Squamous Cell Carcinoma	Stage IVA	1509-02	TRUE
13722.58cfa831e4b0c9d6adf6c6b6	58cfa831e4b0c9d6adf6c6b6	TCGA-CQ-7065-01A-11D-2317_120730_SN1222_0140_AC11GKACXX_s_1_rg.sorted.filtered.	WGS	TCGA-CQ-7065-01A-11D-2317_120730_SN1222_0140_AC11GKACXX_s_1_rg.sorted	TCGA-CQ-7065-01A-11D-2317_120730_SN1222_0140_AC11GKACXX_s_1_rg.sorted.bam	15.93	NA	0.13	58cfa831e4b0c9d6adf6c6b6	TCGA-CQ-7065-01A-11D-2317_120730_SN1222_0140_AC11GKACXX_s_1_rg.sorted.bam	Alive	MALE	ASIAN	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CQ-7065-01A	20ECE2CA-8601-4CCA-AEC5-0A5C0B92594D	Primary Tumor	Illumina HiSeq	a7ab0507-8b7a-45aa-9e07-21bfc50fddd0	Head and Neck	40	65B44EBF-F817-4B29-8FB6-01B07BC2E7D1	DFB72780-B485-403B-997C-6F6FD0EF0E75	TCGA-CQ-7065-01A-11D-2317-26	HG19_Broad_variant	TCGA-CQ-7065	TCGA-HNSC	NA	s16040	MD Anderson - Institute for Applied Cancer Science	University Health Network, Toronto	Canada	NO	T2	N0	Head and Neck Squamous Cell Carcinoma	Stage II	2317-26	TRUE
13722.58cfa831e4b0c9d6adf6c6d0	58cfa831e4b0c9d6adf6c6d0	TCGA-CS-4941-01A-01D-1465_130808_SN208_0487_AC28U7ACXX_s_1_rg.sorted.filtered.	WGS	TCGA-CS-4941-01A-01D-1465_130808_SN208_0487_AC28U7ACXX_s_1_rg.sorted	TCGA-CS-4941-01A-01D-1465_130808_SN208_0487_AC28U7ACXX_s_1_rg.sorted.bam	157	1.9	0.15	58cfa831e4b0c9d6adf6c6d0	TCGA-CS-4941-01A-01D-1465_130808_SN208_0487_AC28U7ACXX_s_1_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-CS-4941-01A	FC222F23-B3B2-4AC0-BC61-E8E8FA5CC160	Primary Tumor	Illumina HiSeq	7df56317-1eca-4fb0-af19-36a4bfc5df00	Brain	67	4E5AEE62-DF39-4A74-917C-C3AB154F8D0E	8CA32F59-BA52-49E8-BA72-D2761ED47099	TCGA-CS-4941-01A-01D-1465-02	HG19_Broad_variant	TCGA-CS-4941	TCGA-LGG	234	s8126	Harvard Medical School	Thomas Jefferson University	United States	NO	Not available	Not available	Astrocytoma	Not available	1465-02	TRUE
13722.58cfa831e4b0c9d6adf6c6f4	58cfa831e4b0c9d6adf6c6f4	TCGA-CV-5977-01A-11D-1681_120427_SN1120_0137_BD0T3FACXX_s_3_rg.sorted.filtered.	WGS	TCGA-CV-5977-01A-11D-1681_120427_SN1120_0137_BD0T3FACXX_s_3_rg.sorted	TCGA-CV-5977-01A-11D-1681_120427_SN1120_0137_BD0T3FACXX_s_3_rg.sorted.bam	307	1.9	0.15	58cfa831e4b0c9d6adf6c6f4	TCGA-CV-5977-01A-11D-1681_120427_SN1120_0137_BD0T3FACXX_s_3_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-5977-01A	50239D1D-B3A4-4240-AB83-B24BA67B1299	Primary Tumor	Illumina HiSeq	ccdab134-2f40-4e7a-8b7c-ac1269321d3e	Head and Neck	66	84756AB5-9CB6-4DBD-848C-A85804F22AA1	140E6B2E-7EDD-417D-B720-58BEAB50AEA5	TCGA-CV-5977-01A-11D-1681-02	HG19_Broad_variant	TCGA-CV-5977	TCGA-HNSC	NA	s15896	Harvard Medical School	MD Anderson Cancer Center	None	NO	T3	N2b	Head and Neck Squamous Cell Carcinoma	Stage IVA	1681-02	TRUE
13722.58cfa831e4b0c9d6adf6c752	58cfa831e4b0c9d6adf6c752	TCGA-CV-6939-01A-11D-1911_120504_SN208_0297_BC0VJEACXX_s_1_rg.sorted.filtered.	WGS	TCGA-CV-6939-01A-11D-1911_120504_SN208_0297_BC0VJEACXX_s_1_rg.sorted	TCGA-CV-6939-01A-11D-1911_120504_SN208_0297_BC0VJEACXX_s_1_rg.sorted.bam	193.7	1.9	0.14	58cfa831e4b0c9d6adf6c752	TCGA-CV-6939-01A-11D-1911_120504_SN208_0297_BC0VJEACXX_s_1_rg.sorted.bam	Dead	MALE	WHITE	Not available	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-6939-01A	E7D1F0DD-EEC0-4670-A2BA-00FFE38C6382	Primary Tumor	Illumina HiSeq	28dc7c63-6d80-4648-a356-07e8f846bc80	Head and Neck	60	1ED822F5-FEA5-46DE-9681-EC484DE734D8	8BB4510A-C148-4A9E-8ECF-6F8C8E9309CA	TCGA-CV-6939-01A-11D-1911-02	HG19_Broad_variant	TCGA-CV-6939	TCGA-HNSC	666	s15515	Harvard Medical School	MD Anderson Cancer Center	United States	NO	T4a	N2b	Head and Neck Squamous Cell Carcinoma	Stage IVA	1911-02	TRUE
13722.58cfa831e4b0c9d6adf6c7da	58cfa831e4b0c9d6adf6c7da	TCGA-CV-7091-01A-11D-2317_120623_SN1222_0119_BC0WLLACXX_s_8_rg.sorted.filtered.	WGS	TCGA-CV-7091-01A-11D-2317_120623_SN1222_0119_BC0WLLACXX_s_8_rg.sorted	TCGA-CV-7091-01A-11D-2317_120623_SN1222_0119_BC0WLLACXX_s_8_rg.sorted.bam	289.73	NA	0.15	58cfa831e4b0c9d6adf6c7da	TCGA-CV-7091-01A-11D-2317_120623_SN1222_0119_BC0WLLACXX_s_8_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-7091-01A	2A192049-6435-49AB-8444-DDEB2B9EE774	Primary Tumor	Illumina HiSeq	8a0170b3-9cda-4426-be4b-9e488f6244c2	Head and Neck	54	3AB78DC4-682E-4B5A-ADDA-223ACF0FBB6A	78998DCE-A468-416B-9F81-D64E43B52883	TCGA-CV-7091-01A-11D-2317-26	HG19_Broad_variant	TCGA-CV-7091	TCGA-HNSC	NA	s16342	MD Anderson - Institute for Applied Cancer Science	MD Anderson Cancer Center	United States	NO	T1	N0	Head and Neck Squamous Cell Carcinoma	Stage I	2317-26	TRUE
13722.58cfa831e4b0c9d6adf6c7d0	58cfa831e4b0c9d6adf6c7d0	TCGA-CV-6945-01A-11D-1911_120504_SN208_0297_BC0VJEACXX_s_2_rg.sorted.filtered.	WGS	TCGA-CV-6945-01A-11D-1911_120504_SN208_0297_BC0VJEACXX_s_2_rg.sorted	TCGA-CV-6945-01A-11D-1911_120504_SN208_0297_BC0VJEACXX_s_2_rg.sorted.bam	155.7	1.9	0.14	58cfa831e4b0c9d6adf6c7d0	TCGA-CV-6945-01A-11D-1911_120504_SN208_0297_BC0VJEACXX_s_2_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-6945-01A	15714E69-E075-4688-8F51-C7102FE4CA07	Primary Tumor	Illumina HiSeq	50a2b9f7-d572-47c4-bf4b-3d6255512094	Head and Neck	41	55849997-67DE-4FC6-B7BF-9D02D15920C9	FC2ACD2E-751C-4252-85A1-6C5A8E980964	TCGA-CV-6945-01A-11D-1911-02	HG19_Broad_variant	TCGA-CV-6945	TCGA-HNSC	366	s15775	Harvard Medical School	MD Anderson Cancer Center	United States	NO	T4a	N2	Head and Neck Squamous Cell Carcinoma	Stage IVA	1911-02	TRUE
13722.58cfa831e4b0c9d6adf6c828	58cfa831e4b0c9d6adf6c828	TCGA-CV-7238-01A-11D-2317_120730_SN1222_0140_AC11GKACXX_s_4_rg.sorted.filtered.	WGS	TCGA-CV-7238-01A-11D-2317_120730_SN1222_0140_AC11GKACXX_s_4_rg.sorted	TCGA-CV-7238-01A-11D-2317_120730_SN1222_0140_AC11GKACXX_s_4_rg.sorted.bam	143.73	NA	0.14	58cfa831e4b0c9d6adf6c828	TCGA-CV-7238-01A-11D-2317_120730_SN1222_0140_AC11GKACXX_s_4_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-7238-01A	78FCC813-D0A8-44AA-B004-62810DCA9D12	Primary Tumor	Illumina HiSeq	3eb627a6-bbcf-4699-ad23-e52a26cd4453	Head and Neck	69	831808D5-1883-4F6F-B252-1BB397FBD62A	D051D2CB-F8DE-4E42-B9CF-E7CBE43861A0	TCGA-CV-7238-01A-11D-2317-26	HG19_Broad_variant	TCGA-CV-7238	TCGA-HNSC	NA	s15520	MD Anderson - Institute for Applied Cancer Science	MD Anderson Cancer Center	United States	NO	T2	N0	Head and Neck Squamous Cell Carcinoma	Stage II	2317-26	TRUE
13722.58cfa831e4b0c9d6adf6c88c	58cfa831e4b0c9d6adf6c88c	TCGA-D7-6822-01A-11D-1880_121220_SN1120_0207_BC1JALACXX_s_5_rg.sorted.filtered.	WGS	TCGA-D7-6822-01A-11D-1880_121220_SN1120_0207_BC1JALACXX_s_5_rg.sorted	TCGA-D7-6822-01A-11D-1880_121220_SN1120_0207_BC1JALACXX_s_5_rg.sorted.bam	442.7	1.9	0.14	58cfa831e4b0c9d6adf6c88c	TCGA-D7-6822-01A-11D-1880_121220_SN1120_0207_BC1JALACXX_s_5_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-D7-6822-01A	E2AAABD9-F4BA-4763-A28A-C14D46A4BC5D	Primary Tumor	Illumina HiSeq	b8f8d06c-7bbf-4d0d-8f5a-e3012379df95	Stomach	77	C30AFDA8-FC63-4228-A9A9-42BCDB562ACE	586B20D4-917E-4344-BFBC-A21B12811C69	TCGA-D7-6822-01A-11D-1880-02	HG19_Broad_variant	TCGA-D7-6822	TCGA-STAD	NA	s14769	Harvard Medical School	Greater Poland Cancer Center	Poland	NO	T2	N0	Stomach  Intestinal Adenocarcinoma  Tubular Type	Stage IB	1880-02	TRUE
13722.58cfa831e4b0c9d6adf6c837	58cfa831e4b0c9d6adf6c837	TCGA-CV-7095-01A-21D-2317_120730_SN1222_0140_AC11GKACXX_s_2_rg.sorted.filtered.	WGS	TCGA-CV-7095-01A-21D-2317_120730_SN1222_0140_AC11GKACXX_s_2_rg.sorted	TCGA-CV-7095-01A-21D-2317_120730_SN1222_0140_AC11GKACXX_s_2_rg.sorted.bam	90.73	NA	0.14	58cfa831e4b0c9d6adf6c837	TCGA-CV-7095-01A-21D-2317_120730_SN1222_0140_AC11GKACXX_s_2_rg.sorted.bam	Dead	FEMALE	Not available	HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-7095-01A	D7D49895-032F-4385-8B68-AE16F8675CA7	Primary Tumor	Illumina HiSeq	d944910b-a3cf-45e9-84be-5ea0e6cd6f03	Head and Neck	87	E7D35C82-8992-4CC0-AA65-DF5CAB5727EB	F85FA02B-0695-4F2E-957B-FF11F1E6FCE6	TCGA-CV-7095-01A-21D-2317-26	HG19_Broad_variant	TCGA-CV-7095	TCGA-HNSC	572	s16052	MD Anderson - Institute for Applied Cancer Science	MD Anderson Cancer Center	United States	NO	T2	NX	Head and Neck Squamous Cell Carcinoma	Stage II	2317-26	TRUE
13722.58cfa831e4b0c9d6adf6c850	58cfa831e4b0c9d6adf6c850	TCGA-CV-6948-01A-11D-1911_120504_SN208_0297_BC0VJEACXX_s_3_rg.sorted.filtered.	WGS	TCGA-CV-6948-01A-11D-1911_120504_SN208_0297_BC0VJEACXX_s_3_rg.sorted	TCGA-CV-6948-01A-11D-1911_120504_SN208_0297_BC0VJEACXX_s_3_rg.sorted.bam	263.7	1.9	0.15	58cfa831e4b0c9d6adf6c850	TCGA-CV-6948-01A-11D-1911_120504_SN208_0297_BC0VJEACXX_s_3_rg.sorted.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-6948-01A	FCF0DC48-B889-4593-A15B-AA715AAE7BF5	Primary Tumor	Illumina HiSeq	87c6cf32-e113-471b-86b3-cca360f47616	Head and Neck	79	21844F33-DD12-4940-B42D-2F9FABB2F7BA	8FEEA708-D971-4FD0-8542-1E31A9DFF8EA	TCGA-CV-6948-01A-11D-1911-02	HG19_Broad_variant	TCGA-CV-6948	TCGA-HNSC	1289	s15650	Harvard Medical School	MD Anderson Cancer Center	United States	NO	T4a	N3	Head and Neck Squamous Cell Carcinoma	Stage IVB	1911-02	TRUE
13722.58cfa831e4b0c9d6adf6c86a	58cfa831e4b0c9d6adf6c86a	TCGA-CV-6003-01A-11D-1681_120427_SN1120_0137_BD0T3FACXX_s_4_rg.sorted.filtered.	WGS	TCGA-CV-6003-01A-11D-1681_120427_SN1120_0137_BD0T3FACXX_s_4_rg.sorted	TCGA-CV-6003-01A-11D-1681_120427_SN1120_0137_BD0T3FACXX_s_4_rg.sorted.bam	223	1.9	0.14	58cfa831e4b0c9d6adf6c86a	TCGA-CV-6003-01A-11D-1681_120427_SN1120_0137_BD0T3FACXX_s_4_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-6003-01A	417B357E-C90E-4B63-AE7A-4B782038FFD3	Primary Tumor	Illumina HiSeq	b314312e-2a3f-45dd-a813-870344654395	Head and Neck	50	6892F7E3-630E-45B5-8C30-139161461A85	9DF426C5-E45E-428B-A63C-11D4C1BEB4B2	TCGA-CV-6003-01A-11D-1681-02	HG19_Broad_variant	TCGA-CV-6003	TCGA-HNSC	NA	s16197	Harvard Medical School	MD Anderson Cancer Center	None	NO	T2	N1	Head and Neck Squamous Cell Carcinoma	Stage III	1681-02	TRUE
13722.58cfa831e4b0c9d6adf6c8c0	58cfa831e4b0c9d6adf6c8c0	TCGA-CV-5971-01A-11D-1681_120427_SN1120_0136_AC0JEMACXX_s_4_rg.sorted.filtered.	WGS	TCGA-CV-5971-01A-11D-1681_120427_SN1120_0136_AC0JEMACXX_s_4_rg.sorted	TCGA-CV-5971-01A-11D-1681_120427_SN1120_0136_AC0JEMACXX_s_4_rg.sorted.bam	22	1.9	0.16	58cfa831e4b0c9d6adf6c8c0	TCGA-CV-5971-01A-11D-1681_120427_SN1120_0136_AC0JEMACXX_s_4_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-5971-01A	1465B7EC-8D2B-47DD-8387-977EED44CC86	Primary Tumor	Illumina HiSeq	03c22e39-15a9-4b8a-8db1-cf41d618b7fc	Head and Neck	60	82589B3F-BD41-4ABE-9469-7DD48447DDDC	5739D7DE-98D4-4591-B8B1-E0E9AA9B05DF	TCGA-CV-5971-01A-11D-1681-02	HG19_Broad_variant	TCGA-CV-5971	TCGA-HNSC	NA	s16198	Harvard Medical School	MD Anderson Cancer Center	None	NO	T4a	N2a	Head and Neck Squamous Cell Carcinoma	Stage IVA	1681-02	TRUE
13722.58cfa831e4b0c9d6adf6c898	58cfa831e4b0c9d6adf6c898	TCGA-DU-5854-01A-11D-1703_130806_SN1440_0159_BC29Y3ACXX_s_1_rg.sorted.filtered.	WGS	TCGA-DU-5854-01A-11D-1703_130806_SN1440_0159_BC29Y3ACXX_s_1_rg.sorted	TCGA-DU-5854-01A-11D-1703_130806_SN1440_0159_BC29Y3ACXX_s_1_rg.sorted.bam	66.3	1.9	0.16	58cfa831e4b0c9d6adf6c898	TCGA-DU-5854-01A-11D-1703_130806_SN1440_0159_BC29Y3ACXX_s_1_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-DU-5854-01A	B95AFB1A-A1DF-4D85-AD34-191928E28A77	Primary Tumor	Illumina HiSeq	f499956c-7655-4be7-8a53-44403d30ea04	Brain	57	D5BAA53A-958C-4163-A388-D3C957C891F9	4716DB1C-94F8-40AE-B89B-EA41E6A7E8CE	TCGA-DU-5854-01A-11D-1703-02	HG19_Broad_variant	TCGA-DU-5854	TCGA-LGG	NA	s8562	Harvard Medical School	Henry Ford Hospital	United States	NO	Not available	Not available	Astrocytoma	Not available	1703-02	TRUE
13722.58cfa831e4b0c9d6adf6c90a	58cfa831e4b0c9d6adf6c90a	TCGA-DU-5849-01A-11D-1703_130806_SN1222_0209_AD2AW0ACXX_s_5_rg.sorted.filtered.	WGS	TCGA-DU-5849-01A-11D-1703_130806_SN1222_0209_AD2AW0ACXX_s_5_rg.sorted	TCGA-DU-5849-01A-11D-1703_130806_SN1222_0209_AD2AW0ACXX_s_5_rg.sorted.bam	97.3	1.8	0.14	58cfa831e4b0c9d6adf6c90a	TCGA-DU-5849-01A-11D-1703_130806_SN1222_0209_AD2AW0ACXX_s_5_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-DU-5849-01A	5AF8ADA5-86B5-4832-8A8E-E975ECCA5515	Primary Tumor	Illumina HiSeq	d4f0a4e9-de7c-498f-89e7-aad71fb01915	Brain	48	9E0E239F-CED4-4CF3-BF3C-5EC8224D760B	7732E26C-3B82-4D03-A331-82D8088CEB44	TCGA-DU-5849-01A-11D-1703-02	HG19_Broad_variant	TCGA-DU-5849	TCGA-LGG	NA	s8349	Harvard Medical School	Henry Ford Hospital	United States	NO	Not available	Not available	Oligodendroglioma	Not available	1703-02	TRUE
13722.58cfa831e4b0c9d6adf6c8d8	58cfa831e4b0c9d6adf6c8d8	TCGA-CV-6951-01A-11D-1911_120504_SN208_0297_BC0VJEACXX_s_4_rg.sorted.filtered.	WGS	TCGA-CV-6951-01A-11D-1911_120504_SN208_0297_BC0VJEACXX_s_4_rg.sorted	TCGA-CV-6951-01A-11D-1911_120504_SN208_0297_BC0VJEACXX_s_4_rg.sorted.bam	62.7	1.9	0.14	58cfa831e4b0c9d6adf6c8d8	TCGA-CV-6951-01A-11D-1911_120504_SN208_0297_BC0VJEACXX_s_4_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-6951-01A	91728CD6-ED91-49DC-9279-FAEDBE211A9D	Primary Tumor	Illumina HiSeq	ec458668-da73-4d3e-8ac6-08a0e974b879	Head and Neck	57	9EE0F161-0976-4697-BF69-7E42E7149FEB	90F9C6C1-B7E9-48E4-9A02-C5FAB56AFD95	TCGA-CV-6951-01A-11D-1911-02	HG19_Broad_variant	TCGA-CV-6951	TCGA-HNSC	915	s15905	Harvard Medical School	MD Anderson Cancer Center	United States	NO	T4a	N2c	Head and Neck Squamous Cell Carcinoma	Stage IVA	1911-02	TRUE
13722.58cfa831e4b0c9d6adf6c945	58cfa831e4b0c9d6adf6c945	TCGA-D7-6818-01A-11D-1880_121220_SN1120_0207_BC1JALACXX_s_1_rg.sorted.filtered.	WGS	TCGA-D7-6818-01A-11D-1880_121220_SN1120_0207_BC1JALACXX_s_1_rg.sorted	TCGA-D7-6818-01A-11D-1880_121220_SN1120_0207_BC1JALACXX_s_1_rg.sorted.bam	113.7	1.9	0.14	58cfa831e4b0c9d6adf6c945	TCGA-D7-6818-01A-11D-1880_121220_SN1120_0207_BC1JALACXX_s_1_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-D7-6818-01A	AA2934F9-8783-428E-88A6-1D04B93FA1FD	Primary Tumor	Illumina HiSeq	5a217dfc-ada8-4dec-8f7c-06be0123b9ef	Stomach	53	953E155F-D9E1-41C8-BA12-351A38195D22	21E75BA4-E4C1-4D8A-BFA2-E4698B4FB46B	TCGA-D7-6818-01A-11D-1880-02	HG19_Broad_variant	TCGA-D7-6818	TCGA-STAD	NA	s15464	Harvard Medical School	Greater Poland Cancer Center	Poland	NO	T2	N3	Stomach  Adenocarcinoma  Diffuse Type	Stage IIIA	1880-02	TRUE
13722.58cfa831e4b0c9d6adf6caee	58cfa831e4b0c9d6adf6caee	TCGA-E1-5303-01A-01D-1465_130806_SN1440_0159_BC29Y3ACXX_s_3_rg.sorted.filtered.	WGS	TCGA-E1-5303-01A-01D-1465_130806_SN1440_0159_BC29Y3ACXX_s_3_rg.sorted	TCGA-E1-5303-01A-01D-1465_130806_SN1440_0159_BC29Y3ACXX_s_3_rg.sorted.bam	46	1.9	0.14	58cfa831e4b0c9d6adf6caee	TCGA-E1-5303-01A-01D-1465_130806_SN1440_0159_BC29Y3ACXX_s_3_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-E1-5303-01A	44A5C3B4-62A7-407B-B492-7069E1A43A26	Primary Tumor	Illumina HiSeq	e94ddca3-3117-4958-85a6-cde716b710dc	Brain	38	150856F7-77DA-4AA5-A28B-310A505AEA24	287AB664-A970-437E-A7F9-EF6C20D2266E	TCGA-E1-5303-01A-01D-1465-02	HG19_Broad_variant	TCGA-E1-5303	TCGA-LGG	2052	s8137	Harvard Medical School	Duke	United States	NO	Not available	Not available	Astrocytoma	Not available	1465-02	TRUE
13722.58cfa831e4b0c9d6adf6cae0	58cfa831e4b0c9d6adf6cae0	TCGA-DJ-A13L-01A-11D-A221_120610_SN1120_0151_AC0WN0ACXX_s_5_rg.sorted.filtered.	WGS	TCGA-DJ-A13L-01A-11D-A221_120610_SN1120_0151_AC0WN0ACXX_s_5_rg.sorted	TCGA-DJ-A13L-01A-11D-A221_120610_SN1120_0151_AC0WN0ACXX_s_5_rg.sorted.bam	32.87	NA	0.15	58cfa831e4b0c9d6adf6cae0	TCGA-DJ-A13L-01A-11D-A221_120610_SN1120_0151_AC0WN0ACXX_s_5_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-DJ-A13L-01A	C7A2F394-3E3F-4C90-9F1E-F2BE3E5B0D6B	Primary Tumor	Illumina HiSeq	9424534d-10ae-4669-9a13-75ab8e7a7432	Thyroid	85	AB13FB1A-8B7F-4D84-84A9-C4F7EE59CAF8	417BD826-C151-459E-AAEA-DFA2CB4182DF	TCGA-DJ-A13L-01A-11D-A221-26	HG19_Broad_variant	TCGA-DJ-A13L	TCGA-THCA	NA	s12105	MD Anderson - Institute for Applied Cancer Science	Memorial Sloan Kettering	United States	NO	T1b	N0	Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features)	Stage I	A221-26	TRUE
13722.58cfa831e4b0c9d6adf6cb22	58cfa831e4b0c9d6adf6cb22	TCGA-E5-A2PC-01A-11D-A204_120926_SN1222_0153_BD1D4MACXX_s_1_rg.sorted.filtered.	WGS	TCGA-E5-A2PC-01A-11D-A204_120926_SN1222_0153_BD1D4MACXX_s_1_rg.sorted	TCGA-E5-A2PC-01A-11D-A204_120926_SN1222_0153_BD1D4MACXX_s_1_rg.sorted.bam	63.68	NA	0.16	58cfa831e4b0c9d6adf6cb22	TCGA-E5-A2PC-01A-11D-A204_120926_SN1222_0153_BD1D4MACXX_s_1_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-E5-A2PC-01A	4107AE6F-502C-4BDC-BF14-E4B3711CBA38	Primary Tumor	Illumina HiSeq	496052c5-5ab2-4852-88e1-348116a86746	Bladder	61	2195B75E-157F-4547-9705-1E7E75666CA8	FABA82E6-FF3D-468C-91EC-A88794619697	TCGA-E5-A2PC-01A-11D-A204-02	HG19_Broad_variant	TCGA-E5-A2PC	TCGA-BLCA	NA	s3289	Harvard Medical School	Roswell Park	United States	NO	T2b	N1	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV	A204-02	TRUE
13722.58cfa831e4b0c9d6adf6cb9e	58cfa831e4b0c9d6adf6cb9e	TCGA-EJ-7328-01A-31D-2111_130502_SN590_0228_AD24A9ACXX_s_2_rg.sorted.filtered.	WGS	TCGA-EJ-7328-01A-31D-2111_130502_SN590_0228_AD24A9ACXX_s_2_rg.sorted	TCGA-EJ-7328-01A-31D-2111_130502_SN590_0228_AD24A9ACXX_s_2_rg.sorted.bam	282.3	NA	0.16	58cfa831e4b0c9d6adf6cb9e	TCGA-EJ-7328-01A-31D-2111_130502_SN590_0228_AD24A9ACXX_s_2_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-EJ-7328-01A	42B7D14F-09E5-4D91-BB98-5FE35907A6A9	Primary Tumor	Illumina HiSeq	09a1120f-21a6-48c2-a9e8-3b229a16fc7f	Prostate	70	4539A7C3-CCA2-4ED0-9310-92CD843AA1CD	C4D292D4-D001-4704-94C9-CC1674F6F16E	TCGA-EJ-7328-01A-31D-2111-02	HG19_Broad_variant	TCGA-EJ-7328	TCGA-PRAD	NA	s3960	Harvard Medical School	University of Pittsburgh	United States	NO	T3a	N0	Prostate Adenocarcinoma Acinar Type	Not available	2111-02	TRUE
13722.58cfa831e4b0c9d6adf6cba6	58cfa831e4b0c9d6adf6cba6	TCGA-EJ-7784-01A-11D-2111_130502_SN590_0229_BD2459ACXX_s_2_rg.sorted.filtered.	WGS	TCGA-EJ-7784-01A-11D-2111_130502_SN590_0229_BD2459ACXX_s_2_rg.sorted	TCGA-EJ-7784-01A-11D-2111_130502_SN590_0229_BD2459ACXX_s_2_rg.sorted.bam	456.3	NA	0.15	58cfa831e4b0c9d6adf6cba6	TCGA-EJ-7784-01A-11D-2111_130502_SN590_0229_BD2459ACXX_s_2_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-EJ-7784-01A	4BC71292-60BB-4B63-86C1-0FE021083804	Primary Tumor	Illumina HiSeq	a2c5ffab-f279-44fb-a025-079de410f1c4	Prostate	63	0D3EC78C-3DA8-443F-BAA6-93CAED5B065C	2B122D7B-B5CE-44CE-B1EA-7E39E42B2A63	TCGA-EJ-7784-01A-11D-2111-02	HG19_Broad_variant	TCGA-EJ-7784	TCGA-PRAD	NA	s3958	Harvard Medical School	University of Pittsburgh	United States	NO	T2c	N0	Prostate Adenocarcinoma Acinar Type	Not available	2111-02	TRUE
13722.58cfa831e4b0c9d6adf6cba5	58cfa831e4b0c9d6adf6cba5	TCGA-EJ-7331-01A-11D-2111_130502_SN590_0228_AD24A9ACXX_s_4_rg.sorted.filtered.	WGS	TCGA-EJ-7331-01A-11D-2111_130502_SN590_0228_AD24A9ACXX_s_4_rg.sorted	TCGA-EJ-7331-01A-11D-2111_130502_SN590_0228_AD24A9ACXX_s_4_rg.sorted.bam	214.3	NA	0.15	58cfa831e4b0c9d6adf6cba5	TCGA-EJ-7331-01A-11D-2111_130502_SN590_0228_AD24A9ACXX_s_4_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-EJ-7331-01A	B424B73A-2DFA-473F-AB56-AB382CD1CDEF	Primary Tumor	Illumina HiSeq	a85ad241-998c-4d85-a63b-903ddeb62201	Prostate	64	5AA2E382-C8DF-44E3-8802-994188B11D55	F2DA114D-161B-46CD-BAA7-46E63DBC5D5C	TCGA-EJ-7331-01A-11D-2111-02	HG19_Broad_variant	TCGA-EJ-7331	TCGA-PRAD	NA	s4139	Harvard Medical School	University of Pittsburgh	United States	NO	T2c	N0	Prostate Adenocarcinoma Acinar Type	Not available	2111-02	TRUE
13722.58cfa831e4b0c9d6adf6cbb5	58cfa831e4b0c9d6adf6cbb5	TCGA-EJ-5507-01A-01D-1572_130315_SN590_0220_BD1WFMACXX_s_7_rg.sorted.filtered.	WGS	TCGA-EJ-5507-01A-01D-1572_130315_SN590_0220_BD1WFMACXX_s_7_rg.sorted	TCGA-EJ-5507-01A-01D-1572_130315_SN590_0220_BD1WFMACXX_s_7_rg.sorted.bam	347.7	1.9	0.15	58cfa831e4b0c9d6adf6cbb5	TCGA-EJ-5507-01A-01D-1572_130315_SN590_0220_BD1WFMACXX_s_7_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-EJ-5507-01A	607200F5-DF80-4F5D-90FB-FDC455A7415B	Primary Tumor	Illumina HiSeq	0dbb7308-269c-4ad8-97c7-e7475ae08189	Prostate	54	F93327F7-0290-4915-97BB-E31BAE2697DD	D2336094-05BD-4E89-84A3-91D641DC31D0	TCGA-EJ-5507-01A-01D-1572-02	HG19_Broad_variant	TCGA-EJ-5507	TCGA-PRAD	NA	s3787	Harvard Medical School	University of Pittsburgh	United States	NO	T3b	N1	Prostate Adenocarcinoma Acinar Type	Not available	1572-02	TRUE
13722.58cfa831e4b0c9d6adf6cbc9	58cfa831e4b0c9d6adf6cbc9	TCGA-EJ-5514-01A-01D-1572_130131_SN1120_0234_AD1PVUACXX_s_7_rg.sorted.filtered.	WGS	TCGA-EJ-5514-01A-01D-1572_130131_SN1120_0234_AD1PVUACXX_s_7_rg.sorted	TCGA-EJ-5514-01A-01D-1572_130131_SN1120_0234_AD1PVUACXX_s_7_rg.sorted.bam	271.7	1.9	0.15	58cfa831e4b0c9d6adf6cbc9	TCGA-EJ-5514-01A-01D-1572_130131_SN1120_0234_AD1PVUACXX_s_7_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-EJ-5514-01A	F82D53B1-3DF8-4249-A615-464C9F4E0A32	Primary Tumor	Illumina HiSeq	581bee6a-6abe-4b55-8dc4-63bb242df1cf	Prostate	66	29AD80A4-B429-495C-885E-A92CFE2E4501	6F8F8AAC-C0DE-46F6-A7CF-502893CC57CB	TCGA-EJ-5514-01A-01D-1572-02	HG19_Broad_variant	TCGA-EJ-5514	TCGA-PRAD	NA	s3439	Harvard Medical School	University of Pittsburgh	United States	NO	T2c	N0	Prostate Adenocarcinoma Acinar Type	Not available	1572-02	TRUE
13722.58cfa831e4b0c9d6adf6cbf4	58cfa831e4b0c9d6adf6cbf4	TCGA-EJ-7782-01A-11D-2111_130502_SN590_0228_AD24A9ACXX_s_8_rg.sorted.filtered.	WGS	TCGA-EJ-7782-01A-11D-2111_130502_SN590_0228_AD24A9ACXX_s_8_rg.sorted	TCGA-EJ-7782-01A-11D-2111_130502_SN590_0228_AD24A9ACXX_s_8_rg.sorted.bam	344.3	NA	0.16	58cfa831e4b0c9d6adf6cbf4	TCGA-EJ-7782-01A-11D-2111_130502_SN590_0228_AD24A9ACXX_s_8_rg.sorted.bam	Alive	MALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-EJ-7782-01A	1426B4BF-F4A5-477C-BBBB-E0E656549764	Primary Tumor	Illumina HiSeq	f92312ba-ec6b-477e-a08c-12c8af6d1775	Prostate	71	951C894E-9354-45AD-834A-FFC04441A3A9	47FB5E53-DD88-4B25-B6EF-C1ABE55FD5BA	TCGA-EJ-7782-01A-11D-2111-02	HG19_Broad_variant	TCGA-EJ-7782	TCGA-PRAD	NA	s3794	Harvard Medical School	University of Pittsburgh	United States	NO	T2c	N0	Prostate Adenocarcinoma Acinar Type	Not available	2111-02	TRUE
13722.58cfa831e4b0c9d6adf6cbf9	58cfa831e4b0c9d6adf6cbf9	TCGA-EJ-7785-01A-11D-2111_130502_SN590_0229_BD2459ACXX_s_4_rg.sorted.filtered.	WGS	TCGA-EJ-7785-01A-11D-2111_130502_SN590_0229_BD2459ACXX_s_4_rg.sorted	TCGA-EJ-7785-01A-11D-2111_130502_SN590_0229_BD2459ACXX_s_4_rg.sorted.bam	160.3	NA	0.15	58cfa831e4b0c9d6adf6cbf9	TCGA-EJ-7785-01A-11D-2111_130502_SN590_0229_BD2459ACXX_s_4_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-EJ-7785-01A	2DEF2A53-D2E8-46F0-8B07-F32DBF1833A4	Primary Tumor	Illumina HiSeq	dfbfaf44-ade6-4c48-88fb-a3898d878853	Prostate	54	63EBD9B1-F118-4315-8722-708F47A07063	196C6111-FF69-40F1-A7AA-973C5AC9106E	TCGA-EJ-7785-01A-11D-2111-02	HG19_Broad_variant	TCGA-EJ-7785	TCGA-PRAD	NA	s3966	Harvard Medical School	University of Pittsburgh	United States	NO	T3a	N0	Prostate Adenocarcinoma Acinar Type	Not available	2111-02	TRUE
13722.58cfa831e4b0c9d6adf6cc60	58cfa831e4b0c9d6adf6cc60	TCGA-EJ-5501-01A-01D-1572_130223_SN590_0214_BC1UJ3ACXX_s_3_rg.sorted.filtered.	WGS	TCGA-EJ-5501-01A-01D-1572_130223_SN590_0214_BC1UJ3ACXX_s_3_rg.sorted	TCGA-EJ-5501-01A-01D-1572_130223_SN590_0214_BC1UJ3ACXX_s_3_rg.sorted.bam	153.7	1.9	0.16	58cfa831e4b0c9d6adf6cc60	TCGA-EJ-5501-01A-01D-1572_130223_SN590_0214_BC1UJ3ACXX_s_3_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-EJ-5501-01A	8DF0C1E8-966C-4F46-AD15-FAE9E745A32E	Primary Tumor	Illumina HiSeq	6e2cf9a5-b8c5-4f44-8800-c95ad84bc9a8	Prostate	55	A1E37A0A-67F5-4A19-A540-A45CB89C4203	759BD886-73F1-4DEF-A446-98DAAC2C5B88	TCGA-EJ-5501-01A-01D-1572-02	HG19_Broad_variant	TCGA-EJ-5501	TCGA-PRAD	NA	s3790	Harvard Medical School	University of Pittsburgh	United States	NO	T3b	N0	Prostate Adenocarcinoma Acinar Type	Not available	1572-02	TRUE
13722.58cfa831e4b0c9d6adf6cbeb	58cfa831e4b0c9d6adf6cbeb	TCGA-EM-A1CW-01A-21D-A13U_120706_SN1222_0122_AC0WPYACXX_s_7_rg.sorted.filtered.	WGS	TCGA-EM-A1CW-01A-21D-A13U_120706_SN1222_0122_AC0WPYACXX_s_7_rg.sorted	TCGA-EM-A1CW-01A-21D-A13U_120706_SN1222_0122_AC0WPYACXX_s_7_rg.sorted.bam	29.55	2.05	0.18	58cfa831e4b0c9d6adf6cbeb	TCGA-EM-A1CW-01A-21D-A13U_120706_SN1222_0122_AC0WPYACXX_s_7_rg.sorted.bam	Alive	FEMALE	Not available	Not available	Thyroid Carcinoma	Aligned reads	TCGA-EM-A1CW-01A	22EB9F00-6869-4D8F-B657-DFD64F81E9E9	Primary Tumor	Illumina HiSeq	9c39283e-3646-4154-8265-d68a2f7de106	Thyroid	39	7045F3E1-5239-4159-9B38-31E4168853D0	2CC2002C-4F0A-47A6-AA0A-35FE1B545A7A	TCGA-EM-A1CW-01A-21D-A13U-02	HG19_Broad_variant	TCGA-EM-A1CW	TCGA-THCA	NA	s12253	Harvard Medical School	University Health Network	Canada	NO	T3	N0	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	Stage I	A13U-02	TRUE
13722.58cfa831e4b0c9d6adf6cc90	58cfa831e4b0c9d6adf6cc90	TCGA-EJ-5518-01A-01D-1572_130131_SN1120_0235_BD1TAFACXX_s_7_rg.sorted.filtered.	WGS	TCGA-EJ-5518-01A-01D-1572_130131_SN1120_0235_BD1TAFACXX_s_7_rg.sorted	TCGA-EJ-5518-01A-01D-1572_130131_SN1120_0235_BD1TAFACXX_s_7_rg.sorted.bam	131.7	1.9	0.15	58cfa831e4b0c9d6adf6cc90	TCGA-EJ-5518-01A-01D-1572_130131_SN1120_0235_BD1TAFACXX_s_7_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-EJ-5518-01A	2B35C119-CDC1-49E2-8229-CA5CDE9E63D0	Primary Tumor	Illumina HiSeq	02ae3fcb-c1fe-400a-8172-0c62a8d4639c	Prostate	66	F12FA61C-FF1B-48E2-BE19-1D52D50DC261	BD026793-2032-4D13-9A6A-A189583A537C	TCGA-EJ-5518-01A-01D-1572-02	HG19_Broad_variant	TCGA-EJ-5518	TCGA-PRAD	NA	s3430	Harvard Medical School	University of Pittsburgh	United States	NO	T4	N0	Prostate Adenocarcinoma Acinar Type	Not available	1572-02	TRUE
13722.58cfa831e4b0c9d6adf6ccc0	58cfa831e4b0c9d6adf6ccc0	TCGA-EJ-5531-01A-01D-1572_130221_SN1120_0239_BD1V59ACXX_s_1_rg.sorted.filtered.	WGS	TCGA-EJ-5531-01A-01D-1572_130221_SN1120_0239_BD1V59ACXX_s_1_rg.sorted	TCGA-EJ-5531-01A-01D-1572_130221_SN1120_0239_BD1V59ACXX_s_1_rg.sorted.bam	81.7	1.9	0.15	58cfa831e4b0c9d6adf6ccc0	TCGA-EJ-5531-01A-01D-1572_130221_SN1120_0239_BD1V59ACXX_s_1_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-EJ-5531-01A	ADF3C2F7-D5F9-41C3-BD8C-7F9F1F22FF73	Primary Tumor	Illumina HiSeq	0993d456-af78-4078-aa16-bd810177c278	Prostate	62	48F3A8B8-110C-49AB-BD85-CE33328C2CF6	90219925-E6E8-40BC-8DD0-BD76F942B48C	TCGA-EJ-5531-01A-01D-1572-02	HG19_Broad_variant	TCGA-EJ-5531	TCGA-PRAD	NA	s3445	Harvard Medical School	University of Pittsburgh	United States	NO	T3a	N0	Prostate Adenocarcinoma Acinar Type	Not available	1572-02	TRUE
13722.58cfa831e4b0c9d6adf6ccf0	58cfa831e4b0c9d6adf6ccf0	TCGA-EJ-5512-01A-01D-1572_130131_SN1120_0234_AD1PVUACXX_s_5_rg.sorted.filtered.	WGS	TCGA-EJ-5512-01A-01D-1572_130131_SN1120_0234_AD1PVUACXX_s_5_rg.sorted	TCGA-EJ-5512-01A-01D-1572_130131_SN1120_0234_AD1PVUACXX_s_5_rg.sorted.bam	100.7	1.9	0.13	58cfa831e4b0c9d6adf6ccf0	TCGA-EJ-5512-01A-01D-1572_130131_SN1120_0234_AD1PVUACXX_s_5_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-EJ-5512-01A	C28F931F-5AB2-4899-9FE9-54024F082D92	Primary Tumor	Illumina HiSeq	1df8e29c-5be8-4dbf-abb8-f0ded9419a14	Prostate	46	D0B41403-8458-45E1-946E-21054FBA65B8	D5F126D6-7AAF-425A-BBEA-E7587A25529D	TCGA-EJ-5512-01A-01D-1572-02	HG19_Broad_variant	TCGA-EJ-5512	TCGA-PRAD	NA	s3954	Harvard Medical School	University of Pittsburgh	United States	NO	T2c	N0	Prostate Adenocarcinoma Acinar Type	Not available	1572-02	TRUE
13722.58cfa831e4b0c9d6adf6cd06	58cfa831e4b0c9d6adf6cd06	TCGA-EJ-5496-01A-01D-1572_130125_SN1120_0233_AD1K3HACXX_s_3_rg.sorted.filtered.	WGS	TCGA-EJ-5496-01A-01D-1572_130125_SN1120_0233_AD1K3HACXX_s_3_rg.sorted	TCGA-EJ-5496-01A-01D-1572_130125_SN1120_0233_AD1K3HACXX_s_3_rg.sorted.bam	253.7	1.9	0.14	58cfa831e4b0c9d6adf6cd06	TCGA-EJ-5496-01A-01D-1572_130125_SN1120_0233_AD1K3HACXX_s_3_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-EJ-5496-01A	6755C231-355F-4CC3-85F1-6306C7F5D44B	Primary Tumor	Illumina HiSeq	00039222-b24d-4c86-b6ac-ffc00b3b6ece	Prostate	59	D0873929-EAC8-42E2-AF6F-DF3CB9CE698C	0A4FA030-2417-4F6F-8B86-5036FCA48F1E	TCGA-EJ-5496-01A-01D-1572-02	HG19_Broad_variant	TCGA-EJ-5496	TCGA-PRAD	NA	s3598	Harvard Medical School	University of Pittsburgh	United States	NO	T2c	N0	Prostate Adenocarcinoma Acinar Type	Not available	1572-02	TRUE
13722.58cfa831e4b0c9d6adf6cd2c	58cfa831e4b0c9d6adf6cd2c	TCGA-EJ-5495-01A-01D-1572_130125_SN1120_0233_AD1K3HACXX_s_1_rg.sorted.filtered.	WGS	TCGA-EJ-5495-01A-01D-1572_130125_SN1120_0233_AD1K3HACXX_s_1_rg.sorted	TCGA-EJ-5495-01A-01D-1572_130125_SN1120_0233_AD1K3HACXX_s_1_rg.sorted.bam	176.7	1.9	0.15	58cfa831e4b0c9d6adf6cd2c	TCGA-EJ-5495-01A-01D-1572_130125_SN1120_0233_AD1K3HACXX_s_1_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-EJ-5495-01A	962DD3D5-8501-4658-8CB9-2424B476124C	Primary Tumor	Illumina HiSeq	a2c14576-771c-460f-a71b-e25651274ca1	Prostate	68	8E53414F-455E-4665-AE0E-9E7405262A96	5644F0E3-3A3B-411A-B28D-C93C3BBD8F86	TCGA-EJ-5495-01A-01D-1572-02	HG19_Broad_variant	TCGA-EJ-5495	TCGA-PRAD	NA	s3597	Harvard Medical School	University of Pittsburgh	United States	NO	T3b	N1	Prostate Adenocarcinoma Acinar Type	Not available	1572-02	TRUE
13722.58cfa831e4b0c9d6adf6cd23	58cfa831e4b0c9d6adf6cd23	TCGA-F1-6874-01A-11D-1880_121220_SN1120_0207_BC1JALACXX_s_7_rg.sorted.filtered.	WGS	TCGA-F1-6874-01A-11D-1880_121220_SN1120_0207_BC1JALACXX_s_7_rg.sorted	TCGA-F1-6874-01A-11D-1880_121220_SN1120_0207_BC1JALACXX_s_7_rg.sorted.bam	373.7	1.9	0.14	58cfa831e4b0c9d6adf6cd23	TCGA-F1-6874-01A-11D-1880_121220_SN1120_0207_BC1JALACXX_s_7_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-F1-6874-01A	106F3344-F699-4B2C-8F62-4AC6C948DDE4	Primary Tumor	Illumina HiSeq	734d68fe-de19-4aef-8031-8ba255233eba	Stomach	79	C28FEBB9-E845-462F-B6A0-CB565EE6A049	273DDC2E-8E77-4F81-85C2-B9A8583D9E1D	TCGA-F1-6874-01A-11D-1880-02	HG19_Broad_variant	TCGA-F1-6874	TCGA-STAD	NA	s14773	Harvard Medical School	UNC	United States	NO	T2	N0	Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS)	Stage IB	1880-02	TRUE
13722.58cfa831e4b0c9d6adf6cd5c	58cfa831e4b0c9d6adf6cd5c	TCGA-EJ-5494-01A-01D-1572_130125_SN208_0451_BD1RB1ACXX_s_7_rg.sorted.filtered.	WGS	TCGA-EJ-5494-01A-01D-1572_130125_SN208_0451_BD1RB1ACXX_s_7_rg.sorted	TCGA-EJ-5494-01A-01D-1572_130125_SN208_0451_BD1RB1ACXX_s_7_rg.sorted.bam	107.7	1.9	0.15	58cfa831e4b0c9d6adf6cd5c	TCGA-EJ-5494-01A-01D-1572_130125_SN208_0451_BD1RB1ACXX_s_7_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-EJ-5494-01A	E27C50E2-2A41-4F8C-9EF8-2BC51FB0C23E	Primary Tumor	Illumina HiSeq	01d186ab-6289-40da-9715-4f766da74b10	Prostate	50	37103479-02BD-45E8-95B3-7A4A78523999	9AA32D54-78ED-4DFC-ACA4-E1A88404F791	TCGA-EJ-5494-01A-01D-1572-02	HG19_Broad_variant	TCGA-EJ-5494	TCGA-PRAD	NA	s4131	Harvard Medical School	University of Pittsburgh	United States	NO	T3a	N0	Prostate Adenocarcinoma Acinar Type	Not available	1572-02	TRUE
13722.58cfa831e4b0c9d6adf6cd8c	58cfa831e4b0c9d6adf6cd8c	TCGA-EJ-7781-01A-11D-2111_130502_SN590_0228_AD24A9ACXX_s_6_rg.sorted.filtered.	WGS	TCGA-EJ-7781-01A-11D-2111_130502_SN590_0228_AD24A9ACXX_s_6_rg.sorted	TCGA-EJ-7781-01A-11D-2111_130502_SN590_0228_AD24A9ACXX_s_6_rg.sorted.bam	168.3	NA	0.16	58cfa831e4b0c9d6adf6cd8c	TCGA-EJ-7781-01A-11D-2111_130502_SN590_0228_AD24A9ACXX_s_6_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-EJ-7781-01A	33283111-9A2F-4D5E-92A5-3435846404F7	Primary Tumor	Illumina HiSeq	bf6c4719-7b88-4975-9591-8bd34c19e3cf	Prostate	65	B5504343-6915-4D15-A81E-641B03C77F24	193083B4-B2E1-486C-A4F5-F62818AEBBC2	TCGA-EJ-7781-01A-11D-2111-02	HG19_Broad_variant	TCGA-EJ-7781	TCGA-PRAD	NA	s4141	Harvard Medical School	University of Pittsburgh	United States	NO	T2c	N0	Prostate Adenocarcinoma Acinar Type	Not available	2111-02	TRUE
13722.58cfa832e4b0c9d6adf6ce14	58cfa832e4b0c9d6adf6ce14	TCGA-EJ-5511-01A-01D-1572_130308_SN590_0219_BC1UVPACXX_s_7_rg.sorted.filtered.	WGS	TCGA-EJ-5511-01A-01D-1572_130308_SN590_0219_BC1UVPACXX_s_7_rg.sorted	TCGA-EJ-5511-01A-01D-1572_130308_SN590_0219_BC1UVPACXX_s_7_rg.sorted.bam	398.7	1.9	0.15	58cfa832e4b0c9d6adf6ce14	TCGA-EJ-5511-01A-01D-1572_130308_SN590_0219_BC1UVPACXX_s_7_rg.sorted.bam	Alive	MALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-EJ-5511-01A	F8A42FEB-FBC9-4A13-BAD5-1DCEFCA2A9BF	Primary Tumor	Illumina HiSeq	dfa7170d-3cc1-43b7-9d24-7be107cf2896	Prostate	55	1DA89009-5DBE-4D62-9406-36330F47B738	5D753860-8965-45E5-A919-C076B53334D4	TCGA-EJ-5511-01A-01D-1572-02	HG19_Broad_variant	TCGA-EJ-5511	TCGA-PRAD	NA	s3600	Harvard Medical School	University of Pittsburgh	United States	NO	T3a	N0	Prostate Adenocarcinoma Acinar Type	Not available	1572-02	TRUE
13722.58cfa831e4b0c9d6adf6cd6c	58cfa831e4b0c9d6adf6cd6c	TCGA-ET-A25R-01A-11D-A16N_120805_SN208_0422_BD16VPACXX_s_4_rg.sorted.filtered.	WGS	TCGA-ET-A25R-01A-11D-A16N_120805_SN208_0422_BD16VPACXX_s_4_rg.sorted	TCGA-ET-A25R-01A-11D-A16N_120805_SN208_0422_BD16VPACXX_s_4_rg.sorted.bam	101.84	1.93	0.17	58cfa831e4b0c9d6adf6cd6c	TCGA-ET-A25R-01A-11D-A16N_120805_SN208_0422_BD16VPACXX_s_4_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-ET-A25R-01A	097B9CF1-EC0C-487C-9ADE-2BDAB12EB4CA	Primary Tumor	Illumina HiSeq	442f6193-a979-40e4-89db-2e541d3ebdb7	Thyroid	51	C29162A3-F162-4D32-AB9A-421BE1FEB13C	77A80565-1BC9-4F0A-AFB3-23955FE283EB	TCGA-ET-A25R-01A-11D-A16N-02	HG19_Broad_variant	TCGA-ET-A25R	TCGA-THCA	NA	s12003	Harvard Medical School	Johns Hopkins	United States	NO	T3	NX	Thyroid Papillary Carcinoma - Tall Cell (>= 50% tall cell features)	Stage III	A16N-02	TRUE
13722.58cfa832e4b0c9d6adf6ce46	58cfa832e4b0c9d6adf6ce46	TCGA-EJ-5504-01A-01D-1572_130315_SN590_0220_BD1WFMACXX_s_1_rg.sorted.filtered.	WGS	TCGA-EJ-5504-01A-01D-1572_130315_SN590_0220_BD1WFMACXX_s_1_rg.sorted	TCGA-EJ-5504-01A-01D-1572_130315_SN590_0220_BD1WFMACXX_s_1_rg.sorted.bam	125.7	1.9	0.15	58cfa832e4b0c9d6adf6ce46	TCGA-EJ-5504-01A-01D-1572_130315_SN590_0220_BD1WFMACXX_s_1_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-EJ-5504-01A	E1C3D1BD-CF8F-4FA4-AC8E-BF9E54F7AAD4	Primary Tumor	Illumina HiSeq	ea018935-4ded-4def-a204-bda7035ba32c	Prostate	65	7D0C0A85-8459-43A3-AC22-F447BB042149	FB332EAD-214E-4D76-BD3C-0774D906F68B	TCGA-EJ-5504-01A-01D-1572-02	HG19_Broad_variant	TCGA-EJ-5504	TCGA-PRAD	NA	s3953	Harvard Medical School	University of Pittsburgh	United States	NO	T3a	N1	Prostate Adenocarcinoma Acinar Type	Not available	1572-02	TRUE
13722.58cfa831e4b0c9d6adf6cdaf	58cfa831e4b0c9d6adf6cdaf	TCGA-FE-A22Z-01A-11D-A16N_120805_SN208_0422_BD16VPACXX_s_3_rg.sorted.filtered.	WGS	TCGA-FE-A22Z-01A-11D-A16N_120805_SN208_0422_BD16VPACXX_s_3_rg.sorted	TCGA-FE-A22Z-01A-11D-A16N_120805_SN208_0422_BD16VPACXX_s_3_rg.sorted.bam	78.59	2.03	0.16	58cfa831e4b0c9d6adf6cdaf	TCGA-FE-A22Z-01A-11D-A16N_120805_SN208_0422_BD16VPACXX_s_3_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-FE-A22Z-01A	78D14F86-896A-4F98-9274-B2E8E387ADD9	Primary Tumor	Illumina HiSeq	ae24ab9d-6983-466a-a7f4-50da56438303	Thyroid	61	D206D300-E0CE-4A40-AF1F-45A685346A6E	B7A31BAC-FD92-47AF-8C9C-E78E3FC1609A	TCGA-FE-A22Z-01A-11D-A16N-02	HG19_Broad_variant	TCGA-FE-A22Z	TCGA-THCA	NA	s12648	Harvard Medical School	Ohio State University	United States	NO	T4a	N1	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	Stage IVA	A16N-02	TRUE
13722.58cfa832e4b0c9d6adf6ce0c	58cfa832e4b0c9d6adf6ce0c	TCGA-FD-A3B6-01A-21D-A210_120912_SN1120_0192_AC18ALACXX_s_3_rg.sorted.filtered.	WGS	TCGA-FD-A3B6-01A-21D-A210_120912_SN1120_0192_AC18ALACXX_s_3_rg.sorted	TCGA-FD-A3B6-01A-21D-A210_120912_SN1120_0192_AC18ALACXX_s_3_rg.sorted.bam	61.5	NA	0.16	58cfa832e4b0c9d6adf6ce0c	TCGA-FD-A3B6-01A-21D-A210_120912_SN1120_0192_AC18ALACXX_s_3_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-FD-A3B6-01A	36054200-3FA4-4541-A25C-47282E4EF88D	Primary Tumor	Illumina HiSeq	15aeae5e-1ef3-4574-a7af-025ac4d4be89	Bladder	75	D6818C85-5857-44B0-AD64-1EEB53B80606	D8D4A23A-F993-4A8F-9414-AD25149B4CB3	TCGA-FD-A3B6-01A-21D-A210-26	HG19_Broad_variant	TCGA-FD-A3B6	TCGA-BLCA	NA	s3298	MD Anderson - Institute for Applied Cancer Science	BLN - University Of Chicago	United States	NO	T2b	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage II	A210-26	TRUE
13722.58cfa832e4b0c9d6adf6ce9c	58cfa832e4b0c9d6adf6ce9c	TCGA-FD-A3B7-01A-31D-A210_120912_SN1120_0192_AC18ALACXX_s_5_rg.sorted.filtered.	WGS	TCGA-FD-A3B7-01A-31D-A210_120912_SN1120_0192_AC18ALACXX_s_5_rg.sorted	TCGA-FD-A3B7-01A-31D-A210_120912_SN1120_0192_AC18ALACXX_s_5_rg.sorted.bam	28.25	NA	0.16	58cfa832e4b0c9d6adf6ce9c	TCGA-FD-A3B7-01A-31D-A210_120912_SN1120_0192_AC18ALACXX_s_5_rg.sorted.bam	Dead	MALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-FD-A3B7-01A	EF5DD4B3-B77A-444A-B5B0-C999A5A3D129	Primary Tumor	Illumina HiSeq	4a37fdf6-816c-46ca-b703-cf3d58b32149	Bladder	66	A307CA46-3A09-4F0C-84AB-9A9E8954DE38	6014D6A8-5495-4D71-AB6E-622E3E6C4DC6	TCGA-FD-A3B7-01A-31D-A210-26	HG19_Broad_variant	TCGA-FD-A3B7	TCGA-BLCA	122	s2901	MD Anderson - Institute for Applied Cancer Science	BLN - University Of Chicago	United States	NO	T3a	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage III	A210-26	TRUE
13722.58cfa832e4b0c9d6adf6cfac	58cfa832e4b0c9d6adf6cfac	TCGA-GE-A2C6-01A-11D-A16N_120805_SN208_0422_BD16VPACXX_s_5_rg.sorted.filtered.	WGS	TCGA-GE-A2C6-01A-11D-A16N_120805_SN208_0422_BD16VPACXX_s_5_rg.sorted	TCGA-GE-A2C6-01A-11D-A16N_120805_SN208_0422_BD16VPACXX_s_5_rg.sorted.bam	75.85	1.8	0.17	58cfa832e4b0c9d6adf6cfac	TCGA-GE-A2C6-01A-11D-A16N_120805_SN208_0422_BD16VPACXX_s_5_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-GE-A2C6-01A	7DEEDEBA-F05B-453C-9DF1-EEB20B0EC72E	Primary Tumor	Illumina HiSeq	4920d08d-433e-4371-8daa-641819a1e53f	Thyroid	33	D717EECF-11DC-4E15-851A-9EA18332A48B	A5FA44A2-8101-4A0C-982C-57337853BACA	TCGA-GE-A2C6-01A-11D-A16N-02	HG19_Broad_variant	TCGA-GE-A2C6	TCGA-THCA	NA	s12123	Harvard Medical School	ABS - IUPUI	United States	NO	T2	N1b	Thyroid Papillary Carcinoma - Classical/usual	Stage I	A16N-02	TRUE
13722.58cfa832e4b0c9d6adf6cfe0	58cfa832e4b0c9d6adf6cfe0	TCGA-GC-A3WC-01A-31D-A233_120904_SN1120_0186_BC1911ACXX_s_1_rg.sorted.filtered.	WGS	TCGA-GC-A3WC-01A-31D-A233_120904_SN1120_0186_BC1911ACXX_s_1_rg.sorted	TCGA-GC-A3WC-01A-31D-A233_120904_SN1120_0186_BC1911ACXX_s_1_rg.sorted.bam	23.27	NA	0.17	58cfa832e4b0c9d6adf6cfe0	TCGA-GC-A3WC-01A-31D-A233_120904_SN1120_0186_BC1911ACXX_s_1_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-GC-A3WC-01A	DB52C68A-ED44-4EC4-9381-D75F9BCBC29A	Primary Tumor	Illumina HiSeq	5d982317-5753-41de-85ef-30ee85c56ba9	Bladder	80	24F9D01B-1210-4716-9466-8FE9F3612B8B	50E62704-6262-4426-BDAE-0490DC108B61	TCGA-GC-A3WC-01A-31D-A233-26	HG19_Broad_variant	TCGA-GC-A3WC	TCGA-BLCA	NA	s3307	MD Anderson - Institute for Applied Cancer Science	International Genomics Consortium	United States	NO	T3	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage III	A233-26	TRUE
13722.58cfa832e4b0c9d6adf6d082	58cfa832e4b0c9d6adf6d082	TCGA-HC-7210-01A-11D-2111_130502_SN590_0229_BD2459ACXX_s_8_rg.sorted.filtered.	WGS	TCGA-HC-7210-01A-11D-2111_130502_SN590_0229_BD2459ACXX_s_8_rg.sorted	TCGA-HC-7210-01A-11D-2111_130502_SN590_0229_BD2459ACXX_s_8_rg.sorted.bam	131.3	NA	0.15	58cfa832e4b0c9d6adf6d082	TCGA-HC-7210-01A-11D-2111_130502_SN590_0229_BD2459ACXX_s_8_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-HC-7210-01A	6A5AF80E-07AD-4CD3-AAAB-5DB1090835D9	Primary Tumor	Illumina HiSeq	e6934494-d8e1-44c6-a343-30a6aa2e6cbc	Prostate	74	9069FC65-9BAE-49F3-9329-B78C8CC6CF1E	D414D851-0AF6-4C8F-8E40-CCA9FDF79488	TCGA-HC-7210-01A-11D-2111-02	HG19_Broad_variant	TCGA-HC-7210	TCGA-PRAD	NA	s3983	Harvard Medical School	International Genomics Consortium	United States	NO	T2a	N0	Prostate Adenocarcinoma Acinar Type	Not available	2111-02	TRUE
13722.58cfa832e4b0c9d6adf6d0f5	58cfa832e4b0c9d6adf6d0f5	TCGA-HC-7209-01A-11D-2111_130502_SN590_0229_BD2459ACXX_s_6_rg.sorted.filtered.	WGS	TCGA-HC-7209-01A-11D-2111_130502_SN590_0229_BD2459ACXX_s_6_rg.sorted	TCGA-HC-7209-01A-11D-2111_130502_SN590_0229_BD2459ACXX_s_6_rg.sorted.bam	121.3	NA	0.15	58cfa832e4b0c9d6adf6d0f5	TCGA-HC-7209-01A-11D-2111_130502_SN590_0229_BD2459ACXX_s_6_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-HC-7209-01A	582D1177-73B0-4A9C-8505-70D6B402BD01	Primary Tumor	Illumina HiSeq	d228a749-988a-4fcb-9f15-e334295216fb	Prostate	60	AA7850AC-FB78-433B-8D55-A24C05935DB5	3C59E423-E1A6-4C67-8A88-63A0817B856E	TCGA-HC-7209-01A-11D-2111-02	HG19_Broad_variant	TCGA-HC-7209	TCGA-PRAD	NA	s3625	Harvard Medical School	International Genomics Consortium	United States	NO	T2c	N0	Prostate Adenocarcinoma Acinar Type	Not available	2111-02	TRUE
13722.58cfa832e4b0c9d6adf6d134	58cfa832e4b0c9d6adf6d134	TCGA-G2-A3VY-01A-11D-A233_120913_SN208_0428_BC188KACXX_s_6_rg.sorted.filtered.	WGS	TCGA-G2-A3VY-01A-11D-A233_120913_SN208_0428_BC188KACXX_s_6_rg.sorted	TCGA-G2-A3VY-01A-11D-A233_120913_SN208_0428_BC188KACXX_s_6_rg.sorted.bam	27.44	NA	0.15	58cfa832e4b0c9d6adf6d134	TCGA-G2-A3VY-01A-11D-A233_120913_SN208_0428_BC188KACXX_s_6_rg.sorted.bam	Alive	MALE	ASIAN	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-G2-A3VY-01A	CD50C69F-0F45-4C57-B61A-8C6B41AB4F7E	Primary Tumor	Illumina HiSeq	fc9767fe-ddfb-4540-b151-0a80300c0a1d	Bladder	66	5A66149F-8FB0-41BC-880C-56D5541E3D94	8263C8A3-7CE5-4487-B8A1-29CE9417D1E3	TCGA-G2-A3VY-01A-11D-A233-26	HG19_Broad_variant	TCGA-G2-A3VY	TCGA-BLCA	NA	s2914	MD Anderson - Institute for Applied Cancer Science	MD Anderson	United States	NO	Not available	Not available	Muscle invasive urothelial carcinoma (pT2 or above)	Stage II	A233-26	TRUE
13722.58cfa832e4b0c9d6adf6d1bb	58cfa832e4b0c9d6adf6d1bb	TCGA-EJ-5509-01A-01D-1572_130308_SN590_0219_BC1UVPACXX_s_3_rg.sorted.filtered.	WGS	TCGA-EJ-5509-01A-01D-1572_130308_SN590_0219_BC1UVPACXX_s_3_rg.sorted	TCGA-EJ-5509-01A-01D-1572_130308_SN590_0219_BC1UVPACXX_s_3_rg.sorted.bam	116.7	1.9	0.14	58cfa832e4b0c9d6adf6d1bb	TCGA-EJ-5509-01A-01D-1572_130308_SN590_0219_BC1UVPACXX_s_3_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-EJ-5509-01A	13CE70A8-785C-4B59-B073-41922CB201F9	Primary Tumor	Illumina HiSeq	6fd44a89-a20c-4ecc-bafe-54da9b58cd9d	Prostate	63	99A7115E-046B-488E-95D2-48C35BD29867	4F3831BE-6C1C-4786-B953-2612753C1E5C	TCGA-EJ-5509-01A-01D-1572-02	HG19_Broad_variant	TCGA-EJ-5509	TCGA-PRAD	NA	s3440	Harvard Medical School	University of Pittsburgh	United States	NO	T2c	N0	Prostate Adenocarcinoma Acinar Type	Not available	1572-02	TRUE
13722.58cfa832e4b0c9d6adf6d254	58cfa832e4b0c9d6adf6d254	TCGA-IR-A3LA-01A-11D-A232_140124_SN1120_0291_AC2PHAACXX_s_7_rg.sorted.filtered.	WGS	TCGA-IR-A3LA-01A-11D-A232_140124_SN1120_0291_AC2PHAACXX_s_7_rg.sorted	TCGA-IR-A3LA-01A-11D-A232_140124_SN1120_0291_AC2PHAACXX_s_7_rg.sorted.bam	56.17	NA	0.15	58cfa832e4b0c9d6adf6d254	TCGA-IR-A3LA-01A-11D-A232_140124_SN1120_0291_AC2PHAACXX_s_7_rg.sorted.bam	Alive	FEMALE	WHITE	Not available	Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-IR-A3LA-01A	7B8C04D7-824D-493D-8F2C-9ED87A907192	Primary Tumor	Illumina HiSeq	96c944ec-9e55-4b27-aa91-b936b4d7cff5	Cervix	60	7925EA80-8AAE-4D99-AFE2-74AD1AAE6D9D	B541AE4A-279F-49A1-9877-1F2226A51737	TCGA-IR-A3LA-01A-11D-A232-26	HG19_Broad_variant	TCGA-IR-A3LA	TCGA-CESC	NA	s1377	MD Anderson - Institute for Applied Cancer Science	Memorial Sloan Kettering	United States	NO	T1b1	N0	Endometrioid Adenocarcinoma of Endocervix	Not available	A232-26	TRUE
13722.58cfa832e4b0c9d6adf6d1d2	58cfa832e4b0c9d6adf6d1d2	TCGA-HQ-A2OE-01A-11D-A204_121002_SN1222_0155_BD1ERHACXX_s_5_rg.sorted.filtered.	WGS	TCGA-HQ-A2OE-01A-11D-A204_121002_SN1222_0155_BD1ERHACXX_s_5_rg.sorted	TCGA-HQ-A2OE-01A-11D-A204_121002_SN1222_0155_BD1ERHACXX_s_5_rg.sorted.bam	71.88	NA	0.16	58cfa832e4b0c9d6adf6d1d2	TCGA-HQ-A2OE-01A-11D-A204_121002_SN1222_0155_BD1ERHACXX_s_5_rg.sorted.bam	Alive	MALE	Not available	Not available	Bladder Urothelial Carcinoma	Aligned reads	TCGA-HQ-A2OE-01A	353C5FCC-9C6A-4AC6-99DC-FB4573B2AE6C	Primary Tumor	Illumina HiSeq	21c45d2f-f8bc-45dc-85d2-790ea5506bc4	Bladder	69	65DBBE08-4645-4552-9A1A-E6F79A621013	B04D2557-D084-4445-97BB-10A6CB59DC6B	TCGA-HQ-A2OE-01A-11D-A204-02	HG19_Broad_variant	TCGA-HQ-A2OE	TCGA-BLCA	NA	s2935	Harvard Medical School	Ontario Institute for Cancer Research (OICR)	Canada	NO	T2a	N2	Muscle invasive urothelial carcinoma (pT2 or above)	Not available	A204-02	TRUE
13722.58cfa832e4b0c9d6adf6d114	58cfa832e4b0c9d6adf6d114	TCGA-G2-A2ES-01A-11D-A17R_120921_SN208_0430_AC18CWACXX_s_7_rg.sorted.filtered.	WGS	TCGA-G2-A2ES-01A-11D-A17R_120921_SN208_0430_AC18CWACXX_s_7_rg.sorted	TCGA-G2-A2ES-01A-11D-A17R_120921_SN208_0430_AC18CWACXX_s_7_rg.sorted.bam	46.96	NA	0.16	58cfa832e4b0c9d6adf6d114	TCGA-G2-A2ES-01A-11D-A17R_120921_SN208_0430_AC18CWACXX_s_7_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-G2-A2ES-01A	72D8EAE8-9EFB-45B2-ACBD-82C6B5732E38	Primary Tumor	Illumina HiSeq	5922785f-2336-403c-9cb6-0843df3383b5	Bladder	85	C2288290-F17A-435C-90E7-5A4913F0C076	52FA3B0A-B5C7-4A74-A798-0DB359029147	TCGA-G2-A2ES-01A-11D-A17R-02	HG19_Broad_variant	TCGA-G2-A2ES	TCGA-BLCA	NA	s2919	Harvard Medical School	MD Anderson	United States	NO	T3b	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage II	A17R-02	TRUE
13722.58cfa832e4b0c9d6adf6d269	58cfa832e4b0c9d6adf6d269	TCGA-K4-A3WS-01A-11D-A23Q_120927_SN208_0432_AC188LACXX_s_1_rg.sorted.filtered.	WGS	TCGA-K4-A3WS-01A-11D-A23Q_120927_SN208_0432_AC188LACXX_s_1_rg.sorted	TCGA-K4-A3WS-01A-11D-A23Q_120927_SN208_0432_AC188LACXX_s_1_rg.sorted.bam	18.56	NA	0.16	58cfa832e4b0c9d6adf6d269	TCGA-K4-A3WS-01A-11D-A23Q_120927_SN208_0432_AC188LACXX_s_1_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-K4-A3WS-01A	68ADACD1-A16E-4489-9E68-792A6BD8811C	Primary Tumor	Illumina HiSeq	891c215b-20ad-4eb3-9e53-87910b1d06f4	Bladder	66	54070AE0-0C10-4C10-B8BB-A7313B80A45F	F1840542-AEBE-4B4C-BA50-1686740847D4	TCGA-K4-A3WS-01A-11D-A23Q-26	HG19_Broad_variant	TCGA-K4-A3WS	TCGA-BLCA	NA	s3131	MD Anderson - Institute for Applied Cancer Science	ABS - Lahey Clinic	United States	NO	T3a	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage III	A23Q-26	TRUE
13722.58cfa832e4b0c9d6adf6d490	58cfa832e4b0c9d6adf6d490	TCGA-VD-AA8M-01A-11D-A40D_140807_SN1440_0194_AC5B5RACXX_s_1_rg.sorted.filtered.	WGS	TCGA-VD-AA8M-01A-11D-A40D_140807_SN1440_0194_AC5B5RACXX_s_1_rg.sorted	TCGA-VD-AA8M-01A-11D-A40D_140807_SN1440_0194_AC5B5RACXX_s_1_rg.sorted.bam	57.94	NA	0.15	58cfa832e4b0c9d6adf6d490	TCGA-VD-AA8M-01A-11D-A40D_140807_SN1440_0194_AC5B5RACXX_s_1_rg.sorted.bam	Alive	MALE	Not available	Not available	Uveal Melanoma	Aligned reads	TCGA-VD-AA8M-01A	9DC5CC23-C903-4FE2-8354-64F8316FF0D4	Primary Tumor	Illumina HiSeq	4a38e73e-520a-4721-a89a-7a2b3b334ee6	Eye	64	DDC9047A-FD34-4874-87B0-72DAB50311E6	ABFED748-0BF8-4E64-8AB1-2A4DA1BB5A62	TCGA-VD-AA8M-01A-11D-A40D-26	HG19_Broad_variant	TCGA-VD-AA8M	TCGA-UVM	NA	s271	MD Anderson - Institute for Applied Cancer Science	University of Liverpool	United Kingdom	NO	T2a	N0	Not available	Stage IIA	A40D-26	TRUE
13722.58cfa832e4b0c9d6adf6d4d4	58cfa832e4b0c9d6adf6d4d4	TCGA-VD-AA8P-01A-11D-A40D_140829_SN208_0523_BC5FKTACXX_s_7_rg.sorted.filtered.	WGS	TCGA-VD-AA8P-01A-11D-A40D_140829_SN208_0523_BC5FKTACXX_s_7_rg.sorted	TCGA-VD-AA8P-01A-11D-A40D_140829_SN208_0523_BC5FKTACXX_s_7_rg.sorted.bam	65.26	NA	0.16	58cfa832e4b0c9d6adf6d4d4	TCGA-VD-AA8P-01A-11D-A40D_140829_SN208_0523_BC5FKTACXX_s_7_rg.sorted.bam	Alive	FEMALE	Not available	Not available	Uveal Melanoma	Aligned reads	TCGA-VD-AA8P-01A	B224E42D-8B6D-4578-963C-BF528B954900	Primary Tumor	Illumina HiSeq	c3957866-f525-4f68-b483-cf444a24bb38	Eye	64	6029915F-6337-4816-998A-9754C770ED93	6331804A-DC4D-4244-9C0D-A5CEC20E593C	TCGA-VD-AA8P-01A-11D-A40D-26	HG19_Broad_variant	TCGA-VD-AA8P	TCGA-UVM	NA	s261	MD Anderson - Institute for Applied Cancer Science	University of Liverpool	United Kingdom	NO	T3a	N0	Not available	Stage IIB	A40D-26	TRUE
13722.58cfa82fe4b0c9d6adf6b5f0	58cfa82fe4b0c9d6adf6b5f0	TCGA-50-5933-01A-11D-1751_110928_SN590_0108_BB01CWACXX_s_6_rg.sorted.filtered.	WGS	TCGA-50-5933-01A-11D-1751_110928_SN590_0108_BB01CWACXX_s_6_rg.sorted	TCGA-50-5933-01A-11D-1751_110928_SN590_0108_BB01CWACXX_s_6_rg.sorted.bam	168.4	2	0.15	58cfa82fe4b0c9d6adf6b5f0	TCGA-50-5933-01A-11D-1751_110928_SN590_0108_BB01CWACXX_s_6_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-50-5933-01A	7A0EA814-F0DE-4BC4-A81A-DAA000559369	Primary Tumor	Illumina HiSeq	ca97b42b-d723-4c0a-8f71-819eca1bb805	Lung	72	D2355F3A-E2CE-4791-B1FB-B570850681DF	1D83B47D-66A8-4AE9-81BB-BDC03FA64AC6	TCGA-50-5933-01A-11D-1751-02	HG19_Broad_variant	TCGA-50-5933	TCGA-LUAD	2393	s11009	Harvard Medical School	University of Pittsburgh	United States	NO	T4	N2	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage IIIB	1751-02	TRUE
13722.58cfa82ee4b0c9d6adf6ae5c	58cfa82ee4b0c9d6adf6ae5c	TCGA-05-4397-01A-01D-1203_120318_SN1120_0124_AC0HNPACXX_s_7_rg.sorted.filtered.	WGS	TCGA-05-4397-01A-01D-1203_120318_SN1120_0124_AC0HNPACXX_s_7_rg.sorted	TCGA-05-4397-01A-01D-1203_120318_SN1120_0124_AC0HNPACXX_s_7_rg.sorted.bam	573.23	1.9	0.14	58cfa82ee4b0c9d6adf6ae5c	TCGA-05-4397-01A-01D-1203_120318_SN1120_0124_AC0HNPACXX_s_7_rg.sorted.bam	Dead	MALE	Not available	Not available	Lung Adenocarcinoma	Aligned reads	TCGA-05-4397-01A	6DFD47D2-831A-4386-9051-F78199A16BB5	Primary Tumor	Illumina HiSeq	09ccfcd9-4865-439b-9162-cf783f33f44d	Lung	65	C4C061CD-E926-400B-B18C-B47C234337CA	5D48DDB3-ED53-49CB-99B9-B75FCECCA1B4	TCGA-05-4397-01A-01D-1203-02	HG19_Broad_variant	TCGA-05-4397	TCGA-LUAD	731	s10643	Harvard Medical School	Indivumed	Germany	NO	T2	N1	Lung Adenocarcinoma Mixed Subtype	Stage IIB	1203-02	TRUE
13722.58cfa82ee4b0c9d6adf6b038	58cfa82ee4b0c9d6adf6b038	TCGA-05-4424-01A-22D-1853_120312_SN1120_0120_AD0PYGACXX_s_1_rg.sorted.filtered.	WGS	TCGA-05-4424-01A-22D-1853_120312_SN1120_0120_AD0PYGACXX_s_1_rg.sorted	TCGA-05-4424-01A-22D-1853_120312_SN1120_0120_AD0PYGACXX_s_1_rg.sorted.bam	16.7	1.9	0.14	58cfa82ee4b0c9d6adf6b038	TCGA-05-4424-01A-22D-1853_120312_SN1120_0120_AD0PYGACXX_s_1_rg.sorted.bam	Alive	MALE	Not available	Not available	Lung Adenocarcinoma	Aligned reads	TCGA-05-4424-01A	66763A0C-6CDA-4832-A0CC-E7B496D78EAA	Primary Tumor	Illumina HiSeq	1e635509-6178-417e-9452-bc77482ee8ed	Lung	70	A4D06D63-8DA9-4C3C-A75D-4079C2238AA8	D1052F23-44EC-4C05-A164-6FBD72DFC9E2	TCGA-05-4424-01A-22D-1853-02	HG19_Broad_variant	TCGA-05-4424	TCGA-LUAD	NA	s11438	Harvard Medical School	Indivumed	Germany	NO	T3	N0	Lung Adenocarcinoma Mixed Subtype	Stage IIB	1853-02	TRUE
13722.58cfa82fe4b0c9d6adf6b6be	58cfa82fe4b0c9d6adf6b6be	TCGA-55-6543-01A-11D-1751_111115_SN590_0111_D09ATACXX_s_8.rg.sorted.filtered.	WGS	TCGA-55-6543-01A-11D-1751_111115_SN590_0111_D09ATACXX_s_8.rg.sorted	TCGA-55-6543-01A-11D-1751_111115_SN590_0111_D09ATACXX_s_8.rg.sorted.bam	127.4	1.9	0.15	58cfa82fe4b0c9d6adf6b6be	TCGA-55-6543-01A-11D-1751_111115_SN590_0111_D09ATACXX_s_8.rg.sorted.bam	Alive	FEMALE	WHITE	Not available	Lung Adenocarcinoma	Aligned reads	TCGA-55-6543-01A	E68219B0-A9C2-49DF-8F0D-DB5EA97FD2DC	Primary Tumor	Illumina HiSeq	0715b83e-fcd8-41e9-88ac-cfeb5fabd3de	Lung	60	8D9491E7-9B14-4988-8FA7-E6AF041120BD	1D88DA12-E71A-4F44-8D71-DA8957BDFCD4	TCGA-55-6543-01A-11D-1751-02	HG19_Broad_variant	TCGA-55-6543	TCGA-LUAD	NA	s10791	Harvard Medical School	International Genomics Consortium	United States	NO	T1b	N0	Lung Bronchioloalveolar Carcinoma Mucinous	Stage IA	1751-02	TRUE
13722.58cfa82ee4b0c9d6adf6b014	58cfa82ee4b0c9d6adf6b014	TCGA-05-4433-01A-22D-1853_120312_SN1120_0120_AD0PYGACXX_s_3_rg.sorted.filtered.	WGS	TCGA-05-4433-01A-22D-1853_120312_SN1120_0120_AD0PYGACXX_s_3_rg.sorted	TCGA-05-4433-01A-22D-1853_120312_SN1120_0120_AD0PYGACXX_s_3_rg.sorted.bam	199.7	1.9	0.16	58cfa82ee4b0c9d6adf6b014	TCGA-05-4433-01A-22D-1853_120312_SN1120_0120_AD0PYGACXX_s_3_rg.sorted.bam	Alive	MALE	Not available	Not available	Lung Adenocarcinoma	Aligned reads	TCGA-05-4433-01A	AEA68827-DC0F-484D-A00D-06DEEAA4B3CE	Primary Tumor	Illumina HiSeq	d1b6064d-6736-4aad-8ad3-70ab64c92e3d	Lung	82	1E9DAC94-1A10-47D0-AE92-81D38A264376	61B1812A-9455-437F-ACF7-D1AC3FA9F215	TCGA-05-4433-01A-22D-1853-02	HG19_Broad_variant	TCGA-05-4433	TCGA-LUAD	NA	s10986	Harvard Medical School	Indivumed	Germany	NO	T2	N0	Lung Adenocarcinoma Mixed Subtype	Stage IB	1853-02	TRUE
13722.58cfa82fe4b0c9d6adf6b6dc	58cfa82fe4b0c9d6adf6b6dc	TCGA-50-5935-01A-11D-1751_110928_SN590_0108_BB01CWACXX_s_8_rg.sorted.filtered.	WGS	TCGA-50-5935-01A-11D-1751_110928_SN590_0108_BB01CWACXX_s_8_rg.sorted	TCGA-50-5935-01A-11D-1751_110928_SN590_0108_BB01CWACXX_s_8_rg.sorted.bam	190.4	1.9	0.15	58cfa82fe4b0c9d6adf6b6dc	TCGA-50-5935-01A-11D-1751_110928_SN590_0108_BB01CWACXX_s_8_rg.sorted.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-50-5935-01A	100430C8-1446-45C8-AF36-B6DBB3DDD0C1	Primary Tumor	Illumina HiSeq	f4ad5c7d-a36e-4d9a-9c36-444e4b443953	Lung	86	98687ADB-F8E9-4E6E-BC1B-396A3DDFAC96	6F0D56B0-E246-4566-AFFB-B8DD5E88B5BA	TCGA-50-5935-01A-11D-1751-02	HG19_Broad_variant	TCGA-50-5935	TCGA-LUAD	653	s10908	Harvard Medical School	University of Pittsburgh	United States	NO	T1	N0	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage IA	1751-02	TRUE
13722.58cfa82fe4b0c9d6adf6b6d2	58cfa82fe4b0c9d6adf6b6d2	TCGA-44-3396-01A-01D-1203_110804_SN208_0216_AD0CLLABXX_s_7_rg.sorted.filtered.	WGS	TCGA-44-3396-01A-01D-1203_110804_SN208_0216_AD0CLLABXX_s_7_rg.sorted	TCGA-44-3396-01A-01D-1203_110804_SN208_0216_AD0CLLABXX_s_7_rg.sorted.bam	472.3	1.9	0.15	58cfa82fe4b0c9d6adf6b6d2	TCGA-44-3396-01A-01D-1203_110804_SN208_0216_AD0CLLABXX_s_7_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-44-3396-01A	3BD6BADB-27FF-4D8D-B206-4D28DC264862	Primary Tumor	Illumina HiSeq	bf55243b-c7c6-46fc-9d54-e1916b0d7ea2	Lung	74	B560DF97-986B-4A88-A0F1-C38A30080EDB	ECCC6A5C-BB25-4591-996A-EE2A7507F771	TCGA-44-3396-01A-01D-1203-02	HG19_Broad_variant	TCGA-44-3396	TCGA-LUAD	NA	s10653	Harvard Medical School	Christiana Healthcare	United States	NO	T2	N2	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage IIIA	1203-02	TRUE
13722.58cfa82fe4b0c9d6adf6b728	58cfa82fe4b0c9d6adf6b728	TCGA-44-6147-01A-11D-1751_111207_SN590_0112_D09CDACXX_s_1_rg.sorted.filtered.	WGS	TCGA-44-6147-01A-11D-1751_111207_SN590_0112_D09CDACXX_s_1_rg.sorted	TCGA-44-6147-01A-11D-1751_111207_SN590_0112_D09CDACXX_s_1_rg.sorted.bam	219	1.9	0.17	58cfa82fe4b0c9d6adf6b728	TCGA-44-6147-01A-11D-1751_111207_SN590_0112_D09CDACXX_s_1_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-44-6147-01A	889AEC8E-14BA-48D9-8FE1-F2416E82B333	Primary Tumor	Illumina HiSeq	a9e60432-a9de-4497-b94d-5ead787d2de3	Lung	67	43F5270A-F2F2-4DD9-83B5-486B805E35B8	E9CE62EF-711E-4252-AC93-97B69C39041A	TCGA-44-6147-01A-11D-1751-02	HG19_Broad_variant	TCGA-44-6147	TCGA-LUAD	NA	s11447	Harvard Medical School	Christiana Healthcare	United States	NO	T1b	NX	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage IA	1751-02	TRUE
13722.58cfa82fe4b0c9d6adf6b70a	58cfa82fe4b0c9d6adf6b70a	TCGA-67-6216-01A-11D-1751_111115_SN590_0111_D09ATACXX_s_1.rg.sorted.filtered.	WGS	TCGA-67-6216-01A-11D-1751_111115_SN590_0111_D09ATACXX_s_1.rg.sorted	TCGA-67-6216-01A-11D-1751_111115_SN590_0111_D09ATACXX_s_1.rg.sorted.bam	355.4	1.9	0.14	58cfa82fe4b0c9d6adf6b70a	TCGA-67-6216-01A-11D-1751_111115_SN590_0111_D09ATACXX_s_1.rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-67-6216-01A	CCECCE70-DD54-4C5B-BF9F-CA87D290CB00	Primary Tumor	Illumina HiSeq	ae4aaef1-8b47-476b-933a-ff69761aa0a9	Lung	57	4EAA4B4A-E9DB-4E65-97D6-7FA1A205DA95	1003F495-01FE-47ED-A717-B8769F0FA3A3	TCGA-67-6216-01A-11D-1751-02	HG19_Broad_variant	TCGA-67-6216	TCGA-LUAD	NA	s11242	Harvard Medical School	St Joseph's Medical Center (MD)	United States	NO	T1a	N0	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage IA	1751-02	TRUE
13722.58cfa82fe4b0c9d6adf6b780	58cfa82fe4b0c9d6adf6b780	TCGA-50-5045-01A-01D-1623_120205_SN590_0136_BD0LRYACXX_s_1_rg.sorted.filtered.	WGS	TCGA-50-5045-01A-01D-1623_120205_SN590_0136_BD0LRYACXX_s_1_rg.sorted	TCGA-50-5045-01A-01D-1623_120205_SN590_0136_BD0LRYACXX_s_1_rg.sorted.bam	1032.7	1.9	0.17	58cfa82fe4b0c9d6adf6b780	TCGA-50-5045-01A-01D-1623_120205_SN590_0136_BD0LRYACXX_s_1_rg.sorted.bam	Dead	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-50-5045-01A	9EE20C0D-A1C3-47F3-ABDA-131B3F190F52	Primary Tumor	Illumina HiSeq	e3bc7a3f-c296-412c-8974-8c21cf01dbfb	Lung	57	BDD75BCA-6224-4743-A367-CB1FF01E8121	42839A7D-81DB-428A-AB3B-072ACD26CA91	TCGA-50-5045-01A-01D-1623-02	HG19_Broad_variant	TCGA-50-5045	TCGA-LUAD	2174	s11004	Harvard Medical School	University of Pittsburgh	United States	NO	T2	N1	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage IA	1623-02	TRUE
13722.58cfa82fe4b0c9d6adf6b82d	58cfa82fe4b0c9d6adf6b82d	TCGA-44-6779-01A-11D-1853_120312_SN1120_0120_AD0PYGACXX_s_8_rg.sorted.filtered.	WGS	TCGA-44-6779-01A-11D-1853_120312_SN1120_0120_AD0PYGACXX_s_8_rg.sorted	TCGA-44-6779-01A-11D-1853_120312_SN1120_0120_AD0PYGACXX_s_8_rg.sorted.bam	62.7	1.9	0.15	58cfa82fe4b0c9d6adf6b82d	TCGA-44-6779-01A-11D-1853_120312_SN1120_0120_AD0PYGACXX_s_8_rg.sorted.bam	Dead	FEMALE	WHITE	Not available	Lung Adenocarcinoma	Aligned reads	TCGA-44-6779-01A	CBBEA9F1-396A-4BF3-B67C-2CAC3394DCEB	Primary Tumor	Illumina HiSeq	ab458a7b-afac-4c72-8db7-45994af6ceb8	Lung	50	5E04D394-7A40-4E89-BA20-892774DCB469	DB5F07FE-8DC0-4259-A6B1-E75B6F1188C5	TCGA-44-6779-01A-11D-1853-02	HG19_Broad_variant	TCGA-44-6779	TCGA-LUAD	500	s11344	Harvard Medical School	Christiana Healthcare	United States	NO	T2	N1	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage IIB	1853-02	TRUE
13722.58cfa82fe4b0c9d6adf6b762	58cfa82fe4b0c9d6adf6b762	TCGA-75-5125-01A-01D-1751_120309_SN208_0273_BC0HEAACXX_s_3_rg.sorted.filtered.	WGS	TCGA-75-5125-01A-01D-1751_120309_SN208_0273_BC0HEAACXX_s_3_rg.sorted	TCGA-75-5125-01A-01D-1751_120309_SN208_0273_BC0HEAACXX_s_3_rg.sorted.bam	628.4	1.9	0.15	58cfa82fe4b0c9d6adf6b762	TCGA-75-5125-01A-01D-1751_120309_SN208_0273_BC0HEAACXX_s_3_rg.sorted.bam	Alive	MALE	Not available	Not available	Lung Adenocarcinoma	Aligned reads	TCGA-75-5125-01A	205759A6-6391-491B-9857-0080C3A5871E	Primary Tumor	Illumina HiSeq	0a5ee83a-046b-41b4-9551-40372fa70b7d	Lung	NA	73A77977-FAB0-486F-8D15-BE8B30C8808A	02DE68CC-AD50-45FD-BB4D-819D6E0F55F5	TCGA-75-5125-01A-01D-1751-02	HG19_Broad_variant	TCGA-75-5125	TCGA-LUAD	NA	s11362	Harvard Medical School	Ontario Institute for Cancer Research (OICR)	Canada	NO	T2	N1	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage IIB	1751-02	TRUE
13722.58cfa82fe4b0c9d6adf6b864	58cfa82fe4b0c9d6adf6b864	TCGA-A5-A0GU-01A-11D-A043_120209_SN1120_0114_BC0DFVACXX_s_5_rg.sorted.filtered.	WGS	TCGA-A5-A0GU-01A-11D-A043_120209_SN1120_0114_BC0DFVACXX_s_5_rg.sorted	TCGA-A5-A0GU-01A-11D-A043_120209_SN1120_0114_BC0DFVACXX_s_5_rg.sorted.bam	101.03	2.18	0.17	58cfa82fe4b0c9d6adf6b864	TCGA-A5-A0GU-01A-11D-A043_120209_SN1120_0114_BC0DFVACXX_s_5_rg.sorted.bam	Alive	FEMALE	WHITE	Not available	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-A5-A0GU-01A	ADC22472-E31D-419F-AEAE-CB01B9423343	Primary Tumor	Illumina HiSeq	7666f932-cff3-4ea2-8650-8d4bdae72cac	Uterus	58	074D4466-E072-42CD-9A6C-A595DC9363E7	BB726D7A-6861-48AA-9BFD-5DF8DAAA1538	TCGA-A5-A0GU-01A-11D-A043-02	HG19_Broad_variant	TCGA-A5-A0GU	TCGA-UCEC	NA	s4241	Harvard Medical School	Cedars Sinai	None	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A043-02	TRUE
13722.58cfa82fe4b0c9d6adf6b760	58cfa82fe4b0c9d6adf6b760	TCGA-75-5122-01A-01D-1751_120309_SN208_0273_BC0HEAACXX_s_1_rg.sorted.filtered.	WGS	TCGA-75-5122-01A-01D-1751_120309_SN208_0273_BC0HEAACXX_s_1_rg.sorted	TCGA-75-5122-01A-01D-1751_120309_SN208_0273_BC0HEAACXX_s_1_rg.sorted.bam	466.4	1.9	0.15	58cfa82fe4b0c9d6adf6b760	TCGA-75-5122-01A-01D-1751_120309_SN208_0273_BC0HEAACXX_s_1_rg.sorted.bam	Dead	MALE	Not available	Not available	Lung Adenocarcinoma	Aligned reads	TCGA-75-5122-01A	78AE716B-0CA5-4C01-A053-D41288385FCD	Primary Tumor	Illumina HiSeq	611aeb0f-3dbe-41c6-8b8e-b4a7c827ac1d	Lung	NA	DD9C2F71-145A-4F7F-8B64-095B1FC75C3D	4ADD8465-F06A-4752-8B9F-A6F790F727B1	TCGA-75-5122-01A-01D-1751-02	HG19_Broad_variant	TCGA-75-5122	TCGA-LUAD	NA	s11249	Harvard Medical School	Ontario Institute for Cancer Research (OICR)	Canada	NO	T2	N0	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage IB	1751-02	TRUE
13722.58cfa82fe4b0c9d6adf6b9a8	58cfa82fe4b0c9d6adf6b9a8	TCGA-67-6215-01A-11D-1751_111115_SN590_0111_D09ATACXX_s_7.rg.sorted.filtered.	WGS	TCGA-67-6215-01A-11D-1751_111115_SN590_0111_D09ATACXX_s_7.rg.sorted	TCGA-67-6215-01A-11D-1751_111115_SN590_0111_D09ATACXX_s_7.rg.sorted.bam	292.4	1.9	0.14	58cfa82fe4b0c9d6adf6b9a8	TCGA-67-6215-01A-11D-1751_111115_SN590_0111_D09ATACXX_s_7.rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-67-6215-01A	DBD5B0DE-94C9-45DD-AFB3-6820A7ECACA2	Primary Tumor	Illumina HiSeq	502bd59b-5e8d-4170-9a24-b18fa50a5dc1	Lung	52	3BA5F6B9-6458-44E2-A0AA-B5C7E5FCD632	483EF1DC-150E-4623-BA11-772ADE84E4E4	TCGA-67-6215-01A-11D-1751-02	HG19_Broad_variant	TCGA-67-6215	TCGA-LUAD	NA	s11555	Harvard Medical School	St Joseph's Medical Center (MD)	United States	NO	T2a	N0	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage IB	1751-02	TRUE
13722.58cfa830e4b0c9d6adf6bada	58cfa830e4b0c9d6adf6bada	TCGA-49-6745-01A-11D-1853_111218_SN208_0258_C054RACXX_s_7_rg.sorted.filtered.	WGS	TCGA-49-6745-01A-11D-1853_111218_SN208_0258_C054RACXX_s_7_rg.sorted	TCGA-49-6745-01A-11D-1853_111218_SN208_0258_C054RACXX_s_7_rg.sorted.bam	88.7	1.9	0.15	58cfa830e4b0c9d6adf6bada	TCGA-49-6745-01A-11D-1853_111218_SN208_0258_C054RACXX_s_7_rg.sorted.bam	Alive	MALE	WHITE	Not available	Lung Adenocarcinoma	Aligned reads	TCGA-49-6745-01A	9C7875AD-AB71-4D48-B2E3-E4C7A46393E9	Primary Tumor	Illumina HiSeq	b4eee7d7-a56c-4927-929e-ac66abe41408	Lung	82	357F3EFE-E2C9-432A-A2B6-75A5FDBAE3BE	A88D69EF-BE3C-4341-AD6C-0F035685862F	TCGA-49-6745-01A-11D-1853-02	HG19_Broad_variant	TCGA-49-6745	TCGA-LUAD	NA	s11451	Harvard Medical School	Johns Hopkins	United States	NO	T2a	N2	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage IIIA	1853-02	TRUE
13722.58cfa82fe4b0c9d6adf6b9e8	58cfa82fe4b0c9d6adf6b9e8	TCGA-A5-A0G9-01A-11D-A043_120318_SN590_0146_AC0KH7ACXX_s_3_rg.sorted.filtered.	WGS	TCGA-A5-A0G9-01A-11D-A043_120318_SN590_0146_AC0KH7ACXX_s_3_rg.sorted	TCGA-A5-A0G9-01A-11D-A043_120318_SN590_0146_AC0KH7ACXX_s_3_rg.sorted.bam	54.22	1.93	0.16	58cfa82fe4b0c9d6adf6b9e8	TCGA-A5-A0G9-01A-11D-A043_120318_SN590_0146_AC0KH7ACXX_s_3_rg.sorted.bam	Alive	FEMALE	WHITE	Not available	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-A5-A0G9-01A	45D58088-D3F4-4EB0-B75C-BCB98C0981DC	Primary Tumor	Illumina HiSeq	daffebdf-d935-425e-8576-3401ef583860	Uterus	79	117A5B33-42C5-4A52-BABE-D9712F3E7472	0DE57B60-95AF-48E2-85CA-58135A314355	TCGA-A5-A0G9-01A-11D-A043-02	HG19_Broad_variant	TCGA-A5-A0G9	TCGA-UCEC	NA	s4778	Harvard Medical School	Cedars Sinai	None	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A043-02	TRUE
13722.58cfa830e4b0c9d6adf6bc8a	58cfa830e4b0c9d6adf6bc8a	TCGA-AP-A0L8-01A-11D-A043_120324_SN1120_0127_BC0L80ACXX_s_5_rg.sorted.filtered.	WGS	TCGA-AP-A0L8-01A-11D-A043_120324_SN1120_0127_BC0L80ACXX_s_5_rg.sorted	TCGA-AP-A0L8-01A-11D-A043_120324_SN1120_0127_BC0L80ACXX_s_5_rg.sorted.bam	128.45	2.03	0.16	58cfa830e4b0c9d6adf6bc8a	TCGA-AP-A0L8-01A-11D-A043_120324_SN1120_0127_BC0L80ACXX_s_5_rg.sorted.bam	Dead	FEMALE	BLACK OR AFRICAN AMERICAN	Not available	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-AP-A0L8-01A	9AA8C2B4-DB32-4899-BF0C-D578CB175E90	Primary Tumor	Illumina HiSeq	41360e8e-e9e9-402a-bd9e-a987e56c920e	Uterus	70	D1A7A58F-7A35-4A94-A337-051AE56DED00	2BE44D5B-CCD6-4DD5-B0C7-C7813B526B94	TCGA-AP-A0L8-01A-11D-A043-02	HG19_Broad_variant	TCGA-AP-A0L8	TCGA-UCEC	1484	s4244	Harvard Medical School	MSKCC	None	NO	Not available	Not available	Serous endometrial adenocarcinoma	Not available	A043-02	TRUE
13722.58cfa830e4b0c9d6adf6bd9a	58cfa830e4b0c9d6adf6bd9a	TCGA-BG-A0M6-01A-31D-A101_120330_SN1120_0129_BD0UCLACXX_s_2_rg.sorted.filtered.	WGS	TCGA-BG-A0M6-01A-31D-A101_120330_SN1120_0129_BD0UCLACXX_s_2_rg.sorted	TCGA-BG-A0M6-01A-31D-A101_120330_SN1120_0129_BD0UCLACXX_s_2_rg.sorted.bam	71.62	1.94	0.14	58cfa830e4b0c9d6adf6bd9a	TCGA-BG-A0M6-01A-31D-A101_120330_SN1120_0129_BD0UCLACXX_s_2_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-BG-A0M6-01A	002724FA-7051-49FA-9C58-4BCB7EBA4AC6	Primary Tumor	Illumina HiSeq	0db41cb8-f118-4d04-a002-22df953a0dec	Uterus	73	66E4B080-E6EF-4531-9B69-1B27F15C5669	61C058D9-E5DC-4D74-B378-28B8F0A2BF78	TCGA-BG-A0M6-01A-31D-A101-02	HG19_Broad_variant	TCGA-BG-A0M6	TCGA-UCEC	NA	s4249	Harvard Medical School	University of Pittsburgh	None	NO	Not available	Not available	Serous endometrial adenocarcinoma	Not available	A101-02	TRUE
13722.58cfa830e4b0c9d6adf6bc82	58cfa830e4b0c9d6adf6bc82	TCGA-AP-A0LI-01A-11D-A043_120301_SN590_0142_AD0LPVACXX_s_7_rg.sorted.filtered.	WGS	TCGA-AP-A0LI-01A-11D-A043_120301_SN590_0142_AD0LPVACXX_s_7_rg.sorted	TCGA-AP-A0LI-01A-11D-A043_120301_SN590_0142_AD0LPVACXX_s_7_rg.sorted.bam	85.32	1.85	0.15	58cfa830e4b0c9d6adf6bc82	TCGA-AP-A0LI-01A-11D-A043_120301_SN590_0142_AD0LPVACXX_s_7_rg.sorted.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	Not available	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-AP-A0LI-01A	E1E8DC66-467C-48A5-BE56-3DB4F665B9F1	Primary Tumor	Illumina HiSeq	9fe530df-5c54-45fa-a25d-65e1a7d0110b	Uterus	67	981D9E3B-63C5-41E9-827F-7F1D268D62F4	D80E9147-7A64-4AB0-891A-2D97D0634EAB	TCGA-AP-A0LI-01A-11D-A043-02	HG19_Broad_variant	TCGA-AP-A0LI	TCGA-UCEC	NA	s5387	Harvard Medical School	MSKCC	None	NO	Not available	Not available	Serous endometrial adenocarcinoma	Not available	A043-02	TRUE
13722.58cfa830e4b0c9d6adf6bdb3	58cfa830e4b0c9d6adf6bdb3	TCGA-BG-A0MG-01A-21D-A101_120330_SN1120_0129_BD0UCLACXX_s_5_rg.sorted.filtered.	WGS	TCGA-BG-A0MG-01A-21D-A101_120330_SN1120_0129_BD0UCLACXX_s_5_rg.sorted	TCGA-BG-A0MG-01A-21D-A101_120330_SN1120_0129_BD0UCLACXX_s_5_rg.sorted.bam	57.94	1.87	0.14	58cfa830e4b0c9d6adf6bdb3	TCGA-BG-A0MG-01A-21D-A101_120330_SN1120_0129_BD0UCLACXX_s_5_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-BG-A0MG-01A	9CDE90C8-2BE0-4328-A032-FF1DC19E66FD	Primary Tumor	Illumina HiSeq	30b3e5f5-4066-401d-9cf3-5ee64b9014ef	Uterus	73	96B6826D-8A4C-45F5-8CD3-B5988AA5FD0E	755BD772-9331-402B-832B-2933AAECFC71	TCGA-BG-A0MG-01A-21D-A101-02	HG19_Broad_variant	TCGA-BG-A0MG	TCGA-UCEC	NA	s4248	Harvard Medical School	University of Pittsburgh	None	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A101-02	TRUE
13722.58cfa830e4b0c9d6adf6be68	58cfa830e4b0c9d6adf6be68	TCGA-BJ-A28Z-01A-11D-A16N_120718_SN590_0169_AC0WL7ACXX_s_2_rg.sorted.filtered.	WGS	TCGA-BJ-A28Z-01A-11D-A16N_120718_SN590_0169_AC0WL7ACXX_s_2_rg.sorted	TCGA-BJ-A28Z-01A-11D-A16N_120718_SN590_0169_AC0WL7ACXX_s_2_rg.sorted.bam	46.06	1.81	0.15	58cfa830e4b0c9d6adf6be68	TCGA-BJ-A28Z-01A-11D-A16N_120718_SN590_0169_AC0WL7ACXX_s_2_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-BJ-A28Z-01A	6BA76174-620E-4851-857A-D0ADBFD6F3E6	Primary Tumor	Illumina HiSeq	3d2be877-3825-44b4-99b1-b3c314e68c0c	Thyroid	46	D9689254-AFE2-4544-AF54-E02670BD5EBD	F353E9F5-A869-4BE1-ACC4-A832D77285D4	TCGA-BJ-A28Z-01A-11D-A16N-02	HG19_Broad_variant	TCGA-BJ-A28Z	TCGA-THCA	NA	s12508	Harvard Medical School	University of Pittsburgh	United States	NO	T3	N1a	Thyroid Papillary Carcinoma - Classical/usual	Stage III	A16N-02	TRUE
13722.58cfa830e4b0c9d6adf6be55	58cfa830e4b0c9d6adf6be55	TCGA-AP-A0LT-01A-11D-A043_120327_SN590_0149_AD0U12ACXX_s_1_rg.sorted.filtered.	WGS	TCGA-AP-A0LT-01A-11D-A043_120327_SN590_0149_AD0U12ACXX_s_1_rg.sorted	TCGA-AP-A0LT-01A-11D-A043_120327_SN590_0149_AD0U12ACXX_s_1_rg.sorted.bam	118.49	2.07	0.17	58cfa830e4b0c9d6adf6be55	TCGA-AP-A0LT-01A-11D-A043_120327_SN590_0149_AD0U12ACXX_s_1_rg.sorted.bam	Alive	FEMALE	WHITE	Not available	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-AP-A0LT-01A	43714E9A-E9C4-4206-AF92-1D00D2A8AE35	Primary Tumor	Illumina HiSeq	42ca121f-f3b0-4b47-acb4-f1294f88eb39	Uterus	57	C94DD7A5-DD58-4702-A7D1-8199D3F8C9CC	B057AD28-5D99-48BC-B642-7E548914F1B1	TCGA-AP-A0LT-01A-11D-A043-02	HG19_Broad_variant	TCGA-AP-A0LT	TCGA-UCEC	NA	s4242	Harvard Medical School	MSKCC	None	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A043-02	TRUE
13722.58cfa830e4b0c9d6adf6be38	58cfa830e4b0c9d6adf6be38	TCGA-B5-A0JY-01A-11D-A101_120330_SN208_0280_AD0UKLACXX_s_6_rg.sorted.filtered.	WGS	TCGA-B5-A0JY-01A-11D-A101_120330_SN208_0280_AD0UKLACXX_s_6_rg.sorted	TCGA-B5-A0JY-01A-11D-A101_120330_SN208_0280_AD0UKLACXX_s_6_rg.sorted.bam	80.24	1.95	0.16	58cfa830e4b0c9d6adf6be38	TCGA-B5-A0JY-01A-11D-A101_120330_SN208_0280_AD0UKLACXX_s_6_rg.sorted.bam	Alive	FEMALE	WHITE	Not available	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-B5-A0JY-01A	61935424-44D0-4211-81C1-C925E436EAC5	Primary Tumor	Illumina HiSeq	e463dbb2-091a-4183-98b6-a90c2e55ffae	Uterus	50	95F418CE-FCD9-4402-BC24-1520F45CB6B7	88CE0037-F3F9-4F45-BF14-36A58FF61A3D	TCGA-B5-A0JY-01A-11D-A101-02	HG19_Broad_variant	TCGA-B5-A0JY	TCGA-UCEC	NA	s4784	Harvard Medical School	Duke	United States	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A101-02	TRUE
13722.58cfa830e4b0c9d6adf6bf3d	58cfa830e4b0c9d6adf6bf3d	TCGA-BR-4187-01A-01D-1128_120805_SN1222_0142_AD16TGACXX_s_5_rg.sorted.filtered.	WGS	TCGA-BR-4187-01A-01D-1128_120805_SN1222_0142_AD16TGACXX_s_5_rg.sorted	TCGA-BR-4187-01A-01D-1128_120805_SN1222_0142_AD16TGACXX_s_5_rg.sorted.bam	138.9	1.9	0.15	58cfa830e4b0c9d6adf6bf3d	TCGA-BR-4187-01A-01D-1128_120805_SN1222_0142_AD16TGACXX_s_5_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-BR-4187-01A	12071070-D06B-4C7B-A7B1-77C84963ABE6	Primary Tumor	Illumina HiSeq	1da3a244-39ae-4b4d-baed-e4d9b312f777	Stomach	56	144FB4ED-63BB-4908-B678-6026E09566A3	57CF858D-FF3F-4528-96DB-5A820C9B78DE	TCGA-BR-4187-01A-01D-1128-02	HG19_Broad_variant	TCGA-BR-4187	TCGA-STAD	NA	s15046	Harvard Medical School	Asterand	Russia	NO	TX	NX	Stomach  Adenocarcinoma  Not Otherwise Specified (NOS)	Not available	1128-02	TRUE
13722.58cfa830e4b0c9d6adf6bf87	58cfa830e4b0c9d6adf6bf87	TCGA-BJ-A3PR-01A-11D-A221_120524_SN1120_0144_AC0VNCACXX_s_7_rg.sorted.filtered.	WGS	TCGA-BJ-A3PR-01A-11D-A221_120524_SN1120_0144_AC0VNCACXX_s_7_rg.sorted	TCGA-BJ-A3PR-01A-11D-A221_120524_SN1120_0144_AC0VNCACXX_s_7_rg.sorted.bam	45.84	NA	0.15	58cfa830e4b0c9d6adf6bf87	TCGA-BJ-A3PR-01A-11D-A221_120524_SN1120_0144_AC0VNCACXX_s_7_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-BJ-A3PR-01A	FD036EC5-3FFB-40B1-8002-943BE0E2532E	Primary Tumor	Illumina HiSeq	c8c8646f-54e4-4440-bf91-d2cd90083c44	Thyroid	69	E058A8E1-ED00-48A5-A46B-77538D7B73F1	57FD6BDA-C7B4-4B74-B21A-B7FF5D1C87EE	TCGA-BJ-A3PR-01A-11D-A221-26	HG19_Broad_variant	TCGA-BJ-A3PR	TCGA-THCA	NA	s12358	MD Anderson - Institute for Applied Cancer Science	University of Pittsburgh	United States	NO	T1a	N0	Thyroid Papillary Carcinoma - Classical/usual	Stage I	A221-26	TRUE
13722.58cfa830e4b0c9d6adf6bf7e	58cfa830e4b0c9d6adf6bf7e	TCGA-B5-A0JV-01A-11D-A101_120330_SN208_0280_AD0UKLACXX_s_5_rg.sorted.filtered.	WGS	TCGA-B5-A0JV-01A-11D-A101_120330_SN208_0280_AD0UKLACXX_s_5_rg.sorted	TCGA-B5-A0JV-01A-11D-A101_120330_SN208_0280_AD0UKLACXX_s_5_rg.sorted.bam	90.33	1.92	0.15	58cfa830e4b0c9d6adf6bf7e	TCGA-B5-A0JV-01A-11D-A101_120330_SN208_0280_AD0UKLACXX_s_5_rg.sorted.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	Not available	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-B5-A0JV-01A	233E947A-D5E2-48E5-A8CE-5DA1ABB20681	Primary Tumor	Illumina HiSeq	2c99d5d5-1f92-452e-9370-59486a6d7bce	Uterus	63	42199E5A-9F4F-4445-9E6E-114D47BA67FA	7132C5C6-9DC5-42A8-863F-D82280266427	TCGA-B5-A0JV-01A-11D-A101-02	HG19_Broad_variant	TCGA-B5-A0JV	TCGA-UCEC	NA	s4783	Harvard Medical School	Duke	United States	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A101-02	TRUE
13722.58cfa830e4b0c9d6adf6c1aa	58cfa830e4b0c9d6adf6c1aa	TCGA-BA-5555-01A-01D-1509_120420_SN1120_0135_BD0T5FACXX_s_2_rg.sorted.filtered.	WGS	TCGA-BA-5555-01A-01D-1509_120420_SN1120_0135_BD0T5FACXX_s_2_rg.sorted	TCGA-BA-5555-01A-01D-1509_120420_SN1120_0135_BD0T5FACXX_s_2_rg.sorted.bam	213.7	1.9	0.16	58cfa830e4b0c9d6adf6c1aa	TCGA-BA-5555-01A-01D-1509_120420_SN1120_0135_BD0T5FACXX_s_2_rg.sorted.bam	Alive	MALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-BA-5555-01A	8970F713-4A7A-4125-892C-6A34139371D8	Primary Tumor	Illumina HiSeq	cd7725ec-bc8e-4c93-aba5-19dbdeb78b0d	Head and Neck	54	2920CA1C-6035-4350-ADA4-C60D485DBFFF	4AB42DF9-A215-4965-A125-CC0C4122FF06	TCGA-BA-5555-01A-01D-1509-02	HG19_Broad_variant	TCGA-BA-5555	TCGA-HNSC	NA	s15609	Harvard Medical School	UNC	None	NO	T3	N2c	Head and Neck Squamous Cell Carcinoma	Stage IVA	1509-02	TRUE
13722.58cfa830e4b0c9d6adf6c1b6	58cfa830e4b0c9d6adf6c1b6	TCGA-BA-4076-01A-01D-1431_120310_SN590_0145_BD0RGYACXX_s_5_rg.sorted.filtered.	WGS	TCGA-BA-4076-01A-01D-1431_120310_SN590_0145_BD0RGYACXX_s_5_rg.sorted	TCGA-BA-4076-01A-01D-1431_120310_SN590_0145_BD0RGYACXX_s_5_rg.sorted.bam	333.33	1.9	0.15	58cfa830e4b0c9d6adf6c1b6	TCGA-BA-4076-01A-01D-1431_120310_SN590_0145_BD0RGYACXX_s_5_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-BA-4076-01A	7DE19081-D5FD-468C-AD0D-F6E3E8B2AD70	Primary Tumor	Illumina HiSeq	f67d413c-c33d-4d97-9853-0b00f93f2304	Head and Neck	39	FD99FD83-4040-4738-8A5A-E42D36ECFE0E	54F77A3E-290A-4073-8012-4873579E95E9	TCGA-BA-4076-01A-01D-1431-02	HG19_Broad_variant	TCGA-BA-4076	TCGA-HNSC	415	s15749	Harvard Medical School	UNC	None	NO	TX	NX	Head and Neck Squamous Cell Carcinoma	Not available	1431-02	TRUE
13722.58cfa830e4b0c9d6adf6c1f6	58cfa830e4b0c9d6adf6c1f6	TCGA-BG-A0M4-01A-11D-A101_120330_SN1120_0129_BD0UCLACXX_s_1_rg.sorted.filtered.	WGS	TCGA-BG-A0M4-01A-11D-A101_120330_SN1120_0129_BD0UCLACXX_s_1_rg.sorted	TCGA-BG-A0M4-01A-11D-A101_120330_SN1120_0129_BD0UCLACXX_s_1_rg.sorted.bam	66.56	2.03	0.15	58cfa830e4b0c9d6adf6c1f6	TCGA-BG-A0M4-01A-11D-A101_120330_SN1120_0129_BD0UCLACXX_s_1_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-BG-A0M4-01A	73E5310D-BA8C-4CBC-AA4F-E06206F898F4	Primary Tumor	Illumina HiSeq	6f34976e-c9a0-4b3f-afb6-d476e4d9f22d	Uterus	60	E6E7E411-45CF-47A1-BCF0-7AE800A61A8D	238A1E43-B716-479B-82C8-0E62A30F9BE9	TCGA-BG-A0M4-01A-11D-A101-02	HG19_Broad_variant	TCGA-BG-A0M4	TCGA-UCEC	NA	s4429	Harvard Medical School	University of Pittsburgh	None	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A101-02	TRUE
13722.58cfa830e4b0c9d6adf6c1c0	58cfa830e4b0c9d6adf6c1c0	TCGA-BB-4225-01A-01D-1431_120423_SN590_0153_BC0KJ3ACXX_s_3_rg.sorted.filtered.	WGS	TCGA-BB-4225-01A-01D-1431_120423_SN590_0153_BC0KJ3ACXX_s_3_rg.sorted	TCGA-BB-4225-01A-01D-1431_120423_SN590_0153_BC0KJ3ACXX_s_3_rg.sorted.bam	56.7	1.9	0.15	58cfa830e4b0c9d6adf6c1c0	TCGA-BB-4225-01A-01D-1431_120423_SN590_0153_BC0KJ3ACXX_s_3_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-BB-4225-01A	C1F50A22-38DF-41CC-A1F4-F7985504A7AC	Primary Tumor	Illumina HiSeq	4903ac5e-6fa0-41de-b272-c4139a3c0632	Head and Neck	73	AC42070B-F4D6-47BE-96AA-A713D66A0072	F7E6BD4D-3E7C-427E-8618-FAFB3731E597	TCGA-BB-4225-01A-01D-1431-02	HG19_Broad_variant	TCGA-BB-4225	TCGA-HNSC	NA	s16024	Harvard Medical School	Johns Hopkins	United States	NO	TX	NX	Head and Neck Squamous Cell Carcinoma	Not available	1431-02	TRUE
13722.58cfa830e4b0c9d6adf6c2c6	58cfa830e4b0c9d6adf6c2c6	TCGA-CF-A1HS-01A-11D-A13U_121011_SN590_0184_BC192GACXX_s_5_rg.sorted.filtered.	WGS	TCGA-CF-A1HS-01A-11D-A13U_121011_SN590_0184_BC192GACXX_s_5_rg.sorted	TCGA-CF-A1HS-01A-11D-A13U_121011_SN590_0184_BC192GACXX_s_5_rg.sorted.bam	42.45	1.95	0.16	58cfa830e4b0c9d6adf6c2c6	TCGA-CF-A1HS-01A-11D-A13U_121011_SN590_0184_BC192GACXX_s_5_rg.sorted.bam	Alive	FEMALE	ASIAN	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-CF-A1HS-01A	A73C0842-39C5-4C2C-AA6A-F31341A4F36E	Primary Tumor	Illumina HiSeq	ed90abf4-1d04-41ce-9de3-9dcf24c1e375	Bladder	75	0A01E5BA-5549-4027-9E84-1BBB163A8F07	B8F18CDA-053F-4E40-8978-7524A4C0B49A	TCGA-CF-A1HS-01A-11D-A13U-02	HG19_Broad_variant	TCGA-CF-A1HS	TCGA-BLCA	NA	s2875	Harvard Medical School	ILSbio	Vietnam	NO	T3	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage III	A13U-02	TRUE
13722.58cfa830e4b0c9d6adf6c266	58cfa830e4b0c9d6adf6c266	TCGA-C5-A1BQ-01C-11D-A20X_140106_SN590_0243_AC371BACXX_s_2_rg.sorted.filtered.	WGS	TCGA-C5-A1BQ-01C-11D-A20X_140106_SN590_0243_AC371BACXX_s_2_rg.sorted	TCGA-C5-A1BQ-01C-11D-A20X_140106_SN590_0243_AC371BACXX_s_2_rg.sorted.bam	43.3	NA	0.15	58cfa830e4b0c9d6adf6c266	TCGA-C5-A1BQ-01C-11D-A20X_140106_SN590_0243_AC371BACXX_s_2_rg.sorted.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-C5-A1BQ-01C	E77C3F70-08D1-40D3-B038-F09A519423CC	Primary Tumor	Illumina HiSeq	58d97d84-99da-4b08-ae63-7e49f4b861b7	Cervix	65	6EF38E19-07AC-4032-8FB4-59129A126D3F	359691B6-9EB5-40F2-8F9E-16AA5A1D32F4	TCGA-C5-A1BQ-01C-11D-A20X-26	HG19_Broad_variant	TCGA-C5-A1BQ	TCGA-CESC	604	s1170	MD Anderson - Institute for Applied Cancer Science	Medical College of Wisconsin	United States	NO	Not available	Not available	Cervical Squamous Cell Carcinoma	Not available	A20X-26	TRUE
13722.58cfa830e4b0c9d6adf6c29a	58cfa830e4b0c9d6adf6c29a	TCGA-B5-A0JR-01A-13D-A043_120403_SN1222_0094_BD0UKBACXX_s_6_rg.sorted.filtered.	WGS	TCGA-B5-A0JR-01A-13D-A043_120403_SN1222_0094_BD0UKBACXX_s_6_rg.sorted	TCGA-B5-A0JR-01A-13D-A043_120403_SN1222_0094_BD0UKBACXX_s_6_rg.sorted.bam	91.47	2.12	0.14	58cfa830e4b0c9d6adf6c29a	TCGA-B5-A0JR-01A-13D-A043_120403_SN1222_0094_BD0UKBACXX_s_6_rg.sorted.bam	Alive	FEMALE	WHITE	Not available	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-B5-A0JR-01A	A766D113-BC3F-4448-A4E5-F391FB0C0E22	Primary Tumor	Illumina HiSeq	1e3ae5a0-6439-4dba-a151-f107d43c65cf	Uterus	73	07381A09-5CBD-4744-86EC-41A81E470204	E4F782AB-1668-4730-95D9-CB28E3CF61FD	TCGA-B5-A0JR-01A-13D-A043-02	HG19_Broad_variant	TCGA-B5-A0JR	TCGA-UCEC	NA	s4786	Harvard Medical School	Duke	United States	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A043-02	TRUE
13722.58cfa830e4b0c9d6adf6c2ce	58cfa830e4b0c9d6adf6c2ce	TCGA-B5-A0JN-01A-11D-A101_120330_SN208_0280_AD0UKLACXX_s_3_rg.sorted.filtered.	WGS	TCGA-B5-A0JN-01A-11D-A101_120330_SN208_0280_AD0UKLACXX_s_3_rg.sorted	TCGA-B5-A0JN-01A-11D-A101_120330_SN208_0280_AD0UKLACXX_s_3_rg.sorted.bam	73.22	2.09	0.15	58cfa830e4b0c9d6adf6c2ce	TCGA-B5-A0JN-01A-11D-A101_120330_SN208_0280_AD0UKLACXX_s_3_rg.sorted.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	Not available	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-B5-A0JN-01A	B60F22AC-A659-4F33-B01D-820E86A9A5C9	Primary Tumor	Illumina HiSeq	19c2a28e-bdeb-46af-b33e-e9849fc553ed	Uterus	84	684C6894-FD49-4934-8962-9628ECE734FB	EB2131FF-4AE0-4814-81F3-A480A0DEBB2E	TCGA-B5-A0JN-01A-11D-A101-02	HG19_Broad_variant	TCGA-B5-A0JN	TCGA-UCEC	NA	s4245	Harvard Medical School	Duke	United States	NO	Not available	Not available	Serous endometrial adenocarcinoma	Not available	A101-02	TRUE
13722.58cfa831e4b0c9d6adf6c401	58cfa831e4b0c9d6adf6c401	TCGA-CH-5791-01A-11D-1572_130125_SN208_0451_BD1RB1ACXX_s_1_rg.sorted.filtered.	WGS	TCGA-CH-5791-01A-11D-1572_130125_SN208_0451_BD1RB1ACXX_s_1_rg.sorted	TCGA-CH-5791-01A-11D-1572_130125_SN208_0451_BD1RB1ACXX_s_1_rg.sorted.bam	145.7	2	0.17	58cfa831e4b0c9d6adf6c401	TCGA-CH-5791-01A-11D-1572_130125_SN208_0451_BD1RB1ACXX_s_1_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-CH-5791-01A	829BED0C-C40D-44FD-AEE8-6C7589DB60F9	Primary Tumor	Illumina HiSeq	e2778c71-6feb-40df-8b1e-8d8f0e889beb	Prostate	72	C14B5C15-994B-4739-870B-A50984D274A1	500F071A-6697-4880-BBD0-9054CCAE108A	TCGA-CH-5791-01A-11D-1572-02	HG19_Broad_variant	TCGA-CH-5791	TCGA-PRAD	NA	s3417	Harvard Medical School	Indivumed	Germany	NO	T3a	N0	Prostate Adenocarcinoma Acinar Type	Not available	1572-02	TRUE
13722.58cfa831e4b0c9d6adf6c4da	58cfa831e4b0c9d6adf6c4da	TCGA-CG-4477-01A-01D-1154_121029_SN208_0438_AC18NJACXX_s_2_rg.sorted.filtered.	WGS	TCGA-CG-4477-01A-01D-1154_121029_SN208_0438_AC18NJACXX_s_2_rg.sorted	TCGA-CG-4477-01A-01D-1154_121029_SN208_0438_AC18NJACXX_s_2_rg.sorted.bam	281.2	1.9	0.14	58cfa831e4b0c9d6adf6c4da	TCGA-CG-4477-01A-01D-1154_121029_SN208_0438_AC18NJACXX_s_2_rg.sorted.bam	Alive	FEMALE	Not available	Not available	Stomach Adenocarcinoma	Aligned reads	TCGA-CG-4477-01A	18D0AAE7-9694-4252-B8FE-16E62DADAB07	Primary Tumor	Illumina HiSeq	a2b4b066-6bb7-401c-9ff9-e88bee42884b	Stomach	58	6D7C7B4E-6913-487D-9DC3-DDA901434192	3AE56504-30EE-4C03-9F69-C5B415DE6738	TCGA-CG-4477-01A-01D-1154-02	HG19_Broad_variant	TCGA-CG-4477	TCGA-STAD	NA	s14764	Harvard Medical School	Indivumed	Germany	NO	T2a	N0	Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS)	Stage IB	1154-02	TRUE
13722.58cfa831e4b0c9d6adf6c4be	58cfa831e4b0c9d6adf6c4be	TCGA-BR-4367-01A-01D-1154_130815_VM001_0002_VMR0002CXX_s_3_rg.sorted.filtered.	WGS	TCGA-BR-4367-01A-01D-1154_130815_VM001_0002_VMR0002CXX_s_3_rg.sorted	TCGA-BR-4367-01A-01D-1154_130815_VM001_0002_VMR0002CXX_s_3_rg.sorted.bam	65.9	1.9	0.14	58cfa831e4b0c9d6adf6c4be	TCGA-BR-4367-01A-01D-1154_130815_VM001_0002_VMR0002CXX_s_3_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-BR-4367-01A	D139BD0C-2EEB-44EC-856B-E77CB03D294E	Primary Tumor	Illumina HiSeq	98785371-4af3-4d04-acc8-5c53c8076618	Stomach	78	1506E790-C21C-4419-B11B-14250C947FB5	174658D3-1933-47FD-A883-5F4AFA169778	TCGA-BR-4367-01A-01D-1154-02	HG19_Broad_variant	TCGA-BR-4367	TCGA-STAD	NA	s14611	Harvard Medical School	Asterand	Russia	NO	TX	N1	Stomach  Adenocarcinoma  Not Otherwise Specified (NOS)	Not available	1154-02	TRUE
13722.58cfa831e4b0c9d6adf6c47a	58cfa831e4b0c9d6adf6c47a	TCGA-BT-A3PK-01A-21D-A221_120906_SN208_0426_BC194HACXX_s_3_rg.sorted.filtered.	WGS	TCGA-BT-A3PK-01A-21D-A221_120906_SN208_0426_BC194HACXX_s_3_rg.sorted	TCGA-BT-A3PK-01A-21D-A221_120906_SN208_0426_BC194HACXX_s_3_rg.sorted.bam	57.66	NA	0.17	58cfa831e4b0c9d6adf6c47a	TCGA-BT-A3PK-01A-21D-A221_120906_SN208_0426_BC194HACXX_s_3_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-BT-A3PK-01A	73041FCF-F3B6-4851-B34D-1D62A1FCF6FE	Primary Tumor	Illumina HiSeq	637e8bd5-61ee-4d45-8cc5-e3b89950d020	Bladder	80	F09E1EEB-BCD5-4DBA-92F0-7D4B34B81CE7	EE975BE9-76BF-4B5A-BF4C-155750C168CD	TCGA-BT-A3PK-01A-21D-A221-26	HG19_Broad_variant	TCGA-BT-A3PK	TCGA-BLCA	NA	s2858	MD Anderson - Institute for Applied Cancer Science	University of Pittsburgh	United States	NO	T2b	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage II	A221-26	TRUE
13722.58cfa831e4b0c9d6adf6c426	58cfa831e4b0c9d6adf6c426	TCGA-CN-4727-01A-01D-1431_120504_SN590_0155_AC0KTHACXX_s_7_rg.sorted.filtered.	WGS	TCGA-CN-4727-01A-01D-1431_120504_SN590_0155_AC0KTHACXX_s_7_rg.sorted	TCGA-CN-4727-01A-01D-1431_120504_SN590_0155_AC0KTHACXX_s_7_rg.sorted.bam	81.7	1.9	0.14	58cfa831e4b0c9d6adf6c426	TCGA-CN-4727-01A-01D-1431_120504_SN590_0155_AC0KTHACXX_s_7_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CN-4727-01A	12D05E8F-8D13-47C1-B713-2250F6ABCEF9	Primary Tumor	Illumina HiSeq	f26c4909-b285-4ca0-ac40-fe65ad4a6a1a	Head and Neck	56	F102AEF0-94B8-4D26-8055-35B76DA9DD5F	E42C764C-98DB-4E55-A625-B1443E6C4B3A	TCGA-CN-4727-01A-01D-1431-02	HG19_Broad_variant	TCGA-CN-4727	TCGA-HNSC	NA	s15495	Harvard Medical School	University of Pittsburgh	United States	NO	T4a	N0	Head and Neck Squamous Cell Carcinoma	Stage IVA	1431-02	TRUE
13722.58cfa831e4b0c9d6adf6c580	58cfa831e4b0c9d6adf6c580	TCGA-BR-4368-01A-01D-1154_130815_VM001_0002_VMR0002CXX_s_5_rg.sorted.filtered.	WGS	TCGA-BR-4368-01A-01D-1154_130815_VM001_0002_VMR0002CXX_s_5_rg.sorted	TCGA-BR-4368-01A-01D-1154_130815_VM001_0002_VMR0002CXX_s_5_rg.sorted.bam	215.2	1.9	0.15	58cfa831e4b0c9d6adf6c580	TCGA-BR-4368-01A-01D-1154_130815_VM001_0002_VMR0002CXX_s_5_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-BR-4368-01A	449BF2BE-B20E-4AD0-9FFB-910D83114018	Primary Tumor	Illumina HiSeq	138fe28f-1055-4872-99b0-71ca92e3494a	Stomach	78	87239062-9EA0-4987-AD13-5A2DDED4FF82	1AED45C5-BB15-43D4-9C04-291B7C5B4428	TCGA-BR-4368-01A-01D-1154-02	HG19_Broad_variant	TCGA-BR-4368	TCGA-STAD	NA	s14469	Harvard Medical School	Asterand	Russia	NO	T4	N2	Stomach  Adenocarcinoma  Not Otherwise Specified (NOS)	Stage IV	1154-02	TRUE
13722.58cfa830e4b0c9d6adf6c184	58cfa830e4b0c9d6adf6c184	TCGA-BA-4075-01A-01D-1431_120310_SN590_0145_BD0RGYACXX_s_3_rg.sorted.filtered.	WGS	TCGA-BA-4075-01A-01D-1431_120310_SN590_0145_BD0RGYACXX_s_3_rg.sorted	TCGA-BA-4075-01A-01D-1431_120310_SN590_0145_BD0RGYACXX_s_3_rg.sorted.bam	430.33	1.9	0.16	58cfa830e4b0c9d6adf6c184	TCGA-BA-4075-01A-01D-1431_120310_SN590_0145_BD0RGYACXX_s_3_rg.sorted.bam	Dead	MALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-BA-4075-01A	6FA62461-E721-415A-8B0F-363B84292B82	Primary Tumor	Illumina HiSeq	85bcc36c-7376-4108-ac13-c495a75d3e00	Head and Neck	49	4DC36C31-35D8-4263-B141-C734545540A9	4B0B38F4-AC21-4F3E-8A8E-A69FBA619629	TCGA-BA-4075-01A-01D-1431-02	HG19_Broad_variant	TCGA-BA-4075	TCGA-HNSC	283	s16169	Harvard Medical School	UNC	None	NO	T3	N0	Head and Neck Squamous Cell Carcinoma	Stage III	1431-02	TRUE
13722.58cfa831e4b0c9d6adf6c54a	58cfa831e4b0c9d6adf6c54a	TCGA-CN-4730-01A-01D-1431_120513_SN590_0157_AD0PU3ACXX_s_5_rg.sorted.filtered.	WGS	TCGA-CN-4730-01A-01D-1431_120513_SN590_0157_AD0PU3ACXX_s_5_rg.sorted	TCGA-CN-4730-01A-01D-1431_120513_SN590_0157_AD0PU3ACXX_s_5_rg.sorted.bam	23.7	1.9	0.14	58cfa831e4b0c9d6adf6c54a	TCGA-CN-4730-01A-01D-1431_120513_SN590_0157_AD0PU3ACXX_s_5_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CN-4730-01A	35C1F2C6-771C-4533-82DF-F8E2EC7107D7	Primary Tumor	Illumina HiSeq	56942e06-fb67-4bf4-993e-16cb67f52239	Head and Neck	62	8270C53E-F2CF-4F57-A1AC-A8BA978CC1C8	094C2014-ABA2-4C11-B076-27EA61C7A48E	TCGA-CN-4730-01A-01D-1431-02	HG19_Broad_variant	TCGA-CN-4730	TCGA-HNSC	NA	s15496	Harvard Medical School	University of Pittsburgh	None	NO	T4a	N1	Head and Neck Squamous Cell Carcinoma	Stage IVA	1431-02	TRUE
13722.58cfa831e4b0c9d6adf6c5e7	58cfa831e4b0c9d6adf6c5e7	TCGA-CN-5367-01A-01D-1431_120420_SN1120_0134_AC0J8YACXX_s_2_rg.sorted.filtered.	WGS	TCGA-CN-5367-01A-01D-1431_120420_SN1120_0134_AC0J8YACXX_s_2_rg.sorted	TCGA-CN-5367-01A-01D-1431_120420_SN1120_0134_AC0J8YACXX_s_2_rg.sorted.bam	214.7	1.9	0.15	58cfa831e4b0c9d6adf6c5e7	TCGA-CN-5367-01A-01D-1431_120420_SN1120_0134_AC0J8YACXX_s_2_rg.sorted.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CN-5367-01A	61D0709C-D148-413B-A7B5-C0C82ED2F32F	Primary Tumor	Illumina HiSeq	9ab4b634-5191-4a97-b9df-f75528b90bae	Head and Neck	60	379F9E65-54F3-4566-B018-3F3EEE6A4DF4	1380173D-316F-4821-8B98-654AD1050A38	TCGA-CN-5367-01A-01D-1431-02	HG19_Broad_variant	TCGA-CN-5367	TCGA-HNSC	352	s15762	Harvard Medical School	University of Pittsburgh	None	NO	T4a	N2b	Head and Neck Squamous Cell Carcinoma	Stage IVA	1431-02	TRUE
13722.58cfa831e4b0c9d6adf6c600	58cfa831e4b0c9d6adf6c600	TCGA-CG-4466-01A-01D-1154_130815_VM001_0005_VMR0005CXX_s_4_rg.sorted.filtered.	WGS	TCGA-CG-4466-01A-01D-1154_130815_VM001_0005_VMR0005CXX_s_4_rg.sorted	TCGA-CG-4466-01A-01D-1154_130815_VM001_0005_VMR0005CXX_s_4_rg.sorted.bam	143.3	1.9	0.14	58cfa831e4b0c9d6adf6c600	TCGA-CG-4466-01A-01D-1154_130815_VM001_0005_VMR0005CXX_s_4_rg.sorted.bam	Alive	FEMALE	Not available	Not available	Stomach Adenocarcinoma	Aligned reads	TCGA-CG-4466-01A	2F1B96B2-7031-4F7D-9490-14728D320F3E	Primary Tumor	Illumina HiSeq	ca26b1dd-13f3-4f26-9cb8-922cb4b53a59	Stomach	81	0BC4ABB4-047B-4C8D-9F79-5B9EB32969E9	623D5E6A-A5D3-4580-BEF7-04673D42A1D0	TCGA-CG-4466-01A-01D-1154-02	HG19_Broad_variant	TCGA-CG-4466	TCGA-STAD	NA	s14760	Harvard Medical School	Indivumed	Germany	NO	T2a	N0	Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS)	Stage IB	1154-02	TRUE
13722.58cfa831e4b0c9d6adf6c59a	58cfa831e4b0c9d6adf6c59a	TCGA-CN-4737-01A-01D-1431_120412_SN208_0283_AD0V1GACXX_s_4_rg.sorted.filtered.	WGS	TCGA-CN-4737-01A-01D-1431_120412_SN208_0283_AD0V1GACXX_s_4_rg.sorted	TCGA-CN-4737-01A-01D-1431_120412_SN208_0283_AD0V1GACXX_s_4_rg.sorted.bam	142	1.9	0.15	58cfa831e4b0c9d6adf6c59a	TCGA-CN-4737-01A-01D-1431_120412_SN208_0283_AD0V1GACXX_s_4_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CN-4737-01A	1F744ADA-6DE1-446D-B62C-76A7FC8B40AF	Primary Tumor	Illumina HiSeq	db7d0f46-b4eb-4cad-8324-08d0a5781624	Head and Neck	19	BA5D40F5-56A2-438B-92B8-6EB7DB6D6AFA	43003723-9C58-4B5E-8F47-56B4BDA476A0	TCGA-CN-4737-01A-01D-1431-02	HG19_Broad_variant	TCGA-CN-4737	TCGA-HNSC	NA	s15754	Harvard Medical School	University of Pittsburgh	None	NO	T2	N2b	Head and Neck Squamous Cell Carcinoma	Stage IVA	1431-02	TRUE
13722.58cfa831e4b0c9d6adf6c5f5	58cfa831e4b0c9d6adf6c5f5	TCGA-CN-5355-01A-01D-1431_120412_SN208_0283_AD0V1GACXX_s_7_rg.sorted.filtered.	WGS	TCGA-CN-5355-01A-01D-1431_120412_SN208_0283_AD0V1GACXX_s_7_rg.sorted	TCGA-CN-5355-01A-01D-1431_120412_SN208_0283_AD0V1GACXX_s_7_rg.sorted.bam	322.7	1.9	0.16	58cfa831e4b0c9d6adf6c5f5	TCGA-CN-5355-01A-01D-1431_120412_SN208_0283_AD0V1GACXX_s_7_rg.sorted.bam	Alive	MALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CN-5355-01A	45A10908-19E6-421A-8903-1440BFA57C9D	Primary Tumor	Illumina HiSeq	083daa5f-0e79-4402-94b2-48a892a5a4f1	Head and Neck	64	63535469-D402-4BA2-9AB5-986E6ED80F55	180BC055-9C10-4B84-80C4-3DF00742719D	TCGA-CN-5355-01A-01D-1431-02	HG19_Broad_variant	TCGA-CN-5355	TCGA-HNSC	NA	s15501	Harvard Medical School	University of Pittsburgh	None	NO	T4a	N0	Head and Neck Squamous Cell Carcinoma	Stage IVA	1431-02	TRUE
13722.58cfa831e4b0c9d6adf6c640	58cfa831e4b0c9d6adf6c640	TCGA-CG-4466-01A-01D-1154_121212_SN1120_0205_AC1F18ACXX_s_1_rg.sorted.filtered.	WGS	TCGA-CG-4466-01A-01D-1154_121212_SN1120_0205_AC1F18ACXX_s_1_rg.sorted	TCGA-CG-4466-01A-01D-1154_121212_SN1120_0205_AC1F18ACXX_s_1_rg.sorted.bam	143.3	1.9	0.14	58cfa831e4b0c9d6adf6c640	TCGA-CG-4466-01A-01D-1154_121212_SN1120_0205_AC1F18ACXX_s_1_rg.sorted.bam	Alive	FEMALE	Not available	Not available	Stomach Adenocarcinoma	Aligned reads	TCGA-CG-4466-01A	2F1B96B2-7031-4F7D-9490-14728D320F3E	Primary Tumor	Illumina HiSeq	a8cb52d3-64c6-4fca-a59c-b177968a7489	Stomach	81	0BC4ABB4-047B-4C8D-9F79-5B9EB32969E9	623D5E6A-A5D3-4580-BEF7-04673D42A1D0	TCGA-CG-4466-01A-01D-1154-02	HG19_Broad_variant	TCGA-CG-4466	TCGA-STAD	NA	s14987	Harvard Medical School	Indivumed	Germany	NO	T2a	N0	Stomach  Intestinal Adenocarcinoma  Not Otherwise Specified (NOS)	Stage IB	1154-02	TRUE
13722.58cfa831e4b0c9d6adf6c634	58cfa831e4b0c9d6adf6c634	TCGA-CN-5361-01A-01D-1431_120418_SN1222_0098_BD0T68ACXX_s_2_rg.sorted.filtered.	WGS	TCGA-CN-5361-01A-01D-1431_120418_SN1222_0098_BD0T68ACXX_s_2_rg.sorted	TCGA-CN-5361-01A-01D-1431_120418_SN1222_0098_BD0T68ACXX_s_2_rg.sorted.bam	225.7	1.9	0.15	58cfa831e4b0c9d6adf6c634	TCGA-CN-5361-01A-01D-1431_120418_SN1222_0098_BD0T68ACXX_s_2_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CN-5361-01A	044579EF-16A6-4F00-B951-EDC423D8A14F	Primary Tumor	Illumina HiSeq	490cddf8-816a-45f5-acbf-3fd898eb3479	Head and Neck	80	C807171A-4433-4246-A454-C5CF768DA8AA	A4E6D494-865F-4F60-B9C6-13C9C0CEA6AB	TCGA-CN-5361-01A-01D-1431-02	HG19_Broad_variant	TCGA-CN-5361	TCGA-HNSC	NA	s16184	Harvard Medical School	University of Pittsburgh	None	NO	T4a	N2a	Head and Neck Squamous Cell Carcinoma	Stage IVA	1431-02	TRUE
13722.58cfa831e4b0c9d6adf6c619	58cfa831e4b0c9d6adf6c619	TCGA-CN-5356-01A-01D-1431_120412_SN208_0283_AD0V1GACXX_s_8_rg.sorted.filtered.	WGS	TCGA-CN-5356-01A-01D-1431_120412_SN208_0283_AD0V1GACXX_s_8_rg.sorted	TCGA-CN-5356-01A-01D-1431_120412_SN208_0283_AD0V1GACXX_s_8_rg.sorted.bam	301.7	1.9	0.15	58cfa831e4b0c9d6adf6c619	TCGA-CN-5356-01A-01D-1431_120412_SN208_0283_AD0V1GACXX_s_8_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CN-5356-01A	E1FED7AA-2BCE-45AE-B0C6-7F50EF97E425	Primary Tumor	Illumina HiSeq	c8e59618-fd16-4e8e-abe2-e3d5d674390c	Head and Neck	56	BCB5DA85-78D6-4519-9740-378587B1BD37	199B42E1-301A-49AD-A364-BBF4FAD8B049	TCGA-CN-5356-01A-01D-1431-02	HG19_Broad_variant	TCGA-CN-5356	TCGA-HNSC	NA	s15885	Harvard Medical School	University of Pittsburgh	None	NO	T3	N0	Head and Neck Squamous Cell Carcinoma	Stage III	1431-02	TRUE
13722.58cfa831e4b0c9d6adf6c64e	58cfa831e4b0c9d6adf6c64e	TCGA-CN-4741-01A-01D-1431_120412_SN208_0283_AD0V1GACXX_s_6_rg.sorted.filtered.	WGS	TCGA-CN-4741-01A-01D-1431_120412_SN208_0283_AD0V1GACXX_s_6_rg.sorted	TCGA-CN-4741-01A-01D-1431_120412_SN208_0283_AD0V1GACXX_s_6_rg.sorted.bam	215.7	1.9	0.14	58cfa831e4b0c9d6adf6c64e	TCGA-CN-4741-01A-01D-1431_120412_SN208_0283_AD0V1GACXX_s_6_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CN-4741-01A	277B02E9-DED5-4980-845D-AF53690000AC	Primary Tumor	Illumina HiSeq	cd19ee2f-be9d-446a-9045-e7bfcafb49aa	Head and Neck	75	03C9108A-5139-4BAC-9641-C7DBBEDEF420	FAA30C0B-E008-4313-A2AB-1D641F98E2B9	TCGA-CN-4741-01A-01D-1431-02	HG19_Broad_variant	TCGA-CN-4741	TCGA-HNSC	NA	s15760	Harvard Medical School	University of Pittsburgh	None	NO	T4a	N0	Head and Neck Squamous Cell Carcinoma	Stage IVA	1431-02	TRUE
13722.58cfa831e4b0c9d6adf6c642	58cfa831e4b0c9d6adf6c642	TCGA-CN-4734-01A-01D-1431_120412_SN208_0283_AD0V1GACXX_s_1_rg.sorted.filtered.	WGS	TCGA-CN-4734-01A-01D-1431_120412_SN208_0283_AD0V1GACXX_s_1_rg.sorted	TCGA-CN-4734-01A-01D-1431_120412_SN208_0283_AD0V1GACXX_s_1_rg.sorted.bam	72.7	1.9	0.15	58cfa831e4b0c9d6adf6c642	TCGA-CN-4734-01A-01D-1431_120412_SN208_0283_AD0V1GACXX_s_1_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CN-4734-01A	B80FDC9A-341D-4277-9664-8E8F770D9DDD	Primary Tumor	Illumina HiSeq	4b3be461-622d-492e-8465-1d0d1167701c	Head and Neck	70	20614787-1E55-40F0-88DE-080640EB8A03	EA9125C8-3F3B-47CE-AD79-802692B1FB4A	TCGA-CN-4734-01A-01D-1431-02	HG19_Broad_variant	TCGA-CN-4734	TCGA-HNSC	NA	s15759	Harvard Medical School	University of Pittsburgh	None	NO	T2	N0	Head and Neck Squamous Cell Carcinoma	Stage II	1431-02	TRUE
13722.58cfa831e4b0c9d6adf6c688	58cfa831e4b0c9d6adf6c688	TCGA-CU-A0YO-01A-11D-A10R_120926_SN590_0182_BD1EAGACXX_s_5_rg.sorted.filtered.	WGS	TCGA-CU-A0YO-01A-11D-A10R_120926_SN590_0182_BD1EAGACXX_s_5_rg.sorted	TCGA-CU-A0YO-01A-11D-A10R_120926_SN590_0182_BD1EAGACXX_s_5_rg.sorted.bam	30.08	1.91	0.16	58cfa831e4b0c9d6adf6c688	TCGA-CU-A0YO-01A-11D-A10R_120926_SN590_0182_BD1EAGACXX_s_5_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-CU-A0YO-01A	4A9EF220-922C-49CF-BBED-D173B214ED31	Primary Tumor	Illumina HiSeq	98d555c2-93ae-4db5-9b19-43655d10609d	Bladder	84	9E190462-39FC-41B2-B1D6-2DA150412FCF	A407711E-26FF-4C0C-9391-326A51614BB7	TCGA-CU-A0YO-01A-11D-A10R-02	HG19_Broad_variant	TCGA-CU-A0YO	TCGA-BLCA	149	s3097	Harvard Medical School	UNC	United States	NO	T3a	N2	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV	A10R-02	TRUE
13722.58cfa831e4b0c9d6adf6c684	58cfa831e4b0c9d6adf6c684	TCGA-CN-4738-01A-02D-1509_120420_SN1120_0135_BD0T5FACXX_s_7_rg.sorted.filtered.	WGS	TCGA-CN-4738-01A-02D-1509_120420_SN1120_0135_BD0T5FACXX_s_7_rg.sorted	TCGA-CN-4738-01A-02D-1509_120420_SN1120_0135_BD0T5FACXX_s_7_rg.sorted.bam	122.7	1.9	0.15	58cfa831e4b0c9d6adf6c684	TCGA-CN-4738-01A-02D-1509_120420_SN1120_0135_BD0T5FACXX_s_7_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CN-4738-01A	97640EF0-0259-4244-95BA-48D28C60B372	Primary Tumor	Illumina HiSeq	142fc981-c09b-4d94-96d3-b0d48b4d59f2	Head and Neck	53	8277E744-0508-47D5-9CEA-11DCF7F56D35	0EABE3ED-367B-4055-8700-0036E6A0FB1D	TCGA-CN-4738-01A-02D-1509-02	HG19_Broad_variant	TCGA-CN-4738	TCGA-HNSC	436	s16176	Harvard Medical School	University of Pittsburgh	None	NO	T4a	N0	Head and Neck Squamous Cell Carcinoma	Stage IVA	1509-02	TRUE
13722.58cfa831e4b0c9d6adf6c6c8	58cfa831e4b0c9d6adf6c6c8	TCGA-CU-A3KJ-01A-11D-A21C_120914_SN590_0179_AD13PPACXX_s_7_rg.sorted.filtered.	WGS	TCGA-CU-A3KJ-01A-11D-A21C_120914_SN590_0179_AD13PPACXX_s_7_rg.sorted	TCGA-CU-A3KJ-01A-11D-A21C_120914_SN590_0179_AD13PPACXX_s_7_rg.sorted.bam	49.18	NA	0.15	58cfa831e4b0c9d6adf6c6c8	TCGA-CU-A3KJ-01A-11D-A21C_120914_SN590_0179_AD13PPACXX_s_7_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-CU-A3KJ-01A	A75584BC-BEF7-48F6-B4B3-C1472A3AF768	Primary Tumor	Illumina HiSeq	6b7a9ee7-ee89-4473-9170-7372313595f7	Bladder	75	3D92F5A6-949A-4176-9309-4294CCA6FC25	25847D62-9932-4A04-9B00-378794D2CE72	TCGA-CU-A3KJ-01A-11D-A21C-26	HG19_Broad_variant	TCGA-CU-A3KJ	TCGA-BLCA	NA	s3098	MD Anderson - Institute for Applied Cancer Science	UNC	United States	NO	T3b	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage III	A21C-26	TRUE
13722.58cfa831e4b0c9d6adf6c772	58cfa831e4b0c9d6adf6c772	TCGA-CQ-7068-01A-11D-2317_120730_SN1222_0140_AC11GKACXX_s_6_rg.sorted.filtered.	WGS	TCGA-CQ-7068-01A-11D-2317_120730_SN1222_0140_AC11GKACXX_s_6_rg.sorted	TCGA-CQ-7068-01A-11D-2317_120730_SN1222_0140_AC11GKACXX_s_6_rg.sorted.bam	637.73	NA	0.15	58cfa831e4b0c9d6adf6c772	TCGA-CQ-7068-01A-11D-2317_120730_SN1222_0140_AC11GKACXX_s_6_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CQ-7068-01A	8EBE8C25-5EF9-42D4-9414-8313227B673F	Primary Tumor	Illumina HiSeq	77b40e7d-41a7-4e5d-a3e9-ce1e2d077c98	Head and Neck	80	1C86E4AF-03CE-477C-BE08-0CFA565861B7	F0B87929-92F5-4AB9-849F-00F970E56577	TCGA-CQ-7068-01A-11D-2317-26	HG19_Broad_variant	TCGA-CQ-7068	TCGA-HNSC	NA	s15506	MD Anderson - Institute for Applied Cancer Science	University Health Network, Toronto	Canada	NO	T2	N0	Head and Neck Squamous Cell Carcinoma	Stage II	2317-26	TRUE
13722.58cfa831e4b0c9d6adf6c801	58cfa831e4b0c9d6adf6c801	TCGA-CN-6018-01A-11D-1681_120425_SN1222_0099_AC0JCEACXX_s_3_rg.sorted.filtered.	WGS	TCGA-CN-6018-01A-11D-1681_120425_SN1222_0099_AC0JCEACXX_s_3_rg.sorted	TCGA-CN-6018-01A-11D-1681_120425_SN1222_0099_AC0JCEACXX_s_3_rg.sorted.bam	96	1.9	0.14	58cfa831e4b0c9d6adf6c801	TCGA-CN-6018-01A-11D-1681_120425_SN1222_0099_AC0JCEACXX_s_3_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CN-6018-01A	55838E1F-07E8-49CA-89D6-46216BABC6F7	Primary Tumor	Illumina HiSeq	ce9ca233-92c4-44b8-b97f-b56f1f73cb5a	Head and Neck	85	1A3E8C8B-9E99-499A-9BA7-4CDFC11B106D	7F0998E4-AF05-42C5-962C-5EA4D8993EB0	TCGA-CN-6018-01A-11D-1681-02	HG19_Broad_variant	TCGA-CN-6018	TCGA-HNSC	NA	s15498	Harvard Medical School	University of Pittsburgh	United States	NO	T4a	N2b	Head and Neck Squamous Cell Carcinoma	Stage IVA	1681-02	TRUE
13722.58cfa831e4b0c9d6adf6c8e6	58cfa831e4b0c9d6adf6c8e6	TCGA-CV-6960-01A-41D-2317_120623_SN1222_0118_AD13T1ACXX_s_6_rg.sorted.filtered.	WGS	TCGA-CV-6960-01A-41D-2317_120623_SN1222_0118_AD13T1ACXX_s_6_rg.sorted	TCGA-CV-6960-01A-41D-2317_120623_SN1222_0118_AD13T1ACXX_s_6_rg.sorted.bam	52.73	NA	0.13	58cfa831e4b0c9d6adf6c8e6	TCGA-CV-6960-01A-41D-2317_120623_SN1222_0118_AD13T1ACXX_s_6_rg.sorted.bam	Dead	MALE	BLACK OR AFRICAN AMERICAN	Not available	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-6960-01A	2C985B30-0F8F-4C8F-A924-CC6AAD7EBF0D	Primary Tumor	Illumina HiSeq	5fdfb781-64fd-48dd-9d26-3de7bfdf5908	Head and Neck	49	967F6CC9-95D2-4666-A20A-717D768613A4	F41864FE-49FA-4037-AF02-E3F8E2515614	TCGA-CV-6960-01A-41D-2317-26	HG19_Broad_variant	TCGA-CV-6960	TCGA-HNSC	862	s15902	MD Anderson - Institute for Applied Cancer Science	MD Anderson Cancer Center	United States	NO	T3	N0	Head and Neck Squamous Cell Carcinoma	Stage III	2317-26	TRUE
13722.58cfa831e4b0c9d6adf6c900	58cfa831e4b0c9d6adf6c900	TCGA-DU-6399-01A-12D-1703_130813_SN1440_0160_AD2B87ACXX_s_3_rg.sorted.filtered.	WGS	TCGA-DU-6399-01A-12D-1703_130813_SN1440_0160_AD2B87ACXX_s_3_rg.sorted	TCGA-DU-6399-01A-12D-1703_130813_SN1440_0160_AD2B87ACXX_s_3_rg.sorted.bam	39.3	1.9	0.17	58cfa831e4b0c9d6adf6c900	TCGA-DU-6399-01A-12D-1703_130813_SN1440_0160_AD2B87ACXX_s_3_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-DU-6399-01A	4EF429BE-C345-4258-9B42-B56E215E1A2C	Primary Tumor	Illumina HiSeq	bcd63f96-cd75-4e38-826d-5304bd0d18db	Brain	54	41555F97-0269-4F3D-AB13-6B0AE08D1FF5	329097BC-E434-4EA7-B0AC-EFF202C58C6F	TCGA-DU-6399-01A-12D-1703-02	HG19_Broad_variant	TCGA-DU-6399	TCGA-LGG	2000	s8754	Harvard Medical School	Henry Ford Hospital	United States	NO	Not available	Not available	Oligodendroglioma	Not available	1703-02	TRUE
13722.58cfa831e4b0c9d6adf6c8de	58cfa831e4b0c9d6adf6c8de	TCGA-CV-7429-01A-11D-2317_120710_SN590_0165_BC0VU7ACXX_s_4_rg.sorted.filtered.	WGS	TCGA-CV-7429-01A-11D-2317_120710_SN590_0165_BC0VU7ACXX_s_4_rg.sorted	TCGA-CV-7429-01A-11D-2317_120710_SN590_0165_BC0VU7ACXX_s_4_rg.sorted.bam	262.73	NA	0.15	58cfa831e4b0c9d6adf6c8de	TCGA-CV-7429-01A-11D-2317_120710_SN590_0165_BC0VU7ACXX_s_4_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-7429-01A	44D99F11-EF5B-45D7-B7DF-B5C5893D878F	Primary Tumor	Illumina HiSeq	4860e1b8-251e-4894-91f2-c9416a9b7f28	Head and Neck	55	A8A03639-FAD0-4B1B-9802-E3882BBFC7B8	18E1FCE0-D678-48D9-AD23-432E23C9077D	TCGA-CV-7429-01A-11D-2317-26	HG19_Broad_variant	TCGA-CV-7429	TCGA-HNSC	107	s15908	MD Anderson - Institute for Applied Cancer Science	MD Anderson Cancer Center	United States	NO	T4a	N2b	Head and Neck Squamous Cell Carcinoma	Stage IVA	2317-26	TRUE
13722.58cfa831e4b0c9d6adf6c914	58cfa831e4b0c9d6adf6c914	TCGA-DK-A1AA-01A-11D-A13U_121025_SN590_0188_AC190CACXX_s_3_rg.sorted.filtered.	WGS	TCGA-DK-A1AA-01A-11D-A13U_121025_SN590_0188_AC190CACXX_s_3_rg.sorted	TCGA-DK-A1AA-01A-11D-A13U_121025_SN590_0188_AC190CACXX_s_3_rg.sorted.bam	72.54	1.95	0.16	58cfa831e4b0c9d6adf6c914	TCGA-DK-A1AA-01A-11D-A13U_121025_SN590_0188_AC190CACXX_s_3_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-DK-A1AA-01A	56D8A1B8-1268-4362-A7F1-77B76FBF1B59	Primary Tumor	Illumina HiSeq	006c1498-f327-4fff-8936-7d7cb06639f4	Bladder	57	577700D1-C366-41EF-8A0D-E50DEEFB5E3C	6482BD80-A3F1-4169-A9F2-B45A9445035C	TCGA-DK-A1AA-01A-11D-A13U-02	HG19_Broad_variant	TCGA-DK-A1AA	TCGA-BLCA	NA	s3107	Harvard Medical School	Memorial Sloan Kettering	United States	NO	T3	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage III	A13U-02	TRUE
13722.58cfa831e4b0c9d6adf6ca0d	58cfa831e4b0c9d6adf6ca0d	TCGA-DK-A1AD-01A-11D-A13U_121025_SN590_0188_AC190CACXX_s_5_rg.sorted.filtered.	WGS	TCGA-DK-A1AD-01A-11D-A13U_121025_SN590_0188_AC190CACXX_s_5_rg.sorted	TCGA-DK-A1AD-01A-11D-A13U_121025_SN590_0188_AC190CACXX_s_5_rg.sorted.bam	55.51	1.93	0.17	58cfa831e4b0c9d6adf6ca0d	TCGA-DK-A1AD-01A-11D-A13U_121025_SN590_0188_AC190CACXX_s_5_rg.sorted.bam	Alive	MALE	WHITE	Not available	Bladder Urothelial Carcinoma	Aligned reads	TCGA-DK-A1AD-01A	88A521CE-A5E9-4C6F-83D4-EC36A62FEDB6	Primary Tumor	Illumina HiSeq	26694fc3-c6e4-45f9-82f0-57b6f4955b4b	Bladder	69	C79F4327-675D-4651-994D-E683096DF9C3	86DF29FD-B5F6-4316-BC89-DC9386D177C6	TCGA-DK-A1AD-01A-11D-A13U-02	HG19_Broad_variant	TCGA-DK-A1AD	TCGA-BLCA	NA	s2711	Harvard Medical School	Memorial Sloan Kettering	United States	NO	T3b	N2	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV	A13U-02	TRUE
13722.58cfa831e4b0c9d6adf6c94f	58cfa831e4b0c9d6adf6c94f	TCGA-D7-5578-01A-01D-1598_121023_SN208_0437_BD1H3FACXX_s_2_rg.sorted.filtered.	WGS	TCGA-D7-5578-01A-01D-1598_121023_SN208_0437_BD1H3FACXX_s_2_rg.sorted	TCGA-D7-5578-01A-01D-1598_121023_SN208_0437_BD1H3FACXX_s_2_rg.sorted.bam	331	1.88	0.15	58cfa831e4b0c9d6adf6c94f	TCGA-D7-5578-01A-01D-1598_121023_SN208_0437_BD1H3FACXX_s_2_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-D7-5578-01A	A3C1F9A2-9174-48CF-81DC-2AFCFDC4BA9C	Primary Tumor	Illumina HiSeq	306aee2b-5fac-4825-952b-d838746530a5	Stomach	80	E88D8673-C0BE-4549-8DAF-100187608F17	A00E8607-F965-421B-B0ED-57C09488F514	TCGA-D7-5578-01A-01D-1598-02	HG19_Broad_variant	TCGA-D7-5578	TCGA-STAD	NA	s15401	Harvard Medical School	Greater Poland Cancer Center	Poland	NO	T3	N2	Stomach  Intestinal Adenocarcinoma  Tubular Type	Stage IIIA	1598-02	TRUE
13722.58cfa831e4b0c9d6adf6c985	58cfa831e4b0c9d6adf6c985	TCGA-DJ-A13W-01A-11D-A10R_120617_SN1222_0116_AC0WMMACXX_s_1_rg.sorted.filtered.	WGS	TCGA-DJ-A13W-01A-11D-A10R_120617_SN1222_0116_AC0WMMACXX_s_1_rg.sorted	TCGA-DJ-A13W-01A-11D-A10R_120617_SN1222_0116_AC0WMMACXX_s_1_rg.sorted.bam	50.62	1.95	0.15	58cfa831e4b0c9d6adf6c985	TCGA-DJ-A13W-01A-11D-A10R_120617_SN1222_0116_AC0WMMACXX_s_1_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-DJ-A13W-01A	3B48CC5E-3396-4DD5-893D-54B75B98B016	Primary Tumor	Illumina HiSeq	ab5fa454-36a6-4d10-bfda-443dd6709cd8	Thyroid	45	4DCA97A5-B0E5-4383-8CC5-B6FF07741647	8A15A4FE-F286-422D-9D50-33ABBD885250	TCGA-DJ-A13W-01A-11D-A10R-02	HG19_Broad_variant	TCGA-DJ-A13W	TCGA-THCA	NA	s11992	Harvard Medical School	Memorial Sloan Kettering	United States	NO	T1b	N0	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	Stage I	A10R-02	TRUE
13722.58cfa831e4b0c9d6adf6c976	58cfa831e4b0c9d6adf6c976	TCGA-DK-A1A6-01A-11D-A13U_121011_SN590_0184_BC192GACXX_s_7_rg.sorted.filtered.	WGS	TCGA-DK-A1A6-01A-11D-A13U_121011_SN590_0184_BC192GACXX_s_7_rg.sorted	TCGA-DK-A1A6-01A-11D-A13U_121011_SN590_0184_BC192GACXX_s_7_rg.sorted.bam	85.12	1.95	0.15	58cfa831e4b0c9d6adf6c976	TCGA-DK-A1A6-01A-11D-A13U_121011_SN590_0184_BC192GACXX_s_7_rg.sorted.bam	Alive	MALE	WHITE	Not available	Bladder Urothelial Carcinoma	Aligned reads	TCGA-DK-A1A6-01A	9C274536-3CA1-4F0E-93A8-1688074D862F	Primary Tumor	Illumina HiSeq	66e30a9a-052c-40b8-ac7c-a241a6b87d6e	Bladder	53	7AD1CD01-0EA2-4FA4-9B05-C280BD256546	CACE3242-E727-4E1F-9427-B952E10C9B12	TCGA-DK-A1A6-01A-11D-A13U-02	HG19_Broad_variant	TCGA-DK-A1A6	TCGA-BLCA	NA	s2892	Harvard Medical School	Memorial Sloan Kettering	United States	NO	T2a	N1	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV	A13U-02	TRUE
13722.58cfa831e4b0c9d6adf6ca21	58cfa831e4b0c9d6adf6ca21	TCGA-DJ-A1QD-01A-11D-A14U_120717_SN1120_0175_AC1179ACXX_s_6_rg.sorted.filtered.	WGS	TCGA-DJ-A1QD-01A-11D-A14U_120717_SN1120_0175_AC1179ACXX_s_6_rg.sorted	TCGA-DJ-A1QD-01A-11D-A14U_120717_SN1120_0175_AC1179ACXX_s_6_rg.sorted.bam	61.38	2	0.18	58cfa831e4b0c9d6adf6ca21	TCGA-DJ-A1QD-01A-11D-A14U_120717_SN1120_0175_AC1179ACXX_s_6_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-DJ-A1QD-01A	DA201150-748E-4B74-BB35-10C995E26079	Primary Tumor	Illumina HiSeq	df7bafb3-c992-479d-be29-dae220124025	Thyroid	20	A8307181-67CE-4A79-8D23-76CEEE1D2761	781162AA-AAFA-4C44-B9AF-727917E8C9F4	TCGA-DJ-A1QD-01A-11D-A14U-02	HG19_Broad_variant	TCGA-DJ-A1QD	TCGA-THCA	NA	s12367	Harvard Medical School	Memorial Sloan Kettering	United States	NO	T2	N1b	Thyroid Papillary Carcinoma - Classical/usual	Stage I	A14U-02	TRUE
13722.58cfa831e4b0c9d6adf6ca90	58cfa831e4b0c9d6adf6ca90	TCGA-DU-5872-01A-11D-1703_130808_SN208_0488_BC294YACXX_s_6_rg.sorted.filtered.	WGS	TCGA-DU-5872-01A-11D-1703_130808_SN208_0488_BC294YACXX_s_6_rg.sorted	TCGA-DU-5872-01A-11D-1703_130808_SN208_0488_BC294YACXX_s_6_rg.sorted.bam	31.7	1.8	0.17	58cfa831e4b0c9d6adf6ca90	TCGA-DU-5872-01A-11D-1703_130808_SN208_0488_BC294YACXX_s_6_rg.sorted.bam	Alive	FEMALE	BLACK OR AFRICAN AMERICAN	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-DU-5872-01A	48607130-C09A-491D-882F-7D2591D13182	Primary Tumor	Illumina HiSeq	ed7bb33a-0d4e-4215-b4c5-2dc1250d882b	Brain	43	048550EE-189D-483D-B07F-B77F10278420	CF245938-DD0C-42FE-9A39-09F29FF12F23	TCGA-DU-5872-01A-11D-1703-02	HG19_Broad_variant	TCGA-DU-5872	TCGA-LGG	NA	s8350	Harvard Medical School	Henry Ford Hospital	United States	NO	Not available	Not available	Oligoastrocytoma	Not available	1703-02	TRUE
13722.58cfa831e4b0c9d6adf6ca7f	58cfa831e4b0c9d6adf6ca7f	TCGA-DK-A1A5-01A-11D-A13U_121002_SN1222_0154_AC1A3DACXX_s_1_rg.sorted.filtered.	WGS	TCGA-DK-A1A5-01A-11D-A13U_121002_SN1222_0154_AC1A3DACXX_s_1_rg.sorted	TCGA-DK-A1A5-01A-11D-A13U_121002_SN1222_0154_AC1A3DACXX_s_1_rg.sorted.bam	59.04	1.91	0.16	58cfa831e4b0c9d6adf6ca7f	TCGA-DK-A1A5-01A-11D-A13U_121002_SN1222_0154_AC1A3DACXX_s_1_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-DK-A1A5-01A	904A8757-E0C5-41EF-B583-C8F170CAAAC1	Primary Tumor	Illumina HiSeq	3aa26bad-446a-4391-a584-27b78fc638e8	Bladder	79	A9EF3EC5-B1C1-481F-89CF-1729FAB50173	C4A751AF-E8CC-452A-9B5B-99D4B0AC585D	TCGA-DK-A1A5-01A-11D-A13U-02	HG19_Broad_variant	TCGA-DK-A1A5	TCGA-BLCA	65	s2889	Harvard Medical School	Memorial Sloan Kettering	United States	NO	T2b	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage II	A13U-02	TRUE
13722.58cfa831e4b0c9d6adf6cb12	58cfa831e4b0c9d6adf6cb12	TCGA-EA-A3HS-01A-11D-A20X_140106_SN590_0243_AC371BACXX_s_3_rg.sorted.filtered.	WGS	TCGA-EA-A3HS-01A-11D-A20X_140106_SN590_0243_AC371BACXX_s_3_rg.sorted	TCGA-EA-A3HS-01A-11D-A20X_140106_SN590_0243_AC371BACXX_s_3_rg.sorted.bam	76.91	NA	0.16	58cfa831e4b0c9d6adf6cb12	TCGA-EA-A3HS-01A-11D-A20X_140106_SN590_0243_AC371BACXX_s_3_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-EA-A3HS-01A	753EE373-FBCF-4349-B9B2-5A41936E27E9	Primary Tumor	Illumina HiSeq	684e83c6-0894-4bfd-a2ee-6b1877c74f82	Cervix	35	0835FA38-9870-472E-B9A0-2A2652807BC5	E87CC37B-FD44-4DD9-9D14-455B89C6D4C2	TCGA-EA-A3HS-01A-11D-A20X-26	HG19_Broad_variant	TCGA-EA-A3HS	TCGA-CESC	NA	s1522	MD Anderson - Institute for Applied Cancer Science	Asterand	Russia	NO	T1b	N0	Cervical Squamous Cell Carcinoma	Not available	A20X-26	TRUE
13722.58cfa831e4b0c9d6adf6cbaf	58cfa831e4b0c9d6adf6cbaf	TCGA-EK-A3GN-01A-11D-A20X_140417_SN590_0248_AC3EUFACXX_s_2_rg.sorted.filtered.	WGS	TCGA-EK-A3GN-01A-11D-A20X_140417_SN590_0248_AC3EUFACXX_s_2_rg.sorted	TCGA-EK-A3GN-01A-11D-A20X_140417_SN590_0248_AC3EUFACXX_s_2_rg.sorted.bam	50.85	NA	0.14	58cfa831e4b0c9d6adf6cbaf	TCGA-EK-A3GN-01A-11D-A20X_140417_SN590_0248_AC3EUFACXX_s_2_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-EK-A3GN-01A	F727FCB9-E457-4643-9468-F739133B7E9C	Primary Tumor	Illumina HiSeq	b9e845ee-3e61-4ccf-b14e-f8a6b8481bd3	Cervix	47	EB5034E2-D4A7-48E0-9524-31DDD63C9D94	49F2E671-D283-4B5C-B8A3-490C0A383FC1	TCGA-EK-A3GN-01A-11D-A20X-26	HG19_Broad_variant	TCGA-EK-A3GN	TCGA-CESC	NA	s1364	MD Anderson - Institute for Applied Cancer Science	Gynecologic Oncology Group	United States	NO	TX	NX	Cervical Squamous Cell Carcinoma	Not available	A20X-26	TRUE
13722.58cfa831e4b0c9d6adf6cbbe	58cfa831e4b0c9d6adf6cbbe	TCGA-EK-A3GM-01A-11D-A20X_140131_SN590_0247_AC3FDBACXX_s_4_rg.sorted.filtered.	WGS	TCGA-EK-A3GM-01A-11D-A20X_140131_SN590_0247_AC3FDBACXX_s_4_rg.sorted	TCGA-EK-A3GM-01A-11D-A20X_140131_SN590_0247_AC3FDBACXX_s_4_rg.sorted.bam	59.88	NA	0.15	58cfa831e4b0c9d6adf6cbbe	TCGA-EK-A3GM-01A-11D-A20X_140131_SN590_0247_AC3FDBACXX_s_4_rg.sorted.bam	Alive	FEMALE	WHITE	HISPANIC OR LATINO	Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-EK-A3GM-01A	CB780C10-8810-4384-B829-954AAB1C16C8	Primary Tumor	Illumina HiSeq	2ec77e09-5fb7-4247-9027-1db441eab2b8	Cervix	65	A4B92B76-FF87-475E-924B-840F652FC019	4981CFD4-2A8C-4CF8-8AC2-31BDF9DC02CD	TCGA-EK-A3GM-01A-11D-A20X-26	HG19_Broad_variant	TCGA-EK-A3GM	TCGA-CESC	NA	s1186	MD Anderson - Institute for Applied Cancer Science	Gynecologic Oncology Group	United States	NO	Not available	Not available	Endocervical Type of Adenocarcinoma	Not available	A20X-26	TRUE
13722.58cfa831e4b0c9d6adf6cbb4	58cfa831e4b0c9d6adf6cbb4	TCGA-EK-A2RN-01A-12D-A20X_140117_SN590_0246_BC37BDACXX_s_2_rg.sorted.filtered.	WGS	TCGA-EK-A2RN-01A-12D-A20X_140117_SN590_0246_BC37BDACXX_s_2_rg.sorted	TCGA-EK-A2RN-01A-12D-A20X_140117_SN590_0246_BC37BDACXX_s_2_rg.sorted.bam	17.97	NA	0.17	58cfa831e4b0c9d6adf6cbb4	TCGA-EK-A2RN-01A-12D-A20X_140117_SN590_0246_BC37BDACXX_s_2_rg.sorted.bam	Alive	FEMALE	WHITE	Not available	Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-EK-A2RN-01A	B610D391-0C9D-4114-94D6-5E4AA4270122	Primary Tumor	Illumina HiSeq	def278f8-93eb-4373-a525-98b2cf12af7a	Cervix	45	24BACABF-8C6F-416A-B1F3-B0BAAA2F0AD9	3B5905A9-4B73-4946-A10B-D3E7ECAFFC7C	TCGA-EK-A2RN-01A-12D-A20X-26	HG19_Broad_variant	TCGA-EK-A2RN	TCGA-CESC	NA	s1368	MD Anderson - Institute for Applied Cancer Science	Gynecologic Oncology Group	United States	NO	T2b	N1	Cervical Squamous Cell Carcinoma	Not available	A20X-26	TRUE
13722.58cfa831e4b0c9d6adf6cbf1	58cfa831e4b0c9d6adf6cbf1	TCGA-EM-A3O3-01A-11D-A221_120611_SN1222_0115_BD141KACXX_s_5_rg.sorted.filtered.	WGS	TCGA-EM-A3O3-01A-11D-A221_120611_SN1222_0115_BD141KACXX_s_5_rg.sorted	TCGA-EM-A3O3-01A-11D-A221_120611_SN1222_0115_BD141KACXX_s_5_rg.sorted.bam	48.3	NA	0.16	58cfa831e4b0c9d6adf6cbf1	TCGA-EM-A3O3-01A-11D-A221_120611_SN1222_0115_BD141KACXX_s_5_rg.sorted.bam	Alive	FEMALE	Not available	Not available	Thyroid Carcinoma	Aligned reads	TCGA-EM-A3O3-01A	2A398AF1-AEA5-4AAE-AB00-A2DC152F965A	Primary Tumor	Illumina HiSeq	52b6fd69-3b74-441b-a40b-77c172dd0979	Thyroid	83	60C1BA59-C04E-4237-A8B9-FA0D894BBAFA	EEBDC565-A071-4356-8CBF-1560A8BB034D	TCGA-EM-A3O3-01A-11D-A221-26	HG19_Broad_variant	TCGA-EM-A3O3	TCGA-THCA	NA	s12111	MD Anderson - Institute for Applied Cancer Science	University Health Network	Canada	NO	T2	N1a	Thyroid Papillary Carcinoma - Classical/usual	Stage III	A221-26	TRUE
13722.58cfa831e4b0c9d6adf6cbfe	58cfa831e4b0c9d6adf6cbfe	TCGA-DU-6405-01A-11D-1703_130813_SN1440_0160_AD2B87ACXX_s_6_rg.sorted.filtered.	WGS	TCGA-DU-6405-01A-11D-1703_130813_SN1440_0160_AD2B87ACXX_s_6_rg.sorted	TCGA-DU-6405-01A-11D-1703_130813_SN1440_0160_AD2B87ACXX_s_6_rg.sorted.bam	241.3	1.9	0.14	58cfa831e4b0c9d6adf6cbfe	TCGA-DU-6405-01A-11D-1703_130813_SN1440_0160_AD2B87ACXX_s_6_rg.sorted.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-DU-6405-01A	9239A22E-80B1-49A2-B0D5-CBAB7E415254	Primary Tumor	Illumina HiSeq	2d1d4000-347f-44e4-8ff3-b61fea3daeb3	Brain	51	54BFF4F3-312D-4E1A-8327-F08F5A270EAC	9593D4DE-0DAB-4D1E-B86C-AF91CAC938E6	TCGA-DU-6405-01A-11D-1703-02	HG19_Broad_variant	TCGA-DU-6405	TCGA-LGG	605	s8359	Harvard Medical School	Henry Ford Hospital	United States	NO	Not available	Not available	Astrocytoma	Not available	1703-02	TRUE
13722.58cfa831e4b0c9d6adf6cc03	58cfa831e4b0c9d6adf6cc03	TCGA-DU-7010-01A-11D-2022_130910_SN208_0495_BD2FGNACXX_s_3_rg.sorted.filtered.	WGS	TCGA-DU-7010-01A-11D-2022_130910_SN208_0495_BD2FGNACXX_s_3_rg.sorted	TCGA-DU-7010-01A-11D-2022_130910_SN208_0495_BD2FGNACXX_s_3_rg.sorted.bam	193	NA	0.16	58cfa831e4b0c9d6adf6cc03	TCGA-DU-7010-01A-11D-2022_130910_SN208_0495_BD2FGNACXX_s_3_rg.sorted.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-DU-7010-01A	834E560A-A506-456D-BAF2-A206CA058153	Primary Tumor	Illumina HiSeq	61859b0d-b4a7-4c67-bf02-21422618f2f2	Brain	58	A6DA348E-A70C-4620-BFCB-2AFBE893284B	3EF3E4F1-9B47-4F11-9024-85242ECEE397	TCGA-DU-7010-01A-11D-2022-02	HG19_Broad_variant	TCGA-DU-7010	TCGA-LGG	456	s8355	Harvard Medical School	Henry Ford Hospital	United States	NO	Not available	Not available	Astrocytoma	Not available	2022-02	TRUE
13722.58cfa831e4b0c9d6adf6cc13	58cfa831e4b0c9d6adf6cc13	TCGA-DU-6402-01A-11D-1703_130813_SN1440_0160_AD2B87ACXX_s_4_rg.sorted.filtered.	WGS	TCGA-DU-6402-01A-11D-1703_130813_SN1440_0160_AD2B87ACXX_s_4_rg.sorted	TCGA-DU-6402-01A-11D-1703_130813_SN1440_0160_AD2B87ACXX_s_4_rg.sorted.bam	234.3	1.9	0.15	58cfa831e4b0c9d6adf6cc13	TCGA-DU-6402-01A-11D-1703_130813_SN1440_0160_AD2B87ACXX_s_4_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-DU-6402-01A	152F028E-EE29-40E0-8E75-5CAFFFACBD45	Primary Tumor	Illumina HiSeq	d556f16a-ad20-42eb-8e92-57114d46e174	Brain	52	0E594B0A-05E4-40C8-80BA-0D4BB08E437D	A60A9995-6A02-4035-9C3E-2FEE0E6E87C5	TCGA-DU-6402-01A-11D-1703-02	HG19_Broad_variant	TCGA-DU-6402	TCGA-LGG	214	s8563	Harvard Medical School	Henry Ford Hospital	United States	NO	Not available	Not available	Astrocytoma	Not available	1703-02	TRUE
13722.58cfa831e4b0c9d6adf6cc24	58cfa831e4b0c9d6adf6cc24	TCGA-DU-7292-01A-11D-2022_130911_SN1222_0218_BC2A1NACXX_s_1_rg.sorted.filtered.	WGS	TCGA-DU-7292-01A-11D-2022_130911_SN1222_0218_BC2A1NACXX_s_1_rg.sorted	TCGA-DU-7292-01A-11D-2022_130911_SN1222_0218_BC2A1NACXX_s_1_rg.sorted.bam	28	NA	0.14	58cfa831e4b0c9d6adf6cc24	TCGA-DU-7292-01A-11D-2022_130911_SN1222_0218_BC2A1NACXX_s_1_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-DU-7292-01A	145F87A3-5E86-4A87-8E49-B166A2271D02	Primary Tumor	Illumina HiSeq	06fe9cf9-6572-4026-9990-7ec39cd21278	Brain	69	BD3011C5-FCF0-4B28-8D82-1175F69B118B	A3B00BDD-7250-4E6F-8F83-6CC01D672EF4	TCGA-DU-7292-01A-11D-2022-02	HG19_Broad_variant	TCGA-DU-7292	TCGA-LGG	242	s8361	Harvard Medical School	Henry Ford Hospital	United States	NO	Not available	Not available	Astrocytoma	Not available	2022-02	TRUE
13722.58cfa831e4b0c9d6adf6cc0b	58cfa831e4b0c9d6adf6cc0b	TCGA-DU-6403-01A-11D-1703_130813_SN1440_0160_AD2B87ACXX_s_5_rg.sorted.filtered.	WGS	TCGA-DU-6403-01A-11D-1703_130813_SN1440_0160_AD2B87ACXX_s_5_rg.sorted	TCGA-DU-6403-01A-11D-1703_130813_SN1440_0160_AD2B87ACXX_s_5_rg.sorted.bam	180.3	1.9	0.14	58cfa831e4b0c9d6adf6cc0b	TCGA-DU-6403-01A-11D-1703_130813_SN1440_0160_AD2B87ACXX_s_5_rg.sorted.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-DU-6403-01A	8DAA29C0-F652-4130-A004-5183BBE30C63	Primary Tumor	Illumina HiSeq	d17b6f47-d1c9-4916-8722-8b6908f8552a	Brain	60	664226B3-6C8B-4E0A-A75B-955D65E62DA9	97CFB7E8-82E2-43BD-A458-376AD3CD7CFE	TCGA-DU-6403-01A-11D-1703-02	HG19_Broad_variant	TCGA-DU-6403	TCGA-LGG	354	s8135	Harvard Medical School	Henry Ford Hospital	United States	NO	Not available	Not available	Oligoastrocytoma	Not available	1703-02	TRUE
13722.58cfa831e4b0c9d6adf6cc2f	58cfa831e4b0c9d6adf6cc2f	TCGA-DU-7008-01A-11D-2022_130910_SN208_0495_BD2FGNACXX_s_1_rg.sorted.filtered.	WGS	TCGA-DU-7008-01A-11D-2022_130910_SN208_0495_BD2FGNACXX_s_1_rg.sorted	TCGA-DU-7008-01A-11D-2022_130910_SN208_0495_BD2FGNACXX_s_1_rg.sorted.bam	111	NA	0.15	58cfa831e4b0c9d6adf6cc2f	TCGA-DU-7008-01A-11D-2022_130910_SN208_0495_BD2FGNACXX_s_1_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-DU-7008-01A	427C40F6-D1BD-49F2-B303-A975793B937E	Primary Tumor	Illumina HiSeq	3a51e8e7-621e-4d62-bb3d-cb6700af6a43	Brain	41	7A0C3571-4265-4D36-AFBC-FA234970F94B	7602BA72-B5E0-49C7-940A-6E9EFBDB5C58	TCGA-DU-7008-01A-11D-2022-02	HG19_Broad_variant	TCGA-DU-7008	TCGA-LGG	NA	s8566	Harvard Medical School	Henry Ford Hospital	United States	NO	Not available	Not available	Oligodendroglioma	Not available	2022-02	TRUE
13722.58cfa831e4b0c9d6adf6cc80	58cfa831e4b0c9d6adf6cc80	TCGA-EL-A3T6-01A-11D-A221_120523_SN1222_0108_AC0VL4ACXX_s_7_rg.sorted.filtered.	WGS	TCGA-EL-A3T6-01A-11D-A221_120523_SN1222_0108_AC0VL4ACXX_s_7_rg.sorted	TCGA-EL-A3T6-01A-11D-A221_120523_SN1222_0108_AC0VL4ACXX_s_7_rg.sorted.bam	40.31	NA	0.15	58cfa831e4b0c9d6adf6cc80	TCGA-EL-A3T6-01A-11D-A221_120523_SN1222_0108_AC0VL4ACXX_s_7_rg.sorted.bam	Alive	FEMALE	WHITE	HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-EL-A3T6-01A	90507BAA-B716-4BCF-A18E-9D8AE97D809A	Primary Tumor	Illumina HiSeq	fb31d05f-8a2e-416d-92b9-fd333e80561f	Thyroid	34	61367375-8317-4CAE-86CF-2FD65AB8ABC8	C1FE07E8-83AC-47A7-B8E5-FA62DE03BB17	TCGA-EL-A3T6-01A-11D-A221-26	HG19_Broad_variant	TCGA-EL-A3T6	TCGA-THCA	NA	s12518	MD Anderson - Institute for Applied Cancer Science	MD Anderson	United States	NO	T3	N0	Thyroid Papillary Carcinoma - Classical/usual	Stage I	A221-26	TRUE
13722.58cfa831e4b0c9d6adf6cce7	58cfa831e4b0c9d6adf6cce7	TCGA-EK-A3GJ-01A-21D-A20X_140106_SN590_0243_AC371BACXX_s_1_rg.sorted.filtered.	WGS	TCGA-EK-A3GJ-01A-21D-A20X_140106_SN590_0243_AC371BACXX_s_1_rg.sorted	TCGA-EK-A3GJ-01A-21D-A20X_140106_SN590_0243_AC371BACXX_s_1_rg.sorted.bam	68.37	NA	0.16	58cfa831e4b0c9d6adf6cce7	TCGA-EK-A3GJ-01A-21D-A20X_140106_SN590_0243_AC371BACXX_s_1_rg.sorted.bam	Alive	FEMALE	NATIVE HAWAIIAN OR OTHER PACIFIC ISLANDER	Not available	Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-EK-A3GJ-01A	DEDA68DD-E9AD-45CC-9DBB-1C5836EF6519	Primary Tumor	Illumina HiSeq	dde88a3f-8602-42a1-9b43-037c49cb3d34	Cervix	51	93AB0265-4851-4A8E-BEE3-496EA8DE56F7	1DE48F6B-49E4-4FE8-9D1B-0C7773DD7671	TCGA-EK-A3GJ-01A-21D-A20X-26	HG19_Broad_variant	TCGA-EK-A3GJ	TCGA-CESC	NA	s1192	MD Anderson - Institute for Applied Cancer Science	Gynecologic Oncology Group	United States	NO	T1b1	N0	Cervical Squamous Cell Carcinoma	Not available	A20X-26	TRUE
13722.58cfa831e4b0c9d6adf6ccde	58cfa831e4b0c9d6adf6ccde	TCGA-EM-A1CV-01A-11D-A13U_120706_SN1222_0122_AC0WPYACXX_s_4_rg.sorted.filtered.	WGS	TCGA-EM-A1CV-01A-11D-A13U_120706_SN1222_0122_AC0WPYACXX_s_4_rg.sorted	TCGA-EM-A1CV-01A-11D-A13U_120706_SN1222_0122_AC0WPYACXX_s_4_rg.sorted.bam	104.75	1.89	0.17	58cfa831e4b0c9d6adf6ccde	TCGA-EM-A1CV-01A-11D-A13U_120706_SN1222_0122_AC0WPYACXX_s_4_rg.sorted.bam	Alive	FEMALE	Not available	Not available	Thyroid Carcinoma	Aligned reads	TCGA-EM-A1CV-01A	762EDDB5-1B47-4B79-B20A-1EDFB07C0705	Primary Tumor	Illumina HiSeq	54060b82-ddf3-4449-aa9c-baaa4d66f1b7	Thyroid	32	95D077B1-E4F3-48EA-84BC-F663FD438693	DEC98438-085F-40C3-8751-D50BA12C8584	TCGA-EM-A1CV-01A-11D-A13U-02	HG19_Broad_variant	TCGA-EM-A1CV	TCGA-THCA	NA	s12521	Harvard Medical School	University Health Network	Canada	NO	T1	N0	Thyroid Papillary Carcinoma - Classical/usual	Stage I	A13U-02	TRUE
13722.58cfa831e4b0c9d6adf6cda5	58cfa831e4b0c9d6adf6cda5	TCGA-FE-A3PB-01A-11D-A221_120524_SN1120_0144_AC0VNCACXX_s_2_rg.sorted.filtered.	WGS	TCGA-FE-A3PB-01A-11D-A221_120524_SN1120_0144_AC0VNCACXX_s_2_rg.sorted	TCGA-FE-A3PB-01A-11D-A221_120524_SN1120_0144_AC0VNCACXX_s_2_rg.sorted.bam	45.08	NA	0.15	58cfa831e4b0c9d6adf6cda5	TCGA-FE-A3PB-01A-11D-A221_120524_SN1120_0144_AC0VNCACXX_s_2_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-FE-A3PB-01A	05A8268A-6B33-429B-8638-8C9BB366EF28	Primary Tumor	Illumina HiSeq	cc57e94a-0d41-4543-a4d8-3b42fc1afd8c	Thyroid	33	955243D6-118F-41B7-BC8A-D3DDF7AD00B6	F89BA6FD-2785-49F3-8611-5147D09C6AC0	TCGA-FE-A3PB-01A-11D-A221-26	HG19_Broad_variant	TCGA-FE-A3PB	TCGA-THCA	NA	s12650	MD Anderson - RPPA Core Facility (Proteomics)	Ohio State University	United States	NO	T3	N1a	Thyroid Papillary Carcinoma - Classical/usual	Stage I	A221-26	TRUE
13722.58cfa832e4b0c9d6adf6cdfc	58cfa832e4b0c9d6adf6cdfc	TCGA-FD-A3SN-01A-12D-A233_120830_SN208_0423_AC190AACXX_s_7_rg.sorted.filtered.	WGS	TCGA-FD-A3SN-01A-12D-A233_120830_SN208_0423_AC190AACXX_s_7_rg.sorted	TCGA-FD-A3SN-01A-12D-A233_120830_SN208_0423_AC190AACXX_s_7_rg.sorted.bam	33.16	NA	0.15	58cfa832e4b0c9d6adf6cdfc	TCGA-FD-A3SN-01A-12D-A233_120830_SN208_0423_AC190AACXX_s_7_rg.sorted.bam	Alive	MALE	WHITE	HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-FD-A3SN-01A	0FB043D3-D86B-4CD8-8C01-9E2B3E965BB0	Primary Tumor	Illumina HiSeq	2281a267-dad6-42d6-9df2-8d37a696c507	Bladder	79	127892ED-8A7A-41CB-8ABE-353E09E6D327	B0AD1373-0C51-41A3-9F8B-BDE28C67CFB8	TCGA-FD-A3SN-01A-12D-A233-26	HG19_Broad_variant	TCGA-FD-A3SN	TCGA-BLCA	NA	s2719	MD Anderson - Institute for Applied Cancer Science	BLN - University Of Chicago	United States	NO	T3b	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage III	A233-26	TRUE
13722.58cfa832e4b0c9d6adf6ce63	58cfa832e4b0c9d6adf6ce63	TCGA-GV-A3QH-01A-11D-A221_120830_SN590_0178_AD143RACXX_s_5_rg.sorted.filtered.	WGS	TCGA-GV-A3QH-01A-11D-A221_120830_SN590_0178_AD143RACXX_s_5_rg.sorted	TCGA-GV-A3QH-01A-11D-A221_120830_SN590_0178_AD143RACXX_s_5_rg.sorted.bam	38.38	NA	0.14	58cfa832e4b0c9d6adf6ce63	TCGA-GV-A3QH-01A-11D-A221_120830_SN590_0178_AD143RACXX_s_5_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-GV-A3QH-01A	33BC6A7C-9844-41E3-96B3-1E34BB3FEDD5	Primary Tumor	Illumina HiSeq	5672aee8-638c-45c6-af4f-0ccc5e2a1b45	Bladder	67	DEB7311F-E747-44EC-92C3-1E56CD5CACF2	B14D2F40-53F3-4A3A-8FA8-1BE7F102CA25	TCGA-GV-A3QH-01A-11D-A221-26	HG19_Broad_variant	TCGA-GV-A3QH	TCGA-BLCA	NA	s3129	MD Anderson - Institute for Applied Cancer Science	BLN - Cleveland Clinic	United States	NO	Not available	NX	Muscle invasive urothelial carcinoma (pT2 or above)	Stage II	A221-26	TRUE
13722.58cfa832e4b0c9d6adf6ce8b	58cfa832e4b0c9d6adf6ce8b	TCGA-FY-A3RA-01A-11D-A221_120611_SN1222_0114_AC0WL3ACXX_s_6_rg.sorted.filtered.	WGS	TCGA-FY-A3RA-01A-11D-A221_120611_SN1222_0114_AC0WL3ACXX_s_6_rg.sorted	TCGA-FY-A3RA-01A-11D-A221_120611_SN1222_0114_AC0WL3ACXX_s_6_rg.sorted.bam	38.77	NA	0.17	58cfa832e4b0c9d6adf6ce8b	TCGA-FY-A3RA-01A-11D-A221_120611_SN1222_0114_AC0WL3ACXX_s_6_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-FY-A3RA-01A	58FF4366-20A3-40A2-A87A-551E17CDB5D3	Primary Tumor	Illumina HiSeq	a7a005ec-f27f-4c17-8bb6-879c800bb0ae	Thyroid	21	E67E2BBE-8C3F-41B1-BE3C-C89555A10AEE	40CA310C-DB41-44D5-A76C-72938CF4AED0	TCGA-FY-A3RA-01A-11D-A221-26	HG19_Broad_variant	TCGA-FY-A3RA	TCGA-THCA	NA	s12651	MD Anderson - Institute for Applied Cancer Science	International Genomics Consortium	United States	NO	T2	NX	Thyroid Papillary Carcinoma - Classical/usual	Stage I	A221-26	TRUE
13722.58cfa832e4b0c9d6adf6ce99	58cfa832e4b0c9d6adf6ce99	TCGA-FY-A3R8-01A-11D-A221_120524_SN1120_0144_AC0VNCACXX_s_3_rg.sorted.filtered.	WGS	TCGA-FY-A3R8-01A-11D-A221_120524_SN1120_0144_AC0VNCACXX_s_3_rg.sorted	TCGA-FY-A3R8-01A-11D-A221_120524_SN1120_0144_AC0VNCACXX_s_3_rg.sorted.bam	51.96	NA	0.15	58cfa832e4b0c9d6adf6ce99	TCGA-FY-A3R8-01A-11D-A221_120524_SN1120_0144_AC0VNCACXX_s_3_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-FY-A3R8-01A	C77976B6-35EA-4623-A92A-6D9440A978E6	Primary Tumor	Illumina HiSeq	7d0e9d6d-fb33-481e-93f7-84ae9641ce75	Thyroid	62	BAA64E5A-237E-44AC-8B22-2D86E710F7DB	3D9D0EC4-8C81-40D9-886F-8813570E732D	TCGA-FY-A3R8-01A-11D-A221-26	HG19_Broad_variant	TCGA-FY-A3R8	TCGA-THCA	NA	s12392	MD Anderson - Institute for Applied Cancer Science	International Genomics Consortium	United States	NO	T3	NX	Thyroid Papillary Carcinoma - Classical/usual	Stage III	A221-26	TRUE
13722.58cfa832e4b0c9d6adf6cf22	58cfa832e4b0c9d6adf6cf22	TCGA-G9-6364-01A-21D-1784_130215_SN590_0211_AC1UJWACXX_s_7_rg.sorted.filtered.	WGS	TCGA-G9-6364-01A-21D-1784_130215_SN590_0211_AC1UJWACXX_s_7_rg.sorted	TCGA-G9-6364-01A-21D-1784_130215_SN590_0211_AC1UJWACXX_s_7_rg.sorted.bam	79.4	1.9	0.13	58cfa832e4b0c9d6adf6cf22	TCGA-G9-6364-01A-21D-1784_130215_SN590_0211_AC1UJWACXX_s_7_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-G9-6364-01A	F8D8B417-5945-42A5-850A-FBC04B4F0E61	Primary Tumor	Illumina HiSeq	01dfbaf5-2c53-4f89-97c0-f845932cfde5	Prostate	72	242C8BCB-F8D3-4D3A-ABB1-0AB5D74D3BCB	6E0AAA4D-9ACC-4E63-AC7E-5B478D6406B5	TCGA-G9-6364-01A-21D-1784-02	HG19_Broad_variant	TCGA-G9-6364	TCGA-PRAD	NA	s4147	Harvard Medical School	Roswell Park	United States	NO	T3a	N0	Prostate Adenocarcinoma Acinar Type	Not available	1784-02	TRUE
13722.58cfa832e4b0c9d6adf6cec4	58cfa832e4b0c9d6adf6cec4	TCGA-EM-A1YB-01A-11D-A14U_120717_SN1120_0175_AC1179ACXX_s_1_rg.sorted.filtered.	WGS	TCGA-EM-A1YB-01A-11D-A14U_120717_SN1120_0175_AC1179ACXX_s_1_rg.sorted	TCGA-EM-A1YB-01A-11D-A14U_120717_SN1120_0175_AC1179ACXX_s_1_rg.sorted.bam	31.49	1.93	0.17	58cfa832e4b0c9d6adf6cec4	TCGA-EM-A1YB-01A-11D-A14U_120717_SN1120_0175_AC1179ACXX_s_1_rg.sorted.bam	Alive	FEMALE	Not available	Not available	Thyroid Carcinoma	Aligned reads	TCGA-EM-A1YB-01A	B43A4F92-7A13-4558-A97E-7B3FEB2D70C9	Primary Tumor	Illumina HiSeq	13add68c-df0c-4f19-8032-d084a8cedcab	Thyroid	73	13C7182D-EF93-48A7-9569-EED7714CEC40	59B09269-9CB6-4AD9-874D-5237896747A1	TCGA-EM-A1YB-01A-11D-A14U-02	HG19_Broad_variant	TCGA-EM-A1YB	TCGA-THCA	NA	s12751	Harvard Medical School	University Health Network	Canada	NO	T2	NX	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	Stage II	A14U-02	TRUE
13722.58cfa832e4b0c9d6adf6cee4	58cfa832e4b0c9d6adf6cee4	TCGA-EM-A3O8-01A-11D-A221_120530_SN1222_0111_BD12L1ACXX_s_2_rg.sorted.filtered.	WGS	TCGA-EM-A3O8-01A-11D-A221_120530_SN1222_0111_BD12L1ACXX_s_2_rg.sorted	TCGA-EM-A3O8-01A-11D-A221_120530_SN1222_0111_BD12L1ACXX_s_2_rg.sorted.bam	55.95	NA	0.15	58cfa832e4b0c9d6adf6cee4	TCGA-EM-A3O8-01A-11D-A221_120530_SN1222_0111_BD12L1ACXX_s_2_rg.sorted.bam	Alive	FEMALE	Not available	Not available	Thyroid Carcinoma	Aligned reads	TCGA-EM-A3O8-01A	97B5017C-2066-4472-AB3F-31CFE64A6762	Primary Tumor	Illumina HiSeq	63701f3e-e258-497f-a7b6-1dddce3369f2	Thyroid	33	7F540311-430C-46B2-98C8-F314B27ECB0E	F125CCA1-271D-4716-9746-9AB9DD2A1C43	TCGA-EM-A3O8-01A-11D-A221-26	HG19_Broad_variant	TCGA-EM-A3O8	TCGA-THCA	NA	s12252	MD Anderson - Institute for Applied Cancer Science	University Health Network	Canada	NO	T1b	N0	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	Stage I	A221-26	TRUE
13722.58cfa832e4b0c9d6adf6cf96	58cfa832e4b0c9d6adf6cf96	TCGA-G9-6351-01A-21D-1957_130405_SN590_0222_BD21LGACXX_s_2_rg.sorted.filtered.	WGS	TCGA-G9-6351-01A-21D-1957_130405_SN590_0222_BD21LGACXX_s_2_rg.sorted	TCGA-G9-6351-01A-21D-1957_130405_SN590_0222_BD21LGACXX_s_2_rg.sorted.bam	149.7	1.9	0.15	58cfa832e4b0c9d6adf6cf96	TCGA-G9-6351-01A-21D-1957_130405_SN590_0222_BD21LGACXX_s_2_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-G9-6351-01A	F59B9C65-46E8-4CC3-AA71-8844F6C2273C	Primary Tumor	Illumina HiSeq	ddf40c8c-cec5-4f4b-853a-1541566f51b5	Prostate	51	92436584-12D6-4CF2-9AB1-CDF98E4E8260	DE6145E0-8D30-4CA1-A169-0BDC7E5BC57A	TCGA-G9-6351-01A-21D-1957-02	HG19_Broad_variant	TCGA-G9-6351	TCGA-PRAD	NA	s3618	Harvard Medical School	Roswell Park	United States	NO	T2c	Not available	Prostate Adenocarcinoma Acinar Type	Not available	1957-02	TRUE
13722.58cfa832e4b0c9d6adf6cf9f	58cfa832e4b0c9d6adf6cf9f	TCGA-H2-A3RH-01A-11D-A221_120610_SN1120_0151_AC0WN0ACXX_s_2_rg.sorted.filtered.	WGS	TCGA-H2-A3RH-01A-11D-A221_120610_SN1120_0151_AC0WN0ACXX_s_2_rg.sorted	TCGA-H2-A3RH-01A-11D-A221_120610_SN1120_0151_AC0WN0ACXX_s_2_rg.sorted.bam	62.17	NA	0.15	58cfa832e4b0c9d6adf6cf9f	TCGA-H2-A3RH-01A-11D-A221_120610_SN1120_0151_AC0WN0ACXX_s_2_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-H2-A3RH-01A	0314B145-2F3A-4A90-A580-375B5F0A63A4	Primary Tumor	Illumina HiSeq	dddfb702-cb09-4a5f-b023-b31d89ec07a8	Thyroid	41	1A9E811D-1C60-409C-A7D2-1D58AFA473E9	8358E269-BD6E-4189-86AB-520C84405DAA	TCGA-H2-A3RH-01A-11D-A221-26	HG19_Broad_variant	TCGA-H2-A3RH	TCGA-THCA	NA	s12532	MD Anderson - Institute for Applied Cancer Science	Christiana Healthcare	United States	NO	T1b	N0	Thyroid Papillary Carcinoma - Follicular (>= 99% follicular patterned)	Stage I	A221-26	TRUE
13722.58cfa832e4b0c9d6adf6cfbe	58cfa832e4b0c9d6adf6cfbe	TCGA-G9-6385-01A-11D-1784_130301_SN590_0217_BC1UHMACXX_s_7_rg.sorted.filtered.	WGS	TCGA-G9-6385-01A-11D-1784_130301_SN590_0217_BC1UHMACXX_s_7_rg.sorted	TCGA-G9-6385-01A-11D-1784_130301_SN590_0217_BC1UHMACXX_s_7_rg.sorted.bam	249.4	1.9	0.14	58cfa832e4b0c9d6adf6cfbe	TCGA-G9-6385-01A-11D-1784_130301_SN590_0217_BC1UHMACXX_s_7_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-G9-6385-01A	E82A04CF-E81E-43C6-9CD9-0E29FA0F00AE	Primary Tumor	Illumina HiSeq	53da3cf6-b29e-4b1f-9d51-c1f9648b6634	Prostate	66	CFE4B1FA-B658-49D3-87AD-6DF7D75A58DF	00D3CD80-E6C2-4408-8F10-3656BD371157	TCGA-G9-6385-01A-11D-1784-02	HG19_Broad_variant	TCGA-G9-6385	TCGA-PRAD	NA	s3456	Harvard Medical School	Roswell Park	United States	NO	T2c	Not available	Prostate Adenocarcinoma Acinar Type	Not available	1784-02	TRUE
13722.58cfa832e4b0c9d6adf6d024	58cfa832e4b0c9d6adf6d024	TCGA-GC-A3BM-01A-11D-A23Q_120926_SN1222_0153_BD1D4MACXX_s_3_rg.sorted.filtered.	WGS	TCGA-GC-A3BM-01A-11D-A23Q_120926_SN1222_0153_BD1D4MACXX_s_3_rg.sorted	TCGA-GC-A3BM-01A-11D-A23Q_120926_SN1222_0153_BD1D4MACXX_s_3_rg.sorted.bam	51.48	NA	0.15	58cfa832e4b0c9d6adf6d024	TCGA-GC-A3BM-01A-11D-A23Q_120926_SN1222_0153_BD1D4MACXX_s_3_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-GC-A3BM-01A	7840AEA9-40C4-473E-BE33-8FA0B9F332C9	Primary Tumor	Illumina HiSeq	1901f2a9-837a-482c-8073-472f3c4d9ba1	Bladder	70	5C631CE8-F96A-4C35-A459-556FC4AB21E1	5FE3FF9D-CCF4-4C76-820D-26FD5D1FCD15	TCGA-GC-A3BM-01A-11D-A23Q-26	HG19_Broad_variant	TCGA-GC-A3BM	TCGA-BLCA	NA	s2924	MD Anderson - Institute for Applied Cancer Science	International Genomics Consortium	United States	NO	T2b	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage II	A23Q-26	TRUE
13722.58cfa832e4b0c9d6adf6d042	58cfa832e4b0c9d6adf6d042	TCGA-FU-A3EO-01A-11D-A20X_140106_SN590_0244_BC384EACXX_s_1_rg.sorted.filtered.	WGS	TCGA-FU-A3EO-01A-11D-A20X_140106_SN590_0244_BC384EACXX_s_1_rg.sorted	TCGA-FU-A3EO-01A-11D-A20X_140106_SN590_0244_BC384EACXX_s_1_rg.sorted.bam	43.71	NA	0.16	58cfa832e4b0c9d6adf6d042	TCGA-FU-A3EO-01A-11D-A20X_140106_SN590_0244_BC384EACXX_s_1_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma	Aligned reads	TCGA-FU-A3EO-01A	B7F2958F-256E-4C30-9C61-11E76DDB36BA	Primary Tumor	Illumina HiSeq	31874bb0-fa47-43d4-8135-1be05e8163eb	Cervix	55	59F1684E-5631-4E1E-A1DC-91739F7C159C	50DBFC58-57DC-4878-8506-7B6B21899DF5	TCGA-FU-A3EO-01A-11D-A20X-26	HG19_Broad_variant	TCGA-FU-A3EO	TCGA-CESC	NA	s1201	MD Anderson - Institute for Applied Cancer Science	International Genomics Consortium	United States	NO	T2b	N0	Endocervical Type of Adenocarcinoma	Not available	A20X-26	TRUE
13722.58cfa832e4b0c9d6adf6d0dd	58cfa832e4b0c9d6adf6d0dd	TCGA-HW-7495-01A-11D-2022_130913_SN1440_0168_BD2B0UACXX_s_3_rg.sorted.filtered.	WGS	TCGA-HW-7495-01A-11D-2022_130913_SN1440_0168_BD2B0UACXX_s_3_rg.sorted	TCGA-HW-7495-01A-11D-2022_130913_SN1440_0168_BD2B0UACXX_s_3_rg.sorted.bam	107	NA	0.15	58cfa832e4b0c9d6adf6d0dd	TCGA-HW-7495-01A-11D-2022_130913_SN1440_0168_BD2B0UACXX_s_3_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-HW-7495-01A	49967A57-7C12-46BB-8D71-CEBBB17C9935	Primary Tumor	Illumina HiSeq	10d85d7f-6926-453a-bfef-d1b9d129d9d1	Brain	45	1CCC7965-99A5-420A-B5AB-F9853B50E3B1	07DDE76E-E126-4D66-BA85-059F076B7D04	TCGA-HW-7495-01A-11D-2022-02	HG19_Broad_variant	TCGA-HW-7495	TCGA-LGG	NA	s8577	Harvard Medical School	MSKCC	United States	NO	Not available	Not available	Oligodendroglioma	Not available	2022-02	TRUE
13722.58cfa832e4b0c9d6adf6d026	58cfa832e4b0c9d6adf6d026	TCGA-GD-A3OQ-01A-32D-A221_120902_SN1222_0147_AC195DACXX_s_4_rg.sorted.filtered.	WGS	TCGA-GD-A3OQ-01A-32D-A221_120902_SN1222_0147_AC195DACXX_s_4_rg.sorted	TCGA-GD-A3OQ-01A-32D-A221_120902_SN1222_0147_AC195DACXX_s_4_rg.sorted.bam	40.42	NA	0.15	58cfa832e4b0c9d6adf6d026	TCGA-GD-A3OQ-01A-32D-A221_120902_SN1222_0147_AC195DACXX_s_4_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-GD-A3OQ-01A	2E85C30C-C4C4-4096-9EEF-4EB2C7D991A3	Primary Tumor	Illumina HiSeq	a07d0456-032d-409c-af8d-c4d6349ef4db	Bladder	48	E3D22638-C0AE-48AA-A523-8C9A6CFBF063	F77305E9-430E-4E7D-97A6-C97FFDDC3B65	TCGA-GD-A3OQ-01A-32D-A221-26	HG19_Broad_variant	TCGA-GD-A3OQ	TCGA-BLCA	NA	s2923	MD Anderson - Institute for Applied Cancer Science	ABS - IUPUI	United States	NO	T4a	N1	Muscle invasive urothelial carcinoma (pT2 or above)	Stage IV	A221-26	TRUE
13722.58cfa832e4b0c9d6adf6d132	58cfa832e4b0c9d6adf6d132	TCGA-FY-A3R6-01A-11D-A221_120611_SN1222_0115_BD141KACXX_s_1_rg.sorted.filtered.	WGS	TCGA-FY-A3R6-01A-11D-A221_120611_SN1222_0115_BD141KACXX_s_1_rg.sorted	TCGA-FY-A3R6-01A-11D-A221_120611_SN1222_0115_BD141KACXX_s_1_rg.sorted.bam	10.85	NA	0.16	58cfa832e4b0c9d6adf6d132	TCGA-FY-A3R6-01A-11D-A221_120611_SN1222_0115_BD141KACXX_s_1_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-FY-A3R6-01A	905469D2-4C97-4293-A20C-1B1F0462A25D	Primary Tumor	Illumina HiSeq	bd320251-720a-4498-a699-419a2544fe75	Thyroid	57	65414BA0-8800-4626-9488-10D79274CF32	EFF7FEA8-DF07-4DAD-BD26-7384906844E9	TCGA-FY-A3R6-01A-11D-A221-26	HG19_Broad_variant	TCGA-FY-A3R6	TCGA-THCA	NA	s12258	MD Anderson - Institute for Applied Cancer Science	International Genomics Consortium	United States	NO	T2	N1b	Thyroid Papillary Carcinoma - Classical/usual	Stage IVA	A221-26	TRUE
13722.58cfa832e4b0c9d6adf6d191	58cfa832e4b0c9d6adf6d191	TCGA-FE-A3PC-01A-11D-A221_120524_SN1120_0145_BD12MWACXX_s_2_rg.sorted.filtered.	WGS	TCGA-FE-A3PC-01A-11D-A221_120524_SN1120_0145_BD12MWACXX_s_2_rg.sorted	TCGA-FE-A3PC-01A-11D-A221_120524_SN1120_0145_BD12MWACXX_s_2_rg.sorted.bam	48.5	NA	0.15	58cfa832e4b0c9d6adf6d191	TCGA-FE-A3PC-01A-11D-A221_120524_SN1120_0145_BD12MWACXX_s_2_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Thyroid Carcinoma	Aligned reads	TCGA-FE-A3PC-01A	A86AC3B5-B5E9-4420-8DE0-A358FCAD85B6	Primary Tumor	Illumina HiSeq	7072b927-397f-4821-a834-0b1e21ec3434	Thyroid	37	7A5628FF-C5C2-4F25-809B-640415323477	8B0BF4B5-9846-473B-A2DB-8390B0DB90A7	TCGA-FE-A3PC-01A-11D-A221-26	HG19_Broad_variant	TCGA-FE-A3PC	TCGA-THCA	NA	s12647	MD Anderson - Institute for Applied Cancer Science	Ohio State University	United States	NO	T3	N1	Thyroid Papillary Carcinoma - Classical/usual	Stage I	A221-26	TRUE
13722.58cfa832e4b0c9d6adf6d1da	58cfa832e4b0c9d6adf6d1da	TCGA-HI-7169-01A-11D-2111_130607_SN590_0232_BD26R5ACXX_s_3_rg.sorted.filtered.	WGS	TCGA-HI-7169-01A-11D-2111_130607_SN590_0232_BD26R5ACXX_s_3_rg.sorted	TCGA-HI-7169-01A-11D-2111_130607_SN590_0232_BD26R5ACXX_s_3_rg.sorted.bam	54.6	NA	0.13	58cfa832e4b0c9d6adf6d1da	TCGA-HI-7169-01A-11D-2111_130607_SN590_0232_BD26R5ACXX_s_3_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-HI-7169-01A	11FB5853-8EEB-4AD8-825D-3EAAF3FA08D6	Primary Tumor	Illumina HiSeq	9537d469-d484-46ee-a6e8-6bb3461148c5	Prostate	55	AEEF0836-305C-465C-A9CA-6C1825353AE7	58543208-CB10-466F-A0FC-6C5202B8F13D	TCGA-HI-7169-01A-11D-2111-02	HG19_Broad_variant	TCGA-HI-7169	TCGA-PRAD	NA	s4155	Harvard Medical School	Fox Chase	United States	NO	T3a	N0	Prostate Adenocarcinoma Acinar Type	Not available	2111-02	TRUE
13722.58cfa832e4b0c9d6adf6d1c5	58cfa832e4b0c9d6adf6d1c5	TCGA-HI-7171-01A-12D-2111_130607_SN590_0232_BD26R5ACXX_s_7_rg.sorted.filtered.	WGS	TCGA-HI-7171-01A-12D-2111_130607_SN590_0232_BD26R5ACXX_s_7_rg.sorted	TCGA-HI-7171-01A-12D-2111_130607_SN590_0232_BD26R5ACXX_s_7_rg.sorted.bam	127.3	NA	0.14	58cfa832e4b0c9d6adf6d1c5	TCGA-HI-7171-01A-12D-2111_130607_SN590_0232_BD26R5ACXX_s_7_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-HI-7171-01A	931FEB14-3F69-41C1-8435-5FD4FB775BDF	Primary Tumor	Illumina HiSeq	0dc8ef7a-58a8-4b25-ad57-4c31592151e2	Prostate	56	B9D6C505-4D71-4189-925F-36914241B831	5A0710CB-B515-48F7-94B1-5DCD72B30F3F	TCGA-HI-7171-01A-12D-2111-02	HG19_Broad_variant	TCGA-HI-7171	TCGA-PRAD	1329	s3814	Harvard Medical School	Fox Chase	United States	NO	T3b	N0	Prostate Adenocarcinoma Acinar Type	Not available	2111-02	TRUE
13722.58cfa832e4b0c9d6adf6d3e3	58cfa832e4b0c9d6adf6d3e3	TCGA-V4-A9EL-01A-11D-A40D_140808_SN590_0253_AC499NACXX_s_1_rg.sorted.filtered.	WGS	TCGA-V4-A9EL-01A-11D-A40D_140808_SN590_0253_AC499NACXX_s_1_rg.sorted	TCGA-V4-A9EL-01A-11D-A40D_140808_SN590_0253_AC499NACXX_s_1_rg.sorted.bam	36.66	NA	0.17	58cfa832e4b0c9d6adf6d3e3	TCGA-V4-A9EL-01A-11D-A40D_140808_SN590_0253_AC499NACXX_s_1_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Uveal Melanoma	Aligned reads	TCGA-V4-A9EL-01A	8DE236F1-C029-44DF-A2A9-319145488BAA	Primary Tumor	Illumina HiSeq	37f105ff-ac0b-4651-9c5f-008d937dc883	Eye	60	DB91E719-82B1-4E9A-AB28-AC67B726340B	50022AEA-CB52-4402-9FC2-C8A4EC1600FF	TCGA-V4-A9EL-01A-11D-A40D-26	HG19_Broad_variant	TCGA-V4-A9EL	TCGA-UVM	NA	s199	MD Anderson - Institute for Applied Cancer Science	Institut Curie	France	NO	T4a	N0	Not available	Stage IIIA	A40D-26	TRUE
13722.58cfa832e4b0c9d6adf6d49c	58cfa832e4b0c9d6adf6d49c	TCGA-V4-A9F4-01A-11D-A40D_140715_SN1440_0193_BC4K41ACXX_s_4_rg.sorted.filtered.	WGS	TCGA-V4-A9F4-01A-11D-A40D_140715_SN1440_0193_BC4K41ACXX_s_4_rg.sorted	TCGA-V4-A9F4-01A-11D-A40D_140715_SN1440_0193_BC4K41ACXX_s_4_rg.sorted.bam	55.04	NA	0.16	58cfa832e4b0c9d6adf6d49c	TCGA-V4-A9F4-01A-11D-A40D_140715_SN1440_0193_BC4K41ACXX_s_4_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Uveal Melanoma	Aligned reads	TCGA-V4-A9F4-01A	4B9FD822-17AA-4A22-8E17-175A72931D5D	Primary Tumor	Illumina HiSeq	1f82d81a-7827-4bb8-89b2-fc4bd009cdde	Eye	41	AD550F5E-1469-4A09-9CDA-3F069B1AE258	1837571E-8D54-4BA2-A9FB-B7160BFD38BB	TCGA-V4-A9F4-01A-11D-A40D-26	HG19_Broad_variant	TCGA-V4-A9F4	TCGA-UVM	NA	s236	MD Anderson - Institute for Applied Cancer Science	Institut Curie	France	NO	T4a	N0	Not available	Stage IIIA	A40D-26	TRUE
13722.58cfa832e4b0c9d6adf6d412	58cfa832e4b0c9d6adf6d412	TCGA-V4-A9EX-01A-11D-A40D_140714_SN1440_0192_AC3RUUACXX_s_1_rg.sorted.filtered.	WGS	TCGA-V4-A9EX-01A-11D-A40D_140714_SN1440_0192_AC3RUUACXX_s_1_rg.sorted	TCGA-V4-A9EX-01A-11D-A40D_140714_SN1440_0192_AC3RUUACXX_s_1_rg.sorted.bam	48.32	NA	0.15	58cfa832e4b0c9d6adf6d412	TCGA-V4-A9EX-01A-11D-A40D_140714_SN1440_0192_AC3RUUACXX_s_1_rg.sorted.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uveal Melanoma	Aligned reads	TCGA-V4-A9EX-01A	892E7630-B11E-47BD-987C-327D33258E11	Primary Tumor	Illumina HiSeq	9f56ee51-fd1c-43d8-9e64-faacd67069e0	Eye	55	69F3ECE7-394D-4FA7-93E7-B6DCD538831A	9A4969D9-222E-4BA3-B0F4-34F42C0D1A19	TCGA-V4-A9EX-01A-11D-A40D-26	HG19_Broad_variant	TCGA-V4-A9EX	TCGA-UVM	730	s210	MD Anderson - Institute for Applied Cancer Science	Institut Curie	France	NO	T4a	N0	Not available	Stage IIIA	A40D-26	TRUE
13722.58cfa832e4b0c9d6adf6d4e5	58cfa832e4b0c9d6adf6d4e5	TCGA-V4-A9F1-01A-11D-A40D_140715_SN1440_0193_BC4K41ACXX_s_1_rg.sorted.filtered.	WGS	TCGA-V4-A9F1-01A-11D-A40D_140715_SN1440_0193_BC4K41ACXX_s_1_rg.sorted	TCGA-V4-A9F1-01A-11D-A40D_140715_SN1440_0193_BC4K41ACXX_s_1_rg.sorted.bam	51.84	NA	0.17	58cfa832e4b0c9d6adf6d4e5	TCGA-V4-A9F1-01A-11D-A40D_140715_SN1440_0193_BC4K41ACXX_s_1_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Uveal Melanoma	Aligned reads	TCGA-V4-A9F1-01A	94F3D9B0-0EE4-4F6A-A8FF-CE7A4D8FAB76	Primary Tumor	Illumina HiSeq	83f97de6-ac60-4cc0-bcff-bdecfe40f951	Eye	46	6C6A3062-B453-434B-9168-7837CAABC4EF	706721D2-3759-4664-BFB7-8FF7273C2786	TCGA-V4-A9F1-01A-11D-A40D-26	HG19_Broad_variant	TCGA-V4-A9F1	TCGA-UVM	NA	s226	MD Anderson - Institute for Applied Cancer Science	Institut Curie	France	NO	T3a	N0	Not available	Stage IIB	A40D-26	TRUE
13722.58cfa832e4b0c9d6adf6d4cc	58cfa832e4b0c9d6adf6d4cc	TCGA-VD-A8KL-01A-11D-A40D_140731_SN208_0522_AC59K7ACXX_s_7_rg.sorted.filtered.	WGS	TCGA-VD-A8KL-01A-11D-A40D_140731_SN208_0522_AC59K7ACXX_s_7_rg.sorted	TCGA-VD-A8KL-01A-11D-A40D_140731_SN208_0522_AC59K7ACXX_s_7_rg.sorted.bam	30.16	NA	0.15	58cfa832e4b0c9d6adf6d4cc	TCGA-VD-A8KL-01A-11D-A40D_140731_SN208_0522_AC59K7ACXX_s_7_rg.sorted.bam	Alive	FEMALE	Not available	Not available	Uveal Melanoma	Aligned reads	TCGA-VD-A8KL-01A	A9F956A0-660F-4185-A843-D9911D2484DE	Primary Tumor	Illumina HiSeq	e7c1dbaa-f0ee-479a-b2ad-cbbb8555e36e	Eye	77	86E0C8DD-546C-4B53-A56B-2C985E58CE68	4D1068DC-E769-4374-B895-4430A9B03322	TCGA-VD-A8KL-01A-11D-A40D-26	HG19_Broad_variant	TCGA-VD-A8KL	TCGA-UVM	NA	s263	MD Anderson - Institute for Applied Cancer Science	University of Liverpool	United Kingdom	NO	T3a	NX	Not available	Stage IIB	A40D-26	TRUE
13722.58cfa832e4b0c9d6adf6d4ba	58cfa832e4b0c9d6adf6d4ba	TCGA-VD-A8K7-01B-11D-A40D_140716_SN208_0519_BC5946ACXX_s_4_rg.sorted.filtered.	WGS	TCGA-VD-A8K7-01B-11D-A40D_140716_SN208_0519_BC5946ACXX_s_4_rg.sorted	TCGA-VD-A8K7-01B-11D-A40D_140716_SN208_0519_BC5946ACXX_s_4_rg.sorted.bam	27.7	NA	0.16	58cfa832e4b0c9d6adf6d4ba	TCGA-VD-A8K7-01B-11D-A40D_140716_SN208_0519_BC5946ACXX_s_4_rg.sorted.bam	Alive	MALE	Not available	Not available	Uveal Melanoma	Aligned reads	TCGA-VD-A8K7-01B	6103E640-8B62-4E39-908B-B62A0DEBEB0E	Primary Tumor	Illumina HiSeq	649c4e6f-5b69-4d14-b5cc-99938c78d650	Eye	39	1B626599-EC44-409D-8123-ED69D8442C19	4208E47B-01BB-4C91-9411-F214F46F656C	TCGA-VD-A8K7-01B-11D-A40D-26	HG19_Broad_variant	TCGA-VD-A8K7	TCGA-UVM	NA	s260	MD Anderson - Institute for Applied Cancer Science	University of Liverpool	United Kingdom	NO	T4a	NX	Not available	Stage IIIA	A40D-26	TRUE
13722.58cfa82de4b0c9d6adf6a5dc	58cfa82de4b0c9d6adf6a5dc	5c54cebf17d98a845d11ad5d5185f4a0.filtered.	WGS	5c54cebf17d98a845d11ad5d5185f4a0	5c54cebf17d98a845d11ad5d5185f4a0.bam	37.22	1.8	0.07	58cfa82de4b0c9d6adf6a5dc	5c54cebf17d98a845d11ad5d5185f4a0.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-B6-A0RU-01A	6956473B-92E5-4069-A26B-B48E280E76F2	Primary Tumor	Illumina HiSeq	2efc5248-9be4-4e98-a400-f2ee744ac29d	Breast	40	C94232F8-2E37-46D0-B12A-B8E920E659D9	97064332-1D4F-4571-93FF-354FFE6D7DF9	TCGA-B6-A0RU-01A-11D-A12L-09	GRCh37-lite	TCGA-B6-A0RU	TCGA-BRCA	NA	s5950	Washington University School of Medicine	Duke	United States	NO	T1c	N0 (i-)	Other  specify	Stage IA	A12L-09	FALSE
13722.58cfa82ee4b0c9d6adf6aa51	58cfa82ee4b0c9d6adf6aa51	G35155.TCGA-CR-5243-01A-01D-1512-08.2.filtered.	WGS	G35155.TCGA-CR-5243-01A-01D-1512-08.2	G35155.TCGA-CR-5243-01A-01D-1512-08.2.bam	348.7	1.9	0.05	58cfa82ee4b0c9d6adf6aa51	G35155.TCGA-CR-5243-01A-01D-1512-08.2.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CR-5243-01A	E37F479F-CA05-45E4-AC6D-A974BED6E7F8	Primary Tumor	Illumina HiSeq	9b40a7ed-a315-4294-ade6-8b2194292f0b	Head and Neck	51	D89D46EA-9A7A-4FD8-B11E-9C9CA4780119	297E8B35-5B8B-4D5B-B812-86165F949A20	TCGA-CR-5243-01A-01D-1512-08	HG19_Broad_variant	TCGA-CR-5243	TCGA-HNSC	NA	s15873	Broad Institute of MIT and Harvard	Vanderbilt University	None	NO	TX	NX	Head and Neck Squamous Cell Carcinoma	Not available	1512-08	FALSE
13722.58cfa82ee4b0c9d6adf6aa64	58cfa82ee4b0c9d6adf6aa64	G35155.TCGA-CN-5373-01A-01D-1434-08.2.filtered.	WGS	G35155.TCGA-CN-5373-01A-01D-1434-08.2	G35155.TCGA-CN-5373-01A-01D-1434-08.2.bam	165.7	1.9	0.05	58cfa82ee4b0c9d6adf6aa64	G35155.TCGA-CN-5373-01A-01D-1434-08.2.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CN-5373-01A	546F01D5-AED5-4FB8-91C0-0FD5E0FDE935	Primary Tumor	Illumina HiSeq	25d55985-95b6-4558-b42e-5c32684d89b0	Head and Neck	55	9D73D061-F1E1-47BA-929D-FEEB6C191279	00988676-1E9B-4E00-B4AA-A8F86C21B206	TCGA-CN-5373-01A-01D-1434-08	HG19_Broad_variant	TCGA-CN-5373	TCGA-HNSC	NA	s15872	Broad Institute of MIT and Harvard	University of Pittsburgh	None	NO	T1	N0	Head and Neck Squamous Cell Carcinoma	Stage I	1434-08	FALSE
13722.58cfa82ee4b0c9d6adf6ab12	58cfa82ee4b0c9d6adf6ab12	G35155.TCGA-CQ-6220-01A-11D-1912-08.2.filtered.	WGS	G35155.TCGA-CQ-6220-01A-11D-1912-08.2	G35155.TCGA-CQ-6220-01A-11D-1912-08.2.bam	342.7	1.9	0.05	58cfa82ee4b0c9d6adf6ab12	G35155.TCGA-CQ-6220-01A-11D-1912-08.2.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CQ-6220-01A	96D0CEFE-7949-4736-A7DC-1E4FA94765EC	Primary Tumor	Illumina HiSeq	34bb201c-76f4-432d-b2d3-a46d882b205d	Head and Neck	69	E0E75203-3982-40B2-A057-FAA8433DFB7A	65E67EDA-16A4-4DFD-94A9-546C76D94A02	TCGA-CQ-6220-01A-11D-1912-08	HG19_Broad_variant	TCGA-CQ-6220	TCGA-HNSC	985	s15748	Broad Institute of MIT and Harvard	University Health Network, Toronto	Canada	NO	T3	N0	Head and Neck Squamous Cell Carcinoma	Stage III	1912-08	FALSE
13722.58cfa82ee4b0c9d6adf6ab7e	58cfa82ee4b0c9d6adf6ab7e	G35155.TCGA-CQ-5323-01A-01D-1683-08.2.filtered.	WGS	G35155.TCGA-CQ-5323-01A-01D-1683-08.2	G35155.TCGA-CQ-5323-01A-01D-1683-08.2.bam	481	1.9	0.05	58cfa82ee4b0c9d6adf6ab7e	G35155.TCGA-CQ-5323-01A-01D-1683-08.2.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CQ-5323-01A	DEEFDD62-4D35-40C9-AD4C-0B593F35CFF7	Primary Tumor	Illumina HiSeq	a8f7b17a-acda-474e-be1c-c3a584542451	Head and Neck	82	3AC5396D-B92F-41D5-A3F0-603AA52AAFA3	892067EF-C465-46EA-8F91-10636DD0081B	TCGA-CQ-5323-01A-01D-1683-08	HG19_Broad_variant	TCGA-CQ-5323	TCGA-HNSC	NA	s15874	Broad Institute of MIT and Harvard	University Health Network, Toronto	Canada	NO	T1	N0	Head and Neck Squamous Cell Carcinoma	Stage I	1683-08	FALSE
13722.58cfa82ee4b0c9d6adf6aba6	58cfa82ee4b0c9d6adf6aba6	G35155.TCGA-CR-6471-01A-11D-1870-08.2.filtered.	WGS	G35155.TCGA-CR-6471-01A-11D-1870-08.2	G35155.TCGA-CR-6471-01A-11D-1870-08.2.bam	90.7	1.9	0.05	58cfa82ee4b0c9d6adf6aba6	G35155.TCGA-CR-6471-01A-11D-1870-08.2.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CR-6471-01A	EDA29281-E803-4217-8603-D6A388408611	Primary Tumor	Illumina HiSeq	280b365a-3459-4fa2-9daa-644b077065dd	Head and Neck	58	4F845FB4-4724-455F-88F2-09DE7259A484	C087E87F-867C-45DD-8645-5AB774E4827C	TCGA-CR-6471-01A-11D-1870-08	HG19_Broad_variant	TCGA-CR-6471	TCGA-HNSC	1202	s15607	Broad Institute of MIT and Harvard	Vanderbilt University	United States	NO	T4a	N1	Head and Neck Squamous Cell Carcinoma	Stage IVA	1870-08	FALSE
13722.58cfa82ee4b0c9d6adf6ab1c	58cfa82ee4b0c9d6adf6ab1c	G35155.TCGA-CV-7406-01A-11D-2078-08.2.filtered.	WGS	G35155.TCGA-CV-7406-01A-11D-2078-08.2	G35155.TCGA-CV-7406-01A-11D-2078-08.2.bam	161.7	NA	0.05	58cfa82ee4b0c9d6adf6ab1c	G35155.TCGA-CV-7406-01A-11D-2078-08.2.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CV-7406-01A	2C6D6C93-FB6D-47F7-A868-5E9A82C75D4C	Primary Tumor	Illumina HiSeq	378f5b8c-a067-4ecf-af73-b546498381c4	Head and Neck	49	39D9F003-89E6-4349-B060-F5A604789FB3	8C9EFFA8-ACB6-4DB0-874A-8F0DF386924C	TCGA-CV-7406-01A-11D-2078-08	HG19_Broad_variant	TCGA-CV-7406	TCGA-HNSC	1748	s15486	Broad Institute of MIT and Harvard	MD Anderson Cancer Center	United States	NO	T2	N0	Head and Neck Squamous Cell Carcinoma	Stage II	2078-08	FALSE
13722.58cfa82ee4b0c9d6adf6ab8d	58cfa82ee4b0c9d6adf6ab8d	G35155.TCGA-DQ-7591-01A-11D-2078-08.2.filtered.	WGS	G35155.TCGA-DQ-7591-01A-11D-2078-08.2	G35155.TCGA-DQ-7591-01A-11D-2078-08.2.bam	482.7	NA	0.05	58cfa82ee4b0c9d6adf6ab8d	G35155.TCGA-DQ-7591-01A-11D-2078-08.2.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-DQ-7591-01A	3EF779CF-772E-445E-93C8-E1094EA8B878	Primary Tumor	Illumina HiSeq	17aee7fb-ed6f-46de-8dc7-ad13153b83a3	Head and Neck	62	FB144A86-0EB9-4754-BD74-8BA4BFFE7666	4068A2FC-452D-4B2C-88D8-72D30097527B	TCGA-DQ-7591-01A-11D-2078-08	HG19_Broad_variant	TCGA-DQ-7591	TCGA-HNSC	NA	s15871	Broad Institute of MIT and Harvard	University of Michigan	United States	NO	TX	NX	Head and Neck Squamous Cell Carcinoma	Not available	2078-08	FALSE
13722.58cfa82ee4b0c9d6adf6abe9	58cfa82ee4b0c9d6adf6abe9	G35155.TCGA-CR-6481-01A-11D-1870-08.2.filtered.	WGS	G35155.TCGA-CR-6481-01A-11D-1870-08.2	G35155.TCGA-CR-6481-01A-11D-1870-08.2.bam	88.7	1.9	0.05	58cfa82ee4b0c9d6adf6abe9	G35155.TCGA-CR-6481-01A-11D-1870-08.2.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CR-6481-01A	9A76BD98-1D2B-4D0F-9772-883520FF6210	Primary Tumor	Illumina HiSeq	577ba651-2ad3-4e83-a94c-547efbe03ebe	Head and Neck	47	04652163-A674-446F-9E86-607DE19E4C34	5E7D2531-81C1-48BB-9C0A-1867D1F83F92	TCGA-CR-6481-01A-11D-1870-08	HG19_Broad_variant	TCGA-CR-6481	TCGA-HNSC	NA	s15869	Broad Institute of MIT and Harvard	Vanderbilt University	United States	NO	Not available	Not available	Head and Neck Squamous Cell Carcinoma	Not available	1870-08	FALSE
13722.58cfa82ee4b0c9d6adf6ac6c	58cfa82ee4b0c9d6adf6ac6c	G35155.TCGA-HD-7754-01A-11D-2078-08.2.filtered.	WGS	G35155.TCGA-HD-7754-01A-11D-2078-08.2	G35155.TCGA-HD-7754-01A-11D-2078-08.2.bam	471.73	NA	0.05	58cfa82ee4b0c9d6adf6ac6c	G35155.TCGA-HD-7754-01A-11D-2078-08.2.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-HD-7754-01A	10F53522-9AE7-47B9-80AA-B4B481561465	Primary Tumor	Illumina HiSeq	58f7e425-aa07-404f-afe5-6a47488d4296	Head and Neck	69	ADB496A1-07EB-45B9-8690-00184143300E	233ECDC4-0B42-4533-8908-64AC7D3AC33B	TCGA-HD-7754-01A-11D-2078-08	HG19_Broad_variant	TCGA-HD-7754	TCGA-HNSC	NA	s16167	Broad Institute of MIT and Harvard	International Genomics Consortium	United States	NO	T2	N2b	Head and Neck Squamous Cell Carcinoma	Stage IVA	2078-08	FALSE
13722.58cfa82ee4b0c9d6adf6abf5	58cfa82ee4b0c9d6adf6abf5	G35155.TCGA-CR-7368-01A-11D-2129-08.2.filtered.	WGS	G35155.TCGA-CR-7368-01A-11D-2129-08.2	G35155.TCGA-CR-7368-01A-11D-2129-08.2.bam	250.7	NA	0.05	58cfa82ee4b0c9d6adf6abf5	G35155.TCGA-CR-7368-01A-11D-2129-08.2.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Head and Neck Squamous Cell Carcinoma	Aligned reads	TCGA-CR-7368-01A	27C28C89-F4E7-4AEC-A806-C0DA7756E47F	Primary Tumor	Illumina HiSeq	71be6814-d02e-4639-9836-25de17a1ec0f	Head and Neck	54	0C4C4B41-05AC-48CE-B5C0-A639FFAFC411	4B194AB3-D213-4A7A-BE46-909B4F0C7291	TCGA-CR-7368-01A-11D-2129-08	HG19_Broad_variant	TCGA-CR-7368	TCGA-HNSC	NA	s15875	Broad Institute of MIT and Harvard	Vanderbilt University	United States	NO	T4a	N1	Head and Neck Squamous Cell Carcinoma	Stage IVA	2129-08	FALSE
13722.58cfa82fe4b0c9d6adf6b524	58cfa82fe4b0c9d6adf6b524	TCGA-29-1705-01A-01D-0926-12_Illumina.filtered.	WGS	TCGA-29-1705-01A-01D-0926-12_Illumina	TCGA-29-1705-01A-01D-0926-12_Illumina.bam	135.7	1.9	0.15	58cfa82fe4b0c9d6adf6b524	TCGA-29-1705-01A-01D-0926-12_Illumina.bam	Dead	FEMALE	WHITE	Not available	Ovarian Serous Cystadenocarcinoma	Aligned reads	TCGA-29-1705-01A	F9C835DB-2AB6-4BF5-826F-48723493C0EC	Primary Tumor	Illumina HiSeq	862f409b-92fe-4bea-95cc-97f8beae4add	Ovary	47	FD3E7BA8-21A5-438B-82EE-482ED6905310	6730E18B-CC34-493E-AAE2-54E51D5D9CFF	TCGA-29-1705-01A-01D-0926-12	NCBI36_BCM_variant	TCGA-29-1705	TCGA-OV	555	s17530	Baylor College of Medicine	Duke	None	NO	Not available	Not available	Serous Cystadenocarcinoma	Not available	0926-12	TRUE
13722.58cfa82fe4b0c9d6adf6b8fb	58cfa82fe4b0c9d6adf6b8fb	TCGA-AA-3518-01A-02D-1525-10_Illumina.filtered.	WGS	TCGA-AA-3518-01A-02D-1525-10_Illumina	TCGA-AA-3518-01A-02D-1525-10_Illumina.bam	3.86	1.9	0.05	58cfa82fe4b0c9d6adf6b8fb	TCGA-AA-3518-01A-02D-1525-10_Illumina.bam	Alive	FEMALE	Not available	Not available	Colon Adenocarcinoma	Aligned reads	TCGA-AA-3518-01A	C5C4A0A5-900D-483D-9282-475654D63265	Primary Tumor	Illumina HiSeq	7d2638fc-9574-4f2a-baf2-495e6ba99e93	Colorectal	81	BC08B757-ED0A-44C0-88CD-85496BB72A75	F4B9D98F-7B76-4EAA-9595-10B0973D5FF7	TCGA-AA-3518-01A-02D-1525-10	NCBI36_BCM_variant	TCGA-AA-3518	TCGA-COAD	NA	s13027	Baylor College of Medicine	Indivumed	Germany	NO	T3	N0	Colon Adenocarcinoma	Stage IIA	1525-10	TRUE
13722.58cfa830e4b0c9d6adf6ba6a	58cfa830e4b0c9d6adf6ba6a	TCGA-A2-A04P-01A-31D-A128-09_IlluminaGA-DNASeq_whole.filtered.	WGS	TCGA-A2-A04P-01A-31D-A128-09_IlluminaGA-DNASeq_whole	TCGA-A2-A04P-01A-31D-A128-09_IlluminaGA-DNASeq_whole.bam	66.09	2.03	0.08	58cfa830e4b0c9d6adf6ba6a	TCGA-A2-A04P-01A-31D-A128-09_IlluminaGA-DNASeq_whole.bam	Dead	FEMALE	BLACK OR AFRICAN AMERICAN	Not available	Breast Invasive Carcinoma	Aligned reads	TCGA-A2-A04P-01A	CCD4A24B-D8CC-4686-9DEE-C98B0C5A8D21	Primary Tumor	Illumina HiSeq	680a94d4-95ae-4e50-b380-28f9f3c3be71	Breast	36	E4DEE88B-58D0-4953-AD4A-A2DF876F3C95	A85CF239-FF51-46E7-9B88-4C2CB49C66B9	TCGA-A2-A04P-01A-31D-A128-09	GRCh37-lite	TCGA-A2-A04P	TCGA-BRCA	548	s5958	Washington University School of Medicine	Walter Reed	None	NO	T2	N3c	Infiltrating Ductal Carcinoma	Stage IIIC	A128-09	TRUE
13722.58cfa830e4b0c9d6adf6bb32	58cfa830e4b0c9d6adf6bb32	TCGA-AA-A00R-01A-01D-A126-10_Illumina.filtered.	WGS	TCGA-AA-A00R-01A-01D-A126-10_Illumina	TCGA-AA-A00R-01A-01D-A126-10_Illumina.bam	205.35	1.73	0.08	58cfa830e4b0c9d6adf6bb32	TCGA-AA-A00R-01A-01D-A126-10_Illumina.bam	Alive	FEMALE	Not available	Not available	Colon Adenocarcinoma	Aligned reads	TCGA-AA-A00R-01A	CA22EDD4-EB7C-4677-84AA-6F0354459A19	Primary Tumor	Illumina HiSeq	a3f8272c-4b21-47f7-be7c-d4fc4cbb70b0	Colorectal	64	F72EEAE9-F7F5-4576-A072-5021119117D6	05780D48-80E7-4D70-B00C-081F8A9519F2	TCGA-AA-A00R-01A-01D-A126-10	NCBI36_BCM_variant	TCGA-AA-A00R	TCGA-COAD	NA	s13370	Baylor College of Medicine	Indivumed	Germany	NO	T2	N0	Colon Adenocarcinoma	Stage I	A126-10	FALSE
13722.58cfa82fe4b0c9d6adf6b7ee	58cfa82fe4b0c9d6adf6b7ee	TCGA-91-6829-01A-21D-1853_120305_SN1120_0119_BD0REAACXX_s_2_rg.sorted.filtered.	WGS	TCGA-91-6829-01A-21D-1853_120305_SN1120_0119_BD0REAACXX_s_2_rg.sorted	TCGA-91-6829-01A-21D-1853_120305_SN1120_0119_BD0REAACXX_s_2_rg.sorted.bam	62.7	1.9	0.15	58cfa82fe4b0c9d6adf6b7ee	TCGA-91-6829-01A-21D-1853_120305_SN1120_0119_BD0REAACXX_s_2_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Lung Adenocarcinoma	Aligned reads	TCGA-91-6829-01A	1427CD18-5AD3-491A-9981-908E31AE49DB	Primary Tumor	Illumina HiSeq	be9bb40c-b149-4b91-b271-b8881bb90d6f	Lung	78	9B416640-9AEC-4B0D-AA88-B94287375950	E6E4F55E-8C3A-45E9-8F3B-9FDFE9D2965D	TCGA-91-6829-01A-21D-1853-02	HG19_Broad_variant	TCGA-91-6829	TCGA-LUAD	1258	s11361	Harvard Medical School	ABS - IUPUI	United States	NO	T2	N0	Lung Bronchioloalveolar Carcinoma Nonmucinous	Stage IB	1853-02	TRUE
13722.58cfa82fe4b0c9d6adf6b668	58cfa82fe4b0c9d6adf6b668	TCGA-55-6642-01A-11D-1853_120310_SN590_0144_AD0PNFACXX_s_1_rg.sorted.filtered.	WGS	TCGA-55-6642-01A-11D-1853_120310_SN590_0144_AD0PNFACXX_s_1_rg.sorted	TCGA-55-6642-01A-11D-1853_120310_SN590_0144_AD0PNFACXX_s_1_rg.sorted.bam	245.7	1.9	0.14	58cfa82fe4b0c9d6adf6b668	TCGA-55-6642-01A-11D-1853_120310_SN590_0144_AD0PNFACXX_s_1_rg.sorted.bam	Alive	MALE	WHITE	Not available	Lung Adenocarcinoma	Aligned reads	TCGA-55-6642-01A	474B86D9-D897-467D-85D4-51DFA26EA107	Primary Tumor	Illumina HiSeq	9b12800d-6911-4d3f-a25e-4d1b686b63aa	Lung	63	08D8F333-08F9-4268-99B7-61F7B057F542	93AF51CC-26FF-4904-84BC-2DFFB317D86A	TCGA-55-6642-01A-11D-1853-02	HG19_Broad_variant	TCGA-55-6642	TCGA-LUAD	NA	s11552	Harvard Medical School	International Genomics Consortium	United States	NO	T2	N0	Lung Adenocarcinoma- Not Otherwise Specified (NOS)	Stage IB	1853-02	TRUE
13722.58cfa830e4b0c9d6adf6bd41	58cfa830e4b0c9d6adf6bd41	TCGA-AG-3593-01A-01D-1525-10_Illumina.filtered.	WGS	TCGA-AG-3593-01A-01D-1525-10_Illumina	TCGA-AG-3593-01A-01D-1525-10_Illumina.bam	495.85	1.9	0.05	58cfa830e4b0c9d6adf6bd41	TCGA-AG-3593-01A-01D-1525-10_Illumina.bam	Alive	FEMALE	Not available	Not available	Rectum Adenocarcinoma	Aligned reads	TCGA-AG-3593-01A	10290E91-9784-4F94-8DAA-B5D9A8B0EFB9	Primary Tumor	Illumina HiSeq	d2b54a0a-394a-4174-afce-c86c43e4524d	Colorectal	72	EFFCA0F1-E81D-47CD-8287-392A2B6AB786	FAFF4626-615B-416A-B7A6-9D177DCC94A9	TCGA-AG-3593-01A-01D-1525-10	NCBI36_BCM_variant	TCGA-AG-3593	TCGA-READ	NA	s2130	Baylor College of Medicine	Indivumed	Germany	NO	T3	N0	Rectal Adenocarcinoma	Stage IIA	1525-10	TRUE
13722.58cfa830e4b0c9d6adf6be26	58cfa830e4b0c9d6adf6be26	TCGA-BH-A0WA-01A-11D-A128-09_IlluminaGA-DNASeq_whole.filtered.	WGS	TCGA-BH-A0WA-01A-11D-A128-09_IlluminaGA-DNASeq_whole	TCGA-BH-A0WA-01A-11D-A128-09_IlluminaGA-DNASeq_whole.bam	63.5	1.95	0.07	58cfa830e4b0c9d6adf6be26	TCGA-BH-A0WA-01A-11D-A128-09_IlluminaGA-DNASeq_whole.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Breast Invasive Carcinoma	Aligned reads	TCGA-BH-A0WA-01A	786E8DBE-442E-4551-87B3-B4C333B04DD4	Primary Tumor	Illumina HiSeq	1671f5e8-9bbd-41c1-803e-c518d5ba004f	Breast	82	8EF7AD6F-A6E4-405C-B20E-D547985BD9D6	EDDFBFB9-3AE8-449B-B870-46062A2571C1	TCGA-BH-A0WA-01A-11D-A128-09	GRCh37-lite	TCGA-BH-A0WA	TCGA-BRCA	NA	s6631	Washington University School of Medicine	University of Pittsburgh	None	NO	T1c	N0 (i-)	Not available	Stage I	A128-09	TRUE
13722.58cfa830e4b0c9d6adf6c032	58cfa830e4b0c9d6adf6c032	TCGA-BR-6852-01A-11D-1880_130115_SN590_0207_AC1H8PACXX_s_7_rg.sorted.filtered.	WGS	TCGA-BR-6852-01A-11D-1880_130115_SN590_0207_AC1H8PACXX_s_7_rg.sorted	TCGA-BR-6852-01A-11D-1880_130115_SN590_0207_AC1H8PACXX_s_7_rg.sorted.bam	385.7	1.9	0.15	58cfa830e4b0c9d6adf6c032	TCGA-BR-6852-01A-11D-1880_130115_SN590_0207_AC1H8PACXX_s_7_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-BR-6852-01A	44799C67-61CD-4F3E-BDBC-423E2E0FD2E8	Primary Tumor	Illumina HiSeq	bff2f642-516a-4072-95aa-f213a4555f79	Stomach	64	F230ED0B-8D08-4546-9762-923097B4BF02	20F8131D-3F7E-47C5-AE84-A3886A387514	TCGA-BR-6852-01A-11D-1880-02	HG19_Broad_variant	TCGA-BR-6852	TCGA-STAD	NA	s15387	Harvard Medical School	Asterand	Ukraine	NO	T3	N0	Stomach  Adenocarcinoma  Not Otherwise Specified (NOS)	Stage IIA	1880-02	TRUE
13722.58cfa830e4b0c9d6adf6c2f5	58cfa830e4b0c9d6adf6c2f5	TCGA-BR-6803-01A-11D-1880_130329_SN590_0221_BD1WHDACXX_s_7_rg.sorted.filtered.	WGS	TCGA-BR-6803-01A-11D-1880_130329_SN590_0221_BD1WHDACXX_s_7_rg.sorted	TCGA-BR-6803-01A-11D-1880_130329_SN590_0221_BD1WHDACXX_s_7_rg.sorted.bam	91.7	1.9	0.14	58cfa830e4b0c9d6adf6c2f5	TCGA-BR-6803-01A-11D-1880_130329_SN590_0221_BD1WHDACXX_s_7_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Stomach Adenocarcinoma	Aligned reads	TCGA-BR-6803-01A	2F90209B-7464-4D7E-83D1-67850C263DED	Primary Tumor	Illumina HiSeq	af361f62-8dd0-4336-9fa9-41cdc800b18e	Stomach	54	E56FE72A-760A-4A60-9013-EA611080BA3F	D2F16739-9EAA-465D-95BA-D13C3AEB9A40	TCGA-BR-6803-01A-11D-1880-02	HG19_Broad_variant	TCGA-BR-6803	TCGA-STAD	NA	s15308	Harvard Medical School	Asterand	Russia	NO	T3	N0	Stomach  Adenocarcinoma  Diffuse Type	Stage IIA	1880-02	TRUE
13722.58cfa831e4b0c9d6adf6c48e	58cfa831e4b0c9d6adf6c48e	TCGA-C4-A0F6-01A-11D-A10R_120920_SN1222_0150_AC1927ACXX_s_1_rg.sorted.filtered.	WGS	TCGA-C4-A0F6-01A-11D-A10R_120920_SN1222_0150_AC1927ACXX_s_1_rg.sorted	TCGA-C4-A0F6-01A-11D-A10R_120920_SN1222_0150_AC1927ACXX_s_1_rg.sorted.bam	74.36	1.93	0.16	58cfa831e4b0c9d6adf6c48e	TCGA-C4-A0F6-01A-11D-A10R_120920_SN1222_0150_AC1927ACXX_s_1_rg.sorted.bam	Alive	FEMALE	Not available	Not available	Bladder Urothelial Carcinoma	Aligned reads	TCGA-C4-A0F6-01A	4FF9B4F2-6D04-4FED-8796-155902A8BF28	Primary Tumor	Illumina HiSeq	2332be3a-c2a5-446a-ae60-b8f873fe1866	Bladder	82	905D2BF1-08CB-4260-8188-00B60D881CF2	1765E178-12BD-4682-AB4A-368C4DCB5AEE	TCGA-C4-A0F6-01A-11D-A10R-02	HG19_Broad_variant	TCGA-C4-A0F6	TCGA-BLCA	NA	s3084	Harvard Medical School	Indivumed	Germany	NO	T3b	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage III	A10R-02	TRUE
13722.58cfa831e4b0c9d6adf6c95b	58cfa831e4b0c9d6adf6c95b	TCGA-DU-5847-01A-11D-1703_130806_SN1222_0209_AD2AW0ACXX_s_3_rg.sorted.filtered.	WGS	TCGA-DU-5847-01A-11D-1703_130806_SN1222_0209_AD2AW0ACXX_s_3_rg.sorted	TCGA-DU-5847-01A-11D-1703_130806_SN1222_0209_AD2AW0ACXX_s_3_rg.sorted.bam	173.3	1.9	0.14	58cfa831e4b0c9d6adf6c95b	TCGA-DU-5847-01A-11D-1703_130806_SN1222_0209_AD2AW0ACXX_s_3_rg.sorted.bam	Alive	FEMALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-DU-5847-01A	92A7C445-2217-400A-BDCD-DF41502416B6	Primary Tumor	Illumina HiSeq	a76674c6-34c4-4c06-b7e4-eb602b3bc5fa	Brain	34	C68FC12C-C538-4A89-9F6E-C0800A5A6B53	F83FB674-A46C-47DE-BAD8-36605068D2E2	TCGA-DU-5847-01A-11D-1703-02	HG19_Broad_variant	TCGA-DU-5847	TCGA-LGG	NA	s8136	Harvard Medical School	Henry Ford Hospital	United States	NO	Not available	Not available	Astrocytoma	Not available	1703-02	TRUE
13722.58cfa831e4b0c9d6adf6ca3c	58cfa831e4b0c9d6adf6ca3c	TCGA-DH-5143-01A-01D-1465_130808_SN208_0488_BC294YACXX_s_5_rg.sorted.filtered.	WGS	TCGA-DH-5143-01A-01D-1465_130808_SN208_0488_BC294YACXX_s_5_rg.sorted	TCGA-DH-5143-01A-01D-1465_130808_SN208_0488_BC294YACXX_s_5_rg.sorted.bam	48	1.9	0.16	58cfa831e4b0c9d6adf6ca3c	TCGA-DH-5143-01A-01D-1465_130808_SN208_0488_BC294YACXX_s_5_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-DH-5143-01A	DCD0856D-423A-40D7-8070-4C0988D61416	Primary Tumor	Illumina HiSeq	9e2bca97-d504-4863-b306-8f559a2cc8a1	Brain	30	570101B6-3670-4D1A-A94D-0DDC8DF42061	55952783-8C2C-4528-A544-B4C962AB634A	TCGA-DH-5143-01A-01D-1465-02	HG19_Broad_variant	TCGA-DH-5143	TCGA-LGG	NA	s8753	Harvard Medical School	University of Florida	United States	NO	Not available	Not available	Oligoastrocytoma	Not available	1465-02	TRUE
13722.58cfa831e4b0c9d6adf6ca0c	58cfa831e4b0c9d6adf6ca0c	TCGA-DK-A1AE-01A-11D-A13U_121002_SN1222_0154_AC1A3DACXX_s_7_rg.sorted.filtered.	WGS	TCGA-DK-A1AE-01A-11D-A13U_121002_SN1222_0154_AC1A3DACXX_s_7_rg.sorted	TCGA-DK-A1AE-01A-11D-A13U_121002_SN1222_0154_AC1A3DACXX_s_7_rg.sorted.bam	76.27	1.91	0.17	58cfa831e4b0c9d6adf6ca0c	TCGA-DK-A1AE-01A-11D-A13U_121002_SN1222_0154_AC1A3DACXX_s_7_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-DK-A1AE-01A	493A4FF2-37A5-4B79-928D-83DBFE534556	Primary Tumor	Illumina HiSeq	31314a75-c671-479c-aff0-437d0965f1fc	Bladder	84	67865453-D515-4D63-84E8-CFB2686A211D	885B8E06-182F-437B-9183-B454643A64EC	TCGA-DK-A1AE-01A-11D-A13U-02	HG19_Broad_variant	TCGA-DK-A1AE	TCGA-BLCA	NA	s2710	Harvard Medical School	Memorial Sloan Kettering	United States	NO	T3	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage III	A13U-02	TRUE
13722.58cfa831e4b0c9d6adf6ca56	58cfa831e4b0c9d6adf6ca56	TCGA-DU-5852-01A-11D-1703_130806_SN1222_0209_AD2AW0ACXX_s_7_rg.sorted.filtered.	WGS	TCGA-DU-5852-01A-11D-1703_130806_SN1222_0209_AD2AW0ACXX_s_7_rg.sorted	TCGA-DU-5852-01A-11D-1703_130806_SN1222_0209_AD2AW0ACXX_s_7_rg.sorted.bam	172.3	1.9	0.16	58cfa831e4b0c9d6adf6ca56	TCGA-DU-5852-01A-11D-1703_130806_SN1222_0209_AD2AW0ACXX_s_7_rg.sorted.bam	Dead	FEMALE	WHITE	NOT HISPANIC OR LATINO	Brain Lower Grade Glioma	Aligned reads	TCGA-DU-5852-01A	9ED5AF0E-C87F-46FF-81E7-9D3041B4034E	Primary Tumor	Illumina HiSeq	9dd03595-2a2f-4fc1-9cd1-52a490696f01	Brain	61	101AAA90-FE0A-42B7-BCC7-4F44E29883EC	E5AF958A-0014-4259-970D-5E0EA3CAE376	TCGA-DU-5852-01A-11D-1703-02	HG19_Broad_variant	TCGA-DU-5852	TCGA-LGG	205	s8347	Harvard Medical School	Henry Ford Hospital	United States	NO	Not available	Not available	Oligoastrocytoma	Not available	1703-02	TRUE
13722.58cfa831e4b0c9d6adf6ca5a	58cfa831e4b0c9d6adf6ca5a	TCGA-DK-A3IN-01A-11D-A210_120911_SN1120_0189_BD1D04ACXX_s_1_rg.sorted.filtered.	WGS	TCGA-DK-A3IN-01A-11D-A210_120911_SN1120_0189_BD1D04ACXX_s_1_rg.sorted	TCGA-DK-A3IN-01A-11D-A210_120911_SN1120_0189_BD1D04ACXX_s_1_rg.sorted.bam	36.12	NA	0.15	58cfa831e4b0c9d6adf6ca5a	TCGA-DK-A3IN-01A-11D-A210_120911_SN1120_0189_BD1D04ACXX_s_1_rg.sorted.bam	Dead	MALE	WHITE	NOT HISPANIC OR LATINO	Bladder Urothelial Carcinoma	Aligned reads	TCGA-DK-A3IN-01A	FC0032DB-B6D8-4DA3-BD1B-BEEC4196ABF0	Primary Tumor	Illumina HiSeq	ff3d1235-2aed-4091-a8a2-72340b403e05	Bladder	72	F8C14183-3982-44E5-967E-03967EAA8123	11901B8B-BE4C-4914-8D50-06EA0128EB39	TCGA-DK-A3IN-01A-11D-A210-26	HG19_Broad_variant	TCGA-DK-A3IN	TCGA-BLCA	250	s2890	MD Anderson - Institute for Applied Cancer Science	Memorial Sloan Kettering	United States	NO	T4a	N0	Muscle invasive urothelial carcinoma (pT2 or above)	Stage III	A210-26	TRUE
13722.58cfa831e4b0c9d6adf6cc92	58cfa831e4b0c9d6adf6cc92	TCGA-EJ-5510-01A-01D-1572_130308_SN590_0219_BC1UVPACXX_s_5_rg.sorted.filtered.	WGS	TCGA-EJ-5510-01A-01D-1572_130308_SN590_0219_BC1UVPACXX_s_5_rg.sorted	TCGA-EJ-5510-01A-01D-1572_130308_SN590_0219_BC1UVPACXX_s_5_rg.sorted.bam	52.7	1.9	0.15	58cfa831e4b0c9d6adf6cc92	TCGA-EJ-5510-01A-01D-1572_130308_SN590_0219_BC1UVPACXX_s_5_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-EJ-5510-01A	4A3D9EFE-F24E-4135-8A70-E202651E7A81	Primary Tumor	Illumina HiSeq	95ce00b3-cfc9-4400-ab07-de043b39cccf	Prostate	48	3EAE6B68-D333-4B36-9E70-D2BED19C1DFA	495CB006-3042-4F8A-9AFA-9C10415DBB26	TCGA-EJ-5510-01A-01D-1572-02	HG19_Broad_variant	TCGA-EJ-5510	TCGA-PRAD	NA	s3603	Harvard Medical School	University of Pittsburgh	United States	NO	T2c	N0	Prostate Adenocarcinoma Acinar Type	Not available	1572-02	TRUE
13722.58cfa832e4b0c9d6adf6ceda	58cfa832e4b0c9d6adf6ceda	TCGA-EJ-5505-01A-01D-1572_130315_SN590_0220_BD1WFMACXX_s_3_rg.sorted.filtered.	WGS	TCGA-EJ-5505-01A-01D-1572_130315_SN590_0220_BD1WFMACXX_s_3_rg.sorted	TCGA-EJ-5505-01A-01D-1572_130315_SN590_0220_BD1WFMACXX_s_3_rg.sorted.bam	164.7	1.9	0.14	58cfa832e4b0c9d6adf6ceda	TCGA-EJ-5505-01A-01D-1572_130315_SN590_0220_BD1WFMACXX_s_3_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-EJ-5505-01A	1EA3B879-5451-49FB-B930-16E9B5627F18	Primary Tumor	Illumina HiSeq	156ad547-dfb8-48c9-88b9-6842c81fead1	Prostate	57	A31147E1-4A52-4233-BC27-B0DFA6708DC6	3AB7712C-40E4-4752-AC1D-0CB9D7345413	TCGA-EJ-5505-01A-01D-1572-02	HG19_Broad_variant	TCGA-EJ-5505	TCGA-PRAD	NA	s3605	Harvard Medical School	University of Pittsburgh	United States	NO	T2c	N0	Prostate Adenocarcinoma Acinar Type	Not available	1572-02	TRUE
13722.58cfa832e4b0c9d6adf6cedd	58cfa832e4b0c9d6adf6cedd	TCGA-EJ-5508-01A-02D-1572_130308_SN590_0219_BC1UVPACXX_s_1_rg.sorted.filtered.	WGS	TCGA-EJ-5508-01A-02D-1572_130308_SN590_0219_BC1UVPACXX_s_1_rg.sorted	TCGA-EJ-5508-01A-02D-1572_130308_SN590_0219_BC1UVPACXX_s_1_rg.sorted.bam	256.7	1.9	0.15	58cfa832e4b0c9d6adf6cedd	TCGA-EJ-5508-01A-02D-1572_130308_SN590_0219_BC1UVPACXX_s_1_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Prostate Adenocarcinoma	Aligned reads	TCGA-EJ-5508-01A	BD18DD01-D894-4BDD-9CE2-E25705A52A57	Primary Tumor	Illumina HiSeq	69098ac9-e4d2-44cd-ae04-e179d90a749e	Prostate	65	E3969BF5-B0CC-49E3-B8CB-3D9E98F1676D	706963B3-03D9-4990-AE75-09F8781D79B7	TCGA-EJ-5508-01A-02D-1572-02	HG19_Broad_variant	TCGA-EJ-5508	TCGA-PRAD	NA	s3784	Harvard Medical School	University of Pittsburgh	United States	NO	T3a	N0	Prostate Adenocarcinoma Acinar Type	Not available	1572-02	TRUE
13722.58cfa832e4b0c9d6adf6d0cc	58cfa832e4b0c9d6adf6d0cc	TCGA-IG-A3QL-01A-11D-A248_121212_SN1120_0205_AC1F18ACXX_s_7_rg.sorted.filtered.	WGS	TCGA-IG-A3QL-01A-11D-A248_121212_SN1120_0205_AC1F18ACXX_s_7_rg.sorted	TCGA-IG-A3QL-01A-11D-A248_121212_SN1120_0205_AC1F18ACXX_s_7_rg.sorted.bam	27.52	NA	0.15	58cfa832e4b0c9d6adf6d0cc	TCGA-IG-A3QL-01A-11D-A248_121212_SN1120_0205_AC1F18ACXX_s_7_rg.sorted.bam	Alive	MALE	WHITE	NOT HISPANIC OR LATINO	Esophageal Carcinoma	Aligned reads	TCGA-IG-A3QL-01A	0AC08ECF-4D70-48A4-9DFD-F44032551CB9	Primary Tumor	Illumina HiSeq	da10bdbe-12f7-41ed-b836-1689589d7ba2	Esophagus	54	D571A2B3-892B-46C4-883C-FDED4980492F	A48A75A1-B82B-4F4A-A04F-DFF6B1E801F1	TCGA-IG-A3QL-01A-11D-A248-26	HG19_Broad_variant	TCGA-IG-A3QL	TCGA-ESCA	NA	s1824	MD Anderson - Institute for Applied Cancer Science	Asterand	Russia	NO	T2	N0	Not available	Stage IIA	A248-26	TRUE
13722.58cfa83ce4b0c9d6adf73090	58cfa83ce4b0c9d6adf73090	f6f0bc109f78a22318fcd55e02cd9e0e.filtered.	WGS	f6f0bc109f78a22318fcd55e02cd9e0e	f6f0bc109f78a22318fcd55e02cd9e0e.bam	54.22	1.93	0.08	58cfa83ce4b0c9d6adf73090	f6f0bc109f78a22318fcd55e02cd9e0e.bam	Alive	FEMALE	WHITE	Not available	Uterine Corpus Endometrial Carcinoma	Aligned reads	TCGA-A5-A0G9-01A	45D58088-D3F4-4EB0-B75C-BCB98C0981DC	Primary Tumor	Illumina HiSeq	5394f784-0e1a-4fe2-82e6-a4ba4d7f95b4	Uterus	79	117A5B33-42C5-4A52-BABE-D9712F3E7472	EAE45FBE-9F7D-4F59-A0A9-1F0F0D69AFC4	TCGA-A5-A0G9-01A-11D-A066-09	GRCh37-lite	TCGA-A5-A0G9	TCGA-UCEC	NA	s4575	Washington University School of Medicine	Cedars Sinai	None	NO	Not available	Not available	Endometrioid endometrial adenocarcinoma	Not available	A066-09	TRUE
